PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fingrova, Z; Ambroz, D; Jansa, P; Kuchar, J; Lindner, J; Kunstyr, J; Aschermann, M; Linhart, A; Havranek, S				Fingrova, Zdenka; Ambroz, David; Jansa, Pavel; Kuchar, Jan; Lindner, Jaroslav; Kunstyr, Jan; Aschermann, Michael; Linhart, Ales; Havranek, Stepan			The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; EUROPEAN-SOCIETY; TASK-FORCE; GUIDELINES; ARRHYTHMIAS; MANAGEMENT; DIAGNOSIS; RELEVANCE	Purpose Patients with pulmonary hypertension (PH) frequently suffer from supraventricular tachycardias (SVT). The main purpose of our study was to identify the cumulative incidence of SVT in patients with different etiologies of PH. The secondary objective was to analyse the clinical impact of SVT. Methods We retrospectively studied the prevalence of SVT and the clinical outcome in 755 patients (41% males; 60 15 years; mean follow-up 3.8 2.8 years) with PH of different etiologies. The prevalence of SVT was analysed separately in isolated pre-capillary PH (Ipc-PH) and in patients with combined post- and pre-capillary PH (Cpc-PH). Results The prevalence of SVT in the Ipc-PH group (n = 641) was 25% (n = 162). The most prevalent arrhythmias were atrial fibrillation followed by a typical atrial flutter (17% and 4.4% of all Icp-PH patients). An excessive prevalence of SVT was found in patients with pulmonary arterial hypertension associated with congenital heart disease (35%, p = 0.01). Out of the overall study population, Cpc-PH was present in 114 (15%) patients. Patients with Cpc-PH manifested a higher prevalence of SVT than subjects with Ipc-PH (58; 51% vs. 162; 25%; p <0.0001) and were more likely to have persistent or permanent atrial fibrillation (38; 29% vs. 61; 10%; p <0.0001). Parameters significantly associated with mortality in a multivariate analysis included age, male gender, functional exercise capacity and right atrial diameter (p < 0.05). Neither diagnosis of SVT nor type of arrhythmia predicted mortality. Conclusions The study detected a significant prevalence of SVT in the population of PH of different origins. Different spectrum and prevalence of arrhythmia might be expected in different etiologies of PH. Patients with an elevated post-capillary pressure showed a higher arrhythmia prevalence, predominantly due to an excessive number of atrial fibrillations. The diagnosis of SVT was not associated with mortality.	[Fingrova, Zdenka; Ambroz, David; Jansa, Pavel; Kuchar, Jan; Aschermann, Michael; Linhart, Ales; Havranek, Stepan] Charles Univ Prague, Gen Univ Hosp, Fac Med 1, Dept Med 2,Dept Cardiovasc Med, Prague, Czech Republic; [Kuchar, Jan] Reg Hosp Tabor, Tabor, Czech Republic; [Lindner, Jaroslav] Gen Univ Hosp, Charles Univ, Fac Med 1, Dept Surg 2,Dept Cardiovasc Surg, Prague, Czech Republic; [Kunstyr, Jan] Charles Univ Prague, Gen Univ Hosp, Dept Anaesthesiol Resuscitat & Intens Med, Fac Med 1, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Charles University Prague; General University Hospital Prague; Charles University Prague; General University Hospital Prague	Havranek, S (corresponding author), Charles Univ Prague, Gen Univ Hosp, Fac Med 1, Dept Med 2,Dept Cardiovasc Med, Prague, Czech Republic.	stepan.havranek@lf1.cuni.cz	Havranek, Stepan/G-6768-2017; Fingrova, Zdenka/G-6776-2017; Jansa, Pavel/O-2302-2017; Lindner, Jaroslav/I-4599-2017; Linhart, Ales/O-2375-2017	Havranek, Stepan/0000-0001-9694-0344; Fingrova, Zdenka/0000-0002-1259-6644; Jansa, Pavel/0000-0002-3711-7064; Lindner, Jaroslav/0000-0001-8432-4069; Linhart, Ales/0000-0002-3372-7850	Ministry of Health of the Czech Republic [NV18-02-00027]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	The study was supported by Ministry of Health of the Czech Republic, grant nr. NV18-02-00027.	Ausma J, 1997, CIRCULATION, V96, P3157, DOI 10.1161/01.CIR.96.9.3157; Borlaug BA, 2010, CIRC-HEART FAIL, V3, P588, DOI 10.1161/CIRCHEARTFAILURE.109.930701; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Cannillo M, 2015, AM J CARDIOL, V116, P1883, DOI 10.1016/j.amjcard.2015.09.039; Cha YM, 2004, CIRCULATION, V109, P2839, DOI 10.1161/01.CIR.0000132470.78896.A8; Crijns HJGM, 2000, EUR HEART J, V21, P1238, DOI 10.1053/euhj.1999.2107; D'Alto M, 2017, CHEST, V151, P119, DOI 10.1016/j.chest.2016.08.1439; Daliento L, 1998, EUR HEART J, V19, P1845, DOI 10.1053/euhj.1998.1046; Fingrova Z, 2019, BMC CARDIOVASC DISOR, V19, DOI 10.1186/s12872-019-1142-z; Folino AF, 2003, LUNG, V181, P321, DOI 10.1007/s00408-003-1034-x; Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176; Galie N, 2004, EUR HEART J, V25, P2243, DOI 10.1016/j.ehj.2004.09.014; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; GILLETTE PC, 1985, JAMA-J AM MED ASSOC, V253, P391, DOI 10.1001/jama.253.3.391; Havranek S, 2020, EUR HEART J SUPPL, V22, pF30, DOI 10.1093/eurheartj/suaa096; Hsu LF, 2004, NEW ENGL J MED, V351, P2373, DOI 10.1056/NEJMoa041018; Lazzerini PE, 2014, AUTOIMMUN REV, V13, P936, DOI 10.1016/j.autrev.2014.05.007; Maisel WH, 2003, AM J CARDIOL, V91, p2D, DOI 10.1016/S0002-9149(02)03373-8; Medi C, 2012, J CARDIOVASC ELECTR, V23, P614, DOI 10.1111/j.1540-8167.2011.02255.x; MIDDLEKAUFF HR, 1991, CIRCULATION, V84, P40, DOI 10.1161/01.CIR.84.1.40; MORILLO CA, 1995, CIRCULATION, V91, P1588, DOI 10.1161/01.CIR.91.5.1588; Olsson KM, 2013, INT J CARDIOL, V167, P2300, DOI 10.1016/j.ijcard.2012.06.024; Opitz CF, 2016, J AM COLL CARDIOL, V68, P368, DOI 10.1016/j.jacc.2016.05.047; Page RL, 2016, HEART RHYTHM, V13, pE136, DOI 10.1016/j.hrthm.2015.09.019; Pietra GG, 2004, J AM COLL CARDIOL, V43, p25S, DOI 10.1016/j.jacc.2004.02.033; Rich JD, 2013, INT J CARDIOL, V167, P669, DOI 10.1016/j.ijcard.2012.03.071; Roh SY, 2011, CIRC-ARRHYTHMIA ELEC, V4, P815, DOI 10.1161/CIRCEP.110.960435; Rottlaender D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033902; Ruiz-Cano MJ, 2011, INT J CARDIOL, V146, P105, DOI 10.1016/j.ijcard.2010.09.065; Schrier RW, 2008, CLIN J AM SOC NEPHRO, V3, P1232, DOI 10.2215/CJN.01960408; Simonneau G, 2004, J AM COLL CARDIOL, V43, p5S, DOI 10.1016/j.jacc.2004.02.037; Smith B, 2018, PULM CIRC, V8, DOI 10.1177/2045894018790316; SPACH MS, 1994, J CARDIOVASC ELECTR, V5, P182, DOI 10.1111/j.1540-8167.1994.tb01157.x; Sun PY, 2012, CHEST, V141, P374, DOI 10.1378/chest.10-3331; Tongers J, 2007, AM HEART J, V153, P127, DOI 10.1016/j.ahj.2006.09.008; Wen L, 2014, AM J CARDIOL, V114, P1420, DOI 10.1016/j.amjcard.2014.07.079	37	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245752	10.1371/journal.pone.0245752	http://dx.doi.org/10.1371/journal.pone.0245752			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471824	Green Published, gold			2022-12-26	WOS:000639428800069
J	Matsuhashi, S; Asai, M; Fukasawa, K				Matsuhashi, Saeko; Asai, Motoaki; Fukasawa, Keita			Estimations and projections of Avena fatua dynamics under multiple management scenarios in crop fields using simplified longitudinal monitoring	PLOS ONE			English	Article							SUSTAINABLE WEED MANAGEMENT; BARLEY HORDEUM-VULGARE; POPULATION-DYNAMICS; HERBICIDES; MODEL; SEED; EMERGENCE	Integrated weed management (IWM) is currently the most appropriate and effective method of agricultural weed control. To determine the most effective strategy, it is necessary to compare the effects of different control options and their rotation. Avena fatua (common wild oat) is one of the most common and economically threatening grass weed species of cereal crops worldwide. To examine the effects of non-chemical weed management options (farmland use, delayed sowing, and summer irrigation) on control of A. fatua, we recorded coverage levels and field conditions in 41 sites during the spring growing season of winter wheat for about 10 years. A transition matrix model was then constructed to project coverage levels of A. fatua under each management option using ordinal logistic regression. The results showed that farmland use had a remarkable effect on coverage; notably, planting of paddy rice and vegetables, which respectively eliminated the effect of coverage in the previous year and facilitated rapid convergence of coverage to 0%. Thus, although 90% of fields under continuous wheat cultivation were found to be at risk of A. fatua colonization, the risk was reduced to almost 0% with rotation of effective farmland use. As summer irrigation was also effective, more than 50% of wheat fields with the option continuously converged to no risk for A. fatua colonization. When the different management cycles were repeated, the effects were observed within 3 years, with a steady state reached in less than 10 years. Overall, these results suggest that simplified monitoring data could help decision-making on IWM, thereby helping to improve the efficiency of agricultural production.	[Matsuhashi, Saeko] Natl Agr & Food Res Org, CARC, Tsukuba, Japan; [Asai, Motoaki] Natl Agr & Food Res Org, TARC, Fukushima, Japan; [Fukasawa, Keita] Natl Inst Environm Studies, Tsukuba, Japan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; National Institute for Environmental Studies - Japan	Matsuhashi, S (corresponding author), Natl Agr & Food Res Org, CARC, Tsukuba, Japan.	sae.matsuhashi@affrc.go.jp		Matsuhashi, Saeko/0000-0002-8510-3599	Ministry of Agriculture, Forestry and Fisheries, Japan a JSPS [JPJ0079666];  [19K20493]	Ministry of Agriculture, Forestry and Fisheries, Japan a JSPS; 	a grant from the commissioned project study (JPJ0079666) from the Ministry of Agriculture, Forestry and Fisheries, Japan a JSPS Grant-in-Aid for Early-Career Scientists (19K20493) awarded to S. Matsuhashi.	Agresti A, 2002, CATEGORICAL DATA ANA, P710, DOI [10.1002/0471249688, DOI 10.1002/0471249688]; Agricultural Production Bureau Ministry of Agriculture Forestry and Fisheries of Japan, 2013, SURV OCC DAM WEEDS W; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson RL, 2005, AGRON J, V97, P1579, DOI 10.2134/agronj2005.0194; Asai M., 2005, Journal of Weed Science and Technology, V50, P73, DOI 10.3719/weed.50.73; Asai M., 2020, Journal of Weed Science and Technology, V65, P103; Asai M., 2010, Journal of Weed Science and Technology, V55, P158, DOI 10.3719/weed.55.158; Bajwa AA, 2017, ENVIRON SCI POLLUT R, V24, P19465, DOI 10.1007/s11356-017-9810-y; Beckie HJ, 2012, CAN J PLANT SCI, V92, P1329, DOI 10.4141/CJPS2012-005; Blackshaw R.E., 2002, P INT C ENV SUST AGR, P305, DOI DOI 10.2134/CS2016-49-2-8; Blackshaw RE, 2005, WEED TECHNOL, V19, P190, DOI 10.1614/WT-04-128R; Blanco AM, 2014, ECOL MODEL, V272, P293, DOI 10.1016/j.ecolmodel.2013.10.013; BROWN D. A., 1953, Weeds, V2, P295, DOI 10.2307/4040108; Buhler DD, 2002, WEED SCI, V50, P273, DOI 10.1614/0043-1745(2002)050[0273:AIAAOF]2.0.CO;2; Burns EE, 2018, WEED RES, V58, P357, DOI 10.1111/wre.12315; CABI (Centre for Agruculture and Bioscience International), 2020, INVASIVE SPECIES COM; Chikowo R, 2009, AGR ECOSYST ENVIRON, V132, P237, DOI 10.1016/j.agee.2009.04.009; Christensen R.H.B., 2019, ORDINAL REGRESSION M, P12, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/PACKAGE=0RDINAL/; Florax RJGM, 2005, EUR REV AGRIC ECON, V32, P441, DOI 10.1093/erae/jbi025; Freckleton RP, 2018, PEST MANAG SCI, V74, P2287, DOI 10.1002/ps.4759; Freckleton RP, 2011, AM NAT, V177, P1, DOI 10.1086/657621; Ghasemaghaei Maryam, 2019, GLIA, V104, P69, DOI [10.1016/j.jbusres.2019.07.006, 10.1016/j.ijheh.2019.05.004, DOI https://doi.org/10.5014/ajot.2019.73S201]; Harker KN, 2016, WEED SCI, V64, P170, DOI 10.1614/WS-D-15-00133.1; Harker KN, 2013, WEED TECHNOL, V27, P1, DOI 10.1614/WT-D-12-00109.1; Harker KN, 2009, WEED SCI, V57, P326, DOI 10.1614/WS-08-165.1; Heap I, 2014, PEST MANAG SCI, V70, P1306, DOI 10.1002/ps.3696; Jabran K, 2017, ADV AGRON, V145, P97, DOI 10.1016/bs.agron.2017.05.002; Kida Y, 2006, J WEED SCI TECHNOL, V51, P87; KIRKLAND KJ, 1993, J SUSTAIN AGR, V3, P95, DOI 10.1300/J064v03n03_07; Liebman M, 2016, ECOL APPL, V26, P1352, DOI 10.1002/15-0995; Mace K, 2007, AGR SYST, V93, P115, DOI 10.1016/j.agsy.2006.04.007; MARTIN RJ, 1993, AUST J EXP AGR, V33, P159, DOI 10.1071/EA9930159; Mertens SK, 2002, ECOL APPL, V12, P1125, DOI 10.1890/1051-0761(2002)012[1125:WPACRE]2.0.CO;2; Mickelson JA, 2006, WEED SCI, V54, P255; Moss S, 2019, PEST MANAG SCI, V75, P1205, DOI 10.1002/ps.5267; Nakatani K., 2015, Journal of Weed Science and Technology, V60, P158, DOI 10.3719/weed.60.158; Neve P, 2018, WEED RES, V58, P250, DOI 10.1111/wre.12304; O'Donovan JT, 2013, WEED SCI, V61, P328, DOI 10.1614/WS-D-12-00168.1; O'Donovan JT, 2000, WEED TECHNOL, V14, P624, DOI 10.1614/0890-037X(2000)014[0624:WOAFII]2.0.CO;2; Ohno H., 2016, CLIMATE BIOSPHERE, V16, P71, DOI 10.2480/cib.J-16-028; Page ER, 2006, WEED SCI, V54, P838, DOI 10.1614/WS-05-142R1.1; R Core Team, 2018, R LANG ENV STAT COMP; SATORRE EH, 1992, WEED RES, V32, P45, DOI 10.1111/j.1365-3180.1992.tb01861.x; Shibayama H., 2000, Journal of Weed Science and Technology, V45, P207, DOI 10.3719/weed.45.207; Taylor CM, 2004, J APPL ECOL, V41, P1049, DOI 10.1111/j.0021-8901.2004.00979.x	45	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245217	10.1371/journal.pone.0245217	http://dx.doi.org/10.1371/journal.pone.0245217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449954	gold, Green Published			2022-12-26	WOS:000609991600014
J	Vidal, LS; Ayala, R; Stan, GB; Ledesma-Amaro, R				Selles Vidal, Lara; Ayala, Rafael; Stan, Guy-Bart; Ledesma-Amaro, Rodrigo			rfaRm: An R client-side interface to facilitate the analysis of the Rfam database of RNA families	PLOS ONE			English	Article								rfaRm is an R package providing a client-side interface for the Rfam database of non-coding RNA and other structured RNA elements. The package facilitates the search of the Rfam database by keywords or sequences, as well as the retrieval of all available information about specific Rfam families, such as member sequences, multiple sequence alignments, secondary structures and covariance models. By providing such programmatic access to the Rfam database, rfaRm enables genomic workflows to incorporate information about non-coding RNA, whose potential cannot be fully exploited just through interactive access to the database. The features of rfaRm are demonstrated by using it to analyze the SARS-CoV-2 genome as an example case.	[Selles Vidal, Lara; Stan, Guy-Bart; Ledesma-Amaro, Rodrigo] Imperial Coll London, Fac Engn, Dept Bioengn, London, England; [Ayala, Rafael] Imperial Coll London, Fac Med, Dept Infect Dis, London, England	Imperial College London; Imperial College London	Vidal, LS; Stan, GB; Ledesma-Amaro, R (corresponding author), Imperial Coll London, Fac Engn, Dept Bioengn, London, England.	lara.selles12@imperial.ac.uk; g.stan@imperial.ac.uk; r.ledesma-amaro@imperial.ac.uk	Ayala, Rafael/AAE-2073-2022; Ledesma-Amaro, Rodrigo/A-7545-2017	Ayala, Rafael/0000-0002-9332-4623; Selles Vidal, Lara/0000-0003-2537-6824; Ledesma-Amaro, Rodrigo/0000-0003-2631-5898	ERA CoBioTech UKRI/BBSRC project SyCoLim [BB/T011408/1]; Biotechnology and Biological Sciences Research Council (BBSRC); EPSRC Fellowship for Growth, Engineering and Phyisical Sciences Research Council [EP/M002187/1]; BBSRC [BB/T011408/1] Funding Source: UKRI; EPSRC [EP/M002187/1] Funding Source: UKRI	ERA CoBioTech UKRI/BBSRC project SyCoLim; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC Fellowship for Growth, Engineering and Phyisical Sciences Research Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	RLA, GBS and LSV acknowledge the ERA CoBioTech UKRI/BBSRC project SyCoLim (BB/T011408/1), Biotechnology and Biological Sciences Research Council (BBSRC) (https://bbsrc.ukri.org/).GBS acknowledges the EPSRC Fellowship for Growth (EP/M002187/1), Engineering and Phyisical Sciences Research Council (https://epsrc.ukri.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Kalvari I, 2018, NUCLEIC ACIDS RES, V46, pD335, DOI 10.1093/nar/gkx1038; Lai D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks241; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Ooms J, 2020, **DATA OBJECT**; Ooms J, 2018, **DATA OBJECT**; Page` s H., 2019, BIOSTRINGS EFFICIENT; Wang LG, 2020, MOL BIOL EVOL, V37, P599, DOI 10.1093/molbev/msz240	10	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245280	10.1371/journal.pone.0245280	http://dx.doi.org/10.1371/journal.pone.0245280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449976	Green Published, gold			2022-12-26	WOS:000609991600009
J	Zhao, NQ; Tan, HW; Wang, L; Han, L; Cheng, YL; Feng, Y; Li, T; Liu, XL				Zhao, Naiqian; Tan, Huiwen; Wang, Li; Han, Le; Cheng, Yanli; Feng, Ying; Li, Ting; Liu, Xiaoling			Palmitate induces fat accumulation via repressing FoxO1-mediated ATGL-dependent lipolysis in HepG2 hepatocytes	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; SWITCH GENE 2; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; ADIPOSE LIPOLYSIS; FOXO1; LIVER; TRANSCRIPTION; EXPRESSION; OBESITY	Obesity is closely associated with non-alcoholic fatty liver disease (NAFLD), and elevated serum palmitate is the link between obesity and excessive hepatic lipid accumulation. Forkhead box O-1 (FoxO1) is one of the FoxO family members of transcription factors and can stimulate adipose triglyceride lipase (ATGL) and suppress its inhibitor G0/G1 switch gene 2 (G0S2) expression in the liver. However, previous researches have also shown conflicting results regarding the role of FoxO1 in hepatic lipid accumulation. We therefore examined the role of FoxO1 as a downstream suppressor to palmitate-stimulated hepatic steatosis. Palmitate significantly promoted lipid accumulation but inhibited lipid decomposition in human HepG2 hepatoma cells. Palmitate also significantly reduced FoxO1, ATGL and its activator comparative gene identification-58 (CGI-58) expression but increased peroxisome proliferator-activated receptor gamma (PPAR gamma) and its target gene G0S2 expression. FoxO1 overexpression significantly increased palmitate-inhibited ATGL and CGI-58 expression but reduced palmitate-stimulated PPAR gamma and its target gene G0S2 expression. FoxO1 overexpression also inhibited lipid accumulation and promoted lipolysis in palmitate-treated hepatocytes. Overall, these results indicate that FoxO1-mediated ATGL-dependent lipolysis may be an effective molecular mechanism in protecting hepatocytes from palmitate-induced fat accumulation.	[Zhao, Naiqian; Wang, Li; Han, Le; Cheng, Yanli; Feng, Ying; Li, Ting; Liu, Xiaoling] Shanxi Med Univ, Dept Gerontol, Hosp 2, Taiyuan, Shanxi, Peoples R China; [Tan, Huiwen] Sichuan Univ, Dept Endocrinol & Metab, West China Hosp, Chengdu, Sichuan, Peoples R China	Shanxi Medical University; Sichuan University	Zhao, NQ (corresponding author), Shanxi Med Univ, Dept Gerontol, Hosp 2, Taiyuan, Shanxi, Peoples R China.	m18235150464@163.com	Liu, Xiaoling/HGD-3566-2022	Zhao, Naiqian/0000-0002-7641-167X	Key Research and Development (R&D) Projects of Shanxi Province [201803D31131]; Key Provincial Science and Technology Project of Sichuan [2016SZ0058]; Scientific Research Foundation for the Returned Overseas Chinese Scholars of Shanxi Province [200372]; Science Foundation of Shanxi Province [041072-2]	Key Research and Development (R&D) Projects of Shanxi Province; Key Provincial Science and Technology Project of Sichuan; Scientific Research Foundation for the Returned Overseas Chinese Scholars of Shanxi Province(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Science Foundation of Shanxi Province	This research was supported by Key Research and Development (R&D) Projects of Shanxi Province (#201803D31131); the Key Provincial Science and Technology Project of Sichuan (#2016SZ0058); Scientific Research Foundation for the Returned Overseas Chinese Scholars of Shanxi Province (#200372); the Science Foundation of Shanxi Province (#041072-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Chakrabarti P, 2009, J BIOL CHEM, V284, P13296, DOI 10.1074/jbc.C800241200; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; Cornaciu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026349; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Egnatchik RA, 2014, METABOLISM, V63, P283, DOI 10.1016/j.metabol.2013.10.009; Fan WQ, 2009, J BIOL CHEM, V284, P12188, DOI 10.1074/jbc.M808915200; Fruci B, 2013, INT J MOL SCI, V14, P22933, DOI 10.3390/ijms141122933; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Gao L, 2016, J HEPATOL, V65, P125, DOI 10.1016/j.jhep.2016.03.006; Jaeger D, 2015, J HEPATOL, V63, P437, DOI 10.1016/j.jhep.2015.02.035; Kamikubo R, 2016, MOL NUTR FOOD RES, V60, P2228, DOI 10.1002/mnfr.201600197; Kim JJ, 2009, DIABETES, V58, P1275, DOI 10.2337/db08-1001; Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034; Lambertucci RH, 2008, J CELL PHYSIOL, V216, P796, DOI 10.1002/jcp.21463; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Miao HM, 2015, CLIN SCI, V128, P493, DOI 10.1042/CS20140414; Mittendorfer B, 2009, OBESITY, V17, P1872, DOI 10.1038/oby.2009.224; Ng M, 2014, LANCET, V384, P746; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Park JY, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0709-1; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Schroeder-Gloeckler JM, 2007, J BIOL CHEM, V282, P15717, DOI 10.1074/jbc.M701329200; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Song ZY, 2007, BASIC CLIN PHARMACOL, V101, P262, DOI 10.1111/j.1742-7843.2007.00116.x; Tikhanovich I, 2013, J GASTROEN HEPATOL, V28, P125, DOI 10.1111/jgh.12021; Wang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072315; Xi Y, 2016, BIOCHEM BIOPH RES CO, V472, P617, DOI 10.1016/j.bbrc.2016.03.015; Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhang W, 2016, CELL REP, V15, P349, DOI 10.1016/j.celrep.2016.03.021; Zhang XD, 2014, DIABETES, V63, P934, DOI 10.2337/db13-1422	38	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0243938	10.1371/journal.pone.0243938	http://dx.doi.org/10.1371/journal.pone.0243938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449950	Green Published, gold			2022-12-26	WOS:000609991600010
J	Lee, C; Hong, WJ; Jung, KH; Hong, HC; Kim, DY; Ok, HC; Choi, MS; Park, SK; Kim, J; Koh, HJ				Lee, Choonseok; Hong, Woo-Jong; Jung, Ki-Hong; Hong, Ha-Cheol; Kim, Dool-Yi; Ok, Hyun-Choong; Choi, Man-Soo; Park, Soo-Kwon; Kim, Jaehyun; Koh, Hee-Jong			Arachis hypogaea resveratrol synthase 3 alters the expression pattern of UDP-glycosyltransferase genes in developing rice seeds	PLOS ONE			English	Article							STILBENE SYNTHASE GENE; FUNCTIONAL-CHARACTERIZATION; RESVERATROL SYNTHASE; FLAVONOID GLUCOSYLTRANSFERASES; CATALYTIC-PROPERTIES; VITIS-VINIFERA; ANTIOXIDANT; METABOLISM; GRAPEVINE; PICEID	The resveratrol-producing rice (Oryza sativa L.) inbred lines, Iksan 515 (I.515) and Iksan 526 (I.526), developed by the expression of the groundnut (Arachis hypogaea) resveratrol synthase 3 (AhRS3) gene in the japonica rice cultivar Dongjin, accumulated both resveratrol and its glucoside, piceid, in seeds. Here, we investigated the effect of the AhRS3 transgene on the expression of endogenous piceid biosynthesis genes (UGTs) in the developing seeds of the resveratrol-producing rice inbred lines. Ultra-performance liquid chromatography (UPLC) analysis revealed that I.526 accumulates significantly higher resveratrol and piceid in seeds than those in I.515 seeds and, in I.526 seeds, the biosynthesis of resveratrol and piceid reached peak levels at 41 days after heading (DAH) and 20 DAH, respectively. Furthermore, RNA-seq analysis showed that the expression patterns of UGT genes differed significantly between the 20 DAH seeds of I.526 and those of Dongjin. Quantitative real-time PCR (RT-qPCR) analyses confirmed the data from RNA-seq analysis in seeds of Dongjin, I.515 and I.526, respectively, at 9 DAH, and in seeds of Dongjin and I.526, respectively, at 20 DAH. A total of 245 UGTs, classified into 31 UGT families, showed differential expression between Dongjin and I.526 seeds at 20 DAH. Of these, 43 UGTs showed more than 2-fold higher expression in I.526 seeds than in Dongjin seeds. In addition, the expression of resveratrol biosynthesis genes (PAL, C4H and 4CL) was also differentially expressed between Dongjin and I.526 developing seeds. Collectively, these data suggest that AhRS3 altered the expression pattern of UGT genes, and PAL, C4H and 4CL in developing rice seeds.	[Lee, Choonseok; Koh, Hee-Jong] Seoul Natl Univ, Res Inst Agr & Life Sci & Plant Genom, Dept Plant Sci, Seoul, South Korea; [Lee, Choonseok; Koh, Hee-Jong] Seoul Natl Univ, Breeding Inst, Seoul, South Korea; [Hong, Woo-Jong; Jung, Ki-Hong] Kyung Hee Univ, Grad Sch Biotechnol, Yongin, Gyeonggi Do, South Korea; [Hong, Ha-Cheol] Natl Inst Agr Sci, Wonju, Jeollabuk Do, South Korea; [Kim, Dool-Yi; Choi, Man-Soo; Kim, Jaehyun] Natl Inst Crop Sci, Wonju, Jeollabuk Do, South Korea; [Ok, Hyun-Choong; Park, Soo-Kwon] Rural Dev Adm, Jeonju, Jeollabuk Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University; National Institute of Agricultural Sciences; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; Rural Development Administration (RDA), Republic of Korea	Koh, HJ (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci & Plant Genom, Dept Plant Sci, Seoul, South Korea.; Koh, HJ (corresponding author), Seoul Natl Univ, Breeding Inst, Seoul, South Korea.; Kim, J (corresponding author), Natl Inst Crop Sci, Wonju, Jeollabuk Do, South Korea.	kjh2022@korea.kr; heejkoh@snu.ac.kr	Jung, Ki Hong/L-5570-2019	Jung, Ki Hong/0000-0003-0427-5901; Hong, Woo-Jong/0000-0001-7240-6171	Next-Generation BioGreen 21 Program, Rural Development Administration (RDA), Republic of Korea [PJ01118801, PJ013165]	Next-Generation BioGreen 21 Program, Rural Development Administration (RDA), Republic of Korea	This research was funded by the Next-Generation BioGreen 21 Program, Rural Development Administration (RDA), Republic of Korea, PJ01118801 and PJ013165. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anterola AM, 2002, PHYTOCHEMISTRY, V61, P221, DOI 10.1016/S0031-9422(02)00211-X; APPERT C, 1994, EUR J BIOCHEM, V225, P491, DOI 10.1111/j.1432-1033.1994.00491.x; Baek SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057930; Bock KW, 2016, BIOCHEM PHARMACOL, V99, P11, DOI 10.1016/j.bcp.2015.10.001; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; Chen L, 2001, J CHROMATOGR A, V907, P343, DOI 10.1016/S0021-9673(00)00960-2; Chen LJ, 2015, PLANT CELL REP, V34, P885, DOI 10.1007/s00299-015-1751-7; Cui LL, 2016, J EXP BOT, V67, P2285, DOI 10.1093/jxb/erw053; D'Introno A, 2009, PLANT BIOTECHNOL J, V7, P422, DOI 10.1111/j.1467-7652.2009.00409.x; Delaunois B, 2009, PLANT BIOTECHNOL J, V7, P2, DOI 10.1111/j.1467-7652.2008.00377.x; Duan D, 2015, J EXP BOT, V66, P3243, DOI 10.1093/jxb/erv137; Gachon CMM, 2005, TRENDS PLANT SCI, V10, P542, DOI 10.1016/j.tplants.2005.09.007; Gao YG, 2016, MOL MED REP, V14, P5481, DOI 10.3892/mmr.2016.5936; Giorcelli A, 2004, TRANSGENIC RES, V13, P203, DOI 10.1023/B:TRAG.0000034658.64990.7f; Giovinazzo G, 2005, PLANT BIOTECHNOL J, V3, P57, DOI 10.1111/j.1467-7652.2004.00099.x; Guo DD, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1962-0; Guo DD, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01409; Hall D, 2007, PLANT J, V49, P579, DOI 10.1111/j.1365-313X.2006.02987.x; HILLIS WE, 1966, PHYTOCHEMISTRY, V5, P1075, DOI 10.1016/S0031-9422(00)86101-4; HILLIS WE, 1962, BIOCHEM J, V82, P435, DOI 10.1042/bj0820435; Hung LM, 2000, CARDIOVASC RES, V47, P549, DOI 10.1016/S0008-6363(00)00102-4; Husken A, 2005, THEOR APPL GENET, V111, P1553, DOI 10.1007/s00122-005-0085-1; INGHAM JL, 1976, PHYTOCHEMISTRY, V15, P1791, DOI 10.1016/S0031-9422(00)97494-6; Isayenkova J, 2006, PHYTOCHEMISTRY, V67, P1598, DOI 10.1016/j.phytochem.2006.06.026; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jeandet P, 2021, NAT PROD REP, V38, P1282, DOI 10.1039/d0np00030b; Jeandet P, 2020, BIOTECHNOL ADV, V39, DOI 10.1016/j.biotechadv.2019.107461; Jyske T, 2016, PLANT PHYSIOL, V172, P913, DOI 10.1104/pp.16.00990; Kiselev KV, 2016, PHYTOCHEMISTRY, V131, P57, DOI 10.1016/j.phytochem.2016.08.011; Koja E, 2018, BIOSCI BIOTECH BIOCH, V82, P1790, DOI 10.1080/09168451.2018.1491286; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; LANGCAKE P, 1976, PHYSIOL PLANT PATHOL, V9, P77, DOI 10.1016/0048-4059(76)90077-1; LANZ T, 1990, PLANTA, V181, P169, DOI 10.1007/BF02411534; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu ZY, 2011, PLANT CELL REP, V30, P2027, DOI 10.1007/s00299-011-1110-2; LOZOYA E, 1988, EUR J BIOCHEM, V176, P661, DOI 10.1111/j.1432-1033.1988.tb14328.x; Masada S, 2009, PLANT CELL PHYSIOL, V50, P1401, DOI 10.1093/pcp/pcp088; Meng QH, 2016, FOOD CHEM TOXICOL, V96, P215, DOI 10.1016/j.fct.2016.07.032; Morelli R, 2006, MOL CELL BIOCHEM, V282, P65, DOI 10.1007/s11010-006-1260-7; Nagatomo Y, 2014, PLANT J, V80, P437, DOI 10.1111/tpj.12645; Noguchi A, 2009, PLANT CELL, V21, P1556, DOI 10.1105/tpc.108.063826; Okitsu N, 2018, PLANT CELL PHYSIOL, V59, P2075, DOI 10.1093/pcp/pcy129; Olas B, 2005, BBA-BIOMEMBRANES, V1714, P125, DOI 10.1016/j.bbamem.2005.06.008; Paquette S, 2003, PHYTOCHEMISTRY, V62, P399, DOI 10.1016/S0031-9422(02)00558-7; PEREZ CM, 1975, PLANT PHYSIOL, V56, P579, DOI 10.1104/pp.56.5.579; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pfaffl MW, 2004, A Z QUANTITATIVE PCR, P87; POWELL RG, 1994, PHYTOCHEMISTRY, V35, P335, DOI 10.1016/S0031-9422(00)94759-9; Qin Yang, 2013, Plant Breeding and Biotechnology, V1, P406, DOI 10.9787/PBB.2013.1.4.406; RDA, 2010, MAIN RES ACH DEV PRO; Romero-Perez AI, 2001, J AGR FOOD CHEM, V49, P210, DOI 10.1021/jf000745o; RUPPRICH N, 1978, H-S Z PHYSIOL CHEM, V359, P165; SCHRODER G, 1988, EUR J BIOCHEM, V172, P161, DOI 10.1111/j.1432-1033.1988.tb13868.x; Serafini M, 2000, J NUTR BIOCHEM, V11, P585, DOI 10.1016/S0955-2863(00)00124-8; Szankowski I, 2003, PLANT CELL REP, V22, P141, DOI 10.1007/s00299-003-0668-8; Trapero A, 2012, PLANT PHYSIOL, V159, P1335, DOI 10.1104/pp.112.198069; URBAN P, 1994, EUR J BIOCHEM, V222, P843, DOI 10.1111/j.1432-1033.1994.tb18931.x; Wang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061642; Witte S, 2009, PLANTA, V229, P1135, DOI 10.1007/s00425-009-0902-x; Wu YQ, 2020, J AGR FOOD CHEM, V68, P998, DOI 10.1021/acs.jafc.9b07008; Xu WR, 2019, PLANT CELL ENVIRON, V42, P2979, DOI 10.1111/pce.13600; Zhang MM, 2017, BBA-MOL BASIS DIS, V1863, P1962, DOI 10.1016/j.bbadis.2016.09.003	63	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245446	10.1371/journal.pone.0245446	http://dx.doi.org/10.1371/journal.pone.0245446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444365	gold, Green Published			2022-12-26	WOS:000609988100001
J	Pagabeleguem, S; Toe, AI; Pooda, SH; Dera, KM; Belem, AS; Belem, AMG; Sanou, GMSO; Ira, M; Kabore, BA; Percoma, L; Sidibe, I				Pagabeleguem, Soumaila; Toe, Ange Irenee; Pooda, Sie Hermann; Dera, Kiswendsida Mikhailou; Belem, Abdou Salam; Belem, Adrien Marie Gaston; Ouedraogo Sanou, Gisele Marie Sophie; Ira, Mamadou; Kabore, Benewende Aristide; Percoma, Lassane; Sidibe, Issa			Optimizing the feeding frequency to maximize the production of sterile males in tsetse mass-rearing colonies	PLOS ONE			English	Article							GLOSSINA-MORSITANS-MORSITANS; DIPTERA; REPRODUCTION; FLIES	Tsetse flies are cyclical vectors of trypanosomes, the causative agents of sleeping sickness or Human African Trypanosomosis and nagana or African Animal Trypanosomosis in Sub-Saharan Africa. The Insectarium de Bobo-Dioulasso (IBD) was created and equipped in the frame of Pan African Tsetse and Trypanosomosis Eradication Campaign (PATTEC) with the main goal to provide sterile males for the different eradication programs in West Africa which is already the case with the ongoing eradication program in Senegal. The aim of this study was to identify the best feeding regime in mass-rearing colonies of Glossina palpalis gambiensis to optimize the yield of sterile males. We investigated the mortality and fecundity for various feeding regimes and day alternation (3x: Monday-Wednesday-Friday, 4x: Monday-Wednesday-Friday-Saturday, 4x: Monday-Wednesday-Thursday-Friday and 6x: all days except Sunday) on adult tsetse flies in routine rearing over 60 days after emergence. The day alternation in the 4 blood meals per week (feeding regimes 2 and 3) had no effect on tsetse fly mortality and fecundity. The best feeding regime was the regime of 4 blood meals per week which resulted in higher significant fecundity (PPIF = 2.5; P = 0.003) combined with lower mortality of females (P = 0.0003) than the 3 blood meals per week (PPIF = 2.0) and in similar fecundity (PPIF = 2.6; P = 0.70) and mortality (P = 0.51) than the 6 blood meals per week. This feeding regime was extended to the whole colonies, resulting in an improved yield of sterile males for the ongoing eradication program in Senegal and would be more cost-effective for the implementation of the next-coming sterile insect technique (SIT) programs in West Africa.	[Pagabeleguem, Soumaila; Pooda, Sie Hermann] Univ Dedougou UDDG, Dedougou, Burkina Faso; [Pagabeleguem, Soumaila; Toe, Ange Irenee; Pooda, Sie Hermann; Dera, Kiswendsida Mikhailou; Belem, Abdou Salam; Ouedraogo Sanou, Gisele Marie Sophie; Ira, Mamadou; Kabore, Benewende Aristide; Percoma, Lassane; Sidibe, Issa] Insectarium Bobo Dioulasso Campagne Eradicat mouc, Bobo Dioulasso, Burkina Faso; [Belem, Abdou Salam] Ecole Privee Elevage & Sante Anim EPESA, Bobo Dioulasso, Burkina Faso; [Belem, Adrien Marie Gaston] Univ Nazi Boni UNB, Bobo Dioulasso, Burkina Faso; [Percoma, Lassane] Ecole Lutte Anti Tse tse ELAT, Bobo Dioulasso, Burkina Faso; [Sidibe, Issa] Ctr Int Rech Dev Elevage Zone Subhumide CIRDES, Bobo Dioulasso, Burkina Faso		Pagabeleguem, S (corresponding author), Univ Dedougou UDDG, Dedougou, Burkina Faso.; Pagabeleguem, S (corresponding author), Insectarium Bobo Dioulasso Campagne Eradicat mouc, Bobo Dioulasso, Burkina Faso.	pagasoum@yahoo.fr	Pagabeleguem, Soumaïla/S-3195-2019	Pagabeleguem, Soumaïla/0000-0001-8620-5231	Insectarium de Bobo-Dioulasso -Campagne d'Eradication de la mouche Tse-tseet de la Trypanosomose (IBD-CETT); International Atomic Energy Agency (IAEA) [22660]	Insectarium de Bobo-Dioulasso -Campagne d'Eradication de la mouche Tse-tseet de la Trypanosomose (IBD-CETT); International Atomic Energy Agency (IAEA)(International Atomic Energy Agency)	This work was supported by the Insectarium de Bobo-Dioulasso -Campagne d'Eradication de la mouche Tse-tseet de la Trypanosomose (IBD-CETT; https://www.pattec.bf/) through its operating budget 2018 allocated by the State of Burkina Faso and the International Atomic Energy Agency (IAEA; https://www.iaea.org/) through the Research Contract No. 22660. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], **DATA OBJECT**; Bassene MD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006172; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BAUER B, 1984, REV ELEVAGE MED VET, V37, P9; Bouyer J, 2010, J MED ENTOMOL, V47, P543, DOI 10.1603/ME09149; Bretz F, 2011, MULTIPLE COMP USING, DOI DOI 10.1201/9781420010909; Budd LT, 1999, DFID FUNDED TSETSE T; Buxton PA, 1934, PHILOS T ROY SOC B, V224, P175, DOI 10.1098/rstb.1934.0018; Buxton PA, 1955, NATURAL HIST TSETSE; CUISANCE D, 1984, REV ELEV MED VET PAY, V37, P449; De Beer CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168799; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Diallo S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216802; FAO/ IAEA, 2006, STAND OP PROC MASS R; Feldmann U, 1994, TECHNIQUES INSECT RE, P449; GASTON KA, 1993, PHYSIOL ENTOMOL, V18, P130, DOI 10.1111/j.1365-3032.1993.tb00459.x; Hursey B. S., 1995, World Animal Review, P67; IAEA, 2000, IAEA314D400CT02169; Itard J., 1976, Revue Elev Med vet Pays trop, V29, P43; Kabayo JP, 2002, TRENDS PARASITOL, V18, P473, DOI 10.1016/S1471-4922(02)02371-1; LANGLEY PA, 1975, B ENTOMOL RES, V65, P129, DOI 10.1017/S0007485300005836; LANGLEY PA, 1974, J INSECT PHYSIOL, V20, P2157, DOI 10.1016/0022-1910(74)90041-9; LANGLEY PA, 1990, PHYSIOL ENTOMOL, V15, P415, DOI 10.1111/j.1365-3032.1990.tb00530.x; Lenth RV., 2021, EMMEANS ESTIMATED MA; Lyons CL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-226; Mangiafico SS., 2016, SUMMARY ANAL EXTENSI; Pagabeleguem S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1805-x; Pagabeleguem S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0869-3; Percoma L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2609-3; R Core Team, 2021, R LANGUAGE ENV STAT; Sanchez AH, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12081284; Seck MT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004229; SELLIN E, 1979, REV ELEV MED VET PAY, V32, P335, DOI 10.19182/remvt.8124; TAKKEN W, 1986, B ENTOMOL RES, V76, P275, DOI 10.1017/S0007485300014747; Tower John, 2009, Journal of Biology (London), V8, P38, DOI 10.1186/jbiol141; Tsegaye M, 2020, BIOMED J SCI TECH RE, V28, P21313, DOI DOI 10.26717/BJSTR.2020.28.004604; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123	37	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245503	10.1371/journal.pone.0245503	http://dx.doi.org/10.1371/journal.pone.0245503			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444421	gold, Green Published			2022-12-26	WOS:000609988100076
J	Coly, S; Garrido, M; Abrial, D; Yao, AF				Coly, Sylvain; Garrido, Myriam; Abrial, David; Yao, Anne-Francoise			Bayesian hierarchical models for disease mapping applied to contagious pathologies	PLOS ONE			English	Article							SPACE-TIME VARIATION; INFORMATION CRITERION; SPATIOTEMPORAL MODELS; PATTERNS; POISSON; RISKS	Disease mapping aims to determine the underlying disease risk from scattered epidemiological data and to represent it on a smoothed colored map. This methodology is based on Bayesian inference and is classically dedicated to non-infectious diseases whose incidence is low and whose cases distribution is spatially (and eventually temporally) structured. Over the last decades, disease mapping has received many major improvements to extend its scope of application: integrating the temporal dimension, dealing with missing data, taking into account various a prioris (environmental and population covariates, assumptions concerning the repartition and the evolution of the risk), dealing with overdispersion, etc. We aim to adapt this approach to model rare infectious diseases proposing specific and generic variants of this methodology. In the context of a contagious disease, the outcome of a primary case can in addition generate secondary occurrences of the pathology in a close spatial and temporal neighborhood; this can result in local overdispersion and in higher spatial and temporal dependencies due to direct and/or indirect transmission. In consequence, we test models including a Negative Binomial distribution (instead of the usual Poisson distribution) to deal with local overdispersion. We also use a specific spatio-temporal link in order to better model the stronger spatial and temporal dependencies due to the transmission of the disease. We have proposed and tested 60 Bayesian hierarchical models on 400 simulated datasets and bovine tuberculosis real data. This analysis shows the relevance of the CAR (Conditional AutoRegressive) processes to deal with the structure of the risk. We can also conclude that the negative binomial models outperform the Poisson models with a Gaussian noise to handle overdispersion. In addition our study provided relevant maps which are congruent with the real risk (simulated data) and with the knowledge concerning bovine tuberculosis (real data).	[Coly, Sylvain; Garrido, Myriam; Abrial, David] Ctr INRA Auvergne Rhone Alpes, Unite Epidemiol Malad Anim & Zoonot, St Genes Champanelle, France; [Coly, Sylvain; Yao, Anne-Francoise] Univ Clermon Auvergne, CNRS, Lab Math UMR 6620, Aubiere, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI)	Garrido, M (corresponding author), Ctr INRA Auvergne Rhone Alpes, Unite Epidemiol Malad Anim & Zoonot, St Genes Champanelle, France.	myriam.garrido@inra.fr			INRA (Institut Nationnal de la Recherche Agronomique, France); region Auvregne Rhone-Alpes	INRA (Institut Nationnal de la Recherche Agronomique, France); region Auvregne Rhone-Alpes	This work has been realized thanks to the financial support of INRA (Institut Nationnal de la Recherche Agronomique, France, http://www.inra.fr/) and the Auvergne region (France, now region Auvregne Rhone-Alpes, https://www.auvergnerhonealpes.fr/) who co-funded the Ph.D. of S. Coly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan JJ, 2008, ENVIRON HEALTH PERSP, V116, P1111, DOI 10.1289/ehp.10814; Abrial D, 2014, NEW DIS MAPPING METH, P1; Ando T, 2007, BIOMETRIKA, V94, P443, DOI 10.1093/biomet/asm017; [Anonymous], 2011, SRS B, V46, P1; [Anonymous], 2003, ADV APPL STAT; ANSES DGAL, 2011, B EPIDEMIOLOGIQUE SA; Assuncao RM, 2001, STAT MED, V20, P2319, DOI 10.1002/sim.844; BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Besag J. E., 1989, J APPL STAT, V16, P395, DOI [10.1080/02664768900000049, DOI 10.1080/02664768900000049]; Best N, 2005, STAT METHODS MED RES, V14, P35, DOI 10.1191/0962280205sm388oa; Celeux G, 2006, BAYESIAN ANAL, V1, P651, DOI 10.1214/06-BA122; CLAYTON D, 1987, BIOMETRICS, V43, P671, DOI 10.2307/2532003; Congdon P, 2005, TRENDS INEQUALITY IN; Cressie N.A.C., 2015, STAT SPATIAL DATA; Ugarte MD, 2014, STAT METHODS MED RES, V23, P507, DOI 10.1177/0962280214527528; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gelman A, 2014, STAT COMPUT, V24, P997, DOI 10.1007/s11222-013-9416-2; Grange JM, 1996, GUIDELINES SPECIATIO; Joe H, 2005, BIOMETRICAL J, V47, P219, DOI 10.1002/bimj.200410102; Knorr-Held L, 2002, BIOMETRICS, V58, P492, DOI 10.1111/j.0006-341X.2002.00492.x; Lagazio C, 2001, STAT MODEL, V1, P17, DOI 10.1177/1471082X0100100103; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Lawson AB, 2005, PREV VET MED, V71, P141, DOI 10.1016/j.prevetmed.2005.07.002; Lawson AB, 2000, STAT MED, V19, P2217; Leroux B, 1999, STAT MODELS EPIDEMIO, P135; Lowe R, 2011, COMPUT GEOSCI-UK, V37, P371, DOI 10.1016/j.cageo.2010.01.008; MacNab YC, 2003, BIOMETRICS, V59, P305, DOI 10.1111/1541-0420.00037; MacNab YC, 2001, BIOMETRICS, V57, P949, DOI 10.1111/j.0006-341X.2001.00949.x; MANTON KG, 1989, J AM STAT ASSOC, V84, P637, DOI 10.2307/2289644; Martinez-Beneito MA, 2008, STAT MED, V27, P2874, DOI 10.1002/sim.3103; Mason TJ, 1976, ATLAS CANC MORTALITY; Nobre AA, 2005, ENVIRONMETRICS, V16, P291, DOI 10.1002/env.704; Ocana-Riola R, 2007, STAT MED, V26, P4489, DOI 10.1002/sim.2861; OIE, 2012, FOWL TYPH PULL DIS M, V7th, P1; Richardson S, 2006, STAT METHODS MED RES, V15, P385, DOI 10.1191/0962280206sm458oa; Schmid V, 2004, BIOMETRICS, V60, P1034, DOI 10.1111/j.0006-341X.2004.00259.x; Schrodle B, 2011, J R STAT SOC C-APPL, V60, P261, DOI 10.1111/j.1467-9876.2010.00740.x; Spiegelhalter DJ, 2014, J R STAT SOC B, V76, P485, DOI 10.1111/rssb.12062; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Staubach C, 2011, VET PARASITOL, V179, P77, DOI 10.1016/j.vetpar.2011.01.065; Sun DC, 2000, STAT MED, V19, P2015, DOI 10.1002/1097-0258(20000815)19:15<2015::AID-SIM422>3.0.CO;2-E; Torabi M, 2010, CAN J STAT, V38, P698, DOI 10.1002/cjs.10073; TSUTAKAWA RK, 1988, J AM STAT ASSOC, V83, P37, DOI 10.2307/2288916; van der Linde A, 2005, STAT NEERL, V59, P45; Waller LA, 1996, HIERARCHICAL SPATIO; Wikle CK, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002806; Xia H, 1998, STAT MED, V17, P2025, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2025::AID-SIM865>3.0.CO;2-M	50	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0222898	10.1371/journal.pone.0222898	http://dx.doi.org/10.1371/journal.pone.0222898			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439868	Green Published, gold, Green Submitted			2022-12-26	WOS:000609985300038
J	Shackleton, N; Li, EL; Gibb, S; Kvalsvig, A; Baker, M; Sporle, A; Bentley, R; Milne, BJ				Shackleton, Nichola; Li, Eileen; Gibb, Sheree; Kvalsvig, Amanda; Baker, Michael; Sporle, Andrew; Bentley, Rebecca; Milne, Barry J.			The relationship between income poverty and child hospitalisations in New Zealand: Evidence from longitudinal household panel data and Census data	PLOS ONE			English	Article							HEALTH; INEQUALITIES	Background Very little high quality evidence exists on the causal relationship between income poverty and childhood health. We provide a comprehensive overview of the association between household income poverty and hospitalisations for children. Methods We used New Zealand's Integrated Data Infrastructure (IDI) to link income poverty data from the Survey of Family, Income and Employment (SoFIE; n = 21,759 households) and the 2013 New Zealand Census (n = 523,302 households) to publicly funded hospital records of children aged 0-17 (SoFIE: n = 39,459; Census, n = 986,901). Poverty was defined as equivalised household income below 60% of the median income, calculated both before and after housing costs, and using both self-reported and tax-recorded income. Results Correlations for the association between income poverty and hospitalisation were small (ranging from 0.02 to 0.05) and risk ratios were less than 1.35 for all but the rarest outcome-oral health hospitalisation. Weak or absent associations were apparent across age groups, waves of data collection, cumulative effects, and for estimates generated from fixed effects models and random effect models adjusted for age and ethnicity. Alternative measures of deprivation (area-level deprivation and material deprivation) showed stronger associations with hospitalisations (risk ratios ranged from 1.27-2.55) than income-based poverty measures. Conclusion Income poverty is at best weakly associated with hospitalisation in childhood. Measures of deprivation may have a stronger association. Income measures alone may not be sufficient to capture the diversity of household economic circumstances when assessing the poverty-health relationship.	[Shackleton, Nichola; Li, Eileen; Milne, Barry J.] Univ Auckland, Ctr Methods & Policy Applicat Social Sci, Auckland, New Zealand; [Gibb, Sheree; Kvalsvig, Amanda; Baker, Michael] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [Sporle, Andrew] Univ Auckland, Dept Stat, Auckland, New Zealand; [Bentley, Rebecca] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Hlth Equity, Melbourne, Australia	University of Auckland; University of Otago; University of Auckland; University of Melbourne	Milne, BJ (corresponding author), Univ Auckland, Ctr Methods & Policy Applicat Social Sci, Auckland, New Zealand.	b.milne@auckland.ac.nz		Gibb, Sheree/0000-0002-9708-8816; Li, Eileen/0000-0001-8251-4942	Health Research Council of New Zealand [HRC17-250]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This research was funded by a grant (Ref HRC17-250) from the Health Research Council of New Zealand (www.https://hrc.govt.nz) awarded to BM (Principal Investigator) and NS, SG, AK, MB, AS and RB (named investigators). The sponsors played no role in the study design, data collection, analysis, decision to publish, and the preparation of the manuscript.	Alexander K, 2014, LONG SHADOW FAMILY B; Alkire S, 2011, J ECON INEQUAL, V9, P289, DOI 10.1007/s10888-011-9181-4; Alkire S, 2011, J PUBLIC ECON, V95, P476, DOI 10.1016/j.jpubeco.2010.11.006; Alkire S, 2008, MANY DIMENSIONS OF POVERTY, P89; Anderson P, 2012, NEW ZEAL MED J, V125, P25; [Anonymous], 2005, NZ MED J; Atkinson J., 2014, NZDEP2013 INDEX DEPR; Baker MG, 2012, LANCET, V379, P1112, DOI 10.1016/S0140-6736(11)61780-7; Barker C, 2016, AGE, V150, P863; Boston J., 2014, CHILD POVERTY NZ; Bourguignon F., 2003, J ECON INEQUAL, V1, P25, DOI DOI 10.1023/A:1023913831342; Byrnes CA, 2010, J PAEDIATR CHILD H, V46, P521, DOI 10.1111/j.1440-1754.2010.01853.x; Carter K, 2009, 4 SOFIE U OT; Carter KN, 2010, INT J EPIDEMIOL, V39, P653, DOI 10.1093/ije/dyp215; Conger RD, 2010, J MARRIAGE FAM, V72, P685, DOI 10.1111/j.1741-3737.2010.00725.x; CONGER RD, 1994, CHILD DEV, V65, P541, DOI 10.1111/j.1467-8624.1994.tb00768.x; Cooper K., 2013, DOES MONEY AFFECT CH; Cooper K, 2017, DOES MONEY AFFECT CH, P203; Currie A, 2007, J HEALTH ECON, V26, P213, DOI 10.1016/j.jhealeco.2006.08.003; Dale M, 2014, OUR CHILDREN OUR CHO; DeWalt Darren A, 2009, Pediatrics, V124 Suppl 3, pS265, DOI 10.1542/peds.2009-1162B; Doyle O, 2005, IMPACT PARENTAL INCO; Easton B, 2002, EC HLTH STATUS HOUSE; Gunasekara FI, 2012, NEW ZEAL MED J, V125, P95; Gutierrez RG, 2003, STATA J, V3, P412; Hargreaves DS, 2015, HEALTH AFFAIR, V34, P2113, DOI 10.1377/hlthaff.2015.0709; Jensen J., 1988, INCOME EQUIVALENCES; Marmot M, 2015, LANCET, V386, P2442, DOI 10.1016/S0140-6736(15)00150-6; Mills Clair, 2012, BMC Public Health, V12, P384, DOI 10.1186/1471-2458-12-384; Milne BJ, 2019, INT J EPIDEMIOLOGY; MOH NZ, 2019, ANN DAT EXPL 2018 19; Najman JM, 2010, J ADOLESCENT HEALTH, V46, P538, DOI 10.1016/j.jadohealth.2009.12.001; OECD, 2018, POOR CHILDR RICH COU; Perry B, 2017, MAT WELLBEING NEW ZE; Perry B, 2018, HOUSEHOLD INCOMES NE; Power C, 1997, BRIT MED BULL, V53, P210; Propper C, 2007, HEALTH ECON, V16, P1245, DOI 10.1002/hec.1221; Rabe-Hesketh S., 2012, MULTILEVEL LONGITUDI; Salmond C, 2006, SOC SCI MED, V62, P1474, DOI 10.1016/j.socscimed.2005.08.008; Salmond C, 2005, NZDEP2001 INDEX DEPR; Sanders LM, 2009, ARCH PEDIAT ADOL MED, V163, P131, DOI 10.1001/archpediatrics.2008.539; Shackleton N, 2018, COMMUNITY DENT ORAL, V46, P288, DOI 10.1111/cdoe.12364; Shackleton N, 2017, J EARLY CHILD RES, V15, P238, DOI 10.1177/1476718X15606479; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Simpson J, 2017, TE OHONGA AKE HLTH S; St John S, 2008, END LIF CAR CLIN PRO; StataCorp, 2017, STAT REL 15 STAT SOF, DOI DOI 10.2307/2234838; Statistics New Zealand, 2017, STAT STAND ETHN ETHN; Thomson WM, 2004, COMMUNITY DENT ORAL, V32, P345, DOI 10.1111/j.1600-0528.2004.00173.x; Violato M, 2009, SOC SCI MED, V69, P955, DOI 10.1016/j.socscimed.2009.06.036; Wickham S, 2016, ARCH DIS CHILD, V101, P759, DOI 10.1136/archdischild-2014-306746	51	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0243920	10.1371/journal.pone.0243920	http://dx.doi.org/10.1371/journal.pone.0243920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4UT	33439879	Green Published, gold			2022-12-26	WOS:000609985300027
J	Egieyeh, S; Egieyeh, E; Malan, S; Christofells, A; Fielding, B				Egieyeh, Samuel; Egieyeh, Elizabeth; Malan, Sarel; Christofells, Alan; Fielding, Burtram			Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2)	PLOS ONE			English	Article							ACE2	Drug repurposing for COVID-19 has several potential benefits including shorter development time, reduced costs and regulatory support for faster time to market for treatment that can alleviate the current pandemic. The current study used molecular docking, molecular dynamics and protein-protein interaction simulations to predict drugs from the Drug Bank that can bind to the SARS-CoV-2 spike protein interacting surface on the human angiotensin-converting enzyme 2 (hACE2) receptor. The study predicted a number of peptide-based drugs, including Sar9 Met (O2)11-Substance P and BV2, that might bind sufficiently to the hACE2 receptor to modulate the protein-protein interaction required for infection by the SARS-CoV-2 virus. Such drugs could be validated in vitro or in vivo as potential inhibitors of the interaction of SARS-CoV-2 spike protein with the human angiotensin-converting enzyme 2 (hACE2) in the airway. Exploration of the proposed and current pharmacological indications of the peptide drugs predicted as potential inhibitors of the interaction between the spike protein and hACE2 receptor revealed that some of the predicted peptide drugs have been investigated for the treatment of acute respiratory distress syndrome (ARDS), viral infection, inflammation and angioedema, and to stimulate the immune system, and potentiate antiviral agents against influenza virus. Furthermore, these predicted drug hits may be used as a basis to design new peptide or peptidomimetic drugs with better affinity and specificity for the hACE2 receptor that may prevent interaction between SARS-CoV-2 spike protein and hACE2 that is prerequisite to the infection by the SARS-CoV-2 virus.	[Egieyeh, Samuel] Univ Western Cape, Sch Pharm, Pharmacol & Clin Pharm Unit, Computat Pharmacol & Cheminformat Res Grp, Cape Town, South Africa; [Egieyeh, Elizabeth] Univ Western Cape, Sch Pharm, Pharmacol & Clin Pharm Unit, Cape Town, South Africa; [Malan, Sarel] Univ Western Cape, Sch Pharm, Pharmaceut Chem Unit, Cape Town, South Africa; [Christofells, Alan] Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council, Bioinformat Unit, Cape Town, South Africa; [Fielding, Burtram] Univ Western Cape, Dept Med Biosci, Mol Biol & Virol Res Lab, Cape Town, South Africa	University of the Western Cape; University of the Western Cape; University of the Western Cape; South African Medical Research Council; University of the Western Cape; University of the Western Cape	Egieyeh, S (corresponding author), Univ Western Cape, Sch Pharm, Pharmacol & Clin Pharm Unit, Computat Pharmacol & Cheminformat Res Grp, Cape Town, South Africa.	segieyeh@uwc.ac.za	Egieyeh, Elizabeth/GNM-8111-2022; Fielding, Burtram/S-3240-2019; Malan, Sarel/AAA-4189-2020; christoffels, alan/C-3269-2014	Egieyeh, Elizabeth/0000-0003-3973-0468; Fielding, Burtram/0000-0002-1873-3363; Malan, Sarel/0000-0002-1640-6457; EGIEYEH, SAMUEL/0000-0002-7462-6669; christoffels, alan/0000-0002-0420-2916				Akhtar R, 2019, PAK J PHARM SCI, V32, P2215; [Anonymous], 2015, NUCLEIC ACIDS RES, V43, pD204, DOI [10.1093/nar/gku989, DOI 10.1093/NAR/GKU989]; Bojadzic D, 2018, CURR TOP MED CHEM, V18, P674, DOI 10.2174/1568026618666180531092503; Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016; Hamming I, 2007, J PATHOL, V212, P1, DOI 10.1002/path.2162; Hollingsworth SA, 2018, NEURON, V99, P1129, DOI 10.1016/j.neuron.2018.08.011; Hospital A, 2012, BIOINFORMATICS, V28, P1278, DOI 10.1093/bioinformatics/bts139; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jamwal S, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118105; Jiang SB, 2020, LANCET, V395, P949, DOI 10.1016/S0140-6736(20)30419-0; Keng CT, 2005, J VIROL, V79, P3289, DOI 10.1128/JVI.79.6.3289-3296.2005; Onufriev AV, 2019, ANNU REV BIOPHYS, V48, P275, DOI 10.1146/annurev-biophys-052118-115325; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Ou XY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15216; Oudit GY, 2003, TRENDS CARDIOVAS MED, V13, P93, DOI 10.1016/S1050-1738(02)00233-5; Park Kyungsoo, 2019, Transl Clin Pharmacol, V27, P59, DOI 10.12793/tcp.2019.27.2.59; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qaseem A, 2020, ANN INTERN MED, V173, pW48, DOI 10.7326/M20-3862; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Senanayake SL., 2020, FUTURE DRUG DISCOV, DOI [10.4155/fdd-2020-0010, DOI 10.4155/FDD-2020-0010]; Sethi A., 2019, DRUG DISCOVERY DEV; Thomas-Rddel D, 2020, ANAESTHESIST, V69, P225, DOI [10.1007/s00101-020-00758-x, 10.1007/s00101-020-00760-3]; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; WHO, 2020, WEEKLY EPIDEMIOLOGIC; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; Xiao FX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085958; Zauli G, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01156	29	12	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0245258	10.1371/journal.pone.0245258	http://dx.doi.org/10.1371/journal.pone.0245258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4OF	33417604	Green Published, gold			2022-12-26	WOS:000630020100024
J	Yoshida, K; Yokoi, A; Sugiyama, M; Oda, S; Kitami, K; Tamauchi, S; Ikeda, Y; Yoshikawa, N; Nishino, K; Niimi, K; Suzuki, S; Kikkawa, F; Yokoi, T; Kajiyama, H				Yoshida, Kosuke; Yokoi, Akira; Sugiyama, Mai; Oda, Shingo; Kitami, Kazuhisa; Tamauchi, Satoshi; Ikeda, Yoshiki; Yoshikawa, Nobuhisa; Nishino, Kimihiro; Niimi, Kaoru; Suzuki, Shiro; Kikkawa, Fumitaka; Yokoi, Tsuyoshi; Kajiyama, Hiroaki			Expression of the chrXq27.3 miRNA cluster in recurrent ovarian clear cell carcinoma and its impact on cisplatin resistance	ONCOGENE			English	Article							CANCER CELLS; IDENTIFICATION; MIR-509-3P; SENSITIVITY; MICRORNAS; APOPTOSIS; GENES	Ovarian clear cell carcinoma (OCCC) is a histological subtype of epithelial ovarian cancer and exhibits dismal prognosis due to chemoresistance. Moreover, only few effective therapeutic options exist for patients with recurrent OCCC, and an understanding of its molecular characteristics is essential for the development of novel therapeutic approaches. In the present study, we investigated unique MicroRNAs (miRNA) profiles in recurrent/metastatic OCCC and the role of miRNAs in cisplatin resistance. Comprehensive miRNA sequencing revealed that expression of several miRNAs, including miR-508-3p, miR-509-3p, miR-509-3-5p, and miR-514a-3p was remarkably less in recurrent cancer tissues when compared with that in paired primary cancer tissues. These miRNAs are located in the chrXq27.3 region on the genome. Moreover, its expression was negative in omental metastases in two patients with advanced OCCC. In vitro analyses revealed that overexpression of miR-509-3p and miR-509-3-5p reversed cisplatin resistance and yes-associated protein 1 (YAP1) was partially responsible for the resistance. Immunohistochemistry revealed that YAP1 expression was inversely correlated with the chrXq27.3 miRNA cluster expression. In conclusion, these findings suggest that alteration of the chrXq27.3 miRNA cluster could play a critical role in chemoresistance and miRNAs in the cluster and their target genes can be potential therapeutic targets.	[Yoshida, Kosuke; Yokoi, Akira; Kitami, Kazuhisa; Tamauchi, Satoshi; Ikeda, Yoshiki; Yoshikawa, Nobuhisa; Nishino, Kimihiro; Niimi, Kaoru; Suzuki, Shiro; Kikkawa, Fumitaka; Kajiyama, Hiroaki] Nagoya Univ, Dept Obstet & Gynecol, Grad Sch Med, Nagoya, Aichi, Japan; [Yoshida, Kosuke; Yokoi, Akira] Nagoya Univ, Inst Adv Res, Nagoya, Aichi, Japan; [Yoshida, Kosuke; Oda, Shingo; Yokoi, Tsuyoshi] Nagoya Univ, Div Clin Pharmacol, Dept Drug Safety Sci, Grad Sch Med, Nagoya, Aichi, Japan; [Sugiyama, Mai] Nagoya Univ, Dept Obstet & Gynecol Collaborat Res, Bell Res Ctr, Grad Sch Med, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University	Yokoi, A (corresponding author), Nagoya Univ, Dept Obstet & Gynecol, Grad Sch Med, Nagoya, Aichi, Japan.; Yokoi, A (corresponding author), Nagoya Univ, Inst Adv Res, Nagoya, Aichi, Japan.	ayokoi@med.nagoya-u.ac.jp	YOSHIKAWA, NOBUHISA/AAE-5967-2021; YOSHIDA, Kosuke/AAM-6507-2020	YOSHIDA, Kosuke/0000-0003-1484-4872; Ikeda, Yoshiki/0000-0002-9456-0468; Yoshikawa, Nobuhisa/0000-0001-8662-9421	Japan Society for the Promotion of Science [16K15704, 16H02616, 17H04338, 19H03797, 20K22806]; Practical Research for Innovative Cancer Control, Japan Agency for Medical Research and Development (AMED) [20ck0106630h0001]; Aichi Cancer Research Foundation; Program for Promoting the Enhancement of Research Universities at Nagoya University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Practical Research for Innovative Cancer Control, Japan Agency for Medical Research and Development (AMED); Aichi Cancer Research Foundation(Aichi Cancer Research Foundation); Program for Promoting the Enhancement of Research Universities at Nagoya University	We express our highest appreciation to all members of the Department of Drug Safety Sciences, Division of Clinical Pharmacology, and Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine. Moreover, we received technical support from the Division for Medical Research Engineering, Nagoya University Graduate School of Medicine. Furthermore, we thank Enago (https://www.enago.jp/) for English editing of this manuscript. This study was supported by a Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research: Grant Numbers 16K15704, 16H02616, 17H04338, 19H03797, and 20K22806, and Practical Research for Innovative Cancer Control, Japan Agency for Medical Research and Development (AMED): Grant Number 20ck0106630h0001. Aichi Cancer Research Foundation supported as well. Moreover, research reported in this publication was supported by the Program for Promoting the Enhancement of Research Universities as young researcher units for the advancement of new and undeveloped fields at Nagoya University.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anglesio MS, 2011, GYNECOL ONCOL, V121, P407, DOI 10.1016/j.ygyno.2011.01.005; Bagnoli M, 2011, ONCOTARGET, V2, P1265, DOI 10.18632/oncotarget.401; Boone JD, 2015, GYNECOL ONCOL, V138, P486, DOI 10.1016/j.ygyno.2015.05.022; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chan CK, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160275; Chen W, 2017, PHARMACOGENOMICS, V18, P1671, DOI 10.2217/pgs-2017-0115; Chen W, 2016, PHARMACOGENOMICS, V17, P187, DOI 10.2217/pgs.15.166; Chorn G, 2012, RNA, V18, P1796, DOI 10.1261/rna.031278.111; Damia G, 2019, CANCERS, V11, DOI 10.3390/cancers11010119; Das MK, 2016, CANCER GENOM PROTEOM, V13, P63; Elgaaen BV, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-80; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Ghafouri-Fard S, 2020, EXP MOL PATHOL, V113, DOI 10.1016/j.yexmp.2020.104381; Ghosh S, 2019, BIOORG CHEM, V88, DOI 10.1016/j.bioorg.2019.102925; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Kabekkodu SP, 2020, WIRES RNA, V11, DOI 10.1002/wrna.1563; Li J, 2016, ONCOGENE, V35, P5501, DOI 10.1038/onc.2016.90; Matsui M, 2016, MOL THER, V24, P946, DOI 10.1038/mt.2016.39; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Mihanfar A, 2019, J CELL PHYSIOL, V234, P3180, DOI 10.1002/jcp.26060; Nam EJ, 2016, ONCOTARGET, V7, P70524, DOI 10.18632/oncotarget.12045; Niu LL, 2019, GENE, V686, P63, DOI 10.1016/j.gene.2018.11.011; Ozata DM, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.464; Pan YH, 2016, ONCOTARGET, V7, P25930, DOI 10.18632/oncotarget.8412; Ramaiah M, 2019, EMBO REP, V20, DOI 10.15252/embr.201846566; Reggiani F, 2020, BBA-REV CANCER, V1873, DOI 10.1016/j.bbcan.2020.188341; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Song J, 2018, ONCOL LETT, V16, P3949, DOI 10.3892/ol.2018.9141; Streicher KL, 2012, ONCOGENE, V31, P1558, DOI 10.1038/onc.2011.345; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-199; Wang XH, 2016, BIOCHEM BIOPH RES CO, V478, P676, DOI 10.1016/j.bbrc.2016.08.006; Wei X, 2019, ONCOL REP, V42, P2768, DOI 10.3892/or.2019.7370; Xia Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109575; Yan TT, 2018, CANCER RES, V78, P1751, DOI 10.1158/0008-5472.CAN-17-2101; Yoshida K, 2019, CARCINOGENESIS, V40, P1435, DOI 10.1093/carcin/bgz135; Yoshida K, 2018, ONCOL LETT, V16, P515, DOI 10.3892/ol.2018.8610; Zanconato F, 2019, NAT REV CANCER, V19, P454, DOI 10.1038/s41568-019-0168-y; Zhai QN, 2012, BIOCHEM BIOPH RES CO, V419, P621, DOI 10.1016/j.bbrc.2012.02.060; Zhao LJ, 2019, ONCOGENE, V38, P2305, DOI 10.1038/s41388-018-0577-5; Zhou YF, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00139	44	8	8	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2021	40	7					1255	1268		10.1038/s41388-020-01595-3	http://dx.doi.org/10.1038/s41388-020-01595-3		JAN 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QK0LS	33420363	hybrid, Green Published			2022-12-26	WOS:000607346000011
J	Zhang, HY; Zhang, YM; Chen, XC; Li, JH; Zhang, ZY; Yu, HY				Zhang, Huiyuan; Zhang, Yameng; Chen, Xiaochun; Li, Juhong; Zhang, Ziyang; Yu, Haiyang			Effects of statins on cytokines levels in gingival crevicular fluid and saliva and on clinical periodontal parameters of middle-aged and elderly patients with type 2 diabetes mellitus	PLOS ONE			English	Article							SIMVASTATIN; DIFFERENTIATION; HEALTHY; ALPHA; CELLS	Objective To analyze the effect of statins on cytokines levels in gingival crevicular fluid (GCF) and saliva and on clinical periodontal parameters of middle-aged and elderly patients with type 2 diabetes mellitus (T2DM). Methods Systemically healthy controls (C group, n = 62), T2DM patients not taking statins (D group, n = 57) and T2DM patients taking statins (S group, n = 24) were recruited. In each group, subjects (40-85 years) were subclassified into the h (periodontal health)group, the g (gingivitis) group or the p (periodontitis) group according to different periodontal conditions. 17 cytokines in gingival crevicular fluid (GCF) and saliva samples of each subject were measured utilizing the Luminex technology kit. Further, HbA1c (glycated hemoglobin), FPG (fasting plasma glucose), PD (probing depth), CAL (clinical attachment level), BOP (bleeding on probing), GI (gingival index) and PI (periodontal index) were recorded. Data distribution was tested through the Shapiro-Wilk test, upon which the Kruskal-Wallis test was applied followed by Mann-Whitney U test and Bonferroni's correction. Results Levels of IFN-gamma, IL-5, IL-10 and IL-13 in the saliva of the Dh group were significantly lower than those in the Ch group, while factor IL-4 was higher (p<0.05). Levels of MIP-3 alpha, IL-7 and IL-2 in GCF of the Dh group were considerably higher than those in the Ch group (p<0.05), while that of IL-23 was considerably lower. Compared with the Cg group, levels of IFN-gamma, IL-4, IL-5, IL-6, IL-10 and IL-13 were significantly lower in the saliva of the Dg group (p<0.05). Lower levels of IFN-gamma, IL-5 and IL-10 were detected in the Sg group than those in the Cg group (p< 0.05). At the same time, levels of IL-1 beta, IL-6, IL-7, IL-13, IL-17, IL-21 and MIP-3 alpha in the gingival crevicular fluid of the Sg group were lower in comparison with the Dg group. In addition, lower levels of IL-4 and higher levels of IL-7 in GCF were identified in the Dg group than those in the Cg group, while in the Sg group, lower levels of IL-4, MIP-1 alpha and MIP-3 alpha were observed than those in the Cg group (p<0.05). Lower levels of IFN-gamma, IL-6, IL-10, IL-13 and I-TAC were found in the Sp group compared with those in the Cp group. The IFN-gamma, IL-6 and IL-10 levels were lower in the Dp group than those in the Cp group (p<0.05). Meanwhile, in the Sp group, lower levels of pro-inflammatory factors IFN-gamma, IL-1 beta, IL-2, IL-6, IL-7, IL-21 and TNF-alpha, in addition to higher levels of anti-inflammatory factors IL-4 and IL-5 in gingival crevicular fluid, were identified than those in the Dp group. Higher levels of IFN-gamma, IL-1 beta,IL-2,IL-7,IL-21 and TNF-alpha and a lower level of IL-5 in the Dp group were identified than those in the Cp group (p<0.05). Moreover, statins were able to substantially reduce PD in T2DM patients with periodontitis, indicating an obvious influence on the levels of cytokines secreted by Th1 cells, Th2 cells and Th17 cells, as revealed by PCA (principal component analysis). Conclusion Statins are associated with reduced PD and cytokines levels in the GCF and saliva of T2DM patients with periodontitis.	[Zhang, Huiyuan; Zhang, Yameng; Yu, Haiyang] Sichuan Univ, State Key Lab Oral Dis, Chengdu, Peoples R China; [Zhang, Huiyuan; Zhang, Yameng; Yu, Haiyang] Sichuan Univ, Natl Clin Res Ctr Oral Dis, Chengdu, Peoples R China; [Zhang, Huiyuan; Zhang, Yameng; Yu, Haiyang] Sichuan Univ, West China Hosp Stomatol, Chengdu, Peoples R China; [Chen, Xiaochun; Li, Juhong; Zhang, Ziyang] Shenzhen Ctr Chron Dis Control, Shenzhen, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Yu, HY (corresponding author), Sichuan Univ, State Key Lab Oral Dis, Chengdu, Peoples R China.; Yu, HY (corresponding author), Sichuan Univ, Natl Clin Res Ctr Oral Dis, Chengdu, Peoples R China.; Yu, HY (corresponding author), Sichuan Univ, West China Hosp Stomatol, Chengdu, Peoples R China.	yhyang6812@qq.com			National Key Research and Development Program of China in the 13th five year plan	National Key Research and Development Program of China in the 13th five year plan	This research is supported by funding from the National Key Research and Development Program of China in the 13th five year plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosio LMB, 2018, J PERIODONTAL RES, V53, P12, DOI 10.1111/jre.12480; Ansari SA, 2018, LIFE SCI, V205, P125, DOI 10.1016/j.lfs.2018.05.026; Ari VC, 2016, INFLAMMATION, V39, P1547, DOI 10.1007/s10753-016-0390-7; Atieh MA, 2014, DIABETES RES CLIN PR, V104, pE38, DOI 10.1016/j.diabres.2014.02.002; Baeza M, 2020, J APPL ORAL SCI, V28, DOI 10.1590/1678-7757-2019-0248; Bahammam MA, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/8481735; Bertl K, 2018, J PERIODONTAL RES, V53, P267, DOI 10.1111/jre.12514; Bi CS, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12827; Broniarek I, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041485; Bunte K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143394; Caceres M, 2011, J PERIODONTAL RES, V46, P456, DOI 10.1111/j.1600-0765.2011.01360.x; Camacho-Alonso F, 2020, CLIN ORAL INVEST, V24, P1479, DOI 10.1007/s00784-019-03180-9; Cekici A, 2014, PERIODONTOL 2000, V64, P57, DOI 10.1111/prd.12002; Dalcico R, 2013, J PERIODONTOL, V84, P1145, DOI 10.1902/jop.2012.120114; de Araujo RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075322; de Oliveira DM, 2015, INFLAMMOPHARMACOLOGY, V23, P343, DOI 10.1007/s10787-015-0252-1; Deschamps-Lenhardt S, 2019, ORAL DIS, V25, P385, DOI 10.1111/odi.12834; Feres M, 2018, INT DENT J, V68, P39, DOI 10.1111/idj.12326; Fu CY, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/6712591; Giro G, 2021, CLIN ORAL INVEST, V25, P1291, DOI 10.1007/s00784-020-03435-w; Glurich I, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1228-0; Hajishengallis G, 2017, PERIODONTOL 2000, V75, P116, DOI 10.1111/prd.12181; Helenius-Hietala J, 2019, LIVER INT, V39, P583, DOI 10.1111/liv.13985; Hoang T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082218; Howait M, 2019, J IMMUNOL, V202, P2035, DOI 10.4049/jimmunol.1801161; Inagaki-Katashiba N, 2019, EUR J IMMUNOL, V49, P2051, DOI 10.1002/eji.201847992; Javed F, 2012, J PERIODONTOL, V83, P156, DOI 10.1902/jop.2011.110207; Jia MM, 2020, CANCER PREV RES, V13, P1007, DOI 10.1158/1940-6207.CAPR-20-0018; Katsanos AH, 2020, JAMA NEUROL, V77, P1308, DOI 10.1001/jamaneurol.2020.2494; Kouhpeikar H, 2020, CURR ATHEROSCLER REP, V22, DOI 10.1007/s11883-020-00837-9; Kumar G, 2020, GENET TEST MOL BIOMA, V24, P431, DOI 10.1089/gtmb.2020.0037; Liang LW, 2020, METABOLISM, V107, DOI 10.1016/j.metabol.2020.154226; Liu ST, 2012, HUM CELL, V25, P29, DOI 10.1007/s13577-011-0028-x; Mardegan GP, 2017, CLIN ORAL IMPLAN RES, V28, pe10, DOI 10.1111/clr.12846; Martinez-Aguilar VM, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/7984891; Melguizo-Rodriguez L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21145173; Montero E, 2020, DIABETES OBES METAB, V22, P2120, DOI 10.1111/dom.14131; Aguilera EM, 2020, CARDIOVASC RES, V116, P28, DOI 10.1093/cvr/cvz201; Nascimento GG, 2018, ACTA DIABETOL, V55, P653, DOI 10.1007/s00592-018-1120-4; Nguyen ATM, 2020, DIABETES RES CLIN PR, V165, DOI 10.1016/j.diabres.2020.108244; Noh MK, 2013, EXP THER MED, V6, P847, DOI 10.3892/etm.2013.1222; Pan WY, 2019, INT J ORAL SCI, V11, DOI 10.1038/s41368-019-0064-z; Pokhrel NK, 2017, J PERIODONTOL, V88, P390, DOI 10.1902/jop.2016.160536; Poston CJ, 2016, ORAL DIS, V22, P438, DOI 10.1111/odi.12474; Ribeiro FV, 2011, J PERIODONTOL, V82, P1187, DOI 10.1902/jop.2011.100643; Rigoni TS, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00886; Saewong S, 2013, ARCH ORAL BIOL, V58, P964, DOI 10.1016/j.archoralbio.2013.03.002; Sangwan Aditi, 2016, Eur J Dent, V10, P69, DOI 10.4103/1305-7456.175685; Simpson TC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004714.pub3; Singhal S, 2016, J ORAL SCI, V58, P547, DOI 10.2334/josnusd.16-0017; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Suarez LJ, 2020, J APPL ORAL SCI, V28, DOI 10.1590/1678-7757-2019-0490; Tabrizi R, 2019, PHARMACOL RES, V141, P85, DOI 10.1016/j.phrs.2018.12.010; Tanaka H, 2019, J EPIDEMIOL, V29, P1, DOI 10.2188/jea.JE20170155; Teshome A, 2016, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-016-0249-1; Tonetti MS, 2018, J CLIN PERIODONTOL, V45, pS149, DOI [10.1111/jcpe.12945, 10.1002/JPER.18-0006]; Waldron C, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012628.pub2; Zhang XJ, 2020, CELL METAB, V32, P176, DOI 10.1016/j.cmet.2020.06.015; Zhao BJ, 2014, FUND CLIN PHARMACOL, V28, P583, DOI 10.1111/fcp.12050	59	0	0	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0244806	10.1371/journal.pone.0244806	http://dx.doi.org/10.1371/journal.pone.0244806			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4OF	33417619	Green Published, gold			2022-12-26	WOS:000630020100012
J	Jiang, YX; Luo, WQ; Wang, B; Yi, ZM; Gong, P; Xiong, Y				Jiang, Yixuan; Luo, Wenqiong; Wang, Bin; Yi, Zumu; Gong, Ping; Xiong, Yi			1 alpha,25-Dihydroxyvitamin D3 ameliorates diabetes-induced bone loss by attenuating FoxO1-mediated autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D; OSTEOBLAST PROLIFERATION; HIGH GLUCOSE; IN-VIVO; FOXO1; METABOLISM; INSULIN; AKT; DIFFERENTIATION; PATHOGENESIS	Autophagy is vital for maintaining cellular homeostasis through removing impaired organelles. It has recently been found to play pivotal roles in diabetes mellitus (DM), which is associated with increased bone fracture risk and loss of bone density. However, the mechanism whereby autophagy modulates DM-induced bone loss is not fully elucidated. Previous work has shown that 1 alpha,25-Dihydroxyvitamin D3 (1,25D) exerts positive effects on autophagy, thus affecting bone metabolism. Here, we investigated whether autophagy was involved in the regulation of diabetic bone metabolism. Using Micro-CT, Elisa, histology, and histomorphometry analysis, we demonstrated that 1,25D rescues glucose metabolism dysfunction and ameliorates bone loss in diabetic mice. In vitro, 1,25D alleviated primary osteoblast dysfunction and intracellular oxidative stress through reducing prolonged high-glucose-mediated excessive autophagy in primary osteoblasts, reflected by decreased protein level of Beclin1 and LC3. Of note, the autophagy activator rapamycin (RAP) ablated the positive effects of 1,25D in diabetic environment, leading to a marked increase in autolysosomes and autophagosomes, examined by mRFP-GFP-LC3 fluorescence double labeling. The excessive autophagy induced by high glucose was deleterious to proliferation and differentiation of primary osteoblasts. Additionally, biochemical studies identified that PI3K/Akt signaling could be activated by 1,25D, resulting in the inhibition of FoxO1. We confirmed that FoxO1 deficiency alleviated high-glucose-induced autophagy and improved biological functions of primary osteoblasts. Together, our results suggest that the PI3K/Akt/FoxO1 signaling pathway is involved in the osteoprotective effect of 1,25D by attenuating autophagy in diabetes, providing a novel insight for the prevention and treatment of diabetes-caused bone loss.	[Jiang, Yixuan; Luo, Wenqiong; Wang, Bin; Yi, Zumu; Gong, Ping; Xiong, Yi] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Peoples R China; [Jiang, Yixuan; Luo, Wenqiong; Wang, Bin; Gong, Ping; Xiong, Yi] Sichuan Univ, West China Hosp Stomatol, Dept Oral Implantol, Chengdu, Peoples R China	Sichuan University; Sichuan University	Xiong, Y (corresponding author), Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Peoples R China.; Xiong, Y (corresponding author), Sichuan Univ, West China Hosp Stomatol, Dept Oral Implantol, Chengdu, Peoples R China.	xiongraise@163.com	XIONG, Yi/HGU-1217-2022	Xiong, Yi/0000-0002-6676-202X	Sichuan Science and Technology Program [2020JDRC0055]; West China Hospital Basic and Applied Basic Research Foundation [RD-02-201913]; China Postdoctoral Science Foundation [2019M653442]	Sichuan Science and Technology Program; West China Hospital Basic and Applied Basic Research Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by Sichuan Science and Technology Program (2020JDRC0055), West China Hospital Basic and Applied Basic Research Foundation (RD-02-201913) and China Postdoctoral Science Foundation (2019M653442).	Amaravadi R, 2016, GENE DEV, V30, P1913, DOI 10.1101/gad.287524.116; Bartolome A, 2013, BIOCHEM J, V455, P329, DOI 10.1042/BJ20130562; Cao J, 2018, DIABETES, V67, P46, DOI 10.2337/db17-0546; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dusso AS, 2011, KIDNEY INT SUPPL, V1, P136, DOI 10.1038/kisup.2011.30; Epstein S, 2016, OSTEOPOROSIS INT, V27, P1931, DOI 10.1007/s00198-015-3454-x; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; Guo F, 2018, BRAIN PATHOL, V28, P3, DOI 10.1111/bpa.12545; Guo XP, 2020, J NUTR BIOCHEM, V80, DOI 10.1016/j.jnutbio.2020.108380; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Huang XJ, 2018, INT J BIOL SCI, V14, P1483, DOI 10.7150/ijbs.27173; Iyer S, 2017, J BONE MINER RES, V32, P60, DOI 10.1002/jbmr.2934; Kim J, 2018, MOL CELLS, V41, P11, DOI 10.14348/molcells.2018.2228; Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35; Lecka-Czernik B, 2017, DIABETOLOGIA, V60, P1163, DOI 10.1007/s00125-017-4269-4; Lee CT, 2019, J STEROID BIOCHEM, V185, P200, DOI 10.1016/j.jsbmb.2018.09.002; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048; Levine B, 2015, TRENDS CELL BIOL, V25, P533, DOI 10.1016/j.tcb.2015.05.004; Li HX, 2018, AUTOPHAGY, V14, P1726, DOI 10.1080/15548627.2018.1483807; Liu LH, 2016, CELL CYCLE, V15, P2033, DOI 10.1080/15384101.2016.1192732; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Marasco MR, 2018, ENDOCRINOLOGY, V159, P2127, DOI 10.1210/en.2017-03273; Matsuzaki T, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan0746; Meng HZ, 2015, J BIOL CHEM, V290, P28189, DOI 10.1074/jbc.M115.669499; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Mitri J, 2014, ENDOCRIN METAB CLIN, V43, P205, DOI 10.1016/j.ecl.2013.09.010; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Napoli N, 2017, NAT REV ENDOCRINOL, V13, P208, DOI 10.1038/nrendo.2016.153; O-Sullivan I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8079; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; Ramalingam M, 2016, BIOMOL THER, V24, P589, DOI 10.4062/biomolther.2016.030; Sacerdote A, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1201-y; Saline M, 2019, J BIOL CHEM, V294, P13106, DOI 10.1074/jbc.RA119.008649; Schmidt AM, 2018, ARTERIOSCL THROM VAS, V38, pE1, DOI 10.1161/ATVBAHA.117.310221; Schreiber KH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11174-0; Sellmeyer DE, 2016, DIABETES, V65, P1757, DOI 10.2337/db16-0063; Teixeira CC, 2010, J BIOL CHEM, V285, P31055, DOI 10.1074/jbc.M109.079962; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang XJ, 2016, MOL CELL ENDOCRINOL, V429, P62, DOI 10.1016/j.mce.2016.03.036; Welsh J, 2018, J STEROID BIOCHEM, V177, P15, DOI 10.1016/j.jsbmb.2017.07.025; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Xiong Y, 2017, J BIOL CHEM, V292, P20270, DOI 10.1074/jbc.M117.796367; Yamamoto Suguru, 2013, Biochem J, V456, pe1, DOI 10.1042/BJ20131282; Yan JT, 2018, PHARMACOL RES, V130, P466, DOI 10.1016/j.phrs.2017.12.026; Yang JH, 2010, CELL BIOCHEM FUNCT, V28, P334, DOI 10.1002/cbf.1668; Yao HL, 2018, MOL MED REP, V17, P6681, DOI 10.3892/mmr.2018.8657; Zhang XY, 2008, J BONE MINER RES, V23, P1238, DOI [10.1359/jbmr.080326, 10.1359/JBMR.080326]	53	7	7	5	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100287	10.1016/j.jbc.2021.100287	http://dx.doi.org/10.1016/j.jbc.2021.100287			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33450223	Green Published, gold			2022-12-26	WOS:000672866400263
J	Rowe, SJ; Mecaskey, RJ; Nasef, M; Talton, RC; Sharkey, RE; Halliday, JC; Dunkle, JA				Rowe, Sebastian J.; Mecaskey, Ryan J.; Nasef, Mohamed; Talton, Rachel C.; Sharkey, Rory E.; Halliday, Joshua C.; Dunkle, Jack A.			Shared requirements for key residues in the antibiotic resistance enzymes ErmC and ErmE suggest a common mode of RNA recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						rRNA; rRNA methylation; RNA methyltransferase; RNA modification; antibiotic resistance; ribosomal ribonucleic acid; ribosomal RNA; erythromycin	DOMAIN-V; METHYLTRANSFERASE; RIBOSOME; ACCURACY; ELEMENTS; BINDING; TARGET; SITE	Erythromycin-resistance methyltransferases are SAM dependent Rossmann fold methyltransferases that convert A2058 of 23S rRNA to m(6) (2)A2058. This modification sterically blocks binding of several classes of antibiotics to 23S rRNA, resulting in a multidrug-resistant phenotype in bacteria expressing the enzyme. ErmC is an erythromycin resistance methyltransferase found in many Gram-positive pathogens, whereas ErmE is found in the soil bacterium that biosynthesizes erythromycin. Whether ErmC and ErmE, which possess only 24% sequence identity, use similar structural elements for rRNA substrate recognition and positioning is not known. To investigate this question, we used structural data from related proteins to guide site-saturation mutagenesis of key residues and characterized selected variants by antibiotic susceptibility testing, single turnover kinetics, and RNA affinity-binding assays. We demonstrate that residues in alpha 4, alpha 5, and the alpha 5-alpha 6 linker are essential for methyltransferase function, including an aromatic residue on alpha 4 that likely forms stacking interactions with the substrate adenosine and basic residues in alpha 5 and the alpha 5-alpha 6 linker that likely mediate conformational rearrangements in the protein and cognate rRNA upon interaction. The functional studies led us to a new structural model for the ErmC or ErmE-rRNA complex.	[Rowe, Sebastian J.; Mecaskey, Ryan J.; Nasef, Mohamed; Talton, Rachel C.; Sharkey, Rory E.; Halliday, Joshua C.; Dunkle, Jack A.] Univ Alabama, Dept Chem & Biochem, Tuscaloosa, AL 35487 USA	University of Alabama System; University of Alabama Tuscaloosa	Dunkle, JA (corresponding author), Univ Alabama, Dept Chem & Biochem, Tuscaloosa, AL 35487 USA.	jadunkle@ua.edu		Nasef, Mohamed/0000-0003-2056-6311; Rowe, Sebastian/0000-0002-0937-1524; Dunkle, Jack/0000-0001-6252-0587	NIAID, National Institutes of Health [R15AI131159]	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grant R15AI131159 (to J. A. D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Bhujbalrao R, 2019, J AM CHEM SOC, V141, P1425, DOI 10.1021/jacs.8b10277; Blackburn GM, 2006, NUCLEIC ACIDS IN CHEMISTRY AND BIOLOGY, THIRD EDITION, P1, DOI 10.1039/9781847555380; Boehringer D, 2012, J BIOL CHEM, V287, P10453, DOI 10.1074/jbc.M111.318121; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Czerwoniec A., 2009, DNA RNA MODIFICATION, P289; Dunkle JA, 2014, P NATL ACAD SCI USA, V111, P6275, DOI 10.1073/pnas.1402789111; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Hansen LH, 2011, CHEMBIOCHEM, V12, P610, DOI 10.1002/cbic.201000606; Hutchison CA, 2016, SCIENCE, V351, DOI 10.1126/science.aad6253; Ittisoponpisan S, 2019, J MOL BIOL, V431, P2197, DOI 10.1016/j.jmb.2019.04.009; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Linpinsel Jo L, 2012, Methods Mol Biol, V941, P43, DOI 10.1007/978-1-62703-113-4_4; Liu XD, 2019, NUCLEIC ACIDS RES, V47, P7648, DOI 10.1093/nar/gkz505; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; Manickam N, 2016, NUCLEIC ACIDS RES, V44, P1871, DOI 10.1093/nar/gkv1506; Maravic G, 2003, J MOL BIOL, V332, P99, DOI 10.1016/S0022-2836(03)00863-5; Maravic G, 2003, NUCLEIC ACIDS RES, V31, P4941, DOI 10.1093/nar/gkg666; Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265; Ranjan N, 2017, J AM CHEM SOC, V139, P5857, DOI 10.1021/jacs.7b00727; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Schwalm EL, 2016, SCIENCE, V352, P309, DOI 10.1126/science.aad5367; Sergeeva OV, 2015, BIOCHIMIE, V117, P110, DOI 10.1016/j.biochi.2014.11.019; Stsiapanava A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51174-0; Sullivan B, 2013, ENZYME MICROB TECH, V53, P70, DOI 10.1016/j.enzmictec.2013.02.012; VESTER B, 1994, J BACTERIOL, V176, P6999, DOI 10.1128/JB.176.22.6999-7004.1994; Vester B, 1998, J MOL BIOL, V282, P255, DOI 10.1006/jmbi.1998.2024; Villsen ID, 1999, J MOL BIOL, V286, P365, DOI 10.1006/jmbi.1998.2504; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	32	2	2	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17476	17485		10.1074/jbc.RA120.014280	http://dx.doi.org/10.1074/jbc.RA120.014280			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453992	Green Published, hybrid			2022-12-26	WOS:000603272300008
J	Sullivan, ED; Longley, MJ; Copeland, WC				Sullivan, Eric D.; Longley, Matthew J.; Copeland, William C.			Polymerase gamma efficiently replicates through many natural template barriers but stalls at the HSP1 quadruplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA structure; DNA polymerase &#947; G-quadruplex; mtDNA deletion; DNA replication; heavy-strand promoter; mitochondrial DNA (mtDNA); mitochondrial DNA damage	HUMAN MITOCHONDRIAL-DNA; HEAVY-STRAND PROMOTER; BASE EXCISION-REPAIR; SUNLIGHT EXPOSURE; ACCESSORY SUBUNIT; RNA-POLYMERASE; DELETION; SEQUENCE; TRANSCRIPTION; MAINTENANCE	Faithful replication of the mitochondrial genome is carried out by a set of key nuclear-encoded proteins. DNA polymerase gamma is a core component of the mtDNA replisome and the only replicative DNA polymerase localized to mitochondria. The asynchronous mechanism of mtDNA replication predicts that the replication machinery encounters dsDNA and unique physical barriers such as structured genes, G-quadruplexes, and other obstacles. In vitro experiments here provide evidence that the polymerase gamma heterotrimer is well-adapted to efficiently synthesize DNA, despite the presence of many naturally occurring roadblocks. However, we identified a specific G-quadruplex-forming sequence at the heavy-strand promoter (HSP1) that has the potential to cause significant stalling of mtDNA replication. Furthermore, this structured region of DNA corresponds to the break site for a large (3,895 bp) deletion observed in mitochondrial disease patients. The presence of this deletion in humans correlates with UV exposure, and we have found that efficiency of polymerase gamma DNA synthesis is reduced after this quadruplex is exposed to UV in vitro.	[Sullivan, Eric D.; Longley, Matthew J.; Copeland, William C.] NIH, Mitochondrial DNA Replicat Grp, Natl Inst Environm Hlth Sci, Genome Integr & Struct Biol Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Copeland, WC (corresponding author), NIH, Mitochondrial DNA Replicat Grp, Natl Inst Environm Hlth Sci, Genome Integr & Struct Biol Lab, Res Triangle Pk, NC 27709 USA.	copelan1@niehs.nih.gov	Copeland, William/C-4242-2019	Copeland, William/0000-0002-0359-0953; Sullivan, Eric/0000-0002-7308-0529	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences [ES065078]	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences Grant ES065078 (to W. C. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bedrat A, 2016, NUCLEIC ACIDS RES, V44, P1746, DOI 10.1093/nar/gkw006; Berneburg M, 2004, J INVEST DERMATOL, V122, P1277, DOI 10.1111/j.0022-202X.2004.22502.x; Bharti SK, 2014, J BIOL CHEM, V289, P29975, DOI 10.1074/jbc.M114.567073; Bhattacharyya D, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00038; Brazda V, 2019, BIOINFORMATICS, V35, P3493, DOI 10.1093/bioinformatics/btz087; Butler TJ, 2020, HUM MOL GENET, V29, P1292, DOI 10.1093/hmg/ddaa043; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; CHANG DD, 1984, CELL, V36, P635, DOI 10.1016/0092-8674(84)90343-X; CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777; Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010; Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007; DeBalsi KL, 2017, J BIOL CHEM, V292, P4198, DOI 10.1074/jbc.M116.773341; Dong DW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-677; Eddy S, 2016, BIOCHEMISTRY-US, V55, P5218, DOI 10.1021/acs.biochem.6b00374; Falabella M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41464-y; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fan L, 1999, P NATL ACAD SCI USA, V96, P9527, DOI 10.1073/pnas.96.17.9527; Fuste JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004832; Fuste JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021; Gendron SP, 2013, MUTAGENESIS, V28, P197, DOI 10.1093/mutage/ges071; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213; Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227; Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402; Harbottle A, 2010, BRIT J DERMATOL, V163, P1291, DOI 10.1111/j.1365-2133.2010.10001.x; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; KAGUNI LS, 1982, P NATL ACAD SCI-BIOL, V79, P983, DOI 10.1073/pnas.79.4.983; Kamath-Loeb AS, 2001, J BIOL CHEM, V276, P16439, DOI 10.1074/jbc.M100253200; Kasiviswanathan R, 2013, J BIOL CHEM, V288, P14247, DOI 10.1074/jbc.M113.458802; Kasiviswanathan R, 2012, J BIOL CHEM, V287, P9222, DOI 10.1074/jbc.M111.306852; Kasiviswanathan R, 2011, J BIOL CHEM, V286, P31490, DOI 10.1074/jbc.M111.252460; Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015; Kaur P, 2018, NUCLEIC ACIDS RES, V46, P11287, DOI 10.1093/nar/gky875; Kazak L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062340; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Krishnan KJ, 2004, J INVEST DERMATOL, V123, P1020, DOI 10.1111/j.0022-202X.2004.23457.x; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w; Lujan SA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02138-5; MORAES CT, 1991, MOL CELL BIOL, V11, P1631, DOI 10.1128/MCB.11.3.1631; MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359; Murakami E, 2003, J BIOL CHEM, V278, P36403, DOI 10.1074/jbc.M306236200; Persson O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08673-5; Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0; Ray AJ, 2000, J INVEST DERMATOL, V115, P674, DOI 10.1046/j.1523-1747.2000.00092.x; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Smith JE, 2014, NUCLEIC ACIDS RES, V42, P5007, DOI 10.1093/nar/gku163; Smith-Carpenter JE, 2019, PHOTOCHEM PHOTOBIOL, V95, P252, DOI 10.1111/php.12991; Su DGT, 2009, P NATL ACAD SCI USA, V106, P12861, DOI 10.1073/pnas.0902386106; Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105; WONG TW, 1985, CELL, V42, P951, DOI 10.1016/0092-8674(85)90291-0; Wu CC, 2019, NUCLEIC ACIDS RES, V47, P5405, DOI 10.1093/nar/gkz241; Zollo O, 2012, P NATL ACAD SCI USA, V109, P6508, DOI 10.1073/pnas.1118594109	64	5	5	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17802	17815		10.1074/jbc.RA120.015390	http://dx.doi.org/10.1074/jbc.RA120.015390			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454015	hybrid, Green Published			2022-12-26	WOS:000603272300031
J	Yeh, YC; Cappelleri, JC; Marston, XL; Shelbaya, A				Yeh, Yu-Chen; Cappelleri, Joseph C.; Marston, Xiaocong L.; Shelbaya, Ahmed			Effects of dose titration on adherence and treatment duration of pregabalin among patients with neuropathic pain: A MarketScan database study	PLOS ONE			English	Article							DIABETIC PERIPHERAL NEUROPATHY; HEALTH-CARE COSTS; MEDICATION ADHERENCE; PHARMACOLOGICAL-TREATMENT; EFNS GUIDELINES; TOLERABILITY; PERSISTENCE; DULOXETINE; EFFICACY; BURDEN	Objective To examine pregabalin dose titration and its impact on treatment adherence and duration in patients with neuropathic pain (NeP). Methods MarketScan database (2009-2014) was used to extract a cohort of incident adult pregabalin users with NeP who had at least 12 months of follow-up data. Any dose augmentation within 45 days following the first pregabalin claim was defined as dose titration. Adherence (measured by medication possession ratio/MPR) and persistence (measured as the duration of continuous treatment) were compared between the cohorts with and without dose titration. Logistic regressions and Cox proportional hazards models were used to identify the factors associated with adherence (MPR >= 0.8) and predictors of time to discontinuation. Results Among the 5,186 patients in the analysis, only 18% of patients had dose titration. Patients who had dose titration were approximately 2.6 times as likely to be adherent (MPR >= 0.8) (odds ratio = 2.59, P < 0.001) than those who did not have dose titration. Kaplan-Meier analysis shows that the time to discontinuation or switch was significantly longer among patients who had dose titration (4.99 vs. 4.04 months, P = 0.009). Conclusions Dose titration was associated with improved treatment adherence and persistence among NeP patients receiving pregabalin. The findings will provide valuable evidence to increase physician awareness of dose recommendations in the prescribing information and to educate patients on the importance of titration and adherence.	[Yeh, Yu-Chen] Pharmerit Int, Newton, MA 02458 USA; [Cappelleri, Joseph C.] Pfizer Inc, Dept Global Biometr & Data Management, New York, NY USA; [Marston, Xiaocong L.] Pharmerit Int, Shanghai, Peoples R China; [Shelbaya, Ahmed] Pfizer Inc, Dept Hlth Econ & Outcomes Res, New York, NY USA; [Shelbaya, Ahmed] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Pfizer; Pfizer; Columbia University	Yeh, YC (corresponding author), Pharmerit Int, Newton, MA 02458 USA.	ycyeh74@hotmail.com			Pfizer	Pfizer(Pfizer)	Yu-Chen Yeh and Xiaocong L. Marston are employees of Pharmerit International, who were paid consultants to Pfizer in connection with this study. Ahmed Shelbaya and Joseph C. Cappelleri are employees and stockholders of Pfizer Inc. This study was sponsored by Pfizer. All authors were involved in the study design, data collection, analysis, decision to publish, and preparation of the manuscript.	Alexander J, 2018, ADV THER, V35, P382, DOI 10.1007/s12325-018-0664-6; Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; Centre for Clinical Practice at NICE (UK)-National Institute for Health and Care Excellence: Clinical Guidelines, 2010, NEUR PAIN PHARM MAN; Cruccu G, 2007, EUR J NEUROL, V14, P952, DOI 10.1111/j.1468-1331.2007.01916.x; Dworkin RH, 2013, PAIN, V154, P2249, DOI 10.1016/j.pain.2013.06.004; Emir B, 2017, CLIN THER, V39, P98, DOI 10.1016/j.clinthera.2016.11.015; Farin E, 2013, J BEHAV MED, V36, P246, DOI 10.1007/s10865-012-9419-z; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Federal Drug Administration, 2004, HIGHL PRESCR INF LYR; Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Freeman R, 2008, DIABETES CARE, V31, P1448, DOI 10.2337/dc07-2105; Gharibian D, 2013, CLIN J PAIN, V29, P377, DOI 10.1097/AJP.0b013e31825e45d9; Gilron I, 2015, MAYO CLIN PROC, V90, P532, DOI 10.1016/j.mayocp.2015.01.018; Gustavsson A, 2013, PAIN MED, V14, P1072, DOI 10.1111/pme.12095; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Iuga AO, 2014, RISK MANAG HEALTHC P, V7, P35, DOI 10.2147/RMHP.S19801; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Kozma CM, 2013, PATIENT PREFER ADHER, V7, P509, DOI 10.2147/PPA.S40736; Langley Paul C, 2013, J Med Econ, V16, P85, DOI 10.3111/13696998.2012.729548; Lesser H, 2004, NEUROLOGY, V63, P2104, DOI 10.1212/01.WNL.0000145767.36287.A1; LIANG MH, 1989, ARTHRITIS RHEUM, V32, P1107, DOI 10.1002/anr.1780320909; Liu XC, 2011, CLINICOECONOMIC OUTC, V3, P63, DOI 10.2147/CEOR.S17846; Mailis A, 2012, PAIN RES MANAG, V17, P150, DOI 10.1155/2012/794325; Marlow NM, 2018, PAIN PRACT, V18, P154, DOI 10.1111/papr.12585; McCarberg B, 2006, AM J MANAG CARE, V12, pS263; Rini BI, 2013, LANCET ONCOL, V14, P1233, DOI 10.1016/S1470-2045(13)70464-9; Rosner B., 2015, FUNDAMENTALS BIOSTAT; Sansone Randy A, 2012, Innov Clin Neurosci, V9, P41; Schaefer C, 2014, CLINICOECONOMIC OUTC, V6, P483, DOI 10.2147/CEOR.S63323; Serpell M, 2017, J PAIN RES, V10, P1769, DOI 10.2147/JPR.S129832; Shneker BF, 2005, ANN PHARMACOTHER, V39, P2029, DOI 10.1345/aph.1G078; Smith BH, 2012, CURR PAIN HEADACHE R, V16, P191, DOI 10.1007/s11916-012-0256-0; van Hecke O, 2014, PAIN, V155, P654, DOI 10.1016/j.pain.2013.11.013; van Seventer R, 2006, CURR MED RES OPIN, V22, P375, DOI 10.1185/030079906X80404; Wu CH, 2012, DEPRESS ANXIETY, V29, P506, DOI 10.1002/da.21952; Zeber JE, 2013, VALUE HEALTH, V16, P891, DOI 10.1016/j.jval.2013.04.014; Zhao Y, 2011, PAIN PRACT, V11, P204, DOI 10.1111/j.1533-2500.2010.00412.x; Zhao Y, 2011, CURR MED RES OPIN, V27, P785, DOI 10.1185/03007995.2011.554807	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0242467	10.1371/journal.pone.0242467	http://dx.doi.org/10.1371/journal.pone.0242467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471834	gold, Green Published			2022-12-26	WOS:000639428800028
J	Dumuid, D; Wake, M; Burgner, D; Tremblay, MS; Okely, AD; Edwards, B; Dwyer, T; Olds, T				Dumuid, Dorothea; Wake, Melissa; Burgner, David; Tremblay, Mark S.; Okely, Anthony D.; Edwards, Ben; Dwyer, Terence; Olds, Timothy			Balancing time use for children's fitness and adiposity: Evidence to inform 24-hour guidelines for sleep, sedentary time and physical activity	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; HEALTH INDICATORS; POPULATION EPIDEMIOLOGY; BEHAVIOR; CONCORDANCE; DURATION; YOUTH	Purpose Daily time spent on one activity cannot change without compensatory changes in others, which themselves may impact on health outcomes. Optimal daily activity combinations may differ across outcomes. We estimated optimal daily activity durations for the highest fitness and lowest adiposity. Methods Cross-sectional Child Health CheckPoint data (1182 11-12-year-olds; 51% boys) from the population-based Longitudinal Study of Australian Children were used. Daily activity composition (sleep, sedentary time, light physical activity [LPA], moderate-to-vigorous physical activity [MVPA]) was from 8-day, 24-hour accelerometry. We created composite outcomes for fitness (VO2max; standing long jump) and adiposity (waist-to-height ratio; body mass index; fat-to-fat-free log-ratio). Adjusted compositional models regressed activity log-ratios against each outcome. Best activity compositions (optimal time-use zones) were plotted in quaternary tetrahedrons; the overall optimal time-use composition was the center of the overlapping area. Results Time-use composition was associated with fitness and adiposity (all measures p<0.001). Optimal time use differed for fitness and adiposity. While both maximized MVPA and minimized sedentary time, optimal fitness days had higher LPA (3.4 h) and shorter sleep (8.25 h), but optimal adiposity days had lower LPA (1.0 h) and longer sleep (10.9 h). Balancing both outcomes, the overall optimal time-use composition was (mean [range]): 10.2 [9.5; 10.5] h sleep, 9.9 [8.8; 11.2] h sedentary time, 2.4 [1.8; 3.2] h LPA and 1.5 [1.5; 1.5] h MVPA. Conclusion Optimal time use for children's fitness and adiposity involves trade-offs. To best balance both outcomes, estimated activity durations for sleep and LPA align with, but for MVPA exceed, 24-h guidelines.	[Dumuid, Dorothea; Olds, Timothy] Univ South Australia, Allied Hlth & Human Performance, Alliance Res Exercise Nutr & Act ARENA, Adelaide, SA, Australia; [Wake, Melissa; Burgner, David; Dwyer, Terence] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Wake, Melissa; Burgner, David; Dwyer, Terence] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Tremblay, Mark S.] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Tremblay, Mark S.] Univ Ottawa, Dept Pediat, Ottawa, ON, Canada; [Okely, Anthony D.] Univ Wollongong, Fac Social Sci, Early Start, Wollongong, NSW, Australia; [Okely, Anthony D.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Edwards, Ben] Australian Natl Univ, Ctr Social Res & Methods, Canberra, ACT, Australia; [Dwyer, Terence] Univ Oxford, Oxford Martin Sch, Oxford, England; [Dwyer, Terence] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England	University of South Australia; Murdoch Children's Research Institute; University of Melbourne; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Wollongong; University of Wollongong; Australian National University; University of Oxford; University of Oxford	Dumuid, D (corresponding author), Univ South Australia, Allied Hlth & Human Performance, Alliance Res Exercise Nutr & Act ARENA, Adelaide, SA, Australia.	dot.dumuid@unisa.edu.au	Tremblay, Mark/ABI-5477-2020; Olds, Tim/A-1223-2008; Okely, Anthony D/R-1679-2018; Dumuid, Dot/HCI-5863-2022; Wake, Melissa/J-1396-2012	Olds, Tim/0000-0001-6894-5519; Okely, Anthony D/0000-0002-1626-8170; Dumuid, Dorothea/0000-0003-3057-0963; Wake, Melissa/0000-0001-7501-9257	National Health and Medical Research Council (NHMRC) [1162166]; National Heart Foundation of Australia [102084, 100660]; NHMRC [1160906, 1175744, 1176858]; NHMRC of Australia [1041352, 1109355]; Royal Children's Hospital Foundation [2014-241]; Murdoch Children's Research Institute (MCRI), The University of Melbourne; Financial Markets Foundation for Children [2014-055, 2016-310]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); Royal Children's Hospital Foundation; Murdoch Children's Research Institute (MCRI), The University of Melbourne; Financial Markets Foundation for Children; Victorian Government's Operational Infrastructure Support Program	DD was supported by the National Health and Medical Research Council (NHMRC) [Early Career Fellowship 1162166] and the National Heart Foundation of Australia [Postgraduate Fellowship 102084]. MWwas supported by the NHMRC [Principal Research Fellowship 1160906]. DB was supported by an NHMRC Investigator Grant [1175744]. ADO was supported by an NHMRC Leadership Fellowship [1176858]. The Child Health CheckPoint was supported by the NHMRC of Australia [Project Grants 1041352, 1109355], The Royal Children's Hospital Foundation [2014-241], the Murdoch Children's Research Institute (MCRI), The University of Melbourne, the National Heart Foundation of Australia [100660] and the Financial Markets Foundation for Children [2014-055, 2016-310]. Research at the MCRI is supported by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler D., 2003, P 35 S INT COMP SCI, P1; [Anonymous], 2018, VOX             0919; Australian Bureau of Statistics, 2016, CENS POP HOUS SOC EC; Australian Government Department of Health, 2019, AUSTR 24 HOUR MOV GU; Bernard P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204682; BLAKEMORE T, 2009, AUST SOC POLICY, V0008; Bond L, 2006, J ADOLESCENCE, V29, P709, DOI 10.1016/j.adolescence.2005.10.001; BOREHAM CAG, 1990, J SPORT MED PHYS FIT, V30, P19; Carson V, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220009; Carson V, 2016, APPL PHYSIOL NUTR ME, V41, pS294, DOI 10.1139/apnm-2016-0026; Chaput JP, 2016, APPL PHYSIOL NUTR ME, V41, pS266, DOI 10.1139/apnm-2015-0627; Chastin SFM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139984; Cliff DP, 2016, OBES REV, V17, P330, DOI 10.1111/obr.12371; Clifford SA, 2019, BMJ OPEN, V9, P95, DOI 10.1136/bmjopen-2018-023698; Clifford SA, 2019, BMJ OPEN, V9, P3, DOI 10.1136/bmjopen-2017-020261; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dumuid D, 2021, STAT METHODS MED RES, V30, P331, DOI 10.1177/0962280220955221; Dumuid D, 2020, J BONE MINER RES, V35, P2393, DOI 10.1002/jbmr.4143; Dumuid D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072220; Dumuid D, 2019, J PEDIATR-US, V208, P43, DOI 10.1016/j.jpeds.2018.12.030; Dumuid D, 2018, STAT METHODS MED RES, V27, P3726, DOI 10.1177/0962280217710835; Eijsvogels TMH, 2016, J AM COLL CARDIOL, V67, P316, DOI 10.1016/j.jacc.2015.11.034; Fairclough SJ, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0521-z; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; Fraysse F, 2019, BMJ OPEN, V9, P136, DOI 10.1136/bmjopen-2018-023194; Fuligni AJ, 2018, CHILD DEV, V89, pe18, DOI 10.1111/cdev.12729; Gralla MH, 2019, AM J LIFESTYLE MED, V13, P61, DOI 10.1177/1559827615624417; Gray M, 2005, FAMILY MATTERS, P4; Haapala EA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67983-7; Javaheri S, 2011, J PEDIATR-US, V158, P617, DOI 10.1016/j.jpeds.2010.09.080; Jensky-Squires NE, 2008, BRIT J NUTR, V100, P859, DOI 10.1017/S0007114508925460; Marfell-Jones M. J., 2012, INT STANDARDS ANTHRO; MARTINFERNANDEZ J. A., 2011, COMPOSITIONAL DATA A; Matricciani L, 2019, SLEEP MED REV, V46, P136, DOI 10.1016/j.smrv.2019.04.011; Nevill AM, 2020, J SPORT HEALTH SCI, V9, P90, DOI 10.1016/j.jshs.2019.05.001; New Zealand Ministry of Health, 2017, SIT LESS MOV MOR SLE; Paruthi S, 2016, J CLIN SLEEP MED, V12, P1549, DOI 10.5664/jcsm.6288; Pedisic Z, 2017, KINESIOLOGY, V49, P252; Phillips LRS, 2013, J SCI MED SPORT, V16, P124, DOI 10.1016/j.jsams.2012.05.013; Poitras VJ, 2016, APPL PHYSIOL NUTR ME, V41, pS197, DOI 10.1139/apnm-2015-0663; Ridley K, 2018, J SCI MED SPORT, V21, P930, DOI 10.1016/j.jsams.2018.01.019; Sanders T, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0881-7; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; Straker L, 2018, BRIT J SPORT MED, V52, P818, DOI 10.1136/bjsports-2017-097765; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Tompuri TT, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00226; Tremblay MS, 2020, J PHYS ACT HEALTH, V17, P92, DOI 10.1123/jpah.2019-0401; Tremblay MS, 2016, APPL PHYSIOL NUTR ME, V41, pIII, DOI [10.1139/apnm-2016-0203, 10.1139/apnm-2016-0151]; van den Boogaart KG, 2008, COMPUT GEOSCI-UK, V34, P320, DOI 10.1016/j.cageo.2006.11.017; van Hees VT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142533; Wake M, 2014, FAM MATTERS, V95, P15	51	7	7	7	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245501	10.1371/journal.pone.0245501	http://dx.doi.org/10.1371/journal.pone.0245501			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465128	Green Published, gold, Green Accepted			2022-12-26	WOS:000611969200046
J	Santos, CD; Costa, SF; Souza, FS; Mendes, JMF; de Pinheiro, CGM; Moreira, DRD; Silva, LK; de Lima, VMF; Oliveira, GGD				Santos, Catiule de Oliveira; Costa, Sidnei Ferro; Souza, Fabiana Santana; Ferreira Mendes, Jessica Mariane; Melo de Pinheiro, Cristiane Garboggini; de Magalhaes Moreira, Diogo Rodrigo; Silva, Luciano Kalabric; Felix de Lima, Valeria Marcal; de Sa Oliveira, Geraldo Gileno			Blocking IL-10 signaling with soluble IL-10 receptor restores in vitro specific lymphoproliferative response in dogs with leishmaniasis caused by Leishmania infantum	PLOS ONE			English	Article							INHIBITS CYTOKINE SYNTHESIS; INTERFERON-GAMMA-PRODUCTION; T-CELL PROLIFERATION; INTERLEUKIN-10 RECEPTOR; HUMAN MONOCYTES; MAST-CELLS; ANTIINFLAMMATORY CYTOKINES; VISCERAL LEISHMANIASIS; EXPRESSION; BLOCKADE	rIL-10 plays a major role in restricting exaggerated inflammatory and immune responses, thus preventing tissue damage. However, the restriction of inflammatory and immune responses by IL-10 can also favor the development and/or persistence of chronic infections or neoplasms. Dogs that succumb to canine leishmaniasis (CanL) caused by L. infantum develop exhaustion of T lymphocytes and are unable to mount appropriate cellular immune responses to control the infection. These animals fail to mount specific lymphoproliferative responses and produce interferon gamma and TNF-alpha that would activate macrophages and promote destruction of intracellular parasites. Blocking IL-10 signaling may contribute to the treatment of CanL. In order to obtain a tool for this blockage, the present work endeavored to identify the canine casIL-10R1 amino acid sequence, generate a recombinant baculovirus chromosome encoding this molecule, which was expressed in insect cells and subsequently purified to obtain rcasIL-10R1. In addition, rcasIL-10R1 was able to bind to homologous IL-10 and block IL-10 signaling pathway, as well as to promote lymphoproliferation in dogs with leishmaniasis caused by L. infantum.	[Santos, Catiule de Oliveira; Souza, Fabiana Santana; Ferreira Mendes, Jessica Mariane; Melo de Pinheiro, Cristiane Garboggini; de Magalhaes Moreira, Diogo Rodrigo; Silva, Luciano Kalabric; de Sa Oliveira, Geraldo Gileno] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Lab Struct & Mol Pathol LAPEM, Tissue Engn & Immunopharmacol Lab LETI,Pathol & M, Salvador, BA, Brazil; [Costa, Sidnei Ferro; Felix de Lima, Valeria Marcal] Sao Paulo State Univ UNESP, Sch Vet Med, Dept Clin Med Surg & Anim Reprod, Aracatuba, Brazil	Fundacao Oswaldo Cruz; Universidade Estadual Paulista	Oliveira, GGD (corresponding author), Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Lab Struct & Mol Pathol LAPEM, Tissue Engn & Immunopharmacol Lab LETI,Pathol & M, Salvador, BA, Brazil.	geraldo.oliveira@fiocruz.br	de Lima, Valéria M.F./B-7867-2013; Moreira, Diogo Rodrigo M./S-9071-2019; de Sá Oliveira, Geraldo Gileno/AAO-4099-2021; Silva, Luciano/L-9041-2013	de Lima, Valéria M.F./0000-0002-0954-5045; Moreira, Diogo Rodrigo M./0000-0003-3323-4404; de Sá Oliveira, Geraldo Gileno/0000-0001-6065-6480; Silva, Luciano/0000-0002-7739-4082	Master Degree Scholarhip, FAPESB; Scientific initiation program, FAPESB; Coordination for the Improvement of Higher Education Personnel (CAPES) [001]; National Council for Scientific and Technological Development (CNPq) [400063/2016-6]; Sao Paulo Research Foundation (FAPESP) [2017/10906-8]; CNPq/INCT-DT [573839/2008-5]; CNPq-PROEP [400913/2013-5]	Master Degree Scholarhip, FAPESB; Scientific initiation program, FAPESB; Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq/INCT-DT; CNPq-PROEP	COS, Master Degree Scholarhip, FAPESB FSS, Scientific initiation program, FAPESB SFC, JMFM, CGMP, Coordination for the Improvement of Higher Education Personnel (CAPES) -Finance Code 001 VMFL, National Council for Scientific and Technological Development (CNPq) process #400063/2016-6 and Sao Paulo Research Foundation (FAPESP), process #2017/10906-8. GGSO, CNPq/INCT-DT, process #573839/2008-5 and CNPq-PROEP, process #400913/2013-5 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A.K., 2018, CELL MOL IMMUNOL; Asiedu C, 2007, CYTOKINE, V40, P183, DOI 10.1016/j.cyto.2007.09.008; Baneth G, 2008, TRENDS PARASITOL, V24, P324, DOI 10.1016/j.pt.2008.04.001; Berezhnoy A, 2012, MOL THER, V20, P1242, DOI 10.1038/mt.2012.18; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Boggiatto PM, 2010, CLIN VACCINE IMMUNOL, V17, P267, DOI 10.1128/CVI.00456-09; Boshtam M, 2017, INFLAMMATION, V40, P340, DOI 10.1007/s10753-016-0477-1; Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948; Bunn PT, 2018, J IMMUNOL, V201, P3362, DOI 10.4049/jimmunol.1701582; BURD PR, 1989, J EXP MED, V170, P245, DOI 10.1084/jem.170.1.245; CAPSONI F, 1995, J LEUKOCYTE BIOL, V58, P351, DOI 10.1002/jlb.58.3.351; Cardoso JMdO, 2018, TRATAMENTO LEISHMANI; Cavaillon JM, 2001, CELL MOL BIOL, V47, P695; Clutton G, 2015, HUM VACC IMMUNOTHER, V11, P1030, DOI 10.1080/21645515.2015.1009809; Costa SF, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008021; Creery WD, 1996, EUR J IMMUNOL, V26, P1273, DOI 10.1002/eji.1830260614; CUNHA FQ, 1992, BIOCHEM BIOPH RES CO, V182, P1155, DOI 10.1016/0006-291X(92)91852-H; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; de Souza EP, 2001, ACTA TROP, V80, P69, DOI 10.1016/S0001-706X(01)00150-4; DELPRETE G, 1993, J IMMUNOL, V150, P353; Diaz-Valdes N, 2011, HEPATOLOGY, V53, P23, DOI 10.1002/hep.23980; DING L, 1992, J IMMUNOL, V148, P3133; Esch KJ, 2013, J IMMUNOL, V191, P5542, DOI 10.4049/jimmunol.1301810; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gabrysova L, 2014, CURR TOP MICROBIOL, V380, P157, DOI 10.1007/978-3-662-43492-5_8; GHALIB HW, 1993, J CLIN INVEST, V92, P324, DOI 10.1172/JCI116570; Groux H, 1998, J IMMUNOL, V160, P3188; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; GRUBER MF, 1994, J IMMUNOL, V152, P1354; Imlach W, 2002, J GEN VIROL, V83, P1049, DOI 10.1099/0022-1317-83-5-1049; Kuga S, 1996, EXP HEMATOL, V24, P151; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MACATONIA SE, 1993, J IMMUNOL, V150, P3755; Magalhaes PO, 2007, J PHARM PHARM SCI, V10, P388; MALEFYT RD, 1991, J EXP MED, V174, P1209; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murray HW, 2002, INFECT IMMUN, V70, P6284, DOI 10.1128/IAI.70.11.6284-6293.2002; Naing A, 2018, CANCER CELL, V34, P775, DOI 10.1016/j.ccell.2018.10.007; Naiyer MM, 2013, HUM IMMUNOL, V74, P28, DOI 10.1016/j.humimm.2012.09.002; Ni GY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153939; Pinheiro CMP, 2016, REV GEST ORGAN, V9, P36; Pletnev S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-10; do Nascimento PRP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073873; Rigopoulou EI, 2005, CLIN IMMUNOL, V117, P57, DOI 10.1016/j.clim.2005.06.003; Santin AD, 2000, J VIROL, V74, P4729, DOI 10.1128/JVI.74.10.4729-4737.2000; Saraiva M, 2020, J EXP MED, V217, DOI 10.1084/jem.20190418; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Solano-Gallego L, 2009, VET PARASITOL, V165, P1, DOI 10.1016/j.vetpar.2009.05.022; SPITTLER A, 1995, IMMUNOLOGY, V85, P311; Strauss-Ayali D, 2005, INT J PARASITOL, V35, P63, DOI 10.1016/j.ijpara.2004.10.015; TAN JC, 1995, J BIOL CHEM, V270, P12906, DOI 10.1074/jbc.270.21.12906; TAN JC, 1993, J BIOL CHEM, V268, P21053; THOMPSONSNIPES LA, 1991, J EXP MED, V173, P507, DOI 10.1084/jem.173.2.507; Waldmann H, 2019, METHODS MOL BIOL, V1904, P1, DOI 10.1007/978-1-4939-8958-4_1; Walker DM, 2014, CELL MOL LIFE SCI, V71, P1245, DOI 10.1007/s00018-013-1491-1; Walter MR, 2014, CURR TOP MICROBIOL, V380, P191, DOI 10.1007/978-3-662-43492-5_9; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; WHITFORD M, 1989, J VIROL, V63, P1393, DOI 10.1128/JVI.63.3.1393-1399.1989; WILLEMS F, 1994, EUR J IMMUNOL, V24, P1007, DOI 10.1002/eji.1830240435; Wilson EB, 2011, CURR TOP MICROBIOL, V350, P39, DOI 10.1007/82_2010_96; Yoon SI, 2006, J BIOL CHEM, V281, P35088, DOI 10.1074/jbc.M606791200; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012; Zijlstra EE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1721-0	65	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0239171	10.1371/journal.pone.0239171	http://dx.doi.org/10.1371/journal.pone.0239171			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465107	Green Published, gold			2022-12-26	WOS:000611969200012
J	Anvekar, AP; Nathan, EA; Doherty, DA; Patole, SK				Anvekar, Ajay P.; Nathan, Elizabeth A.; Doherty, Dorota A.; Patole, Sanjay K.			Effect of shift work on fatigue and sleep in neonatal registrars	PLOS ONE			English	Article							PSYCHOMOTOR VIGILANCE TASK; REACTION-TIME; RISK; PERFORMANCE; HEALTH; CONSEQUENCES; VARIABILITY; IMPAIRMENT; ALERTNESS; DISORDER	Objective We aimed to study fatigue and sleep in registrars working 12-hour rotating shifts in our tertiary neonatal intensive unit. Methods and participants This study involved neonatal registrar's working day (08:00-21:00) and night (20:30-08:30) shifts. Participants maintained a sleep diary, answered a self-reported sleepiness questionnaire assessing subjective sleepiness, and performed a 10-minute psychomotor vigilance task (PVT) at the start and end of each shift. Primary outcomes: (1) Fatigue at the (i) "start vs end" of day and night shifts, (ii) end of the "day vs night" shifts, and (iii) end of "first vs last shift" in block of day and night shifts. (2) Duration and quality of sleep before the "day vs night" shifts. Mean reaction time (RTM), relative coefficient of variation (RTCV), and lapses (reaction time > 500ms) were used as measures of fatigue on PVT. Secondary outcome: Subjective sleepiness (self-reported sleepiness questionnaire) at the 'start vs end" of day and night shifts. Results Fifteen registrars completed the study. Acuity was comparable for all shifts. (1) Psychomotor responses were impaired at the end vs start of day shifts [RTM (p = 0.014), lapses (p = 0.001)], end vs start of night shifts [RTM (p = 0.007), RTCV (p = 0.003), lapses (p<0.001)] and end of night vs day shifts [RTM (p = 0.007), RTCV (p = 0.046), lapses (p = 0.001)]. Only lapses were significantly increased at the end of the last (p = 0.013) vs first shift (p = 0.009) in a block of day and night shifts. (2) Duration of sleep before the night (p = 0.019) and consecutive night shifts was decreased significantly (p = 0.034). Subjective sleepiness worsened after day (p = 0.014) and night shifts (p<0.001). Conclusion Fatigue worsened after the 12-hour day and night shifts with a greater change after night shifts. Lapses increased after block of day and night shifts. Sleep was decreased before night shifts. Our findings need to be confirmed in larger studies.	[Anvekar, Ajay P.] Perth Children Hosp, Dept Neonatal Paediat, Perth, WA, Australia; [Nathan, Elizabeth A.; Doherty, Dorota A.] KEM Hosp Women, Women & Infants Res Fdn, Perth, WA, Australia; [Nathan, Elizabeth A.; Doherty, Dorota A.] Univ Western Australia, Sch Med, Div Obstet & Gynaecol, Perth, WA, Australia; [Nathan, Elizabeth A.; Doherty, Dorota A.; Patole, Sanjay K.] King Edward Mem Hosp, Dept Neonatal Paediat, Perth, WA, Australia; [Patole, Sanjay K.] Univ Western Australia, Sch Med, Perth, WA, Australia; [Anvekar, Ajay P.] Fiona Stanley Hosp, Dept Neonatal Paediat, Perth, WA, Australia	University of Western Australia; King Edward Memorial Hospital; University of Western Australia; University of Western Australia	Patole, SK (corresponding author), King Edward Mem Hosp, Dept Neonatal Paediat, Perth, WA, Australia.; Patole, SK (corresponding author), Univ Western Australia, Sch Med, Perth, WA, Australia.	sanjay.patole@health.wa.gov.au		, Sanjay/0000-0001-6704-8912; Doherty, Dorota/0000-0002-5507-9065				AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Akerstedt T, 2009, SLEEP MED CLIN, V4, P257, DOI 10.1016/j.jsmc.2009.03.001; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; Basner M, 2018, SLEEP, V41, DOI 10.1093/sleep/zsx187; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Bihari S, 2020, OCCUP MED-OXFORD, V70, P107, DOI 10.1093/occmed/kqaa013; Brown DL, 2009, AM J EPIDEMIOL, V169, P1370, DOI 10.1093/aje/kwp056; Bureau of Labor Statistics, STAND OCC CLASS GROU; Bushnell PT, 2010, IND HEALTH, V48, P395, DOI 10.2486/indhealth.MSSW-03; Carney CE, 2012, SLEEP, V35, P287, DOI 10.5665/sleep.1642; Costa G, 2006, CHRONOBIOL INT, V23, P1125, DOI 10.1080/07420520601087491; Czeisler CA, 2007, COLD SPRING HARB SYM, V72, P579, DOI 10.1101/sqb.2007.72.064; Davy J, 2018, CHRONOBIOL INT, V35, P169, DOI 10.1080/07420528.2017.1391277; DIJK DJ, 1995, J NEUROSCI, V15, P3526; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; Dorrian J, THESIS; Drake CL, 2004, SLEEP, V27, P1453, DOI 10.1093/sleep/27.8.1453; Duffy JF, 2009, SLEEP MED CLIN, V4, P165, DOI 10.1016/j.jsmc.2009.01.004; Folkard S, 2006, AM J IND MED, V49, P953, DOI 10.1002/ajim.20307; Frost P, 2009, SCAND J WORK ENV HEA, V35, P163, DOI 10.5271/sjweh.1319; Hansen J, 2006, CANCER CAUSE CONTROL, V17, P531, DOI 10.1007/s10552-005-9006-5; Jewett ME, 1999, SLEEP, V22, P171, DOI 10.1093/sleep/22.2.171; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Kamimori GH, 2015, PSYCHOPHARMACOLOGY, V232, P2031, DOI 10.1007/s00213-014-3834-5; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Khitrov MY, 2014, BEHAV RES METHODS, V46, P140, DOI 10.3758/s13428-013-0339-9; Knutson A, 2010, SCAND J WORK ENV HEA, V36, P85, DOI 10.5271/sjweh.2897; Kubo T, 2006, AM J EPIDEMIOL, V164, P549, DOI 10.1093/aje/kwj232; Lamond N, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.11.e13; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Lee IS, 2010, J CLIN SLEEP MED, V6, P163; Lockley SW, 2007, JT COMM J QUAL PATIE, V33, P7, DOI 10.1016/S1553-7250(07)33109-7; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Mahoney MM, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/813764; Maich KHG, 2018, BEHAV SLEEP MED, V16, P117, DOI 10.1080/15402002.2016.1173556; Martin-Gill C, 2018, PREHOSP EMERG CARE, V22, P47, DOI 10.1080/10903127.2017.1376136; Matthews G, 2002, EMOTION, V2, P315, DOI 10.1037//1528-3542.2.4.315; McMenamin TM, 2007, MON LABOR REV, V130, P3; Mulrine HM, 2012, CHRONOBIOL INT, V29, P1249, DOI 10.3109/07420528.2012.719957; Natale V, 2015, PSYCHOSOM MED, V77, P413, DOI 10.1097/PSY.0000000000000177; Ohayon MM, 2010, CHRONOBIOL INT, V27, P575, DOI 10.3109/07420521003749956; Oriyama S, 2017, J OCCUPATIONAL HLTH, P17, DOI [10.1539/joh.16-0167-OA, DOI 10.1539/JOH.16-0167-OA]; Rogers A. E., 2008, PATIENT SAFETY QUALI; Ruggiero JS, 2014, BIOL RES NURS, V16, P134, DOI 10.1177/1099800413476571; Ruggiero JS, 2012, BIOL RES NURS, V14, P225, DOI 10.1177/1099800411408413; Saksvik IB, 2011, SLEEP MED REV, V15, P221, DOI 10.1016/j.smrv.2010.07.002; Sallinen M, 2004, J SLEEP RES, V13, P285, DOI 10.1111/j.1365-2869.2004.00425.x; Scheer FAJL, 2008, J BIOL RHYTHM, V23, P353, DOI 10.1177/0748730408318081; Steinborn MB, 2018, PSYCHOL ASSESSMENT, V30, P339, DOI 10.1037/pas0000482; Steinborn MB, 2016, APPL COGNITIVE PSYCH, V30, P92, DOI 10.1002/acp.3172; Steinborn Michael B, 2010, Adv Cogn Psychol, V5, P105, DOI 10.2478/v10053-008-0070-8; Surani S, 2015, J PATIENT SAF, V11, P215, DOI 10.1097/PTS.0000000000000089; Temple JL, 2018, PREHOSP EMERG CARE, V22, P37, DOI 10.1080/10903127.2017.1382624; Thorpy MJ, 2012, NEUROTHERAPEUTICS, V9, P687, DOI 10.1007/s13311-012-0145-6; Tucker P, 2012, COND WORK EMPLOY SER; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2004, SLEEP, V27, P423; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; Watson NF, 2015, SLEEP, V38, P843, DOI 10.5665/sleep.4716; Wickwire EM, 2017, CHEST, V151, P1156, DOI 10.1016/j.chest.2016.12.007; Wilson M, 2019, ACCIDENT ANAL PREV, V126, P43, DOI 10.1016/j.aap.2017.09.023; Wright KP, 2013, SLEEP MED REV, V17, P41, DOI 10.1016/j.smrv.2012.02.002	63	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245428	10.1371/journal.pone.0245428	http://dx.doi.org/10.1371/journal.pone.0245428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4VV	33444333	Green Published, gold			2022-12-26	WOS:000609988100028
J	Bennett, J; Rachunok, B; Flage, R; Nateghi, R				Bennett, Jackson; Rachunok, Benjamin; Flage, Roger; Nateghi, Roshanak			Mapping climate discourse to climate opinion: An approach for augmenting surveys with social media to enhance understandings of climate opinion in the United States	PLOS ONE			English	Article							FRAMES	Surveys are commonly used to quantify public opinions of climate change and to inform sustainability policies. However, conducting large-scale population-based surveys is often a difficult task due to time and resource constraints. This paper outlines a machine learning framework-grounded in statistical learning theory and natural language processing-to augment climate change opinion surveys with social media data. The proposed framework maps social media discourse to climate opinion surveys, allowing for discerning the regionally distinct topics and themes that contribute to climate opinions. The analysis reveals significant regional variation in the emergent social media topics associated with climate opinions. Furthermore, significant correlation is identified between social media discourse and climate attitude. However, the dependencies between topic discussion and climate opinion are not always intuitive and often require augmenting the analysis with a topic's most frequent n-grams and most representative tweets to effectively interpret the relationship. Finally, the paper concludes with a discussion of how these results can be used in the policy framing process to quickly and effectively understand constituents' opinions on critical issues.	[Bennett, Jackson; Rachunok, Benjamin; Nateghi, Roshanak] Purdue Univ, Sch Ind Engn, W Lafayette, IN 47907 USA; [Bennett, Jackson; Nateghi, Roshanak] Purdue Univ, Ecol Sci & Engn, W Lafayette, IN 47907 USA; [Flage, Roger] Univ Stavanger, Dept Safety Econ & Planning, Stavanger, Norway	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Universitetet i Stavanger	Bennett, J (corresponding author), Purdue Univ, Sch Ind Engn, W Lafayette, IN 47907 USA.; Bennett, J (corresponding author), Purdue Univ, Ecol Sci & Engn, W Lafayette, IN 47907 USA.	benne105@purdue.edu		Rachunok, Benjamin/0000-0001-6405-978X; Flage, Roger/0000-0002-2967-9104	National Science Foundation [1826161, 1728209]; Purdue Graduate School Charles C. Chappelle Fellowship	National Science Foundation(National Science Foundation (NSF)); Purdue Graduate School Charles C. Chappelle Fellowship	RN - National Science Foundation Grant #1826161 (https://www.nsf.gov/) RN - National Science Foundation Grant #1728209 (https://www.nsf.gov/) JB - Purdue Graduate School Charles C. Chappelle Fellowship (https://www.purdue.edu/gradschool/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An X., 2014, KDD; Bird Steven, 2009, NATURAL LANGUAGE PRO; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Breiman L., 2001, MACH LEARN, V45, P5; Cannell C.F., 1981, SOCIOL METHODOL, V12, P389, DOI DOI 10.2307/270748; Cody EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136092; Fownes JR, 2018, SOCIOL COMPASS, V12, DOI 10.1111/soc4.12587; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Glynn C.J., 2015, PUBLIC OPINION; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hamilton LC, 2009, INT J CLIMATOL, V29, P2348, DOI 10.1002/joc.1930; Herring SC, 2015, B AM METEOROL SOC, V96, pS1, DOI 10.1175/BAMS-D-15-00157.1; Howe PD, 2015, NAT CLIM CHANGE, V5, P596, DOI 10.1038/nclimate2583; Jang SM, 2015, GLOBAL ENVIRON CHANG, V32, P11, DOI 10.1016/j.gloenvcha.2015.02.010; Kirilenko AP, 2015, GLOBAL ENVIRON CHANG, V30, P92, DOI 10.1016/j.gloenvcha.2014.11.003; Kirilenko AP, 2014, GLOBAL ENVIRON CHANG, V26, P171, DOI 10.1016/j.gloenvcha.2014.02.008; KROSNICK JA, 1991, APPL COGNITIVE PSYCH, V5, P213, DOI 10.1002/acp.2350050305; Mann ME, 2015, P NATL ACAD SCI USA, V112, P3858, DOI 10.1073/pnas.1503667112; McCallum, 2002, MALLET MACHINE LEARN; Milfont TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103180; Nisbet MC, 2009, ENVIRONMENT, V51, P12, DOI 10.3200/ENVT.51.2.12-23; Palen L, 2016, SCIENCE, V353, P224, DOI 10.1126/science.aag2579; Pasek J., 2010, OXFORD HDB AM ELECTI, P27; Pearce W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094785; Rehurek R, 2010, P LREC 2010 WORKSHOP, P45; Roder M, 2015, WSDM'15: PROCEEDINGS OF THE EIGHTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING, P399, DOI 10.1145/2684822.2685324; Roxburgh N, 2019, GLOBAL ENVIRON CHANG, V54, P50, DOI 10.1016/j.gloenvcha.2018.11.004; Silva C, 2003, IEEE IJCNN, P1661; Turner C, 1985, SURVEYING SUBJECTIVE, V2; Williams HTP, 2015, GLOBAL ENVIRON CHANG, V32, P126, DOI 10.1016/j.gloenvcha.2015.03.006; Zhao WNX, 2011, LECT NOTES COMPUT SC, V6611, P338, DOI 10.1007/978-3-642-20161-5_34	32	4	4	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245319	10.1371/journal.pone.0245319	http://dx.doi.org/10.1371/journal.pone.0245319			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4VV	33444371	Green Published, gold			2022-12-26	WOS:000609988100045
J	Mitchell, G; Leonard, L; Carter, G; Santin, O; Wilson, CB				Mitchell, Gary; Leonard, Laurence; Carter, Gillian; Santin, Olinda; Brown Wilson, Christine			Evaluation of a 'serious game' on nursing student knowledge and uptake of influenza vaccination	PLOS ONE			English	Article							HEALTH-CARE WORKERS; SEASONAL INFLUENZA; ATTITUDES; IMMUNIZATION	Background Influenza is a serious global healthcare issue that is associated with between 290,000 to 650,000 deaths annually. The aim of this study is to evaluate the effect of a 'serious game' about influenza, on nursing student attitude, knowledge and uptake of the influenza vaccination. Methods 1306 undergraduate nursing students were invited, via email, to play an online game about influenza between September 2018 and March 2019. 430 nursing students accessed the game and completed an 8-item questionnaire measuring their attitudes to influenza between September 2018 and March 2019. In April 2019, 356 nursing students from this sample completed a follow-up 2-item questionnaire about their uptake of the influenza vaccination. A larger separate 40-item knowledge questionnaire was completed by a year one cohort of 124 nursing students in August 2018 prior to receiving access to the game and then after access to the game had ended, in April 2019. This sample was selected to determine the extent to which the game improved knowledge about influenza amongst a homogenous group. Results In the year preceding this study, 36.7% of the sample received an influenza vaccination. This increased to 47.8% after accessing to the game. Nursing students reported perceived improvements in their knowledge, intention to get the vaccination and intention to recommend the vaccination to their patients after playing the game. Nursing students who completed the 40-item pre- and post-knowledge questionnaire scored an average of 68.6% before receiving access to the game and 85.2% after. Using Paired T-Tests statistical analysis, it was determined that this 16.6% increase was highly statistically significant (P < 0.001). Conclusions The research highlights that the influenza game can improve knowledge and intention to become vaccinated. This study suggests that improvement in influenza knowledge is likely to encourage more nursing students to receive the influenza vaccination.	[Mitchell, Gary; Leonard, Laurence; Carter, Gillian; Santin, Olinda; Brown Wilson, Christine] Queens Univ Belfast, Sch Nursing & Midwifery, Belfast, Antrim, North Ireland	Queens University Belfast	Mitchell, G (corresponding author), Queens Univ Belfast, Sch Nursing & Midwifery, Belfast, Antrim, North Ireland.	Gary.Mitchell@qub.ac.uk		Mitchell, Gary/0000-0003-2133-2998; Santin, Olinda/0000-0001-7600-0259				Abu-Gharbieh Eman, 2010, Int J Med Sci, V7, P319; Advisory Committee on Immunization Practices (ACIP), 2020, REC AD IMM SCHED US; Akl EA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006411.pub4; [Anonymous], 2017, DIG ENDOSC S1, V29, P1, DOI [10.1111/den.2017.29. issue-S1/issuetoc, DOI 10.1017/S0954394517000060]; [Anonymous], 2015, DIABETOL KLIN SA, V4, pA1; Baguelin M, 2012, VACCINE, V30, P3459, DOI 10.1016/j.vaccine.2012.03.019; Baranowski T, 2008, AM J PREV MED, V34, P74, DOI 10.1016/j.amepre.2007.09.027; Betsch C, 2012, VACCINE, V30, P1143, DOI 10.1016/j.vaccine.2011.12.021; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Black CL, 2018, MMWR-MORBID MORTAL W, V67, P1050, DOI 10.15585/mmwr.mm6738a2; Blakely G, 2010, NURS HEALTH SCI, V12, P27, DOI 10.1111/j.1442-2018.2009.00479.x; Blakely G, 2009, J ADV NURS, V65, P259, DOI 10.1111/j.1365-2648.2008.04843.x; Burgess RA, 2021, LANCET, V397, P8, DOI 10.1016/S0140-6736(20)32642-8; Marti MC, 2014, ENFERM INFEC MICR CL, V32, P259, DOI 10.1016/j.eimc.2014.02.002; Castro-Sanchez E, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0137-0; Chen SC, 2012, VACCINE, V30, P493, DOI 10.1016/j.vaccine.2011.04.032; Cornally Nicola, 2013, Br J Nurs, V22, P1207; Cozza V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2067-9; Cugelman B, 2013, JMIR SERIOUS GAMES, V1, P2, DOI 10.2196/games.3139; Dennison L, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2583; Derber CJ, 2012, CURR INFECT DIS REP, V14, P627, DOI 10.1007/s11908-012-0291-3; European Centre for Disease Prevention and Control, 2015, SEAS INFL VACC ANT E; FitzSimons D, 2014, VACCINE, V32, P4849, DOI 10.1016/j.vaccine.2014.06.072; Ford M., NURS TIMES; Ghandora H, 2019, HUM VACC IMMUNOTHER, V15, P700, DOI 10.1080/21645515.2018.1543523; Hofmann F, 2006, INFECTION, V34, P142, DOI 10.1007/s15010-006-5109-5; Hollmeyer H, 2013, INFLUENZA OTHER RESP, V7, P604, DOI 10.1111/irv.12002; Hollmeyer HG, 2009, VACCINE, V27, P3935, DOI 10.1016/j.vaccine.2009.03.056; Hopman CE, 2011, J HOSP INFECT, V77, P327, DOI 10.1016/j.jhin.2010.10.009; Hulo S, 2017, VACCINE, V35, P205, DOI 10.1016/j.vaccine.2016.11.086; Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2; Kin C, 2017, VACCINE, V35, P1482, DOI 10.1016/j.vaccine.2017.02.001; Koharchik L. S., 2012, Journal of Infection Prevention, V13, P186, DOI 10.1177/1757177412462494; Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9; Lehmann B.A., 2015, BMC PUBLIC HLTH; Lewthwaite P, 2014, OCCUP MED-OXFORD, V64, P348, DOI 10.1093/occmed/kqu048; Maltezou HC, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030047; Molnar A, 2019, TRENDS MICROBIOL, V27, P1, DOI 10.1016/j.tim.2018.09.007; National Health Service, WHO SHOULD HAV FLU V; National Institute of Clinical Excellence, 2020, IMM SEAS INFL; Paget J, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.020421; Petek D, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3659-8; Public Health England, 2020, SEAS INFL VACC UPT H; Schmid P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170550; Seale H, 2010, INFLUENZA OTHER RESP, V4, P41, DOI 10.1111/j.1750-2659.2009.00112.x; Shrikrishna D, 2015, BMJ OPEN RESPIR RES, V2, DOI 10.1136/bmjresp-2015-000079; Socan M, 2013, EUR J PUBLIC HEALTH, V23, P92, DOI 10.1093/eurpub/cks006; Stead M, 2019, INFECT DIS HEALTH, V24, P3, DOI 10.1016/j.idh.2018.09.082; Troeger C, 2018, LANCET INFECT DIS, V18, P1191, DOI 10.1016/S1473-3099(18)30310-4; World Health Organization, 2019, GLOBAL INFLUENZA STR; Yu ZG, 2019, INT J COMPUT GAMES T, V2019, DOI 10.1155/2019/4797032	51	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245389	10.1371/journal.pone.0245389	http://dx.doi.org/10.1371/journal.pone.0245389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444348	Green Published, gold			2022-12-26	WOS:000609988100034
J	Ong, SWX; Hui, TCH; Lee, YS; Mohideen, SMH; Young, BE; Tan, CH; Lye, DC				Ong, Sean Wei Xiang; Hui, Terrence Chi Hong; Lee, Yeong Shyan; Haja Mohideen, Salahudeen Mohamed; Young, Barnaby Edward; Tan, Cher Heng; Lye, David Chien			High-risk chest radiographic features associated with COVID-19 disease severity	PLOS ONE			English	Article								Objectives High-risk CXR features in COVID-19 are not clearly defined. We aimed to identify CXR features that correlate with severe COVID-19. Methods All confirmed COVID-19 patients admitted within the study period were screened. Those with suboptimal baseline CXR were excluded. CXRs were reviewed by three independent radiologists and opacities recorded according to zones and laterality. The primary endpoint was defined as hypoxia requiring supplemental oxygen, and CXR features were assessed for association with this endpoint to identify high-risk features. These features were then used to define criteria for a high-risk CXR, and clinical features and outcomes of patients with and without baseline high-risk CXR were compared using logistic regression analysis. Results 109 patients were included. In the initial analysis of 40 patients (36.7%) with abnormal baseline CXR, presence of bilateral opacities, multifocal opacities, or any upper or middle zone opacity were associated with supplemental oxygen requirement. Of the entire cohort, 29 patients (26.6%) had a baseline CXR with at least one of these features. Having a high-risk baseline CXR was significantly associated with requiring supplemental oxygen in univariate (odds ratio 14.0, 95% confidence interval 3.90-55.60) and multivariate (adjusted odds ratio 8.38, 95% CI 2.43-28.97, P = 0.001) analyses. Conclusion We identified several high-risk CXR features that are significantly associated with severe illness. The association of upper or middle zone opacities with severe illness has not been previously emphasized. Recognition of these specific high-risk CXR features is important to prioritize limited healthcare resources for sicker patients.	[Ong, Sean Wei Xiang; Young, Barnaby Edward; Lye, David Chien] Natl Ctr Infect Dis, Singapore, Singapore; [Ong, Sean Wei Xiang; Young, Barnaby Edward; Lye, David Chien] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore; [Hui, Terrence Chi Hong; Lee, Yeong Shyan; Tan, Cher Heng] Tan Tock Seng Hosp, Dept Diagnost Radiol, Singapore, Singapore; [Haja Mohideen, Salahudeen Mohamed] Singapore Gen Hosp, Dept Diagnost Radiol, Singapore, Singapore; [Young, Barnaby Edward; Tan, Cher Heng; Lye, David Chien] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Lye, David Chien] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore	National Centre for Infectious Diseases Singapore; Tan Tock Seng Hospital; Tan Tock Seng Hospital; Singapore General Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Tan, CH (corresponding author), Tan Tock Seng Hosp, Dept Diagnost Radiol, Singapore, Singapore.; Tan, CH (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.	cher_heng_tan@ttsh.com.sg	Lye, David/ABF-4402-2021; Young, Barnaby/GVR-9935-2022; Ong, Sean/AAO-9560-2020	Ong, Sean/0000-0002-8570-436X; Lye, David/0000-0003-0324-0205; Young, Barnaby/0000-0003-1010-2230	NMRC COVID-19 Research Fund [COVID19RF-001]	NMRC COVID-19 Research Fund	Funding: This study was funded by the NMRC COVID-19 Research Fund (COVID19RF-001). The funding sources had no role in study design, data analysis and collection, interpretation of results, or decision to submit the paper for publication.	Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; [Anonymous], 2020, COVID 19 CRF ISARIC; [Anonymous], 2020, THOR IM COVID 19 INF; Borghesi A, 2020, RADIOL MED, V125, P461, DOI 10.1007/s11547-020-01202-1; Cleverley J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2426; Colombi D, 2020, RADIOLOGY, V296, pE86, DOI 10.1148/radiol.2020201433; Galloway JB, 2020, J INFECTION, V81, P282, DOI 10.1016/j.jinf.2020.05.064; Gong J, 2020, CLIN INFECT DIS, V71, P833, DOI 10.1093/cid/ciaa443; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hui TCH, 2020, QUANT IMAG MED SURG, V10, P1540, DOI 10.21037/qims-20-642; Ji D, 2020, CLIN INFECT DIS, V71, P1393, DOI 10.1093/cid/ciaa414; Li LL, 2020, THERANOSTICS, V10, P6113, DOI 10.7150/thno.46569; Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033; Liu YP, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-2372; Rubin GD, 2020, RADIOLOGY, V296, P172, DOI [10.1016/j.chest.2020.04.003, 10.1148/radiol.2020201365]; Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012; Wong HYF., 2019, RADIOLOGY, DOI [10.1148/radiol.2020201160, DOI 10.1148/RADIOL.2020201160]; Yang Q, 2020, EUR J RADIOL, V127, DOI 10.1016/j.ejrad.2020.109008; Zeng YW, 2020, QUANT IMAG MED SURG, V10, P1150, DOI 10.21037/qims.2020.04.10	20	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245518	10.1371/journal.pone.0245518	http://dx.doi.org/10.1371/journal.pone.0245518			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444415	Green Published, gold			2022-12-26	WOS:000609988100089
J	Satpathy, S; Patra, A; Hussain, MD; Kazi, M; Aldughaim, MS; Ahirwar, B				Satpathy, Swaha; Patra, Arjun; Hussain, Muhammad Delwar; Kazi, Mohsin; Aldughaim, Mohammed S.; Ahirwar, Bharti			A fraction of Pueraria tuberosa extract, rich in antioxidant compounds, alleviates ovariectomized-induced osteoporosis in rats and inhibits growth of breast and ovarian cancer cells	PLOS ONE			English	Article							BONE LOSS; ESTROGEN; GENISTEIN; DAIDZEIN; FRACTURE; FLAVONOIDS; DIFFERENCE; MIRIFICA; UTERUS; LINN.	Pueraria tuberosa (Roxb. ex Willd.) DC., known as Indian Kudzu belongs to family Fabaceae and it is solicited as "Rasayana" drugs in Ayurveda. In the present study, we analyzed the efficacy of an ethyl acetate fraction from the tuber extract of Pueraria tuberosa (fraction rich in antioxidant compounds, FRAC) against menopausal osteoporosis, and breast and ovarian cancer cells. The FRAC from Pueraria tuberosa was characterized for its phenolic composition (total phenolic and flavonoid amount). Antioxidant property (in vitro assays) of the FRAC was also carried out followed by the analysis of the FRAC for its antiosteoporotic and anticancer potentials. The antiosteoporotic activity of FRAC was investigated in ovariectomy-induced osteoporosis in rats. The cytotoxicity effect was determined in breast and ovarian cancer cells. Gas chromatography/mass spectrometry (GC/MS) analysis of the FRAC was performed to determine its various phytoconstituents. Docking analysis was performed to verify the interaction of bioactive molecules with estrogen receptors (ERs). The FRAC significantly improved various biomechanical and biochemical parameters in a dose-dependent manner in the ovariectomized rats. FRAC also controlled the increased body weight and decreased uterus weight following ovariectomy in rats. Histopathology of the femur demonstrated the restoration of typical bone structure and trabecular width in ovariectomized animals after treatment with FRAC and raloxifene. The FRAC also exhibited in vitro cytotoxicity in the breast (MCF-7 and MDA-MB-231) and ovarian (SKOV-3) cancer cells. Furthermore, genistein and daidzein exhibited a high affinity towards both estrogen receptors (alpha and beta) in the docking study revealing the probable mechanism of the antiosteoporotic activity. GC/MS analysis confirmed the presence of other bioactive molecules such as stigmasterol, beta-sitosterol, and stigmasta-3,5-dien-7-one. The FRAC from Pueraria tuberosa has potential for treatment of menopausal osteoporosis. Also, the FRAC possesses anticancer activity.	[Satpathy, Swaha; Patra, Arjun; Ahirwar, Bharti] Guru Ghasidas Univ, Inst Pharm, Bilaspur, CG, India; [Hussain, Muhammad Delwar] Calif Hlth Sci Univ, Coll Pharm, Dept Pharmaceut & Biomed Sci, Clovis, CA 93612 USA; [Kazi, Mohsin] King Saud Univ, Coll Pharm, Dept Pharmaceut, Riyadh, Saudi Arabia; [Aldughaim, Mohammed S.] King Fahad Med City, Res Ctr, Riyadh, Saudi Arabia; [Satpathy, Swaha] Sambalpur Univ, Dept Biotechnol & Bioinformat, Sambalpur, Odisha, India	Guru Ghasidas Vishwavidyalaya; California Health Sciences University (CHSU); King Saud University; King Fahad Medical City; Sambalpur University	Satpathy, S (corresponding author), Guru Ghasidas Univ, Inst Pharm, Bilaspur, CG, India.; Hussain, MD (corresponding author), Calif Hlth Sci Univ, Coll Pharm, Dept Pharmaceut & Biomed Sci, Clovis, CA 93612 USA.; Satpathy, S (corresponding author), Sambalpur Univ, Dept Biotechnol & Bioinformat, Sambalpur, Odisha, India.	swaha22@rediffmail.com; dhussain@chsu.edu	Kazi, Mohsin/B-4417-2010	Kazi, Mohsin/0000-0002-5611-0378	University Grants Commission, New Delhi, India [F.NO.563/2016(IC)]	University Grants Commission, New Delhi, India(University Grants Commission, India)	The authors deeply acknowledge University Grants Commission, New Delhi, India, for financial support as Raman Fellowship [F.NO.563/2016(IC)] to AP.	Arjmandi BH, 1996, J NUTR, V126, P161, DOI 10.1093/jn/126.1.161; Arjun P, 2009, PHARMACOGN MAG, V5, P51; Bidwell JP, 2013, CURR OSTEOPOROS REP, V11, P117, DOI 10.1007/s11914-013-0139-2; Desai S, 2017, J ETHNOPHARMACOL, V199, P1, DOI 10.1016/j.jep.2017.01.031; El-Shitany NA, 2010, PHYTOMEDICINE, V17, P116, DOI 10.1016/j.phymed.2009.05.012; Gaete L, 2012, J MED FOOD, V15, P1081, DOI 10.1089/jmf.2011.0322; Gambacciani M, 2014, MENOPAUSE REV, V13, P213, DOI 10.5114/pm.2014.44996; GREEN CJ, 1981, LAB ANIM, V15, P163, DOI 10.1258/002367781780959107; Halleen JM, 2000, J BONE MINER RES, V15, P1337, DOI 10.1359/jbmr.2000.15.7.1337; Harisa GI, 2017, SAUDI PHARM J, V25, P120, DOI 10.1016/j.jsps.2016.05.007; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Hertrampf T, 2007, BONE, V40, P1529, DOI 10.1016/j.bone.2007.02.006; Hirota K, 2010, J AGR FOOD CHEM, V58, P5821, DOI 10.1021/jf903911e; Ishimi Y, 2000, BIOCHEM BIOPH RES CO, V274, P697, DOI 10.1006/bbrc.2000.3175; Jia M, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/364604; Kaplan JR, 2004, ILAR J, V45, P89, DOI 10.1093/ilar.45.2.89; Keshri G, 2007, CONTRACEPTION, V76, P400, DOI 10.1016/j.contraception.2007.07.009; Kharazmi M, 2014, ANN RHEUM DIS, V73, P1594, DOI 10.1136/annrheumdis-2013-205080; Kolios L, 2010, PLANTA MED, V76, P850, DOI 10.1055/s-0029-1240798; Kraenzlin ME, 2011, NAT REV ENDOCRINOL, V7, P647, DOI 10.1038/nrendo.2011.108; Madaan R, 2011, INDIAN J PHARM SCI, V73, P666, DOI 10.4103/0250-474X.100242; Maji AK, 2014, NAT PROD RES, V28, P2111, DOI 10.1080/14786419.2014.928291; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Nadia ME, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/706905; Nazrun AS, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/142702; Occhiuto F, 2007, PHYTOTHER RES, V21, P130, DOI 10.1002/ptr.2037; OMI N, 1995, BONE, V17, pS163, DOI 10.1016/8756-3282(95)00329-C; Patra A, 2018, INT J NANOMED, V13, P2869, DOI 10.2147/IJN.S153094; Picherit C, 2000, J NUTR, V130, P1675, DOI 10.1093/jn/130.7.1675; Pires DEV, 2015, J MED CHEM, V58, P4066, DOI 10.1021/acs.jmedchem.5b00104; Powers Chelsea N., 2015, In Silico Pharmacology, V3, P4, DOI 10.1186/s40203-015-0008-z; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sanchez-Rodriguez MA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-124; Satpathy S, 2018, S AFR J BOT, V117, P247, DOI 10.1016/j.sajb.2018.05.033; Satpathy S, 2017, J LIQ CHROMATOGR R T, V40, P499, DOI 10.1080/10826076.2017.1329743; Satpathy Swaha, 2015, J Complement Integr Med, V12, P251, DOI 10.1515/jcim-2015-0034; Shirwaikar A, 2003, J ETHNOPHARMACOL, V89, P245, DOI 10.1016/j.jep.2003.08.004; Spigno G, 2009, J FOOD ENG, V93, P210, DOI 10.1016/j.jfoodeng.2009.01.006; Subramanian S, 2012, INT J PHARM SCI RES, V3, P228, DOI 10.13040/IJPSR.0975-8232.3(1).227-34; Sulaiman C. T., 2015, Asian Pacific Journal of Reproduction, V4, P153; Suthon S, 2016, J NAT MED-TOKYO, V70, P225, DOI 10.1007/s11418-016-0965-5; Tanaka T, 2011, J AGR FOOD CHEM, V59, P13230, DOI 10.1021/jf2031617; Urasopon N, 2008, MATURITAS, V59, P137, DOI 10.1016/j.maturitas.2008.01.001; Wasnich RD, 1998, J CLIN DENSITOM, V1, P259, DOI 10.1385/JCD:1:3:259; World Health Organization Scientific Group, 2007, SCI GROUP ASS OST PR; Yogesh HS, 2011, J ETHNOPHARMACOL, V134, P334, DOI 10.1016/j.jep.2010.12.013	47	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0240068	10.1371/journal.pone.0240068	http://dx.doi.org/10.1371/journal.pone.0240068			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444328	gold, Green Published			2022-12-26	WOS:000609988100093
J	Paul, S; Dadwal, R; Singh, S; Shaw, D; Chakrabarti, A; Rudramurthy, SM; Ghosh, AK				Paul, Saikat; Dadwal, Rajneesh; Singh, Shreya; Shaw, Dipika; Chakrabarti, Arunaloke; Rudramurthy, Shivaprakash M.; Ghosh, Anup K.			Rapid detection of ERG11 polymorphism associated azole resistance in Candida tropicalis	PLOS ONE			English	Article							T-ARMS-PCR; DRUG-RESISTANCE; SUSCEPTIBILITY; MECHANISMS; VALIDATION; MUTATIONS; EUCAST; GENE	Increasing reports of azole resistance in Candida tropicalis, highlight the development of rapid resistance detection techniques. Nonsynonymous mutations in the lanosterol C14 alpha-demethylase (ERG11) gene is one of the predominant mechanisms of azole resistance in C. tropicalis. We evaluated the tetra primer-amplification refractory mutation system-PCR (T-ARMS-PCR), restriction site mutation (RSM), and high-resolution melt (HRM) analysis methods for rapid resistance detection based on ERG11 polymorphism in C. tropicalis. Twelve azole-resistant and 19 susceptible isolates of C. tropicalis were included. DNA sequencing of the isolates was performed to check the ERG11 polymorphism status among resistant and susceptible isolates. Three approaches T-ARMS-PCR, RSM, and HRM were evaluated and validated for the rapid detection of ERG11 mutation. The fluconazole MICs for the 12 resistant and 19 susceptible isolates were 32-256 mg/L and 0.5-1 mg/L, respectively. The resistant isolates showed A339T and C461T mutations in the ERG11 gene. The T-ARMS-PCR and RSM approaches discriminated all the resistant and susceptible isolates, whereas HRM analysis differentiated all except one susceptible isolate. The sensitivity, specificity, analytical sensitivity, time, and cost of analysis suggests that these three methods can be utilized for the rapid detection of ERG11 mutations in C. tropicalis. Additionally, an excellent concordance with DNA sequencing was noted for all three methods. The rapid, sensitive, and inexpensive T-ARMS-PCR, RSM, and HRM approaches are suitable for the detection of azole resistance based on ERG11 polymorphism in C. tropicalis and can be implemented in clinical setups for batter patient management.	[Paul, Saikat; Dadwal, Rajneesh; Singh, Shreya; Shaw, Dipika; Chakrabarti, Arunaloke; Rudramurthy, Shivaprakash M.; Ghosh, Anup K.] Postgrad Inst Med Educ & Res PGIMER, Dept Med Microbiol, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Ghosh, AK (corresponding author), Postgrad Inst Med Educ & Res PGIMER, Dept Med Microbiol, Chandigarh, India.	anupkg3@gmail.com	Dadwal, Rajneesh/AAO-9851-2021	Dadwal, Rajneesh/0000-0002-8539-3071; PAUL, SAIKAT/0000-0003-3670-4125; Ghosh, Anup/0000-0002-0341-6680	Indian Council of Medical Research (ICMR), Government of India [71/2-Edu-16/4856]	Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR))	We have completed the study as a part of a PhD thesis and by utilizing the institutional research grant (No. 71/2-Edu-16/4856 Dated: 12/12/2017, Budget allotment of Rs. 4,75,000/-). Additionally, the manpower for this study was supported by the Indian Council of Medical Research (ICMR), Government of India.	Abbes S, 2011, MED MYCOL, V49, P10, DOI 10.3109/13693786.2010.493561; Alastruey-Izquierdo A, 2012, CURR FUNGAL INFECT R, V6, P229, DOI 10.1007/s12281-012-0100-3; Alyethodi Rafeeque R, 2018, BMC Res Notes, V11, P132, DOI 10.1186/s13104-018-3236-6; Arastehfar A, 2020, MED MYCOL, V58, P766, DOI 10.1093/mmy/myz124; Caban M, 2016, CURR MICROBIOL, V73, P172, DOI 10.1007/s00284-016-1039-3; Calderone R.A.C.C.J., 2012, CANDIDA CANDIDIASIS; Chakrabarti A, 2015, INTENS CARE MED, V41, P285, DOI 10.1007/s00134-014-3603-2; Chen PY, 2019, EMERG INFECT DIS, V25, P1668, DOI 10.3201/eid2509.190520; Choi MJ, 2016, ANTIMICROB AGENTS CH, V60, P3653, DOI 10.1128/AAC.02652-15; Chong Y, 2012, J INFECT CHEMOTHER, V18, P741, DOI 10.1007/s10156-012-0412-9; Clinical and Laboratory Standards Institute, 2012, M27S4 CLSI S; CLSI (Clinical and Laboratory Standards Institute), 2008, M27A3 CLSI, V28, P25; Collins A, 2012, OPEN BIOINFORM J, V6, P55, DOI [DOI 10.2174/1875036201206010055, 10.2174/18750 36201206010055]; Eddouzi J, 2013, ANTIMICROB AGENTS CH, V57, P3182, DOI 10.1128/AAC.00555-13; Espinel-Ingroff A, 2013, CURR FUNGAL INFECT R, V7, P59, DOI 10.1007/s12281-012-0125-7; Etlik O, 2011, MOL CELL PROBE, V25, P177, DOI 10.1016/j.mcp.2011.04.005; EUCAST, 2017, BREAKPOINT TABLES IN; Fan X, 2019, CLIN MICROBIOL INFEC, V25, P885, DOI 10.1016/j.cmi.2018.11.007; Fan X, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00464; Ghosh AK, 2015, CLIN MICROBIOL INFEC, V21, P372, DOI 10.1016/j.cmi.2014.11.009; Heidari MM, 2017, IRAN J BIOTECHNOL, V15, P208, DOI 10.15171/ijb.1307; Hou X, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01811-18; Jenkins GJS, 1998, MUTAT RES-FUND MOL M, V405, P209, DOI 10.1016/S0027-5107(98)00138-9; Jiang C, 2013, J ANTIMICROB CHEMOTH, V68, P778, DOI 10.1093/jac/dks481; Kidd SE, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02903; Kim TH, 2010, FOLIA MICROBIOL, V55, P301, DOI 10.1007/s12223-010-0045-2; Lin PC, 2012, CLIN CHIM ACTA, V413, P1092, DOI 10.1016/j.cca.2012.03.007; Loeffler J, 2000, CLIN CHEM, V46, P631; Lortholary O, 2017, INTENS CARE MED, V43, P652, DOI 10.1007/s00134-017-4743-y; Mandviwala T, 2010, J MOL DIAGN, V12, P91, DOI 10.2353/jmoldx.2010.090085; Megri Y, 2020, ANTIMICROB RESIST IN, V9, DOI 10.1186/s13756-020-00710-z; Paul S, 2020, J GLOB ANTIMICROB RE, V22, P553, DOI 10.1016/j.jgar.2020.04.018; Perlin DS, 2017, LANCET INFECT DIS, V17, pE383, DOI 10.1016/S1473-3099(17)30316-X; Perlin DS, 2009, CURR OPIN INFECT DIS, V22, P568, DOI 10.1097/QCO.0b013e3283321ce5; Pfaller MA, 2014, DIAGN MICR INFEC DIS, V79, P198, DOI 10.1016/j.diagmicrobio.2014.03.004; Schalasta, 1997, BIOCHEMS; Shankarnarayan SA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58187-0; Steingrimsdottir H, 1996, MUTAT RES-FUND MOL M, V353, P109, DOI 10.1016/0027-5107(95)00244-8; Tan JW, 2015, MYCOPATHOLOGIA, V179, P213, DOI 10.1007/s11046-014-9831-8; Medrano RFV, 2014, MOL BIOTECHNOL, V56, P599, DOI 10.1007/s12033-014-9734-4; Wang HP, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-167; Whaley SG, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02173; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wu PF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.74; Xisto MIDS, 2017, J ANTIMICROB CHEMOTH, V72, P988, DOI 10.1093/jac/dkw558; Zhao YN, 2016, ANTIMICROB AGENTS CH, V60, P6573, DOI 10.1128/AAC.01574-16; Zuza-Alves DL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01927	47	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0245160	10.1371/journal.pone.0245160	http://dx.doi.org/10.1371/journal.pone.0245160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439909	Green Published, gold			2022-12-26	WOS:000609985300010
J	Cui, Y; Guo, LT; Mu, QX; Cheng, Q; Kang, L; He, YN; Tang, M; Wu, QY				Cui, Yu; Guo, Langtao; Mu, Qixia; Cheng, Qin; Kang, Lu; He, Yani; Tang, Min; Wu, Qunying			Sleep deprivation did not enhance the success rate of chloral hydrate sedation for non-invasive procedural sedation in pediatric patients	PLOS ONE			English	Article							SAFETY; EFFICACY	Study objective In Asian countries, oral chloral hydrate is the most commonly used sedative for non-invasive procedures. Theoretically, mild sleep deprivation could be considered as one of assisted techniques. However, there is no consensus on sleep deprivation facilitating the sedation during non-painful procedures in children. The aim of our study is to analyze the clinical data of children undergoing non-invasive procedural sedation retrospectively and to evaluate the association between mild sleep deprivation and sedative effects in non-invasive procedures. Measurements Consecutive patients undergoing chloral hydrate sedation for non-invasive procedures between December 1, 2019 to June 30, 2020 were included in this study. The propensity score analysis with 1: 1 ratio was used to match the baseline variables between patients with sleep deprivation and non-sleep deprivation. The primary outcome was the failure rate of sedation with the initial dose. The secondary outcomes included the failure rate of sedation after supplementation of chloral hydrate, the incidence of major and minor adverse events, initial and supplemental dose of chloral hydrate, and the length of sedation time. Main results Of the 7789 patients undergoing chloral hydrate sedation, 6352 were treated with sleep deprivation and 1437 with non-sleep deprivation. After propensity score matching, 1437 pairs were produced. The failure rate of sedation with initial chlorate hydrate was not significantly different in two groups (8.6% [123/1437] vs. 10.6% [152/1437], p = 0.08), nor were the failure rates with supplemental chlorate hydrate (0.8% [12/1437] vs. 0.9% [13/1437], p = 1) and the length of sedation time (58 [45, 75] vs. 58 [45, 75] min; p = 0.93). Conclusions The current results do not support sleep deprivation have a beneficial effect in reducing the pediatric chloral hydrate sedation failure rate. The routine use of sleep deprivation for pediatric sedation is unnecessary.	[Cui, Yu; Guo, Langtao; Mu, Qixia; Cheng, Qin; Kang, Lu; He, Yani; Tang, Min; Wu, Qunying] UESTC Chengdu Womens & Childrens Cent Hosp, Dept Anesthesiol, Affiliated Hosp, Sch Med, Chengdu, Sichuan, Peoples R China		Cui, Y (corresponding author), UESTC Chengdu Womens & Childrens Cent Hosp, Dept Anesthesiol, Affiliated Hosp, Sch Med, Chengdu, Sichuan, Peoples R China.	cuiyu19831001@163.com	guo, langtao/GVS-1692-2022	Cui, Yu/0000-0002-1481-9389				Caldwell JC, 2006, ENVIRON HEALTH PERSP, V114, P1457, DOI 10.1289/ehp.8692; Karaoui M, 2018, AM J OPHTHALMOL, V192, P39, DOI 10.1016/j.ajo.2018.05.003; Krauss B, 2006, LANCET, V367, P766, DOI 10.1016/S0140-6736(06)68230-5; Lei H, 2020, ACTA ANAESTH SCAND, V64, P464, DOI 10.1111/aas.13509; Malia L, 2019, AM J EMERG MED, V37, P85, DOI 10.1016/j.ajem.2018.04.063; Mataftsi A, 2017, BRIT J OPHTHALMOL, V101, P1423, DOI 10.1136/bjophthalmol-2016-309449; Ong HT, 2004, CLIN NEUROPHYSIOL, V115, P951, DOI 10.1016/j.clinph.2003.11.012; Seo JS, 2013, EMERG MED J, V30, DOI 10.1136/emermed-2011-200997; Shields CH, 2004, PEDIATRICS, V113, P1204, DOI 10.1542/peds.113.5.1204; Shuangquan Qu, 2017, CHIN J ANESTHSIOL, V37, P1254; Thomas DA, 1996, EUR RESPIR J, V9, P932, DOI 10.1183/09031936.96.09050932; Valenzuela DG, 2016, INT J PEDIATR OTORHI, V83, P175, DOI 10.1016/j.ijporl.2016.02.006; Wilson ME, 2014, J PEDIAT OPHTH STRAB, V51, P154, DOI 10.3928/01913913-20140311-01; Zielinska M, 2019, PEDIATR ANESTH, V29, P583, DOI 10.1111/pan.13615	14	2	2	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245338	10.1371/journal.pone.0245338	http://dx.doi.org/10.1371/journal.pone.0245338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434236	Green Published, gold			2022-12-26	WOS:000609979700015
J	Gomes, LMRD; Czeczko, NG; Araujo, RLTM; Cartagenes, MDD; Neto, JOB; Garcia, JBS				Gomes, Lyvia Maria Rodrigues de Sousa; Czeczko, Nicolau Gregori; Araujo, Rayanne Luiza Tajra Mualem; Cartagenes, Maria do Socorro de Sousa; Barbosa Neto, Jose Osvaldo; Garcia, Joao Batista Santos			Effect of intra-articular dexmedetomidine on experimental osteoarthritis in rats	PLOS ONE			English	Article							ARTHROSCOPIC KNEE SURGERY; ARTICULAR-CARTILAGE; PAIN; MODEL; ANALGESIA; MORPHINE; AGONISTS; NERVE; ROPIVACAINE; BUPIVACAINE	Pharmacological treatment of osteoarthritis is still inadequate due to the low efficacy of the drugs used. Dexmedetomidine via the intra-articular (i.a.) route might be an option for the treatment of osteoarthritis-associated pain. The present study assessed the analgesic and anti-inflammatory effects of dexmedetomidine administered via the i.a. route in different doses in an experimental model of rat knee osteoarthritis induced with monosodium iodoacetate. Rats were allocated to four groups with 24 animals in each group. The OA (osteoarthritis), DEX-1 (dexmedetomidine in dose of 1 mu g/kg) and DEX-3 (dexmedetomidine in dose of 3 mu g/kg) groups were subjected to induction of osteoarthritis through injection of monosodium iodoacetate (MIA) via the i.a. route on the right knee; the control group was not subjected to osteoarthritis induction. Clinical assessment was performed on day 0 (before osteoarthritis induction) and then on days 5, 10, 14, 21 and 28 after induction. Treatment was performed on day 7 via the i.a. route, consisting of dexmedetomidine in doses of 1 and 3 mu g/kg, while group OA received 0.9% normal saline. The animals were euthanized on days 7, 14, 21 and 28. Samples of the synovial membrane were collected for histopathological analysis, and the popliteal lymph nodes were collected for measurement of cytokines (interleukin [IL] IL-6, tumor necrosis factor alpha [TNF-alpha]). Dexmedetomidine (1 and 3 mu g/kg) significantly reduced the animals' weight distribution deficit during the chronic-degenerative stage of osteoarthritis and improved the pain threshold throughout the entire experiment. Histological analysis showed that dexmedetomidine did not cause any additional damage to the synovial membrane. The TNF-alpha levels decreased significantly in the DEX-3 group on day 28 compared with the OA group. Dexmedetomidine reduced pain, as evidenced by clinical parameters of osteoarthritis in rats, but did not have an anti-inflammatory effect on histological evaluation.	[Gomes, Lyvia Maria Rodrigues de Sousa; Araujo, Rayanne Luiza Tajra Mualem; Cartagenes, Maria do Socorro de Sousa; Garcia, Joao Batista Santos] Univ Fed Maranhao, Dept Anesthesia Pain & Palliat Care, Sao Luis, Maranhao, Brazil; [Gomes, Lyvia Maria Rodrigues de Sousa; Cartagenes, Maria do Socorro de Sousa; Barbosa Neto, Jose Osvaldo; Garcia, Joao Batista Santos] Univ Fed Maranhao, Expt Lab Study Pain, Sao Luis, Maranhao, Brazil; [Czeczko, Nicolau Gregori] Evangel Fac Parana, Curitiba, Parana, Brazil	Universidade Federal do Maranhao; Universidade Federal do Maranhao; Faculdade Evangelica do Parana	Neto, JOB (corresponding author), Univ Fed Maranhao, Expt Lab Study Pain, Sao Luis, Maranhao, Brazil.	osvaldo1983@me.com		Barbosa Neto, Jose Osvaldo/0000-0003-2005-3137				Al-Metwalli RR, 2008, BRIT J ANAESTH, V101, P395, DOI 10.1093/bja/aen184; Ansah OB, 2007, ANESTH ANALG, V105, P245, DOI 10.1213/01.ane.0000265850.08385.a6; Bezerra MM, 2004, BRIT J PHARMACOL, V141, P172, DOI 10.1038/sj.bjp.0705600; Bove SE, 2003, OSTEOARTHR CARTILAGE, V11, P821, DOI 10.1016/S1063-4584(03)00163-8; Brito MVH, 1998, ACT CIR BRAS, V13, P3; Brummett CM, 2011, ANESTHESIOLOGY, V115, P836, DOI 10.1097/ALN.0b013e318221fcc9; BUTTERWORTH JF, 1993, ANESTH ANALG, V76, P295; Calado GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141886; Cardoso ML, 2010, PLANTA MED, V76, P113, DOI 10.1055/s-0029-1186003; Cheng F, 2019, PHARM BIOL, V57, P649, DOI 10.1080/13880209.2019.1651874; Combe R, 2004, NEUROSCI LETT, V370, P236, DOI 10.1016/j.neulet.2004.08.023; Cook AD, 2018, TRENDS IMMUNOL, V39, P240, DOI 10.1016/j.it.2017.12.003; Courtney CA, 2010, J ORTHOP SPORT PHYS, V40, P818, DOI 10.2519/jospt.2010.3314; Cylwik Jacek, 2004, Folia Morphol (Warsz), V63, P237; Das Anjan, 2015, Oman Med J, V30, P257, DOI 10.5001/omj.2015.52; de Rezende MU, 2013, ACTA ORTOP BRAS, V21, P120, DOI 10.1590/S1413-78522013000200010; Devi M Manjula, 2018, Anesth Essays Res, V12, P848, DOI 10.4103/aer.AER_153_18; El Shamaa HA, 2014, SAUDI J ANAESTH, V8, P155, DOI 10.4103/1658-354X.130677; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fernihough J, 2004, PAIN, V112, P83, DOI 10.1016/j.pain.2004.08.004; Ferreira-Gomes J, 2012, MOL PAIN, V8, DOI [10.1186/1744-8069-850, 10.1186/1744-8069-8-50]; Gentili M, 1996, PAIN, V64, P593, DOI 10.1016/0304-3959(95)00188-3; Guneli E, 2007, PHARMACOL BIOCHEM BE, V88, P9, DOI 10.1016/j.pbb.2007.06.006; Gursoy S, 2011, UPSALA J MED SCI, V116, P238, DOI 10.3109/03009734.2011.597889; Guzman RE, 2003, TOXICOL PATHOL, V31, P619, DOI 10.1080/01926230390241800; Hochman JR, 2010, ARTHRIT CARE RES, V62, P1019, DOI 10.1002/acr.20142; Ismail EA, 2017, KOREAN J PAIN, V30, P134, DOI 10.3344/kjp.2017.30.2.134; Jang Y, 2014, INT J MED SCI, V11, P226, DOI 10.7150/ijms.7897; Kalff KM, 2010, EUR J PHARMACOL, V641, P108, DOI 10.1016/j.ejphar.2010.05.022; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Lin TF, 2009, BRIT J ANAESTH, V102, P117, DOI 10.1093/bja/aen320; Manuar MB, 2014, SAUDI J ANAESTH, V8, P233, DOI 10.4103/1658-354X.130727; Nethra SS, 2015, INDIAN J ANAESTH, V59, P177, DOI 10.4103/0019-5049.153040; Peng K, 2018, SCI REP, P8, DOI [10.1038/s41598-017-18329-3, DOI 10.1038/S41598-017-18329-3]; Perritt E, 2017, EGYPT J ANAESTH, V33, P195, DOI 10.1016/j.egja.2017.02.004; Piao GY, 2014, ARCH MED SCI, V10, P19, DOI 10.5114/aoms.2014.40730; Pomonis JD, 2005, PAIN, V114, P339, DOI 10.1016/j.pain.2004.11.008; Ribeiro Castro R, 2007, CLIN RHEUMATOL, V26, P1398, DOI 10.1007/s10067-007-0570-9; Schuelert N, 2009, NEUROSCI LETT, V465, P184, DOI 10.1016/j.neulet.2009.08.063; Silva A, 2008, PAIN, V140, P446, DOI 10.1016/j.pain.2008.09.025; Sukegawa S, 2014, ANESTH ANALG, V118, P473, DOI 10.1213/ANE.0000000000000060; TenBroek EM, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0921-5; Wojdasiewicz P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/561459; Zhang JX, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0042-8	44	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245194	10.1371/journal.pone.0245194	http://dx.doi.org/10.1371/journal.pone.0245194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434210	Green Published, gold			2022-12-26	WOS:000609979700049
J	Gebremedhin, S; Bekele, T				Gebremedhin, Samson; Bekele, Tilahun			Evaluating the African food supply against the nutrient intake goals set for preventing diet-related non-communicable diseases: 1990 to 2017 trend analysis	PLOS ONE			English	Article							195 COUNTRIES; CONSUMPTION; CHOLESTEROL; BURDEN; ENERGY; FRUIT; FAT	Background Population intake goals intended to prevent diet-related non-communicable diseases (NCDs) have been defined for multiple nutrients. Yet, little is known whether the existing food supply in Africa is in conformity with these goals or not. We evaluated the African food balances against the recommendations for macronutrients, free sugars, types of fatty acids, cholesterol and fruits and vegetables over 1990 to 2017, and provided regional, sub-regional and country-level estimates. Methods The per capita supply of 95 food commodities for 45 African countries (1990-2017) was accessed from the FAOSTAT database and converted into calories, carbohydrate, fat, protein, free sugars, cholesterol, saturated (SFA), monounsaturated (MUFA), and polyunsaturated (PUFA) fatty acids contents using the Food Data Central database. The supply of fruits and vegetables was also computed. Results In Africa the energy supply increased by 16.6% from 2,685 in 1990 to 3,132 kcal/person/day in 2017. However, the energy contribution of carbohydrate, fat and protein remained constant and almost within acceptable range around 73, 10 and 9%, respectively. In 2017, calories from fats surpassed the 20% limit in upper-middle- or high-income and Southern Africa countries. Energy from SFA remained within range (< 10%) but that of PUFA was below the minimum desirable level of 6% in 28 countries. Over the period, energy from free sugars remained constant around 7% but the figure exceeded the limit of 10% in upper-middle- or high-income countries (14.7%) and in Southern (14.8%) and Northern (10.5%) sub-regions. Between 1990 and 2017 the availability of dietary cholesterol per person surged by 14% but was below the upper limit of 300 mg/day. The supply of fruits and vegetables increased by 27.5% from 279 to 356 g/capita/day; yet, with the exception of Northern Africa, the figure remained below the target of 400 g/capita/day in all sub-regions. Conclusion According to this population level data, in Africa most population intake goals are within acceptable range. Yet, the supply of fruits and vegetables and PUFAs are suboptimal and the increasing energy contributions of free sugars and fats are emerging concerns in specific sub-regions.	[Gebremedhin, Samson] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia; [Bekele, Tilahun] Addis Ababa Univ, Ctr Food Sci & Nutr, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Gebremedhin, S (corresponding author), Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia.	samsongmgs@yahoo.com						Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Bennett JE, 2020, LANCET, V396, P918, DOI 10.1016/S0140-6736(20)31761-X; Bentham J, 2020, NAT FOOD, V1, DOI 10.1038/s43016-019-0012-2; Berger S, 2015, AM J CLIN NUTR, V102, P276, DOI 10.3945/ajcn.114.100305; Branca F, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l296; Dain K, 2018, INT J HEALTH POLICY, V7, P282, DOI 10.15171/ijhpm.2017.93; Drewnowski A, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-3; FAO, 2019, FAOSTAT NEW FOOD BAL; FAO, KEY DIFF NEW OLD FOO; FAO, 2010, FATS FATT AC HUM NUT; FAO. Food and Agriculture Organization of the United Nations, 2001, PAST NEW MILL; FAOSTAT,, 2019, FOOD BAL OLD METH PO; Food and Agriculture Organisation (FAO), 2003, FOOD EN METH AN CONV; Golzarand M, 2012, PUBLIC HEALTH NUTR, V15, P1835, DOI 10.1017/S1368980011003673; Gouda HN, 2019, LANCET GLOB HEALTH, V7, pE1375, DOI 10.1016/S2214-109X(19)30374-2; Grundy Scott M., 1997, American Journal of Clinical Nutrition, V66, p988S, DOI 10.1093/ajcn/66.4.988S; Hawkes C, 2020, LANCET, V395, P142, DOI 10.1016/S0140-6736(19)32506-1; Hayes KC, 2002, ASIA PAC J CLIN NUTR, V11, pS394, DOI 10.1046/j.1440-6047.11.s.7.13.x; Headey DD, 2019, J NUTR, V149, P2020, DOI 10.1093/jn/nxz158; Heinonen Marina, 1992, Journal of Food Composition and Analysis, V5, P198, DOI 10.1016/0889-1575(92)90038-L; Herforth A, 2019, ADV NUTR, V10, P590, DOI 10.1093/advances/nmy130; HOPKINS PN, 1992, AM J CLIN NUTR, V55, P1060, DOI 10.1093/ajcn/55.6.1060; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; Martinez R, 2020, LANCET GLOB HEALTH, V8, pE511, DOI 10.1016/S2214-109X(20)30035-8; Mason-D'Croz D, 2019, LANCET PLANET HEALTH, V3, pE318, DOI [10.17632/d7m5h5zvw7.1, 10.1016/S2542-5196(19)30095-6]; Micha R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175149; Micha R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2272; Newens KJ, 2016, J HUM NUTR DIET, V29, P225, DOI 10.1111/jhn.12338; Putnam JJ, 1999, STAT B, VSB-965; Roser M., 2013, OUR WORLD DATA FOOD; Ruel MT, 2005, PATTERNS COMP FRUITS; Sanders TAB, 2000, AM J CLIN NUTR, V71, p176S, DOI 10.1093/ajcn/71.1.176s; Schmidhuber J, 2018, LANCET PLANET HEALTH, V2, pE353, DOI 10.1016/S2542-5196(18)30170-0; Sheehy T, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0471-1; Sheehy T, 2013, PUBLIC HEALTH NUTR, V16, P1693, DOI 10.1017/S136898001200537X; Smit LA, 2009, ANN NUTR METAB, V55, P44, DOI 10.1159/000228995; Soliman GA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060780; Steyn NP, 2014, ANN NY ACAD SCI, V1311, P88, DOI 10.1111/nyas.12433; U.S. Department of Agriculture U.S. Department of Health and Human Services, 2010, DIET GUID AM, V7th; United Nations Statistics Division, 2020, STAND COUNTR AR COD; US Department of Agriculture (USDA), FOODDATA CENTR; Wells JC, 2020, LANCET, V395, P75, DOI 10.1016/S0140-6736(19)32472-9; WHO, 2003, WHO TECH REP SER, V916, P1; WHO, 2020, NONC DIS PROGR MON; World Bank, 2021, WORLD BANK COUNTRY L, DOI DOI 10.1596/36370; World Health Organisation, 2021, NONC DIS; World Health Organization, 2015, INF NOT INT SUG REC	47	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0245241	10.1371/journal.pone.0245241	http://dx.doi.org/10.1371/journal.pone.0245241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428662	Green Published, gold			2022-12-26	WOS:000630036100045
J	Ochiiwa, H; Ailiken, G; Yokoyama, M; Yamagata, K; Nagano, H; Yoshimura, C; Muraoka, H; Ishida, K; Haruma, T; Nakayama, A; Hashimoto, N; Murata, K; Nishimura, M; Kawashima, Y; Ohara, O; Ohkubo, S; Tanaka, T				Ochiiwa, Hiroaki; Ailiken, Guzhanuer; Yokoyama, Masataka; Yamagata, Kazuyuki; Nagano, Hidekazu; Yoshimura, Chihoko; Muraoka, Hiromi; Ishida, Keiji; Haruma, Tomonori; Nakayama, Akitoshi; Hashimoto, Naoko; Murata, Kazutaka; Nishimura, Motoi; Kawashima, Yusuke; Ohara, Osamu; Ohkubo, Shuichi; Tanaka, Tomoaki			TAS4464, a NEDD8-activating enzyme inhibitor, activates both intrinsic and extrinsic apoptotic pathways via c-Myc-mediated regulation in acute myeloid leukemia	ONCOGENE			English	Article							PEVONEDISTAT TAK-924/MLN4924; PHASE-I; CULLIN; NEDD8; FLIP; MLN4924; PROTEIN; CHEMORESISTANCE; TRANSCRIPTION; EXPRESSION	TAS4464, a potent, selective small molecule NEDD8-activating enzyme (NAE) inhibitor, leads to inactivation of cullin-RING E3 ubiquitin ligases (CRLs) and consequent accumulations of its substrate proteins. Here, we investigated the antitumor properties and action mechanism of TAS4464 in acute myeloid leukemia (AML). TAS4464 induced apoptotic cell death in various AML cell lines. TAS4464 treatments resulted in the activation of both the caspase-9-mediated intrinsic apoptotic pathway and caspase-8-mediated extrinsic apoptotic pathway in AML cells; combined treatment with inhibitors of these caspases markedly diminished TAS4464-induced apoptosis. In each apoptotic pathway, TAS4464 induced the mRNA transcription of the intrinsic proapoptotic factor NOXA and decreased that of the extrinsic antiapoptotic factor c-FLIP. RNA-sequencing analysis showed that the signaling pathway of the CRL substrate c-Myc was enriched after TAS4464 treatment. Chromatin immunoprecipitation (ChIP) assay revealed that TAS4464-induced c-Myc bound to the PMAIP1 (encoding NOXA) and CFLAR (encoding c-FLIP) promoter regions, and siRNA-mediated c-Myc knockdown neutralized both TAS4464-mediated NOXA induction and c-FLIP downregulation. TAS4464 activated both caspase-8 and caspase-9 along with an increase in NOXA and a decrease in c-FLIP, resulting in complete tumor remission in a human AML xenograft model. These findings suggest that NAE inhibition leads to anti-AML activity via a novel c-Myc-dependent apoptosis induction mechanism.	[Ochiiwa, Hiroaki; Yoshimura, Chihoko; Muraoka, Hiromi; Ishida, Keiji; Haruma, Tomonori; Ohkubo, Shuichi] Taiho Pharmaceut Co Ltd, Discovery & Preclin Res Div, 3 Okubo, Tsukuba, Ibaraki 3002611, Japan; [Ailiken, Guzhanuer; Yokoyama, Masataka; Yamagata, Kazuyuki; Nagano, Hidekazu; Nakayama, Akitoshi; Hashimoto, Naoko; Murata, Kazutaka; Tanaka, Tomoaki] Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba 2608670, Japan; [Nishimura, Motoi] Chiba Univ Hosp, Div Lab Med Clin Genet & Prote, Chiba 2608670, Japan; [Kawashima, Yusuke; Ohara, Osamu] Kazusa DNA Res Inst, Dept Appl Genom, Kisarazu, Chiba 2920818, Japan	Taiho Pharmaceutical; Chiba University; Chiba University; Kazusa DNA Research Institute	Ohkubo, S (corresponding author), Taiho Pharmaceut Co Ltd, Discovery & Preclin Res Div, 3 Okubo, Tsukuba, Ibaraki 3002611, Japan.; Tanaka, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba 2608670, Japan.	s-ohkubo@taiho.co.jp; tomoaki@restaff.chiba-u.jp	Ohara, Osamu/G-5448-2015	Ohara, Osamu/0000-0002-3328-9571; YAMAGATA, Kazuyuki/0000-0002-5804-6090	Taiho Pharmaceutical Co., Ltd., Japan; Fostering Joint International Research [19KK0407]; Naito Foundation; Novartis Foundation (Japan); Cell Science Research Foundation; Princess Takamatsu Cancer Research Fund; Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care; Hamaguchi biochemistry Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Yamaguchi endocrine Foundation; Donated Fund of Next Generation Hormone Academy for Human Health Longevity; Takeda Science Foundation;  [19H03708];  [20K08397];  [20K07561];  [18K08464];  [19K07635];  [18K07439]	Taiho Pharmaceutical Co., Ltd., Japan; Fostering Joint International Research; Naito Foundation(Naito Memorial Foundation); Novartis Foundation (Japan)(Novartis); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Princess Takamatsu Cancer Research Fund; Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care; Hamaguchi biochemistry Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Yamaguchi endocrine Foundation; Donated Fund of Next Generation Hormone Academy for Human Health Longevity; Takeda Science Foundation(Takeda Science Foundation (TSF)); ; ; ; ; ; 	This study was funded by Taiho Pharmaceutical Co., Ltd., Japan, and was supported by Grants-in-Aid for Scientific Research-KAKENHI-, Scientific Research [(B) #19H03708, (C) #20K08397, (C) #20K07561, (C) #18K08464, (C) #19K07635, (C) #18K07439], and Fostering Joint International Research [(A) #19KK0407]. This work was partly supported by the Takeda Science Foundation, the Naito Foundation, the Novartis Foundation (Japan), the Cell Science Research Foundation, the Princess Takamatsu Cancer Research Fund, the Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care, the Hamaguchi biochemistry Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Yamaguchi endocrine Foundation and the Donated Fund of Next Generation Hormone Academy for Human Health & Longevity.	Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Bhatia S, 2016, INVEST NEW DRUG, V34, P439, DOI 10.1007/s10637-016-0348-5; Bogenberger J, 2017, ONCOTARGET, V8, P107206, DOI 10.18632/oncotarget.22284; Chen H, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0008-7; Conti S, 2016, CELL SIGNAL, V28, P1262, DOI 10.1016/j.cellsig.2016.06.003; DiNardo CD, 2019, BLOOD, V133, P7, DOI 10.1182/blood-2018-08-868752; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kawashima Y, 2019, J PROTEOME RES, V18, P301, DOI 10.1021/acs.jproteome.8b00609; Kiechle FL, 2002, CLIN CHIM ACTA, V326, P27, DOI 10.1016/S0009-8981(02)00297-8; Knorr KLB, 2015, CELL DEATH DIFFER, V22, P2133, DOI 10.1038/cdd.2015.74; Konopleva M, 2002, BRIT J HAEMATOL, V118, P521, DOI 10.1046/j.1365-2141.2002.03637.x; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Kumar C Chandra, 2011, Genes Cancer, V2, P95, DOI 10.1177/1947601911408076; Li LH, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju083; Li XX, 2019, ONCOTARGETS THER, V12, P3295, DOI 10.2147/OTT.S194549; Lockhart AC, 2019, INVEST NEW DRUG, V37, P87, DOI 10.1007/s10637-018-0610-0; McLornan D, 2013, BRIT J HAEMATOL, V160, P188, DOI 10.1111/bjh.12108; Mehta SV, 2013, NEOPLASMA, V60, P666, DOI 10.4149/neo_2013_085; Muraoka H, 2019, CANCER SCI, V110, P3802, DOI 10.1111/cas.14209; Pan Yongfu, 2012, Int J Biochem Mol Biol, V3, P273; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Phesse TJ, 2014, CELL DEATH DIFFER, V21, P956, DOI 10.1038/cdd.2014.15; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Sarantopoulos J, 2016, CLIN CANCER RES, V22, P847, DOI 10.1158/1078-0432.CCR-15-1338; Shah JJ, 2016, CLIN CANCER RES, V22, P34, DOI 10.1158/1078-0432.CCR-15-1237; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Soucy TA, 2009, CLIN CANCER RES, V15, P3912, DOI 10.1158/1078-0432.CCR-09-0343; Stennicke HR, 1998, BBA-PROTEIN STRUCT M, V1387, P17, DOI 10.1016/S0167-4838(98)00133-2; Sweet K, 2014, CURR HEMATOL MALIG R, V9, P109, DOI 10.1007/s11899-014-0199-0; Swords RT, 2015, BRIT J HAEMATOL, V169, P534, DOI 10.1111/bjh.13323; Tanaka T, 2020, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.hqbzkh1f6, DOI 10.5061/DRYAD.HQBZKH1F6]; Wirth M, 2014, NUCLEIC ACIDS RES, V42, P10433, DOI 10.1093/nar/gku763; Xie P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.195; Xie P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4733; Yoshimura C, 2019, MOL CANCER THER, V18, P1205, DOI 10.1158/1535-7163.MCT-18-0644; Zhao LQ, 2011, MOL CANCER THER, V10, P2415, DOI 10.1158/1535-7163.MCT-11-0401; Zhou LS, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0979-1	43	11	11	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2021	40	7					1217	1230		10.1038/s41388-020-01586-4	http://dx.doi.org/10.1038/s41388-020-01586-4		JAN 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QK0LS	33420360	Green Published, hybrid			2022-12-26	WOS:000607346000017
J	Hassuna, NA; El Feky, M; Hussein, AARM; Mahmoud, MA; Idriss, NK; Abdelwahab, SF; Ibrahim, MA				Hassuna, Noha A.; El Feky, Mohamed; Hussein, Aliae A. R. Mohamed; Mahmoud, Manal A.; Idriss, Naglaa K.; Abdelwahab, Sayed F.; Ibrahim, Maggie A.			Interleukin-18 and interferon-gamma single nucleotide polymorphisms in Egyptian patients with tuberculosis	PLOS ONE			English	Article							PROMOTER POLYMORPHISM; GENE POLYMORPHISMS; IL-18 GENE; PULMONARY TUBERCULOSIS; SUSCEPTIBILITY; ASSOCIATION; EXPRESSION; CHILDREN	Background Interleukin-18 (IL-18) and interferon-gamma (IFN-gamma) are cytokines of crucial role in inflammation and immune reactions. There is a growing evidence supporting important roles for IL-18 and IFN gamma in tuberculosis (TB) infection and anti-tuberculosis immunity. Objective To evaluate the role of polymorphisms in IL-18-607 and -137 and INF-gamma +874 in susceptibility to TB infection among Egyptian patients. Methods A case control study was conducted to investigate the polymorphism at IL-18-607, -137 and INF-gamma+874 by sequence specific primer-polymerase chain reaction (SSP- PCR) in 105 patients with pulmonary and extra pulmonary tuberculosis and 106 controls. Results A significant protective effect against TB was found in homozygous CC genotype at IL-18 -137G/C, in addition to a 7-fold risk with GG and GC genotypes in the recessive model. Apart from a decreased risk with the AC genotype, no association was detected between the susceptibility to TB and different genotypes or alleles at the IL-18 -607A/C site. The homozygous AA genotype in INF-gamma+874 showed a significant higher risk to TB than the homozygous TT or heterozygous AT genotypes with nearly a 2-fold risk of TB infection with the A allele. Regarding haplotype association, the GC haplotype was strongly associated with TB infection compared to other haplotypes. Conclusion These findings suggest; for the first time in Egypt; a significant risk to TB infection with SNP at the IL-18-137G/C with no LD with SNP at the IL-18-607 site. The homozygous AA genotype in INF-gamma+874 showed a significant higher risk to TB than the homozygous TT or heterozygous AT genotypes.	[Hassuna, Noha A.; Abdelwahab, Sayed F.] Menia Univ, Dept Med Microbiol & Immunol, Fac Med, Al Minya, Egypt; [El Feky, Mohamed; Ibrahim, Maggie A.] Assiut Univ, Dept Med Microbiol & Immunol, Fac Med, Assiut, Egypt; [Hussein, Aliae A. R. Mohamed; Mahmoud, Manal A.] Assiut Univ, Dept Chest Dis & TB, Fac Med, Assiut, Egypt; [Idriss, Naglaa K.] Assiut Univ, Dept Med Biochem, Fac Med, Assiut, Egypt; [Abdelwahab, Sayed F.] Taif Univ, Dept Pharmaceut & Ind Pharm, Taif Coll Pharm, Div Pharmaceut Microbiol, At Taif, Saudi Arabia	Egyptian Knowledge Bank (EKB); Minia University; Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Assiut University; Taif University	Hassuna, NA (corresponding author), Menia Univ, Dept Med Microbiol & Immunol, Fac Med, Al Minya, Egypt.	nohaanwar@mu.edu.eg	Hassuna, Noha A/O-8537-2016; Abdelwahab, Sayed F./P-1481-2016	Hassuna, Noha A/0000-0001-6702-2341; Abdelwahab, Sayed F./0000-0002-9636-7485	Taif University, Taif, Saudi Arabia [TURSP-2020/51]	Taif University, Taif, Saudi Arabia	Taif University Researchers Supporting Project number (TURSP-2020/51), Taif University, Taif, Saudi Arabia. Mohamed R Abdelrahman for revising the language of the manuscript.	Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; Ansari A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004778; Asefi V, 2009, J LARYNGOL OTOL, V123, P444, DOI 10.1017/S0022215108003733; BCSC, 2009, INTR INFL UVEIT, P223; Ben Selma W, 2011, DNA CELL BIOL, V30, P379, DOI 10.1089/dna.2010.1157; Chang JT, 2000, EUR J IMMUNOL, V30, P1113, DOI 10.1002/(SICI)1521-4141(200004)30:4<1113::AID-IMMU1113>3.0.CO;2-P; Collins HL, 2001, IMMUNOLOGY, V103, P1, DOI 10.1046/j.1365-2567.2001.01236.x; Furin J, 2019, LANCET, V393, P1642, DOI 10.1016/S0140-6736(19)30308-3; Giedraitis V, 2001, J NEUROIMMUNOL, V112, P146, DOI 10.1016/S0165-5728(00)00407-0; Gutlapalli VR, 2016, HUM IMMUNOL, V77, P1264, DOI 10.1016/j.humimm.2016.08.001; Harishankar M, 2007, INT J IMMUNOGENET, V34, P317, DOI 10.1111/j.1744-313X.2007.00714.x; Harishankar M, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00213; Kumar NP, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz257; Laird S, 2006, REPROD BIOMED ONLINE, V13, P13, DOI 10.1016/S1472-6483(10)62011-1; Leandro ACCS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/901740; Lee SH, 2011, INT J TUBERC LUNG D, V15, P1246, DOI 10.5588/ijtld.11.0031; Lee SW, 2015, J MICROBIOL IMMUNOL, V48, P376, DOI 10.1016/j.jmii.2013.11.009; Lv LS, 2018, INFECT DRUG RESIST, V11, P147, DOI 10.2147/IDR.S153499; Meenakshi P, 2013, SCAND J IMMUNOL, V78, P92, DOI 10.1111/sji.12055; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Moran A, 2007, INT J TUBERC LUNG D, V11, P113; Morris GAJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016656; Mosaad YM, 2010, SCAND J IMMUNOL, V72, P358, DOI 10.1111/j.1365-3083.2010.02426.x; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Onay H, 2010, SCAND J INFECT DIS, V42, P39, DOI 10.3109/00365540903253502; Pavlovna KO, 2008, MEDIATORS INFLAMMATI, V2008; Perrey C, 1999, TRANSPL IMMUNOL, V7, P127, DOI 10.1016/S0966-3274(99)80030-6; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; Rossouw M, 2003, LANCET, V361, P1871, DOI 10.1016/S0140-6736(03)13491-5; Segat L, 2006, IMMUNOGENETICS, V58, P471, DOI 10.1007/s00251-006-0104-7; Shen C, 2013, MOL BIOL REP, V40, P5477, DOI 10.1007/s11033-013-2647-7; Shen L, 2017, J CLIN CELL IMMUNOL, V8, P514; Song CH, 2002, SCAND J IMMUNOL, V56, P611, DOI 10.1046/j.1365-3083.2002.01143.x; Subbarayan PR, 2002, BIOTECHNIQUES, V33, P1231, DOI 10.2144/02336bm10; Taheri M, 2012, Prague Med Rep, V113, P16; Thammaroj J, 2015, SE ASIAN J TROP MED, V46, P71; Wu SQ, 2019, CYTOKINE, V123, DOI 10.1016/j.cyto.2019.154775; Wu SQ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39249-4; Yim JJ, 2010, RESPIROLOGY, V15, P241, DOI 10.1111/j.1440-1843.2009.01690.x; Zhen LB, 2019, AFR HEALTH SCI, V19, P1311, DOI 10.4314/ahs.v19i1.2; Zhou C, 2015, INFECT GENET EVOL, V36, P376, DOI 10.1016/j.meegid.2015.10.014	41	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2021	16	1							e0244949	10.1371/journal.pone.0244949	http://dx.doi.org/10.1371/journal.pone.0244949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PS6NW	33412574	Green Published, gold			2022-12-26	WOS:000608044300089
J	Qasim, SL; Sierra, L; Shuck, R; Kurenbekova, L; Patel, TD; Rajapakshe, K; Wulff, J; Nakahata, K; Kim, HR; Landesman, Y; Unger, TJ; Coarfa, C; Yustein, JT				Qasim, Shawki L.; Sierra, Laura; Shuck, Ryan; Kurenbekova, Lyazat; Patel, Tajhal D.; Rajapakshe, Kimal; Wulff, Jade; Nakahata, Kengo; Kim, Ha Ram; Landesman, Yosef; Unger, T. J.; Coarfa, Cristian; Yustein, Jason T.			p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma	ONCOGENE			English	Article							BETA-CATENIN; CELL-LINES; PAK4; TRANSLOCATION; TUMORS; CYTOTOXICITY; CONSISTENCY; CHROMOSOME; ACTIVATION; GROWTH	Ewing sarcoma (ES) is the second most common bone tumor in children and young adults. Unfortunately, there have been minimal recent advancements in improving patient outcomes, especially in metastatic and recurrent diseases. In this study, we investigated the biological role of p21-activated kinases (PAKs) in ES, and the ability to therapeutically target them in high-risk disease. Via informatics analysis, we established the inverse association of PAK1 and PAK4 expression with clinical stage and outcome in ES patients. Through expression knockdown and small-molecule inhibition of PAKs, utilizing FRAX-597, KPT-9274, and PF-3758309 in multiple ES cell lines and patient-derived xenograft models, we further explored the role of PAKs in ES tumor growth and metastatic capabilities. In vitro studies in several ES cell lines indicated that diminishing PAK1 and PAK4 expression reduces tumor cell viability, migratory, and invasive properties. In vivo studies using PAK4 inhibitors, KPT-9274 and PF-3758309 demonstrated significant inhibition of primary and metastatic tumor formation, while transcriptomic analysis of PAK4-inhibitor-treated tumors identified concomitant suppression of Notch, beta-catenin, and hypoxia-mediated signatures. In addition, the analysis showed enrichment of anti-tumor immune regulatory mechanisms, including interferon (IFN)-gamma and IFN-alpha responses. Altogether, our molecular and pre-clinical studies are the first to establish a critical role for PAKs in ES development and progression, and consequently as viable therapeutic targets for the treatment of high-risk ES in the near future.	[Qasim, Shawki L.; Sierra, Laura; Shuck, Ryan; Kurenbekova, Lyazat; Patel, Tajhal D.; Wulff, Jade; Nakahata, Kengo; Kim, Ha Ram; Yustein, Jason T.] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Qasim, Shawki L.; Sierra, Laura; Shuck, Ryan; Kurenbekova, Lyazat; Patel, Tajhal D.; Wulff, Jade; Nakahata, Kengo; Kim, Ha Ram; Yustein, Jason T.] Baylor Coll Med, Texas Childrens Hematol Ctr, Houston, TX 77030 USA; [Qasim, Shawki L.; Sierra, Laura; Shuck, Ryan; Kurenbekova, Lyazat; Patel, Tajhal D.; Wulff, Jade; Nakahata, Kengo; Kim, Ha Ram; Yustein, Jason T.] Baylor Coll Med, Faris D Virani Ewing Sarcoma Ctr, Houston, TX 77030 USA; [Rajapakshe, Kimal; Coarfa, Cristian; Yustein, Jason T.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Rajapakshe, Kimal; Coarfa, Cristian; Yustein, Jason T.] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA; [Landesman, Yosef; Unger, T. J.] Karyopharm Therapeut Inc, Newton, MA 02459 USA; [Yustein, Jason T.] Baylor Coll Med, Canc & Cell Biol Program, Houston, TX 77030 USA	Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Yustein, JT (corresponding author), Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA.; Yustein, JT (corresponding author), Baylor Coll Med, Texas Childrens Hematol Ctr, Houston, TX 77030 USA.; Yustein, JT (corresponding author), Baylor Coll Med, Faris D Virani Ewing Sarcoma Ctr, Houston, TX 77030 USA.; Yustein, JT (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Yustein, JT (corresponding author), Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA.; Yustein, JT (corresponding author), Baylor Coll Med, Canc & Cell Biol Program, Houston, TX 77030 USA.	yustein@bcm.edu			Cancer Prevention and Research Institute of Texas (CPRIT) post-doctoral training grant [RP160283]; Faris D. Virani Ewing sarcoma Center; Cytometry and Cell Sorting Core at Baylor College of Medicine; CPRIT Core Facility Support Award [CPRIT-RP180672]; NIH [CA125123, RR024574]	Cancer Prevention and Research Institute of Texas (CPRIT) post-doctoral training grant; Faris D. Virani Ewing sarcoma Center; Cytometry and Cell Sorting Core at Baylor College of Medicine; CPRIT Core Facility Support Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Cancer Prevention and Research Institute of Texas (CPRIT) post-doctoral training grant RP160283 (S.Q.) and The Faris D. Virani Ewing sarcoma Center. This project was supported by the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the CPRIT Core Facility Support Award (CPRIT-RP180672) and the NIH (CA125123 and RR024574).	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Aboukameel A, 2017, MOL CANCER THER, V16, P76, DOI 10.1158/1535-7163.MCT-16-0205; Abu Aboud O, 2016, MOL CANCER THER, V15, P2119, DOI 10.1158/1535-7163.MCT-16-0197; [Anonymous], 2018, CELLTITER GLO LUMINE; Arias-Romero LE, 2010, ONCOGENE, V29, P5839, DOI 10.1038/onc.2010.318; Batra S, 2004, CANCER RES, V64, P5415, DOI 10.1158/0008-5472.CAN-04-0377; BLOOM ET, 1972, CANCER RES, V32, P960; Callow MG, 2002, J BIOL CHEM, V277, P550, DOI 10.1074/jbc.M105732200; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; Co LLC S-A, 96992 CELL COUNT KIT; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Hawkins AG, 2018, MOL CELL PROTEOMICS, V17, P901, DOI 10.1074/mcp.RA118.000596; He H, 2013, P21 ACTIVATED KINASE; Heske CM, 2017, CLIN CANCER RES, V23, P7301, DOI 10.1158/1078-0432.CCR-17-1121; Jin-Xing Y, 2018, EXPRESSION PAK4 BREA; JOUNG M, 2012, EPJ WEB C, V32; Li Y, 2012, BBA-MOL CELL RES, V1823, P465, DOI 10.1016/j.bbamcr.2011.11.013; Liu YY, 2008, MOL CANCER RES, V6, P1215, DOI 10.1158/1541-7786.MCR-08-0087; Lu W, 2013, ONCOL REP, V29, P1547, DOI 10.3892/or.2013.2237; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Mileshkin LR, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.e13607; Mutz CN, 2017, ONCOTARGET, V8, P24679, DOI 10.18632/oncotarget.14976; Naing A, 2017, ANN ONCOL, P28; Pedersen EA, 2016, CANCER RES, V76, P5040, DOI 10.1158/0008-5472.CAN-15-3422; Pietsch T, 2018, MHH ES 1 NEW EWING S; Qu J, 2001, MOL CELL BIOL, V21, P3523, DOI 10.1128/MCB.21.10.3523-3533.2001; Radu M, PAK SIGNALING DEV PR; Rane C, 2017, SCI REP-UK, V7, DOI 10.1038/srep42555; Rane CK, 2019, SEMIN CANCER BIOL, V54, P40, DOI 10.1016/j.semcancer.2018.01.006; Reynolds C P, 1988, Prog Clin Biol Res, V271, P291; Ries LAG, 1975, NIH PUB; Ryu BJ, 2014, MOL CELL BIOCHEM, V389, P69, DOI 10.1007/s11010-013-1928-8; Salamon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095822; Satterfield L, 2017, INT J CANCER, V141, P2062, DOI 10.1002/ijc.30909; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Siu MK, 2018, P21 ACTIVATED KINASE; Stiller CA, 2006, EUR J CANCER, V42, P2006, DOI 10.1016/j.ejca.2006.06.002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Technologies L, 2018, LIP RNAIMAX REAG PRO; TURCCAREL C, 1984, CANCER GENET CYTOGEN, V12, P1, DOI 10.1016/0165-4608(84)90002-5; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V32, P229, DOI 10.1016/0165-4608(88)90285-3; Volchenboum SL, 2015, J PATHOL CLIN RES, V1, P83, DOI 10.1002/cjp2.9; WHANGPENG J, 1986, CANCER GENET CYTOGEN, V21, P185, DOI 10.1016/0165-4608(86)90001-4; Yeo D, 2018, ROLE P21 ACTIVATED K; Yeo D, 2018, FRAX597 PAK1 INHIBIT; ZUCMAN J, 1992, GENE CHROMOSOME CANC, V5, P271, DOI 10.1002/gcc.2870050402	47	6	6	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2021	40	6					1176	1190		10.1038/s41388-020-01600-9	http://dx.doi.org/10.1038/s41388-020-01600-9		JAN 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QG0OL	33414491				2022-12-26	WOS:000605931900001
J	Scheffler, RJ; Sugimoto, Y; Bratton, BP; Ellison, CK; Koch, MD; Donia, MS; Gitai, Z				Scheffler, Robert J.; Sugimoto, Yuki; Bratton, Benjamin P.; Ellison, Courtney K.; Koch, Matthias D.; Donia, Mohamed S.; Gitai, Zemer			Pseudomonas aeruginosa detachment from surfaces via a self-made small molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOFILM RESISTANCE; MECHANISMS; MICROSCOPY; DISPERSION; MOTILITY; IMAGE	Pseudomonas aeruginosa is a significant threat in both healthcare and industrial biofouling. Surface attachment of P. aeruginosa is particularly problematic as surface association induces virulence and is necessary for the ensuing process of biofilm formation, which hampers antibiotic treatments. Previous efforts have searched for dispersal agents of mature biofilm collectives, but there are no known factors that specifically disperse individual surface-attached P. aeruginosa. In this study, we develop a quantitative single-cell surface-dispersal assay and use it to show that P. aeruginosa itself produces factors that can stimulate its dispersal. Through bioactivity-guided fractionation, mass spectrometry, and nuclear magnetic resonance, we elucidated the structure of one such factor, 2-methyl-4-hydroxyquinoline (MHQ). MHQ is an alkyl quinolone with a previously unknown activity and is synthesized by the PqsABC enzymes. Pure MHQ is sufficient to disperse P. aeruginosa, but the dispersal activity of natural P. aeruginosa conditioned media requires additional factors. Whereas other alkyl quinolones have been shown to act as antibiotics or membrane depolarizers, MHQ lacks these activities and known antibiotics do not induce dispersal. In contrast, we show that MHQ inhibits the activity of Type IV Pili (TFP) and that TFP targeting can explain its dispersal activity. Our work thus identifies single-cell surface dispersal as a new activity of P. aeruginosa-produced small molecules, characterizes MHQ as a promising dispersal agent, and establishes TFP inhibition as a viable mechanism for P. aeruginosa dispersal.	[Scheffler, Robert J.; Sugimoto, Yuki; Bratton, Benjamin P.; Ellison, Courtney K.; Koch, Matthias D.; Donia, Mohamed S.; Gitai, Zemer] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Bratton, Benjamin P.; Ellison, Courtney K.; Koch, Matthias D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University; Princeton University	Gitai, Z (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	zgitai@princeton.edu		Donia, Mohamed/0000-0002-9604-2912; Scheffler, Robert/0000-0002-8213-2626; Ellison, Courtney/0000-0003-3259-079X; Bratton, Benjamin/0000-0003-1128-2560; Koch, Matthias/0000-0003-4408-9900	National Institutes of Health [DP1AI124669, T32 GM007388, DP2AI124441]; National Science Foundation [NSF PHY-1734030]; Damon Runyon Cancer Research Foundation [DRG 2385-20]; German Research Foundation [DFG KO5239/1-1]; National Cancer Institute [NCI-CCSG P30CA072720-5921]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Damon Runyon Cancer Research Foundation; German Research Foundation(German Research Foundation (DFG)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided in part by National Institutes of Health (DP1AI124669: Z. G., B. P. B., and R. J. S.; T32 GM007388: R. J. S., and DP2AI124441: M. S. D.). Additional funding provided by the National Science Foundation (NSF PHY-1734030: B. P. B., M. D. K, and C. K. E.), Damon Runyon Cancer Research Foundation (DRG 2385-20: C. K. E.), the German Research Foundation (DFG KO5239/1-1: M. D. K), and for the FCRF by the National Cancer Institute (NCI-CCSG P30CA072720-5921). The opinions, findings, and conclusions or recommendations expressed in this material contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health or the National Science Foundation.	Aubey F, 2019, P NATL ACAD SCI USA, V116, P8481, DOI 10.1073/pnas.1817757116; Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Chuang SK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12153-1; Conrad JC, 2011, BIOPHYS J, V100, P1608, DOI 10.1016/j.bpj.2011.02.020; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; de Anda J, 2017, ACS NANO, V11, P9340, DOI 10.1021/acsnano.7b04738; Denis K, 2019, NAT MICROBIOL, V4, P972, DOI 10.1038/s41564-019-0395-8; Drees SL, 2015, CHEM BIOL, V22, P611, DOI 10.1016/j.chembiol.2015.04.012; Dubern JF, 2008, MOL BIOSYST, V4, P882, DOI 10.1039/b803796p; Edelstein A. D., 2014, J BIOL METHODS, V1; Ellison CK, 2019, NAT PROTOC, V14, P1803, DOI 10.1038/s41596-019-0162-6; Ellison CK, 2017, SCIENCE, V358, P535, DOI 10.1126/science.aan5706; Epstein AK, 2011, P NATL ACAD SCI USA, V108, P995, DOI 10.1073/pnas.1011033108; Feinbaum RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002813; Hall S, 2016, TOXINS, V8, DOI 10.3390/toxins8080236; Heeb S, 2011, FEMS MICROBIOL REV, V35, P247, DOI 10.1111/j.1574-6976.2010.00247.x; Hmelo LR, 2015, NAT PROTOC, V10, P1820, DOI 10.1038/nprot.2015.115; Huang W, 2018, NUCLEIC ACIDS RES, V46, pD575, DOI 10.1093/nar/gkx1061; Kaletsky R, 2020, NATURE, V586, P445, DOI 10.1038/s41586-020-2699-5; Kang OY, 2019, ORG CHEM FRONT, V6, P183, DOI 10.1039/c8qo00884a; Koch M. D., 2020, COMPETITIVE BINDING, DOI [10.1101/2020.02.12.946426, DOI 10.1101/2020.02.12.946426]; Lee CK, 2020, MBIO, V11, DOI 10.1128/mBio.02644-19; Lee CK, 2018, P NATL ACAD SCI USA, V115, P4471, DOI 10.1073/pnas.1720071115; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Leiman SA, 2013, J BACTERIOL, V195, P5391, DOI 10.1128/JB.00975-13; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Lin JS, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00230; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Martin JK, 2020, CELL, V181, P1518, DOI 10.1016/j.cell.2020.05.005; MORIHARA K, 1965, J BIOL CHEM, V240, P3295; Mulcahy LR, 2014, MICROB ECOL, V68, P1, DOI 10.1007/s00248-013-0297-x; Novo D, 1999, CYTOMETRY, V35, P55, DOI 10.1002/(SICI)1097-0320(19990101)35:1<55::AID-CYTO8>3.0.CO;2-2; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Persat A, 2015, P NATL ACAD SCI USA, V112, P7563, DOI 10.1073/pnas.1502025112; Petrova OE, 2012, P NATL ACAD SCI USA, V109, P16690, DOI 10.1073/pnas.1207832109; Royt PW, 2007, BIOORG CHEM, V35, P175, DOI 10.1016/j.bioorg.2006.10.004; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Santajit S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2475067; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siryaporn A, 2014, P NATL ACAD SCI USA, V111, P16860, DOI 10.1073/pnas.1415712111; Soberon-Chavez G, 2005, APPL MICROBIOL BIOT, V68, P718, DOI 10.1007/s00253-005-0150-3; SUCI PA, 1994, ANTIMICROB AGENTS CH, V38, P2125, DOI 10.1128/AAC.38.9.2125	45	4	4	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100279	10.1016/j.jbc.2021.100279	http://dx.doi.org/10.1016/j.jbc.2021.100279			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33450229	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400255
J	Shinoda, Y; Haga, Y; Akagawa, K; Fukunaga, K				Shinoda, Yasuharu; Haga, Yudai; Akagawa, Koichiro; Fukunaga, Kohji			Wildtype sigma 1 receptor and the receptor agonist improve ALS-associated mutation-induced insolubility and toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						&#963; receptor; protein aggregation; oligomerization; cell death; subcellular fractionation; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); fluorescence recovery after photobleaching (FRAP)	ENDOPLASMIC-RETICULUM; DETERGENT INSOLUBILITY; ALKALINE-PHOSPHATASE; SQSTM1 MUTATIONS; MOTOR NEUROPATHY; BINDING-SITES; ER STRESS; PROTEIN; GENE; JUVENILE	Genetic mutations related to ALS, a progressive neurological disease, have been discovered in the gene encoding sigma-1 receptor (sigma 1R). We previously reported that sigma 1RE102Q elicits toxicity in cells. The sigma 1R forms oligomeric states that are regulated by ligands. Nevertheless, little is known about the effect of ALS-related mutations on oligomer formation. Here, we transfected NSC-34 cells, a motor neuronal cell line, and HEK293T cells with sigma 1R-mCherry (mCh), sigma 1RE102Q-mCh, or nontagged forms to investigate detergent solubility and subcellular distribution using immunocytochemistry and fluorescence recovery after photobleaching. The oligomeric state was determined using crosslinking procedure. sigma 1Rs were soluble to detergents, whereas the mutants accumulated in the insoluble fraction. Within the soluble fraction, peak distribution of mutants appeared in higher sucrose density fractions. Mutants formed intracellular aggregates that were co-stained with p62, ubiquitin, and phosphorylated pancreatic eukaryotic translation initiation factor-2-alpha kinase in NSC-34 cells but not in HEK293T cells. The aggregates had significantly lower recovery in fluorescence recovery after photobleaching. Acute treatment with sigma 1R agonist SA4503 failed to improve recovery, whereas prolonged treatment for 48 h significantly decreased sigma 1RE102Q-mCh insolubility and inhibited apoptosis. Whereas sigma 1R-mCh formed monomers and dimers, sigma 1RE102Q-mCh also formed trimers and tetramers. SA4503 reduced accumulation of the four types in the insoluble fraction and increased monomers in the soluble fraction. The sigma 1RE102Q insolubility was diminished by sigma 1R-mCh co-expression. These results suggest that the agonist and WT sigma 1R modify the detergent insolubility, toxicity, and oligomeric state of sigma 1RE102Q, which may lead to promising new treatments for sigma 1R-related ALS.	[Shinoda, Yasuharu; Haga, Yudai; Akagawa, Koichiro; Fukunaga, Kohji] Tohoku Univ, Dept Pharmacol, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan	Tohoku University	Fukunaga, K (corresponding author), Tohoku Univ, Dept Pharmacol, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan.	koji.fukunaga.c1@tohoku.ac.jp	Shinoda, Yasuharu/AAE-6135-2019; Fukunaga, Kohji/AAI-8811-2021	Shinoda, Yasuharu/0000-0001-9910-048X; 	JSPS [20K16128]; Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development, AMED [JP19dm0107071, JP20dm0107071]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was partly supported by JSPS Grant-in-Aid for Early-Career Scientists Grant number 20K16128 (Y. S.) and by the Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development, AMED (JP19dm0107071 and JP20dm0107071) (K. F.).	Abramyan AM, 2020, COMPUT STRUCT BIOTEC, V18, P199, DOI 10.1016/j.csbj.2019.12.012; Al-Chalabi A, 1998, HUM MOL GENET, V7, P2045, DOI 10.1093/hmg/7.13.2045; Al-Saif A, 2011, ANN NEUROL, V70, P913, DOI 10.1002/ana.22534; Almendra Luciano, 2018, Acta Myol, V37, P2; Bhuiyan MS, 2011, EUR J PHARMACOL, V650, P621, DOI 10.1016/j.ejphar.2010.10.055; Blokhuis AM, 2013, ACTA NEUROPATHOL, V125, P777, DOI 10.1007/s00401-013-1125-6; CERNEUS DP, 1993, J BIOL CHEM, V268, P3150; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; Chu UB, 2016, MOL PHARMACOL, V89, P142, DOI 10.1124/mol.115.101170; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Dreser A, 2017, CELL DEATH DIFFER, V24, P1655, DOI 10.1038/cdd.2017.88; Fahed AC, 2014, ANN NEUROL, V75, P793, DOI 10.1002/ana.24164; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Fujimura K, 1997, BIOORGAN MED CHEM, V5, P1675, DOI 10.1016/S0968-0896(97)00093-X; Gomez-Soler M, 2014, J MED CHEM, V57, P238, DOI 10.1021/jm401529t; Gregianin E, 2016, HUM MOL GENET, V25, P3741, DOI 10.1093/hmg/ddw220; Gromek KA, 2014, J BIOL CHEM, V289, P20333, DOI 10.1074/jbc.M113.537993; HANADA K, 1995, J BIOL CHEM, V270, P6254, DOI 10.1074/jbc.270.11.6254; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P718, DOI 10.1124/jpet.103.051284; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P726, DOI 10.1124/jpet.103.051292; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2011, HISTOCHEM CELL BIOL, V135, P627, DOI 10.1007/s00418-011-0811-5; Hayashi T, 2010, MOL PHARMACOL, V77, P517, DOI 10.1124/mol.109.062539; Hirano M, 2013, NEUROLOGY, V80, P458, DOI 10.1212/WNL.0b013e31827f0fe5; Hong WC, 2020, J PHARMACOL EXP THER, V373, P290, DOI 10.1124/jpet.119.262790; Horga A, 2016, NEUROLOGY, V87, P1607, DOI 10.1212/WNL.0000000000003212; Izumi Y, 2018, GERIATR GERONTOL INT, V18, P1519, DOI 10.1111/ggi.13506; Kubota H, 2011, METHODS, V53, P267, DOI 10.1016/j.ymeth.2010.12.035; Le Ber I, 2013, JAMA NEUROL, V70, P1403, DOI 10.1001/jamaneurol.2013.3849; Li XB, 2015, NEUROLOGY, V84, P2430, DOI 10.1212/WNL.0000000000001680; Marriott KSC, 2012, J PHARMACOL EXP THER, V343, P578, DOI 10.1124/jpet.112.198168; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; Mavlyutov TA, 2010, NEUROSCIENCE, V167, P247, DOI 10.1016/j.neuroscience.2010.02.022; Mavylutov T, 2018, PROTEIN CELL, V9, P733, DOI 10.1007/s13238-017-0468-5; MICKELSON MM, 1985, RES COMMUN CHEM PATH, V47, P255; Mishra AK, 2015, BIOCHEM J, V466, P263, DOI 10.1042/BJ20141321; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076941; Nandhagopal R, 2018, EUR J NEUROL, V25, P395, DOI 10.1111/ene.13519; Nango H, 2017, J PHARMACOL SCI, V135, P64, DOI 10.1016/j.jphs.2017.09.001; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Prause J, 2013, HUM MOL GENET, V22, P1581, DOI 10.1093/hmg/ddt008; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Ramakrishnan NK, 2014, PSYCHOPHARMACOLOGY, V231, P3997, DOI 10.1007/s00213-014-3533-2; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Schmidt HR, 2019, TRENDS PHARMACOL SCI, V40, P636, DOI 10.1016/j.tips.2019.07.006; Schmidt HR, 2016, NATURE, V532, P527, DOI 10.1038/nature17391; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shioda N, 2019, J NEUROSCI, V39, P7551, DOI 10.1523/JNEUROSCI.0079-19.2019; Shioda N, 2012, J BIOL CHEM, V287, P23318, DOI 10.1074/jbc.M112.349142; Singh NP, 2000, EXP CELL RES, V256, P328, DOI 10.1006/excr.2000.4810; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Su TP, 2016, TRENDS PHARMACOL SCI, V37, P262, DOI 10.1016/j.tips.2016.01.003; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Tagashira H, 2014, BBA-GEN SUBJECTS, V1840, P3320, DOI 10.1016/j.bbagen.2014.08.012; Tagashira H, 2013, BBA-GEN SUBJECTS, V1830, P3082, DOI 10.1016/j.bbagen.2012.12.029; TAM SW, 1984, P NATL ACAD SCI-BIOL, V81, P5618, DOI 10.1073/pnas.81.17.5618; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Van Den Bosch L, 1999, LIFE SCI, V65, P1597, DOI 10.1016/S0024-3205(99)00405-1; Ververis A, 2020, J MED GENET, V57, P178, DOI 10.1136/jmedgenet-2019-106108; Watanabe S, 2016, EMBO MOL MED, V8, P1421, DOI 10.15252/emmm.201606403; Wong AYC, 2016, MOL PHARMACOL, V90, P238, DOI 10.1124/mol.116.104018; Yano H, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01356; Yano H, 2018, NEUROPHARMACOLOGY, V133, P264, DOI 10.1016/j.neuropharm.2018.01.042; Yu Z., 2013, BIO-PROTOCOL, V3, pe754, DOI [10.21769/BioProtoc.754, DOI 10.21769/BIOPROTOC.754, 10.7314/APJCP.2014.15.3.1465]	68	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17573	17587		10.1074/jbc.RA120.015012	http://dx.doi.org/10.1074/jbc.RA120.015012			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453999	hybrid, Green Published			2022-12-26	WOS:000603272300015
J	Le Billan, F; Perrot, J; Carceller, E; Travers, S; Viengchareun, S; Kolkhof, P; Lombes, M; Fagart, J				Le Billan, Florian; Perrot, Julie; Carceller, Elena; Travers, Simon; Viengchareun, Say; Kolkhof, Peter; Lombes, Marc; Fagart, Jerome			Antagonistic effects of finerenone and spironolactone on the aldosterone-regulated transcriptome of human kidney cells	FASEB JOURNAL			English	Article						mineralocorticoid; nuclear receptor; RNA&#8208; sequencing; steroid hormone	EPITHELIAL SODIUM-CHANNEL; BASE-LINE CHARACTERISTICS; MINERALOCORTICOID RECEPTOR; HEART-FAILURE; BAY 94-8862; DISEASE; MODULATION; MECHANISMS; EXPRESSION; PROTECTS	Aldosterone, the main mineralocorticoid hormone in humans, plays a pivotal role in the control of water and salt reabsorption via activation of the mineralocorticoid receptor (MR). Alterations in MR signaling pathway lead to renal dysfunction, including chronic kidney disease and renal fibrosis, that can be prevented or treated with mineralocorticoid receptor antagonists (MRAs). Here, we used RNA-Sequencing to analyze effects of two MRAs, spironolactone and finerenone, on the aldosterone-induced transcriptome of a human renal cell line stably expressing the MR. Bioinformatics analysis of the data set reveals the identity of hundreds of genes induced or repressed by aldosterone. Their regulation is modulated in a time-dependent manner and, for the induced genes, depends on the aldosterone-driven direct binding of the MR onto its genomic targets that we have previously characterized. Although both MRAs block aldosterone-induced as well as aldosterone-repressed genes qualitatively similarly, finerenone has a quantitatively more efficient antagonism on some aldosterone-induced genes. Our data provide the first complete transcriptome for aldosterone on a human renal cell line and identifies pro-inflammatory markers (IL6, IL11, CCL7, and CXCL8) as aldosterone-repressed genes.	[Le Billan, Florian; Perrot, Julie; Carceller, Elena; Travers, Simon; Viengchareun, Say; Lombes, Marc; Fagart, Jerome] Univ Paris Saclay, INSERM, Physiol & Physiopathol Endocriniennes, Le Kremlin Bicetre, France; [Kolkhof, Peter] Bayer AG, Preclin Res Cardiovasc Pharmaceut Res & Dev, Wuppertal, Germany; [Le Billan, Florian] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada; [Fagart, Jerome] Ecole Polytech, CNRS UMR 7654, Lab Biochim BIOC, Palaiseau, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Bayer AG; University of Toronto; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Polytechnique de Paris	Lombes, M; Fagart, J (corresponding author), Inserm U1185, Fac Med Paris Saclay, 63 Rue Gabriel Peri, F-94276 Le Kremlin Bicetre, France.; Fagart, J (corresponding author), Ecole Polytech, CNRS UMR 7654, Lab Biochim BIOC, Palaiseau, France.	marc.lombes@u-psud.fr; jerome.fagart@inserm.fr	Fagart, Jerome/S-4581-2018; Viengchareun, Say/GOV-6812-2022	Fagart, Jerome/0000-0002-7965-0553; viengchareun, say/0000-0003-4280-3250; Le Billan, Florian/0000-0002-3400-9295				Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Amazit L, 2015, J BIOL CHEM, V290, P21876, DOI 10.1074/jbc.M115.657957; Amrouche L, 2017, J AM SOC NEPHROL, V28, P479, DOI 10.1681/ASN.2016010045; Barfacker L, 2012, CHEMMEDCHEM, V7, P1385, DOI 10.1002/cmdc.201200081; Baker ME, 2017, J ENDOCRINOL, V234, pT1, DOI 10.1530/JOE-16-0661; Bakris GL, 2019, AM J NEPHROL, V50, P333, DOI 10.1159/000503713; Barrera-Chimal J, 2018, KIDNEY INT, V93, P1344, DOI 10.1016/j.kint.2017.12.016; Belden Z, 2017, AM J NEPHROL, V46, P298, DOI 10.1159/000480652; Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; Bonny O, 2013, NEPHROL DIAL TRANSPL, V28, P2421, DOI 10.1093/ndt/gft319; Corden B, 2020, BRIT J PHARMACOL, V177, P1695, DOI 10.1111/bph.15013; Cui SY, 2017, ENDOCRINOLOGY, V158, P1671, DOI 10.1210/en.2016-1781; Deppe CE, 2002, ENDOCRINOLOGY, V143, P1932, DOI 10.1210/en.143.5.1932; Ewels Philip, 2016, F1000Res, V5, P2824, DOI 10.12688/f1000research.10335.2; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Fraccarollo D, 2008, HYPERTENSION, V51, P905, DOI 10.1161/HYPERTENSIONAHA.107.100941; Gauer S, 2007, KIDNEY INT, V72, P1081, DOI 10.1038/sj.ki.5002473; Ge YN, 2019, MOL THER-NUCL ACIDS, V17, P741, DOI 10.1016/j.omtn.2019.07.007; Gong YY, 2018, MOL CELL ENDOCRINOL, V471, P22, DOI 10.1016/j.mce.2017.05.024; Gonzalez J, 2013, BIOCHEM BIOPH RES CO, V438, P257, DOI 10.1016/j.bbrc.2013.07.025; Gousseva N, 2003, GENE EXPRESSION, V11, P163, DOI 10.3727/000000003108749053; Grune J, 2018, HYPERTENSION, V71, P599, DOI 10.1161/HYPERTENSIONAHA.117.10360; Gumz ML, 2009, J CLIN INVEST, V119, P2423, DOI 10.1172/JCI36908; Gumz ML, 2003, AM J PHYSIOL-RENAL, V285, pF664, DOI 10.1152/ajprenal.00353.2002; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kolkhof P, 2017, J ENDOCRINOL, V234, pT125, DOI 10.1530/JOE-16-0600; Kolkhof P, 2014, J CARDIOVASC PHARM, V64, P69, DOI 10.1097/FJC.0000000000000091; Lattenist L, 2017, HYPERTENSION, V69, P870, DOI 10.1161/HYPERTENSIONAHA.116.08526; Le Billan F, 2018, FASEB J, V32, P5626, DOI 10.1096/fj.201800391RR; Le Billan F, 2015, FASEB J, V29, P3977, DOI 10.1096/fj.15-274266; Liu SY, 2018, J DIABETES INVEST, V9, P1182, DOI 10.1111/jdi.12828; Magno AL, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7010019; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Miyata KN, 2020, TRANSL RES, V217, P1, DOI 10.1016/j.trsl.2019.11.001; Morgado-Pascual JL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/783538; Moritoh Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32072; Park EJ, 2018, AM J PHYSIOL-RENAL, V314, pF329, DOI 10.1152/ajprenal.00358.2017; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 2013, EUR HEART J, V34, P2453, DOI 10.1093/eurheartj/eht187; Poulsen SB, 2018, PHYSIOL GENOMICS, V50, P343, DOI 10.1152/physiolgenomics.00084.2017; Quinkler M, 2005, CIRCULATION, V112, P1435, DOI 10.1161/CIRCULATIONAHA.105.539122; Robert-Nicoud M, 2001, P NATL ACAD SCI USA, V98, P2712, DOI 10.1073/pnas.051603198; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruilope LM, 2019, AM J NEPHROL, V50, P345, DOI 10.1159/000503712; Sheng JQ, 2019, J CELL PHYSIOL, V234, P3043, DOI 10.1002/jcp.27124; Shibata S, 2017, J ENDOCRINOL, V234, pT35, DOI 10.1530/JOE-16-0669; Shrestha A, 2019, ADV EXP MED BIOL, V1165, P325, DOI 10.1007/978-981-13-8871-2_15; Swanson EA, 2019, PHYSIOL GENOMICS, V51, P125, DOI 10.1152/physiolgenomics.00119.2018; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Wang Q, 2004, J STEROID BIOCHEM, V91, P197, DOI 10.1016/j.jsbmb.2004.04.007; Yamada Y, 2018, INT J MOL MED, V42, P2415, DOI 10.3892/ijmm.2018.3852; Yang FQ, 2014, INT J CLIN EXP PATHO, V7, P110; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700; Zhao XP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24220-6; Zhao XP, 2014, DIABETOLOGIA, V57, P1986, DOI 10.1007/s00125-014-3297-6; Zhou YF, 2019, BIOL RES, V52, DOI 10.1186/s40659-019-0236-5; Zhu HQ, 2017, INT J BIOL SCI, V13, P1489, DOI 10.7150/ijbs.21637	59	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21314	10.1096/fj.202002043RR	http://dx.doi.org/10.1096/fj.202002043RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33417258				2022-12-26	WOS:000647789600054
J	Eustace, A; Esser, LF; Mremi, R; Malonza, PK; Mwaya, RT				Eustace, Abraham; Esser, Luiz Fernando; Mremi, Rudolf; Malonza, Patrick K.; Mwaya, Reginald T.			Protected areas network is not adequate to protect a critically endangered East Africa Chelonian: Modelling distribution of pancake tortoise, Malacochersus tornieri under current and future climates	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; CONSERVATION; HABITAT; STABILIZATION; UNCERTAINTY; REPTILE; PATHWAY; REGIONS; SHIFTS	While the international pet trade and habitat destruction have been extensively discussed as major threats to the survival of the pancake tortoise (Malacochersus tornieri), the impact of climate change on the species remains unknown. In this study, we used species distribution modelling to predict the current and future distribution of pancake tortoises in Zambezian and Somalian biogeographical regions. We used 224 pancake tortoise occurrences obtained from Tanzania, Kenya and Zambia to estimate suitable and stable areas for the pancake tortoise in all countries present in these regions. We also used a protected area network to assess how many of the suitable and stable areas are protected for the conservation of this critically endangered species. Our model predicted the expansion of climatically suitable habitats for pancake tortoises from four countries and a total area of 90,668.75 km(2) to ten countries in the future and an area of 343,459.60-401,179.70 km(2). The model also showed that a more significant area of climatically suitable habitat for the species lies outside of the wildlife protected areas. Based on our results, we can predict that pancake tortoises may not suffer from habitat constriction. However, the species will continue to be at risk from the international pet trade, as most of the identified suitable habitats remain outside of protected areas. We suggest that efforts to conserve the pancake tortoise should not only focus on protected areas but also areas that are unprotected, as these comprise a large proportion of the suitable and stable habitats available following predicted future climate change.	[Eustace, Abraham] Tanzania Wildlife Management Author, Morogoro, Tanzania; [Esser, Luiz Fernando] Univ Fed Rio Grande do Sul, Programa Posgrad Bot, Lab Fitoecol & Fitogeog, Porto Alegre, RS, Brazil; [Mremi, Rudolf; Mwaya, Reginald T.] Coll African Wildlife Management, Mweka, Moshi, Tanzania; [Malonza, Patrick K.] Natl Museums Kenya, Herpetol Sect, Nairobi, Kenya	Universidade Federal do Rio Grande do Sul	Eustace, A (corresponding author), Tanzania Wildlife Management Author, Morogoro, Tanzania.	abrah15@gmail.com	Esser, Luíz Fernando/AAB-5032-2019	Esser, Luíz Fernando/0000-0003-2982-7223; Eustace, Abraham/0000-0002-6980-0503				Ackerman R.A., 2004, P15; Ahmadi M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42792-9; Araujo MB, 2002, P ROY SOC B-BIOL SCI, V269, P1971, DOI 10.1098/rspb.2002.2121; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Baez JC, 2012, BIODIVERS CONSERV, V21, P65, DOI 10.1007/s10531-011-0164-3; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Beaumont LJ, 2016, ECOL MODEL, V342, P135, DOI 10.1016/j.ecolmodel.2016.10.004; Bellis J, 2020, CONSERV BIOL, V34, P1473, DOI 10.1111/cobi.13518; Bombi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077093; Brown JH., 2003, ROTATIONAL SPECTROSC; Burgess N., 2004, Terrestrial ecoregions of Africa and Madagascar: a conservation assessment; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Chamberlain S, 2018, **DATA OBJECT**; Chamberlain S, 2020, **DATA OBJECT**; Chansa Wilbroad, 2006, Salamandra, V42, P187; Church RL, 1996, BIOL CONSERV, V76, P105, DOI 10.1016/0006-3207(95)00102-6; COE MJ, 1993, T ROY SOC S AFR, V48, P233, DOI 10.1080/00359199309520273; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Deharveng L., 2019, ENCY CAVES, V3rd ed., P146, DOI DOI 10.1016/B978-0-12-814124-3.00040-6; Esser HJ, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3515-7; Fathinia B, 2020, ZOOL MIDDLE EAST, V66, P197, DOI 10.1080/09397140.2020.1757910; Franklin J, 2013, DIVERS DISTRIB, V19, P1217, DOI 10.1111/ddi.12125; Franklin J, 2010, DIVERS DISTRIB, V16, P321, DOI 10.1111/j.1472-4642.2010.00641.x; Garcia RA, 2014, SCIENCE, V344, P486, DOI 10.1126/science.1247579; Gonzalez-Fernandez A, 2018, PEERJ, V6, DOI 10.7717/peerj.4618; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hannah L, 2020, ECOGRAPHY, V43, P943, DOI 10.1111/ecog.05166; Houniet DT, 2009, AFR J HERPETOL, V58, P28, DOI 10.1080/21564574.2009.9635577; International Union for Conservation of Nature (IUCN), 2013, GUID REINTR OTH CONS; Iverson JB, 2003, EMYSYSTEM WORLD TURT; Kabigumila J., 2002, TANZANIA J SCI, V28, P34; Karger DN, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.122; Khan S, 2020, HERPETOL CONSERV BIO, V15, P212; Klemens Michael W., 1995, Chelonian Conservation and Biology, V1, P197; Krechemer FD, 2020, J APPL ECOL, V57, P1829, DOI 10.1111/1365-2664.13650; Kyalo NS, 2008, CONSERVATION MANAGEM; Linder H. P., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P229; Linder HP, 2012, J BIOGEOGR, V39, P1189, DOI 10.1111/j.1365-2699.2012.02728.x; Malonza Patrick Kenyatta, 2004, Journal of East African Natural History, V92, P81, DOI 10.2982/0012-8317(2003)92[81:EADOTP]2.0.CO;2; Mammola S, 2018, ECOGRAPHY, V41, P1194, DOI 10.1111/ecog.03464; Martinez-Freiria F, 2016, DIVERS DISTRIB, V22, P432, DOI 10.1111/ddi.12406; Martinez-Freiria F, 2013, NATURWISSENSCHAFTEN, V100, P877, DOI 10.1007/s00114-013-1088-4; Masui T, 2011, CLIMATIC CHANGE, V109, P59, DOI 10.1007/s10584-011-0150-5; McHenry J, 2019, GLOBAL CHANGE BIOL, V25, P4208, DOI 10.1111/gcb.14828; Meng H., 2016, BIOL CONSERV, DOI [10.1016/j.biocon.2016.04.008, DOI 10.1016/J.BIOCON.2016.04.008]; Moll Don, 1996, Chelonian Conservation and Biology, V2, P26; Mwaya Reginald T., 2009, Salamandra, V45, P115; Mwaya RT, 2019, IUCN RED LIST THREAT; Mwaya RT, 2018, CHELONIAN RES MONOGR, DOI [10.3854/crm.5.107.tornieri.v1.2018, DOI 10.3854/CRM.5.107.TORNIERI.V1.2018]; Naimi B, 2016, ECOGRAPHY, V39, P368, DOI 10.1111/ecog.01881; Naimi B, 2014, ECOGRAPHY, V37, P191, DOI 10.1111/j.1600-0587.2013.00205.x; Oh SG, 2017, THEOR APPL CLIMATOL, V129, P243, DOI 10.1007/s00704-016-1782-1; Pachauri RK, 2014, 2014 IEEE STUDENTS' CONFERENCE ON ELECTRICAL, ELECTRONICS AND COMPUTER SCIENCE (SCEECS); Palacio FX, 2018, J AVIAN BIOL, V49, DOI 10.1111/jav.01743; R Core Team, 2021, R LANGUAGE ENV STAT; Rajpar M. N., 2018, Tropical forests, P37; RAPHAEL BL, 1994, J ZOO WILDLIFE MED, V25, P63; Real R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053646; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Salas EAL, 2017, HERPETOL CONSERV BIO, V12, P522; Sanderson BM, 2015, J CLIMATE, V28, P5171, DOI 10.1175/JCLI-D-14-00362.1; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sousa-Guedes D, 2020, CLIMATE, V8, DOI 10.3390/cli8030042; Spawls S, 2002, FIELD GUIDE REPTILES; Srinivasulu Aditya, 2016, Journal of Threatened Taxa, V8, P8883, DOI 10.11609/jott.2723.8.6.8883-8892; Terribile LC, 2012, NAT CONSERVACAO, V10, P152, DOI 10.4322/natcon.2012.025; Thomson AM, 2011, CLIMATIC CHANGE, V109, P77, DOI 10.1007/s10584-011-0151-4; Thulin M, 1994, P 13 PLEN M AETFAT Z, P1105; Tomillo PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037602; UNEP-WCMC IUCN, 2020, PROTECTED PLANET WOR; Villero D, 2017, BIODIVERS CONSERV, V26, P251, DOI 10.1007/s10531-016-1243-2; Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]; White F., 1983, Natural Resources Research, UNESCO, V20; White TH, 2015, J NAT CONSERV, V28, P149, DOI 10.1016/j.jnc.2015.10.002; Wood RC, 1997, CONSERVATION RESTORA; Zacarias DA, 2007, HABITAT ANAL POPULAT	80	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0238669	10.1371/journal.pone.0238669	http://dx.doi.org/10.1371/journal.pone.0238669			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471868	Green Submitted, gold, Green Published			2022-12-26	WOS:000639428800074
J	Odo, DB; Mekonnen, AG				Odo, Daniel Bogale; Mekonnen, Alemayehu Gonie			Availability and factors influencing community level handwashing facility in Ethiopia: Implication for prevention of infectious diseases	PLOS ONE			English	Article							HYGIENE INTERVENTIONS; SANITATION; DIARRHEA; BEHAVIOR; WATER; SETTINGS; CHILDREN	Background Handwashing is one of the most effective ways to prevent transmission of infectious diseases. A substantial body of research has examined the status and determinants of handwashing facilities in healthcare settings and schools. However, its status at home in the community, especially in developing countries, remains unclear. This study aimed to examine the availability and factors influencing basic handwashing facilities at households in Ethiopia. Method We analysed the 2016 Ethiopian Demographic and Health Survey (EDHS) data. EDHS employed a two-stage stratified cluster sampling technique. Data were collected from the lowest administrative unit (kebele). A multivariable logistic regression model that allowed cluster-level random effects was employed to examine factors that affect the availability of basic handwashing facilities (water plus soap) at households. Estimates from the regression model are reported as odds ratios (ORs) with standard errors clustered at the DHS cluster level to account for a sampling methodology. Results In our sample, only 1292 (8% [95% CI, 7.6%-8.4%]) of the households had basic handwashing facilities. Compared with head of household who had no formal education, the odds of having basic handwashing facilities was higher among head of household who completed secondary level of education (adjusted odds ratio [AOR] = 1.83; 95% CI: 1.35-2.49) and higher level of education (AOR = 2.35; 95% CI: 1.63-3.39). Odds of having basic handwashing facilities was increased with having radio (AOR = 1.32; 95% CI: 1.10-1.63) and television (AOR = 1.49; 95% CI: 1.10-2.02) at home. Households that had improved latrine were two times more likely to have basic handwashing facilities (AOR = 2.09; 95% CI: 1.56-2.80). Being at higher household wealth quintiles was associated with increased odds of having basic handwashing facilities. Conclusion Very low basic handwashing facilities was demonstrated by this study, whereas, awareness and socio-economic related factors were identified as a determinants for its availability in the household. Greater efforts are needed to increase the coverage of community-level handwashing facilities.	[Odo, Daniel Bogale] Arsi Univ, Coll Hlth Sci, Dept Publ Hlth, Asela, Oromia Regional, Ethiopia; [Mekonnen, Alemayehu Gonie] Debre Berhan Univ, Coll Hlth Sci, Dept Nursing, Debre Berhan, Amhara Regional, Ethiopia		Odo, DB (corresponding author), Arsi Univ, Coll Hlth Sci, Dept Publ Hlth, Asela, Oromia Regional, Ethiopia.	dbogale386@gmail.com		Odo, Daniel/0000-0001-7412-5584				Adane M, 2018, J COMMUN HEALTH, V43, P400, DOI 10.1007/s10900-017-0437-1; [Anonymous], 2020, ETHIOPIA RACES BOLST; Assefa Y, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0470-1; Belachew A. B., 2018, J PREV MED HYG, V59, pE219, DOI 10.15167/2421-4248/jpmh2018.59.3.826; Chittleborough CR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-757; Clasen T, 2014, LANCET GLOB HEALTH, V2, pE645, DOI 10.1016/S2214-109X(14)70307-9; CSA Ethiopia and ICF, 2016, ETH DEM HLTH SURV 20; Dagne H, 2019, ITAL J PEDIATR, V45, DOI 10.1186/s13052-019-0713-z; Doronina O, 2017, J NURS SCHOLARSHIP, V49, P143, DOI 10.1111/jnu.12274; Ethiopian Ministry of Health, 2015, HLTH SECT TRANSF PLA; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Galiani S, 2016, HEALTH ECON, V25, P1545, DOI 10.1002/hec.3273; Hulland KRS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-877; ICRC, 2020, ETH COVID 19 FACT SH; To KG, 2016, GLOBAL HEALTH ACTION, V9, P101, DOI 10.3402/gha.v9.29207; McGuinness SL, 2018, TROP MED INT HEALTH, V23, P816, DOI 10.1111/tmi.13080; Moncion K, 2019, Can Commun Dis Rep, V45, P12, DOI 10.14745/ccdr.v45i01a02; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Pruss-Ustun A., 2008, SAFER WATER BETTER H; Ram P, 2013, PRACTICAL GUIDANCE M; Schmidt WP, 2019, INT J ENVIRON HEAL R, V29, P71, DOI 10.1080/09603123.2018.1511772; Staniford LJ, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8301-0; Talaat M, 2011, EMERG INFECT DIS, V17, P619, DOI 10.3201/eid1704.101353; UN, 2019, SUSTAINABLE DEV GOAL; Watson J, 2019, INT J HYG ENVIR HEAL, V222, P177, DOI 10.1016/j.ijheh.2018.09.002; White S, 2020, INT J HYG ENVIR HEAL, V227, DOI 10.1016/j.ijheh.2020.113512; WHO/UNICEF, 2020, HYG BAS PREC 19 GLOB; Willmott M, 2016, ARCH DIS CHILD, V101, P42, DOI 10.1136/archdischild-2015-308875; Wilson S, 2011, CRIT PUBLIC HEALTH, V21, P119, DOI 10.1080/09581591003786122; Woldemichael A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213896; Wolf J, 2019, INT J EPIDEMIOL, V48, P1204, DOI 10.1093/ije/dyy253; Wolf J, 2018, TROP MED INT HEALTH, V23, P508, DOI 10.1111/tmi.13051	32	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0243228	10.1371/journal.pone.0243228	http://dx.doi.org/10.1371/journal.pone.0243228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465087	Green Published, gold			2022-12-26	WOS:000611969200039
J	Vousden, N; Bunch, K; Knight, M				Vousden, Nicola; Bunch, Kathryn; Knight, Marian		UKOSS Influenza Co-Investigators	Incidence, risk factors and impact of seasonal influenza in pregnancy: A national cohort study	PLOS ONE			English	Article							VACCINE UPTAKE; VIRUS-INFECTION; H1N1 INFLUENZA; BIRTH OUTCOMES; PRETERM BIRTH; PHASE 4; IMMUNIZATION; WOMEN; EPIDEMIOLOGY; METAANALYSIS	Background Pregnant women are particularly vulnerable to severe infection from influenza resulting in poor neonatal outcomes. The majority of evidence relates to pandemic 2009 A/H1N1 influenza. The objective of this study was to describe the characteristics and outcomes of pregnant women hospitalised with seasonal influenza. Methods This national, prospective, observational cohort study used the UK Obstetric Surveillance System (UKOSS) to identify all pregnant women admitted to hospital between 01/11/2016 and 31/10/2018 with laboratory confirmed influenza at any gestation and up to two days after giving birth. These were compared to women admitted to give birth that did not have influenza. Baseline characteristics, immunization status, maternal and perinatal outcomes were compared. Results There were 405 women admitted to hospital with laboratory confirmed influenza in pregnancy: 2.7 per 10,000 maternities. Compared to 694 comparison women, women with influenza were less likely to be professionally employed (aOR 0.59, 95%CI 0.39-0.89) or immunised in the relevant season (aOR 0 center dot 59, 0 center dot 39-0 center dot 89) and more likely to have asthma (aOR 2.42, 1.30-4.49) or have had a previous pregnancy complication (aOR 2 center dot 47, 1 center dot 33-4 center dot 61). They were more likely to be admitted to intensive care (aOR 21.3, 2.78-163.1) and to have a cesarean birth (aOR 1 center dot 42, 1 center dot 02-1.98). Their babies were more likely to be admitted to neonatal intensive care (aOR 1.86, 1 center dot 01-3 center dot 42). Conclusions Immunization reduces the risk of hospitalisation with influenza in pregnancy which is associated with increased risk of morbidity for both the mother and baby. There is a continued need to increase awareness of safety and effectiveness of immunization in pregnancy and provision within antenatal care settings, especially for high-risk groups.	[Vousden, Nicola] Kings Coll London, Sch Populat Hlth & Environm Sci, Fac Life Sci & Med, London, England; [Vousden, Nicola; Bunch, Kathryn; Knight, Marian] Univ Oxford, Policy Res Unit Maternal Hlth & Care, Natl Perinatal Epidemiol Unit, Oxford, England	University of London; King's College London; University of Oxford	Knight, M (corresponding author), Univ Oxford, Policy Res Unit Maternal Hlth & Care, Natl Perinatal Epidemiol Unit, Oxford, England.	marian.knight@npeu.ox.ac.uk			National Institute for Health Research (NIHR) Health Technology Assessment Programme [11/46/12]; National Institute for Health Research (NIHR) Policy Research Programme in the Department of Health and Social Care, England [108/0001]	National Institute for Health Research (NIHR) Health Technology Assessment Programme(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) Policy Research Programme in the Department of Health and Social Care, England	This work was supported by the National Institute for Health Research (NIHR) Health Technology Assessment Programme [11/46/12, MK](https://www.journalslibrary.nihr.ac.uk/programmes/hta/) and the National Institute for Health Research (NIHR) Policy Research Programme in the Department of Health and Social Care, England [108/0001, MK](https://www.nihr.ac.uk/explore-nihr/funding-programmes/policyresearch.htm).The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allotey J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3320; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Beigi RH, 2009, CLIN INFECT DIS, V49, P1784, DOI 10.1086/649013; Bodeker B, 2014, VACCINE, V32, P4131, DOI 10.1016/j.vaccine.2014.06.007; Bratton KN, 2015, CLIN INFECT DIS, V60, pE11, DOI 10.1093/cid/ciu915; Collins J, 2014, HUM VACC IMMUNOTHER, V10, P2922, DOI 10.4161/21645515.2014.971606; Fell DB, 2015, BJOG-INT J OBSTET GY, V122, P17, DOI 10.1111/1471-0528.12977; Fell DB, 2018, EPIDEMIOLOGY, V29, P107, DOI [10.1097/ede.0000000000000753, 10.1097/EDE.0000000000000753]; Fell DB, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016526; Fell DB, 2017, VACCINE, V35, P5738, DOI 10.1016/j.vaccine.2017.08.037; Freund R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020900; Giles ML, 2019, HUM VACC IMMUNOTHER, V15, P687, DOI 10.1080/21645515.2018.1540807; He J, 2017, KIDNEY BLOOD PRESS R, V42, P232, DOI 10.1159/000477221; Healy CM, 2015, VACCINE, V33, P5445, DOI 10.1016/j.vaccine.2015.08.028; Ishola DA, 2013, J PUBLIC HEALTH-UK, V35, P570, DOI 10.1093/pubmed/fds109; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Katz MA, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1333-5; Knight M, 2005, BJOG-INT J OBSTET GY, V112, P263, DOI 10.1111/j.1471-0528.2005.00609.x; Knight M KS, 2014, SAVING LIVES IMPROVI; Laake I, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3435-8; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Mertz D, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4318-3; Mertz D, 2017, VACCINE, V35, P521, DOI 10.1016/j.vaccine.2016.12.012; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; National Institute for Health and Care Excellence, 2018, FLU VACC INCR UPT EV; NCCN Clinical Practice, 2018, ACUTE MYELOID LEUKEM, VV2, pMS28; Nunes MC, 2016, AM J PERINAT, V33, P1104, DOI 10.1055/s-0036-1586101; Ortiz JR, 2016, VACCINE, V34, P5400, DOI 10.1016/j.vaccine.2016.07.045; Prasad N, 2019, J INFECT DIS, V219, P1893, DOI 10.1093/infdis/jiz035; Public Health England, 2019, SEAS INFL VACC UPT G; Public Health England, 2019, INFL GREEN BOOK; Puig-Barbera J, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4017-0; Regan AK, 2017, EPIDEMIOL INFECT, V145, P2930, DOI [10.1017/s0950268817001972, 10.1017/S0950268817001972]; Sammon CJ, 2013, HUM VACC IMMUNOTHER, V9, P917, DOI 10.4161/hv.23277; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Steinhoff MC, 2017, LANCET INFECT DIS, V17, P981, DOI 10.1016/S1473-3099(17)30252-9; Tapia MD, 2016, LANCET INFECT DIS, V16, P1026, DOI 10.1016/S1473-3099(16)30054-8; Thompson MG, 2019, CLIN INFECT DIS, V68, P1444, DOI 10.1093/cid/ciy737; Vishram B, 2018, HUM VACC IMMUNOTHER, V14, P179, DOI 10.1080/21645515.2017.1382789; Wilcox CR, 2019, PEDIATR INFECT DIS J, V38, P625, DOI 10.1097/INF.0000000000002242; World Health Organization, 2012, WHO POS PAP INFL VAC WHO POS PAP INFL VAC; Xu J, 2016, VACCINE, V34, P3149, DOI 10.1016/j.vaccine.2016.04.057; Yates L, 2010, HEALTH TECHNOL ASSES, V14, P121; Yuen CYS, 2014, VACCINE, V32, P4602, DOI 10.1016/j.vaccine.2014.06.067; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	46	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0244986	10.1371/journal.pone.0244986	http://dx.doi.org/10.1371/journal.pone.0244986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449966	Green Published, Green Submitted, gold			2022-12-26	WOS:000609991600049
J	Chen, L; Du, QR; Yu, M; Guo, X; Zhao, W				Chen, Ling; Du, Qirui; Yu, Miao; Guo, Xin; Zhao, Wu			Measuring the effect of residual stress on the machined subsurface of Inconel 718 by nanoindentation	PLOS ONE			English	Article							TIP RADIUS; THIN-FILMS; HARDNESS; BEHAVIOR; METALS	Inconel 718 alloy is widely used in aero-engines and high-temperature environments. However, residual stress caused by processing and molding leads to an uneven distribution of internal pressure, which reduces the reliability of service process. Therefore, numerical simulation of the nanoindentation process was applied to evaluate the effect of residual stress on the machined subsurface of Inconel 718. A gradient material model of Inconel 718 was established in ABAQUS finite element software. Mechanical properties based on nanoindentation testing showed an influence of residual stress in combination with indenter geometry. The orthogonal experimental results show that under diverse residual stress states, the indenter's geometry can affect the pile-up of the material surface after nanoindentation and significantly influence the test results. With increases in piling-up, the error caused by residual stress on the characterization of the mechanical properties of the hardened layer increases. Through the establishment of a numerical model, the influence of residual stress can be predicted within nanoindentation depths of 300 nm.	[Chen, Ling; Du, Qirui; Yu, Miao; Guo, Xin; Zhao, Wu] Sichuan Univ, Sch Mech Engn, Chengdu, Peoples R China; [Chen, Ling; Du, Qirui; Yu, Miao; Guo, Xin; Zhao, Wu] Innovat Method & Creat Design Key Lab Sichuan Pro, Chengdu, Peoples R China	Sichuan University	Chen, L (corresponding author), Sichuan Univ, Sch Mech Engn, Chengdu, Peoples R China.; Chen, L (corresponding author), Innovat Method & Creat Design Key Lab Sichuan Pro, Chengdu, Peoples R China.	chenlingscu@scu.edu.cn			National Science Foundation for Young Scientist of China [51805340]; Fundamental Research Funds for the Central Universities [2019SCU12075]; key research & development projects of Sichuan province, China [2020ZDZX0025]	National Science Foundation for Young Scientist of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); key research & development projects of Sichuan province, China	This research is supported by the National Science Foundation for Young Scientist of China (Grant No. 51805340) and the Fundamental Research Funds for the Central Universities (2019SCU12075). Moreover, this works also thanks to the financial support by key research & development projects (Grant Agreement No.2020ZDZX0025) of Sichuan province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulaziz S., 2019, J KING SAUD U ENG SC, V31, P61, DOI [10.1016/j.jksues.2017.02.001, DOI 10.1016/J.JKSUES.2017.02.001]; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Bowman KJ, 2004, MECH BEHAV MAT; Bressan JD, 2005, WEAR, V258, P115, DOI 10.1016/j.wear.2004.05.021; Bucaille JL, 2003, ACTA MATER, V51, P1663, DOI 10.1016/S1359-6454(02)00568-2; Calabri L, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/39/395002; Chen L., 2014, MODEL NUMER SIMUL MA, V4, P153, DOI DOI 10.4236/RNASMS.2014.44017; Dean J, 2011, ACTA MATER, V59, P2749, DOI 10.1016/j.actamat.2011.01.014; DOERNER MF, 1988, CRIT REV SOLID STATE, V14, P225, DOI 10.1080/10408438808243734; Fan Z, 2006, ACTA MECH SINICA-PRC, V22, P1, DOI 10.1007/s10409-005-0084-0; Fischer-Cripps AC, 2011, MECH ENG SER, P213, DOI 10.1007/978-1-4419-9872-9_12; Hertz H., 1882, J ANGEW MATH, V92, P156, DOI [10.1515/9783112342404-004, DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]; Jandera M, 2014, THIN WALL STRUCT, V83, P12, DOI 10.1016/j.tws.2014.03.013; Jha KK, 2014, COMP MATER SCI, V85, P32, DOI 10.1016/j.commatsci.2013.12.005; Jha KK, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/41/415501; Khan MK, 2011, COMP MATER SCI, V50, P2967, DOI 10.1016/j.commatsci.2011.05.015; Knapp JA, 1999, J APPL PHYS, V85, P1460, DOI 10.1063/1.369178; Lichinchi M, 1998, THIN SOLID FILMS, V312, P240, DOI 10.1016/S0040-6090(97)00739-6; McElhaney KW, 1998, J MATER RES, V13, P1300, DOI 10.1557/JMR.1998.0185; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Roters F, 2010, ACTA MATER, V58, P1152, DOI 10.1016/j.actamat.2009.10.058; SHIH CW, 1991, J MATER RES, V6, P2623, DOI 10.1557/JMR.1991.2623; Tiwari AK, 2019, MEAS CONTROL-UK, V52, P1252, DOI 10.1177/0020294019858107; Wang Y, 2016, RESULTS PHYS, V6, P509, DOI 10.1016/j.rinp.2016.08.008; Wu Y, 2019, MATER CHARACT, V155, DOI 10.1016/j.matchar.2019.109788; Xu ZH, 2005, ACTA MATER, V53, P1913, DOI 10.1016/j.actamat.2005.01.002; Zambaldi C, 2010, ACTA MATER, V58, P3516, DOI 10.1016/j.actamat.2010.02.025; Zambaldi C, 2012, J MATER RES, V27, P356, DOI 10.1557/jmr.2011.334	28	1	1	7	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245391	10.1371/journal.pone.0245391	http://dx.doi.org/10.1371/journal.pone.0245391			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444341	Green Published, gold			2022-12-26	WOS:000609988100050
J	Choi, S; Moon, S; Baek, J				Choi, Seungwon; Moon, Seunghyuk; Baek, Jongduk			A metal artifact reduction method for small field of view CT imaging	PLOS ONE			English	Article							RAY COMPUTED-TOMOGRAPHY; RECONSTRUCTION; ALGORITHM; OBJECTS	Several sinogram inpainting based metal artifact reduction (MAR) methods have been proposed to reduce metal artifact in CT imaging. The sinogram inpainting method treats metal trace regions as missing data and estimates the missing information. However, a general assumption with these methods is that data truncation does not occur and that all metal objects still reside within the field-of-view (FOV). These assumptions are usually violated when the FOV is smaller than the object. Thus, existing inpainting based MAR methods are not effective. In this paper, we propose a new MAR method to effectively reduce metal artifact in the presence of data truncation. The main principle of the proposed method involves using a newly synthesized sinogram instead of the originally measured sinogram. The initial reconstruction step involves obtaining a small FOV image with the truncation artifact removed. The final step is to conduct sinogram inpainting based MAR methods, i.e., linear and normalized MAR methods, on the synthesized sinogram from the previous step. The proposed method was verified for extended cardiac-torso simulations, clinical data, and experimental data, and its performance was quantitatively compared with those of previous methods (i.e., linear and normalized MAR methods directly applied to the originally measured sinogram data). The effectiveness of the proposed method was further demonstrated by reducing the residual metal artifact that were present in the reconstructed images obtained using the previous method.	[Choi, Seungwon; Moon, Seunghyuk; Baek, Jongduk] Yonsei Univ, Sch Integrated Technol, Incheon, South Korea; [Choi, Seungwon; Moon, Seunghyuk; Baek, Jongduk] Yonsei Univ, Yonsei Inst Convergence Technol, Incheon, South Korea	Yonsei University; Yonsei University	Baek, J (corresponding author), Yonsei Univ, Sch Integrated Technol, Incheon, South Korea.	jongdukbaek@yonsei.ac.kr			Bio and Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science and ICT [NRF-2019R1A2C2084936, 2020R1A4A1016619]; Korea Medical Device Development Fund - Korea government (the Ministry of Science and ICT); Korea Medical Device Development Fund - Korea government (Ministry of Trade, Industry and Energy); Korea Medical Device Development Fund - Korea government (Ministry of Health AMP; Welfare, Republic of Korea); Korea Medical Device Development Fund - Korea government (Ministry of Food and Drug Safety) [202011A03]	Bio and Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science and ICT; Korea Medical Device Development Fund - Korea government (the Ministry of Science and ICT); Korea Medical Device Development Fund - Korea government (Ministry of Trade, Industry and Energy); Korea Medical Device Development Fund - Korea government (Ministry of Health AMP; Welfare, Republic of Korea); Korea Medical Device Development Fund - Korea government (Ministry of Food and Drug Safety)	This research was supported by the Bio and Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science and ICT (NRF-2019R1A2C2084936 and 2020R1A4A1016619) and the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, Republic of Korea, the Ministry of Food and Drug Safety) (202011A03).	AAPM, 2016, LOW DOSE CT GRAND CH; Biguri A, 2016, BIOMED PHYS ENG EXPR, V2, DOI 10.1088/2057-1976/2/5/055010; Boas EF, 2012, IMAGING MED, V4, P229, DOI DOI 10.2217/IIM.12.13; Boas FE, 2011, RADIOLOGY, V259, P894, DOI 10.1148/radiol.11101782; Boone JM, SIMULATION XRAY SPEC; Chang ZQ, 2017, IEEE T MED IMAGING, V36, P277, DOI 10.1109/TMI.2016.2606338; Choi J, 2011, J X-RAY SCI TECHNOL, V19, P457, DOI 10.3233/XST-2011-0307; Claus BE, 2017, P 14 INT M FULL 3 DI, P631, DOI DOI 10.12059/FULLY3D.2017-11-3110004; De Man B, 1999, IEEE T NUCL SCI, V46, P691, DOI 10.1109/23.775600; Elbakri IA, 2002, IEEE T MED IMAGING, V21, P89, DOI 10.1109/42.993128; Ghani MU, 2020, IEEE T COMPUT IMAG, V6, P181, DOI 10.1109/TCI.2019.2937221; Gjesteby L, 2017, PROC SPIE, V10391, DOI 10.1117/12.2274427; GLOVER GH, 1981, MED PHYS, V8, P799, DOI 10.1118/1.595032; Hubbell J.H., 1995, TABLES XRAY MASS ATT, P5632; KALENDER WA, 1987, RADIOLOGY, V164, P576, DOI 10.1148/radiology.164.2.3602406; Kyriakou Y, 2010, MED PHYS, V37, P5179, DOI 10.1118/1.3477088; La Riviere PJ, 2006, IEEE T MED IMAGING, V25, P1022, DOI 10.1109/TMI.2006.875429; Lin W., P IEEE C COMP VIS PA, P10512; Mahnken AH, 2003, INVEST RADIOL, V38, P769, DOI 10.1097/01.rli.0000086495.96457.54; Mehranian A, 2013, IEEE T NUCL SCI, V60, P3318, DOI 10.1109/TNS.2013.2275919; Meyer E, 2010, MED PHYS, V37, P5482, DOI 10.1118/1.3484090; Muller J., 2009, Proceedings of the SPIE - The International Society for Optical Engineering, V7258, DOI 10.1117/12.813515; Nam H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179022; Nasirudin RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124831; Ohnesorge B, 2000, MED PHYS, V27, P39, DOI 10.1118/1.598855; Park HS, 2016, IEEE T MED IMAGING, V35, P480, DOI 10.1109/TMI.2015.2478905; Segars WP, 2008, MED PHYS, V35, P3800, DOI 10.1118/1.2955743; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Xing Y., 2008, PROC IEEE NUCL SCI S, P4175, DOI 10.1109/NSSMIC.2008.4774201; Yazdia M, 2005, INT J RADIAT ONCOL, V62, P1224, DOI 10.1016/j.ijrobp.2005.02.052; Yu HY, 2007, ACAD RADIOL, V14, P495, DOI 10.1016/j.acra.2006.12.015; Zhang XM, 2011, MED PHYS, V38, P701, DOI 10.1118/1.3533711; Zhang YB, 2018, IEEE T MED IMAGING, V37, P1370, DOI 10.1109/TMI.2018.2823083; Zhao SY, 2001, J X-RAY SCI TECHNOL, V10, P67; Zhao SY, 2000, IEEE T MED IMAGING, V19, P1238, DOI 10.1109/42.897816	35	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0227656	10.1371/journal.pone.0227656	http://dx.doi.org/10.1371/journal.pone.0227656			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444344	gold, Green Submitted, Green Published			2022-12-26	WOS:000609988100053
J	McKinney, CA; Bedenice, D; Pacheco, AP; Oliveira, BCM; Paradis, MR; Mazan, M; Widmer, G				McKinney, Caroline A.; Bedenice, Daniela; Pacheco, Ana P.; Oliveira, Bruno C. M.; Paradis, Mary-Rose; Mazan, Melissa; Widmer, Giovanni			Assessment of clinical and microbiota responses to fecal microbial transplantation in adult horses with diarrhea	PLOS ONE			English	Article							AKKERMANSIA-MUCINIPHILA; COLITIS	Background and aims Fecal microbial transplantation (FMT) is empirically implemented in horses with colitis to facilitate resolution of diarrhea. The purpose of this study was to assess FMT as a clinical treatment and modulator of fecal microbiota in hospitalized horses with colitis. Methods A total of 22 horses with moderate to severe diarrhea, consistent with a diagnosis of colitis, were enrolled at two referral hospitals (L1: n = 12; L2: n = 10). FMT was performed in all 12 patients on 3 consecutive days at L1, while treatment at L2 consisted of standard care without FMT. Manure was collected once daily for 4 days from the rectum in all colitis horses, prior to FMT for horses at L1, and from each manure sample used for FMT. Fecal samples from 10 clinically healthy control horses housed at L2, and 30 healthy horses located at 5 barns in regional proximity to L1 were also obtained to characterize the regional healthy equine microbiome. All fecal microbiota were analyzed using 16S amplicon sequencing. Results and conclusions As expected, healthy horses at both locations showed a greater alpha-diversity and lower beta-diversity compared to horses with colitis. The fecal microbiome of healthy horses clustered by location, with L1 horses showing a higher prevalence of Kiritimatiellaeota. Improved manure consistency (lower diarrhea score) was associated with a greater alpha-diversity in horses with colitis at both locations (L1: r = -0.385, P = 0.006; L2: r = -0.479, P = 0.002). Fecal transplant recipients demonstrated a greater overall reduction in diarrhea score (median: 4 +/- 3 grades), compared to untreated horses (median: 1.5 +/- 3 grades, P = 0.021), with a higher incidence in day-over-day improvement in diarrhea (22/36 (61%) vs. 10/28 (36%) instances, P = 0.011). When comparing microbiota of diseased horses at study conclusion to that of healthy controls, FMT-treated horses showed a lower mean UniFrac distance (0.53 +/- 0.27) than untreated horses (0.62 +/- 0.26, P<0.001), indicating greater normalization of the microbiome in FMT-treated patients.	[McKinney, Caroline A.; Bedenice, Daniela; Paradis, Mary-Rose; Mazan, Melissa] Tufts Univ, Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA 02155 USA; [Pacheco, Ana P.] Oregon State Univ, Carlson Coll Vet Med, Dept Clin Sci, Corvallis, OR 97331 USA; [Oliveira, Bruno C. M.] Univ Estadual Paulista UNESP, Fac Med Vet, Aracatuba, Brazil; [Oliveira, Bruno C. M.; Widmer, Giovanni] Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA USA	Tufts University; Oregon State University; Universidade Estadual Paulista; Tufts University	Bedenice, D (corresponding author), Tufts Univ, Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA 02155 USA.	Daniela.bedenice@tufts.edu		McKinney, Caroline/0000-0003-3167-2558	Dorothy Russell Havemeyer Foundation [V320001 PV1215]; American College of Veterinary Internal Medicine Resident Research grant [102783-00001]; National Institute of Allergy and Infectious Disease (NIAID) [R21AI125891]	Dorothy Russell Havemeyer Foundation; American College of Veterinary Internal Medicine Resident Research grant; National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the Dorothy Russell Havemeyer Foundation grant V320001 PV1215 (MRP, DB)(http://www.havemeyerfoundation.org/research.htm), the American College of Veterinary Internal Medicine Resident Research grant 102783-00001 (CM, DB) (https://www.acvim.org/Awards-Grants/Fellowships_Grants) and the National Institute of Allergy and Infectious Disease (NIAID) award R21AI125891 (GW) (https://www.niaid.nih.gov/research/research-funded-niaid).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold CE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232905; Biddle AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077599; Byndloss MX, 2018, MUCOSAL IMMUNOL, V11, P1299, DOI 10.1038/s41385-018-0010-y; Cani PD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01765; Chapman A, 2009, ACUTE DIARRHEA HOSPI; Chen HT, 2020, EXP THER MED, V19, P2650, DOI 10.3892/etm.2020.8512; Cohen ND, 1999, J AM VET MED ASSOC, V214, P382; Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07; Costa MC, 2015, VET J, V205, P74, DOI 10.1016/j.tvjl.2015.03.018; Costa MC, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0335-7; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Costa Marcio C., 2012, Animal Health Research Reviews, V13, P121, DOI 10.1017/S1466252312000035; Daly K, 2012, BRIT J NUTR, V107, P989, DOI 10.1017/S0007114511003825; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Dias DPM, 2018, PESQUI VET BRASIL, V38, P1564, DOI [10.1590/1678-5150-PVB-5521, 10.1590/1678-5150-pvb-5521]; Divers T.J, 2014, 11 INT EQ COL RES S; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards JE, 2020, ANIM MICROBIOME, V2, DOI 10.1186/s42523-020-0023-1; Ericsson AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166523; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Garber A, 2020, J EQUINE VET SCI, V88, DOI 10.1016/j.jevs.2020.102943; Hamilton MJ, 2013, GUT MICROBES, V4, P125, DOI 10.4161/gmic.23571; Hashimoto-Hill S, 2011, J VET INTERN MED, V25, P1414, DOI 10.1111/j.1939-1676.2011.00808.x; Hassel F, 2006, ENTERITIS COLITIS HO; Jea Suez, 2018, CELL, V174; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Laustsen LEJ, 2018, P EUR WORKSH EQ NUTR; Li DT, 2016, BIOTECHNOL ADV, V34, P1210, DOI 10.1016/j.biotechadv.2016.08.003; Liu SX, 2017, WORLD J GASTROENTERO, V23, P8570, DOI 10.3748/wjg.v23.i48.8570; Looft T, 2012, GUT MICROBES, V3, P463, DOI 10.4161/gmic.21288; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; McKinney CA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230148; Morrison PK, 2020, BMC VET RES, V16, DOI 10.1186/s12917-020-02295-6; Morrison PK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03017; Mullen KR, 2018, EQUINE VET EDUC, V30, P151, DOI 10.1111/eve.12559; Naylor RJ, 2009, EQUINE VET EDUC, V21, P494, DOI 10.2746/095777309X468140; Oliveira BCM, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01408-18; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pereira GQ, 2018, J VET INTERN MED, V32, P707, DOI 10.1111/jvim.15072; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rodriguez C, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0514-5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Spring S, 2016, ISME J, V10, P2801, DOI 10.1038/ismej.2016.84; Staley C, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0549-6; Steelman SM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-231; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Westcott SL, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00073-17	51	9	9	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0244381	10.1371/journal.pone.0244381	http://dx.doi.org/10.1371/journal.pone.0244381			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444319	Green Published, gold			2022-12-26	WOS:000609988100091
J	Galili, B; Tekpli, X; Kristensen, VN; Yakhini, Z				Galili, Ben; Tekpli, Xavier; Kristensen, Vessela N.; Yakhini, Zohar			Efficient gene expression signature for a breast cancer immuno-subtype	PLOS ONE			English	Article							LYMPHOCYTES; DISCOVERY	Motivation and background The patient's immune system plays an important role in cancer pathogenesis, prognosis and susceptibility to treatment. Recent work introduced an immune related breast cancer. This subtyping is based on the expression profiles of the tumor samples. Specifically, one study showed that analyzing 658 genes can lead to a signature for subtyping tumors. Furthermore, this classification is independent of other known molecular and clinical breast cancer subtyping. Finally, that study shows that the suggested subtyping has significant prognostic implications. Results In this work we develop an efficient signature associated with survival in breast cancer. We begin by developing a more efficient signature for the above-mentioned breast cancer immune-based subtyping. This signature represents better performance with a set of 579 genes that obtains an improved Area Under Curve (AUC). We then determine a set of 193 genes and an associated classification rule that yield subtypes with a much stronger statistically significant (log rank p-value < 2 x 10(-4) in a test cohort) difference in survival. To obtain these improved results we develop a feature selection process that matches the high-dimensionality character of the data and the dual performance objectives, driven by survival and anchored by the literature subtyping.	[Galili, Ben; Yakhini, Zohar] Technion Israel Inst Technol, Comp Sci Dept, Haifa, Israel; [Tekpli, Xavier; Kristensen, Vessela N.] Oslo Univ Hosp, Inst Canc Res, Dept Canc Genet, Oslo, Norway; [Yakhini, Zohar] Interdisciplinary Ctr, Arazi Sch Comp Sci, Herzliyya, Israel	Technion Israel Institute of Technology; University of Oslo; Reichman University	Galili, B; Yakhini, Z (corresponding author), Technion Israel Inst Technol, Comp Sci Dept, Haifa, Israel.; Tekpli, X; Kristensen, VN (corresponding author), Oslo Univ Hosp, Inst Canc Res, Dept Canc Genet, Oslo, Norway.; Yakhini, Z (corresponding author), Interdisciplinary Ctr, Arazi Sch Comp Sci, Herzliyya, Israel.	benga@cs.technion.ac.il; xavier.tekpli@medisin.uio.no; v.n.kristensen@medisin.uio.no; zohar.syakhini@idc.ac.il		Yakhini, Zohar/0000-0002-0420-5412; Galili, Ben/0000-0003-3067-667X	European Union [847912]	European Union(European Commission)	This project received funding from the European Union's Horizon 2020 Research and Innovation Programme under Grant agreement No. 847912. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali HR, 2014, ANN ONCOL, V25, P1536, DOI 10.1093/annonc/mdu191; Ali HR, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002194; Avivar-Valderas Alvaro, 2018, Oncotarget, V9, P21444, DOI 10.18632/oncotarget.25118; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bense RD, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw192; Blok EJ, 2018, CANCER TREAT REV, V62, P74, DOI 10.1016/j.ctrv.2017.10.012; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Denkert C, 2018, LANCET ONCOL, V19, P40, DOI 10.1016/S1470-2045(17)30904-X; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HODGES JL, 1963, ANN MATH STAT, V34, P598, DOI 10.1214/aoms/1177704172; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Manuel M, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19545; Meinshausen N, 2007, COMPUT STAT DATA AN, V52, P374, DOI 10.1016/j.csda.2006.12.019; PAPATESTAS AE, 1976, CANCER, V37, P164, DOI 10.1002/1097-0142(197601)37:1<164::AID-CNCR2820370123>3.0.CO;2-H; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; PATI YC, 1993, CONFERENCE RECORD OF THE TWENTY-SEVENTH ASILOMAR CONFERENCE ON SIGNALS, SYSTEMS & COMPUTERS, VOLS 1 AND 2, P40, DOI 10.1109/ACSSC.1993.342465; Pham Trang T, 2013, Genes Cancer, V4, P419, DOI 10.1177/1947601913513950; Prat A, 2015, BREAST, V24, pS26, DOI 10.1016/j.breast.2015.07.008; Pruneri G, 2018, BREAST, V37, P207, DOI 10.1016/j.breast.2017.03.010; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Steinfeld I, 2008, BIOINFORMATICS, V24, pI90, DOI 10.1093/bioinformatics/btn279; Tekpli X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13329-5; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966	28	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245215	10.1371/journal.pone.0245215	http://dx.doi.org/10.1371/journal.pone.0245215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434192	Green Published, gold			2022-12-26	WOS:000609979700014
J	Wang, ZL; Shi, YP; Ying, CT; Jiang, Y; Hu, JF				Wang, Zhenlin; Shi, Yuping; Ying, Chenting; Jiang, Yang; Hu, Jiangfeng			Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-kappa B signaling	ONCOGENE			English	Article							MESENCHYMAL TRANSITION; CELL; EXPRESSION; PROGRESSION; LANDSCAPE; DIFFERENTIATION; ANGIOGENESIS; METASTASIS; PROGNOSIS; SUBTYPES	Procollagen lysyl hydroxylase 1 (PLOD1) is highly expressed in malignant tumors such as esophageal squamous cell carcinoma, gastric cancer, and colorectal cancer. Bioinformatics analysis revealed that PLOD1 is associated with the progression of GBM, particularly the most malignant mesenchymal subtype (MES). Moreover, in the TCGA and CGGA datasets, the mean survival time of patients with high PLOD1 expression was significantly shorter than that of patients with low expression. The clinical samples confirmed this result. Therefore, we aimed to investigate the effect of PLOD1 on the development of mesenchymal GBM in vitro and in vivo and its possible mechanisms. Molecular experiments were conducted on the patient-derived glioma stem cells and found that PLOD1 expressed higher in tumor tissues and cancer cell lines of patients with GBM, especially in the MES. PLOD1 also enhanced tumor viability, proliferation, migration, and promoted MES transition while inhibited apoptosis. Tumor xenograft results also indicated that PLOD1 overexpression significantly promotes malignant behavior of tumors. Mechanistically, bioinformatics analysis further revealed that PLOD1 expression was closely associated with the NF-kappa B signaling pathway. Besides, we also found that hypoxic environments also enhanced the tumor-promoting effects of PLOD1. In conclusion, overexpression of PLOD1 may be an important factor in the enhanced invasiveness and MES transition of GBM. Thus, PLOD1 is a potential treatment target for mesenchymal GBM or even all GBM.	[Wang, Zhenlin] Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Shanghai Gen Hosp, 100 Haining Rd, Shanghai, Peoples R China; [Shi, Yuping] Shanghai Jiao Tong Univ, Shanghai TongRen Hosp, Dept Nephrol, Sch Med, 1111 Xianxia Rd, Shanghai, Peoples R China; [Ying, Chenting] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Orthoped, Sch Med, 100 Haining Rd, Shanghai, Peoples R China; [Jiang, Yang] Tongji Univ, Shanghai Peoples Hosp 10, Dept Neurosurg, Sch Med, Shanghai 200072, Peoples R China; [Hu, Jiangfeng] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Gastroenterol, Sch Med, 100 Haining Rd, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University; Shanghai Jiao Tong University	Jiang, Y (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Neurosurg, Sch Med, Shanghai 200072, Peoples R China.; Hu, JF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Gastroenterol, Sch Med, 100 Haining Rd, Shanghai, Peoples R China.	windjy0523@qq.com; doctorhjf@foxmail.com			National Natural Science Foundation of China [81900544]; Shanghai Sailing Program [19YF1439000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Sailing Program	We thank Zhitao Jing at the Department of Neurosurgery, The First Affiliated Hospital of China Medical University for molecular experimental technical support. This work was sponsored by grants from the National Natural Science Foundation of China (Grant 81900544) and Shanghai Sailing Program (Grant 19YF1439000).	Auffinger Brenda, 2012, F1000 Med Rep, V4, P18; Behnan J, 2019, BRAIN, V142, P847, DOI 10.1093/brain/awz044; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Bush NAO, 2017, CURR ONCOL REP, V19, DOI 10.1007/s11912-017-0585-6; Cai X., 2018, ONCOTARGET, V9, P9540, DOI [10.18632/oncotarget.23476, DOI 10.18632/ONCOTARGET.23476]; Cheng P, 2016, CANCER RES, V76, P7219, DOI 10.1158/0008-5472.CAN-15-2860; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Du HZ, 2017, BIOMED PHARMACOTHER, V90, P670, DOI 10.1016/j.biopha.2017.04.023; Engler JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043339; Friedmann-Morvinski D, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501292; Gilkes DM, 2013, MOL CANCER RES, V11, P456, DOI 10.1158/1541-7786.MCR-12-0629; Giunta C, 2005, MOL GENET METAB, V86, P269, DOI 10.1016/j.ymgme.2005.04.014; Han S, 2014, BRIT J CANCER, V110, P2560, DOI 10.1038/bjc.2014.162; Hofbauer KH, 2003, EUR J BIOCHEM, V270, P4515, DOI 10.1046/j.1432-1033.2003.03846.x; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huse JT, 2011, GLIA, V59, P1190, DOI 10.1002/glia.21165; Ji XJ, 2014, INT J CANCER, V135, P574, DOI 10.1002/ijc.28699; Jiang Y, 2019, J PATHOL, V249, P26, DOI 10.1002/path.5278; Jiang Y, 2019, CANCER RES, V79, P2593, DOI 10.1158/0008-5472.CAN-18-3297; Jiang Y, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0210-1; Kundu S, 2016, MOL CANCER RES, V14, P1243, DOI 10.1158/1541-7786.MCR-16-0223; Li B, 2012, CLIN CANCER RES, V18, P5595, DOI 10.1158/1078-0432.CCR-12-1427; Li LW, 2017, AM J TRANSL RES, V9, P3741; Li W, 2012, NEURO-ONCOLOGY, V14, P958, DOI 10.1093/neuonc/nos116; Liu P, 2018, MED SCI MONITOR, V24, P2098, DOI 10.12659/MSM.906945; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mao P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/pnas.1221478110; Moreno M, 2017, CELL REP, V21, P2183, DOI 10.1016/j.celrep.2017.10.083; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Oudin MJ, 2016, CANCER DISCOV, V6, P516, DOI 10.1158/2159-8290.CD-15-1183; Peinado H, 2008, CANCER RES, V68, P4541, DOI 10.1158/0008-5472.CAN-07-6345; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qi YF, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00066; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Song YF, 2020, NEURO-ONCOLOGY, V22, P46, DOI 10.1093/neuonc/noz136; Srivastava C, 2018, INT J CANCER, V142, P805, DOI 10.1002/ijc.31092; Sun L, 2016, BIOMED PHARMACOTHER, V81, P145, DOI 10.1016/j.biopha.2016.03.053; Trong PD, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102903; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Venteicher AS, 2017, SCIENCE, V355, DOI 10.1126/science.aai8478; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wade A, 2013, FEBS J, V280, P2399, DOI 10.1111/febs.12109; Waghmare I, 2014, STEM CELL TRANSL MED, V3, P1262, DOI 10.5966/sctm.2014-0086; Wang DZ, 2018, GENET TEST MOL BIOMA, V22, P366, DOI 10.1089/gtmb.2018.0009; Wang HX, 2015, NEOPLASIA, V17, P239, DOI 10.1016/j.neo.2015.02.002; Wang QH, 2017, CANCER CELL, V32, P42, DOI 10.1016/j.ccell.2017.06.003; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xue H, 2016, AUTOPHAGY, V12, P1129, DOI 10.1080/15548627.2016.1178446; Yamada Y, 2019, MOL ONCOL, V13, P1898, DOI 10.1002/1878-0261.12532; Yamini B, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090125; Zhang YS, 2018, BIOMED PHARMACOTHER, V104, P566, DOI 10.1016/j.biopha.2018.05.079; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	58	18	18	1	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2021	40	8					1458	1475		10.1038/s41388-020-01635-y	http://dx.doi.org/10.1038/s41388-020-01635-y		JAN 2021	18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QM6NM	33420370	hybrid, Green Published			2022-12-26	WOS:000607346000006
J	Xu, YY; Guo, J; Liu, J; Xie, Y; Li, X; Jiang, HM; Wang, JJ; Peng, ZY; Wang, JY; Wang, S; Wan, C; Chen, LT; Zhong, YP; Liu, BZ; Liu, ZQ				Xu, Yinyin; Guo, Jing; Liu, Jing; Xie, Ying; Li, Xin; Jiang, Hongmei; Wang, Jingjing; Peng, Ziyi; Wang, Jingya; Wang, Sheng; Wan, Chao; Chen, Lanting; Zhong, Yuping; Liu, Beizhong; Liu, Zhiqiang			Hypoxia-induced CREB cooperates MMSET to modify chromatin and promote DKK1 expression in multiple myeloma	ONCOGENE			English	Article							BONE-DISEASE; DICKKOPF-1 DKK1; IN-VIVO; GROWTH; SUPPRESSION; ANTIBODY; GENE	Myeloma cells produce excessive levels of dickkopf-1 (DKK1), which mediates the inhibition of Wnt signaling in osteoblasts, leading to multiple myeloma (MM) bone disease. Nevertheless, the precise mechanisms underlying DKK1 overexpression in myeloma remain incompletely understood. Herein, we provide evidence that hypoxia promotes DKK1 expression in myeloma cells. Under hypoxic conditions, p38 kinase phosphorylated cAMP-responsive element-binding protein (CREB) and drove its nuclear import to activate DKK1 transcription. In addition, high levels of DKK1 were associated with the presence of focal bone lesions in patients with t(4;14) MM, overexpressing the histone methyltransferase MMSET, which was identified as a downstream target gene of hypoxia-inducible factor (HIF)-1 alpha. Furthermore, we found that CREB could recruit MMSET, leading to the stabilization of HIF-1 alpha protein and the increased dimethylation of histone H3 at lysine 36 on the DKK1 promoter. Knockdown of CREB in myeloma cells alleviated the suppression of osteoblastogenesis by myeloma-secreted DKK1 in vitro. Combined treatment with a CREB inhibitor and the hypoxia-activated prodrug TH-302 (evofosfamide) significantly reduced MM-induced bone destruction in vivo. Taken together, our findings reveal that hypoxia and a cytogenetic abnormality regulate DKK1 expression in myeloma cells, and provide an additional rationale for the development of therapeutic strategies that interrupt DKK1 to cure MM.	[Xu, Yinyin; Liu, Beizhong] Chongqing Med Univ, Clin Lab, Yongchuan Hosp, Chongqing, Peoples R China; [Xu, Yinyin; Wan, Chao; Liu, Beizhong] Chongqing Med Univ, Dept Lab Med, Key Lab Lab Med Diagnost, Minist Educ, Chongqing, Peoples R China; [Guo, Jing; Liu, Jing; Xie, Ying; Li, Xin; Jiang, Hongmei; Wang, Jingjing; Peng, Ziyi; Wang, Jingya; Wang, Sheng; Liu, Zhiqiang] Tianjin Med Univ, Prov & Minist Cosponsored Collaborat Innovat Ctr, Tianjin Key Lab Cellular Homeostasis & Human Dis, Dept Physiol & Pathophysiol,Sch Basic Med Sci, Tianjin, Peoples R China; [Chen, Lanting] Chongqing Med Univ, Dept Hematol, Yongchuan Hosp, Chongqing, Peoples R China; [Zhong, Yuping] Qingdao Municipal Hosp, Dept Hematol, Qingdao, Shandong, Peoples R China; [Liu, Zhiqiang] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc, Tianjin Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China	Chongqing Medical University; Chongqing Medical University; Tianjin Medical University; Chongqing Medical University; Qingdao Municipal Hospital; Tianjin Medical University	Liu, BZ (corresponding author), Chongqing Med Univ, Clin Lab, Yongchuan Hosp, Chongqing, Peoples R China.; Liu, BZ (corresponding author), Chongqing Med Univ, Dept Lab Med, Key Lab Lab Med Diagnost, Minist Educ, Chongqing, Peoples R China.; Liu, ZQ (corresponding author), Tianjin Med Univ, Prov & Minist Cosponsored Collaborat Innovat Ctr, Tianjin Key Lab Cellular Homeostasis & Human Dis, Dept Physiol & Pathophysiol,Sch Basic Med Sci, Tianjin, Peoples R China.; Liu, ZQ (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc, Tianjin Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.	liubeizhong@cqmu.edu.cn; zhiqiangliu@tmu.edu.cn	WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022; Liu, Zhiqiang/E-6950-2014; Wang, Jin/GYA-2019-2022; wang, jing/GVT-8700-2022	Liu, Zhiqiang/0000-0002-0677-8097; Liu, Jing/0000-0002-2112-2416	National Natural Science Foundation of China [81670201, 81870161, 82070221, 81900215, 81772280]; Natural Science Foundation of Tianjin [16JCYBJC42600]; Natural Science Foundation of Beijing [7162067]; Talent Project of Tianjin Medical University [11601501/2016KJ0317]; College Student Innovation Program of Tianjin Medical University [201810062011]; Development Program of Yongchuan Hospital of Chongqing Medical University [YJJC201706]; Innovation Project of Postgraduate Program of Yongchuan Hospital of Chongqing Medical University [YJSCX201901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Talent Project of Tianjin Medical University; College Student Innovation Program of Tianjin Medical University; Development Program of Yongchuan Hospital of Chongqing Medical University; Innovation Project of Postgraduate Program of Yongchuan Hospital of Chongqing Medical University	This work was supported by the National Natural Science Foundation of China (81670201, 81870161, 82070221, ZL; 81900215, Jingya W; 81772280, BL), the Natural Science Foundation of Tianjin (16JCYBJC42600, ZL), the Natural Science Foundation of Beijing (7162067, ZP), the Talent Project of Tianjin Medical University (11601501/2016KJ0317, ZL), the College Student Innovation Program of Tianjin Medical University (201810062011, XL), the Development Program of Yongchuan Hospital of Chongqing Medical University (YJJC201706, Yinyin X), and the Innovation Project of Postgraduate Program of Yongchuan Hospital of Chongqing Medical University (YJSCX201901, Yinyin X).	Abe Masahiro, 2019, Clin Calcium, V29, P349, DOI 10.20837/4201903349; Adamik J, 2019, JBMR, V3; Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Bhaskar Archana, 2016, Int J Adv Res (Indore), V4, P706; Borsi E, 2015, TRANSL RES, V165, P641, DOI 10.1016/j.trsl.2014.12.001; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Colla S, 2007, BLOOD, V109, P4470, DOI 10.1182/blood-2006-11-056747; Craig JC, 2001, J BIOL CHEM, V276, P11719, DOI 10.1074/jbc.M010263200; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Eda Homare, 2016, Cancer Treat Res, V169, P251; Fulciniti M, 2009, BLOOD, V114, P371, DOI 10.1182/blood-2008-11-191577; Garces JJ, 2020, LEUKEMIA, V34, P589, DOI 10.1038/s41375-019-0588-4; Guo KT, 2014, J CANCER RES CLIN, V140, P1261, DOI 10.1007/s00432-014-1642-2; He J, 2012, CANCER RES, V72, P6393, DOI 10.1158/0008-5472.CAN-12-2664; Heath DJ, 2009, J BONE MINER RES, V24, P425, DOI 10.1359/JBMR.081104; Intini G, 2015, BONE, V75, P151, DOI 10.1016/j.bone.2015.01.008; Liu H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8949; Liu ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085571; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Muz B, 2019, HAEMATOLOGICA, V104, DOI 10.3324/haematol.2018.194688; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Pozzi S, 2013, BONE, V53, P487, DOI 10.1016/j.bone.2013.01.012; Qian JF, 2007, BLOOD, V110, P1587, DOI 10.1182/blood-2007-03-082529; Qiang YW, 2008, BLOOD, V112, P196, DOI 10.1182/blood-2008-01-132134; Rajkumar SV, 2020, AM J HEMATOL, V95, P548, DOI 10.1002/ajh.25791; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-268862; Schoenhals M, 2017, CELL CYCLE, V16, P1104, DOI 10.1080/15384101.2017.1317408; Silvestris F, 2004, BRIT J HAEMATOL, V126, P475, DOI 10.1111/j.1365-2141.2004.05084.x; Storti P, 2013, LEUKEMIA, V27, P1697, DOI 10.1038/leu.2013.24; Terpos E, 2018, BLOOD CANCER J, V8, DOI 10.1038/s41408-017-0037-4; Tosi P, 2008, EUR J HAEMATOL, V80, P31, DOI 10.1111/j.1600-0609.2007.00974.x; van Andel H, 2019, LEUKEMIA, V33, P1063, DOI 10.1038/s41375-019-0404-1; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040955; Wu C, 2018, CANCER MED-US, V7, P3899, DOI 10.1002/cam4.1596; Xie Y, 2020, ONCOGENE, V39, P922, DOI 10.1038/s41388-019-1037-6; Xie ZG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/636514; Yaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712; Yang P, 2012, MOL CELL BIOL, V32, P3121, DOI 10.1128/MCB.00204-12; Zhou FL, 2013, BLOOD REV, V27, P261, DOI 10.1016/j.blre.2013.08.002; Zhu HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep26859	40	10	11	0	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2021	40	7					1231	1241		10.1038/s41388-020-01590-8	http://dx.doi.org/10.1038/s41388-020-01590-8		JAN 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QK0LS	33420361	hybrid, Green Published			2022-12-26	WOS:000607346000018
J	Knecht, KM; Hu, YX; Rubene, D; Cook, M; Ziegler, SJ; Jonsson, SR; Xiong, Y				Knecht, Kirsten M.; Hu, Yingxia; Rubene, Diana; Cook, Matthew; Ziegler, Samantha J.; Jonsson, Stefan R.; Xiong, Yong			Maedi-visna virus Vif protein uses motifs distinct from HIV-1 Vif to bind zinc and the cofactor required for A3 degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; CBF-BETA; STRUCTURAL BASIS; HCCH MOTIF; APOBEC3; LENTIVIRUSES; HOST; CYCLOPHILIN; HIJACKING; EVOLUTION	The mammalian apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3 or A3) family of cytidine deaminases restrict viral infections by mutating viral DNA and impeding reverse transcription. To overcome this antiviral activity, most lentiviruses express a viral accessory protein called the virion infectivity factor (Vif), which recruits A3 proteins to cullin-RING E3 ubiquitin ligases such as cullin-5 (Cul5) for ubiquitylation and subsequent proteasomal degradation. Although Vif proteins from primate lentiviruses such as HIV-1 utilize the transcription factor core-binding factor subunit beta as a noncanonical cofactor to stabilize the complex, the maedi-visna virus (MVV) Vif hijacks cyclophilin A (CypA) instead. Because core-binding factor subunit beta and CypA are both highly conserved among mammals, the requirement for two different cellular cofactors suggests that these two A3-targeting Vif proteins have different biochemical and structural properties. To investigate this topic, we used a combination of in vitro biochemical assays and in vivo A3 degradation assays to study motifs required for the MVV Vif to bind zinc ion, Cul5, and the cofactor CypA. Our results demonstrate that although some common motifs between the HIV-1 Vif and MVV Vif are involved in recruiting Cul5, different determinants in the MVV Vif are required for cofactor binding and stabilization of the E3 ligase complex, such as the zinc-binding motif and N- and C-terminal regions of the protein. Results from this study advance our understanding of the mechanism of MVV Vif recruitment of cellular factors and the evolution of lentiviral Vif proteins.	[Knecht, Kirsten M.; Hu, Yingxia; Cook, Matthew; Ziegler, Samantha J.; Xiong, Yong] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Rubene, Diana; Jonsson, Stefan R.] Univ Iceland, Inst Expt Pathol, Keldur, Iceland	Yale University; University of Iceland	Xiong, Y (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	yong.xiong@yale.edu		Knecht, Kirsten/0000-0001-5892-3770	predoctoral program in Biophysics NIH [T32 GM008283]; National Institutes of Health [AI116313]; University of Iceland Research Fund	predoctoral program in Biophysics NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iceland Research Fund	K. M. K. was supported by the predoctoral program in Biophysics NIH T32 GM008283. This work was supported by the National Institutes of Health grant AI116313 (to Y. X.) and University of Iceland Research Fund (to S. R. J). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Aydin H, 2014, STRUCTURE, V22, P668, DOI 10.1016/j.str.2014.02.011; Barry Michele, 2006, Sci STKE, V2006, ppe21; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Fribourgh JL, 2014, J VIROL, V88, P3309, DOI 10.1128/JVI.03824-13; Gifford RJ, 2012, TRENDS GENET, V28, P89, DOI 10.1016/j.tig.2011.11.003; Gu QY, 2018, J VIROL, V92, DOI 10.1128/JVI.01697-17; Guo YY, 2014, NATURE, V505, P229, DOI 10.1038/nature12884; Harris RS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005958; Highland MA, 2017, VET PATHOL, V54, P353, DOI 10.1177/0300985817695517; Hu YX, 2019, NAT STRUCT MOL BIOL, V26, P1176, DOI 10.1038/s41594-019-0343-6; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Kane JR, 2015, CELL REP, V11, P1236, DOI 10.1016/j.celrep.2015.04.038; Kim DY, 2013, MOL CELL, V49, P632, DOI 10.1016/j.molcel.2012.12.012; Klase Z, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003997; Larue RS, 2010, J VIROL, V84, P8193, DOI 10.1128/JVI.00685-10; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mehle A, 2006, J BIOL CHEM, V281, P17259, DOI 10.1074/jbc.M602413200; da Cruz JCM, 2013, VIRUSES-BASEL, V5, P1867, DOI 10.3390/v5071867; Paul I, 2006, P NATL ACAD SCI USA, V103, P18475, DOI 10.1073/pnas.0604150103; Ramirez H, 2013, VIRUSES-BASEL, V5, P1175, DOI 10.3390/v5041175; Sabel CE, 2010, ANAL BIOCHEM, V397, P218, DOI 10.1016/j.ab.2009.10.037; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Stern MA, 2010, J VIROL, V84, P7378, DOI 10.1128/JVI.00584-10; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Watashi K, 2007, DRUG TARGET INSIGHT, V2, P9; Xiao ZX, 2006, VIROLOGY, V349, P290, DOI 10.1016/j.virol.2006.02.002; Yoshikawa R, 2016, MICROBIOL IMMUNOL, V60, P427, DOI 10.1111/1348-0421.12387; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zhang WY, 2014, J VIROL, V88, P12528, DOI 10.1128/JVI.02072-14; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zhao ZL, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00565	37	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100045	10.1074/jbc.RA120.015828	http://dx.doi.org/10.1074/jbc.RA120.015828			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33465707	gold, Green Published			2022-12-26	WOS:000672866400028
J	Wilson, KA; Mostyn, SN; Frangos, ZJ; Shimmon, S; Rawling, T; Vandenberg, RJ; O'Mara, ML				Wilson, Katie A.; Mostyn, Shannon N.; Frangos, Zachary J.; Shimmon, Susan; Rawling, Tristan; Vandenberg, Robert J.; O'Mara, Megan L.			The allosteric inhibition of glycine transporter 2 by bioactive lipid analgesics is controlled by penetration into a deep lipid cavity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTENT	The role of lipids in modulating membrane protein function is an emerging and rapidly growing area of research. The rational design of lipids that target membrane proteins for the treatment of pathological conditions is a novel extension in this field and provides a step forward in our understanding of membrane transporters. Bioactive lipids show considerable promise as analgesics for the treatment of chronic pain and bind to a high-affinity allosteric-binding site on the human glycine transporter 2 (GlyT2 or SLC6A5). Here, we use a combination of medicinal chemistry, electrophysiology, and computational modeling to develop a rational structure-activity relationship for lipid inhibitors and demonstrate the key role of the lipid tail interactions for GlyT2 inhibition. Specifically, we examine how lipid inhibitor head group stereochemistry, tail length, and double-bond position promote enhanced inhibition. Overall, the L-stereoisomer is generally a better inhibitor than the D-stereoisomer, longer tail length correlates with greater potency, and the position of the double bond influences the activity of the inhibitor. We propose that the binding of the lipid inhibitor deep into the allosteric-binding pocket is critical for inhibition. Furthermore, this provides insight into the mechanism of inhibition of GlyT2 and highlights how lipids can modulate the activity of membrane proteins by binding to cavities between helices. The principles identified in this work have broader implications for the development of a larger class of compounds that could target SLC6 transporters for disease treatment.	[Wilson, Katie A.; O'Mara, Megan L.] Australian Natl Univ, Coll Sci, Res Sch Chem, Canberra, ACT, Australia; [Mostyn, Shannon N.; Frangos, Zachary J.; Vandenberg, Robert J.] Univ Sydney, Sch Med Sci, Discipline Pharmacol, Sydney, NSW, Australia; [Shimmon, Susan; Rawling, Tristan] Univ Technol Sydney, Sch Math & Phys Sci, Sydney, NSW, Australia	Australian National University; University of Sydney; University of Technology Sydney	O'Mara, ML (corresponding author), Australian Natl Univ, Coll Sci, Res Sch Chem, Canberra, ACT, Australia.	megan.omara@anu.edu.au	Wilson, Katie/HHZ-4634-2022; O'Mara, Megan/AAY-5934-2021; Wilson, Katie/AAA-8566-2019; Vandenberg, Robert/E-6018-2016	O'Mara, Megan/0000-0002-8764-1585; Wilson, Katie/0000-0002-4951-127X; Frangos, Zachary/0000-0002-5499-4050; Vandenberg, Robert/0000-0003-1523-4814; Rawling, Tristan/0000-0002-6624-6586	National Health and Medical Research Council [APP1144429]; Australian Government; Government of Western Australia	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government(Australian GovernmentCGIAR); Government of Western Australia	This work was supported by a grant from the National Health and Medical Research Council (APP1144429). This research was undertaken with the assistance of resources and services from the National Computational Infrastructure, which is supported by the Australian Government; and the Pawsey Supercomputing Centre, which is supported by the Australian Government and the Government of Western Australia.	Bai JY, 2015, BRIT J PHARMACOL, V172, P5281, DOI 10.1111/bph.13314; Carland JE, 2018, ACS CHEM NEUROSCI, V9, P603, DOI 10.1021/acschemneuro.7b00407; Caulfield WL, 2001, J MED CHEM, V44, P2679, DOI 10.1021/jm0011272; Cioffi CL, 2018, J MED CHEM, V61, P2652, DOI 10.1021/acs.jmedchem.7b00956; Eulenburg V, 2005, TRENDS BIOCHEM SCI, V30, P325, DOI 10.1016/j.tibs.2005.04.004; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Goldberg DS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-770; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hua T, 2016, CELL, V167, P750, DOI 10.1016/j.cell.2016.10.004; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Mostyn SN, 2020, ACS CHEM NEUROSCI, V11, P1250, DOI 10.1021/acschemneuro.9b00655; Mostyn SN, 2019, ELIFE, V8, DOI 10.7554/eLife.47150; Mostyn SN, 2019, J MED CHEM, V62, P2466, DOI 10.1021/acs.jmedchem.8b01775; Mostyn SN, 2017, ACS CHEM NEUROSCI, V8, P1949, DOI 10.1021/acschemneuro.7b00105; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Stroet M, 2018, J CHEM THEORY COMPUT, V14, P5834, DOI 10.1021/acs.jctc.8b00768; Subramanian N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157583; Takahashi E, 2014, BIOORG MED CHEM LETT, V24, P4603, DOI 10.1016/j.bmcl.2014.06.059; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vandenberg RJ, 2016, NEUROCHEM INT, V98, P89, DOI 10.1016/j.neuint.2015.12.007; Vandenberg RJ, 2014, TRENDS PHARMACOL SCI, V35, P423, DOI 10.1016/j.tips.2014.05.006; Volkow N, 2018, ANNU REV MED, V69, P451, DOI 10.1146/annurev-med-011817-044739; Xu TX, 2005, NEUROREPORT, V16, P1227, DOI 10.1097/00001756-200508010-00019; Zeppelin T, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005907	28	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100282	10.1016/j.jbc.2021.100282	http://dx.doi.org/10.1016/j.jbc.2021.100282			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33450225	Green Published, gold			2022-12-26	WOS:000672866400258
J	Yu, D; Kaur, G; Blumenthal, RM; Zhang, X; Cheng, XD				Yu, Dan; Kaur, Gundeep; Blumenthal, Robert M.; Zhang, Xing; Cheng, Xiaodong			Enzymatic characterization of three human RNA adenosine methyltransferases reveals diverse substrate affinities and reaction optima	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M(6)A METHYLTRANSFERASE; CRYSTAL-STRUCTURE; PROTEIN; N-6-METHYLADENOSINE; SCATTERING; METTL16; DOMAIN; METHYLATION; MECHANISM; SUGGESTS	RNA methylations of varied RNA species (mRNA, tRNA, rRNA, non-coding RNA) generate a range of modified nucleotides, including N6-methyladenosine. Here we study the enzymology of three human RNA methyltransferases that methylate the adenosine amino group in diverse contexts, when it is: the first transcribed nucleotide after the mRNA cap (PCIF1), at position 1832 of 18S rRNA (MettL5-Trm112 complex), and within a hairpin in the 30 UTR of the S-adenosyl-L-methionine synthetase (MettL16). Among these three enzymes, the catalytic efficiency ranges from PCIF1, with the fastest turnover rate of >230 h(-1) mu M-1 on mRNA cap analog, down to MettL16, which has the lowest rate of similar to 3 h(-1) mu M-1 acting on an RNA hairpin. Both PCIF1 and MettL5 have a binding affinity (K-m) of similar to 1 mu M or less for both substrates of SAM and RNA, whereas MettL16 has significantly lower binding affinities for both (Km >0.4 mM for SAM and similar to 10 mu M for RNA). The three enzymes are active over a wide pH range (similar to 5.4-9.4) and have different preferences for ionic strength. Sodium chloride at 200 mM markedly diminished methylation activity of MettL5-Trm112 complex, whereas MettL16 had higher activity in the range of 200 to 500 mM NaCl. Zinc ion inhibited activities of all three enzymes. Together, these results illustrate the diversity of RNA adenosine methyltransferases in their enzymatic mechanisms and substrate specificities and underline the need for assay optimization in their study.	[Yu, Dan; Kaur, Gundeep; Zhang, Xing; Cheng, Xiaodong] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA; [Blumenthal, Robert M.] Univ Toledo, Dept Med Microbiol & Immunol, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Blumenthal, Robert M.] Univ Toledo, Program Bioinformat, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA	University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Zhang, X; Cheng, XD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA.	XZhang21@mdanderson.org; XCheng5@mdanderson.org		Cheng, Xiaodong/0000-0002-6967-6362	U.S. National Institutes of Health (NIH) [R35GM134744]; Cancer Prevention and Research Institute of Texas (CPRIT) [RR160029]; Department of Energy's Office of Biological and Environmental Research Integrated Diffraction Analysis Technology Program, NIGMS [P30 GM124169-01]; ALS-ENABLE; CPRIT [RP190602]	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); Department of Energy's Office of Biological and Environmental Research Integrated Diffraction Analysis Technology Program, NIGMS; ALS-ENABLE; CPRIT	This work was supported by U.S. National Institutes of Health (NIH) [R35GM134744 to X. C.]; Cancer Prevention and Research Institute of Texas (CPRIT) [RR160029 to X. C. who is a CPRIT Scholar in Cancer Research]. The SAXS data collection at SIBYLS beamline was supported by Department of Energy's Office of Biological and Environmental Research Integrated Diffraction Analysis Technology Program, NIGMS grant P30 GM124169-01, and ALS-ENABLE. CPRIT RP190602 partially supports the EM Core at Baylor College of Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ACHWAL CW, 1983, FEBS LETT, V158, P353, DOI 10.1016/0014-5793(83)80612-7; Akey DL, 2011, J MOL BIOL, V413, P438, DOI 10.1016/j.jmb.2011.08.040; Akichika S, 2019, SCIENCE, V363, P141, DOI 10.1126/science.aav0080; Ayadi L, 2019, BBA-GENE REGUL MECH, V1862, P253, DOI 10.1016/j.bbagrm.2018.11.009; Boo SH, 2020, EXP MOL MED, V52, P400, DOI 10.1038/s12276-020-0407-z; Boulias K, 2019, MOL CELL, V75, P631, DOI 10.1016/j.molcel.2019.06.006; Bourgeois G, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010007; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Cheng X, 1999, S ADENOSYLMETHIONINE; Cozza G, 2018, FEBS J, V285, P4674, DOI 10.1111/febs.14689; Dai SB, 2020, J BIOL CHEM, V295, P10901, DOI 10.1074/jbc.RA120.014072; Dai SB, 2020, J BIOL CHEM, V295, P2582, DOI 10.1074/jbc.RA119.012319; Dai SB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11554-6; Deng X, 2015, NUCLEIC ACIDS RES, V43, P6557, DOI 10.1093/nar/gkv596; Dlugosz M, 2003, EUR BIOPHYS J BIOPHY, V31, P608, DOI 10.1007/s00249-002-0258-7; Dong GP, 2020, ACS COMB SCI, V22, P422, DOI 10.1021/acscombsci.0c00077; Douvlataniotis K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay3335; Doxtader KA, 2018, MOL CELL, V71, P1001, DOI 10.1016/j.molcel.2018.07.025; Dyer KN, 2014, METHODS MOL BIOL, V1091, P245, DOI 10.1007/978-1-62703-691-7_18; Fan H, 2003, BIOCHEM BIOPH RES CO, V301, P378, DOI 10.1016/S0006-291X(02)03015-2; Ferrer JL, 2005, PLANT PHYSIOL, V137, P1009, DOI 10.1104/pp.104.048751; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Frye M, 2016, NAT REV GENET, V17, P365, DOI 10.1038/nrg.2016.47; Ganesan A, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0776-0; Garcia IG, 2010, J MOL BIOL, V395, P390, DOI 10.1016/j.jmb.2009.10.045; Greenberg MVC, 2019, NAT REV MOL CELL BIO, V20, P590, DOI 10.1038/s41580-019-0159-6; Hirose Y, 2008, BIOCHEM BIOPH RES CO, V369, P449, DOI 10.1016/j.bbrc.2008.02.042; Hodel AE, 1996, CELL, V85, P247, DOI 10.1016/S0092-8674(00)81101-0; Hsiao K, 2016, EPIGENOMICS-UK, V8, P321, DOI 10.2217/epi.15.113; Ignatova VV, 2020, GENE DEV, V34, P715, DOI [10.1101/gad.333369.119, 10.1126/sciadv.aaz4551]; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; KENNEDY CD, 1990, BIOCHEM EDUC, V18, P35, DOI 10.1016/0307-4412(90)90017-I; Kikhney AG, 2015, FEBS LETT, V589, P2570, DOI 10.1016/j.febslet.2015.08.027; Kilchert C, 2020, WIRES RNA, V11, DOI 10.1002/wrna.1582; Kolev SK, 2018, METALLOMICS, V10, P659, DOI 10.1039/c8mt00043c; Leismann J, 2020, EMBO REP, V21, DOI 10.15252/embr.201949443; Li WJ, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0121-y; Liu J, 2020, SCIENCE, V367, P580, DOI 10.1126/science.aay6018; Liu S, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02012-4; Liu XL, 2021, CELL RES, V31, P94, DOI 10.1038/s41422-020-0317-6; MADEN BEH, 1986, J MOL BIOL, V189, P681, DOI 10.1016/0022-2836(86)90498-5; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Maret W, 2013, BIOMETALS, V26, P197, DOI 10.1007/s10534-013-9613-7; Mendel M, 2018, MOL CELL, V71, P986, DOI 10.1016/j.molcel.2018.08.004; Murray IA, 2018, NUCLEIC ACIDS RES, V46, P840, DOI 10.1093/nar/gkx1191; Musheev MU, 2020, NAT CHEM BIOL, V16, P630, DOI 10.1038/s41589-020-0504-2; Tran NV, 2019, NUCLEIC ACIDS RES, V47, P7719, DOI 10.1093/nar/gkz619; Tran NV, 2018, NUCLEIC ACIDS RES, V46, P8483, DOI 10.1093/nar/gky638; Nye TM, 2020, CRIT REV BIOCHEM MOL, V55, P576, DOI 10.1080/10409238.2020.1828257; Pandey RR, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108038; Pendleton KE, 2017, CELL, V169, P824, DOI 10.1016/j.cell.2017.05.003; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rivas G, 2016, TRENDS BIOCHEM SCI, V41, P970, DOI 10.1016/j.tibs.2016.08.013; Rong BW, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108544; Ru WX, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200091; Sanchez-Romero MA, 2020, NAT REV MICROBIOL, V18, P7, DOI 10.1038/s41579-019-0286-2; Schiffers S, 2017, ANGEW CHEM INT EDIT, V56, P11268, DOI 10.1002/anie.201700424; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Sendinc E, 2019, MOL CELL, V75, P620, DOI 10.1016/j.molcel.2019.05.030; Shima H, 2017, CELL REP, V21, P3354, DOI 10.1016/j.celrep.2017.11.092; Singh S, 2008, J BIOL CHEM, V283, P22628, DOI 10.1074/jbc.M800503200; Some D, 2019, JOVE-J VIS EXP, DOI 10.3791/59615; Sun HX, 2019, CELL RES, V29, P80, DOI 10.1038/s41422-018-0117-4; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Warda AS, 2017, EMBO REP, V18, P2004, DOI 10.15252/embr.201744940; Wolf A, 2013, BIOCHEM J, V453, P357, DOI 10.1042/BJ20130529; Woodcock CB, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0119-5; Wu TP, 2016, NATURE, V532, P329, DOI 10.1038/nature17640; Wyrzykowski J, 2003, J BACTERIOL, V185, P1701, DOI 10.1128/JB.185.5.1701-1704.2003; Xie Q, 2018, CELL, V175, P1228, DOI 10.1016/j.cell.2018.10.006; Xing M, 2020, EMBO REP, V21, DOI 10.15252/embr.201949863; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zeng Y, 2020, GENE DEV, V34, P1546, DOI 10.1101/gad.341925.120; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6	79	7	7	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100270	10.1016/j.jbc.2021.100270	http://dx.doi.org/10.1016/j.jbc.2021.100270			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33428944	Green Published, gold			2022-12-26	WOS:000672866400246
J	Guiney, SJ; Adlard, PA; Lei, P; Mawal, CH; Bush, AI; Finkelstein, DI; Ayton, S				Guiney, Stephanie J.; Adlard, Paul A.; Lei, Peng; Mawal, Celeste H.; Bush, Ashley, I; Finkelstein, David, I; Ayton, Scott			Fibrillar alpha-synuclein toxicity depends on functional lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-synuclein; cell viability; lysosomes; Parkinson&apos; s disease; alpha-synuclein (a-synuclein); lysosome; Parkinson disease; cell death; iron	Q-VD-OPH; PARKINSONS-DISEASE; CELL-DEATH; SUBSTANTIA-NIGRA; CATHEPSIN-B; MEMBRANE PERMEABILIZATION; PROTEIN-DEGRADATION; CEREBROSPINAL-FLUID; CASPASE INHIBITOR; IRON CONTENT	Neurodegeneration in Parkinson's disease (PD) can be recapitulated in animals by administration of alpha-synuclein preformed fibrils (PFFs) into the brain. However, the mechanism by which these PFFs induce toxicity is unknown. Iron is implicated in PD pathophysiology, so we investigated whether alpha-synuclein PFFs induce ferroptosis, an iron-dependent cell death pathway. A range of ferroptosis inhibitors were added to a striatal neuron-derived cell line (STHdhQ7/7 cells), a dopaminergic neuron-derived cell line (SN4741 cells), and WT primary cortical neurons, all of which had been intoxicated with alpha-synuclein PFFs. Viability was not recovered by these inhibitors except for liproxstatin-1, a best-in-class ferroptosis inhibitor, when used at high doses. High-dose liproxstatin-1 visibly enlarged the area of a cell that contained acidic vesicles and elevated the expression of several proteins associated with the autophagy-lysosomal pathway similarly to the known lysosomal inhibitors, chloroquine and bafilomycin A1. Consistent with high-dose liproxstatin-1 protecting via a lysosomal mechanism, we further de-monstrated that loss of viability induced by alpha-synuclein PFFs was attenuated by chloroquine and bafilomycin A1 as well as the lysosomal cysteine protease inhibitors, leupeptin, E-64D, and Ca-074-Me, but not other autophagy or lysosomal enzyme inhibitors. We confirmed using immunofluorescence microscopy that heparin prevented uptake of alpha-synuclein PFFs into cells but that chloroquine did not stop alpha-synuclein uptake into lysosomes despite impairing lysosomal function and inhibiting alpha-synuclein toxicity. Together, these data suggested that alpha-synuclein PFFs are toxic in functional lysosomes in vitro. Therapeutic strategies that prevent alpha-synuclein fibril uptake into lysosomes may be of benefit in PD.	[Guiney, Stephanie J.; Adlard, Paul A.; Lei, Peng; Mawal, Celeste H.; Bush, Ashley, I; Finkelstein, David, I; Ayton, Scott] Melbourne Dementia Res Ctr, Parkville, Vic, Australia; [Guiney, Stephanie J.; Adlard, Paul A.; Lei, Peng; Mawal, Celeste H.; Bush, Ashley, I; Finkelstein, David, I; Ayton, Scott] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Guiney, Stephanie J.; Adlard, Paul A.; Lei, Peng; Bush, Ashley, I; Finkelstein, David, I; Ayton, Scott] Univ Melbourne, Parkville, Vic, Australia; [Lei, Peng] Sichuan Univ, West China Hosp, Dept Neurol, Collaborat Ctr Biotherapy, Chengdu, Peoples R China; [Lei, Peng] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Collaborat Ctr Biotherapy, Chengdu, Peoples R China	Florey Institute of Neuroscience & Mental Health; University of Melbourne; Sichuan University; Sichuan University	Ayton, S (corresponding author), Melbourne Dementia Res Ctr, Parkville, Vic, Australia.; Ayton, S (corresponding author), Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia.; Ayton, S (corresponding author), Univ Melbourne, Parkville, Vic, Australia.	scott.ayton@florey.edu.au	Ayton, Scott/J-8000-2015; Finkelstein, David/B-9617-2009; Ayton, Scott/AAJ-3414-2021; Lei, Peng/F-6326-2010; Bush, Ashley I./A-1186-2007	Ayton, Scott/0000-0002-3479-2427; Finkelstein, David/0000-0002-8167-4917; Lei, Peng/0000-0001-5652-1962; Bush, Ashley I./0000-0001-8259-9069; Guiney, Stephanie/0000-0003-2864-6148	Australian National Health and Medical Research Council (NHMRC); Government of Victoria from the Operational Infrastructure Support Grant	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Government of Victoria from the Operational Infrastructure Support Grant	This work was supported by funds from the Australian National Health and Medical Research Council (NHMRC). The Florey Institute of Neuroscience and Mental Health is supported by the Government of Victoria, in particular funding from the Operational Infrastructure Support Grant.	Abdelmotilib H, 2017, NEUROBIOL DIS, V105, P84, DOI 10.1016/j.nbd.2017.05.014; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; AOYAGI T, 1969, J ANTIBIOT, V22, P558, DOI 10.7164/antibiotics.22.558; Asano T, 2011, MOL CELL BIOL, V31, P2040, DOI 10.1128/MCB.01437-10; Ayton S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/581256; BAICI A, 1982, EUR J BIOCHEM, V129, P33, DOI 10.1111/j.1432-1033.1982.tb07017.x; Bandres-Ciga S, 2019, MOVEMENT DISORD, V34, P460, DOI 10.1002/mds.27614; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Brojatsch J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095032; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Choubey V, 2011, J BIOL CHEM, V286, P10814, DOI 10.1074/jbc.M110.132514; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Cleeter MWJ, 2013, NEUROCHEM INT, V62, P1, DOI 10.1016/j.neuint.2012.10.010; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Crabtree D, 2014, J NEUROCHEM, V128, P950, DOI 10.1111/jnc.12497; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dehay B, 2013, MOVEMENT DISORD, V28, P725, DOI 10.1002/mds.25462; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Do Van B, 2016, NEUROBIOL DIS, V94, P169, DOI 10.1016/j.nbd.2016.05.011; Duffy MF, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1171-z; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Eusebi P, 2017, MOVEMENT DISORD, V32, P1389, DOI 10.1002/mds.27110; Fairfoul G, 2016, ANN CLIN TRANSL NEUR, V3, P812, DOI 10.1002/acn3.338; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fernandes HJR, 2016, STEM CELL REP, V6, P342, DOI 10.1016/j.stemcr.2016.01.013; FIRESTONE RA, 1979, J MED CHEM, V22, P1130, DOI 10.1021/jm00195a026; Freeman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062143; Freeze B, 2018, NEUROIMAGE-CLIN, V18, P456, DOI 10.1016/j.nicl.2018.01.009; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Groveman BR, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0508-2; Guiney SJ, 2017, NEUROCHEM INT, V104, P34, DOI 10.1016/j.neuint.2017.01.004; Hambright WS, 2017, REDOX BIOL, V12, P8, DOI 10.1016/j.redox.2017.01.021; Harms AS, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0494-9; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Henry AG, 2015, HUM MOL GENET, V24, P6013, DOI 10.1093/hmg/ddv314; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Huang ZW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003083; Ihse E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08720-5; Iwata A, 2003, HUM MOL GENET, V12, P2625, DOI 10.1093/hmg/ddg283; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Karpowicz RJ, 2017, J BIOL CHEM, V292, P13482, DOI 10.1074/jbc.M117.780296; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Klionsky DJ, 2011, AUTOPHAGY, V7, P1, DOI 10.4161/auto.7.1.14130; Klucken J, 2012, AUTOPHAGY, V8, P754, DOI 10.4161/auto.19371; KNIGHT CG, 1976, BIOCHEM J, V155, P117, DOI 10.1042/bj1550117; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kuzelova K, 2011, J CELL BIOCHEM, V112, P3334, DOI 10.1002/jcb.23263; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Li J, 2002, NEUROTOXICOLOGY, V23, P553, DOI 10.1016/S0161-813X(02)00066-9; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Lima H, 2013, CELL CYCLE, V12, P1868, DOI 10.4161/cc.24903; Lu SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173771; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Mahoney-Sanchez L, 2021, PROG NEUROBIOL, V196, DOI 10.1016/j.pneurobio.2020.101890; MARCINISZYN J, 1976, J BIOL CHEM, V251, P7088; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; McGlinchey RP, 2015, P NATL ACAD SCI USA, V112, P9322, DOI 10.1073/pnas.1500937112; Minakaki G, 2018, AUTOPHAGY, V14, P98, DOI 10.1080/15548627.2017.1395992; Mislick KA, 1996, P NATL ACAD SCI USA, V93, P12349, DOI 10.1073/pnas.93.22.12349; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; OHKUMA S, 1981, J CELL BIOL, V90, P656, DOI 10.1083/jcb.90.3.656; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Okada M, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.579961; Onishi A, 2016, FRONT BIOSCI-LANDMRK, V21, P1372, DOI 10.2741/4462; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paumier KL, 2015, NEUROBIOL DIS, V82, P185, DOI 10.1016/j.nbd.2015.06.003; PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Petrucci S, 2016, PARKINSONISM RELAT D, V22, pS16, DOI 10.1016/j.parkreldis.2015.08.015; Poehler AM, 2014, AUTOPHAGY, V10, P2171, DOI 10.4161/auto.36436; Radisky DC, 1998, BIOCHEM J, V336, P201, DOI 10.1042/bj3360201; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; RATAN RR, 1994, J NEUROCHEM, V62, P376; Ruiz-Irastorza G, 2010, ANN RHEUM DIS, V69, P20, DOI 10.1136/ard.2008.101766; Sacino AN, 2017, J NEUROCHEM, V140, P662, DOI 10.1111/jnc.13743; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; SATOYOSHI E, 1992, INTERNAL MED, V31, P841, DOI 10.2169/internalmedicine.31.841; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEGLEN PO, 1976, EXP CELL RES, V100, P276, DOI 10.1016/0014-4827(76)90148-8; Sheng XH, 2017, PHYS CHEM CHEM PHYS, V19, P13153, DOI 10.1039/c7cp00804j; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Steverding D., 2011, OPEN ENZYME INHIBITI, V4, P11, DOI [10.2174/1874940201104010011, DOI 10.2174/1874940201104010011]; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Teplova VV, 2007, J BIOENERG BIOMEMBR, V39, P321, DOI 10.1007/s10863-007-9095-9; Tessa C, 2014, HUM BRAIN MAPP, V35, P3932, DOI 10.1002/hbm.22449; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Tsujimura A, 2015, NEUROBIOL DIS, V73, P244, DOI 10.1016/j.nbd.2014.10.011; UMEZAWA H, 1970, J ANTIBIOT, V23, P259, DOI 10.7164/antibiotics.23.259; Vandenabeele P, 2013, CELL DEATH DIFFER, V20, P185, DOI 10.1038/cdd.2012.151; Wang RQ, 2015, EXP THER MED, V9, P2088, DOI 10.3892/etm.2015.2432; Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; Xu J, 2007, BRAIN RES, V1139, P220, DOI 10.1016/j.brainres.2006.12.074; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	121	15	16	4	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17497	17513		10.1074/jbc.RA120.013428	http://dx.doi.org/10.1074/jbc.RA120.013428			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453994	Green Published, hybrid			2022-12-26	WOS:000603272300010
J	Hilton, A; Jeong, M; Hsu, JH; Cao, F; Choi, W; Wang, XW; Yu, C; Jo, YK				Hilton, Angelyn; Jeong, Myunghwan; Hsu, Jui-Hung; Cao, Fan; Choi, Woongchul; Wang, Xinwang; Yu, Choongho; Jo, Young-Ki			Thermal treatment using microwave irradiation for the phytosanitation of Xylella fastidiosa in pecan graftwood	PLOS ONE			English	Article							BACTERIAL LEAF SCORCH; CARBON NANOTUBES; CATALYSTS	Pecan bacterial leaf scorch caused by Xylella fastidiosa is an emerging disease for the U.S. and international pecan industries and can be transmitted from scion to rootstock via grafting. With the expanse of global transportation and trade networks, phytosanitation is critical for reducing the spread of economically significant pathogens, such as X. fastidiosa. We developed and evaluated thermal treatments using microwave irradiation and microwave absorbers [sterile deionized water (dH(2)O) and carbon nanotubes (CNTs)] as novel disinfectant methods for remediating X. fastidiosa in pecan scions. Partial submergence of scions in dH(2)O or CNT dispersions resulted in the transport of microwave absorbers in the xylem tissue via transpiration but did not compromise plant health. The microwave absorbers effectively transferred heat to the scion wood to reach an average temperature range of 55-65 degrees C. Microwave radiation exposure for 6 sec (3 sec for two iterations) of CNT- or dH(2)O-treated scions reduced the frequency of X. fastidiosa-positive in pecan scions without negatively affecting plant viability when compared to the control group (dH(2)O-treated with no microwave). The efficacy of the new thermal treatments based on microwave irradiation was comparable to the conventional hot-water treatment (HWT) method, in which scions were submerged in 46 degrees C water for 30 min. Microwave irradiation can be employed to treat X. fastidiosa-infected scions where the conventional HWT treatment is not feasible. This study is the first report to demonstrate novel thermal treatment methods based on the microwave irradiation and microwave absorbers of dH(2)O and CNT as an application for the phytosanitation of xylem-inhabiting bacteria in graftwood.	[Hilton, Angelyn; Cao, Fan; Jo, Young-Ki] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Hilton, Angelyn; Wang, Xinwang] USDA ARS, Pecan Breeding & Genet, Washington, DC 20250 USA; [Jeong, Myunghwan; Hsu, Jui-Hung; Choi, Woongchul; Yu, Choongho] Texas A&M Univ, Dept Mech Engn Mat Sci & Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station	Jo, YK (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA.; Yu, C (corresponding author), Texas A&M Univ, Dept Mech Engn Mat Sci & Engn, College Stn, TX 77843 USA.	chyu@tamu.edu; ykjo@tamu.edu		JO, YOUNG-KI/0000-0002-1426-7721; Yu, Choongho/0000-0002-5996-2285; Wang, Xinwang/0000-0002-5679-0764	USDA ARS [CRIS 3091-21000-042-00D]; USDA-ARS [CRIS 604221220-012-00-D]; National Plant Germplasm System Grant [58-3091-6-022]; Southern Integrative Pest Management (IPM) Center Program [1702922]	USDA ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Plant Germplasm System Grant; Southern Integrative Pest Management (IPM) Center Program	This work was supported by USDA ARS CRIS 3091-21000-042-00D "Management of the National Collection of Carya Genetic Resources and Associated Information"; USDA-ARS CRIS 604221220-012-00-D "Mitigating Alternate Bearing of Pecan"; National Plant Germplasm System Grant 58-3091-6-022 "Screening Xylella fastidiosa in the USDA ARS National Collection of Genetic Resources for Carya"; and the Southern Integrative Pest Management (IPM) Center Program (project #1702922). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RPP, 2004, CURR MICROBIOL, V48, P368, DOI 10.1007/s00284-003-4219-x; Bock CH, 2018, PLANT HLTH PROG, V19, P284, DOI 10.1094/PHP-08-18-0045-S; Bragard C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4225; Choi K, 2018, ACS APPL MATER INTER, V10, P23891, DOI 10.1021/acsami.8b06850; Choi W, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201704877; Choi W, 2016, J POWER SOURCES, V313, P128, DOI 10.1016/j.jpowsour.2016.02.074; DIPROSE MF, 1984, BOT REV, V50, P171, DOI 10.1007/BF02861092; EFSA, 2020, EFSA J, V18, DOI 10.2903/j.efsa.2020.6114; EFSA, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4378; Hilton AE, 2017, PLANT DIS, V101, P1949, DOI 10.1094/PDIS-02-17-0298-PDN; Hilton A, 2020, EUR J PLANT PATHOL, V157, P899, DOI 10.1007/s10658-020-02050-5; Hsu JH, 2020, NANO ENERGY, V67, DOI 10.1016/j.nanoen.2019.104282; Khodakovskaya MV, 2011, P NATL ACAD SCI USA, V108, P1028, DOI 10.1073/pnas.1008856108; Kim T, 2014, CARBON LETT, V15, P15, DOI 10.5714/CL.2014.15.1.015; Knox OGG, 2013, CROP PROT, V50, P12, DOI 10.1016/j.cropro.2013.03.009; Kumar M, 2010, J NANOSCI NANOTECHNO, V10, P3739, DOI 10.1166/jnn.2010.2939; Liu QL, 2009, NANO LETT, V9, P1007, DOI 10.1021/nl803083u; Maxwell A., 2013, HORTICULTURE PLANTS, P1171, DOI [10.1007/978-94-017-8560-0_9, DOI 10.1007/978-94-017-8560-0_9]; Melanson RA, 2015, ACTA HORTIC, V1070, P201; Melnyk CW, 2015, CURR BIOL, V25, pR183, DOI 10.1016/j.cub.2015.01.029; Mondal A, 2011, J NANOPART RES, V13, P4519, DOI 10.1007/s11051-011-0406-z; Mukherjee A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00172; Nesbitt ML, 2002, HORTTECHNOLOGY, V12, P257, DOI 10.21273/HORTTECH.12.2.257; Paton KR, 2008, CARBON, V46, P1935, DOI 10.1016/j.carbon.2008.08.001; Peter DH, 2009, TREES-STRUCT FUNCT, V23, P381, DOI 10.1007/s00468-008-0287-7; Purcell A. H., 1997, Journal of Plant Pathology, V79, P99; Randall JJ, 2015, ACTA HORTIC, V1070, P89; Rapicavoli J, 2018, MOL PLANT PATHOL, V19, P786, DOI 10.1111/mpp.12585; Rosborough J, 1949, B TEXAS AGR EXTENSIO; ROSENBERG U, 1987, FOOD TECHNOL-CHICAGO, V41, P92; Ryu Y, 2012, J MATER CHEM, V22, P6959, DOI [10.1039/c2jm16000e, 10.1039/c2jm16000c]; Ryu Y, 2011, SOLID STATE COMMUN, V151, P1932, DOI 10.1016/j.ssc.2011.09.022; Ryu YT, 2011, CARBON, V49, P4745, DOI 10.1016/j.carbon.2011.06.082; Salata OV, 2004, J Nanobiotechnology, V2, P3, DOI 10.1186/1477-3155-2-3; Sanderlin RS, 2008, PLANT DIS, V92, P1124, DOI 10.1094/PDIS-92-7-1124; Sanderlin RS, 2006, HORTSCIENCE, V41, P1455, DOI 10.21273/HORTSCI.41.6.1455; Sanderlin RS, 2000, PLANT DIS, V84, P1282, DOI 10.1094/PDIS.2000.84.12.1282; Sanderlin RS, 2005, PLANT DIS, V89, P446, DOI 10.1094/PD-89-0446; Sanderlin RS, 2003, PLANT DIS, V87, P259, DOI 10.1094/PDIS.2003.87.3.259; Sarma SJ, 2015, CRIT REV ENV SCI TEC, V45, P905, DOI 10.1080/10643389.2014.924177; Scarselli M, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/31/313202; Sicard A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221119; Sicard A, 2018, ANNU REV PHYTOPATHOL, V56, P181, DOI 10.1146/annurev-phyto-080417-045849; SMITH MW, 1992, J AM SOC HORTIC SCI, V117, P745, DOI 10.21273/JASHS.117.5.745; Soriano-Martin ML, 2006, CROP PROT, V25, P52, DOI 10.1016/j.cropro.2005.03.016; SPARKS D, 1993, J AM SOC HORTIC SCI, V118, P29, DOI 10.21273/JASHS.118.1.29; Srilatha B, 2011, J NANOMED NANOTECHNO, V2; Thompson TE, 2012, HANDB PLANT BREED, V8, P771, DOI 10.1007/978-1-4419-0763-9_20; Vazquez E, 2009, ACS NANO, V3, P3819, DOI 10.1021/nn901604j; Verma SK, 2019, SCI TOTAL ENVIRON, V667, P485, DOI 10.1016/j.scitotenv.2019.02.409; Vian A, 2006, PLANT SIGNAL BEHAV, V1, P67, DOI 10.4161/psb.1.2.2434; Vitanza S, 2015, ISSUES AGR, V40; Wood BW, 1998, J AM SOC HORTIC SCI, V123, P1023, DOI 10.21273/JASHS.123.6.1023; Yang G, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201800595; Yang G, 2016, NANO ENERGY, V22, P607, DOI 10.1016/j.nanoen.2016.02.055; Yang G, 2015, ENERG ENVIRON SCI, V8, P1799, DOI 10.1039/c5ee00682a; Yu CH, 2011, ACS NANO, V5, P1297, DOI 10.1021/nn102999h	57	3	3	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0244758	10.1371/journal.pone.0244758	http://dx.doi.org/10.1371/journal.pone.0244758			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471831	Green Published, gold			2022-12-26	WOS:000639428800008
J	Peng, WP; Cui, S; Song, C				Peng, Weiping; Cui, Shuang; Song, Cheng			One-time-pad cipher algorithm based on confusion mapping and DNA storage technology	PLOS ONE			English	Article							IMAGE ENCRYPTION ALGORITHM; SEMI-TENSOR PRODUCT; MOLECULAR COMPUTATION; INFORMATION-STORAGE; MATRIX; ROBUST	In order to solve the problems of low computational security in the encoding mapping and difficulty in practical operation of biological experiments in DNA-based one-time-pad cryptography, we proposed a one-time-pad cipher algorithm based on confusion mapping and DNA storage technology. In our constructed algorithm, the confusion mapping methods such as chaos map, encoding mapping, confusion encoding table and simulating biological operation process are used to increase the key space. Among them, the encoding mapping and the confusion encoding table provide the realization conditions for the transition of data and biological information. By selecting security parameters and confounding parameters, the algorithm realizes a more random dynamic encryption and decryption process than similar algorithms. In addition, the use of DNA storage technologies including DNA synthesis and high-throughput sequencing ensures a viable biological encryption process. Theoretical analysis and simulation experiments show that the algorithm provides both mathematical and biological security, which not only has the difficult advantage of cracking DNA biological experiments, but also provides relatively high computational security.	[Peng, Weiping; Cui, Shuang; Song, Cheng] Henan Polytech Univ, Sch Comp Sci & Technol, Jiaozuo, Henan, Peoples R China	Henan Polytechnic University	Cui, S (corresponding author), Henan Polytech Univ, Sch Comp Sci & Technol, Jiaozuo, Henan, Peoples R China.	211809010008@home.hpu.edu.cn						ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Adleman LM, 1999, J COMPUT BIOL, V6, P53, DOI 10.1089/cmb.1999.6.53; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Chen J., 2003, P 2003 INT S CIRC SY; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; Cox JPL, 2001, TRENDS BIOTECHNOL, V19, P247, DOI 10.1016/S0167-7799(01)01671-7; Erlich Y, 2017, SCIENCE, V355, P950, DOI 10.1126/science.aaj2038; Gehani A., 2004, ASPECTS MOL COMPUTIN, V54, P233; Goldman N, 2013, NATURE, V494, P77, DOI 10.1038/nature11875; Hirabayashi M, 2010, PROC INFO COMMUN, V2, P174; Hirabayashi Miki, 2009, Nucleic Acids Symp Ser (Oxf), P79, DOI 10.1093/nass/nrp040; Li W, 2013, NANO LETT, V13, P2980, DOI 10.1021/nl4016107; [李一凡 Li Yifan], 2017, [信息网络安全, Netinfo Security], P43; Liu HJ, 2012, APPL SOFT COMPUT, V12, P1457, DOI 10.1016/j.asoc.2012.01.016; Liu HJ, 2011, OPT COMMUN, V284, P3895, DOI 10.1016/j.optcom.2011.04.001; Liu HJ, 2010, COMPUT MATH APPL, V59, P3320, DOI 10.1016/j.camwa.2010.03.017; Meiser LC, 2020, NAT PROTOC, V15, P86, DOI 10.1038/s41596-019-0244-5; [彭维平 Peng Weiping], 2019, [计算机应用研究, Application Research of Computers], V36, P2190; Peng WP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206612; Skinner GM., 2007, J BIONANOSCI, V1, P17, DOI [10.1166/jbns.2007.005, DOI 10.1166/JBNS.2007.005]; Song TQ, 2019, NAT NANOTECHNOL, V14, P1075, DOI 10.1038/s41565-019-0544-5; Thangavel M, 2018, CLUSTER COMPUT, V21, P1411, DOI 10.1007/s10586-017-1368-4; Wan RZ., 2014, COMPUTER MEASUREMENT, V22, P3278; Wang XY, 2015, OPT LASER ENG, V73, P53, DOI 10.1016/j.optlaseng.2015.03.022; Wang XY, 2010, NONLINEAR DYNAM, V62, P615, DOI 10.1007/s11071-010-9749-8; Wang XY, 2020, INFORM SCIENCES, V539, P195, DOI 10.1016/j.ins.2020.06.030; Wang XY, 2020, INFORM SCIENCES, V507, P16, DOI 10.1016/j.ins.2019.08.041; Wang XY, 2015, OPT LASER ENG, V66, P10, DOI 10.1016/j.optlaseng.2014.08.005; Wang XY, 2012, SIGNAL PROCESS, V92, P1101, DOI 10.1016/j.sigpro.2011.10.023; Wang ZC., 2014, COMPUTER ENG APPL, V38, P86; Xian YJ, 2021, INFORM SCIENCES, V547, P1154, DOI 10.1016/j.ins.2020.09.055; Yang J, 2014, CHINESE SCI BULL, V59, P1192, DOI 10.1007/s11434-014-0170-4; Zhang C, 2011, CHINESE SCI BULL, V56, P3566, DOI 10.1007/s11434-011-4725-3; Zhang Xun-Cai, 2008, Chinese Journal of Computers, V31, P2129, DOI 10.3724/SP.J.1016.2008.02129; Zhang YQ, 2015, APPL SOFT COMPUT, V26, P10, DOI 10.1016/j.asoc.2014.09.039; Zhang YQ, 2014, INFORM SCIENCES, V273, P329, DOI 10.1016/j.ins.2014.02.156	37	0	0	8	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245506	10.1371/journal.pone.0245506	http://dx.doi.org/10.1371/journal.pone.0245506			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471849	gold, Green Published			2022-12-26	WOS:000639428800041
J	Ellingjord-Dale, M; Papadimitriou, N; Katsoulis, M; Yee, C; Dimou, N; Gill, D; Aune, D; Ong, JS; MacGregor, S; Elsworth, B; Lewis, SJ; Martin, RM; Riboli, E; Tsilidis, KK				Ellingjord-Dale, Merete; Papadimitriou, Nikos; Katsoulis, Michail; Yee, Chew; Dimou, Niki; Gill, Dipender; Aune, Dagfinn; Ong, Jue-Sheng; MacGregor, Stuart; Elsworth, Benjamin; Lewis, Sarah J.; Martin, Richard M.; Riboli, Elio; Tsilidis, Konstantinos K.			Coffee consumption and risk of breast cancer: A Mendelian randomization study	PLOS ONE			English	Article							SEX-HORMONE CONCENTRATIONS; CAFFEINE INTAKE; CAUSAL INFERENCE; NO ASSOCIATION; TEA INTAKE; PREMENOPAUSAL; LOCI; SUSCEPTIBILITY; VARIANTS; HEALTH	Background Observational studies have reported either null or weak protective associations for coffee consumption and risk of breast cancer. Methods We conducted a two-sample Mendelian randomization (MR) analysis to evaluate the relationship between coffee consumption and breast cancer risk using 33 single-nucleotide polymorphisms (SNPs) associated with coffee consumption from a genome-wide association (GWA) study on 212,119 female UK Biobank participants of White British ancestry. Risk estimates for breast cancer were retrieved from publicly available GWA summary statistics from the Breast Cancer Association Consortium (BCAC) on 122,977 cases (of which 69,501 were estrogen receptor (ER)-positive, 21,468 ER-negative) and 105,974 controls of European ancestry. Random-effects inverse variance weighted (IVW) MR analyses were performed along with several sensitivity analyses to assess the impact of potential MR assumption violations. Results One cup per day increase in genetically predicted coffee consumption in women was not associated with risk of total (IVW random-effects; odds ratio (OR): 0.91, 95% confidence intervals (CI): 0.80-1.02, P: 0.12, P for instrument heterogeneity: 7.17e-13), ER-positive (OR = 0.90, 95% CI: 0.79-1.02, P: 0.09) and ER-negative breast cancer (OR: 0.88, 95% CI: 0.75-1.03, P: 0.12). Null associations were also found in the sensitivity analyses using MR-Egger (total breast cancer; OR: 1.00, 95% CI: 0.80-1.25), weighted median (OR: 0.97, 95% CI: 0.89-1.05) and weighted mode (OR: 1.00, CI: 0.93-1.07). Conclusions The results of this large MR study do not support an association of genetically predicted coffee consumption on breast cancer risk, but we cannot rule out existence of a weak association.	[Ellingjord-Dale, Merete; Yee, Chew; Gill, Dipender; Aune, Dagfinn; Riboli, Elio; Tsilidis, Konstantinos K.] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Papadimitriou, Nikos; Dimou, Niki] Int Agcy Res Canc, Sect Nutr & Metab, Lyon, France; [Katsoulis, Michail] UCL, Fac Populat Hlth Sci, Inst Hlth Informat Res, London, England; [Aune, Dagfinn] Bjorknes Univ Coll, Dept Nutr, Oslo, Norway; [Aune, Dagfinn] Oslo Univ Hosp, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway; [Ong, Jue-Sheng; MacGregor, Stuart] QIMR Berghofer Med Res Inst, Dept Genet & Computat Biol, Stat Genet, Brisbane, Qld, Australia; [Ong, Jue-Sheng; Elsworth, Benjamin; Lewis, Sarah J.; Martin, Richard M.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Lewis, Sarah J.; Martin, Richard M.] Univ Bristol, Bristol Med Sch, Dept Populat Hlth Sci, Bristol, Avon, England; [Martin, Richard M.] Univ Hosp Bristol NHS Fdn Trust & Univ Bristol, Natl Inst Hlth Res NIHR, Bristol Biomed Res Ctr, Bristol, Avon, England; [Tsilidis, Konstantinos K.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Ioannina, Greece	Imperial College London; World Health Organization; International Agency for Research on Cancer (IARC); University of London; University College London; University of Oslo; QIMR Berghofer Medical Research Institute; University of Bristol; University of Bristol; University of Ioannina	Ellingjord-Dale, M (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.	m.ellingjord-dale@imperial.ac.uk	Macgregor, Stuart/C-6442-2009; Ong, Jue Sheng/B-3595-2018	Macgregor, Stuart/0000-0001-6731-8142; Katsoulis, Michail/0000-0002-1756-9530; Ong, Jue Sheng/0000-0002-6062-710X; Aune, Dagfinn/0000-0002-4533-1722; Tsilidis, Konstantinos/0000-0002-8452-8472; Papadimitriou, Nikos/0000-0001-8294-7262; Gill, Dipender/0000-0001-7312-7078; Martin, Richard/0000-0002-7992-7719; Riboli, Elio/0000-0001-6795-6080; Dimou, Niki/0000-0003-1678-9328; Elsworth, Benjamin/0000-0001-7328-4233	World Cancer Research Fund International Regular Grant Programme [WCRF 2014/1180]; Cancer Research UK [C18281/A19169]; Medical Research Council [MC_UU_12013/1, MC_UU_12013/2, MC_UU_12013/3]; University of Bristol; National Institute for Health Research (NIHR) Bristol Biomedical Research Centre - National Institute for Health Research (NIHR); University Hospitals Bristol NHS Foundation Trust	World Cancer Research Fund International Regular Grant Programme; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; National Institute for Health Research (NIHR) Bristol Biomedical Research Centre - National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); University Hospitals Bristol NHS Foundation Trust	This work was supported by the World Cancer Research Fund International Regular Grant Programme (WCRF 2014/1180 to Konstantinos K. Tsilidis). RMM was supported by a Cancer Research UK (C18281/A19169) programme grant (the Integrative Cancer Epidemiology Programme) and is part of the Medical Research Council Integrative Epidemiology Unit at the University of Bristol supported by the Medical Research Council (MC_UU_12013/1, MC_UU_12013/2, and MC_UU_12013/3) and the University of Bristol. RMM is also supported by the National Institute for Health Research (NIHR) Bristol Biomedical Research Centre which is funded by the National Institute for Health Research (NIHR) and is a partnership between University Hospitals Bristol NHS Foundation Trust and the University of Bristol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2012, MOL PSYCHIATR, V17, P1116, DOI 10.1038/mp.2011.101; [Anonymous], 2013, J CARDIOLOGY CASES, V8, pe13; [Anonymous], 2017, REPORT TWCRFTE DIET; [Anonymous], 2016, CANC DISCOV; Baker JA, 2006, J NUTR, V136, P166, DOI 10.1093/jn/136.1.166; Bhoo-Pathy N, 2015, BREAST CANCER RES, P17, DOI [10.1186/s13058-015-0523-1, DOI 10.1186/S13058-015-0523-1]; Boggs DA, 2010, CANCER CAUSE CONTROL, V21, P1941, DOI 10.1007/s10552-010-9622-6; Bowden J, 2016, INT J EPIDEMIOL, V45, P1961, DOI 10.1093/ije/dyw220; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Brazel DM, 2019, BIOL PSYCHIAT, V85, P946, DOI 10.1016/j.biopsych.2018.11.024; Burgess S TS, 2015, MENDELIAN RANDOMIZAT; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Cavin C, 2002, FOOD CHEM TOXICOL, V40, P1155, DOI 10.1016/S0278-6915(02)00029-7; Clarke TK, 2017, MOL PSYCHIATR, V22, P1376, DOI 10.1038/mp.2017.153; Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107; Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Davies NM, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k601; Day FR, 2015, NAT GENET, V47, P1294, DOI 10.1038/ng.3412; Del Greco MF, 2015, STAT MED, V34, P2926, DOI 10.1002/sim.6522; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Evangelou E, 2019, NAT HUM BEHAV, V3, P950, DOI 10.1038/s41562-019-0653-z; EWERTZ M, 1990, INT J CANCER, V46, P779, DOI 10.1002/ijc.2910460505; Fagherazzi G, 2011, PUBLIC HEALTH NUTR, V14, P1315, DOI 10.1017/S1368980011000371; FOLSOM AR, 1993, AM J EPIDEMIOL, V138, P380, DOI 10.1093/oxfordjournals.aje.a116870; Fung TT, 2012, BREAST CANCER RES TR, V132, P1157, DOI 10.1007/s10549-011-1942-z; Ganmaa D, 2008, INT J CANCER, V122, P2071, DOI 10.1002/ijc.23336; Gierach GL, 2012, INT J CANCER, V131, P452, DOI 10.1002/ijc.26372; Gomez-Ruiz JA, 2007, J AGR FOOD CHEM, V55, P6962, DOI 10.1021/jf0710985; Greenland S, 2018, INT J EPIDEMIOL, V47, P358, DOI 10.1093/ije/dyx275; Grosso G, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600930; Grosso G, 2016, EUR J EPIDEMIOL, V31, P1191, DOI 10.1007/s10654-016-0202-2; Guo YR, 2013, HUM MOL GENET, V22, P184, DOI 10.1093/hmg/dds396; Hartwig FP, 2017, INT J EPIDEMIOL, V46, P1985, DOI 10.1093/ije/dyx102; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Hirvonen T, 2006, ANN EPIDEMIOL, V16, P503, DOI 10.1016/j.annepidem.2005.09.011; Jiang WJ, 2013, GYNECOL ONCOL, V129, P620, DOI 10.1016/j.ygyno.2013.03.014; Kichaev G, 2019, AM J HUM GENET, V104, P65, DOI 10.1016/j.ajhg.2018.11.008; Kotsopoulos J, 2009, CANCER-AM CANCER SOC, V115, P2765, DOI 10.1002/cncr.24328; Lafranconi A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020112; Larsson SC, 2009, CANCER CAUSE CONTROL, V20, P2039, DOI 10.1007/s10552-009-9396-x; LAVECCHIA C, 1986, SURGERY, V100, P477; Li JM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2879; Linner RK, 2019, NAT GENET, V51, P245, DOI 10.1038/s41588-018-0309-3; Liu MZ, 2019, NAT GENET, V51, P237, DOI 10.1038/s41588-018-0307-5; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; LUBIN F, 1985, J NATL CANCER I, V74, P569; Lukic M, 2016, EUR J EPIDEMIOL, V31, P905, DOI 10.1007/s10654-016-0142-x; Mannisto S, 1999, J CLIN EPIDEMIOL, V52, P429, DOI 10.1016/S0895-4356(99)00010-4; McKay JD, 2017, NAT GENET, V49, P1126, DOI 10.1038/ng.3892; MCLAUGHLIN CC, 1992, CANCER CAUSE CONTROL, V3, P175, DOI 10.1007/BF00051658; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Michels KB, 2002, ANN EPIDEMIOL, V12, P21, DOI 10.1016/S1047-2797(01)00238-1; Nagata C, 1998, NUTR CANCER, V30, P21, DOI 10.1080/01635589809514635; Nilsson LM, 2010, CANCER CAUSE CONTROL, V21, P1533, DOI 10.1007/s10552-010-9582-x; Nkondjock A, 2009, CANCER LETT, V277, P121, DOI 10.1016/j.canlet.2008.08.022; Oh JK, 2015, INT J CANCER, V137, P1979, DOI 10.1002/ijc.29569; Ong JS, 2019, INT J EPIDEMIOL, V48, P1447, DOI 10.1093/ije/dyz144; Palmer TM, 2011, AM J EPIDEMIOL, V173, P1392, DOI 10.1093/aje/kwr026; Patel YM, 2016, CANCER RES, V76, P5768, DOI 10.1158/0008-5472.CAN-16-0446; Paternoster L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024303; Pathy NB, 2010, BREAST CANCER RES TR, V121, P461, DOI 10.1007/s10549-009-0583-y; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Pierce BL, 2011, INT J EPIDEMIOL, V40, P740, DOI 10.1093/ije/dyq151; ROSENBERG L, 1985, AM J EPIDEMIOL, V122, P391, DOI 10.1093/oxfordjournals.aje.a114120; Schatzkin A, 2009, CANCER PREV RES, V2, P104, DOI 10.1158/1940-6207.CAPR-08-0070; Sisti JS, 2015, CANCER EPIDEM BIOMAR, V24, P1174, DOI 10.1158/1055-9965.EPI-15-0246; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spiller W DN, 2017, SOFTWARE APPL PROFIL; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sulem P, 2011, HUM MOL GENET, V20, P2071, DOI 10.1093/hmg/ddr086; VATTEN LJ, 1990, BRIT J CANCER, V62, P267, DOI 10.1038/bjc.1990.274; Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7; Verduijn M, 2010, NEPHROL DIAL TRANSPL, V25, P1394, DOI 10.1093/ndt/gfq098; Woolcott CG, 2010, ENDOCR-RELAT CANCER, V17, P125, DOI 10.1677/ERC-09-0211; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Yavorska OO, 2017, INT J EPIDEMIOL, V46, P1734, DOI 10.1093/ije/dyx034; Zhong VW, 2019, HUM MOL GENET, V28, P2449, DOI 10.1093/hmg/ddz061	79	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0236904	10.1371/journal.pone.0236904	http://dx.doi.org/10.1371/journal.pone.0236904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465101	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000611969200018
J	Basten, D; Muller, M; Ott, M; Pankratz, O; Rosenkranz, C				Basten, Dirk; Mueller, Marcel; Ott, Marion; Pankratz, Oleg; Rosenkranz, Christoph			Impact of time pressure on software quality: A laboratory experiment on a game-theoretical model	PLOS ONE			English	Article							PROJECT-MANAGEMENT; PRISONERS-DILEMMA; INFORMATION; COOPERATION; PERFORMANCE; PERSONALITY; ONLINE	Research suggests the relationship between time pressure and software quality to be more complex than presumed. While software developers can adjust their output to improve observed performance at the expense of software quality, the latter has been found to increase with time pressure in case of work-pace dependent incentives. An untested, but widely disseminated game-theoretical model seeks to resolve this contradiction and hypothesizes that high rates of time pressure avoid so-called 'shortcuts', which occur in the form of imperfections induced by developers to meet unrealistically tight deadlines. We conduct two laboratory experiments to empirically test this model for the first time. Our results corroborate the model with regard to its suggestion that shortcuts can be reduced if developers perceive unrealistic deadlines as ever-present. However, we also show that the actual critical probability of unrealistic deadlines-the point at which shortcut taking is drastically reduced-is above the theoretical one. Although final conclusions on the impact of time pressure on software quality remain to be drawn, our results suggest that-considering the contingencies of our study-time pressure helps in striving for quality in software projects.	[Basten, Dirk; Pankratz, Oleg; Rosenkranz, Christoph] Univ Cologne, Cologne Inst Informat Syst, Cologne, Germany; [Mueller, Marcel; Ott, Marion] Rhein Westfal TH Aachen, Sch Business & Econ, Aachen, Germany; [Ott, Marion] ZEW Leibniz Ctr European Econ Res, Mannheim, Germany	University of Cologne; RWTH Aachen University; Zentrum fur Europaische Wirtschaftsforschung (ZEW)	Rosenkranz, C (corresponding author), Univ Cologne, Cologne Inst Informat Syst, Cologne, Germany.	rosenkranz@wiso.uni-koeln.de	Ott, Marion/F-7635-2018; Rosenkranz, Christoph/E-8628-2015	Ott, Marion/0000-0001-5199-4664; Rosenkranz, Christoph/0000-0003-4286-4176				ANDREONI J, 1993, ECON J, V103, P570, DOI 10.2307/2234532; [Anonymous], 2013, 34 INT C INF SYST MI; Asdemir K, 2012, INFORM SYST RES, V23, P804, DOI 10.1287/isre.1110.0391; Austin RD, 2001, INFORM SYST RES, V12, P195, DOI 10.1287/isre.12.2.195.9699; Berander P, 2004, 2004 INTERNATIONAL SYMPOSIUM ON EMPIRICAL SOFTWARE ENGINEERING, PROCEEDINGS, P167; Biggeleben M., 2011, THESIS; Charaf MC, 2013, INFORM SYST J, V23, P115, DOI 10.1111/j.1365-2575.2012.00408.x; Chong DSF, 2011, IEEE T ENG MANAGE, V58, P71, DOI 10.1109/TEM.2010.2048914; Cohn M., 2009, ADDISON WESLEY, Vxxviii, P475; Cooper CL., 2017, HDB STRESS HLTH GUID; Cooper R, 1996, GAME ECON BEHAV, V12, P187, DOI 10.1006/game.1996.0013; Costello S. H., 1984, SIGSOFT Software Engineering Notes, V9, P15, DOI 10.1145/1010941.1010947; Dal Bo P, 2005, AM ECON REV, V95, P1591; DeMarco T., 1982, CONTROLLING SOFTWARE, Vxii, P284, DOI 10.5455/AIM.2012.21.63-66; Devetag G, 2007, EXP ECON, V10, P331, DOI 10.1007/s10683-007-9178-9; Field A., 2012, DISCOVERING STAT USI; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fisher CW, 2003, INFORM SYST RES, V14, P170, DOI 10.1287/isre.14.2.170.16017; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fitzgerald B, 2006, EUR J INFORM SYST, V15, P200, DOI 10.1057/palgrave.ejis.3000605; GERSICK CJG, 1988, ACAD MANAGE J, V31, P9, DOI 10.2307/256496; Gevers JMP, 2006, APPL PSYCHOL-INT REV, V55, P52, DOI 10.1111/j.1464-0597.2006.00228.x; Hameri A.-P., 2002, INT J PROJ MANAG, V20, P143, DOI [10.1016/S0263-7863(00)00044-2, DOI 10.1016/S0263-7863(00)00044-2]; Host M., 2000, Empirical Software Engineering, V5, P201, DOI 10.1023/A:1026586415054; Hummel M, 2015, COMMUN ASSOC INF SYS, V36, P273, DOI DOI 10.17705/1CAIS.03615; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Jorgensen M, 2013, IEEE SOFTWARE, V30, P74, DOI 10.1109/MS.2012.70; Kampenes VB, 2007, INFORM SOFTWARE TECH, V49, P1073, DOI 10.1016/j.infsof.2007.02.015; KARAU SJ, 1992, J EXP SOC PSYCHOL, V28, P542, DOI 10.1016/0022-1031(92)90045-L; Karlstrom D, 2006, EMPIR SOFTW ENG, V11, P203, DOI 10.1007/s10664-006-6402-8; KELLY JR, 1985, J PERS SOC PSYCHOL, V49, P395, DOI 10.1037/0022-3514.49.2.395; Kocher MG, 2006, J ECON BEHAV ORGAN, V61, P375, DOI 10.1016/j.jebo.2004.11.013; Lee B, 2004, SOFTWARE QUAL J, V12, P59, DOI 10.1023/B:SQJO.0000013359.71560.47; Levina N, 2005, INFORM SYST RES, V16, P109, DOI 10.1287/isre.1050.0055; Lounsbury JW, 2007, J INF TECHNOL, V22, P174, DOI 10.1057/palgrave.jit.2000094; Lounsbury JW, 2004, PERS INDIV DIFFER, V37, P181, DOI 10.1016/j.paid.2003.08.010; Lounsbury JW, 2004, J BUS PSYCHOL, V18, P427; Mahaney RC, 2003, J SYST SOFTWARE, V68, P1, DOI 10.1016/S0164-1212(02)00132-2; Mahaney RC, 2006, RES HUM R M, P85; Mantyla MV, 2014, 36TH INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING (ICSE 2014), P83, DOI 10.1145/2568225.2568245; Mantyla MV, 2013, INFORM SOFTWARE TECH, V55, P986, DOI 10.1016/j.infsof.2012.12.004; Maruping LM, 2015, ACAD MANAGE J, V58, P1313, DOI 10.5465/amj.2012.0468; McConnell S., 1996, RAPID DEV TAMING WIL; Nan N, 2009, IEEE T SOFTWARE ENG, V35, P624, DOI 10.1109/TSE.2009.18; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; Perlow LA, 1999, ADMIN SCI QUART, V44, P57, DOI 10.2307/2667031; Recker J, 2017, PROJ MANAG J, V48, P99, DOI 10.1177/875697281704800208; Shah H, 2014, INFORM SOFTWARE TECH, V56, P6, DOI 10.1016/j.infsof.2013.04.005; Shao BBM, 2014, DECIS SUPPORT SYST, V59, P15, DOI 10.1016/j.dss.2013.10.002; Siau K, 2010, J DATABASE MANAGE, V21, P80, DOI 10.4018/jdm.2010112304; Terpstra T, 1952, INDAGATIONES MATHEMA, V14, P327; Topi H, 2005, INT J HUM-COMPUT ST, V62, P349, DOI 10.1016/j.ijhcs.2004.10.003; Varas F., 2014, WORKING PAPER SERIES; Waller MJ, 2002, ACAD MANAGE J, V45, P1046, DOI 10.2307/3069329; Wang ETG, 2008, INFORM MANAGE-AMSTER, V45, P438, DOI 10.1016/j.im.2008.05.003; Wohlin C, 2000, EXPT SOFTWARE ENG IN, P204; ZAKAY D, 1984, ERGONOMICS, V27, P273, DOI 10.1080/00140138408963489	58	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245599	10.1371/journal.pone.0245599	http://dx.doi.org/10.1371/journal.pone.0245599			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4XD	33449957	Green Published, gold			2022-12-26	WOS:000609991600045
J	Dadras, O; Nakayama, T; Kihara, M; Ono-Kihara, M; Seyedalinaghi, S; Dadras, F				Dadras, Omid; Nakayama, Takeo; Kihara, Masahiro; Ono-Kihara, Masako; Seyedalinaghi, Seyedahmad; Dadras, Fateme			The prevalence and associated factors of adverse pregnancy outcomes among Afghan women in Iran; Findings from community-based survey	PLOS ONE			English	Article							FOOD INSECURITY; MENTAL-HEALTH; INTIMATE PARTNER; IMMIGRANT; CARE; DISCRIMINATION; COMPLICATIONS; FAMILIES; REFUGEES; VIOLENCE	Backgrounds An estimated 2.5 million Afghans are living in the Iran and almost half of them are young women at the childbearing ages. Although the evidence indicates lower rates of antenatal care and higher incidence of pregnancy complications in Afghan compared to Iranian women, the underlying reasons are not well defined. Therefore, in the present study, we aimed to explore the prevalence and associated sociodemographic factors of adverse pregnancy outcomes and examine the impact of intimate partner violence, food insecurity, poor mental health, and housing issues on pregnancy outcome in Afghan women living in Iran. Methods In July 2019, we enrolled 424 Afghan women aged 18-44 years old using the time-location sampling at three community health centers in the south region of Tehran province. The data was collected through face to face interviews using the researcher-developed questionnaire. Using bivariate and multivariate analysis, the impact of poor antenatal care, intimate partner violence, food insecurity, and poor mental health was assessed on the incidence of adverse pregnancy outcome. Results More than half (56.6%) of Afghan women reported at least one pregnancy complication in their recent pregnancy. The results showed that undocumented, illiterate, and unemployed Afghan women with lower socioeconomic status are more likely to experience adverse pregnancy outcomes. Furthermore, we observed lower prevalence of adverse pregnancy outcomes among documented immigrants with health insurance compared to those with no health insurance. It is also been found that the food insecurity [Adjusted OR = 3.35, 95% CI (1.34-8.36)], poor antenatal care [Adjusted OR = 10.50, 95% CI (5.40-20.39)], intimate partner violence [Adjusted OR = 2.72, 95% CI (1.10-6.77)], and poor mental health [Adjusted OR = 4.77, 95% CI (2.54-8.94)] could adversely impact the pregnancy outcome and we observed higher incidence of adverse outcomes among those suffering from these situations. Conclusion To our knowledge, this is the first study that explored the prevalence and associated factors of adverse pregnancy outcomes and the impact of intimate partner violence, food insecurity, poor mental health on pregnancy outcome among Afghan women in Iran. Enhancing the psychosocial support and empowering Afghan women through expanding the social network and safety net should be a priority for the central government and international parties. Psychological counseling should be incorporated into routine maternity care for Afghan refugees. Access to free antenatal care is a right for all Afghan women and it should be facilitated by universal health insurance for all Afghans regardless of their legal status.	[Dadras, Omid; Nakayama, Takeo; Kihara, Masahiro] Kyoto Univ, Grad Sch Med, Dept Hlth Informat, Kyoto, Japan; [Ono-Kihara, Masako] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Global Hlth Interdisciplinary Unit, Kyoto, Japan; [Seyedalinaghi, Seyedahmad] Univ Tehran Med Sci, Iranian Inst Reduct High Risk Behav, Iranian Res Ctr HIV AIDS, Tehran, Iran; [Dadras, Fateme] Univ Tehran Med Sci, Dept Obstet & Gynecol, Tehran, Iran	Kyoto University; Kyoto University; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Dadras, O (corresponding author), Kyoto Univ, Grad Sch Med, Dept Hlth Informat, Kyoto, Japan.	omiddadras@yahoo.com	NAKAYAMA, Takeo/HCH-0537-2022; Dadras, Omid/X-2514-2019; SeyedAlinaghi, SeyedAhmad/M-2938-2017	Dadras, Omid/0000-0001-9385-2170; SeyedAlinaghi, SeyedAhmad/0000-0003-3210-7905				Abbasi-Shavazi M, 2005, AFGHANISTAN RES EVAL; Abdollahi F, 2015, J FAM COMMUNITY MED, V22, P13, DOI 10.4103/2230-8229.149577; Abdollahi M, 2015, ECOL FOOD NUTR, V54, P187, DOI 10.1080/03670244.2013.834819; [Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y; Beiser M, 2016, J NERV MENT DIS, V204, P464, DOI 10.1097/NMD.0000000000000516; Dadras O, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03121-5; Dadras O, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-02969-x; Delkhosh M, 2019, HEALTH CARE WOMEN IN, V40, P213, DOI 10.1080/07399332.2018.1529766; Ellis BH, 2010, AM J ORTHOPSYCHIAT, V80, P564, DOI 10.1111/j.1939-0025.2010.01061.x; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gundersen C, 2015, HEALTH AFFAIR, V34, P1830, DOI 10.1377/hlthaff.2015.0645; Higginbottom GMA, 2015, SYST REV, V4, DOI 10.1186/2046-4053-4-13; Hobel C, 2003, J NUTR, V133, p1709S, DOI 10.1093/jn/133.5.1709S; Hollander AC, 2013, J NERV MENT DIS, V201, P645, DOI 10.1097/NMD.0b013e31829dbd64; IOM, 2018, INT MIGR REP; IUNHCR, 2011, UNHCR GLOB APP 2011; Ivers LC, 2011, AM J CLIN NUTR, V94, p1740S, DOI 10.3945/ajcn.111.012617; Kharaghani R, 2016, ARCH IRAN MED, V19, P64, DOI 0161901/AIM.0012; Korinek K, 2011, SOC SCI MED, V72, P1695, DOI 10.1016/j.socscimed.2011.02.046; Laditka SB, 2005, WOMEN HEALTH, V41, P1, DOI 10.1300/J013v41n03_01; Laraia BA, 2010, J AM DIET ASSOC, V110, P692, DOI 10.1016/j.jada.2010.02.014; Lindsay KL, 2012, J HUM NUTR DIET, V25, P534, DOI 10.1111/j.1365-277X.2012.01253.x; Mohammadi S, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0617-8; Omidvar N, 2013, J HEALTH POPUL NUTR, V31, P356; Otoukesh S, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-82; Pernice R, 1996, J SOC PSYCHOL, V136, P511, DOI 10.1080/00224545.1996.9714033; Reed MM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-100; Sano Y, 2011, J FAM ECON ISS, V32, P111, DOI 10.1007/s10834-010-9219-y; Sharifi Nasibeh, 2017, J Caring Sci, V6, P371, DOI 10.15171/jcs.2017.035; Small R, 2002, BIRTH-ISS PERINAT C, V29, P266, DOI 10.1046/j.1523-536X.2002.00201.x; Tavakolipour S, 2019, J MIDWIFERY REPROD H, V7, P1726, DOI [10.22038/JMRH.2019.32423.1353, DOI 10.22038/JMRH.2019.32423.1353]; Thomas PE, 2010, AUST NZ J OBSTET GYN, V50, P419, DOI 10.1111/j.1479-828X.2010.01210.x; Tober DM, 2006, MED ANTHROPOL Q, V20, P50, DOI 10.1525/maq.2006.20.1.50; UNHCR, 2014, ISL REP IR SOL STRAT; Witt WP, 2012, MATERN CHILD HLTH J, V16, P1525, DOI 10.1007/s10995-011-0916-4	35	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245007	10.1371/journal.pone.0245007	http://dx.doi.org/10.1371/journal.pone.0245007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4XD	33449922	gold, Green Published			2022-12-26	WOS:000609991600002
J	Miyashita, A; Suzuki, S				Miyashita, Ayana; Suzuki, Satoru			A method for measuring the forces acting on a tree trunk using strain gauges	PLOS ONE			English	Article							WIND-TUNNEL MEASUREMENTS; MECHANICAL STABILITY; DRAG RELATIONSHIPS; CONSTANT-STRESS; DAMAGE; DENSITY; GROWTH; SPRUCE; FIELD; PINE	The wind force acted on a tree constantly changes in magnitude, direction, and distribution. We developed a method to measure simultaneously the amount of force (F), centroid of the distributed force (C), and direction of force (D) on a tree trunk using four strain gauges. F and C were estimated from the difference in the bending moments at two different positions along the long axis of the stem. D was estimated using the difference in the sensor outputs at two different radial positions at the same height. In principle, the two strain gauges should be oriented precisely 90 degrees apart; however, this is unrealistic on an actual tree trunk. To calculate D, we developed a new method to detect the radial position and modulus of elasticity of each strain gauge after attaching it. We conducted three types of experiment. First, we loaded a wood pole with weights arranged in 11 patterns to test the accuracies of F and C for a distributed load. Next, we applied tensile forces to the wood pole and an evergreen conifer sapling from eight directions to test the accuracy of D, F, and C. On average, estimation errors were < 2% for both the distributed load and circumferential tensile load. Our method can estimate F, C, and D precisely, even if the wood is uneven and the strain gauges are not aligned. This is a great advantage for field wind force measurements.	[Miyashita, Ayana; Suzuki, Satoru] Forestry & Forest Prod Res Inst FFPRI, Ctr Forest Damage & Risk Management, Tsukuba, Ibaraki, Japan	Forestry & Forest Products Research Institute - Japan	Miyashita, A (corresponding author), Forestry & Forest Prod Res Inst FFPRI, Ctr Forest Damage & Risk Management, Tsukuba, Ibaraki, Japan.	ayanamiyashita@ffpri.affrc.go.jp		Miyashita, Ayana/0000-0003-3619-9114	Forestry and Forest Products Research Institute [201908]	Forestry and Forest Products Research Institute(Forestry & Forest Products Research Institute - Japan)	A.M. received research grand #201908 of the Forestry and Forest Products Research Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackburn GRA, 1997, GROWTH MECH RESPONSE; Crook MJ, 1997, J EXP BOT, V48, P1703, DOI 10.1093/jexbot/48.314.1703; DEAN TJ, 1986, ANN BOT-LONDON, V58, P833, DOI 10.1093/oxfordjournals.aob.a087265; Department of Wood materials the Japanese Government Forestry Experiment Station, 1975, 300 SPEC WORLD US WO; Duperat M, 2021, FORESTRY, V94, P141, DOI 10.1093/forestry/cpaa023; Dupont S, 2008, AGR FOREST METEOROL, V148, P976, DOI 10.1016/j.agrformet.2008.01.014; Forest Products Laboratory, 2010, WOOD HDB WOOD ENG MA; Gardiner BA, 1997, FORESTRY, V70, P233, DOI 10.1093/forestry/70.3.233; GARDINER BA, 1994, BOUND-LAY METEOROL, V67, P161, DOI 10.1007/BF00705512; Gardiner B, 2008, FORESTRY, V81, P447, DOI 10.1093/forestry/cpn022; Gardiner B, 2016, PLANT SCI, V245, P94, DOI 10.1016/j.plantsci.2016.01.006; Hale SE, 2012, EUR J FOREST RES, V131, P203, DOI 10.1007/s10342-010-0448-2; Ido H, 2013, J WOOD SCI, V59, P67, DOI 10.1007/s10086-012-1297-z; James KR, 2008, AGR FOREST METEOROL, V148, P1055, DOI 10.1016/j.agrformet.2008.02.003; James KR, 2006, AM J BOT, V93, P1522, DOI 10.3732/ajb.93.10.1522; Kamimura K, 2012, EUR J FOREST RES, V131, P219, DOI 10.1007/s10342-011-0508-2; Kamimura K, 2016, CAN J FOREST RES, V46, P88, DOI 10.1139/cjfr-2015-0237; Kitagawa K, 2015, EUR J FOREST RES, V134, P403, DOI 10.1007/s10342-014-0859-6; Koizumi A, 2016, J WOOD SCI, V62, P363, DOI 10.1007/s10086-016-1556-5; MAYHEAD GJ, 1973, AGR METEOROL, V12, P123, DOI 10.1016/0002-1571(73)90013-7; Minamino R, 2014, AM J BOT, V101, P1085, DOI 10.3732/ajb.1400135; Moore JR, 2005, AGR FOREST METEOROL, V132, P78, DOI 10.1016/j.agrformet.2005.07.007; Moore JR, 2004, TREES-STRUCT FUNCT, V18, P195, DOI 10.1007/s00468-003-0295-6; MORGAN J, 1994, TREE PHYSIOL, V14, P49, DOI 10.1093/treephys/14.1.49; Nicoll BC, 2005, CAN J FOREST RES, V35, P2360, DOI [10.1139/x05-157, 10.1139/X05-157]; Niklas KJ, 2000, TREES-STRUCT FUNCT, V14, P230, DOI 10.1007/s004680050008; Noguchi H, 2009, J JPN SOC COAST FOR, V8, P80; Peltola H, 1999, CAN J FOREST RES, V29, P647, DOI 10.1139/cjfr-29-6-647; Peltola H, 2000, FOREST ECOLOGY MANAG, P135; Peltola HM, 2006, AM J BOT, V93, P1501, DOI 10.3732/ajb.93.10.1501; Ribeiro GHPM, 2016, FOREST ECOL MANAG, V380, P1, DOI 10.1016/j.foreco.2016.08.039; Rudnicki M, 2004, CAN J FOREST RES, V34, P666, DOI [10.1139/x03-233, 10.1139/X03-233]; Stokes A, 1999, PLANT SOIL, V217, P17, DOI 10.1023/A:1004613126353; Suzuki S, 2016, SUMM ANN C JAP SOC C, P32; Vollsinger S, 2005, CAN J FOREST RES, V35, P1238, DOI 10.1139/x05-051; Wellpott A., 2008, THESIS U EDINBURGH; Yamashita K, 2000, MOKUZAI GAKKAISHI, V46, P510	37	0	0	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245631	10.1371/journal.pone.0245631	http://dx.doi.org/10.1371/journal.pone.0245631			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449960	Green Published, gold			2022-12-26	WOS:000609991600057
J	Zhang, X; Liu, Y; Dai, L; Shi, G; Deng, J; Luo, Q; Xie, Q; Cheng, L; Li, CL; Lin, Y; Wang, QN; Fan, P; Zhang, HT; Su, XL; Zhang, S; Yang, Y; Hu, X; Gong, QY; Yu, DC; Zheng, L; Deng, HX				Zhang, Xin; Liu, Yi; Dai, Lei; Shi, Gang; Deng, Jie; Luo, Qiang; Xie, Qian; Cheng, Lin; Li, Chunlei; Lin, Yi; Wang, Qingnan; Fan, Ping; Zhang, Hantao; Su, Xiaolan; Zhang, Shuang; Yang, Yang; Hu, Xun; Gong, Qiyong; Yu, Dechao; Zheng, Lei; Deng, Hongxin			BATF2 prevents glioblastoma multiforme progression by inhibiting recruitment of myeloid-derived suppressor cells	ONCOGENE			English	Article							STEM-CELLS; EXTRACELLULAR VESICLES; CANCER; INFLAMMATION; METASTASIS; ACTIVATION; AP-1	The basic leucine zipper ATF-like transcription factor 2 (BATF2) has been implicated in inflammatory responses and anti-tumour effects. Little, however, is known regarding its extracellular role in maintaining a non-supportive cancer microenvironment. Here, we show that BATF2 inhibits glioma growth and myeloid-derived suppressor cells (MDSCs) recruitment. Interestingly, extracellular vesicles (EVs) from BATF2-overexpressing glioma cell lines (BATF2-EVs) inhibited MDSCs chemotaxis in vitro. Moreover, BATF2 inhibited intracellular SDF-1 alpha and contributes to decreased SDF-1 alpha in EVs. In addition, BATF2 downregulation-induced MDSCs recruitment were reversed by blocking SDF-1 alpha/CXCR4 signalling upon AMD3100 treatment. Specifically, detection of EVs in 24 pairs of gliomas and healthy donors at different stages revealed that the abundance of BATF2-positive EVs in plasma (BATF2(+) plEVs) can distinguish stage III-IV glioma from stage I-II glioma and healthy donors. Taken together, our study identified novel regulatory functions of BATF2 in regulating MDSCs recruitment, providing a prognostic value in terms of the number of BATF2(+) plEVs in glioma stage.	[Zhang, Xin; Liu, Yi; Dai, Lei; Shi, Gang; Deng, Jie; Cheng, Lin; Li, Chunlei; Lin, Yi; Wang, Qingnan; Zhang, Hantao; Su, Xiaolan; Yang, Yang; Yu, Dechao; Deng, Hongxin] Sichuan Univ, West China Hosp, State Key Lab Biotherapy & Canc Ctr, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Xin; Liu, Yi; Dai, Lei; Shi, Gang; Deng, Jie; Cheng, Lin; Li, Chunlei; Lin, Yi; Wang, Qingnan; Zhang, Hantao; Su, Xiaolan; Yang, Yang; Yu, Dechao; Deng, Hongxin] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Xin; Zheng, Lei] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou 510515, Guangdong, Peoples R China; [Luo, Qiang; Gong, Qiyong] Sichuan Univ, West China Hosp, Huaxi MR Res Ctr, Dept Radiol, Chengdu 610041, Sichuan, Peoples R China; [Xie, Qian] Sichuan Univ, Gen Practice Dept, West China Hosp, Chengdu 610041, Sichuan, Peoples R China; [Fan, Ping; Hu, Xun] Sichuan Univ, West China Hosp, Huaxi Biobank, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Shuang] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu 610041, Sichuan, Peoples R China	Sichuan University; Southern Medical University - China; Sichuan University; Sichuan University; Sichuan University; Sichuan University	Deng, HX (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy & Canc Ctr, Chengdu 610041, Sichuan, Peoples R China.; Deng, HX (corresponding author), Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Sichuan, Peoples R China.; Zheng, L (corresponding author), Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou 510515, Guangdong, Peoples R China.	nfyyzhenglei@smu.edu.cn; denghongx@scu.edu.cn	Gong, Qiyong/W-3052-2019	Gong, Qiyong/0000-0002-5912-4871; Liu, Yi/0000-0003-3108-7981; Deng, Hongxin/0000-0001-5094-1376	National Natural Science Foundation of China [81772939, 81902147]; National Key R&D Program of China [2017YFA0105702]; 1.3.5 project for disciplines of excellence in West China Hospital, Sichuan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; 1.3.5 project for disciplines of excellence in West China Hospital, Sichuan University	Our study was supported by the National Natural Science Foundation of China Program grant (no. 81772939), National Natural Science Foundation of China Program grant (no. 81902147), the National Key R&D Program of China grant (no. 2017YFA0105702) and 1.3.5 project for disciplines of excellence in West China Hospital, Sichuan University.	Alexander BM, 2018, CLIN CANCER RES, V24, P737, DOI 10.1158/1078-0432.CCR-17-0764; Andrade AF, 2017, INVEST NEW DRUG, V35, P26, DOI 10.1007/s10637-016-0401-4; Boussiotis VA, 2018, ONCOGENE, V37, P1121, DOI 10.1038/s41388-017-0024-z; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Chen G, 2018, NATURE, V560, P382, DOI 10.1038/s41586-018-0392-8; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Dai L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11996; Dash R, 2010, ONCOGENE, V29, P4412, DOI 10.1038/onc.2010.194; Dash R, 2014, CANCER RES, V74, P563, DOI 10.1158/0008-5472.CAN-13-1062; Devignes CS, 2018, P NATL ACAD SCI USA, V115, pE992, DOI 10.1073/pnas.1718009115; Dorayappan KDP, 2018, ONCOGENE, V37, P3806, DOI 10.1038/s41388-018-0189-0; Dubinski D, 2016, NEURO-ONCOLOGY, V18, P807, DOI 10.1093/neuonc/nov280; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Genschmer KR, 2019, CELL, V176, P113, DOI 10.1016/j.cell.2018.12.002; Guo F, 2016, ONCOGENE, V35, P816, DOI 10.1038/onc.2015.139; Hu BL, 2016, CELL, V167, P1281, DOI 10.1016/j.cell.2016.10.039; Hu Y, 2019, J CLIN INVEST, V129, P3072, DOI 10.1172/JCI124979; Huang Q, 2011, TUMOR BIOL, V32, P1191, DOI 10.1007/s13277-011-0222-1; Huse JT, 2014, CLIN CANCER RES, V20, P5601, DOI 10.1158/1078-0432.CCR-14-0831; Janssens R, 2018, CELL MOL IMMUNOL, V15, P299, DOI 10.1038/cmi.2017.107; Jin X, 2012, BRAIN, V135, P1055, DOI 10.1093/brain/aws028; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kabe Y, 2018, CLIN CHEM, V64, P1463, DOI 10.1373/clinchem.2018.291963; Kalinichenko SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039505; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Keklikoglou I, 2019, NAT CELL BIOL, V21, P190, DOI 10.1038/s41556-018-0256-3; Khalife J, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129348; Kucharzewska P, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20304; Lee SY, 2016, GENES DIS, V3, P198, DOI 10.1016/j.gendis.2016.04.007; Li WH, 2014, APMIS, V122, P1080, DOI 10.1111/apm.12261; Liao YX, 2013, INT J MOL MED, V32, P1239, DOI 10.3892/ijmm.2013.1521; Liu ZB, 2015, CLIN CANCER RES, V21, P1752, DOI 10.1158/1078-0432.CCR-14-1564; Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005; Morad G, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1627164; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Ricklefs F, 2016, CANCER RES, V76, P2876, DOI 10.1158/0008-5472.CAN-15-3432; Santiago-Dieppa DR, 2014, EXPERT REV MOL DIAGN, V14, P819, DOI 10.1586/14737159.2014.943193; Schmid RS, 2016, NEURO-ONCOLOGY, V18, P962, DOI 10.1093/neuonc/nov321; Shao HL, 2018, CHEM REV, V118, P1917, DOI 10.1021/acs.chemrev.7b00534; Shao HL, 2012, NAT MED, V18, P1835, DOI 10.1038/nm.2994; Solito S, 2011, BLOOD, V118, P2254, DOI 10.1182/blood-2010-12-325753; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Tan JN, 2017, J IMMUNOL, V198, P2269, DOI 10.4049/jimmunol.1600610; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Tian Y, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2019.1697028; Wang XX, 2018, CELL STEM CELL, V22, P514, DOI 10.1016/j.stem.2018.03.011; Weller M, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.17	50	7	7	1	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2021	40	8					1516	1530		10.1038/s41388-020-01627-y	http://dx.doi.org/10.1038/s41388-020-01627-y		JAN 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QM6NM	33452462	hybrid, Green Published			2022-12-26	WOS:000607998600012
J	Ni, HF; Klugkist, I; van der Drift, S; Jorritsma, R; Hooijer, G; Nielen, M				Ni, Haifang; Klugkist, Irene; van der Drift, Saskia; Jorritsma, Ruurd; Hooijer, Gerrit; Nielen, Mirjam			Expert opinion as priors for random effects in Bayesian prediction models: Subclinical ketosis in dairy cows as an example	PLOS ONE			English	Article							MILK TEST; MISSPECIFICATION	Random effects regression models are routinely used for clustered data in etiological and intervention research. However, in prediction models, the random effects are either neglected or conventionally substituted with zero for new clusters after model development. In this study, we applied a Bayesian prediction modelling method to the subclinical ketosis data previously collected by Van der Drift et al. (2012). Using a dataset of 118 randomly selected Dutch dairy farms participating in a regular milk recording system, the authors proposed a prediction model with milk measures as well as available test-day information as predictors for the diagnosis of subclinical ketosis in dairy cows. While their original model included random effects to correct for the clustering, the random effect term was removed for their final prediction model. With the Bayesian prediction modelling approach, we first used non-informative priors for the random effects for model development as well as for prediction. This approach was evaluated by comparing it to the original frequentist model. In addition, herd level expert opinion was elicited from a bovine health specialist using three different scales of precision and incorporated in the prediction as informative priors for the random effects, resulting in three more Bayesian prediction models. Results showed that the Bayesian approach could naturally take the clustering structure of clusters into account by keeping the random effects in the prediction model. Expert opinion could be explicitly combined with individual level data for prediction. However in this dataset, when elicited expert opinion was incorporated, little improvement was seen at the individual level as well as at the herd level. When the prediction models were applied to the 118 herds, at the individual cow level, with the original frequentist approach we obtained a sensitivity of 82.4% and a specificity of 83.8% at the optimal cutoff, while with the three Bayesian models with elicited expert opinion, we obtained sensitivities ranged from 78.7% to 84.6% and specificities ranged from 75.0% to 83.6%. At the herd level, 30 out of 118 within herd prevalences were correctly predicted by the original frequentist approach, and 31 to 44 herds were correctly predicted by the three Bayesian models with elicited expert opinion. Further investigation in expert opinion and distributional assumption for the random effects was carried out and discussed.	[Ni, Haifang; Jorritsma, Ruurd; Hooijer, Gerrit; Nielen, Mirjam] Univ Utrecht, Dept Populat Hlth Sci, Div Farm Anim Hlth, Utrecht, Netherlands; [Ni, Haifang; Klugkist, Irene] Univ Utrecht, Dept Methodol & Stat, Fac Social & Behav Sci, Utrecht, Netherlands; [van der Drift, Saskia] Royal GD Anim Hlth, Deventer, Netherlands	Utrecht University; Utrecht University	Klugkist, I (corresponding author), Univ Utrecht, Dept Methodol & Stat, Fac Social & Behav Sci, Utrecht, Netherlands.	I.klugkist@uu.nl		Hooijer, Gerrit/0000-0003-2084-9469	Department of Population Health Sciences, division Farm Animal Health	Department of Population Health Sciences, division Farm Animal Health	Department of Population Health Sciences, division Farm Animal Health provided support in the form of salary for HN, RJ, GH and MN. Department of Methodology and Statistics provided support in the form of salary for HN, IK. Royal GD Animal Health provided support in the form of salary for SD. Dutch-Flemish Cattle Improvement Cooperative (CRV) organization provided support in funding for the initial data collection by SD. The funder of the initial data collection (CRV) did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2004, COMPUT STAT DATA AN, V47, P639, DOI 10.1016/j.csda.2003.12.009; Azzalini A, 2014, SKEW NORMAL RELATED; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; BUTLER SM, 1992, STAT MED, V11, P1981, DOI 10.1002/sim.4780111416; Goldhawk C, 2009, J DAIRY SCI, V92, P4971, DOI 10.3168/jds.2009-2242; Heagerty PJ, 2001, BIOMETRIKA, V88, P973, DOI 10.1093/biomet/88.4.973; Jorritsma R, 1998, VET QUART, V20, P108, DOI 10.1080/01652176.1998.9694851; Krogh MA, 2011, J DAIRY SCI, V94, P2360, DOI 10.3168/jds.2010-3816; Litiere S, 2007, BIOMETRICS, V63, P1038, DOI 10.1111/j.1541-0420.2007.00782.x; McCulloch CE, 2011, STAT SCI, V26, P388, DOI 10.1214/11-STS361; Ni HF, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0543-5; O'Hagan A., 2006, UNCERTAIN JUDGEMENTS, DOI 10.1002/0470033312; Oetzel GR, 2004, VET CLIN N AM-FOOD A, V20, P651, DOI 10.1016/j.cvfa.2004.06.006; R Core Team, 2021, R LANGUAGE ENV STAT; Raboisson D, 2014, J DAIRY SCI, V97, P7547, DOI 10.3168/jds.2014-8237; Spiegelhalter DJ., 2004, BAYESIAN APPROACHES; Stan Development Team, 2018, RSTAN R INT STAN R P; Steyerberg EW, 2019, CLIN PREDICTION MODE, V2nd, DOI 10.1007/978-0-387-77244-8; Tremblay M, 2018, J DAIRY SCI, V101, P7311, DOI 10.3168/jds.2017-13582; van der Drift SGA, 2012, J DAIRY SCI, V95, P4886, DOI 10.3168/jds.2011-4417	21	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0244752	10.1371/journal.pone.0244752	http://dx.doi.org/10.1371/journal.pone.0244752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444385	Green Published, gold			2022-12-26	WOS:000609988100002
J	Rashid, U; Iqbal, A; Liang, HY; Khan, W; Ashraf, MW				Rashid, Umair; Iqbal, Azhar; Liang, Haiyi; Khan, Waris; Ashraf, Muhammad Waqar			Dynamics of water conveying zinc oxide through divergent-convergent channels with the effect of nanoparticles shape when Joule dissipation are significant	PLOS ONE			English	Article							HEAT-TRANSFER; FLOW; FLUID; NANOFLUID	Aim of study The shape effects of nanoparticles are very significant in fluid flow and heat transfer. In this paper, we discuss the effects of nanoparticles shape in nanofluid flow between divergent-convergent channels theoretically. In this present study, various shapes of nanoparticles, namely sphere, column and lamina in zinc oxide-water nanofluid are used. The effect of the magnetic field and joule dissipation are also considered. Research methodology The system of nonlinear partial differential equations (PDEs) is converted into ordinary differential equations (ODES). The analytical solutions are successfully obtained and compared with numerical solutions. The Homotopy perturbation method and NDsolve method are used to compare analytical and numerical results respectively. Conclusion The results show that the lamina shape nanoparticles have higher performance in temperature disturbance and rate of heat transfer as compared to other shapes of nanoparticles.	[Rashid, Umair; Liang, Haiyi] Univ Sci & Technol China, Dept Modern Mech, CAS Key Lab Mech Behav & Design Mat, Hefei, Anhui, Peoples R China; [Iqbal, Azhar; Ashraf, Muhammad Waqar] Prince Mohammad Bin Fahd Univ, Math & Nat Sci, Al Khobar, Saudi Arabia; [Liang, Haiyi] Anhui Chungu 3D Printing Inst Intelligent Equipme, IAT Chungu Joint Lab Addit Mfg, Wuhu, Anhui, Peoples R China; [Khan, Waris] Hazara Univ, Dept Math & Stat, Mansehra, Khyber Pakhtunk, Pakistan	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Prince Mohammad Bin Fahd University; Hazara University	Liang, HY (corresponding author), Univ Sci & Technol China, Dept Modern Mech, CAS Key Lab Mech Behav & Design Mat, Hefei, Anhui, Peoples R China.; Iqbal, A (corresponding author), Prince Mohammad Bin Fahd Univ, Math & Nat Sci, Al Khobar, Saudi Arabia.; Liang, HY (corresponding author), Anhui Chungu 3D Printing Inst Intelligent Equipme, IAT Chungu Joint Lab Addit Mfg, Wuhu, Anhui, Peoples R China.	aiqbal@pmu.edu.sa; hyliang@ustc.edu.cn	Iqbal, Azhar/V-1023-2019; Iqbal, Azhar/AAY-1299-2021; Rashid, Umair/HII-8805-2022	Iqbal, Azhar/0000-0002-5103-6092; Khan, Waris/0000-0002-4286-5403; Ashraf, Muhammad Waqar/0000-0002-7087-9714				Abbasbandy S, 2012, MECCANICA, V47, P1379, DOI 10.1007/s11012-011-9520-3; [Anonymous], 2008, LETTURE CLASSENSI, VXXXVII, P119; Ashwinkumar GP, 2021, HEAT TRANSF, V50, P1679, DOI 10.1002/htj.21947; Dinarvand S, 2019, J THERM ANAL CALORIM, V138, P845, DOI 10.1007/s10973-019-08127-6; Fereidoon A, 2011, APPL HOMOTOPY PERTUR, V2011, DOI [10.1166/jbn.2011.1319, DOI 10.1166/JBN.2011.1319]; Hatami M, 2014, J MOL LIQ, V194, P251, DOI 10.1016/j.molliq.2014.03.002; Hatamie A, 2015, LANGMUIR, V31, P10913, DOI 10.1021/acs.langmuir.5b02341; He JH, 2006, INT J MOD PHYS B, V20, P2561, DOI 10.1142/S0217979206034819; Jiang JH, 2018, BIOINORG CHEM APPL, V2018, DOI 10.1155/2018/1062562; Kezzar M, 2018, J APPL COMPUT MECH, V4, P352, DOI 10.22055/JACM.2018.24959.1221; Khan U, 2017, RESULTS PHYS, V7, P361, DOI 10.1016/j.rinp.2016.12.020; Koriko OK, 2020, ARAB J SCI ENG, V45, P455, DOI 10.1007/s13369-019-04223-9; Mabood F, 2021, J THERM ANAL CALORIM, V146, P227, DOI 10.1007/s10973-020-09943-x; Mahanthesh B, 2020, J THERM ANAL CALORIM, V141, P37, DOI 10.1007/s10973-019-08985-0; Makinde OD, 2018, INT J NONLIN SCI NUM, V19, P93, DOI 10.1515/ijnsns-2016-0087; Mishra PK, 2017, DRUG DISCOV TODAY, V22, P1825, DOI 10.1016/j.drudis.2017.08.006; Mohyud-Din ST, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814016637318; Newman MD, 2009, J AM ACAD DERMATOL, V61, P685, DOI 10.1016/j.jaad.2009.02.051; Oketch Ochieng F, 2018, HYDROMAGNETIC JEFFER, V14, P1101; Rashid U., 2020, ADV NANOPARTICLES, V9, P23, DOI [10.4236/anp.2020.91002, DOI 10.4236/ANP.2020.91002]; Registered W, 2 DIMENSIONAL STEADY, P37, DOI [10.1080/14786440408635327, DOI 10.1080/14786440408635327]; Ruszkiewicz AJA, 2017, TOXICOL REPORTS, DOI [10.1016/j.toxrep.2017.05.006, DOI 10.1016/J.T0XREP.2017.05.006]; Samrat SP, 2018, FRONT HEAT MASS TRAN, V10, DOI 10.5098/hmt.10.31; Shah NA, 2020, PHYS SCRIPTA, V95, DOI 10.1088/1402-4896/aba8c6; Smijs TG, 2011, NANOTECHNOL SCI APPL, V4, P95, DOI 10.2147/NSA.S19419; Tlili I, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61215-8; Wing M, 2019, WATER NANOFLUID FLAT, P1, DOI [10.1515/cppm-2019-0092, DOI 10.1515/CPPM-2019-0092]	27	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245208	10.1371/journal.pone.0245208	http://dx.doi.org/10.1371/journal.pone.0245208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444406	Green Published, gold			2022-12-26	WOS:000609988100005
J	Yoshioka, R; Imamura, H; Ichida, H; Gyoda, Y; Mizuno, T; Mise, Y; Saiura, A				Yoshioka, Ryuji; Imamura, Hiroshi; Ichida, Hirofumi; Gyoda, Yu; Mizuno, Tomoya; Mise, Yoshihiro; Saiura, Akio			Simulation training in pancreatico-jejunostomy using an inanimate biotissue model improves the technical skills of hepatobiliary-pancreatic surgical fellows	PLOS ONE			English	Article							OBJECTIVE STRUCTURED ASSESSMENT; HOSPITAL VOLUME; PERFORMANCE; MORTALITY; OUTCOMES; CANCER; IMPACT; OSATS	Background Technical proficiency of the operating surgeons is one of the most important factors in the safe performance of pancreaticoduodenectomy. The objective of the present study was to investigate whether surgical simulation of pancreatico-jejunostomy (PJ) using an inanimate biotissue model could improve the technical proficiency of hepato-biliary pancreatic (HBP) surgical fellows. Methods The biotissue drill consisted of sewing biotissues to simulate PJ. The drill was repeated a total of five times by each of the participant surgical fellows. The improvement of the surgical fellows' technical proficiency was evaluated by the supervisor surgeons using the Objective Structured Assessment of Technical Skills (OSATS) scale. Results Eight HBP surgical fellows completed all the 5 drills. Both the OSATS 25 score and OSATS summary score, assessed by the two supervisor surgeons, improved steadily with repeated execution of the PJ drill. The average OSATS score, as assessed by both the supervisor surgeons, improved significantly from the first to the final drill, with a P value of 0.003 and 0.014 for the assessment by the two surgeons, respectively. On the other hand, no chronological alteration was observed in time of procedure (P = 0.788). Conclusion Repeated execution of a biotissue PJ drill improved the HBP surgical fellows' technical proficiency, as evaluated by OSATS. The present study lends support to the evidence that simulation training can contribute to shortening of the time required to negotiate the learning curve for the technique of PJ in the actual operating room.	[Yoshioka, Ryuji; Imamura, Hiroshi; Ichida, Hirofumi; Gyoda, Yu; Mizuno, Tomoya; Mise, Yoshihiro; Saiura, Akio] Juntendo Univ, Dept Hepatobiliary Pancreat Surg, Grad Sch, Tokyo, Japan	Juntendo University	Saiura, A (corresponding author), Juntendo Univ, Dept Hepatobiliary Pancreat Surg, Grad Sch, Tokyo, Japan.	a-saiura@juntendo.ac.jp						Beane JD, 2021, ANN SURG, V274, pE355, DOI 10.1097/SLA.0000000000003628; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Birkmeyer JD, 2013, NEW ENGL J MED, V369, P1434, DOI 10.1056/NEJMsa1300625; Boone BA, 2015, JAMA SURG, V150, P416, DOI 10.1001/jamasurg.2015.17; Cameron JL, 2006, ANN SURG, V244, P10, DOI 10.1097/01.sla.0000217673.04165.ea; Datta V, 2004, J AM COLL SURGEONS, V199, P603, DOI 10.1016/j.jamcollsurg.2004.05.269; Fernandez-del Castillo C, 2012, SURGERY, V152, pS56, DOI 10.1016/j.surg.2012.05.022; Fisher WE, 2012, AM J SURG, V203, P684, DOI 10.1016/j.amjsurg.2011.05.006; Hogg ME, 2016, ANN SURG, V264, P482, DOI 10.1097/SLA.0000000000001862; Hoshijima H, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017712; Kawakatsu S, 2018, BMC SURG, V18, DOI 10.1186/s12893-018-0420-5; Kim CG, 2012, WORLD J GASTROENTERO, V18, P4175, DOI 10.3748/wjg.v18.i31.4175; Lemmens VEPP, 2011, BRIT J SURG, V98, P1455, DOI 10.1002/bjs.7581; Martin JA, 1997, BRIT J SURG, V84, P273, DOI 10.1046/j.1365-2168.1997.02502.x; Niitsu H, 2013, SURG TODAY, V43, P271, DOI 10.1007/s00595-012-0313-7; Schmidt CM, 2010, ARCH SURG-CHICAGO, V145, P634, DOI 10.1001/archsurg.2010.118; Simunovic M, 2010, ANN SURG ONCOL, V17, P2537, DOI 10.1245/s10434-010-1114-0; Tam V, 2017, J SURG EDUC, V74, P1057, DOI 10.1016/j.jsurg.2017.05.016; Tseng JF, 2007, SURGERY, V141, P694, DOI 10.1016/j.surg.2007.04.001; van Hove PD, 2010, BRIT J SURG, V97, P972, DOI 10.1002/bjs.7115; Yoshioka R, 2014, BRIT J SURG, V101, P523, DOI 10.1002/bjs.9420	22	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0244915	10.1371/journal.pone.0244915	http://dx.doi.org/10.1371/journal.pone.0244915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439895	Green Published, gold			2022-12-26	WOS:000609985300024
J	Guang, AG; Howison, M; Zapata, F; Lawrence, C; Dunn, CW				Guang, August; Howison, Mark; Zapata, Felipe; Lawrence, Charles; Dunn, Casey W.			Revising transcriptome assemblies with phylogenetic information	PLOS ONE			English	Article							RNA-SEQ; DISTRIBUTIONS	A common transcriptome assembly error is to mistake different transcripts of the same gene as transcripts from multiple closely related genes. This error is difficult to identify during assembly, but in a phylogenetic analysis such errors can be diagnosed from gene phylogenies where they appear as clades of tips from the same species with improbably short branch lengths. treeinform is a method that uses phylogenetic information across species to refine transcriptome assemblies within species. It identifies transcripts of the same gene that were incorrectly assigned to multiple genes and reassign them as transcripts of the same gene. The treeinform method is implemented in Agalma, available at , and the general approach is relevant in a variety of other contexts.	[Guang, August] Brown Univ, Ctr Computat Biol Human Dis, Providence, RI 02912 USA; [Guang, August] Brown Univ, Ctr Computat & Visualizat, Providence, RI 02912 USA; [Howison, Mark] Res Improving Peoples Lives, Providence, RI USA; [Zapata, Felipe] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Lawrence, Charles] Brown Univ, Dept Appl Math, Providence, RI 02912 USA; [Dunn, Casey W.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	Brown University; Brown University; University of California System; University of California Los Angeles; Brown University; Yale University	Guang, AG (corresponding author), Brown Univ, Ctr Computat Biol Human Dis, Providence, RI 02912 USA.; Guang, AG (corresponding author), Brown Univ, Ctr Computat & Visualizat, Providence, RI 02912 USA.	august_guang@brown.edu		Dunn, Casey/0000-0003-0628-5150; Zapata, Felipe/0000-0002-9386-0573	National Sciences Foundation [DGE-0966060]; NSF [OCI-0725070, ACI-1238993]; NSF IGERT [DGE-0966060, P20GM109035]; National Institute of General Medical Sciences of the National Institutes of Health; COBRE Center for Computational Biology of Human Disease; Division of Ocean Sciences [OCE-1760838]	National Sciences Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NSF IGERT(National Science Foundation (NSF)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); COBRE Center for Computational Biology of Human Disease; Division of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by National Sciences Foundation grant DGE-0966060, the Blue Waters computing project (itself supported by NSF OCI-0725070 and ACI-1238993). AG was also supported in part by NSF IGERT (DGE-0966060) and Institutional Development Award Number P20GM109035 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds COBRE Center for Computational Biology of Human Disease. CL was supported by Division of Ocean Sciences grant OCE-1760838. This research was conducted using computational resources at the Brown Center for Computation and Visualization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschmied J, 2002, GENETICS, V161, P259; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2013, TEXTS STAT SCI SERIE; Boussau B, 2013, GENOME RES, V23, P323, DOI 10.1101/gr.141978.112; Conover W.J., 1981, J R STAT SOC A, DOI [10.2307/2981807, DOI 10.2307/2981807]; Davidson NM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0410-6; Dunn CW, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-330; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Ellegren H, 2016, NAT REV GENET, V17, P422, DOI 10.1038/nrg.2016.58; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Gernhard T, 2008, J THEOR BIOL, V253, P769, DOI 10.1016/j.jtbi.2008.04.005; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guang A, 2016, TRENDS ECOL EVOL, V31, P116, DOI 10.1016/j.tree.2015.12.007; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Han MV, 2013, MOL BIOL EVOL, V30, P1987, DOI 10.1093/molbev/mst100; Hsieh PH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44499-3; Iniguez LP, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00014; Koch NM, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1300-4; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Li B, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0553-5; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Munro C, 2018, MOL PHYLOGENET EVOL, V127, P823, DOI 10.1016/j.ympev.2018.06.030; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Spitzer M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-110; Talavera D, 2007, PLOS COMPUT BIOL, V3, P375, DOI 10.1371/journal.pcbi.0030033; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077; Yang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-328; Young DS, 2019, ADV DATA ANAL CLASSI, V13, P1053, DOI 10.1007/s11634-019-00361-y	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0244202	10.1371/journal.pone.0244202	http://dx.doi.org/10.1371/journal.pone.0244202			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434218	Green Published, gold			2022-12-26	WOS:000609979700013
J	Mandereau-Bruno, L; Leger, D; Delmas, MC				Mandereau-Bruno, Laurence; Leger, Damien; Delmas, Marie-Christine			Obstructive sleep apnea: A sharp increase in the prevalence of patients treated with nasal CPAP over the last decade in France	PLOS ONE			English	Article							POPULATION; GENDER	Introduction Obstructive sleep apnea (OSA) is a frequent condition. In the absence of treatment, OSA is associated with a higher risk of traffic accidents and a large variety of diseases. The objectives of this study were to describe the characteristics of patients treated for OSA in France and assess the time trends in treatment. Methods The French National Health Data System is an individual database with data on all healthcare reimbursements for the entire French population. Based on this database, we included all patients aged 20 years or over who were treated with continuous positive airway pressure (CPAP) or mandibular advancement splint (MAS) between 2009 and 2018. Negative binomial models, adjusted for age, were used to assess time trends in treatment prevalence and incidence rates. Results In 2017, 2.3% of French adults aged >= 20 years were treated with CPAP (men: 3.3%; women: 1.3%). The highest prevalence was observed in people aged 70-74 years (5.0%). From 2009 to 2018, the annual prevalence of CPAP increased 3-fold and the annual incidence 1.9-fold. During the same period, the rate of patients reimbursed for MAS (first prescription or renewal) was multiplied by 7.6. The proportion of patients treated with CPAP in 2017 who were no longer treated in the subsequent year was 6.9%. Discussion The sharp increase in the incidence of OSA treatment probably reflects a better recognition of the disease in France. However, the prevalence of OSA treatment remains lower than expected based on the international literature. Further studies are needed to identify the obstacles to an optimal management of individuals with OSA in France.	[Mandereau-Bruno, Laurence; Delmas, Marie-Christine] French Natl Publ Hlth Agcy, Sante Publ France, St Maurice, France; [Leger, Damien] Univ Paris, EA 7330 VIFASOM, Paris, France; [Leger, Damien] Univ Paris, APHP Hotel Dieu, Ctr Sommeil & Vigilance, Paris, France	Institute of Public Health Surveillance; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Delmas, MC (corresponding author), French Natl Publ Hlth Agcy, Sante Publ France, St Maurice, France.	marie-christine.delmas@santepubliquefrance.fr		DELMAS, Marie-Christine/0000-0001-6415-3899				[Anonymous], 2013, REV EUR STAND POP RE; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Fuentes S, 2020, DIABETES METAB, V46, P472, DOI 10.1016/j.diabet.2019.12.006; Fuhrman C, 2012, SLEEP MED, V13, P852, DOI 10.1016/j.sleep.2012.04.005; Giskes K, 2008, OBESITY, V16, P1377, DOI 10.1038/oby.2008.54; Guglielmi O, 2019, SLEEP MED, V57, P100, DOI 10.1016/j.sleep.2019.01.042; Haute Autorite de sante, 2014, REV CAT HOM DISP MED; Heinzer R, 2015, LANCET RESP MED, V3, P310, DOI 10.1016/S2213-2600(15)00043-0; Institut national de la sante et de la recherche medicale Kantar Health Roche Sas, 2012, OBEPI 2012 ENQ NAT S; Javaheri S, 2017, J AM COLL CARDIOL, V69, P841, DOI 10.1016/j.jacc.2016.11.069; Kapsimalis F, 2002, SLEEP, V25, P412; Mandereau-Bruno L., 2017, Bulletin Epidemiologique Hebdomadaire, P586; McIsaac DI, 2015, ANESTHESIOLOGY, V123, P253, DOI 10.1097/ALN.0000000000000692; Myers KA, 2013, JAMA-J AM MED ASSOC, V310, P731, DOI 10.1001/jama.2013.276185; Namen AM, 2016, ANN AM THORAC SOC, V13, P2027, DOI 10.1513/AnnalsATS.201603-152OC; REDLINE S, 1994, AM J RESP CRIT CARE, V149, P722, DOI 10.1164/ajrccm.149.3.8118642; Reutrakul S, 2017, CHEST, V152, P1070, DOI 10.1016/j.chest.2017.05.009; Rey G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-33; Richard JB, 2015, RESULTATS DETAILLES; Rotenberg BW, 2016, J OTOLARYNGOL-HEAD N, V45, DOI 10.1186/s40463-016-0156-0; Senaratna CV, 2017, SLEEP MED REV, V34, P70, DOI 10.1016/j.smrv.2016.07.002; Societe de Pneumologie de Langue Francaise SocieteFrancaise d'Anesthesie Reanimation Societe Francaise deCardiologie SFdMdT Societe Francaise d'ORL, 2010, REV MAL RESPIR, V27, P806; Thornton JD, 2010, SLEEP, V33, P1255, DOI 10.1093/sleep/33.9.1255; Tufik S, 2010, SLEEP MED, V11, P441, DOI 10.1016/j.sleep.2009.10.005; Tuppin P, 2017, REV EPIDEMIOL SANTE, V65, pS149, DOI 10.1016/j.respe.2017.05.004; Verdot C., 2017, B EPID MIOL HEBDOMAD, V13, P234; Vernay M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-215; Wickwire EM, 2020, SLEEP, V43, DOI 10.1093/sleep/zsaa122; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 2002, ARCH INTERN MED, V162, P893, DOI 10.1001/archinte.162.8.893; Young Terry, 2009, WMJ, V108, P246	33	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245392	10.1371/journal.pone.0245392	http://dx.doi.org/10.1371/journal.pone.0245392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434230	Green Published, gold			2022-12-26	WOS:000609979700048
J	Rees-Punia, E; Guinter, MA; Gapstur, SM; Wang, Y; Patel, AV				Rees-Punia, Erika; Guinter, Mark A.; Gapstur, Susan M.; Wang, Ying; Patel, Alpa, V			Composition of time in movement behaviors and weight change in Latinx, Black and white participants	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; SLEEP DURATION; OBESITY; PREVENTION; GAIN; FITNESS; ADULTS; RISK	Background The relationship between time-use behaviors and prospective weight change is poorly understood. Methods A subset of Cancer Prevention Study-3 participants (n = 549, 58% women, 66% non-Latinx white) self-reported weight in 2015 and 2018 and completed an accelerometer protocol for seven days. Sedentary time, sleep, light, moderate, and vigorous intensity physical activity (PA) were treated as a compositional variable and multiple linear regression was used to examine associations between activity composition and weight change stratified by sex and race/ethnicity. Compositional isotemporal substitution analysis was used to quantify change in weight associated with reallocating 30 min./day. Results Activity composition was associated with weight change among women (p = 0.007), but not men (p = 0.356), and among Latinx (p = 0.032) and white participants (p = 0.001), but not Black participants (p = 0.903). Replacement of 30 min./day sedentary time with moderate-vigorous PA was associated with 3.49 lbs. loss (-6.76, -0.22) in Latinx participants and replacement with sleep was associated with 1.52 (0.25, 2.79) and 1.31 (0.40, 2.21) lbs. gain in white women and men. Conclusion The distribution of time spent in daily behaviors was associated with three-year weight change in women, Latinx, and white participants. This was the first longitudinal compositional study of weight change; thus, more studies are needed.	[Rees-Punia, Erika; Guinter, Mark A.; Gapstur, Susan M.; Wang, Ying; Patel, Alpa, V] Amer Canc Soc, Atlanta, GA 30329 USA	American Cancer Society	Rees-Punia, E (corresponding author), Amer Canc Soc, Atlanta, GA 30329 USA.	Erika.Rees-Punia@cancer.org	Rees-Punia, Erika/GRO-3693-2022	Rees-Punia, Erika/0000-0003-1121-1578	American Cancer Society (ACS)	American Cancer Society (ACS)(American Cancer Society)	The American Cancer Society (ACS) funds the creation, maintenance, and updating of the Cancer Prevention Study-3. The authors confirm that some access restrictions apply to the data underlying thefindings. Data are from the Cancer Prevention Study 3 and are available from the American Cancer Society by following the ACS Data Access Procedures (https://www.cancer.org/content/dam/cancer-org/research/epidemiology/cancer-prevention-study-data-access-policies.pdf) for researchers who meet the criteria for access to confidential data. Requests may be sent to Alpa V. Patel, PhD.	AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139; Anderson RL, 2019, RELIABILITY VALIDITY, V2, P157; Boogaart Kg, 2014, COMPOSITIONS COMPOSI; Carson V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4852-0; Chastin SFM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139984; Choi L, 2012, MED SCI SPORT EXER, V44, P2009, DOI 10.1249/MSS.0b013e318258cb36; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Chomistek AK, 2016, J PHYS ACT HEALTH, V13, P416, DOI 10.1123/jpah.2015-0152; Dumuid D, 2018, MATURITAS, V110, P104, DOI 10.1016/j.maturitas.2018.02.003; Dumuid D, 2018, STAT METHODS MED RES, V27, P3726, DOI 10.1177/0962280217710835; Fairclough Stuart J, 2018, Prev Med Rep, V11, P254, DOI 10.1016/j.pmedr.2018.07.011; Fairclough SJ, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0521-z; Heinonen I, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002901; Hodge JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231229; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Jakicic JM, 2019, MED SCI SPORT EXER, V51, P1262, DOI 10.1249/MSS.0000000000001938; Leite MLC, 2016, STAT METHODS MED RES, V25, P3057, DOI 10.1177/0962280214560047; Lyden K, 2014, MED SCI SPORT EXER, V46, P386, DOI 10.1249/MSS.0b013e3182a42a2d; Mekary RA, 2009, INT J OBESITY, V33, P1039, DOI 10.1038/ijo.2009.127; Okely AD, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4867-6; Patel AV, 2017, CANCER-AM CANCER SOC, V123, P2014, DOI 10.1002/cncr.30561; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Pedisic Z, 2017, KINESIOLOGY, V49, P252; Rees-Punia E, 2019, MED SCI SPORT EXER, V51, P41, DOI 10.1249/MSS.0000000000001743; Rosenberg L, 2013, AM J PREV MED, V45, P262, DOI 10.1016/j.amepre.2013.04.016; Smith PF, 2016, J NEUROSCI METH, V271, P154, DOI 10.1016/j.jneumeth.2016.07.008; Talarico R, 2018, INT J OBESITY, V42, P1508, DOI 10.1038/s41366-018-0053-x; Tremblay MS, 2016, APPL PHYSIOL NUTR ME, V41, pIII, DOI [10.1139/apnm-2016-0203, 10.1139/apnm-2016-0151]; Tsilimigras MCB, 2016, ANN EPIDEMIOL, V26, P330, DOI 10.1016/j.annepidem.2016.03.002; Yuan CZ, 2018, AM J EPIDEMIOL, V187, P1051, DOI 10.1093/aje/kwx328	30	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0244566	10.1371/journal.pone.0244566	http://dx.doi.org/10.1371/journal.pone.0244566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4OF	33417624	Green Published, gold			2022-12-26	WOS:000630020100010
J	Yan, HH; Ren, ZC; Deng, D; Yang, KH; Yang, C; Zhou, PP; Wight, CP; Ren, CZ; Peng, YY				Yan, Honghai; Ren, Zichao; Deng, Di; Yang, Kehan; Yang, Chuang; Zhou, Pingping; Wight, Charlene P.; Ren, Changzhong; Peng, Yuanying			New evidence confirming the CD genomic constitutions of the tetraploid Avena species in the section Pachycarpa Baum	PLOS ONE			English	Article								The tetraploid Avena species in the section Pachycarpa Baum, including A. insularis, A. maroccana, and A. murphyi, are thought to be involved in the evolution of hexaploid oats; however, their genome designations are still being debated. Repetitive DNA sequences play an important role in genome structuring and evolution, so understanding the chromosomal organization and distribution of these sequences in Avena species could provide valuable information concerning genome evolution in this genus. In this study, the chromosomal organizations and distributions of six repetitive DNA sequences (including three SSR motifs (TTC, AAC, CAG), one 5S rRNA gene fragment, and two oat A and C genome specific repeats) were investigated using non-denaturing fluorescence in situ hybridization (ND-FISH) in the three tetraploid species mentioned above and in two hexaploid oat species. Preferential distribution of the SSRs in centromeric regions was seen in the A and D genomes, where as few signals were detected in the C genomes. Some intergenomic translocations were observed in the tetraploids; such translocations were also detected between the C and D genomes in the hexaploids. These results provide robust evidence for the presence of the D genome in all three tetraploids, strongly suggesting that the genomic constitution of these species is DC and not AC, as had been thought previously.	[Yan, Honghai; Ren, Zichao; Deng, Di; Yang, Kehan; Yang, Chuang; Zhou, Pingping; Peng, Yuanying] Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Peoples R China; [Wight, Charlene P.] Agr & Agri Food Canada, Ottawa Res & Dev Ctr, Ottawa, ON, Canada; [Ren, Changzhong] Baicheng Acad Agr Sci, Baicheng, Peoples R China	Sichuan Agricultural University; Agriculture & Agri Food Canada	Peng, YY (corresponding author), Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Peoples R China.	yy.peng@hotmail.com		Peng, Yuanying/0000-0002-3304-3301	National Natural Science Foundation of China [32072025, 31801430]; Sichuan International (Hong Kong/Macao/Taiwan) Innovation Cooperation in Science and Technology [2019YFH0125]; Jilin Scientific and Technological Development Program [20200402034NC]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan International (Hong Kong/Macao/Taiwan) Innovation Cooperation in Science and Technology; Jilin Scientific and Technological Development Program	This work was financially supported by the National Natural Science Foundation of China (Grant No. 32072025, 31801430), Sichuan International (Hong Kong/Macao/Taiwan) Innovation Cooperation in Science and Technology (Grant No. 2019YFH0125) and Jilin Scientific and Technological Development Program (Grant No. 20200402034NC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum B.R., 1977, MONOGRAPH GENUS AVEN; Cai ZX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1025; Carmona A, 2013, THEOR APPL GENET, V126, P949, DOI 10.1007/s00122-012-2028-y; Chew P, 2016, THEOR APPL GENET, V129, P1405, DOI 10.1007/s00122-016-2712-4; Coffman F.A., 1977, OAT HIST IDENTIFICAT, VVolume 1516; Cuadrado A, 1998, CHROMOSOMA, V107, P587, DOI 10.1007/s004120050345; Cuadrado A, 2007, CHROMOSOME RES, V15, P711, DOI 10.1007/s10577-007-1156-8; Cuadrado A, 2010, CHROMOSOMA, V119, P495, DOI 10.1007/s00412-010-0273-x; Dou QW, 2016, COMP CYTOGENET, V10, P465, DOI 10.3897/CompCytogen.v10i4.9666; FOMINAYA A, 1988, GENOME, V30, P633, DOI 10.1139/g88-107; Fu SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10552; Fu Y., 2018, SCI REP-UK, V8, P4245, DOI [10.1038/s41598-018-20586-9, DOI 10.1038/S41598-018-20586-9]; GERLACH WL, 1980, NUCLEIC ACIDS RES, V8, P4851, DOI 10.1093/nar/8.21.4851; JELLEN EN, 1994, GENOME, V37, P613, DOI 10.1139/g94-087; JELLEN EN, 1993, GENOME, V36, P1129, DOI 10.1139/g93-151; Jellen EN, 2000, GENET RESOUR CROP EV, V47, P227, DOI 10.1023/A:1008769105071; Kolano B, 2011, GENOME, V54, P710, DOI 10.1139/G11-035; Komuro S, 2013, GENOME, V56, P131, DOI 10.1139/gen-2013-0003; Ladizinsky, 2012, STUDIES OAT EVOLUTIO; Ladizinsky G, 1998, GENET RESOUR CROP EV, V45, P263, DOI 10.1023/A:1008657530466; LADIZINSKY G, 1971, EUPHYTICA, V20, P380, DOI 10.1007/BF00035663; Leggett JM, 1994, CHROMOSOME RES, V2, P163, DOI 10.1007/BF01553495; LEGGETT JM, 1995, OAT CROP PRODUCTION; Li CD, 2000, CROP SCI, V40, P1755, DOI 10.2135/cropsci2000.4061755x; Linares C, 1998, P NATL ACAD SCI USA, V95, P12450, DOI 10.1073/pnas.95.21.12450; Liu Q, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1769-z; Liu Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep41944; Loskutov IG, 2001, RUSS J GENET+, V37, P467, DOI 10.1023/A:1016697812009; Luo XM, 2018, ACTA PHYSIOL PLANT, V40, DOI 10.1007/s11738-018-2721-9; Luo XM, 2018, GENET RESOUR CROP EV, V65, P1625, DOI 10.1007/s10722-018-0639-0; Luo XM, 2018, GENOME, V61, P63, DOI 10.1139/gen-2017-0132; Mehrotra Shweta, 2014, Genomics Proteomics & Bioinformatics, V12, P164, DOI 10.1016/j.gpb.2014.07.003; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Oliver RE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058068, 10.1371/journal.pone.0062488]; Peng YY, 2008, GENOME, V51, P137, DOI [10.1139/G07-111, 10.1139/g07-111]; Peng YY, 2010, THEOR APPL GENET, V121, P985, DOI 10.1007/s00122-010-1367-9; Peng YY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200047; RAJHATHY T, 1972, NATURE-NEW BIOL, V239, P217, DOI 10.1038/newbio239217a0; Sanz MJ, 2010, THEOR APPL GENET, V121, P1541, DOI 10.1007/s00122-010-1409-3; Shelukhina OY, 2007, RUSS J GENET+, V43, P613, DOI 10.1134/S102279540706004X; SOLANO R, 1992, THEOR APPL GENET, V83, P602, DOI 10.1007/BF00226904; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Wang K, 2012, THEOR APPL GENET, V124, P1173, DOI 10.1007/s00122-011-1777-3; Xi W, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20082031; Yan HH, 2014, GENOME, V57, P267, DOI 10.1139/gen-2014-0075; Yan HH, 2016, THEOR APPL GENET, V129, P2133, DOI 10.1007/s00122-016-2762-7; Yan HH, 2016, GENOME, V59, P209, DOI 10.1139/gen-2015-0132; Zhang HK, 2014, PLANT CELL, V26, P2761, DOI 10.1105/tpc.114.128439; Zhao X, 2011, J GENET GENOMICS, V38, P39, DOI 10.1016/j.jcg.2010.12.005; Zheng JS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01049; Zhou PingPing, 2019, Acta Agronomica Sinica, V45, P1604, DOI 10.3724/SP.J.1006.2019.81091; Zimmer CM, 2018, EUPHYTICA, V214, DOI 10.1007/s10681-018-2182-7	52	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0240703	10.1371/journal.pone.0240703	http://dx.doi.org/10.1371/journal.pone.0240703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4OF	33417607	gold, Green Published			2022-12-26	WOS:000630020100001
J	Quintero-Barceinas, RS; Gehringer, F; Ducker, C; Saxton, J; Shaw, PE				Quintero-Barceinas, Reyna Sara; Gehringer, Franziska; Ducker, Charles; Saxton, Janice; Shaw, Peter E.			ELK-1 ubiquitination status and transcriptional activity are modulated independently of F-Box protein FBXO25	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERK PHOSPHORYLATION; ACTIVATION; SRF; EXPRESSION; PROMOTES; USP17	The mitogen-responsive, ETS-domain transcription factor ELK-1 stimulates the expression of immediate early genes at the onset of the cell cycle and participates in early developmental programming. ELK-1 is subject to multiple levels of posttranslational control, including phosphorylation, SUMOylation, and ubiquitination. Recently, removal of monoubiquitin from the ELK-1 ETS domain by the Ubiquitin Specific Protease USP17 was shown to augment ELK-1 transcriptional activity and promote cell proliferation. Here we have used coimmunoprecipitation experiments, protein turnover and ubiquitination assays, RNA-interference and gene expression analyses to examine the possibility that USP17 acts antagonistically with the F-box protein FBXO25, an E3 ubiquitin ligase previously shown to promote ELK-1 ubiquitination and degradation. Our data confirm that FBXO25 and ELK-1 interact in HEK293T cells and that FBXO25 is active toward Hand1 and HAX1, two of its other candidate substrates. However, our data indicate that FBXO25 neither promotes ubiquitination of ELK-1 nor impacts on its transcriptional activity and suggest that an E3 ubiquitin ligase other than FBXO25 regulates ELK-1 ubiquitination and function.	[Quintero-Barceinas, Reyna Sara; Gehringer, Franziska; Ducker, Charles; Saxton, Janice; Shaw, Peter E.] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Transcript & Signal Transduct Lab, Nottingham, England; [Gehringer, Franziska] Univ Ulm, Ulm, Germany	University of Nottingham; Ulm University	Shaw, PE (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Life Sci, Transcript & Signal Transduct Lab, Nottingham, England.	peter.shaw1@nottingham.ac.uk		Ducker, Charles/0000-0003-0323-5983	Conacyt fellowship; Erasmus fellowship; BBSRC-DTP studentship [BB/D526602/1]	Conacyt fellowship(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Erasmus fellowship; BBSRC-DTP studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	D This work was supported by a Conacyt fellowship to R. Q. B., an Erasmus fellowship to F. G., and a BBSRC-DTP studentship to C. D. (grant number BB/D526602/1).	Baumann U, 2014, NAT MED, V20, P1401, DOI 10.1038/nm.3740; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; Ducker C, 2021, INT J BIOCHEM CELL B, V130, DOI 10.1016/j.biocel.2020.105886; Ducker C, 2019, NUCLEIC ACIDS RES, V47, P4495, DOI 10.1093/nar/gkz166; Esnault C, 2017, MOL CELL, V65, P1081, DOI 10.1016/j.molcel.2017.02.005; Evans EL, 2011, NUCLEIC ACIDS RES, V39, P6390, DOI 10.1093/nar/gkr266; Galbraith MD, 2013, NUCLEIC ACIDS RES, V41, P10241, DOI 10.1093/nar/gkt837; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Goke J, 2013, MOL CELL, V50, P844, DOI 10.1016/j.molcel.2013.04.030; Gualdrini F, 2016, MOL CELL, V64, P1048, DOI 10.1016/j.molcel.2016.10.016; Hagens O, 2006, BBA-GEN SUBJECTS, V1760, P110, DOI 10.1016/j.bbagen.2005.09.018; Jang JW, 2011, BIOCHEM BIOPH RES CO, V410, P183, DOI 10.1016/j.bbrc.2011.05.011; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Maragno ALGC, 2006, BBA-GEN SUBJECTS, V1760, P966, DOI 10.1016/j.bbagen.2006.03.020; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; McFarlane C, 2010, CANCER RES, V70, P3329, DOI 10.1158/0008-5472.CAN-09-4152; Nentwich O, 2009, DEV BIOL, V336, P313, DOI 10.1016/j.ydbio.2009.09.039; Rizzo F, 2016, DEV BIOL, V416, P173, DOI 10.1016/j.ydbio.2016.05.026; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Teixeira FR, 2013, J BIOL CHEM, V288, P28152, DOI 10.1074/jbc.M113.504308; Teixeira FR, 2010, PROTEOMICS, V10, P2746, DOI 10.1002/pmic.200900419; van der Laan S, 2013, MOL CELL, V52, P366, DOI 10.1016/j.molcel.2013.10.003; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005	26	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100214	10.1074/jbc.RA120.014616	http://dx.doi.org/10.1074/jbc.RA120.014616			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33428929	Green Published, gold			2022-12-26	WOS:000672866400192
J	Fouad, SA; Malaak, FA; El-Nabarawi, MA; Abu Zeid, K; Ghoneim, AM				Fouad, Shahinaze A.; Malaak, Fady A.; El-Nabarawi, Mohamed A.; Abu Zeid, Khalid; Ghoneim, Amira M.			Preparation of solid dispersion systems for enhanced dissolution of poorly water soluble diacerein: In-vitro evaluation, optimization and physiologically based pharmacokinetic modeling	PLOS ONE			English	Article							PHYSICOCHEMICAL PROPERTIES; FORMULATION; SOLUBILITY; PREDICTION; BIOAVAILABILITY; SUBSTANCE; IBUPROFEN; NAPROXEN; IMPROVE; LIVER	Diacerein (DCN), a BCS II compound, suffers from poor aqueous solubility and limited bioavailability. Solid dispersion systems (SD) of DCN were prepared by solvent evaporation, using hydrophilic polymers. In-vitro dissolution studies were performed and dissolution parameters were evaluated. I-Optimal factorial design was employed to study the effect of formulation variables (drug:polymer ratio and polymer type) on the measured responses including; drug content (DC) (%), dissolution efficiency at 15 min (DE ((15 min))%) and 60 min (DE ((60 min))%) and mean dissolution time (MDT) (min). The optimized SD was selected, prepared and evaluated, allowing 10.83 and 3.42 fold increase in DE ((15 min))%, DE ((60 min))%, respectively and 6.07 decrease in MDT, compared to plain drug. DSC, XRD analysis and SEM micrographs confirmed complete amorphization of DCN within the optimized SD. Physiologically based pharmacokinetic (PBPK) modeling was employed to predict PK parameters of DCN in middle aged healthy adults and geriatrics. Simcyp((R)) software established in-vivo plasma concentration time curves of the optimized SD, compared to plain DCN. Relative bioavailability of the optimized SD compared to plain drug was 229.52% and 262.02% in healthy adults and geriatrics, respectively. Our study reports the utility of PBPK modeling for formulation development of BCS II APIs, via predicting their oral bio-performance.	[Fouad, Shahinaze A.; Malaak, Fady A.; Abu Zeid, Khalid] Ahram Canadian Univ, Fac Pharm, Dept Pharmaceut, Giza, Egypt; [El-Nabarawi, Mohamed A.] Cairo Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Cairo, Egypt; [Ghoneim, Amira M.] Future Univ Egypt, Fac Pharmaceut Sci & Pharmaceut Ind, Dept Pharmaceut & Pharmaceut Technol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Future University in Egypt	Fouad, SA (corresponding author), Ahram Canadian Univ, Fac Pharm, Dept Pharmaceut, Giza, Egypt.	shahinazeamry9@gmail.com		, Shahinaze Amry Aly Fouad/0000-0001-8980-4619; Adel Malaak, Fady/0000-0002-3774-5714				Beloica S, 2015, EUR J PHARM SCI, V75, P151, DOI 10.1016/j.ejps.2015.03.027; BETTINETTI GP, 1992, THERMOCHIM ACTA, V199, P165, DOI 10.1016/0040-6031(92)80260-4; Biswal S, 2009, TROP J PHARM RES, V8, P417; Biswal S, 2009, AAPS PHARMSCITECH, V10, P329, DOI 10.1208/s12249-009-9212-7; Bolourchian N, 2013, IRAN J PHARM RES, V12, P9; Charoenchaitrakool M, 2000, IND ENG CHEM RES, V39, P4794, DOI 10.1021/ie000151a; Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1; Dangprasirt P, 1998, DRUG DEV IND PHARM, V24, P947, DOI 10.3109/03639049809097274; Doshi DH, 1997, DRUG DEV IND PHARM, V23, P1167, DOI 10.3109/03639049709146154; El-nawawy T., 2012, INT J NOVEL DRUG DEL, V2, P297; Ellison CA, 2020, REGUL TOXICOL PHARM, V114, DOI 10.1016/j.yrtph.2020.104667; Elsayed I, 2014, INT J NANOMED, V9, P2943, DOI 10.2147/IJN.S63395; Fabian E, 2019, ARCH TOXICOL, V93, P401, DOI 10.1007/s00204-018-2372-z; Flood J, 2010, AM J MANAG CARE, V16, pS48; Fouad SA, 2018, DRUG DEV IND PHARM, V44, P1443, DOI 10.1080/03639045.2018.1459675; Frank KJ, 2012, INT J NANOMED, V7, P5757, DOI 10.2147/IJN.S36571; Ghoneim AM, 2020, DRUG DES DEV THER, V14, P1469, DOI 10.2147/DDDT.S246229; Grant N, 2011, J COLLOID INTERF SCI, V356, P573, DOI 10.1016/j.jcis.2011.01.056; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Huang YB, 2004, EUR J PHARM BIOPHARM, V58, P607, DOI 10.1016/j.ejpb.2004.03.037; Jamei M, 2009, EXPERT OPIN DRUG MET, V5, P211, DOI [10.1517/17425250802691074, 10.1517/17425250802691074 ]; Jones B, 2012, J QUAL TECHNOL, V44, P85, DOI 10.1080/00224065.2012.11917886; Kaur D, 2018, BRAZ J PHARM SCI, V54, DOI 10.1590/s2175-97902018000417534; KHAN KA, 1975, J PHARM PHARMACOL, V27, P48, DOI 10.1111/j.2042-7158.1975.tb09378.x; Kilicarslan M, 2003, INT J PHARM, V252, P99, DOI 10.1016/S0378-5173(02)00630-0; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Klotz U, 2009, DRUG METAB REV, V41, P67, DOI 10.1080/03602530902722679; Knopp MM, 2015, J PHARM SCI-US, V104, P2905, DOI 10.1002/jps.24410; Konno H, 2008, PHARM RES, V25, P969, DOI 10.1007/s11095-007-9331-3; Kostewicz ES, 2014, EUR J PHARM SCI, V57, P300, DOI 10.1016/j.ejps.2013.09.008; Kovar L, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12060578; Kumar SGV, 2006, YAKUGAKU ZASSHI, V126, P657, DOI 10.1248/yakushi.126.657; Li DX, 2010, BIOL PHARM BULL, V33, P279, DOI 10.1248/bpb.33.279; Lin YJ, 2020, J HAZARD MATER, V399, DOI 10.1016/j.jhazmat.2020.122856; Louthrenoo W, 2019, CLIN RHEUMATOL, V38, P2461, DOI 10.1007/s10067-019-04587-1; MAGNARD O, 1993, BIOPHARM DRUG DISPOS, V14, P401, DOI 10.1002/bdd.2510140506; Mura P, 1996, DRUG DEV IND PHARM, V22, P909, DOI 10.3109/03639049609065920; Nguyen G, 2017, MAHIDOL U J PHARM SC, V44, P32; Nicolas P, 1998, CLIN PHARMACOKINET, V35, P347, DOI 10.2165/00003088-199835050-00002; Paradkar A, 2004, INT J PHARM, V271, P281, DOI 10.1016/j.ijpharm.2003.11.014; Parekh KK, 2017, INT J PHARM SCI RES, V8, P1643, DOI 10.13040/IJPSR.0975-8232.8(4).1643-53; Parrott N, 2005, BASIC CLIN PHARMACOL, V96, P193, DOI 10.1111/j.1742-7843.2005.pto960308.x; Reddy VP, 2018, DRUG METAB DISPOS, V46, P1259, DOI 10.1124/dmd.118.080648; Rhee SJ, 2017, EUR J DRUG METAB PH, V42, P973, DOI 10.1007/s13318-017-0418-x; Riekes MK, 2010, MAT SCI ENG C-MATER, V30, P1008, DOI 10.1016/j.msec.2010.05.001; Rioux N, 2016, DRUG METAB DISPOS, V44, P934, DOI 10.1124/dmd.115.068031; Rowland M, 2011, ANNU REV PHARMACOL, V51, P45, DOI 10.1146/annurev-pharmtox-010510-100540; SEKIZAKI H, 1995, CHEM PHARM BULL, V43, P988; Shamma RN, 2018, J DRUG DELIV SCI TEC, V43, P343, DOI 10.1016/j.jddst.2017.10.023; Shin SC, 1998, INT J PHARM, V175, P17, DOI 10.1016/S0378-5173(98)00260-9; Soliman MS, 2005, PHARMAZIE, V60, P288; Teaima M, 2020, DRUG DES DEV THER, V14, P2741, DOI 10.2147/DDDT.S258571; Turhan KN, 2001, J FOOD SCI, V66, P59, DOI 10.1111/j.1365-2621.2001.tb15581.x; Van den Berg WB, 2004, PRESSE MED, V33, pS10; Verscheijden LFM, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007117; Watt Fiona E, 2017, Eur Med J Rheumatol, V2, P50; Wojcik-Pastuszka D, 2019, MATERIALS, V12, DOI 10.3390/ma12081202; Wu K, 2009, J PHARM SCI-US, V98, P2422, DOI 10.1002/jps.21598; Yamashita K, 2003, INT J PHARMACEUT, V267, P79, DOI 10.1016/j.ijpharm.2003.07.010; Yang XD, 2016, TROP J PHARM RES, V15, P1123, DOI 10.4314/tjpr.v15i6.2; Yi T, 2008, EUR J PHARM BIOPHARM, V70, P439, DOI 10.1016/j.ejpb.2008.05.001; Zaki RM., 2013, INT J DRUG DELIVERY, V5, P99; Zhang Y, 2010, AAPS J, V12, P263, DOI 10.1208/s12248-010-9185-1	63	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245482	10.1371/journal.pone.0245482	http://dx.doi.org/10.1371/journal.pone.0245482			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471832	Green Published, gold			2022-12-26	WOS:000639428800011
J	Jatsch, AS; Ruther, J				Jatsch, Anne-Sophie; Ruther, Joachim			Acetone application for administration of bioactive substances has no negative effects on longevity, fitness, and sexual communication in a parasitic wasp	PLOS ONE			English	Article							JUVENILE-HORMONE; INSECTICIDAL ACTIVITY; NASONIA-VITRIPENNIS; PHEROMONE PRODUCTION; ESSENTIAL OIL; SUBLETHAL; FEMALES; BIOSYNTHESIS; DOPAMINE; HYDROCARBONS	Administration of defined amounts of bioactive substances is a perseverative problem in physiological studies on insects. Apart from feeding and injection, topical application of solutions of the chemicals is most commonly used for this purpose. The solvents used should be non-toxic and have least possible effects on the studied parameters. Acetone is widely used for administration of chemical substances to insects, but possible side-effects of acetone application on fitness and behavioral parameters have been rarely investigated. Here we study the effects of acetone application (207 nl) on fitness and sexual communication in the parasitic wasp Nasonia giraulti Darling. Application of acetone had neither negative effects on longevity nor on offspring number and offspring sex ratio of treated wasps. Treatment of females hampered courtship and mating of N. giraulti couples neither directly after application nor one day after. Male sex pheromone titers were not influenced by acetone treatment. Three application examples demonstrate that topical acetone application is capable of bringing active amounts of insect hormones, neuromodulators, and biosynthetic precursors even in tiny insects. We advocate the use of acetone as a convenient, conservative, and broadly applicable vehicle for studying the effects of bioactive substances in insects.	[Jatsch, Anne-Sophie; Ruther, Joachim] Univ Regensburg, Inst Zool, Regensburg, Germany	University of Regensburg	Ruther, J (corresponding author), Univ Regensburg, Inst Zool, Regensburg, Germany.	joachim.ruther@ur.de		Ruther, Joachim/0000-0002-1295-347X; Jatsch, Anne-Sophie/0000-0002-2075-1325				Abdel-Latief M, 2008, P NATL ACAD SCI USA, V105, P8914, DOI 10.1073/pnas.0801559105; Abramson CI, 2015, ALCOHOL, V49, P245, DOI 10.1016/j.alcohol.2015.02.005; ADAMS TS, 1984, J INSECT PHYSIOL, V30, P287, DOI 10.1016/0022-1910(84)90129-X; [Anonymous], 1999, SIDS IN ASS REP SIAR; Barron AB, 2007, J INSECT PHYSIOL, V53, P187, DOI 10.1016/j.jinsphys.2006.11.009; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Blaul B, 2014, INSECT BIOCHEM MOLEC, V51, P33, DOI 10.1016/j.ibmb.2014.05.007; Blaul B, 2011, P ROY SOC B-BIOL SCI, V278, P3286, DOI 10.1098/rspb.2011.0001; Breeze TD, 2016, TRENDS ECOL EVOL, V31, P927, DOI 10.1016/j.tree.2016.09.002; Buellesbach J, 2013, J EVOLUTION BIOL, V26, P2467, DOI 10.1111/jeb.12242; Buellesbach J, 2018, FRONT ZOOL, V15, DOI 10.1186/s12983-018-0263-z; Coelho AAM, 2006, NEOTROP ENTOMOL, V35, P133, DOI 10.1590/S1519-566X2006000100018; Cook N, 2016, ECOL ENTOMOL, V41, P693, DOI 10.1111/een.12344; DARLING DC, 1990, ANN ENTOMOL SOC AM, V83, P352, DOI 10.1093/aesa/83.3.352; de Borba TM, 2018, BIOTECHNOL PROGR, V34, P1102, DOI 10.1002/btpr.2672; Debernard S, 1995, EXPERIENTIA, V51, P1220, DOI 10.1007/BF01944740; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dubrovsky EB, 2000, DEV BIOL, V224, P486, DOI 10.1006/dbio.2000.9800; Emlen DJ, 1999, J INSECT PHYSIOL, V45, P45, DOI 10.1016/S0022-1910(98)00096-1; ENDEMANN G, 1982, J BIOL CHEM, V257, P3434; FEYEREISEN R, 1976, GEN COMP ENDOCR, V29, P319, DOI 10.1016/0016-6480(76)90044-7; GOLDSTEIN RS, 1991, J COMP PHYSIOL A, V168, P103, DOI 10.1007/BF00217108; Guez D, 2001, NEUROBIOL LEARN MEM, V76, P183, DOI 10.1006/nlme.2000.3995; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Heider J, 2016, J MOL MICROB BIOTECH, V26, P152, DOI 10.1159/000441500; Hummelbrunner LA, 2001, J AGR FOOD CHEM, V49, P715, DOI 10.1021/jf000749t; Irazoqui G, 2007, J MOL CATAL B-ENZYM, V46, P43, DOI 10.1016/j.molcatb.2007.02.005; Jurenka R.A., 2020, INSECT PHEROMONE BIO, V2nd, P13, DOI [10.1016/j.ibmb.2019.103260, DOI 10.1016/J.IBMB.2019.103260]; KISSEBAH AH, 1974, DIABETOLOGIA, V10, P69, DOI 10.1007/BF00421416; Leather SR, 2015, ECOL ENTOMOL, V40, P36, DOI 10.1111/een.12207; Lenschow M, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00014; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Lynch JA, 2015, GENETICS, V199, P897, DOI 10.1534/genetics.112.147512; Mair MM, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00184; MATUCHA M, 1991, J CHROMATOGR, V588, P251, DOI 10.1016/0021-9673(91)85030-J; Muller C, 2018, BASIC APPL ECOL, V30, P1, DOI 10.1016/j.baae.2018.05.001; Mus F., 2017, SCI REP-UK, P7, DOI [10.1038/s41598-017-00035-9, DOI 10.1038/S41598-017-00035-9]; Myers JH, 2017, ANNU REV ENTOMOL, V62, P207, DOI 10.1146/annurev-ento-010715-023826; Nazir A, 2003, TOXICOL MECH METHOD, V13, P147, DOI 10.1080/15376510309846; Niehuis O, 2013, NATURE, V494, P345, DOI 10.1038/nature11838; Ollerton J, 2017, ANNU REV ECOL EVOL S, V48, P353, DOI 10.1146/annurev-ecolsys-110316-022919; Pajaro-Castro N, 2019, J TOXICOL ENV HEAL A, V82, P28, DOI 10.1080/15287394.2018.1546245; Pajaro-Castro N, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060667; Pamminger T, 2016, J INSECT PHYSIOL, V95, P1, DOI 10.1016/j.jinsphys.2016.09.004; Pavela R, 2018, IND CROP PROD, V113, P46, DOI 10.1016/j.indcrop.2018.01.021; Planes L, 2013, J PEST SCI, V86, P321, DOI 10.1007/s10340-012-0440-3; Prager L, 2019, INSECT BIOCHEM MOLEC, V115, DOI 10.1016/j.ibmb.2019.103256; Rantala MJ, 2003, P ROY SOC B-BIOL SCI, V270, P2257, DOI 10.1098/rspb.2003.2472; Raychoudhury R, 2010, HEREDITY, V104, P278, DOI 10.1038/hdy.2009.147; Rosenheim JA, 1998, ANNU REV ENTOMOL, V43, P421, DOI 10.1146/annurev.ento.43.1.421; Ruther J., 2020, INSECT PHEROMONE BIO, V2nd, P237; Ruther J, 2008, J CHEM ECOL, V34, P99, DOI 10.1007/s10886-007-9411-1; Ruther J, 2007, J EXP BIOL, V210, P2163, DOI 10.1242/jeb.02789; Ruther J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089214; Ruther J, 2014, J CHEM ECOL, V40, P56, DOI 10.1007/s10886-013-0372-2; Ruther J, 2010, ANIM BEHAV, V80, P1035, DOI 10.1016/j.anbehav.2010.09.008; Ruther J, 2009, P ROY SOC B-BIOL SCI, V276, P3303, DOI 10.1098/rspb.2009.0738; SCHAL C, 1994, ARCH INSECT BIOCHEM, V25, P375, DOI 10.1002/arch.940250411; Scheiner R, 2002, BEHAV BRAIN RES, V136, P545, DOI 10.1016/S0166-4328(02)00205-X; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Semmelmann F, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.201038; SINGH D, 1987, INDIAN J EXP BIOL, V25, P569; SMAGGHE G, 1994, PESTIC SCI, V42, P85, DOI 10.1002/ps.2780420204; SONG BJ, 1989, J BIOL CHEM, V264, P3568; Sreng L, 1999, ARCH INSECT BIOCHEM, V40, P165, DOI 10.1002/(SICI)1520-6327(1999)40:4&lt;165::AID-ARCH1&gt;3.0.CO;2-5; Steiner S, 2006, J CHEM ECOL, V32, P1687, DOI 10.1007/s10886-006-9102-3; Tappert L, 2017, SCI REP-UK, V7, DOI 10.1038/srep42756; Taverner PD, 2001, PESTIC BIOCHEM PHYS, V69, P153, DOI 10.1006/pest.2000.2527; Teal PEA, 2000, P NATL ACAD SCI USA, V97, P3708, DOI 10.1073/pnas.060034397; THEOPHILIDIS G, 1994, NEUROSCI LETT, V181, P91, DOI 10.1016/0304-3940(94)90567-3; Tunc I, 1997, J STORED PROD RES, V33, P181, DOI 10.1016/S0022-474X(96)00021-5; VANDENASSEM J, 1980, BEHAVIOUR, V75, P301, DOI 10.1163/156853980X00456; Vogt, 2020, INSECT PHEROMONE BIO, P123; Wang XZ, 2020, G3-GENES GENOM GENET, V10, P2565, DOI 10.1534/g3.120.401200; Werren JH, 2010, EMERGING MODEL ORGANISMS: LABORATORY MANUAL, VOL 2, P267, DOI 10.1101/pdb.emo134; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; ZHAO CH, 1995, J CHEM ECOL, V21, P1495, DOI 10.1007/BF02035148; Zotti MJ, 2013, INSECT SCI, V20, P743, DOI 10.1111/1744-7917.12008	78	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245698	10.1371/journal.pone.0245698	http://dx.doi.org/10.1371/journal.pone.0245698			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471848	gold, Green Published			2022-12-26	WOS:000639428800021
J	Wilkaniec, A; Borowiak-Sobkowiak, B; Irzykowska, L; Bres, W; Swierk, D; Pardela, L; Durak, R; Srodulska-Wielgus, J; Wielgus, K				Wilkaniec, Agnieszka; Borowiak-Sobkowiak, Beata; Irzykowska, Lidia; Bres, Wlodzimierz; Swierk, Dariusz; Pardela, Lukasz; Durak, Roma; Srodulska-Wielgus, Jadwiga; Wielgus, Krzysztof			Biotic and abiotic factors causing the collapse of Robinia pseudoacacia L. veteran trees in urban environments	PLOS ONE			English	Article							CYDALIMA-PERSPECTALIS WALKER; HEALTH CONDITION; HORSE-CHESTNUT; CLIMATE-CHANGE; INVASIVE TREE; STREET TREES; GREEN SPACES; SALT STRESS; LEPIDOPTERA; ECOSYSTEMS	Robinia pseudoacacia L. is an interesting example of how one plant species can be considered invasive or useful depending on its environment. In the past this tree species was planted for decorative purposes and for wood in Poland. For many years it was recommended in poor and degraded habitats because it facilitated late-successional plant species. The aim of this study was to verify if black locust can still be regarded as a resistant tree species in urban greenery. The health condition of old tree specimens growing along streets and in parks was compared. The occurrence of pests and pathogens on R. pseudoacacia trees was assessed and the content of mineral elements in leaves was examined. The research results showed that the health of black locust trees growing in the urban environment in Polish cities, especially along streets (in comparison to park sites), deteriorated significantly due to the interaction of harmful biotic and abiotic factors. Increased level of toxic metals (Fe, Zn, Pb, Mn and Cd) in plant tissues and the accumulation of pests and pathogens negatively influenced the health of R. pseudoacacia.	[Wilkaniec, Agnieszka; Swierk, Dariusz] Poznan Univ Life Sci, Dept Landscape Architecture, Poznan, Poland; [Borowiak-Sobkowiak, Beata] Poznan Univ Life Sci, Dept Entomol & Environm Protect, Poznan, Poland; [Irzykowska, Lidia] Poznan Univ Life Sci, Dept Phytopathol Seed Sci & Technol, Poznan, Poland; [Bres, Wlodzimierz] Poznan Univ Life Sci, Dept Plant Nutr, Poznan, Poland; [Pardela, Lukasz] Wroclaw Univ Environm & Life Sci, Inst Landscape Architecture, Wroclaw, Poland; [Durak, Roma] Univ Rzeszow, Dept Expt Biol & Chem, Rzeszow, Poland; [Srodulska-Wielgus, Jadwiga; Wielgus, Krzysztof] Cracow Univ Technol, Inst Landscape Architecture, Fac Architecture, Krakow, Poland	Poznan University of Life Sciences; Poznan University of Life Sciences; Poznan University of Life Sciences; Poznan University of Life Sciences; Wroclaw University of Environmental & Life Sciences; University of Rzeszow; Cracow University of Technology	Wilkaniec, A (corresponding author), Poznan Univ Life Sci, Dept Landscape Architecture, Poznan, Poland.	agnieszka.wilkaniec@puls.edu.pl	Pardela, Lukasz/S-7934-2016; Irzykowska, Lidia/X-4450-2018	Swierk, Dariusz/0000-0001-7700-8359; Wielgus, Krzysztof/0000-0003-1663-5740; Durak, Roma/0000-0001-9100-766X; Irzykowska, Lidia/0000-0001-5731-1668; Bres, Wlodzimierz/0000-0002-0061-3531; Borowiak-Sobkowiak, Beata/0000-0002-4485-7925; Srodulska-Wielgus, Jadwiga/0000-0001-7395-0662; Pardela, Lukasz/0000-0003-4635-6216; Wilkaniec, Agnieszka/0000-0001-9503-8340	Polish Ministry of Science and Higher Education's program: "Regional Initiative Excellence" in the years 2019-2022 [005/RID/2018/19]	Polish Ministry of Science and Higher Education's program: "Regional Initiative Excellence" in the years 2019-2022	This study was funded in part by the Polish Ministry of Science and Higher Education's program: "Regional Initiative Excellence" in the years 2019-2022 in the form of a grant (No. 005/RID/2018/19) awarded to AW, BBS, LI, WB, and DS. No additional external funding was received for this study.	BAKAY L., 2014, PENSEE, V76, P88; Baker R, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.671; Barredo J. I., 2015, Bulletin OEPP, V45, P273, DOI 10.1111/epp.12208; Bassuk N., 1985, SCI MANAGEMENT VEGET, V195, P49; Bayer D, 2018, URBAN FOR URBAN GREE, V35, P129, DOI 10.1016/j.ufug.2018.08.011; Benesperi R, 2012, BIODIVERS CONSERV, V21, P3555, DOI 10.1007/s10531-012-0380-5; Bennewicz J., 2011, URBAN FAUNA STUDIES, P121; Blaik Tomasz, 2016, Przyroda Sudetow, V19, P121; Bolund P, 1999, ECOL ECON, V29, P293, DOI 10.1016/S0921-8009(99)00013-0; Borowiak-Sobkowiak Beata, 2008, Polish Journal of Entomology, V77, P5; Borowski J., 2009, WYZNACZANIE WSP CZYN; Borowski J., 2006, ROCZ DEDROLOGICZNY, V54, P83; Bres W., 2008, NAUKA PRZYR TECHNOL, V2, P31; Brundu G, 2020, NEOBIOTA, P65, DOI 10.3897/neobiota.61.58380; Bryson GM, 2002, COMMUN SOIL SCI PLAN, V33, P67, DOI 10.1081/CSS-120002378; Buchholz S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137723; Buszko Jaroslaw, 2000, Polish Entomological Monographs, V1, P1; Carroll SP, 2005, ECOL LETT, V8, P944, DOI 10.1111/j.1461-0248.2005.00800.x; Cavanagh JAE, 2009, URBAN FOR URBAN GREE, V8, P21, DOI 10.1016/j.ufug.2008.10.002; Cekstere G, 2013, URBAN FOR URBAN GREE, V12, P69, DOI 10.1016/j.ufug.2012.09.004; Chireceanu C., 2011, Romanian Journal for Plant Protection, V4, P28; Cierjacks A, 2013, J ECOL, V101, P1623, DOI 10.1111/1365-2745.12162; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; DANSO SKA, 1995, SOIL BIOL BIOCHEM, V27, P415, DOI 10.1016/0038-0717(95)98612-R; Deutscher J, 2019, SCI TOTAL ENVIRON, V655, P1495, DOI 10.1016/j.scitotenv.2018.11.277; Dmuchowski W, 2013, FRESEN ENVIRON BULL, V22, P987; Dudek K, 2017, EUR J ENTOMOL, V114, P350, DOI 10.14411/eje.2017.044; Dzwonko Z, 1997, J APPL ECOL, V34, P861, DOI 10.2307/2405277; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Equiza MA, 2017, URBAN FOR URBAN GREE, V21, P16, DOI 10.1016/j.ufug.2016.11.003; Erteld W, 1952, ROBINIE FALSHE AKAZI; Frohlich A, 2020, LANDSCAPE URBAN PLAN, V202, DOI 10.1016/j.landurbplan.2020.103869; Grabosky J, 2016, URBAN FOR URBAN GREE, V16, P103, DOI 10.1016/j.ufug.2016.02.002; H KL., 2019, RES REPORT; Hanover J. W., 1990, Fast growing trees and nitrogen fixing trees: international conference Marburg, October 8th-12th, 1989., P175; Heger T, 2014, OIKOS, V123, P741, DOI 10.1111/j.1600-0706.2013.01263.x; Hillier JG., 2014, HILLIER MANUAL TREES; Horneck DA, 1998, HANDBOOK OF REFERENCE METHODS FOR PLANT ANALYSIS, P75; Hulle M, 2010, CR BIOL, V333, P497, DOI 10.1016/j.crvi.2010.03.005; Huntley JC, 1990, SILVICS N AM, V2, P755; Hwang YH, 2019, URBAN FOR URBAN GREE, V38, P165, DOI 10.1016/j.ufug.2018.12.005; Irzykowska L, 2013, BIOLOGIA, V68, P851, DOI 10.2478/s11756-013-0222-2; Jaworski Tomasz, 2013, Lesne Prace Badawcze, V74, P345; Jim CY, 2008, J ENVIRON MANAGE, V88, P665, DOI 10.1016/j.jenvman.2007.03.035; Jim CY, 2009, CITIES, V26, P187, DOI 10.1016/j.cities.2009.03.003; Jones JB., 1991, PLANT ANAL HDB PRACT, P127; Kabata-Pendias A, 2010, TRACE ELEMENTS SOILS, Vfourth, DOI [DOI 10.1201/B10158, 10.1201/9781420039900]; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kehr R., 1996, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V48, P197; Kiritani K, 2006, POPUL ECOL, V48, P5, DOI 10.1007/s10144-005-0225-0; Kleinbauer I, 2010, BIOL CONSERV, V143, P382, DOI 10.1016/j.biocon.2009.10.024; Kohler A., 1963, BEITR NATURK FORSCH, V12, P3; Kong L, 2017, SUSTAIN CITIES SOC, V31, P12, DOI 10.1016/j.scs.2017.01.018; Kowarik I, 2013, PRESLIA, V85, P113; Kozuchowski K., 2001, PRZEGLAD GEOFIZYCZ Z, V1-2, P81; Kundzewicz ZW, 2018, ACTA GEOPHYS, V66, P1509, DOI 10.1007/s11600-018-0220-4; Le Roux DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099403; Leps J, 2003, MULTIVARIATE ANAL EC; Lindenmayer DB, 2017, BIOL REV, V92, P1434, DOI 10.1111/brv.12290; Lubiarz Magdalena, 2011, P39; Lukaszkiewicz J., 2010, ROCZNIK POLSKIEGO TO, V58, P25; Majdecki L, TABELA WIEKOWA DRZEW; Mally R, 2010, EUR J ENTOMOL, V107, P393, DOI 10.14411/eje.2010.048; Marosz A, 2011, DENDROBIOLOGY, V66, P49; Marzani QA., 2016, J U DUHOK, V19, P593; McKinney ML, 2018, URBAN FOR URBAN GREE, V29, P334, DOI 10.1016/j.ufug.2017.09.004; Michalska B., 2011, Prace i Studia Geograficzne, V47, P67; Michalska B., 2009, ENV ASPECTS CLIMATE, P89; Morgenroth J, 2016, URBAN FOR URBAN GREE, V15, P1, DOI 10.1016/j.ufug.2015.11.003; Moshki A., 2011, Research Journal of Environmental Sciences, V5, P259, DOI 10.3923/rjes.2011.259.268; Nadgorska-Socha A, 2017, CHEMOSPHERE, V183, P471, DOI 10.1016/j.chemosphere.2017.05.128; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Oltean Ion, 2017, Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca Agriculture, V74, P26, DOI 10.15835/buasvmcn-agr:12655; Pardela L, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12114721; Pauleit Stephan, 2002, Urban Forestry & Urban Greening, V1, P83, DOI 10.1078/1618-8667-00009; Rahmonov O., 2009, ACTA ECOL SIN, V29, P237, DOI [10.1016/j.chnaes.2009.08.006, DOI 10.1016/J.CHNAES.2009.08.006]; REBELE F, 1994, GLOBAL ECOL BIOGEOGR, V4, P173, DOI 10.2307/2997649; Roloff A, 1989, FLORA GEHOLZE; Roslon-Szerynska E., 2009, METODA OCENY KONDYCJ; Sadlo J, 2017, NEOBIOTA, P1, DOI 10.3897/neobiota.35.11909; Sciubidlo A, 2019, POL J ENVIRON STUD, V28, P4403, DOI 10.15244/pjoes/94997; Sienkiewicz-Paderewska D, 2017, URBAN FOR URBAN GREE, V21, P74, DOI 10.1016/j.ufug.2016.11.010; Siitonen J, 2015, EUROPE'S CHANGING WOODS AND FORESTS FROM WILDWOOD TO MANAGED LANDSCAPES, P140, DOI 10.1079/9781780643373.0140; Sjoman H, 2016, URBAN FOR URBAN GREE, V18, P237, DOI 10.1016/j.ufug.2016.06.011; Sjoman H, 2015, URBAN FOR URBAN GREE, V14, P858, DOI 10.1016/j.ufug.2015.08.004; Skrynetska I, 2018, INT J ENVIRON RES, V12, P255, DOI 10.1007/s41742-018-0088-9; Skrzypynska Malgorzata, 2007, Dipteron - Wroclaw, V23, P26; slusarczyk T., 2012, PRZ PRZYRODNICZY, V23, P11; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stagoll K, 2012, CONSERV LETT, V5, P115, DOI 10.1111/j.1755-263X.2011.00216.x; Suplat S., 1992, PRACE OGRODU BOTANIC, V2, P115; Szczepanowska HB, 2009, METODA WYCENY WARTOS; Threlfall CG, 2018, URBAN FOR URBAN GREE, V29, P348, DOI 10.1016/j.ufug.2017.05.012; Tokarska-Guzik B., 2005, ESTABLISHMENT SPREAD; Torchin ME, 2002, PARASITOLOGY, V124, pS137, DOI 10.1017/S0031182002001506; Vadas E., 1914, MONOGRAPHIE ROBINIE; van den Berg M, 2015, URBAN FOR URBAN GREE, V14, P806, DOI 10.1016/j.ufug.2015.07.008; Van Driesche RG., 2013, FOREST PEST INSECTS, DOI [10.1603/ec13047, DOI 10.1603/EC13047]; Vavra JCH., 2013, THAYENSIA, V10, P39; Vitkova M, 2017, FOREST ECOL MANAG, V384, P287, DOI 10.1016/j.foreco.2016.10.057; Wan JZ, 2020, URBAN FOR URBAN GREE, V47, DOI 10.1016/j.ufug.2019.126520; Wilkaniec A, 2018, FRESEN ENVIRON BULL, V27, P2082; Wilkaniec B., 2012, PHYTOPATHOLOGIA, V65, P19; Wilkaniec Barbara, 2013, Journal of Plant Protection Research, V53, P60, DOI 10.2478/jppr-2013-0009; Wojda T., 2015, Papers on Global Change - IGBP, V22, P101; Wu YX, 2020, INSECTS, V11, DOI 10.3390/insects11030167; Yamamura K, 1998, APPL ENTOMOL ZOOL, V33, P289, DOI 10.1303/aez.33.289	107	5	5	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245398	10.1371/journal.pone.0245398	http://dx.doi.org/10.1371/journal.pone.0245398			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM1OE	33471798	gold, Green Published			2022-12-26	WOS:000639428800065
J	Nishi, K; Haji, T; Matsumoto, T; Hayakawa, C; Maeda, K; Okano, S; Yokoo, T; Iwai, S				Nishi, Kotaro; Haji, Takafumi; Matsumoto, Takuya; Hayakawa, Chisato; Maeda, Kenichi; Okano, Shozo; Yokoo, Takashi; Iwai, Satomi			Timing urinary tract reconstruction in rats to avoid hydronephrosis and fibrosis in the transplanted fetal metanephros as assessed using imaging	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TGF-BETA; URETERAL OBSTRUCTION; KIDNEY; VEGF; ULTRASOUND; EXPRESSION; GENERATION; RECOVERY; EMBRYO	Chronic kidney disease leads to high morbidity rates among humans. Kidney transplantation is often necessary for severe symptoms; however, options for new curative treatments are desired because of donor shortage. For example, it has been established that the kidneys can efficiently generate urine after transplantation of the metanephros, ureter, and bladder as a group. After transplantation, the urine can indirectly flow into the recipient's bladder using a stepwise peristaltic ureter system method where the anastomosis is created via the recipient's ureter for urinary tract reconstruction. However, the growth of the regenerated metanephros varies significantly, whereas the time window for successful completion of the stepwise peristaltic ureter system that does not cause hydronephrosis of the metanephros with bladder (ureter) is quite narrow. Therefore, this study was conducted to periodically and noninvasively evaluate the growth of the transplanted metanephros, ureter, and bladder in rats through computed tomography and ultrasonography. The ultrasonographic findings highly correlated to the computed tomography findings and clearly showed the metanephros and bladder. We found that the degree of growth of the metanephros and the bladder after transplantation differed in each case. Most of the rats were ready for urinary tract reconstruction within 21 days after transplantation. Optimizing the urinary tract reconstruction using ultrasonography allowed for interventions to reduce long-term tubular dilation of the metanephros due to inhibited overdilation of the fetal bladder, thereby decreasing the fibrosis caused possibly by transforming growth factor-beta 1. These results may be significantly related to the long-term maturation of the fetal metanephros and can provide new insights into the physiology of transplant regeneration of the metanephros in higher animals. Thus, this study contributes to the evidence base for the possibility of kidney regeneration in human clinical trials.	[Nishi, Kotaro; Haji, Takafumi; Matsumoto, Takuya; Hayakawa, Chisato; Maeda, Kenichi; Okano, Shozo; Iwai, Satomi] Kitasato Univ, Sch Vet Med, Lab Small Anim Surg 2, Towada, Aomori, Japan; [Yokoo, Takashi] Jikei Univ, Sch Med, Div Nephrol & Hypertens, Dept Internal Med,Minato Ku, Tokyo, Japan; [Yokoo, Takashi; Iwai, Satomi] Meiji Univ, Int Inst Bioresource Res, Kawasaki, Kanagawa, Japan	Kitasato University; Jikei University; Meiji University	Iwai, S (corresponding author), Kitasato Univ, Sch Vet Med, Lab Small Anim Surg 2, Towada, Aomori, Japan.; Iwai, S (corresponding author), Meiji Univ, Int Inst Bioresource Res, Kawasaki, Kanagawa, Japan.	iwai@vmas.kitasato-u.ac.jp		Nishi, Kotaro/0000-0002-4961-2038				AKHURST RJ, 1990, DEVELOPMENT, V108, P645; Barberet V, 2010, VET RADIOL ULTRASOUN, V51, P324, DOI 10.1111/j.1740-8261.2009.01656.x; Chaudhary NI, 2007, EUR RESPIR J, V29, P976, DOI 10.1183/09031936.00152106; Chevalier RL, 2002, KIDNEY INT, V61, P2033, DOI 10.1046/j.1523-1755.2002.00359.x; Chevalier RL, 1999, KIDNEY INT, V55, P793, DOI 10.1046/j.1523-1755.1999.055003793.x; Clancy MJ, 2009, TRANSPLANTATION, V88, P151, DOI 10.1097/TP.0b013e3181abbe9d; Distler JHW, 2003, Q J NUCL MED, V47, P149; Dockrell MEC, 2009, NEPHRON EXP NEPHROL, V112, pE71, DOI 10.1159/000221834; FERNBACH SK, 1993, PEDIATR RADIOL, V23, P478, DOI 10.1007/BF02012459; Fujimoto E, 2017, CLIN EXP NEPHROL, V21, P579, DOI 10.1007/s10157-016-1337-x; Fujimoto T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43482-2; GATHERER D, 1990, DEVELOPMENT, V110, P445; Higgins SP, 2018, CELL SIGNAL, V43, P1, DOI 10.1016/j.cellsig.2017.11.005; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Ichikawa I, 2002, KIDNEY INT, V61, P889, DOI 10.1046/j.1523-1755.2002.00188.x; Isaksen CV, 2000, ULTRASOUND OBST GYN, V15, P177, DOI 10.1046/j.1469-0705.2000.00065.x; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kariya T, 2018, AM J PHYSIOL-RENAL, V314, pF167, DOI 10.1152/ajprenal.00052.2017; Kim HC, 2008, J ULTRAS MED, V27, P1673, DOI 10.7863/jum.2008.27.12.1673; Lin SL, 2011, AM J PATHOL, V178, P911, DOI 10.1016/j.ajpath.2010.10.012; Mancini M, 2006, J CLIN ULTRASOUND, V34, P184, DOI 10.1002/jcu.20212; Marshall D, 2005, TRANSPL P, V37, P194, DOI 10.1016/j.transproceed.2004.12.283; Matsumoto K, 2012, STEM CELLS, V30, P1228, DOI 10.1002/stem.1101; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Mills KT, 2015, KIDNEY INT, V88, P950, DOI 10.1038/ki.2015.230; Moeller BJ, 2004, SEMIN RADIAT ONCOL, V14, P215, DOI 10.1016/j.semradonc.2004.04.005; Nagai E, 1986, PROG MED, V6, P2378; Noto H, 1987, J JAPANESE UROLOGY, V78, P1071; Okada T, 1998, J MORPHOL, V238, P337, DOI 10.1002/(SICI)1097-4687(199812)238:3<337::AID-JMOR5>3.0.CO;2-D; PETERS CA, 1993, J UROLOGY, V150, P597, DOI 10.1016/S0022-5347(17)35559-3; Rogers SA, 1998, KIDNEY INT, V54, P27, DOI 10.1046/j.1523-1755.1998.00971.x; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Souma T, 2013, J AM SOC NEPHROL, V24, P1599, DOI 10.1681/ASN.2013010030; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Tajiri S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33256-7; Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695; Truong LD, 2011, CONTRIB NEPHROL, V169, P311, DOI 10.1159/000314578; Tufro A, 2000, DEV BIOL, V227, P558, DOI 10.1006/dbio.2000.9845; Tyson R, 2013, VET RADIOL ULTRASOUN, V54, P127, DOI 10.1111/vru.12007; Vera-Donoso CD, 2015, ACTAS UROL ESP, V39, P527, DOI 10.1016/j.acuro.2015.04.002; Yamanaka S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01922-5; Yokoo T, 2005, P NATL ACAD SCI USA, V102, P3296, DOI 10.1073/pnas.0406878102; Yokoo T, 2008, MED MOL MORPHOL, V41, P5, DOI 10.1007/s00795-008-0396-9; Yokoo T, 2008, TRANSPLANTATION, V85, P1654, DOI 10.1097/TP.0b013e318173a35d; Yokoo T, 2006, J AM SOC NEPHROL, V17, P1026, DOI 10.1681/ASN.2005101043; Yokote S, 2015, P NATL ACAD SCI USA, V112, P12980, DOI 10.1073/pnas.1507803112	46	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0231233	10.1371/journal.pone.0231233	http://dx.doi.org/10.1371/journal.pone.0231233			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449930	Green Published, Green Submitted, gold			2022-12-26	WOS:000609991600059
J	Patti, MA; Li, N; Eliot, M; Newschaffer, C; Yolton, K; Khoury, J; Chen, AM; Lanphear, BP; Lyall, K; Hertz-Picciotto, I; Fallin, MD; Croen, LA; Braun, JM				Patti, Marisa A.; Li, Nan; Eliot, Melissa; Newschaffer, Craig; Yolton, Kimberly; Khoury, Jane; Chen, Aimin; Lanphear, Bruce P.; Lyall, Kristen; Hertz-Picciotto, Irva; Fallin, Margaret Daniele; Croen, Lisa A.; Braun, Joseph M.			Association between self-reported caffeine intake during pregnancy and social responsiveness scores in childhood: The EARLI and HOME studies	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; HEALTH-CARE USE; DEVELOPMENTAL-DISABILITIES; DIAGNOSTIC INTERVIEW; DATASHAPER APPROACH; INCREASED RISK; US CHILDREN; LIFE-STYLE; BEHAVIOR; TRAITS	Maternal nutrition during gestation has been investigated for its role in child neurodevelopment. However, little is known about the potential impact of gestational caffeine exposure on child autistic behaviors. Here, we assess the relation between maternal caffeine intake during pregnancy and children's behavioral traits related to Autism Spectrum Disorder (ASD). We harmonized data from two pregnancy cohorts, Early Autism Risk Longitudinal Investigation (EARLI) (n = 120), an enriched-risk cohort of mothers who previously had a child with ASD, from Pennsylvania, Maryland, and Northern California (2009-2012), and the Health Outcomes and Measures of the Environment (HOME) Study (n = 269), a general population cohort from Cincinnati, Ohio (2003-2006). Mothers self-reported caffeine intake twice during pregnancy. Caregivers reported child behavioral traits related to ASD using the Social Responsiveness Scale (SRS) when children were aged 3-8 years. Higher scores indicate more ASD-related behaviors. We estimated covariate-adjusted differences in continuous SRS T-scores per interquartile range increase in caffeine intake. Self-reported caffeine intake during pregnancy was positively associated with SRS T-scores among children in EARLI (beta: 2.0; 95% CI -0.1, 4.0), but to a lesser extent in HOME (beta: 0.6; 95% CI -0.5, 1.6). In HOME, pre-pregnancy body mass index (BMI) modified the association between caffeine intake and SRS T-scores, where more positive associations were observed among women with higher BMIs. Our findings suggest gestational caffeine intake may represent a marker of vulnerability to childhood ASD-related behaviors. Additional studies are warranted to extend these findings.	[Patti, Marisa A.; Li, Nan; Eliot, Melissa; Braun, Joseph M.] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA; [Newschaffer, Craig; Lyall, Kristen] Drexel Univ, AJ Drexel Autism Inst, Philadelphia, PA 19104 USA; [Newschaffer, Craig] Penn State Univ, Coll Hlth & Human Dev, State Coll, PA USA; [Yolton, Kimberly; Khoury, Jane] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Yolton, Kimberly; Khoury, Jane; Chen, Aimin] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Lanphear, Bruce P.] Simon Fraser Univ, Dept Hlth Sci, Vancouver, BC, Canada; [Hertz-Picciotto, Irva] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Fallin, Margaret Daniele] Johns Hopkins Univ, Dept Mental Hlth, Baltimore, MD USA; [Croen, Lisa A.] Kaiser Permanente Northern Calif Oakland, Div Res, Oakland, CA USA	Brown University; Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Simon Fraser University; University of California System; University of California Davis; Johns Hopkins University	Patti, MA (corresponding author), Brown Univ, Dept Epidemiol, Providence, RI 02912 USA.	marisa_patti@brown.edu	Yunkunis, Kimberly/AAO-5605-2021	Li, Nan/0000-0002-7529-0781	National Institute of Environmental Health Sciences (NIEHS) [R01 ES026903, R01 ES016443, R01 ES024381, R01 ES020349, R01 ES011261, R01 ES014575]	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by funding from the National Institute of Environmental Health Sciences (NIEHS) (https://www.niehs.nih.gov/), to CN with grant numbers R01 ES026903 and R01 ES016443, JMB with grant number R01 ES024381, AM with grant number R01 ES020349, and BPL with grant numbers R01 ES011261 and R01 ES014575. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Aden Ulrika, 2011, Handb Exp Pharmacol, P373, DOI 10.1007/978-3-642-13443-2_14; AJAREM JS, 1993, BEHAV PHARMACOL, V4, P541; [Anonymous], 2019, US COFF CONS SHAR TY; [Anonymous], 2020, DEFINING ADULT OVERW; AZ S, 2014, WOMEN STUDIES, V4, P93; BARR HM, 1991, NEUROTOXICOL TERATOL, V13, P441, DOI 10.1016/0892-0362(91)90093-C; Barr SH.MMartinAP, 1981, DRUG METABOLISM IMMA; Bekkhus M, 2010, ACTA PAEDIATR, V99, P925, DOI 10.1111/j.1651-2227.2010.01744.x; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; Boulet SL, 2009, ARCH PEDIAT ADOL MED, V163, P19, DOI 10.1001/archpediatrics.2008.506; Braun JM, 2017, NEUROTOXICOLOGY, V62, P192, DOI 10.1016/j.neuro.2017.07.027; Braun JM, 2017, INT J EPIDEMIOL, V46, P24, DOI 10.1093/ije/dyw006; Christensen DL, 2016, J DEV BEHAV PEDIATR, V37, P1, DOI 10.1097/DBP.0000000000000235; CONCANNON JT, 1983, J PHARMACOL EXP THER, V226, P673; Constantino J. N., 2005, SOCIAL RESPONSIVENES; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Constantino JN, 2004, J CHILD PSYCHOL PSYC, V45, P719, DOI 10.1111/j.1469-7610.2004.00266.x; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Constantino JN, 2007, J AM ACAD CHILD PSY, V46, P1668, DOI 10.1097/chi.0b013e318157cb23; Del-Ponte B, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012749; Dobson NR, 2018, PEDIATR RES, V84, P333, DOI 10.1038/s41390-018-0089-6; Duvall JA, 2007, AM J PSYCHIAT, V164, P656, DOI 10.1176/appi.ajp.164.4.656; ELLENHORN MJ, 1978, CLIN TOXICOL, V13, P439, DOI 10.3109/15563657808988250; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365, DOI DOI 10.1016/J.JACR.2018.09.023; Fenster L, 1991, Epidemiology, V2, P168, DOI 10.1097/00001648-199105000-00002; Fenster L, 1991, Epidemiology, V2, P313, DOI 10.1097/00001648-199107000-00017; Fisher CE, 1996, LIFE SCI, V58, P701, DOI 10.1016/S0024-3205(96)80009-9; Fortier I, 2011, INT J EPIDEMIOL, V40, P1314, DOI 10.1093/ije/dyr106; Fortier I, 2011, AM J EPIDEMIOL, V174, P261, DOI 10.1093/aje/kwr194; Fortier I, 2010, INT J EPIDEMIOL, V39, P1383, DOI 10.1093/ije/dyq139; Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027; Frazier TW, 2014, AUTISM, V18, P31, DOI 10.1177/1362361313500382; Galera C, 2016, BIOL PSYCHIAT, V80, P720, DOI 10.1016/j.biopsych.2015.08.034; GOLDSTEIN A, 1962, BIOCHEM PHARMACOL, V11, P166, DOI 10.1016/0006-2952(62)90106-5; GRIMM VE, 1988, INT J NEUROSCI, V41, P15, DOI 10.3109/00207458808985738; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; HILL R M, 1977, Clinical Obstetrics and Gynecology, V20, P381, DOI 10.1097/00003081-197706000-00018; Jung Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04413-1; Kaiser L, 2008, J AM DIET ASSOC, V108, P553, DOI 10.1016/j.jada.2008.01.030; Kim S, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121236; Klebanoff MA, 2015, AM J EPIDEMIOL, V182, P1023, DOI 10.1093/aje/kwv136; Knight CA, 2004, FOOD CHEM TOXICOL, V42, P1923, DOI 10.1016/j.fct.2004.05.002; KNUTTI R, 1981, EUR J CLIN PHARMACOL, V21, P121, DOI 10.1007/BF00637512; Landrum REri, COLL STUDENTS USE CA, P6; Laureano-Melo R, 2016, METAB BRAIN DIS, V31, P1071, DOI 10.1007/s11011-016-9847-5; Li N, 2017, INT J EPIDEMIOL, V46, P1836, DOI 10.1093/ije/dyx203; Li N, 2017, EUR J EPIDEMIOL, V32, P1007, DOI 10.1007/s10654-017-0301-8; Linnet KM, 2009, ACTA PAEDIATR, V98, P173, DOI 10.1111/j.1651-2227.2008.00980.x; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lyall K, 2014, INT J EPIDEMIOL, V43, P443, DOI 10.1093/ije/dyt282; May Susanne, 2005, Dose-Response, V3, P474, DOI 10.2203/dose-response.003.04.004; Mikkelsen SH, 2017, J PEDIATR-US, V189, P120, DOI 10.1016/j.jpeds.2017.06.051; Moss BG, 2014, AM J HEALTH PROMOT, V28, P181, DOI 10.4278/ajhp.120705-QUAN-325; National Center for Biotechnology Information, PUBCHEM COMP DAT; Newschaffer CJ, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-7; Oken E, 2005, ENVIRON HEALTH PERSP, V113, P1376, DOI 10.1289/ehp.8041; Parsons AG, 2008, BRIT J NUTR, V99, P1133, DOI 10.1017/S0007114507853359; PERUZZI G, 1985, NEUROBEH TOXICOL TER, V7, P453; Purkayastha P, 2015, CURR MED CHEM, V22, P1850, DOI 10.2174/0929867322666150209152712; R Core Team, 2013, R LANG ENV STAT COMP; Reynolds LC, 2014, J PERINATOL, V34, P688, DOI 10.1038/jp.2014.80; RICE DC, 1990, NEUROTOXICOL TERATOL, V12, P429, DOI 10.1016/0892-0362(90)90004-V; ROSNER B, 1982, AM J EPIDEMIOL, V116, P722, DOI 10.1093/oxfordjournals.aje.a113455; Rusmevichientong Pimbucha, 2018, Calif J Health Promot, V16, P24; Schieve LA, 2012, RES DEV DISABIL, V33, P467, DOI 10.1016/j.ridd.2011.10.008; Scholl TO, 2000, AM J CLIN NUTR, V71, p1295S, DOI 10.1093/ajcn/71.5.1295s; Smith-Warner SA, 2006, AM J EPIDEMIOL, V163, P1053, DOI 10.1093/aje/kwj127; Stein Z, 1991, Epidemiology, V2, P163; SWENSON RR, 1990, PEPTIDES, V11, P927, DOI 10.1016/0196-9781(90)90011-S; Taylor R, 2020, CUREUS, V12, DOI 10.7759/cureus.10864; Tollanes MC, 2016, J NUTR, V146, P1701, DOI 10.3945/jn.116.232272; Treur JL, 2016, ADDICTION, V111, P1059, DOI 10.1111/add.13298; Valicenti-McDermott M, 2014, J CHILD NEUROL, V29, P360, DOI 10.1177/0883073812474489; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Virkud YV, 2009, AM J MED GENET B, V150B, P328, DOI 10.1002/ajmg.b.30810; Walker CK, 2015, JAMA PEDIATR, V169, P154, DOI 10.1001/jamapediatrics.2014.2645; WEST GL, 1986, NEUROBEH TOXICOL TER, V8, P29; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Xu GF, 2018, JAMA-J AM MED ASSOC, V319, P81, DOI 10.1001/jama.2017.17812; 2018, CURR OPIN TOXICOL, V10	80	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245079	10.1371/journal.pone.0245079	http://dx.doi.org/10.1371/journal.pone.0245079			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4XD	33449933	gold, Green Published			2022-12-26	WOS:000609991600054
J	Rago, M; Placidi, L; Polsoni, M; Rambaldi, G; Cusumano, D; Greco, F; Indovina, L; Menna, S; Placidi, E; Stimato, G; Teodoli, S; Mattiucci, GC; Chiesa, S; Marazzi, F; Masiello, V; Valentini, V; De Spirito, M; Azario, L				Rago, Maria; Placidi, Lorenzo; Polsoni, Mattia; Rambaldi, Giulia; Cusumano, Davide; Greco, Francesca; Indovina, Luca; Menna, Sebastiano; Placidi, Elisa; Stimato, Gerardina; Teodoli, Stefania; Mattiucci, Gian Carlo; Chiesa, Silvia; Marazzi, Fabio; Masiello, Valeria; Valentini, Vincenzo; De Spirito, Marco; Azario, Luigi			Evaluation of a generalized knowledge-based planning performance for VMAT irradiation of breast and locoregional lymph nodes-Internal mammary and/or supraclavicular regions	PLOS ONE			English	Article							MODULATED ARC THERAPY; RESOLUTION OPTIMIZER PRO; RADIATION-THERAPY; LUNG-CANCER; AT-RISK; RADIOTHERAPY; VALIDATION; QUALITY; IMRT; IMPACT	Purpose To evaluate the performance of eleven Knowledge-Based (KB) models for planning optimization (RapidPlan(TM) (RP), Varian) of Volumetric Modulated Arc Therapy (VMAT) applied to whole breast comprehensive of nodal stations, internal mammary and/or supraclavicular regions. Methods and materials Six RP models have been generated and trained based on 120 VMAT plans data set with different criteria. Two extra-structures were delineated: a PTV for the optimization and a ring structure. Five more models, twins of the previous models, have been created without the need of these structures. Results All models were successfully validated on an independent cohort of 40 patients, 30 from the same institute that provided the training patients and 10 from an additional institute, with the resulting plans being of equal or better quality compared with the clinical plans. The internal validation shows that the models reduce the heart maximum dose of about 2 Gy, the mean dose of about 1 Gy and the V-20Gy of 1.5 Gy on average. Model R and L together with model B without optimization structures ensured the best outcomes in the 20% of the values compared to other models. The external validation observed an average improvement of at least 16% for the V-5Gy of lungs in RP plans. The mean heart dose and for the V-20Gy for lung IPSI were almost halved. The models reduce the maximum dose for the spinal canal of more than 2 Gy on average Conclusions All KB models allow a homogeneous plan quality and some dosimetric gains, as we saw in both internal and external validation. Sub-KB models, developed by splitting right and left breast cases or including only whole breast with locoregional lymph nodes, have shown good performances, comparable but slightly worse than the general model. Finally, models generated without the optimization structures, performed better than the original ones.	[Rago, Maria; Placidi, Lorenzo; Valentini, Vincenzo; De Spirito, Marco; Azario, Luigi] Univ Cattolica Sacro Cuore, Rome, Italy; [Placidi, Lorenzo; Cusumano, Davide; Greco, Francesca; Indovina, Luca; Menna, Sebastiano; Placidi, Elisa; Stimato, Gerardina; Teodoli, Stefania; Mattiucci, Gian Carlo; Chiesa, Silvia; Marazzi, Fabio; Masiello, Valeria; Valentini, Vincenzo; De Spirito, Marco; Azario, Luigi] Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy; [Polsoni, Mattia; Rambaldi, Giulia] Osped San Giovanni Calibita, Fatebenefratelli Isola Tiberina, Rome, Italy; [Polsoni, Mattia; Rambaldi, Giulia] Amethyst Radioterapia Italia, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Placidi, L (corresponding author), Univ Cattolica Sacro Cuore, Rome, Italy.; Placidi, L (corresponding author), Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy.	lorenzo.placidi@policlinicogemelli.it	Placidi, Lorenzo/AAB-5254-2022; indovina, luca/ABF-4641-2021; Chiesa, Silvia/Q-7291-2016	Placidi, Lorenzo/0000-0003-0058-9145; indovina, luca/0000-0001-8073-9005; Masiello, Valeria/0000-0001-7589-7623; Chiesa, Silvia/0000-0003-0168-3459; Azario, Luigi/0000-0001-8575-8627; Marazzi, Fabio/0000-0003-0977-0143				[Anonymous], 2014, PHAS 3 TRIAL ACC WHO; Appenzoller LM, 2012, MED PHYS, V39, P7446, DOI 10.1118/1.4761864; Berry SL, 2016, RADIOTHER ONCOL, V120, P349, DOI 10.1016/j.radonc.2016.06.010; Binny D, 2018, MED DOSIM, V43, P267, DOI 10.1016/j.meddos.2017.10.003; Boman E, 2016, PHYS MEDICA, V32, P1428, DOI 10.1016/j.ejmp.2016.10.012; Borst GR, 2010, INT J RADIAT ONCOL, V78, P1345, DOI 10.1016/j.ijrobp.2009.10.006; Buschmann M, 2018, STRAHLENTHER ONKOL, V194, P333, DOI 10.1007/s00066-017-1246-2; Cagni E, 2018, PHYS MEDICA, V55, P98, DOI 10.1016/j.ejmp.2018.11.002; Castriconi R, 2019, PHYS MEDICA, V57, P231, DOI 10.1016/j.ejmp.2018.12.002; Chang ATY, 2016, INT J RADIAT ONCOL, V95, P981, DOI 10.1016/j.ijrobp.2016.02.017; Chatterjee A, 2017, INT J RADIAT ONCOL, V99, P1021, DOI 10.1016/j.ijrobp.2017.07.012; Clark CH, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150251; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Das IJ, 2008, JNCI-J NATL CANCER I, V100, P300, DOI 10.1093/jnci/djn020; Fogliata A, 2017, RADIAT ONCOL, V12, DOI 10.1186/s13014-017-0808-x; Fogliata A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145137; Fogliata A, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0530-5; Fogliata A, 2014, RADIOTHER ONCOL, V113, P385, DOI 10.1016/j.radonc.2014.11.009; Fogliata A, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-82; Foy JJ, 2017, PRACT RADIAT ONCOL, V7, pE355, DOI 10.1016/j.prro.2017.02.007; Fusella M, 2018, MED PHYS, V45, P2611, DOI 10.1002/mp.12896; Good D, 2013, INT J RADIAT ONCOL, V87, P176, DOI 10.1016/j.ijrobp.2013.03.015; Hansen Christian Ronn, 2016, Clin Transl Radiat Oncol, V1, P2, DOI 10.1016/j.ctro.2016.08.001; Hjelstuen MHB, 2012, ACTA ONCOL, V51, P333, DOI 10.3109/0284186X.2011.618510; Hussein M, 2016, RADIOTHER ONCOL, V120, P473, DOI 10.1016/j.radonc.2016.06.022; Jiang F, 2017, J APPL CLIN MED PHYS, V18, P9, DOI 10.1002/acm2.12038; Johansen S, 2009, ACTA ONCOL, V48, P495, DOI 10.1080/02841860802657227; Kachnic LA, 2011, J NATL CANCER I, V103, P777, DOI 10.1093/jnci/djr136; Kamima T, 2019, PHYS MEDICA, V64, P174, DOI 10.1016/j.ejmp.2019.07.004; Kan MWK, 2013, INT J RADIAT ONCOL, V85, pE73, DOI 10.1016/j.ijrobp.2012.08.031; Krayenbuehl J, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-1113-z; Krayenbuehl J, 2017, RADIAT ONCOL, V12, DOI 10.1186/s13014-017-0896-7; Kubo K, 2019, PHYS MEDICA, V67, P132, DOI 10.1016/j.ejmp.2019.10.032; Kubo K, 2017, PHYS MEDICA, V44, P199, DOI 10.1016/j.ejmp.2017.06.026; Li N, 2017, INT J RADIAT ONCOL, V97, P164, DOI 10.1016/j.ijrobp.2016.10.005; Michalski A, 2012, J MED IMAG RADIAT ON, V56, P499, DOI 10.1111/j.1754-9485.2012.02434.x; Miles EA, 2005, RADIOTHER ONCOL, V77, P241, DOI 10.1016/j.radonc.2005.10.011; Moore KL, 2015, INT J RADIAT ONCOL, V92, P228, DOI 10.1016/j.ijrobp.2015.01.046; Nelms BE, 2012, PRACT RADIAT ONCOL, V2, P296, DOI 10.1016/j.prro.2011.11.012; Nichols GP, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-66; Nicolini G, 2010, PHYS MED BIOL, V55, pN347, DOI 10.1088/0031-9155/55/12/N01; Nicolini G, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-27; Nissen HD, 2013, RADIOTHER ONCOL, V106, P28, DOI 10.1016/j.radonc.2012.10.016; Offersen BV, 2015, RADIOTHER ONCOL, V114, P3, DOI 10.1016/j.radonc.2014.11.030; Osman SOS, 2014, RADIOTHER ONCOL, V112, P17, DOI 10.1016/j.radonc.2014.04.004; Peters LJ, 2010, J CLIN ONCOL, V28, P2996, DOI 10.1200/JCO.2009.27.4498; Popescu CC, 2010, INT J RADIAT ONCOL, V76, P287, DOI 10.1016/j.ijrobp.2009.05.038; Qiu JJ, 2010, INT J RADIAT ONCOL, V78, P288, DOI 10.1016/j.ijrobp.2009.10.036; Quan EM, 2012, INT J RADIAT ONCOL, V84, pE69, DOI 10.1016/j.ijrobp.2012.02.017; Remouchamps VM, 2003, INT J RADIAT ONCOL, V55, P392, DOI 10.1016/S0360-3016(02)04143-3; Roach D, 2019, PHYS IMAG RADIAT ONC, V10, P7, DOI 10.1016/j.phro.2019.04.007; Scaggion A, 2018, PHYS MEDICA, V53, P86, DOI 10.1016/j.ejmp.2018.08.016; Schubert C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178034; Scorsetti M, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-145; Sharfo AWM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169202; Sheng Y, 2017, MED PHYS, V44, P5617, DOI 10.1002/mp.12556; Smith A, 2019, TECHNOL CANCER RES T, V18, DOI 10.1177/1533033819851763; Snyder KC, 2016, J APPL CLIN MED PHYS, V17, P263, DOI 10.1120/jacmp.v17i6.6429; Spruijt KH, 2013, INT J RADIAT ONCOL, V85, P506, DOI 10.1016/j.ijrobp.2012.03.040; Stranzl H, 2009, STRAHLENTHER ONKOL, V185, P155, DOI 10.1007/s00066-009-1939-2; Subramaniam S, 2012, STRAHLENTHER ONKOL, V188, P484, DOI 10.1007/s00066-012-0075-6; Symonds P., 2012, TXB RADIOTHERAPY, V7th; Teoh M, 2011, BRIT J RADIOL, V84, P967, DOI 10.1259/bjr/22373346; Tol JP, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0542-1; Tol JP, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0388-6; Tol JP, 2015, INT J RADIAT ONCOL, V91, P612, DOI 10.1016/j.ijrobp.2014.11.014; Toscas JI, 2010, RADIOTHER ONCOL, V96, P192, DOI 10.1016/j.radonc.2010.05.007; Tsai PF, 2012, J APPL CLIN MED PHYS, V13, P62, DOI 10.1120/jacmp.v13i5.3806; Ueda Y, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-0994-1; van Duren-Koopman MJ, 2018, PRACT RADIAT ONCOL, V8, P332, DOI 10.1016/j.prro.2018.03.008; Voet PWJ, 2014, INT J RADIAT ONCOL, V88, P1175, DOI 10.1016/j.ijrobp.2013.12.046; Wang JZ, 2013, PHYS MED BIOL, V58, pN181, DOI 10.1088/0031-9155/58/13/N181; Wang JQ, 2017, RADIAT ONCOL, V12, DOI 10.1186/s13014-017-0822-z; Wu BB, 2017, RADIOTHER ONCOL, V123, P57, DOI 10.1016/j.radonc.2017.01.012; Yin Y, 2012, MED DOSIM, V37, P287, DOI 10.1016/j.meddos.2011.11.001; Yuan LL, 2012, MED PHYS, V39, P6868, DOI 10.1118/1.4757927; Zhang XD, 2011, PHYS MED BIOL, V56, P3873, DOI 10.1088/0031-9155/56/13/009	77	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245305	10.1371/journal.pone.0245305	http://dx.doi.org/10.1371/journal.pone.0245305			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449952	Green Published, gold			2022-12-26	WOS:000609991600030
J	Dreher, A; Pietrowsky, R; Loerbroks, A				Dreher, Annegret; Pietrowsky, Reinhard; Loerbroks, Adrian			Pandemic-related attitudes, stressors and work outcomes among medical assistants during the SARS-CoV-2 ("Coronavirus") pandemic in Germany: A cross-sectional Study	PLOS ONE			English	Article							HEALTH-CARE WORKERS; INFLUENZA; PREPAREDNESS	Background The SARS-CoV-2 virus has spread rapidly around the globe since December 2019 creating much uncertainty among medical staff. Due to close patient contact, medical assistants are at increased risk of an infection. Several studies have investigated psychological consequences of the SARS-CoV-2 pandemic on medical staff, yet studies in the outpatient setting are scarce and studies addressing medical assistants are lacking. This study aimed to investigate pandemic-related stressors, attitudes, and work outcomes among medical assistants and to identify possible determinants. Methods The population under study were medical assistants across entire Germany. A self-devised online questionnaire was published between April 7th, 2020, and April 14th. including questions on pandemic-related stressors, attitudes and work outcomes. Additionally, symptoms of depression and anxiety disorder were measured by PHQ-2 and GAD-2, respectively. Logistic regression was performed to identify possible determinants. Results 2150 medical assistants provided complete data (98.0% female, mean age 37.6 years). Major stressors were uncertainty about the temporal scope of the pandemic (95.1% agreement), about how to act correctly (77.5%), feelings of not being allowed to let patients down (75.9%), uncertainty about one's financial situation (67.4%) and about contact persons for further information (67.1%). One third (29.9%) of the study population screened positively for depression and 42.6% for anxiety disorder. Feeling burdened by one's financial situation was significantly associated with working in specialist practices (1.32 [1.08-1.62]), caring for children (1.51 [1.22-1.87]), depression (1.28 [1.01-1.62]), and anxiety disorder (1.93 [1.55-2.39]). Feeling burdened by thoughts about virus contraction at work was also significantly associated with working in specialist practices (1.33 [1.07-1.64]), caring for children (1.33 [1.07-1.66]), depression (1.54 [1.18-2.00]), and anxiety (4.71 [3.71-5.98]). Conclusions This study provides novel evidence regarding major SARS-CoV-2 pandemic-related stressors among medical assistants and suggests need for special support for medical assistants caring for children and working in specialist practices.	[Dreher, Annegret; Loerbroks, Adrian] Univ Duesseldorf, Inst Occupat Social & Environm Med, Ctr Hlth & Soc, Fac Med, Dusseldorf, Germany; [Pietrowsky, Reinhard] Univ Duesseldorf, Inst Expt Psychol, Dept Clin Psychol, Dusseldorf, Germany		Loerbroks, A (corresponding author), Univ Duesseldorf, Inst Occupat Social & Environm Med, Ctr Hlth & Soc, Fac Med, Dusseldorf, Germany.	Adrian.loerbroks@uni-duesseldorf.de		Dreher, Annegret/0000-0002-5007-648X	Association of Medical Professionals (Verband medizinischer Fachberufe e.V.)	Association of Medical Professionals (Verband medizinischer Fachberufe e.V.)	We are indebted to the Association of Medical Professionals (Verband medizinischer Fachberufe e.V.) for support related to the questionnaire design and participant recruitment and to Mr. Norbert Anduleit for setting up the online questionnaire.	Bai Y, 2004, PSYCHIAT SERV, V55, P1055, DOI 10.1176/appi.ps.55.9.1055; Cai HZ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924171; de Zwart O, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-114; European Centre for Disease Prevention and Control, 2020, COVID 19 SIT UPD WOR; Goulia P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-322; Hu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044723; Kramer V, 2021, EUR ARCH PSY CLIN N, V271, P271, DOI 10.1007/s00406-020-01183-2; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kuo FL, 2020, KAOHSIUNG J MED SCI, V36, P944, DOI 10.1002/kjm2.12294; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Li RL, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021413; Liao QY, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-169; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Lu W, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112936; Luo M, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113190; McMullan C, 2016, INT EMERG NURS, V26, P3, DOI 10.1016/j.ienj.2015.10.004; National Association of Statutory Health Insurance Physicians National Association of Statutory Health Insurance Funds, 2015, AGR DEL MED SERV NON; Ning XJ, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02838-z; Statista, 2020, INFL H5N1 DEATHS AV; Statista, 2020, INFL H1N1 DEATHS COU; Statistics of the Federal Employment Agency, 2020, TABL EMPL PROF KIDB; Tan BYQ, 2020, ANN INTERN MED, V173, P317, DOI 10.7326/M20-1083; Viehmann A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176658; Wong KC, 2020, J ORTHOP SURG RES, V15, DOI 10.1186/s13018-020-01862-9; Wong SYS, 2012, INT J INFECT DIS, V16, pE687, DOI 10.1016/j.ijid.2012.03.015; Wong TY, 2008, ANN ACAD MED SINGAP, V37, P96; World Health Organization, 2020, VIRT PRESS C COVID 1; Wu Y, 2020, J PAIN SYMPTOM MANAG, V60, pE60, DOI 10.1016/j.jpainsymman.2020.04.008; Zhang WR, 2020, PSYCHOTHER PSYCHOSOM, V89, P242, DOI 10.1159/000507639	29	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245473	10.1371/journal.pone.0245473	http://dx.doi.org/10.1371/journal.pone.0245473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4VV	33444419	Green Published, gold			2022-12-26	WOS:000609988100092
J	Teshale, AB; Worku, MG; Tesema, GA				Teshale, Achamyeleh Birhanu; Worku, Misganaw Gebrie; Tesema, Getayeneh Antehunegn			Spatial distribution and determinants of the change in pre-lacteal feeding practice over time in Ethiopia: A spatial and multivariate decomposition analysis	PLOS ONE			English	Article							PRELACTEAL; NEWBORNS; INITIATION	Background Pre-lacteal feeding persists in low and middle-income countries as deep-rooted nutritional malpractice. It imposes significant negative consequences on neonatal health, including increased risk of illness and mortality. Different studies revealed that pre-lacteal feeding practice is decreased over time. Even though different studies are done on the prevalence and determinants of pre-lacteal feeding practice, up to our knowledge, the spatial distribution and the determinants of the change in pre-lacteal feeding practice over time are not researched. Objective To assess the spatial distribution and determinants of the change in pre-lacteal feeding practice over time in Ethiopia. Methods We used the Ethiopian demographic and health surveys (EDHSs) data. For this study, a total weighted sample of 14672 (5789 from EDHS 2005, 4510 from EDHS 2011, and 4373 from EDHS 2016) reproductive-age women who gave birth within two years preceding the respective surveys and whoever breastfeed were used. The logit-based multivariate decomposition analysis was used to identify factors that contributed to the decrease in pre-lacteal feeding practice over the last 10 years (from 2005 to 2016). Using the 2016 EDHS data, we also conducted a spatial analysis by using ArcGIS version 10.3 and SaTScan version 9.6 software to explore the spatial distribution and hotspot clusters of pre-lacteal feeding practice. Result Pre-lacteal feeding practice was decreased from 29% [95% Confidence interval (CI): 27.63-29.96%] in 2005 to 8% [95% CI: 7.72-8.83%] in 2016 with annual rate of reduction of 7.2%. The overall decomposition analysis showed that about 20.31% of the overall decrease in pre-lacteal feeding practice over the last 10 years was attributable to the difference in composition of women (endowment) across the surveys, while, the remaining 79.39% of the overall decrease was explained by the difference in the effect of characteristics (coefficient) across the surveys. In the endowment component, the difference in composition of residence, perception of distance from the health facility, maternal educational level, wealth status, occupation, ANC visit, place of delivery, the timing of breastfeeding initiation, and wanted last-child/pregnancy were found to be significant contributing factors for the decrease in pre-lacteal feeding practice. After controlling for the role of compositional changes, the difference in the effect of distance from the health facility, wealth status, occupation, antenatal care (ANC) visit, and wanted last-child/pregnancy across the surveys were significantly contributed to the observed decrease in pre-lacteal feeding practice. Regarding the spatial distribution, pre-lacteal feeding practice was non-random in Ethiopia in which the primary and secondary clusters' of pre-lacteal feeding identified in Somalia and the Afar region respectively. Conclusion Pre-lacteal feeding practice has shown a significant decline over the 10-year period. Program interventions considering women with poor maternal health service utilization such as ANC visits, women with poor socioeconomic status, women with an unintended pregnancy, and women from remote areas especially at border areas such as Somali and Afar could decrease pre-lacteal feeding practice in Ethiopia.	[Teshale, Achamyeleh Birhanu; Tesema, Getayeneh Antehunegn] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia; [Worku, Misganaw Gebrie] Univ Gondar, Sch Med, Coll Med & Hlth Sci, Dept Human Anat, Gondar, Ethiopia	University of Gondar; University of Gondar	Teshale, AB (corresponding author), Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia.	achambir08@gmail.com	Teshale, Achamyeleh/HHN-8416-2022	Teshale, Achamyeleh/0000-0002-7572-9993				Abageda M, 2015, J PREG CHILD HLTH, V2, P182, DOI 10.4172/2376-127X.1000182; Agho KE, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080462; Asim M, 2020, INT BREASTFEED J, V15, DOI 10.1186/s13006-020-00295-8; Balogun OO, 2016, MATERN CHILD HLTH J, V20, P363, DOI 10.1007/s10995-015-1835-6; Bhandari S, 2019, INT BREASTFEED J, V14, DOI 10.1186/s13006-019-0208-y; *CENTR STAT AG, 2006, ETH DEM HLTH SURV 20; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; Chandrashekhar TS, 2007, PUBLIC HEALTH NUTR, V10, P192, DOI 10.1017/S1368980007248475; Chea N, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0149-x; Derso T, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0116-y; Egata G, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-8; FMOH, 2004, NAT STRAT INF YOUNG; Gao Y, 2020, CURRENT DEV NUTR S2, V4, P829; Gebre E, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0556-x; Jimoh AO, 2018, S AFRICAN J CLIN NUT, V31, P13; Khanal V, 2016, WOMEN BIRTH, V29, P12, DOI 10.1016/j.wombi.2015.07.006; Khanal V, 2014, J PEDIATR GASTR NUTR, V59, P162, DOI 10.1097/MPG.0000000000000429; Khanal V, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-9; Kumari S, 2018, J COMMUNITY MED PUBL, V5, P2959; Laroia N, 2006, BREASTFEED MED, V1, P94, DOI 10.1089/bfm.2006.1.94; Legesse M, 2014, INT BREASTFEED J, V9, DOI 10.1186/s13006-014-0025-2; McKenna KM, 2009, J MIDWIFERY WOM HEAL, V54, P78, DOI 10.1016/j.jmwh.2008.07.012; Ministry of Health in Ethiopia, 2013, GOV FED DEM REP ETH; Nguyen PH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-932; Ogundele T, 2019, PAN AFR MED J, V34, DOI 10.11604/pamj.2019.34.172.17642; Patel A, 2013, J HUM LACT, V29, P572, DOI 10.1177/0890334412474718; Powers DA, 2011, STATA J, V11, P556, DOI 10.1177/1536867X1101100404; Raina Sunil K, 2012, J Family Med Prim Care, V1, P27, DOI 10.4103/2249-4863.94446; Shankar Kanagasabapathy, 2015, International Journal of Biomedical and Advance Research, V6, P484; Sinning M, 2008, STATA J, V8, P480, DOI 10.1177/1536867X0800800402; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Takele WW, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-018-0308-y; Tarekegn SM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-161; Tariku A, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0074-9; Tekaly G, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1284-7; Tewabe T, 2018, ETHIOP J HEALTH SCI, V28, P393, DOI 10.4314/ejhs.v28i4.5; Tongun JB, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1523304; WHO, 2009, INF YOUNG CHILD FEED; Wolde TF, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4044-3	40	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0244574	10.1371/journal.pone.0244574	http://dx.doi.org/10.1371/journal.pone.0244574			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444391	Green Published, gold			2022-12-26	WOS:000609988100035
J	Case, GV; Storey, KM; Parmeley, LE; Schulz, LC				Van Gronigen Case, Gerialisa; Storey, Kathryn M.; Parmeley, Lauren E.; Schulz, Laura C.			Effects of maternal nutrient restriction during the periconceptional period on placental development in the mouse	PLOS ONE			English	Article							AMINO-ACID-TRANSPORT; PITUITARY-ADRENAL AXIS; FETAL-GROWTH; GENE-EXPRESSION; BIRTH-WEIGHT; WILD-TYPE; NUTRITIONAL MANIPULATION; CARDIOVASCULAR-DISEASE; GLUCOSE-TRANSPORTER; DNA METHYLATION	Maternal undernutrition has detrimental effects on fetal development and adult health. Total caloric restriction during early pregnancy followed by adequate nutrition for the remainder of gestation, is particularly linked to cardiovascular and metabolic disease risks during adulthood. The placenta is responsible for transport of nutrients from the maternal to fetal circulation, and the efficiency with which it does so can be adjusted to the maternal nutrient supply. There is evidence that placental adaptations to nutrient restriction in early pregnancy may be retained even when adequate nutrition is restored later in pregnancy, leading to a potential mismatch between placental efficiency and maternal nutrient supplies. However, in the mouse, 50% caloric restriction from days 1.5-11.5 of gestation, while temporarily altering placental structure and gene expression, had no significant effect on day 18.5. The periconceptional period, during which oocyte maturation, fertilization, and preimplantation development occur may be especially critical in creating lasting impact on the placenta. Here, mice were subjected to 50% caloric restriction from 3 weeks prior to pregnancy through d11.5, and then placental structure, the expression of key nutrient transporters, and global DNA methylation levels were examined at gestation d18.5. Prior exposure to caloric restriction increased maternal blood space area, but decreased expression of the key System A amino acid transporter Slc38a4 at d18.5. Neither placental and fetal weights, nor placental DNA methylation levels were affected. Thus, total caloric restriction beginning in the periconceptional period does have a lasting impact on placental development in the mouse, but without changing placental efficiency.	[Van Gronigen Case, Gerialisa; Storey, Kathryn M.; Parmeley, Lauren E.; Schulz, Laura C.] Univ Missouri, Dept Obstet Gynecol & Womens Hlth, Columbia, MO 65211 USA; [Van Gronigen Case, Gerialisa; Storey, Kathryn M.; Parmeley, Lauren E.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Schulz, LC (corresponding author), Univ Missouri, Dept Obstet Gynecol & Womens Hlth, Columbia, MO 65211 USA.	schulzl@missouri.edu		Storey, Kathryn/0000-0002-2158-4784; Schulz, Laura/0000-0001-8722-6616	National Institutes of Health [IMSD R25GM056901]; University of Missouri Mission Enhancement	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Missouri Mission Enhancement	This work was funded by the National Institutes of Health IMSD R25GM056901 to GVGC, and University of Missouri Mission Enhancement to LCS. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730; Belkacemi L, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-105; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Bispham J, 2003, ENDOCRINOLOGY, V144, P3575, DOI 10.1210/en.2003-0320; Bleker OP, 2005, NESTLE NUTR WORKS SE, V55, P183; Bloise E, 2012, ENDOCRINOLOGY, V153, P3457, DOI 10.1210/en.2011-1921; BOILEAU P, 1995, J CLIN INVEST, V96, P309, DOI 10.1172/JCI118036; Carter MG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r61; Chen PY, 2013, PHYSIOL GENOMICS, V45, P565, DOI 10.1152/physiolgenomics.00034.2013; Cleal JK, 2008, J NEUROENDOCRINOL, V20, P419, DOI 10.1111/j.1365-2826.2008.01662.x; Coan PM, 2008, J PHYSIOL-LONDON, V586, P4567, DOI 10.1113/jphysiol.2008.156133; Coan PM, 2011, J PHYSIOL-LONDON, V589, P3659, DOI 10.1113/jphysiol.2011.208629; Coan PM, 2010, J PHYSIOL-LONDON, V588, P527, DOI 10.1113/jphysiol.2009.181214; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; Dahl KDC, 2005, MOL CELL BIOL, V25, P10479, DOI 10.1128/MCB.25.23.10479-10491.2005; Dandrea J, 2001, REPRODUCTION, V122, P793, DOI 10.1530/rep.0.1220793; de Waal E, 2015, HUM MOL GENET, V24, P6975, DOI 10.1093/hmg/ddv400; Dimasuay KG, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00012; Dong F, 2005, GROWTH HORM IGF RES, V15, P291, DOI 10.1016/j.ghir.2005.05.003; Duttaroy AK, 2009, PROG LIPID RES, V48, P52, DOI 10.1016/j.plipres.2008.11.001; Edwards LJ, 2002, AM J PHYSIOL-REG I, V283, pR669, DOI 10.1152/ajpregu.00736.2001; El-Hashash AHK, 2010, MECH DEVELOP, V127, P1, DOI 10.1016/j.mod.2009.09.004; Feil D, 2006, J PHYSIOL-LONDON, V572, P87, DOI 10.1113/jphysiol.2005.102681; Feuer SK, 2017, J DEV ORIG HLTH DIS, V8, P403, DOI 10.1017/S204017441700023X; FIELDER PJ, 1987, AM J PHYSIOL, V253, pE40, DOI 10.1152/ajpendo.1987.253.1.E40; Fleming TP, 2004, BIOL REPROD, V71, P1046, DOI 10.1095/biolreprod.104.030957; Frankel S, 1996, LANCET, V348, P1478, DOI 10.1016/S0140-6736(96)03482-4; Ganguly A, 2018, J NUTR BIOCHEM, V62, P192, DOI 10.1016/j.jnutbio.2018.09.001; Ganguly A, 2016, ENDOCRINOLOGY, V157, P4041, DOI 10.1210/en.2016-1259; Ganguly A, 2012, ENDOCRINOLOGY, V153, P3995, DOI 10.1210/en.2011-1973; Gardner DS, 2006, J ENDOCRINOL, V190, P203, DOI 10.1677/joe.1.06751; Gardner DS, 2004, HYPERTENSION, V43, P1290, DOI 10.1161/01.HYP.0000126991.67203.7b; Gluckman PD, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0109; Gopalakrishnan GS, 2004, AM J PHYSIOL-REG I, V287, pR12, DOI 10.1152/ajpregu.00687.2003; Harper JL, 2015, REPRODUCTION, V150, P165, DOI 10.1530/REP-15-0010; Heasman L, 1999, P NUTR SOC, V58, P283, DOI 10.1017/S0029665199000397; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Kaiser S, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.114.126474; Kalisch-Smith JI, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.172205; Kavitha JV, 2014, FASEB J, V28, P1294, DOI 10.1096/fj.13-242271; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li JH, 2009, AM J PATHOL, V175, P1380, DOI 10.2353/ajpath.2009.090096; Li YH, 2019, EPIGENETICS-US, V14, P850, DOI 10.1080/15592294.2019.1615357; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumey LH, 1998, PLACENTA, V19, P105; Malandro MS, 1996, AM J PHYSIOL-CELL PH, V271, pC295, DOI 10.1152/ajpcell.1996.271.1.C295; Matoba S, 2019, P NATL ACAD SCI USA, V116, P21047, DOI 10.1073/pnas.1907884116; MCCRABB GJ, 1991, BRIT J NUTR, V65, P157, DOI 10.1079/BJN19910077; MCGIVAN JD, 1994, BIOCHEM J, V299, P321, DOI 10.1042/bj2990321; Natale DRC, 2006, METH MOLEC MED, V121, P275; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ojha S, 2015, REPROD FERT DEVELOP, V27, P1205, DOI 10.1071/RD14007; Oliver MH, 2005, PEDIATR RES, V57, P591, DOI 10.1203/01.PDR.0000155942.18096.9C; Outhwaite JE, 2015, PLACENTA, V36, P951, DOI 10.1016/j.placenta.2015.05.013; Pangas SA, 2014, KNOBIL NEILLS PHYSL; Pankevich DE, 2010, J NEUROSCI, V30, P16399, DOI 10.1523/JNEUROSCI.1955-10.2010; Poore KR, 2010, J PHYSIOL-LONDON, V588, P2219, DOI 10.1113/jphysiol.2010.187682; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Rawn SM, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132431; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Roberts CT, 2001, PLACENTA, V22, P177, DOI 10.1053/plac.2000.0602; Rooke JA, 2007, THERIOGENOLOGY, V67, P639, DOI 10.1016/j.theriogenology.2006.09.040; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Schaiff WT, 2007, ENDOCRINOLOGY, V148, P3625, DOI 10.1210/en.2007-0211; Schulz LC, 2010, P NATL ACAD SCI USA, V107, P16757, DOI 10.1073/pnas.1012911107; Schulz LC, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.103218; Sferruzzi-Perri AN, 2009, BIOL REPROD, V81, P207, DOI 10.1095/biolreprod.108.073312; Shafiee A, 2018, STEM CELL REP, V10, P890, DOI 10.1016/j.stemcr.2018.01.011; Simmons DG, 2007, DEV BIOL, V304, P567, DOI 10.1016/j.ydbio.2007.01.009; Simmons DG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-352; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Symonds M. E., 2003, Archives of Physiology and Biochemistry, V111, P45, DOI 10.1076/apab.111.1.45.15141; Talton OO, 2016, ENDOCRINOLOGY, V157, P2636, DOI 10.1210/en.2016-1039; Tobi EW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6592; Townsend KL, 2008, ENDOCRINE, V33, P176, DOI 10.1007/s12020-008-9070-1; Tunster SJ, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-017-0154-6; Van Baak TE, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1374-0; Vaughan OR, 2017, PROG MOL BIOL TRANSL, V145, P217, DOI 10.1016/bs.pmbts.2016.12.008; Velazquez MA, 2019, J ENDOCRINOL, V242, pT33, DOI 10.1530/JOE-18-0676; Wang PX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049720; Watkins AJ, 2015, REPRODUCTION, V149, P563, DOI 10.1530/REP-14-0667; Yang Y, 2017, CELL, V169, P243, DOI 10.1016/j.cell.2017.02.005; Yu KF, 2020, MOL METAB, V42, DOI 10.1016/j.molmet.2020.101053; Zhu MJ, 2007, PLACENTA, V28, P1192, DOI 10.1016/j.placenta.2007.05.004	84	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0244971	10.1371/journal.pone.0244971	http://dx.doi.org/10.1371/journal.pone.0244971			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444393	gold, Green Published			2022-12-26	WOS:000609988100037
J	Wu, Q; Madni, GR				Wu, Qiong; Madni, Ghulam Rasool			Environmental protection in selected one belt one road economies through institutional quality: Prospering transportation and industrialization	PLOS ONE			English	Article							CARBON-DIOXIDE EMISSIONS; KUZNETS CURVE; ENERGY-CONSUMPTION; CO2 EMISSIONS; GHG EMISSIONS; URBANIZATION; GROWTH; DEGRADATION; EFFICIENCY; IMPACT	The effects of economic development on natural environment is explored by momentous literature, this study focuses on exploring the role of institutional quality for environmental protection in the selected One Belt One Road (OBOR) economies. The main goal of the paper is to find the threshold level of institutional quality that may minimize CO2 emissions in the atmosphere due to widespread industrialization and transportation. The data is selected for the panel of 33 OBOR economies over the time period of 1986-2018. The panel threshold regression technique is applied to determine the threshold level of institutional quality. The estimated results of the study reveal that 2.315 is the threshold level of institutional quality in selected partner OBOR countries. If quality of institutions is above the threshold level then CO2 emission do not contribute significantly for environmental deterioration in spite of growing industrialization and transportation and vice versa. The study emphasized to improve the institutional quality up to threshold level to get potential gains from industrialization and transportation.	[Wu, Qiong] Taiyuan Univ Technol, Int Cooperat Div, Taiyuan, Peoples R China; [Madni, Ghulam Rasool] Univ Educ, Dept Econ & Business Adm, Lahore, Pakistan	Taiyuan University of Technology	Madni, GR (corresponding author), Univ Educ, Dept Econ & Business Adm, Lahore, Pakistan.	ghulam.rasool@ue.edu.pk	Madni, Ghulam Rasool/AAM-7738-2021; Madni, Ghulam Rasool/AED-1658-2022	Madni, Ghulam Rasool/0000-0002-3908-5772; 				Acemoglu D, 2005, HANDB ECON, V22, P385; Akbostanci E, 2009, ENERG POLICY, V37, P861, DOI 10.1016/j.enpol.2008.09.088; Al-Mulali U, 2015, ENERGY, V84, P382, DOI 10.1016/j.energy.2015.03.004; Ali HS, 2017, ENVIRON SCI POLLUT R, V24, P1967, DOI 10.1007/s11356-016-7935-z; [Anonymous], BELT ROAD SUMM; [Anonymous], 2006, INT J SCI TECHNOL; Anwar A, 2020, ENVIRON SCI POLLUT R, V27, P7053, DOI 10.1007/s11356-019-07255-8; Baum H, 2002, TRANSPORT AND ECONOMIC DEVELOPMENT, P5; Brandon C, 1994, FINANCE DEV, P21; Caner M, 2004, ECONOMET THEOR, V20, P813, DOI 10.1017/S0266466604205011; Cervero R, 1996, TRANSPORT RES A-POL, V30, P361, DOI 10.1016/0965-8564(95)00033-X; Cervero R, 2011, INT J SUST DEV WORLD, V18, P210, DOI 10.1080/13504509.2011.570801; Chaitanya K, 2007, 897 U MICH WD I; Chang TC, 1999, J ENVIRON MANAGE, V56, P247, DOI 10.1006/jema.1999.0288; Dale VH, 1997, ECOL APPL, V7, P753, DOI 10.1890/1051-0761(1997)007[0753:TRBLUC]2.0.CO;2; Dasgupta S., 2016, POLITICAL EC ENERGY; Dhakal S, 2010, CURR OPIN ENV SUST, V2, P277, DOI 10.1016/j.cosust.2010.05.007; Ekins P, 1997, ENVIRON PLANN A, V29, P805, DOI 10.1068/a290805; Farhad M, 2018, BANGLADESH ENV SYST, DOI [10.1186/s4006, DOI 10.1186/S4006]; Green Industrial Policy, 2017, GREEN IND POLICY CON; Grossman G. M., 1991, Working Paper Series - National Bureau of Economic Research (Massachusetts); H Baum, 2000, KEY ISSUES TRANSPORT; Hansen BE, 2000, ECONOMETRICA, V68, P575, DOI 10.1111/1468-0262.00124; Hansen BE, 1996, ECONOMETRICA, V64, P413, DOI 10.2307/2171789; Howard KWF, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5752-9; Ibrahim MH, 2016, S AFR J ECON, V84, P323, DOI 10.1111/saje.12095; IEA, 2020, CO2 EM FUEL COMB; Johansson PO, 2007, ENVIRON RESOUR ECON, V37, P77, DOI 10.1007/s10640-007-9112-9; Klinger JM, 2020, TERRIT POLIT GOV, V8, P657, DOI 10.1080/21622671.2019.1582358; Knack S, 1997, Q J ECON, V112, P1251, DOI 10.1162/003355300555475; Koomen E, 2007, GEOJOURNAL LIB, V90, P1, DOI 10.1007/1-4020-5648-6; Lau ALD, 2005, SOC INDIC RES, V72, P403, DOI 10.1007/s11205-004-0561-z; Li J, 2011, ENERG POLICY, V39, P3503, DOI 10.1016/j.enpol.2011.03.049; Liu XY, 2018, J CLEAN PROD, V172, P178, DOI 10.1016/j.jclepro.2017.10.156; Madni G.R., 2017, PAK EC SOC REV, V55, P79; Madni GR, 2019, SOC INDIC RES, V142, P581, DOI 10.1007/s11205-018-1924-1; McCormack F, 2011, PUBLIC MANAGER, V40, P37; Mensbrugghe D, 2019, WORLD BANK POLICY RE; Middleton M, 2003, 11 S ED; Nasir M, 2011, ENERG POLICY, V39, P1857, DOI 10.1016/j.enpol.2011.01.025; NORTH DC, 1991, J ECON PERSPECT, V5, P97, DOI 10.1257/jep.5.1.97; Ozturk I, 2015, ENVIRON SCI POLLUT R, V22, P15459, DOI 10.1007/s11356-015-4757-3; Ozturk I, 2010, APPL ENERG, V87, P1938, DOI 10.1016/j.apenergy.2009.10.010; Paramati SR, 2007, ENV SCI POLLUT RES, P1; Rauf A, 2018, ENVIRON SCI POLLUT R, V25, P32066, DOI 10.1007/s11356-018-3052-5; Richardson M, 2018, ENVIRON HUMANITIES, V10, P1, DOI 10.1215/22011919-4385444; Rodrik D, 2004, J ECON GROWTH, V9, P131, DOI 10.1023/B:JOEG.0000031425.72248.85; Shahbaz M, 2014, RENEW SUST ENERG REV, V31, P575, DOI 10.1016/j.rser.2013.12.028; Shahbaz M, 2013, RENEW SUST ENERG REV, V25, P494, DOI 10.1016/j.rser.2013.05.021; Sharma R.K., 2012, INT J RES REV ENG SC, V1, P61; Shaw R P, 1992, Environ Impact Assess Rev, V12, P11, DOI 10.1016/0195-9255(92)90003-G; Sinha A, 2017, J CLEAN PROD, V168, P1217, DOI 10.1016/j.jclepro.2017.09.071; Song T, 2008, CHINA ECON REV, V19, P381, DOI 10.1016/j.chieco.2007.10.001; Stern DI, 1996, WORLD DEV, V24, P1151, DOI 10.1016/0305-750X(96)00032-0; Teo HC, 2019, ENVIRONMENTS, V6, DOI 10.3390/environments6060072; The World Bank, 2016, DIG DIV; Tunc GI, 2009, ENERG POLICY, V37, P4689, DOI 10.1016/j.enpol.2009.06.019; Uddin MGS, 2016, ENERG SOURCE PART B, V11, P282, DOI 10.1080/15567249.2012.694577; Wagner M, 2008, RESOUR ENERGY ECON, V30, P388, DOI 10.1016/j.reseneeco.2007.11.001; Waheed R, 2018, J CLEAN PROD, V172, P4231, DOI 10.1016/j.jclepro.2017.10.287; Wang Y, 2016, OBES REV, V17, P1179, DOI 10.1111/obr.12463; WEPA, 2010, STAT WAT ENV ISS CAM; Worrell E, 2009, ENERG EFFIC, V2, P109, DOI 10.1007/s12053-008-9032-8; Xu B, 2016, ENERG POLICY, V98, P328, DOI 10.1016/j.enpol.2016.09.003; Zakhidov AA, 2008, ADV MATER, V20, P3481, DOI 10.1002/adma.200800557; Zhao CH, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10010278	68	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0240851	10.1371/journal.pone.0240851	http://dx.doi.org/10.1371/journal.pone.0240851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4VV	33444315	gold, Green Published			2022-12-26	WOS:000609988100079
J	Ben Lagha, A; Azelmat, J; Vaillancourt, K; Grenier, D				Ben Lagha, Amel; Azelmat, Jabrane; Vaillancourt, Katy; Grenier, Daniel			A polyphenolic cinnamon fraction exhibits anti-inflammatory properties in a monocyte/macrophage model	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; NF-KAPPA-B; PPAR-GAMMA; PORPHYROMONAS-GINGIVALIS; ESSENTIAL OIL; PERIODONTITIS; MODULATION; LIPOPOLYSACCHARIDE; CONSTITUENTS; INFLAMMATION	Periodontal diseases are bacteria-induced inflammatory disorders that lead to the destruction of the tooth-supporting tissues. Active compounds endowed with a capacity to regulate the inflammatory response are regarded as potential therapeutic agents for the treatment of periodontal diseases. The aim of this study was to characterize the anti-inflammatory properties of a polyphenolic cinnamon fraction. Chromatographic and mass spectrometry analyses of the polyphenolic composition of the cinnamon fraction revealed that phenolic acids, flavonoids (flavonols, anthocyanins, flavan-3-ols), and procyanidins make up 9.22%, 0.72%, and 10.63% of the cinnamon fraction, respectively. We used a macrophage model stimulated with lipopolysaccharides (LPS) from either Aggregatibacter actinomycetemcomitans or Escherichia coli to show that the cinnamon fraction dose-dependently reduced IL-6, IL-8, and TNF-alpha secretion. Evidence was brought that this inhibition of cytokine secretion may result from the ability of the fraction to prevent LPS-induced NF-kappa B activation. We also showed that the cinnamon fraction reduces LPS binding to monocytes, which may contribute to its anti-inflammatory properties. Lastly, using a competitor assay, it was found that the cinnamon fraction may represent a natural PPAR-gamma ligand. Within the limitations of this in vitro study, the cinnamon fraction was shown to exhibit a therapeutic potential for the treatment of periodontal diseases due to its anti-inflammatory properties.	[Ben Lagha, Amel; Azelmat, Jabrane; Vaillancourt, Katy; Grenier, Daniel] Univ Laval, Fac Dent, Oral Ecol Res Grp, Quebec City, PQ, Canada	Laval University	Grenier, D (corresponding author), Univ Laval, Fac Dent, Oral Ecol Res Grp, Quebec City, PQ, Canada.	Daniel.Grenier@greb.ulaval.ca	Grenier, Daniel/E-5557-2015	Grenier, Daniel/0000-0003-0878-4674	Laboratoire de Controle Microbiologique de l'Universite Laval [2019-03-12]	Laboratoire de Controle Microbiologique de l'Universite Laval	The present study was supported by the Laboratoire de Controle Microbiologique de l'Universite Laval (#2019-03-12).	AlJehani YA, 2014, INT J DENT, V2014, DOI 10.1155/2014/182513; Anderson RA, 2004, J AGR FOOD CHEM, V52, P65, DOI 10.1021/jf034916b; [Anonymous], 2017, J SAFETY ENV, V2017, P15; Ben Lagha A, 2019, CYTOKINE, V115, P64, DOI 10.1016/j.cyto.2018.12.009; Ben Lagha A, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-017-2072-x; Ben Lagha A, 2015, J AGR FOOD CHEM, V63, P6999, DOI 10.1021/acs.jafc.5b01525; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Chao LK, 2005, J AGR FOOD CHEM, V53, P7274, DOI 10.1021/jf051151u; de Souza JAC, 2012, J APPL ORAL SCI, V20, P128, DOI 10.1590/S1678-77572012000200002; Curtis MA, 2020, PERIODONTOL 2000, V83, P14, DOI 10.1111/prd.12296; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; Dudonne S, 2014, J AGR FOOD CHEM, V62, P3244, DOI 10.1021/jf404965z; Golan-Goldhirsh A, 2014, PHYTOCHEM REV, V13, P107, DOI 10.1007/s11101-013-9293-5; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hajishengallis G, 2020, PERIODONTOL 2000, V84, P14, DOI 10.1111/prd.12331; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hasturk H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00118; Hong JW, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-237; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kumar PS, 2017, J PHYSIOL-LONDON, V595, P465, DOI 10.1113/JP272427; La VD, 2010, ANTIMICROB AGENTS CH, V54, P1778, DOI 10.1128/AAC.01432-09; Liu YCG, 2010, PERIODONTOL 2000, V52, P163, DOI 10.1111/j.1600-0757.2009.00321.x; Loos BG, 2020, PERIODONTOL 2000, V83, P26, DOI 10.1111/prd.12297; Mateos-Martin ML, 2012, ANAL BIOANAL CHEM, V402, P1327, DOI 10.1007/s00216-011-5557-3; Madureira DF, 2018, J EVID-BASED DENT PR, V18, P315, DOI 10.1016/j.jebdp.2018.04.001; Marciano DP, 2014, CELL METAB, V19, P193, DOI 10.1016/j.cmet.2013.12.009; Martin H, 2010, MUTAT RES-FUND MOL M, V690, P57, DOI 10.1016/j.mrfmmm.2009.09.009; Ranasinghe P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-275; Rao PV, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/642942; Reynolds MA, 2014, PERIODONTOL 2000, V64, P7, DOI 10.1111/prd.12047; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; Stadler AF, 2016, J CLIN PERIODONTOL, V43, P727, DOI 10.1111/jcpe.12557; Sulijaya B, 2019, ARCH ORAL BIOL, V105, P72, DOI 10.1016/j.archoralbio.2019.07.002; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tanaka T, 2008, J AGR FOOD CHEM, V56, P5864, DOI 10.1021/jf800921r; Triantafilou K, 2000, CYTOMETRY, V41, P316, DOI 10.1002/1097-0320(20001201)41:4<316::AID-CYTO10>3.3.CO;2-Q; Tung YT, 2008, BIORESOURCE TECHNOL, V99, P3908, DOI 10.1016/j.biortech.2007.07.050; Tung YT, 2010, PHARM BIOL, V48, P1130, DOI 10.3109/13880200903527728; Veilleux MP, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2730-2; Wu Q, 2017, CELL PHYSIOL BIOCHEM, V41, P1360, DOI 10.1159/000465455; Yanakiev S, 2020, MOLECULES, V25, DOI 10.3390/molecules25184184; Yucel-Lindberg T, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.8; ZAPPA U, 1991, J CLIN PERIODONTOL, V18, P508, DOI 10.1111/j.1600-051X.1991.tb00082.x	45	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0244805	10.1371/journal.pone.0244805	http://dx.doi.org/10.1371/journal.pone.0244805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439867	Green Published, gold			2022-12-26	WOS:000609985300034
J	Zucchi, D; Tani, C; Elefante, E; Stagnaro, C; Carli, L; Signorini, V; Ferro, F; Trentin, F; Fulvio, G; Cardelli, C; Di Battista, M; Governato, G; Figliomeni, A; Mosca, M				Zucchi, Dina; Tani, Chiara; Elefante, Elena; Stagnaro, Chiara; Carli, Linda; Signorini, Viola; Ferro, Francesco; Trentin, Francesca; Fulvio, Giovanni; Cardelli, Chiara; Di Battista, Marco; Governato, Gianmaria; Figliomeni, Antonio; Mosca, Marta			Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: Weighting the risk of infection and flare	PLOS ONE			English	Article							COVID-19	Introduction The aim of this study was to investigate the incidence and clinical presentation of SARS-CoV-2 infections in a Systemic Lupus Erythematosus (SLE) cohort; to assess correlations with disease characteristics and rheumatic therapy; and to evaluate the occurrence of treatment discontinuation and its impact on disease activity. Materials and methods SLE patients monitored by a single Italian centre were interviewed between February and July 2020. Patients were considered to be positive for SARS-CoV-2 infections in case of 1) positive nasopharyngeal swab; 2) positive serology associated with COVID19 suggesting symptoms. The following data were also recorded: clinical symptoms, adoption of social distancing measures, disease activity and treatment discontinuation. Results 332 patients were enrolled in the study. Six patients (1.8%) tested positive for SARS-CoV-2 infection, with the incidence being significantly higher in the subgroup of patients treated with biological Disease-Modifying Anti-Rheumatic Drugs (p = 0.005), while no difference was observed for other therapies, age at enrollment, disease duration, type of cumulative organ involvement or adoption of social isolation. The course of the disease was mild. Thirty-six patients (11.1%) discontinued at least part of their therapy during this time period, and 27 (8.1%) cases of disease flare were recorded. Correlation between flare and discontinuation of therapy was statistically significant (p<0.001). No significant increase of rate of flare in a subgroup of the same patients during 2020 was observed. Conclusion Treatment discontinuation seems to be an important cause of disease flare. Our findings suggest that abrupt drug withdrawal should be avoided or evaluated with caution on the basis of individual infection risk and comorbidities.	[Zucchi, Dina; Tani, Chiara; Elefante, Elena; Stagnaro, Chiara; Carli, Linda; Signorini, Viola; Ferro, Francesco; Trentin, Francesca; Fulvio, Giovanni; Cardelli, Chiara; Di Battista, Marco; Governato, Gianmaria; Figliomeni, Antonio; Mosca, Marta] Univ Pisa, Dept Clin & Expt Med, Rheumatol Unit, Pisa, Italy	University of Pisa	Mosca, M (corresponding author), Univ Pisa, Dept Clin & Expt Med, Rheumatol Unit, Pisa, Italy.	marta.mosca@med.unipi.it	Cardelli, Chiara/AHD-5350-2022; Fulvio, Giovanni/AHD-4533-2022	Cardelli, Chiara/0000-0001-6407-6213; Fulvio, Giovanni/0000-0003-0130-4412; Zucchi, Dina/0000-0002-2161-2562; Di Battista, Marco/0000-0002-4788-5729				Aringer M, 2019, ARTHRITIS RHEUMATOL, V71, P1400, DOI [10.1002/art.40930, 10.1136/annrheumdis-2018-214819]; Bozzalla Cassione E, 2020, ANN RHEUMATIC DIS; Danza A, 2013, LUPUS, V22, P1286, DOI 10.1177/0961203313493032; Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Griffiths B, 2005, BEST PRACT RES CL RH, V19, P685, DOI 10.1016/j.berh.2005.03.010; Kastritis E, 2020, RHEUMATOL INT, V40, P1353, DOI 10.1007/s00296-020-04629-x; Landewe Robert Bm, 2020, Ann Rheum Dis, V79, P851, DOI 10.1136/annrheumdis-2020-217877; Mathian A, 2020, ANN RHEUM DIS, V79, P837, DOI 10.1136/annrheumdis-2020-217566; Ministry of Health, 2020, DAT PROC MAN IT CIV; Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630; Rostaing L, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002025; Scire CA, 2020, CLIN EXP RHEUMATOL, V38, P748; Worldometers, 2020, REAL TIM STAT PROJ; Zen M, 2020, J AUTOIMMUN, V112, DOI 10.1016/j.jaut.2020.102502	15	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0245274	10.1371/journal.pone.0245274	http://dx.doi.org/10.1371/journal.pone.0245274			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439910	Green Published, gold			2022-12-26	WOS:000609985300050
J	Sarnak, DO; Wood, SN; Zimmerman, LA; Karp, C; Makumbi, F; Kibira, SPS; Moreau, C				Sarnak, Dana O.; Wood, Shannon N.; Zimmerman, Linnea A.; Karp, Celia; Makumbi, Fredrick; Kibira, Simon P. S.; Moreau, Caroline			The role of partner influence in contraceptive adoption, discontinuation, and switching in a nationally representative cohort of Ugandan women	PLOS ONE			English	Article							UNMET NEED; COUPLES; POWER; NEGOTIATION; BEHAVIOR	Background Understanding contraceptive use dynamics is critical to addressing unmet need for contraception. Despite evidence that male partners may influence contraceptive decision-making, few studies have prospectively examined the supportive ways that men influence women's contraceptive use and continuation. Objective This study sought to understand the predictive effect of partner influence, defined as partner's fertility intentions and support for contraception, and discussions about avoiding pregnancy prior to contraceptive use, on contraceptive use dynamics (continuation, discontinuation, switching, adoption) over a one-year period. Methods This study uses nationally representative longitudinal data of Ugandan women aged 15-49 collected in 2018-2019 (n = 4,288 women baseline; n = 2,755 women one-year follow-up). Two analytic sub-samples of women in union and in need of contraception at baseline were used (n = 618 contraceptive users at baseline for discontinuation/switching analysis; n = 687 contraceptive non-users at baseline for adoption analysis). Primary dependent variables encompassed contraceptive use dynamics (continuation, discontinuation, switching, and adoption); three independent variables assessed partner influence. For each sub-sample, bivariate associations explored differences in sociodemographic and partner influences by contraceptive dynamics. Multinomial regression models were used to examine discontinuation and switching for contraceptive users at baseline; logistic regression identified predictors of contraceptive adoption among non-users at baseline. Results Among users at baseline, 26.3% of women switched methods and 31.5% discontinued contraceptive use by follow-up. Multinomial logistic regression, adjusting for women's characteristics, indicated the relative risk of contraceptive discontinuation doubled when women did not discuss pregnancy avoidance with their partner prior to contraceptive use. Partner influence was not related to method switching. Among non-users at baseline, partner support for future contraceptive use was associated with nearly three-fold increased odds of contraceptive adoption. Significance These results highlight the potentially supportive role of male partners in contraceptive adoption. Future research is encouraged to elucidate the complex pathways between couple-based decision-making and contraceptive dynamics through further prospective studies.	[Sarnak, Dana O.; Wood, Shannon N.; Zimmerman, Linnea A.; Karp, Celia; Moreau, Caroline] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA; [Makumbi, Fredrick] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Kibira, Simon P. S.] Makerere Univ, Sch Publ Hlth, Dept Community Hlth & Behav Sci, Kampala, Uganda; [Moreau, Caroline] INSERM, Soins & Sante Primaire, CESP Ctr Res Epidemiol & Populat Hlth U1018, Villejuif, France	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University; Makerere University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Sarnak, DO (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.	dsarnak1@jhu.edu		Zimmerman, Linnea A/0000-0002-0118-0889; Kibira, Simon Peter Sebina/0000-0002-7385-423X; MAKUMBI, FREDRICK/0000-0002-6460-7325; Sarnak, Dana/0000-0003-3976-4860; Wood, Shannon/0000-0003-4389-3526	Bill & Melinda Gates Foundation, Seattle, WA [OPP1163880]	Bill & Melinda Gates Foundation, Seattle, WA(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation, Seattle, WA [OPP1163880; Investigator: AO Tsui]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MM, 2010, STUD FAMILY PLANN, V41, P129, DOI 10.1111/j.1728-4465.2010.00234.x; [Anonymous], 2019, NAT METHODS, V16, P1, DOI 10.1038/s41592-018-0292-8; [Anonymous], 2014, LANCET INFECT DIS, V14, P1, DOI 10.1016/S1473-3099(13)70368-2; [Anonymous], 2018, AM J TRANSPLANT S1, V18, P10, DOI DOI 10.1109/JSEN.2018.2870228; Baschieri A, 2013, J BIOSOC SCI, V45, P145, DOI 10.1017/S0021932012000569; Bawah AA, 2002, STUD FAMILY PLANN, V33, P185, DOI 10.1111/j.1728-4465.2002.00185.x; Blanc AK, 2002, STUD FAMILY PLANN, V33, P127, DOI 10.1111/j.1728-4465.2002.00127.x; Bradley SE., 2009, DHS ANAL STUDIES; Choiriyyah I, 2018, STUD FAMILY PLANN, V49, P143, DOI 10.1111/sifp.12053; Dereuddre R, 2017, SOC SCI RES, V64, P263, DOI 10.1016/j.ssresearch.2016.10.004; Eliason S, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-34; Ezeanolue EE, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2216-1; Harrington EK, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0669-x; Harrington EK, 2016, CULT HEALTH SEX, V18, P453, DOI 10.1080/13691058.2015.1091507; Heck CJ, 2018, CONTRACEPTION, V98, P41, DOI 10.1016/j.contraception.2018.02.017; Jain AK, 2017, STUD FAMILY PLANN, V48, P269, DOI 10.1111/sifp.12023; Jain Anrudh K, 2013, Int Perspect Sex Reprod Health, V39, P133, DOI 10.1363/3913313; Karp C, 2020, SOC SCI MED, V258, DOI 10.1016/j.socscimed.2020.113086; Kibira SPS, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08977-y; Koffi AK, 2012, STUD FAMILY PLANN, V43, P33, DOI 10.1111/j.1728-4465.2012.00300.x; Mack N, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004317.pub5; Mackenzie ASC, 2020, INFLUENCES PARTNER O; Malama K, 2020, AM J OBSTET GYNECOL, V222, DOI 10.1016/j.ajog.2020.01.007; Miller E, 2010, CONTRACEPTION, V81, P316, DOI 10.1016/j.contraception.2009.12.004; Miller WB, 2004, POP STUD-J DEMOG, V58, P193, DOI 10.1080/0032472042000213712; Mumah JN, 2015, STUD FAMILY PLANN, V46, P369, DOI 10.1111/j.1728-4465.2015.00038.x; Norris A, 2017, DOES IT MATTER SHES; Obare F, 2021, CULT HEALTH SEX, V23, P1748, DOI 10.1080/13691058.2020.1807605; Pearson E, 2014, STUD FAMILY PLANN, V45, P339, DOI 10.1111/j.1728-4465.2014.00395.x; Sarnak D, PREDICTIVE UTILITY U, DOI [10.1016/j.conx.2020.100022, DOI 10.1016/J.C0NX.2020.100022]; Sedgh G, 2014, STUD FAMILY PLANN, V45, P151, DOI 10.1111/j.1728-4465.2014.00382.x; Silverman JG, 2020, ECLINICALMEDICINE, V22, DOI 10.1016/j.eclinm.2020.100359; Silverman JG, 2019, SSM-POPUL HLTH, V9, DOI 10.1016/j.ssmph.2019.100484; Staveteig S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182076; Tsui AO, 2017, POPUL DEV REV, V43, P166, DOI 10.1111/padr.12051; USAID, 2020, DEM HLTH SURV STAT C; Wingood GM, 2000, HEALTH EDUC BEHAV, V27, P539, DOI 10.1177/109019810002700502; Wolff B, 2000, STUD FAMILY PLANN, V31, P124, DOI 10.1111/j.1728-4465.2000.00124.x; Zimmerman L, 2017, STUD FAMILY PLANN, V48, P293, DOI 10.1111/sifp.12031	39	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0238662	10.1371/journal.pone.0238662	http://dx.doi.org/10.1371/journal.pone.0238662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4SP	33434205	gold, Green Published			2022-12-26	WOS:000609979700050
J	Choi, S; Han, S; Nah, S; Lee, YH; Cho, YS; Lim, H; Kim, MS; Kim, GW				Choi, Sungwoo; Han, Sangsoo; Nah, Sangun; Lee, Young Hwan; Cho, Young Soon; Lim, Hoon; Kim, Myeong Sik; Kim, Gi Woon			Effect of ethanol in carbon monoxide poisoning and delayed neurologic sequelae: A prospective observational study	PLOS ONE			English	Article								Objectives Carbon monoxide (CO) is one of the most common poisoning substances, which causes mortality and morbidity worldwide. Delayed neurologic sequelae (DNS) have been reported to occur from several days to months after exposure to CO. Thus, there is a need for prevention, recognition, and treatment of DNS. Patients with CO poisoning as a component of intentional suicide often also consume ethanol, but there is debate regarding its role in DNS. We explored whether ethanol has a neuroprotective effect in CO poisoning. Methods This prospective observational study included patients who visited the emergency department from August 2016 to August 2019 due to CO poisoning. After treatment of acute CO poisoning, patients were interviewed by telephone to ascertain whether DNS had occurred within 2 weeks, 1 month, and 3 months from the time of CO exposure. Results During the study period, 171 patients were enrolled. 28 patients (16.37%) developed DNS. The initial Glasgow Coma Scale (GCS) scores were 15 (10.5-15) for the non-DNS group and 10 (7-15) for the DNS group (p = 0.002). The ethanol levels were 11.01 +/- 17.58 mg/dL and 1.49 +/- 2.63 mg/dL for each group (p < 0.001). In multivariate logistic regression analysis, the GCS score had an odds ratio of 0.770 (p < 0.001) and the ethanol level had 0.882 (p < 0.030) for onset of DNS. Conclusions Higher ethanol level and higher initial GCS score were associated with lower incidence of DNS. Ethanol could have a neuroprotective effect on the occurrence of DNS in CO poisoning patients.	[Choi, Sungwoo; Han, Sangsoo; Nah, Sangun; Lee, Young Hwan; Cho, Young Soon; Lim, Hoon; Kim, Myeong Sik; Kim, Gi Woon] Soonchunhyang Univ, Dept Emergency Med, Bucheon Hosp, Bucheon Si, Gyeonggi Do, South Korea	Soonchunhyang University	Kim, GW (corresponding author), Soonchunhyang Univ, Dept Emergency Med, Bucheon Hosp, Bucheon Si, Gyeonggi Do, South Korea.	flyingguy0202@daum.net	Han, Sangsoo/AAK-5908-2020	Han, Sangsoo/0000-0002-9709-3332; Cho, Young Soon/0000-0002-6843-9517; Choi, Sungwoo/0000-0001-6548-4921; Nah, Sangun/0000-0003-2667-2211	Soonchunhyang University Research Fund [20200031]	Soonchunhyang University Research Fund	This work was supported by the Soonchunhyang University Research Fund (Grant no. 20200031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleecker Margit L, 2015, Handb Clin Neurol, V131, P191, DOI 10.1016/B978-0-444-62627-1.00024-X; Budygin EA, 2001, J PHARMACOL EXP THER, V297, P27; Chandrasekar A, 2017, INT IMMUNOPHARMACOL, V51, P66, DOI 10.1016/j.intimp.2017.08.002; CHOI IS, 1983, ARCH NEUROL-CHICAGO, V40, P433, DOI 10.1001/archneur.1983.04050070063016; Douglas JG, 2016, INTRO CLIN NEUROLOGY, V5th ed, P43; Ernst A, 1998, NEW ENGL J MED, V339, P1603, DOI 10.1056/NEJM199811263392206; Galea M, 2005, AUST J PHYSIOTHER, V51, P198, DOI 10.1016/S0004-9514(05)70034-9; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Hampson NB, 2015, UNDERSEA HYPERBAR M, V42, P159; Hampson NB, 2013, J EMERG MED, V44, P625, DOI 10.1016/j.jemermed.2012.08.033; Heuvel FO, 2019, BRAIN BEHAV IMMUN, V81, P228, DOI 10.1016/j.bbi.2019.06.019; Hopkins RO, 2007, AM J RESP CRIT CARE, V176, P1001, DOI 10.1164/rccm.200702-290OC; Huang CC, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100349; Jasper BW, 2005, COGN BEHAV NEUROL, V18, P127, DOI 10.1097/01.wnn.0000160820.07836.cf; Jeon SB, 2018, JAMA NEUROL, V75, P436, DOI 10.1001/jamaneurol.2017.4618; Kim GT, 2014, RESUSCITATION, V85, pS110; Kim HH, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009569; Kuroda H, 2015, NEUROTOXICOLOGY, V48, P35, DOI 10.1016/j.neuro.2015.03.002; Liao SC, 2019, J NEUROL SCI, V396, P187, DOI 10.1016/j.jns.2018.11.025; Liao WC, 2019, J FORMOS MED ASSOC, V118, P821, DOI 10.1016/j.jfma.2018.09.005; Mimura K, 1999, Seishin Shinkeigaku Zasshi, V101, P592; Moon JM, 2020, CLIN TOXICOL, V58, P161, DOI 10.1080/15563650.2019.1625915; Oh S, 2015, NEURAL REGEN RES, V10, P36, DOI 10.4103/1673-5374.150644; Prockop LD, 2007, J NEUROL SCI, V262, P122, DOI 10.1016/j.jns.2007.06.037; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Sonmez BM, 2018, TURK J EMERG MED, V18, P167, DOI 10.1016/j.tjem.2018.04.002; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; Weaver LK, 2009, NEW ENGL J MED, V360, P1217, DOI 10.1056/NEJMcp0808891; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121	29	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0245265	10.1371/journal.pone.0245265	http://dx.doi.org/10.1371/journal.pone.0245265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428685	gold, Green Published			2022-12-26	WOS:000630036100050
J	Ferreira, LB; da Cunha, FF; Zanetti, SS				Ferreira, Lucas Borges; da Cunha, Fernando Franca; Zanetti, Sidney Sara			Selecting models for the estimation of reference evapotranspiration for irrigation scheduling purposes	PLOS ONE			English	Article								Alternative models for the estimation of reference evapotranspiration (ETo) are typically assessed using traditional error metrics, such as root mean square error (RMSE), which may not be sufficient to select the best model for irrigation scheduling purposes. Thus, this study analyzes the performance of the original and calibrated Hargreaves-Samani (HS), Romanenko (ROM) and Jensen-Haise (JH) equations, initially assessed using traditional error metrics, for use in irrigation scheduling, considering the simulation of different irrigation intervals/time scales. Irrigation scheduling was simulated using meteorological data collected in Vicosa-MG and Mocambinho-MG, Brazil. The Penman-Monteith FAO-56 equation was used as benchmark. In general, the original equations did not perform well to estimate ETo, except the ROM and HS equations used at Vicosa and Mocambinho, respectively. Calibration and the increase in the time scale provided performance gains. When applied in irrigation scheduling, the calibrated HS and JH equations showed the best performances. Even with greater errors in estimating ETo, the calibrated HS equation performed similarly or better than the calibrated JH equation, as it had errors with greater potential to be canceled during the soil water balance. Finally, in addition to using error metrics, the performance of the models throughout the year should be considered in their assessment. Furthermore, simulating the application of ETo models in irrigation scheduling can provide valuable information for choosing the most suitable model.	[Ferreira, Lucas Borges; da Cunha, Fernando Franca] Univ Fed Vicosa, Dept Agr Engn, Vicosa, MG, Brazil; [Zanetti, Sidney Sara] Univ Fed Espirito Santo, Dept Forest & Wood Sci, Alegre, ES, Brazil	Universidade Federal de Vicosa; Universidade Federal do Espirito Santo	Ferreira, LB (corresponding author), Univ Fed Vicosa, Dept Agr Engn, Vicosa, MG, Brazil.	contato.lucasbf@gmail.com	Zanetti, Sidney S./L-8263-2013	Zanetti, Sidney S./0000-0001-9135-3925	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; CNPq, National Council for Scientific and Technological Development - Brazil	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq, National Council for Scientific and Technological Development - Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The present study was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001 and CNPq, National Council for Scientific and Technological Development - Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Almorox J, 2018, THEOR APPL CLIMATOL, V131, P693, DOI 10.1007/s00704-016-1996-2; [Anonymous], 1963, J IRR DRAIN DIV-ASCE, DOI [10.1061/JRCEA4.0000287, DOI 10.1061/JRCEA4.0000287]; Antonopoulos VZ, 2017, COMPUT ELECTRON AGR, V132, P86, DOI 10.1016/j.compag.2016.11.011; Bernardo S., 2019, MANUAL IRRIGACAO, V9<feminine; Ferreira LB, 2020, PESQUI AGROPECU BRAS, V55, DOI [10.1590/s1678-3921.pab2020.v55.01839, 10.1590/S1678-3921.pab2020.v55.01839]; Ferreira LB, 2019, J HYDROL, V572, P556, DOI 10.1016/j.jhydrol.2019.03.028; Gu Z, 2020, J IRRIG DRAIN ENG, V146, DOI 10.1061/(ASCE)IR.1943-4774.0001464; Hadria R, 2021, J ARID ENVIRON, V184, DOI 10.1016/j.jaridenv.2020.104318; Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; Hargreaves GH, 2003, J IRRIG DRAIN ENG, V129, P53, DOI 10.1061/(ASCE)0733-9437(2003)129:1(53); Liu XY, 2017, AGR WATER MANAGE, V184, P145, DOI 10.1016/j.agwat.2017.01.017; Mehdizadeh S, 2017, COMPUT ELECTRON AGR, V139, P103, DOI 10.1016/j.compag.2017.05.002; Pandey PK, 2016, INT SOIL WATER CONSE, V4, P52, DOI 10.1016/j.iswcr.2016.02.003; Pereira LS, 2020, AGR WATER MANAGE, DOI [10.1016/j.agwat.2020.106583, DOI 10.1016/J.AGWAT.2020.106583]; Pereira LS, 2015, AGR WATER MANAGE, V147, P4, DOI 10.1016/j.agwat.2014.07.031; Quej VH, 2019, J HYDROL ENG, V24, DOI 10.1061/(ASCE)HE.1943-5584.0001747; Ramadan KM, 2018, COMPUT ELECTRON AGR, DOI [10.1016/j.compag.2018.09.037, DOI 10.1016/J.COMPAG.2018.09.037]; Santos IS, 2020, BIOSCI J, V36, P886, DOI 10.14393/BJ-v36n3a2020-47862; Vellidis G, 2016, COMPUT ELECTRON AGR, V127, P249, DOI 10.1016/j.compag.2016.06.021; Wu LF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217520	21	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0245270	10.1371/journal.pone.0245270	http://dx.doi.org/10.1371/journal.pone.0245270			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428674	Green Published, gold			2022-12-26	WOS:000630036100051
J	Song, YY; Yu, HY; Baek, SK; Lee, YH; Lee, MW				Song, Yong-Yeon; Yu, Hwa-Young; Baek, Seung-Kook; Lee, Young-Hoon; Lee, Min-Woo			Short-term effect of anti-VEGF for chronic central serous chorioretinopathy according to the presence of choroidal neovascularization using optical coherence tomography angiography	PLOS ONE			English	Article								Purpose To analyze the short-term therapeutic efficacy of intravitreal injection of bevacizumab (IVB) for chronic central serous chorioretinopathy (CSC) according to the presence of choroidal neovascularization (CNV) using optical coherence tomography angiography (OCTA). Methods A retrospective chart review was perfomed on cases of CSC with CNV (Group 1: n = 31) and an age-matched cases of CSC without CNV (Group 2: n = 30). The response to IVB was evaluated by changes in best-corrected visual acuity (BCVA), central macular thickness (CMT), choroidal thickness (CT), and pachyvessel diameter. Univariate and multivariate linear regression analyses were performed to identify factors associated with the visual outcome of chronic CSC with CNV after IVB. Results At baseline, the CT values differed significantly between Groups 1 and 2 (371.55 +/- 67.09 vs. 417.33 +/- 71.32 mu m, p = 0.01). In Group 1, BCVA improved significantly (p < 0.001), and CMT (p < 0.001), CT (p = 0.001) and pachyvessel diameter (p = 0.045) decreased significantly, after IVB. In Group 2, only pachyvessel diameter (p = 0.001) was significantly smaller after IVB. Univariate analysis showed that the initial CT (B = 0.002, p = 0.026) and pachyvessel diameter (B = 0.002, p = 0.001) significantly affected visual outcome. In multivariate analysis, the initial pachyvessel diameter exhibited significant results (B = 0.002, p = 0.001). Conclusions IVB showed less effective short-term outcomes in chronic CSC patients without CNV than in patients with CNV. In chronic CSC with CNV, the short-term visual outcome after IVB was better in patients with a thinner choroid and smaller pachyvessels.	[Song, Yong-Yeon; Yu, Hwa-Young; Baek, Seung-Kook; Lee, Young-Hoon; Lee, Min-Woo] Konyang Univ, Dept Ophthalmol, Coll Med, Daejeon, South Korea	Konyang University; Konyang University Hospital	Lee, MW (corresponding author), Konyang Univ, Dept Ophthalmol, Coll Med, Daejeon, South Korea.	bogus1105@gmail.com		lee, minwoo/0000-0002-5614-077X				Arsan A, 2018, EYE, V32, P726, DOI 10.1038/eye.2017.293; Baek J, 2019, CLIN EXP OPHTHALMOL, V47, P498, DOI 10.1111/ceo.13438; Baek J, 2018, GRAEF ARCH CLIN EXP, V256, P2309, DOI 10.1007/s00417-018-4143-1; Bonini MA, 2015, JAMA OPHTHALMOL, V133, P899, DOI 10.1001/jamaophthalmol.2015.1320; Bousquet E, 2018, RETINA-J RET VIT DIS, V38, P629, DOI 10.1097/IAE.0000000000001580; BRANCATO R, 1987, GRAEF ARCH CLIN EXP, V225, P166, DOI 10.1007/BF02175443; Chan WM, 2007, AM J OPHTHALMOL, V143, P977, DOI 10.1016/j.ajo.2007.02.039; Chung YR, 2013, EYE, V27, P1339, DOI 10.1038/eye.2013.236; Chung YR, 2019, RETINA-J RET VIT DIS, V39, P134, DOI 10.1097/IAE.0000000000001917; Coscas G, 2016, DEV OPHTHALMOL, V56, P37, DOI 10.1159/000442775; Dansingani KK, 2016, RETINA-J RET VIT DIS, V36, P499, DOI 10.1097/IAE.0000000000000742; Dansingani KK, 2015, AM J OPHTHALMOL, V160, P1243, DOI 10.1016/j.ajo.2015.08.028; de Carlo TE, 2016, OSLI RETINA, V47, P128, DOI 10.3928/23258160-20160126-05; Fung AT, 2012, RETINA-J RET VIT DIS, V32, P1829, DOI 10.1097/IAE.0b013e3182680a66; Huang WC, 2009, EYE, V23, P488, DOI 10.1038/eye.2008.55; Inoue M, 2011, OPHTHALMOLOGICA, V225, P37, DOI 10.1159/000314709; Kim GA, 2015, EYE, V29, P732, DOI 10.1038/eye.2015.58; Lai TYY, 2018, RETINA-J RET VIT DIS, V38, P1464, DOI 10.1097/IAE.0000000000001744; Lee MW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229134; LEVINE R, 1989, OPHTHALMOLOGY, V96, P854; Loo RH, 2002, RETINA-J RET VIT DIS, V22, P19, DOI 10.1097/00006982-200202000-00004; Matsumoto H, 2020, JPN J OPHTHALMOL, V64, P203, DOI 10.1007/s10384-020-00722-7; Matsumoto H, 2018, JPN J OPHTHALMOL, V62, P144, DOI 10.1007/s10384-018-0562-0; Montero JA, 2011, EUR J OPHTHALMOL, V21, P503, DOI 10.5301/EJO.2011.6290; Moreira-Neto CA, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/8125267; Nagai N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47738-9; Nicholson B, 2013, SURV OPHTHALMOL, V58, P103, DOI 10.1016/j.survophthal.2012.07.004; Padron-Perez N, 2018, INVEST OPHTH VIS SCI, V59, P1119, DOI 10.1167/iovs.17-22144; Quaranta-El Maftouhi M, 2015, AM J OPHTHALMOL, V160, P581, DOI 10.1016/j.ajo.2015.06.016; Savastano MC, 2021, RETINA-J RET VIT DIS, V41, P302, DOI 10.1097/IAE.0000000000002810; Schaal KB, 2009, EUR J OPHTHALMOL, V19, P613, DOI 10.1177/112067210901900415; Schworm B, 2020, GRAEF ARCH CLIN EXP, V258, P1013, DOI 10.1007/s00417-020-04623-w; Shiraki K, 1997, INT OPHTHALMOL, V21, P43, DOI 10.1023/A:1005898714237; Spaide RF, 2018, PROG RETIN EYE RES, V64, P1, DOI 10.1016/j.preteyeres.2017.11.003; Sulzbacher F, 2019, GRAEF ARCH CLIN EXP, V257, P1581, DOI 10.1007/s00417-019-04297-z; Wang M, 2008, ACTA OPHTHALMOL, V86, P126, DOI 10.1111/j.1600-0420.2007.00889.x; Yannuzzi LA, 2010, AM J OPHTHALMOL, V149, P361, DOI 10.1016/j.ajo.2009.11.017	37	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0245342	10.1371/journal.pone.0245342	http://dx.doi.org/10.1371/journal.pone.0245342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428683	gold, Green Published			2022-12-26	WOS:000630036100060
J	Kothapalli, A; Staecker, H; Mellott, AJ				Kothapalli, Abihith; Staecker, Hinrich; Mellott, Adam J.			Supervised machine learning for automated classification of human Wharton's Jelly cells and mechanosensory hair cells	PLOS ONE			English	Article							GENE-THERAPY; REGENERATION; ALGORITHM	Tissue engineering and gene therapy strategies offer new ways to repair permanent damage to mechanosensory hair cells (MHCs) by differentiating human Wharton's Jelly cells (HWJCs). Conventionally, these strategies require the classification of each cell as differentiated or undifferentiated. Automated classification tools, however, may serve as a novel method to rapidly classify these cells. In this paper, images from previous work, where HWJCs were differentiated into MHC-like cells, were examined. Various cell features were extracted from these images, and those which were pertinent to classification were identified. Different machine learning models were then developed, some using all extracted data and some using only certain features. To evaluate model performance, the area under the curve (AUC) of the receiver operating characteristic curve was primarily used. This paper found that limiting algorithms to certain features consistently improved performance. The top performing model, a voting classifier model consisting of two logistic regressions, a support vector machine, and a random forest classifier, obtained an AUC of 0.9638. Ultimately, this paper illustrates the viability of a novel machine learning pipeline to automate the classification of undifferentiated and differentiated cells. In the future, this research could aid in automated strategies that determine the viability of MHC-like cells after differentiation.	[Kothapalli, Abihith] Blue Valley West High Sch, Overland Pk, KS USA; [Staecker, Hinrich] Univ Kansas, Med Ctr, Dept Otolaryngol Head & Neck Surg, Kansas City, KS 66103 USA; [Mellott, Adam J.] Univ Kansas, Med Ctr, Dept Plast Surg, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Mellott, AJ (corresponding author), Univ Kansas, Med Ctr, Dept Plast Surg, Kansas City, KS 66103 USA.	amellott@kumc.edu		Kothapalli, Abihith/0000-0002-7517-342X				Al Shalabi L, 2006, DEPCOS-RELCOMEX 2006, P207; Cruz-Roa AA, 2013, LECT NOTES COMPUT SC, V8150, P403, DOI 10.1007/978-3-642-40763-5_50; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Bewick V, 2005, CRIT CARE, V9, P112, DOI 10.1186/cc3045; Breiman L., 2001, MACH LEARN, V45, P5; Buitinck L, 2013, ARXIV PREPRINT ARXIV; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chalfoun J, 2015, J MICROSC-OXFORD, V260, P86, DOI 10.1111/jmi.12269; Chauhan NK, 2018, 2018 INTERNATIONAL CONFERENCE ON COMPUTING, POWER AND COMMUNICATION TECHNOLOGIES (GUCON), P340; Chira S, 2015, ONCOTARGET, V6, P30675, DOI 10.18632/oncotarget.5169; Chu C, 2012, NEUROIMAGE, V60, P59, DOI 10.1016/j.neuroimage.2011.11.066; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cox BC, 2014, DEVELOPMENT, V141, P816, DOI 10.1242/dev.103036; Cunningham P., 2020, ARXIV PREPRINT ARXIV; Dean J., 2012, NIPS; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Forge A, 2000, AUDIOL NEURO-OTOL, V5, P3, DOI 10.1159/000013861; Goldberger J., 2005, NEURIPS; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; HANSEN LK, 1990, IEEE T PATTERN ANAL, V12, P993, DOI 10.1109/34.58871; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kesser BW, 2009, ADV OTO-RHINO-LARYNG, V66, P64, DOI 10.1159/000218208; Kim J, 2020, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00443; Lee S-I., 2006, EFFICIENT L 1 REGULA; Levin A, 2018, J TISSUE ENG, V9, DOI 10.1177/2041731418781696; LI CH, 1993, PATTERN RECOGN, V26, P617, DOI 10.1016/0031-3203(93)90115-D; Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Mellott AJ, 2015, TISSUE ENG PT A, V21, P1795, DOI [10.1089/ten.tea.2014.0340, 10.1089/ten.TEA.2014.0340]; Mohan N, 2015, REGEN MED, V10, P709, DOI 10.2217/rme.15.38; Murtagh F., 1991, NEUROCOMPUTING, V2, P183, DOI [10.1016/0925-2312(91)90023-5, DOI 10.1016/0925-2312(91)90023-5]; Neal CA, 2018, JOVE-J VIS EXP, DOI 10.3791/56523; Nguyen AH, 2019, J BIOL ENG, V13, DOI 10.1186/s13036-019-0185-0; Oei RW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213626; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Osisanwo F.Y., 2017, INT J COMPUT TRENDS, V48, P128, DOI DOI 10.14445/22312803/IJCTT-V48P126; Parker MA, 2011, J SPEECH LANG HEAR R, V54, P1709, DOI 10.1044/1092-4388(2011/10-0149); Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Phaisangittisagul E, 2016, P INT CONF INTELL, P174, DOI 10.1109/ISMS.2016.14; PRAAGMAN J, 1985, EUR J OPER RES, V19, P144, DOI 10.1016/0377-2217(85)90321-2; Pudil P, 1998, FEATURE EXTRACTION C; Ronaghi M, 2014, STEM CELLS DEV, V23, P1275, DOI 10.1089/scd.2014.0033; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; SAUNDERS JE, 1995, OTOLARYNG HEAD NECK, V113, P23, DOI 10.1016/S0194-5998(95)70140-0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shahjalal M A, 2019, 2019 IEEE 62 INT MID; Shouval R, 2015, J CLIN ONCOL, V33, P3144, DOI 10.1200/JCO.2014.59.1339; Singh A, 2016, PROCEEDINGS OF THE 10TH INDIACOM - 2016 3RD INTERNATIONAL CONFERENCE ON COMPUTING FOR SUSTAINABLE GLOBAL DEVELOPMENT, P1310; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604; Syeda-Mahmood T, 2018, J AM COLL RADIOL, V15, P569, DOI 10.1016/j.jacr.2018.01.028; Thomsen K, 2020, J DERMATOL TREAT, V31, P496, DOI 10.1080/09546634.2019.1682500; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028	54	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0245234	10.1371/journal.pone.0245234	http://dx.doi.org/10.1371/journal.pone.0245234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4OF	33417611	Green Published, gold			2022-12-26	WOS:000630020100023
J	Lu, YW; Li, XD; Liu, HL; Xue, J; Zeng, Z; Dong, XR; Zhang, T; Wu, G; Yang, KY; Xu, SB				Lu, Yanwei; Li, Xudong; Liu, Hongli; Xue, Jun; Zeng, Zhen; Dong, Xiaorong; Zhang, Tao; Wu, Gang; Yang, Kunyu; Xu, Shuangbing			beta-Trcp and CK1 delta-mediated degradation of LZTS2 activates PI3K/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma	ONCOGENE			English	Article							ZIPPER TUMOR-SUPPRESSOR; UBIQUITIN LIGASE; MEDIATED DEGRADATION; RADIORESISTANCE; PROLIFERATION; PROTEINS; CATENIN; FAMILY; EXPORT	Distant metastasis is the leading cause of treatment failure in patients with hepatocellular carcinoma (HCC). However, the underlying mechanisms have not been fully elucidated. Here, we report that Leucine zipper tumor suppressor 2 (LZTS2) is downregulated and correlated with poor prognosis in HCC. Furthermore, we provide evidence that LZTS2 associates with p85 to inhibit the activation of PI3K/AKT signaling and impairs HCC tumorigenesis and metastasis in vitro and in vivo. Moreover, we identify LZTS2 as a bona fide substrate of the E3 ligase beta-Trcp and protein kinase CK1 delta, which are responsible for the ubiquitination and degradation of LZTS2. Importantly, we show that the beta-Trcp and CK1 delta-mediated degradation of LZTS2 promotes HCC progression and metastasis by activating PI3K/AKT signaling. Collectively, our study not only illustrates the roles of LZTS2 in regulating HCC tumorigenesis and metastasis but also reveals a novel posttranslational modification of LZTS2 by beta-Trcp and CK1 delta, indicating that the beta-Trcp/CK1 delta/LZTS2/PI3K axis may be a novel oncogenic driver involved in HCC progression and metastasis.	[Lu, Yanwei; Li, Xudong; Liu, Hongli; Xue, Jun; Zeng, Zhen; Dong, Xiaorong; Zhang, Tao; Wu, Gang; Yang, Kunyu; Xu, Shuangbing] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology	Wu, G; Yang, KY; Xu, SB (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan 430022, Peoples R China.	xhzlwg@163.com; yangky71@aliyun.com; xsb723@hust.edu.cn		Xu, Shuangbing/0000-0002-9166-7788	Hubei Provincial Natural Science Fund for Distinguished Young Scholars [2019CFA063]; National Natural Science Foundation of China [81874041]; Wuhan Science and Technology Bureau [2019020701011437]	Hubei Provincial Natural Science Fund for Distinguished Young Scholars; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan Science and Technology Bureau	This work was supported by the Hubei Provincial Natural Science Fund for Distinguished Young Scholars (2019CFA063 to SX), the National Natural Science Foundation of China (81874041 to SX), and the grants from the Wuhan Science and Technology Bureau (2019020701011437 to SX).	Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014; Buetow L, 2016, NAT REV MOL CELL BIO, V17, P626, DOI 10.1038/nrm.2016.91; Cabeza-Arvelaiz Y, 2001, ONCOGENE, V20, P6707, DOI 10.1038/sj.onc.1204866; Cui QZ, 2013, J HISTOCHEM CYTOCHEM, V61, P659, DOI 10.1369/0022155413495875; Dehan E, 2009, MOL CELL, V33, P109, DOI 10.1016/j.molcel.2008.12.020; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Huang LY., 2018, NAT COMMUN, V9; Huang YM, 2018, THERANOSTICS, V8, P1286, DOI 10.7150/thno.22552; Johnson DT, 2013, J BIOL CHEM, V288, P3727, DOI 10.1074/jbc.M112.417568; Kim JM, 2011, MOL CELL BIOCHEM, V346, P125, DOI 10.1007/s11010-010-0599-y; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Li YY, 2011, J BIOL CHEM, V286, P45116, DOI 10.1074/jbc.M111.267328; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Lu YW, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.434; Ma J, 2018, CELL DEATH DIFFER, V25, P1473, DOI 10.1038/s41418-017-0055-6; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Peng Y, 2011, J BIOL CHEM, V286, P40331, DOI 10.1074/jbc.M111.302059; Rosenberg LH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8773; Senft D, 2018, NAT REV CANCER, V18, P69, DOI 10.1038/nrc.2017.105; Shaik S, 2012, J EXP MED, V209, P1289, DOI 10.1084/jem.20112446; Shen ZS, 2018, WORLD J SURG ONCOL, V16, DOI 10.1186/s12957-018-1349-y; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Thyssen G, 2006, MOL CELL BIOL, V26, P8857, DOI 10.1128/MCB.01031-06; Wang ZF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7833; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wen W, 2012, HEPATOLOGY, V55, P1787, DOI 10.1002/hep.25596; Xie J, 2018, THERANOSTICS, V8, P650, DOI 10.7150/thno.21963; Xu SB, 2018, CANCER LETT, V420, P38, DOI 10.1016/j.canlet.2018.01.067; Xu SB, 2014, MOL CELL PROTEOMICS, V13, P2986, DOI 10.1074/mcp.M113.036699; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Zhang DM, 2014, J MOL NEUROSCI, V53, P637, DOI 10.1007/s12031-014-0230-x; Zheng NN, 2016, BBA-REV CANCER, V1866, P12, DOI 10.1016/j.bbcan.2016.05.001; Zheng NN, 2016, INT J BIOCHEM CELL B, V73, P99, DOI 10.1016/j.biocel.2016.02.005	37	6	6	4	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2021	40	7					1269	1283		10.1038/s41388-020-01596-2	http://dx.doi.org/10.1038/s41388-020-01596-2		JAN 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QK0LS	33420362	Green Published, hybrid			2022-12-26	WOS:000607346000010
J	Rangel, J; Shepherd, TF; Gonzalez, AN; Hillhouse, A; Konganti, K; Ing, NH				Rangel, Juliana; Shepherd, Tonya F.; Gonzalez, Alejandra N.; Hillhouse, Andrew; Konganti, Kranti; Ing, Nancy H.			Transcriptomic analysis of the honey bee (Apis mellifera) queen spermathecae reveals genes that may be involved in sperm storage after mating	PLOS ONE			English	Article							RNA-SEQ DATA; SEMINAL FLUID; INSEMINATION VOLUME; EFFECTIVE PATERNITY; ALPHA-GLUCOSIDASE; EXPRESSION; DROSOPHILA; VIABILITY; PROTEOME; TREHALASE	Honey bee (Apis mellifera) queens have a remarkable organ, the spermatheca, which successfully stores sperm for years after a virgin queen mates. This study uniquely characterized and quantified the transcriptomes of the spermathecae from mated and virgin honey bee queens via RNA sequencing to identify differences in mRNA levels based on a queen's mating status. The transcriptome of drone semen was analyzed for comparison. Samples from three individual bees were independently analyzed for mated queen spermathecae and virgin queen spermathecae, and three pools of semen from ten drones each were collected from three separate colonies. In total, the expression of 11,233 genes was identified in mated queen spermathecae, 10,521 in virgin queen spermathecae, and 10,407 in drone semen. Using a cutoff log(2) fold-change value of 2.0, we identified 212 differentially expressed genes between mated and virgin spermathecal queen tissues: 129 (1.4% of total) were up-regulated and 83 (0.9% of total) were down-regulated in mated queen spermathecae. Three genes in mated queen spermathecae, three genes in virgin queen spermathecae and four genes in drone semen that were more highly expressed in those tissues from the RNA sequencing data were further validated by real time quantitative PCR. Among others, expression of Kielin/chordin-like and Trehalase mRNAs was highest in the spermathecae of mated queens compared to virgin queen spermathecae and drone semen. Expression of the mRNA encoding Alpha glucosidase 2 was higher in the spermathecae of virgin queens. Finally, expression of Facilitated trehalose transporter 1 mRNA was greatest in drone semen. This is the first characterization of gene expression in the spermathecae of honey bee queens revealing the alterations in mRNA levels within them after mating. Future studies will extend to other reproductive tissues with the purpose of relating levels of specific mRNAs to the functional competence of honey bee queens and the colonies they head.	[Rangel, Juliana; Shepherd, Tonya F.; Gonzalez, Alejandra N.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Hillhouse, Andrew; Konganti, Kranti] Texas A&M Univ, Texas A&M Inst Genome Sci & Soc, College Stn, TX USA; [Ing, Nancy H.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Rangel, J (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	jrangel@tamu.edu			USDA-NIFA award [2015-67013-23170]; Texas AgriLife Research Hatch Project [TEX09557]	USDA-NIFA award; Texas AgriLife Research Hatch Project	This study was supported in part by funding to JR and NHI from a USDA-NIFA award (2015-67013-23170), and by Texas AgriLife Research Hatch Project (TEX09557) to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lawati H, 2009, J INSECT PHYSIOL, V55, P116, DOI 10.1016/j.jinsphys.2008.10.010; ALUMOT E, 1969, COMP BIOCHEM PHYSIOL, V28, P1419, DOI 10.1016/0010-406X(69)90579-9; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ayutthaya PPN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198484; Baer B, 2005, APIDOLOGIE, V36, P187, DOI 10.1051/apido:2005013; Baer B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r67; Baer B, 2009, PROTEOMICS, V9, P2085, DOI 10.1002/pmic.200800708; Berg S, 1997, APIDOLOGIE, V28, P449, DOI 10.1051/apido:19970611; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chiba S, 1997, BIOSCI BIOTECH BIOCH, V61, P1233, DOI 10.1271/bbb.61.1233; Cobey SW, 2007, APIDOLOGIE, V38, P390, DOI 10.1051/apido:2007029; Collins AM, 2006, INSECT MOL BIOL, V15, P541, DOI 10.1111/j.1365-2583.2006.00674.x; Collins AM, 2000, APIDOLOGIE, V31, P421, DOI 10.1051/apido:2000132; Collins AM, 2004, INSECT MOL BIOL, V13, P141, DOI 10.1111/j.0962-1075.2004.00469.x; Collins AM, 1999, THERIOGENOLOGY, V51, P1513, DOI 10.1016/S0093-691X(99)00094-1; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; den Boer SPA, 2008, BEHAV ECOL SOCIOBIOL, V62, P1843, DOI 10.1007/s00265-008-0613-5; den Boer SPA, 2009, J INSECT PHYSIOL, V55, P538, DOI 10.1016/j.jinsphys.2009.01.012; GESSNER B, 1976, J INSECT PHYSIOL, V22, P1469, DOI 10.1016/0022-1910(76)90212-2; Gogel S, 2006, MOL CELL NEUROSCI, V33, P188, DOI 10.1016/j.mcn.2006.07.004; Gonzalez AN, 2018, APIDOLOGIE, V49, P224, DOI 10.1007/s13592-017-0546-y; Gorshkov V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125068; Gotoh A, 2017, SCI REP-UK, V7, P5972, DOI [10.1038/s41598-017-05818-8, DOI 10.1038/s41598-017-05818-8]; Harbo J.R., 1986, P361; Heifetz Y, 2010, THERIOGENOLOGY, V73, P723, DOI 10.1016/j.theriogenology.2009.11.001; Holman L, 2009, FUNCT ECOL, V23, P180, DOI 10.1111/j.1365-2435.2008.01509.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ishimaru Y, 2016, P NATL ACAD SCI USA, V113, P5634, DOI 10.1073/pnas.1600612113; Kaewmuangmoon J, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-16; Kanamori Y, 2010, INSECT BIOCHEM MOLEC, V40, P30, DOI 10.1016/j.ibmb.2009.12.006; Katoh Y, 2009, J BIOL CHEM, V284, P27646, DOI 10.1074/jbc.M109.034884; Keller L, 1998, INSECT SOC, V45, P235, DOI 10.1007/s000400050084; Kilaparty SP, 2014, EVOL BIOINFORM, V10, P239, DOI 10.4137/EBO.S18948; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; King M, 2011, J INSECT PHYSIOL, V57, P409, DOI 10.1016/j.jinsphys.2010.12.011; Klenk M, 2004, APIDOLOGIE, V35, P371, DOI 10.1051/apido:2004029; Koeniger G., 1986, BEE BREEDING GENETIC, P235; Kubota M, 2004, BIOSCI BIOTECH BIOCH, V68, P2346, DOI 10.1271/bbb.68.2346; Liberti J, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1144-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Masuoka Y, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007338; Nino EL, 2013, INSECT MOL BIOL, V22, P233, DOI 10.1111/imb.12016; Nino EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078637; Nino EL, 2012, J INSECT PHYSIOL, V58, P1082, DOI 10.1016/j.jinsphys.2012.04.015; Orr TJ, 2012, CURR BIOL, V22, pR8, DOI 10.1016/j.cub.2011.11.003; Pascini TV, 2017, ZOOLOGY, V121, P56, DOI 10.1016/j.zool.2016.12.001; Pascini TV, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6543-y; Paynter E, 2017, SCI REP-UK, V7, DOI 10.1038/srep40236; Peng T, 2016, INSECT MOL BIOL, V25, P450, DOI 10.1111/imb.12230; Pitnick S, 1999, EVOLUTION, V53, P1804, DOI [10.2307/2640442, 10.1111/j.1558-5646.1999.tb04564.x]; Poland V, 2011, MOL ECOL, V20, P2643, DOI 10.1111/j.1365-294X.2011.05029.x; Ram KR, 2007, INTEGR COMP BIOL, V47, P427, DOI 10.1093/icb/icm046; Richard FJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000980; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Shukla E, 2015, GLYCOBIOLOGY, V25, P357, DOI 10.1093/glycob/cwu125; Snodgrass R.E., 1985, ANATOMY HONEY BEE; Sturup M, 2013, BEHAV ECOL, V24, P1192, DOI 10.1093/beheco/art049; TAKEWAKI S, 1993, BIOSCI BIOTECH BIOCH, V57, P1508, DOI 10.1271/bbb.57.1508; Tarpy DR, 2002, ANN ENTOMOL SOC AM, V95, P513, DOI 10.1603/0013-8746(2002)095[0513:SEEPAE]2.0.CO;2; Tarpy DR, 2004, INSECT SOC, V51, P203, DOI 10.1007/s00040-004-0734-4; VERMA LR, 1973, COMP BIOCHEM PHYSIOL, V44, P1325, DOI 10.1016/0300-9629(73)90272-7; Wilde J, 1994, ZOOTECHNICA, V39, P135; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; Winston M., 1987, The biology of the honey bee.; Wolfner MF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001191; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	71	8	9	7	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0244648	10.1371/journal.pone.0244648	http://dx.doi.org/10.1371/journal.pone.0244648			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4OF	33417615	gold, Green Published			2022-12-26	WOS:000630020100011
J	Yin, LJ; Li, JJ; Wang, J; Pu, TJ; Wei, J; Li, QL; Wu, BJ				Yin, Lijuan; Li, Jingjing; Wang, Jing; Pu, Tianjie; Wei, Jing; Li, Qinlong; Wu, Boyang Jason			MAOA promotes prostate cancer cell perineural invasion through SEMA3C/PlexinA2/NRP1-cMET signaling	ONCOGENE			English	Article							MONOAMINE-OXIDASE; RECEPTOR; METASTASIS; EXPRESSION; GROWTH; NEUROGENESIS; ACTIVATION; MECHANISMS; REGULATOR; SURVIVAL	Perineural invasion (PNI), a pathologic feature defined as cancer cell invasion in, around, and through nerves, is an indicator of poor prognosis and survival in prostate cancer (PC). Despite widespread recognition of the clinical significance of PNI, the molecular mechanisms are largely unknown. Here, we report that monoamine oxidase A (MAOA) is a clinically and functionally important mediator of PNI in PC. MAOA promotes PNI of PC cells in vitro and tumor innervation in an orthotopic xenograft model. Mechanistically, MAOA activates SEMA3C in a Twist1-dependent transcriptional manner, which in turn stimulates cMET to facilitate PNI via autocrine or paracrine interaction with coactivated PlexinA2 and NRP1. Furthermore, MAOA inhibitor treatment effectively reduces PNI of PC cells in vitro and tumor-infiltrating nerve fiber density along with suppressed xenograft tumor growth and progression in mice. Collectively, these findings characterize the contribution of MAOA to the pathogenesis of PNI and provide a rationale for using MAOA inhibitors as a targeted treatment for PNI in PC.	[Yin, Lijuan; Li, Qinlong] Cedars Sinai Med Ctr, Dept Med, Samuel Oschin Comprehens Canc Inst, Urooncol Res Program, Los Angeles, CA 90048 USA; [Li, Jingjing; Wang, Jing; Pu, Tianjie; Wei, Jing; Wu, Boyang Jason] Washington State Univ, Coll Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Spokane, WA 99202 USA; [Yin, Lijuan] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu 610041, Sichuan, Peoples R China; [Li, Jingjing] Shanghai Jiao Tong Univ, Sch Pharm, Lab Regener, Shanghai 200240, Peoples R China	Cedars Sinai Medical Center; Washington State University; Sichuan University; Shanghai Jiao Tong University	Wu, BJ (corresponding author), Washington State Univ, Coll Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Spokane, WA 99202 USA.	boyang.wu@wsu.edu	Pu, Tianjie/AFD-8574-2022; Pu, Tianjie/AAE-9454-2022	Li, Jingjing/0000-0002-0661-5642	DOD Prostate Cancer Research Program [W81XWH-15-1-0493, W81XWH-19-1-0279]; NIH/NCI [R37CA233658]; WSU startup fund	DOD Prostate Cancer Research Program; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); WSU startup fund	We thank Gina Chu (Cedars-Sinai Medical Center) for technical help, Leland W.K. Chung (Cedars-Sinai Medical Center) for comprehensive support of this study, and Gary Mawyer for editorial assistance. This work was supported by DOD Prostate Cancer Research Program grants W81XWH-15-1-0493 and W81XWH-19-1-0279, NIH/NCI grant R37CA233658, and the WSU startup fund to BJW.	Ayala GE, 2008, CLIN CANCER RES, V14, P7593, DOI 10.1158/1078-0432.CCR-08-1164; Bakst RL, 2016, J NEUROL SURG PART B, V77, P96, DOI 10.1055/s-0036-1571835; Binmadi NO, 2012, AM J PATHOL, V180, P1232, DOI 10.1016/j.ajpath.2011.12.009; Bortolato M, 2008, ADV DRUG DELIVER REV, V60, P1527, DOI 10.1016/j.addr.2008.06.002; CARDEN MJ, 1987, J NEUROSCI, V7, P3489; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Chen WR, 2007, J PERIPHER NERV SYST, V12, P121, DOI 10.1111/j.1529-8027.2007.00131.x; Chilton JK, 2006, DEV BIOL, V292, P13, DOI 10.1016/j.ydbio.2005.12.048; Ciftci S, 2015, PROSTATE, V75, P1783, DOI 10.1002/pros.23067; DeLancey JO, 2013, UROLOGY, V81, P354, DOI 10.1016/j.urology.2012.09.034; Deng XY, 2014, CANCER TREAT REV, V40, P730, DOI 10.1016/j.ctrv.2014.04.003; Ding Y, 2013, CLIN CANCER RES, V19, P6101, DOI 10.1158/1078-0432.CCR-12-3669; Eide T, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-4; Flamand V, 2010, J CANCER RES CLIN, V136, P1761, DOI 10.1007/s00432-010-0835-6; Gaur S, 2019, PROSTATE, V79, P667, DOI 10.1002/pros.23774; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; He SB, 2014, P NATL ACAD SCI USA, V111, pE2008, DOI 10.1073/pnas.1402944111; Herman JG, 2007, INT J ONCOL, V30, P1231; Huyett P, 2017, JOVE-J VIS EXP, DOI 10.3791/55043; Jobling P, 2015, CANCER RES, V75, P1777, DOI 10.1158/0008-5472.CAN-14-3180; Khatiwada P, 2020, PEERJ, V8, DOI 10.7717/peerj.8921; Knudsen BS, 2002, UROLOGY, V60, P1113, DOI 10.1016/S0090-4295(02)01954-4; KO KR, 2018, SCI REP UK, V8; Kraus RD, 2019, ADV RADIAT ONCOL, V4, P96, DOI 10.1016/j.adro.2018.09.006; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Li JJ, 2020, ONCOGENE, V39, P3305, DOI 10.1038/s41388-020-1217-4; Liebig C, 2009, CANCER-AM CANCER SOC, V115, P3379, DOI 10.1002/cncr.24396; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Maru N, 2001, HUM PATHOL, V32, P828, DOI 10.1053/hupa.2001.26456; Parra LM, 2010, NAT NEUROSCI, V13, P29, DOI 10.1038/nn.2457; Peacock JW, 2018, EMBO MOL MED, V10, P219, DOI 10.15252/emmm.201707689; Pundavela J, 2014, AM J PATHOL, V184, P3156, DOI 10.1016/j.ajpath.2014.08.009; Saloman JL, 2016, TRENDS NEUROSCI, V39, P880, DOI 10.1016/j.tins.2016.10.002; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Swiercz JM, 2004, J CELL BIOL, V165, P869, DOI 10.1083/jcb.200312094; Tam KJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11914-6; Tam KJ, 2017, ONCOTARGET, V8, P9617, DOI 10.18632/oncotarget.14168; True L, 2006, P NATL ACAD SCI USA, V103, P10991, DOI 10.1073/pnas.0603678103; VILLERS A, 1989, J UROLOGY, V142, P763, DOI 10.1016/S0022-5347(17)38881-X; Westerink RHS, 2008, ACTA PHYSIOL, V192, P273, DOI 10.1111/j.1748-1716.2007.01805.x; Wong VV, 1997, J BIOL CHEM, V272, P5187, DOI 10.1074/jbc.272.8.5187; Wu JB, 2017, CANCER CELL, V31, P368, DOI 10.1016/j.ccell.2017.02.003; Wu JB, 2014, J CLIN INVEST, V124, P2891, DOI 10.1172/JCI70982; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhang DX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10798	47	15	15	6	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2021	40	7					1362	1374		10.1038/s41388-020-01615-2	http://dx.doi.org/10.1038/s41388-020-01615-2		JAN 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QK0LS	33420365	Green Accepted			2022-12-26	WOS:000607346000001
J	Rahman, MM; Mohiuddin, M; Keka, IS; Yamada, K; Tsuda, M; Sasanuma, H; Andreani, J; Guerois, R; Borde, V; Charbonnier, JB; Takeda, S				Rahman, Md Maminur; Mohiuddin, Mohiuddin; Keka, Islam Shamima; Yamada, Kousei; Tsuda, Masataka; Sasanuma, Hiroyuki; Andreani, Jessica; Guerois, Raphael; Borde, Valerie; Charbonnier, Jean-Baptiste; Takeda, Shunichi			Genetic evidence for the involvement of mismatch repair proteins, PMS2 and MLH3, in a late step of homologous recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						homologous recombination; PMS2; MLH3; MLH1; MUS81; GEN1; resolvase; joint molecules; mutL homolog 1 (MLH1); mutL homolog 3 (MLH3); Holliday junction; endonuclease	STRAND-BREAK REPAIR; HOLLIDAY JUNCTION RESOLUTION; MUTL-ALPHA; DNA-REPAIR; ESSENTIAL ROLES; HUMAN-CELLS; MUS81; ENDONUCLEASE; MAINTENANCE; PATHWAYS	Homologous recombination (HR) repairs DNA double-strand breaks using intact homologous sequences as template DNA. Broken DNA and intact homologous sequences form joint molecules (JMs), including Holliday junctions (HJs), as HR intermediates. HJs are resolved to form crossover and noncrossover products. A mismatch repair factor, MLH3 endonuclease, produces the majority of crossovers during meiotic HR, but it remains elusive whether mismatch repair factors promote HR in nonmeiotic cells. We disrupted genes encoding the MLH3 and PMS2 endonucleases in the human B cell line, TK6, generating null MLH3(-/-) and PMS2(-/-) mutant cells. We also inserted point mutations into the endonuclease motif of MLH3 and PMS2 genes, generating endonuclease death MLH3(DN/DN) and PMS2(EK/EK) cells. MLH3(-/-) and MLH3(DN/DN) cells showed a very similar phenotype, a 2.5-fold decrease in the frequency of heteroallelic HR-dependent repair of restriction enzyme-induced double-strand breaks. PMS2(-/-) and PMS2(EK/EK) cells showed a phenotype very similar to that of the MLH3 mutants. These data indicate that MLH3 and PMS2 promote HR as an endonuclease. The MLH3(DN/DN) and PMS2(EK/EK) mutations had an additive effect on the heteroallelic HR. MLH3(DN/DN)/PMS2(EK/EK) cells showed normal kinetics of gamma-irradiation-induced Rad51 foci but a significant delay in the resolution of Rad51 foci and a 3-fold decrease in the number of cisplatin-induced sister chromatid exchanges. The ectopic expression of the Gen1 HJ re-solvase partially reversed the defective heteroallelic HR of MLH3(DN/DN)/PMS2(EK/EK) cells. Taken together, we propose that MLH3 and PMS2 promote HR as endonucleases, most likely by processing JMs in mammalian somatic cells.	[Rahman, Md Maminur; Mohiuddin, Mohiuddin; Keka, Islam Shamima; Yamada, Kousei; Tsuda, Masataka; Sasanuma, Hiroyuki; Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Yoshida Konoe Cho, Kyoto, Japan; [Andreani, Jessica; Guerois, Raphael; Charbonnier, Jean-Baptiste] Univ Paris Saclay, CNRS, Commissariat Energie Atom CEA, Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France; [Borde, Valerie] PSL Res Univ, UMR3244, CNRS, Inst Curie, Paris, France; [Mohiuddin, Mohiuddin; Keka, Islam Shamima] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON, Canada; [Tsuda, Masataka] Hiroshima Univ, Grad Sch Integrated Sci Life, Program Math & Life Sci, Higashihiroshima, Japan	Kyoto University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Hiroshima University	Takeda, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Yoshida Konoe Cho, Kyoto, Japan.	stakeda@rg.med.kyoto-u.ac.jp	Charbonnier, Jean-Baptiste/A-3868-2009; Mohiuddin, Mohiuddin/AAD-5338-2022	Charbonnier, Jean-Baptiste/0000-0002-5219-1983; Mohiuddin, Mohiuddin/0000-0003-1899-6734; Keka, Shamima Islam/0000-0002-7826-2508; Tsuda, Masataka/0000-0002-1267-3777; Andreani, Jessica/0000-0003-4435-9093	Ministry of Education, Science, Sport, and Culture [KAKENHI 25650006, 23221005, 19K22561, 16H06306, KAKENHI 16H02953, 18H04900, 19H04267]; Agence Nationale de la Recherche (ANR) Grant [ANR-15-CE11-0011]; French Infrastructure for Integrated Structural Biology (FRISBI) Grant [ANR-10-INBS-05]; Japan Society for the Promotion of Science Core-to-Core Program, Advanced Research Networks	Ministry of Education, Science, Sport, and Culture; Agence Nationale de la Recherche (ANR) Grant(French National Research Agency (ANR)); French Infrastructure for Integrated Structural Biology (FRISBI) Grant; Japan Society for the Promotion of Science Core-to-Core Program, Advanced Research Networks(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was directly supported by grants-in-aid from the Ministry of Education, Science, Sport, and Culture (KAKENHI 25650006, 23221005, 19K22561, and 16H06306 (to S. T.) and KAKENHI 16H02953, 18H04900, and 19H04267 (to H. S.)), Agence Nationale de la Recherche (ANR) Grant ANR-15-CE11-0011 (to V. B. and J.-B. C.), and by French Infrastructure for Integrated Structural Biology (FRISBI) Grant ANR-10-INBS-05 (to J.-B. C.). This work was also supported by the Japan Society for the Promotion of Science Core-to-Core Program, Advanced Research Networks (to S. T.). This study was conducted through the Joint Research Program of the Radiation Biology Center, Kyoto.	Abraham J, 2003, EMBO J, V22, P6137, DOI 10.1093/emboj/cdg580; Al-Sweel N, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006974; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; Bannister LA, 2004, DNA REPAIR, V3, P465, DOI 10.1016/j.dnarep.2004.01.001; Bernstein KA, 2009, CELL, V137, P807, DOI 10.1016/j.cell.2009.05.007; Cannavo E, 2020, NATURE, V586, P618, DOI 10.1038/s41586-020-2592-2; Castor D, 2013, MOL CELL, V52, P221, DOI 10.1016/j.molcel.2013.08.036; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chan YW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5844; Chen PC, 2005, CANCER RES, V65, P8662, DOI 10.1158/0008-5472.CAN-05-0742; Deschenes SM, 2007, CANCER LETT, V249, P148, DOI 10.1016/j.canlet.2006.08.008; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Elliott B, 2001, MOL CELL BIOL, V21, P2671, DOI 10.1128/MCB.21.8.2671-2682.2001; Fischer JM, 2016, DNA REPAIR, V39, P46, DOI 10.1016/j.dnarep.2015.12.011; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Fowler P, 2010, MUTAT RES-GEN TOX EN, V702, P171, DOI 10.1016/j.mrgentox.2010.02.016; Fujita M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060043; Garner E, 2013, CELL REP, V5, P207, DOI 10.1016/j.celrep.2013.08.041; Goellner EM, 2015, DNA REPAIR, V32, P24, DOI 10.1016/j.dnarep.2015.04.010; Gueneau E, 2013, NAT STRUCT MOL BIOL, V20, P461, DOI 10.1038/nsmb.2511; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hodskinson MRG, 2014, MOL CELL, V54, P472, DOI 10.1016/j.molcel.2014.03.014; Hoffmann ER, 2004, CYTOGENET GENOME RES, V107, P232, DOI 10.1159/000080601; Honma M, 2003, ENVIRON MOL MUTAGEN, V42, P288, DOI 10.1002/em.10201; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Jiricny J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012633; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kadyrova LY, 2020, P NATL ACAD SCI USA, V117, P3535, DOI 10.1073/pnas.1914718117; Kaur H, 2015, MOL CELL, V57, P583, DOI 10.1016/j.molcel.2015.01.020; Keka IS, 2015, NUCLEIC ACIDS RES, V43, P6359, DOI 10.1093/nar/gkv621; Kikuchi K, 2013, CANCER RES, V73, P4362, DOI 10.1158/0008-5472.CAN-12-3154; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kulkarni DS, 2020, NATURE, V586, P623, DOI 10.1038/s41586-020-2645-6; Kunkel TA, 2015, ANNU REV GENET, V49, P291, DOI 10.1146/annurev-genet-112414-054722; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; Lorenz A, 2010, NUCLEIC ACIDS RES, V38, P1866, DOI 10.1093/nar/gkp1179; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Matton N, 2000, J BIOL CHEM, V275, P17808, DOI 10.1074/jbc.M909794199; McPherson JP, 2004, SCIENCE, V304, P1822, DOI 10.1126/science.1094557; Mehta A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016428; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Mohiuddin, 2016, DNA REPAIR, V40, P67, DOI 10.1016/j.dnarep.2016.02.002; Mohiuddin, 2014, ARCH TOXICOL, V88, P145, DOI 10.1007/s00204-013-1084-7; Mohiuddin M, 2019, NUCLEIC ACIDS RES, V47, P2966, DOI 10.1093/nar/gkz009; Mohiuddin M, 2018, P NATL ACAD SCI USA, V115, P12793, DOI 10.1073/pnas.1716349115; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Neuwirth EAH, 2007, MOL CELL BIOL, V27, P5261, DOI 10.1128/MCB.01852-06; Hoa NN, 2015, GENES CELLS, V20, P1059, DOI 10.1111/gtc.12310; Nishant KT, 2008, GENETICS, V179, P747, DOI 10.1534/genetics.108.086645; Pamidi A, 2007, CANCER RES, V67, P8527, DOI 10.1158/0008-5472.CAN-07-1161; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakuma T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03379; Sanchez A., 2020, 16876623 BIORXIV, DOI [10.1101/2019.12.16.876623, DOI 10.1101/2019.12.16.876623]; Sarbajna S, 2014, GENE DEV, V28, P1124, DOI 10.1101/gad.238303.114; Schwartz EK, 2011, CHROMOSOMA, V120, P109, DOI 10.1007/s00412-010-0304-7; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Shcherbakova PV, 2001, MOL CELL BIOL, V21, P940, DOI 10.1128/MCB.21.3.940-951.2001; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Shimizu N, 2020, GENOME INSTABILITY D, V1, P184, DOI [10.1007/s42764-020-00015-w, DOI 10.1007/S42764-020-00015-W]; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Srivatsan A, 2014, J BIOL CHEM, V289, P9352, DOI 10.1074/jbc.M114.552190; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Suzuki T, 2016, MOL CELL BIOL, V36, P2877, DOI 10.1128/MCB.00443-16; Svetlanov A, 2008, GENETICS, V178, P1937, DOI 10.1534/genetics.107.084798; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Tang SM, 2015, MOL CELL, V57, P607, DOI 10.1016/j.molcel.2015.01.021; Toledo M, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008177; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Wang XW, 2016, DNA CELL BIOL, V35, P585, DOI 10.1089/dna.2015.3022; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; West SC, 2017, COLD SH Q B, V82, P207, DOI 10.1101/sqb.2017.82.034256; West SC, 2015, COLD SH Q B, V80, P103, DOI 10.1101/sqb.2015.80.027649; Wyatt HDM, 2017, MOL CELL, V65, P848, DOI 10.1016/j.molcel.2017.01.031; Wyatt HDM, 2013, MOL CELL, V52, P234, DOI 10.1016/j.molcel.2013.08.035; Yoshimoto K, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00186; Zakharyevich K, 2012, CELL, V149, P334, DOI 10.1016/j.cell.2012.03.023; Zeng M, 2000, CANCER RES, V60, P4889; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	88	8	9	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17460	17475		10.1074/jbc.RA120.013521	http://dx.doi.org/10.1074/jbc.RA120.013521			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453991	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000603272300007
J	Abdrabou, A; Wang, ZX				Abdrabou, Abdalla; Wang, Zhixiang			Regulation of the nuclear speckle localization and function of Rac1	FASEB JOURNAL			English	Article						hnRNPA1; nuclear speckle; nucleus; PBR; phosphorylation; pre&#8208; mRNA splicing; Rac1; SRSF2; U2 snRNP; U2A&#8242	HNRNP A1; PHOSPHORYLATION; PROTEINS; ACTIVATION; MECHANISM; DYNAMICS; GTPASES; KINASE	Despite significant evidence that Rac1 is localized to the nucleus, little is known regarding the function and biological significance of nuclear Rac1. Here, we showed that in response to EGF Rac1 was translocated to nuclear speckles and co-localized with the nuclear speckle marker Serine/arginine-rich splicing factor 2 (SRSF2) in Cos-7 cells. We also showed that the nuclear speckle localization of Rac1 was dependent on its T108 phosphorylation and facilitated by Rac1 polybasic region (PBR) that contains a nuclear localization signal and Rac1 GTPase activity. To gain insight into the function of Rac1 in nuclear speckles, we searched for Rac1 binding proteins in the nucleus. We isolated nuclear fraction of HEK 293 cells and incubated with GST-Rac1 and the phosphomimetic GST-Rac1T108E. We identified 463 proteins that were associated with GST-Rac1T108E, but not with GST-Rac1 by LC-MS/MS. Three notable groups of these proteins are: the heterogeneous nuclear ribonucleoproteins (hnRNPs), small nuclear ribonucleoproteins (snRNPs), and SRSFs, all of which are involved in pre-mRNA splicing and associated with nuclear speckles. We further showed by co-immunoprecipitation that Rac1 interacts with SRSF2, hnRNPA1, and U2A ' in response to EGF. The interaction is dependent on T108 phosphorylation and facilitated by Rac1 PBR and GTPase activity. We showed that hnRNPA1 translocated in and out of nucleus in response to EGF in a similar pattern to Rac1. Rac1 only partially colocalized with U2A ' that localizes to the actual splicing sites adjacent to nuclear speckle. Finally, we showed that Rac1 regulated EGF-induced pre-mRNA splicing and this is mediated by T108 phosphorylation. We conclude that in response to EGF, T108 phosphorylated Rac1 is targeted to nuclear speckles, interacts with multiple groups of proteins involved in pre-mRNA splicing, and regulates EGF-induced pre-mRNA splicing.	[Abdrabou, Abdalla; Wang, Zhixiang] Univ Alberta, Fac Med & Dent, Dept Med Genet & Signal, Transduct Res Grp, Edmonton, AB, Canada	University of Alberta	Wang, ZX (corresponding author), Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB T6G 2H7, Canada.; Wang, ZX (corresponding author), Univ Alberta, Fac Med & Dent, Signal Transduct Res Grp, Edmonton, AB T6G 2H7, Canada.	zhixiang.wang@ualberta.ca			CIHR [RES0030993] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Abdrabou A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091006; Abdrabou A, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120263; ANDO S, 1992, J BIOL CHEM, V267, P25709; Bekenstein U, 2013, MOL CELL NEUROSCI, V56, P436, DOI 10.1016/j.mcn.2012.12.002; Carrizzo A, 2014, CURR DRUG TARGETS, V15, P1231, DOI 10.2174/1389450115666141027110156; Chang FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028587; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Eilbracht J, 2001, P NATL ACAD SCI USA, V98, P3849, DOI 10.1073/pnas.071042298; Falaleeva M, 2016, P NATL ACAD SCI USA, V113, pE1625, DOI 10.1073/pnas.1519292113; Galganski L, 2017, NUCLEIC ACIDS RES, V45, P10350, DOI 10.1093/nar/gkx759; Goncalves V, 2014, RNA, V20, P474, DOI 10.1261/rna.041376.113; Hall LL, 2006, ANAT REC PART A, V288A, P664, DOI 10.1002/ar.a.20336; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; HEDLEY ML, 1995, P NATL ACAD SCI USA, V92, P11524, DOI 10.1073/pnas.92.25.11524; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Justilien V, 2017, CANCER CELL, V31, P256, DOI 10.1016/j.ccell.2016.12.010; Karpel-Massler G, 2013, MOL CANCER THER, V12, P1783, DOI 10.1158/1535-7163.MCT-13-0052; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Lamond AI, 2003, CURR BIOL, V13, pR825, DOI 10.1016/j.cub.2003.10.012; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Liu M, 2012, TRENDS CELL BIOL, V22, P365, DOI 10.1016/j.tcb.2012.04.004; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Moissoglu K., 2014, CELL LOGIST, V4, pe943618, DOI [10.4161/21592780.2014.943618, DOI 10.4161/21592780.2014.943618]; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Navarro-Lerida I, 2015, DEV CELL, V32, P318, DOI 10.1016/j.devcel.2014.12.019; Olson Michael F, 2018, Small GTPases, V9, P203, DOI 10.1080/21541248.2016.1218407; Orgaz Jose L, 2014, Small GTPases, V5, pe29019, DOI 10.4161/sgtp.29019; Pagani F, 2003, HUM MOL GENET, V12, P1111, DOI 10.1093/hmg/ddg131; Pelisch F, 2012, J CELL BIOCHEM, V113, P2319, DOI 10.1002/jcb.24103; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; Salichs E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000397; Sandrock K, 2010, TRAFFIC, V11, P198, DOI 10.1111/j.1600-0854.2009.01015.x; Schoentaube J, 2009, CELL MICROBIOL, V11, P1816, DOI 10.1111/j.1462-5822.2009.01373.x; Schwarz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044358; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Symons M, 2000, TRENDS CELL BIOL, V10, P415, DOI 10.1016/S0962-8924(00)01832-8; Tong JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147103; Tong JF, 2013, MOL CELL BIOL, V33, P4538, DOI 10.1128/MCB.00822-13; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang F, 2017, CELL RES, V27, P540, DOI 10.1038/cr.2017.7; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014	49	1	2	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21235	10.1096/fj.202001694R	http://dx.doi.org/10.1096/fj.202001694R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33417283				2022-12-26	WOS:000647789600100
J	Kozai, K; Iqbal, K; Moreno-Irusta, A; Scott, RL; Simon, ME; Dhakal, P; Fields, PE; Soares, MJ				Kozai, Keisuke; Iqbal, Khursheed; Moreno-Irusta, Ayelen; Scott, Regan L.; Simon, Mikaela E.; Dhakal, Pramod; Fields, Patrick E.; Soares, Michael J.			Protective role of IL33 signaling in negative pregnancy outcomes associated with lipopolysaccharide exposure	FASEB JOURNAL			English	Article						fetal growth restriction; IL33; lipopolysaccharide; pregnancy outcome; placental development	GROWTH RESTRICTION IMPACTS; NATURAL-KILLER-CELLS; REGULATORY T-CELLS; HEMOCHORIAL PLACENTATION; INTERLEUKIN 33; SOLUBLE ST2; FETAL-DEATH; IN-VIVO; INFLAMMATION; IL-33	Interleukin 33 (IL33) signaling has been implicated in the establishment and maintenance of pregnancy and in pregnancy disorders. The goal of this project was to evaluate the role of IL33 signaling in rat pregnancy. The rat possesses hemochorial placentation with deep intrauterine trophoblast invasion; features also characteristic of human placentation. We generated and characterized a germline mutant rat model for IL33 using CRISPR/Cas9 genome editing. IL33 deficient rats exhibited deficits in lung responses to an inflammatory stimulus (Sephadex G-200) and to estrogen-induced uterine eosinophilia. Female rats deficient in IL33 were fertile and exhibited pregnancy outcomes (gestation length and litter size) similar to wild-type rats. Placental weight was adversely affected by the disruption of IL33 signaling. A difference in pregnancy-dependent adaptations to lipopolysaccharide (LPS) exposure was observed between wild-type and IL33 deficient pregnancies. Pregnancy in wild-type rats treated with LPS did not differ significantly from pregnancy in vehicle-treated wild-type rats. In contrast, LPS treatment decreased fetal survival rate, fetal and placental weights, and increased fetal growth restriction in IL33 deficient rats. In summary, a new rat model for investigating IL33 signaling has been established. IL33 signaling participates in the regulation of placental development and protection against LPS-induced fetal and placental growth restriction.	[Kozai, Keisuke; Iqbal, Khursheed; Moreno-Irusta, Ayelen; Scott, Regan L.; Simon, Mikaela E.; Dhakal, Pramod; Fields, Patrick E.; Soares, Michael J.] Univ Kansas, Inst Reprod & Perinatal Res, Dept Pathol & Lab Med, Med Ctr, Kansas City, KS 66160 USA; [Soares, Michael J.] Univ Kansas, Dept Pediat, Med Ctr, Kansas City, KS 66160 USA; [Soares, Michael J.] Univ Kansas, Dept Obstet & Gynecol, Med Ctr, Kansas City, KS 66160 USA; [Soares, Michael J.] Childrens Mercy, Childrens Mercy Res Inst, Ctr Perinatal Res, Kansas City, MO USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Children's Mercy Hospital	Kozai, K; Soares, MJ (corresponding author), Univ Kansas, Dept Pathol & Lab Med, Med Ctr, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	kkozai@kumc.edu; msoares@kumc.edu	Fields, Patrick E/G-4878-2012	Iqbal, Khursheed/0000-0002-6742-4591; Fields, Patrick/0000-0002-6797-4139; Moreno, Ayelen/0000-0001-6810-6475; Kozai, Keisuke/0000-0003-2645-7431				Ain R, 2006, METH MOLEC MED, V121, P295; Ain R, 2005, J ENDOCRINOL, V185, P253, DOI 10.1677/joe.1.06039; Ain R, 2003, DEV BIOL, V260, P176, DOI 10.1016/S0012-1606(03)00210-0; Altara R, 2018, CARDIOVASC RES, V114, P1578, DOI 10.1093/cvr/cvy166; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Briffa JF, 2017, PLACENTA, V59, P30, DOI 10.1016/j.placenta.2017.09.006; Bronson SL, 2016, NEUROPSYCHOPHARMACOL, V41, P207, DOI 10.1038/npp.2015.231; Bronson SL, 2014, ENDOCRINOLOGY, V155, P2635, DOI 10.1210/en.2014-1040; Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619; Celik H, 2002, EUR J OBSTET GYN R B, V103, P22, DOI 10.1016/S0301-2115(02)00018-0; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chakraborty D, 2016, P NATL ACAD SCI USA, V113, pE7212, DOI 10.1073/pnas.1612626113; Chakraborty D, 2011, P NATL ACAD SCI USA, V108, P16295, DOI 10.1073/pnas.1109478108; Chakraborty S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26590-3; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Chan JC, 2018, BIOL PSYCHIAT, V83, P886, DOI 10.1016/j.biopsych.2017.10.005; Chavan AR, 2017, CURR OPIN GENET DEV, V47, P24, DOI 10.1016/j.gde.2017.08.004; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714; Cotechini T, 2014, PLACENTA, V35, P575, DOI 10.1016/j.placenta.2014.05.002; Cotechini T, 2014, J EXP MED, V211, P165, DOI 10.1084/jem.20130295; Cotechini T, 2012, THROMB HAEMOSTASIS, V107, P864, DOI 10.1160/TH11-10-0730; CROSS M, 1988, P NATL ACAD SCI USA, V85, P6232, DOI 10.1073/pnas.85.17.6232; Dekel N, 2010, AM J REPROD IMMUNOL, V63, P17, DOI 10.1111/j.1600-0897.2009.00792.x; Dyer KD, 2013, IMMUNOL LETT, V150, P41, DOI 10.1016/j.imlet.2012.12.002; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Falcon BJ, 2012, THROMB HAEMOSTASIS, V107, P438, DOI 10.1160/TH11-09-0626; FINN CA, 1986, BIOL REV, V61, P313, DOI 10.1111/j.1469-185X.1986.tb00657.x; Fock V, 2013, J IMMUNOL, V191, P3734, DOI 10.4049/jimmunol.1300490; Gokdemir IE, 2016, J MATERN-FETAL NEO M, V29, P2450, DOI 10.3109/14767058.2015.1087497; Granne I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024463; Guimond MJ, 1997, BIOL REPROD, V56, P169, DOI 10.1095/biolreprod56.1.169; Haddad EB, 2002, J IMMUNOL, V168, P3004, DOI 10.4049/jimmunol.168.6.3004; Horton MA, 1996, J LEUKOCYTE BIOL, V60, P285, DOI 10.1002/jlb.60.2.285; Howerton CL, 2012, HORM BEHAV, V62, P237, DOI 10.1016/j.yhbeh.2012.03.007; Hu WT, 2015, J REPROD IMMUNOL, V109, P52, DOI 10.1016/j.jri.2015.01.004; Huang BH, 2017, NAT MED, V23, P128, DOI 10.1038/nm.4244; Johnston LK, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00051; Johnston LK, 2016, J IMMUNOL, V197, P3445, DOI 10.4049/jimmunol.1600611; Kaitu'u-Lino TJ, 2012, J REPROD IMMUNOL, V95, P46, DOI 10.1016/j.jri.2012.06.003; Kamrani A, 2020, HORM MOL BIOL CLIN I, V41, DOI 10.1515/hmbci-2020-0010; Kleemann R, 1996, EXP TOXICOL PATHOL, V48, P233, DOI 10.1016/S0940-2993(96)80004-2; Krey G, 2008, J MOL MED, V86, P999, DOI 10.1007/s00109-008-0379-2; Kubota K, 2016, P NATL ACAD SCI USA, V113, P4212, DOI 10.1073/pnas.1601825113; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Lin Y, 2006, J REPROD IMMUNOL, V71, P87, DOI 10.1016/j.jri.2006.01.005; Liu J, 2018, EBIOMEDICINE, V33, P196, DOI 10.1016/j.ebiom.2018.06.003; Martin NT, 2016, NAT IMMUNOL, V17, P122, DOI 10.1038/ni.3370; Masiero M, 2013, CANCER CELL, V24, P229, DOI 10.1016/j.ccr.2013.06.004; Matsubara S, 1998, INT ARCH ALLERGY IMM, V116, P67, DOI 10.1159/000023927; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Nteeba J, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001243; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Odegaard JI, 2016, CELL, V166, P841, DOI 10.1016/j.cell.2016.06.040; PIJNENBORG R, 1981, PLACENTA, V2, P71, DOI 10.1016/S0143-4004(81)80042-2; Pijnenborg R., 2010, PLACENTAL BED DISORD, P127; Plaks V, 2008, J CLIN INVEST, V118, P3954, DOI 10.1172/JCI36682; POLLARD JW, 1991, DEV BIOL, V148, P273, DOI 10.1016/0012-1606(91)90336-2; Renaud SJ, 2017, BIOL REPROD, V96, P145, DOI 10.1095/biolreprod.116.142752; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; Robb KP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175805; Romero R, 2018, J MATERN-FETAL NEO M, V31, P418, DOI 10.1080/14767058.2017.1286319; Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005; Salker MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052252; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Scott LM, 2017, CYTOKINE, V99, P194, DOI 10.1016/j.cyto.2017.07.005; Shao YJ, 2014, NAT PROTOC, V9, P2493, DOI 10.1038/nprot.2014.171; SILVER RM, 1994, BIOL REPROD, V50, P1108, DOI 10.1095/biolreprod50.5.1108; Soares MJ, 2012, PLACENTA, V33, P233, DOI 10.1016/j.placenta.2011.11.026; Soares MJ, 2018, BIOL REPROD, V99, P196, DOI 10.1093/biolre/ioy049; SOARES MJ, 1987, J REPROD FERTIL, V79, P93; SPICER BA, 1990, BRIT J PHARMACOL, V101, P821, DOI 10.1111/j.1476-5381.1990.tb14164.x; Stojkovic S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25171; Sykes L, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/967629; TCHERNITCHIN A, 1974, NATURE, V248, P142, DOI 10.1038/248142a0; TCHERNITCHIN X, 1976, DIFFERENTIATION, V5, P151, DOI 10.1111/j.1432-0436.1976.tb00906.x; Tondeleir D, 2009, CELL MOTIL CYTOSKEL, V66, P798, DOI 10.1002/cm.20350; Topping V, 2013, J MATERN-FETAL NEO M, V26, P327, DOI 10.3109/14767058.2012.735724; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Wallgard E, 2008, ARTERIOSCL THROM VAS, V28, P1469, DOI 10.1161/ATVBAHA.108.165738; Wang D, 2000, J ENDOCRINOL, V167, P15, DOI 10.1677/joe.0.1670015; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Wiemers D, 2003, J ENDOCRINOL, V179, P335, DOI 10.1677/joe.0.1790335; Yuan SM, 2015, REV BRAS CIR CARDIOV, V30, P644, DOI 10.5935/1678-9741.20150081; Zhang JH, 2016, CELL TISSUE RES, V363, P249, DOI 10.1007/s00441-015-2315-4; Zhou X., 2018, MEDIAT INFLAMM, V2018, DOI DOI 10.1155/2018/9787239	88	4	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21272	10.1096/fj.202001782RR	http://dx.doi.org/10.1096/fj.202001782RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33423320	Green Accepted			2022-12-26	WOS:000647789600059
J	Salah, MM; Ahmed, EA; Alhussain, ZA; Ahmed, HH; El-Morshedy, M; Eliwa, MS				Salah, Mukhtar M.; Ahmed, Essam A.; Alhussain, Ziyad A.; Ahmed, Hanan Haj; El-Morshedy, M.; Eliwa, M. S.			Statistical inferences for type-II hybrid censoring data from the alpha power exponential distribution	PLOS ONE			English	Article							LIKELIHOOD; PARAMETER	This paper describes a method for computing estimates for the location parameter mu > 0 and scale parameter lambda > 0 with fixed shape parameter alpha of the alpha power exponential distribution (APED) under type-II hybrid censored (T-IIHC) samples. We compute the maximum likelihood estimations (MLEs) of (mu, lambda) by applying the Newton-Raphson method (NRM) and expectation maximization algorithm (EMA). In addition, the estimate hazard functions and reliability are evaluated by applying the invariance property of MLEs. We calculate the Fisher information matrix (FIM) by applying the missing information rule, which is important in finding the asymptotic confidence interval. Finally, the different proposed estimation methods are compared in simulation studies. A simulation example and real data example are analyzed to illustrate our estimation methods.	[Salah, Mukhtar M.; Alhussain, Ziyad A.; Eliwa, M. S.] Majmaah Univ, Dept Math, Coll Sci Al Zulfi, Majmaah, Saudi Arabia; [Ahmed, Essam A.] Sohag Univ, Math Dept, Sohag, Egypt; [Ahmed, Hanan Haj] King Faisal Univ, Dept Basic Sci, Preparatory Year Deanship, Al Hufuf, Al Ahsa, Saudi Arabia; [El-Morshedy, M.] Prince Sattam Bin Abdulaziz Univ, Coll Sci & Humanities Al Kharj, Dept Math, Al Kharj, Saudi Arabia; [El-Morshedy, M.; Eliwa, M. S.] Mansoura Univ, Fac Sci, Dept Math, Mansoura, Egypt	Majmaah University; Egyptian Knowledge Bank (EKB); Sohag University; King Faisal University; Prince Sattam Bin Abdulaziz University; Egyptian Knowledge Bank (EKB); Mansoura University	Ahmed, EA (corresponding author), Sohag Univ, Math Dept, Sohag, Egypt.	essam.mohamed@science.sohag.edu.eg	Eliwa, Mohammed Saber/AAK-6130-2021; El-morshedy, Mahmoud/AAF-3809-2020	Eliwa, Mohammed Saber/0000-0001-5619-210X; El-morshedy, Mahmoud/0000-0002-7585-5519	Deanship of Scientific Research at Majmaah University [RGP-2019-2]	Deanship of Scientific Research at Majmaah University	The authors extend their appreciation to the Deanship of Scientific Research at Majmaah University for funding this work under project number No. (RGP-2019-2).	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Bader M.G., 1982, PROGR SCI ENG COMPOS, P1129, DOI DOI 10.12691/AJAMS-6-5-5; Balakrishnan N, 2013, COMPUT STAT DATA AN, V57, P166, DOI 10.1016/j.csda.2012.03.025; Balakrishnan N, 2012, COMMUN STAT-THEOR M, V41, P1511, DOI 10.1080/03610926.2010.543300; Banerjee A, 2008, IEEE T RELIAB, V57, P369, DOI 10.1109/TR.2008.916890; Childs A, 2003, ANN I STAT MATH, V55, P319, DOI 10.1023/A:1026326020003; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dey S, 2014, STAT METHODOL, V18, P101, DOI 10.1016/j.stamet.2013.07.007; Dong BW, 2018, J ADV TRANSPORT, DOI 10.1155/2018/2702360; EPSTEIN B, 1954, ANN MATH STAT, V25, P555, DOI 10.1214/aoms/1177728723; Greene W.H., 2007, ECONOMETRIC ANAL; Kohansal A, 2015, COMMUN STAT-SIMUL C, V44, P1273, DOI 10.1080/03610918.2013.794285; Kundu D, 2007, J STAT PLAN INFER, V137, P2127, DOI 10.1016/j.jspi.2006.06.043; Kundu D, 2009, COMMUN STAT-THEOR M, V38, P2030, DOI 10.1080/03610920802192505; LOUIS TA, 1982, J ROY STAT SOC B MET, V44, P226; Mahdavi A, 2017, COMMUN STAT-THEOR M, V46, P6543, DOI 10.1080/03610926.2015.1130839; McLachlan G., 2007, EM ALGORITHM EXTENSI, V382; Ng HKT, 2002, COMPUT STAT DATA AN, V39, P371, DOI 10.1016/S0167-9473(01)00091-3; Salah M, 2016, JURNAL PENDIDIKAN DA, V5, P1, DOI [10.18576/jsap/050301, DOI 10.18576/JSAP/050206]; Salah MM, 2020, J MATH-UK, V2020, DOI 10.1155/2020/2584184; Salah MM, 2018, J STAT THEORY APPL, V17, P1; Sen T, 2018, ANN DATA SCI, V5, P679, DOI [10.1007/s40745-018-0158-z, DOI 10.1007/S40745-018-0158-Z]; Sharma VK, 2017, STATISTICA, V77, P385; Singh K., 2017, INT J DATA SCI, V2, P352, DOI [10.1504/IJDS.2017.088104, DOI 10.1504/IJDS.2017.088104]; Singh SK, 2013, INT J SYST ASSUR ENG, V4, P241, DOI 10.1007/s13198-013-0172-7; Zeng Q, 2020, J TRANSP SAF SECUR, V12, P566, DOI 10.1080/19439962.2018.1516259; Zeng Q, 2017, ACCIDENT ANAL PREV, V99, P184, DOI 10.1016/j.aap.2016.11.018	27	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0244316	10.1371/journal.pone.0244316	http://dx.doi.org/10.1371/journal.pone.0244316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471841	Green Published, gold			2022-12-26	WOS:000639428800005
J	Zhao, JH; Zhu, QS; Li, YW; Wang, LL				Zhao, Jian-Hui; Zhu, Qiu-Shuang; Li, Yi-Wen; Wang, Li-Li			Determinants of the intensity of uremic pruritus in patients receiving maintenance hemodialysis: A cross-sectional study	PLOS ONE			English	Article							5-D ITCH SCALE; PARATHYROIDECTOMY; INFLAMMATION	Background Uremic pruritus (UP) is a common and frustrating symptom in patients receiving hemodialysis (HD). The majority of patients have mild to moderate itching of the skin, and a small percentage have severe itching, which seriously affects their quality of life and survival rate. However, little is known about factors that influence the intensity of itching in patients. Methods A cross-sectional study on uremic pruritus in male and female patients receiving HD was conducted in September 2019. This study included 148 eligible patients who received HD at the Blood Purification Center of Xinchang County People's Hospital, Zhejiang Province, China from March 2019 to June 2019. We collected general data consisted of age, sex, body mass index (BMI), place of residence, educational level, diabetes mellitus status and duration of HD; as well as clinical, biochemical indicators, including serum calcium (Ca), serum phosphorus (P), serum albumin (ALB), haemoglobin (Hb), serum intact parathyroid hormone (iPTH), pre-dialysis serum urea nitrogen (BUN), normalized protein catabolic rate (nPCR), urea nitrogen clearance index (KT/V), ferritin (FER) and pre-dialysis serum creatinine (sCR). We also assayed the inflammatory cytokine serum high sensitivity C-reactive protein (hs-CRP). The Five-Dimensional Itching Scale (5DIS) was used to evaluate the degree of skin itching (none, mild, moderate, or severe). We used multiple logistic regression to analyze influencing factors on the degree of skin itching in patients with UP. Results Of the 148 patients, 60 had uremic pruritus (incidence rate, 40.54%). These included 22 cases of mild skin itching (14.86%), 30 of moderate skin itching (20.27%), and 8 of severe skin itching (5.41%). Compared with uremia patients without skin pruritus, patients with UP had higher levels of iPTH, Hb, BUN, nPCR, and hs-CRP. The composition ratio showed significant differences between urban and rural patients with different degrees of skin itching (P = 0.017); moreover, the difference of iPTH and hs-CRP levels were statistically significant (P = 0.009 and < 0.001, respectively). Using no itching as a reference, multiple logistic regression analysis showed that as hs-CRP level increased, the patient's risks of mild skin itching (odds ratio [OR] = 1.740; 95% confidence interval [CI], 1.061-2.854; P = 0.028), moderate skin itching (OR = 2.8838 95% CI, 1.744-4.718; P < 0.001), and severe skin itching (OR = 9.440; 95% CI, 3.547-25.124; P < 0.001) all increased as well. Compared with urban residents, rural residents have a higher risk of moderate itching (OR = 3.869; 95% CI, 1.099-13.622; P = 0.035). Conclusion Levels of hs-CRP were associated with the intensity of skin itching in patients with UP. Higher hs-CRP levels were closely related to severe skin itching. The relationship between the intensity of skin itching and the environment in maintenance hemodialysis patients needs further clarification.	[Zhao, Jian-Hui; Zhu, Qiu-Shuang] Xinchang Cty Peoples Hosp, Dept Nephrol, Shaoxing, Zhejiang, Peoples R China; [Zhao, Jian-Hui; Zhu, Qiu-Shuang; Wang, Li-Li] Xinchang Cty Peoples Hosp, Blood Purificat Ctr, Shaoxing, Zhejiang, Peoples R China; [Li, Yi-Wen] Zhejiang Peoples Hosp, Dept Nephrol, Hangzhou, Zhejiang, Peoples R China		Zhao, JH (corresponding author), Xinchang Cty Peoples Hosp, Dept Nephrol, Shaoxing, Zhejiang, Peoples R China.; Zhao, JH (corresponding author), Xinchang Cty Peoples Hosp, Blood Purificat Ctr, Shaoxing, Zhejiang, Peoples R China.	lyzhaojh@126.com		Zhao, Jianhui/0000-0002-6238-6776				Abdelsalam M, 2019, NEPHRON, V143, P120, DOI 10.1159/000501409; Aliasgharpour M, 2018, J NATL MED ASSOC, V110, P270, DOI 10.1016/j.jnma.2017.04.008; Combs SA, 2015, SEMIN NEPHROL, V35, P383, DOI 10.1016/j.semnephrol.2015.06.009; Depner TA, 1996, J AM SOC NEPHROL, V7, P780; DUO LJ, 1987, NEPHRON, V47, P179, DOI 10.1159/000184487; Elman S, 2010, BRIT J DERMATOL, V162, P587, DOI 10.1111/j.1365-2133.2009.09586.x; Grochulska K, 2019, ACTA DERM-VENEREOL, V99, P423, DOI 10.2340/00015555-3125; Huang WK, 2016, SCI REP-UK, V6, DOI 10.1038/srep23450; Jiang X, 2016, INT UROL NEPHROL, V48, P1533, DOI 10.1007/s11255-016-1364-2; Jing Y, 2015, INT J CLIN EXP MED, V8, P11188; Keithi-Reddy SR, 2007, KIDNEY INT, V72, P373, DOI 10.1038/sj.ki.5002197; Kfoury LW, 2012, J NEPHROL, V25, P644, DOI 10.5301/jn.5000039; Khan TM, 2013, J RENAL CARE, V39, P222, DOI 10.1111/j.1755-6686.2013.12038.x; Kimmel M, 2006, NEPHROL DIAL TRANSPL, V21, P749, DOI 10.1093/ndt/gfi204; Lai JW, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0475-z; Levy AR, 2020, AM J KIDNEY DIS, V75, P373, DOI [10.1053/j.ajkd.2019.07.013, 10.1053/j.ajkd.2019.07013]; Liu MH, 2017, THER CLIN RISK MANAG, V13, P255, DOI 10.2147/TCRM.S129133; Mahmudpour M, 2017, IRAN J KIDNEY DIS, V11, P50; Mettang T, 2015, KIDNEY INT, V87, P685, DOI 10.1038/ki.2013.454; Moldovan D, 2015, INT UROL NEPHROL, V47, P1871, DOI 10.1007/s11255-015-1106-x; Momose A, 2017, NEPHRON, V136, P103, DOI 10.1159/000458417; Nofal E, 2016, J DERMATOL TREAT, V27, P515, DOI 10.3109/09546634.2016.1161161; Pakfetrat M, 2018, HEMODIAL INT, V22, P103, DOI 10.1111/hdi.12540; Rayner HC, 2017, CLIN J AM SOC NEPHRO, V12, P2000, DOI 10.2215/CJN.03280317; Schricker S, 2019, ACTA DERM-VENEREOL, V99, P524, DOI 10.2340/00015555-3128; Shirazian S, 2013, J RENAL NUTR, V23, P428, DOI 10.1053/j.jrn.2013.08.002; Tseng CY, 2018, RENAL FAILURE, V40, P514, DOI 10.1080/0886022X.2018.1512871; Wieczorek A, 2020, J EUR ACAD DERMATOL, V34, P2368, DOI 10.1111/jdv.16360; Zhang Y, 2019, RENAL FAILURE, V41, P921, DOI 10.1080/0886022X.2019.1666724	29	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245370	10.1371/journal.pone.0245370	http://dx.doi.org/10.1371/journal.pone.0245370			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471852	Green Published, gold			2022-12-26	WOS:000639428800034
J	Macauley, C; Heller, M; Rausch, A; Kummel, F; Felfer, P				Macauley, Chandra; Heller, Martina; Rausch, Alexander; Kuemmel, Frank; Felfer, Peter			A versatile cryo-transfer system, connecting cryogenic focused ion beam sample preparation to atom probe microscopy	PLOS ONE			English	Article							LOW COPPER CONTENT; INTERGRANULAR CORROSION; MODEL	Atom probe tomography (APT) is a powerful technique to obtain 3D chemical and structural information, however the 'standard' atom probe experimental workflow involves transfer of specimens at ambient conditions. The ability to transfer air- or thermally-sensitive samples between instruments while maintaining environmental control is critical to prevent chemical or morphological changes prior to analysis for a variety of interesting sample materials. In this article, we describe a versatile transfer system that enables cryogenic- or room-temperature transfer of specimens in vacuum or atmospheric conditions between sample preparation stations, a focused ion beam system (Zeiss Crossbeam 540) and a widely used commercial atom probe system (CAMECA LEAP 4000X HR). As an example for the use of this transfer system, we present atom probe data of gallium- (Ga)-free grain boundaries in an aluminum (Al) alloy specimen prepared with a Ga-based FIB.	[Macauley, Chandra; Heller, Martina; Rausch, Alexander; Kuemmel, Frank; Felfer, Peter] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst 1, Mat Sci & Engn Dept, Erlangen, Germany; [Macauley, Chandra; Heller, Martina] Interdisciplinary Ctr Nanostruct Films IZNF, Erlangen, Germany; [Kuemmel, Frank] Tech Univ Munich, Heinz Maier Leibnitz Zentrum MLZ, Garching, Germany	University of Erlangen Nuremberg; Technical University of Munich	Macauley, C (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst 1, Mat Sci & Engn Dept, Erlangen, Germany.; Macauley, C (corresponding author), Interdisciplinary Ctr Nanostruct Films IZNF, Erlangen, Germany.	chandra.macauley@fau.de		Kummel, Frank/0000-0002-8688-3865; Macauley, Chandra/0000-0002-0405-6007	Bavarian Ministry of Economic Affairs and Media, Energy and Technology [IEK-11]; Deutsche Forschungsgemeinschaft (DFG) via the Cluster of Excellence 'Engineering of Advanced Materials' [EXC 315]	Bavarian Ministry of Economic Affairs and Media, Energy and Technology; Deutsche Forschungsgemeinschaft (DFG) via the Cluster of Excellence 'Engineering of Advanced Materials'(German Research Foundation (DFG))	C.M., M.H. and P.F. acknowledge financial support by the Bavarian Ministry of Economic Affairs and Media, Energy and Technology for the joint projects in the framework of the Helmholtz Institute Erlangen-Nurnberg for Renewable Energy (IEK-11) of Forschungszentrum Juich. The authors would also like to acknowledge funding by the Deutsche Forschungsgemeinschaft (DFG) via the Cluster of Excellence 'Engineering of Advanced Materials' (project EXC 315). The funders provided support in the form of salaries for authors CM and MH, but did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YS, 2017, SCIENCE, V355, P1196, DOI 10.1126/science.aal2418; Dubochet J, 2012, J MICROSC-OXFORD, V245, P221, DOI 10.1111/j.1365-2818.2011.03569.x; Ferrovac, 2019, VSN40 NEXGENERATION, P1; Fisher K., 2016, MICROSC MICROANAL, V22, P692, DOI [10.1017/S1431927616004311, DOI 10.1017/S1431927616004311]; Gault B, 2018, J MATER RES, V33, P4018, DOI 10.1557/jmr.2018.375; Gault B, 2012, MATER TODAY, V15, P378, DOI 10.1016/S1369-7021(12)70164-5; Gault B, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3182351; Gerstl S., 2015, MICROSC MICROANAL, V21, P517, DOI [DOI 10.1017/S1431927615003384, 10.1017/S1431927615003384]; Gerstl SS., 2017, MICROSC MICROANAL, V23, P612, DOI DOI 10.1017/S1431927617003737; Halpin JE, 2019, ULTRAMICROSCOPY, V202, P121, DOI 10.1016/j.ultramic.2019.04.005; Hassan AN, 2003, INT DAIRY J, V13, P755, DOI 10.1016/S0958-6946(03)00101-8; Hausol T, 2010, J PHYS CONF SER, V240, DOI 10.1088/1742-6596/240/1/012128; Heinz A, 2000, MAT SCI ENG A-STRUCT, V280, P102, DOI 10.1016/S0921-5093(99)00674-7; Hugo RC, 1998, SCRIPTA MATER, V38, P523, DOI 10.1016/S1359-6462(97)00464-8; Larsen MH, 2006, MATER SCI FORUM, V519-521, P667, DOI 10.4028/www.scientific.net/MSF.519-521.667; Li YZ, 2017, SCIENCE, V358, P506, DOI 10.1126/science.aam6014; Lilensten L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231179; Mayer J, 2007, MRS BULL, V32, P400, DOI 10.1557/mrs2007.63; McCarroll IE, 2020, MATER TODAY ADV, V7, DOI 10.1016/j.mtadv.2020.100090; McKenzie Z.R., 2010, MICROSCOPY SCI TECHN, P1800, DOI DOI 10.HTTP://WWW.F0RMATEX.INF0/MICR0SC0PY4/1800-1810.PDF; Miller M. K., 2005, MICROSC MICROANAL, V11, P808; MILLER M.K., 1989, ATOM PROBE MICROANAL; Miller MK, 2005, ULTRAMICROSCOPY, V102, P287, DOI 10.1016/J.ULTRAMIC.2004.10.011; Moody MP, 2016, MRS BULL, V41, P40, DOI 10.1557/mrs.2015.311; Moody MP, 2011, ULTRAMICROSCOPY, V111, P493, DOI 10.1016/j.ultramic.2010.11.014; Perea DE, 2017, ADV STRUCT CHEM IMAG, V3, DOI 10.1186/s40679-017-0045-2; Schertel A, 2013, J STRUCT BIOL, V184, P355, DOI 10.1016/j.jsb.2013.09.024; Stephenson LT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209211; Svenningsen G, 2006, CORROS SCI, V48, P226, DOI 10.1016/j.corsci.2004.11.025; Svenningsen G, 2006, CORROS SCI, V48, P1528, DOI 10.1016/j.corsci.2005.05.045; Tang F, 2012, ACTA MATER, V60, P1038, DOI 10.1016/j.actamat.2011.10.061; Thompson K, 2007, ULTRAMICROSCOPY, V107, P131, DOI 10.1016/j.ultramic.2006.06.008; Tsuji N, 1999, SCRIPTA MATER, V40, P795, DOI 10.1016/S1359-6462(99)00015-9; Ulfig RM., 2017, MICROSC MICROANAL, V23, P622, DOI [10.1017/S1431927617003786, DOI 10.1017/S1431927617003786]; Unocic KA, 2010, J MICROSC-OXFORD, V240, P227, DOI 10.1111/j.1365-2818.2010.03401.x; Van Leer B., 2017, MICROSC MICROANAL, V23, P296; Xiao Y, 2017, SCRIPTA MATER, V127, P191, DOI 10.1016/j.scriptamat.2016.08.028	38	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245555	10.1371/journal.pone.0245555	http://dx.doi.org/10.1371/journal.pone.0245555			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465106	Green Published, gold			2022-12-26	WOS:000611969200028
J	Zhu, PP; He, F; Hou, YX; Tu, G; Li, Q; Jin, T; Zeng, H; Qin, YL; Wan, XY; Qiao, YN; Qiu, YX; Teng, Y; Liu, MR				Zhu, Pengpeng; He, Fang; Hou, Yixuan; Tu, Gang; Li, Qiao; Jin, Ting; Zeng, Huan; Qin, Yilu; Wan, Xueying; Qiao, Yina; Qiu, Yuxiang; Teng, Yong; Liu, Manran			A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability	ONCOGENE			English	Article							LNCRNA THOR INCREASES; TUMOR HYPOXIA; PROLIFERATION; METASTASIS; HIF-1-ALPHA; EXPRESSION; BINDING; RECOGNITION; INVASION; FEEDBACK	The hostile hypoxic microenvironment takes primary responsibility for the rapid expansion of breast cancer tumors. However, the underlying mechanism is not fully understood. Here, using RNA sequencing (RNA-seq) analysis, we identified a hypoxia-induced long noncoding RNA (lncRNA) KB-1980E6.3, which is aberrantly upregulated in clinical breast cancer tissues and closely correlated with poor prognosis of breast cancer patients. The enhanced lncRNA KB-1980E6.3 facilitates breast cancer stem cells (BCSCs) self-renewal and tumorigenesis under hypoxic microenvironment both in vitro and in vivo. Mechanistically, lncRNA KB-1980E6.3 recruited insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) to form a lncRNA KB-1980E6.3/IGF2BP1/c-Myc signaling axis that retained the stability of c-Myc mRNA through increasing binding of IGF2BP1 with m6A-modified c-Myc coding region instability determinant (CRD) mRNA. In conclusion, we confirm that lncRNA KB-1980E6.3 maintains the stemness of BCSCs through lncRNA KB-1980E6.3/IGF2BP1/c-Myc axis and suggest that disrupting this axis might provide a new therapeutic target for refractory hypoxic tumors.	[Zhu, Pengpeng; Li, Qiao; Jin, Ting; Zeng, Huan; Qin, Yilu; Wan, Xueying; Qiao, Yina; Qiu, Yuxiang; Liu, Manran] Chongqing Med Univ, Key Lab Lab Med Diagnost, Chinese Minist Educ, Chongqing 400016, Peoples R China; [He, Fang] Chongqing Med Univ, Affiliated Hosp 1, Dept Pharm, Chongqing 400016, Peoples R China; [Hou, Yixuan] Chongqing Med Univ, Expt Teaching Ctr Basic Med Sci, Chongqing 400016, Peoples R China; [Tu, Gang] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing 400016, Peoples R China; [Teng, Yong] Dent Coll Georgia, Dept Oral Biol & Dx Sci, Augusta, GA 30907 USA; [Teng, Yong] Augusta Univ, Georgia Canc Ctr, Augusta, GA 30907 USA	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; University System of Georgia; Augusta University	Liu, MR (corresponding author), Chongqing Med Univ, Key Lab Lab Med Diagnost, Chinese Minist Educ, Chongqing 400016, Peoples R China.	manranliu@cqmu.edu.cn	Teng, Yong/AAK-4160-2020	Teng, Yong/0000-0002-1856-7289	National Natural Science Foundation of China (NSFC) [81874199, 31671481, 81472476]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Natural Science Foundation of China (NSFC 81874199, NSFC 31671481, and NSFC 81472476). We would like to thank Reid Loveless for his help in English language editing.	Adinolfi E, 2012, CANCER RES, V72, P2957, DOI 10.1158/0008-5472.CAN-11-1947; Batlle E, 2017, NAT MED, V23, P1124, DOI 10.1038/nm.4409; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Bhandari V, 2019, NAT GENET, V51, P308, DOI 10.1038/s41588-018-0318-2; Bueno MJ, 2011, BLOOD, V117, P6255, DOI 10.1182/blood-2010-10-315432; Chen X, 2018, CLIN CANCER RES, V24, P2002, DOI 10.1158/1078-0432.CCR-17-2376; Chen Y, 2018, J CLIN INVEST, V128, P1937, DOI 10.1172/JCI95089; Cho SW, 2018, CELL, V173, P1398, DOI 10.1016/j.cell.2018.03.068; Choudhry H, 2016, MOL ASPECTS MED, V47-48, P35, DOI 10.1016/j.mam.2016.01.003; De Los Angeles A, 2015, NATURE, V525, P469, DOI 10.1038/nature15515; Deng SJ, 2018, ONCOGENE, V37, P5811, DOI 10.1038/s41388-018-0382-1; Han DL, 2019, NATURE, V566, P270, DOI 10.1038/s41586-019-0916-x; Hua Q, 2020, THERANOSTICS, V10, P4762, DOI 10.7150/thno.43839; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Huang JG, 2016, NUCLEIC ACIDS RES, V44, P3059, DOI 10.1093/nar/gkv1353; Huang XW, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0628-y; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Jing XM, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1089-9; Jung HM, 2013, MOL BIOL CELL, V24, P1638, DOI 10.1091/mbc.E12-12-0891; Kalimutho M, 2019, TRENDS PHARMACOL SCI, V40, P198, DOI 10.1016/j.tips.2019.01.005; Kang CL, 2019, THERANOSTICS, V9, P4421, DOI 10.7150/thno.32854; Kapinova A, 2018, BIOMED PHARMACOTHER, V99, P51, DOI 10.1016/j.biopha.2017.12.104; Kuo TC, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00654-x; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lan J, 2018, P NATL ACAD SCI USA, V115, pE9640, DOI 10.1073/pnas.1809695115; Lee H, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0226-3; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Li HZ, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0738-0; Lin F, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-58; Liu DL, 2016, TUMOR BIOL, V37, P5039, DOI 10.1007/s13277-015-4355-5; Liu L, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00420; Liu ML, 2019, THERANOSTICS, V9, P4795, DOI 10.7150/thno.30988; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Liu YB, 2017, BIOMED PHARMACOTHER, V91, P731, DOI 10.1016/j.biopha.2017.05.007; Luo LY, 2018, ONCOGENE, V37, P6166, DOI 10.1038/s41388-018-0396-8; Luo ML, 2020, JNCI-J NATL CANCER I, V112, P356, DOI 10.1093/jnci/djz134; Marchese FP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1348-2; Muller S, 2019, NUCLEIC ACIDS RES, V47, P375, DOI 10.1093/nar/gky1012; Niu YL, 2020, CANCER RES, V80, P964, DOI 10.1158/0008-5472.CAN-19-1532; Peng WX, 2020, MOL THER, V28, P9, DOI 10.1016/j.ymthe.2019.09.024; Prasetyanti PR, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0600-4; Prensner JR, 2014, NEOPLASIA, V16, P900, DOI 10.1016/j.neo.2014.09.001; Shang YM, 2018, BIOMED PHARMACOTHER, V106, P1243, DOI 10.1016/j.biopha.2018.07.052; Shih JW, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0358-4; Shih JW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15874; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song H, 2018, BIOMED PHARMACOTHER, V108, P338, DOI 10.1016/j.biopha.2018.09.057; Tong J, 2020, HAEMATOLOGICA, V105, P1630, DOI 10.3324/haematol.2019.218289; Wang C, 2019, ONCOGENE, V38, P1611, DOI 10.1038/s41388-018-0548-x; Wang YF, 2014, NEOPLASIA, V16, P1094, DOI 10.1016/j.neo.2014.10.008; Wang YR, 2020, J EXP MED, V217, DOI 10.1084/jem.20190950; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Wen X, 2018, THERANOSTICS, V8, P5676, DOI 10.7150/thno.28538; Wu HJ, 2019, FEBS OPEN BIO, V9, P781, DOI 10.1002/2211-5463.12620; Wu JY, 2019, J HEPATOL, V70, P918, DOI 10.1016/j.jhep.2018.12.015; Xiao ZD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00902-z; Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004; Yang F, 2014, FEBS J, V281, P802, DOI 10.1111/febs.12625; Yang HJ, 2019, BIOCHIMIE, V165, P9, DOI 10.1016/j.biochi.2019.06.012; Yang J, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0954-x; Yang XC, 2018, BIOCHEM BIOPH RES CO, V498, P207, DOI 10.1016/j.bbrc.2018.02.211; Yang ZC, 2018, EXP CELL RES, V368, P194, DOI 10.1016/j.yexcr.2018.04.030; Zhang CZ, 2016, P NATL ACAD SCI USA, V113, pE2047, DOI 10.1073/pnas.1602883113; Zhang X, 2017, NAT COMMUN, V8, P1, DOI [10.1038/s41467-017-01968-5, 10.1038/ncomms14542, 10.1038/s41467-017-00321-0]; Zhang XZ, 2020, CANCERS, V12, DOI 10.3390/cancers12051245; Zheng ZQ, 2019, CANCER RES, V79, P4612, DOI 10.1158/0008-5472.CAN-19-0799; Zhou ML, 2016, STEM CELLS, V34, P55, DOI 10.1002/stem.2219; Zou ZG, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0758-8	68	66	67	6	38	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2021	40	9					1609	1627		10.1038/s41388-020-01638-9	http://dx.doi.org/10.1038/s41388-020-01638-9		JAN 2021	19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QR9UA	33469161	hybrid, Green Published			2022-12-26	WOS:000608959500001
J	Banwell, C; Housen, T; Smurthwaite, K; Trevenar, S; Walker, L; Todd, K; Rosas, M; Kirk, M				Banwell, Cathy; Housen, Tambri; Smurthwaite, Kayla; Trevenar, Susan; Walker, Liz; Todd, Katherine; Rosas, May; Kirk, Martyn			Health and social concerns about living in three communities affected by per- and polyfluoroalkyl substances (PFAS): A qualitative study in Australia	PLOS ONE			English	Article							EVOLVING ENVIRONMENTAL DISASTER; AMPHIBOLE ASBESTOS EXPOSURE; PERFLUORINATED COMPOUNDS; PERFLUOROOCTANOIC ACID; WESTON VILLAGE; SERUM-LIPIDS; CHOLESTEROL; PERFLUOROALKYL; CONTAMINATION; PERSPECTIVES	Background Exposure to per- and polyfluoroalkyl substances (PFAS) is a public health issue globally. In Australia high concentrations of PFAS have been found in environments close to sites where Aqueous Film Forming Foams (AFFF) were historically used for firefighting activities. This has resulted in significant community concern about the potential long-term health effects of these chemicals. Objective We describe residents' perceptions and experiences of PFAS in three regional Australian towns where exposure has occurred. Methods We conducted focus groups to generate free-flowing open discussion on PFAS in three affected communities, including some with significant numbers of First Nations Peoples. We recruited participants using a range of media outlets and postal services. Focus group transcripts were analysed thematically to identify major shared concerns using Atlas Ti. Results One hundred and eighty residents attended fifteen focus groups that were conducted in the three communities. They included 69 First Nations People living in three communities near the town of Katherine in the Northern Territory. Study participants were concerned about potential physical health effects of exposure to PFAS, such as cancer clusters, unexplained deaths, potential exacerbation of existing health conditions, and the future health of their children. They expressed feelings of stress and anxiety about living with uncertainty related to the possible health and the socio-economic impacts of PFAS contamination in their communities. Conclusion While research has concentrated on the physical health effects of PFAS, more attention needs to be given to the immediate psychosocial impacts of living in an affected community.	[Banwell, Cathy; Housen, Tambri; Smurthwaite, Kayla; Trevenar, Susan; Walker, Liz; Todd, Katherine; Kirk, Martyn] Australian Natl Univ, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Rosas, May] Ngaigu Mulu Aboriginal Corp, Katherine, NT, Australia	Australian National University	Banwell, C (corresponding author), Australian Natl Univ, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	Cathy.banwell@anu.edu.au		Banwell, Cathy/0000-0001-6808-1052; Smurthwaite, Kayla/0000-0003-4904-4189; Todd, Katherine Margaret/0000-0002-5387-3361	Australian Government Department of Health	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	This study was funded by the Australian Government Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes G, 2002, SOC SCI MED, V55, P2227, DOI 10.1016/S0277-9536(01)00367-7; Barnes GJ, 2005, J PUBLIC HEALTH-UK, V27, P276, DOI 10.1093/pubmed/fdi036; Behr AC, 2020, TOXICOL IN VITRO, V62, DOI 10.1016/j.tiv.2019.104700; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brown P, 2003, ENVIRON HEALTH PERSP, V111, P1789, DOI 10.1289/ehp.6196; Bruton TA, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0321-6; Buck Robert C., 2011, Integrated Environmental Assessment and Management, V7, P513, DOI 10.1002/ieam.258; Burgess CP, 2009, MED J AUSTRALIA, V190, P567, DOI 10.5694/j.1326-5377.2009.tb02566.x; Cappelletto F, 2003, SOC SCI MED, V56, P1047, DOI 10.1016/S0277-9536(02)00102-8; Clapp JT, 2016, SOC SCI MED, V170, P143, DOI 10.1016/j.socscimed.2016.10.019; Cline RJW, 2015, HEALTH COMMUN, V30, P1135, DOI 10.1080/10410236.2014.922456; Cline RJW, 2014, AM J COMMUN PSYCHOL, V54, P12, DOI 10.1007/s10464-014-9660-4; Cordial P, 2012, ECOPSYCHOLOGY, V4, P201, DOI DOI 10.1089/ECO.2012.0032; Couch, 1993, RES SOC PROBL PUBLIC, V5, P47; Council on Environmental Quality, 2007, COLL NEPA HDB NEPA P; Creswell J. W., 2014, RES DESIGN QUALITATI; CRRC, 2016, 2015 ANN REP; Daley K, 2015, SOC SCI MED, V135, P124, DOI 10.1016/j.socscimed.2015.04.017; Department of Defence (DOD), 2016, PFAS INV MAN PROGR; Dong ZM, 2019, ECOTOX ENVIRON SAFE, V173, P461, DOI 10.1016/j.ecoenv.2019.02.061; Eriksen KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056969; Fletcher T, 2013, ENVIRON INT, V57-58, P2, DOI 10.1016/j.envint.2013.03.008; Foreign Affairs Defence and Trade References Committee, 2016, INQ FIR FOAM CONT A, P106; Friendship KA, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.19003; Frisbee SJ, 2010, ARCH PEDIAT ADOL MED, V164, P860, DOI 10.1001/archpediatrics.2010.163; Galway LP, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13050505; Gill DA, 2012, AM BEHAV SCI, V56, P3, DOI 10.1177/0002764211408585; Gordon JS, 2010, PERCEPTIONS RECREANC; Griffin RJ, 2004, MEDIA PSYCHOL, V6, P23, DOI 10.1207/s1532785xmep0601_2; Guelfo JL, 2018, ENVIRON HEALTH PERSP, V126, DOI 10.1289/EHP2727; Haynes EN, 2016, ENVIRON HEALTH PERSP, V124, pA24, DOI 10.1289/ehp.1510411; Higginbotham N, 2010, HEALTH PLACE, V16, P259, DOI 10.1016/j.healthplace.2009.10.007; Holzer J, 2008, ENVIRON HEALTH PERSP, V116, P651, DOI 10.1289/ehp.11064; Hoover E, 2018, ENVIRON SOCIOL, V4, P8, DOI 10.1080/23251042.2017.1381898; Kannan K, 2005, ARCH ENVIRON CON TOX, V48, P559, DOI 10.1007/s00244-004-0133-x; Kelsey-Sugg, 2019, ABC RADIO NATL, V05, P30; Krueger RA, 1994, FOCUS GROUPS PRACTIC, V2nd; Kwiatkowski R. E., 2009, Impact Assessment and Project Appraisal, V27, P57, DOI 10.3152/146155109X413046; Li Y, 2020, PHYTOCHEM REV, V19, P1, DOI 10.1007/s11101-019-09655-7; Markstrom CA, 2003, AM INDIAN ALASKA NAT, V11, P19; McAuley C, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-55; Mohai P, 2009, ANNU REV ENV RESOUR, V34, P405, DOI 10.1146/annurev.environ.082508-094348; Ohayon JL, 2017, ENVIRON RES, V153, P140, DOI 10.1016/j.envres.2016.12.003; Osofsky HJ, 2011, DISASTER MED PUBLIC, V5, P280, DOI 10.1001/dmp.2011.85; Prior JH, 2019, GEOGR RES-AUST, V57, P52, DOI 10.1111/1745-5871.12312; Rappazzo KM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070691; Ritchie LA, 2007, SOCIOL SPECTRUM, V27, P103, DOI 10.1080/02732170601001037; Sandifer PA, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00373; SANDMAN PM, 1993, RISK ANAL, V13, P585, DOI 10.1111/j.1539-6924.1993.tb01321.x; Scammell MK, 2009, SOC SCI MED, V68, P143, DOI 10.1016/j.socscimed.2008.10.002; Seo SH, 2018, ENVIRON INT, V113, P149, DOI 10.1016/j.envint.2018.01.025; Smart B. E., 1994, ORGANOFLUORINE CHEM, P57, DOI DOI 10.1007/978-1-4899-1202-2_3; Stanifer JW, 2018, CLIN J AM SOC NEPHRO, V13, P1479, DOI 10.2215/CJN.04670418; Steenland K, 2009, AM J EPIDEMIOL, V170, P1268, DOI 10.1093/aje/kwp279; Sunderland EM, 2019, J EXPO SCI ENV EPID, V29, P131, DOI 10.1038/s41370-018-0094-1; Winquist A, 2014, ENVIRON HEALTH PERSP, V122, P1299, DOI 10.1289/ehp.1307943	56	8	8	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245141	10.1371/journal.pone.0245141	http://dx.doi.org/10.1371/journal.pone.0245141			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4VV	33444329	Green Published, gold			2022-12-26	WOS:000609988100031
J	Vangrieken, P; Al-Nasiry, S; Bast, A; Leermakers, PA; Tulen, CBM; Janssen, GMJ; Kaminski, I; Geomini, I; Lemmens, T; Schiffers, PMH; van Schooten, FJ; Remels, AHV				Vangrieken, Philippe; Al-Nasiry, Salwan; Bast, Aalt; Leermakers, Pieter A.; Tulen, Christy B. M.; Janssen, Ger. M. J.; Kaminski, Iris; Geomini, Iris; Lemmens, Titus; Schiffers, Paul M. H.; van Schooten, Frederik J.; Remels, Alex H. V.			Hypoxia-induced mitochondrial abnormalities in cells of the placenta	PLOS ONE			English	Article							OXIDATIVE STRESS; EXPRESSION; MITOPHAGY; AUTOPHAGY; FISSION; FUSION; GROWTH; PREECLAMPSIA; HYPERTENSION; RESPIRATION	Introduction Impaired utero-placental perfusion is a well-known feature of early preeclampsia and is associated with placental hypoxia and oxidative stress. Although aberrations at the level of the mitochondrion have been implicated in PE pathophysiology, whether or not hypoxia-induced mitochondrial abnormalities contribute to placental oxidative stress is unknown. Methods We explored whether abnormalities in mitochondrial metabolism contribute to hypoxia-induced placental oxidative stress by using both healthy term placentae as well as a trophoblast cell line (BeWo cells) exposed to hypoxia. Furthermore, we explored the therapeutic potential of the antioxidants MitoQ and quercetin in preventing hypoxia-induced placental oxidative stress. Results Both in placental explants as well as BeWo cells, hypoxia resulted in reductions in mitochondrial content, decreased abundance of key molecules involved in the electron transport chain and increased expression and activity of glycolytic enzymes. Furthermore, expression levels of key regulators of mitochondrial biogenesis were decreased while the abundance of constituents of the mitophagy, autophagy and mitochondrial fission machinery was increased in response to hypoxia. In addition, placental hypoxia was associated with increased oxidative stress, inflammation, and apoptosis. Moreover, experiments with MitoQ revealed that hypoxia-induced reactive oxygen species originated from the mitochondria in the trophoblasts. Discussion This study is the first to demonstrate that placental hypoxia is associated with mitochondrial-generated reactive oxygen species and significant alterations in the molecular pathways controlling mitochondrial content and function. Furthermore, our data indicate that targeting mitochondrial oxidative stress may have therapeutic benefit in the management of pathologies related to placental hypoxia.	[Vangrieken, Philippe; Bast, Aalt; Leermakers, Pieter A.; Tulen, Christy B. M.; Kaminski, Iris; Geomini, Iris; Lemmens, Titus; van Schooten, Frederik J.; Remels, Alex H. V.] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Dept Pharmacol & Toxicol, Maastricht, Netherlands; [Vangrieken, Philippe] Maastricht Univ, Med Ctr, Dept Internal Med, Sch Cardiovasc Dis CARIM, Maastricht, Netherlands; [Al-Nasiry, Salwan] Maastricht Univ, Med Ctr, Dept Obstet & Gynaecol, Sch Oncol & Dev Biol GROW, Maastricht, Netherlands; [Janssen, Ger. M. J.; Schiffers, Paul M. H.] Maastricht Univ, Med Ctr, Sch Cardiovasc Dis CARIM, Dept Pharmacol & Toxicol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University	Vangrieken, P (corresponding author), Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Dept Pharmacol & Toxicol, Maastricht, Netherlands.; Vangrieken, P (corresponding author), Maastricht Univ, Med Ctr, Dept Internal Med, Sch Cardiovasc Dis CARIM, Maastricht, Netherlands.	p.vangrieken@maastrichtuniversity.nl	Leermakers, Pieter/AAY-1341-2021; Bast, Aalt/I-7809-2013	Leermakers, Pieter/0000-0002-0145-742X; Al-Nasiry, Salwan/0000-0003-0268-2095; Vangrieken, Philippe/0000-0003-0871-7789	NUTRIM Graduate Program	NUTRIM Graduate Program	This study was supported by NUTRIM Graduate Program. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The first author (Philippe Vangrieken), received a salary by the NUTRIM Graduate Program.	Afroze SH, 2016, BBA CLIN, V6, P25, DOI 10.1016/j.bbacli.2016.05.003; Aljunaidy MM, 2018, PHARMACOL RES, V134, P332, DOI 10.1016/j.phrs.2018.05.006; Aouache R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051496; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Arts MJTJ, 2004, FOOD CHEM, V88, P567, DOI 10.1016/j.foodchem.2004.02.008; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Bainbridge SA, 2008, PLACENTA, V29, pS67, DOI 10.1016/j.placenta.2007.11.001; Barroso G, 2006, FERTIL STERIL, V85, P149, DOI 10.1016/j.fertnstert.2005.06.046; Bergmeyer HU., 1974, METHOD ENZYMAT AN, V1, P474; Boland ML, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00292; Bordi M, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00081; Bronson SL, 2016, NEUROPSYCHOPHARMACOL, V41, P207, DOI 10.1038/npp.2015.231; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Cai M, 2019, ONCOL REP, V42, P1125, DOI 10.3892/or.2019.7213; Chen BS, 2012, ENDOCRINOLOGY, V153, P4946, DOI 10.1210/en.2012-1472; Chen ZH, 2017, EMBO REP, V18, P495, DOI 10.15252/embr.201643309; Cheng SB, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2162-4; Chiarello DI, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2018.12.005; Chourasia AH, 2015, EMBO REP, V16, P1145, DOI 10.15252/embr.201540759; Di Santo S, 2003, PLACENTA, V24, P882, DOI 10.1016/S0143-4004(03)00142-5; Ebegboni VJ, 2019, FOOD CHEM, V272, P117, DOI 10.1016/j.foodchem.2018.08.036; Gathiram P, 2016, CARDIOVASC J AFR, V27, P71, DOI 10.5830/CVJA-2016-009; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Higgins JS, 2016, J PHYSIOL-LONDON, V594, P1341, DOI 10.1113/JP271057; Holland O, 2017, PLACENTA, V54, P2, DOI 10.1016/j.placenta.2016.12.012; Holland OJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1190-9; Hung Tai-Ho, 2006, Taiwan J Obstet Gynecol, V45, P189; Iwagaki S, 2004, GYNECOL ENDOCRINOL, V18, P263, DOI 10.1080/0951359042000196277; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Knyazev EN, 2019, B EXP BIOL MED+, V166, P321, DOI 10.1007/s10517-019-04342-1; LaMarca B, 2008, HYPERTENSION, V52, P1161, DOI 10.1161/HYPERTENSIONAHA.108.120881; LaMarca BBD, 2005, HYPERTENSION, V46, P82, DOI 10.1161/01.HYP.0000169152.59854.36; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Leermakers PA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33471-2; Levy R, 2000, AM J PHYSIOL-CELL PH, V278, pC982, DOI 10.1152/ajpcell.2000.278.5.C982; Ling K. H., 1966, METHODS ENZYMOL, V9, P425, DOI [10.1016/0076-6879(66)09087-6, DOI 10.1016/0076-6879(66)09087-6]; Llurba E, 2004, FREE RADICAL BIO MED, V37, P557, DOI 10.1016/j.freeradbiomed.2004.04.035; Malek A, 2001, PLACENTA, V22, pS45, DOI 10.1053/plac.2001.0635; Mando C, 2014, AM J PHYSIOL-ENDOC M, V306, pE404, DOI 10.1152/ajpendo.00426.2013; Many A, 2000, AM J PATHOL, V156, P321, DOI 10.1016/S0002-9440(10)64733-5; Mecklenburgh KI, 2002, BLOOD, V100, P3008, DOI 10.1182/blood-2002-02-0454; Minchenko O, 2003, FEBS LETT, V554, P264, DOI 10.1016/S0014-5793(03)01179-7; Muralimanoharan S, 2012, PLACENTA, V33, P816, DOI 10.1016/j.placenta.2012.07.002; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956; Padmini E, 2009, CLIN CHEM LAB MED, V47, P1073, DOI 10.1515/CCLM.2009.247; Palikaras K, 2014, EXP GERONTOL, V56, P182, DOI 10.1016/j.exger.2014.01.021; Postigo L, 2009, J PHYSIOL-LONDON, V587, P693, DOI 10.1113/jphysiol.2008.163634; Radioforum, 2011, RADIOZURNAL 0822; Rajakumar A, 2000, BIOL REPROD, V63, P559, DOI 10.1095/biolreprod63.2.559; Rajakumar A, 2003, PLACENTA, V24, P199, DOI 10.1053/plac.2002.0893; Saito S, 2013, PLACENTA, V34, pS79, DOI 10.1016/j.placenta.2012.11.026; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Schonenberger MJ, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00042; Schwarten M, 2009, AUTOPHAGY, V5, P690, DOI 10.4161/auto.5.5.8494; Sferruzzi-Perri AN, 2019, P NATL ACAD SCI USA, V116, P1621, DOI 10.1073/pnas.1816056116; Shea TB, 2003, J NEUROSCI METH, V125, P55, DOI 10.1016/S0165-0270(03)00028-1; SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597; Sheridan C, 2010, MITOCHONDRION, V10, P640, DOI 10.1016/j.mito.2010.08.005; Sooranna SR, 1999, HUM REPROD, V14, P536, DOI 10.1093/humrep/14.2.536; Sowter HM, 2001, CANCER RES, V61, P6669; Tong W, 2019, J DEV ORIG HLTH DIS, V10, P322, DOI 10.1017/S204017441900014X; van Patot MCT, 2010, AM J PHYSIOL-REG I, V298, pR166, DOI 10.1152/ajpregu.00383.2009; Vangrieken P, 2020, HYPERTENSION RES, V2020, P1; Vangrieken P, 2020, HISTOL HISTOPATHOL, V35, P849, DOI 10.14670/HH-18-205; Vangrieken P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202648; Wang Z, 1999, J Tongji Med Univ, V19, P209; Wei HF, 2015, BBA-MOL CELL RES, V1853, P2784, DOI 10.1016/j.bbamcr.2015.03.013; Wu H, 2015, ANTIOXID REDOX SIGN, V22, P1032, DOI 10.1089/ars.2014.6204; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Xu ZW, 2018, PROTEOM CLIN APPL, V12, DOI 10.1002/prca.201700165; Yu J, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6323086; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhang Z, 2020, MOL MED REP, V21, P2484, DOI 10.3892/mmr.2020.11050; Zhou XB, 2017, EXP CELL RES, V359, P195, DOI 10.1016/j.yexcr.2017.07.029	77	9	9	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245155	10.1371/journal.pone.0245155	http://dx.doi.org/10.1371/journal.pone.0245155			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434211	Green Published, gold			2022-12-26	WOS:000609979700043
J	Kuo, TC; Wu, MH; Yang, SH; Chen, ST; Hsu, TW; Jhuang, JY; Liao, YY; Tien, YW; Huang, MC				Kuo, Ting-Chun; Wu, Ming-Hsun; Yang, Shih-Hung; Chen, Syue-Ting; Hsu, Tzu-Wen; Jhuang, Jie-Yang; Liao, Ying-Yu; Tien, Yu-Wen; Huang, Min-Chuan			C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin alpha(v)	ONCOGENE			English	Article							CANCER-CELLS; GLYCOSYLATION; ADHESION; FAK	Pancreatic adenocarcinoma (PDAC) is a leading cause of cancer-related death. Altered glycosylation contributes to tumor progression and chemoresistance in many cancers. C1GALT1 is the key enzyme controlling the elongation of GalNAc-type O-glycosylation. Here we showed that C1GALT1 was overexpressed in 85% (107/126) of PDAC tumors compared with adjacent non-tumor tissues. High expression of C1GALT1 was associated with poor disease-free and overall survival (n = 99). C1GALT1 knockdown using siRNA suppressed cell viability, migration, and invasion as well as increased gemcitabine sensitivity in PDAC cells. In contrast, C1GALT1 overexpression enhanced cell migration and invasion. In subcutaneous and pancreatic orthotopic injection models, C1GALT1 knockdown decreased tumor growth and metastasis of PDAC cells in NOD/SCID mice. Mechanistically, C1GALT1 knockdown dramatically suppressed cell-extracellular matrix (ECM) adhesion, which was associated with decreased phosphorylation of FAK at Y397/Y925 and changes in O-glycans on integrins including the beta(1), alpha(v), and alpha(5) subunits. Using functional blocking antibodies, we identified integrin alpha(v) as a critical factor in C1GALT1-mediated invasiveness of PDAC cells. In conclusion, this study not only reveals that C1GALT1 could be a potential therapeutic target for PDAC but also provides novel insights into the role of O-glycosylation in the alpha subunits of integrins.	[Kuo, Ting-Chun; Chen, Syue-Ting; Hsu, Tzu-Wen; Liao, Ying-Yu; Huang, Min-Chuan] Natl Taiwan Univ, Grad Inst Anat & Cell Biol, Coll Med, Taipei, Taiwan; [Kuo, Ting-Chun; Wu, Ming-Hsun; Tien, Yu-Wen] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Kuo, Ting-Chun] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Yang, Shih-Hung] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Jhuang, Jie-Yang] Mackay Mem Hosp, Dept Pathol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Mackay Memorial Hospital	Huang, MC (corresponding author), Natl Taiwan Univ, Grad Inst Anat & Cell Biol, Coll Med, Taipei, Taiwan.; Tien, YW (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan.	ywtien5106@ntu.edu.tw; mchuang@ntu.edu.tw	wu, larry/AAV-5282-2021	wu, larry/0000-0002-8811-9203; KUO, TING-CHUN/0000-0003-1960-1423; TIEN, YU-WEN/0000-0002-9126-2705; HUANG, MIN-CHUAN/0000-0002-0704-3447	National Taiwan University Hospital [105-N3200, 106-N3608, 107-N3965, 109-O02]; Ministry of Science and Technology, Taiwan [107-2314-B-002-233-MY3, 108-2320-B-002 -064 -MY3, 106-2321-B-002-034]	National Taiwan University Hospital(National Taiwan University); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by National Taiwan University Hospital (105-N3200, 106-N3608, 107-N3965, and 109-O02 to Dr TCK) and Ministry of Science and Technology, Taiwan (107-2314-B-002-233-MY3 to Dr TCK, 108-2320-B-002 -064 -MY3 to Dr MCH, and 106-2321-B-002-034 to Dr YWT). In addition, we are grateful to Dr WH Lee (Genomics Research Center, Academia Sinica, Taiwan) for providing human PDAC and HPaSteC cell lines. We thank Dr Kelvin K. Tsai (National Health Research Institutes, Taiwan) for providing human HPDE cells. And we thank Dr CL Hsu and Dr YT Huang (Department of Medical Research, National Taiwan University Hospital, Taiwan) as well as Ms Chun-Chi Chen (Graduate Institute of Anatomy and Cell Biology, National Taiwan University, Taiwan) for their technical support during the study.	Adorno-Cruz V, 2019, GENES DIS, V6, P16, DOI 10.1016/j.gendis.2018.12.003; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Chen CH, 2016, GYNECOL ONCOL, V140, P131, DOI 10.1016/j.ygyno.2015.11.025; Chen ST, 2018, ONCOGENE, V37, P6041, DOI 10.1038/s41388-018-0403-0; Chia J, 2016, BBA-GEN SUBJECTS, V1860, P1623, DOI 10.1016/j.bbagen.2016.03.008; Chou CH, 2017, INT J GYNECOL CANCER, V27, P863, DOI 10.1097/IGC.0000000000000965; Chou CH, 2015, ONCOTARGET, V6, P6123, DOI 10.18632/oncotarget.3045; Chugh S, 2018, GASTROENTEROLOGY, V155, P1608, DOI 10.1053/j.gastro.2018.08.007; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; Garrido-Laguna I, 2015, NAT REV CLIN ONCOL, V12, P319, DOI 10.1038/nrclinonc.2015.53; Guan JL, 1997, INT J BIOCHEM CELL B, V29, P1085, DOI 10.1016/S1357-2725(97)00051-4; Guan JL, 2010, IUBMB LIFE, V62, P268, DOI 10.1002/iub.303; Hakamada K, 2019, ANN GASTROENT SURG, V3, P120, DOI 10.1002/ags3.12244; Hamidi H, 2018, NAT REV CANCER, V18, P532, DOI 10.1038/s41568-018-0038-z; Hatley RJD, 2018, ANGEW CHEM INT EDIT, V57, P3298, DOI 10.1002/anie.201707948; Hung JS, 2014, ONCOTARGET, V5, P2096, DOI 10.18632/oncotarget.1815; Kang R, 2011, AUTOPHAGY, V7, P442, DOI 10.4161/auto.7.4.14681; Klein AP, 2004, CANCER RES, V64, P2634, DOI 10.1158/0008-5472.CAN-03-3823; Lee PC, 2020, ONCOGENE, V39, P2724, DOI 10.1038/s41388-020-1178-7; Lin MC, 2018, ONCOGENE, V37, P5780, DOI 10.1038/s41388-018-0375-0; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092743; Magalhaes A, 2017, CANCER CELL, V31, P733, DOI 10.1016/j.ccell.2017.05.012; Mitra SK, 2006, ONCOGENE, V25, P5969, DOI 10.1038/sj.onc.1209588; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Saitoh M, 2018, J BIOCHEM, V164, P257, DOI 10.1093/jb/mvy047; Tsai CH, 2016, CANCER RES, V76, P5756, DOI 10.1158/0008-5472.CAN-16-0641; Weis SM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006478; Wu YM, 2013, CANCER RES, V73, P5580, DOI 10.1158/0008-5472.CAN-13-0869; Zhang CY, 2018, J CANCER, V9, P2666, DOI 10.7150/jca.25252	29	12	12	2	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2021	40	7					1242	1254		10.1038/s41388-020-01594-4	http://dx.doi.org/10.1038/s41388-020-01594-4		JAN 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QK0LS	33420364	Green Published, hybrid			2022-12-26	WOS:000607346000012
J	Menyanu, EK; Corso, B; Minicuci, N; Rocco, I; Russell, JC; Ware, LJ; Chidumwa, G; Naidoo, NN; Biritwum, RB; Kowal, PR; Schutte, AE; Charlton, KE				Menyanu, Elias K.; Corso, Barbara; Minicuci, Nadia; Rocco, Ilaria; Russell, Joanna C.; Ware, Lisa J.; Chidumwa, Glory; Naidoo, Nirmala N.; Biritwum, Richard B.; Kowal, Paul R.; Schutte, Aletta E.; Charlton, Karen E.			Determinants of change in blood pressure in Ghana: Longitudinal data from WHO-SAGE Waves 1-3	PLOS ONE			English	Article							CARDIOMETABOLIC RISK-FACTORS; CARDIOVASCULAR-DISEASE; PULSE PRESSURE; HYPERTENSION PREVALENCE; MYOCARDIAL-INFARCTION; INCIDENT HYPERTENSION; ARTERIAL STIFFNESS; ESTROGEN-RECEPTORS; GENDER-DIFFERENCES; GLOBAL BURDEN	The prevalence of hypertension is increasing in low- and middle-income countries, however statistics are generally derived from cross sectional surveys that utilize different methodologies and population samples. We investigated blood pressure (BP) changes over 11-12 years in a large cohort of adults aged 50 years and older (n = 820) included in the World Health Organization's Study on global AGEing and adult health (WHO-SAGE Ghana) Wave 1 (2007/8) with follow up in Wave 3 (2019). Participants' BP were measured in triplicate and a survey completed at both time points. Survey instruments collected information on sociodemographic characteristics, lifestyle, health behaviors and chronic conditions. While no significant difference was found in systolic BP between Waves 1 and 3, diastolic BP decreased by 9.7mmHg (mean = 88.6, 15.4 to 78.9, 13.6 respectively) and pulse pressure increased by 9.5mmHg (44.8, 13.7 to 54.3, 14.1). Awareness of hypertension increased by 37%, from (20% to 57%), but no differences were found for the proportion of hypertensives receiving treatment nor those that had controlled BP. Mixed effects modelling showed a decrease in diastolic BP was associated with increasing age, living in rural areas and having health insurance. Factors associated with an increased awareness of hypertension were residing in urban areas, having health insurance and increasing body mass index. While diagnosis of hypertension has improved over time in Ghana, there is an ongoing need to improve its treatment in older adults.	[Menyanu, Elias K.; Charlton, Karen E.] Univ Wollongong, Fac Sci Med & Hlth, Sch Med, Wollongong, NSW, Australia; [Corso, Barbara; Minicuci, Nadia; Rocco, Ilaria] CNR, Neurosci Inst, Padua, Italy; [Russell, Joanna C.] Univ Wollongong, Fac Social Sci, Sch Hlth & Soc, Wollongong, NSW, Australia; [Ware, Lisa J.; Chidumwa, Glory] Univ Witwatersrand, SAMRC Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [Chidumwa, Glory] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Johannesburg, South Africa; [Naidoo, Nirmala N.] WHO, Data Analyt & Delivery Impact Div, Geneva, Switzerland; [Biritwum, Richard B.] Univ Ghana, Accra, Ghana; [Kowal, Paul R.] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand; [Kowal, Paul R.] WHO Sage, Geneva, Switzerland; [Schutte, Aletta E.] Univ New South Wales, Sch Publ Hlth & Community Med, George Inst Global Hlth, Sydney, NSW, Australia; [Charlton, Karen E.] Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia	University of Wollongong; Consiglio Nazionale delle Ricerche (CNR); University of Wollongong; University of Witwatersrand; University of Witwatersrand; World Health Organization; University of Ghana; Chiang Mai University; George Institute for Global Health; University of New South Wales Sydney; University of Sydney; University of Wollongong	Charlton, KE (corresponding author), Univ Wollongong, Fac Sci Med & Hlth, Sch Med, Wollongong, NSW, Australia.; Charlton, KE (corresponding author), Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.	karenc@uow.edu.au	Ware, Lisa Jayne/J-7182-2016; Corso, Barbara/P-1796-2018; Schutte, Aletta/E-5126-2018	Ware, Lisa Jayne/0000-0002-9762-4017; Corso, Barbara/0000-0002-0684-9078; Schutte, Aletta/0000-0001-9217-4937; Chidumwa, Glory/0000-0002-8743-9045	CDC Foundation; Bloomberg Philanthropies; Partnerships & Research Development Fund (PRDF) grant from the Australia Africa Universities Network; WHO [OGHA 04034785, YA1323-08-CN-0020, Y1-AG-1005-01, R01AG034479]; Partnership and Research Development Fund (PRDF) of the Australia Africa Universities Network; South African DSI-NRF Centre of Excellence in Human Development	CDC Foundation(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bloomberg Philanthropies; Partnerships & Research Development Fund (PRDF) grant from the Australia Africa Universities Network; WHO(World Health Organization); Partnership and Research Development Fund (PRDF) of the Australia Africa Universities Network; South African DSI-NRF Centre of Excellence in Human Development	This work is supported by an agreement with the CDC Foundation with financial support provided by Bloomberg Philanthropies, and a Partnerships & Research Development Fund (PRDF) grant from the Australia Africa Universities Network. SAGE is supported by WHO and the Division of Behavioral and Social Research (BSR) at the National Institute on Aging (NIA), US National Institutes of Health, through Interagency Agreements with WHO [OGHA 04034785; YA1323-08-CN-0020; Y1-AG-1005-01] and a Research Project Grant [R01AG034479]. Pilot work was supported by the Partnership and Research Development Fund (PRDF) of the Australia Africa Universities Network. LW is supported by the South African DSI-NRF Centre of Excellence in Human Development.	Abramson BL, 2014, CAN J CARDIOL, V30, P553, DOI 10.1016/j.cjca.2014.02.014; Addis ME, 2003, AM PSYCHOL, V58, P5, DOI 10.1037/0003-066X.58.1.5; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Agyemang C, 2006, PUBLIC HEALTH, V120, P525, DOI 10.1016/j.puhe.2006.02.002; Aikins AD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-S2-S3; Alhamad N, 2015, CARDIOVASC DIAGN THE, V5, P172, DOI 10.3978/j.issn.2223-3652.2015.04.06; [Anonymous], 2006, NAT REP WORLD HLTH S; Ash I, 2013, CURR HYPERTENS REV, V9, P130, DOI 10.2174/15734021113099990010; Awuah RB, 2018, ETHNICITY HLTH, P1, DOI 10.1080/13557858.2018.; Baksi AJ, 2009, J AM COLL CARDIOL, V54, P2087, DOI 10.1016/j.jacc.2009.06.049; Benetos A, 2000, J AM COLL CARDIOL, V35, P673, DOI 10.1016/S0735-1097(99)00586-0; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Cappuccio FP, 2004, HYPERTENSION, V43, P1017, DOI 10.1161/01.HYP.0000126176.03319.d8; Carnethon MR, 2010, HYPERTENSION, V56, P49, DOI 10.1161/HYPERTENSIONAHA.109.147603; Chase NL, 2009, AM J HYPERTENS, V22, P417, DOI 10.1038/ajh.2009.6; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Commodore-Mensah Y, 2014, J HYPERTENS, V32, P464, DOI 10.1097/HJH.0000000000000061; Courtenay WH, 2000, PSYCHOL MEN MASCULIN, V1, P4; Coutinho T, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006079; Coutinho T, 2014, CAN J CARDIOL, V30, P756, DOI 10.1016/j.cjca.2014.03.020; Danaei G, 2014, LANCET DIABETES ENDO, V2, P634, DOI 10.1016/S2213-8587(14)70102-0; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Enkhtungalag B, 2015, CARDIOVASC DIAGN THE, V5, P229, DOI 10.3978/j.issn.2223-3652.2015.04.11; FANG J, 1995, J HYPERTENS, V13, P413; Finch CE, 2007, BIOL HUMAN LONGEVITY; Forman JP, 2009, JAMA-J AM MED ASSOC, V302, P401, DOI 10.1001/jama.2009.1060; Franklin SS, 1997, CIRCULATION, V96, P308; Frimpong-Kwarteng OAT, 2015, J INT COMP EDUC, V24, P67; Geeganage Chamila, 2008, Expert Rev Neurother, V8, P165, DOI 10.1586/14737175.8.2.165; Ghana Statistical Service Ghana Health Service and ICF International, 2015, GHAN DEM HLTH SURV 2; Glasser SP, 2015, AM J HYPERTENS, V28, P987, DOI 10.1093/ajh/hpu265; Guthold R, 2020, LANCET CHILD ADOLESC, V4, P23, DOI 10.1016/S2352-4642(19)30323-2; Hay M, 2016, CLIN SCI, V130, P9, DOI 10.1042/CS20150654; He FJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004549; Health Systems 20/20 Project and Research and Development Division of the Ghana Health Service, 2009, EV EFF NAT HLTH INS; Homan TD., 2020, PHYSL PULSE PRESSURE; Iorga A, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-017-0152-8; Irazola VE, 2016, GLOB HEART, V11, P47, DOI 10.1016/j.gheart.2015.12.008; Kavishe B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0357-9; Kim MJ, 2015, HYPERTENS RES, V38, P783, DOI 10.1038/hr.2015.72; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Kronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONAHA.106.674143; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413; Lamptey P, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4260-5; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Li X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183033; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu FD, 2016, CLIN RES CARDIOL, V105, P677, DOI 10.1007/s00392-016-0972-2; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; Maahs DM, 2005, DIABETES CARE, V28, P301, DOI 10.2337/diacare.28.2.301; Ministry of Health Ghana, 2008, REGENERATIVE HLTH NU; Muiesan ML, 2016, HIGH BLOOD PRESS CAR, V23, P105, DOI 10.1007/s40292-016-0148-1; Nagai Y, 1998, CIRCULATION, V98, P1504, DOI 10.1161/01.CIR.98.15.1504; Nakanishi R, 2017, HYPERTENSION, V70, P293, DOI 10.1161/HYPERTENSIONAHA.117.09402; Nichols WW, 1990, MCDONALDS BLOOD FLOW; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Oladapo OO, 2010, CARDIOVASC J AFR, V21, P26; Phuong do HT, 2016, J CLIN HYPERTENS, P1; Pilleron S, 2017, J AM SOC HYPERTENS, V11, P449, DOI 10.1016/j.jash.2017.04.013; Pinto E, 2007, POSTGRAD MED J, V83, P109, DOI 10.1136/pgmj.2006.048371; Saydah S, 2014, OBESITY, V22, P1888, DOI 10.1002/oby.20761; Smulyan H, 1997, J AM COLL CARDIOL, V29, P1407, DOI 10.1016/S0735-1097(97)00081-8; Tarazi RC, 1986, HDB HYPERTENSION, V7, P225; Tiptaradol S, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/386453; United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH; Vaccarino V, 2000, J AM COLL CARDIOL, V36, P130, DOI 10.1016/S0735-1097(00)00687-2; VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456, DOI 10.1161/01.CIR.88.4.1456; Wang H, GHANA NATL HLTH INSU; Ware LJ, 2019, J HUM HYPERTENS, V33, P157, DOI 10.1038/s41371-018-0125-3; Whelton PK, 2015, ANNU REV PUBL HEALTH, V36, P109, DOI 10.1146/annurev-publhealth-031914-122949; WHELTON PK, 1994, LANCET, V344, P101, DOI 10.1016/S0140-6736(94)91285-8; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Williams B, 2018, BLOOD PRESSURE, V27, P314, DOI [10.1080/08037051.2018.1527177, 10.1097/HJH.0000000000001961]; WITTEMAN JCM, 1994, LANCET, V343, P504, DOI 10.1016/S0140-6736(94)91459-1; Witter S, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-20; World Health Organization, GLOB PHYS ACT QUEST; World Health Organization, 2016, GLOB NCD TARG HIGH B; Wyness LA, 2012, PUBLIC HEALTH NUTR, V15, P254, DOI 10.1017/S1368980011000966	80	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0244807	10.1371/journal.pone.0244807	http://dx.doi.org/10.1371/journal.pone.0244807			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY4OF	33417616	gold, Green Published			2022-12-26	WOS:000630020100013
J	Pantano, F; Croset, M; Driouch, K; Bednarz-Knoll, N; Iuliani, M; Ribelli, G; Bonnelye, E; Wikman, H; Geraci, S; Bonin, F; Simonetti, S; Vincenzi, B; Hong, SS; Sousa, S; Pantel, K; Tonini, G; Santini, D; Clezardin, P				Pantano, Francesco; Croset, Martine; Driouch, Keltouma; Bednarz-Knoll, Natalia; Iuliani, Michele; Ribelli, Giulia; Bonnelye, Edith; Wikman, Harriet; Geraci, Sandra; Bonin, Florian; Simonetti, Sonia; Vincenzi, Bruno; Hong, Saw See; Sousa, Sofia; Pantel, Klaus; Tonini, Giuseppe; Santini, Daniele; Clezardin, Philippe			Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions	ONCOGENE			English	Article							CELL-MIGRATION; OSTEOBLAST DIFFERENTIATION; TUMOR-CELLS; EXPRESSION; LUNG; VOLOCIXIMAB; SURVIVAL; GROWTH; COLONIZATION; INHIBITION	Bone metastasis remains a major cause of mortality and morbidity in breast cancer. Therefore, there is an urgent need to better select high-risk patients in order to adapt patient's treatment and prevent bone recurrence. Here, we found that integrin alpha5 (ITGA5) was highly expressed in bone metastases, compared to lung, liver, or brain metastases. High ITGA5 expression in primary tumors correlated with the presence of disseminated tumor cells in bone marrow aspirates from early stage breast cancer patients (n = 268; p = 0.039). ITGA5 was also predictive of poor bone metastasis-free survival in two separate clinical data sets (n = 855, HR = 1.36, p = 0.018 and n = 427, HR = 1.62, p = 0.024). This prognostic value remained significant in multivariate analysis (p = 0.028). Experimentally, ITGA5 silencing impaired tumor cell adhesion to fibronectin, migration, and survival. ITGA5 silencing also reduced tumor cell colonization of the bone marrow and formation of osteolytic lesions in vivo. Conversely, ITGA5 overexpression promoted bone metastasis. Pharmacological inhibition of ITGA5 with humanized monoclonal antibody M200 (volociximab) recapitulated inhibitory effects of ITGA5 silencing on tumor cell functions in vitro and tumor cell colonization of the bone marrow in vivo. M200 also markedly reduced tumor outgrowth in experimental models of bone metastasis or tumorigenesis, and blunted cancer-associated bone destruction. ITGA5 was not only expressed by tumor cells but also osteoclasts. In this respect, M200 decreased human osteoclast-mediated bone resorption in vitro. Overall, this study identifies ITGA5 as a mediator of breast-to-bone metastasis and raises the possibility that volociximab/M200 could be repurposed for the treatment of ITGA5-positive breast cancer patients with bone metastases.	[Pantano, Francesco; Croset, Martine; Bonnelye, Edith; Geraci, Sandra; Sousa, Sofia; Clezardin, Philippe] INSERM, UMR S1033, LYOS, Lyon, France; [Pantano, Francesco; Croset, Martine; Bonnelye, Edith; Geraci, Sandra; Hong, Saw See; Sousa, Sofia; Clezardin, Philippe] Univ Lyon, Villeurbanne, France; [Pantano, Francesco; Iuliani, Michele; Ribelli, Giulia; Simonetti, Sonia; Vincenzi, Bruno; Tonini, Giuseppe; Santini, Daniele] Campus Biomed Univ Rome, Dept Med Oncol, Rome, Italy; [Driouch, Keltouma; Bonin, Florian] Inst Curie, Serv Genet, Unite Pharmacogen, Paris, France; [Bednarz-Knoll, Natalia; Wikman, Harriet; Pantel, Klaus] Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany; [Bednarz-Knoll, Natalia] Med Univ Gdansk, Lab Translat Oncol, Gdansk, Poland; [Hong, Saw See] INRA, UMR 754, Lyon, France; [Clezardin, Philippe] Univ Sheffield, Oncol & Metab Dept, Sheffield, S Yorkshire, England	Institut National de la Sante et de la Recherche Medicale (Inserm); University Campus Bio-Medico - Rome Italy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Hamburg; University Medical Center Hamburg-Eppendorf; Fahrenheit Universities; Medical University Gdansk; INRAE; University of Sheffield	Clezardin, P (corresponding author), INSERM, UMR S1033, LYOS, Lyon, France.; Clezardin, P (corresponding author), Univ Lyon, Villeurbanne, France.; Clezardin, P (corresponding author), Univ Sheffield, Oncol & Metab Dept, Sheffield, S Yorkshire, England.	philippe.clezardin@inserm.fr	Pantano, Francesco/D-8459-2012; Bonnelye, Edith/AAT-9134-2021; Clezardin, Philippe/M-8071-2014	Pantano, Francesco/0000-0002-2894-9686; Bednarz-Knoll, Natalia/0000-0001-9506-942X; Clezardin, Philippe/0000-0003-0149-4463; Wikman, Harriet/0000-0001-6862-0888	"Ligue contre le cancer" cd69, 2016; Breast Cancer Research Foundation (BCRF, USA) [BCRF-16-096]; Deutsche Forschungsgemeinschaft, SPP microBONE; INSERM, University Claude Bernard Lyon 1; "Project LIA/LEA 2016" of the University of Lyon, within the program "Investissements d'Avenir" [ASC17018CSA, ANR-11-IDEX-0007]; LabEX DEVweCAN of the University of Lyon, within the program "Investissements d'Avenir" [ANR-11-IDEX-0007, ANR-10-LABX-61]; Inca [Transla09-112]	"Ligue contre le cancer" cd69, 2016; Breast Cancer Research Foundation (BCRF, USA); Deutsche Forschungsgemeinschaft, SPP microBONE(German Research Foundation (DFG)); INSERM, University Claude Bernard Lyon 1; "Project LIA/LEA 2016" of the University of Lyon, within the program "Investissements d'Avenir"(French National Research Agency (ANR)); LabEX DEVweCAN of the University of Lyon, within the program "Investissements d'Avenir"(French National Research Agency (ANR)); Inca(Institut National du Cancer (INCA) France)	MC acknowledges the support of "Ligue contre le cancer" cd69, 2016. KD acknowledges the support of Inca (Grant No. Transla09-112). FB is supported by the Breast Cancer Research Foundation (BCRF, USA) (BCRF-16-096, 2016-2017). KP is supported by the Deutsche Forschungsgemeinschaft, SPP microBONE. PC is supported by INSERM, University Claude Bernard Lyon 1, the "Project LIA/LEA 2016" (Grant No.: ASC17018CSA), and the LabEX DEVweCAN (ANR-10-LABX-61) of the University of Lyon, within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) operated by the French National Research Agency (ANR).	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Almokadem S, 2012, EXPERT OPIN BIOL TH, V12, P251, DOI 10.1517/14712598.2012.646985; Anderson JA, 2007, BRIT J CANCER, V96, P1394, DOI 10.1038/sj.bjc.6603720; Bartkowiak K, 2015, CANCER RES, V75, P5367, DOI 10.1158/0008-5472.CAN-14-3728; Bednarz-Knoll N, 2015, ONCOTARGET, V6, P26789, DOI 10.18632/oncotarget.4628; Bell-McGuinn KM, 2011, GYNECOL ONCOL, V121, P273, DOI 10.1016/j.ygyno.2010.12.362; Besse B, 2013, ANN ONCOL, V24, P90, DOI 10.1093/annonc/mds281; Bieche I, 2001, CANCER RES, V61, P1652; Bonnelye E, 2001, J CELL BIOL, V153, P971, DOI 10.1083/jcb.153.5.971; Braun S, 2000, NEW ENGL J MED, V342, P525, DOI 10.1056/NEJM200002243420801; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Coleman RE, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-00216-3; Croset M, 2018, CANCER RES, V78, P5259, DOI 10.1158/0008-5472.CAN-17-3058; Croset M, 2014, J BONE MINER RES, V29, P1886, DOI 10.1002/jbmr.2215; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Duffy MJ, 2008, CLIN CHEM, V54, P1770, DOI 10.1373/clinchem.2008.110056; Fan LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162933; Fehm T, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1869; FIDLER IJ, 1973, EUR J CANCER, V9, P223, DOI 10.1016/S0014-2964(73)80022-2; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Hamidi H, 2018, NAT REV CANCER, V18, P532, DOI 10.1038/s41568-018-0038-z; Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Hosseini H, 2016, NATURE, V540, P552, DOI 10.1038/nature20785; HUGHES DE, 1993, J BONE MINER RES, V8, P527; Imanishi Y, 2007, CANCER RES, V67, P4254, DOI 10.1158/0008-5472.CAN-06-4100; Iuliani M, 2015, ONCOTARGET, V6, P12520, DOI 10.18632/oncotarget.3724; Jami MS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-194; Ju JLA, 2017, MOL CANCER RES, V15, P723, DOI 10.1158/1541-7786.MCR-16-0338; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Khalili P, 2006, MOL CANCER THER, V5, P2271, DOI 10.1158/1535-7163.MCT-06-0100; Korah R, 2004, CANCER RES, V64, P4514, DOI 10.1158/0008-5472.CAN-03-3853; Landemaine T, 2008, CANCER RES, V68, P6092, DOI 10.1158/0008-5472.CAN-08-0436; Lehtinen L, 2012, J PATHOL, V226, P674, DOI 10.1002/path.3956; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Oudin MJ, 2016, CANCER DISCOV, V6, P516, DOI 10.1158/2159-8290.CD-15-1183; Pantel K, 1994, J Hematother, V3, P165, DOI 10.1089/scd.1.1994.3.165; Pecheur I, 2002, FASEB J, V16, P1266, DOI 10.1096/fj.01-0911fje; Peyruchaud O, 2001, J BONE MINER RES, V16, P2027, DOI 10.1359/jbmr.2001.16.11.2027; Pignatelli J, 2012, J CELL BIOL, V197, P421, DOI 10.1083/jcb.201108143; Qin L, 2011, CANCER RES, V71, P1742, DOI 10.1158/0008-5472.CAN-10-3453; Reynaud C, 2017, CANCER RES, V77, P268, DOI 10.1158/0008-5472.CAN-15-2621; Ricart AD, 2008, CLIN CANCER RES, V14, P7924, DOI 10.1158/1078-0432.CCR-08-0378; Schnitt SJ, 2010, MODERN PATHOL, V23, pS60, DOI 10.1038/modpathol.2010.33; Simon KO, 1997, J BIOL CHEM, V272, P29380, DOI 10.1074/jbc.272.46.29380; Sin S, 2011, J NATL CANCER I, V103, P1323, DOI 10.1093/jnci/djr290; Truong HH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004751; VanderVeldeZimmermann D, 1997, EXP CELL RES, V230, P111, DOI 10.1006/excr.1996.3405; Wiedswang G, 2003, CYTOTHERAPY, V5, P40, DOI 10.1080/14653240310000065; Wu ZG, 2018, BIOCHEM BIOPH RES CO, V498, P495, DOI 10.1016/j.bbrc.2018.03.007; Yao HR, 2016, BREAST CANCER RES TR, V157, P489, DOI 10.1007/s10549-016-3844-6; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhang ZZ, 2015, AM J CANCER RES, V5, P772; Zhao YS, 2007, CANCER RES, V67, P5821, DOI 10.1158/0008-5472.CAN-06-4499; Zuo T, 2018, TRANSL ONCOL, V11, P346, DOI 10.1016/j.tranon.2018.01.021	55	24	24	4	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2021	40	7					1284	1299		10.1038/s41388-020-01603-6	http://dx.doi.org/10.1038/s41388-020-01603-6		JAN 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QK0LS	33420367	hybrid, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000607346000004
J	Pond, AJR; Hwang, S; Verd, B; Steventon, B				Pond, Adam Joseph Ronald; Hwang, Seongwon; Verd, Berta; Steventon, Benjamin			A deep learning approach for staging embryonic tissue isolates with small data	PLOS ONE			English	Article							NEURAL-NETWORK; MACHINE; CLASSIFICATION; GENE; BIOLOGY	Machine learning approaches are becoming increasingly widespread and are now present in most areas of research. Their recent surge can be explained in part due to our ability to generate and store enormous amounts of data with which to train these models. The requirement for large training sets is also responsible for limiting further potential applications of machine learning, particularly in fields where data tend to be scarce such as developmental biology. However, recent research seems to indicate that machine learning and Big Data can sometimes be decoupled to train models with modest amounts of data. In this work we set out to train a CNN-based classifier to stage zebrafish tail buds at four different stages of development using small information-rich data sets. Our results show that two and three dimensional convolutional neural networks can be trained to stage developing zebrafish tail buds based on both morphological and gene expression confocal microscopy images, achieving in each case up to 100% test accuracy scores. Importantly, we show that high accuracy can be achieved with data set sizes of under 100 images, much smaller than the typical training set size for a convolutional neural net. Furthermore, our classifier shows that it is possible to stage isolated embryonic structures without the need to refer to classic developmental landmarks in the whole embryo, which will be particularly useful to stage 3D culture in vitro systems such as organoids. We hope that this work will provide a proof of principle that will help dispel the myth that large data set sizes are always required to train CNNs, and encourage researchers in fields where data are scarce to also apply ML approaches.	[Pond, Adam Joseph Ronald; Hwang, Seongwon; Verd, Berta; Steventon, Benjamin] Univ Cambridge, Dept Genet, Cambridge, England; [Verd, Berta] Univ Oxford, Dept Zool, Oxford, England	University of Cambridge; University of Oxford	Verd, B; Steventon, B (corresponding author), Univ Cambridge, Dept Genet, Cambridge, England.; Verd, B (corresponding author), Univ Oxford, Dept Zool, Oxford, England.	berta.verdfernandez@zoo.ox.ac.uk; bjs57@cam.ac.uk	verd, berta/GWZ-8220-2022	Hwang, Seongwon/0000-0003-0805-3708; Verd, Berta/0000-0001-9835-009X	Wellcome Trust [109408/Z/15/Z]; Royal Society [109408/Z/15/Z]; Herchel Smith Postdoctoral Fellowship from the University of Cambridge; Department of Zoology, University of Oxford; Sir Henry Dale Fellowship	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Herchel Smith Postdoctoral Fellowship from the University of Cambridge; Department of Zoology, University of Oxford; Sir Henry Dale Fellowship	BS and SH were supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant Number 109408/Z/15/Z). BV was supported by a Herchel Smith Postdoctoral Fellowship from the University of Cambridge and later by the Department of Zoology, University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Al-Rfou R, 2016, THEANO PYTHON FRAME; Andrews TGR, 2020, METHODS MOL BIOL, V2148, P179, DOI 10.1007/978-1-0716-0623-0_11; Angermueller C, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1189-z; [Anonymous], PROC CVPR IEEE; Barron ATJ, 2018, P NATL ACAD SCI USA, V115, P4607, DOI 10.1073/pnas.1717729115; Beam AL, 2018, JAMA-J AM MED ASSOC, V319, P1317, DOI 10.1001/jama.2017.18391; Buggenthin F, 2017, NAT METHODS, V14, P403, DOI 10.1038/nmeth.4182; Camacho DM, 2018, CELL, V173, P1581, DOI 10.1016/j.cell.2018.05.015; Carvalho LE, 2020, MAR MICROPALEONTOL, V158, DOI 10.1016/j.marmicro.2020.101890; Choi HMT, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.165753; Ciresan D, 2012, PROC CVPR IEEE, P3642, DOI 10.1109/CVPR.2012.6248110; Edelstein D, 2017, AM HIST REV, V122, P400, DOI 10.1093/ahr/122.2.400; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Figueroa RL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-8; Godinez WJ, 2017, BIOINFORMATICS, V33, P2010, DOI 10.1093/bioinformatics/btx069; Haenlein M, 2019, CALIF MANAGE REV, V61, P5, DOI 10.1177/0008125619864925; Hay EA, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006628; Huch M, 2017, DEVELOPMENT, V144, P938, DOI 10.1242/dev.150201; Hug B, 1997, DEV BIOL, V183, P61, DOI 10.1006/dbio.1996.8490; Hung J, 2017, P IEEE C COMP VIS PA, P56; Huss David, 2015, Cold Spring Harb Protoc, V2015, P259, DOI 10.1101/pdb.prot083832; Jeeva M, 2018, SCUFFLE 2 ALGORITHMS; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kraus OZ, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177551; Kraus OZ, 2016, BIOINFORMATICS, V32, P52, DOI 10.1093/bioinformatics/btw252; Krizhevsky A, 2012, ADV NEURAL INF PROCE, V2012, P1; Li YF, 2018, BRIEF BIOINFORM, V19, P325, DOI 10.1093/bib/bbw113; Libbrecht MW, 2015, NAT REV GENET, V16, P321, DOI 10.1038/nrg3920; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Liu SY, 2015, PROCEEDINGS 3RD IAPR ASIAN CONFERENCE ON PATTERN RECOGNITION ACPR 2015, P730, DOI 10.1109/ACPR.2015.7486599; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Moen E, 2019, NAT METHODS, V16, P1233, DOI 10.1038/s41592-019-0403-1; Moretti Franco, 2013, DISTANT READING; nature com, DEEP LEARN MICR; Okuda Y, 2006, DEV DYNAM, V235, P811, DOI 10.1002/dvdy.20678; OShea K, 2015, ARXIV PREPRINT ARXIV; Pal S., 2017, DEEP LEARNING KERAS; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Parnamaa T, 2017, G3-GENES GENOM GENET, V7, P1385, DOI 10.1534/g3.116.033654; Pawlowski N., 2016, BIORXIV, DOI DOI 10.1101/085118; Poplin R, 2018, NAT BIOTECHNOL, V36, P983, DOI 10.1038/nbt.4235; Raczko E, 2017, EUR J REMOTE SENS, V50, P144, DOI 10.1080/22797254.2017.1299557; Schrider DR, 2018, TRENDS GENET, V34, P301, DOI 10.1016/j.tig.2017.12.005; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Serra D, 2019, NATURE, V569, P66, DOI 10.1038/s41586-019-1146-y; Shah S, 2016, DEVELOPMENT, V143, P2862, DOI 10.1242/dev.138560; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI 10.1146/annurev-bioeng-071516-044442; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Silva JCF, 2019, PLANT SCI, V284, P37, DOI 10.1016/j.plantsci.2019.03.020; Simm J, 2018, CELL CHEM BIOL, V25, P611, DOI 10.1016/j.chembiol.2018.01.015; Sommer C, 2017, MOL BIOL CELL, V28, P3428, DOI 10.1091/mbc.E17-05-0333; Somorjai RL, 2003, BIOINFORMATICS, V19, P1484, DOI 10.1093/bioinformatics/btg182; Srinivas S, 2016, FRONT ROBOT AI, V2, DOI 10.3389/frobt.2015.00036; Sullivan DP, 2018, NAT BIOTECHNOL, V36, P820, DOI 10.1038/nbt.4225; Sun YV, 2008, EUR J HUM GENET, V16, P487, DOI 10.1038/sj.ejhg.5201988; Szegedy C, 2013, ADV NEURAL INFORM PR, P2553, DOI DOI 10.5555/2999792.2999897; Trivedi V, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156869; Washburn JD, 2019, P NATL ACAD SCI USA, V116, P5542, DOI 10.1073/pnas.1814551116; Xu CM, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1689-0; Zitnik M, 2019, INFORM FUSION, V50, P71, DOI 10.1016/j.inffus.2018.09.012; Zou J, 2019, NAT GENET, V51, P12, DOI 10.1038/s41588-018-0295-5	62	2	2	9	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0244151	10.1371/journal.pone.0244151	http://dx.doi.org/10.1371/journal.pone.0244151			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4OF	33417603	Green Submitted, Green Published, gold			2022-12-26	WOS:000630020100004
J	Vareslija, D; Ward, E; Purcell, SP; Cosgrove, NS; Cocchiglia, S; O'Halloran, PJ; Charmsaz, S; Bane, FT; Brett, FM; Farrell, M; Cryan, J; Beausang, A; Hudson, L; Turnbul, AK; Dixon, JM; Hill, ADK; Priedigkeit, N; Oesterreich, S; Lee, AV; Sims, AH; Redmond, AM; Carroll, JS; Young, LS				Vareslija, Damir; Ward, Elspeth; Purcell, Siobhan P.; Cosgrove, Nicola S.; Cocchiglia, Sinead; O'Halloran, Philip J.; Charmsaz, Sara; Bane, Fiona T.; Brett, Francesca M.; Farrell, Michael; Cryan, Jane; Beausang, Alan; Hudson, Lance; Turnbul, Arran K.; Dixon, J. Michael; Hill, Arnold D. K.; Priedigkeit, Nolan; Oesterreich, Steffi; Lee, Adrian V.; Sims, Andrew H.; Redmond, Aisling M.; Carroll, Jason S.; Young, Leonie S.			Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype	ONCOGENE			English	Article							STEROID-RECEPTOR; PROTEIN COMPLEX; ALPHA; COACTIVATORS; RESISTANCE; EXPRESSION; TRANSCRIPTION; MECHANISMS; MUTATIONS; THERAPY	Steroid regulated cancer cells use nuclear receptors and associated regulatory proteins to orchestrate transcriptional networks to drive disease progression. In primary breast cancer, the coactivator AIB1 promotes estrogen receptor (ER) transcriptional activity to enhance cell proliferation. The function of the coactivator in ER+ metastasis however is not established. Here we describe AIB1 as a survival factor, regulator of pro-metastatic transcriptional pathways and a promising actionable target. Genomic alterations and functional expression of AIB1 associated with reduced disease-free survival in patients and enhanced metastatic capacity in novel CDX and PDX ex-vivo models of ER+ metastatic disease. Comparative analysis of the AIB1 interactome with complementary RNAseq characterized AIB1 as a transcriptional repressor. Specifically, we report that AIB1 interacts with MTA2 to form a repressive complex, inhibiting CDH1 (encoding E-cadherin) to promote EMT and drive progression. We further report that pharmacological and genetic inhibition of AIB1 demonstrates significant anti-proliferative activity in patient-derived models establishing AIB1 as a viable strategy to target endocrine resistant metastasis. This work defines a novel role for AIB1 in the regulation of EMT through transcriptional repression in advanced cancer cells with a considerable implication for prognosis and therapeutic interventions.	[Vareslija, Damir; Ward, Elspeth; Purcell, Siobhan P.; Cosgrove, Nicola S.; Cocchiglia, Sinead; Charmsaz, Sara; Bane, Fiona T.; Hudson, Lance; Hill, Arnold D. K.; Young, Leonie S.] Royal Coll Surgeons Ireland, Dept Surg, Endocrine Oncol Res Grp, Dublin, Ireland; [O'Halloran, Philip J.] Beaumont Hosp, Dept Neurosurg, Natl Neurosurg Ctr, Dublin, Ireland; [Brett, Francesca M.; Farrell, Michael; Cryan, Jane; Beausang, Alan] Beaumont Hosp, Dept Neuropathol, Natl Neurosurg Ctr, Dublin, Ireland; [Turnbul, Arran K.; Dixon, J. Michael] Breast Canc Now Res Labs, Edinburgh EH4 2XU, Midlothian, Scotland; [Priedigkeit, Nolan; Oesterreich, Steffi; Lee, Adrian V.] Univ Pittsburgh, Univ Pittsburgh Canc Inst, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Oesterreich, Steffi; Lee, Adrian V.] Univ Pittsburgh, Univ Pittsburgh Canc Inst, Magee Womens Res Inst, Dept Womens Canc Res Ctr, Pittsburgh, PA USA; [Lee, Adrian V.] Univ Pittsburgh, Dept Human Genet, Univ Pittsburgh Canc Inst, Pittsburgh, PA USA; [Sims, Andrew H.] Univ Edinburgh, MRC Inst Genet & Mol Med, Western Gen Hosp, Appl Bioinformat Canc Grp,Canc Res UK Ctr, Edinburgh, Midlothian, Scotland; [Redmond, Aisling M.; Carroll, Jason S.] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	Royal College of Surgeons - Ireland; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Edinburgh; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Vareslija, D; Young, LS (corresponding author), Royal Coll Surgeons Ireland, Dept Surg, Endocrine Oncol Res Grp, Dublin, Ireland.	damirvareslija@rcsi.ie; lyoung@rcsi.ie		Ward, Elspeth/0000-0002-7530-2279; O'Halloran, Philip J/0000-0001-9175-8682; Carroll, Jason/0000-0003-3643-0080; Vareslija, Damir/0000-0003-1000-0357; Brett, Francesca/0000-0002-7453-4027; Cosgrove, Nicola/0000-0002-8296-115X	Breast Cancer Ireland [GR 14-0883]; Irish Cancer Society Collaborative Cancer Research Centre grant [CCRC13GAL]; Breast Cancer NOW grant [2018JulPR1094, 2019AugSF1310]; Irish Cancer Society Research Fellowship [STB19VAR]; Walk the Walk	Breast Cancer Ireland; Irish Cancer Society Collaborative Cancer Research Centre grant; Breast Cancer NOW grant; Irish Cancer Society Research Fellowship; Walk the Walk	We would like to acknowledge Robert Bagnall for his technical assistance in performing protein characterization experiments in this manuscript. We would like to acknowledge Aisling Hegarty for her tissue bank and database curation. We are thankful to the patients who generously provided tumor tissue for our studies and to the surgical, pathology and tissue bank colleagues for their substantial assistance and support. We kindly acknowledge the funding support from Breast Cancer Ireland (GR 14-0883)(LY),the Irish Cancer Society Collaborative Cancer Research Centre grant, (CCRC13GAL)(LY) and Breast Cancer NOW grant, 2018JulPR1094 (LY, DV). This work is supported by Irish Cancer Society Research Fellowship STB19VAR (DV). This work is supported by funding from Breast Cancer Now Grant, 2019AugSF1310 with the generous support of Walk the Walk (DV).	Alkner S, 2017, BREAST CANCER RES TR, V166, P481, DOI 10.1007/s10549-017-4416-0; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Arnedos M, 2014, ANN ONCOL, V25, P605, DOI 10.1093/annonc/mdt575; Browne AL, 2018, ONCOGENE, V37, P2008, DOI 10.1038/s41388-017-0042-x; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Covington KR, 2013, BREAST CANCER RES TR, V141, P375, DOI 10.1007/s10549-013-2709-5; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Foulds CE, 2013, MOL CELL, V51, P185, DOI 10.1016/j.molcel.2013.06.007; Fu JJ, 2012, INT J BIOL SCI, V8, P522, DOI 10.7150/ijbs.4164; Fu JJ, 2011, CELL RES, V21, P275, DOI 10.1038/cr.2010.118; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Garee JP, 2014, MOL ENDOCRINOL, V28, P846, DOI 10.1210/me.2013-1379; Gates LA, 2018, ONCOGENE, V37, P4581, DOI 10.1038/s41388-018-0284-2; Giltnane JM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai7993; Groner AC, 2017, J CLIN INVEST, V127, P1126, DOI 10.1172/JCI88885; Guo S, 2014, INT J CLIN ONCOL, V19, P319, DOI 10.1007/s10147-013-0549-2; Hanker AB, 2020, CANCER CELL, V37, P496, DOI 10.1016/j.ccell.2020.03.009; Jansen MPHM, 2013, CANCER RES, V73, P6632, DOI 10.1158/0008-5472.CAN-13-0704; Jeselsohn R, 2018, CANCER CELL, V33, P173, DOI 10.1016/j.ccell.2018.01.004; Jeselsohn R, 2014, CLIN CANCER RES, V20, P1757, DOI 10.1158/1078-0432.CCR-13-2332; Karmakar S, 2010, MOL ENDOCRINOL, V24, P1187, DOI 10.1210/me.2009-0480; Lefebvre C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002201; Ma CX, 2015, NAT REV CANCER, V15, P261, DOI 10.1038/nrc3920; McBryan J, 2015, CLIN CANCER RES, V21, P5371, DOI 10.1158/1078-0432.CCR-14-2155; Mei SL, 2017, NUCLEIC ACIDS RES, V45, pD658, DOI 10.1093/nar/gkw983; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Naeem H, 2007, MOL CELL BIOL, V27, P120, DOI 10.1128/MCB.00815-06; Nguyen VTM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10044; O'Hara J, 2012, CLIN CANCER RES, V18, P3305, DOI 10.1158/1078-0432.CCR-11-3300; Oesterreich S, 2003, CANCER RES, V63, P5203; Padmanaban V, 2019, NATURE, V573, P439, DOI 10.1038/s41586-019-1526-3; Priedigkeit N, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95703; Priedigkeit N, 2017, JAMA ONCOL, V3, P666, DOI 10.1001/jamaoncol.2016.5630; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Rohira AD, 2017, CANCER RES, V77, P4293, DOI 10.1158/0008-5472.CAN-16-2982; Shafi AA, 2018, EUR UROL ONCOL, V1, P325, DOI 10.1016/j.euo.2018.04.019; Siegel MB, 2018, J CLIN INVEST, V128, P1371, DOI 10.1172/JCI96153; Torres-Arzayus MI, 2010, CANCER RES, V70, P4102, DOI 10.1158/0008-5472.CAN-09-4080; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Vareslija D, 2019, JNCI-J NATL CANCER I, V111, P388, DOI 10.1093/jnci/djy110; Vareslija D, 2017, METHODS MOL BIOL, V1501, P327, DOI 10.1007/978-1-4939-6475-8_17; Vareslija D, 2016, CLIN CANCER RES, V22, P2765, DOI 10.1158/1078-0432.CCR-15-1583; Walsh CA, 2014, CANCER RES, V74, P2533, DOI 10.1158/0008-5472.CAN-13-2133; Wang L, 2016, HORM CANCER-US, V7, P229, DOI 10.1007/s12672-016-0261-6; Wang L, 2015, CANCER CELL, V28, P240, DOI 10.1016/j.ccell.2015.07.005; Ward E, 2018, CLIN CANCER RES, V24, P3692, DOI 10.1158/1078-0432.CCR-17-2615; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yan J, 2008, CANCER RES, V68, P5460, DOI 10.1158/0008-5472.CAN-08-0955; Yi P, 2017, MOL CELL, V67, P733, DOI 10.1016/j.molcel.2017.07.026; Zwart W, 2016, CLIN CANCER RES, V22, P479, DOI 10.1158/1078-0432.CCR-14-3277	50	5	6	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2021	40	7					1318	1331		10.1038/s41388-020-01606-3	http://dx.doi.org/10.1038/s41388-020-01606-3		JAN 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QK0LS	33420368	Green Published, hybrid			2022-12-26	WOS:000607346000008
J	Prawesh, S; Padmanabhan, B				Prawesh, Shankar; Padmanabhan, Balaji			A complex systems perspective of news recommender systems: Guiding emergent outcomes with feedback models	PLOS ONE			English	Article							SOCIAL MEDIA; FAKE NEWS; EVOLUTION	Algorithms are increasingly making decisions regarding what news articles should be shown to online users. In recent times, unhealthy outcomes from these systems have been highlighted including their vulnerability to amplifying small differences and offering less choice to readers. In this paper we present and study a new class of feedback models that exhibit a variety of self-organizing behaviors. In addition to showing important emergent properties, our model generalizes the popular "top-N news recommender systems" in a manner that provides media managers a mechanism to guide the emergent outcomes to mitigate potentially unhealthy outcomes driven by the self-organizing dynamics. We use complex adaptive systems framework to model the popularity evolution of news articles. In particular, we use agent-based simulation to model a reader's behavior at the microscopic level and study the impact of various simulation hyperparameters on overall emergent phenomena. This simulation exercise enables us to show how the feedback model can be used as an alternative recommender to conventional top-N systems. Finally, we present a design framework for multi-objective evolutionary optimization that enables recommendation systems to co-evolve with the changing online news readership landscape.	[Prawesh, Shankar] IIT Kanpur, Ind & Management Engn, Kanpur, UP, India; [Padmanabhan, Balaji] Univ S Florida, Muma Coll Business, Tampa, FL 33620 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; State University System of Florida; University of South Florida	Prawesh, S (corresponding author), IIT Kanpur, Ind & Management Engn, Kanpur, UP, India.	sprawesh@iitk.ac.in		prawesh, shankar/0000-0002-1037-3498				Abraham R, 2001, CHAOS AVANT GARDE ME; Adamopoulos P, 2014, PROCEEDINGS OF THE 8TH ACM CONFERENCE ON RECOMMENDER SYSTEMS (RECSYS'14), P153, DOI 10.1145/2645710.2645752; Ali K., 2007, P 16 INT C WORLD WID, P511, DOI [10.1145/1242572.1242642, DOI 10.1145/1242572.1242642]; Amaral LAN, 2007, MANAGE SCI, V53, P1033, DOI 10.1287/mnsc.1060.0696; Anderson P, 1999, ORGAN SCI, V10, P216, DOI 10.1287/orsc.10.3.216; Andrew L, 2014, FEELING LUCKY CAN AL; Anthes G, 2016, COMMUN ACM, V59, P19, DOI 10.1145/2892712; Aral S, 2019, SCIENCE, V365, P858, DOI 10.1126/science.aaw8243; Asadi Someh I, 2018, ICIS 2018 P; Bakshy E, 2015, SCIENCE, V348, P1130, DOI 10.1126/science.aaa1160; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barnes S, 2010, INFORMS J COMPUT, V22, P635, DOI 10.1287/ijoc.1100.0386; Benbya H., 2020, MIS Q, V44, P1, DOI [DOI 10.25300/MISQ/2020/13304, 10.25300/MISQ/2020/13304]; Bilton N, 2012, BITS BLOG 0401; Buchanan M, 2013, FORECAST WHAT PHYS M; Chan S, 2001, ESD 83 RES SEM ENG S; Cinelli M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229129; CLARK WAV, 1991, DEMOGRAPHY, V28, P1, DOI 10.2307/2061333; Corasaniti Nick, 2016, NY TIMES; Craswell N, 2008, PROC INTERNAT C WEB, P87, DOI 10.1145/1341531.1341545; Curry K, 2016, WASHINGTON POST; CynthiaDwork Moritz Hardt, 2012, P 3 INNOVATIONS THEO, P214; Deb K., 2009, MULTIOBJECTIVE OPTIM, V1st; Drinea E, 2002, SIAM PROC S, P308; Drugan MM, 2013, IEEE IJCNN; Easley D, 2010, POWER LAWS RICH GET; Eiben AE, 2015, NATURE, V521, P476, DOI 10.1038/nature14544; Gell-Mann M, 1992, COMPLEXITY COMPLEX A, P177; Ghoshal A, 2015, J MANAGE INFORM SYST, V31, P243, DOI 10.1080/07421222.2014.1001276; Haki K, 2020, MIS QUART, V44, P155, DOI 10.25300/MISQ/2020/14494; Halvey M, 2006, COMMUN ACM, V49, P76, DOI 10.1145/1118178.1118179; Hardt M., 2014, BIG DATA IS UNFAIR M; HOLLAND JH, 1992, DAEDALUS, V121, P17; Huberman BA, 1998, SCIENCE, V280, P95, DOI 10.1126/science.280.5360.95; Huberman BA, 2013, J STAT PHYS, V151, P329, DOI 10.1007/s10955-012-0596-5; Kim A, 2019, J MANAGE INFORM SYST, V36, P931, DOI 10.1080/07421222.2019.1628921; Kumar N, 2019, J MANAGE INFORM SYST, V36, P1313, DOI 10.1080/07421222.2019.1661089; Kumar R, 2010, LINK MINING: MODELS, ALGORITHMS, AND APPLICATIONS, P337, DOI 10.1007/978-1-4419-6515-8_13; Lee D., 2014, ICIS 2014 P; Loreto V, 2016, LECT N MORPHOGENESIS, P59, DOI 10.1007/978-3-319-24403-7_5; Miller Claire Cain, 2015, NEW YORK TIMES; Moravec PL, 2019, MIS QUART, V43, P1343, DOI 10.25300/MISQ/2019/15505; Morgan JS, 2014, ARXIV14121185PHYS; Morik M, 2020, PROCEEDINGS OF THE 43RD INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL (SIGIR '20), P429, DOI 10.1145/3397271.3401100; Nan N, 2011, MIS QUART, V35, P505; Prawesh S, 2014, INFORM SYST RES, V25, P569, DOI 10.1287/isre.2014.0529; RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; Smith EB, 2018, MANAGE SCI, V64, P5405, DOI 10.1287/mnsc.2017.2877; Song YC, 2019, MANAGE SCI, V65, P3737, DOI 10.1287/mnsc.2018.3127; Tanriverdi H, 2007, INFORM SYST RES, V18, P280, DOI 10.1287/isre.1070.0129; Vidgen R, 2009, INFORM SYST RES, V20, P355, DOI 10.1287/isre.1090.0237; Wills A, 2014, FULL NEW YORK TIMES; Winkler R., 2019, WALL STREET J JAN, P22; Wycisk C, 2008, INT J PHYS DISTR LOG, V38, P108, DOI 10.1108/09600030810861198; Yoo E, 2019, J MANAGE INFORM SYST, V36, P1105, DOI 10.1080/07421222.2019.1661096; Yu CS, 2005, THIRD IEEE INTERNATIONAL CONFERENCE ON PERVASIVE COMPUTING AND COMMUNICATIONS, WORKSHOPS, P70; Zechman EM, 2013, ENG APPL ARTIF INTEL, V26, P1442, DOI 10.1016/j.engappai.2013.03.004	59	0	0	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2021	16	1							e0245096	10.1371/journal.pone.0245096	http://dx.doi.org/10.1371/journal.pone.0245096			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PS6NW	33412573	gold, Green Published			2022-12-26	WOS:000608044300096
J	Kimber, MS				Kimber, Matthew S.			How to extend your (polylactosamine) antennae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							GLYCOSYLTRANSFERASES	The elongated antennae decorating eukaryotic glycans are built from polylactosamine repeats. Polylactosamine forms a lectin recognition site and also acts as a platform for presenting diverse additional modifications (e.g., terminal cell-surface antigens); it therefore plays important roles in cell adherence, development, and immunity. Two new papers present a detailed structural and mechanistic investigation of beta 1-3-N-acetylgucosaminyltransferase 2, a key enzyme in antennae synthesis. The resulting insights will also help decipher other members of GT31, the single largest human glycosyltransferase family.	[Kimber, Matthew S.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada	University of Guelph	Kimber, MS (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada.	mkimber@uoguelph.ca		Kimber, Matthew/0000-0001-9454-5586	Natural Sciences and Engineering Research Council of Canada [2020-07113]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Work in the author's laboratory is supported by a Natural Sciences and Engineering Research Council of Canada Discovery grant (2020-07113).	Arthur CM, 2015, METHODS MOL BIOL, V1207, P1, DOI 10.1007/978-1-4939-1396-1_1; Hao Y., 2021, J BIOL CHEM, V296; Kadirvelraj R., 2021, J BIOL CHEM, V296; Kitayama K, 2007, J BIOL CHEM, V282, P30085, DOI 10.1074/jbc.M703695200; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Petit D., 2020, GLYCOBIOLOGY, V25, P3389; Seko A, 2005, GLYCOBIOLOGY, V15, P943, DOI 10.1093/glycob/cwi082; Togayachi A, 2001, J BIOL CHEM, V276, P22032, DOI 10.1074/jbc.M011369200; Varki A., 2017, ESSENTIALS GLYCOBIOL	9	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100212	10.1016/j.jbc.2020.100212	http://dx.doi.org/10.1016/j.jbc.2020.100212			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33453284	gold, Green Published			2022-12-26	WOS:000672866400190
J	Zheng, WW; Chu, Q; Xu, TJ				Zheng, Weiwei; Chu, Qing; Xu, Tianjun			Long noncoding RNA IRL regulates NF-kappa B-mediated immune responses through suppression of miR-27c-3p-dependent IRAK4 downregulation in teleost fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; GENE; INTERLEUKIN-1; MECHANISM; MYD88; NLRS	Growing pieces of evidence show that the long noncoding RNAs (lncRNAs) as new regulators participate in the regulation of various physiological and pathological processes. The study of lncRNA in lower invertebrates is still unclear compared with that in mammals. Here, we identified a novel lncRNA, termed IRAK4-related lncRNA (IRL), as a key regulator for innate immunity in teleost fish. We find that miR-27c-3p inhibits IRAK4 expression and thus weakens the NF-kappa B-mediated signaling pathway. Furthermore, the Gram-negative bacterium Vibrio anguillarum and lipopolysaccharide significantly upregulated host lncRNA IRL expression. Results indicate that IRL functions as a competing endogenous RNA for miR-27c-3p to regulate protein abundance of IRAK4; thus, invading microorganisms are eliminated and immune responses are promoted. Our study also demonstrates the regulation mechanism that lncRNA IRL can competitively adsorb miRNA to regulate the miR-27c-3p/IRAK4 axis that is widespread in teleost fish.	[Zheng, Weiwei; Chu, Qing; Xu, Tianjun] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Lab Fish Mol Immunol, Shanghai, Peoples R China; [Zheng, Weiwei; Chu, Qing; Xu, Tianjun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Xu, Tianjun] Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, Minist Educ, Shanghai, Peoples R China; [Xu, Tianjun] Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China	Shanghai Ocean University; Qingdao National Laboratory for Marine Science & Technology; Shanghai Ocean University; Shanghai Ocean University	Xu, TJ (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, Lab Fish Mol Immunol, Shanghai, Peoples R China.; Xu, TJ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Xu, TJ (corresponding author), Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, Minist Educ, Shanghai, Peoples R China.; Xu, TJ (corresponding author), Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China.	tianjunxu@163.com			National Natural Science Foundation of China [31822057]; National Key Research and Development Project [2018YFD0900503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Project	This study was supported by National Natural Science Foundation of China (31822057) and National Key Research and Development Project (2018YFD0900503).	Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chu Q, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008670; Chu Q, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01623; Chu Q, 2017, J IMMUNOL, V198, P3274, DOI 10.4049/jimmunol.1602064; Chu Q, 2017, J BIOL CHEM, V292, P5282, DOI [10.1074/jbc.M117.777078, 10.1074/jbc.m117.777078]; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Fu T, 2021, GASTRIC CANCER, V24, P45, DOI 10.1007/s10120-020-01096-y; Girardin SE, 2005, J BIOL CHEM, V280, P38648, DOI 10.1074/jbc.M509537200; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hjorton K, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1702-0; Hu GA, 2010, NAT BIOTECHNOL, V28, P91, DOI 10.1038/nbt.1597; Huang MG, 2016, ONCOTARGET, V7, P47186, DOI 10.18632/oncotarget.9706; Hynes J, 2014, ANNU REP MED CHEM, V49, P117, DOI 10.1016/B978-0-12-800167-7.00009-2; Jing ZT, 2018, J IMMUNOL, V201, P2303, DOI 10.4049/jimmunol.1800732; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Li XX, 2008, EUR J IMMUNOL, V38, P614, DOI 10.1002/eji.200838161; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Paraskevopoulou MD, 2016, METHODS MOL BIOL, V1402, P271, DOI 10.1007/978-1-4939-3378-5_21; Patop IL, 2019, EMBO J, V38, DOI 10.15252/embj.2018100836; Pattabiraman G, 2018, J LEUKOCYTE BIOL, V104, P811, DOI 10.1002/JLB.2A1117-449R; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Umar S, 2021, CELL MOL IMMUNOL, V18, P2199, DOI 10.1038/s41423-020-0433-8; Vollmer S, 2017, BIOCHEM J, V474, P2027, DOI 10.1042/BCJ20170097; Xiong YB, 2011, J LEUKOCYTE BIOL, V90, P1141, DOI 10.1189/jlb.0611273; Xu TJ, 2018, J IMMUNOL, V201, P982, DOI 10.4049/jimmunol.1800377; Xu TJ, 2018, J BIOL CHEM, V293, P1386, DOI [10.1074/jbc.RA117.000158, 10.1074/jbc.ra117.000158]; Xu Y, 2014, FEBS LETT, V588, P1692, DOI 10.1016/j.febslet.2014.03.013; Yan BA, 2015, CIRC RES, V116, P1143, DOI 10.1161/CIRCRESAHA.116.305510; Yang XZ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0874-1; Ye F, 2020, CANCER MANAG RES, V12, P2339, DOI 10.2147/CMAR.S246332; Zhang L, 2020, J IMMUNOL, V205, P1620, DOI 10.4049/jimmunol.2000341; Zhou M, 2016, ONCOTARGET, V7, P56383, DOI 10.18632/oncotarget.10891; Zhou M, 2016, ONCOTARGET, V7, P12598, DOI 10.18632/oncotarget.7181; Zhou XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5212	50	22	23	11	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100304	10.1016/j.jbc.2021.100304	http://dx.doi.org/10.1016/j.jbc.2021.100304			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33465375	gold, Green Published			2022-12-26	WOS:000672866400278
J	Chan, SC; Hajarnis, SS; Vrba, SM; Patel, V; Igarashi, P				Chan, Siu Chiu; Hajarnis, Sachin S.; Vrba, Sophia M.; Patel, Vishal; Igarashi, Peter			Hepatocyte nuclear factor 1 beta suppresses canonical Wnt signaling through transcriptional repression of lymphoid enhancer-binding factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HNF-1&#946; &#946; -catenin; LEF1; kidney; histone methylation; tissue-specific transcription factor; Wnt pathway; beta-catenin (B-catenin); transcription repressor; T-cell factor (TCF); cystic kidney disease	WNT/BETA-CATENIN; KIDNEY DEVELOPMENT; GENE-EXPRESSION; RENAL CYSTS; FACTOR-I; HNF-1-BETA; ACTIVATION; DISEASE; MECHANISMS; COMPONENTS	Hepatocyte nuclear factor-1 beta (HNF-1 beta) is a tissue-specific transcription factor that is required for normal kidney development and renal epithelial differentiation. Mutations of HNF-1 beta produce congenital kidney abnormalities and inherited renal tubulopathies. Here, we show that ablation of HNF-1 beta in mIMCD3 renal epithelial cells results in activation of beta-catenin and increased expression of lymphoid enhancer-binding factor 1 (LEF1), a downstream effector in the canonical Wnt signaling pathway. Increased expression and nuclear localization of LEF1 are also observed in cystic kidneys from Hnf1b mutant mice. Expression of dominant-negative mutant HNF-1 beta in mIMCD3 cells produces hyperresponsiveness to exogenous Wnt ligands, which is inhibited by siRNA-mediated knockdown of Lef1. WT HNF-1 beta binds to two evolutionarily conserved sites located 94 and 30 kb from the mouse Lef1 promoter. Ablation of HNF-1 beta decreases H3K27 trimethylation repressive marks and increases beta-catenin occupancy at a site 4 kb upstream to Lef1. Mechanistically, WT HNF-1 beta recruits the polycomb-repressive complex 2 that catalyzes H3K27 trimethylation. Deletion of the beta-catenin-binding domain of LEF1 in HNF-1 beta-deficient cells abolishes the increase in Lef1 transcription and decreases the expression of downstream Wnt target genes. The canonical Wnt target gene, Axin2, is also a direct transcriptional target of HNF-1 beta through binding to negative regulatory elements in the gene promoter. These findings demonstrate that HNF-1 beta regulates canonical Wnt target genes through long-range effects on histone methylation at Wnt enhancers and reveal a new mode of active transcriptional repression by HNF-1 beta.	[Chan, Siu Chiu; Vrba, Sophia M.; Igarashi, Peter] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Hajarnis, Sachin S.; Patel, Vishal; Igarashi, Peter] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Hajarnis, Sachin S.] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA; [Vrba, Sophia M.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Southwestern Medical Center Dallas; Otsuka Pharmaceutical; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Igarashi, P (corresponding author), Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA.; Igarashi, P (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	igarashi@umn.edu	Patel, Vishal/GMW-7076-2022	Patel, Vishal/0000-0003-2875-4659; Igarashi, Peter/0000-0001-8698-1185; Vrba, Sophia/0000-0003-1679-8240	NIDDK, National Institutes of Health [R37DK042921]	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIDDK, National Institutes of Health Grant R37DK042921 (to P. I.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aboudehen K, 2017, J AM SOC NEPHROL, V28, P2887, DOI 10.1681/ASN.2016101095; Aboudehen K, 2016, J AM SOC NEPHROL, V27, P2408, DOI 10.1681/ASN.2015060607; Bai Y, 2002, AM J PHYSIOL-RENAL, V283, pF839, DOI 10.1152/ajprenal.00128.2002; Cadigan KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007906; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chan SC, 2019, P NATL ACAD SCI USA, V116, P24133, DOI 10.1073/pnas.1909452116; Chan SC, 2018, J AM SOC NEPHROL, V29, P2493, DOI 10.1681/ASN.2018040437; Chan SC, 2015, NUCLEIC ACIDS RES, V43, P5880, DOI 10.1093/nar/gkv262; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Chi YI, 2002, MOL CELL, V10, P1129, DOI 10.1016/S1097-2765(02)00704-9; Choi YH, 2013, AM J PHYSIOL-RENAL, V305, pF100, DOI 10.1152/ajprenal.00582.2012; Choi YH, 2011, P NATL ACAD SCI USA, V108, P10679, DOI 10.1073/pnas.1016214108; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Fang S, 2019, ONCOGENE, V38, P4061, DOI 10.1038/s41388-019-0704-y; Feder K, 2020, LEUKEMIA, V34, P1027, DOI 10.1038/s41375-019-0635-1; Ferre S, 2019, PEDIATR NEPHROL, V34, P1325, DOI 10.1007/s00467-018-3990-7; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Gammons M, 2018, CURR OPIN CELL BIOL, V51, P42, DOI 10.1016/j.ceb.2017.10.008; Gong YM, 2009, J AM SOC NEPHROL, V20, P41, DOI 10.1681/ASN.2008020238; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hajarnis SS, 2015, J BIOL CHEM, V290, P24793, DOI 10.1074/jbc.M115.670646; Hiesberger T, 2004, J CLIN INVEST, V113, P814, DOI 10.1172/JCI200420083; Hiesberger T, 2005, J BIOL CHEM, V280, P10578, DOI 10.1074/jbc.M414121200; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Huffstater T, 2020, SEMIN NEPHROL, V40, P126, DOI 10.1016/j.semnephrol.2020.01.004; Igarashi P, 2005, KIDNEY INT, V68, P1944, DOI 10.1111/j.1523-1755.2005.00625.x; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Kim K, 2017, CURR BIOL, V27, P2357, DOI 10.1016/j.cub.2017.06.037; Laugesen A, 2019, MOL CELL, V74, P8, DOI 10.1016/j.molcel.2019.03.011; Ma ZD, 2007, P NATL ACAD SCI USA, V104, P20386, DOI 10.1073/pnas.0705957104; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Shao A, 2020, CELL SIGNAL, V71, DOI 10.1016/j.cellsig.2020.109568; Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165; Tutter AV, 2001, GENE DEV, V15, P3342, DOI 10.1101/gad.946501; Verhave JC, 2016, J AM SOC NEPHROL, V27, P345, DOI 10.1681/ASN.2015050544; Wang YP, 2018, PROG MOL BIOL TRANSL, V153, P181, DOI 10.1016/bs.pmbts.2017.11.019; Yu DD, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0049-3; Zhou D, 2016, LAB INVEST, V96, P156, DOI 10.1038/labinvest.2015.153	44	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17560	17572		10.1074/jbc.RA120.015592	http://dx.doi.org/10.1074/jbc.RA120.015592			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453998	Green Published, hybrid			2022-12-26	WOS:000603272300014
J	Ye, QH; Zeng, XF; Wang, S; Zeng, XZ; Yang, GX; Ye, CCA; Cai, S; Chen, MX; Li, SY; Qiao, SY				Ye, Qianhong; Zeng, Xiangfang; Wang, Shuai; Zeng, Xiangzhou; Yang, Guangxin; Ye, Changchuan; Cai, Shuang; Chen, Meixia; Li, Siyu; Qiao, Shiyan			Butyrate drives the acetylation of histone H3K9 to activate steroidogenesis through PPAR gamma and PGC1 alpha pathways in ovarian granulosa cells	FASEB JOURNAL			English	Article						estradiol; mitochondrial dynamics; mitochondrial function; oxidative stress; progesterone	OXIDATIVE STRESS; MITOCHONDRIAL BIOGENESIS; GENE-EXPRESSION; PROGESTERONE; IMPLANTATION; DECIDUALIZATION; PROLIFERATION; COACTIVATOR; MECHANISMS; APOPTOSIS	Maintaining ovarian steroidogenesis is of critical importance, considering that steroid hormones are required for successful establishment and maintenance of pregnancy and proper development of embryos and fetuses. Investigating the mechanism that butyrate modulates the ovarian steroidogenesis is beneficial for understanding the impact of lipid nutrition on steroidogenesis. Herein, we identified that butyrate improved estradiol and progesterone synthesis in rat primary ovarian granulosa cells and human granulosa KGN cells and discovered the related mechanism. Our data indicated that butyrate was sensed by GPR41 and GPR43 in ovarian granulosa cells. Butyrate primarily upregulated the acetylation of histone H3K9 (H3K9ac). Chromatin immune-precipitation and sequencing (ChIP-seq) data of H3K9ac revealed the influenced pathways involving in the mitochondrial function (including cellular metabolism and steroidogenesis) and cellular antioxidant capacity. Additionally, increasing H3K9ac by butyrate further stimulated the PPAR gamma/CD36/StAR pathways to increase ovarian steroidogenesis and activated PGC1 alpha to enhance mitochondrial dynamics and alleviate oxidative damage. The improvement in antioxidant capacity and mitochondrial dynamics by butyrate enhanced ovarian steroidogenesis. Collectively, butyrate triggers histone H3K9ac to activate steroidogenesis through PPAR gamma and PGC1 alpha pathways in ovarian granulosa cells.	[Ye, Qianhong; Zeng, Xiangfang; Wang, Shuai; Zeng, Xiangzhou; Yang, Guangxin; Ye, Changchuan; Cai, Shuang; Chen, Meixia; Li, Siyu; Qiao, Shiyan] China Agr Univ, State Key Lab Anim Nutr, Minist Agr, Feed Ind Ctr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China; [Ye, Qianhong; Zeng, Xiangfang; Zeng, Xiangzhou; Yang, Guangxin; Ye, Changchuan; Cai, Shuang; Chen, Meixia; Li, Siyu; Qiao, Shiyan] Beijing Key Lab Biofeed Addit, Beijing, Peoples R China; [Wang, Shuai] Huazhong Agr Univ, Coll Anim Sci & Technol, Dept Anim Nutr & Feed Sci, Wuhan, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University	Zeng, XF (corresponding author), China Agr Univ, State Key Lab Anim Nutr, Minist Agr, Feed Ind Ctr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	zengxf@cau.edu.cn						Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; Calvo D, 1998, J LIPID RES, V39, P777; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; CHECK JH, 1987, INT J FERTIL, V32, P192; Chen SD, 2011, INT J MOL SCI, V12, P7199, DOI 10.3390/ijms12107199; Daly K, 2006, DNA CELL BIOL, V25, P49, DOI 10.1089/dna.2006.25.49; Danielian PJ., 2010, BR J OBSTET GYNAECOL, V102, P364; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; DAYA S, 1989, BRIT J OBSTET GYNAEC, V96, P275, DOI 10.1111/j.1471-0528.1989.tb02386.x; Dhungana S, 2016, MATURITAS, V92, P134, DOI 10.1016/j.maturitas.2016.07.008; Diemer T, 2003, ENDOCRINOLOGY, V144, P2882, DOI 10.1210/en.2002-0090; Duan LJ, 2010, EARLY HUM DEV, V86, P41, DOI 10.1016/j.earlhumdev.2009.12.007; Elis S, 2015, THERIOGENOLOGY, V83, P840, DOI 10.1016/j.theriogenology.2014.11.019; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gao X, 2018, CELL REP, V22, P3507, DOI 10.1016/j.celrep.2018.03.017; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Haas DM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003511.pub3; Hong J, 2016, ONCOTARGET, V7, P56071, DOI 10.18632/oncotarget.11267; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kodama A, 2010, HUM REPROD, V25, P751, DOI 10.1093/humrep/dep455; Lin Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097838, 10.1371/journal.pone.0098312]; Liu XJ, 2015, MOL CELL PROTEOMICS, V14, P1489, DOI 10.1074/mcp.M114.044859; Lu NS, 2017, J STEROID BIOCHEM, V172, P89, DOI 10.1016/j.jsbmb.2017.06.004; McRae RS, 2005, ENDOCRINOLOGY, V146, P309, DOI 10.1210/en.2004-0999; Mesegueri S, 2015, HUM MOL GENET, V24, P167, DOI 10.1093/hmg/ddu427; Mollica MP, 2017, DIABETES, V66, P1405, DOI 10.2337/db16-0924; Mumford SL, 2016, AM J CLIN NUTR, V103, P868, DOI 10.3945/ajcn.115.119321; Oyewole AO, 2015, FASEB J, V29, P4766, DOI 10.1096/fj.15-275404; PEPE GJ, 1995, ENDOCR REV, V16, P608, DOI 10.1210/er.16.5.608; Potdar N, 2005, CURR OPIN OBSTET GYN, V17, P424, DOI 10.1097/01.gco.0000175363.20094.bd; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; QUINN PG, 1985, J BIOL CHEM, V260, P2092; Rose S, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-017-0089-z; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Sharov AA, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-24; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66; Tailor D, 2014, MITOCHONDRION, V16, P55, DOI 10.1016/j.mito.2013.10.004; Tan J, 1999, ENDOCRINOLOGY, V140, P5310, DOI 10.1210/en.140.11.5310; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Ye QH, 2019, J NUTR BIOCHEM, V69, P98, DOI 10.1016/j.jnutbio.2019.03.015; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131	46	6	6	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21316	10.1096/fj.202000444R	http://dx.doi.org/10.1096/fj.202000444R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33433947				2022-12-26	WOS:000647789600063
J	Gianniki, M; Siahanidou, T; Botsa, E; Michos, A				Gianniki, Maria; Siahanidou, Tania; Botsa, Evanthia; Michos, Athanasios			Measles epidemic in pediatric population in Greece during 2017-2018: Epidemiological, clinical characteristics and outcomes	PLOS ONE			English	Article							OUTBREAK; HOSPITALIZATIONS; NETHERLANDS; ELIMINATION; REGION	Background and aim A measles outbreak occurred in Greece during 2017-2018 affecting mainly pediatric population. The aim of the study was to describe the epidemiological and clinical characteristics of the cases diagnosed in the major pediatric tertiary hospital of Athens, where 26.5% of national pediatric measles cases were diagnosed and treated. Methods This is a retrospective study of children 0-16 years old, who presented at the emergency department and/or were hospitalized with clinical presentation compatible with measles and diagnosis was confirmed with molecular detection of the measles RNA in pharyngeal swabs. Epidemiological, clinical and laboratory characteristics were retrieved from medical records and analyzed. Results A total of 578 children with measles were identified during the study period. 322 (55.7%) were male with median age 36 months (range:1-193), while the largest number of documented cases (251; 43.4%) were children aged 1-5 years. Most children (429/578; 74.2%) belonged to the Roma minority and only 64 (11.1%) had Greek origin. 497 (91.5%) children were unvaccinated and 37 (6.8%) were partially vaccinated with measles vaccine. Hospitalization was required for 342 (59.2%) children, whereas one or more complications were reported in 230 (67.2%) of them. Most frequent complications were elevated transaminases (139; 40.6%), acute otitis media (72; 21%), dehydration (67; 19.6%) and pneumonia (58; 16.9%). 11 children (3.2%) required intensive care admission for altered mental status/status epilepticus (3), sepsis (2) and ARDS (6). 119/342 (34.8%) children were treated with antibiotics because of possible or confirmed bacterial coinfection. One death was reported, concerning an 11-month-old unvaccinated infant, with underlying dystrophy, who died of sepsis. Conclusion Measles is not an innocent viral infection, as it is still characterized by high morbidity and complications rates. Unvaccinated or partially vaccinated populations could trigger new outbreaks, resulting in significant cost in public health. To avoid future measles outbreaks, high vaccination coverage should be achieved, as well as closing immunity gaps in the population and ensuring high-quality measles surveillance.	[Gianniki, Maria; Siahanidou, Tania; Botsa, Evanthia; Michos, Athanasios] Natl & Kapodistrian Univ Athens, Aghia Sophia Childrens Hosp, Dept Pediat 1, Athens, Greece	National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital	Michos, A (corresponding author), Natl & Kapodistrian Univ Athens, Aghia Sophia Childrens Hosp, Dept Pediat 1, Athens, Greece.	amichos@med.uoa.gr		Michos, Athanasios/0000-0003-1745-1118				Arapovic J, 2019, BOSNIAN J BASIC MED, V19, P210, DOI 10.17305/bjbms.2019.4266; Barrett P, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.27.30277; Bell S, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000874; Berti E, 2016, EPIDEMIOL INFECT, V144, P2605, DOI 10.1017/S0950268816001023; Buckley BS, 2019, CLIN MICROBIOL INFEC, V25, P1213, DOI 10.1016/j.cmi.2019.06.030; Ceccarelli G, 2019, EUR J PUBLIC HEALTH, V29, P966, DOI 10.1093/eurpub/ckz056; Cornelissen L, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000278; degli Atti MC, 2017, PEDIATR INFECT DIS J, V36, P844, DOI 10.1097/INF.0000000000001609; Department of Epidemiological Surveillance and Intervention. National Public Health Organization, UPD REP DOC MEASL CA; Filia A, 2017, EUROSURVEILLANCE, V22, P2, DOI [10.2807/1560-7917.ES.2017.22.37.30614, 10.2807/1560-7917.es.2017.22.37.30614]; Filia A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-169; Comas LG, 2017, HUM VACC IMMUNOTHER, V13, P1078, DOI 10.1080/21645515.2016.1267081; Georgakopoulou T, 2018, EPIDEMIOL INFECT, V146, P1692, DOI [10.1017/S0950268818002170, 10.1017/s0950268818002170]; Georgakopoulou T, 2017, HUM VACC IMMUNOTHER, V13, P190, DOI 10.1080/21645515.2016.1230577; Gioula G, 2007, EPIDEMIOL INFECT, V135, P570, DOI 10.1017/S0950268806007308; Graber EMA, 2020, J EMERG MED, V58, P610, DOI 10.1016/j.jemermed.2020.02.007; Grammens T, 2017, EUROSURVEILLANCE, V22, P5, DOI 10.2807/1560-7917.ES.2017.22.17.30524; Grammens T, 2016, EUROSURVEILLANCE, V21, P17, DOI 10.2807/1560-7917.ES.2016.21.32.30313; Hahne SJM, 2016, J INFECT DIS, V214, P1980, DOI 10.1093/infdis/jiw480; Hester G, 2019, PEDIATR INFECT DIS J, V38, P547, DOI 10.1097/INF.0000000000002221; Hester GZ, 2020, PEDIATR INFECT DIS J, V39, pE45, DOI 10.1097/INF.0000000000002574; Jackson C, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4178-y; Kondova IT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074754; Lo Vecchio A, 2020, ARCH DIS CHILD, V105, P896, DOI 10.1136/archdischild-2018-315290; Maltezou HC, 2018, J HOSP INFECT, V100, pE261, DOI 10.1016/j.jhin.2018.06.007; Mellou K, 2019, EUROSURVEILLANCE, V24, P26, DOI 10.2807/1560-7917.ES.2019.24.27.1800326; Muscat M, 2016, EUROSURVEILLANCE, V21, P19, DOI 10.2807/1560-7917.ES.2016.21.9.30152; Orosz L, 2018, ACTA MICROBIOL IMM H, V65, P127, DOI 10.1556/030.65.2018.014; Palamara M A, 2018, J Prev Med Hyg, V59, pE8, DOI 10.15167/2421-4248/jpmh2018.59.1.853; Panagiotopoulos T., 2020, GREEK NATL STUDY VAC; Pervanidou D, 2010, EUROSURVEILLANCE, V15, P2; Roberts L, 2020, NATURE, V580, P446, DOI 10.1038/d41586-020-01011-6; Saxena S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2392; Strebel PM, 2019, NEW ENGL J MED, V381, P349, DOI 10.1056/NEJMcp1905181; Suijkerbuijk AWM, 2015, EMERG INFECT DIS, V21, P2067, DOI 10.3201/eid2111.150410; Tramuto F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195256; Wilder-Smith AB, 2020, J EPIDEMIOL GLOB HEA, V10, P46, DOI 10.2991/jegh.k.191117.001; World Health Organization. Regional Office for Europe, 2014, EL MEASL RUB FRAM VE; World Health Organization Regional Office for Europe (WHO/Europe), 2017, 6 M EUR REG VER COMM; Woudenberg T, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.3.30443; Zimmerman LA, 2019, MMWR-MORBID MORTAL W, V68, P396, DOI 10.15585/mmwr.mm6817a4	41	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245512	10.1371/journal.pone.0245512	http://dx.doi.org/10.1371/journal.pone.0245512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471833	Green Published, gold			2022-12-26	WOS:000639428800054
J	Noel, SE; Cornell, DJ; Zhang, XY; Mirochnick, JC; Mattei, J; Falcon, LM; Tucker, KL				Noel, Sabrina E.; Cornell, David J.; Zhang, Xiyuan; Mirochnick, Julia C.; Mattei, Josiemer; Falcon, Luis M.; Tucker, Katherine L.			Patterns of change in cardiovascular risk assessments and ankle brachial index among Puerto Rican adults	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; CUMULATIVE BIOLOGICAL RISK; ALLOSTATIC LOAD; PHYSICAL-ACTIVITY; UNITED-STATES; MORTALITY; PREVALENCE; HEALTH; PREDICTION; ASSOCIATION	Background Puerto Rican adults have higher odds of peripheral artery disease (PAD) compared with Mexican Americans. Limited studies have examined relationships between clinical risk assessment scores and ABI measures in this population. Methods Using 2004-2015 data from the Boston Puerto Rican Health Study (BPRHS) (n = 370-583), cross-sectional, 5-y change, and patterns of change in Framingham Risk Score (FRS) and allostatic load (AL) with ankle brachial index (ABI) at 5-y follow-up were assessed among Puerto Rican adults (45-75 y). FRS and AL were calculated at baseline, 2-y and 5-y follow-up. Multivariable linear regression models were used to examine cross-sectional and 5-y changes in FRS and AL with ABI at 5-y. Latent growth mixture modeling identified trajectories of FRS and AL over 5-y, and multivariable linear regression models were used to test associations between trajectory groups at 5-y. Results Greater FRS at 5-y and increases in FRS from baseline were associated with lower ABI at 5-y (beta = -0.149, P = 0.010; beta = -0.171, P = 0.038, respectively). AL was not associated with ABI in cross-sectional or change analyses. Participants in low-ascending (vs. no change) FRS trajectory, and participants in moderate-ascending (vs. low-ascending) AL trajectory, had lower 5-y ABI (beta = -0.025, P = 0.044; beta = -0.016, P = 0.023, respectively). Conclusions FRS was a better overall predictor of ABI, compared with AL. Puerto Rican adults, an understudied population with higher FRS over 5 years, may benefit from intensive risk factor modification to reduce risk of PAD. Additional research examining relationships between FRS and AL and development of PAD is warranted.	[Noel, Sabrina E.; Tucker, Katherine L.] Univ Massachusetts Lowell, Dept Biomed & Nutr Sci, Lowell, MA 01854 USA; [Noel, Sabrina E.; Cornell, David J.] Univ Massachusetts Lowell, Hlth Assessment Lab, Lowell, MA 01854 USA; [Noel, Sabrina E.; Cornell, David J.; Zhang, Xiyuan; Falcon, Luis M.; Tucker, Katherine L.] Univ Massachusetts Lowell, Zuckerberg Coll Hlth Sci, Ctr Populat Hlth, Lowell, MA 01854 USA; [Cornell, David J.] Univ Massachusetts Lowell, Dept Phys Therapy & Kinesiol, Lowell, MA USA; [Mirochnick, Julia C.] Univ Massachusetts Lowell, Dept Publ Hlth, Lowell, MA USA; [Mattei, Josiemer] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Falcon, Luis M.] Univ Massachusetts Lowell, Coll Fine Arts Humanities & Social Sci, Lowell, MA USA	University of Massachusetts System; University of Massachusetts Lowell; University of Massachusetts System; University of Massachusetts Lowell; University of Massachusetts System; University of Massachusetts Lowell; University of Massachusetts System; University of Massachusetts Lowell; University of Massachusetts System; University of Massachusetts Lowell; Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Lowell	Noel, SE (corresponding author), Univ Massachusetts Lowell, Dept Biomed & Nutr Sci, Lowell, MA 01854 USA.; Noel, SE (corresponding author), Univ Massachusetts Lowell, Hlth Assessment Lab, Lowell, MA 01854 USA.; Noel, SE (corresponding author), Univ Massachusetts Lowell, Zuckerberg Coll Hlth Sci, Ctr Populat Hlth, Lowell, MA 01854 USA.	sabrina_noel@uml.edu		Zhang, Xiyuan/0000-0003-0154-7705; Cornell, David/0000-0002-7457-8433	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) [K01 AR067894]; National Institute on Aging (NIH/NIA) [R01 AG055948]; NIH/NIAMS [R01 AR072741]; NIH/NIA [P01 AG023394]; National Heart, Lung, and Blood Institute [P50 HL105185]	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging (NIH/NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SEN is funded by K01 AR067894 through the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS). KLT is funded by R01 AG055948 and R01 AR072741 through the National Institute on Aging (NIH/NIA) and NIH/NIAMS, respectively. The project was funded by P01 AG023394 and P50 HL105185 from NIH/NIA and the National Heart, Lung, and Blood Institute, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison MA, 2006, J AM COLL CARDIOL, V48, P1190, DOI 10.1016/j.jacc.2006.05.049; Allison MA, 2015, J VASC SURG, V62, P665, DOI 10.1016/j.jvs.2015.03.065; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Beckie TM, 2012, BIOL RES NURS, V14, P311, DOI 10.1177/1099800412455688; Bermudez OI, 2002, AM J CLIN NUTR, V76, P1214, DOI 10.1093/ajcn/76.6.1214; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; Conte SM, 2018, HEART LUNG CIRC, V27, P427, DOI 10.1016/j.hlc.2017.10.014; Cortes-Bergoderi M, 2012, REV PANAM SALUD PUBL, V32, P131, DOI 10.1590/S1020-49892012000800007; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Daviglus ML, 2012, JAMA-J AM MED ASSOC, V308, P1775, DOI 10.1001/jama.2012.14517; Delgado-Osorio Hector, 2011, Bol Asoc Med P R, V103, P17; Dhangana R, 2011, J VASC INTERV RADIOL, V22, P1077, DOI 10.1016/j.jvir.2011.04.008; European Stroke O., ESC GUIDELINES DIAGN; Faxon DP, 2004, CIRCULATION, V109, P2595, DOI 10.1161/01.CIR.0000128517.52533.DB; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gallo LC, 2014, PSYCHOSOM MED, V76, P478, DOI 10.1097/PSY.0000000000000095; Gijsberts CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132321; Goldman N, 2004, J WOMENS HEALTH, V13, P393, DOI 10.1089/154099904323087088; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hooi JD, 2004, J CLIN EPIDEMIOL, V57, P294, DOI 10.1016/j.jclinepi.2003.09.003; Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure, 2004, JAMA-J AM MED ASSOC, Vxiv, P86; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Lai CQ, 2009, HUM GENET, V125, P199, DOI 10.1007/s00439-008-0612-7; Laing ST, 2012, ECHOCARDIOGR-J CARD, V29, P1224, DOI 10.1111/j.1540-8175.2012.01774.x; Leahy R, 2012, COLLEGIUM ANTROPOL, V36, P11; Lin JS, 2013, ANN INTERN MED, V159, P333, DOI 10.7326/0003-4819-159-5-201309030-00007; Mattei J, 2018, CLIN NUTR, V37, P1332, DOI 10.1016/j.clnu.2017.06.003; Mattei J, 2010, SOC SCI MED, V70, P1988, DOI 10.1016/j.socscimed.2010.02.024; McDermott MM, 2009, J AM COLL CARDIOL, V53, P1056, DOI 10.1016/j.jacc.2008.09.063; McEwen BS, 1999, ANN NY ACAD SCI, V896, P30, DOI 10.1111/j.1749-6632.1999.tb08103.x; Muthen L.K., 2012, MPLUS USERS GUIDE ST, V7th; Nelson KM, 2007, ETHNIC DIS, V17, P669; North American Association for the Study of Obesity, 2000, PRACT GUID ID EV TRE, Vvii, P77; Novo S, 2002, DIABETES OBES METAB, V4, pS1, DOI 10.1046/j.1463-1326.2002.0040s20s1.x; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P161, DOI 10.1093/oxfordjournals.aje.a112608; Resnick HE, 2004, CIRCULATION, V109, P733, DOI 10.1161/01.CIR.0000112642.63927.54; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Seeman TE, 2004, SOC SCI MED, V58, P1985, DOI 10.1016/S0277-9536(03)00402-7; Seeman TE, 2001, P NATL ACAD SCI USA, V98, P4770, DOI 10.1073/pnas.081072698; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Sofer T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47928-5; Trivedi DP, 2001, J CLIN ENDOCR METAB, V86, P4171, DOI 10.1210/jc.86.9.4171; Tucker KL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-107; United Status Census Bureau, 2017, HISP LAT OR SPEC OR; Viera AJ, 2010, AM FAM PHYSICIAN, V82, P265; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	53	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245236	10.1371/journal.pone.0245236	http://dx.doi.org/10.1371/journal.pone.0245236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM1OE	33471871	gold, Green Published			2022-12-26	WOS:000639428800056
J	Thorsteinsdottir, B; Hickson, LJ; Giblon, R; Pajouhi, A; Connell, N; Branda, M; Vasdev, AK; McCoy, RG; Zand, L; Tangri, N; Shah, ND				Thorsteinsdottir, Bjorg; Hickson, LaTonya J.; Giblon, Rachel; Pajouhi, Atieh; Connell, Natalie; Branda, Megan; Vasdev, Amrit K.; McCoy, Rozalina G.; Zand, Ladan; Tangri, Navdeep; Shah, Nilay D.			Validation of prognostic indices for short term mortality in an incident dialysis population of older adults >75	PLOS ONE			English	Article							STAGE RENAL-DISEASE; PATIENT-CENTERED CARE; ELDERLY-PATIENTS; DECISION-MAKING; EARLY DEATH; KIDNEY-DISEASE; RISK SCORE; END; LIFE; HEMODIALYSIS	Rational and objective Prognosis provides critical knowledge for shared decision making between patients and clinicians. While several prognostic indices for mortality in dialysis patients have been developed, their performance among elderly patients initiating dialysis is unknown, despite great need for reliable prognostication in that context. To assess the performance of 6 previously validated prognostic indices to predict 3 and/or 6 months mortality in a cohort of elderly incident dialysis patients. Study design Validation study of prognostic indices using retrospective cohort data. Indices were compared using the concordance ("c")-statistic, i.e. area under the receiver operating characteristic curve (ROC). Calibration, sensitivity, specificity, positive and negative predictive values were also calculated. Setting & participants Incident elderly (age >= 75 years; n = 349) dialysis patients at a tertiary referral center. Established predictors Variables for six validated prognostic indices for short term (3 and 6 month) mortality prediction (Foley, NCI, REIN, updated REIN, Thamer, and Wick) were extracted from the electronic medical record. The indices were individually applied as per each index specifications to predict 3- and/or 6-month mortality. Results In our cohort of 349 patients, mean age was 81.54.4 years, 66% were male, and median survival was 351 days. The c-statistic for the risk prediction indices ranged from 0.57 to 0.73. Wick ROC 0.73 (0.68, 0.78) and Foley 0.67 (0.61, 0.73) indices performed best. The Foley index was weakly calibrated with poor overall model fit (p <0.01) and overestimated mortality risk, while the Wick index was relatively well-calibrated but underestimated mortality risk. Limitations Small sample size, use of secondary data, need for imputation, homogeneous population. Conclusion Most predictive indices for mortality performed moderately in our incident dialysis population. The Wick and Foley indices were the best performing, but had issues with under and over calibration. More accurate indices for predicting survival in older patients with kidney failure are needed.	[Thorsteinsdottir, Bjorg; Pajouhi, Atieh; Vasdev, Amrit K.; McCoy, Rozalina G.] Mayo Clin, Div Community Internal Med, Dept Med, Rochester, MN 55905 USA; [Thorsteinsdottir, Bjorg; Connell, Natalie] Mayo Clin, Biomed Eth Program, Rochester, MN 55905 USA; [Thorsteinsdottir, Bjorg; Giblon, Rachel; Branda, Megan; Shah, Nilay D.] Mayo Clin, Knowledge Evaluat Res Unit, Rochester, MN 55905 USA; [Thorsteinsdottir, Bjorg; Hickson, LaTonya J.; McCoy, Rozalina G.] Mayo Clin, Kern Ctr Sci Hlth Care Delivery, Rochester, MN 55905 USA; [Hickson, LaTonya J.; Zand, Ladan] Mayo Clin, Div Nephrol & Hypertens, Dept Med, Rochester, MN USA; [Shah, Nilay D.] Mayo Clin, Div Hlth Care Sci Res, Rochester, MN USA; [Branda, Megan] Univ Colorado Denver Anschutz Med Campus, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Tangri, Navdeep] Univ Manitoba, Seven Oaks Gen Hosp, Dept Med, Winnipeg, MB, Canada; [Tangri, Navdeep] Univ Manitoba, Seven Oaks Gen Hosp, Dept Community Hlth Sci, Winnipeg, MB, Canada	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Thorsteinsdottir, B (corresponding author), Mayo Clin, Div Community Internal Med, Dept Med, Rochester, MN 55905 USA.; Thorsteinsdottir, B (corresponding author), Mayo Clin, Biomed Eth Program, Rochester, MN 55905 USA.; Thorsteinsdottir, B (corresponding author), Mayo Clin, Knowledge Evaluat Res Unit, Rochester, MN 55905 USA.; Thorsteinsdottir, B (corresponding author), Mayo Clin, Kern Ctr Sci Hlth Care Delivery, Rochester, MN 55905 USA.	Thorsteinsdottir.bjorg@mayo.edu		Thorsteinsdottr, Bjorg/0000-0002-4397-728X	Mayo Clinic, Robert D and Patricia E. Center for the Science of Health Care Delivery; Extramural Grant Program (EGP) by Satellite Healthcare; National Institute of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K23 DK109134, K23 DK114497]; National Institute on Aging [K23 AG051679]; National Center for Advancing Translational Sciences (NCATS) [UL1 TR000135]; Mayo Clinic from the Food and Drug Administration [U01FD005938]; Centers of Medicare and Medicaid Innovation under the Transforming Clinical Practice Initiative (TCPI); Agency for Healthcare Research and Quality [R01HS025164, R01HS025402, R03HS025517]; National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) [R56HL130496, R01HL131535]; National Science Foundation; Patient Centered Outcomes Research Institute (PCORI)	Mayo Clinic, Robert D and Patricia E. Center for the Science of Health Care Delivery; Extramural Grant Program (EGP) by Satellite Healthcare; National Institute of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mayo Clinic from the Food and Drug Administration; Centers of Medicare and Medicaid Innovation under the Transforming Clinical Practice Initiative (TCPI); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung and Blood Institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); Patient Centered Outcomes Research Institute (PCORI)(Patient-Centered Outcomes Research Institute - PCORI)	This publication was supported by the Mayo Clinic, Robert D and Patricia E. Center for the Science of Health Care Delivery (B.T., R.H., R.G.M, L.J.H), by the Extramural Grant Program (EGP) by Satellite Healthcare, a not-for-profit renal care provider (L.J.H., B.T.), and by the National Institute of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant K23 DK109134 (L.J.H.) K23 DK114497 (RGM) and the National Institute on Aging grant K23 AG051679 (B.T.). Additional support was provided by the National Center for Advancing Translational Sciences (NCATS) grant UL1 TR000135. Dr. Shah has received research support through Mayo Clinic from the Food and Drug Administration to establish Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program (U01FD005938); from the Centers of Medicare and Medicaid Innovation under the Transforming Clinical Practice Initiative (TCPI); from the Agency for Healthcare Research and Quality (R01HS025164, R01HS025402, R03HS025517); from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH; R56HL130496, R01HL131535), National Science Foundation; and from the Patient Centered Outcomes Research Institute (PCORI) to develop a Clinical Data Research Network (LHSNet). Dr. Tangri reports grants and personal fees from AstraZeneca Inc., personal fees from Otsuka Inc., personal fees from Janssen, personal fees from Boehringer Ingelheim and Eli Lilly, grants, and personal fees, and other from Tricida Inc., outside the submitted work. Study contents are the sole responsibility of the authors and do not necessarily represent the official views of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RT, 2019, CLIN J AM SOC NEPHRO, V14, P1213, DOI 10.2215/CJN.00050119; Barrett BJ, 1997, AM J KIDNEY DIS, V29, P214, DOI 10.1016/S0272-6386(97)90032-9; Biehl M., 2010, CRIT CARE MED; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen JCY, 2018, CLIN J AM SOC NEPHRO, V13, P1172, DOI 10.2215/CJN.00590118; Cheung KL, 2014, J GERONTOL A-BIOL, V69, P1033, DOI 10.1093/gerona/glt289; Cohen LM, 2010, CLIN J AM SOC NEPHRO, V5, P72, DOI 10.2215/CJN.03860609; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Combs SA, 2015, AM J KIDNEY DIS, V65, P233, DOI 10.1053/j.ajkd.2014.07.018; Couchoud C, 2009, NEPHROL DIAL TRANSPL, V24, P1553, DOI 10.1093/ndt/gfn698; Couchoud CG, 2015, KIDNEY INT, V88, P1178, DOI 10.1038/ki.2015.245; Crane SJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-338; Davison SN, 2006, CLIN J AM SOC NEPHRO, V1, P1256, DOI 10.2215/CJN.02040606; Davison SN, 2010, CLIN J AM SOC NEPHRO, V5, P195, DOI 10.2215/CJN.05960809; Fitzpatrick J, 2019, NEPHROL DIAL TRANSPL, V34, P346, DOI 10.1093/ndt/gfy124; Floege J, 2015, KIDNEY INT, V87, P996, DOI 10.1038/ki.2014.419; FOLEY RN, 1994, AM J KIDNEY DIS, V23, P836, DOI 10.1016/S0272-6386(12)80137-5; Hickson LJ, 2016, J AM COLL CARDIOL, V67, P1173, DOI 10.1016/j.jacc.2015.12.052; Hickson LJ, 2015, AM J KIDNEY DIS, V65, P592, DOI 10.1053/j.ajkd.2014.10.015; Johansen KL, 2007, J AM SOC NEPHROL, V18, P2960, DOI 10.1681/ASN.2007020221; Kan WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068748; Khan IH, 1998, AM J KIDNEY DIS, V31, P473, DOI 10.1053/ajkd.1998.v31.pm9506684; KHAN IH, 1993, LANCET, V341, P415, DOI 10.1016/0140-6736(93)93003-J; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu JN, 2010, KIDNEY INT, V77, P141, DOI 10.1038/ki.2009.413; McAdams-DeMarco MA, 2018, CLIN J AM SOC NEPHRO, V13, P1339, DOI 10.2215/CJN.10150917; Michel DM, 2005, ADV CHRONIC KIDNEY D, V12, P196, DOI 10.1053/j.ackd.2005.01.003; Morton RL, 2016, NEPHROL DIAL TRANSPL, V31, P46, DOI 10.1093/ndt/gfu394; Moss AH., 2010, SHARED DECISION MAKI; Murtagh FEM, 2007, ADV CHRONIC KIDNEY D, V14, P82, DOI 10.1053/j.ackd.2006.10.001; Nicholas SB, 2015, ADV CHRONIC KIDNEY D, V22, P6, DOI 10.1053/j.ackd.2014.07.002; Norton JM, 2016, J AM SOC NEPHROL, V27, P2576, DOI 10.1681/ASN.2016010027; O'Hare AM, 2014, CLIN J AM SOC NEPHRO, V9, P2189, DOI 10.2215/CJN.01930214; Ramspek CL, 2017, CLIN EPIDEMIOL, V9, P451, DOI 10.2147/CLEP.S139748; Russ AJ, 2012, SEMIN DIALYSIS, V25, P31, DOI 10.1111/j.1525-139X.2011.01047.x; Schell JO, 2012, AM J KIDNEY DIS, V59, P495, DOI 10.1053/j.ajkd.2011.11.023; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; System USRD, 2016, USRDS 2016 ANN DAT R; Thamer M, 2015, AM J KIDNEY DIS, V66, P1024, DOI 10.1053/j.ajkd.2015.05.014; Thorsteinsdottir B, 2015, CLIN J AM SOC NEPHRO, V10, P2094, DOI 10.2215/CJN.09761014; Vandecasteele SJ, 2014, J AM SOC NEPHROL, V25, P1647, DOI 10.1681/ASN.2013101082; Wachterman MW, 2013, JAMA INTERN MED, V173, P1206, DOI 10.1001/jamainternmed.2013.6036; Wachterman MW., 2019, ONE YEAR MORTALITY D; Wagner M, 2011, AM J KIDNEY DIS, V57, P894, DOI 10.1053/j.ajkd.2010.12.023; Weng SF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214365; Wick JP., 2016, AM J KIDNEY DIS, P30, DOI [10.1053/j.ajkd.2016.11.008, DOI 10.1053/J.AJKD.2016.11.008]; Wong SPY, 2014, J AM SOC NEPHROL, V25, P143, DOI 10.1681/ASN.2013050491; Wong SPY, 2012, ARCH INTERN MED, V172, P661, DOI 10.1001/archinternmed.2012.268	48	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0244081	10.1371/journal.pone.0244081	http://dx.doi.org/10.1371/journal.pone.0244081			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471808	gold, Green Published			2022-12-26	WOS:000639428800033
J	Ang, SH; Hwong, WY; Bots, ML; Sivasampu, S; Aziz, AFA; Hoo, FK; Vaartjes, I				Ang, Swee Hung; Hwong, Wen Yea; Bots, Michiel L.; Sivasampu, Sheamini; Aziz, Aznida Firzah Abdul; Hoo, Fan Kee; Vaartjes, Ilonca			Risk of 28-day readmissions among stroke patients in Malaysia (2008-2015): Trends, causes and its associated factors	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; PREVENTABLE READMISSIONS; HOSPITAL READMISSION; 30-DAY READMISSION; GLOBAL BURDEN; HEALTH-CARE; PREDICTORS; EDUCATION; DISEASE	Background and objectives Risk of readmissions is an important quality indicator for stroke care. Such information is limited among low- and middle-income countries. We assessed the trends for 28-day readmissions after a stroke in Malaysia from 2008 to 2015 and evaluated the causes and factors associated with readmissions in 2015. Methods Using the national hospital admission records database, we included all stroke patients who were discharged alive between 2008 and 2015 for this secondary data analysis. The risk of readmissions was described in proportion and trends. Reasons were coded according to the International Classification of Diseases, 10(th) Edition. Multivariable logistic regression was performed to identify factors associated with readmissions. Results Among 151729 patients, 11 to 13% were readmitted within 28 days post-discharge from their stroke events each year. The trend was constant for ischemic stroke but decreasing for hemorrhagic stroke. The leading causes for readmissions were recurrent stroke (32.1%), pneumonia (13.0%) and sepsis (4.8%). The risk of 28-day readmission was higher among those with stroke of hemorrhagic (adjusted odds ratio (AOR): 1.52) and subarachnoid hemorrhage (AOR: 2.56) subtypes, and length of index admission >3 days (AOR: 1.48), but lower among younger age groups of 35-64 (AORs: 0.61-0.75), p values Conclusion The risk of 28-day readmission remained constant from 2008 to 2015, where one in eight stroke patients required readmission, mainly attributable to preventable causes. Age, ethnicity, stroke subtypes and duration of the index admission influenced the risk of readmission. Efforts should focus on minimizing potentially preventable admissions, especially among those at higher risk.	[Ang, Swee Hung; Hwong, Wen Yea; Sivasampu, Sheamini] Minist Hlth, Natl Inst Hlth, Inst Clin Res, Petaling Jaya, Selangor, Malaysia; [Hwong, Wen Yea; Bots, Michiel L.; Vaartjes, Ilonca] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Aziz, Aznida Firzah Abdul] Univ Kebangsaan Malaysia, Fac Med, Dept Family Med, Med Ctr, Bangi, Selangor, Malaysia; [Hoo, Fan Kee] Univ Putra Malaysia, Fac Med, Dept Med, Neurol Unit, Serdang, Selangor, Malaysia; [Ang, Swee Hung] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia	Kementerian Kesihatan Malaysia; Utrecht University; Utrecht University Medical Center; Universiti Kebangsaan Malaysia; Universiti Putra Malaysia; Universiti Malaya	Ang, SH (corresponding author), Minist Hlth, Natl Inst Hlth, Inst Clin Res, Petaling Jaya, Selangor, Malaysia.; Ang, SH (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.	angsh.crc@gmail.com	; Hoo, Fan Kee/J-2591-2013	Ang, SweeHung/0000-0001-6676-6269; Hoo, Fan Kee/0000-0003-1687-627X; Sivasampu, Sheamini/0000-0003-2314-6048	Ministry of Health Malaysia - National Institute of Health grant under the project "Monitoring Stroke Burden in Malaysia: the use of linked national data sources" [NMRR-18-100-39847]; Honours Track of MSc Epidemiology, University Medical Center Utrecht; Netherlands Organization for Scientific Research [022.005.021]; Dutch Heart Foundation	Ministry of Health Malaysia - National Institute of Health grant under the project "Monitoring Stroke Burden in Malaysia: the use of linked national data sources"; Honours Track of MSc Epidemiology, University Medical Center Utrecht; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Heart Foundation(Netherlands Heart Foundation)	This study was funded by a grant from the Ministry of Health Malaysia - National Institute of Health grant under the project "Monitoring Stroke Burden in Malaysia: the use of linked national data sources" (NMRR-18-100-39847). WYH is supported by the Honours Track of MSc Epidemiology, University Medical Center Utrecht with a grant from the Netherlands Organization for Scientific Research (Grant number: 022.005.021). IV is funded by the Dutch Heart Foundation for project Facts and Figures. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang SH, 2019, MED J MALAYSIA S2, V74, P135; [Anonymous], 2012, CLIN PRACT GUID MAN, DOI [10.1161/STR.0b013e3182587839, DOI 10.1161/STR.0B013E3182587839]; [Anonymous], 2016, FACTS HLTH 2016; Aziz AFA, 2014, VALUE HEALTH, V17, pA761, DOI 10.1016/j.jval.2014.08.259; Aziz AFA, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-40; Bambhroliya AB, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1190; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Basu J, 2018, INQUIRY-J HEALTH CAR, V55, DOI 10.1177/0046958018774180; Berry JG, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k497; Bhattacharya P, 2011, J NEUROL SCI, V307, P50, DOI 10.1016/j.jns.2011.05.022; Bjerkreim AT, 2015, J STROKE CEREBROVASC, V24, P2095, DOI 10.1016/j.jstrokecerebrovasdis.2015.05.019; Bjerkreim AT, 2018, STROKE RES TREAT, V2018, DOI 10.1155/2018/7195369; Boden-Albala B, 2013, STROKE, V44, pS48, DOI 10.1161/STROKEAHA.111.000396; Chapman C, 2020, INT J STROKE, V15, P390, DOI 10.1177/1747493019833008; Chen ZM, 1997, LANCET, V349, P1641, DOI 10.1016/S0140-6736(97)04010-5; Chuang Kun-Yang, 2005, J Nurs Res, V13, P117; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI [10.1136/bmj.l94, 10.1016/S1474-4422(19)30034-1, 10.1016/S1474-4422(18)30499-X]; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Hwong WY, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0984-1; Johnson BH, 2016, CLINICOECONOMIC OUTC, V8, P53, DOI 10.2147/CEOR.S95662; Kilkenny MF, 2013, STROKE, V44, P2260, DOI 10.1161/STROKEAHA.111.000531; Klehmet J, 2009, NEUROSCIENCE, V158, P1184, DOI 10.1016/j.neuroscience.2008.07.044; Lee SA, 2019, J INVEST MED, V67, P52, DOI 10.1136/jim-2018-000748; Li HW, 2011, J FORMOS MED ASSOC, V110, P627, DOI 10.1016/j.jfma.2011.08.004; Lichtman JH, 2013, STROKE, V44, P3429, DOI 10.1161/STROKEAHA.113.003165; Lin HJ, 2011, NEUROLOGY, V76, P438, DOI 10.1212/WNL.0b013e31820a0cd8; Marschner IC, 2011, R J, V3, P12; Michael E, 2012, ARPN J SCI TECHNOLOG, V2; Nakagawa K, 2016, STROKE, V47, P2611, DOI 10.1161/STROKEAHA.116.013669; Noh NA, 2016, SOC WORK PUBLIC HLTH, V31, P419, DOI 10.1080/19371918.2015.1125321; R Core Team, 2021, R LANGUAGE ENV STAT; Rao A, 2016, STROKE RES TREAT, V2016, DOI 10.1155/2016/9325368; Shah SV, 2015, J STROKE CEREBROVASC, V24, P1969, DOI 10.1016/j.jstrokecerebrovasdis.2015.04.037; Team RStudio, 2018, RSTUDIO INT DEV R; Vahidy FS, 2017, STROKE, V48, P1386, DOI 10.1161/STROKEAHA.116.016085; Wen TC, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1209-y; Zhong WB, 2016, NEUROL SCI, V37, P1195, DOI 10.1007/s10072-016-2570-5	37	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245448	10.1371/journal.pone.0245448	http://dx.doi.org/10.1371/journal.pone.0245448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465103	Green Published, gold			2022-12-26	WOS:000611969200002
J	da Silva, IV; Soares, BP; Pimpao, C; Pinto, RMA; Costa, T; Freire, JPB; Corrent, E; Chalvon-Demersay, T; Prates, JAM; Lopes, PA; Soveral, G				da Silva, Ines Vieira; Soares, Barbara P.; Pimpao, Catarina; Pinto, Rui M. A.; Costa, Teresa; Freire, Joao P. B.; Corrent, Etienne; Chalvon-Demersay, Tristan; Prates, Jose A. M.; Lopes, Paula A.; Soveral, Graca			Glutamine and cystine-enriched diets modulate aquaporins gene expression in the small intestine of piglets	PLOS ONE			English	Article							BASOLATERAL MEMBRANE-VESICLES; BRUSH-BORDER; WATER CHANNEL; PERMEABILITY; GLUTATHIONE; METABOLISM; PLASMA; PIG; SUPPLEMENTATION; DISEASE	The regulation of glycerol permeability in the gastrointestinal tract is crucial to control fat deposition, lipolysis and gluconeogenesis. Knowing that the amino acid glutamine is a physiological regulator of gluconeogenesis, whereas cystine promotes adiposity, herein we investigated the effects of dietary supplementation with glutamine and cystine on the serum biochemical parameters of piglets fed on amino acid-enriched diets, as well as on the transcriptional profile of membrane water and glycerol channels aquaporins (AQPs) in the ileum portion of the small intestine and its impact on intestinal permeability. Twenty male piglets with an initial body weight of 8.8 +/- 0.89 kg were allocated to four dietary treatments (n = 5) and received, during a four week-period, a basal diet without supplementation (control) or supplemented with 8 kg/ton of glutamine (Gln), cystine (Cys) or the combination of the two amino acids in equal proportions (Gln + Cys). Most biochemical parameters were found improved in piglets fed Gln and Cys diet. mRNA levels of AQP3 were found predominant over the others. Both amino acids, individually or combined, were responsible for a consistent downregulation of AQP1, AQP7 and AQP10, without impacting on water permeability. Conversely, Cys enriched diet upregulated AQP3 enhancing basolateral membranes glycerol permeability and downregulating glycerol kinase (GK) of intestinal cells. Altogether, our data reveal that amino acids dietary supplementation can modulate intestinal AQPs expression and unveil AQP3 as a promising target for adipogenesis regulation.	[da Silva, Ines Vieira; Soares, Barbara P.; Pimpao, Catarina; Pinto, Rui M. A.; Soveral, Graca] Univ Lisbon, Fac Farm, Res Inst Med iMed ULisboa, Lisbon, Portugal; [da Silva, Ines Vieira; Soares, Barbara P.; Pimpao, Catarina; Soveral, Graca] Univ Lisbon, Fac Farm, Dept Bioquim & Biol Humana, Lisbon, Portugal; [Pinto, Rui M. A.] JCS, Lab Anal Clin Dr Joaquim Chaves, Alges, Portugal; [Costa, Teresa] Indukern Portugal Lda, Ctr Empresarial Sintra Estoril 2, Sintra, Portugal; [Freire, Joao P. B.] Univ Lisbon, Inst Super Agron ISA, Dept Ciencias & Engn Biossistemas, LEAF Linking Engn Agr & Food, Lisbon, Portugal; [Corrent, Etienne; Chalvon-Demersay, Tristan] Ajinomoto Anim Nutr Europe, Paris, France; [Prates, Jose A. M.; Lopes, Paula A.] Univ Lisbon, Fac Med Vet, CIISA Ctr Invest Interdisciplinar Sanidade Anim, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa	Soveral, G (corresponding author), Univ Lisbon, Fac Farm, Res Inst Med iMed ULisboa, Lisbon, Portugal.; Soveral, G (corresponding author), Univ Lisbon, Fac Farm, Dept Bioquim & Biol Humana, Lisbon, Portugal.; Lopes, PA (corresponding author), Univ Lisbon, Fac Med Vet, CIISA Ctr Invest Interdisciplinar Sanidade Anim, Lisbon, Portugal.	ampalopes@fmv.ulisboa.pt; gsoveral@ff.ulisboa.pt	Pinto, Rui Manuel/M-4386-2019; Pimpão, Catarina/AAQ-1559-2021; Pinto, Rui Manuel/A-8425-2014; Soveral, Graça/L-1550-2013; Prates, José A M/K-9934-2013	Pinto, Rui Manuel/0000-0002-1667-7871; Pimpão, Catarina/0000-0002-2356-1105; Pinto, Rui Manuel/0000-0002-1667-7871; Soveral, Graça/0000-0001-8487-110X; Prates, José A M/0000-0003-1032-5987	Ajinomoto Animal Nutrition Europe; Indukern Portugal, Lda; Fundacao para a Ciencia e a Tecnologia (FCT, Lisbon, Portugal) [UIDB/00276/2020, PTDC/BTM-SAL/28977/2017, UIDB/04138/2020, UIDP/04138/2020]; FCT Stimulus of Scientific Employment Program [DL57/2016/CP1438/CT0007]	Ajinomoto Animal Nutrition Europe; Indukern Portugal, Lda; Fundacao para a Ciencia e a Tecnologia (FCT, Lisbon, Portugal)(Portuguese Foundation for Science and Technology); FCT Stimulus of Scientific Employment Program(Portuguese Foundation for Science and Technology)	Financial support in the form of research materials was provided by Ajinomoto Animal Nutrition Europe and by Indukern Portugal, Lda. Both funders did not have any additional role in the form of salaries for authors, in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section. Moreover, this study was also supported by Fundacao para a Ciencia e a Tecnologia (FCT, Lisbon, Portugal) through projects UIDB/00276/2020 to CIISA, PTDC/BTM-SAL/28977/2017 and UIDB/04138/2020 and UIDP/04138/2020 to iMed.ULisboa, and FCT Stimulus of Scientific Employment Program to Paula A. Lopes (DL57/2016/CP1438/CT0007).	Agre P, 2004, ANGEW CHEM INT EDIT, V43, P4278, DOI 10.1002/anie.200460804; AGRE P, 1993, AM J PHYSIOL, V265, pF461, DOI 10.1152/ajprenal.1993.265.3.F461; [Anonymous], 2015, TXB VET PHYSL CHEM; Camilleri M, 2019, AM J PHYSIOL-GASTR L, V317, pG17, DOI 10.1152/ajpgi.00063.2019; Carbrey Jennifer M, 2009, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-540-79885-9_1; dos Santos RDC, 2010, JPEN-PARENTER ENTER, V34, P408, DOI 10.1177/0148607110362530; COLAS B, 1980, BIOCHIM BIOPHYS ACTA, V600, P406, DOI 10.1016/0005-2736(80)90444-7; Covaci A, 2006, SCI TOTAL ENVIRON, V366, P361, DOI 10.1016/j.scitotenv.2006.03.006; Cox AJ, 2017, DIABETES METAB, V43, P163, DOI 10.1016/j.diabet.2016.09.004; da Silva IV, 2017, ADV EXP MED BIOL, V969, P227, DOI 10.1007/978-94-024-1057-0_15; DANIELSEN EM, 1995, GASTROENTEROLOGY, V109, P1039, DOI 10.1016/0016-5085(95)90561-8; DIX JA, 1985, BIOCHIM BIOPHYS ACTA, V821, P243, DOI 10.1016/0005-2736(85)90093-8; Elshorbagy AK, 2012, J NUTR BIOCHEM, V23, P332, DOI 10.1016/j.jnutbio.2010.12.009; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Freire J, 2019, EAAP PUBLIC, V138, P307, DOI 10.3920/978-90-8686-891-9_84; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FUJITA M, 1972, BIOCHIM BIOPHYS ACTA, V274, P336, DOI 10.1016/0005-2736(72)90181-2; Genser L, 2018, J PATHOL, V246, P217, DOI 10.1002/path.5134; Gerich JE, 2000, J NUTR, V130, p995S, DOI 10.1093/jn/130.4.995S; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Gu Lu-yun, 2013, Zhonghua Gan Zang Bing Za Zhi, V21, P753, DOI 10.3760/cma.j.issn.1007-3418.2013.10.008; Hardin JA, 2004, CELL TISSUE RES, V318, P313, DOI 10.1007/s00441-004-0932-4; Huang XW, 2017, BIOCHEM BIOPH RES CO, V486, P1097, DOI 10.1016/j.bbrc.2017.03.168; Ikarashi N, 2012, BIOL PHARM BULL, V35, P957; Ishibashi K, 2014, BBA-GEN SUBJECTS, V1840, P1507, DOI 10.1016/j.bbagen.2013.10.039; Ishii M, 2011, CELL PHYSIOL BIOCHEM, V27, P749, DOI 10.1159/000330083; Jackson P.G.G., 2002, CLIN EXAMINATION FAR, P303, DOI [10.1002/9780470752425.app3, DOI 10.1002/9780470752425.APP3]; Jahoor F, 1999, AM J PHYSIOL-ENDOC M, V276, pE205, DOI 10.1152/ajpendo.1999.276.1.E205; Joaquim Leyla Mariane, 2010, Sci. stud., V8, P93, DOI 10.1590/S1678-31662010000100005; Kasumyan AO., 1996, J ICHTHYOL+, V36, P391; Kitchen P, 2015, BBA-GEN SUBJECTS, V1850, P2410, DOI 10.1016/j.bbagen.2015.08.023; Kreida S, 2015, CURR OPIN STRUC BIOL, V33, P126, DOI 10.1016/j.sbi.2015.08.004; Kurihara S, 2007, J VET MED SCI, V69, P1263, DOI 10.1292/jvms.69.1263; Laforenza U, 2016, BBA-BIOMEMBRANES, V1858, P1, DOI 10.1016/j.bbamem.2015.10.004; Laforenza U, 2012, MOL ASPECTS MED, V33, P642, DOI 10.1016/j.mam.2012.03.001; Laforenza U, 2010, BIOL CELL, V102, P457, DOI 10.1042/BC20100023; LIN ECC, 1977, ANNU REV BIOCHEM, V46, P765, DOI 10.1146/annurev.bi.46.070177.004001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyons J, 2000, P NATL ACAD SCI USA, V97, P5071, DOI 10.1073/pnas.090083297; Madeira MS, 2018, J SCI FOOD AGR, V98, P598, DOI 10.1002/jsfa.8504; Madeira MS, 2016, BRIT J NUTR, V115, P1339, DOI 10.1017/S0007114516000453; Mizuguchi H, 1997, CHEM LETT, P895, DOI 10.1246/cl.1997.895; Mobasheri A, 2005, J MOL HISTOL, V36, P1, DOI 10.1007/s10735-004-2633-4; Parr LS, 2018, MOL GENET METAB, V124, P254, DOI 10.1016/j.ymgme.2018.06.001; Pelagalli A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081213; Perriello G, 1997, AM J PHYSIOL-ENDOC M, V272, pE437, DOI 10.1152/ajpendo.1997.272.3.E437; PINCHES SA, 1993, BIOCHEM J, V294, P529, DOI 10.1042/bj2940529; Rodriguez A, 2011, J CLIN ENDOCR METAB, V96, pE586, DOI 10.1210/jc.2010-1408; SHIRAZIBEECHEY SP, 1990, GASTROENTEROLOGY, V98, P676, DOI 10.1016/0016-5085(90)90288-C; Soveral G, 1997, J MEMBRANE BIOL, V158, P219; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Stumvoll M, 1999, KIDNEY INT, V55, P778, DOI 10.1046/j.1523-1755.1999.055003778.x; TACNET F, 1993, J PHYSIOL-LONDON, V465, P57, DOI 10.1113/jphysiol.1993.sp019666; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; TRAKATELLIS Antonios, 2005, OFFICIAL J EUROPEAN; Tsuchiya T, 2016, INT J CLIN ONCOL, V21, P1085, DOI 10.1007/s10147-016-0996-7; VANDERHULST RRWJ, 1993, LANCET, V341, P1363, DOI 10.1016/0140-6736(93)90939-E; VANHEESWIJK MPE, 1986, J MEMBRANE BIOL, V92, P183, DOI 10.1007/BF01870707; Verkman AS, 2009, J EXP BIOL, V212, P1707, DOI 10.1242/jeb.024125; Wang JJ, 2008, J NUTR, V138, P1025, DOI 10.1093/jn/138.6.1025; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Zhu C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091399; Zhu C, 2015, FRONT BIOSCI-LANDMRK, V20, P838, DOI 10.2741/4341	64	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245739	10.1371/journal.pone.0245739	http://dx.doi.org/10.1371/journal.pone.0245739			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465153	Green Published, gold			2022-12-26	WOS:000611969200052
J	Wang, XY; Asami, S; Kitamura, D				Wang, Xinying; Asami, Shohei; Kitamura, Daisuke			A novel cancer immunotherapy using tumor-infiltrating B cells in the APC(min/+) mouse model	PLOS ONE			English	Article							LYMPHOCYTES; EXPRESSION; SURVIVAL; ANTIBODY	Accumulating evidence has suggested a correlation of tumor infiltrating B cells (TiBcs) and a good prognosis of cancer diseases. In some cases, TiBcs appear to have experienced antigen stimulation since they have undergone class-switching and somatic hypermutation and formed tertiary lymphoid structures around tumors together with T cells. Assuming TiBcs include those that recognize some tumor antigens, we sought to investigate their possible usefulness for cell-mediated immunotherapies. To expand usually small number of TiBcs in vitro, we modified our B cell culture system: we transduced B cells with ERT2-Bach2 so that they grow unlimitedly provided with tamoxifen, IL-21 and our original feeder cells. Such cells differentiate into plasma cells and produce antibodies upon withdrawal of tamoxifen, and further by addition of a Bach2-inhibitor in vitro. As a preliminary experiment, thus expanded splenic B cells expressing a transgenic antigen receptor/antibody against hen egg lysozyme were intravenously injected into mice pre-implanted with B16 melanoma cells expressing membrane-bound HEL in the skin, which resulted in suppression of the growth of B16 tumors and prolonged survival of the recipient mice. To test the usefulness of TiBcs for the immunotherapy, we next used APC(min/+) mice as a model that spontaneously develop intestinal tumors. We cultured TiBcs separated from the tumors of APC(min/+) mice as above and confirmed that the antibodies they produce recognize the APC(min/+) tumor. Repeated injection of such TiBcs into adult APC(min/+) mice resulted in suppression of intestinal tumor growth and elongation of the survival of the recipient mice. Serum antibody from the TiBc-recipient mice selectively bound to an antigen expressed in the tumor of APC(min/+) mice. These data suggest a possibility of the novel individualized cancer immunotherapy, in which TiBcs from surgically excised tumor tissues are expanded and infused into the donor patients.	[Wang, Xinying; Asami, Shohei; Kitamura, Daisuke] Tokyo Univ Sci, Res Inst Biomed Sci RIBS, Div Canc Cell Biol, Noda, Chiba, Japan	Tokyo University of Science	Kitamura, D (corresponding author), Tokyo Univ Sci, Res Inst Biomed Sci RIBS, Div Canc Cell Biol, Noda, Chiba, Japan.	kitamura@rs.tus.ac.jp	WANG, XINYING/AAK-2680-2021		Ministry of Education, Culture, Sports, Science and Technology in Japan [17H05803, 19H04818]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported by Grant-in-Aid for Scientific Research on Innovative Area, 17H05803 and 19H04818 (DK), from the Ministry of Education, Culture, Sports, Science and Technology in Japan (https://www.mext.go.jp/en/); and Takeda Science Foundation (https://www.takeda-sci.or.jp).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; [Anonymous], 2019, CIRCULATION, V2019; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; CHIN Y, 1992, ANTICANCER RES, V12, P1463; Coronella-Wood JA, 2003, CANCER IMMUNOL IMMUN, V52, P715, DOI 10.1007/s00262-003-0409-4; Garnelo M, 2017, GUT, V66, P342, DOI 10.1136/gutjnl-2015-310814; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Leclerc D, 2004, J CELL BIOCHEM, V93, P1242, DOI 10.1002/jcb.20236; Linnebacher M, 2012, ONCOIMMUNOLOGY, V1, P1186, DOI 10.4161/onci.20641; Liu ZD, 2020, CELL, V180, P1037, DOI 10.1016/j.cell.2020.02.046; Lu YW, 2020, CELL, V180, P1081, DOI 10.1016/j.cell.2020.02.015; MOSER AR, 1995, EUR J CANCER, V31A, P1061, DOI 10.1016/0959-8049(95)00181-H; Moutai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092732; Nielsen JS, 2012, CLIN CANCER RES, V18, P3281, DOI 10.1158/1078-0432.CCR-12-0234; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Reuschenbach M, 2009, CANCER IMMUNOL IMMUN, V58, P1535, DOI 10.1007/s00262-009-0733-4; ROSSEN RD, 1977, J NATL CANCER I, V58, P1205, DOI 10.1093/jnci/58.5.1205; Roudko V, 2020, CELL, V183, P1634, DOI 10.1016/j.cell.2020.11.004; Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395; Shen M, 2016, ONCOTARGET, V7, P55828, DOI 10.18632/oncotarget.10094; Wang SS, 2019, CELL MOL IMMUNOL, V16, P6, DOI 10.1038/s41423-018-0027-x; Watanabe M, 1999, BREAST CANCER RES TR, V53, P199, DOI 10.1023/A:1006145507567; Watanabe-Matsui M, 2011, BLOOD, V117, P5438, DOI 10.1182/blood-2010-07-296483; Yuen GJ, 2016, TRENDS CANCER, V2, P747, DOI 10.1016/j.trecan.2016.10.010	28	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245608	10.1371/journal.pone.0245608	http://dx.doi.org/10.1371/journal.pone.0245608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465122	Green Published, gold			2022-12-26	WOS:000611969200019
J	Inobhas, A; Chansangpetch, S; Manassakorn, A; Tantisevi, V; Rojanapongpun, P				Inobhas, Abhibol; Chansangpetch, Sunee; Manassakorn, Anita; Tantisevi, Visanee; Rojanapongpun, Prin			Effect of oral statin use on mitomycin-C augmented trabeculectomy outcomes	PLOS ONE			English	Article							GLAUCOMA FILTRATION SURGERY; WOUND-HEALING MODULATION; ANGIOGENESIS; CLASSIFICATION; INFLAMMASOME; ACTIVATION; LOVASTATIN; THERAPY; BLEBS; CELLS	Purpose The effect of statins on wound healing is controversial, and their effect on trabeculectomy outcomes remains unclear. This study aimed to examine the relationship between oral statin use and trabeculectomy outcomes. Methods Medical records of patients who underwent primary mitomycin-C augmented trabeculectomy with 2 years of follow-up were reviewed. Pre- and postoperative intraocular pressures (IOP) and numbers of medications, subconjunctival 5-fluorouracil (5-FU) injections, and bleb-needling procedures were compared between statin users and nonusers. Failure was defined as an eye that failed to achieve a 20% lowering of IOP from baseline or had an IOP > 21 mm Hg, as well as an eye that required further surgical intervention, developed hypotony, or had no light perception visual acuity. Results In total, 158 subjects were enrolled, with 47 eyes from statin users and 111 eyes from statin nonusers. The 24-month cumulative probability of failure was 78.7% for statin users and 60.4% for nonusers (P = .013). Cox proportional-hazards modeling showed a significantly higher hazard risk in statin users (adjusted hazard ratio 1.61, P = .026). There were no significant between-group differences in mean IOPs or number of medications (both P > .05) at 24 months. Multivariable Poisson regression analysis that statin use was associated with increased numbers of 5-FU injections (P = .014) and bleb-needling procedures (P = .031). Conclusions This study demonstrated that oral statin use was associated with higher rates of trabeculectomy failure and increased numbers of 5-FU injections and bleb-needling procedures.	[Inobhas, Abhibol; Chansangpetch, Sunee; Manassakorn, Anita; Tantisevi, Visanee; Rojanapongpun, Prin] Chulalongkorn Univ, Dept Ophthalmol, Fac Med, Bangkok, Thailand; [Inobhas, Abhibol; Chansangpetch, Sunee; Manassakorn, Anita; Tantisevi, Visanee; Rojanapongpun, Prin] King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Bangkok, Thailand; [Chansangpetch, Sunee; Manassakorn, Anita; Tantisevi, Visanee; Rojanapongpun, Prin] Chulalongkorn Univ, Glaucoma Res Unit, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University	Chansangpetch, S (corresponding author), Chulalongkorn Univ, Dept Ophthalmol, Fac Med, Bangkok, Thailand.; Chansangpetch, S (corresponding author), King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Bangkok, Thailand.; Chansangpetch, S (corresponding author), Chulalongkorn Univ, Glaucoma Res Unit, Bangkok, Thailand.	bae_sunnee@yahoo.co.uk		Inobhas, Abhibol/0000-0001-5679-7088				Akershoek JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179350; Asai J, 2012, AM J PATHOL, V181, P2217, DOI 10.1016/j.ajpath.2012.08.023; Atreides Sean-Paul A., 2004, International Ophthalmology Clinics, V44, P61, DOI 10.1097/00004397-200404420-00007; BRAODWAY D, 1993, BRIT J OPHTHALMOL, V77, P590, DOI 10.1136/bjo.77.9.590; Cantor LB, 2003, J GLAUCOMA, V12, P266, DOI 10.1097/00061198-200306000-00015; Chang L, 2000, SURV OPHTHALMOL, V45, P49, DOI 10.1016/S0039-6257(00)00135-1; Cordeiro MF, 1999, BRIT J OPHTHALMOL, V83, P1219, DOI 10.1136/bjo.83.11.1219; Costa VP, 1997, OPHTHALMOLOGY, V104, P1215, DOI 10.1016/S0161-6420(97)30155-9; Coward WR, 2006, J IMMUNOL, V176, P5284, DOI 10.4049/jimmunol.176.9.5284; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Eberlein M, 2001, BRIT J PHARMACOL, V133, P1172, DOI 10.1038/sj.bjp.0704173; Faler Byron J, 2006, Perspect Vasc Surg Endovasc Ther, V18, P55, DOI 10.1177/153100350601800123; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Gedde SJ, 2009, AM J OPHTHALMOL, V148, P670, DOI 10.1016/j.ajo.2009.06.018; Harasymowycz P, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/6509809; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Kang JH, 2019, JAMA OPHTHALMOL, V137, P756, DOI 10.1001/jamaophthalmol.2019.0900; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Lantuejoul S, 2002, EUR RESPIR J, V19, P577, DOI 10.1183/09031936.02.00258802; Liarte S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020306; Lusthaus JA, 2010, CLIN EXP OPHTHALMOL, V38, P831, DOI 10.1111/j.1442-9071.2010.02349.x; Maeda T, 2003, ENDOCRINOLOGY, V144, P681, DOI 10.1210/en.2002-220682; Maheshwari D, 2019, INDIAN J OPHTHALMOL, V67, P1080, DOI 10.4103/ijo.IJO_1328_18; Medina RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002584; Meyer-Ter-Vehn T, 2008, INVEST OPHTH VIS SCI, V49, P3955, DOI 10.1167/iovs.07-1610; Nakao T, 2007, J PHARMACOL SCI, V105, P334, DOI 10.1254/jphs.FP0070682; Ozgonul C, 2014, CURR EYE RES, V39, P451, DOI 10.3109/02713683.2013.851704; Park HYL, 2012, ARCH OPHTHALMOL-CHIC, V130, P685, DOI 10.1001/archophthalmol.2011.2799; Park JH, 2016, INVEST OPHTH VIS SCI, V57, P1871, DOI 10.1167/iovs.15-19003; Skaletz-Rorowski A, 2003, CURR OPIN LIPIDOL, V14, P599, DOI 10.1097/00041433-200312000-00008; SKUTA GL, 1987, SURV OPHTHALMOL, V32, P149, DOI 10.1016/0039-6257(87)90091-9; Song J, 2005, INVEST OPHTH VIS SCI, V46, P2424, DOI 10.1167/iovs.04-0776; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Weis M, 2002, CIRCULATION, V105, P739, DOI 10.1161/hc0602.103393; Whigham B, 2018, OPHTHAL EPIDEMIOL, V25, P207, DOI 10.1080/09286586.2017.1399427; Xu JF, 2012, AM J RESP CRIT CARE, V185, P547, DOI 10.1164/rccm.201108-1574OC; Yamanaka O, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0134-8; Zambarakji HJ, 2006, INVEST OPHTH VIS SCI, V47, P2623, DOI 10.1167/iovs.05-0855	39	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245429	10.1371/journal.pone.0245429	http://dx.doi.org/10.1371/journal.pone.0245429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449961	gold, Green Published			2022-12-26	WOS:000609991600035
J	Chaves, LSM; Bergo, ES; Conn, JE; Laporta, GZ; Prist, PR; Sallum, MAM				Chaves, Leonardo Suveges Moreira; Bergo, Eduardo Sterlino; Conn, Jan E.; Laporta, Gabriel Zorello; Prist, Paula Ribeiro; Sallum, Maria Anice Mureb			Anthropogenic landscape decreases mosquito biodiversity and drives malaria vector proliferation in the Amazon rainforest	PLOS ONE			English	Article							ANOPHELES-DARLINGI; DIPTERA-CULICIDAE; LARVAL HABITATS; GLOBAL PATTERNS; LAND-USE; DEFORESTATION; DIVERSITY; DISEASE; TRANSMISSION; FRONTIER	Inter-relationships among mosquito vectors, Plasmodium parasites, human ecology, and biotic and abiotic factors, drive malaria risk. Specifically, rural landscapes shaped by human activities have a great potential to increase the abundance of malaria vectors, putting many vulnerable people at risk. Understanding at which point the abundance of vectors increases in the landscape can help to design policies and interventions for effective and sustainable control. Using a dataset of adult female mosquitoes collected at 79 sites in malaria endemic areas in the Brazilian Amazon, this study aimed to (1) verify the association among forest cover percentage (PLAND), forest edge density (ED), and variation in mosquito diversity; and to (2) test the hypothesis of an association between landscape structure (i.e., PLAND and ED) and Nyssorhynchus darlingi (Root) dominance. Mosquito collections were performed employing human landing catch (HLC) (peridomestic habitat) and Shannon trap combined with HLC (forest fringe habitat). Nyssorhynchus darlingi abundance was used as the response variable in a generalized linear mixed model, and the Shannon diversity index (H') of the Culicidae community, PLAND, and the distance house-water drainage were used as predictors. Three ED categories were also used as random effects. A path analysis was used to understand comparative strengths of direct and indirect relationships among Amazon vegetation classes, Culicidae community, and Ny. darlingi abundance. Our results demonstrate that Ny. darlingi is negatively affected by H ' and PLAND of peridomestic habitat, and that increasing these variables (one-unit value at beta(0) = 768) leads to a decrease of 226 (P < 0.001) and 533 (P = 0.003) individuals, respectively. At the forest fringe, a similar result was found for H' (beta(1) = -218; P < 0.001) and PLAND (beta(1) = -337; P = 0.04). Anthropogenic changes in the Amazon vegetation classes decreased mosquito biodiversity, leading to increased Ny. darlingi abundance. Changes in landscape structure, specifically decreases in PLAND and increases in ED, led to Ny. darlingi becoming the dominant species, increasing malaria risk. Ecological mechanisms involving changes in landscape and mosquito species composition can help to understand changes in the epidemiology of malaria.	[Chaves, Leonardo Suveges Moreira; Sallum, Maria Anice Mureb] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, SP, Brazil; [Bergo, Eduardo Sterlino] Secretaria Estado Saude Sao Paulo, Superintendencia Controle Endemias, Araraquara, SP, Brazil; [Conn, Jan E.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Conn, Jan E.] SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY 12222 USA; [Laporta, Gabriel Zorello] Ctr Univ Saude ABC, Fdn ABC, Setor Posgrad Pesquisa & Inovacao, Santo Andre, SP, Brazil; [Prist, Paula Ribeiro] Univ Sao Paulo, Dept Ecol, Inst Biosci, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Universidade de Sao Paulo	Chaves, LSM (corresponding author), Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, SP, Brazil.	leonardosuveges@usp.br	Bergo, Eduardo/F-5374-2014; Laporta, Gabriel/P-3621-2019; Sallum, Maria Anice Mureb/B-8537-2012; Prist, Paula Ribeiro/E-7801-2015; Suveges Moreira Chaves, Leonardo/R-8787-2017	Bergo, Eduardo/0000-0003-4928-0368; Laporta, Gabriel/0000-0001-7412-9390; Sallum, Maria Anice Mureb/0000-0002-7051-2891; Prist, Paula Ribeiro/0000-0003-2809-0434; Suveges Moreira Chaves, Leonardo/0000-0002-7632-1842	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/26229-7, 2014/26855-5, 2014/09774-1]; National Institutes of Health, USA [2R01AI110112-06A1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; grants 2014/26229-7, 2014/26855-5 and 2014/09774-1), and by National Institutes of Health, USA, grant 2R01AI110112-06A1 to JEC.	Adde A, 2017, J MED ENTOMOL, V54, P597, DOI 10.1093/jme/tjx031; Afrane YA, 2005, J MED ENTOMOL, V42, P974, DOI 10.1603/0022-2585(2005)042[0974:EOMCCB]2.0.CO;2; Afrane YA, 2008, EMERG INFECT DIS, V14, P1533, DOI 10.3201/eid1410.070781; Afrane YA, 2007, AM J TROP MED HYG, V77, P660, DOI 10.4269/ajtmh.2007.77.660; Afrane YA, 2006, AM J TROP MED HYG, V74, P772, DOI 10.4269/ajtmh.2006.74.772; Abella-Medrano CA, 2018, PARASITOL INT, V67, P313, DOI 10.1016/j.parint.2018.01.006; Ashley EA, 2018, LANCET, V391, P1608, DOI 10.1016/S0140-6736(18)30324-6; Austin KF, 2017, AIMS ENVIRON SCI, V4, P217, DOI 10.3934/environsci.2017.2.217; Baeza A, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0108; Bamou R, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3049-4; Barlow J, 2016, NATURE, V535, P144, DOI 10.1038/nature18326; Barros FSM, 2011, B ENTOMOL RES, V101, P643, DOI 10.1017/S0007485311000265; Barros FSM, 2015, AM J TROP MED HYG, V93, P939, DOI 10.4269/ajtmh.15-0042; Bauch SC, 2015, P NATL ACAD SCI USA, V112, P7414, DOI 10.1073/pnas.1406495111; Berazneva J, 2017, AM ECON REV, V107, P516, DOI 10.1257/aer.p20171132; Bourke BP, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2483-2; Brock PM, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2351; Burkett-Cadena ND, 2018, BASIC APPL ECOL, V26, P101, DOI 10.1016/j.baae.2017.09.012; Carrasco-Escobar G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07818-0; Castro MC, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a025601; Caughley G., 1996, CONSERVATION BIOL TH; Chu VM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41651-x; Conn JE, 2002, AM J TROP MED HYG, V66, P18, DOI 10.4269/ajtmh.2002.66.18; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; Cuaresma JC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40678; Cuong DM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-259; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; De Stavola BL, 2015, AM J EPIDEMIOL, V181, P64, DOI 10.1093/aje/kwu239; Dinerstein E, 2017, BIOSCIENCE, V67, P534, DOI 10.1093/biosci/bix014; DiRenzo GV, 2018, ECOL APPL, V28, P1948, DOI 10.1002/eap.1792; EDMAN JD, 1971, ANN ENTOMOL SOC AM, V64, P513, DOI 10.1093/aesa/64.2.513; Farina A, 2000, BIOSCIENCE, V50, P313, DOI 10.1641/0006-3568(2000)050[0313:TCLAAM]2.3.CO;2; FORATTINI O. P., 2002, CULICIDOLOGIA MED ID, VII; Fujisaka S, 1998, BIODIVERS CONSERV, V7, P41, DOI 10.1023/A:1008855612209; Garg T, 2019, J ENVIRON ECON MANAG, V98, DOI 10.1016/j.jeem.2019.102271; Ghazoul J, 2015, TRENDS ECOL EVOL, V30, P622, DOI 10.1016/j.tree.2015.08.001; Guerra CA, 2006, ANN TROP MED PARASIT, V100, P189, DOI 10.1179/136485906X91512; Hahn MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085725; Han BA, 2016, TRENDS PARASITOL, V32, P565, DOI 10.1016/j.pt.2016.04.007; Hasyim H, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2760-8; Hatcher L, 2013, STEP BY STEP APPROAC; Heinrichs JA, 2019, CURRENT LANDSCAPE EC, P1; Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177; IBGE-Brazilian Institute of Geography and Statistics, 2012, MAN TECN GEOC, P1; Jakovac CC, 2016, AGR ECOSYST ENVIRON, V218, P116, DOI 10.1016/j.agee.2015.11.013; Johnson PTJ, 2015, ECOL LETT, V18, P1119, DOI 10.1111/ele.12479; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kindt R., 2005, WORLD; Lainhart W, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0863-4; Laporta GZ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002139; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Lima ID, 2017, MEM I OSWALDO CRUZ, V112, P8, DOI 10.1590/0074-02760160263; Loaiza JR, 2019, TROP MED INT HEALTH, V24, P849, DOI 10.1111/tmi.13244; MacDonald Andrew J., 2019, LANCET PLANET HEALTH, V3, pS13, DOI DOI 10.1016/S2542-5196(19)30156-1; Magioli M, 2016, EUR J WILDLIFE RES, V62, P431, DOI 10.1007/s10344-016-1017-x; Marshall JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26023-1; McGarigal K., 1995, General Technical Report - Pacific Northwest Research Station, USDA Forest Service; Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x; Ministerio da Saude-MS, DAD CID SIV MAL; Mitchell R.J., 1993, DESIGN ANAL ECOLOGIC; Mitja D, 2018, ENVIRON MANAGE, V61, P321, DOI 10.1007/s00267-017-0965-6; de Barros FSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022388; Chaves LSM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25344-5; Moreno M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005337; Terrazas WCM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0859-0; Moua Y, 2017, J MED ENTOMOL, V54, P606, DOI 10.1093/jme/tjw199; Mueller RC, 2016, FUNCT ECOL, V30, P1845, DOI 10.1111/1365-2435.12651; Mueller-Wilm U, 2017, S2PDGSMPCL2ASRNV2; Naranjo-Diaz N, 2020, INFECT GENET EVOL, V78, DOI 10.1016/j.meegid.2019.104114; Oksanen J., 2008, VEGAN PACKAGE VERSIO; Olson SH, 2010, EMERG INFECT DIS, V16, P1108, DOI 10.3201/eid1607.091785; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Lima JBP, 2014, MEM I OSWALDO CRUZ, V109, P685, DOI 10.1590/0074-0276140134; Peres CA, 2016, P NATL ACAD SCI USA, V113, P892, DOI 10.1073/pnas.1516525113; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; Prach K, 2011, TRENDS ECOL EVOL, V26, P119, DOI 10.1016/j.tree.2010.12.007; Prussing C, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2234-4; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Rejmankova E, 2000, J VECTOR ECOL, V25, P229; Rohr JR, 2019, NAT SUSTAIN, V2, P445, DOI 10.1038/s41893-019-0293-3; ROUTLEDGE RD, 1979, J THEOR BIOL, V76, P503, DOI 10.1016/0022-5193(79)90015-8; ROZENDAAL JA, 1992, MED VET ENTOMOL, V6, P16, DOI 10.1111/j.1365-2915.1992.tb00029.x; Rufalco-Moutinho P, 2016, ACTA TROP, V164, P243, DOI 10.1016/j.actatropica.2016.08.032; Sallum MAM, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2753-7; Santos AS, 2018, ECOL ECON, V154, P247, DOI 10.1016/j.ecolecon.2018.08.005; SAWYER D R, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P342; Service M. W., 1993, P120; SHANNON RAYMOND C., 1939, AMER JOUR TROP MED, V19, P131; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; Gil LHS, 2015, REV INST MED TROP SP, V57, P263, DOI 10.1590/S0036-46652015000300014; Stephenson E, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3405-z; Taubert F, 2018, NATURE, V554, P519, DOI 10.1038/nature25508; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; Wanji S, 2003, TROP MED INT HEALTH, V8, P643, DOI 10.1046/j.1365-3156.2003.01070.x; Zimmerman RH, 2006, J MED ENTOMOL, V43, P947, DOI 10.1603/0022-2585(2006)43[947:BHOASD]2.0.CO;2	100	10	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245087	10.1371/journal.pone.0245087	http://dx.doi.org/10.1371/journal.pone.0245087			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444320	Green Published, gold			2022-12-26	WOS:000609988100057
J	Atif, M; Zia, R; Malik, I; Ahmad, N; Sarwar, S				Atif, Muhammad; Zia, Rabia; Malik, Iram; Ahmad, Nafees; Sarwar, Sajjad			Treatment outcomes, antibiotic use and its resistance pattern among neonatal sepsis patients attending Bahawal Victoria Hospital, Pakistan	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; DEVELOPING-COUNTRIES; INFECTIONS; EFFICACY; BIRTH	Background Sepsis is one of the major causes of neonatal mortality in Pakistan. This study aimed to investigate the treatment outcomes, antibiotic use and its resistance pattern among neonatal sepsis patients attending a tertiary care hospital in Pakistan. We also aimed to identify the factors affecting mortality in neonatal sepsis patients. Methods A descriptive, cross-sectional study was conducted in the pediatric wards of the Bahawal Victoria Hospital, Bahawalpur, Pakistan. All eligible neonatal sepsis patients who were registered at the study site from January 1, 2019 to June 30, 2019 were included in the study. The data collection form included information on patient's characteristics, antibiotic use and its sensitivity pattern, laboratory and microbiological data, and final treatment outcomes. Treatment outcomes included, discharged (with treatment success), leave against medical advice (LAMA), discharged on request (DOR) and death. Multivariable binary logistic regression analysis was used to find the independent factors associated with death. A p-value of less than 0.05 was considered statistically significant. Results Among the total 586 patients, 398 (67.9%) were male, 328 (56%) were preterm, 415 (70.8%) were diagnosed with early onset sepsis, 299 (51%) were born with low birth weight. Most of the patients (n = 484, 82.6%) were treated with amikacin+cefotaxime at the start of treatment. Culture was positive in 52 (8.9%) patients and the most commonly identified bacteria included, Klebsiella species (n = 19, 36.5%) followed by E. coli (n = 15, 28.5%) and Staphylococcus aureus (n = 8, 15.4%). The identified bacterial isolates showed high level of resistance against the antibiotics initiated at the start of the treatment, while resistance against piperacillin+tazobactam, imipenem, vancomycin and linezolid was very low. Just under half of the patients (n = 280, 47.8%) successfully completed the treatment (i.e., discharged with treatment success), while 123 (21%) patients died during treatment. In multivariable binary logistic regression, the factors which still remained significantly associated with neonatal death included, preterm delivery (AOR 9.59; 95% CI 4.41, 20.84), sub-optimal birth weight (AOR 5.13; 95% CI 2.19, 12.04), early onset sepsis (AOR 2.99; 95% CI 1.39, 6.41) and length of hospital stay (AOR 0.76; 95% CI 0.67, 0.88). Conclusion The mortality rate associated with sepsis was high in our study cohort. The bacterial isolates showed high level of resistance against the antibiotics started as the empiric therapy. Rational use of antibiotics can decrease the adverse outcomes in neonatal sepsis patients.	[Atif, Muhammad; Zia, Rabia; Malik, Iram] Islamia Univ Bahawalpur, Dept Pharm Practice, Fac Pharm, Bahawalpur, Punjab, Pakistan; [Ahmad, Nafees] Univ Balochistan, Fac Pharm & Hlth Sci, Dept Pharm Practice, Quetta, Balochistan, Pakistan; [Sarwar, Sajjad] Bahawal Victoria Hosp, Dept Pulmonol, Bahawalpur, Punjab, Pakistan	Islamia University of Bahawalpur; University of Balochistan	Atif, M (corresponding author), Islamia Univ Bahawalpur, Dept Pharm Practice, Fac Pharm, Bahawalpur, Punjab, Pakistan.	pharmacist_atif@yahoo.com						Afrin M, 2016, FARIDPUR MED COLL J, V11, P58; [Anonymous], 2010, CLIN INFECT DIS S3, V50, pS173, DOI 10.1086/651488; [Anonymous], 2018, ACAD EMERG MED, V25, pS8, DOI 10.1111/acem.13424; Atif M., 2020, DRUG SAFETY DEV COUN, P287, DOI [10.1016/B978-0-12-819837-7.00024-8, DOI 10.1016/B978-0-12-819837-7.00024-8]; Atif M, 2020, INT J HEALTH PLAN M, V35, P1041, DOI 10.1002/hpm.3016; Atif M, 2019, INFECT DRUG RESIST, V12, P687, DOI 10.2147/IDR.S189114; Atif Muhammad, 2016, J Pharm Policy Pract, V9, P27, DOI 10.1186/s40545-016-0076-4; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Chaurasia S, 2016, LANCET GLOB HEALTH, V4, pE752, DOI 10.1016/S2214-109X(16)30148-6; Chong E, 2013, J PERINATOL, V33, P529, DOI 10.1038/jp.2012.169; Clinical and Laboratory Standards Institute, 2013, M100S23 CLIN LAB STA; Department of Public Enterprises, 2019, PUBLIC ENTERPRISES S; Devpura B, 2016, INT J PEDIAT, V2016, DOI 10.1155/2016/1897039; Downie L, 2013, ARCH DIS CHILD, V98, P146, DOI 10.1136/archdischild-2012-302033; Ekman B, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05361-4; El Haleim MA, 2009, RES J MED MED SCI, V4, P67; Fleischmann-Struzek C, 2018, LANCET RESP MED, V6, P223, DOI 10.1016/S2213-2600(18)30063-8; Fleming PF, 2012, J NEONATAL NURSING, V18, P98; Flidel-Rimon O, 2006, SCAND J INFECT DIS, V38, P36, DOI 10.1080/00365540500372879; Fu ZH, 2018, PUBLIC FINANCE RES, V04, P2, DOI [10.19477/j.cnki.11-1077/f.2018.04.001, DOI 10.19477/J.CNKI.11-1077/F.2018.04.001]; Fuchs A, 2018, PAEDIATR INT CHILD H, V38, pS3, DOI 10.1080/20469047.2017.1408738; Getabelew A, 2018, INT J PEDIAT, V2018, DOI 10.1155/2018/7801272; Hafsa A, 2011, BANGLADESH J MED SCI, V10, P187; Hashemian SM, 2018, DRUG DES DEV THER, V12, P1759, DOI 10.2147/DDDT.S164515; Hornik CP, 2012, EARLY HUM DEV, V88, pS69, DOI 10.1016/S0378-3782(12)70019-1; IBGE Instituto Brasileiro de Geografia e Estatistica, 2019, CENS AGR 2017 RES DE, V8, P1, DOI [10.5603/DK.2019.0001, DOI 10.5603/DK.2019.0001]; Joly-Guillou ML, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-72; Kanodia P, 2015, J COL MED SCI NEPAL, V11, P20; Khaliq A, 2019, BIOCATAL AGR BIOTECH, V20, DOI 10.1016/j.bcab.2019.101233; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Le Doare K, 2015, J PEDIAT INF DIS SOC, V4, P11, DOI 10.1093/jpids/piu014; MacCarrick T, 2018, G134 P IMPROVING S1, V103, pA55; Malik I, 2020, THER INNOV REGUL SCI, V54, P492, DOI 10.1007/s43441-019-00081-7; Malik I, 2020, RES SOC ADMIN PHARM, V16, P848, DOI 10.1016/j.sapharm.2020.02.018; Mazhar A, 2011, J PAK MED ASSOC, V61, P625; Mhada TV, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-904; Mohsen L, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0225-9; Movahedian AH, 2006, IRAN J PUBLIC HEALTH, V35, P84; Nizami N, 2015, CLIN CHARACTERISTICS, V6, P855; Noh JW, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16060932; Pius S, 2017, PEDIAT INFECT DIS, V2, P2573; Pokhrel B, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1176-x; Raha BK, 2014, MED TODAY, V26, P18, DOI [10.3329/medtoday.v26i1.21306, DOI 10.3329/MEDTODAY.V26I1.21306]; Saleem AF, 2013, INT J INFECT DIS, V17, pE961, DOI 10.1016/j.ijid.2013.04.007; Sankar MJ, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5314; Sarasam S., 2017, J MED SCI CLIN RES, V4, P19327, DOI 10.18535/jmscr/v5i3.159; Shane AL, 2017, LANCET, V390, P1770, DOI 10.1016/S0140-6736(17)31002-4; Simonsen KA, 2014, CLIN MICROBIOL REV, V27, P21, DOI 10.1128/CMR.00031-13; Singh M., 2019, NEONATAL SEPSIS; Tewabe Tilahun, 2017, BMC Res Notes, V10, P265, DOI 10.1186/s13104-017-2573-1; Thapa S, 2019, INT J PEDIAT, V2019, DOI 10.1155/2019/3784529; Thaver D, 2009, PEDIATR INFECT DIS J, V28, pS3, DOI 10.1097/INF.0b013e3181958755; United Nations International Children's Emergency Fund, 2015, MAT NEWB HLTH DISP P; United Nations International Children's Emergency Fund, 2020, NEON MORT 2020; Waiker VP, 2015, WORLD J PLAST SURG, V4, P50; Wall SN, 2009, INT J GYNECOL OBSTET, V107, pS47, DOI 10.1016/j.ijgo.2009.07.013; World Bank, 2020, MORT RAT NEON PER 10; Yadav Nikita Singh, 2018, BMC Res Notes, V11, P301, DOI 10.1186/s13104-018-3394-6; Yasmeen S, 2017, PAK ARMED FORCES MED, V67, P1044; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	61	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0244866	10.1371/journal.pone.0244866	http://dx.doi.org/10.1371/journal.pone.0244866			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439876	gold, Green Published			2022-12-26	WOS:000609985300045
J	Ciancio, G; Farag, A; Gonzalez, J; Vincenzi, P; Gaynor, JJ				Ciancio, Gaetano; Farag, Ahmed; Gonzalez, Javier; Vincenzi, Paolo; Gaynor, Jeffrey J.			Results of a previously unreported extravesical ureteroneocystostomy technique without ureteral stenting in 500 consecutive kidney transplant recipients	PLOS ONE			English	Article							URETEROVESICAL REIMPLANTATION TECHNIQUES; URINARY-TRACT-INFECTION; RENAL-TRANSPLANTATION; UROLOGIC COMPLICATIONS; LICH-GREGOIR; VESICOURETERAL REFLUX; COMPARING TAGUCHI; IMPLANTATION; REJECTION	Urologic complications can still occur following kidney transplantation, sometimes requiring multiple radiological and/or surgical procedures to fully correct the problem. Previously proposed extravesical ureteral reimplantation techniques still carry non-negligible risks of the patient developing urologic complications. About 10 years ago, a new set of modifications to the Lich-Gregoir technique was developed at our center, with the goal of further minimizing the occurrence of urologic complications, and without the need for initial ureteral stent placement. It was believed that an improvement in the surgical technique to minimize the risk of developing urologic complications was possible without the need for stent placement at the time of transplant. In this report, we describe the advantages of this technique (i.e., mobilized bladder, longer spatulation of the ureter, inclusion of bladder mucosa with detrusor muscle layer in the ureteral anastomosis, and use of a right angle clamp in the ureteral orifice to ensure that it does not become stenosed). We also retrospectively report our experience in using this technique among 500 consecutive (prospectively followed) kidney transplant recipients transplanted at our center since 2014. During the first 12mo post-transplant, only 1.4%(7/500) of patients developed a urologic complication; additionally, only 1.0%(5/500) required surgical repair of their original ureteroneocystostomy. Five patients(1.0%) developed a urinary leak, with 3/5 having distal ureteral necrosis, and 1/5 subsequently developing a ureteral stricture. Two other patients developed ureteral stenosis, one due to stricture and one due to ureteral stones. These overall results are excellent when compared with other reports in the literature, especially those in which routine stenting was performed. In summary, we believe that the advantages in using this modified extravesical ureteroneocystostomy technique clearly help in lowering the early post-transplant risk of developing urologic complications. Importantly, these results were achieved without the need for ureteral stent placement at the time of transplant.	[Ciancio, Gaetano; Farag, Ahmed; Vincenzi, Paolo; Gaynor, Jeffrey J.] Univ Miami, Miller Sch Med, Jackson Mem Hosp, Dept Surg, Miami, FL 33136 USA; [Ciancio, Gaetano] Univ Miami, Miller Sch Med, Dept Urol, Jackson Mem Hosp, Miami, FL 33136 USA; [Ciancio, Gaetano; Farag, Ahmed; Vincenzi, Paolo; Gaynor, Jeffrey J.] Univ Miami, Jackson Mem Hosp, Miller Sch Med, Miami Transplant Inst, Miami, FL 33136 USA; [Farag, Ahmed] Zagazig Univ, Dept Surg, Sch Med, Zagazig, Egypt; [Gonzalez, Javier] Hosp Gen Univ Gregorio Maranon, Dept Urol, Madrid, Spain	University of Miami; University of Miami; University of Miami; Egyptian Knowledge Bank (EKB); Zagazig University; General University Gregorio Maranon Hospital	Ciancio, G (corresponding author), Univ Miami, Miller Sch Med, Jackson Mem Hosp, Dept Surg, Miami, FL 33136 USA.; Ciancio, G (corresponding author), Univ Miami, Miller Sch Med, Dept Urol, Jackson Mem Hosp, Miami, FL 33136 USA.; Ciancio, G (corresponding author), Univ Miami, Jackson Mem Hosp, Miller Sch Med, Miami Transplant Inst, Miami, FL 33136 USA.	gciancio@med.miami.edu	Vincenzi, Paolo/ABA-3044-2021	Vincenzi, Paolo/0000-0002-5446-2556; Gaynor, Jeffrey/0000-0002-9607-7509				Abbott KC, 2004, AM J KIDNEY DIS, V44, P353, DOI 10.1053/j.ajkd.2004.04.040; Abou-Elela A, 2007, INT UROL NEPHROL, V39, P1005, DOI 10.1007/s11255-007-9204-z; Alberts VP, 2014, TRANSPL INT, V27, P593, DOI 10.1111/tri.12301; Ameer A, 2011, ANN TRANSPL, V16, P82; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; AUH YH, 1986, RADIOLOGY, V159, P319, DOI 10.1148/radiology.159.2.2938210; BARRY JM, 1985, J UROLOGY, V134, P249, DOI 10.1016/S0022-5347(17)47113-8; Buttigieg Jesmar, 2018, World J Transplant, V8, P142, DOI 10.5500/wjt.v8.i5.142; Frober R, 2007, BJU INT, V100, P949, DOI 10.1111/j.1464-410X.2007.07207.x; GREGOIR W, 1962, Acta Urol Belg, V30, P286; Junge K, 2012, LANGENBECK ARCH SURG, V397, P255, DOI 10.1007/s00423-011-0780-0; Kayler L, 2010, TRANSPL P, V42, P1413, DOI 10.1016/j.transproceed.2010.04.016; Kayler L, 2012, CLIN TRANSPLANT, V26, pE372, DOI 10.1111/j.1399-0012.2012.01655.x; Kok NFM, 2008, TRANSPLANTATION, V85, P1760, DOI 10.1097/TP.0b013e318172802d; Lapointe SP, 1998, J UROLOGY, V159, P1662, DOI 10.1097/00005392-199805000-00085; Lee JR, 2013, TRANSPLANTATION, V96, P732, DOI 10.1097/TP.0b013e3182a04997; Lee RS, 2007, TRANSPL P, V39, P1461, DOI 10.1016/j.transproceed.2006.11.017; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LICH R, 1961, J UROLOGY, V86, P554, DOI 10.1016/S0022-5347(17)65219-4; Loupy A, 2017, AM J TRANSPLANT, V17, P28, DOI 10.1111/ajt.14107; Mangus RS, 2004, AM J TRANSPLANT, V4, P1889, DOI 10.1111/j.1600-6143.2004.00595.x; MCDONALD JC, 1979, ANN SURG, V190, P663, DOI 10.1097/00000658-197911000-00018; Mitra Subhashis, 2011, Curr Infect Dis Rep, V13, P579, DOI 10.1007/s11908-011-0210-z; Molenaar NM, 2017, PROG TRANSPLANT, V27, P196, DOI 10.1177/1526924817699965; Neuhaus TJ, 1997, J UROLOGY, V157, P1400, DOI 10.1016/S0022-5347(01)64999-1; Ooms LSS, 2020, TRANSPL INT, V33, P1190, DOI 10.1111/tri.13638; POLITANO VA, 1958, J UROLOGY, V79, P932, DOI 10.1016/S0022-5347(17)66369-9; Secin FP, 2002, J UROLOGY, V168, P926, DOI 10.1016/S0022-5347(05)64544-2; SHANFIELD I, 1972, TRANSPL P, V4, P637; STARZL TE, 1989, TRANSPLANT P, V21, P3856; Streeter EH, 2002, BJU INT, V90, P627, DOI 10.1046/j.1464-410X.2002.03004.x; TAGUCHI Y, 1971, J UROLOGY, V105, P194, DOI 10.1016/S0022-5347(17)61491-5; Tillou X, 2009, TRANSPL P, V41, P3317, DOI 10.1016/j.transproceed.2009.08.046; Veale JL, 2007, J UROLOGY, V177, P632, DOI 10.1016/j.juro.2006.09.042; Whang M, 2011, TRANSPL P, V43, P1619, DOI 10.1016/j.transproceed.2011.02.014; Whang M, 2003, TRANSPLANT P, V35, P1375, DOI 10.1016/S0041-1345(03)00519-0; Whang M, 2020, TRANSPL P, V52, P186, DOI 10.1016/j.transproceed.2019.10.008; Wilson CH, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004925.pub3; Woodruff M W, 1973, Urology, V1, P414, DOI 10.1016/0090-4295(73)90370-1; Zargar MA, 2005, TRANSPL P, V37, P3077, DOI 10.1016/j.transproceed.2005.08.006; Zorgdrager M, 2016, ANN TRANSPL, V21, DOI 10.12659/AOT.898748	46	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0244248	10.1371/journal.pone.0244248	http://dx.doi.org/10.1371/journal.pone.0244248			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428659	Green Published, gold			2022-12-26	WOS:000630036100016
J	Sahin-Toth, J; Kovacs, E; Tothpal, A; Juhasz, J; Forro, B; Banyai, K; Havril, K; Horvath, A; Ghidan, A; Dobay, O				Sahin-Toth, Judit; Kovacs, Eszter; Tothpal, Adrienn; Juhasz, Janos; Forro, Barbara; Banyai, Krisztian; Havril, Kata; Horvath, Andrea; Ghidan, Agoston; Dobay, Orsolya			Whole genome sequencing of coagulase positive staphylococci from a dog-and-owner screening survey	PLOS ONE			English	Article								Background Staphylococcus aureus and S. pseudintermedius are the two most common coagulase positive staphylococci (CPS). S. aureus is more prevalent among humans, whereas S. pseudintermedius is more commonly isolated from dogs, however, both can cause various community and hospital acquired diseases in humans. Methods In the current study we screened 102 dogs and 84 owners in Hungary. We tested the antibiotic susceptibility of the strains and in order to get a better picture of the clonal relationship of the strains, we used pulsed-field gel electrophoresis. In addition, three pairs of isolates with identical PFGE patterns were whole genome sequenced, MLST and spa types were established. Results Carriage rate of S. aureus was 23.8% in humans and 4.9% in dogs and two cases of co-carriage were found among dogs and owners. S. pseudintermedius carriage rate was 2.4% and 34.3%, respectively, with only one co-carriage. The isolates were generally rather susceptible to the tested antibiotics, but high tetracycline resistance of S. pseudintermedius strains was noted. The co-carried isolates shared almost the same resistance genes (including tet(K), bla(Z), norA, mepR, lmrS, fosB) and virulence gene pattern. Apart from the common staphylococcal enzymes and cytotoxins, we found enterotoxins and exfoliative toxins as well. The two S. aureus pairs belonged to ST45-t630, ST45-t671 and ST15-t084, ST15t084, respectively. The co-carried S. pseudintermedius isolates shared the same housekeeping gene alleles determining a novel sequence type ST1685. Conclusions Based on the genomic data, dog-owner co-carried strains displayed only insignificant differences therefore provided evidence for potential human-to-dog and dog-to-human transmission.	[Sahin-Toth, Judit; Kovacs, Eszter; Tothpal, Adrienn; Juhasz, Janos; Havril, Kata; Horvath, Andrea; Ghidan, Agoston; Dobay, Orsolya] Semmelweis Univ, Inst Med Microbiol, Budapest, Hungary; [Juhasz, Janos] Pazmany Peter Catholic Univ, Fac Informat Technol & Bion, Budapest, Hungary; [Forro, Barbara; Banyai, Krisztian] Ctr Agr Res, Inst Vet Med Res, Budapest, Hungary	Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute	Dobay, O (corresponding author), Semmelweis Univ, Inst Med Microbiol, Budapest, Hungary.	dobay.orsolya@med.semmelweis-univ.hu		Dobay, Orsolya/0000-0001-7094-2288; Sahin-Toth, Judit/0000-0002-2007-7836; Tothpal, Adrienn/0000-0002-5204-9450				Aamot HV, 2012, J CLIN MICROBIOL, V50, P3111, DOI 10.1128/JCM.01352-12; Abdel-Moein KA, 2011, VECTOR-BORNE ZOONOT, V11, P627, DOI 10.1089/vbz.2010.0272; Alcock BP, 2020, NUCLEIC ACIDS RES, V48, pD517, DOI 10.1093/nar/gkz935; [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; [Anonymous], 2014, DARLING LAB COMPUTAT; [Anonymous], 2003, VFDB VIRULENCE FACTO; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bannoehr J, 2009, J CLIN MICROBIOL, V47, P469, DOI 10.1128/JCM.01915-08; Bean DC, 2016, AUST VET J, V94, P456, DOI 10.1111/avj.12528; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Borjesson S, 2015, EUR J CLIN MICROBIOL, V34, P839, DOI 10.1007/s10096-014-2300-y; Chen L, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9040264; Conceicao T, 2007, CLIN MICROBIOL INFEC, V13, P971, DOI 10.1111/j.1469-0691.2007.01794.x; Cuny C, 2015, ANTIBIOTICS-BASEL, V4, P521, DOI 10.3390/antibiotics4040521; Saei HD, 2020, ARCH MICROBIOL, V202, P115, DOI 10.1007/s00203-019-01722-z; Denis O, 2006, ANTIMICROB AGENTS CH, V50, P2680, DOI 10.1128/AAC.00272-06; Drayss M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212052; Dweba CC, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8020079; European Committee on Antimicrobial Susceptibility Testing, BREAKPOINT TABLES IN; European Medicines Agency, 2017, EUR DAT SAL VET ANT; Farkas R, 2020, PARASITOL RES, V119, P129, DOI 10.1007/s00436-019-06478-5; Fazakerley J, 2010, VET DERMATOL, V21, P578, DOI 10.1111/j.1365-3164.2010.00894.x; Fazakerley J, 2009, VET DERMATOL, V20, P179, DOI 10.1111/j.1365-3164.2009.00745.x; Fitzgerald JR, 2009, VET DERMATOL, V20, P490, DOI 10.1111/j.1365-3164.2009.00828.x; Futagawa-Saito K, 2009, FEMS MICROBIOL LETT, V301, P176, DOI 10.1111/j.1574-6968.2009.01823.x; Guardabassi L, 2004, J ANTIMICROB CHEMOTH, V54, P321, DOI 10.1093/jac/dkh332; Guardabassi L, 2004, VET MICROBIOL, V98, P23, DOI 10.1016/j.vetmic.2003.09.021; Haag AF, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.GPP3-0060-2019; Heaton CJ, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9020089; Hnot ML, 2015, VET DERMATOL, V26, P334, DOI 10.1111/vde.12227; Horvath A, 2020, ANN CLIN MICROB ANTI, V19, DOI 10.1186/s12941-020-00357-z; Huang TM, 2019, J APPL MICROBIOL, V126, P1899, DOI 10.1111/jam.14266; Hur BA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230049; Iyori K, 2010, FEMS MICROBIOL LETT, V312, P169, DOI 10.1111/j.1574-6968.2010.02113.x; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Joosten P, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9020087; KHAMBATY FM, 1994, EPIDEMIOL INFECT, V113, P75, DOI 10.1017/S0950268800051487; Kosecka-Strojek M, 2018, PET TO MAN TRAVELLIN, P11, DOI [10.1016/B978-0-12-813547-1.00002-9, DOI 10.24425/119041]; Krisztina L, 2011, ACTA MICROBIOL IMM H, V58, P75, DOI 10.1556/AMicr.58.2011.1.8; Larsen J, 2016, ANTIMICROB AGENTS CH, V60, P4401, DOI 10.1128/AAC.00426-16; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Laub K, 2018, ACTA MICROBIOL IMM H, V65, P59, DOI 10.1556/030.65.2018.001; Laub K, 2017, ACTA MICROBIOL IMM H, V64, P51, DOI 10.1556/030.64.2017.001; Letertre C, 2003, J APPL MICROBIOL, V95, P38, DOI 10.1046/j.1365-2672.2003.01957.x; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mateus A, 2011, J SMALL ANIM PRACT, V52, P515, DOI 10.1111/j.1748-5827.2011.01098.x; Menyhart-Laub K, 2017, EPIDEMIOLOGY STAPHYL; National Bacteriological Surveillance Management Team, NBS ANN REP; Nelson C. T., 2020, CURRENT CANINE GUIDE; Papadopoulos P, 2019, FOOD MICROBIOL, V84, DOI 10.1016/j.fm.2019.103249; Paul NC, 2011, ZOONOSES PUBLIC HLTH, V58, P533, DOI 10.1111/j.1863-2378.2011.01398.x; Paul NC, 2012, VET MICROBIOL, V160, P420, DOI 10.1016/j.vetmic.2012.06.012; Peschel A, 2013, NAT REV MICROBIOL, V11, P667, DOI 10.1038/nrmicro3110; Quinn PJ, 2011, VET MICROBIOLOGY MIC, P357; Robb AR, 2017, JMM CASE REPORTS, V4, P1; Rubin JE, 2010, VET MICROBIOL, V143, P440, DOI 10.1016/j.vetmic.2009.11.012; Sasaki T, 2007, J CLIN MICROBIOL, V45, P1118, DOI 10.1128/JCM.02193-06; Sergelidis D, 2017, LETT APPL MICROBIOL, V64, P409, DOI 10.1111/lam.12735; Shukla SK, 2010, J CLIN MICROBIOL, V48, P3582, DOI 10.1128/JCM.00657-10; Soedarmanto I, 2011, RES VET SCI, V91, pE25, DOI 10.1016/j.rvsc.2011.01.027; Solyman SM, 2013, J CLIN MICROBIOL, V51, P306, DOI 10.1128/JCM.02421-12; Szabo J, 2009, EUR J CLIN MICROBIOL, V28, P129, DOI 10.1007/s10096-008-0588-1; The Wellcome Trust The Department of Zoology University of Oxford, PUBL DAT MOL TYP; Unnerstad HE, 2018, VET MICROBIOL, V225, P114, DOI 10.1016/j.vetmic.2018.09.017; Van Hoovels L, 2006, J CLIN MICROBIOL, V44, P4609, DOI 10.1128/JCM.01308-06; Vitale M, 2018, FOODBORNE PATHOG DIS, V15, P177, DOI 10.1089/fpd.2017.2338; Waller A, 2005, VET J, V169, P315, DOI 10.1016/j.tvjl.2005.02.011; Walther B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035197; Wan MT, 2012, J APPL MICROBIOL, V112, P205, DOI 10.1111/j.1365-2672.2011.05179.x; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Yoon JW, 2010, VET DERMATOL, V21, P484, DOI 10.1111/j.1365-3164.2009.00874.x; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang Y, 2018, FOODBORNE PATHOG DIS, V15, P437, DOI 10.1089/fpd.2017.2408	73	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0245351	10.1371/journal.pone.0245351	http://dx.doi.org/10.1371/journal.pone.0245351			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428679	gold, Green Published			2022-12-26	WOS:000630036100061
J	Iorga, A; Donovan, K; Shojaie, L; Johnson, H; Kwok, J; Suda, J; Lee, BT; Aghajan, M; Shao, L; Liu, ZX; Dara, L				Iorga, Andrea; Donovan, Katherine; Shojaie, Layla; Johnson, Heather; Kwok, Janet; Suda, Jo; Lee, Brian T.; Aghajan, Mariam; Shao, Ling; Liu, Zhang-Xu; Dara, Lily			Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-INJURY; CELL-DEATH; NECROPTOSIS; NECROSIS; APOPTOSIS; UBIQUITINATION; HEPATOTOXICITY; HEPATOCYTES; INHIBITION; KINASES	Acetaminophen (APAP)-induced liver necrosis is a form of regulated cell death (RCD) in which APAP activates the mitogen-activated protein kinases (MAPKs) and specifically the c-Jun-N-terminal kinase (JNK) pathway, leading to necrotic cell death. Previously, we have shown that receptor interacting protein kinase-1 (RIPK1) knockdown is also protective against APAP RCD upstream of JNK. However, whether the kinase or platform function of RIPK1 is involved in APAP RCD is not known. To answer this question, we used genetic mouse models of targeted hepatocyte RIPK1 knockout (RIPK1(HepCKO)) or kinase dead knock-in (RIPK1(D138N)) and adult hepatocyte specific knockout of the cytoprotective protein A20 (A20(HepCKO)), known to interact with RIPK1, to study its potential involvement in MAPK signaling. We observed no difference in injury between WT and RIPK1D138N mice post APAP. However, RIPK1(HepCKO) was protective. We found that RIPK1(HepCKO) mice had attenuated pJNK activation, while A20 was simultaneously upregulated. Conversely, A20(HepCKO) markedly worsened liver injury from APAP. Mechanistically, we observed a significant upregulation of apoptosis signal-regulating kinase 1 (ASK1) and increased JNK activation in A20(HepCKO) mice compared with littermate controls. We also demonstrated that A20 coimmunoprecipitated (co-IP) with both RIPK1 and ASK1, and that in the presence of RIPK1, there was less A20-ASK1 association than in its absence. We conclude that the kinase-independent platform function of RIPK1 is involved in APAP toxicity. Adult RIPK1(HepCKO) mice are protected against APAP by upregulating A20 and attenuating JNK signaling through ASK1, conversely, A20(HepCKO) worsens injury from APAP.	[Iorga, Andrea; Johnson, Heather; Kwok, Janet; Lee, Brian T.; Shao, Ling; Liu, Zhang-Xu; Dara, Lily] Univ Southern Calif, Div Gastrointestinal & Liver Dis, Dept Med, Keck Sch Med, Los Angeles, CA 90007 USA; [Iorga, Andrea; Donovan, Katherine; Shojaie, Layla; Johnson, Heather; Suda, Jo; Shao, Ling; Liu, Zhang-Xu; Dara, Lily] Univ Southern Calif, Keck Sch Med, USC Res Ctr Liver Dis, Los Angeles, CA 90007 USA; [Suda, Jo] Cedar Sinai Med Ctr, Los Angeles, CA USA; [Aghajan, Mariam] IONIS Pharmaceut, Carlsbad, CA USA	University of Southern California; University of Southern California; Cedars Sinai Medical Center; Ionis Pharmaceuticals, Inc.	Dara, L (corresponding author), Univ Southern Calif, Div Gastrointestinal & Liver Dis, Dept Med, Keck Sch Med, Los Angeles, CA 90007 USA.; Dara, L (corresponding author), Univ Southern Calif, Keck Sch Med, USC Res Ctr Liver Dis, Los Angeles, CA 90007 USA.	lily.dara@usc.edu	Donovan, Katherine/GSJ-2005-2022; Lee, Brian T/AAX-3191-2021; Iorga, Andrea/AAU-8447-2021	Lee, Brian T/0000-0002-0621-4304; Iorga, Andrea/0000-0001-7809-9184; Donovan, Katherine/0000-0002-8757-4415	USC Research Center for Liver Diseases, National Institutes of Health [P30 DK048522, K08DK109141]	USC Research Center for Liver Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Analytical-Metabolomics-Instrumentation, Cell and Tissue Imaging, and Liver Histology Cores of the USC Research Center for Liver Diseases, National Institutes of Health P30 DK048522 and K08DK109141 (L. D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An JF, 2013, J HEPATOL, V58, P297, DOI 10.1016/j.jhep.2012.10.002; Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Catrysse L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.154; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Chen DS, 2019, HEPATOLOGY, V69, P2164, DOI 10.1002/hep.30422; Dara L, 2020, LIVER: BIOLOGY AND PATHOBIOLOGY, 6TH EDITION, 6 EDITION, P701; Dara L, 2017, CELL DEATH BIOL DIS, P1, DOI 10.1007/978-3-319-53774-0_1; Dara L, 2018, SEMIN LIVER DIS, V38, P73, DOI 10.1055/s-0038-1629924; Dara L, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.89; Dara L, 2015, HEPATOLOGY, V62, P1847, DOI 10.1002/hep.27939; Deutsch M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.126; Dorronsoro A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.494; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Gunther C, 2016, J CLIN INVEST, V126, P4346, DOI 10.1172/JCI87545; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Iorga A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051018; Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336; Jaeschke H, 2019, ARCH TOXICOL, V93, P3491, DOI 10.1007/s00204-019-02597-1; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Lee WM, 2017, J HEPATOL, V67, P1324, DOI 10.1016/j.jhep.2017.07.005; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Nakagawa H, 2008, GASTROENTEROLOGY, V135, P1311, DOI 10.1053/j.gastro.2008.07.006; Newton K, 2015, TRENDS CELL BIOL, V25, P347, DOI 10.1016/j.tcb.2015.01.001; Pinna F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00610; Priem D, 2020, TRENDS IMMUNOL, V41, P421, DOI 10.1016/j.it.2020.03.001; Ramachandran A, 2013, HEPATOLOGY, V58, P2099, DOI 10.1002/hep.26547; Schneider AT, 2016, HEPATOLOGY, V64, P306, DOI 10.1002/hep.28225; Shrikhande GV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014240; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; Simpson DS, 2021, SEMIN CELL DEV BIOL, V109, P76, DOI 10.1016/j.semcdb.2020.08.008; Suda J, 2016, J IMMUNOL, V197, P3120, DOI 10.4049/jimmunol.1600690; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Takemoto K, 2014, FEBS OPEN BIO, V4, P777, DOI 10.1016/j.fob.2014.08.007; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Win S, 2018, HEPATOLOGY, V67, P2013, DOI 10.1002/hep.29689; Win S, 2011, J BIOL CHEM, V286, P35071, DOI 10.1074/jbc.M111.276089; Won M, 2010, CELL DEATH DIFFER, V17, P1830, DOI 10.1038/cdd.2010.47; Zhang J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.295; Zhang P, 2018, NAT MED, V24, P84, DOI 10.1038/nm.4453; Zhang YF, 2014, TOXICOL LETT, V225, P445, DOI 10.1016/j.toxlet.2014.01.005	41	7	7	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100300	10.1016/j.jbc.2021.100300	http://dx.doi.org/10.1016/j.jbc.2021.100300			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33460648	Green Published, gold			2022-12-26	WOS:000672866400274
J	Ren, SQ; Breuillaud, L; Yao, W; Yin, T; Norris, KA; Zehntner, SP; D'Adamio, L				Ren, Siqiang; Breuillaud, Lionel; Yao, Wen; Yin, Tao; Norris, Kelly A.; Zehntner, Simone P.; D'Adamio, Luciano			TNF-alpha-mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer's disease pathology in young Trem2(R47H) rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; NECROSIS-FACTOR-ALPHA; MOUSE MODEL; SYNAPTIC PLASTICITY; INTERFERON-GAMMA; MEMORY DEFICITS; MYELOID CELLS-2; BETA; RECEPTOR; EXPRESSION	Alzheimer's disease (AD) is a neurodegenerative dementia associated with deposition of amyloid plaques and neurofibrillary tangles, formed by amyloid beta (A beta) peptides and phosphor-tau, respectively, in the central nervous system. Approximately 2% of AD cases are due to familial AD (FAD); similar to 98% of cases are sporadic AD (SAD). Animal models with FAD are commonly used to study SAD pathogenesis. Because mechanisms leading to FAD and SAD may be distinct, to study SAD pathogenesis, we generated Trem2(R47H) knock-in rats, which carry the SAD risk factor p.R47H variant of the microglia gene triggering receptor expressed on myeloid cells 2 (TREM2). Trem2(R47H) rats produce human-A beta from a humanized-App rat allele because human-A beta is more toxic than rodent-A beta and the pathogenic role of the p.R47H TREM2 variant has been linked to human-A beta-clearing deficits. Using periadolescent Trem2(R47H) rats, we previously demonstrated that supraphysiological tumor necrosis factor-alpha (TNF-alpha) boosts glutamatergic transmission, which is excitatory, and suppresses long-term potentiation, a surrogate of learning and memory. Here, we tested the effect of the p.R47H variant on the inhibitory neurotransmitter gamma-aminobutyric acid. We report that GABAergic transmission is decreased in Trem2(R47H/R47H) rats. This decrease is due to acute and reversible action of TNF-alpha and is not associated with increased human-A beta levels and AD pathology. Thus, the p.R47H variant changes the excitatory/inhibitory balance, favoring excitation. This imbalance could potentiate glutamate excitotoxicity and contribute to neuronal dysfunction, enhanced neuronal death, and neurodegeneration. Future studies will determine whether this imbalance represents an early, A beta-independent pathway leading to dementia and may reveal the AD-modifying therapeutic potential of TNF-alpha inhibition in the central nervous system.	[Ren, Siqiang; Yao, Wen; Yin, Tao; Norris, Kelly A.; D'Adamio, Luciano] Rutgers State Univ, Jacqueline Krieger Klein Ctr Alzheimers Dis & Neu, Physiol & Neurosci New Jersey Med Sch, Brain Hlth Inst,Dept Pharmacol, Newark, NJ 07102 USA; [Breuillaud, Lionel; Zehntner, Simone P.] Biospect Inc, Montreal, PQ, Canada	Rutgers State University Newark; Rutgers State University New Brunswick	D'Adamio, L (corresponding author), Rutgers State Univ, Jacqueline Krieger Klein Ctr Alzheimers Dis & Neu, Physiol & Neurosci New Jersey Med Sch, Brain Hlth Inst,Dept Pharmacol, Newark, NJ 07102 USA.	luciano.dadamio@rutgers.edu			NIH/NIA [R01AG052286, RF1AG064821-01, 1R01AG033007-01A109]	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	L.D. was funded by the NIH/NIA R01AG052286, RF1AG064821-01, and 1R01AG033007-01A109. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez A, 2007, NEUROBIOL AGING, V28, P533, DOI 10.1016/j.neurobiolaging.2006.02.012; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Cheng X, 2014, DRUG DISCOV TODAY, V19, P1822, DOI 10.1016/j.drudis.2014.06.029; Chung WS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020370; Del Prete D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108576; Eyre MD, 2012, J NEUROSCI, V32, P5853, DOI 10.1523/JNEUROSCI.6495-11.2012; Fanutza T, 2015, ELIFE, V4, DOI 10.7554/eLife.09743; FILLIT H, 1991, NEUROSCI LETT, V129, P318, DOI 10.1016/0304-3940(91)90490-K; Fotinopoulou A, 2005, J BIOL CHEM, V280, P30768, DOI 10.1074/jbc.C500231200; Groemer TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018754; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim DH, 2016, BEHAV BRAIN RES, V311, P384, DOI 10.1016/j.bbr.2016.06.001; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Kohli BM, 2012, J PROTEOME RES, V11, P4075, DOI 10.1021/pr300123g; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Lundgren JL, 2015, J NEUROCHEM, V135, P606, DOI 10.1111/jnc.13287; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Matsuda S, 2011, NEUROBIOL AGING, V32, P1400, DOI 10.1016/j.neurobiolaging.2009.08.005; McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006; Medeiros R, 2007, J NEUROSCI, V27, P5394, DOI 10.1523/JNEUROSCI.5047-06.2007; Montgomery SL, 2011, AM J PATHOL, V179, P2053, DOI 10.1016/j.ajpath.2011.07.001; Norstrom EM, 2010, J NEUROSCI, V30, P15677, DOI 10.1523/JNEUROSCI.4464-10.2010; Ogoshi F, 2005, EXP NEUROL, V193, P384, DOI 10.1016/j.expneurol.2004.12.026; Perry RT, 2001, NEUROBIOL AGING, V22, P873, DOI 10.1016/S0197-4580(01)00291-3; Perry RT, 2001, AM J MED GENET, V105, P332, DOI 10.1002/ajmg.1371; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Ren SQ, 2020, ELIFE, V9, DOI 10.7554/eLife.57513; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shi JQ, 2011, J AM GERIATR SOC, V59, P1142, DOI 10.1111/j.1532-5415.2011.03445.x; Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053; Sly LM, 2001, BRAIN RES BULL, V56, P581, DOI 10.1016/S0361-9230(01)00730-4; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Tamayev R, 2010, P NATL ACAD SCI USA, V107, P20822, DOI 10.1073/pnas.1011689107; Tamayev R, 2010, J NEUROSCI, V30, P14915, DOI 10.1523/JNEUROSCI.3917-10.2010; Tambini MD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60800-1; Tambini MD, 2019, AGING CELL, V18, DOI 10.1111/acel.13033; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Tarkowski E, 2003, BRAIN RES BULL, V61, P255, DOI 10.1016/S0361-9230(03)00088-1; Tarkowski E, 2003, DEMENT GERIATR COGN, V15, P207, DOI 10.1159/000068780; Tobinick Edward, 2006, MedGenMed, V8, P25; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Wu B, 2013, P NATL ACAD SCI USA, V110, P15091, DOI 10.1073/pnas.1304171110; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Xia D, 2015, NEURON, V85, P967, DOI 10.1016/j.neuron.2015.02.010; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Yao W, 2019, J NEUROSCI, V39, P6992, DOI 10.1523/JNEUROSCI.0207-19.2019; Yao W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41340-9; Zehntner SP, 2008, J HISTOCHEM CYTOCHEM, V56, P873, DOI 10.1369/jhc.2008.950345; Zhao YJ, 2018, NEURON, V97, P1023, DOI 10.1016/j.neuron.2018.01.031; Zhou SL, 2019, J ALZHEIMERS DIS, V68, P1171, DOI 10.3233/JAD-181038; Zhou YY, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00202	59	11	11	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100089	10.1074/jbc.RA120.016395	http://dx.doi.org/10.1074/jbc.RA120.016395			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33434745	gold, Green Published			2022-12-26	WOS:000672866400070
J	Wilkerson, A; Bhat, N; Pham, HQH; Yuksel, S; Butovich, I				Wilkerson, Amber; Bhat, Nita; Hoang Quoc Hai Pham; Yuksel, Seher; Butovich, Igor			Physiological effects of inactivation and the roles of Elovl3/ELOVL3 in maintaining ocular homeostasis	FASEB JOURNAL			English	Article						Elovl3; elongase of very long chain fatty acids; lipid homeostasis; meibogenesis; meibomian glands; meibum; transcriptomics	CHAIN FATTY-ACIDS; MEIBOMIAN GLANDS; HUMAN MEIBUM; ACOX2 DEFICIENCY; WAX ESTERS; TEAR FILM; EXPRESSION; LIPIDS; GENE; BIOSYNTHESIS	Recently, elongase of very long chain fatty acids-3 (ELOVL3) was demonstrated to play a pivotal role in physiology and biochemistry of the ocular surface by maintaining a proper balance in the lipid composition of meibum. The goal of this study was to further investigate the effects of ELOVL3 ablation in homozygous Elovl3-knockout mice (E3hom) in comparison with age and sex matched wild-type controls (E3wt). Slit lamp examination of the ocular surface of mice, and histological examination of their ocular tissues, highlighted a severe negative impact of Elovl3 inactivating mutation on the Meibomian glands (MG) and conjunctiva of mice. MG transcriptomes of the E3hom and E3wt mice were assessed and revealed a range of up- and downregulated genes related to lipid biosynthesis, inflammation, and stress response, compared with E3wt mice. Heat stage polarized light microscopy was used to assess melting characteristics of normal and abnormal meibum. The loss of Elovl3 led to a 8 degrees C drop in the melting temperature of meibum in E3hom mice, and increased its fluidity. Also noted were the excessive accumulation of lipid material and tears around the eye and severe ocular inflammation, among other abnormalities.	[Wilkerson, Amber; Bhat, Nita; Hoang Quoc Hai Pham; Yuksel, Seher; Butovich, Igor] Univ Texas Southwestern Med Ctr Dallas, Dept Ophthalmol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Bhat, Nita] Howard Univ Hosp, Dept Internal Med, Washington, DC USA; [Hoang Quoc Hai Pham] City Hope Natl Med Ctr, Beckman Res Inst, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [Butovich, Igor] Univ Texas Southwestern Med Ctr Dallas, Grad Sch Biomed Sci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard University; City of Hope; Beckman Research Institute of City of Hope; University of Texas System; University of Texas Southwestern Medical Center Dallas	Butovich, I (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Ophthalmol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	igor.butovich@utsouthwestern.edu		Pham, Hoang Quoc Hai/0000-0002-9044-5008	NEI NIH HHS [R01 EY024324] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Andres-Benito P, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00546; Berdyshev E, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98006; Berruyer C, 2006, J EXP MED, V203, P2817, DOI 10.1084/jem.20061640; BRAUNINGER GE, 1972, AM J OPHTHALMOL, V73, P132, DOI 10.1016/0002-9394(72)90315-7; Butovich IA, 2007, J LIPID RES, V48, P2220, DOI 10.1194/jlr.M700237-JLR200; Butovich IA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184539; Butovich IA, 2019, FASEB J, V33, P10034, DOI 10.1096/fj.201900725R; Butovich IA, 2019, OCUL SURF, V17, P793, DOI 10.1016/j.jtos.2019.03.002; Butovich IA, 2009, METHODS MOL BIOL, V579, P221, DOI 10.1007/978-1-60761-322-0_11; Butovich IA, 2017, EXP EYE RES, V163, P2, DOI 10.1016/j.exer.2017.06.020; Butovich IA, 2016, BBA-MOL CELL BIOL L, V1861, P538, DOI 10.1016/j.bbalip.2016.03.024; Butovich IA, 2014, INVEST OPHTH VIS SCI, V55, P87, DOI 10.1167/iovs.13-13355; Butovich IA, 2012, INVEST OPHTH VIS SCI, V53, P3766, DOI 10.1167/iovs.11-9333; Butovich IA, 2010, INVEST OPHTH VIS SCI, V51, P5508, DOI 10.1167/iovs.10-5419; CASON J, 1948, J ORG CHEM, V13, P227, DOI 10.1021/jo01160a010; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; EFRON N, 1989, CURR EYE RES, V8, P901; Ferdinandusse S, 2018, BBA-MOL BASIS DIS, V1864, P952, DOI 10.1016/j.bbadis.2017.12.032; GINSBURG GS, 1984, PROG LIPID RES, V23, P135, DOI 10.1016/0163-7827(84)90002-X; IYENGAR BTR, 1969, LIPIDS, V4, P28, DOI 10.1007/BF02531790; Jansen PAM, 2009, J INVEST DERMATOL, V129, P2167, DOI 10.1038/jid.2009.67; Jeyalatha MV, 2017, EXP EYE RES, V163, P29, DOI 10.1016/j.exer.2017.06.009; Jia F, 2016, J BIOL CHEM, V291, P2967, DOI 10.1074/jbc.M115.676650; Jump DB, 2009, METHODS MOL BIOL, V579, P375, DOI 10.1007/978-1-60761-322-0_19; Keyes BE, 2016, CELL, V167, P1323, DOI 10.1016/j.cell.2016.10.052; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Klinngam W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45966-7; Knothe G, 2009, J AM OIL CHEM SOC, V86, P843, DOI 10.1007/s11746-009-1423-2; Koh S, 2016, CORNEA, V35, pS83, DOI 10.1097/ICO.0000000000000998; Lamort AS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080815; Lu H, 2013, CHEM PHYS LIPIDS, V170, P55, DOI 10.1016/j.chemphyslip.2013.03.005; MCCULLEY J P, 1984, International Ophthalmology Clinics, V24, P65, DOI 10.1097/00004397-198402420-00008; McCulley J P, 1997, Trans Am Ophthalmol Soc, V95, P79; McCulley James P, 2003, Ocul Surf, V1, P97; McMahon A, 2013, LIPIDS, V48, P513, DOI 10.1007/s11745-013-3755-9; McMahon A, 2011, J LIPID RES, V52, P1128, DOI 10.1194/jlr.M014415; Miyamoto M, 2020, ELIFE, V9, DOI 10.7554/eLife.53582; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; MONDINO BJ, 1984, AM J OPHTHALMOL, V97, P496, DOI 10.1016/S0002-9394(14)76134-3; MORGAN PB, 1995, EYE, V9, P615, DOI 10.1038/eye.1995.149; Mudgil P, 2014, INVEST OPHTH VIS SCI, V55, P7272, DOI 10.1167/iovs.14-15512; Mueller N, 2019, J MED GENET, V56, P164, DOI 10.1136/jmedgenet-2018-105711; Nakamura K, 2015, NEUROPATHOLOGY, V35, P432, DOI 10.1111/neup.12204; NICOLAIDES N, 1981, INVEST OPHTH VIS SCI, V20, P522; Reneker LW, 2020, BRIT J OPHTHALMOL, V104, P999, DOI 10.1136/bjophthalmol-2019-314466; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Sassa T, 2018, FASEB J, V32, P2966, DOI 10.1096/fj.201700947R; Shi HB, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9060389; SINGH H, 1990, J LIPID RES, V31, P217; Sledge S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091862; Sperl W, 2000, EUR J PEDIATR, V159, P54, DOI 10.1007/s004310050010; Suzuki T, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.2.18; Suzuki Tomo, 2012, Cornea, V31 Suppl 1, pS41, DOI 10.1097/ICO.0b013e31826a04dd; Tiffany John M, 2008, Dev Ophthalmol, V41, P1, DOI 10.1159/000131066; Tjondrokoesoemo A, 2016, J BIOL CHEM, V291, P9920, DOI 10.1074/jbc.M116.719054; Tsai PS, 2006, BRIT J OPHTHALMOL, V90, P372, DOI 10.1136/bjo.2005.080846; Urata K, 1997, FETT-LIPID, V99, P327, DOI 10.1002/lipi.19970990905; Vilarinho S, 2016, P NATL ACAD SCI USA, V113, P11289, DOI 10.1073/pnas.1613228113; Villarreal-Gonzalez AJ, 2020, RHEUMATOL INT, V40, P1249, DOI 10.1007/s00296-020-04568-7; Vogel B, 2016, METHODSX, V3, P407, DOI 10.1016/j.mex.2016.05.002; Wang B, 2017, J STRUCT BIOL, V200, P279, DOI 10.1016/j.jsb.2017.08.001; Wilkerson A, 2019, INVEST OPHTH VIS SCI, V60; Yuksel S, 2019, INVEST OPHTH VIS SCI, V60	63	4	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21327	10.1096/fj.202002323R	http://dx.doi.org/10.1096/fj.202002323R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33455016	Green Accepted			2022-12-26	WOS:000647789600004
J	Baiya, S; Pengthaisong, S; Kitjaruwankul, S; Cairns, JRK				Baiya, Supaporn; Pengthaisong, Salila; Kitjaruwankul, Sunan; Cairns, James R. Ketudat			Structural analysis of rice Os4BGlu18 monolignol beta-glucosidase	PLOS ONE			English	Article							CELL-WALL LIGNIFICATION; CRYSTAL-STRUCTURE; PROVIDE INSIGHTS; LIGNIN; SPECIFICITY; OLIGOSACCHARIDE; VALIDATION; MACHINERY; MECHANISM; DYNAMICS	Monolignol glucosides are storage forms of monolignols, which are polymerized to lignin to strengthen plant cell walls. The conversion of monolignol glucosides to monolignols is catalyzed by monolignol beta -glucosidases. Rice Os4BGlu18 beta -glucosidase catalyzes hydrolysis of the monolignol glucosides, coniferin, syringin, and p-coumaryl alcohol glucoside more efficiently than other natural substrates. To understand more clearly the basis for substrate specificity of a monolignol beta -glucosidase, the structure of Os4BGlu18 was determined by X-ray crystallography. Crystals of Os4BGlu18 and its complex with delta -gluconolactone diffracted to 1.7 and 2.1 angstrom resolution, respectively. Two protein molecules were found in the asymmetric unit of the P2(1)2(1)2(1) space group of their isomorphous crystals. The Os4BGlu18 structure exhibited the typical (beta/alpha)(8) TIM barrel of glycoside hydrolase family 1 (GH1), but the four variable loops and two disulfide bonds appeared significantly different from other known structures of GH1 beta -glucosidases. Molecular docking studies of the Os4BGlu18 structure with monolignol substrate ligands placed the glycone in a similar position to the delta -gluconolactone in the complex structure and revealed the interactions between protein and ligands. Molecular docking, multiple sequence alignment, and homology modeling identified amino acid residues at the aglycone-binding site involved in substrate specificity for monolignol beta -glucosides. Thus, the structural basis of substrate recognition and hydrolysis by monolignol beta -glucosidases was elucidated.	[Baiya, Supaporn; Kitjaruwankul, Sunan] Kasetsart Univ, Fac Sci Sriracha, Sriracha Campus, Sriracha, Chonburi, Thailand; [Pengthaisong, Salila; Cairns, James R. Ketudat] Suranaree Univ Technol, Inst Sci, Sch Chem, Muang, Nakhon Ratchasi, Thailand; [Pengthaisong, Salila; Cairns, James R. Ketudat] Suranaree Univ Technol, Ctr Biomol Struct Funct & Applicat, Muang, Nakhon Ratchasi, Thailand	Suranaree University of Technology; Suranaree University of Technology	Cairns, JRK (corresponding author), Suranaree Univ Technol, Inst Sci, Sch Chem, Muang, Nakhon Ratchasi, Thailand.; Cairns, JRK (corresponding author), Suranaree Univ Technol, Ctr Biomol Struct Funct & Applicat, Muang, Nakhon Ratchasi, Thailand.	cairns@sut.ac.th			SPring-8; Institute for Protein Research, Osaka University; Synchrotron Radiation Protein Crystallography Facility of the National Core Facility Program for Biotechnology; Ministry of Science and Technology; NSRRC; Thailand Research Fund; Suranaree University of Technology (SUT) [BRG5980015, RSA6280073]; Faculty of Science at Sriracha Kasetsart University; SUT; Thailand Science Research and Innovation (TSRI)	SPring-8(SPring-8); Institute for Protein Research, Osaka University; Synchrotron Radiation Protein Crystallography Facility of the National Core Facility Program for Biotechnology; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); NSRRC; Thailand Research Fund(Thailand Research Fund (TRF)); Suranaree University of Technology (SUT); Faculty of Science at Sriracha Kasetsart University; SUT; Thailand Science Research and Innovation (TSRI)	Data collection was supported by grants from SPring-8 and the Institute for Protein Research, Osaka University (http://www.protein.osaka-u.ac.jp/en/).Data collection at the NSRRC was supported by Synchrotron Radiation Protein Crystallography Facility of the National Core Facility Program for Biotechnology, Ministry of Science and Technology and the NSRRC, a national user facility supported by the Ministry of Science and Technology, Taiwan, ROC. This work was supported by the Thailand Research Fund (trf.or.th/eng/) and Suranaree University of Technology (SUT, www.sut.ac.th) (grants BRG5980015 and RSA6280073). SB was partially supported by the Faculty of Science at Sriracha Kasetsart University. SP was supported by a full-time postdoctoral researcher grant from SUT and Thailand Science Research and Innovation (TSRI).	Baiya S, 2018, PLANT PHYSIOL BIOCH, V127, P223, DOI 10.1016/j.plaphy.2018.03.026; Baiya S, 2014, PLANT SCI, V227, P101, DOI 10.1016/j.plantsci.2014.07.009; BARRETT T, 1995, STRUCTURE, V3, P951, DOI 10.1016/S0969-2126(01)00229-5; Barros J, 2015, ANN BOT-LONDON, V115, P1053, DOI 10.1093/aob/mcv046; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Burmeister WP, 1997, STRUCTURE, V5, P663, DOI 10.1016/S0969-2126(97)00221-9; Cairns JRK, 2015, PLANT SCI, V241, P246, DOI 10.1016/j.plantsci.2015.10.014; Chapelle A, 2012, PLANT PHYSIOL, V160, P1204, DOI 10.1104/pp.112.203364; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chuenchor W, 2008, J MOL BIOL, V377, P1200, DOI 10.1016/j.jmb.2008.01.076; Chuenchor W, 2011, J STRUCT BIOL, V173, P169, DOI 10.1016/j.jsb.2010.09.021; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Czjzek M, 2000, P NATL ACAD SCI USA, V97, P13555, DOI 10.1073/pnas.97.25.13555; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Dharmawardhana, 1998, LIGNIN LIGNAN BIOSYN, P76; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escamilla-Trevino LL, 2006, PHYTOCHEMISTRY, V67, P1651, DOI 10.1016/j.phytochem.2006.05.022; Florindo RN, 2018, NEW BIOTECHNOL, V40, P218, DOI 10.1016/j.nbt.2017.08.012; Gloster TM, 2010, ORG BIOMOL CHEM, V8, P305, DOI 10.1039/b915870g; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Huis R, 2012, PLANT PHYSIOL, V158, P1893, DOI 10.1104/pp.111.192328; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jeng WY, 2012, ACTA CRYSTALLOGR D, V68, P829, DOI 10.1107/S0907444912013224; JENKINS J, 1995, FEBS LETT, V362, P281, DOI 10.1016/0014-5793(95)00252-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaneda M, 2008, PLANT PHYSIOL, V147, P1750, DOI 10.1104/pp.108.121533; Ketudat Cairns J, 2017, J APPL SCI, V16, P37, DOI [10.14416/j.appsci.2017.10.001, DOI 10.14416/J.APPSCI.2017.10.001]; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin JS, 2016, PLANT J, V88, P26, DOI 10.1111/tpj.13229; Morikawa Y, 2010, HOLZFORSCHUNG, V64, P61, DOI 10.1515/HF.2010.015; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nijikken Y, 2007, FEBS LETT, V581, P1514, DOI 10.1016/j.febslet.2007.03.009; Opassiri R, 2003, PLANT SCI, V165, P627, DOI 10.1016/S0168-9452(03)00235-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rizvi SMD, 2013, EXCLI J, V12, P831; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sansenya S, 2011, ARCH BIOCHEM BIOPHYS, V510, P62, DOI 10.1016/j.abb.2011.04.005; Sanz-Aparicio J, 1998, J MOL BIOL, V275, P491, DOI 10.1006/jmbi.1997.1467; Seshadri S, 2009, PLANT PHYSIOL, V151, P47, DOI 10.1104/pp.109.139436; Sharma K, 2019, CARBOHYD RES, V483, DOI 10.1016/j.carres.2019.107750; Steeves V, 2001, PHYTOCHEMISTRY, V57, P1085, DOI 10.1016/S0031-9422(01)00107-8; Tankrathok A, 2013, ACTA CRYSTALLOGR D, V69, P2124, DOI 10.1107/S0907444913020568; Terashima N, 2016, HOLZFORSCHUNG, V70, P801, DOI 10.1515/hf-2015-0224; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Verdoucq L, 2004, J BIOL CHEM, V279, P31796, DOI 10.1074/jbc.M402918200; Wang C, 2019, P NATL ACAD SCI USA, V116, P22331, DOI 10.1073/pnas.1903695116; Zheng H, 2017, ACTA CRYSTALLOGR D, V73, P223, DOI 10.1107/S2059798317001061	52	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0241325	10.1371/journal.pone.0241325	http://dx.doi.org/10.1371/journal.pone.0241325			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471829	Green Submitted, gold, Green Published			2022-12-26	WOS:000639428800012
J	Okabe-Miyamoto, K; Folk, D; Lyubomirsky, S; Dunn, EW				Okabe-Miyamoto, Karynna; Folk, Dunigan; Lyubomirsky, Sonja; Dunn, Elizabeth W.			Changes in social connection during COVID-19 social distancing: It's not (household) size that matters, it's who you're with	PLOS ONE			English	Article							LONELINESS; HAPPINESS; SCALE; MODEL; NEED	To slow the transmission of COVID-19, countries around the world have implemented social distancing and stay-at-home policies-potentially leading people to rely more on household members for their sense of closeness and belonging. To understand the conditions under which people felt the most connected, we examined whether changes in overall feelings of social connection varied by household size and composition. In two pre-registered studies, undergraduates in Canada (N-Study 1 = 548) and adults primarily from the U.S. and U.K. (N-Study 2 = 336) reported their perceived social connection once before and once during the pandemic. In both studies, living with a partner robustly and uniquely buffered shifts in social connection during the first phases of the pandemic (beta (Study 1) = .22, beta (Study 2) = .16). In contrast, neither household size nor other aspects of household composition predicted changes in connection. We discuss implications for future social distancing policies that aim to balance physical health with psychological health.	[Okabe-Miyamoto, Karynna; Lyubomirsky, Sonja] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA; [Folk, Dunigan; Dunn, Elizabeth W.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of California System; University of California Riverside; University of British Columbia	Okabe-Miyamoto, K (corresponding author), Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA.	kokab001@ucr.edu		Okabe-Miyamoto, Karynna/0000-0003-4225-3164	UC Riverside	UC Riverside	UC Riverside provided financial support to recruit participants for Study 2 (S. L. and K.O. M.), but did not play any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of each of the authors are articulated in the "author contributions" section.	BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Bernstein MJ, 2018, J SOC PERS RELAT, V35, P372, DOI 10.1177/0265407517691366; CDC, 2020, COVID 19 PAND; CDC, 2020, SOCIAL DISTANCING; Chen YRR, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4596; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; Dunn J., 2020, WORK HOME ALONGSIDE; Ellison NB, 2011, NEW MEDIA SOC, V13, P873, DOI 10.1177/1461444810385389; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Finkel E., 2018, ALL OR NOTHING MARRI; Folk D, 2020, COLLABRA-PSYCHOL, V6, DOI 10.1525/collabra.365; Fritz MM., 2019, EXAMINING SOCIAL PRO; Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Greenfield EA, 2011, J APPL GERONTOL, V30, P524, DOI 10.1177/0733464810364985; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Jacques-Hamilton R, 2019, J EXP PSYCHOL GEN, V148, P1538, DOI 10.1037/xge0000516; Jiang M., 2020, REASON ZOOM CALLS DR; Knispel S., 2020, FUTURITY; Kock N, 2004, ORGAN SCI, V15, P327, DOI 10.1287/orsc.1040.0071; Lambert L., 2020, CORONAVIRUS DEATH TO; Lauder W, 2004, J ADV NURS, V46, P88, DOI 10.1111/j.1365-2648.2003.02968.x; Lee RM, 2001, J COUNS PSYCHOL, V48, P310; Lucas RE, 2003, J PERS SOC PSYCHOL, V84, P527, DOI 10.1037/0022-3514.84.3.527; Margolis S, 2020, J EXP PSYCHOL GEN, V149, P719, DOI 10.1037/xge0000668; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Marks GN, 1999, SOC INDIC RES, V46, P301; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; Mehl MR, 2010, PSYCHOL SCI, V21, P539, DOI 10.1177/0956797610362675; Nelson SK, 2014, PSYCHOL BULL, V140, P846, DOI 10.1037/a0035444; Peer E, 2017, J EXP SOC PSYCHOL, V70, P153, DOI 10.1016/j.jesp.2017.01.006; Pietromonaco PR, 2017, AM PSYCHOL, V72, P531, DOI 10.1037/amp0000129; Popovich N., 2020, NEW YORK TIMES; Quoidbach J, 2019, PSYCHOL SCI, V30, P1111, DOI 10.1177/0956797619849666; Reis HT., 2004, PERCEIVED PARTNER RE; RUSSELL D, 1980, J PERS SOC PSYCHOL, V39, P472, DOI 10.1037/0022-3514.39.3.472; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Sheldon KM, 2012, MOTIV EMOTION, V36, P439, DOI 10.1007/s11031-012-9279-4; Stage H., 2020, INDEPENDENT; Sun J, 2020, J PERS SOC PSYCHOL, V119, P1478, DOI 10.1037/pspp0000272; Sundstrom G, 2009, EUR J AGEING, V6, P267, DOI 10.1007/s10433-009-0134-8; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Victor CR, 2012, J PSYCHOL, V146, P85, DOI 10.1080/00223980.2011.613875; WALTHER JB, 1992, COMMUN RES, V19, P52, DOI 10.1177/009365092019001003; WHO, 2020, COR DIS 2010 COVID 1; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; Williamson HC, 2020, PSYCHOL SCI, V31, P1479, DOI 10.1177/0956797620972688; Wood L, 2005, SOC SCI MED, V61, P1159, DOI 10.1016/j.socscimed.2005.01.017	49	40	40	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245009	10.1371/journal.pone.0245009	http://dx.doi.org/10.1371/journal.pone.0245009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM1OE	33471811	Green Submitted, gold, Green Published			2022-12-26	WOS:000639428800007
J	Becart, S; Whittington, KB; Prislovsky, A; Rao, NL; Rosloniec, EF				Becart, Stephane; Whittington, Karen B.; Prislovsky, Amanda; Rao, Navin L.; Rosloniec, Edward F.			The role of posttranslational modifications in generating neo-epitopes that bind to rheumatoid arthritis-associated HLA-DR alleles and promote autoimmune T cell responses	PLOS ONE			English	Article							SHARED EPITOPE; II COLLAGEN; CITRULLINATED PROTEINS; IMMUNE-RESPONSE; DBA/1J MICE; MOUSE MODEL; SUSCEPTIBILITY; PEPTIDE; GENES; AUTOANTIBODIES	While antibodies to citrullinated proteins have become a diagnostic hallmark in rheumatoid arthritis (RA), we still do not understand how the autoimmune T cell response is influenced by these citrullinated proteins. To investigate the role of citrullinated antigens in HLA-DR1- and DR4-restricted T cell responses, we utilized mouse models that express these MHC-II alleles to determine the relationship between citrullinated peptide affinity for these DR molecules and the ability of these peptides to induce a T cell response. Using a set of peptides from proteins thought to be targeted by the autoimmune T cell responses in RA, aggrecan, vimentin, fibrinogen, and type II collagen, we found that while citrullination can enhance the binding affinity for these DR alleles, it does not always do so, even when in the critical P4 position. Moreover, if peptide citrullination does enhance HLA-DR binding affinity, it does not necessarily predict the generation of a T cell response. Conversely, citrullinated peptides can stimulate T cells without changing the peptide binding affinity for HLA-DR1 or DR4. Furthermore, citrullination of an autoantigen, type II collagen, which enhances binding affinity to HLA-DR1 did not enhance the severity of autoimmune arthritis in HLA-DR1 transgenic mice. Additional analysis of clonal T cell populations stimulated by these peptides indicated cross recognition of citrullinated and wild type peptides can occur in some instances, while in others cases the citrullination generates a novel T cell epitope. Finally, cytokine profiles of the wild type and citrullinated peptide stimulated T cells unveiled a significant disconnect between proliferation and cytokine production. Altogether, these data demonstrate the lack of support for a simplified model with universal correlation between affinity for HLA-DR alleles, immunogenicity and arthritogenicity of citrullinated peptides. Additionally they highlight the complexity of both T cell receptor recognition of citrulline as well as its potential conformational effects on the peptide:HLA-DR complex as recognized by a self-reactive cell receptor.	[Becart, Stephane] Janssen Res & Dev LLC, Immunol Discovery, San Diego, CA USA; [Whittington, Karen B.; Prislovsky, Amanda; Rosloniec, Edward F.] Vet Affairs Med Ctr, Memphis, TN 38104 USA; [Rao, Navin L.] Janssen Res & Dev LLC, Immunol Discovery, Spring House, PA USA; [Rosloniec, Edward F.] Univ Tennessee, Dept Med, Hlth Sci Ctr, Memphis, TN 38104 USA; [Rosloniec, Edward F.] Univ Tennessee, Dept Pathol, Hlth Sci Ctr, Memphis, TN 38163 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Rosloniec, EF (corresponding author), Vet Affairs Med Ctr, Memphis, TN 38104 USA.; Rosloniec, EF (corresponding author), Univ Tennessee, Dept Med, Hlth Sci Ctr, Memphis, TN 38104 USA.; Rosloniec, EF (corresponding author), Univ Tennessee, Dept Pathol, Hlth Sci Ctr, Memphis, TN 38163 USA.	erosloniec@uthsc.edu			Department of Veterans Affairs; Janssen Research and Development	Department of Veterans Affairs(US Department of Veterans Affairs); Janssen Research and Development	This work was supported by a Merit Review grant from the Department of Veterans Affairs (E.F.R.), and by funding from Janssen Research and Development. Janssen Research and Development provided financial support in the form of author's salaries (S.B and N.L.R.), and study design, data analyses, and preparation of the manuscript (E.F.R).	Auger I, 2020, ARTHRITIS RHEUMATOL, V72, P903, DOI 10.1002/art.41189; Balandraud N, 2021, J AUTOIMMUN, V116, DOI 10.1016/j.jaut.2020.102542; Balandraud N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064108; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Burkhardt H, 2005, EUR J IMMUNOL, V35, P1643, DOI 10.1002/eji.200526000; Burska AN, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/492873; du Montcel ST, 2005, ARTHRITIS RHEUM-US, V52, P1063, DOI 10.1002/art.20989; Dusad A, 2014, IMMUNOL RES, V58, P51, DOI 10.1007/s12026-013-8479-7; Ferucci ED, 2005, SEMIN ARTHRITIS RHEU, V34, P662, DOI 10.1016/j.semarthrit.2004.08.003; Gonzalez-Gay MA, 2002, SEMIN ARTHRITIS RHEU, V31, P355, DOI 10.1053/sarh.2002.32552; GORGA JC, 1991, RES IMMUNOL, V142, P401, DOI 10.1016/0923-2494(91)90038-K; Hida S, 2004, J AUTOIMMUN, V23, P141, DOI 10.1016/j.jaut.2004.06.002; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Hill JA, 2008, J EXP MED, V205, P967, DOI 10.1084/jem.20072051; James EA, 2014, ARTHRITIS RHEUMATOL, V66, P1712, DOI 10.1002/art.38637; James EA, 2010, ARTHRITIS RHEUM-US, V62, P2909, DOI 10.1002/art.27594; Kampstra ASB, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1153-4; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Klein L, 2015, CELL, V163, P794, DOI 10.1016/j.cell.2015.10.057; Knipp M, 2000, ANAL BIOCHEM, V286, P257, DOI 10.1006/abio.2000.4805; Knuckley B, 2010, BIOCHEMISTRY-US, V49, P4852, DOI 10.1021/bi100363t; Latham KA, 2005, J IMMUNOL, V174, P3978, DOI 10.4049/jimmunol.174.7.3978; Law SC, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3848; Lundberg K, 2005, ARTHRITIS RES THER, V7, pR458, DOI 10.1186/ar1697; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; Michou L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1949; Moreno I, 1996, J RHEUMATOL, V23, P6; Morgan AW, 2008, ARTHRITIS RHEUM, V58, P1275, DOI 10.1002/art.23432; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Nepom GT, 2001, RHEUM DIS CLIN N AM, V27, P305, DOI 10.1016/S0889-857X(05)70203-9; NEPOM GT, 1989, ARTHRITIS RHEUM, V32, P15, DOI 10.1002/anr.1780320104; Nissim A, 2005, ARTHRITIS RHEUM-US, V52, P3829, DOI 10.1002/art.21479; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Penzotti JE, 1996, J AUTOIMMUN, V9, P287, DOI 10.1006/jaut.1996.0037; Qian ZH, 2010, J IMMUNOL, V185, P110, DOI 10.4049/jimmunol.1000416; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Roncarolo MG, 2018, IMMUNITY, V49, P1004, DOI 10.1016/j.immuni.2018.12.001; Rosloniec EF, 2006, J IMMUNOL, V177, P3884, DOI 10.4049/jimmunol.177.6.3884; Rosloniec Edward F, 2001, Curr Protoc Immunol, VChapter 15, DOI [10.1002/0471142735.im1505s89, 10.1002/0471142735.im1505s20]; Rosloniec EF, 2002, J IMMUNOL, V168, P253, DOI 10.4049/jimmunol.168.1.253; Rosloniec EF, 1998, J IMMUNOL, V160, P2573; Rosloniec EF, 1997, J EXP MED, V185, P1113, DOI 10.1084/jem.185.6.1113; Rubin B, 2004, SCAND J IMMUNOL, V60, P112, DOI 10.1111/j.0300-9475.2004.01457.x; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Sidney J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177140; Snir O, 2011, ARTHRITIS RHEUM-US, V63, P2873, DOI 10.1002/art.30445; STASTNY P, 1983, IMMUNOL REV, V70, P113, DOI 10.1111/j.1600-065X.1983.tb00712.x; Strollo R, 2013, ARTHRITIS RHEUM-US, V65, P1702, DOI 10.1002/art.37964; Thiele GM, 2012, INT IMMUNOPHARMACOL, V13, P424, DOI 10.1016/j.intimp.2012.05.007; Ting YT, 2018, J BIOL CHEM, V293, P3236, DOI 10.1074/jbc.RA117.001013; Turesson C, 2005, ARTHRITIS RES THER, V7, pR1386, DOI 10.1186/ar1837; van der Helm-van Mil AHM, 2006, ARTHRITIS RHEUM-US, V54, P1117, DOI 10.1002/art.21739; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P2113, DOI 10.1002/art.20316; von Delwig A, 2010, ARTHRITIS RHEUM-US, V62, P143, DOI 10.1002/art.25064; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, pR142, DOI 10.1186/ar1149; WINCHESTER R, 1992, RHEUM DIS CLIN N AM, V18, P761; WORDSWORTH BP, 1989, P NATL ACAD SCI USA, V86, P10049, DOI 10.1073/pnas.86.24.10049	60	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245541	10.1371/journal.pone.0245541	http://dx.doi.org/10.1371/journal.pone.0245541			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465118	gold, Green Published			2022-12-26	WOS:000611969200025
J	Mugiyo, H; Chimonyo, VGP; Sibanda, M; Kunz, R; Nhamo, L; Masemola, CR; Dalin, C; Modi, AT; Mabhaudhi, T				Mugiyo, Hillary; Chimonyo, Vimbayi G. P.; Sibanda, Mbulisi; Kunz, Richard; Nhamo, Luxon; Masemola, Cecelia R.; Dalin, Caroline; Modi, Albert T.; Mabhaudhi, Tafadzwa			Multi-criteria suitability analysis for neglected and underutilised crop species in South Africa	PLOS ONE			English	Article							LAND SUITABILITY; AQUACROP MODEL; FOOD; AGRICULTURE; GIS; FRAMEWORK; ART	Several neglected and underutilised species (NUS) provide solutions to climate change and creating a Zero Hunger world, the Sustainable Development Goal 2. Several NUS are drought and heat stress-tolerant, making them ideal for improving marginalised cropping systems in drought-prone areas. However, owing to their status as NUS, current crop suitability maps do not include them as part of the crop choices. This study aimed to develop land suitability maps for selected NUS [sorghum, (Sorghum bicolor), cowpea (Vigna unguiculata), amaranth and taro (Colocasia esculenta)] using Analytic Hierarchy Process (AHP) in ArcGIS. Multidisciplinary factors from climatic, soil and landscape, socio-economic and technical indicators overlaid using Weighted Overlay Analysis. Validation was done through field visits, and area under the curve (AUC) was used to measure AHP model performance. The results indicated that sorghum was highly suitable (S1) = 2%, moderately suitable (S2) = 61%, marginally suitable (S3) = 33%, and unsuitable (N1) = 4%, cowpea S1 = 3%, S2 = 56%, S3 = 39%, N1 = 2%, amaranth S1 = 8%, S2 = 81%, S3 = 11%, and taro S1 = 0.4%, S2 = 28%, S3 = 64%, N1 = 7%, of calculated arable land of SA (12 655 859 ha). Overall, the validation showed that the mapping exercises exhibited a high degree of accuracies (i.e. sorghum AUC = 0.87, cowpea AUC = 0.88, amaranth AUC = 0.95 and taro AUC = 0.82). Rainfall was the most critical variable and criteria with the highest impact on land suitability of the NUS. Results of this study suggest that South Africa has a huge potential for NUS production. The maps developed can contribute to evidence-based and site-specific recommendations for NUS and their mainstreaming. Also, the maps can be used to design appropriate production guidelines and to support existing policy frameworks which advocate for sustainable intensification of marginalised cropping systems through increased crop diversity and the use of stress-tolerant food crops.	[Mugiyo, Hillary; Chimonyo, Vimbayi G. P.; Sibanda, Mbulisi; Nhamo, Luxon; Masemola, Cecelia R.; Modi, Albert T.; Mabhaudhi, Tafadzwa] Univ KwaZulu Natal, Ctr Transformat Agr & Food Syst, Sch Agr Earth & Environm Sci, Pietermaritzburg, South Africa; [Kunz, Richard; Nhamo, Luxon; Mabhaudhi, Tafadzwa] Univ KwaZulu Natal, Ctr Water Resources Res, Sch Agr Earth & Environm Sci, Scottsville, South Africa; [Nhamo, Luxon] Water Res Commiss South Africa, Pretoria, South Africa; [Dalin, Caroline] UCL, Inst Sustainable Resources, London, England	University of Kwazulu Natal; University of Kwazulu Natal; University of London; University College London	Mugiyo, H (corresponding author), Univ KwaZulu Natal, Ctr Transformat Agr & Food Syst, Sch Agr Earth & Environm Sci, Pietermaritzburg, South Africa.	mugiyoh@gmail.com	Mabhaudhi, Tafadzwanashe/AAF-2418-2019; Nhamo, Luxon/H-4000-2019	Mabhaudhi, Tafadzwanashe/0000-0002-9323-8127; Nhamo, Luxon/0000-0003-2944-1769; Chimonyo, Vimbayi/0000-0001-9912-9848; Mugiyo, Hillary/0000-0002-2121-357X	Water Research Commission of South Africa through WRC Project [K5/2717//4]; Adaptation Fund; Wellcome Trust's Our Planet, Our Health Programme [205200/Z/16/Z]; SHEFS project; URP	Water Research Commission of South Africa through WRC Project; Adaptation Fund; Wellcome Trust's Our Planet, Our Health Programme; SHEFS project; URP	The authors would like to thank the Water Research Commission of South Africa for funding through WRC Project No. K5/2717//4 on "Developing a guideline for rainfed production of underutilised indigenous crops and estimating green water use of indigenous crops based on available models within selected bio-climatic regions of South Africa", the uMngeni Resilience Project (URP, funded by the Adaptation Fund) and the Sustainable and Healthy Food Systems (SHEFS) Programme, supported through the Wellcome Trust's Our Planet, Our Health Programme [grant number: 205200/Z/16/Z]. CD, ATM and TM are supported by the SHEFS project. VGPC, CM ATM and TM are supported by the URP.	Abrams L, 2018, UNLOCKING POTENTIAL; Akinci H, 2013, COMPUT ELECTRON AGR, V97, P71, DOI 10.1016/j.compag.2013.07.006; Akinola R, 2020, REV INDIGENOUS FOOD, P1; Akpoti K, 2019, AGR SYST, V173, P172, DOI 10.1016/j.agsy.2019.02.013; Alexander K, 2012, IJRRAS; [Anonymous], 2011, RESEARCHER; [Anonymous], 2015, INT J RES ENG TECHNO, V3, P2321; [Anonymous], 2007, LAND WATER DISCUSSIO; [Anonymous], 2013, U VERMONT HIST REV, VXXIV, P1; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Bagherzadeh A, 2016, MODEL EARTH SYST ENV, V2, DOI 10.1007/s40808-016-0152-4; Baldermann S, 2016, CRIT REV PLANT SCI, V35, P106, DOI 10.1080/07352689.2016.1201399; Benke KK, 2010, J SPAT SCI, V55, P257, DOI 10.1080/14498596.2010.521975; Boatemaa S, 2019, FOOD CONTROL, V104, P333, DOI 10.1016/j.foodcont.2019.05.009; Brandt P, 2017, AGR SYST, V151, P234, DOI 10.1016/j.agsy.2015.12.011; Ceballos-Silva A, 2003, AGR ECOSYST ENVIRON, V95, P371, DOI 10.1016/S0167-8809(02)00180-9; Chandio IA, 2013, ARAB J GEOSCI, V6, P3059, DOI 10.1007/s12517-012-0568-8; Chen Y, 2012, ENVIRON MODELL SOFTW, V38, P147, DOI 10.1016/j.envsoft.2012.05.010; Chibarabada TP, 2020, AGR FOREST METEOROL, V281, DOI 10.1016/j.agrformet.2019.107850; Chimonyo VGP, 2016, AGR WATER MANAGE, V177, P317, DOI 10.1016/j.agwat.2016.08.021; Chivenge P, 2015, INT J ENV RES PUB HE, V12, P5685, DOI 10.3390/ijerph120605685; Consoli S, 2014, AGR WATER MANAGE, V143, P71, DOI 10.1016/j.agwat.2014.06.012; Cools N, 2003, AGR ECOSYST ENVIRON, V95, P327, DOI 10.1016/S0167-8809(02)00045-2; de la Hey M, 2017, J S AFR STUD, V43, P753, DOI 10.1080/03057070.2016.1265336; Drimie S, 2016, ADV FOOD SECURITY SU; Duchemin B, 2006, AGR WATER MANAGE, V79, P1, DOI 10.1016/j.agwat.2005.02.013; Ebert AW, 2014, SUSTAINABILITY-BASEL, V6, P319, DOI 10.3390/su6010319; Escola A, 2017, PRECIS AGRIC, V18, P111, DOI 10.1007/s11119-016-9474-5; Feng QY, 2017, ENVIRON MODELL SOFTW, V93, P356, DOI 10.1016/j.envsoft.2017.03.027; Fontes MPF, 2009, LAND USE POLICY, V26, P589, DOI 10.1016/j.landusepol.2008.08.010; Gago J, 2015, AGR WATER MANAGE, V153, P9, DOI 10.1016/j.agwat.2015.01.020; Garrity DP, 2010, FOOD SECUR, V2, P197, DOI 10.1007/s12571-010-0070-7; Gregory PJ, 2019, PLANTA, V250, P979, DOI 10.1007/s00425-019-03179-2; Han MY, 2018, LAND USE POLICY, V70, P521, DOI 10.1016/j.landusepol.2017.07.022; Hardy M., 2011, RAINFED FARMING SYST, P395; Harvey M, 2010, FOOD POLICY, DOI [10.1016/j.foodpol.2010.06.004, DOI 10.1016/J.FOODPOL.2010.06.004]; IPCC, 2018, GLOB 1 5 C IPCC SPEC; Jelokhani-Niaraki M, 2015, CITIES, V45, P60, DOI 10.1016/j.cities.2015.03.007; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Kaim A, 2018, ENVIRON MODELL SOFTW, V105, P79, DOI 10.1016/j.envsoft.2018.03.031; Kazemi H, 2018, ECOL ENG, V116, P1, DOI 10.1016/j.ecoleng.2018.02.021; Kepe T, 2014, LAND USE POLICY, V36, P267, DOI 10.1016/j.landusepol.2013.08.013; Kim H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28291-3; Lin Y, 2015, COMPUT ELECTRON AGR, V119, P61, DOI 10.1016/j.compag.2015.10.011; Liu JG, 2010, REMOTE SENS ENVIRON, V114, P1167, DOI 10.1016/j.rse.2010.01.004; Lynch RES and SD, 2004, DICT GEOTECHNICAL EN, P848; Mabhaudhi T, 2013, AGR WATER MANAGE, V121, P102, DOI 10.1016/j.agwat.2013.01.009; Mabhaudhi T, 2019, PLANTA, V250, P695, DOI 10.1007/s00425-019-03129-y; Mabhaudhi T, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11010172; Mabhaudhi T, 2014, AGR FOREST METEOROL, V192, P132, DOI 10.1016/j.agrformet.2014.03.013; Mabhaudhi T, 2014, AGRON J, V106, P243, DOI 10.2134/agronj2013.0355; Macomber MM, 1984, WORLD GEODETIC SYSTE, V1984; Malczewski J, 2004, PROG PLANN, V62, P3, DOI 10.1016/j.progress.2003.09.002; Malczewski J, 2006, INT J APPL EARTH OBS, V8, P270, DOI 10.1016/j.jag.2006.01.003; Malczewski J, 2006, INT J GEOGR INF SCI, V20, P703, DOI 10.1080/13658810600661508; Massawe F, 2016, TRENDS PLANT SCI, V21, P365, DOI 10.1016/j.tplants.2016.02.006; Mendoza GA, 2006, FOREST ECOL MANAG, V230, P1, DOI 10.1016/j.foreco.2006.03.023; Modi A. T., 2003, Development Southern Africa, V20, P675, DOI 10.1080/0376835032000149306; Musakwa W, 2018, ENVIRON DEV SUSTAIN, V20, P2281, DOI 10.1007/s10668-017-9989-6; Nasrollahi N, 2017, ECOL INDIC, V72, P239, DOI 10.1016/j.ecolind.2016.08.026; National Planning Commission, 2012, INT INCL RUR EC, P217; Nyathi MK, 2018, AGR WATER MANAGE, V208, P107, DOI 10.1016/j.agwat.2018.06.012; Nzeyimana I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107449; R Core Team, 2021, R LANGUAGE ENV STAT; Rabia A. H., 2013, International Journal of Environmental Science and Development, V4, P1; Raihana ARN, 2015, INT J FOOD PROP, V18, P2380, DOI 10.1080/10942912.2014.980946; Ranjitkar S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163916; Reshmidevi TV, 2009, AGR SYST, V101, P101, DOI 10.1016/j.agsy.2009.04.001; Romano G, 2015, LAND USE POLICY, V48, P131, DOI 10.1016/j.landusepol.2015.05.013; Rosell JR, 2012, COMPUT ELECTRON AGR, V81, P124, DOI 10.1016/j.compag.2011.09.007; S BE, 2018, J CROHNS COLITIS, V12, pS049; Saaty R. W., 2016, DECISION MAKING COMP, V1; Saaty T, 1980, ANAL HIERARCHY PROCE; SAATY TL, 1990, EUR J OPER RES, V48, P9, DOI 10.1016/0377-2217(90)90057-I; Saaty TL., 1980, ANAL HIERARCHY PROCE; Schiefer J, 2016, AGR ECOSYST ENVIRON, V230, P283, DOI 10.1016/j.agee.2016.06.021; Schulze RE, 2002, S AFRICAN ATLAS CLIM; Senay SD, 2019, INSECTS, V10, DOI 10.3390/insects10030065; Shackleton CM, 2014, LAND USE POLICY, V36, P500, DOI 10.1016/j.landusepol.2013.10.002; Sharma R, 2018, COMPUT ELECTRON AGR, V155, P103, DOI 10.1016/j.compag.2018.10.001; Shumsky S, 2014, LAND USE POLICY, V38, P48, DOI 10.1016/j.landusepol.2013.10.014; Singh Rawat K, 2019, AGR WATER MANAGE, DOI [10.1016/j.agwat.2019.05.038, DOI 10.1016/J.AGWAT.2019.05.038]; Singha Chiranjit, 2016, Agricultural Science Digest, V37, P125, DOI 10.18805/ar.v37i2.10737; Smithers J, 2000, LONG DURATION DESIGN, V811; Statistics SA, 2018, OV POV IN S AFR ASS; Steduto P., 2012, CROP YIELD RESPONSE, DOI DOI 10.1016/J.ECOLMODEL.2004.06.005; Jeong JS, 2014, LAND USE POLICY, V41, P550, DOI 10.1016/j.landusepol.2014.04.012; Sun HY, 2017, AGR WATER MANAGE, V179, P324, DOI 10.1016/j.agwat.2016.08.002; Nguyen TT, 2015, AGR ECOSYST ENVIRON, V200, P1, DOI 10.1016/j.agee.2014.10.015; Thow AM, 2018, FOOD SECUR, V10, P1105, DOI 10.1007/s12571-018-0813-4; Tibesigwa B, 2017, ENVIRON DEV SUSTAIN, V19, P607, DOI 10.1007/s10668-015-9755-6; Tshabalala T, 2020, S AFR J BOT, V129, P161, DOI 10.1016/j.sajb.2019.04.010; Ugbaje SU, 2019, COMPUT ELECTRON AGR, V158, P51, DOI 10.1016/j.compag.2019.01.011; Waha K, 2013, GLOBAL ENVIRON CHANG, V23, P130, DOI 10.1016/j.gloenvcha.2012.11.001; Williams G, 2011, USE R, P3, DOI 10.1007/978-1-4419-9890-3; Wolfert S, 2017, AGR SYST, V153, P69, DOI 10.1016/j.agsy.2017.01.023; Yi XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069498; Zabel F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107522; Zabihi H, 2015, COMPUT ELECTRON AGR, V117, P114, DOI 10.1016/j.compag.2015.07.014; Ziadat FM, 2007, GEODERMA, V140, P73, DOI 10.1016/j.geoderma.2007.03.004	100	7	7	8	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0244734	10.1371/journal.pone.0244734	http://dx.doi.org/10.1371/journal.pone.0244734			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PY3TH	33465120	Green Published, gold			2022-12-26	WOS:000611969200023
J	Yousefinaghani, S; Dara, R; Poljak, Z; Song, F; Sharif, S				Yousefinaghani, Samira; Dara, Rozita; Poljak, Zvonimir; Song, Fei; Sharif, Shayan			A framework for the risk prediction of avian influenza occurrence: An Indonesian case study	PLOS ONE			English	Article							SUBTYPE H5N1; WILD BIRDS; VIRUS H5N1; POULTRY; PATTERN; SPREAD; SURVEILLANCE; PERFORMANCE; OUTBREAKS; GROWTH	Avian influenza viruses can cause economically devastating diseases in poultry and have the potential for zoonotic transmission. To mitigate the consequences of avian influenza, disease prediction systems have become increasingly important. In this study, we have proposed a framework for the prediction of the occurrence and spread of avian influenza events in a geographical area. The application of the proposed framework was examined in an Indonesian case study. An extensive list of historical data sources containing disease predictors and target variables was used to build spatiotemporal and transactional datasets. To combine disparate sources, data rows were scaled to a temporal scale of 1-week and a spatial scale of 1-degree x 1-degree cells. Given the constructed datasets, underlying patterns in the form of rules explaining the risk of occurrence and spread of avian influenza were discovered. The created rules were combined and ordered based on their importance and then stored in a knowledge base. The results suggested that the proposed framework could act as a tool to gain a broad understanding of the drivers of avian influenza epidemics and may facilitate the prediction of future disease events.	[Yousefinaghani, Samira; Dara, Rozita; Song, Fei] Univ Guelph, Sch Comp Sci, Guelph, ON, Canada; [Poljak, Zvonimir] Univ Guelph, Dept Populat Med, Ontario Vet Coll, Guelph, ON, Canada; [Sharif, Shayan] Univ Guelph, Dept Pathobiol, Guelph, ON, Canada	University of Guelph; University of Guelph; University of Guelph	Dara, R (corresponding author), Univ Guelph, Sch Comp Sci, Guelph, ON, Canada.	drozita@uoguelph.ca		Yousefinaghani, Samira/0000-0001-5805-4608	Egg Farmers of Canada; Chicken Farmers of Saskatchewan; Canadian Poultry Research Council; University of Guelph's Food from Thought initiative; Canada First Research Excellence Fund	Egg Farmers of Canada; Chicken Farmers of Saskatchewan; Canadian Poultry Research Council; University of Guelph's Food from Thought initiative; Canada First Research Excellence Fund	This work was funded by Egg Farmers of Canada, Chicken Farmers of Saskatchewan, and the Canadian Poultry Research Council. This research is supported in part by the University of Guelph's Food from Thought initiative, thanks to funding from the Canada First Research Excellence Fund.	Alkhamis M, 2016, AVIAN DIS, V60, P146, DOI 10.1637/11106-042115-Reg; [Anonymous], RAST 1 0 25; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Artois J, 2018, EMERG INFECT DIS, V24, P87, DOI 10.3201/eid2401.171393; Belkhiria J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190824; Belkhiria J, 2016, SCI REP-UK, V6, DOI 10.1038/srep33161; Benard C, 2019, SIRUS MAKING RANDOM; BirdLife, 2019, INT HDB BIRDS WORLD; Biswas PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098471; Bologna G, 2018, APPL COMPUT INTELL S, V2018, DOI 10.1155/2018/4084850; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Chiu DY, 2004, PROC INT CONF DATA, P375, DOI 10.1109/ICDE.2004.1320012; Darksky, DARK SKY API; Dhingra MS, 2016, ELIFE, V5, DOI 10.7554/eLife.19571; Dhingra MS, 2014, SPAT SPATIO-TEMPORAL, V11, P45, DOI 10.1016/j.sste.2014.06.003; Dizon FSV, 2019, ARXIV190111376; EMPRES-i, GLOB AN DIS INF SYST; Erraguntla M, 2010, P 43 HAW INT C SYST, P1; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; Feare CJ, 2010, AVIAN DIS, V54, P201, DOI 10.1637/8766-033109-ResNote.1; Fournie G, 2016, SCI REP-UK, V6, DOI 10.1038/srep29463; Frieman JH, 2008, ANN APPL STAT, V2, P916, DOI 10.1214/07-AOAS148; Gaidet N, 2010, J APPL ECOL, V47, P1147, DOI 10.1111/j.1365-2664.2010.01845.x; Ge E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029617; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Gilbert M, 2007, AGR ECOSYST ENVIRON, V119, P409, DOI 10.1016/j.agee.2006.09.001; Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116; Guerrini L, 2014, GEOSPATIAL HEALTH, V8, P445, DOI 10.4081/gh.2014.33; Haghighi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30828; Han JW, 2007, DATA MIN KNOWL DISC, V15, P55, DOI 10.1007/s10618-006-0059-1; He F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07475-3; Henning J, 2009, VET RES, V40, DOI 10.1051/vetres:2008053; Huysmans J., 2006, SSRN ELECT J, DOI [DOI 10.2139/SSRN.961358, 10.2139/ssrn.961358]; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Krawczyk B, 2016, PROG ARTIF INTELL, V5, P221, DOI 10.1007/s13748-016-0094-0; Lin Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23326-1; Lin Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0104195, 10.1371/journal.pone.0091095]; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loth L, 2010, PREV VET MED, V96, P104, DOI 10.1016/j.prevetmed.2010.05.013; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; Molnar C, 2020, LULU COM; Mu J. E., 2014, British Journal of Environment and Climate Change, V4, P166, DOI 10.9734/BJECC/2014/8888; Pavade G, 2011, REV SCI TECH OIE, V30, P661; Pei J, 2004, IEEE T KNOWL DATA EN, V16, P1424, DOI 10.1109/TKDE.2004.77; Peterson AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000261; Rodrigues LD, 2015, J MEDIEV IBER STUD, V7, P176, DOI 10.1080/17546559.2015.1016545; Said AM, 2009, INT J COMPUT SCI NET, V9, P266; Si YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053362; Si YL, 2010, ECOL SOC, V15, DOI 10.5751/es-03622-150326; Soliman A, 2012, J WILDLIFE DIS, V48, P669, DOI 10.7589/0090-3558-48.3.669; Stevens KB, 2013, SPAT SPATIO-TEMPORAL, V4, P1, DOI 10.1016/j.sste.2012.11.002; Sun LQ, 2018, PREV VET MED, V152, P32, DOI 10.1016/j.prevetmed.2018.02.008; Tian HY, 2015, ECOL MODEL, V306, P6, DOI 10.1016/j.ecolmodel.2014.08.005; Wang XX, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep42722; Ward MP, 2009, ZOONOSES PUBLIC HLTH, V56, P1, DOI 10.1111/j.1863-2378.2008.01150.x; Welte VR, 2004, ANN NY ACAD SCI, V1026, P19, DOI 10.1196/annals.1307.003; Wint G. R. W., 2007, GRIDDED LIVESTOCK WO, P131; WorldClim, GLOB CLIM DAT; Wu T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208197; Xu Z, 2017, BIOSYST ENG, V157, P109, DOI 10.1016/j.biosystemseng.2017.03.004; Young SG, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090886; Yupiana Y, 2010, INT J INFECT DIS, V14, pE800, DOI 10.1016/j.ijid.2010.03.014; 2018, CURR OPIN TOXICOL, V10	63	1	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245116	10.1371/journal.pone.0245116	http://dx.doi.org/10.1371/journal.pone.0245116			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449934	gold, Green Published			2022-12-26	WOS:000609991600043
J	Fernandez, JG; Vilches, IM; Rodriguez, AB; Torres, IC; Romay, EIC; Arata, IG; Aroca, JJ; Rodriguez, RL; Lacomba, DL; Cuadrado, LM; Esteban, LM; Garcia, LJM; Monzo, LM; Nieto-Borrajo, E; Delgado, MP; Menchero, SP; Hernandez, CS; Testillano, ES; Garcia-Martinez, J				Garralda Fernandez, Javier; Molero Vilches, Ignacio; Bermejo Rodriguez, Alfredo; Cano Torres, Isabel; Colino Romay, Elda Isabel; Garcia Arata, Isabel; Jaqueti Aroca, Jeronimo; Lillo Rodriguez, Rosa; Lopez Lacomba, Daniel; Mazon Cuadrado, Luis; Molina Esteban, Laura; Morales Garcia, Luis Javier; Moratilla Monzo, Laura; Nieto-Borrajo, Elva; Pacheco Delgado, Maria; Prieto Menchero, Santiago; Sanchez Hernandez, Cristina; Sanchez Testillano, Eva; Garcia-Martinez, Jesus			Impact of SARS-CoV-2 pandemic among health care workers in a secondary teaching hospital in Spain	PLOS ONE			English	Article							COVID-19	Background The COVID-19 pandemic has posed a huge challenge to healthcare systems and their personnel worldwide. The study of the impact of SARS-CoV-2 infection among healthcare workers (HCW), through prevalence studies, will let us know viral expansion, individuals at most risk and the most exposed areas in healthcare organizations. The aim of this study is to gauge the impact of SARS-CoV-2 pandemic in our hospital workforce and identify groups and areas at increased risk. Methods and findings This is a cross-sectional and incidence study carried out on healthcare workers based on molecular and serological diagnosis of SARS-CoV-2 infection. Of the 3013 HCW invited to participate, 2439 (80.9%) were recruited, including 674 (22.4%) who had previously consulted at the Occupational Health Service (OHS) for confirmed exposure and/or presenting symptoms suggestive of COVID-19. A total of 411 (16.9%) and 264 (10.8%) healthcare workers were SARS-CoV-2 IgG and rRT-PCR positive, respectively. The cumulative prevalence considering all studies (IgG positive HCW and/or rRT-PCR positive detection) was 485 (19.9%). SARS-CoV-2 IgG-positive patients in whom the virus was not detected were 221 (9.1%); up to 151 of them (68.3%) did not report any compatible symptoms nor consult at the OHS for this reason. Men became more infected than women (25% vs 18.5%, p = 0.0009), including when data were also classified by age. COVID-19 cumulative prevalence among the HCW assigned to medical departments was higher (25.2%) than others, as well as among medical staff (25.4%) compared with other professional categories (p<0.01). Conclusions The global impact of the COVID-19 pandemic on HCW of our centre has been 19.9%. Doctors and medical services personnel have had the highest prevalence of SARS-CoV-2 infection, but many of them have not presented compatible symptoms. This emphasizes the performance of continuous surveillance methods of the most exposed health personnel and not only based on the appearance of symptoms.	[Garralda Fernandez, Javier; Molero Vilches, Ignacio; Bermejo Rodriguez, Alfredo; Cano Torres, Isabel; Garcia Arata, Isabel; Jaqueti Aroca, Jeronimo; Lillo Rodriguez, Rosa; Lopez Lacomba, Daniel; Molina Esteban, Laura; Morales Garcia, Luis Javier; Nieto-Borrajo, Elva; Pacheco Delgado, Maria; Prieto Menchero, Santiago; Sanchez Hernandez, Cristina; Garcia-Martinez, Jesus] Hosp Univ Fuenlabrada, Lab Med, Fuenlabrada, Spain; [Bermejo Rodriguez, Alfredo; Moratilla Monzo, Laura] Univ Rey Juan Carlos, Fac Hlth Sci, Madrid, Spain; [Colino Romay, Elda Isabel; Mazon Cuadrado, Luis; Sanchez Testillano, Eva] Hosp Univ Fuenlabrada, Occupat Hlth Serv, Fuenlabrada, Spain; [Moratilla Monzo, Laura] Hosp Univ Fuenlabrada, Prevent Med Serv, Fuenlabrada, Spain; [Garcia-Martinez, Jesus] Univ Rey Juan Carlos, Escuela Int Doctorado, Madrid, Spain	Hospital Universitario Fuenlabrada; Universidad Rey Juan Carlos; Hospital Universitario Fuenlabrada; Hospital Universitario Fuenlabrada; Universidad Rey Juan Carlos	Garcia-Martinez, J (corresponding author), Hosp Univ Fuenlabrada, Lab Med, Fuenlabrada, Spain.	jgmartinez@salud.madrid.org		MORATILLA MONZO, LAURA/0000-0003-2213-0888; Molina, Laura/0000-0003-0277-909X; Garralda Fernandez, Javier/0000-0002-7627-9461; NIETO-BORRAJO, ELVA/0000-0002-0984-1485; Garcia-Martinez, Jesus/0000-0002-5843-451X				Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Black JRM, 2020, LANCET, V395, P1418, DOI 10.1016/S0140-6736(20)30917-X; Centro Nacional de Epidemiologia, ISCIII CNE RENAVE; Chen YX, 2020, J INFECTION, V81, P420, DOI 10.1016/j.jinf.2020.05.067; Conti P, 2020, J BIOL REG HOMEOS AG, V34, P327, DOI 10.23812/CONTI-E; Ehrlich H, 2020, AM J EMERG MED, V38, P1527, DOI 10.1016/j.ajem.2020.04.024; Evans S., 2020, MEDRXIV, DOI [10.1101/2020.05.12.20095562, DOI 10.1101/2020.05.12.20095562]; Felice C, 2020, J COMMUN HEALTH, V45, P675, DOI 10.1007/s10900-020-00845-5; Galan I, 2020, SARS COV 2 SEROPREVA, DOI [10.1101/2020.05.29.20116731, DOI 10.1101/2020.05.29.20116731]; Garcia-Basteiro AL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17318-x; Gargaglioni LH, 2020, J APPL PHYSIOL, V128, P1533, DOI 10.1152/japplphysiol.00335.2020; Giri B, 2021, ANAL BIOANAL CHEM, V413, P35, DOI 10.1007/s00216-020-02889-x; Ha JF, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13578; Heinzerling A, 2020, MMWR-MORBID MORTAL W, V69, P472, DOI 10.15585/mmwr.mm6915e5; Instituto Salud Carlos III, NAT STUD SARS COV2 S; Karlberg J, 2004, AM J EPIDEMIOL, V159, P229, DOI 10.1093/aje/kwh056; Korth J, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104437.; Kucirka LM, 2020, ANN INTERN MED, V173, P262, DOI 10.7326/M20-1495; Lai XQ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9666; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lippi G, 2020, CLIN CHEM LAB MED, V58, P1156, DOI 10.1515/cclm-2020-0473; Lorentzen Henrik Frank, 2020, Dan Med J, V67; Meng YF, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008520; Michelozzi P, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.19.2000620; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Paderno A, 2020, OTOLARYNG HEAD NECK, V163, P671, DOI 10.1177/0194599820932162; Padoan A, 2020, CLIN CHEM LAB MED, V58, P1081, DOI 10.1515/cclm-2020-0443; Picard A., 2020, GLOBE MAIL, DOI DOI 10.1352/1934-9556-58.6.486; Ren LL, 2020, CHINESE MED J-PEKING, V133, P1015, DOI 10.1097/CM9.0000000000000722; Rivett L, 2020, ELIFE, V9, DOI 10.7554/eLife.58728; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Servicio de Epidemiologia de la Comunidad de Madrid, INF EP SEM COM MADR, P23; Steensels D, 2020, JAMA-J AM MED ASSOC, V324, P195, DOI 10.1001/jama.2020.11160; The Lancet Hiv null, 2020, LANCET HIV, V7, pe75; Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748; Zhang ZR, 2020, FRONT MED-PRC, V14, P229, DOI 10.1007/s11684-020-0765-x; Zhou T, 2020, J EVID-BASED MED, V13, P3, DOI 10.1111/jebm.12376	37	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245001	10.1371/journal.pone.0245001	http://dx.doi.org/10.1371/journal.pone.0245001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444392	Green Submitted, gold, Green Published			2022-12-26	WOS:000609988100060
J	Kimprasit, T; Nunome, M; Iida, K; Murakami, Y; Wong, ML; Wu, CH; Kobayashi, R; Hengjan, Y; Takemae, H; Yonemitsu, K; Kuwata, R; Shimoda, H; Si, LF; Sohn, JH; Asakawa, S; Ichiyanagi, K; Maeda, K; Oh, HS; Mizutani, T; Kimura, J; Iida, A; Hondo, E				Kimprasit, Thachawech; Nunome, Mitsuo; Iida, Keisuke; Murakami, Yoshitaka; Wong, Min-Liang; Wu, Chung-Hsin; Kobayashi, Ryosuke; Hengjan, Yupadee; Takemae, Hitoshi; Yonemitsu, Kenzo; Kuwata, Ryusei; Shimoda, Hiroshi; Si, Lifan; Sohn, Joon-Hyuk; Asakawa, Susumu; Ichiyanagi, Kenji; Maeda, Ken; Oh, Hong-Shik; Mizutani, Tetsuya; Kimura, Junpei; Iida, Atsuo; Hondo, Eiichi			Dispersal history of Miniopterus fuliginosus bats and their associated viruses in east Asia	PLOS ONE			English	Article							DEGRADATION RATES; GENETIC DIVERSITY; DNA-DEGRADATION; FRUIT BATS; HOST; CORONAVIRUSES; EVOLUTIONARY; DYNAMICS; BEHAVIOR; HABITAT	In this study, we examined the role of the eastern bent-winged bat (Miniopterus fuliginosus) in the dispersion of bat adenovirus and bat alphacoronavirus in east Asia, considering their gene flows and divergence times (based on deep-sequencing data), using bat fecal guano samples. Bats in China moved to Jeju Island and/or Taiwan in the last 20,000 years via the Korean Peninsula and/or Japan. The phylogenies of host mitochondrial D-loop DNA was not significantly congruent with those of bat adenovirus (m(XY)(2) = 0.07, p = 0.08), and bat alphacoronavirus (m(XY)(2) = 0.48, p = 0.20). We estimate that the first divergence time of bats carrying bat adenovirus in five caves studied (designated as K1, K2, JJ, N2, and F3) occurred approximately 3.17 million years ago. In contrast, the first divergence time of bat adenovirus among bats in the 5 caves was estimated to be approximately 224.32 years ago. The first divergence time of bats in caves CH, JJ, WY, N2, F1, F2, and F3 harboring bat alphacoronavirus was estimated to be 1.59 million years ago. The first divergence time of bat alphacoronavirus among the 7 caves was estimated to be approximately 2,596.92 years ago. The origin of bat adenovirus remains unclear, whereas our findings suggest that bat alphacoronavirus originated in Japan. Surprisingly, bat adenovirus and bat alphacoronavirus appeared to diverge substantially over the last 100 years, even though our gene-flow data indicate that the eastern bent-winged bat serves as an important natural reservoir of both viruses.	[Kimprasit, Thachawech; Iida, Keisuke; Kobayashi, Ryosuke; Hengjan, Yupadee; Takemae, Hitoshi; Iida, Atsuo; Hondo, Eiichi] Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Morphol, Nagoya, Aichi, Japan; [Nunome, Mitsuo] Nagoya Univ, Grad Sch Bioagr Sci, Avian Biosci Res Ctr, Nagoya, Aichi, Japan; [Murakami, Yoshitaka] Toho Univ, Dept Med Stat, Tokyo, Japan; [Wong, Min-Liang] Natl Chung Hsing Univ, Dept Vet Med, Taichung, Taiwan; [Wu, Chung-Hsin] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Yonemitsu, Kenzo; Kuwata, Ryusei; Shimoda, Hiroshi; Maeda, Ken] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Microbiol, Yamaguchi, Japan; [Si, Lifan] Henan Univ Sci & Technol, Coll Anim Sci & Technol, Luoyang, Henan, Peoples R China; [Sohn, Joon-Hyuk; Kimura, Junpei] Seoul Natl Univ, Coll Vet Med, Lab Anat & Cell Biol, Seoul, South Korea; [Sohn, Joon-Hyuk; Kimura, Junpei] Seoul Natl Univ, Coll Vet Med, Res Inst Vet Sci, Seoul, South Korea; [Asakawa, Susumu] Nagoya Univ, Grad Sch Bioagr Sci, Lab Soil Biol & Chem, Nagoya, Aichi, Japan; [Ichiyanagi, Kenji] Nagoya Univ, Grad Sch Bioagr Sci, Lab Genome & Epigenome Dynam, Nagoya, Aichi, Japan; [Oh, Hong-Shik] Jeju Natl Univ, Inst Sci Educ, Jeju, South Korea; [Mizutani, Tetsuya] Tokyo Univ Agr & Technol, Res & Educ Ctr Prevent Global Infect Dis Anim, Tokyo, Japan	Nagoya University; Nagoya University; Toho University; National Chung Hsing University; National Taiwan Normal University; Yamaguchi University; Henan University of Science & Technology; Seoul National University (SNU); Seoul National University (SNU); Nagoya University; Nagoya University; Jeju National University; Tokyo University of Agriculture & Technology	Hondo, E (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Morphol, Nagoya, Aichi, Japan.	ehondo@agr.nagoya-u.ac.jp	Takemae, Hitoshi/AEP-5503-2022; Wu, Chung-Hsin/B-7176-2015; MIZUTANI, Tetsuya/G-1086-2013	Wu, Chung-Hsin/0000-0002-4470-2448; MIZUTANI, Tetsuya/0000-0003-2570-0452; IIDA, Atsuo/0000-0002-0138-5366; Maeda, Ken/0000-0002-3488-5439; Ichiyanagi, Kenji/0000-0002-6831-6525	e-ASIA Joint Research Program (Japan Agency for Medical Research and Development)	e-ASIA Joint Research Program (Japan Agency for Medical Research and Development)	e-ASIA Joint Research Program (Japan Agency for Medical Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; Allocati N, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.48; [Anonymous], 2005, EXOTIC DVM, V7, P31; Balbuena JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061048; Banerjee A, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010041; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Bintanja R, 2005, NATURE, V437, P125, DOI 10.1038/nature03975; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Cai P, 2006, ENVIRON SCI TECHNOL, V40, P2971, DOI 10.1021/es0522985; Chu DKW, 2006, J GEN VIROL, V87, P2461, DOI 10.1099/vir.0.82203-0; Demay SM, 2013, MOL ECOL RESOUR, V13, P654, DOI 10.1111/1755-0998.12104; Dovih P, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007733; Doysabas KCC, 2019, VIRUS RES, V259, P62, DOI 10.1016/j.virusres.2018.10.020; Duan SM, 2003, BIOMED ENVIRON SCI, V16, P246; Enchery F, 2017, INT REV IMMUNOL, V36, P108, DOI 10.1080/08830185.2016.1255883; Endo K, 2019, MAMMALIA, V83, P610, DOI 10.1515/mammalia-2018-0115; England LS, 1998, WORLD J MICROB BIOT, V14, P163, DOI 10.1023/A:1008865609698; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fan Y, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030210; GOUGH PM, 1983, AM J VET RES, V44, P2078; Grimmberger, 1997, BATS EUROPE N AM; Hackenbrack N, 2017, J VIROL, V91, DOI [10.1128/JVI.01504-16, 10.1128/jvi.01504-16]; Hase K, 2016, BEHAV PROCESS, V128, P126, DOI 10.1016/j.beproc.2016.04.017; He B, 2015, EMERG INFECT DIS, V21, P1675, DOI 10.3201/eid2109.150260; Hengjan Y, 2017, J VET MED SCI, V79, P1125, DOI 10.1292/jvms.16-0643; Hiryu S, 2018, J EXP BIOL, V221, P1; Hoffmann C, 2016, SCI REP-UK, V6, DOI 10.1038/srep37952; Hu SC, 2018, EMERG INFECT DIS, V24, P782, DOI 10.3201/eid2404.171696; Iida K, 2017, J VET MED SCI, V79, P1142, DOI 10.1292/jvms.17-0152; Itani M, 2011, ACTA MED OKAYAMA, V65, P299; Joffrin L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63799-7; Kobayashi T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37224-z; Kohl C, 2012, J VIROL, V86, P1888, DOI 10.1128/JVI.05974-11; Larizza A, 2002, J MOL EVOL, V54, P145, DOI 10.1007/s00239-001-0063-4; Li S, 2015, ECOL EVOL, V5, P1214, DOI 10.1002/ece3.1428; Li Y, 2010, J VIROL, V84, P3889, DOI 10.1128/JVI.02497-09; Lin YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127377; Liu T, 2016, PEERJ, V4, DOI 10.7717/peerj.2472; LORENZ MG, 1987, APPL ENVIRON MICROB, V53, P2948, DOI 10.1128/AEM.53.12.2948-2952.1987; Maeda K., 2009, B CTR NAT ENV ED NAR, V10, P31; Maeda K, 2008, EMERG INFECT DIS, V14, P347, DOI 10.3201/eid1402.070932; MANTEL N, 1967, CANCER RES, V27, P209; Matsuda Y, 2020, VET MED SCI, P1; Ogawa H, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120371; Oleksy R, 2015, GLOB ECOL CONSERV, V3, P678, DOI 10.1016/j.gecco.2015.02.012; Petit E, 1999, EVOLUTION, V53, P1247, DOI 10.1111/j.1558-5646.1999.tb04537.x; Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002; R Core Team, 2021, R LANGUAGE ENV STAT; Randhawa N, 2020, ONE HEALTH OUTLOOK, V2, DOI 10.1186/s42522-020-00020-9; Richter HV, 2008, J ZOOL, V275, P172, DOI 10.1111/j.1469-7998.2008.00425.x; Rodrigues L, 2008, J ZOOL, V274, P116, DOI 10.1111/j.1469-7998.2007.00361.x; Rodrigues L., 2005, NATURSCHUTZ BIOL VIE, V28, P1; Saeki K, 2009, MICROBES ENVIRON, V24, P175, DOI 10.1264/jsme2.ME09117; Shirato K, 2012, VIRUS GENES, V44, P40, DOI 10.1007/s11262-011-0661-1; Smith CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014696; Streicker DG, 2016, P NATL ACAD SCI USA, V113, P10926, DOI 10.1073/pnas.1606587113; Suzuki H, 2013, HEREDITY, V111, P375, DOI 10.1038/hdy.2013.60; Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036; Tsoleridis T, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030084; Lo VT, 2020, TRANSBOUND EMERG DIS, V67, P2839, DOI 10.1111/tbed.13653; Veith M, 2004, HEREDITY, V93, P342, DOI 10.1038/sj.hdy.6800509; Wang N, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040379; WILMER JW, 1994, P ROY SOC B-BIOL SCI, V257, P193, DOI 10.1098/rspb.1994.0115; Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11; Yassin A, 2010, MOL PHYLOGENET EVOL, V57, P509, DOI 10.1016/j.ympev.2010.08.020; Zeghbib S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52209-2	68	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0244006	10.1371/journal.pone.0244006	http://dx.doi.org/10.1371/journal.pone.0244006			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444317	Green Published, gold			2022-12-26	WOS:000609988100013
J	Mansoor, H; Khan, SA; Afghani, T; Assir, MZ; Ali, M; Khan, WA				Mansoor, Hassan; Khan, Saad Alam; Afghani, Tayyab; Assir, Muhammad Zaman; Ali, Mahmood; Khan, Wajid Ali			Utility of teleconsultation in accessing eye care in a developing country during COVID-19 pandemic	PLOS ONE			English	Article							TELE-OPHTHALMOLOGY; SMARTPHONE; TELEMEDICINE; EXPERIENCE; ACCURATE; PROMISE	Objective To evaluate the utility of teleconsultation in the provision of eye care services during the COVID-19 lockdown. Disparities in the consultation burden of sub-specialities and socio-demographic differences in teleconsultation utilization were also assessed. Methods Al-Shifa Trust Eye Hospital Rawalpindi began audio and video teleconsultation using broadband telecommunication services during the lockdown. Patients' and consultations' data gathered during the first three weeks after the commencement of this programme were compared with data from the four weeks prior to lockdown. The weekly consultation ratio and overall consultation burden of sub-specialities were measured. Chi-Square tests of association determined the relationship between different variables (socioeconomic status and consultation characteristics) and consultation modality (on-site vs online). Results In total, 17507 on-site consultations (4377/week) were conducted compared to 1431 teleconsultations (477/week), which maintained 10.89% of the weekly pre-lockdown eye care services. The post-lockdown teleconsultation programme saw a relatively higher percentage of service utility among female (47.09% vs 44.71%), younger-age (31.33 +/- 19.45 vs 41.25 +/- 23.32 years) and higher-socioeconomic-status (32.21% vs 0.30%) patients compared to pre-lockdown on-site consultations. The most common indication for teleconsultation was red-eye (16.70%). While cornea and glaucoma clinics maintained most of the pre-lockdown services (30.42% and 29% respectively), the highest dropout was seen in optometric and vitreoretinal services supporting only 5.54% and 8.28% of pre-lockdown services, respectively. Conclusion Digital initiatives could partially maintain eye care services during the lockdown. Focused strategies to improve teleconsultation utilization are required during the pandemic and beyond.	[Mansoor, Hassan; Khan, Saad Alam; Afghani, Tayyab; Ali, Mahmood; Khan, Wajid Ali] Al Shifa Trust Eye Hosp, Rawalpindi, Pakistan; [Assir, Muhammad Zaman] Univ Hlth Sci, Allama Iqbal Med Coll, Dept Med, Lahore, Pakistan	University of Health Science - Pakistan	Mansoor, H; Khan, WA (corresponding author), Al Shifa Trust Eye Hosp, Rawalpindi, Pakistan.	drwajidalikhan@yahoo.com; hassan-mansoor@hotmail.com		Mansoor, Hassan/0000-0002-7198-0582; Ali, Mahmood/0000-0003-0963-9014; Afghani, Tayyab/0000-0003-3350-0178				Ackerman MJ, 2010, TELEMED J E-HEALTH, V16, P93, DOI 10.1089/tmj.2009.0153; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2021, WORLD FACTBOOK; [Anonymous], 2020, CHEMCATCHEM, V12, pXXX; [Anonymous], 2014, NEUROL MED CHIR TO S, V54, P9; Anwar M, 2012, PUBLIC HEALTH, V126, P507, DOI 10.1016/j.puhe.2012.02.006; Astbury Nick, 2009, Community Eye Health, V22, P3; Ayatollahi Haleh, 2017, Open Med Inform J, V11, P20, DOI 10.2174/1874431101711010020; Bourdon H, 2020, J FR OPHTALMOL, V43, P577, DOI 10.1016/j.jfo.2020.05.005; Contreras CM, 2020, J GASTROINTEST SURG, V24, P1692, DOI 10.1007/s11605-020-04623-5; Cutler DM, 2020, JAMA-J AM MED ASSOC, V323, P2003, DOI 10.1001/jama.2020.7242; de Araujo AL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231034; Deshmukh AV, 2020, INDIAN J OPHTHALMOL, V68, P1387, DOI 10.4103/ijo.IJO_1675_20; Gerbutavicius R, 2021, OPHTHALMOLOGE, V118, P89, DOI 10.1007/s00347-020-01286-0; Greenhalgh T, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1182; Harris C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175011; Heaven D, 2019, NATURE, V566, P141, DOI 10.1038/d41586-019-00447-9; Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539; Hong Z, 2020, J MED INTERNET RES, V22, DOI 10.2196/19577; Hussain Rizwana, 2019, J Ayub Med Coll Abbottabad, V31, P201; Johnson CA, 2017, AM J OPHTHALMOL, V182, P147, DOI 10.1016/j.ajo.2017.08.007; Karthikeyan Siddharth Karuppasamy, 2019, Oman J Ophthalmol, V12, P73, DOI 10.4103/ojo.OJO_226_2018; Kemp MT, 2020, TRAUMA SURG ACUTE CA, V5, DOI 10.1136/tsaco-2020-000481; Khairat S, 2019, J AM MED INFORM ASSN, V26, P796, DOI 10.1093/jamia/ocz108; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Leite H, 2020, PUBLIC MONEY MANAGE, V40, P483, DOI 10.1080/09540962.2020.1748855; Loeb AE, 2020, J AM ACAD ORTHOP SUR, V28, pE469, DOI 10.5435/JAAOS-D-20-00380; Mann DM, 2020, J AM MED INFORM ASSN, V27, P1132, DOI 10.1093/jamia/ocaa072; Marsden J, 2000, J ADV NURS, V31, P401, DOI 10.1046/j.1365-2648.2000.01285.x; Matimba A, 2016, J TELEMED TELECARE, V22, P311, DOI 10.1177/1357633X15604083; Moazzami B, 2020, J CLIN VIROL, V126, DOI 10.1016/j.jcv.2020.104345; Mohammadpour M, 2017, INT J OPHTHALMOL-CHI, V10, P1909, DOI 10.18240/ijo.2017.12.19; Morse AR, 2014, OPHTHALMOLOGY, V121, P809, DOI 10.1016/j.ophtha.2013.10.033; Nagra M, 2020, CONTACT LENS ANTERIO, V43, P204, DOI 10.1016/j.clae.2020.04.002; Newton MJ, 2014, SURV OPHTHALMOL, V59, P559, DOI 10.1016/j.survophthal.2014.02.003; Ohannessian R, 2020, JMIR PUBLIC HLTH SUR, V6, P121, DOI 10.2196/18810; Olu O, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00341; Pathipati AS, 2016, GRAEF ARCH CLIN EXP, V254, P1175, DOI 10.1007/s00417-016-3291-4; Perera C, 2015, EYE, V29, P888, DOI 10.1038/eye.2015.60; Perkel JM, 2017, NATURE, V542, P125, DOI 10.1038/542125a; Portnoy J, 2020, J ALLER CL IMM-PRACT, V8, P1489, DOI 10.1016/j.jaip.2020.03.008; Prathiba Vijayaraghavan, 2011, Int J Family Med, V2011, P683267, DOI 10.1155/2011/683267; PTA, 2019, TEL IND; Rajalakshmi R, 2018, EYE, V32, P1138, DOI 10.1038/s41433-018-0064-9; Raju B, 2016, INDIAN J OPHTHALMOL, V64, P663, DOI 10.4103/0301-4738.194325; Rodin Alexander, 2017, JMIR Mhealth Uhealth, V5, pe84, DOI 10.2196/mhealth.7055; Rono HK, 2018, LANCET GLOB HEALTH, V6, pE924, DOI [10.1016/S2214-109X(18)30244-4, 10.1016/s2214-109x(18)30244-4]; Saedon H, 2020, OPHTHALMOL THER, V9, P401, DOI 10.1007/s40123-020-00262-w; Saleem SM, 2020, AM J OPHTHALMOL, V216, P237, DOI 10.1016/j.ajo.2020.04.029; Sarfraz Mariyam, 2015, J Ayub Med Coll Abbottabad, V27, P843; Sharma Luv K, 2009, Med Leg J, V77, P61; Shilo S, 2020, NAT MED, V26, P29, DOI 10.1038/s41591-019-0727-5; Sood S, 2007, TELEMED J E-HEALTH, V13, P573, DOI 10.1089/tmj.2006.0073; Sorkin N, 2016, OPTOMETRY VISION SCI, V93, P667, DOI 10.1097/OPX.0000000000000873; Sreelatha OK, 2016, CLIN OPHTHALMOL, V10, P285, DOI 10.2147/OPTH.S80487; Stenberg PL, 2018, EC INFORM B; Tang RA, 2005, J TELEMED TELECARE, V11, P391, DOI 10.1258/135763305775013509; Ting DSW, 2020, NAT MED, V26, P459, DOI 10.1038/s41591-020-0824-5; Tofigh S, 2015, EYE, V29, P1464, DOI 10.1038/eye.2015.138; Union IT, 2014, ICT FACTS FIG WORLD; Verma M, 2009, INDIAN J OPHTHALMOL, V57, P381, DOI 10.4103/0301-4738.55078; Wong JKW, 2021, GRAEF ARCH CLIN EXP, V259, P1663, DOI 10.1007/s00417-020-04753-1; World Bank, 2013, PAK DAT; Wu YD, 2010, IEEE T INF TECHNOL B, V14, P1259, DOI 10.1109/TITB.2010.2058124; Xu XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34603; Yeung WK, 2019, NPJ DIGIT MED, V2, DOI [10.1038/s41746-019-0154-5, 10.1038/s41746-019-0195-9]	66	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245343	10.1371/journal.pone.0245343	http://dx.doi.org/10.1371/journal.pone.0245343			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4VV	33444381	Green Published, gold			2022-12-26	WOS:000609988100080
J	Nishide, Y; Kageyama, D; Tanaka, Y; Yokoi, K; Jouraku, A; Futahashi, R; Fukatsu, T				Nishide, Yudai; Kageyama, Daisuke; Tanaka, Yoshiaki; Yokoi, Kakeru; Jouraku, Akiya; Futahashi, Ryo; Fukatsu, Takema			Effectiveness of orally-delivered double-stranded RNA on gene silencing in the stinkbug Plautia stali	PLOS ONE			English	Article							INTERFERENCE; KNOCKDOWN; DSRNA; PARALOGUES; PEST; BUG	Development of a reliable method for RNA interference (RNAi) by orally-delivered double-stranded RNA (dsRNA) is potentially promising for crop protection. Considering that RNAi efficiency considerably varies among different insect species, it is important to seek for the practical conditions under which dsRNA-mediated RNAi effectively works against each pest insect. Here we investigated RNAi efficiency in the brown-winged green stinkbug Plautia stali, which is notorious for infesting various fruits and crop plants. Microinjection of dsRNA into P. stali revealed high RNAi efficiency-injection of only 30 ng dsRNA into last-instar nymphs was sufficient to knockdown target genes as manifested by their phenotypes, and injection of 300 ng dsRNA suppressed the gene expression levels by 80% to 99.9%. Knockdown experiments by dsRNA injection showed that multicopper oxidase 2 (MCO2), vacuolar ATPase (vATPase), inhibitor of apoptosis (IAP), and vacuolar-sorting protein Snf7 are essential for survival of P. stali, as has been demonstrated in other insects. By contrast, P. stali exhibited very low RNAi efficiency when dsRNA was orally administered. When 1000 ng/mu L of dsRNA solution was orally provided to first-instar nymphs, no obvious phenotypes were observed. Consistent with this, RT-qPCR showed that the gene expression levels were not affected. A higher concentration of dsRNA (5000 ng/mu L) induced mortality in some cohorts, and the gene expression levels were reduced to nearly 50%. Simultaneous oral administration of dsRNA against potential RNAi blocker genes did not improve the RNAi efficiency of the target genes. In conclusion, P. stali shows high sensitivity to RNAi with injected dsRNA but, unlike the allied pest stinkbugs Halyomorpha halys and Nezara viridula, very low sensitivity to RNAi with orally-delivered dsRNA, which highlights the varied sensitivity to RNAi across different species and limits the applicability of the molecular tool for controlling this specific insect pest.	[Nishide, Yudai; Kageyama, Daisuke; Tanaka, Yoshiaki; Yokoi, Kakeru; Jouraku, Akiya] Natl Agr & Food Res Org NARO, Inst Agrobiol Sci Ohwashi, Tsukuba, Ibaraki, Japan; [Futahashi, Ryo; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Fukatsu, Takema] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo, Japan; [Fukatsu, Takema] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; University of Tsukuba	Nishide, Y (corresponding author), Natl Agr & Food Res Org NARO, Inst Agrobiol Sci Ohwashi, Tsukuba, Ibaraki, Japan.; Fukatsu, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan.; Fukatsu, T (corresponding author), Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo, Japan.; Fukatsu, T (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	nishiyu0@affrc.go.jp; t-fukatsu@aist.go.jp	Kageyama, Daisuke/B-4460-2010; Futahashi, Ryo/I-2825-2018	Kageyama, Daisuke/0000-0002-9026-9825; Futahashi, Ryo/0000-0003-4791-7054; Yokoi, Kakeru/0000-0002-6672-5341	JSPS KAKENHI [JP16K21613, JP19K06080]; JST ERATO [JPMJER1803, JPMJER1902]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST ERATO(Japan Science & Technology Agency (JST))	This study was supported by the JSPS KAKENHI Grant JP16K21613 and JP19K06080 to Y.N. and the JST ERATO grant JPMJER1803 and JPMJER1902 to T.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE Y, 1995, JPN J APPL ENTOMOL Z, V39, P109, DOI 10.1303/jjaez.39.109; Allen ML, 2012, J INSECT PHYSIOL, V58, P391, DOI 10.1016/j.jinsphys.2011.12.014; Bachman PM, 2016, REGUL TOXICOL PHARM, V81, P77, DOI 10.1016/j.yrtph.2016.08.001; Bansal R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152730; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; Christiaens O, 2014, CURR OPIN INSECT SCI, V6, P15, DOI 10.1016/j.cois.2014.09.012; Christiaens O, 2014, PEPTIDES, V53, P307, DOI 10.1016/j.peptides.2013.12.014; Dong XL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05971-0; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Galdeano DM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171847; Ghodke AB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47357-4; Ghosh SKB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171861; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Hayashi T, 2015, APPL ENVIRON MICROB, V81, P2603, DOI 10.1128/AEM.04057-14; He BC, 2013, ADV MATER, V25, P4580, DOI 10.1002/adma.201301201; Hosokawa T, 2016, ZOOL LETT, V2, DOI 10.1186/s40851-016-0061-4; Hosokawa T, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2015.11, 10.1038/NMICROBIOL.2015.11]; Joga MR, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00553; Khajuria C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197059; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Kunte N, 2020, PEST MANAG SCI, V76, P26, DOI 10.1002/ps.5588; Li HC, 2015, PLANT CELL ENVIRON, V38, P2277, DOI 10.1111/pce.12546; Li J, 2013, INSECT SCI, V20, P31, DOI [10.1111/j.1744-7917.2012.01558.x, 10.1111/j.1744-7917.2012.01550.x]; Li J, 2011, PEST MANAG SCI, V67, P852, DOI 10.1002/ps.2124; Luan JB, 2013, INSECT BIOCHEM MOLEC, V43, P740, DOI 10.1016/j.ibmb.2013.05.012; Luo YA, 2017, INSECT BIOCHEM MOLEC, V88, P21, DOI 10.1016/j.ibmb.2017.07.005; Miller SC, 2008, DEV GENES EVOL, V218, P505, DOI 10.1007/s00427-008-0238-8; Miller SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047431; Nishide Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60340-8; Nishide Y, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2207; Nishide Y, 2017, APPL ENTOMOL ZOOL, V52, P407, DOI 10.1007/s13355-017-0495-y; Oishi S, 2019, ZOOL LETT, V5, DOI 10.1186/s40851-019-0134-2; Okude G, 2017, APPL ENTOMOL ZOOL, V52, P379, DOI 10.1007/s13355-017-0489-9; Petrick JS, 2016, REGUL TOXICOL PHARM, V81, P57, DOI 10.1016/j.yrtph.2016.07.009; Schaefer CW., 2000, HETEROPTERA EC IMPOR, V1; Sharma R, 2021, PEST MANAG SCI, V77, P77, DOI 10.1002/ps.6017; Singh S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191116; Spit J, 2017, INSECT BIOCHEM MOLEC, V81, P103, DOI 10.1016/j.ibmb.2017.01.004; Sugahara R, 2017, INSECT MOL BIOL, V26, P332, DOI 10.1111/imb.12297; Sugahara R, 2016, J PESTIC SCI, V41, P44, DOI 10.1584/jpestics.D15-080; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Thairu MW, 2017, INSECT MOL BIOL, V26, P356, DOI 10.1111/imb.12301; Thakur N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087235; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Walker WB, 2011, ENTOMOL EXP APPL, V138, P83, DOI 10.1111/j.1570-7458.2010.01078.x; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wuriyanghan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066050; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Yu R, 2014, INT J BIOL SCI, V10, P1171, DOI 10.7150/ijbs.9598; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang J, 2017, TRENDS BIOTECHNOL, V35, P871, DOI 10.1016/j.tibtech.2017.04.009; Zhu F, 2011, PEST MANAG SCI, V67, P175, DOI 10.1002/ps.2048	54	2	2	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245081	10.1371/journal.pone.0245081	http://dx.doi.org/10.1371/journal.pone.0245081			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444324	Green Published, gold			2022-12-26	WOS:000609988100065
J	Cennamo, G; Montorio, D; Fossataro, F; Fossataro, C; Tranfa, F				Cennamo, Gilda; Montorio, Daniela; Fossataro, Federica; Fossataro, Claudia; Tranfa, Fausto			Evaluation of vessel density in disorganization of retinal inner layers after resolved diabetic macular edema using optical coherence tomography angiography	PLOS ONE			English	Article							VISUAL-ACUITY; ISCHEMIA; EYES	Purpose To evaluate the retinal vessel density (VD) in the macular region and the foveal avascular zone (FAZ) area using optical coherence tomography angiography (OCTA) in patients with and without disorganization of retinal inner layers (DRILs) after resolution of diabetic macular edema. Methods Thirty-seven eyes of 37 DRIL patients (mean age 63 +/- 13.97 years), 30 eyes of 30 no DRIL patients and 35 eyes of 35 controls were enrolled in this study. We evaluated the VD in the macular region of superficial capillary plexus (SCP), deep capillary plexus (DCP) and FAZ area. Results DRIL and no DRIL groups showed decreased VD in SCP and DCP (p<0.05) and a larger FAZ area (p<0.001) compared to controls. However, DRIL patients revealed a statistically significant reduction in VD of SCP (p = 0.041) and a greater FAZ area (p<0.001) with respect to no DRIL patients. We found a significant negative correlation between the VD of the foveal SCP (r = -0.414, p = 0.011), foveal DCP (r = -0.358, p = 0.025) and best corrected visual acuity (BCVA) in DRIL group. Moreover there was a significant positive correlation between the FAZ area (r = 0.425, p = 0.034) and BCVA. Therefore, in presence of DRILs lower VD values of SCP and DCP and a larger FAZ area correlated with a worse visual acuity. In no DRILs group, there was a significant negative correlation between the VD of the foveal DCP and BCVA. Conclusion OCTA highlights the role of retinal vascular ischemia in the pathogenesis of DRILs. This parameter could represent an important functional predictive factor in diabetic patients.	[Cennamo, Gilda] Univ Naples Federico II, Publ Hlth Dept, Eye Clin, Naples, Italy; [Montorio, Daniela; Fossataro, Federica; Fossataro, Claudia; Tranfa, Fausto] Univ Naples Federico II, Dept Neurosci Reprod Sci & Dent, Naples, Italy	University of Naples Federico II; University of Naples Federico II	Cennamo, G (corresponding author), Univ Naples Federico II, Publ Hlth Dept, Eye Clin, Naples, Italy.	xgilda@hotmail.com	Fossataro, Federica/AAU-9316-2021; Montorio, Daniela/AAJ-8687-2020	Fossataro, Federica/0000-0001-5798-1899; CENNAMO, Gilda/0000-0003-4253-1929				Agrawal R, 2016, EXPERT REV MED DEVIC, V13, P519, DOI 10.1080/17434440.2016.1186540; Babiuch AS, 2019, JAMA OPHTHALMOL, V137, P38, DOI 10.1001/jamaophthalmol.2018.4484; Balaratnasingam C, 2016, OPHTHALMOLOGY, V123, P2352, DOI 10.1016/j.ophtha.2016.07.008; Browning DJ, 2007, OPHTHALMOLOGY, V114, P525, DOI 10.1016/j.ophtha.2006.06.052; Cennamo G, 2020, PHOTODIAGN PHOTODYN, V30, DOI 10.1016/j.pdpdt.2020.101702; Cennamo G, 2019, OPHTHALMIC RES, V61, P19, DOI 10.1159/000492897; Chalam K V, 2016, J Ophthalmic Vis Res, V11, P84, DOI 10.4103/2008-322X.180709; Coscas G, 2016, JAMA OPHTHALMOL, V134, P373, DOI 10.1001/jamaophthalmol.2015.4821; Das R, 2018, JAMA OPHTHALMOL, V136, P202, DOI 10.1001/jamaophthalmol.2017.6256; Durbin MK, 2017, JAMA OPHTHALMOL, V135, P370, DOI 10.1001/jamaophthalmol.2017.0080; Huang D, 2016, DEV OPHTHALMOL, V56, P6, DOI 10.1159/000442770; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Kim AY, 2016, INVEST OPHTH VIS SCI, V57, pOCT362, DOI 10.1167/iovs.15-18904; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1464; Lavia C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219164; Mastropasqua L, 2019, INT J OPHTHALMOL-CHI, V12, P1589, DOI 10.18240/ijo.2019.10.11; Moein HR, 2018, RETINA-J RET VIT DIS, V38, P2277, DOI 10.1097/IAE.0000000000001902; Moss SE, 1998, OPHTHALMOLOGY, V105, P998, DOI 10.1016/S0161-6420(98)96025-0; Nesper PL, 2017, INVEST OPHTH VIS SCI, V58, P307, DOI 10.1167/iovs.17-21787; Nicholson L, 2015, CLIN EXP OPHTHALMOL, V43, P735, DOI 10.1111/ceo.12557; Onishi AC, 2019, RETINA-J RET VIT DIS, V39, P1588, DOI 10.1097/IAE.0000000000002179; Radwan SH, 2015, JAMA OPHTHALMOL, V133, P820, DOI 10.1001/jamaophthalmol.2015.0972; Sakata K, 2006, OPHTHALMOLOGY, V113, P1385, DOI 10.1016/j.ophtha.2006.04.023; Samara WA, 2016, AM J OPHTHALMOL, V166, P76, DOI 10.1016/j.ajo.2016.03.033; Sim DA, 2013, INVEST OPHTH VIS SCI, V54, P2353, DOI 10.1167/iovs.12-11103; Spaide RF, 2018, PROG RETIN EYE RES, V64, P1, DOI 10.1016/j.preteyeres.2017.11.003; Sun JK, 2015, DIABETES, V64, P2560, DOI 10.2337/db14-0782; Sun JK, 2014, JAMA OPHTHALMOL, V132, P1309, DOI 10.1001/jamaophthalmol.2014.2350	28	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0244789	10.1371/journal.pone.0244789	http://dx.doi.org/10.1371/journal.pone.0244789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434213	gold, Green Published			2022-12-26	WOS:000609979700036
J	Li, YL; Wen, WL; Guo, XY; Yu, ZT; Gu, SH; Yan, HP; Zhao, CJ				Li, Yinglun; Wen, Weiliang; Guo, Xinyu; Yu, Zetao; Gu, Shenghao; Yan, Haipeng; Zhao, Chunjiang			High-throughput phenotyping analysis of maize at the seedling stage using end-to-end segmentation network	PLOS ONE			English	Article							PLANT; RECOGNITION; PRECISION; EXTRACTION; PHENOMICS; IMAGES; CROP	Image processing technologies are available for high-throughput acquisition and analysis of phenotypes for crop populations, which is of great significance for crop growth monitoring, evaluation of seedling condition, and cultivation management. However, existing methods rely on empirical segmentation thresholds, thus can have insufficient accuracy of extracted phenotypes. Taking maize as an example crop, we propose a phenotype extraction approach from top-view images at the seedling stage. An end-to-end segmentation network, named PlantU-net, which uses a small amount of training data, was explored to realize automatic segmentation of top-view images of a maize population at the seedling stage. Morphological and color related phenotypes were automatic extracted, including maize shoot coverage, circumscribed radius, aspect ratio, and plant azimuth plane angle. The results show that the approach can segment the shoots at the seedling stage from top-view images, obtained either from the UAV or tractor-based high-throughput phenotyping platform. The average segmentation accuracy, recall rate, and F1 score are 0.96, 0.98, and 0.97, respectively. The extracted phenotypes, including maize shoot coverage, circumscribed radius, aspect ratio, and plant azimuth plane angle, are highly correlated with manual measurements (R-2 = 0.96-0.99). This approach requires less training data and thus has better expansibility. It provides practical means for high-throughput phenotyping analysis of early growth stage crop populations.	[Li, Yinglun; Zhao, Chunjiang] Jilin Agr Univ, Coll Resources & Environm, Changchun, Peoples R China; [Li, Yinglun; Wen, Weiliang; Guo, Xinyu; Gu, Shenghao; Zhao, Chunjiang] Beijing Res Ctr Informat Technol Agr, Beijing, Peoples R China; [Wen, Weiliang; Guo, Xinyu; Yu, Zetao; Gu, Shenghao; Zhao, Chunjiang] Natl Engn Res Ctr Informat Technol Agr, Beijing Key Lab Digital Plant, Beijing, Peoples R China; [Yan, Haipeng] Beijing Shunxin Agr Sci & Technol Co Ltd, Beijing, Peoples R China	Jilin Agricultural University; Beijing Academy of Agriculture & Forestry	Zhao, CJ (corresponding author), Jilin Agr Univ, Coll Resources & Environm, Changchun, Peoples R China.; Wen, WL; Zhao, CJ (corresponding author), Beijing Res Ctr Informat Technol Agr, Beijing, Peoples R China.; Wen, WL; Zhao, CJ (corresponding author), Natl Engn Res Ctr Informat Technol Agr, Beijing Key Lab Digital Plant, Beijing, Peoples R China.	wlwen37@163.com; zhaocj@nercita.org.cn		Weiliang, Wen/0000-0001-7184-5121	Construction of Collaborative Innovation Center of Beijing Academy of Agricultural and Forestry Sciences [KJCX201917]; National Natural Science Foundation of China [31871519, 32071891]; Reform and Development Project of Beijing Academy of agricultural and Forestry Sciences, China Agriculture Research System [CARS-02, PT2020-24]; Beijing Shunxin Agricultural Science and Technology Co., Ltd.	Construction of Collaborative Innovation Center of Beijing Academy of Agricultural and Forestry Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Reform and Development Project of Beijing Academy of agricultural and Forestry Sciences, China Agriculture Research System; Beijing Shunxin Agricultural Science and Technology Co., Ltd.	This work was supported by Construction of Collaborative Innovation Center of Beijing Academy of Agricultural and Forestry Sciences (KJCX201917), the National Natural Science Foundation of China (31871519, 32071891), Reform and Development Project of Beijing Academy of agricultural and Forestry Sciences, China Agriculture Research System (CARS-02), and the Construction of Scientific Research and Innovation Platform in Beijing Academy of Agriculture and Forestry Sciences (PT2020-24). HY is a paid employee of Beijing Shunxin Agricultural Science and Technology Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenya G, 2013, IEEE ROBOT AUTOM MAG, V20, P50, DOI 10.1109/MRA.2012.2230118; Andrade-Sanchez P, 2014, FUNCT PLANT BIOL, V41, P68, DOI 10.1071/FP13126; Barbedo JGA, 2019, BIOSYST ENG, V180, P96, DOI 10.1016/j.biosystemseng.2019.02.002; Barth R, 2019, COMPUT ELECTRON AGR, V161, P291, DOI 10.1016/j.compag.2017.11.040; Berry JC, 2018, PEERJ, V6, DOI 10.7717/peerj.5727; Chen GF, 2012, SENSOR LETT, V10, P433, DOI 10.1166/sl.2012.1882; Choudhury SD, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00508; Cinat P, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11091023; Dmitry K, 2019, IEEE CVF C COMP VIS; Dobos O, 2019, DEEP LEARNING BASED; Gao LW, 2019, COMPUT ELECTRON AGR, V164, DOI 10.1016/j.compag.2019.104924; Gehan MA, 2017, PEERJ, V5, DOI 10.7717/peerj.4088; Gevaert CM, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8121025; Goclawski J, 2012, INT J AP MAT COM-POL, V22, P669, DOI 10.2478/v10006-012-0050-5; Goutte C, 2005, LECT NOTES COMPUT SC, V3408, P345; Hamuda E, 2016, COMPUT ELECTRON AGR, V125, P184, DOI 10.1016/j.compag.2016.04.024; Holman FH, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8121031; Janssens O, P EUR SIGN PROC C EU; Kumar J. P., 2019, Information Processing in Agriculture, V6, P233; Kumar JP, 2018, J INF SCI ENG, V34, P671, DOI 10.6688/JISE.2018.34.3.6; Lee U, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196615; Li YA, 2017, J ELECTRON IMAGING, V26, DOI 10.1117/1.JEI.26.5.053028; Lievre M, 2013, WIRES DEV BIOL, V2, P809, DOI 10.1002/wdev.119; Lin K, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00155; Lu H, 2016, BIOSYST ENG, V147, P139, DOI 10.1016/j.biosystemseng.2016.04.007; Ma JC, 2018, COMPUT ELECTRON AGR, V154, P18, DOI 10.1016/j.compag.2018.08.048; Ma X, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215676; Mahlein AK, 2016, PLANT DIS, V100, P241, DOI 10.1094/PDIS-03-15-0340-FE; Mochida K, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giy153; Kumar JP, 2020, MACH VISION APPL, V31, DOI 10.1007/s00138-019-01056-2; Primicerio J, 2012, PRECIS AGRIC, V13, P517, DOI 10.1007/s11119-012-9257-6; Richard CAI, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0055-9; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Salma S, 2019, DATA AUGMENTATION RG; Scharr H, 2016, MACH VISION APPL, V27, P585, DOI 10.1007/s00138-015-0737-3; Sekulska-Nalewajko J, 2016, METHODS, V109, P114, DOI 10.1016/j.ymeth.2016.05.018; Nguyen TTN, 2018, COMPUT ELECTRON AGR, V155, P412, DOI 10.1016/j.compag.2018.10.042; Velumani K., 2017, ISPRS ANN PHOTOGRAMM, VIV, P149; Wang G, 2017, COMPUT INTEL NEUROSC, V2017, DOI 10.1155/2017/2917536; Wang Y, 2018, PEERJ, V6, DOI 10.7717/peerj.5036; Ward D., 2019, BR MACH VIS C 2018 B; Wen WL, 2019, AGR FOREST METEOROL, V276, DOI 10.1016/j.agrformet.2019.05.025; Wen WeiLiang, 2018, Scientia Agricultura Sinica, V51, P1034; Wen WeiLiang, 2018, Transactions of the Chinese Society of Agricultural Engineering, V34, P192; White JW, 2012, FIELD CROP RES, V133, P101, DOI 10.1016/j.fcr.2012.04.003; Wu Q, 2015, SPECTROSC SPECT ANAL, V35, P178, DOI 10.3964/j.issn.1000-0593(2015)01-0178-06; Yang WN, 2020, MOL PLANT, V13, P187, DOI 10.1016/j.molp.2020.01.008; Yang WN, 2015, J EXP BOT, V66, P5605, DOI 10.1093/jxb/erv100; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7; Yin X, 2018, IEEE T PATTERN ANAL, V40, P1411, DOI 10.1109/TPAMI.2017.2728065; Zhang SW, 2019, NEURAL COMPUT APPL, V31, P1225, DOI 10.1007/s00521-017-3067-8; Zhao CJ, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00714; Zheng YY, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19051058; Zhou CQ, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9112389; Zhou CQ, 2018, IEEE T GEOSCI REMOTE, V56, P4618, DOI 10.1109/TGRS.2018.2830823	55	7	7	11	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0241528	10.1371/journal.pone.0241528	http://dx.doi.org/10.1371/journal.pone.0241528			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434222	Green Submitted, gold, Green Published			2022-12-26	WOS:000609979700024
J	Ide, K; Asami, T; Suda, A; Yoshimi, A; Fujita, J; Nomoto, M; Roppongi, T; Hino, K; Takahashi, Y; Watanabe, K; Shimada, T; Hamasaki, T; Endo, E; Kaneko, T; Suzuki, M; Kubota, K; Saigusa, Y; Kato, H; Odawara, T; Nakajima, H; Takeuchi, I; Goto, T; Aihara, M; Hishimoto, A				Ide, Keiko; Asami, Takeshi; Suda, Akira; Yoshimi, Asuka; Fujita, Junichi; Nomoto, Munetaka; Roppongi, Tomohide; Hino, Kousuke; Takahashi, Yuichi; Watanabe, Kaori; Shimada, Tomoko; Hamasaki, Toyoko; Endo, Emi; Kaneko, Tomoko; Suzuki, Michiko; Kubota, Kazumi; Saigusa, Yusuke; Kato, Hideaki; Odawara, Toshinari; Nakajima, Hideaki; Takeuchi, Ichiro; Goto, Takahisa; Aihara, Michiko; Hishimoto, Akitoyo			The psychological effects of COVID-19 on hospital workers at the beginning of the outbreak with a large disease cluster on the Diamond Princess cruise ship	PLOS ONE			English	Article							ACUTE-RESPIRATORY-SYNDROME; HEALTH-CARE WORKERS; 2003 SARS OUTBREAK; MENTAL-HEALTH; IMPACT; STRESS; QUESTIONNAIRE; NURSES; JAPAN; RISK	The aim of the present study was to investigate the psychological effects of the COVID-19 outbreak and associated factors on hospital workers at the beginning of the outbreak with a large disease cluster on the Diamond Princess cruise ship. This cross-sectional, survey-based study collected demographic data, mental health measurements, and stress-related questionnaires from workers in 2 hospitals in Yokohama, Japan, from March 23, 2020, to April 6, 2020. The prevalence rates of general psychological distress and event-related distress were assessed using the 12-item General Health Questionnaire (GHQ-12) and the 22-item Impact of Event Scale-Revised (IES-R), respectively. Exploratory factor analysis was conducted on the 26-item stress-related questionnaires. Multivariable logistic regression analysis was performed to identify factors associated with mental health outcomes for workers both at high-and low-risk for infection of COVID-19. A questionnaire was distributed to 4133 hospital workers, and 2697 (65.3%) valid questionnaires were used for analyses. Overall, 536 (20.0%) were high-risk workers, 944 (35.0%) of all hospital workers showed general distress, and 189 (7.0%) demonstrated event-related distress. Multivariable logistic regression analyses revealed that 'Feeling of being isolated and discriminated' was associated with both the general and event-related distress for both the high- and low-risk workers. In this survey, not only high-risk workers but also low-risk workers in the hospitals admitting COVID-19 patients reported experiencing psychological distress at the beginning of the outbreak.	[Ide, Keiko; Asami, Takeshi; Suda, Akira; Yoshimi, Asuka; Hishimoto, Akitoyo] Yokohama City Univ Med, Dept Psychiat, Yokohama, Kanagawa, Japan; [Ide, Keiko; Asami, Takeshi; Suda, Akira; Yoshimi, Asuka; Fujita, Junichi; Nomoto, Munetaka; Roppongi, Tomohide; Hino, Kousuke; Takahashi, Yuichi; Hishimoto, Akitoyo] Yokohama City Univ, Dept Psychiat, Sch Med, Yokohama, Kanagawa, Japan; [Ide, Keiko] Yokohama City Univ Med, Hlth Management Off, Yokohama, Kanagawa, Japan; [Fujita, Junichi] Yokohama City Univ Med, Dept Child Psychiat, Yokohama, Kanagawa, Japan; [Nomoto, Munetaka; Roppongi, Tomohide] Yokohama City Univ, Psychiat Ctr, Med Ctr, Yokohama, Kanagawa, Japan; [Hino, Kousuke; Takeuchi, Ichiro] Yokohama City Univ, Adv Emergency Med Serv Ctr, Med Ctr, Yokohama, Kanagawa, Japan; [Takahashi, Yuichi] Yokohama East Area Habilitat Ctr Children, Yokohama, Kanagawa, Japan; [Watanabe, Kaori] Yokohama City Univ Med, Nursing Dept, Yokohama, Kanagawa, Japan; [Shimada, Tomoko; Hamasaki, Toyoko] Yokohama City Univ Med, Patient Care & Safety Management Dept, Yokohama, Kanagawa, Japan; [Endo, Emi; Kaneko, Tomoko; Suzuki, Michiko] Yokohama City Univ, Nursing Dept, Med Ctr, Yokohama, Kanagawa, Japan; [Kubota, Kazumi; Saigusa, Yusuke] Yokohama City Univ, Dept Biostat, Grad Sch Med, Yokohama, Kanagawa, Japan; [Kato, Hideaki] Yokohama City Univ Med, Infect Prevent & Control Dept, Yokohama, Kanagawa, Japan; [Kato, Hideaki; Nakajima, Hideaki] Yokohama City Univ, Dept Hematol & Clin Immunol, Sch Med, Yokohama, Kanagawa, Japan; [Odawara, Toshinari] Yokohama City Univ, Hlth Management Ctr, Yokohama, Kanagawa, Japan; [Takeuchi, Ichiro] Yokohama City Univ Med, Adv Crit Care Med, Yokohama, Kanagawa, Japan; [Goto, Takahisa] Yokohama City Univ, Dept Anesthesiol & Crit Care Med, Grad Sch Med, Yokohama, Kanagawa, Japan; [Aihara, Michiko] Yokohama City Univ, Dept Environm Immunodermatol, Grad Sch Med, Yokohama, Kanagawa, Japan	Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University	Asami, T; Hishimoto, A (corresponding author), Yokohama City Univ Med, Dept Psychiat, Yokohama, Kanagawa, Japan.; Asami, T; Hishimoto, A (corresponding author), Yokohama City Univ, Dept Psychiat, Sch Med, Yokohama, Kanagawa, Japan.	t_asami@yokohama-cu.ac.jp; hishipon@yokohama-cu.ac.jp	kubota, kazumi/AFS-2460-2022		JSPS KAKENHI [17H04249, 17K10313]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from JSPS KAKENHI Grant-in-Aid for Scientific Research (B) 17H04249 (A.H.), and Grant-in-Aid for Scientific Research (C) 17K10313(T.A.) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Brooks SK, 2018, J OCCUP ENVIRON MED, V60, P248, DOI 10.1097/JOM.0000000000001235; Bukhari EE, 2016, J INFECT DEV COUNTR, V10, P845, DOI 10.3855/jidc.6925; Chan AOM, 2004, OCCUP MED-OXFORD, V54, P190, DOI 10.1093/occmed/kqh027; Doi Y, 2003, PSYCHIAT CLIN NEUROS, V57, P379, DOI 10.1046/j.1440-1819.2003.01135.x; FONTANA A, 1994, J NERV MENT DIS, V182, P677, DOI 10.1097/00005053-199412000-00001; Gao JL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231924; Garcia-Fernandez L, 2022, PSYCHOL MED, V52, P195, DOI 10.1017/S0033291720002019; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Goldberg DP, 1998, PSYCHOL MED, V28, P915, DOI 10.1017/S0033291798006874; Hamer M, 2010, AM J PREV MED, V38, P375, DOI 10.1016/j.amepre.2009.12.030; Hori D, 2016, ENVIRON HEALTH PREV, V21, P410, DOI 10.1007/s12199-016-0541-3; Ikeda A, 2017, PSYCHOL MED, V47, P1936, DOI 10.1017/S0033291717000320; Imai H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-672; Jung SJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213441; Kato H, 2020, J INFECT CHEMOTHER, V26, P865, DOI 10.1016/j.jiac.2020.05.005; Kisely S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1642; Koh D, 2005, MED CARE, V43, P676, DOI 10.1097/01.mlr.0000167181.36730.cc; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lee SM, 2018, COMPR PSYCHIAT, V87, P123, DOI 10.1016/j.comppsych.2018.10.003; Lee Y, 2020, PSYCHIAT CLIN NEUROS, V74, P552, DOI 10.1111/pcn.13101; Lu W, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112936; Marston BJ, 2020, MMWR MORB MORTAL WKL, DOI [10.15585/mmwr.mm6912-3, DOI 10.15585/MMWR.MM6912-3]; Matsuishi K, 2012, PSYCHIAT CLIN NEUROS, V66, P353, DOI 10.1111/j.1440-1819.2012.02336.x; Maunder R, 2004, PHILOS T R SOC B, V359, P1117, DOI 10.1098/rstb.2004.1483; Maunder R, 2003, CAN MED ASSOC J, V168, P1245; Maunder RG, 2004, PSYCHOSOM MED, V66, P938, DOI 10.1097/01.psy.0000145673.84698.18; Nickell LA, 2004, CAN MED ASSOC J, V170, P793, DOI 10.1503/cmaj.1031077; Phua DH, 2005, ACAD EMERG MED, V12, P322, DOI 10.1197/j.aem.2004.11.015; REIDY G, 2020, IS IT JAPAN TIM 0320; Rossi R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10185; Sasaki N, 2020, PSYCHIAT CLIN NEUROS, V74, P501, DOI 10.1111/pcn.13095; Shigemura J, 2020, PSYCHIAT CLIN NEUROS, V74, P281, DOI 10.1111/pcn.12988; Shigemura J, 2012, JAMA-J AM MED ASSOC, V308, P667, DOI 10.1001/jama.2012.9699; Takeuchi I, 2020, ACUTE MED SURG, V7, DOI 10.1002/ams2.506; Tam CWC, 2004, PSYCHOL MED, V34, P1197, DOI 10.1017/S0033291704002247; Weiss D MC, 1997, IMPACT EVENT SCALE R	37	7	7	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0245294	10.1371/journal.pone.0245294	http://dx.doi.org/10.1371/journal.pone.0245294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY4UJ	33428676	gold, Green Published			2022-12-26	WOS:000630036100054
J	Linstrom, MA; Preiser, W; Nkosi, NN; Vreede, HW; Korsman, SNJ; Zemlin, AE; van Zyl, GU				Linstrom, Michael A.; Preiser, Wolfgang; Nkosi, Nokwazi N.; Vreede, Helena W.; Korsman, Stephen N. J.; Zemlin, Annalise E.; van Zyl, Gert U.			HIV false positive screening serology due to sample contamination reduced by a dedicated sample and platform in a high prevalence environment	PLOS ONE			English	Article								Automated testing of HIV serology on clinical chemistry analysers has become common. High sample throughput, high HIV prevalence and instrument design could all contribute to sample cross-contamination by microscopic droplet carry-over from seropositive samples to seronegative samples resulting in false positive low-reactive results. Following installation of an automated shared platform at our public health laboratory, we noted an increase in low reactive and false positive results. Subsequently, we investigated HIV serology screening test results for a period of 21 months. Of 485 initially low positive or equivocal samples 411 (85%) tested negative when retested using an independently collected sample. As creatinine is commonly requested with HIV screening, we used it as a proxy for concomitant clinical chemistry testing, indicating that a sample had likely been tested on a shared high-throughput instrument. The contamination risk was stratified between samples passing the clinical chemistry module first versus samples bypassing it. The odds ratio for a false positive HIV serology result was 4.1 (95% CI: 1.69-9.97) when creatinine level was determined first, versus not, on the same sample, suggesting contamination on the chemistry analyser. We subsequently issued a notice to obtain dedicated samples for HIV serology and added a suffix to the specimen identifier which restricted testing to a dedicated instrument. Low positive and false positive rates were determined before and after these interventions. Based on measured rates in low positive samples we estimate that before the intervention, of 44 117 HIV screening serology samples, 753 (1.71%) were false positive, declining to 48 of 7 072 samples (0.68%) post-intervention (p<0.01). Our findings showed that automated high throughput shared diagnostic platforms are at risk of generating false-positive HIV test results, due to sample contamination and that measures are required to address this. Restricting HIV serology samples to a dedicated platform resolved this problem.	[Linstrom, Michael A.; Preiser, Wolfgang; Nkosi, Nokwazi N.; Zemlin, Annalise E.; van Zyl, Gert U.] Tygerberg Hosp, Natl Hlth Lab Serv, Cape Town, South Africa; [Linstrom, Michael A.; Preiser, Wolfgang; Nkosi, Nokwazi N.; van Zyl, Gert U.] Univ Stellenbosch, Dept Pathol, Div Med Virol, Cape Town, South Africa; [Vreede, Helena W.; Korsman, Stephen N. J.] Groote Schuur Hosp, Natl Hlth Lab Serv, Cape Town, South Africa; [Vreede, Helena W.] Univ Cape Town, Dept Pathol, Div Chem Pathol, Cape Town, South Africa; [Korsman, Stephen N. J.] Univ Cape Town, Dept Pathol, Div Med Virol, Cape Town, South Africa; [Zemlin, Annalise E.] Univ Stellenbosch, Dept Pathol, Div Chem Pathol, Cape Town, South Africa	Tygerberg Hospital; Stellenbosch University; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; Stellenbosch University; University of Cape Town	Linstrom, MA (corresponding author), Tygerberg Hosp, Natl Hlth Lab Serv, Cape Town, South Africa.; Linstrom, MA (corresponding author), Univ Stellenbosch, Dept Pathol, Div Med Virol, Cape Town, South Africa.	michael.linstrom@nhls.ac.za	Preiser, Wolfgang/J-4875-2016	Preiser, Wolfgang/0000-0002-0254-7910; Linstrom, Michael/0000-0002-7509-1010; Zemlin, AE/0000-0001-7621-4679; Korsman, Stephen/0000-0002-1667-4363				Blaich A, 2017, J VIROL METHODS, V249, P143, DOI 10.1016/j.jviromet.2017.09.005; Chacon L, 2017, J CLIN VIROL, V92, P11, DOI 10.1016/j.jcv.2017.04.014; Hardie DR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182167; Liang SC, 2018, J CLIN LAB ANAL, V32, DOI 10.1002/jcla.22287; Moodley D, 2008, SAMJ S AFR MED J, V98, P707; National Health Laboratory Services, 2019, Q SUFF OFF NOT; National Institute for Health and Care Excellence, 2015, TYP 1 DIAB AD DIAGN, DOI DOI 10.1016/J.ANNEMERGMED.2013.12.004; Pilcher CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080629; Roche &REG;, 2017, EL HIV COMB PT V1 0; Song EY, 2012, J MED VIROL, V84, P1884, DOI 10.1002/jmv.23423; Uettwiller-Geiger DL, 2019, AM J CLIN PATHOL, V151, P377, DOI 10.1093/ajcp/aqy153; Wang LC, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0463-0; Western Cape Department of Health, 2019, CORR VACC TUB HIV RE, P1; World Health Organization, 2015, WHO REC ASS HIV TEST	14	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0245189	10.1371/journal.pone.0245189	http://dx.doi.org/10.1371/journal.pone.0245189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428663	gold, Green Published			2022-12-26	WOS:000630036100040
J	Yin, XK; Wang, YL; Wang, F; Feng, WX; Bai, SM; Zhao, WW; Feng, LL; Wei, MB; Qin, CL; Wang, F; Chen, ZL; Yi, HJ; Huang, Y; Xie, PY; Kim, T; Wang, YN; Hou, JW; Li, CW; Liu, QT; Fan, XJ; Hung, MC; Wan, XB				Yin, Xin-Ke; Wang, Yun-Long; Wang, Fei; Feng, Wei-Xing; Bai, Shao-Mei; Zhao, Wan-Wen; Feng, Li-Li; Wei, Ming-Biao; Qin, Cao-Litao; Wang, Fang; Chen, Zhi-Li; Yi, Hong-Jun; Huang, Yan; Xie, Pei-Yi; Kim, Taewan; Wang, Ying-Nai; Hou, Jun-Wei; Li, Chia-Wei; Liu, Quentin; Fan, Xin-Juan; Hung, Mien-Chie; Wan, Xiang-Bo			PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer	ONCOGENE			English	Article							STRAND BREAK REPAIR; RECTAL-CANCER; LUNG-CANCER; PROTEIN; P54(NRB); REGULATOR; METHYLTRANSFERASES; PROGRESSION; MUTATIONS; CETUXIMAB	Arginine methylation is an important posttranslational modification catalyzed by protein arginine methyltransferases (PRMTs). However, the role of PRMTs in colorectal cancer (CRC) progression is not well understood. Here we report that non-POU domain-containing octamer-binding protein (NONO) is overexpressed in CRC tissue and is a potential marker for poor prognosis in CRC patients. NONO silencing resulted in decreased proliferation, migration, and invasion of CRC cells, whereas overexpression had the opposite effect. In a xenograft model, tumors derived from NONO-deficient CRC cells were smaller than those derived from wild-type (WT) cells, and PRMT1 inhibition blocked CRC xenograft progression. A mass spectrometry analysis indicated that NONO is a substrate of PRMT1. R251 of NONO was asymmetrically dimethylated by PRMT1 in vitro and in vivo. Compared to NONO WT cells, NONO R251K mutant-expressing CRC cells showed reduced proliferation, migration, and invasion, and PRMT1 knockdown or pharmacological inhibition abrogated the malignant phenotype associated with NONO asymmetric dimethylation in both KRAS WT and mutant CRC cells. Compared to adjacent normal tissue, PRMT1 was highly expressed in the CRC zone in clinical specimens, which was correlated with poor overall survival in patients with locally advanced CRC. These results demonstrate that PRMT1-mediated methylation of NONO at R251 promotes CRC growth and metastasis, and suggest that PRMT1 inhibition may be an effective therapeutic strategy for CRC treatment regardless of KRAS mutation status.	[Yin, Xin-Ke; Wang, Yun-Long; Zhao, Wan-Wen; Wang, Fang; Fan, Xin-Juan; Wan, Xiang-Bo] Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Guangzhou 510655, Guangdong, Peoples R China; [Wang, Yun-Long; Feng, Wei-Xing; Bai, Shao-Mei; Feng, Li-Li; Wei, Ming-Biao; Qin, Cao-Litao; Wan, Xiang-Bo] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Radiat Oncol, Guangzhou 510655, Guangdong, Peoples R China; [Wang, Fei] Sun Yat Sen Univ, Affiliated Hosp 7, Dept Gastroenterol, Shenzhen 518107, Guangdong, Peoples R China; [Chen, Zhi-Li; Yi, Hong-Jun; Huang, Yan; Fan, Xin-Juan] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Pathol, Guangzhou 510655, Guangdong, Peoples R China; [Xie, Pei-Yi] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Radiol, Guangzhou 510655, Guangdong, Peoples R China; [Kim, Taewan] Shenzhen Univ, Carson Canc Stem Cell Vaccines R&D Ctr, Int Canc Ctr, Base Int Sci & Technol Cooperat,Hlth Sci Ctr, Shenzhen 518055, Peoples R China; [Kim, Taewan] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Wang, Ying-Nai; Hou, Jun-Wei; Li, Chia-Wei; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Li, Chia-Wei] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Liu, Quentin] Dalian Med Univ, Inst Canc Stem Cell, Dalian 116044, Liaoning, Peoples R China; [Liu, Quentin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China; [Hung, Mien-Chie] China Med Univ, Grad Inst Biomed Sci, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ, Res Ctr Canc Biol, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ, Res Ctr Mol Med, Taichung 404, Taiwan; [Hung, Mien-Chie] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan; [Wan, Xiang-Bo] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Engn, Guangzhou 510655, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Shenzhen University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center; Academia Sinica - Taiwan; Dalian Medical University; State Key Lab Oncology South China; Sun Yat Sen University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Sun Yat Sen University	Fan, XJ; Wan, XB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Guangzhou 510655, Guangdong, Peoples R China.; Wan, XB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Radiat Oncol, Guangzhou 510655, Guangdong, Peoples R China.; Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.; Hung, MC (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung 404, Taiwan.; Hung, MC (corresponding author), China Med Univ, Res Ctr Canc Biol, Taichung 404, Taiwan.; Hung, MC (corresponding author), China Med Univ, Res Ctr Mol Med, Taichung 404, Taiwan.; Hung, MC (corresponding author), Asia Univ, Dept Biotechnol, Taichung 413, Taiwan.; Wan, XB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Engn, Guangzhou 510655, Guangdong, Peoples R China.	fanxjuan@mail.sysu.edu.cn; mhung@cmu.edu.tw; wanxbo@mail.sysu.edu.cn	Hou, Junwei/ADR-3580-2022; Li, Chia-Wei/AAC-8660-2019; Kim, Taewan/M-5867-2013; Hung, Mien-Chie/ABD-5911-2021	Li, Chia-Wei/0000-0002-2531-2866; Kim, Taewan/0000-0002-7202-009X; Hung, Mien-Chie/0000-0003-4317-4740; Wang, Ying-Nai/0000-0002-5275-6729; Wang, Yun-Long/0000-0002-5925-6938	Guangdong Science and Technology Project [2017B090901065, 2019B030316003]; Natural Science Foundation of China [81872188, 81902867, 81903152]; Natural Science Foundation of Guangdong Province [2019A1515010901, 2020A1515010314]; China Postdoctoral Science Foundation [2019M663301]	Guangdong Science and Technology Project; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the Guangdong Science and Technology Project (No. 2017B090901065, No. 2019B030316003), Natural Science Foundation of China (No. 81872188, No. 81902867, No. 81903152), Natural Science Foundation of Guangdong Province (No. 2019A1515010901, No. 2020A1515010314), and China Postdoctoral Science Foundation (No. 2019M663301).	Alfano L, 2016, ONCOGENE, V35, P567, DOI 10.1038/onc.2015.107; Alfano L, 2018, J CELL PHYSIOL, V233, P4338, DOI 10.1002/jcp.26269; Amelio AL, 2007, P NATL ACAD SCI USA, V104, P20314, DOI 10.1073/pnas.0707999105; Ansorena E, 2002, HEPATOLOGY, V35, P274, DOI 10.1053/jhep.2002.30419; Bang YJ, 2010, LANCET, V376, P1302; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Benson A, 2018, J NATL COMPR CANC NE, V16, P874, DOI 10.6004/jnccn.2018.0061; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen ZR, 2016, J CLIN INVEST, V126, P2267, DOI 10.1172/JCI85250; Deshar R, 2019, NUCLEIC ACIDS RES, V47, P762, DOI 10.1093/nar/gky1166; Dienstmann R, 2015, J CLIN ONCOL, V33, P1787, DOI 10.1200/JCO.2014.60.0213; Eram MS, 2016, ACS CHEM BIOL, V11, P772, DOI 10.1021/acschembio.5b00839; Feng PF, 2020, J CELL MOL MED, V24, P4368, DOI 10.1111/jcmm.15141; Greenblatt SM, 2016, EXP HEMATOL, V44, P435, DOI 10.1016/j.exphem.2016.03.009; Herrmann F, 2005, J BIOL CHEM, V280, P38005, DOI 10.1074/jbc.M502458200; Ho TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep34529; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Hu SB, 2015, GENE DEV, V29, P630, DOI 10.1101/gad.257048.114; Hu ZX, 2020, HEPATOLOGY, V72, P548, DOI 10.1002/hep.31062; Iino K, 2020, CANCER SCI, V111, P148, DOI 10.1111/cas.14240; Jaafar L, 2017, NUCLEIC ACIDS RES, V45, P1848, DOI 10.1093/nar/gkw1209; Lei NZ, 2009, NUCLEIC ACIDS RES, V37, P832, DOI 10.1093/nar/gkn941; Li SY, 2009, NUCLEIC ACIDS RES, V37, P6746, DOI 10.1093/nar/gkp741; Li X, 2019, EXPERT OPIN THER PAT, V29, P97, DOI 10.1080/13543776.2019.1567711; Liao HW, 2015, J CLIN INVEST, V125, P4529, DOI 10.1172/JCI82826; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Luo MK, 2012, ACS CHEM BIOL, V7, P443, DOI 10.1021/cb200519y; Mircsof D, 2015, NAT NEUROSCI, V18, P1731, DOI 10.1038/nn.4169; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Petti E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08863-1; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Proteau A, 2005, J MOL BIOL, V346, P1163, DOI 10.1016/j.jmb.2004.12.034; Qin YY, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaw9960; Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836; Schiffnery S, 2011, CARCINOGENESIS, V32, P1176, DOI 10.1093/carcin/bgr103; Siegel RL, 2019, CA-CANCER J CLIN, V69, P7, DOI 10.3322/caac.21551; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Snijders AP, 2015, RNA, V21, P347, DOI 10.1261/rna.045138.114; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Tsofack SP, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-145; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Van den Eynde M, 2018, CANCER CELL, V34, P1012, DOI 10.1016/j.ccell.2018.11.003; Wang L, 2014, CANCER CELL, V25, P21, DOI 10.1016/j.ccr.2013.12.007; Yamamoto Ryuji, 2018, Oncotarget, V9, P10510, DOI 10.18632/oncotarget.24063; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yu T, 2017, CANCER RES, V77, P5782, DOI 10.1158/0008-5472.CAN-17-0671; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608; Zhu Z, 2016, ONCOGENE, V35, P1399, DOI 10.1038/onc.2015.197	49	14	14	4	21	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2021	40	7					1375	1389		10.1038/s41388-020-01617-0	http://dx.doi.org/10.1038/s41388-020-01617-0		JAN 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QK0LS	33420374	hybrid, Green Published			2022-12-26	WOS:000607346000009
J	Brown, NP; Vergara, AM; Whelan, AB; Guerra, P; Bolger, TA				Brown, Nicolette P.; Vergara, Ashley M.; Whelan, Alisha B.; Guerra, Paolo; Bolger, Timothy A.			Medulloblastoma-associated mutations in the DEAD-box RNA helicase DDX3X/DED1 cause specific defects in translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ANALYSIS; SACCHAROMYCES-CEREVISIAE; INTELLECTUAL DISABILITY; MESSENGER-RNA; COMMON-CAUSE; PROTEIN; DDX3; DED1P; INITIATION; RESOLUTION	Medulloblastoma is the most common pediatric brain cancer, and sequencing studies identified frequent mutations in DDX3X, a DEAD-box RNA helicase primarily implicated in translation. Forty-two different sites were identified, suggesting that the functional effects of the mutations are complex. To investigate how these mutations are affecting DDX3X cellular function, we constructed a full set of equivalent mutant alleles in DED1, the Saccharomyces cerevisiae ortholog of DDX3X, and characterized their effects in vivo and in vitro. Most of the medulloblastoma-associated mutants in DDX3X/DED1 (ded1-mam) showed substantial growth defects, indicating that functional effects are conserved in yeast. Further, while translation was affected in some mutants, translation defects affecting bulk mRNA were neither consistent nor correlated with the growth phenotypes. Likewise, increased formation of stress granules in ded1-mam mutants was common but did not correspond to the severity of the mutants' growth defects. In contrast, defects in translating mRNAs containing secondary structure in their 5' untranslated regions (UTRs) were found in almost all ded1-mam mutants and correlated well with growth phenotypes. We thus conclude that these specific translation defects, rather than generalized effects on translation, are responsible for the observed cellular phenotypes and likely contribute to DDX3X-mutant medulloblastoma. Examination of ATPase activity and RNA binding of recombinant mutant proteins also did not reveal a consistent defect, indicating that the translation defects are derived from multiple enzymatic deficiencies. This work suggests that future studies into medulloblastoma pathology should focus on this specific translation defect, while taking into account the wide spectrum of DDX3X mutations.	[Brown, Nicolette P.; Vergara, Ashley M.; Whelan, Alisha B.; Guerra, Paolo; Bolger, Timothy A.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Whelan, Alisha B.] Virginia Commonwealth Univ, Dept Forens Sci, Richmond, VA USA	University of Arizona; Virginia Commonwealth University	Bolger, TA (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	tbolger@arizona.edu		Bolger, Timothy/0000-0001-9526-4110	American Cancer Society [RSG-1326301-RMC]; National Institutes of Health [1R01-GM136827]; Arizona Biomedical Research Commission [ADHS14-082993]	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arizona Biomedical Research Commission	This work was supported by the American Cancer Society (RSG-1326301-RMC), the National Institutes of Health (1R01-GM136827), and the Arizona Biomedical Research Commission (ADHS14-082993). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other funding organizations.	Alcazar-Roman AR, 2010, J BIOL CHEM, V285, P16683, DOI 10.1074/jbc.M109.082370; Anderson P, 2015, BBA-GENE REGUL MECH, V1849, P861, DOI 10.1016/j.bbagrm.2014.11.009; Aryanpur PP, 2019, MOL BIOL CELL, V30, P2171, DOI 10.1091/mbc.E18-11-0702; Aryanpur PP, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00139-17; Aylett CHS, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0186; Beckham C, 2008, MOL BIOL CELL, V19, P984, DOI 10.1091/mbc.E07-09-0954; Berthelot K, 2004, MOL MICROBIOL, V51, P987, DOI 10.1046/j.1365-2958.2003.03898.x; Blessing Melissa M, 2020, Surg Pathol Clin, V13, P235, DOI 10.1016/j.path.2020.01.003; Blok LS, 2015, AM J HUM GENET, V97, P343, DOI 10.1016/j.ajhg.2015.07.004; Bolger TA, 2011, J BIOL CHEM, V286, P39750, DOI 10.1074/jbc.M111.299321; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; Epling LB, 2015, J MOL BIOL, V427, P1779, DOI 10.1016/j.jmb.2015.02.015; Floor SN, 2016, J BIOL CHEM, V291, P2412, DOI 10.1074/jbc.M115.700625; Gao XM, 2019, BRIT J PHARMACOL, V176, P4421, DOI 10.1111/bph.14790; Gerashchenko MV, 2012, P NATL ACAD SCI USA, V109, P17394, DOI 10.1073/pnas.1120799109; Guenther UP, 2018, NATURE, V559, P130, DOI 10.1038/s41586-018-0258-0; Gulay S, 2020, ELIFE, V9, DOI 10.7554/eLife.58243; Gupta N, 2018, ELIFE, V7, DOI 10.7554/eLife.38892; Hanzlik E, 2015, CHILD NERV SYST, V31, P1869, DOI 10.1007/s00381-015-2867-3; Hilliker A, 2011, MOL CELL, V43, P962, DOI 10.1016/j.molcel.2011.08.008; Hondele M, 2019, NATURE, V573, P144, DOI 10.1038/s41586-019-1502-y; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Iost I, 1999, J BIOL CHEM, V274, P17677, DOI 10.1074/jbc.274.25.17677; Iserman C, 2020, CELL, V181, P818, DOI 10.1016/j.cell.2020.04.009; Jiang L, 2015, NAT GENET, V47, P1061, DOI 10.1038/ng.3358; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Lai MC, 2008, MOL BIOL CELL, V19, P3847, DOI 10.1091/mbc.E07-12-1264; Lee CS, 2008, NUCLEIC ACIDS RES, V36, P4708, DOI 10.1093/nar/gkn454; Lennox AL, 2020, NEURON, V106, P404, DOI 10.1016/j.neuron.2020.01.042; Li Qian, 2018, Oncotarget, V9, P30189, DOI 10.18632/oncotarget.23773; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; Mabbott DJ, 2008, NEUROPSYCHOLOGY, V22, P159, DOI 10.1037/0894-4105.22.2.159; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Oh S, 2016, ONCOTARGET, V7, P28169, DOI 10.18632/oncotarget.8612; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Ris MD, 2001, J CLIN ONCOL, V19, P3470, DOI 10.1200/JCO.2001.19.15.3470; Robichaud N, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032896; Robichaud N, 2017, CURR OPIN CELL BIOL, V45, P102, DOI 10.1016/j.ceb.2017.05.007; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Sen ND, 2015, GENOME RES, V25, P1196, DOI 10.1101/gr.191601.115; Sharma D, 2017, J MOL BIOL, V429, P3730, DOI 10.1016/j.jmb.2017.10.008; Sharma D, 2014, CRIT REV BIOCHEM MOL, V49, P343, DOI 10.3109/10409238.2014.931339; Shen L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124402; Shih JW, 2008, ONCOGENE, V27, P700, DOI 10.1038/sj.onc.1210687; Shih JW, 2012, BIOCHEM J, V441, P119, DOI 10.1042/BJ20110739; Soto-Rifo R, 2012, EMBO J, V31, P3745, DOI 10.1038/emboj.2012.220; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Valentin-Vega YA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25996; Wang X, 2018, ANN CLIN TRANSL NEUR, V5, P1277, DOI 10.1002/acn3.622	55	5	5	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100296	10.1016/j.jbc.2021.100296	http://dx.doi.org/10.1016/j.jbc.2021.100296			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33460649	Green Published, gold			2022-12-26	WOS:000672866400270
J	Kim, D; Castano, M; Lujan, LK; Woo, JA; Liggett, SB				Kim, Donghwa; Castano, Maria; Lujan, Lauren K.; Woo, Jung A.; Liggett, Stephen B.			The short third intracellular loop and cytoplasmic tail of bitter taste receptors provide functionally relevant GRK phosphorylation sites in TAS2R14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-PROMOTED DESENSITIZATION; KINASE-MEDIATED PHOSPHORYLATION; BETA-2-ADRENERGIC RECEPTOR; PROTEIN; SALMETEROL; IDENTIFICATION; ASTHMA; INTERNALIZATION; BRONCHODILATORS; SUBSENSITIVITY	For most G protein-coupled receptors, the third intracellular loop (IL3) and carboxy-terminal tail (CT) are sites for G protein-coupled receptor kinase (GRK)-mediated phosphorylation, leading to beta-arrestin binding and agonist-specific desensitization. These regions of bitter taste receptors (TAS2Rs) are extremely short compared with the superfamily, and their function in desensitization is unknown. TAS2R14 expressed on human airway smooth muscle cells relax the cell, suggesting a novel target for bronchodilators. To assess IL3 and CT in agonist-promoted TAS2R14 desensitization (tachyphylaxis), we generated fusion proteins of both the WT sequence and Ala substituted for Ser/Thr in the IL3 and CT sequences. In vitro, activated GRK2 phosphorylated WT IL3 and WT CT proteins but not Ala-substituted forms. TAS2R14s with mutations in IL3 (IL-5A), CT (CT-5A), and in both regions (IL/CT-10A) were expressed in human embryonic kidney 293T cells. IL/CT-10A and CT-5A failed to undergo desensitization of the intracellular calcium response compared with WT, indicating that functional desensitization by GRK phosphorylation is at residues in the CT. Desensitization of TAS2R14 was blocked by GRK2 knockdown in human airway smooth muscle cells. Receptor:beta-arrestin binding was absent in IL/CT-10A and CT-5A and reduced in IL-5A, indicating a role for IL3 phosphorylation in the beta-arrestin interaction for this function. Agonist-promoted internalization of IL-5A and CT-5A receptors was impaired, and they failed to colocalize with early endosomes. Thus, agonist-promoted functional desensitization of TAS2R14 occurs by GRK phosphorylation of CT residues and beta-arrestin binding. However, beta-arrestin function in the internalization and trafficking of the receptor also requires GRK phosphorylation of IL3 residues.	[Kim, Donghwa; Castano, Maria; Lujan, Lauren K.] Univ S Florida, Morsani Coll Med, Dept Med, Tampa, FL 33620 USA; [Woo, Jung A.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Liggett, Stephen B.] Univ S Florida, Morsani Coll Med, Dept Med & Mol Pharmacol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Liggett, SB (corresponding author), Univ S Florida, Morsani Coll Med, Dept Med & Mol Pharmacol, Tampa, FL 33620 USA.	sliggett@usf.edu	Kim, Donghwa/AAJ-8148-2021	Kim, Donghwa/0000-0002-8994-8513; Lujan, Lauren/0000-0002-5342-7126; Liggett, Stephen B./0000-0002-0128-3669; Woo, Jung A/0000-0002-9194-1361	National Institutes of Health [HL114471, HL155532]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grant HL114471 and HL155532 to S. B. L. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; An SS, 2017, CELL SIGNAL, V41, P82, DOI 10.1016/j.cellsig.2017.02.002; BHAGAT R, 1995, CHEST, V108, P1235, DOI 10.1378/chest.108.5.1235; Booth H, 1996, THORAX, V51, P1100, DOI 10.1136/thx.51.11.1100; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; Cazzola M, 2019, EUR RESPIR REV, V28, DOI 10.1183/16000617.0095-2019; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chen YJ, 2013, J NEUROCHEM, V124, P189, DOI 10.1111/jnc.12071; CHEUNG D, 1992, NEW ENGL J MED, V327, P1198, DOI 10.1056/NEJM199210223271703; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Deshpande DA, 2011, NAT MED, V17, P776, DOI 10.1038/nm0711-776b; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; EASON MG, 1995, J BIOL CHEM, V270, P4681, DOI 10.1074/jbc.270.9.4681; EASON MG, 1992, J BIOL CHEM, V267, P25473; Einstein R, 2008, P NATL ACAD SCI USA, V105, P5230, DOI 10.1073/pnas.0801319105; Gagnon L, 2019, J BIOL CHEM, V294, P17409, DOI 10.1074/jbc.RA119.010324; GREEN SA, 1994, J BIOL CHEM, V269, P26215; GROVE A, 1995, LANCET, V346, P201, DOI 10.1016/S0140-6736(95)91265-7; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; Huang WJ, 2020, NATURE, V579, P303, DOI 10.1038/s41586-020-1953-1; Jewell-Motz EA, 2000, J BIOL CHEM, V275, P28989, DOI 10.1074/jbc.M005381200; JewellMotz EA, 1996, J BIOL CHEM, V271, P18082, DOI 10.1074/jbc.271.30.18082; Kim D, 2019, AM J RESP CELL MOL, V60, P532, DOI 10.1165/rcmb.2018-0189OC; Kim DW, 2017, AM J RESP CELL MOL, V56, P762, DOI 10.1165/rcmb.2016-0373OC; Kim D, 2016, J BIOL CHEM, V291, P17616, DOI 10.1074/jbc.M116.722736; Kim OJ, 2004, J BIOL CHEM, V279, P7999, DOI 10.1074/jbc.M308281200; KRAAN J, 1985, J ALLERGY CLIN IMMUN, V76, P628, DOI 10.1016/0091-6749(85)90786-9; Lee H, 2007, MOL CELL BIOL, V27, P2103, DOI 10.1128/MCB.00572-06; Liang M, 1998, MOL PHARMACOL, V54, P44, DOI 10.1124/mol.54.1.44; LIGGETT SB, 1992, J BIOL CHEM, V267, P4740; LIGGETT SB, 1993, P NATL ACAD SCI USA, V90, P3665, DOI 10.1073/pnas.90.8.3665; Maestri-El Kouhen O, 2000, J BIOL CHEM, V275, P36659, DOI 10.1074/jbc.M006788200; Mafi A, 2020, P NATL ACAD SCI USA, V117, P16346, DOI 10.1073/pnas.1918264117; Matera MG, 2011, TRENDS PHARMACOL SCI, V32, P495, DOI 10.1016/j.tips.2011.04.003; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; NEWNHAM DM, 1995, THORAX, V50, P497, DOI 10.1136/thx.50.5.497; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Palmer TM, 2000, MOL PHARMACOL, V57, P539, DOI 10.1124/mol.57.3.539; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P14152, DOI 10.1074/jbc.272.22.14152; Rajagopal S, 2017, CELL SIGNAL, V41, P9, DOI 10.1016/j.cellsig.2017.01.024; Robinett KS, 2014, AM J RESP CELL MOL, V50, P678, DOI 10.1165/rcmb.2013-0439RC; Robinett KS, 2011, AM J RESP CELL MOL, V45, P1069, DOI 10.1165/rcmb.2011-0061OC; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Salpeter SR, 2010, AM J MED, V123, P322, DOI 10.1016/j.amjmed.2009.07.035; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Staus DP, 2020, NATURE, V579, P297, DOI 10.1038/s41586-020-1954-0; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Wang WCH, 2009, P NATL ACAD SCI USA, V106, P15007, DOI 10.1073/pnas.0906034106; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Woo JA, 2019, FASEB J, V33, P12213, DOI 10.1096/fj.201802627RR; Woo JAA, 2020, P NATL ACAD SCI USA, V117, P5006, DOI 10.1073/pnas.1917194117	56	1	1	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100216	10.1074/jbc.RA120.016056	http://dx.doi.org/10.1074/jbc.RA120.016056			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33465377	gold, Green Published			2022-12-26	WOS:000672866400194
J	van Dierendonck, XAMH; Sancerni, T; Alves-Guerra, MC; Stienstra, R				van Dierendonck, Xanthe A. M. H.; Sancerni, Tiphaine; Alves-Guerra, Marie-Clotilde; Stienstra, Rinke			The role of uncoupling protein 2 in macrophages and its impact on obesity-induced adipose tissue inflammation and insulin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						uncoupling protein 2; immunometabolism; adipose tissue inflammation; obesity; insulin resistance; diabetes; macrophage; metabolism; inflammation	OXIDATIVE STRESS; LIPID-METABOLISM; UCP2; IMMUNOMETABOLISM; ACTIVATION; RISK; GENE; CELL; PROLIFERATION; POLYMORPHISM	The development of a chronic, low-grade inflammation originating from adipose tissue in obese subjects is widely recognized to induce insulin resistance, leading to the development of type 2 diabetes. The adipose tissue microenvironment drives specific metabolic reprogramming of adipose tissue macrophages, contributing to the induction of tissue inflammation. Uncoupling protein 2 (UCP2), a mitochondrial anion carrier, is thought to separately modulate inflammatory and metabolic processes in macrophages and is up-regulated in macrophages in the context of obesity and diabetes. Here, we investigate the role of UCP2 in macrophage activation in the context of obesity-induced adipose tissue inflammation and insulin resistance. Using a myeloid-specific knockout of UCP2 (Ucp2(Delta LysM)), we found that UCP2 deficiency significantly increases glycolysis and oxidative respiration, both unstimulated and after inflammatory conditions. Strikingly, fatty acid loading abolished the metabolic differences between Ucp2(Delta LysM) macrophages and their floxed controls. Furthermore, Ucp2(Delta LysM) macrophages show attenuated pro-inflammatory responses toward Toll-like receptor-2 and -4 stimulation. To test the relevance of macrophage-specific Ucp2 deletion in vivo, Ucp2(Delta LysM) and Ucp2(fl/fl) mice were rendered obese and insulin resistant through high-fat feeding. Although no differences in adipose tissue inflammation or insulin resistance was found between the two genotypes, adipose tissue macrophages isolated from diet-induced obese Ucp2(Delta LysM) mice showed decreased TNF alpha secretion after ex vivo lipopolysaccharide stimulation compared with their Ucp2(fl/fl) littermates. Together, these results demonstrate that although UCP2 regulates both metabolism and the inflammatory response of macrophages, its activity is not crucial in shaping macrophage activation in the adipose tissue during obesity-induced insulin resistance.	[van Dierendonck, Xanthe A. M. H.; Stienstra, Rinke] Wageningen Univ, Div Human Nutr & Hlth, Nutr Metab & Genom Grp, Wageningen, Netherlands; [van Dierendonck, Xanthe A. M. H.; Stienstra, Rinke] Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, Nijmegen, Netherlands; [Sancerni, Tiphaine; Alves-Guerra, Marie-Clotilde] Univ Paris, Inst Cochin, INSERM, CNRS, F-75014 Paris, France	Wageningen University & Research; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Stienstra, R (corresponding author), Wageningen Univ, Div Human Nutr & Hlth, Nutr Metab & Genom Grp, Wageningen, Netherlands.; Stienstra, R (corresponding author), Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, Nijmegen, Netherlands.	rinke.stienstra@wur.nl	Alves-Guerra, Marie-Clotilde/P-4356-2017	Alves-Guerra, Marie-Clotilde/0000-0002-7918-1216; van Dierendonck, Xanthe/0000-0002-9855-8701	Vidi Grant from the NWO; Dutch Diabetes Foundation [2015.82.1824]	Vidi Grant from the NWO; Dutch Diabetes Foundation	This work was supported by Vidi Grant from the NWO and by Dutch Diabetes Foundation senior fellowship 2015.82.1824 (to R. S.).	Aguilar E, 2019, CELL REP, V28, P2306, DOI 10.1016/j.celrep.2019.07.097; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Alves-Guerra MC, 2003, J BIOL CHEM, V278, P42307, DOI 10.1074/jbc.M306951200; Andersen G, 2013, INT J OBESITY, V37, P175, DOI 10.1038/ijo.2012.22; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bouillaud F, 2016, BBA-MOL CELL RES, V1863, P2443, DOI 10.1016/j.bbamcr.2016.04.013; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; Boutens L, 2018, DIABETOLOGIA, V61, P942, DOI 10.1007/s00125-017-4526-6; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Couplan E, 2002, J BIOL CHEM, V277, P26268, DOI 10.1074/jbc.M202535200; Dalmas E, 2014, DIABETES, V63, P1966, DOI 10.2337/db13-1511; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Emre Y, 2010, FEBS LETT, V584, P1437, DOI 10.1016/j.febslet.2010.03.014; Esterbauer H, 2001, NAT GENET, V28, P178, DOI 10.1038/88911; Esteves P, 2014, CANCER RES, V74, P3971, DOI 10.1158/0008-5472.CAN-13-3383; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Hurtaud C, 2006, CELL MOL LIFE SCI, V63, P1780, DOI 10.1007/s00018-006-6129-0; Kim JD, 2019, CELL METAB, V30, P952, DOI 10.1016/j.cmet.2019.08.010; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Lachmandas E, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.246; Li N, 2017, REDOX BIOL, V13, P541, DOI 10.1016/j.redox.2017.07.012; Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903; Lyssenko V, 2005, PLOS MED, V2, P1299, DOI 10.1371/journal.pmed.0020345; Martinez-Hervas S, 2012, EUR J CLIN INVEST, V42, P171, DOI 10.1111/j.1365-2362.2011.02570.x; Mattiasson G, 2006, ANTIOXID REDOX SIGN, V8, P1, DOI 10.1089/ars.2006.8.1; Medvedev AV, 2001, J BIOL CHEM, V276, P10817, DOI 10.1074/jbc.M010587200; Meyer TE, 2010, CANCER EPIDEM BIOMAR, V19, P558, DOI 10.1158/1055-9965.EPI-09-0902; Moon JS, 2015, J CLIN INVEST, V125, P665, DOI 10.1172/JCI78253; Nubel T, 2008, BBA-BIOENERGETICS, V1777, P48, DOI 10.1016/j.bbabio.2007.11.002; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Oktavianthi S, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-41; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Rousset S, 2006, CYTOKINE, V35, P135, DOI 10.1016/j.cyto.2006.07.012; Salopuro T, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-94; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HL, 2015, MOL CELL BIOL, V35, P1055, DOI 10.1128/MCB.01122-14; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001	43	7	7	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17535	17548		10.1074/jbc.RA120.014868	http://dx.doi.org/10.1074/jbc.RA120.014868			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453996	Green Published, hybrid			2022-12-26	WOS:000603272300012
J	Hirata, T; Yamamoto, K; Ikeda, K; Arita, M				Hirata, Tsuyoshi; Yamamoto, Kimiko; Ikeda, Kazutaka; Arita, Makoto			Functional lipidomics of vascular endothelial cells in response to laminar shear stress	FASEB JOURNAL			English	Article						endothelial cells; ether lipid; lipidomics; shear stress; VCAM&#8208; 1	PROTEIN-KINASE-C; NITRIC-OXIDE SYNTHASE; AUTOLYSIN ACTIVITY; GENE-EXPRESSION; UP-REGULATION; ETHER LIPIDS; FLOW; ACTIVATION; CAVEOLAE; MECHANOTRANSDUCTION	Laminar shear stress generated by blood flow stimulates endothelial cells and activates signal transduction, which plays an important role in vascular homeostasis. Several lines of evidence indicate that membrane and intracellular lipids are involved in the signal transduction of biomechanical stresses. In this study, we performed global profiling of cellular lipids from human pulmonary artery endothelial cells (HPAEC) exposed to laminar shear stress. A total of 761 species of lipids were successfully annotated, with 198 of these species significantly changed in response to shear stress for 24 hours. Ether-linked lipids containing an alkyl moiety with a medium chain length (C11-C14) were uniquely upregulated, and the administration of their biosynthetic precursor 1-O-dodecyl-rac-glycerol attenuated phorbol 12-myristate 13-acetate (PMA) induced vascular cell adhesion molecule-1 (VCAM-1) expression. Given the pro-inflammatory and atherogenic roles of VCAM-1, our findings suggest that the induction of a specific group of lipids (ie, ether-linked lipids with medium length alkyl side chain) may confer atheroprotective and anti-inflammatory roles to vascular endothelial cells under flow conditions.	[Hirata, Tsuyoshi; Ikeda, Kazutaka; Arita, Makoto] RIKEN, Lab Metabol, Ctr Integrat Med Sci, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Hirata, Tsuyoshi; Arita, Makoto] Yokohama City Univ, Grad Sch Med Life Sci, Cellular & Mol Epigenet Lab, Yokohama, Kanagawa, Japan; [Yamamoto, Kimiko] Univ Tokyo, Grad Sch Med, Dept Biomed Engn, Lab Syst Physiol, Tokyo, Japan; [Ikeda, Kazutaka] Kazusa DNA Res Inst, Lab Biomol Anal, Kisarazu, Japan; [Arita, Makoto] Keio Univ, Grad Sch Pharmaceut Sci, Div Physiol Chem & Metab, Tokyo, Japan	RIKEN; Yokohama City University; University of Tokyo; Kazusa DNA Research Institute; Keio University	Arita, M (corresponding author), RIKEN, Lab Metabol, Ctr Integrat Med Sci, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	makoto.arita@riken.jp		Arita, Makoto/0000-0001-9902-0463				Ando A, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0324-9; Aoyagi R, 2017, J LIPID RES, V58, P2229, DOI 10.1194/jlr.D077123; Bailey KA., 2017, SCI REP-UK, V7, P1; Balleza D, 2012, CHANNELS, V6, P220, DOI 10.4161/chan.21085; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Bergan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075904; Boyd NL, 2003, AM J PHYSIOL-HEART C, V285, pH1113, DOI 10.1152/ajpheart.00302.2003; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brites P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028539; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Chun TH, 1997, HYPERTENSION, V29, P1296, DOI 10.1161/01.HYP.29.6.1296; Conway DE, 2013, J CELL SCI, V126, P5101, DOI 10.1242/jcs.138313; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Czarny M, 2004, AM J PHYSIOL-HEART C, V287, pH1344, DOI 10.1152/ajpheart.00222.2004; Czarny M, 2003, J BIOL CHEM, V278, P4424, DOI 10.1074/jbc.M210375200; Dai G, 2007, CIRC RES, V101, P723, DOI 10.1161/CIRCRESAHA.107.152942; Dean JM, 2018, PROTEIN CELL, V9, P196, DOI 10.1007/s13238-017-0423-5; DeVerse JS, 2013, AM J PHYSIOL-HEART C, V305, pH1149, DOI 10.1152/ajpheart.00311.2013; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorninger F, 2017, FEBS LETT, V591, P2761, DOI 10.1002/1873-3468.12788; Fan WD, 2015, J CELL SCI, V128, P70, DOI 10.1242/jcs.154252; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; Ford DA, 1996, FEBS LETT, V394, P99, DOI 10.1016/0014-5793(96)00930-1; Garcia-Cardena G, 2001, P NATL ACAD SCI USA, V98, P4478, DOI 10.1073/pnas.071052598; HALLGREN B, 1962, J LIPID RES, V3, P39; Heo KS, 2014, MOL CELLS, V37, P435, DOI [10.14348/molcells.2014.0078, 10.14348/molcells.2014.0108]; Hermann M, 2006, J CARDIOVASC PHARM, V47, pS21, DOI 10.1097/00005344-200605001-00005; Houck KL, 2008, AM J PHYSIOL-HEART C, V295, pH1657, DOI 10.1152/ajpheart.00141.2008; Iannitti T, 2010, MAR DRUGS, V8, P2267, DOI 10.3390/md8082267; KRAFT AS, 1982, J BIOL CHEM, V257, P13193; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee J, 2012, ANAL SCI, V28, P801, DOI 10.2116/analsci.28.801; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; LIN HJ, 1976, J LIPID RES, V17, P53; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Mandel H, 1998, BIOCHEM BIOPH RES CO, V250, P369, DOI 10.1006/bbrc.1998.9321; Marigny K, 2002, ACTA PHYSIOL SCAND, V176, P263, DOI 10.1046/j.1365-201X.2002.01037.x; Mun GI, 2012, BIOCHEM BIOPH RES CO, V420, P450, DOI 10.1016/j.bbrc.2012.03.016; Okahara K, 1998, ARTERIOSCL THROM VAS, V18, P1922, DOI 10.1161/01.ATV.18.12.1922; Rizzo V, 2003, AM J PHYSIOL-HEART C, V285, pH1720, DOI 10.1152/ajpheart.00344.2002; Rizzo V, 1998, J BIOL CHEM, V273, P34724, DOI 10.1074/jbc.273.52.34724; ROBINSON M, 1995, BBA-LIPID LIPID MET, V1254, P361, DOI 10.1016/0005-2760(94)00200-I; Rog T, 2016, BBA-BIOMEMBRANES, V1858, P97, DOI 10.1016/j.bbamem.2015.10.023; Russell-Puleri S, 2017, AM J PHYSIOL-HEART C, V312, pH485, DOI 10.1152/ajpheart.00035.2016; Rybin VO, 2003, J BIOL CHEM, V278, P14555, DOI 10.1074/jbc.M212644200; Saemisch M, 2019, AM J PHYSIOL-CELL PH, V316, pC210, DOI 10.1152/ajpcell.00005.2018; SDOUGOS HP, 1984, J FLUID MECH, V138, P379, DOI 10.1017/S0022112084000161; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; Styger R, 2002, BBA-MOL CELL BIOL L, V1585, P39, DOI 10.1016/S1388-1981(02)00320-7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TAKADA Y, 1994, BIOCHEM BIOPH RES CO, V205, P1345, DOI 10.1006/bbrc.1994.2813; Topper JN, 1996, P NATL ACAD SCI USA, V93, P10417, DOI 10.1073/pnas.93.19.10417; Tsugawa H, 2020, NAT BIOTECHNOL, V38, P1159, DOI 10.1038/s41587-020-0531-2; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; van Thienen JV, 2006, CARDIOVASC RES, V72, P231, DOI 10.1016/j.cardiores.2006.07.008; VED HS, 1984, J BIOL CHEM, V259, P8122; VED HS, 1984, J BIOL CHEM, V259, P8115; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Wang KC, 2016, P NATL ACAD SCI USA, V113, P11525, DOI 10.1073/pnas.1613121113; WARNE TR, 1995, J BIOL CHEM, V270, P11147, DOI 10.1074/jbc.270.19.11147; White CR, 2007, PHILOS T R SOC B, V362, P1459, DOI 10.1098/rstb.2007.2128; Yamamoto K, 2007, AM J PHYSIOL-HEART C, V293, pH1646, DOI 10.1152/ajpheart.01385.2006; Yamamoto K, 2018, CIRC J, V82, P2691, DOI 10.1253/circj.CJ-18-0052; Yamamoto K, 2015, AM J PHYSIOL-HEART C, V309, pH1178, DOI 10.1152/ajpheart.00241.2015; Yamamoto K, 2013, J CELL SCI, V126, P1227, DOI 10.1242/jcs.119628; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100	70	10	10	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21301	10.1096/fj.202002144R	http://dx.doi.org/10.1096/fj.202002144R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33421194	hybrid			2022-12-26	WOS:000647789600093
J	Scharinger, K; Maxeiner, S; Schalla, C; Rutten, S; Zenke, M; Sechi, A				Scharinger, Katja; Maxeiner, Sebastian; Schalla, Carmen; Rutten, Stephan; Zenke, Martin; Sechi, Antonio			LSP1-myosin1e bimolecular complex regulates focal adhesion dynamics and cell migration	FASEB JOURNAL			English	Article						Actin cytoskeleton remodeling; focal adhesions; cell motility; macrophages	LYMPHOCYTE-SPECIFIC PROTEIN-1; LEUKOCYTE-SPECIFIC PROTEIN-1; NEUTROPHIL ACTIN DYSFUNCTION; MYOSIN 1E; ENA/VASP PROTEINS; ARP2/3 COMPLEX; NAD 47/89; P50 LSP1; CYTOSKELETON; MOTILITY	Several cytoskeleton-associated proteins and signaling pathways work in concert to regulate actin cytoskeleton remodeling, cell adhesion, and migration. Although the leukocyte-specific protein 1 (LSP1) has been shown to interact with the actin cytoskeleton, its function in the regulation of actin cytoskeleton dynamics is, as yet, not fully understood. We have recently demonstrated that the bimolecular complex between LSP1 and myosin1e controls actin cytoskeleton remodeling during phagocytosis. In this study, we show that LSP1 downregulation severely impairs cell migration, lamellipodia formation, and focal adhesion dynamics in macrophages. Inhibition of the interaction between LSP1 and myosin1e also impairs these processes resulting in poorly motile cells, which are characterized by few and small lamellipodia. Furthermore, cells in which LSP1-myosin1e interaction is inhibited are typically associated with inefficient focal adhesion turnover. Collectively, our findings show that the LSP1-myosin1e bimolecular complex plays a pivotal role in the regulation of actin cytoskeleton remodeling and focal adhesion dynamics required for cell migration.	[Scharinger, Katja; Maxeiner, Sebastian; Schalla, Carmen; Zenke, Martin; Sechi, Antonio] Rhein Westfal TH Aachen, Inst Biomed Engn, Dept Cell Biol, Pauwelsstr 30, D-52074 Aachen, Germany; [Rutten, Stephan] Rhein Westfal TH Aachen, Inst Pathol, Electron Microscopy Facil, Aachen, Germany	RWTH Aachen University; RWTH Aachen University	Sechi, A (corresponding author), Rhein Westfal TH Aachen, Inst Biomed Engn, Dept Cell Biol, Pauwelsstr 30, D-52074 Aachen, Germany.	antonio.sechi@rwth-aachen.de	Sechi, Antonio S/A-5595-2009	Sechi, Antonio S/0000-0002-1374-1794				Anand AR, 2009, BLOOD, V114, P3588, DOI 10.1182/blood-2009-02-206342; Berginski Matthew E, 2013, F1000Res, V2, P68, DOI 10.12688/f1000research.2-68.v1; BERSHADSKY AD, 1991, CELL MOTIL CYTOSKEL, V19, P152, DOI 10.1002/cm.970190303; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Carballo E, 1996, J IMMUNOL, V156, P1709; Cervero P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02904-x; Cheng J, 2012, MOL BIOL CELL, V23, P2891, DOI 10.1091/mbc.E11-04-0383; COATES TD, 1991, BLOOD, V78, P1338; Finkelstein E, 2004, J CELL SCI, V117, P1533, DOI 10.1242/jcs.00986; Gamper I, 2016, MOL BIOL CELL, V27, P277, DOI 10.1091/mbc.E15-06-0426; Geese M, 2002, MOL BIOL CELL, V13, P2383, DOI 10.1091/mbc.E02-01-0058; Gupta P, 2013, BIOL OPEN, V2, P1288, DOI 10.1242/bio.20135827; Hannigan M, 2001, J LEUKOCYTE BIOL, V69, P497; Harrison RE, 2004, J CELL SCI, V117, P2151, DOI 10.1242/jcs.00955; HOWARD T, 1994, BLOOD, V83, P231; Howard TH, 1998, BLOOD, V91, P4786, DOI 10.1182/blood.V91.12.4786.412k25_4786_4795; Huang CK, 1997, J BIOL CHEM, V272, P17, DOI 10.1074/jbc.272.1.17; Hwang SH, 2015, P NATL ACAD SCI USA, V112, pE6535, DOI 10.1073/pnas.1514152112; Iskratsch T, 2013, DEV CELL, V27, P545, DOI 10.1016/j.devcel.2013.11.003; JONGSTRA J, 1988, MOL IMMUNOL, V25, P687, DOI 10.1016/0161-5890(88)90104-6; JONGSTRA J, 1994, MOL IMMUNOL, V31, P1125, DOI 10.1016/0161-5890(94)90026-4; Jongstra-Bilen J, 2000, BLOOD, V96, P1827, DOI 10.1182/blood.V96.5.1827.h8001827_1827_1835; JONGSTRABILEN J, 1990, J IMMUNOL, V144, P1104; KADIYALA RK, 1990, EUR J IMMUNOL, V20, P2417; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; KLEIN DP, 1989, MOL CELL BIOL, V9, P3043, DOI 10.1128/MCB.9.7.3043; KLEIN DP, 1990, J IMMUNOL, V145, P2967; Koka S, 2003, J CELL SCI, V116, P1745, DOI 10.1242/jcs.00386; Koral K, 2015, HEPATOLOGY, V61, P537, DOI 10.1002/hep.27444; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Lammel U, 2014, DEVELOPMENT, V141, P1366, DOI 10.1242/dev.101352; Li Y, 2000, BLOOD, V96, P1100, DOI 10.1182/blood.V96.3.1100.015k33_1100_1105; Liu LX, 2005, J EXP MED, V201, P409, DOI 10.1084/jem.20040830; Mathieson PW, 2012, CLIN KIDNEY J, V5, P498, DOI 10.1093/ckj/sfs153; MATSUMOTO N, 1993, J BIOCHEM-TOKYO, V113, P630, DOI 10.1093/oxfordjournals.jbchem.a124094; MATSUMOTO N, 1995, J BIOCHEM-TOKYO, V118, P237, DOI 10.1093/oxfordjournals.jbchem.a124885; MATSUMOTO N, 1995, J BIOCHEM, V117, P222, DOI 10.1093/oxfordjournals.jbchem.a124714; Maxeiner S, 2015, MOL BIOL CELL, V26, P1652, DOI 10.1091/mbc.E14-05-1005; May RC, 1999, CURR BIOL, V9, P759, DOI 10.1016/S0960-9822(99)80337-6; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Miyoshi EK, 2001, LEUKEMIA RES, V25, P57, DOI 10.1016/S0145-2126(00)00079-5; Palker TJ, 1998, HYBRIDOMA, V17, P497, DOI 10.1089/hyb.1998.17.497; Petri B, 2011, BLOOD, V117, P942, DOI 10.1182/blood-2010-02-270561; Prasad A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40648; Prasad A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048854; Pust S, 2005, EMBO J, V24, P1287, DOI 10.1038/sj.emboj.7600595; Ramaekers FCS, 2004, J PATHOL, V204, P351, DOI 10.1002/path.1665; Rapsomaniki MA, 2012, BIOINFORMATICS, V28, P1800, DOI 10.1093/bioinformatics/bts241; Schulze N, 2014, J CELL SCI, V127, P1379, DOI 10.1242/jcs.134627; Sechi A, 2016, ADV MATER INTERFACES, V3, DOI 10.1002/admi.201600455; Sechi AS, 2004, FRONT BIOSCI, V9, P1294, DOI 10.2741/1324; Sirotkin V, 2005, J CELL BIOL, V170, P637, DOI 10.1083/jcb.200502053; Tanimura S, 2016, J CELL BIOL, V214, P475, DOI 10.1083/jcb.201503123; VASILIEV JM, 1970, J EMBRYOL EXP MORPH, V24, P625; Wang CJ, 2002, J IMMUNOL, V169, P415, DOI 10.4049/jimmunol.169.1.415; Way M, 1998, FOLIA MICROBIOL, V43, P305, DOI 10.1007/BF02818616; WEHLAND J, 1983, J CELL BIOL, V97, P1467, DOI 10.1083/jcb.97.5.1467; Wong MJ, 2003, BBA-MOL CELL RES, V1642, P17, DOI 10.1016/S0167-4889(03)00082-X; Wu Y, 2007, BIOCHEM BIOPH RES CO, V358, P170, DOI 10.1016/j.bbrc.2007.04.104; Wurflinger T, 2011, J MICROSC-OXFORD, V241, P37, DOI 10.1111/j.1365-2818.2010.03404.x; Zamir E, 2001, J CELL SCI, V114, P3583; Zhang QH, 2000, J IMMUNOL, V165, P2052, DOI 10.4049/jimmunol.165.4.2052; Zhang QH, 2001, CELL MOTIL CYTOSKEL, V49, P179, DOI 10.1002/cm.1031	65	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21268	10.1096/fj.202000740RR	http://dx.doi.org/10.1096/fj.202000740RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33470457	Green Submitted			2022-12-26	WOS:000647789600094
J	Adduci, LB; Leon, VA; Schlotelburg, A; Busch, M; Fraschina, J				Adduci, Luciana B.; Leon, Vanina A.; Schloetelburg, Annika; Busch, Maria; Fraschina, Jimena			Avoidance behaviour in laboratory house mice (Musmusculus) and Norway rats (Rattus norvegicus) towards predator odours	PLOS ONE			English	Article							MUS-MUSCULUS; DEFENSIVE BEHAVIORS; FOX ODOR; CAT ODOR; EXPOSURE; TMT; TRIMETHYLTHIAZOLINE; RESPONSES; STRESS; CONSEQUENCES	Mus musculus and Rattus sp. are considered pest species because they reach high densities in urban areas, crop fields and food storage and productive systems such as breeding farms and orchards. Their control relies mainly on rodenticide application, but the effectiveness of this application is reduced due to behavioural responses and resistance. Novel methods are based on the use of chemical signals as odours that may be attractants, repellents or may reduce the reproductive success of pest species. The aim of this paper is to study the aversive effect of TMT, cat urine and cat body odour on predator-inexperienced Mus musculus and Rattus norvegicus under laboratory conditions. The experimental apparatus comprised three boxes connected by PVC pipes in a linear arrangement. In lateral boxes, odour sources or distilled water were introduced, while animals were placed in the central box at the beginning of the experiment. Rats showed freezing behaviour, reduced visits in the presence of TMT and cat fur. Mice reduced their visits with cat body and cat urine. This study provides evidence of the usefulness of using fear responses as a way to control rodent pests, which must be adapted to the environment and species to be applied.	[Adduci, Luciana B.; Leon, Vanina A.; Busch, Maria; Fraschina, Jimena] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Intendente Guiraldes 2160,Ciudad Univ,C1428EGA, Buenos Aires, DF, Argentina; [Adduci, Luciana B.; Leon, Vanina A.; Busch, Maria; Fraschina, Jimena] Univ Buenos Aires, Inst Ecol Genet & Evoluc Buenos Aires IEGEBA, UBA CONICET, Intendente Guiraldes 2160,Ciudad Univ,C1428EGA, Buenos Aires, DF, Argentina; [Schloetelburg, Annika] Humboldt Univ, Inst Agr & Hort, Div Land Use Syst, Fac Life Sci, Berlin, Germany	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Humboldt University of Berlin	Fraschina, J (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Intendente Guiraldes 2160,Ciudad Univ,C1428EGA, Buenos Aires, DF, Argentina.; Fraschina, J (corresponding author), Univ Buenos Aires, Inst Ecol Genet & Evoluc Buenos Aires IEGEBA, UBA CONICET, Intendente Guiraldes 2160,Ciudad Univ,C1428EGA, Buenos Aires, DF, Argentina.	jfraschina@ege.fcen.uba.ar			ANPCYT (Agencia Nacional de Promocion Cientifica y Tecnica) [PICT 2013-0721]; CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) [PIP 1122015010922]; UBACYT (Universidad de Buenos Aires) [UBACyT 20020130100282BA]	ANPCYT (Agencia Nacional de Promocion Cientifica y Tecnica)(ANPCyT); CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UBACYT (Universidad de Buenos Aires)(University of Buenos Aires)	B.M. ANPCYT (Agencia Nacional de Promocion Cientifica y Tecnica -PICT 2013-0721) CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas -PIP 1122015010922) and UBACYT (Universidad de Buenos Aires -UBACyT 20020130100282BA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adduci LB., 2019, PEST MANAG SCI, P75, DOI [10.1002/ps.5498, DOI 10.1002/PS.5498]; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Bates D, 2018, MATRIX SPARSE DENSE; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bedoya-Perez MA, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00136; BINDRA D, 1958, J EXP ANAL BEHAV, V1, P341, DOI 10.1901/jeab.1958.1-341; Blanchard DC, 2003, PROG NEURO-PSYCHOPH, V27, P1177, DOI 10.1016/j.pnpbp.2003.09.012; Blanchard DC, 2003, BEHAV NEUROSCI, V117, P360, DOI 10.1037/0735-7044.117.2.360; Blanchard DC, 2001, NEUROSCI BIOBEHAV R, V25, P205, DOI 10.1016/S0149-7634(01)00009-4; Bolbroe T, 2000, ANN ZOOL FENN, V37, P169; Brakes CR, 2005, J APPL ECOL, V42, P118, DOI 10.1111/j.1365-2664.2005.00997.x; Brooks M. E., 2017, MODELING ZERO INFLAT, DOI 10.1101/132753; Buckle AP, 1994, RODENT PESTS THEIR C; Busch M, 2015, PEST MANAG SCI, V71, P1599, DOI 10.1002/ps.3962; Dielenberg RA, 2001, NEUROSCI BIOBEHAV R, V25, P597, DOI 10.1016/S0149-7634(01)00044-6; Dielenberg RA, 2001, NEUROSCIENCE, V104, P1085, DOI 10.1016/S0306-4522(01)00150-6; Fendt M, 2005, NEUROSCI BIOBEHAV R, V29, P1145, DOI 10.1016/j.neubiorev.2005.04.018; Feoktistova NY., 2003, ACIAR MONOGRAPHS SER, P173; FILE SE, 1993, PHYSIOL BEHAV, V54, P1109, DOI 10.1016/0031-9384(93)90333-B; Geduhn A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139191; Guidobono JS, 2010, PEST MANAG SCI, V66, P162, DOI 10.1002/ps.1850; Hansen SC, 2015, CROP PROT, V78, P270, DOI 10.1016/j.cropro.2015.09.019; Harrison XA, 2015, PEERJ, V3, DOI 10.7717/peerj.1114; Horii Y, 2010, BEHAV BRAIN RES, V214, P317, DOI 10.1016/j.bbr.2010.05.047; Lenth R, 2020, **DATA OBJECT**; Leon VA, 2010, CAN J ZOOL, V88, P427, DOI 10.1139/Z10-014; Leon VA, 2020, INT J PEST MANAGE, V66, P7, DOI 10.1080/09670874.2018.1538543; Lovera R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005722; Macdonald DW, 2015, RODENT PESTS AND THEIR CONTROL, 2ND EDITION, P1, DOI 10.1079/9781845938178.0001; McGregor IS, 2002, BEHAV BRAIN RES, V129, P1, DOI 10.1016/S0166-4328(01)00324-2; Mino MH, 2007, INT J PEST MANAGE, V53, P311, DOI 10.1080/09670870601105949; Morrow BA, 2000, BRAIN RES, V864, P146, DOI 10.1016/S0006-8993(00)02174-0; Munoz-Abellan C, 2010, PHYSIOL BEHAV, V99, P388, DOI 10.1016/j.physbeh.2009.12.008; Osada K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061753; Parsons MH, 2018, BIOL REV, V93, P98, DOI 10.1111/brv.12334; Pelz HJ, 2005, GENETICS, V170, P1839, DOI 10.1534/genetics.104.040360; Schlotelburg A, 2019, J PEST SCI, V92, P677, DOI 10.1007/s10340-018-1028-3; SPRUIJT BM, 1992, PHYSIOL REV, V72, P825, DOI 10.1152/physrev.1992.72.3.825; Staples LG, 2008, NEUROSCIENCE, V151, P937, DOI 10.1016/j.neuroscience.2007.11.039; Stenseth NC, 2003, FRONT ECOL ENVIRON, V1, P367, DOI 10.2307/3868189; Timm RM, 1987, CONTROL MAMMAL PESTS; VERNETMAURY E, 1984, J CHEM ECOL, V10, P1007, DOI 10.1007/BF00987509; Villafane IEG, 2001, BRIT POULTRY SCI, V42, P300, DOI 10.1080/00071660120055241; Voznessenskaya V, 2015, CHEM SENSES, V40, P263; Voznessenskaya VV., 2003, PREDATOR ODOURS REPR, P251; WILLIAMS JL, 1990, ANIM LEARN BEHAV, V18, P453, DOI 10.3758/BF03205327; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	47	6	6	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245441	10.1371/journal.pone.0245441	http://dx.doi.org/10.1371/journal.pone.0245441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471855	Green Published			2022-12-26	WOS:000639428800015
J	Cardoso, NC; Papadopoulos, AO; Kana, BD				Cardoso, Nicole C.; Papadopoulos, Andrea O.; Kana, Bavesh D.			Mycobacterium smegmatis does not display functional redundancy in nitrate reductase enzymes	PLOS ONE			English	Article							FUSED MOLYBDOPTERIN SYNTHASE; NITROGEN-METABOLISM; RESPONSE REGULATOR; ASSIMILATION; TUBERCULOSIS; MUTANTS; NARGHJI; NITRITE; IDENTIFICATION; PATHWAYS	Reduction of nitrate to nitrite in bacteria is an essential step in the nitrogen cycle, catalysed by a variety of nitrate reductase (NR) enzymes. The soil dweller, Mycobacterium smegmatis is able to assimilate nitrate and herein we set out to confirm the genetic basis for this by probing NR activity in mutants defective for putative nitrate reductase (NR) encoding genes. In addition to the annotated narB and narGHJI, bioinformatics identified three other putative NR-encoding genes: MSMEG_4206, MSMEG_2237 and MSMEG_6816. To assess the relative contribution of each, the corresponding gene loci were deleted using two-step allelic replacement, individually and in combination. The resulting strains were tested for their ability to assimilate nitrate and reduce nitrate under aerobic and anaerobic conditions, using nitrate assimilation and modified Griess assays. We demonstrated that narB, narGHJI, MSMEG_2237 and MSMEG_6816 were individually dispensable for nitrate assimilation and for nitrate reductase activity under aerobic and anaerobic conditions. Only deletion of MSMEG_4206 resulted in significant reduction in nitrate assimilation under aerobic conditions. These data confirm that in M. smegmatis, narB, narGHJI, MSMEG_2237 and MSMEG_6816 are not required for nitrate reduction as MSMEG_4206 serves as the sole assimilatory NR.	[Cardoso, Nicole C.; Papadopoulos, Andrea O.; Kana, Bavesh D.] Univ Witwatersrand, DST NRF Ctr Excellence Biomed TB Res, Natl Hlth Lab Serv, Fac Hlth Sci, Johannesburg, South Africa	National Health Laboratory Service; National Research Foundation - South Africa; University of Witwatersrand	Kana, BD (corresponding author), Univ Witwatersrand, DST NRF Ctr Excellence Biomed TB Res, Natl Hlth Lab Serv, Fac Hlth Sci, Johannesburg, South Africa.	bavesh.kana@nhls.ac.za	Kana, Bavesh/HCH-3258-2022	Kana, Bavesh/0000-0001-9713-3480	South African National Research Foundation [DCOE015]; South African Medical Research Council; Department of Health	South African National Research Foundation(National Research Foundation - South Africa); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health	BK, NC, AOP DCOE015 South African National Research Foundation BK, NC, AOP South African Medical Research Council, with funds from the Department of Health The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon J, 2008, J BACTERIOL, V190, P7108, DOI 10.1128/JB.00855-08; Amon J, 2009, J MOL MICROB BIOTECH, V17, P20, DOI 10.1159/000159195; Angeby KAK, 2002, J CLIN MICROBIOL, V40, P553, DOI 10.1128/JCM.40.2.553-555.2002; [Anonymous], 2013, 16072013 PNEN; Antczak M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35844-z; Berney M, 2014, P NATL ACAD SCI USA, V111, P11479, DOI 10.1073/pnas.1407034111; Chopin A, 1998, MOL MICROBIOL, V29, P664, DOI 10.1046/j.1365-2958.1998.00946.x; Deshayes C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r20; Gonzalez PJ, 2006, J INORG BIOCHEM, V100, P1015, DOI 10.1016/j.jinorgbio.2005.11.024; Hille R, 2014, CHEM REV, V114, P3963, DOI 10.1021/cr400443z; JeSSberger Nadja, 2013, BMC Res Notes, V6, P482, DOI 10.1186/1756-0500-6-482; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kapopoulou A, 2011, TUBERCULOSIS, V91, P8, DOI 10.1016/j.tube.2010.09.006; Khan A, 2008, MICROB PATHOGENESIS, V44, P71, DOI 10.1016/j.micpath.2007.08.006; Khan A, 2006, MICROB PATHOGENESIS, V41, P90, DOI 10.1016/j.micpath.2006.04.006; Khan A, 2012, MICROBIOL-SGM, V158, P301, DOI 10.1099/mic.0.054759-0; Malm S, 2009, MICROBIOL-SGM, V155, P1332, DOI 10.1099/mic.0.023275-0; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Morozkina EV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1151, DOI 10.1134/S0006297907100124; Morozkina EV, 2007, APPL BIOCHEM MICRO+, V43, P544, DOI 10.1134/S0003683807050079; Narrandes NC, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0355-2; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pecsi I, 2014, MBIO, V5, DOI 10.1128/mBio.01093-14; Richardson DJ, 2001, CELL MOL LIFE SCI, V58, P165, DOI 10.1007/PL00000845; Richardson DJ, 1999, CURR OPIN CHEM BIOL, V3, P207, DOI 10.1016/S1367-5931(99)80034-9; Sears HJ, 1997, ARCH MICROBIOL, V167, P61, DOI 10.1007/s002030050417; SIDDIQUI RA, 1993, J BACTERIOL, V175, P5867, DOI 10.1128/JB.175.18.5867-5876.1993; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Sohaskey CD, 2003, J BACTERIOL, V185, P7247, DOI 10.1128/JB.185.24.7247-7256.2003; Tan W, 2020, J BIOL CHEM, V295, P5051, DOI 10.1074/jbc.RA120.012859; Thamdrup B, 2012, ANNU REV ECOL EVOL S, V43, P407, DOI 10.1146/annurev-ecolsys-102710-145048; Tsikas D, 2007, J CHROMATOGR B, V851, P51, DOI 10.1016/j.jchromb.2006.07.054; Wayne L. G., 1998, Tubercle and Lung Disease, V79, P127, DOI 10.1054/tuld.1998.0015; Weber I, 2000, MOL MICROBIOL, V35, P1017, DOI 10.1046/j.1365-2958.2000.01794.x; Williams MJ, 2011, J BACTERIOL, V193, P98, DOI 10.1128/JB.00774-10	35	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245745	10.1371/journal.pone.0245745	http://dx.doi.org/10.1371/journal.pone.0245745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471823	gold, Green Published			2022-12-26	WOS:000639428800037
J	Kurose, S; Onishi, K; Takao, N; Miyauchi, T; Takahashi, K; Kimura, Y				Kurose, Satoshi; Onishi, Katsuko; Takao, Nana; Miyauchi, Takumi; Takahashi, Kazuhisa; Kimura, Yutaka			Association of serum adiponectin and myostatin levels with skeletal muscle in patients with obesity: A cross-sectional study	PLOS ONE			English	Article							ENDOTHELIAL FUNCTION; INSULIN SENSITIVITY; MASS; ADIPOCYTE; EXERCISE; RESISTANCE; STRENGTH; DECREASE; MICE	Background Adiponectin has been reported to be associated with lower skeletal muscle mass and skeletal strength and may be involved in skeletal muscle regulation along with myostatin. This study aims to evaluate the association between serum adiponectin and myostatin levels and identify independent factors using body composition and metabolic parameters in patients with obesity. Methods Overall, 148 patients (age, 45.9 +/- 14.3 years, body mass index, 37.2 +/- 8.0 kg/m(2)) who initially visited the outpatient clinic of obesity between November 2013 and November 2019 were included. Body composition was measured using InBody 720 and dual energy X-ray absorptiometry. In addition, muscle strength, vascular function, and metabolic parameters were measured. Serum levels of adiponectin, leptin, myostatin, and irisin were measured from blood samples. Results The serum adiponectin level was 2.9 mu g/mL (1.7-4.1 mu g/mL), and the serum myostatin level was 2398.4 pg/mL (1,777.1-2952.5 pg/mL). The stepwise regression analysis revealed less leg strength, homeostasis model assessment of insulin resistance, and C-reactive protein as an independent predictor of serum adiponectin levels based on the significance of the univariate analysis (R-2 = 0.190, P < 0.001). A high appendicular lean mass/body weight, reactive hyperemia index, and irisin were independent factors for serum myostatin levels (R-2 = 0.260, P < 0.001) Conclusion The serum adiponectin level was associated with less muscle strength. Although serum myostatin was associated with a high appendicular lean mass, it is possible that myostatin was regulated by the percentage of body weight from appendicular lean mass.	[Kurose, Satoshi; Onishi, Katsuko; Kimura, Yutaka] Kansai Med Univ, Dept Hlth Sci, Hirakata, Osaka, Japan; [Takao, Nana; Miyauchi, Takumi; Kimura, Yutaka] Kansai Med Univ Hosp, Hlth Sci Ctr, Hirakata, Osaka, Japan; [Takahashi, Kazuhisa] Kansai Med Univ, Dept Med 2, Hirakata, Osaka, Japan	Kansai Medical University; Kansai Medical University; Kansai Medical University	Kurose, S (corresponding author), Kansai Med Univ, Dept Hlth Sci, Hirakata, Osaka, Japan.	kurosesa@hirakata.kmu.ac.jp			Japan Society for the Promotion of Science (JSPS), KAKENHI [JP19K20026]	Japan Society for the Promotion of Science (JSPS), KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS), KAKENHI Grant Number JP19K20026.	Allen DL, 2011, MED SCI SPORT EXER, V43, P1828, DOI 10.1249/MSS.0b013e3182178bb4; Amor M, 2019, EXP CLIN ENDOCR DIAB, V127, P550, DOI 10.1055/a-0641-5546; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bellanger Tracie Manuel, 2005, J La State Med Soc, V157 Spec No 1, pS42; Bonetti PO, 2003, J AM COLL CARDIOL, V41, P1761, DOI 10.1016/S0735-1097(03)00329-2; Camporez JPG, 2016, P NATL ACAD SCI USA, V113, P2212, DOI 10.1073/pnas.1525795113; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Gorgens SW, 2015, PROG MOL BIOL TRANSL, V135, P313, DOI 10.1016/bs.pmbts.2015.07.002; Gonzalez-Gil AM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061899; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; Hamrick MW, 2006, INT J OBESITY, V30, P868, DOI 10.1038/sj.ijo.0803200; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214, DOI 10.1093/ajcn/52.2.214; Huang C, 2015, NUTR METAB CARDIOVAS, V25, P594, DOI 10.1016/j.numecd.2015.03.010; Huang C, 2014, NUTR METAB CARDIOVAS, V24, P42, DOI 10.1016/j.numecd.2013.03.006; Huh JY, 2014, INT J OBESITY, V38, P1538, DOI 10.1038/ijo.2014.42; Ingelsson E, 2009, J CLIN ENDOCR METAB, V94, P953, DOI 10.1210/jc.2008-1772; Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058; Kirk B, 2020, CURR OSTEOPOROS REP, V18, P388, DOI 10.1007/s11914-020-00599-y; Krause MP, 2008, AM J PHYSIOL-CELL PH, V295, pC203, DOI 10.1152/ajpcell.00030.2008; Kurose S, 2014, OBES RES CLIN PRACT, V8, pE106, DOI 10.1016/j.orcp.2012.10.005; Li FN, 2017, CYTOKINE GROWTH F R, V33, P73, DOI 10.1016/j.cytogfr.2016.10.003; Liu XH, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14152; Loncar G, 2013, EUR J INTERN MED, V24, P818, DOI 10.1016/j.ejim.2013.09.011; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Nishizawa H, 2002, DIABETES, V51, P2734, DOI 10.2337/diabetes.51.9.2734; Parida S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102519; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Peng LN, 2018, J CACHEXIA SARCOPENI, V9, P635, DOI 10.1002/jcsm.12302; Qiu SQ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000854; Sampaio RAC, 2014, GERIATR GERONTOL INT, V14, P109, DOI 10.1111/ggi.12206; Tanaka M, 2018, DIABETES RES CLIN PR, V142, P195, DOI 10.1016/j.diabres.2018.05.041	33	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245678	10.1371/journal.pone.0245678	http://dx.doi.org/10.1371/journal.pone.0245678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465151	Green Published, gold			2022-12-26	WOS:000611969200030
J	Zivich, PN; Huang, W; Walsh, A; Dutta, P; Eisenberg, M; Aiello, AE				Zivich, Paul N.; Huang, Will; Walsh, Ali; Dutta, Prabal; Eisenberg, Marisa; Aiello, Allison E.			Measuring office workplace interactions and hand hygiene behaviors through electronic sensors: A feasibility study	PLOS ONE			English	Article							INFECTIOUS-DISEASES; CONTACT DIARIES; TRANSMISSION	Office-based workplaces are an important but understudied context for infectious disease transmission. We examined the feasibility of two different sensors (Opos and Bluetooth beacons) for collecting person-to-person contacts and hand hygiene in office-based workplaces. Opo is an interaction sensor that captures sensor-to-sensor interactions through ultrasonic frequencies, which correspond to face-to-face contacts between study participants. Opos were additionally used to measure hand hygiene events by affixing sensors to soap and alcohol-based hand sanitizer dispensers. Bluetooth beacons were used in conjunction with a smartphone application and recorded proximity contacts between study participants. Participants in two office sites were followed for one-week in their workplace in March 2018. Contact patterns varied by time of day and day of the week. Face-to-face contacts were of shorter mean duration than proximity contacts. Supervisors had fewer proximity contacts but more face-to-face contacts than non-supervisors. Self-reported hand hygiene was substantively higher than sensor-collected hand hygiene events and duration of hand washing events was short (median: 9 seconds, range: 2.5-33 seconds). Given that office settings are key environments in which working age populations spend a large proportion of their time and interactions, a better characterization of empirical social networks and hand hygiene behaviors for workplace interactions are needed to mitigate outbreaks and prepare for pandemics. Our study demonstrates that implementing sensor technologies for tracking interactions and behaviors in offices is feasible and can provide new insights into real-world social networks and hygiene practices. We identified key social interactions, variability in hand hygiene, and differences in interactions by workplace roles. High-resolution network data will be essential for identifying the most effective ways to mitigate infectious disease transmission and develop pandemic preparedness plans for the workplace setting.	[Zivich, Paul N.; Aiello, Allison E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Zivich, Paul N.; Aiello, Allison E.] Carolina Populat Ctr, Chapel Hill, NC 27516 USA; [Huang, Will; Dutta, Prabal] Univ Calif Berkley, Coll Engn, Berkeley, CA USA; [Walsh, Ali] Univ Michigan, Sch Nursing, Dept Syst Populat & Leadership, Ann Arbor, MI 48109 USA; [Eisenberg, Marisa] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Berkeley; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Aiello, AE (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.; Aiello, AE (corresponding author), Carolina Populat Ctr, Chapel Hill, NC 27516 USA.	aaiello@unc.edu	Walsh, Alison (Ali) R./ABF-3163-2021	Walsh, Alison (Ali) R./0000-0002-6123-5730	GOJO Industries Incorporated; National Institute of Child Health and Human Development [T32HD091058]	GOJO Industries Incorporated; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by a financial gift from GOJO Industries Incorporated (http://gojo.com/en?sc_lang=en) awarded to Allison E Aiello. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Institute of Child Health and Human Development, T32HD091058, Paul N Zivich.	[Anonymous], 2019, AM TIM US SURV SUMM; BROUGHALL JM, 1984, J HOSP INFECT, V5, P447, DOI 10.1016/0195-6701(84)90016-1; Contzen N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136445; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P751, DOI 10.15585/mmwr.mm6924e1; DeMaio T., 1984, SURVEYING SUBJECTIVE, P257, DOI 10.2458/v7i2.20321; Ellingson K, 2014, INFECT CONT HOSP EP, V35, P937, DOI [10.1086/677145, 10.1017/S0899823X00193900]; Ferguson N, 2007, NATURE, V446, P733, DOI 10.1038/446733a; Funk S, 2015, EPIDEMICS-NETH, V10, P21, DOI 10.1016/j.epidem.2014.09.005; Gostin LO, 2020, JAMA-J AM MED ASSOC, V323, P2137, DOI 10.1001/jama.2020.5460; Hovi T, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0691-4; Jenner EA, 2006, J HOSP INFECT, V63, P418, DOI 10.1016/j.jhin.2006.03.012; Larson EL, 2004, ASSESSING NURSES HAN; Leecaster M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153690; Machinery AfC, 2014; Mastrandrea Rossana, 2015, BMC Res Notes, V8, P426, DOI 10.1186/s13104-015-1409-0; Mastrandrea R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136497; Nematian SSS, 2017, AM J INFECT CONTROL, V45, pE65, DOI 10.1016/j.ajic.2017.03.007; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; Smieszek T, 2012, EPIDEMIOL INFECT, V140, P744, DOI 10.1017/S0950268811001130; Smieszek T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-136; Surgeoner BV, 2009, J ENVIRON HEALTH, V72, P24; Swoboda SM, 2004, CRIT CARE MED, V32, P358, DOI 10.1097/01.CCm.0000108866.48795.0F; Thumma J, 2009, AM J INFECT CONTROL, V37, P70, DOI 10.1016/j.ajic.2007.12.008; VanderWeele TJ, 2019, INT J EPIDEMIOL, V48, P1032, DOI 10.1093/ije/dyz010; Venkatesh AK, 2008, AM J INFECT CONTROL, V36, P199, DOI 10.1016/j.ajic.2007.11.005; Zivich PN, 2018, AM J INFECT CONTROL, V46, P448, DOI 10.1016/j.ajic.2017.10.006	27	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0243358	10.1371/journal.pone.0243358	http://dx.doi.org/10.1371/journal.pone.0243358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465139	Green Published, gold			2022-12-26	WOS:000611969200043
J	Souto, BD; de Araujo, ACB; Hamann, PRV; Bastos, AD; Cunha, ID; Peixoto, J; Kruger, RH; Noronha, EF; Quirino, BF				Souto, Betulia de Morais; de Araujo, Ana Carolina Bitencourt; Hamann, Pedro Ricardo Vieira; Bastos, Andressa de Rezende; Cunha, Isabel de Souza; Peixoto, Julianna; Kruger, Ricardo Henrique; Noronha, Eliane Ferreira; Quirino, Betania Ferraz			Functional screening of a Caatinga goat (Capra hircus) rumen metagenomic library reveals a novel GH3 beta-xylosidase	PLOS ONE			English	Article							FAMILY 43; SEQUENCE ALIGNMENT; PURIFICATION; HYDROLYSIS; EXPRESSION; IDENTIFICATION; BIOTECHNOLOGY; GENERATION; PREDICTION; PREVOTELLA	Functional screening of metagenomic libraries is an effective approach for identification of novel enzymes. A Caatinga biome goat rumen metagenomic library was screened using esculin as a substrate, and a gene from an unknown bacterium encoding a novel GH3 enzyme, BGL11, was identified. None of the BGL11 closely related genes have been previously characterized. Recombinant BGL11 was obtained and kinetically characterized. Substrate specificity of the purified protein was assessed using seven synthetic aryl substrates. Activity towards nitrophenyl-beta-D-glucopyranoside (pNPG), 4-nitrophenyl-beta-D-xylopyranoside (pNPX) and 4-nitrophenyl-beta-D-cellobioside (pNPC) suggested that BGL11 is a multifunctional enzyme with beta-glucosidase, beta-xylosidase, and cellobiohydrolase activities. However, further testing with five natural substrates revealed that, although BGL11 has multiple substrate specificity, it is most active towards xylobiose. Thus, in its native goat rumen environment, BGL11 most likely functions as an extracellular beta-xylosidase acting on hemicellulose. Biochemical characterization of BGL11 showed an optimal pH of 5.6, and an optimal temperature of 50 degrees C. Enzyme stability, an important parameter for industrial application, was also investigated. At 40 degrees C purified BGL11 remained active for more than 15 hours without reduction in activity, and at 50 degrees C, after 7 hours of incubation, BGL11 remained 60% active. The enzyme kinetic parameters of K-m and V-max using xylobiose were determined to be 3.88 mM and 38.53 mu mol.min(-1).mg(-1), respectively, and the K-cat was 57.79 s(-1). In contrast to BLG11, most beta-xylosidases kinetically studied belong to the GH43 family and have been characterized only using synthetic substrates. In industry, beta-xylosidases can be used for plant biomass deconstruction, and the released sugars can be fermented into valuable bio-products, ranging from the biofuel ethanol to the sugar substitute xylitol.	[Souto, Betulia de Morais; de Araujo, Ana Carolina Bitencourt; Bastos, Andressa de Rezende; Quirino, Betania Ferraz] Embrapa Agroenergy, Genet & Biotechnol Lab, Brasilia, DF, Brazil; [Hamann, Pedro Ricardo Vieira; Peixoto, Julianna; Kruger, Ricardo Henrique; Noronha, Eliane Ferreira] Univ Brasilia, Dept Cellular Biol, Enzymol Lab, Brasilia, DF, Brazil; [Cunha, Isabel de Souza] Univ Catolica Brasilia, Genom Sci & Biotechnol Program, Brasilia, DF, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Universidade Catolica de Brasilia	Quirino, BF (corresponding author), Embrapa Agroenergy, Genet & Biotechnol Lab, Brasilia, DF, Brazil.	betania.quirino@embrapa.br	Noronha, Eliane F./D-4812-2016; Hamann, Pedro/ABC-5184-2021	Hamann, Pedro/0000-0002-6654-0646	FAP-DF; CNPq; CAPES; Macroprograma 2 Embrapa	FAP-DF(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Macroprograma 2 Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA))	This work was suported by grants from FAP-DF, CNPq, CAPES and Macroprograma 2 Embrapa.	Alahuhta M, 2010, ACTA CRYSTALLOGR F, V66, P878, DOI 10.1107/S1744309110022529; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An LL, 2005, LEUKEMIA RES, V29, P535, DOI 10.1016/j.leukres.2004.11.009; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; Bosetto A, 2016, APPL BIOCHEM BIOTECH, V178, P766, DOI 10.1007/s12010-015-1908-4; Campos E, 2014, MICROBIOL RES, V169, P213, DOI 10.1016/j.micres.2013.06.004; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CHINCHETRU MA, 1989, INT J BIOCHEM, V21, P469, DOI 10.1016/0020-711X(89)90126-2; Choengpanya K, 2015, PROTEIN EXPRES PURIF, V115, P132, DOI 10.1016/j.pep.2015.07.004; Cunha I.S., 2010, THESIS U CATOLICA BR; Cunha IS, 2009, CONSTRUCAO BIBLIOTEC; Cunha IS, 2011, ANAEROBE, V17, P118, DOI 10.1016/j.anaerobe.2011.04.018; de Jong A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-299; Dodd D, 2009, GCB BIOENERGY, V1, P2, DOI 10.1111/j.1757-1707.2009.01004.x; Dodd D, 2009, J BACTERIOL, V191, P3328, DOI 10.1128/JB.01628-08; Falck P, 2016, GLYCOBIOLOGY, V26, P193, DOI 10.1093/glycob/cwv092; Frank K, 2008, BIOINFORMATICS, V24, P2172, DOI 10.1093/bioinformatics/btn422; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Hatti-Kaul R, 2007, TRENDS BIOTECHNOL, V25, P119, DOI 10.1016/j.tibtech.2007.01.001; HEALY FG, 1995, APPL MICROBIOL BIOT, V43, P667, DOI [10.1007/s002530050468, 10.1007/BF00164771]; HOWARD BH, 1960, BIOCHEM J, V74, P173, DOI 10.1042/bj0740173; Inoue H, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2145-x; Jee JG, 2002, J BIOL CHEM, V277, P1388, DOI 10.1074/jbc.M109726200; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jordan DB, 2017, APPL BIOCHEM BIOTECH, V182, P250, DOI 10.1007/s12010-016-2324-0; Jordan DB, 2013, APPL MICROBIOL BIOT, V97, P4415, DOI 10.1007/s00253-012-4475-4; Kataeva IA, 2002, APPL ENVIRON MICROB, V68, P4292, DOI 10.1128/AEM.68.9.4292-4300.2002; Kim DR, 2018, BIOTECHNOL BIOPROC E, V23, P168, DOI 10.1007/s12257-017-0246-5; LITTLE E, 1994, J MOL EVOL, V39, P631, DOI 10.1007/BF00160409; MARTIN C, 1994, J ANIM SCI, V72, P2962, DOI 10.2527/1994.72112962x; MATSUO M, 1984, AGR BIOL CHEM TOKYO, V48, P1845, DOI 10.1080/00021369.1984.10866400; MATSUO M, 1984, AGR BIOL CHEM TOKYO, V48, P1853, DOI 10.1080/00021369.1984.10866401; Matsuzawa T, 2015, APPL MICROBIOL BIOT, V99, P8943, DOI 10.1007/s00253-015-6647-5; Michlmayr H, 2013, APPL ENVIRON MICROB, V79, P6747, DOI 10.1128/AEM.02130-13; Mohammadi S, 2019, INT J PEPT RES THER, V25, P1279, DOI 10.1007/s10989-018-9775-9; Naville M, 2011, RNA BIOL, V8, P11, DOI 10.4161/rna.8.1.13346; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; Nieto-Dominguez M, 2015, APPL ENVIRON MICROB, V81, P6380, DOI 10.1128/AEM.01744-15; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Sambrook J., 2001, MOL CLONING LAB MANU; Shi H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-27; Solovjev V, 2011, METAGENOMICITAPP, P61; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Teng C, 2011, BIORESOURCE TECHNOL, V102, P1822, DOI 10.1016/j.biortech.2010.09.055; VANDOORSLAER E, 1985, CARBOHYD RES, V140, P342, DOI 10.1016/0008-6215(85)85136-3; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Wagschal K, 2012, PROCESS BIOCHEM, V47, P366, DOI 10.1016/j.procbio.2011.07.009; Wagschal K, 2009, APPL BIOCHEM BIOTECH, V155, P304, DOI 10.1007/s12010-008-8362-5; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10; Wohlgemuth R, 2010, CURR OPIN BIOTECH, V21, P713, DOI 10.1016/j.copbio.2010.09.016; Zhang SY, 2014, PROCESS BIOCHEM, V49, P1422, DOI 10.1016/j.procbio.2014.05.020	56	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245118	10.1371/journal.pone.0245118	http://dx.doi.org/10.1371/journal.pone.0245118			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449963	Green Published, gold			2022-12-26	WOS:000609991600048
J	Torres, S; Lama, C; Mantecon, L; Flemetakis, E; Infante, C				Torres, Sonia; Lama, Carmen; Mantecon, Lalia; Flemetakis, Emmanouil; Infante, Carlos			Selection and validation of reference genes for quantitative real-time PCR in the green microalgae Tetraselmis chui	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; INTERNAL REFERENCE GENES; HOUSEKEEPING GENES; MESSENGER-RNA; PHAEODACTYLUM-TRICORNUTUM; EXPRESSION NORMALIZATION; ALPHA-TUBULIN; ALGA; CHLAMYDOMONAS; IDENTIFICATION	Quantitative real-time reverse transcription PCR (RT-qPCR) is a highly sensitive technique that can be applied to analyze how genes are modulated by culture conditions, but identification of appropriate reference genes for normalization is a critical factor to be considered. For this reason, the expression stability of 18 candidate reference genes was evaluated for the green microalgae Tetraselmis chui using the widely employed algorithms geNorm, NormFinder, BestKeeper, the comparative Delta C-T method, and RefFinder. Microalgae samples were collected from large scale outdoor photobioreactors during the growing phase (OUT_GP), and during the semi-continuous phase at different times of the day (OUT_DC). Samples from standard indoor cultures under highly controlled conditions (IND) were also collected to complement the other data. Different rankings for the candidate reference genes were obtained depending on the culture conditions and the algorithm employed. After comparison of the achieved ranks with the different methods, the references genes selected for samples from specific culture conditions were ALD and EFL in OUT_GP, RPL32 and UBCE in OUT_DC, and cdkA and UBCE in IND. Moreover, the genes EFL and cdkA or EFL and UBCE appeared as appropriate combinations for pools generated from all samples (ALL). Examination in the OUT_DC cultures of genes encoding the large and small subunits of ADP-glucose pyrophosphorylase (AGPL and AGPS, respectively) confirmed the reliability of the identified reference genes, RPL32 and UBCE. The present study represents a useful contribution for studies of gene expression in T. chui, and also represents the first step to set-up an RT-qPCR platform for quality control of T. chui biomass production in industrial facilities.	[Torres, Sonia; Lama, Carmen; Mantecon, Lalia; Infante, Carlos] Fitoplancton Marino SL, Cadiz, Spain; [Flemetakis, Emmanouil] Agr Univ Athens, Dept Biotechnol, Lab Mol Biol, Athens, Greece	Agricultural University of Athens	Infante, C (corresponding author), Fitoplancton Marino SL, Cadiz, Spain.	carlos.infante@easyalgae.com		Flemetakis, Emmanouil/0000-0003-2530-9592; Infante, Carlos/0000-0002-6158-9344	Research Council of Norway [267872]; EU project Algae4a-b "Development of Microalgae-based novel high added-value products for the Cosmetic and Aquaculture industry" [H2020-MSCA-RISE15, 691102]; Fitoplancton Marino, S.L.	Research Council of Norway(Research Council of Norway); EU project Algae4a-b "Development of Microalgae-based novel high added-value products for the Cosmetic and Aquaculture industry"; Fitoplancton Marino, S.L.	This work was co-funded by the project A2F "Algae to Future" (number 267872) from the Research Council of Norway, and by the EU project Algae4a-b "Development of Microalgae-based novel high added-value products for the Cosmetic and Aquaculture industry" (H2020-MSCA-RISE15; grant agreement 691102). Fitoplancton Marino, S.L. also provided support in the form of salaries for ST, CL, LM, and CI. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelfi MG, 2014, J EXP MAR BIOL ECOL, V451, P74, DOI 10.1016/j.jembe.2013.11.003; Aggarwal A, 2018, J MOL DIAGN, V20, P326, DOI 10.1016/j.jmoldx.2018.01.009; Aminfar Z, 2019, BIOCATAL AGR BIOTECH, V20, DOI 10.1016/j.bcab.2019.101246; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Ballicora MA, 2004, PHOTOSYNTH RES, V79, P1, DOI 10.1023/B:PRES.0000011916.67519.58; Barkia I, 2019, MAR DRUGS, V17, DOI 10.3390/md17050304; Borowitzka MA, 2018, MICROALGAE IN HEALTH AND DISEASE PREVENTION, P23, DOI 10.1016/B978-0-12-811405-6.00003-7; Branyikova I, 2011, BIOTECHNOL BIOENG, V108, P766, DOI 10.1002/bit.23016; BROWN MR, 1992, J EXP MAR BIOL ECOL, V161, P91, DOI 10.1016/0022-0981(92)90192-D; Bule Mohammed Hussen, 2018, Front Biosci (Schol Ed), V10, P197; Busi MV, 2014, STARCH-STARKE, V66, P28, DOI 10.1002/star.201200211; Cao SN, 2012, BIOCHEM BIOPH RES CO, V424, P118, DOI 10.1016/j.bbrc.2012.06.086; Carreres BM, 2019, ALGAL RES, V40, DOI 10.1016/j.algal.2019.101477; Cerezuela R, 2012, FISH PHYSIOL BIOCHEM, V38, P1729, DOI 10.1007/s10695-012-9670-9; Cerezuela R, 2012, FISH SHELLFISH IMMUN, V33, P342, DOI 10.1016/j.fsi.2012.05.004; Chapman JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141853; Chauton MS, 2013, PLANT PHYSIOL, V161, P1034, DOI 10.1104/pp.112.206177; Chen C, 2016, BRAZ J MICROBIOL, V47, P259, DOI 10.1016/j.bjm.2015.11.031; Chu P, 2016, INT J SCI, V3, P150; Chung CC, 2003, APPL ENVIRON MICROB, V69, P754, DOI 10.1128/AEM.69.2.754-759.2003; Cocquyt E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-39; Conceicao LEC, 2010, AQUAC RES, V41, P613, DOI 10.1111/j.1365-2109.2009.02242.x; de los Reyes P, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01217; De Spiegelaere W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122515; Ding Y, 2015, J APPL PHYCOL, V27, P1365, DOI 10.1007/s10811-014-0423-2; Dong MT, 2012, CURR GENET, V58, P13, DOI 10.1007/s00294-011-0361-3; Figueroa CM, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01564; Findeisen P, 2014, GENOME BIOL EVOL, V6, P2274, DOI 10.1093/gbe/evu187; Fu W, 2017, STUD NAT PROD CHEM, V54, P199, DOI 10.1016/B978-0-444-63929-5.00006-1; Gantasala Nagavara Prasad, 2013, BMC Res Notes, V6, P312, DOI 10.1186/1756-0500-6-312; Garcia JL, 2017, MICROB BIOTECHNOL, V10, P1017, DOI 10.1111/1751-7915.12800; Guarnieri MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025851; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Guo R, 2013, J APPL PHYCOL, V25, P1101, DOI 10.1007/s10811-012-9908-z; Guo R, 2012, EUR J PROTISTOL, V48, P199, DOI 10.1016/j.ejop.2011.11.001; Heimann K., 2015, HDB MARINE MICROALGA, P25, DOI DOI 10.1016/B978-0-12-800776-1.00003-0; Hovde BT, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005469; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; IGLESIAS AA, 1994, PLANT PHYSIOL, V104, P1287, DOI 10.1104/pp.104.4.1287; Ji NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132183; Kang LK, 2012, APPL ENVIRON MICROB, V78, P6051, DOI 10.1128/AEM.00935-12; Kianianmomeni A, 2013, MOL BIOL REP, V40, P6691, DOI 10.1007/s11033-013-2784-z; Kohsler M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67035-0; Kong FN, 2015, J APPL PHYCOL, V27, P1003, DOI 10.1007/s10811-014-0359-6; Koski LB, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-151; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Kumar D, 2018, J APPL GENET, V59, P419, DOI 10.1007/s13353-018-0466-1; Lauritano C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39860-5; Lee MA, 2015, ECOTOXICOLOGY, V24, P863, DOI 10.1007/s10646-015-1430-z; Letsiou S, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00221; Li B, 2014, ACTA OCEANOL SIN, V33, P152, DOI 10.1007/s13131-014-0526-2; Li L, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0839-8; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Liu CL, 2012, EXTREMOPHILES, V16, P419, DOI 10.1007/s00792-012-0441-4; Liu Q, 2020, J PHYCOL, V56, P310, DOI 10.1111/jpy.12936; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mantecon L, 2019, FOOD CHEM TOXICOL, V133, DOI 10.1016/j.fct.2019.110810; Monnier A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-192; Mou SL, 2015, J PLANT BIOCHEM BIOT, V24, P276, DOI 10.1007/s13562-014-0268-4; Niaz Z, 2019, J APPL PHYCOL, V31, P1819, DOI 10.1007/s10811-018-1664-2; Oakley RV, 2007, PLANT PHYSIOL, V145, P961, DOI 10.1104/pp.107.107086; Patelou M, 2020, ALGAL RES, V45, DOI 10.1016/j.algal.2019.101735; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poliner E, 2015, PLANT J, V83, P1097, DOI 10.1111/tpj.12944; Radakovits R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1688; Rahman NA, 2017, INT AQUAT RES, V9, P235, DOI 10.1007/s40071-017-0173-2; Rismani-Yazdi H, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-74; Rosic NN, 2011, MAR BIOTECHNOL, V13, P355, DOI 10.1007/s10126-010-9308-9; Sarker N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21723-0; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Schulze F, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4356-4; Shi XG, 2020, J APPL PHYCOL, V32, P431, DOI 10.1007/s10811-019-01961-z; Shim J, 2016, ALGAE-SEOUL, V31, P167, DOI 10.4490/algae.2016.31.5.25; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sorokina O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-36; Stanchi F, 2000, BIOCHEM BIOPH RES CO, V270, P1111, DOI 10.1006/bbrc.2000.2571; Suzuki S, 2016, GENOME BIOL EVOL, V8, P2672, DOI 10.1093/gbe/evw188; Tang X, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-017-0238-7; Tibbetts SM, 2015, J APPL PHYCOL, V27, P1109, DOI 10.1007/s10811-014-0428-x; Tirichine L, 2011, PLANT J, V66, P45, DOI 10.1111/j.1365-313X.2011.04540.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Vaz BD, 2016, CURR OPIN FOOD SCI, V7, P73, DOI 10.1016/j.cofs.2015.12.006; Wang JX, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193076; Wang Z, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49479-1; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Wu S, 2016, J OCEAN U CHINA, V15, P137, DOI 10.1007/s11802-016-2847-6; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yi ZZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040635; Zachleder V, 2014, ALGAL BIOREFINERIES, P237, DOI DOI 10.1007/978-94-007-7494-0_9; Cesare P, 2015, PHYTOCHEMISTRY, V116, P78, DOI 10.1016/j.phytochem.2015.02.024; Zhang JC, 2019, GENES-BASEL, V10, DOI 10.3390/genes10060451; Zhao ZT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06746; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405; Zones JM, 2015, PLANT CELL, V27, P2743, DOI 10.1105/tpc.15.00498	99	4	4	6	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245495	10.1371/journal.pone.0245495	http://dx.doi.org/10.1371/journal.pone.0245495			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444403	Green Published, gold			2022-12-26	WOS:000609988100069
J	Goic, M; Bozanic-Leal, MS; Badal, M; Basso, LJ				Goic, Marcel; Bozanic-Leal, Mirko S.; Badal, Magdalena; Basso, Leonardo J.			COVID-19: Short-term forecast of ICU beds in times of crisis	PLOS ONE			English	Article							SERIES; MODELS; PREDICTION; EPIDEMIC; PACKAGE; SPREAD	By early May 2020, the number of new COVID-19 infections started to increase rapidly in Chile, threatening the ability of health services to accommodate all incoming cases. Suddenly, ICU capacity planning became a first-order concern, and the health authorities were in urgent need of tools to estimate the demand for urgent care associated with the pandemic. In this article, we describe the approach we followed to provide such demand forecasts, and we show how the use of analytics can provide relevant support for decision making, even with incomplete data and without enough time to fully explore the numerical properties of all available forecasting methods. The solution combines autoregressive, machine learning and epidemiological models to provide a short-term forecast of ICU utilization at the regional level. These forecasts were made publicly available and were actively used to support capacity planning. Our predictions achieved average forecasting errors of 4% and 9% for one- and two-week horizons, respectively, outperforming several other competing forecasting models.	[Goic, Marcel; Bozanic-Leal, Mirko S.; Badal, Magdalena] Univ Chile, Dept Ind Engn, Santiago, Chile; [Bozanic-Leal, Mirko S.; Badal, Magdalena; Basso, Leonardo J.] Inst Sistemas Complejos Ingn ISCI, Santiago, Chile; [Basso, Leonardo J.] Univ Chile, Dept Civil Engn, Santiago, Chile	Universidad de Chile; Universidad de Chile	Goic, M (corresponding author), Univ Chile, Dept Ind Engn, Santiago, Chile.	mgoic@uchile.cl	Basso, Leonardo J./H-8799-2013; Goic, Marcel/AAI-8057-2020	Basso, Leonardo J./0000-0001-9097-6266; Goic, Marcel/0000-0002-9782-7447	Instituto Sistemas Complejos de Ingenieri'a, ISCI [ANID PIA AFB180003]; Instituto Milenio para la investigacio'n de imperfecciones de mercado y poli'ticas pu' blicas [IS130002]	Instituto Sistemas Complejos de Ingenieri'a, ISCI; Instituto Milenio para la investigacio'n de imperfecciones de mercado y poli'ticas pu' blicas	All authors acknowledge financial support from Instituto Sistemas Complejos de Ingenieri ' a, ISCI (grant ANID PIA AFB180003). web: https://isci.cl/Marcel Goic also acknowledges partial funding Instituto Milenio para la investigacio ' n de imperfecciones de mercado y poli ' ticas pu ' blicas IS130002. web: http://mipp.cl/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham G, 2009, IEEE T INF TECHNOL B, V13, P380, DOI 10.1109/TITB.2009.2014565; ARMSTRONG JS, 1989, INT J FORECASTING, V5, P585, DOI 10.1016/0169-2070(89)90013-7; BATES JM, 1969, OPER RES QUART, V20, P451, DOI 10.2307/3008764; Bentez-Pena S, 2020, SPARSE ENSEMBLE METH; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Cancino A, 2020, 2 CMMAM2VCEPS; Cancino A, 2020, TECHNICAL REPORT; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; CLEMEN RT, 1989, INT J FORECASTING, V5, P559, DOI 10.1016/0169-2070(89)90012-5; Clements M., 2004, ECONOMET J, V7, P1, DOI DOI 10.1111/J.1368-423X.2004.00119.X; Clouse DS, 1997, IEEE T NEURAL NETWOR, V8, P1065, DOI 10.1109/72.623208; COVID I., 2020, MEDRXIV, V114, DOI [10.1101/2020.03.27.20043752, DOI 10.1101/2020.03.27.20043752]; Crone SF, 2010, NEUROCOMPUTING, V73, P1923, DOI 10.1016/j.neucom.2010.01.017; Dag O, 2016, R J, V8, P379; Ribeiro MHD, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109853; De Livera AM, 2011, J AM STAT ASSOC, V106, P1513, DOI 10.1198/jasa.2011.tm09771; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Elliott G, 2004, J ECONOMETRICS, V122, P47, DOI 10.1016/j.jeconom.2003.10.019; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Farlow SJ, 1984, SELF ORG METHODS MOD, V54; Galetsi P, 2020, J OPER RES SOC, V71, P1511, DOI 10.1080/01605682.2019.1630328; Gallant S I, 1990, IEEE Trans Neural Netw, V1, P179, DOI 10.1109/72.80230; Gatto M, 2020, P NATL ACAD SCI USA, V117, P10484, DOI 10.1073/pnas.2004978117; GRANGER CWJ, 1984, J FORECASTING, V3, P197, DOI 10.1002/for.3980030207; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Hill T, 1996, MANAGE SCI, V42, P1082, DOI 10.1287/mnsc.42.7.1082; Hu Z., 2020, INT J ED EXCELL, DOI DOI 10.18562/IJEE.054; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Hyndman RJ, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i03; IVAKHNENKO AG, 1970, AUTOMATICA, V6, P207, DOI 10.1016/0005-1098(70)90092-0; Ivorra B, 2020, COMMUN NONLINEAR SCI, V88, DOI 10.1016/j.cnsns.2020.105303; Jewell NP, 2020, JAMA-J AM MED ASSOC, V323, P1893, DOI 10.1001/jama.2020.6585; Jones Simon Andrew, 2002, Health Care Manag Sci, V5, P297, DOI 10.1023/A:1020390425029; Jose VRR, 2008, INT J FORECASTING, V24, P163, DOI 10.1016/j.ijforecast.2007.06.001; Kao RR, 2014, TRENDS MICROBIOL, V22, P282, DOI 10.1016/j.tim.2014.02.011; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; KWIATKOWSKI D, 1992, J ECONOMETRICS, V54, P159, DOI 10.1016/0304-4076(92)90104-Y; Littig Steven J, 2007, Health Care Manag Sci, V10, P47, DOI 10.1007/s10729-006-9000-9; MANYIKA JAMES, 2011, BIG DATA NEXT FRONTI, P2; Moral RdA, 2020, ARXIV200600111; Moritz S, 2017, R J, V9, P207; Nambiar R, 2013, IEEE INT CONF BIG DA; Nowotarski J, 2014, ENERG ECON, V46, P395, DOI 10.1016/j.eneco.2014.07.014; Papastefanopoulos V, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10113880; Perc M, 2020, FRONT PHYS-LAUSANNE, V8, DOI 10.3389/fphy.2020.00127; Petropoulos F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231236; Phua Jason, 2020, Lancet Respir Med, V8, P506, DOI 10.1016/S2213-2600(20)30161-2; Raghupathi W, 2014, HEALTH INF SCI SYST, V2, DOI 10.1186/2047-2501-2-3; Rainisch G, 2020, INT J INFECT DIS, V96, P376, DOI 10.1016/j.ijid.2020.05.043; Roda WC, 2020, INFECT DIS MODEL, V5, P271, DOI 10.1016/j.idm.2020.03.001; Roosa K, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020596; Schweigler LM, 2009, ACAD EMERG MED, V16, P301, DOI 10.1111/j.1553-2712.2009.00356.x; Stock JH, 1999, J MONETARY ECON, V44, P293, DOI 10.1016/S0304-3932(99)00027-6; Tang JX, 2016, IEEE T NEUR NET LEAR, V27, P809, DOI 10.1109/TNNLS.2015.2424995; Taylor SJ, 2018, AM STAT, V72, P37, DOI 10.1080/00031305.2017.1380080; Uhlig S., 2020, MODELING PROJECTIONS; Villas-Boas SB, 2020, ARE WE STAYINGHOME F; Wang PP, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110058; Ward MJ, 2014, BUS HORIZONS, V57, P571, DOI 10.1016/j.bushor.2014.06.003; Yang YH, 2004, ECONOMET THEOR, V20, P176, DOI 10.1017/S0266466604201086; Yang ZF, 2020, J THORAC DIS, V12, P165, DOI 10.21037/jtd.2020.02.64; Zou H, 2004, INT J FORECASTING, V20, P69, DOI 10.1016/S0169-2070(03)00004-9	63	19	19	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0245272	10.1371/journal.pone.0245272	http://dx.doi.org/10.1371/journal.pone.0245272			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4UT	33439917	gold, Green Published			2022-12-26	WOS:000609985300047
J	Villegas, M; Loiselle, BA; Kimball, RT; Blake, JG				Villegas, Mariana; Loiselle, Bette A.; Kimball, Rebecca T.; Blake, John G.			Ecological niche differentiation in Chiroxiphia and Antilophia manakins (Aves: Pipridae)	PLOS ONE			English	Article							PREDICTING SPECIES DISTRIBUTIONS; DISTRIBUTION MODELS; CONSERVATISM; BIRDS; SPECIATION; EVOLUTION; RANGES; FOREST; CLASSIFICATION; BIODIVERSITY	Species distribution models are useful for identifying the ecological characteristics that may limit a species' geographic range and for inferring patterns of speciation. Here, we test a hypothesis of niche conservatism across evolutionary time in a group of manakins (Aves: Pipridae), with a focus on Chiroxiphia boliviana, and examine the degree of ecological differentiation with other Chiroxiphia and Antilophia manakins. We tested whether allopatric sister species were more or less similar in environmental space than expected given their phylogenetic distances, which would suggest, respectively, ecological niche conservatism over time or ecologically mediated selection (i.e. niche divergence). We modeled the distribution of nine manakin taxa (C. boliviana, C. caudata, C. lanceolata, C. linearis, C. p. pareola, C. p. regina, C. p. napensis, Antilophia galeata and A. bokermanni) using Maxent. We first performed models for each taxon and compared them. To test our hypothesis we followed three approaches: (1) we tested whether C. boliviana could predict the distribution of the other manakin taxa and vice versa; (2) we compared the ecological niches by using metrics of niche overlap, niche equivalency and niche similarity; and (3) lastly, we tested whether niche differentiation corresponded to phylogenetic distances calculated from two recent phylogenies. All models had high training and test AUC values. Mean AUC ratios were high (>0.8) for most taxa, indicating performance better than random. Results suggested niche conservatism, and high niche overlap and equivalency between C. boliviana and C. caudata, but we found very low values between C. boliviana and the rest of the taxa. We found a negative, but not significant, relationship between niche overlap and phylogenetic distance, suggesting an increase in ecological differentiation and niche divergence over evolutionary time. Overall, we give some insights into the evolution of C. boliviana, proposing that ecological selection may have influenced its speciation.	[Villegas, Mariana; Loiselle, Bette A.; Blake, John G.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32609 USA; [Loiselle, Bette A.] Univ Florida, Ctr Latin Amer Studies, Gainesville, FL USA; [Kimball, Rebecca T.] Univ Florida, Dept Biol, Gainesville, FL USA; [Villegas, Mariana] Univ Saskatchewan, Dept Vet Pathol & Environm & Climate Change Canad, Saskatoon, SK, Canada	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Saskatchewan	Villegas, M (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32609 USA.; Villegas, M (corresponding author), Univ Saskatchewan, Dept Vet Pathol & Environm & Climate Change Canad, Saskatoon, SK, Canada.	mariana.villegas@gmail.com		Villegas, Mariana/0000-0001-9944-7272	College of Agricultural and Life Sciences at the University of Florida; Manakin Genomics RCN [NSF-DEB 1457541]	College of Agricultural and Life Sciences at the University of Florida; Manakin Genomics RCN	This research was funded by a Matching Assistantship from the College of Agricultural and Life Sciences at the University of Florida, awarded to M.V. There was no additional external funding received for this study.; We thank M. AnciAes for kindly providing occurrence locations and for her comments on some earlier models; and also I. Areta and J.P. Gomez for kindly providing additional occurrence locations of C. boliviana and C. lanceolata, respectively. We are particularly thankful to S.M. Silva and R. Leite for sharing trees of the clade, and with the Manakin Genomics RCN (Grant No. NSF-DEB 1457541) for the fruitful discussions and collaborations which contributed to this work. We are indebted to eBird and the numerous provider museums, GBIF and ORNIS, as well as to R.L. Hijmans and colleagues for respectively making occurrence locations and global climate data freely available on the Web. This study was part of the PhD dissertation of M.V., at the Department of Wildlife Ecology and Conservation, University of Florida.	Anciaes M, 2006, CONDOR, V108, P778, DOI 10.1650/0010-5422(2006)108[778:CCEONM]2.0.CO;2; Anciaes M, 2009, J AVIAN BIOL, V40, P591, DOI 10.1111/j.1600-048X.2009.04597.x; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2010, MAPPING SPECIES DIST; Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Barve N, 2008, TOOL PARTIAL ROC 1 0; Barve N., 2013, ENMGADGETS TOOLS PRE; Batalha H, 2013, J ORNITHOL, V154, P41, DOI 10.1007/s10336-012-0866-7; BATES JM, 1994, AUK, V111, P507; Bates JM, 1998, J BIOGEOGR, V25, P783, DOI 10.1046/j.1365-2699.1998.2540783.x; Brawn JD, 2017, NAT CLIM CHANGE, V7, P133, DOI [10.1038/nclimate3183, 10.1038/NCLIMATE3183]; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Brumfield RT, 2001, EVOLUTION, V55, P2070; Buermann W, 2008, J BIOGEOGR, V35, P1160, DOI 10.1111/j.1365-2699.2007.01858.x; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Cadena CD, 2012, P ROY SOC B-BIOL SCI, V279, P194, DOI 10.1098/rspb.2011.0720; Duraes R, 2008, BEHAV ECOL SOCIOBIOL, V62, P1947, DOI 10.1007/s00265-008-0626-0; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Feilhauer H, 2012, REMOTE SENS-BASEL, V4, P2057, DOI 10.3390/rs4072057; Feng X, 2019, NAT ECOL EVOL, V3, P1382, DOI 10.1038/s41559-019-0972-5; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Freeman BG, 2015, AM NAT, V186, P470, DOI 10.1086/682703; Godsoe W, 2009, NEW PHYTOL, V183, P589, DOI 10.1111/j.1469-8137.2009.02942.x; Graham CH, 2010, J BIOGEOGR, V37, P1863, DOI 10.1111/j.1365-2699.2010.02356.x; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Grinnell J., 1917, Auk Cambridge Mass, V34; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hasui E, 2009, STUD NEOTROP FAUNA E, V44, P149, DOI 10.1080/01650520903381729; Hijmans RJ, 2004, DIVA GIS VERSION 7 1; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jiguet F, 2010, J FIELD ORNITHOL, V81, P325, DOI 10.1111/j.1557-9263.2010.00289.x; Kirwan GM, 2012, COTINGAS MANAKINS; Knouft JH, 2006, ECOLOGY, V87, pS29, DOI 10.1890/0012-9658(2006)87[29:PAOTEO]2.0.CO;2; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; Loiselle BA, 2007, AUK, V124, P420, DOI 10.1642/0004-8038(2007)124[420:EASSOL]2.0.CO;2; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Macleod R, 2005, BIRD CONSERV INT, V15, P361, DOI 10.1017/S095927090500064X; Martin MD, 2011, AM MIDL NAT, V166, P404, DOI 10.1674/0003-0031-166.2.404; Martinez-Meyer E, 2006, J BIOGEOGR, V33, P1779, DOI [10.1111/j.1365-2699.2006.01612.x, 10.1111/j.1365-2699.2006.01482_33_10.x]; McCormack JE, 2010, EVOLUTION, V64, P1231, DOI 10.1111/j.1558-5646.2009.00900.x; McDonald DB, 2001, EVOLUTION, V55, P1443; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Ohlson JI, 2013, MOL PHYLOGENET EVOL, V69, P796, DOI 10.1016/j.ympev.2013.06.024; Owens HL, 2020, ECOL EVOL, V10, P6967, DOI 10.1002/ece3.6359; Parra JL, 2004, ECOGRAPHY, V27, P350, DOI 10.1111/j.0906-7590.2004.03822.x; Parra JL, 2010, AM NATURALIST, V176, P537, DOI [10.1086/656495, DOI 10.1086/656495]; Pearman PB, 2010, ECOGRAPHY, V33, P990, DOI 10.1111/j.1600-0587.2010.06443.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pyron RA, 2015, BIOL REV, V90, P1248, DOI 10.1111/brv.12154; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Ramirez-Villegas J, 2014, J NAT CONSERV, V22, P391, DOI 10.1016/j.jnc.2014.03.007; Rato C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127980; Rice NH, 2003, BIOL J LINN SOC, V80, P369, DOI 10.1046/j.1095-8312.2003.00242.x; Richardson, 2005, WORLDCLIM VERSION 13; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Scott GR, 2011, J EXP BIOL, V214, P2455, DOI 10.1242/jeb.052548; Shipley JR, 2013, AUK, V130, P476, DOI 10.1525/auk.2013.12151; Sick H, 1985, ORNITHOLOGICAL MONOG, V36, P233; Silva DP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113246, 10.1371/journal.pone.0096846]; Silva SM, 2018, MOL PHYLOGENET EVOL, V127, P706, DOI 10.1016/j.ympev.2018.06.016; Skeels A, 2019, AM NAT, V193, P240, DOI 10.1086/701125; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Steinbauer MJ, 2016, GLOBAL ECOL BIOGEOGR, V25, P792, DOI 10.1111/geb.12425; Strubbe D, 2014, BIOL INVASIONS, V16, P759, DOI 10.1007/s10530-013-0539-3; Tello JG, 2009, CLADISTICS, V25, P429, DOI 10.1111/j.1096-0031.2009.00254.x; U.S. Geological Survey, 2016, DIG EL MOD DEM HYDR; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Werneck FP, 2011, QUATERNARY SCI REV, V30, P1630, DOI 10.1016/j.quascirev.2011.03.009; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Williams SE, 2008, DIVERS DISTRIB, V14, P69, DOI 10.1111/j.1472-4642.2007.00418.x; Zink RM, 2014, J BIOGEOGR, V41, P999, DOI 10.1111/jbi.12252; Zurell D, 2018, J BIOGEOGR, V45, P1459, DOI 10.1111/jbi.13351	82	3	3	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0243760	10.1371/journal.pone.0243760	http://dx.doi.org/10.1371/journal.pone.0243760			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439873	Green Published, gold			2022-12-26	WOS:000609985300031
J	Vega-Solano, J; Blanco-Metzler, A; Madriz-Morales, K; Fernandes-Nilson, EA; Labonte, ME				Vega-Solano, Jaritza; Blanco-Metzler, Adriana; Madriz-Morales, Karol; Fernandes-Nilson, Eduardo-Augusto; Labonte, Marie Eve			Impact of salt intake reduction on CVD mortality in Costa Rica: A scenario modelling study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; CANCER; DIET	Cardiovascular diseases (CVD) represent the leading cause of death in Costa Rica and high blood pressure was associated with a mortality rate of 29% in 2018. The average household sodium intake in the country is also two times higher than the World Health Organization recommendation. The objective of this study was to estimate the impact of reducing salt intake on CVD mortality in Costa Rica using a scenario simulation model. The Preventable Risk Integrated ModEl (PRIME) was used to estimate the number of deaths that would be averted or delayed in the Costa Rican population by following the national and the international guidelines to reduce salt consumption, according to two scenarios: A) 46% reduction and B) 15% reduction, both at an energy intake of 2171 kcal. The scenarios estimated that between 4% and 13%, respectively, of deaths due to CVD would be prevented or postponed. The highest percentages of deaths prevented or postponed by type of CVD would be related to Coronary heart disease (39% and 38%, respectively), Hypertensive disease (32% and 33%, respectively), and Stroke (22% in both). The results demonstrate that reducing salt consumption could prevent or postpone an important number of deaths in Costa Rica. More support for existing policies and programs urges.	[Vega-Solano, Jaritza; Blanco-Metzler, Adriana; Madriz-Morales, Karol] Costa Rican Inst Res & Teaching Nutr & Hlth INCIE, Tres Rios, Cartago, Costa Rica; [Fernandes-Nilson, Eduardo-Augusto] Univ Sao Paulo, Ctr Epidemiol Res Hlth & Nutr, Sao Paulo, SP, Brazil; [Labonte, Marie Eve] Univ Laval, Ctr Nutr Sante & Soc NUTRISS, Inst Nutr & Funct Foods INAF, Quebec City, PQ, Canada	Universidade de Sao Paulo; Laval University	Blanco-Metzler, A (corresponding author), Costa Rican Inst Res & Teaching Nutr & Hlth INCIE, Tres Rios, Cartago, Costa Rica.	ablanco@inciensa.sa.cr		Labonte, Marie-Eve/0000-0001-9745-0443	IDRC PROJECT [108167]; International Development Reserch Center of Canada	IDRC PROJECT; International Development Reserch Center of Canada	A.B.M. awarded IDRC PROJECT 108167, from "The International Development Reserch Center of Canada". Website: https://www.idrc.ca/en The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Belanger M, 2014, PUBLIC HEALTH, V128, P222, DOI 10.1016/j.puhe.2013.11.003; Blanco-Metzler A, 2016, IMPLEMENTACION PROGR; Blanco-Metzler A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091020; Brouillard AM, 2019, AM J MED, V132, P1199, DOI 10.1016/j.amjmed.2019.04.040; Caja Costarricense del Seguro Social, 2011, VIG FACT RIESG CARD, P41; Castro B.V., 2017, THESIS; Colin-Ramirez Eloisa, 2017, Nutrients, V9, DOI 10.3390/nu9080810; Egnell M, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0817-2; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; Laatikainen T, 2006, EUR J CLIN NUTR, V60, P965, DOI 10.1038/sj.ejcn.1602406; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Labonte ME, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226975; Mill José Geraldo, 2019, Rev. bras. epidemiol., V22, pE190009.SUPL.2, DOI 10.1590/1980-549720190009.supl.2; Ministerio de Salud Costa, 2011, PLAN NAT DEV SAN, P3; Moreira PVL, 2018, PUBLIC HEALTH NUTR, V21, P181, DOI 10.1017/S1368980017002063; Neupane D, 2020, J CLIN HYPERTENS, V22, P273, DOI 10.1111/jch.13813; Nilson EAF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235514; Organizacion Panamericana de la Salud, 2018, SHAKE MEN SAL MAS SA; Organization W. H, 2020, H DEMENTIA; Organization WH, 2018, NONCOMMUNICABLE DIS; Pan American Health Organization (PAHO), 2013, SALT SMART AM GUID C, P91; Pietinen P, 2010, PUBLIC HEALTH NUTR, V13, P901, DOI 10.1017/S1368980010001072; Saha S, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061434; Saha S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16050890; Sarno F, 2013, REV SAUDE PUBL, V47, P571, DOI 10.1590/S0034-8910.2013047004418; Scarborough P, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/748750; Scarborough P, 2012, J EPIDEMIOL COMMUN H, V66, P420, DOI 10.1136/jech.2010.114520; Webb M, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6699; WHO, 2017, TACKLING NCDS BEST B; World Health Organization, 2012, GUID SOD INT AD CHIL; World Health Organization, ICD 11 MORT MORB STA	33	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245388	10.1371/journal.pone.0245388	http://dx.doi.org/10.1371/journal.pone.0245388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434241	Green Published, gold			2022-12-26	WOS:000609979700032
J	Peters, JL; Perry, MJ; McNeely, E; Wright, RO; Heiger-Bernays, W; Weuve, J				Peters, Junenette L.; Perry, Melissa J.; McNeely, Eileen; Wright, Robert O.; Heiger-Bernays, Wendy; Weuve, Jennifer			The association of cadmium and lead exposures with red cell distribution width	PLOS ONE			English	Article								Elevated red blood cell distribution width (RDW), traditionally an indicator of anemia, has now been recognized as a risk marker for cardiovascular disease incidence and mortality. Experimental and acute exposure studies suggest that cadmium and lead individually affect red blood cell production; however, associations between environmental exposures and RDW have not been explored. We evaluated relationships of environmental cadmium and lead exposures to RDW. We used data from 24,607 participants aged =20 years in the National Health and Nutrition Examination Survey (2003-2016) with information on blood concentrations of cadmium and lead, RDW and socio-demographic factors. In models adjusted for age, sex, race/ethnicity, education, poverty income ratio, BMI, alcohol consumption, smoking status and serum cotinine, RDW was increasingly elevated across progressively higher quartiles of blood cadmium concentration. A doubling of cadmium concentration was associated with 0.16 higher RDW (95% CI: 0.14, 0.18) and a doubling of lead concentration with 0.04 higher RDW (95% CI: 0.01, 0.06). Also, higher cadmium and lead concentrations were associated with increased odds of high RDW (RDW>14.8%). The associations were more pronounced in women and those with low-to-normal mean corpuscular volume (MCV) and held even after controlling for iron, folate or vitamin B12 deficiencies. In analysis including both metals, cadmium remained associated with RDW, whereas the corresponding association for lead was substantially attenuated. In this general population sample, blood cadmium and lead exposures were positively associated with RDW. The associations may indicate hemolytic or erythropoietic mechanisms by which exposure increases mortality risk.	[Peters, Junenette L.; Heiger-Bernays, Wendy] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA; [Perry, Melissa J.] George Washington Univ, Dept Environm & Occupat Hlth, Washington, DC USA; [McNeely, Eileen] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Wright, Robert O.] Mt Sinai Hosp, Icahn Sch Med, New York, NY USA; [Weuve, Jennifer] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Boston University; George Washington University; Harvard University; Harvard T.H. Chan School of Public Health; Icahn School of Medicine at Mount Sinai; Boston University	Peters, JL (corresponding author), Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA.	petersj@bu.edu		/0000-0003-4542-4563	Harvard University Robert Wood Johnson Health and Society Seed Grant;  [P30ES023515]	Harvard University Robert Wood Johnson Health and Society Seed Grant; 	This study was funded by the Harvard University Robert Wood Johnson Health and Society Seed Grant (JLP and JW). Funding was also received from P30ES023515 (ROW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ATSDR), 2012, TOXICOLOGICAL PROFIL; Agency for Toxic Substances and Disease Registry (ATSDR), 2007, TOXICOLOGICAL PROFIL, DOI [DOI 10.1201/9781420061888, 10.1201/9781420061888]; Aoki Y, 2017, ENVIRON RES, V155, P193, DOI 10.1016/j.envres.2017.02.016; Arbel Y, 2014, THROMB HAEMOSTASIS, V111, P300, DOI 10.1160/TH13-07-0567; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Baranowska-Bosiacka I, 2012, BRAIN RES, V1435, P56, DOI 10.1016/j.brainres.2011.11.062; Beyazit Y, 2012, HEPATO-GASTROENTEROL, V59, P1469, DOI 10.5754/hge10676; Bradman A, 2001, ENVIRON HEALTH PERSP, V109, P1079, DOI 10.2307/3454964; Bressler JP, 2004, ANN NY ACAD SCI, V1012, P142, DOI 10.1196/annals.1306.011; Camaschella C, 2015, NEW ENGL J MED, V372, P1832, DOI 10.1056/NEJMra1401038; Chen PC, 2010, AM J EPIDEMIOL, V171, P214, DOI 10.1093/aje/kwp360; Chowdhury R., 2018, BMJ-BRIT MED J, V362, pk3310, DOI [10.1136/bmj.k3310, DOI 10.1136/BMJ.K3310]; Chun YS, 2000, EUR J BIOCHEM, V267, P4198, DOI 10.1046/j.1432-1327.2000.01453.x; Dugdale AE, 2018, J LAB PRECIS MED, P3; Ellingsen TS, 2015, THROMB HAEMOSTASIS, V113, P193, DOI 10.1160/TH14-04-0335; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Fibach E, 2008, CURR MOL MED, V8, P609, DOI 10.2174/156652408786241384; Foy BH, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.22058; Friberg L, 1971, CADMIUM ENV; Genchi G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113782; George J W, 1979, Vet Clin Pathol, V8, P23; GOYER RA, 1989, TOXICOL LETT, V46, P153, DOI 10.1016/0378-4274(89)90124-0; Horiguchi H, 2000, BLOOD, V96, P3743, DOI 10.1182/blood.V96.12.3743.h8003743_3743_3747; HORIGUCHI H, 1994, ARCH TOXICOL, V68, P632, DOI 10.1007/s002040050124; Horiguchi H, 2011, TOXICOL SCI, V122, P198, DOI 10.1093/toxsci/kfr100; Horne BD, 2012, CARDIOLOGY, V122, P213, DOI 10.1159/000341244; Johri N, 2010, BIOMETALS, V23, P783, DOI 10.1007/s10534-010-9328-y; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Karabulut A, 2012, CORONARY ARTERY DIS, V23, P68, DOI 10.1097/MCA.0b013e32834f1188; Katsaros M, 2020, ANN GASTROENTEROL, V33, P348, DOI 10.20524/aog.2020.0486; LACOMBE C, 1991, AM J KIDNEY DIS, V18, P14; Li N, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/7089493; Lippi G., 2017, ACTA BIOMED, V87, P323; Lippi G, 2008, SCAND J CLIN LAB INV, V68, P745, DOI 10.1080/00365510802213550; LoghmanAdham M, 1997, ENVIRON HEALTH PERSP, V105, P928, DOI 10.4103/0019-5278.44689; Loprinzi PD, 2016, ETHNIC DIS, V26, P45, DOI 10.18865/ed.26.1.45; Madden EF, 2000, DRUG CHEM TOXICOL, V23, P1, DOI 10.1081/DCT-100100098; Messaoudi I, 2009, BIOL TRACE ELEM RES, V130, P152, DOI 10.1007/s12011-009-8324-y; Mohanty JG, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00084; Moubarac JC, 2013, REV SAUDE PUBL, V47, P104, DOI 10.1590/S0034-89102013000100014; Mucsi I, 2014, INT UROL NEPHROL, V46, P641, DOI 10.1007/s11255-013-0530-z; Navas-Acien A, 2007, ENVIRON HEALTH PERSP, V115, P472, DOI 10.1289/ehp.9785; Oh HJ, 2012, NEPHROL DIAL TRANSPL, V27, P589, DOI 10.1093/ndt/gfr307; PAGLIA DE, 1975, J CLIN INVEST, V56, P1164, DOI 10.1172/JCI108192; Patel KV, 2007, BLOOD, V109, P4663, DOI 10.1182/blood-2006-10-055384; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp163; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Peters JL, 2007, ENVIRON HEALTH PERSP, V115, P1154, DOI 10.1289/ehp.10002; Peters JL, 2010, ENVIRON RES, V110, P199, DOI 10.1016/j.envres.2009.12.004; Pierce CN, 2005, PERFUSION-UK, V20, P83, DOI 10.1191/0267659105pf793oa; Pilling LC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203504; Pires JB, 2002, TOXICOLOGY, V175, P247, DOI 10.1016/S0300-483X(02)00091-4; Rai D, 2020, HISTOLOGY RETICULOCY; Rees DC, 2003, BRIT J HAEMATOL, V120, P375, DOI 10.1046/j.1365-2141.2003.03980.x; Salvagno GL, 2015, CRIT REV CL LAB SCI, V52, P86, DOI 10.3109/10408363.2014.992064; Sanchez JR., 2020, HISTOLOGY BASOPHILIC; SAXENA S, 1988, AM J CLIN PATHOL, V89, P660, DOI 10.1093/ajcp/89.5.660; Semba RD, 2010, CLIN NUTR, V29, P600, DOI 10.1016/j.clnu.2010.03.001; Semenza GL, 2014, ANNU REV PHYSIOL, V76, P39, DOI 10.1146/annurev-physiol-021113-170322; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Skjelbakken T, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001109; Straat M, 2012, TRANSFUS MED HEMOTH, V39, P353, DOI 10.1159/000342229; Sugawara E, 1990, Kitasato Arch Exp Med, V63, P15; Tajuddin SM, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1313-6; Tellez-Plaza M, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0356-2; THOMPSON WG, 1988, ARCH INTERN MED, V148, P2128, DOI 10.1001/archinte.148.10.2128; Tsaih SW, 2001, ENVIRON HEALTH PERSP, V109, P995, DOI 10.2307/3454952; Turcato G, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.06.35; Vajpayee N., 2011, HENRYS CLIN DIAGNOSI, V22nd, P510; VALENTINE WN, 1976, J CLIN INVEST, V58, P926, DOI 10.1172/JCI108545; Wright RO, 2003, J PEDIATR-US, V142, P9, DOI 10.1067/mpd.2003.mpd0344; Zalawadiya SK, 2012, VASC MED, V17, P155, DOI 10.1177/1358863X12442443	72	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0245173	10.1371/journal.pone.0245173	http://dx.doi.org/10.1371/journal.pone.0245173			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33429420	Green Published, gold			2022-12-26	WOS:000630036100038
J	Sun, W; Wu, YH; Tang, DX; Li, XL; An, L				Sun, Wei; Wu, Yuanhua; Tang, Dongxin; Li, Xiaoliang; An, Lei			Melamine disrupts spatial reversal learning and learning strategy via inhibiting hippocampal BDNF-mediated neural activity	PLOS ONE			English	Article							LONG-TERM DEPRESSION; EXPOSURE INDUCES IMPAIRMENTS; MORRIS WATER MAZE; SYNAPTIC PLASTICITY; MEMORY-SYSTEMS; COGNITIVE DEFICITS; PREFRONTAL CORTEX; VITAMINS C; GLUTAMATERGIC TRANSMISSION; OXIDATIVE STRESS	Although several studies showed adverse neurotoxic effects of melamine on hippocampus (HPC)-dependent learning and reversal learning, the evidence for this mechanism is still unknown. We recently demonstrated that intra-hippocampal melamine injection affected the induction of long-term depression, which is associated with novelty acquisition and memory consolidation. Here, we infused melamine into the HPC of rats, and employed behavioral tests, immunoblotting, immunocytochemistry and electrophysiological methods to sought evidence for its effects on cognitive flexibility. Rats with intra-hippocampal infusion of melamine displayed dose-dependent increase in trials to the criterion in reversal learning, with no locomotion or motivation defect. Compared with controls, melamine-treated rats avoided HPC-dependent place strategy. Meanwhile, the learning-induced BDNF level in the HPC neurons was significantly reduced. Importantly, bilateral intra-hippocampal BDNF infusion could effectively mitigate the suppressive effects of melamine on neural correlate with reversal performance, and rescue the strategy bias and reversal learning deficits. Our findings provide first evidence for the effect of melamine on cognitive flexibility and suggest that the reversal learning deficit is due to the inability to use place strategy. Furthermore, the suppressive effects of melamine on BDNF-mediated neural activity could be the mechanism, thus advancing the understanding of compulsive behavior in melamine-induced and other neuropsychiatric disorders.	[Sun, Wei; Tang, Dongxin; An, Lei] Guizhou Univ Tradit Chinese Med, Behav Neurosci Lab, Affiliated Hosp 1, Guiyang, Peoples R China; [Sun, Wei; An, Lei] Guizhou Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Pediat, Guiyang, Guizhou, Peoples R China; [Wu, Yuanhua; An, Lei] Guizhou Univ Tradit Chinese Med, Dept Neurol, Affiliated Hosp 1, Guiyang, Peoples R China; [Li, Xiaoliang] Jinan Hosp, Dept Neurol, Jinan, Peoples R China	Guizhou University of Traditional Chinese Medicine; Guizhou University of Traditional Chinese Medicine; Guizhou University of Traditional Chinese Medicine	An, L (corresponding author), Guizhou Univ Tradit Chinese Med, Behav Neurosci Lab, Affiliated Hosp 1, Guiyang, Peoples R China.; An, L (corresponding author), Guizhou Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Pediat, Guiyang, Guizhou, Peoples R China.; An, L (corresponding author), Guizhou Univ Tradit Chinese Med, Dept Neurol, Affiliated Hosp 1, Guiyang, Peoples R China.	al_totti@sina.com	An, Lei/GQB-0039-2022		National Natural Science Foundation of China [31700929]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants from the National Natural Science Foundation of China (31700929) to LA.	Afonso P, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav3577; Agarwal G, 2014, SCIENCE, V344, P626, DOI 10.1126/science.1250444; An L, 2014, FREE RADICAL RES, V48, P239, DOI 10.3109/10715762.2013.861598; An L, 2019, PHARMACOL BIOCHEM BE, V186, DOI 10.1016/j.pbb.2019.172791; An L, 2018, BRAIN STRUCT FUNCT, V223, P4099, DOI 10.1007/s00429-018-1742-x; An L, 2018, TOXICOL SCI, V163, P385, DOI 10.1093/toxsci/kfx039; An L, 2017, NEUROTOX RES, V32, P301, DOI 10.1007/s12640-017-9731-z; An L, 2017, NEUROTOXICOLOGY, V62, P56, DOI 10.1016/j.neuro.2017.05.008; An L, 2017, TOXICOL LETT, V269, P55, DOI 10.1016/j.toxlet.2017.02.005; An L, 2016, NEUROTOX RES, V29, P218, DOI 10.1007/s12640-015-9578-0; An L, 2015, ALCOHOL, V49, P581, DOI 10.1016/j.alcohol.2015.05.004; An L, 2015, PHARMACOL BIOCHEM BE, V132, P152, DOI 10.1016/j.pbb.2015.03.009; An L, 2014, REPROD TOXICOL, V49, P78, DOI 10.1016/j.reprotox.2014.07.081; An L, 2014, NEUROTOXICOLOGY, V44, P132, DOI 10.1016/j.neuro.2014.06.009; An L, 2013, BEHAV BRAIN RES, V256, P564, DOI 10.1016/j.bbr.2013.09.017; An L, 2013, ALCOHOL CLIN EXP RES, V37, P763, DOI 10.1111/acer.12040; An L, 2013, NEUROBIOL LEARN MEM, V100, P18, DOI 10.1016/j.nlm.2012.12.003; An L, 2012, PHARMACOL BIOCHEM BE, V102, P196, DOI 10.1016/j.pbb.2012.04.009; An L, 2011, TOXICOL LETT, V206, P276, DOI 10.1016/j.toxlet.2011.08.009; Bartsch T, 2010, SCIENCE, V328, P1412, DOI 10.1126/science.1188160; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bekinschtein P, 2014, NEUROPHARMACOLOGY, V76, P677, DOI 10.1016/j.neuropharm.2013.04.024; Bhalla V, 2009, KIDNEY INT, V75, P774, DOI 10.1038/ki.2009.16; Burgdorf J, 2015, BEHAV BRAIN RES, V294, P177, DOI 10.1016/j.bbr.2015.07.039; CFS, 2008, CTR FOOD SAF FREQ AS; Chan JYW, 2011, FOOD CHEM TOXICOL, V49, P1544, DOI 10.1016/j.fct.2011.03.046; Cho WH, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00176; D'Amore DE, 2013, NEUROPHARMACOLOGY, V75, P312, DOI 10.1016/j.neuropharm.2013.07.033; da Costa GG, 2012, TOXICOL APPL PHARM, V262, P99, DOI 10.1016/j.taap.2012.04.031; de Bruin JPC, 2001, NEUROBIOL LEARN MEM, V75, P164, DOI 10.1006/nlme.2000.3962; de Pins B, 2019, J NEUROSCI, V39, P2441, DOI 10.1523/JNEUROSCI.2121-18.2019; Dietz B, 2017, NEUROPHARMACOLOGY, V115, P30, DOI 10.1016/j.neuropharm.2016.02.026; Dong ZF, 2013, NEUROPHARMACOLOGY, V64, P65, DOI 10.1016/j.neuropharm.2012.06.027; Duffy S, 2008, NEUROPSYCHOPHARMACOL, V33, P1004, DOI 10.1038/sj.npp.1301486; Esvald EE, 2020, J NEUROSCI, V40, P1405, DOI 10.1523/JNEUROSCI.0367-19.2019; Galvin C, 2015, NEUROPSYCHOPHARMACOL, V40, P2269, DOI 10.1038/npp.2015.76; Gokcen E, 2014, BRIT J PSYCHOL, V105, P187, DOI 10.1111/bjop.12033; Gold PE, 2004, NEUROBIOL LEARN MEM, V82, P230, DOI 10.1016/j.nlm.2004.07.003; Graybeal C, 2011, NAT NEUROSCI, V14, P1507, DOI 10.1038/nn.2954; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Han YG, 2011, CELL MOL NEUROBIOL, V31, P65, DOI 10.1007/s10571-010-9554-4; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; Harvey DR, 2008, NEUROBIOL LEARN MEM, V89, P462, DOI 10.1016/j.nlm.2007.08.013; Harvey E, 2019, HIPPOCAMPUS, V29, P1101, DOI 10.1002/hipo.23127; Hernandez LF, 2013, J NEUROSCI, V33, P4782, DOI 10.1523/JNEUROSCI.3746-12.2013; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Hwang IK, 2011, CELL MOL NEUROBIOL, V31, P669, DOI 10.1007/s10571-011-9686-1; Kim DH, 2012, NEUROPSYCHOPHARMACOL, V37, P422, DOI 10.1038/npp.2011.189; Kim TH, 2012, ARCH TOXICOL, V86, P1885, DOI 10.1007/s00204-012-0910-7; Lau D, 2015, CELL REP, V12, P1353, DOI 10.1016/j.celrep.2015.07.038; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; MCDONALD RJ, 1994, BEHAV NEURAL BIOL, V61, P260, DOI 10.1016/S0163-1047(05)80009-3; MHARZI M, 1992, BEHAV NEURAL BIOL, V58, P171, DOI 10.1016/0163-1047(92)90426-5; Mills F, 2014, P NATL ACAD SCI USA, V111, P8631, DOI 10.1073/pnas.1404670111; Mizumori SJY, 2004, NEUROBIOL LEARN MEM, V82, P278, DOI 10.1016/j.nlm.2004.07.007; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Musumeci G, 2011, REV NEUROSCIENCE, V22, P303, DOI 10.1515/RNS.2011.031; Ninan I, 2010, J NEUROSCI, V30, P8866, DOI 10.1523/JNEUROSCI.1405-10.2010; Oliveira MGM, 1997, NEUROBIOL LEARN MEM, V68, P32, DOI 10.1006/nlme.1996.3761; Orsini CA, 2012, NEUROSCI BIOBEHAV R, V36, P1773, DOI 10.1016/j.neubiorev.2011.12.014; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Patterson SL, 2015, NEUROPHARMACOLOGY, V96, P11, DOI 10.1016/j.neuropharm.2014.12.020; Peters J, 2010, SCIENCE, V328, P1288, DOI 10.1126/science.1186909; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Rajasethupathy P, 2015, NATURE, V526, P653, DOI 10.1038/nature15389; Regier PS, 2015, J NEUROPHYSIOL, V114, P1399, DOI 10.1152/jn.00189.2015; Rogers J, 2017, NEUROBIOL LEARN MEM, V139, P37, DOI 10.1016/j.nlm.2016.12.007; Rosas-Vidal LE, 2018, NEUROPSYCHOPHARMACOL, V43, P2636, DOI 10.1038/s41386-018-0176-8; Rosas-Vidal LE, 2014, NEUROPSYCHOPHARMACOL, V39, P2161, DOI 10.1038/npp.2014.64; Sakata K, 2013, P NATL ACAD SCI USA, V110, P15103, DOI 10.1073/pnas.1222872110; Sakhaie N, 2020, INT J DEV NEUROSCI; Skilleter AJ, 2015, PSYCHOL MED, V45, P841, DOI 10.1017/S0033291714001925; Sun W, 2020, MOL NEUROBIOL, V57, P4642, DOI 10.1007/s12035-020-02051-9; Sun W, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0165-19.2019; Sun W, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01439; Sun W, 2018, NEUROPHARMACOLOGY, V131, P11, DOI 10.1016/j.neuropharm.2017.12.018; Tyan YC, 2009, ANAL BIOANAL CHEM, V395, P729, DOI 10.1007/s00216-009-3009-0; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; U. S. Food and Drug Administration, 2011, REP REC REP ENT AERS; Wang Y, 2011, TOXICOL IND HEALTH, V27, P571, DOI 10.1177/0748233710395347; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; Wingard JC, 2015, BEHAV PROCESS, V118, P85, DOI 10.1016/j.beproc.2015.06.004; World Health Organization, 2008, TOX HLTH ASP MEL CYA; Yang JJ, 2011, TOXICOLOGY, V289, P167, DOI 10.1016/j.tox.2011.08.011; Yang Y, 2012, TOXICOL LETT, V214, P63, DOI 10.1016/j.toxlet.2012.08.010	85	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0245326	10.1371/journal.pone.0245326	http://dx.doi.org/10.1371/journal.pone.0245326			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY4UJ	33428671	Green Published, gold			2022-12-26	WOS:000630036100057
J	Tokunaga, H; Iida, K; Hozawa, A; Ogishima, S; Watanabe, Y; Shigeta, S; Shimada, M; Yamaguchi-Kabata, Y; Tadaka, S; Katsuoka, F; Ito, S; Kumada, K; Hamanaka, Y; Fuse, N; Kinoshita, K; Yamamoto, M; Yaegashi, N; Yasuda, J				Tokunaga, Hideki; Iida, Keita; Hozawa, Atsushi; Ogishima, Soichi; Watanabe, Yoh; Shigeta, Shogo; Shimada, Muneaki; Yamaguchi-Kabata, Yumi; Tadaka, Shu; Katsuoka, Fumiki; Ito, Shin; Kumada, Kazuki; Hamanaka, Yohei; Fuse, Nobuo; Kinoshita, Kengo; Yamamoto, Masayuki; Yaegashi, Nobuo; Yasuda, Jun			Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2)	PLOS ONE			English	Article								Identification of the population frequencies of definitely pathogenic germline variants in two major hereditary breast and ovarian cancer syndrome (HBOC) genes, BRCA1/2, is essential to estimate the number of HBOC patients. In addition, the identification of moderately penetrant HBOC gene variants that contribute to increasing the risk of breast and ovarian cancers in a population is critical to establish personalized health care. A prospective cohort subjected to genome analysis can provide both sets of information. Computational scoring and prospective cohort studies may help to identify such likely pathogenic variants in the general population. We annotated the variants in the BRCA1 and BRCA2 genes from a dataset of 3,552 whole-genome sequences obtained from members of a prospective cohorts with genome data in the Tohoku Medical Megabank Project (TMM) with InterVar software. Computational impact scores (CADD_phred and Eigen_raw) and minor allele frequencies (MAFs) of pathogenic (P) and likely pathogenic (LP) variants in ClinVar were used for filtration criteria. Familial predispositions to cancers among the 35,000 TMM genome cohort participants were analyzed to verify the identified pathogenicity. Seven potentially pathogenic variants were newly identified. The sisters of carriers of these moderately deleterious variants and definite P and LP variants among members of the TMM prospective cohort showed a statistically significant preponderance for cancer onset, from the self-reported cancer history. Filtering by computational scoring and MAF is useful to identify potentially pathogenic variants in BRCA genes in the Japanese population. These results should help to follow up the carriers of variants of uncertain significance in the HBOC genes in the longitudinal prospective cohort study.	[Tokunaga, Hideki; Shigeta, Shogo; Shimada, Muneaki; Yaegashi, Nobuo] Tohoku Univ, Dept Obstet & Gynecol, Grad Sch Med, Sendai, Miyagi, Japan; [Tokunaga, Hideki; Ogishima, Soichi; Shimada, Muneaki; Kumada, Kazuki; Kinoshita, Kengo; Yamamoto, Masayuki] Tohoku Univ, Adv Res Ctr Innovat Next Generat Med, Sendai, Miyagi, Japan; [Iida, Keita; Hozawa, Atsushi; Ogishima, Soichi; Yamaguchi-Kabata, Yumi; Tadaka, Shu; Katsuoka, Fumiki; Ito, Shin; Kumada, Kazuki; Hamanaka, Yohei; Fuse, Nobuo; Kinoshita, Kengo; Yamamoto, Masayuki; Yaegashi, Nobuo; Yasuda, Jun] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi, Japan; [Iida, Keita] Osaka Univ, Inst Prot Res, Lab Cell Syst, Suita, Osaka, Japan; [Watanabe, Yoh] Tohoku Med & Pharmaceut Univ, Dept Obstet & Gynecol, Sendai, Miyagi, Japan; [Katsuoka, Fumiki; Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Sendai, Miyagi, Japan; [Ito, Shin; Kinoshita, Kengo; Yasuda, Jun] Tohoku Univ, Grad Sch Informat Sci, Dept Appl Informat Sci, Sendai, Miyagi, Japan; [Ito, Shin; Kinoshita, Kengo; Yasuda, Jun] Miyagi Canc Ctr Res Inst, Div Mol & Cellular Oncol, Natori, Miyagi, Japan; [Kinoshita, Kengo] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Osaka University; Tohoku Medical & Pharmaceutical University; Tohoku University; Tohoku University; Miyagi Cancer Center; Tohoku University	Yasuda, J (corresponding author), Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi, Japan.; Yasuda, J (corresponding author), Tohoku Univ, Grad Sch Informat Sci, Dept Appl Informat Sci, Sendai, Miyagi, Japan.; Yasuda, J (corresponding author), Miyagi Canc Ctr Res Inst, Div Mol & Cellular Oncol, Natori, Miyagi, Japan.	jun-yasuda@miyagi-pho.jp	Hamanaka, Yohei/GVS-1245-2022; Yamamoto, Masayuki/A-4873-2010; Kinoshita, Kengo/E-9688-2011	Hamanaka, Yohei/0000-0003-4169-7767; Yamamoto, Masayuki/0000-0002-9073-9436; Kinoshita, Kengo/0000-0003-3453-2171; Katsuoka, Fumiki/0000-0003-0939-7887; Tadaka, Shu/0000-0002-8256-0735	JSPS KAKENHI [JP17K07193, JP19H03795, JP17K11265]; National Cancer Center Research and Development Fund [29-A-3]; AMED [JP17km0405001]; Tohoku Medical Megabank Project through the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Reconstruction Agency, MEXT, Japan; Japan Agency for Medical Research and development (AMED) [JP17km0105001, JP17km0105002]; AMED GRIFIN project [JP17km0405203, JP18km0405203]; Facilitation of R&D Platform for AMED Genome Medicine Support by AMED [JP17km0405001]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); AMED; Tohoku Medical Megabank Project through the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Reconstruction Agency, MEXT, Japan; Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED)); AMED GRIFIN project; Facilitation of R&D Platform for AMED Genome Medicine Support by AMED	This work was supported by JSPS KAKENHI (Grant Number JP17K07193, JP19H03795, and JP17K11265) for JY, NY, and MS, respectively. This work was supported by The National Cancer Center Research and Development Fund (29-A-3) and AMED (Grant Number JP19ck0106319) for NY and HT, respectively. This work was supported in part by the Tohoku Medical Megabank Project through the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan for MY; the Reconstruction Agency, MEXT, Japan for MY; by the Japan Agency for Medical Research and development (AMED; Grant numbers JP17km0105001 and JP17km0105002) awarded to MY; and AMED GRIFIN project (grant numbers JP17km0405203 and JP18km0405203) awarded to MY. All computational resources were provided by the ToMMo supercomputer system (http://sc.megabank.tohoku.ac.jp/en), which is supported by the Facilitation of R&D Platform for AMED Genome Medicine Support conducted by AMED (Grant number JP17km0405001) awarded to MY.	Arai M, 2018, J HUM GENET, V63, P447, DOI 10.1038/s10038-017-0355-1; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Bonnet C, 2008, J MED GENET, V45, P438, DOI 10.1136/jmg.2007.056895; Campbell PJ, 2020, NATURE, V578, P82, DOI 10.1038/s41586-020-1969-6; Casey MJ, 2016, FAM CANCER, V15, P371, DOI 10.1007/s10689-016-9878-4; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cline MS, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007752; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Enomoto T, 2019, INT J GYNECOL CANCER, V29, P1043, DOI 10.1136/ijgc-2019-000384; Findlay GM, 2018, NATURE, V562, P217, DOI 10.1038/s41586-018-0461-z; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; George SHL, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00108; He KY, 2019, HUM GENET, V138, P199, DOI 10.1007/s00439-019-01975-0; Hozawa A, 2021, J EPIDEMIOL, V31, P65, DOI 10.2188/jea.JE20190271; Huang KL, 2018, CELL, V173, P355, DOI 10.1016/j.cell.2018.03.039; Ionita-Laza I, 2016, NAT GENET, V48, P214, DOI 10.1038/ng.3477; Kawaku S, 2013, J HUM GENET, V58, P618, DOI 10.1038/jhg.2013.71; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Koshiba S, 2018, GENES CELLS, V23, P406, DOI 10.1111/gtc.12588; Kurian AW, 2017, J CLIN ONCOL, V35, P2232, DOI 10.1200/JCO.2016.71.6480; Kuriyama S, 2020, INT J EPIDEMIOL, V49, DOI 10.1093/ije/dyz169; Kuriyama S, 2016, J EPIDEMIOL, V26, P493, DOI 10.2188/jea.JE20150268; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee JS, 2018, J MED GENET, V55, P794, DOI 10.1136/jmedgenet-2018-105565; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li Q, 2017, AM J HUM GENET, V100, P267, DOI 10.1016/j.ajhg.2017.01.004; Manolio TA, 2012, AM J EPIDEMIOL, V175, P859, DOI 10.1093/aje/kwr453; Minegishi N, 2019, TOHOKU J EXP MED, V248, P45, DOI 10.1620/tjem.248.45; Momozawa Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06581-8; Nagasaki M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9018; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Noordermeer SM, 2019, TRENDS CELL BIOL, V29, P820, DOI 10.1016/j.tcb.2019.07.008; Okada Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03274-0; Quang D, 2015, BIOINFORMATICS, V31, P761, DOI 10.1093/bioinformatics/btu703; Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, pD886, DOI 10.1093/nar/gky1016; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sakurada S, 2018, JPN J CLIN ONCOL, V48, P794, DOI 10.1093/jjco/hyy095; Shimelis H, 2017, CANCER RES, V77, P2789, DOI 10.1158/0008-5472.CAN-16-2568; Spurdle AB, 2012, HUM MUTAT, V33, P2, DOI 10.1002/humu.21628; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Sugano K, 2008, CANCER SCI, V99, P1967, DOI 10.1111/j.1349-7006.2008.00944.x; Tadaka S, 2019, HUM GENOME VAR, V6, DOI 10.1038/s41439-019-0059-5; Tadaka S, 2018, NUCLEIC ACIDS RES, V46, pD551, DOI 10.1093/nar/gkx978; Takai-Igarashi T, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0494-5; Tung NM, 2018, BRIT J CANCER, V119, P141, DOI 10.1038/s41416-018-0127-5; Wallen ZD, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000271; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yamaguchi-Kabata Y, 2018, J HUM GENET, V63, P213, DOI 10.1038/s10038-017-0347-1; Yasuda J, 2019, J BIOCHEM, V165, P139, DOI 10.1093/jb/mvy096; Yoshida T, 2010, CANCER SCI, V101, P1582, DOI 10.1111/j.1349-7006.2010.01590.x; Zhou WD, 2015, NAT METHODS, V12, P1002, DOI 10.1038/nmeth.3622; Zink F, 2017, BLOOD, V130, P742, DOI 10.1182/blood-2017-02-769869	54	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0236907	10.1371/journal.pone.0236907	http://dx.doi.org/10.1371/journal.pone.0236907			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428613	Green Published, Green Submitted, gold			2022-12-26	WOS:000630036100003
J	Szymczak-Kulus, K; Weidler, S; Bereznicka, A; Mikolajczyk, K; Kaczmarek, R; Bednarz, B; Zhang, T; Urbaniak, A; Olczak, M; Park, EY; Majorczyk, E; Kapczynska, K; Lukasiewicz, J; Wuhrer, M; Unverzagt, C; Czerwinski, M				Szymczak-Kulus, Katarzyna; Weidler, Sascha; Bereznicka, Anna; Mikolajczyk, Krzysztof; Kaczmarek, Radoslaw; Bednarz, Bartosz; Zhang, Tao; Urbaniak, Anna; Olczak, Mariusz; Park, Enoch Y.; Majorczyk, Edyta; Kapczynska, Katarzyna; Lukasiewicz, Jolanta; Wuhrer, Manfred; Unverzagt, Carlo; Czerwinski, Marcin			Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; AMINO-ACID; UDP-GALACTOSE; GLYCOPROTEINS; EXPRESSION; GLOBOTRIAOSYLCERAMIDE; GLYCOSPHINGOLIPIDS; SPECIFICITY; TISSUE; TRISACCHARIDE	The humanGb3/CD77 synthase, encoded by theA4GALT gene, is an unusually promiscuous glycosyltransferase. It synthesizes the Gala1 -> 4Gal linkage on two different glycosphingolipids (GSLs), producing globotriaosylceramide (Gb3, CD77, P-k) and the P1 antigen. Gb3 is themajor receptor for Shiga toxins (Stxs) produced by enterohemorrhagic Escherichia coli. A single amino acid sub-stitution (p.Q211E) ramps up the enzyme's promiscuity, rendering it able to attach Gal both to another Gal residue and to GalNAc, giving rise toNOR1 andNOR2GSLs. HumanGb3/CD77 synthase was long believed to transfer Gal only to GSL acceptors, therefore its GSL products were, by default, considered the only human Stx receptors. Here, using soluble, recombinant human Gb3/CD77 synthase and p.Q211E mutein, we demonstrate that both enzymes can synthesize the P1 glycotope (terminal Gal-alpha 1 -> 4Gal beta 1 -> 4GlcNAc-R) on a complex type N-glycan and a syntheticN-glycoprotein (saposinD). Moreover, by transfection of CHO-Lec2 cells with vectors encoding human Gb3/CD77 synthase and its p.Q211E mutein, we demonstrate that both enzymes produce P1 glycotopes on N-glycoproteins, with the mutein exhibiting elevated activity. These P1-terminatedN-glycoproteins are recognized by Stx1 but not Stx2 B subunits. Finally, cytotoxicity assays showthat Stx1 can useP1N-glycoproteins produced in CHO-Lec2 cells as functional receptors. We conclude that Stx1 can recognize and use P1 N-glycoproteins in addition to its canonicalGSL receptors to enter and kill the cells, while Stx2 can use GSLs only. Collectively, these results may have important implications for our understanding of the Shiga toxin pathology.	[Szymczak-Kulus, Katarzyna; Bereznicka, Anna; Mikolajczyk, Krzysztof; Kaczmarek, Radoslaw; Czerwinski, Marcin] Hirszfeld Inst Immunol & Expt Therapy, Lab Glycobiol, Wroclaw, Poland; [Weidler, Sascha; Unverzagt, Carlo] Univ Bayreuth, Dept Bioorgan Chem, Bayreuth, Germany; [Bednarz, Bartosz] Hirszfeld Inst Immunol & Expt Therapy, Lab Mol Biol Microorganisms, Wroclaw, Poland; [Zhang, Tao; Wuhrer, Manfred] Leiden Univ, Ctr Prote & Metabol, Med Ctr, Leiden, Netherlands; [Urbaniak, Anna] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Biochem & Mol Biol, Wroclaw, Poland; [Olczak, Mariusz] Univ Wroclaw, Fac Biotechnol, Dept Biochem, Wroclaw, Poland; [Park, Enoch Y.] Shizuoka Univ, Lab Biotechnol, Shizuoka, Japan; [Majorczyk, Edyta] Opole Univ Technol, Fac Phys Educ & Physiotherapy, Opole, Poland; [Kapczynska, Katarzyna] Hirszfeld Inst Immunol & Expt Therapy, Lab Med Microbiol, Wroclaw, Poland; [Lukasiewicz, Jolanta] Hirszfeld Inst Immunol & Expt Therapy, Lab Microbial Immunochem & Vaccines, Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; University of Bayreuth; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wroclaw University of Environmental & Life Sciences; University of Wroclaw; Shizuoka University; Opole University of Technology; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Czerwinski, M (corresponding author), Hirszfeld Inst Immunol & Expt Therapy, Lab Glycobiol, Wroclaw, Poland.	marcin.czerwinski@hirszfeld.pl	Wuhrer, Manfred/ABE-9168-2020	Wuhrer, Manfred/0000-0002-0814-4995; Mikolajczyk, Krzysztof/0000-0003-1879-2205; Bereznicka, Anna/0000-0002-7228-0772; Szymczak-Kulus, Katarzyna/0000-0003-2660-3662; Lukasiewicz, Jolanta/0000-0001-8081-7261; Czerwinski, Marcin/0000-0003-2859-3699; Kaczmarek, Radoslaw/0000-0001-8084-1958; Urbaniak, Anna/0000-0002-2803-0952; Majorczyk, Edyta/0000-0001-7248-9544; Kapczynska, Katarzyna/0000-0003-2722-9596; Bednarz, Bartosz/0000-0003-3983-5868; Olczak, Mariusz/0000-0001-8629-6364; Park, Enoch Y./0000-0002-7840-1424	National Science Centre of Poland Opus Project [2014/13/B/NZ6/00227]	National Science Centre of Poland Opus Project	This work was funded by National Science Centre of Poland Opus Project 2014/13/B/NZ6/00227 (M. C.). The study was approved by the Wroclaw Medical University Bioethics Committee, Consent 641/2014, December 14, 2014.	Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; Anugraham M, 2015, RAPID COMMUN MASS SP, V29, P545, DOI 10.1002/rcm.7130; Arvidsson I, 2015, J IMMUNOL, V194, P2309, DOI 10.4049/jimmunol.1402470; BITZAN M, 1994, INFECT IMMUN, V62, P3337, DOI 10.1128/IAI.62.8.3337-3347.1994; Brigotti M, 2008, J LEUKOCYTE BIOL, V84, P1019, DOI 10.1189/jlb.0308157; Brigotti M, 2018, INT J MED MICROBIOL, V308, P940, DOI 10.1016/j.ijmm.2018.06.013; Bruyand M, 2018, MED MALADIES INFECT, V48, P167, DOI 10.1016/j.medmal.2017.09.012; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Cherian RM, 2014, GLYCOBIOLOGY, V24, P26, DOI 10.1093/glycob/cwt086; Cid E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37515-5; Cody EM, 2019, PEDIATR CLIN N AM, V66, P235, DOI 10.1016/j.pcl.2018.09.011; Cooling L, 2015, CLIN MICROBIOL REV, V28, P801, DOI 10.1128/CMR.00109-14; Cooling LLW, 2005, BLOOD, V105, P3356, DOI 10.1182/blood-2004-08-3080; Cooper CA, 2001, PROTEOMICS, V1, P340, DOI 10.1002/1615-9861(200102)1:2<340::AID-PROT340>3.0.CO;2-B; Daniels G., 2013, HUMAN BLOOD GROUPS; DEGRANDIS S, 1989, J BIOL CHEM, V264, P12520; Devenish J, 1998, CAN J MICROBIOL, V44, P28, DOI 10.1139/cjm-44-1-28; Duk M, 2005, GLYCOBIOLOGY, V15, P109, DOI 10.1093/oxfordjournals.glycob.a034964; Ferrando ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175639; Gallegos KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030368; Geyer PE, 2016, MOL CANCER THER, V15, P1008, DOI 10.1158/1535-7163.MCT-15-0633; Graf CGF, 2017, ANGEW CHEM INT EDIT, V56, P5252, DOI 10.1002/anie.201701362; Harvey DJ, 2020, MASS SPECTROM REV, V39, P586, DOI 10.1002/mas.21622; HASELBERGER CG, 1982, FEBS LETT, V149, P126, DOI 10.1016/0014-5793(82)81086-7; Hellberg A., 2020, ISBT SCI SER, V15, P40; Henion TR, 2001, J BIOL CHEM, V276, P30261, DOI 10.1074/jbc.M102979200; Jacob F, 2014, BRIT J CANCER, V111, P1634, DOI 10.1038/bjc.2014.455; Jacob F, 2018, CANCER RES, V78, P2952, DOI 10.1158/0008-5472.CAN-17-2223; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kaczmarek R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196627; Kaczmarek R, 2016, GLYCOCONJUGATE J, V33, P963, DOI 10.1007/s10719-016-9716-9; Kaczmarek R, 2016, BIOCHEM BIOPH RES CO, V470, P168, DOI 10.1016/j.bbrc.2016.01.017; Kaczmarek R, 2014, TRANSFUS MED REV, V28, P126, DOI 10.1016/j.tmrv.2014.04.007; Karlsson NG, 2004, RAPID COMMUN MASS SP, V18, P2282, DOI 10.1002/rcm.1626; Karlsson NG, 2004, J AM SOC MASS SPECTR, V15, P659, DOI 10.1016/j.jasms.2004.01.002; Karpman D, 2006, SEMIN THROMB HEMOST, V32, P128, DOI 10.1055/s-2006-939769; Karve SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101173; Kato T, 2015, J BIOTECHNOL, V209, P50, DOI 10.1016/j.jbiotec.2015.06.403; Kavaliauskiene S, 2017, TOXINS, V9, DOI 10.3390/toxins9020044; Kellokumpu S, 2016, CELL MOL LIFE SCI, V73, P305, DOI 10.1007/s00018-015-2066-0; Khoder-Agha F, 2019, J BIOL CHEM, V294, P14383, DOI 10.1074/jbc.RA119.009539; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; Lai Y.-J., 2014, TRANSFUSION, V126, P3668; Lee MS, 2019, TOXINS, V11, DOI 10.3390/toxins11040212; Lee YC, 1999, J BIOL CHEM, V274, P11958, DOI 10.1074/jbc.274.17.11958; LEE YC, 1994, J BIOL CHEM, V269, P10028; Liu YY, 2013, ADV CANCER RES, V117, P59, DOI 10.1016/B978-0-12-394274-6.00003-0; Majowicz SE, 2014, FOODBORNE PATHOG DIS, V11, P447, DOI 10.1089/fpd.2013.1704; MARCUS DM, 1971, TRANSFUSION, V11, P16, DOI 10.1111/j.1537-2995.1971.tb04368.x; Maszczak-Seneczko D, 2011, FEBS LETT, V585, P3090, DOI 10.1016/j.febslet.2011.08.038; Mikolajczyk K., 2021, BIORXIV; Miller JJ, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2019.129437; Miyake M, 2000, ANAL BIOCHEM, V281, P202, DOI 10.1006/abio.2000.4559; Mondal N, 2018, J BIOL CHEM, V293, P7300, DOI 10.1074/jbc.RA117.000775; Morimoto K, 2020, J BIOL CHEM, V295, P9490, DOI 10.1074/jbc.RA120.013926; Muthing J, 2012, GLYCOBIOLOGY, V22, P849, DOI 10.1093/glycob/cws009; Okajima T, 1999, J BIOL CHEM, V274, P11479, DOI 10.1074/jbc.274.17.11479; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; Owczarek TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084191; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Pezeshkian W, 2016, SOFT MATTER, V12, P5164, DOI 10.1039/c6sm00464d; Roche N, 2007, MICROBES INFECT, V9, P605, DOI 10.1016/j.micinf.2007.01.023; Stahl AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006990; STANLEY P, 1983, METHOD ENZYMOL, V96, P157; Stenfelt L, 2019, TRANSFUSION, V59, P1108, DOI 10.1111/trf.15115; Suchanowska A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.408286; Suzuki N, 2006, BBA-GEN SUBJECTS, V1760, P538, DOI 10.1016/j.bbagen.2005.10.005; Takahashi N, 2001, J BIOL CHEM, V276, P23230, DOI 10.1074/jbc.M101380200; Taniguchi N., 2014, HDB GLYCOSYLTRANSFER; Teintenier-Lelievre M, 2005, BIOCHEM J, V392, P665, DOI 10.1042/BJ20051120; Thuresson B, 2011, BLOOD, V117, P678, DOI 10.1182/blood-2010-08-301333; Tsuchida A, 2005, J BIOCHEM, V138, P237, DOI 10.1093/jb/mvi124; Ullmann V, 2012, ANGEW CHEM INT EDIT, V51, P11566, DOI 10.1002/anie.201204272; UNVERZAGT C, 1990, J AM CHEM SOC, V112, P9308, DOI 10.1021/ja00181a037; van Die I, 1999, FEBS LETT, V450, P52, DOI 10.1016/S0014-5793(99)00462-7; Villysson A, 2017, TOXINS, V9, DOI 10.3390/toxins9110376; Volynsky P, 2017, MOL IMMUNOL, V90, P87, DOI 10.1016/j.molimm.2017.06.247; WATKINS WM, 1988, BIOCHIMIE, V70, P1597, DOI 10.1016/0300-9084(88)90295-7; Weissgerber TL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002128; YANG ZT, 1994, J BIOL CHEM, V269, P14620; Zhang T, 2020, MOL OMICS, V16, P355, DOI 10.1039/c9mo00180h; Zhou DP, 1999, EUR J BIOCHEM, V263, P571, DOI 10.1046/j.1432-1327.1999.00541.x; Zhou DP, 2000, J BIOL CHEM, V275, P22631, DOI 10.1074/jbc.C000263200; Zumbrun SD, 2010, INFECT IMMUN, V78, P4488, DOI 10.1128/IAI.00620-10	84	7	7	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100299	10.1016/j.jbc.2021.100299	http://dx.doi.org/10.1016/j.jbc.2021.100299			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33460651	Green Published, gold			2022-12-26	WOS:000672866400273
J	Heo, JW; No, MH; Cho, J; Choi, Y; Cho, EJ; Park, DH; Kim, TW; Kim, CJ; Seo, DY; Han, J; Jang, YC; Jung, SJ; Kang, JH; Kwak, HB				Heo, Jun-Won; No, Mi-Hyun; Cho, Jinkyung; Choi, Youngju; Cho, Eun-Jeong; Park, Dong-Ho; Kim, Tae-Woon; Kim, Chang-Ju; Seo, Dae Yun; Han, Jin; Jang, Young C.; Jung, Su-Jeen; Kang, Ju-Hee; Kwak, Hyo-Bum			Moderate aerobic exercise training ameliorates impairment of mitochondrial function and dynamics in skeletal muscle of high-fat diet-induced obese mice	FASEB JOURNAL			English	Article						aerobic exercise; insulin resistance; mitochondrial function; mitochondrial dynamics; skeletal muscle	INSULIN-RESISTANCE; OXIDATIVE STRESS; DYSFUNCTION; FIBERS	The purpose of this study is to determine whether moderate aerobic exercise training improves high-fat diet-induced alterations in mitochondrial function and structure in the skeletal muscle. Male 4-week-old C57BL/6 mice were randomly divided into four groups: control (CON), control plus exercise (CON + EX), high-fat diet (HFD), and high-fat diet plus exercise (HFD + EX). After obesity was induced by 20 weeks of 60% HFD, treadmill exercise training was performed at 13-16 m/min, 40-50 min/day, and 6 days/week for 12 weeks. Mitochondrial structure, function, and dynamics, and mitophagy were analyzed in the skeletal muscle fibers from the red gastrocnemius. Exercise training increased mitochondrial number and area and reduced high-fat diet-induced obesity and hyperglycemia. In addition, exercise training attenuated mitochondrial dysfunction in the permeabilized myofibers, indicating that HFD-induced decrease of mitochondrial O-2 respiration and Ca2+ retention capacity and increase of mitochondrial H2O2 emission were attenuated in the HFD + EX group compared to the HFD group. Exercise also ameliorated HFD-induced imbalance of mitochondrial fusion and fission, demonstrating that HFD-induced decrease in fusion protein levels was elevated, and increase in fission protein levels was reduced in the HFD + EX groups compared with the HFD group. Moreover, dysregulation of mitophagy induced by HFD was mitigated in the HFD + EX group, indicating a decrease in PINK1 protein level. Our findings demonstrated that moderate aerobic exercise training mitigated obesity-induced insulin resistance by improving mitochondrial function, and reversed obesity-induced mitochondrial structural damage by improving mitochondrial dynamics and mitophagy, suggesting that moderate aerobic exercise training may play a therapeutic role in protecting the skeletal muscle against mitochondrial impairments and insulin resistance induced by obesity.	[Heo, Jun-Won; Cho, Eun-Jeong; Park, Dong-Ho; Kang, Ju-Hee; Kwak, Hyo-Bum] Inha Univ, Dept Biomed Sci, Program Biomed Sci & Engn, Incheon, South Korea; [Heo, Jun-Won; Cho, Jinkyung; Choi, Youngju; Cho, Eun-Jeong; Park, Dong-Ho; Kang, Ju-Hee; Kwak, Hyo-Bum] Inha Univ, Inst Sports & Arts Convergence, Incheon, South Korea; [No, Mi-Hyun; Park, Dong-Ho; Kwak, Hyo-Bum] Inha Univ, Dept Kinesiol, Incheon, South Korea; [Kim, Tae-Woon; Kim, Chang-Ju] Kyung Hee Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Seo, Dae Yun; Han, Jin] Inje Univ, Coll Med, Cardiovasc & Metab Dis Ctr, Dept Physiol,Natl Res Lab Mitochondria Signaling, Busan, South Korea; [Jang, Young C.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Jung, Su-Jeen] Seoil Univ, Dept Leisure Sports, Seoul, South Korea; [Kang, Ju-Hee] Inha Univ, Coll Med, Dept Pharmacol, Incheon, South Korea	Inha University; Inha University; Inha University; Kyung Hee University; Inje University; University System of Georgia; Georgia Institute of Technology; Inha University	Kang, JH (corresponding author), Inha Univ, Dept Pharmacol, Dept Biomed Sci, Program Biomed Sci & Engn, 100 Inha Ro, Incheon 22212, South Korea.; Kwak, HB (corresponding author), Inha Univ, Dept Kinesiol, Dept Biomed Sci, Program Biomed Sci & Engn, 100 Inha Ro, Incheon 22212, South Korea.	johykang@inha.ac.kr; kwakhb@inha.ac.kr	Cho, Jinkyung/ABC-8116-2021	Seo, Dae Yun/0000-0002-4377-5792				Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Calonne J, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00119; Campello S, 2014, BBA-BIOENERGETICS, V1837, P451, DOI 10.1016/j.bbabio.2013.11.010; Carter HN, 2015, PHYSIOLOGY, V30, P208, DOI 10.1152/physiol.00039.2014; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Choi JW, 2018, METABOLISM, V78, P43, DOI 10.1016/j.metabol.2017.09.005; Chomentowski P, 2011, J CLIN ENDOCR METAB, V96, P494, DOI 10.1210/jc.2010-0822; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261; Di Meo S, 2017, J ENDOCRINOL, V233, pR15, DOI 10.1530/JOE-16-0598; DiFranco M, 2008, P NATL ACAD SCI USA, V105, P14698, DOI 10.1073/pnas.0802217105; Fealy CE, 2018, TRANSL RES, V202, P69, DOI 10.1016/j.trsl.2018.07.011; Fealy CE, 2014, J APPL PHYSIOL, V117, P239, DOI 10.1152/japplphysiol.01064.2013; Greene NP, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12470; Han DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019739; Heo JW, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102301; Hey-Mogensen M, 2010, DIABETOLOGIA, V53, P1976, DOI 10.1007/s00125-010-1813-x; Iqbal S, 2014, AM J PHYSIOL-CELL PH, V306, pC1176, DOI 10.1152/ajpcell.00017.2014; Jacob S, 2020, CARDIOVASC ENDOCR ME, V9, P1, DOI 10.1097/XCE.0000000000000196; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Konopka AR, 2015, DIABETES, V64, P2104, DOI 10.2337/db14-1701; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349; Lanza IR, 2013, AM J PHYSIOL-ENDOC M, V304, pE1391, DOI 10.1152/ajpendo.00584.2012; Leduc-Gaudet JP, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13548; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Lin HY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7514383; Liu RH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092810; Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027; Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556; Ng M, 2014, LANCET, V384, P746; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Schefer V, 1996, EXP GERONTOL, V31, P387, DOI 10.1016/0531-5565(95)02032-2; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Venditti P, 2014, FREE RADICAL RES, V48, P1179, DOI 10.3109/10715762.2014.937341; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; Yoo SZ, 2019, J EXERC REHABIL, V15, P512, DOI 10.12965/jer.1938380.190; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zorzano Antonio, 2009, Archives of Physiology and Biochemistry, V115, P1, DOI 10.1080/13813450802676335; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	43	8	9	5	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21340	10.1096/fj.202002394R	http://dx.doi.org/10.1096/fj.202002394R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33455027	Bronze			2022-12-26	WOS:000647789600040
J	Lin, YS; Tsai, ML; Hsieh, IC; Wen, MS; Wang, CY				Lin, Yu-Sheng; Tsai, Ming-Lung; Hsieh, I-Chang; Wen, Ming-Shien; Wang, Chao-Yung			Deficiency of circadian gene cryptochromes in bone marrow-derived cells protects against atherosclerosis in LDLR-/- mice	FASEB JOURNAL			English	Article						circadian rhythm; cryptochrome; atherosclerosis; LDLR; macrophages	RHYTHM; CHOLESTEROL; METABOLISM	Cryptochromes are photoreceptors that mediate the circadian entrainment by light in plants and animals. They are also involved in magnetic field sensing in some animals. Recent studies suggest that cryptochromes play an essential role in metabolism and cardiovascular disease. However, the tissue-specific function of cryptochromes in atherosclerosis is unknown. We transplanted bone marrow from wild-type (WT) and cryptochrome 1/2 knockout (Cry1/2 KO) mice into irradiated recipient low-density lipoprotein receptor knockout (LDLR-/-) mice and induced atherosclerosis with a high cholesterol diet for 12 weeks. There was a reduction in atherosclerotic plaques and macrophage accumulation in the aorta of LDLR-/- mice that received Cry1/2 KO bone marrow compared to mice that received WT bone marrow. Bone marrow-derived macrophages (BMDMs) from Cry1/2 KO mice exhibited impaired uptake of low-density lipoprotein, and subsequently, impaired foam cell formation. Analysis of macrophage mRNA circadian oscillations revealed that the circadian rhythm of the LDLR mRNAs was lost in Cry1/2 KO BMDMs. Reinstalling the circadian oscillatory LDLR mRNAs using adenovirus into the BMDMs was able to rescue the lipid uptake and foam cell formation function. However, the noncircadian oscillatory LDLR mRNAs exhibited reduced ability to rescue the macrophage functions. These findings indicate that cryptochromes in bone marrow-derived cells are critical mediators of atherosclerosis through regulation of the LDLR mRNA circadian rhythm. Therapeutic measures targeting cryptochromes in the macrophage may have important implications for atherosclerosis.	[Lin, Yu-Sheng] Chang Gung Univ, Chang Gung Mem Hosp, Healthcare Ctr, Coll Med, Taoyuan, Taiwan; [Lin, Yu-Sheng; Tsai, Ming-Lung; Hsieh, I-Chang; Wen, Ming-Shien; Wang, Chao-Yung] Chang Gung Univ, Chang Gung Mem Hosp, Dept Cardiol, Coll Med, Taoyuan, Taiwan; [Wang, Chao-Yung] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Wang, Chao-Yung] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Health Research Institutes - Taiwan; National Tsing Hua University	Wang, CY (corresponding author), 5 Fu Hsing St, Taoyuan 333, Taiwan.	cwang@ocean.ag	Wang, Chao-Yung/ABA-6757-2021	Wang, Chao-Yung/0000-0003-1546-7298; Lin, Yu-Sheng/0000-0002-7654-6558				Akashi M, 2017, EBIOMEDICINE, V20, P127, DOI 10.1016/j.ebiom.2017.04.034; Anand SN, 2013, J NEUROSCI, V33, P7145, DOI 10.1523/JNEUROSCI.4950-12.2013; BALASUBRAMANIAM S, 1994, BIOCHEM J, V298, P39, DOI 10.1042/bj2980039; Barclay JL, 2013, AM J PHYSIOL-ENDOC M, V304, pE1053, DOI 10.1152/ajpendo.00512.2012; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Cal-Kayitmazbatir S, 2021, FEBS J, V288, P614, DOI 10.1111/febs.15360; Cao Q, 2017, P NATL ACAD SCI USA, V114, P12548, DOI 10.1073/pnas.1619119114; Chang L, 2018, CIRCULATION, V138, P67, DOI 10.1161/CIRCULATIONAHA.117.029972; Chen LH, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00071; Chen WD, 2014, BIOCHEM BIOPH RES CO, V451, P408, DOI 10.1016/j.bbrc.2014.07.138; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Douma LG, 2019, AM J PHYSIOL-REG I, V316, pR50, DOI 10.1152/ajpregu.00381.2017; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Getz GS, 2016, ARTERIOSCL THROM VAS, V36, P1734, DOI 10.1161/ATVBAHA.116.306874; He WY, 2018, IMMUNITY, V49, P1175, DOI 10.1016/j.immuni.2018.10.007; Hirayama J, 2003, J BIOL CHEM, V278, P35620, DOI 10.1074/jbc.M305028200; Huo MY, 2017, FASEB J, V31, P1097, DOI 10.1096/fj.201601030R; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kudo T, 2008, AM J PHYSIOL-ENDOC M, V294, pE120, DOI 10.1152/ajpendo.00061.2007; Lee YJ, 2012, EXP MOL MED, V44, P642, DOI 10.3858/emm.2012.44.11.073; Lin C., 2019, FASEB J, V33, pLB207; Lutshumba J, 2018, ARTERIOSCL THROM VAS, V38, P1063, DOI 10.1161/ATVBAHA.117.310153; Mansukhani NA, 2017, ARTERY RES, V20, P8, DOI 10.1016/j.artres.2017.08.002; McAlpine CS, 2016, CIRC RES, V119, P131, DOI 10.1161/CIRCRESAHA.116.308034; Mendez-Ferrer S, 2009, CURR OPIN HEMATOL, V16, P235, DOI 10.1097/MOH.0b013e32832bd0f5; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Pan XY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13011; Pan XY, 2013, CIRCULATION, V128, P1758, DOI 10.1161/CIRCULATIONAHA.113.002885; Petrovsky N, 2003, IMMUNOL CELL BIOL, V81, P137, DOI 10.1046/j.0818-9641.2002.01148.x; Rikitake Y, 2005, CIRCULATION, V112, P2959, DOI 10.1161/CIRCULATIONAHA.105.584623; Senoo M, 2000, MOL GENET METAB, V69, P269, DOI 10.1006/mgme.2000.2984; Steffens S, 2017, ARTERIOSCL THROM VAS, V37, P1022, DOI 10.1161/ATVBAHA.117.309374; Subramanian M, 2014, J CLIN INVEST, V124, P1296, DOI 10.1172/JCI72051; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Wang CY, 2008, CIRCULATION, V118, P2166, DOI 10.1161/CIRCULATIONAHA.108.790469; Wang CY, 2016, BIOCHEM BIOPH RES CO, V478, P935, DOI 10.1016/j.bbrc.2016.08.054; Wang CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18874; Wang CY, 2015, BIOCHEM BIOPH RES CO, V464, P826, DOI 10.1016/j.bbrc.2015.07.046; Wang YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155075; Winter C, 2018, CELL METAB, V28, P175, DOI 10.1016/j.cmet.2018.05.002; Yang GR, 2020, ARTERIOSCL THROM VAS, V40, P1523, DOI 10.1161/ATVBAHA.120.314318; Yang L, 2015, INT IMMUNOPHARMACOL, V28, P525, DOI 10.1016/j.intimp.2015.07.001; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young ME, 2014, J BIOL RHYTHM, V29, P257, DOI 10.1177/0748730414543141; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214	49	2	2	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21309	10.1096/fj.202001818RRR	http://dx.doi.org/10.1096/fj.202001818RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33423309				2022-12-26	WOS:000647789600045
J	Attwell, K; Lake, J; Sneddon, J; Gerrans, P; Blyth, C; Lee, J				Attwell, Katie; Lake, Joshua; Sneddon, Joanne; Gerrans, Paul; Blyth, Chris; Lee, Julie			Converting the maybes: Crucial for a successful COVID-19 vaccination strategy	PLOS ONE			English	Article								Background Broad community acceptance of a COVID-19 vaccination will be critical for effectively halting the spread of the virus. In this study, we focus on factors that differentiate those who are undecided from those who are either willing or unwilling to accept a prospective COVID-19 vaccine. Methods An online survey in May 2020 assessed Australian adults' willingness to receive a COVID-19 vaccine (yes, maybe, no). A multinomial logistical regression of responses (N = 1,313) was used to identify correlates of vaccine willingness between the three groups. Results 65% were willing to vaccinate, with 27% being in the 'maybe' category. Respondents were more likely to be in the 'maybe' than the 'yes' group when they perceived COVID-19 to be less severe, had less trust in science, were less willing to vaccinate for influenza, and were female. They were more likely to be in the 'maybe' than 'no' group when they perceived COVID-19 as severe, and less likely to be a hoax, had more trust in science, and greater willingness to vaccinate for influenza. A repeat of the survey in November 2020 with a subset of participants found fewer of them saying yes to the vaccine (56%) and more saying maybe (31%). Conclusions The effectiveness of any COVID-19 vaccine rollout will be reliant on maximizing uptake. The significant number of people who remain undecided about whether or not to get a COVID-19 vaccine, despite the ongoing devastating consequences of the virus for individuals, communities, and economies, is concerning. Our findings aid current research seeking to inform policy regarding how to convince the undecided to vaccinate.	[Attwell, Katie] Univ Western Australia, Sch Social Sci, Perth, WA, Australia; [Attwell, Katie; Blyth, Chris] Univ Western Australia, Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Perth, WA, Australia; [Attwell, Katie; Blyth, Chris] Univ Western Australia, Sch Med, Perth, WA, Australia; [Lake, Joshua; Sneddon, Joanne; Gerrans, Paul; Lee, Julie] Univ Western Australia, Ctr Human & Cultural Values, Perth, WA, Australia; [Blyth, Chris] Perth Childrens Hosp, Dept Paediat Infect Dis, Perth, WA, Australia; [Blyth, Chris] QEII Med Ctr, PathWest Lab Med WA, Dept Microbiol, Perth, WA, Australia	University of Western Australia; Telethon Kids Institute; University of Western Australia; Wesfarmers Limited; University of Western Australia; University of Western Australia	Attwell, K (corresponding author), Univ Western Australia, Sch Social Sci, Perth, WA, Australia.; Attwell, K (corresponding author), Univ Western Australia, Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Perth, WA, Australia.; Attwell, K (corresponding author), Univ Western Australia, Sch Med, Perth, WA, Australia.	Katie.attwell@uwa.edu.au	Lee, Julie A/B-6156-2011; Attwell, Kathryn Louise/D-4346-2018	Lee, Julie A/0000-0001-8718-388X; Blyth, Christopher Charles/0000-0003-2017-0683; Sneddon, Joanne/0000-0001-7869-9649; Attwell, Kathryn Louise/0000-0002-0366-2160; Lake, Joshua/0000-0001-9320-3402	Australian Research Council Discovery Early Career Researcher Award from the Australian Government [DE190100158]; Australian Research Council [LP150100434]	Australian Research Council Discovery Early Career Researcher Award from the Australian Government(Australian Research Council); Australian Research Council(Australian Research Council)	Katie Attwell is currently in receipt of an Australian Research Council Discovery Early Career Researcher Award from the Australian Government, DE190100158. Julie Lee is in receipt of Australian Research Council Linkage Grant ARC Linkage Grant LP150100434.	[Anonymous], 2020, ABC NEWS; Australian Government Department of Health., 2020, NAT IMM PROGR INFL V; Australian Government Department of Health, AUSTR COVID 19 VACC; Australian Government Department of Health., REC FLU VACC 2020 PR; Detoc M, 2020, VACCINE, V38, P7002, DOI 10.1016/j.vaccine.2020.09.041; Dodd RH, 2021, LANCET INFECT DIS, V21, P318, DOI 10.1016/S1473-3099(20)30559-4; Eastwood K, 2010, MED J AUSTRALIA, V192, P33, DOI 10.5694/j.1326-5377.2010.tb03399.x; European Social Survey, ESS COR QUEST DEV PO; Gallagher J., 2020, BBC NEWS; Goldman RD, 2020, VACCINE, V38, P7668, DOI 10.1016/j.vaccine.2020.09.084; Larson HJ, 2016, EBIOMEDICINE, V12, P295, DOI 10.1016/j.ebiom.2016.08.042; Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9; Long J.S., 2014, REGRESSION MODELS CA; Malik AA., 2020, ECLINICALMEDICINE, V26, P100495, DOI 10.1016/j.eclinm.2020.100495; Park S, 2022, CRANIO, V40, P174, DOI 10.1080/08869634.2020.1721174; Reiter PL, 2020, VACCINE, V38, P6500, DOI 10.1016/j.vaccine.2020.08.043; Rhodes A, 2021, LANCET INFECT DIS, V21, pE110, DOI 10.1016/S1473-3099(20)30724-6; Schwartz SH., 2019, WHAT DO WE VALUE; Smith DT, 2020, POLITICS-OXFORD, V40, P189, DOI 10.1177/0263395719859457; Witte K, 1996, J Health Commun, V1, P317, DOI 10.1080/108107396127988; World Health Organisation, 2020, LANDSC COVID 19 CAND	21	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245907	10.1371/journal.pone.0245907	http://dx.doi.org/10.1371/journal.pone.0245907			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471821	Green Published, gold			2022-12-26	WOS:000639428800077
J	Cuthbertson, P; Ullmann, T; Budel, C; Varis, A; Namen, A; Seltmann, R; Reed, D; Taimagambetov, Z; Iovita, R				Cuthbertson, Patrick; Ullmann, Tobias; Buedel, Christian; Varis, Aristeidis; Namen, Abay; Seltmann, Reimar; Reed, Denne; Taimagambetov, Zhaken; Iovita, Radu			Finding karstic caves and rockshelters in the Inner Asian mountain corridor using predictive modelling and field survey	PLOS ONE			English	Article							LATE PLEISTOCENE; SITE; TOPOGRAPHY; KAZAKSTAN; ALTAI	The area of the Inner Asian Mountain Corridor (IAMC) follows the foothills and piedmont zones around the northern limits of Asia's interior mountains, connecting two important areas for human evolution: the Fergana valley and the Siberian Altai. Prior research has suggested the IAMC may have provided an area of connected refugia from harsh climates during the Pleistocene. To date, this region contains very few secure, dateable Pleistocene sites, but its widely available carbonate units present an opportunity for discovering cave sites, which generally preserve longer sequences and organic remains. Here we present two models for predicting karstic cave and rockshelter features in the Kazakh portion of the IAMC. The 2018 model used a combination of lithological data and unsupervised landform classification, while the 2019 model used feature locations from the results of our 2017-2018 field surveys in a supervised classification using a minimum-distance classifier and morphometric features derived from the ASTER digital elevation model (DEM). We present the results of two seasons of survey using two iterations of the karstic cave models (2018 and 2019), and evaluate their performance during survey. In total, we identified 105 cave and rockshelter features from 2017-2019. We conclude that this model-led approach significantly reduces the target area for foot survey.	[Cuthbertson, Patrick; Varis, Aristeidis; Namen, Abay; Iovita, Radu] Eberhard Karls Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany; [Ullmann, Tobias; Buedel, Christian] Univ Wurzburg, Inst Geog & Geol, Wurzburg, Germany; [Varis, Aristeidis] Eberhard Karls Univ Tubingen, Inst Archaeol Sci INA, Tubingen, Germany; [Namen, Abay] Al Farabi Kazakh Natl Univ, Fac Hist Archaeol & Ethnol, Dept Archaeol Ethnol & Museol, Alma Ata, Kazakhstan; [Seltmann, Reimar] Nat Hist Museum, Dept Earth Sci, Ctr Russian & Cent EurAsian Mineral Studies, London, England; [Reed, Denne] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Taimagambetov, Zhaken] Natl Museum Republ Kazakhstan, Nur Sultan, Kazakhstan; [Iovita, Radu] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA	Eberhard Karls University of Tubingen; University of Wurzburg; Eberhard Karls University of Tubingen; Al-Farabi Kazakh National University; Natural History Museum London; University of Texas System; University of Texas Austin; New York University	Cuthbertson, P; Iovita, R (corresponding author), Eberhard Karls Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany.; Iovita, R (corresponding author), NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA.	patrick.a.cuthbertson@gmail.com; radu.iovita@uni-tuebingen.de	Namen, Abay/GLR-3745-2022; Iovita, Radu/B-9580-2015; Seltmann, Reimar/K-6157-2015	Namen, Abay/0000-0003-2990-5084; Iovita, Radu/0000-0001-9531-1159; Seltmann, Reimar/0000-0002-4590-6485; Reed, Denne/0000-0001-9325-3100; Varis, Aristeidis/0000-0003-2343-2087; Taimagambetov, Zhaken/0000-0003-3541-0600	European Research Council (ERC) under the European Union [714842]	European Research Council (ERC) under the European Union(European Research Council (ERC))	This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement no 714842; PALAEOSILKROAD project)	Alexeiev DV, 2017, GEOTECTONICS+, V51, P105, DOI 10.1134/S0016852117020029; [Anonymous], GEOLOGICAL MAP KAZAK; Argyriou AV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170727; Beeton TA, 2014, J BIOGEOGR, V41, P95, DOI 10.1111/jbi.12183; Bohner J., 2006, GOTTINGER GEOGRAPHIS, V115, P13; Breiman L., 2001, MACH LEARN, V45, P5; Buslov MM, 2008, RUSS GEOL GEOPHYS+, V49, P648, DOI 10.1016/j.rgg.2008.01.006; Buzhilova A, 2017, CURR ANTHROPOL, V58, pS491, DOI 10.1086/694232; Columbu A, 2020, NAT ECOL EVOL, V4, P1188, DOI 10.1038/s41559-020-1243-1; Conrad O, 2015, GEOSCI MODEL DEV, V8, P1991, DOI 10.5194/gmd-8-1991-2015; Cook, 2002, SPECIAL PUBLICATION, P81, DOI [DOI 10.2110/PEC.02.74.0081, 10.2110/pec.02.74.0081]; De Reu J, 2013, GEOMORPHOLOGY, V186, P39, DOI 10.1016/j.geomorph.2012.12.015; Dennell R, 2017, CURR ANTHROPOL, V58, pS383, DOI 10.1086/694174; Deviese T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08018-8; Dietrich H., 2008, HAMBURGER BEITRAGE P, V19, P37; Douka K, 2019, NATURE, V565, P640, DOI 10.1038/s41586-018-0870-z; Dragut L, 2012, GEOMORPHOLOGY, V141, P21, DOI 10.1016/j.geomorph.2011.12.001; Dzhasybaev E.A., 2018, ARKHEOLOGIYA KAZAKHS, P215; Fitzsimmons KE, 2017, J HUM EVOL, V113, P107, DOI 10.1016/j.jhevol.2017.07.006; Ford D., 2013, KARST HYDROGEOLOGY G; Frachetti MD, 2012, CURR ANTHROPOL, V53, P2, DOI 10.1086/663692; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Glantz M, 2008, J HUM EVOL, V55, P223, DOI 10.1016/j.jhevol.2007.12.007; Glantz M, 2018, QUATERN INT, V466, P82, DOI 10.1016/j.quaint.2016.06.037; Glantz MM, 2010, VERTEBR PALEOBIOL PA, P101, DOI 10.1007/978-90-481-9094-2_8; Gokcumen O, 2020, AM J PHYS ANTHROPOL, V171, P60, DOI 10.1002/ajpa.23951; Gokhman IY., 1957, KRATKIE SOOBSHCHENIY, V67, P54; Grigoriev F.P., 1998, VESTNIK U, V1, P68; Heydari S, 2007, GEOARCHAEOLOGY, V22, P653, DOI 10.1002/gea.20179; Iovita R, 2020, QUATERN INT, V559, P119, DOI 10.1016/j.quaint.2020.02.023; ISLAMOV YI, 1990, ANTHROPOLOGIE, V94, P675; Iwahashi J, 2007, GEOMORPHOLOGY, V86, P409, DOI 10.1016/j.geomorph.2006.09.012; Jennings JN., 1983, KARSTOLOGIA, V1, P61, DOI [10.3406/karst.1983.2041, DOI 10.3406/KARST.1983.2041]; Kim YJ, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11131592; Koller D, 2010, MAKING HIST INTERACT; Kolobova KA, 2011, ARCHAEOL ETHNOL ANTH, V39, P2, DOI 10.1016/j.aeae.2012.02.002; Krivoshapkin AI, 2010, RADIOCARBON, V52, P549, DOI 10.1017/S0033822200045586; Kumin YV, 2009, J HUM EVOL, V57, P91, DOI 10.1016/j.jhevol.2009.04.003; Kvamme KL, 1990, MATH INFORMATION SCI, P257; Li F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216433; Lindsay JB, 2015, GEOMORPHOLOGY, V245, P51, DOI 10.1016/j.geomorph.2015.05.025; Mel R., 2008, ENCY ARCHAEOLOGY, P966; Panyushkina IP, 2019, SOCIO-ENVIRONMENTAL DYNAMICS ALONG THE HISTORICAL SILK ROAD, P379, DOI 10.1007/978-3-030-00728-7_18; Reed D., 2018, NEW GEOSPATIAL APPRO, P211; Reed D, 2015, EVOL ANTHROPOL, V24, P238, DOI 10.1002/evan.21466; Richards J. A., 2012, REMOTE SENSING DIGIT; Schauber A, 2003, ANTIQUITY, V77, P1; Shakalov AA., 2011, NEKOTORYE POYASNENIY; Shakalov AA., 2010, SPELEOLOGIYA SPELEST, P77; Sherwood SC., 2001, MIDCONT J ARCHAEOL, V26, P145, DOI 10.2307/20708157; Shunkov M, 2017, ANTIQUITY, V91, DOI 10.15184/aqy.2017.208; Slon V, 2018, NATURE, V561, P113, DOI 10.1038/s41586-018-0455-x; Slon V, 2017, SCIENCE, V356, P605, DOI 10.1126/science.aam9695; Straus L. G., 1990, ARCHAEOLOGICAL METHO, V2, P255; Taimagambetov K., 1998, ARHEOLOGICHESKIE KOM; Taimagambetov Z.K., 2009, POZDNEPALEOLITICHESK; Trifonov VG, 2008, RUSS GEOL GEOPHYS+, V49, P98, DOI 10.1016/j.rgg.2007.06.012; Weiss A., 2001, ESRI US C 2001 JUN S; Wilson J.P., 2000, TERRAIN ANAL PRINCIP; Yokoyama R, 2002, PHOTOGRAMM ENG REM S, V68, P257; Zhu XK, 2018, HERITAGE-BASEL, V1, P15, DOI 10.3390/heritage1010002; Zuckerberg B, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P45, DOI 10.1007/978-1-4419-7390-0_4	62	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245170	10.1371/journal.pone.0245170	http://dx.doi.org/10.1371/journal.pone.0245170			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM1OE	33471843	Green Submitted, Green Published, gold			2022-12-26	WOS:000639428800032
J	Kulhanek, K; Steinhauer, N; Wilkes, J; Wilson, M; Spivak, M; Sagili, RR; Tarpy, DR; McDermott, E; Garavito, A; Rennich, K; VanEngelsdorp, D				Kulhanek, Kelly; Steinhauer, Nathalie; Wilkes, James; Wilson, Michaela; Spivak, Marla; Sagili, Ramesh R.; Tarpy, David R.; McDermott, Erin; Garavito, Andrew; Rennich, Karen; VanEngelsdorp, Dennis			Survey-derived best management practices for backyard beekeepers improve colony health and reduce mortality	PLOS ONE			English	Article							HONEY-BEE COLONIES; VARROA-DESTRUCTOR; NATIONAL-SURVEY; INVASION; LOSSES; RATES	Honey bee colony losses in the US have exceeded acceptable levels for at least a decade, leaving beekeepers in need of management practices to improve colony health and survival. Here, an empirical Best Management Practice (BMP) regimen was tested, comprised of the top four management practices associated with reduced colony mortality in backyard beekeeping operations according to Bee Informed Partnership Loss and Management survey results. Seven study locations were established across the US, and each location consisted of ten colonies treated according to empirical BMPs and ten according to average beekeeping practice. After 3 years, colonies treated according to empirical BMPs experienced reduced Varroa infestation, viral infection, and mortality compared to colonies managed with Average practices. In addition, BMP colonies produced more new colonies via splits. The colonies under Average practices were given chemical Varroa treatments only once per year, and thus spent more months above economic threshold of 3.0 mites/100 bees. Increased time spent above the economic threshold was significantly correlated to both increased viral infection and colony mortality. This study demonstrates the cumulative effects of management and colony health stressors over months and years, especially the dire importance of regular Varroa monitoring and management.	[Kulhanek, Kelly; Steinhauer, Nathalie; Garavito, Andrew; Rennich, Karen; VanEngelsdorp, Dennis] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Wilkes, James] Appalachian State Univ, Dept Comp Sci, Boone, NC 28608 USA; [Wilson, Michaela] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Spivak, Marla] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Sagili, Ramesh R.] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Tarpy, David R.; McDermott, Erin] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC USA; [Kulhanek, Kelly] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA	University System of Maryland; University of Maryland College Park; University of North Carolina; Appalachian State University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Minnesota System; University of Minnesota Twin Cities; Oregon State University; University of North Carolina; North Carolina State University; Washington State University	Kulhanek, K (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.; Kulhanek, K (corresponding author), Washington State Univ, Dept Entomol, Pullman, WA 99164 USA.	Kelly.kulhanek@wsu.edu		Tarpy, David/0000-0001-8601-6094	Coordinated Agricultural Project (CAP) grant from US Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) [2016-68004-24832]	Coordinated Agricultural Project (CAP) grant from US Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA)	This project was funded by a Coordinated Agricultural Project (CAP) grant from US Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA); award #2016-68004-24832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Alburaki M, 2018, INSECTS, V9, DOI 10.3390/insects9020065; Bailey L., 1991, HONEY BEE PATHOLOGY; Bee Informed P., 2019, MANAGMENT SURVEY RES; Boecking O, 1999, APIDOLOGIE, V30, P141, DOI 10.1051/apido:19990205; Brodschneider R, 2016, J APICULT RES, V55, P375, DOI 10.1080/00218839.2016.1260240; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; DeGrandi-Hoffman G, 2016, APIDOLOGIE, V47, P186, DOI 10.1007/s13592-015-0386-6; Delaplane KS, 2013, J APICULTURAL RES, V52, P1, DOI [10.3896/IBRA.1.52.1.13, DOI 10.3896/IBRA.1.52.1.13]; Di Pasquale G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162818; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Doublet V, 2015, ENVIRON MICROBIOL, V17, P969, DOI 10.1111/1462-2920.12426; Fahey R, 2019, 2017 2018 NATL HONEY; Ferland J, 2017, COMMUNICATION; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Frey E, 2014, J ECON ENTOMOL, V107, P508, DOI 10.1603/EC13381; Frey E, 2011, J APICULT RES, V50, P138, DOI 10.3896/IBRA.1.50.2.05; Fries I, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.14; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Guthrie A., 2018, HONEY BEE HLTH PRODU; Haber AI, 2019, J EC ENTOMOLOGY; Kanbar G, 2003, PARASITOL RES, V90, P349, DOI 10.1007/s00436-003-0827-4; Kang Y, 2016, MATH BIOSCI, V275, P71, DOI 10.1016/j.mbs.2016.02.012; Karl T. R., 1984, HIST CLIMATOLOGY SER, V4-3; Kulhanek K, 2017, J APICULTURAL RES, V2017, P1; Lee KV, 2019, INSECTS, V10, DOI 10.3390/insects10010012; Lee KV, 2015, APIDOLOGIE, V46, P292, DOI 10.1007/s13592-015-0356-z; Loftus JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150362; Mondet F, 2016, SCI REP-UK, V6, DOI 10.1038/srep25444; Naug D, BIOL CONSERVATION; Nolan MP, 2017, APIDOLOGIE, V48, P8, DOI 10.1007/s13592-016-0443-9; Pietropaoli M., 2012, EUR J LNTEGR MED, V15, P93; Piou V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153482; Ramsey SD, 2019, P NATL ACAD SCI USA, V116, P1792, DOI 10.1073/pnas.1818371116; Ratti V, 2012, CANADIAN APPL MATH Q, P1; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Seitz N, 2016, J APICULT RES, V54, P292, DOI 10.1080/00218839.2016.1153294; Smart M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152685; Sperandio G, 2019, SCI TOTAL ENVIRON, V696, DOI 10.1016/j.scitotenv.2019.133795; Spleen AM, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.07; Steinhauer N, 2021, SCI TOTAL ENVIRON, V753, DOI 10.1016/j.scitotenv.2020.141629; Steinhauer N, 2018, CURR OPIN INSECT SCI, V26, P142, DOI 10.1016/j.cois.2018.02.004; Steinhauer NA, 2014, J APICULT RES, V53, P1, DOI 10.3896/IBRA.1.53.1.01; Thoms CA, 2019, AMBIO, V48, P1209, DOI 10.1007/s13280-018-1130-z; Tosi S, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1711; Traynor KS, 2016, SCI REP-UK, V6, DOI 10.1038/srep33207; Underwood RM, 2019, INSECTS, V10, DOI 10.3390/insects10010010; vanEngelsdorp D, 2013, PREV VET MED, V108, P225, DOI 10.1016/j.prevetmed.2012.08.004; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Wu-Smart J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32108; Zheng HQ, 2015, VET MICROBIOL, V177, P1, DOI 10.1016/j.vetmic.2015.02.003	55	13	14	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245490	10.1371/journal.pone.0245490	http://dx.doi.org/10.1371/journal.pone.0245490			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449973	Green Published, gold			2022-12-26	WOS:000609991600026
J	Begun, A; Liubimov, S; Molochkov, A; Niemi, AJ				Begun, Alexander; Liubimov, Sergei; Molochkov, Alexander; Niemi, Antti J.			On topology and knotty entanglement in protein folding	PLOS ONE			English	Article							MODELS	We investigate aspects of topology in protein folding. For this we numerically simulate the temperature driven folding and unfolding of the slipknotted archaeal virus protein AFV3-109. Due to knottiness the (un)folding is a topological process, it engages the entire backbone in a collective fashion. Accordingly we introduce a topological approach to model the process. Our simulations reveal that the (un)folding of AFV3-109 slipknot proceeds through a folding intermediate that has the topology of a trefoil knot. We observe that the final slipknot causes a slight swelling of the folded AFV3-109 structure. We disclose the relative stability of the strands and helices during both the folding and unfolding processes. We confirm results from previous studies that pointed out that it can be very demanding to simulate the formation of knotty self-entanglement, and we explain how the problems are circumvented: The slipknotted AFV3-109 protein is a very slow folder with a topologically demanding pathway, which needs to be properly accounted for in a simulation description. When we either increase the relative stiffness of bending, or when we decrease the speed of ambient cooling, the rate of slipknot formation rapidly increases.	[Begun, Alexander; Liubimov, Sergei; Molochkov, Alexander; Niemi, Antti J.] Far Eastern Fed Univ, Pacific Quantum Ctr, Vladivostok, Russia; [Niemi, Antti J.] Stockholm Univ, Nordita, Stockholm, Sweden; [Niemi, Antti J.] Beijing Inst Technol, Dept Phys, Beijing, Peoples R China	Far Eastern Federal University; Nordic Institute for Theoretical Physics; Stockholm University; Beijing Institute of Technology	Niemi, AJ (corresponding author), Far Eastern Fed Univ, Pacific Quantum Ctr, Vladivostok, Russia.; Niemi, AJ (corresponding author), Stockholm Univ, Nordita, Stockholm, Sweden.; Niemi, AJ (corresponding author), Beijing Inst Technol, Dept Phys, Beijing, Peoples R China.	Antti.Niemi@su.se	Lyubimov, Sergey/AAC-2869-2022; Begun, Alexander/M-9576-2019; Molochkov, Alexander/A-8594-2014	Molochkov, Alexander/0000-0002-3578-703X; Begun, Alexander/0000-0001-8399-0617; Lyubimov, Sergey/0000-0002-7846-3510; Niemi, Antti/0000-0003-3408-5834	Ministry of Science and Higher Education of Russia [0657-2020-0015]; Swedish Research Council [2018-04411]; Carl Trygger Foundation [CTS 18: 276]; Qian Ren grant at BIT; COST Action collaboration [CA17139]	Ministry of Science and Higher Education of Russia; Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger Foundation; Qian Ren grant at BIT; COST Action collaboration	This work was supported by the Ministry of Science and Higher Education of Russia in the form of a grant awarded to AM (0657-2020-0015), the Swedish Research Council in the form of a contract awarded to AJN (2018-04411), and the Carl Trygger Foundation in the form of a grant awarded to AJN (CTS 18: 276). AJN acknowledges the support of a Qian Ren grant at BIT. The research by AJN is also part of a COST Action collaboration (CA17139).	Begun A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47317-y; Bergou M, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360662; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bolinger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000731; Chernodub M, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011916; Covino R, 2014, BIOMOLECULES, V4, P1, DOI 10.3390/biom4010001; Dabrowski-Tumanski P, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/35/354109; Dabrowski-Tumanski P, 2019, NUCLEIC ACIDS RES, V47, pD367, DOI 10.1093/nar/gky1140; Dabrowski-Tumanski P, 2017, POLYMERS-BASEL, V9, DOI 10.3390/polym9090454; Danielsson UH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021910; DePristo MA, 2003, PROTEIN SCI, V12, P2032, DOI 10.1110/ps.0386903; Hu SW, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061908; Jarmolinska AI, 2019, J MOL BIOL, V431, P244, DOI 10.1016/j.jmb.2018.10.012; Keller J, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-12; King NP, 2010, P NATL ACAD SCI USA, V107, P20732, DOI 10.1073/pnas.1007602107; Kolesov G, 2007, NUCLEIC ACIDS RES, V35, pW425, DOI 10.1093/nar/gkm312; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; Krokhotin A, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/32/325103; Lai YL, 2007, NUCLEIC ACIDS RES, V35, pW420, DOI 10.1093/nar/gkm304; Li YQ, 2009, PROTEINS, V76, P665, DOI 10.1002/prot.22380; Liu JJ, 2019, J CHEM PHYS, V150, DOI 10.1063/1.5082627; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lundgren M, 2009, ARXIV09064950; Mallam AL, 2012, NAT CHEM BIOL, V8, P147, DOI 10.1038/nchembio.742; MANSFIELD ML, 1994, NAT STRUCT BIOL, V1, P213, DOI 10.1038/nsb0494-213; Manton N.S., 2004, TOPOLOGICAL SOLITONS; MARKO JF, 1994, MACROMOLECULES, V27, P981, DOI 10.1021/ma00082a015; Molkenthin N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.078102; Niemi AJ, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.106004; Niemi AJ, 2017, LECT NOTES HOUCHES S; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Peng XB, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.062405; Peng XB, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/s12900-014-0027-8; Perego C, 2019, J PHYS-CONDENS MAT, V31, DOI 10.1088/1361-648X/ab2f19; Rotkiewicz P, 2008, J COMPUT CHEM, V29, P1460, DOI 10.1002/jcc.20906; Scalley ML, 1997, P NATL ACAD SCI USA, V94, P10636, DOI 10.1073/pnas.94.20.10636; Sinelnikova A, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032602; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P17783, DOI 10.1073/pnas.1201804109; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, pE1715, DOI 10.1073/pnas.1205918109; Sulkowska JI, 2009, P NATL ACAD SCI USA, V106, P3119, DOI 10.1073/pnas.0811147106; Takhtadzhyan LA, 1987, HAMILTONIAN APPROACH; Takusagawa F, 1996, J AM CHEM SOC, V118, P8945; Taylor WR, 2000, NATURE, V406, P916, DOI 10.1038/35022623; Virnau P, 2006, PLOS COMPUT BIOL, V2, P1074, DOI 10.1371/journal.pcbi.0020122; Virnau P, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/3/033101; Wallin S, 2007, J MOL BIOL, V368, P884, DOI 10.1016/j.jmb.2007.02.035	47	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0244547	10.1371/journal.pone.0244547	http://dx.doi.org/10.1371/journal.pone.0244547			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439862	Green Published, gold			2022-12-26	WOS:000609985300044
J	Vahidy, FS; Pan, AP; Ahnstedt, H; Munshi, Y; Choi, HA; Tiruneh, Y; Nasir, K; Kash, BA; Andrieni, JD; McCullough, LD				Vahidy, Farhaan S.; Pan, Alan P.; Ahnstedt, Hilda; Munshi, Yashasvee; Choi, Huimahn A.; Tiruneh, Yordanos; Nasir, Khurram; Kash, Bita A.; Andrieni, Julia D.; McCullough, Louise D.			Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area	PLOS ONE			English	Article								Introduction Sex is increasingly recognized as an important factor in the epidemiology and outcome of many diseases. This also appears to hold for coronavirus disease 2019 (COVID-19). Evidence from China and Europe has suggested that mortality from COVID-19 infection is higher in men than women, but evidence from US populations is lacking. Utilizing data from a large healthcare provider, we determined if males, as compared to females have a higher likelihood of SARS-CoV-2 susceptibility, and if among the hospitalized COVID-19 patients, male sex is independently associated with COVID-19 severity and poor in-hospital outcomes. Methods and findings Using the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines, we conducted a cross-sectional analysis of data from a COVID-19 Surveillance and Outcomes Registry (CURATOR). Data were extracted from Electronic Medical Records (EMR). A total of 96,473 individuals tested for SARS-CoV-2 RNA in nasopharyngeal swab specimens via Polymerized Chain Reaction (PCR) tests were included. For hospital-based analyses, all patients admitted during the same time-period were included. Of the 96,473 patients tested, 14,992 (15.6%) tested positive, of whom 4,785 (31.9%) were hospitalized and 452 (9.5%) died. Among all patients tested, men were significantly older. The overall SARS-CoV-2 positivity among all tested individuals was 15.5%, and was higher in males as compared to females 17.0% vs. 14.6% [OR 1.20]. This sex difference held after adjusting for age, race, ethnicity, marital status, insurance type, median income, BMI, smoking and 17 comorbidities included in Charlson Comorbidity Index (CCI) [aOR 1.39]. A higher proportion of males (vs. females) experienced pulmonary (ARDS, hypoxic respiratory failure) and extra-pulmonary (acute renal injury) complications during their hospital course. After adjustment, length of stay (LOS), need for mechanical ventilation, and in-hospital mortality were significantly higher in males as compared to females. Conclusions In this analysis of a large US cohort, males were more likely to test positive for COVID-19. In hospitalized patients, males were more likely to have complications, require ICU admission and mechanical ventilation, and had higher mortality than females, independent of age. Sex disparities in COVID-19 vulnerability are present, and emphasize the importance of examining sex-disaggregated data to improve our understanding of the biological processes involved to potentially tailor treatment and risk stratify patients.	[Vahidy, Farhaan S.; Pan, Alan P.; Nasir, Khurram; Kash, Bita A.] Houston Methodist Res Inst, Ctr Outcomes Res, Houston, TX 77030 USA; [Vahidy, Farhaan S.] Houston Methodist, Houston Methodist Neurol Inst, Houston, TX 77030 USA; [Ahnstedt, Hilda; Munshi, Yashasvee; McCullough, Louise D.] UTHealth, McGovern Med Sch, Dept Neurol, Houston, TX USA; [Choi, Huimahn A.] UTHealth, McGovern Med Sch, Dept Neurosurg, Houston, TX USA; [Tiruneh, Yordanos] Univ Texas Hlth Sci Ctr, Tyler, TX USA; [Nasir, Khurram] Houston Methodist, Dept Cardiol, Houston, TX USA; [Kash, Bita A.] Texas A&M, Sch Rural Publ Hlth, College Stn, TX USA; [Kash, Bita A.; Andrieni, Julia D.] Weill Cornell Med Coll, New York, NY USA; [Andrieni, Julia D.] Houston Methodist, Dept Clin Med, Houston, TX USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); The Methodist Hospital System; The Methodist Hospital - Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Vahidy, FS (corresponding author), Houston Methodist Res Inst, Ctr Outcomes Res, Houston, TX 77030 USA.; Vahidy, FS (corresponding author), Houston Methodist, Houston Methodist Neurol Inst, Houston, TX 77030 USA.	fvahidy@houstonmethodist.org		Pan, Alan/0000-0002-8782-8024; Tiruneh, Yordanos/0000-0001-9296-9908				A.Chatterjee, 2020, medRxiv, DOI 10.1101/2020.04.24.20079046; Ahnstedt H, 2019, CELL IMMUNOL, V345, DOI 10.1016/j.cellimm.2019.103960; American Community Survey (ACS), 2018, AM COMMUNITY SURVEY; [Anonymous], 2020, GLOBAL HLTH 50 50 SE; Boehmer TK, 2020, MMWR-MORBID MORTAL W, V69, P1404, DOI 10.15585/mmwr.mm6939e1; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Mauvais-Jarvis F, 2020, LANCET, V396, P565, DOI 10.1016/S0140-6736(20)31561-0; Meng YF, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008520; Rattray NJW, 2020, MEDRXIV, DOI [10.1101/2020.09.06.20189159, DOI 10.1101/2020.09.06.20189159]; Razzaghi Hilda, 2020, MMWR Morb Mortal Wkly Rep, V69, P945, DOI 10.15585/mmwr.mm6929a1; Sharma Garima, 2020, JACC Case Rep, V2, P1407, DOI 10.1016/j.jaccas.2020.04.027; Singh A, 2020, CLIN CHARACTERISTICS, DOI [10.1101/2020.07.19.20157305, DOI 10.1101/2020.07.19.20157305]; Stopsack KH, 2020, CANCER DISCOV, V10, P779, DOI 10.1158/2159-8290.CD-20-0451; Takahashi Takehiro, 2020, medRxiv, DOI 10.1101/2020.06.06.20123414; United States Census Bureau, 2010, US GAZ FIL; Vahidy FS, 2020, JAMA-J AM MED ASSOC, V324, P998, DOI 10.1001/jama.2020.15301; Vahidy FS, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039849	22	80	81	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0245556	10.1371/journal.pone.0245556	http://dx.doi.org/10.1371/journal.pone.0245556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439908	Green Published, gold			2022-12-26	WOS:000609985300035
J	Slupe, AM; Villasana, L; Wright, KM				Slupe, Andrew M.; Villasana, Laura; Wright, Kevin M.			GABAergic neurons are susceptible to BAX-dependent apoptosis following isoflurane exposure in the neonatal period	PLOS ONE			English	Article							CELL-DEATH; DENTATE GYRUS; ANESTHESIA; BRAIN; SEVOFLURANE; ACTIVATION; MICE; MODEL	Exposure to volatile anesthetics during the neonatal period results in acute neuron death. Prior work suggests that apoptosis is the dominant mechanism mediating neuron death. We show that Bax deficiency blocks neuronal death following exposure to isoflurane during the neonatal period. Blocking Bax-mediated neuron death attenuated the neuroinflammatory response of microglia following isoflurane exposure. We find that GABAergic interneurons are disproportionately overrepresented among dying neurons. Despite the increase in neuronal apoptosis induced by isoflurane exposure during the neonatal period, seizure susceptibility, spatial memory retention, and contextual fear memory were unaffected later in life. However, Bax deficiency alone led to mild deficiencies in spatial memory and contextual fear memory, suggesting that normal developmental apoptotic death is important for cognitive function. Collectively, these findings show that while GABAergic neurons in the neonatal brain undergo elevated Bax-dependent apoptotic cell death following exposure to isoflurane, this does not appear to have long-lasting consequences on overall neurological function later in life.	[Slupe, Andrew M.; Villasana, Laura] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA; [Wright, Kevin M.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Wright, KM (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA.	wrighke@ohsu.edu			Foundation for Anesthesia Education and Research (FAER) Research Fellowship Grant [RFG-02-15-17]; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [R01 NS091027]	Foundation for Anesthesia Education and Research (FAER) Research Fellowship Grant; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Foundation for Anesthesia Education and Research (FAER) Research Fellowship Grant (RFG-02-15-17) to AMS and National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) Grant (R01 NS091027) to KMW. https://www.asahq.org/faer https://www.ninds.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers KE, 2015, GLIA, V63, P1694, DOI 10.1002/glia.22835; Amrock LG, 2015, ANESTHESIOLOGY, V122, P87, DOI 10.1097/ALN.0000000000000477; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Boscolo A, 2013, ANESTHESIOLOGY, V118, P1086, DOI 10.1097/ALN.0b013e318289bc9b; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Buckmaster PS, 2017, J COMP NEUROL, V525, P2592, DOI 10.1002/cne.24226; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Edwards DA, 2010, ANESTHESIOLOGY, V112, P567, DOI 10.1097/ALN.0b013e3181cf9138; Ehara A, 2009, ACTA HISTOCHEM CYTOC, V42, P171, DOI 10.1267/ahc.09018; Ferland RJ, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2309; Iijima T, 2000, ANESTH ANALG, V91, P989, DOI 10.1097/00000539-200010000-00041; Istaphanous GK, 2013, ANESTH ANALG, V116, P845, DOI 10.1213/ANE.0b013e318281e988; Jackson WM, 2016, J NEUROSURG ANESTH, V28, P361, DOI 10.1097/ANA.0000000000000348; Jevtovic-Todorovic V, 2018, ANESTHESIOLOGY, V128, P832, DOI 10.1097/ALN.0000000000002047; Kim I, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.403; Lee BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105340; Lee JW, 2009, LEARN MEMORY, V16, P530, DOI 10.1101/lm.1483709; Lee V, 2013, J NEUROPHYSIOL, V110, P2520, DOI 10.1152/jn.00047.2013; Li YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093639; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Loepke AW, 2009, ANESTH ANALG, V108, P90, DOI 10.1213/ane.0b013e31818cdb29; McFarlane L, 2013, SEX DEV, V7, P207, DOI 10.1159/000348677; MEINECKE DL, 1987, J COMP NEUROL, V261, P388, DOI 10.1002/cne.902610305; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Obradovic AL, 2017, MOL NEUROBIOL; Papandrea D, 2009, EXP NEUROL, V215, P60, DOI 10.1016/j.expneurol.2008.09.016; Paxinos G, 2007, ATLAS DEV MOUSE BRAI; Rydbirk R, 2016, SCI REP-UK, V6, DOI 10.1038/srep37116; Samudio-Ruiz SL, 2009, J NEUROCHEM, V109, P1311, DOI 10.1111/j.1471-4159.2009.06049.x; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Schenning KJ, 2017, NEUROTOXICOL TERATOL, V60, P63, DOI 10.1016/j.ntt.2016.11.006; Seubert CN, 2013, ANESTHESIOLOGY, V119, P358, DOI 10.1097/ALN.0b013e318291c04e; Shen X, 2013, ANESTHESIOLOGY, V118, P502, DOI 10.1097/ALN.0b013e3182834d77; Simon DJ, 2012, J NEUROSCI, V32, P17540, DOI 10.1523/JNEUROSCI.3012-12.2012; Southwell DG, 2012, NATURE, V491, P109, DOI 10.1038/nature11523; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tehranian R, 2008, J NEUROTRAUM, V25, P755, DOI 10.1089/neu.2007.0441; Voss LJ, 2008, ANESTH ANALG, V107, P1689, DOI 10.1213/ane.0b013e3181852595; Walters JL, 2017, NEUROTOXICOL TERATOL, V60, P2, DOI 10.1016/j.ntt.2016.11.005; Warner DO, 2018, ANESTHESIOLOGY, V128, P700, DOI 10.1097/ALN.0000000000002121; Xiang H, 1998, J NEUROSCI, V18, P1363; Yan HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055276; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.neuroscience.2005.03.064; Young C, 2003, CELL DEATH DIFFER, V10, P1148, DOI 10.1038/sj.cdd.4401277; Zhang YY, 2010, J BIOL CHEM, V285, P4025, DOI 10.1074/jbc.M109.065664; Zhou ZW, 2011, NEUROSCIENCE, V174, P64, DOI 10.1016/j.neuroscience.2010.10.009	46	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0238799	10.1371/journal.pone.0238799	http://dx.doi.org/10.1371/journal.pone.0238799			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434191	gold, Green Published			2022-12-26	WOS:000609979700012
J	Holmgren, M; Stoverud, KH; Zarrinkoob, L; Wahlin, A; Malm, J; Eklund, A				Holmgren, Madelene; Stoverud, Karen-Helene; Zarrinkoob, Laleh; Wahlin, Anders; Malm, Jan; Eklund, Anders			Middle cerebral artery pressure laterality in patients with symptomatic ICA stenosis	PLOS ONE			English	Article								An internal carotid artery (ICA) stenosis can potentially decrease the perfusion pressure to the brain. In this study, computational fluid dynamics (CFD) was used to study if there was a hemispheric pressure laterality between the contra- and ipsilateral middle cerebral artery (MCA) in patients with a symptomatic ICA stenosis. We further investigated if this MCA pressure laterality (Delta P-MCA) was related to the hemispheric flow laterality (Delta Q) in the anterior circulation, i.e., ICA, proximal MCA and the proximal anterior cerebral artery (ACA). Twenty-eight patients (73 +/- 6 years, range 59-80 years, 21 men) with symptomatic ICA stenosis were included. Flow rates were measured using 4D flow MRI data (PC-VIPR) and vessel geometries were obtained from computed tomography angiography. The Delta P-MCA was calculated from CFD, where patient-specific flow rates were applied at all input- and output boundaries. The Delta P-MCA between the contra- and ipsilateral side was 6.4 +/- 8.3 mmHg (p<0.001) (median 3.9 mmHg, range -1.3 to 31.9 mmHg). There was a linear correlation between the Delta P-MCA and Delta Q(ICA) (r = 0.85, p<0.001) and Delta Q(ACA) (r = 0.71, p<0.001), respectively. The correlation to Delta Q(MCA) was weaker (r = 0.47, p = 0.011). In conclusion, the MCA pressure laterality obtained with CFD, is a promising physiological biomarker that can grade the hemodynamic disturbance in patients with a symptomatic ICA stenosis.	[Holmgren, Madelene; Stoverud, Karen-Helene; Wahlin, Anders; Eklund, Anders] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Zarrinkoob, Laleh; Malm, Jan] Umea Univ, Dept Clin Sci, Neurosci, Umea, Sweden; [Zarrinkoob, Laleh] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Wahlin, Anders; Eklund, Anders] Umea Univ, Umea Ctr Funct Brain Imaging, Umea, Sweden	Umea University; Umea University; Umea University; Umea University	Holmgren, M (corresponding author), Umea Univ, Dept Radiat Sci, Umea, Sweden.	madelene.holmgren@umu.se		Wahlin, Anders/0000-0001-6784-1945; Eklund, Anders/0000-0002-2031-722X; Holmgren, Madelene/0000-0002-1315-7010	Swedish Research Council [2015-05616, 2017-04949, 2016-07213]; County Council of Vasterbotten; Swedish Heart and Lung Foundation [20140592]	Swedish Research Council(Swedish Research CouncilEuropean Commission); County Council of Vasterbotten; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation)	This work was supported by: the Swedish Research Council, grant numbers 2015-05616 (AE), 2017-04949 (AW), 2016-07213 (HPC2N); the County Council of Vasterbotten (AE, AW, JM); and the Swedish Heart and Lung Foundation, grant number 20140592 (JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnaes MS, 2007, STROKE, V38, P2500, DOI 10.1161/STROKEAHA.107.482471; BARNETT HJM, 1991, STROKE, V22, P711, DOI 10.1161/01.STR.22.6.711; Berg P, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.4.FOCUS19181; Berg P, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026108; Bijker JB, 2012, ANESTHESIOLOGY, V116, P658, DOI 10.1097/ALN.0b013e3182472320; Blankensteijn JD, 1997, EUR J VASC ENDOVASC, V14, P446, DOI 10.1016/S1078-5884(97)80122-0; Caplan LR, 2006, CEREBROVASC DIS, V21, P145, DOI 10.1159/000090791; Cebral JR, 2009, J ENG MATH, V64, P367, DOI 10.1007/s10665-009-9266-2; Chnafa C, 2018, AM J NEURORADIOL, V39, P337, DOI 10.3174/ajnr.A5484; Choi CG, 2007, AM J NEURORADIOL, V28, P439; Chongruksut W, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000190.pub3; de Nie AJ, 2001, EUR J VASC ENDOVASC, V21, P220, DOI 10.1053/ejvs.2000.1308; Derdeyn CP, 1999, NEUROLOGY, V53, P251, DOI 10.1212/WNL.53.2.251; Drummond JC, 2019, ANESTH ANALG, V128, P759, DOI 10.1213/ANE.0000000000004034; Dunas T, 2019, J MAGN RESON IMAGING, V50, P511, DOI 10.1002/jmri.26641; Evju O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177566; Fang H, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0560-0; Grinberg L, 2011, ANN BIOMED ENG, V39, P297, DOI 10.1007/s10439-010-0132-1; Grotta JC, 2013, NEW ENGL J MED, V369, P1143, DOI 10.1056/NEJMcp1214999; Gu TL, 2005, AM J NEURORADIOL, V26, P743; Gupta A, 2012, STROKE, V43, P2884, DOI 10.1161/STROKEAHA.112.663716; Hartkamp MJ, 1999, STROKE, V30, P2671, DOI 10.1161/01.STR.30.12.2671; Hendrikse J, 2002, J VASC SURG, V36, P799, DOI 10.1067/mva.2002.127346; Holmgren M, 2020, J MAGN RESON IMAGING, V51, P1516, DOI 10.1002/jmri.26978; Howard DPJ, 2015, STROKE, V46, P182, DOI 10.1161/STROKEAHA.114.007221; Igase K, 2018, YONSEI MED J, V59, P80, DOI 10.3349/ymj.2018.59.1.80; Johnson KM, 2010, MAGN RESON MED, V63, P349, DOI 10.1002/mrm.22202; Klijn CJM, 2010, LANCET NEUROL, V9, P1008, DOI 10.1016/S1474-4422(10)70185-X; Lal BK, 2011, J VASC SURG, V54, P1461, DOI 10.1016/j.jvs.2011.05.001; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06; Liu J, 2017, J CEREBR BLOOD F MET, V37, P2567, DOI 10.1177/0271678X16671321; Liu X, 2016, BIOMECH MODEL MECHAN, V15, P1439, DOI 10.1007/s10237-016-0773-6; Long Q, 2008, J BIOMECH, V41, P2735, DOI 10.1016/j.jbiomech.2008.06.006; Loudon C, 1998, J THEOR BIOL, V191, P63, DOI 10.1006/jtbi.1997.0564; Oelerich M, 1998, NEURORADIOLOGY, V40, P567, DOI 10.1007/s002340050645; Ren Y, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0163-4; Reymond P, 2012, J BIOMECH, V45, P2499, DOI 10.1016/j.jbiomech.2012.07.020; Rivera-Rivera LA, 2016, J CEREBR BLOOD F MET, V36, P1718, DOI 10.1177/0271678X15617171; Shakur SF, 2014, STROKE, V45, P3427, DOI 10.1161/STROKEAHA.114.006622; Soylu AI, 2019, J CLIN NEUROSCI, V68, P250, DOI 10.1016/j.jocn.2019.07.024; Turk AS, 2007, AM J NEURORADIOL, V28, P111; Yamauchi H, 2012, BRAIN, V135, P2515, DOI 10.1093/brain/aws131; Zarrinkoob L, 2019, STROKE, V50, P1081, DOI 10.1161/STROKEAHA.119.024757; Zurada A, 2010, NEUROSURGERY, V67, P1768, DOI 10.1227/NEU.0b013e3181fa7fcb	45	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0245337	10.1371/journal.pone.0245337	http://dx.doi.org/10.1371/journal.pone.0245337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4OF	33417614	Green Published, gold			2022-12-26	WOS:000630020100027
J	Kotthoff, M; Bauer, J; Haag, F; Krautwurst, D				Kotthoff, Matthias; Bauer, Julia; Haag, Franziska; Krautwurst, Dietmar			Conserved C-terminal motifs in odorant receptors instruct their cell surface expression and cAMP signaling	FASEB JOURNAL			English	Article						GPCR; helix 8; intracellular transport; luciferase assay; phylogenetic trees	ENDOPLASMIC-RETICULUM RETENTION; KEY FOOD ODORANT; OLFACTORY RECEPTOR; FUNCTIONAL EXPRESSION; INTRACELLULAR RETENTION; HELIX 8; STRUCTURAL DETERMINANTS; BASIC RESIDUES; D1 RECEPTOR; PROTEIN	The highly individual plasma membrane expression and cAMP signaling of odorant receptors have hampered their ligand assignment and functional characterization in test cell systems. Chaperones have been identified to support the cell surface expression of only a portion of odorant receptors, with mechanisms remaining unclear. The presence of amino acid motifs that might be responsible for odorant receptors' individual intracellular retention or cell surface expression, and thus, for cAMP signaling, is under debate: so far, no such protein motifs have been suggested. Here, we demonstrate the existence of highly conserved C-terminal amino acid motifs, which discriminate at least between class-I and class-II odorant receptors, with their numbers of motifs increasing during evolution, by comparing C-terminal protein sequences from 4808 receptors across eight species. Truncation experiments and mutation analysis of C-terminal motifs, largely overlapping with helix 8, revealed single amino acids and their combinations to have differential impact on the cell surface expression and on stimulus-dependent cAMP signaling of odorant receptors in NxG 108CC15 cells. Our results demonstrate class-specific and individual C-terminal motif equipment of odorant receptors, which instruct their functional expression in a test cell system, and in situ may regulate their individual cell surface expression and intracellular cAMP signaling.	[Kotthoff, Matthias] Hamm Lippstadt Univ Appl Sci, Hamm, Germany; [Bauer, Julia; Haag, Franziska; Krautwurst, Dietmar] Tech Univ Munich, Leibniz Inst Food Syst Biol, Lise Meitner Str 34, D-85354 Freising Weihenstephan, Germany	Leibniz-Institute for Food Systems Biology at the Technical University of Munich; Technical University of Munich	Krautwurst, D (corresponding author), Tech Univ Munich, Leibniz Inst Food Syst Biol, Lise Meitner Str 34, D-85354 Freising Weihenstephan, Germany.	d.krautwurst.leibniz-lsb@tum.de		Haag, Franziska/0000-0003-4210-0475				Aasland R, 2002, FEBS LETT, V513, P141, DOI 10.1016/S0014-5793(01)03295-1; Adipietro KA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002821; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bermak JC, 2002, EUR J CELL BIOL, V81, P77, DOI 10.1078/0171-9335-00222; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Bethune J, 2006, MOL CELL BIOL, V26, P8011, DOI 10.1128/MCB.01055-06; Binkowski B, 2009, CURR OPIN BIOTECH, V20, P14, DOI 10.1016/j.copbio.2009.02.013; Bruno A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042023; Bubnell J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141712; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; Dong CM, 2006, J BIOL CHEM, V281, P38543, DOI 10.1074/jbc.M605734200; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Dwyer ND, 2001, NEURON, V31, P277, DOI 10.1016/S0896-6273(01)00361-0; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396; Flensborg M., 2011, CLC MAIN WORKBENCH; Gassmann M, 2005, MOL PHARMACOL, V68, P137, DOI 10.1124/mol.104.010256; Geithe C., 2015, FLAVOUR SCI, P297; Geithe C, 2017, CELL MOL LIFE SCI, V74, P4209, DOI 10.1007/s00018-017-2576-z; Geithe C, 2017, CHEM SENSES, V42, P181, DOI 10.1093/chemse/bjw117; Gentle IE, 2007, MOL BIOL EVOL, V24, P1149, DOI 10.1093/molbev/msm031; Gidda SK, 2009, PLANT PHYSIOL BIOCH, V47, P867, DOI 10.1016/j.plaphy.2009.05.008; Gimelbrant AA, 2001, J BIOL CHEM, V276, P7285, DOI 10.1074/jbc.M005433200; Gimelbrant AA, 1999, J NEUROCHEM, V72, P2301, DOI 10.1046/j.1471-4159.1999.0722301.x; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Gomez M, 2000, J BIOL CHEM, V275, P29162, DOI 10.1074/jbc.M003630200; Gonzalez-Kristeller DC, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00035; Haag F, 2020, CELL MOL LIFE SCI, V77, P2157, DOI 10.1007/s00018-019-03279-y; Hague C, 2004, P NATL ACAD SCI USA, V101, P13672, DOI 10.1073/pnas.0403854101; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P316; Hermosilla R, 2001, MOL PHARMACOL, V60, P1031, DOI 10.1124/mol.60.5.1031; HORDE, 2011, HUM OLF REC DAT EXPL; Ikegami K, 2020, P NATL ACAD SCI USA, V117, P2957, DOI 10.1073/pnas.1915520117; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jaeger SR, 2013, CURR BIOL, V23, P1601, DOI 10.1016/j.cub.2013.07.030; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Juhl C, 2012, CELL SIGNAL, V24, P1762, DOI 10.1016/j.cellsig.2012.05.002; Katada S, 2004, J NEUROCHEM, V90, P1453, DOI 10.1111/j.1471-4159.2004.02619.x; Kawasaki T, 2015, FEBS LETT, V589, P1136, DOI 10.1016/j.febslet.2015.03.025; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kling RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067244; Knepp AM, 2012, BIOCHEMISTRY-US, V51, P1819, DOI 10.1021/bi3001598; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Krautwurst Dietmar, 2013, Methods Mol Biol, V1003, P85, DOI 10.1007/978-1-62703-377-0_6; Krishna AG, 2002, BIOCHEMISTRY-US, V41, P8298, DOI 10.1021/bi025534m; Kuwasako K, 2011, PEPTIDES, V32, P144, DOI 10.1016/j.peptides.2010.10.005; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Li SJ, 2016, J AM CHEM SOC, V138, P13281, DOI 10.1021/jacs.6b06983; Liu AH, 2003, GENOMICS, V81, P443, DOI 10.1016/S0888-7543(03)00022-3; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Mainland JD, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.2; Mainland JD, 2014, NAT NEUROSCI, V17, P114, DOI 10.1038/nn.3598; Mallouk N, 2002, J MEMBRANE BIOL, V185, P129, DOI 10.1007/s00232-001-0119-9; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; McClintock TS, 1997, MOL BRAIN RES, V48, P270, DOI 10.1016/S0169-328X(97)00099-5; McClintock TS, 2003, NEUROREPORT, V14, P1547, DOI 10.1097/00001756-200308260-00001; Menashe I, 2003, NAT GENET, V34, P143, DOI 10.1038/ng1160; Michelsen K, 2006, TRAFFIC, V7, P903, DOI 10.1111/j.1600-0854.2006.00430.x; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nakashima A, 2013, CELL, V154, P1314, DOI 10.1016/j.cell.2013.08.033; NCBI, 2011, NAT CTR BIOT INF GEN; Neuhaus EM, 2006, CHEM SENSES, V31, P445, DOI 10.1093/chemse/bjj049; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Noe Franziska, 2017, Journal of Biological Methods, V4, pe82, DOI 10.14440/jbm.2017.207; Noe Franziska, 2017, Journal of Biological Methods, V4, pe81, DOI 10.14440/jbm.2017.206; Noe F, 2017, CHEM SENSES, V42, P195, DOI 10.1093/chemse/bjw118; Nufer O, 2003, J BIOL CHEM, V278, P15886, DOI 10.1074/jbc.M211199200; Okamoto Y, 2013, J BIOL CHEM, V288, P9189, DOI 10.1074/jbc.M112.445817; Okamoto Y, 2011, J BIOL CHEM, V286, P7171, DOI 10.1074/jbc.M110.199695; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park J, 2019, J BIOL CHEM, V294, P4759, DOI 10.1074/jbc.RA118.006173; Peterlin Z, 2014, J GEN PHYSIOL, V143, P527, DOI 10.1085/jgp.201311151; Reisert J, 2010, J GEN PHYSIOL, V136, P529, DOI 10.1085/jgp.201010528; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Rodrigues AR, 2017, BBA-MOL CELL RES, V1864, P1217, DOI 10.1016/j.bbamcr.2017.04.004; Rohde HM, 2003, J BIOL CHEM, V278, P52689, DOI 10.1074/jbc.M307983200; Roth D, 2010, BIOCHEM J, V425, P195, DOI 10.1042/BJ20091064; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Samsonova EV, 2007, PROTEINS, V67, P154, DOI 10.1002/prot.21112; Sanz G, 2005, CHEM SENSES, V30, P69, DOI 10.1093/chemse/bji002; Sato T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111930; Sato-Akuhara N, 2016, J NEUROSCI, V36, P4482, DOI 10.1523/JNEUROSCI.3259-15.2016; Scheer A, 1996, EMBO J, V15, P3566, DOI 10.1002/j.1460-2075.1996.tb00726.x; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Sester M, 2013, J VIROL, V87, P6104, DOI 10.1128/JVI.03391-12; Sharon D, 2000, GENE, V260, P87, DOI 10.1016/S0378-1119(00)00467-4; Shepard BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068758; Shikano S, 2005, NAT CELL BIOL, V7, P985, DOI 10.1038/ncb1297; Shikano S, 2003, P NATL ACAD SCI USA, V100, P5783, DOI 10.1073/pnas.1031748100; Shirokova E, 2005, J BIOL CHEM, V280, P11807, DOI 10.1074/jbc.M411508200; Shirokova E, 2008, FASEB J, V22, P1416, DOI 10.1096/fj.07-9233com; STAMNES MA, 1995, P NATL ACAD SCI USA, V92, P8011, DOI 10.1073/pnas.92.17.8011; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Tetsuka M, 2004, ENDOCRINOLOGY, V145, P3712, DOI 10.1210/en.2003-1638; Thielen A, 2005, FEBS LETT, V579, P5227, DOI 10.1016/j.febslet.2005.08.043; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Tsuboi A, 2006, EUR J NEUROSCI, V23, P1436, DOI 10.1111/j.1460-9568.2006.04675.x; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Woo CH, 2015, MOL BIOL CELL, V26, P4280, DOI 10.1091/mbc.E15-06-0361; Wu LF, 2012, J BIOL CHEM, V287, P22287, DOI 10.1074/jbc.M112.345884; Zaarour N, 2012, J BIOL CHEM, V287, P42642, DOI 10.1074/jbc.M112.399162; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198; Zhang JJ, 2012, MOL CELL NEUROSCI, V51, P79, DOI 10.1016/j.mcn.2012.08.006; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200; Zozulya S, 2001, GENOME BIOL, V2; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	124	2	2	2	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21274	10.1096/fj.202000182RR	http://dx.doi.org/10.1096/fj.202000182RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33464692				2022-12-26	WOS:000647789600058
J	Allerton, TD; Savoie, JJ; Fitch, MD; Hellerstein, MK; Stephens, JM; White, U				Allerton, Timothy D.; Savoie, Jonathan J.; Fitch, Mark D.; Hellerstein, Marc K.; Stephens, Jacqueline M.; White, Ursula			Exercise reduced the formation of new adipocytes in the adipose tissue of mice in vivo	PLOS ONE			English	Article							CELL-PROLIFERATION; GENE-EXPRESSION; FAT-CELL; TURNOVER; KINETICS; MARKERS; OBESITY; WHITE; RAT	Exercise has beneficial effects on metabolism and health. Although the skeletal muscle has been a primary focus, exercise also mediates robust adaptations in white adipose tissue. To determine if exercise affects in vivo adipocyte formation, fifty-two, sixteen-week-old C57BL/6J mice were allowed access to unlocked running wheels [Exercise (EX) group; n = 13 males, n = 13 females] or to locked wheels [Sedentary (SED) group; n = 13 males, n = 13 females] for 4-weeks. In vivo adipocyte formation was assessed by the incorporation of deuterium (H-2) into the DNA of newly formed adipocytes in the inguinal and gonadal adipose depots. A two-way ANOVA revealed that exercise significantly decreased new adipocyte formation in the adipose tissue of mice in the EX group relative to the SED group (activity effect; P = 0.02). This reduction was observed in male and female mice (activity effect; P = 0.03). Independent analysis of the depots showed a significant reduction in adipocyte formation in the inguinal (P = 0.05) but not in the gonadal (P = 0.18) of the EX group. We report for the first time that exercise significantly reduced in vivo adipocyte formation in the adipose tissue of EX mice using a physiologic metabolic (H2O)-H-2-labeling protocol.	[Allerton, Timothy D.; Savoie, Jonathan J.; Stephens, Jacqueline M.; White, Ursula] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA; [Fitch, Mark D.; Hellerstein, Marc K.] Univ Calif Berkeley, Berkeley, CA 94720 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of California System; University of California Berkeley	White, U (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA.	ursula.white@pbrc.edu			National Center for Complementary and Integrative Health; Office of Dietary Supplements of the National Institutes of Health [P50AT002776]; University of California at Berkeley College of Natural Resources; Robert C. and Veronica Atkins Foundation; National Center for Complementary and Integrative Health of the National Institutes of Health [T32 AT004094]; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R03DK112006, R01DK121944];  [L30DK122484]	National Center for Complementary and Integrative Health; Office of Dietary Supplements of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at Berkeley College of Natural Resources; Robert C. and Veronica Atkins Foundation; National Center for Complementary and Integrative Health of the National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); 	This work was supported in part by the National Center for Complementary and Integrative Health and the Office of Dietary Supplements of the National Institutes of Health under Award Number P50AT002776 (J.M.S.) (https://www.nccih.nih.gov) and by funds to M.K.H from the University of California at Berkeley College of Natural Resources and the Robert C. and Veronica Atkins Foundation. T.D.A. is supported by T32 AT004094 through the National Center for Complementary and Integrative Health of the National Institutes of Health (https://www.nccih.nih.gov) and by L30DK122484. U.W. is supported by R03DK112006 and R01DK121944 from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (https://www.niddk.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardilouze JL, 2004, CIRCULATION, V109, P47, DOI 10.1161/01.CIR.0000105681.70455.73; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; ASKEW EW, 1976, J NUTR, V106, P1351, DOI 10.1093/jn/106.9.1351; Busch R, 2007, NAT PROTOC, V2, P3045, DOI 10.1038/nprot.2007.420; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; Gollisch KSC, 2009, AM J PHYSIOL-ENDOC M, V297, pE495, DOI 10.1152/ajpendo.90424.2008; Houmard JA, 2004, J APPL PHYSIOL, V96, P101, DOI 10.1152/japplphysiol.00707.2003; Kim SM, 2014, CELL METAB, V20, P1049, DOI 10.1016/j.cmet.2014.10.010; Ku B., 2004, OBES RES, V12, P1604, DOI [10.1038/oby.2004.200, DOI 10.1038/OBY.2004.200]; May FJ, 2017, CELL REP, V18, P1558, DOI 10.1016/j.celrep.2017.01.038; Miyazaki S, 2010, LIFE SCI, V86, P691, DOI 10.1016/j.lfs.2010.03.004; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; Nouws J, 2019, DIABETES, V68, P1168, DOI 10.2337/db18-1162; Peppler WT, 2017, ADIPOCYTE, V6, P1, DOI 10.1080/21623945.2016.1259778; RICHTER EA, 1982, J CLIN INVEST, V69, P785, DOI 10.1172/JCI110517; Ronn T, 2014, ACTA PHYSIOL, V211, P188, DOI 10.1111/apha.12247; Ross Robert, 2008, Can J Cardiol, V24 Suppl D, p25D; Ruschke K, 2010, EUR J ENDOCRINOL, V162, P515, DOI 10.1530/EJE-09-0767; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; STALLKNECHT B, 1991, AM J PHYSIOL, V261, pE410, DOI 10.1152/ajpendo.1991.261.3.E410; Stanford KI, 2017, DIABETES, V66, P2124, DOI 10.2337/db17-0098; Stanford KI, 2015, DIABETES, V64, P2002, DOI 10.2337/db14-0704; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Turner SM, 2007, AM J PHYSIOL-ENDOC M, V292, pE1101, DOI 10.1152/ajpendo.00309.2005; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; White UA, 2017, J CLIN ENDOCR METAB, V102, P2171, DOI 10.1210/jc.2016-4000; White UA, 2016, DIABETES, V65, P1642, DOI 10.2337/db15-1617; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; You T, 2006, INT J OBESITY, V30, P1211, DOI 10.1038/sj.ijo.0803245; You TJ, 2008, CURR DIABETES REP, V8, P7, DOI 10.1007/s11892-008-0003-4; Zevel D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152129	33	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0244804	10.1371/journal.pone.0244804	http://dx.doi.org/10.1371/journal.pone.0244804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471817	Green Published, gold			2022-12-26	WOS:000639428800052
J	El-Sokkary, RH; El-Kholy, A; Eldin, SM; Khater, WS; Gad, DM; Bahgat, S; Negm, EEM; El Kholy, JA; Mowafy, S; Mahmoud, E; Mortada, EM				El-Sokkary, Rehab H.; El-Kholy, Amani; Eldin, Sally Mohy; Khater, Walaa Shawky; Gad, Doaa Mostafa; Bahgat, Shereen; Negm, Essam Edin M.; El Kholy, Jehan Ali; Mowafy, Sherif; Mahmoud, Eman; Mortada, Eman M.			Characteristics and predicting factors of Corona Virus Disease-2019 (COVID-19) among healthcare providers in a developing country	PLOS ONE			English	Article							WORKERS; EGYPT	A limited number of publications have identified risk factors for Corona Virus Disease 2019 (COVID-19) among Healthcare Providers (HCPs). We aimed to assess the clinical and epidemiological characteristics and the predicting factors related to COVID-19 among HCPs in Egypt. A comparative cross-sectional study was conducted among HCPs via an online questionnaire. Out of 440 responses, a total of 385 complete responses were analyzed. The responders' mean age was 37.5 +/- 9.4 years, 215 (55.8%) of the participants were males. They included 77 (20%) confirmed COVID-19 cases; most of them had mild (58.6%) or moderate symptoms (30%), and (9.1%) were asymptomatic. Almost all sustained infection while on duty (97.4%). The sources of infection were either infected patients (39%), colleagues (22.1%), household contacts (5.2%) or uncertain (33.8%). The sources were symptomatic in only 62.3% of cases. Asymptomatic or pre-symptomatic sources accounted for 37.7% of the cases. Exposure occurred during healthcare provision in 66.3% of the cases. The presence of co-morbidities (OR = 2.53, CI 1.47-4.38, P = 0.001), working more than 8 hours per day in isolation hospital (OR = 3.09, CI 1.02-9.35, P = 0.046), training on hand hygiene (OR = 2.31, CI 1.05-5.08, P = 0.038) and adherence to IPC measures (OR = 2.11, CI 1.16-3.81, P = 0.014) were the significant predictors of COVID-19. In conclusion, COVID-19 occurred in 20% of responders. Silent spread from asymptomatic or presymptomatic patients, and infected colleagues in hospital settings is an alarming sign. Proactive infection prevention and control measures are highly encouraged on both strategic and operational levels. Reconsideration of surveillance strategy and work-related regulations in healthcare settings are warranted.	[El-Sokkary, Rehab H.] Zagazig Univ, Med Microbiol & Immunol Dept, Fac Med, Zagazig, Egypt; [El-Kholy, Amani] Cairo Univ, Clin Pathol Dept, Fac Med, Cairo, Egypt; [Eldin, Sally Mohy] Minist Hlth & Populat, Cairo, Egypt; [Khater, Walaa Shawky] Ain Shams Univ, Med Microbiol & Immunol Dept, Fac Med, Cairo, Egypt; [Gad, Doaa Mostafa] Zagazig Univ, Chest Dept, Fac Med, Zagazig, Egypt; [Bahgat, Shereen] Zagazig Univ, Family Med Dept, Fac Med, Zagazig, Egypt; [Negm, Essam Edin M.; Mowafy, Sherif] Zagazig Univ, Fac Med, Anesthesia & Surg Intens Care Dept, Zagazig, Egypt; [El Kholy, Jehan Ali] Cairo Univ, Fac Med, Anesthesia & Surg Intens Care Dept, Cairo, Egypt; [El Kholy, Jehan Ali] Dar Al Fouad Hosp, Infect Prevent & Control Dept, Cairo, Egypt; [Mahmoud, Eman] Menoufeya Univ, Natl Liver Inst, Microbiol & Immunol Dept, Shibin Al Kawm, Egypt; [Mortada, Eman M.] Zagazig Univ, Fac Med, Community Occupat & Environm Med Dept, Zagazig, Egypt; [Mortada, Eman M.] Princess Nourah Bint Abdulrahman Univ, Hlth Sci Dept, Hlth Sci & Rehabil Coll, Riyadh, Saudi Arabia	Egyptian Knowledge Bank (EKB); Zagazig University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Zagazig University; Egyptian Knowledge Bank (EKB); Zagazig University; Egyptian Knowledge Bank (EKB); Zagazig University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Menofia University; Egyptian Knowledge Bank (EKB); Zagazig University; Princess Nourah bint Abdulrahman University	El-Sokkary, RH (corresponding author), Zagazig Univ, Med Microbiol & Immunol Dept, Fac Med, Zagazig, Egypt.	Rehab_elsokkary@yahoo.com	Mortada, Eman/AAP-4354-2020; El-Sokkary, Rehab/B-9599-2018	Mortada, Eman/0000-0002-8660-4299; El-Sokkary, Rehab/0000-0002-8135-7671; Mowafy, Sherif/0000-0002-0357-7986; Khater, Walaa/0000-0003-4007-1375				Wahed WYA, 2020, J COMMUN HEALTH, V45, P1242, DOI 10.1007/s10900-020-00882-0; Ahmed J, 2020, CUREUS, V12, DOI 10.7759/cureus.8550; Arafa A, 2021, J AFFECT DISORDERS, V278, P365, DOI 10.1016/j.jad.2020.09.080; Asaad A, 2020, E MEDITERR HEALTH J, V26, P435, DOI 10.26719/emhj.19.079; Azzab MM, 2016, E MEDITERR HEALTH J, V22, P894, DOI 10.26719/2016.22.12.894; Boskoski I, 2020, GASTROINTEST ENDOSC, V92, P519, DOI 10.1016/j.gie.2020.04.048; CDC COVID-19 Response Team, 2020, MMWR Morb Mortal Wkly Rep, V69, P477, DOI 10.15585/mmwr.mm6915e6; Centers for Disease Control and Prevention, OVERV TEST SARS COV; Centers for Disease Control and Prevention,, 2020, COR DIS 2019 COVID 1; Centers for Disease Control and Prevention, 2020, CORONAVIRUS DIS 2019; Centers for Disease Control and Prevention, 2020, OPT PERS PROT EQU PP; Ejeh FE, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05557; Esakandari H, 2020, BIOL PROCED ONLINE, V22, DOI 10.1186/s12575-020-00128-2; Gericke C.A., 2018, HLTH CARE SYSTEMS PO, P1, DOI [10.1007/978-1-4614-6419-8_7-2, DOI 10.1007/978-1-4614-6419-8_7-2, DOI 10.1007/978-1-4614-6419-8_7]; Ghweil AA, 2020, INFECT DRUG RESIST, V13, P2375, DOI 10.2147/IDR.S263489; Hassany M, 2020, LANCET INFECT DIS, V20, P896, DOI 10.1016/S1473-3099(20)30319-4; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Institute of Social and Preventive Medicine University of Bern, STROBE STAT; Islam MS, 2020, INFECT CONT HOSP EP, V41, P1196, DOI 10.1017/ice.2020.237; Jordan RE, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1198; Khalil S, 2020, ASSIUT SCI NURS J, DOI [10.21608/asnj.2020.39657.1035, DOI 10.21608/ASNJ.2020.39657.1035]; Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112; Lai XQ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9666; Malik UR, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176395; Mandrola John, 2020, Recenti Prog Med, V111, P183, DOI 10.1701/3347.33175; Marmor M, 2020, J HOSP INFECT, V105, P710, DOI 10.1016/j.jhin.2020.06.012; Masoud H, 2020, MANAGEMENT PROTOCOL; Mhango M., 2020, SAF HLTH WORK, P262, DOI 10.1016/j.shaw.2020.06.001; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P17513, DOI 10.1073/pnas.2008373117; Perkins DJ, 2020, EXP BIOL MED, V245, P933, DOI 10.1177/1535370220925768; Ran L, 2020, CLIN INFECT DIS, V71, P2218, DOI 10.1093/cid/ciaa287; SCHWARTZ J, 2020, CLIN INFECT DIS, V71, P858, DOI DOI 10.1093/CID/CIAA255; Talaat M, 2006, AM J INFECT CONTROL, V34, P193, DOI 10.1016/j.ajic.2005.05.028; WHO, 2020, NAM COR DIS COVID 19; WHO Director, DIR GEN OPEN REMARK; World Health Organization, 2020, TECHNICAL REPORT; World Health Organzation, 2020, REP WHO CHI JOINT MI; World Health Organzation, 2020, COR DIS COVID 19 SIT; Yousef RHA, 2020, AM J INFECT CONTROL, V48, P249, DOI 10.1016/j.ajic.2019.07.019; Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012; Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021	43	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245672	10.1371/journal.pone.0245672	http://dx.doi.org/10.1371/journal.pone.0245672			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471839	Green Published, gold			2022-12-26	WOS:000639428800067
J	Wen, LL; Chen, YT; Lee, YCG; Ko, TL; Chou, HC; Juan, SH				Wen, Li-Li; Chen, Yen-Ting; Lee, Yuan-Chii Gladys; Ko, Tsui-Ling; Chou, Hsiu-Chu; Juan, Shu-Hui			Perfluorooctane sulfonate induces autophagy-associated apoptosis through oxidative stress and the activation of extracellular signal-regulated kinases in renal tubular cells	PLOS ONE			English	Article							PERFLUORINATED CHEMICALS; PERFLUOROALKYL ACIDS; ROS; MECHANISMS; RHOA; NEUROTOXICITY; INHIBITION; EXPOSURE; DEATH; RAT	Perfluorooctane sulfonate (PFOS) is among the most abundant organic pollutants and is widely distributed in the environment, wildlife, and humans. Its toxic effects and biological hazards are associated with its long elimination half-life in humans. However, how it affects renal tubular cells (RTCs) remains unclear. In this study, PFOS was observed to mediate the increase in reactive oxygen species (ROS) generation, followed by the activation of the extracellular-signal-regulated kinase 1/2 (ERK1/2) pathway, which induced autophagy in RTCs. Although PFOS treatment induced autophagy after 6 h, prolonged treatment (24 h) reduced the autophagic flux by increasing lysosomal membrane permeability (LMP), leading to increased p62 protein accumulation and subsequent apoptosis. The increase in LMP was visualized through increased green fluorescence with acridine orange staining, and this was attenuated by 3-methyladenine, an autophagy inhibitor. N-acetyl cysteine and an inhibitor of the mitogen-activated protein kinase kinases (U0126) attenuated autophagy and apoptosis. Taken together, these results indicate that ROS activation and ROS-mediated phosphorylated ERK1/2 activation are essential to activate autophagy, resulting in the apoptosis of PFOS-treated RTCs. Our findings provide insight into the mechanism of PFOS-mediated renal toxicity.	[Wen, Li-Li; Chen, Yen-Ting; Juan, Shu-Hui] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Wen, Li-Li] En Chu Kong Hosp, Dept Clin Lab, New Taipei, Taiwan; [Chen, Yen-Ting; Juan, Shu-Hui] Taipei Med Univ, Sch Med, Dept Physiol, Coll Med, Taipei, Taiwan; [Lee, Yuan-Chii Gladys] Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Taipei, Taiwan; [Ko, Tsui-Ling] I Shou Univ, Sch Med Int Students, Coll Med, Kaohsiung, Taiwan; [Chou, Hsiu-Chu] Taipei Med Univ, Sch Med, Dept Anat & Cell Biol, Coll Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; I Shou University; Taipei Medical University	Juan, SH (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan.; Juan, SH (corresponding author), Taipei Med Univ, Sch Med, Dept Physiol, Coll Med, Taipei, Taiwan.	juansh@tmu.edu.tw			Ministry of Science and Technology of Taiwan [MOST105-2628-B-038-010-MY3, MOST108-2320-B-038-024-MY3]; En-Chu-Kong Hospital [ECKH_W10705, ECKH_W10803]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); En-Chu-Kong Hospital	This study was supported by grants from the Ministry of Science and Technology of Taiwan; www.most.gov.tw (MOST105-2628-B-038-010-MY3; MOST108-2320-B-038-024-MY3) and En-Chu-Kong Hospital; www.eck.org.tw/index.aspx? siteid=218&ver=admi (a regional hospital in Taipei County; ECKH_W10705; ECKH_W10803); the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; and no authors received salaries from any of these funders.	Banduseela VC, 2013, PHYSIOL GENOMICS, V45, P477, DOI 10.1152/physiolgenomics.00141.2012; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chang CC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40757-6; Chang CC, 2012, AM J PATHOL, V181, P211, DOI 10.1016/j.ajpath.2012.03.032; Chang CC, 2009, CELL MOL LIFE SCI, V66, P3193, DOI 10.1007/s00018-009-0102-7; Chou HC, 2017, TOXICOL SCI, V160, P217, DOI 10.1093/toxsci/kfx183; Filomeni G, 2010, AUTOPHAGY, V6, P999, DOI 10.4161/auto.6.7.12754; Gao H, 2018, EXP THER MED, V15, P3413, DOI 10.3892/etm.2018.5830; Ge JB, 2016, ENVIRON TOXICOL PHAR, V46, P9, DOI 10.1016/j.etap.2016.06.025; Guo XY, 2016, CHEMOSPHERE, V155, P115, DOI 10.1016/j.chemosphere.2016.04.046; Hsu YH, 2014, J CELL PHYSIOL, V229, P1455, DOI 10.1002/jcp.24583; Hu XZ, 2009, ARCH TOXICOL, V83, P851, DOI 10.1007/s00204-009-0441-z; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kataria A, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0077-9; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Lee HG, 2012, NEUROTOXICOLOGY, V33, P314, DOI 10.1016/j.neuro.2012.01.017; Li ZW, 2017, TOXICOL IN VITRO, V38, P77, DOI 10.1016/j.tiv.2016.11.002; Ma S, 2015, BBA-MOL BASIS DIS, V1852, P271, DOI 10.1016/j.bbadis.2014.05.010; Mao ZX, 2013, J APPL TOXICOL, V33, P1268, DOI 10.1002/jat.2785; Martinet W, 2009, CIRC RES, V104, P304, DOI 10.1161/CIRCRESAHA.108.188318; Oh JH, 2017, MOL MED REP, V15, P2583, DOI 10.3892/mmr.2017.6285; Olsen GW, 1999, J OCCUP ENVIRON MED, V41, P799, DOI 10.1097/00043764-199909000-00012; Perez-Alvarez MJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00060; Qian Y, 2010, J TOXICOL ENV HEAL A, V73, P819, DOI 10.1080/15287391003689317; Shankar A, 2011, AM J EPIDEMIOL, V174, P893, DOI 10.1093/aje/kwr171; Slotkin TA, 2008, ENVIRON HEALTH PERSP, V116, P716, DOI 10.1289/ehp.11253; Sunderland EM, 2019, J EXPO SCI ENV EPID, V29, P131, DOI 10.1038/s41370-018-0094-1; Thibodeaux JR, 2003, TOXICOL SCI, V74, P369, DOI 10.1093/toxsci/kfg121; Watkins AM, 2015, MOL CELL ENDOCRINOL, V400, P90, DOI 10.1016/j.mce.2014.10.020; Wen LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155190; Yao XF, 2014, FOOD CHEM TOXICOL, V67, P96, DOI 10.1016/j.fct.2014.02.017; Zeng YJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030312, 10.1371/journal.pone.0043478]; Zhang L, 2015, FREE RADICAL BIO MED, V89, P452, DOI 10.1016/j.freeradbiomed.2015.08.030; Zhang XD, 2016, MOL PHARMACEUT, V13, P2578, DOI 10.1021/acs.molpharmaceut.6b00405; Zhou J, 2018, J CELL MOL MED, V22, P2908, DOI 10.1111/jcmm.13585	36	2	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245442	10.1371/journal.pone.0245442	http://dx.doi.org/10.1371/journal.pone.0245442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471797	Green Published, gold			2022-12-26	WOS:000639428800014
J	Kameyama, A; Nishijima, R; Yamakoshi, K				Kameyama, Akihiko; Nishijima, Risa; Yamakoshi, Kimi			Bmi-1 regulates mucin levels and mucin O-glycosylation in the submandibular gland of mice	PLOS ONE			English	Article							MOLECULAR MATRIX ELECTROPHORESIS; ORAL HYGIENE; SELF-RENEWAL; GENE; SALIVA; FLOW; EXPRESSION; PROTEINS; DISEASE; DRYNESS	Mucins, the major components of salivary mucus, are large glycoproteins abundantly modified with O-glycans. Mucins present on the surface of oral tissues contribute greatly to the maintenance of oral hygiene by selectively adhering to the surfaces of microbes via mucin O-glycans. However, due to the complex physicochemical properties of mucins, there have been relatively few detailed analyses of the mechanisms controlling the expression of mucin genes and the glycosyltransferase genes involved in glycosylation. Analysis performed using supported molecular matrix electrophoresis, a methodology developed for mucin analysis, and knockout mice without the polycomb group protein Bmi-1 revealed that Bmi-1 regulates mucin levels in the submandibular gland by suppressing the expression of the mucin Smgc gene, and that Bmi-1 also regulates mucin O-glycosylation via suppression of the glycosyltransferase Gcnt3 gene in the submandibular gland.	[Kameyama, Akihiko] Natl Inst Adv Ind Sci & Technol, Cellular & Mol Biotechnol Res Inst, Tsukuba, Ibaraki, Japan; [Nishijima, Risa; Yamakoshi, Kimi] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Mech Aging, Obu, Aichi, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Center for Geriatrics & Gerontology	Yamakoshi, K (corresponding author), Natl Ctr Geriatr & Gerontol, Res Inst, Dept Mech Aging, Obu, Aichi, Japan.	kyama@ncgg.go.jp			Japan Society for the Promotion of Science [16K08636, 17H03808, 19K11785]; Mizutani Foundation for Glycoscience [200049]; National Center for Geriatrics and Gerontology [30-14]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mizutani Foundation for Glycoscience; National Center for Geriatrics and Gerontology	This work was supported by the Grant-in-Aid for Scientific Research program of the Japan Society for the Promotion of Science (KY, 16K08636; AK, 17H03808; KY, 19K11785), the Mizutani Foundation for Glycoscience (AK, 200049), and a grant from the National Center for Geriatrics and Gerontology (KY, 30-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELLATIF HM, 1987, J DENT RES, V66, P13, DOI 10.1177/00220345870660010201; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Culp DJ, 2004, PHYSIOL GENOMICS, V19, P303, DOI 10.1152/physiolgenomics.00161.2004; Das B, 2010, J HISTOCHEM CYTOCHEM, V58, P141, DOI 10.1369/jhc.2009.954891; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Dong WJ, 2012, ANAL CHEM, V84, P8461, DOI 10.1021/ac301678z; Escande F, 2004, BBA-GENE STRUCT EXPR, V1676, P240, DOI 10.1016/j.bbaexp.2004.01.001; GILBERT GH, 1993, COMMUNITY DENT ORAL, V21, P390, DOI 10.1111/j.1600-0528.1993.tb01105.x; GOTTSCHALK A, 1957, BIOCHIM BIOPHYS ACTA, V23, P645, DOI 10.1016/0006-3002(57)90389-X; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; HONDA S, 1980, ANAL CHEM, V52, P1079, DOI 10.1021/ac50057a019; Hopcraft MS, 2010, AUST DENT J, V55, P238, DOI 10.1111/j.1834-7819.2010.01229.x; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Iida M, 2019, ARCH ORAL BIOL, V97, P52, DOI 10.1016/j.archoralbio.2018.10.011; Isaji T, 2019, J BIOL CHEM, V294, P4425, DOI 10.1074/jbc.RA118.005208; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Kameyama A, 2019, BIOCHEM BIOPH RES CO, V513, P186, DOI 10.1016/j.bbrc.2019.03.144; Kameyama A, 2019, BBA-PROTEINS PROTEOM, V1867, P76, DOI 10.1016/j.bbapap.2018.05.006; Kerschner JE, 2010, INT J PEDIATR OTORHI, V74, P864, DOI 10.1016/j.ijporl.2010.04.014; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Matsuno YK, 2011, ELECTROPHORESIS, V32, P1829, DOI 10.1002/elps.201000608; Matsuno Y, 2009, ANAL CHEM, V81, P3816, DOI 10.1021/ac900157c; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nishikaze T, 2017, ANAL CHEM, V89, P2353, DOI 10.1021/acs.analchem.6b04150; OSTERBERG T, 1984, J ORAL REHABIL, V11, P157, DOI 10.1111/j.1365-2842.1984.tb00565.x; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Robbe C, 2003, J BIOL CHEM, V278, P46337, DOI 10.1074/jbc.M302529200; SCHAUER R, 1982, ADV CARBOHYD CHEM BI, V40, P131, DOI 10.1016/S0065-2318(08)60109-2; Sreebny LM, 2000, INT DENT J, V50, P140, DOI 10.1111/j.1875-595X.2000.tb00554.x; Takashima S, 2008, BIOSCI BIOTECH BIOCH, V72, P1155, DOI 10.1271/bbb.80025; van der Maarel-Wierink CD, 2013, GERODONTOLOGY, V30, P3, DOI 10.1111/j.1741-2358.2012.00637.x; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; WU AM, 1994, MOL CELL BIOCHEM, V137, P39, DOI 10.1007/BF00926038; Yamakoshi K, 2015, AGING CELL, V14, P616, DOI 10.1111/acel.12337; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215; Zinzen KM, 2004, GENE, V334, P23, DOI 10.1016/j.gene.2004.03.014; Zussman E, 2007, J DENT RES, V86, P281, DOI 10.1177/154405910708600316	40	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245607	10.1371/journal.pone.0245607	http://dx.doi.org/10.1371/journal.pone.0245607			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465144	Green Published, gold			2022-12-26	WOS:000611969200020
J	de Campos, LD; de Souza-Dias, PGB; Desutter-Grandcolas, L; Nihei, SS				de Campos, Lucas Denadai; Souza-Dias, Pedro Guilherme Barrios de; Desutter-Grandcolas, Laure; Shigueo Nihei, Silvio			Colonization of different biomes drove the diversification of the Neotropical Eidmanacris crickets (Insecta: Orthoptera: Grylloidea: Phalangopsidae)	PLOS ONE			English	Article							BRAZILIAN ATLANTIC FOREST; SPECIES DISTRIBUTIONS; GRYLLIDEA ORTHOPTERA; SAVANNA VEGETATION; MALE GENITALIA; BODY-SIZE; CERRADO; CONSERVATION; SPECIATION; DIVERSITY	The phylogeny of the cricket genus Eidmanacris is used to analyse its historical distribution and diversification in three South American biomes: Atlantic Forest, Cerrado, and Chiquitano Dry Forest. A morphological phylogeny with all the 29 species of Eidmanacris and the Geographically explicit Event Model (GEM) is used to explain their colonization and diversification through three different biomes and their ancestral habitats and distributional areas. We analysed ecologically-significant characters, such as body size and metanotal characters, to test whether if morphology, habitat, or behaviour are connected. The relations of these features with the colonisation of wetter or drier biomes based on the distributional area, phylogeny and diversity of the genus were also tested. The results show that the ancestral distribution of the genus was the Atlantic Forest, and that biome occupancy, habitat, size, and mating behaviour evolved congruently through the phylogeny, drawing a coherent pattern of changes through Eidmanacris evolution toward the colonisation of drier biomes. Our results indicate that gallery forests could play a key role in the distribution and diversification of Eidmanacris species.	[de Campos, Lucas Denadai; Shigueo Nihei, Silvio] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [de Campos, Lucas Denadai; Desutter-Grandcolas, Laure] Sorbonne Univ, Museum Natl Hist Nat, Inst Systemat Evolut & Biodiversite, CNRS,UPMC,EPHE,UA, Paris, France; [Souza-Dias, Pedro Guilherme Barrios de] Univ Fed Rio de Janeiro, Museu Nacl, Dept Entomol, Rio De Janeiro, Brazil	Universidade de Sao Paulo; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Universidade Federal do Rio de Janeiro	de Campos, LD (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil.; de Campos, LD (corresponding author), Sorbonne Univ, Museum Natl Hist Nat, Inst Systemat Evolut & Biodiversite, CNRS,UPMC,EPHE,UA, Paris, France.	lcdenadai@gmail.com	de Campos, Lucas Denadai/AAE-1451-2021	Nihei, Silvio/0000-0002-6887-6282; Denadai de Campos, Lucas/0000-0003-2922-1571	Fundaco de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/09863-4, 2015/19112-9, 2018/23224-5]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/10788-0, 2016/50387-7]; Conselho Nacional de Desenvolvimento Cienti'fico e Tecnolo' gico (CNPq) [403165/2016-4, 303615/2015-0]; Project "Biota de Orthoptera do Brasil" Project/MCT/CNPq/MMA/MEC/CAPES/FNDCT-Acao Transversal/FAPs [47/2010]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [563360/2010-0]; CNPq [563256/2010-9]; FAPESP [2010/52314-0]	Fundaco de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cienti'fico e Tecnolo' gico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Project "Biota de Orthoptera do Brasil" Project/MCT/CNPq/MMA/MEC/CAPES/FNDCT-Acao Transversal/FAPs; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Fundaco de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), processes 2014/09863-4, 2015/19112-9, and 2018/23224-5 (LDC). https://fapesp.br.-Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), processes 2015/10788-0 and 2016/50387-7 (SSN). https://fapesp.br.-Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnolo ' gico (CNPq), processes 403165/2016-4 and 303615/2015-0 (SSN). http://www.cnpq.br -Project "Biota de Orthoptera do Brasil" Project/MCT/CNPq/MMA/MEC/CAPES/FNDCT-Acao Transversal/FAPs No 47/2010 and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), process 563360/2010-0 (LDC and PGBS). http://www.orthoptera.com.br/-Project SISBIOTA-Diptera, CNPq process 563256/2010-9, FAPESP process 2010/52314-0 (LDC and SSN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab'Saber A.N, 1977, GEOMORFOLOGIA, V52, P1, DOI DOI 10.3897/ZOOKEYS.150.2109; Agnarsson I, 2004, ZOOL J LINN SOC-LOND, V141, P447, DOI 10.1111/j.1096-3642.2004.00120.x; Agnarsson I, 2008, CLADISTICS, V24, P51, DOI [10.1111/j.1096-0031.2007.00168.x, 10.1111/j.1096-0031.2008.00229.x]; Alvarez-Presas M, 2014, HEREDITY, V112, P656, DOI 10.1038/hdy.2014.3; Anso J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150920; Antonelli A, 2018, P NATL ACAD SCI USA, V115, P6034, DOI 10.1073/pnas.1713819115; Antonelli A, 2011, TAXON, V60, P403, DOI 10.1002/tax.602010; BISHOP I R, 1974, Mammalia, V38, P489, DOI 10.1515/mamm.1974.38.3.489; Bolfarini MP, 2016, ZOOTAXA, V4083, P526, DOI 10.11646/zootaxa.4083.4.4; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Brown K.S. Jr, 1987, Oxford Monographs on Biogeography, P66; BROWN KEITH, 1967, J LEPIDOPTERISTS SOC, V21, P145; Cabette HSR, 2017, REV BRAS ENTOMOL, V61, P43, DOI 10.1016/j.rbe.2016.10.004; Cardoso MJ, 2009, CONSERV GENET, V10, P1719, DOI 10.1007/s10592-008-9774-z; Carvalho FMV, 2009, BIOL CONSERV, V142, P1392, DOI 10.1016/j.biocon.2009.01.031; CHOPARD L., 1938, BULL SOC ENT FRANCE, V43, P159; CHOWN SL, 1993, FUNCT ECOL, V7, P318, DOI 10.2307/2390211; Chown SL, 1998, CAN J ZOOL, V76, P1123, DOI 10.1139/cjz-76-6-1123; Cigliano M., ORTHOPTERA SPECIES F; Clegg SM, 2002, P NATL ACAD SCI USA, V99, P8127, DOI 10.1073/pnas.102583399; COLE MM, 1960, GEOGR J, V126, P168, DOI 10.2307/1793957; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Coyne J.A., 2004, SPECIATION; Da Silva JMC, 2002, BIOSCIENCE, V52, P225, DOI 10.1641/0006-3568(2002)052[0225:BPACIT]2.0.CO;2; da Silva JMC., 1996, ORNITOL NEOTROP, V7, P1; DaSilva MB, 2017, CURR ZOOL, V63, P525, DOI 10.1093/cz/zow092; DaSilva MB, 2015, CLADISTICS, V31, P692, DOI 10.1111/cla.12121; de Campos LD, 2020, ZOOSYSTEMA, V42, P331, DOI 10.5252/zoosystema2020v42a19; De Campos LD, 2017, ZOOTAXA, V4321, P1, DOI 10.11646/zootaxa.4321.1.1; De Campos LD, 2015, ZOOTAXA, V4018, P228, DOI 10.11646/zootaxa.4018.2.4; DESUTTER L, 1987, ANN SOC ENTOMOL FR, V23, P213; DESUTTER L, 1988, ANN SOC ENTOMOL FR, V24, P343; Desutter L, 1990, THESIS, P348; Desutter-Grandcolas L, 2004, AN ACAD BRAS CIENC, V76, P301, DOI 10.1590/S0001-37652004000200019; Desutter-Grandcolas L, 2003, ZOOL SCR, V32, P525, DOI 10.1046/j.1463-6409.2003.00142.x; Desutter-Grandcolas L., 1995, B MUSEUM NATL HIST N, V16, P453; Desutter-Grandcolas L., 1995, J ORTHOPTERA RES, V1995, P163, DOI DOI 10.2307/3503472; Desutter-Grandcolas Laure, 1993, International Journal of Speleology, V22, P1; Desutter-Grandcolas Laure, 1992, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V14, P93; Dinerstein E., 1995, CONSERVATION ASSESSM; Dinerstein E, 2017, BIOSCIENCE, V67, P534, DOI 10.1093/biosci/bix014; Diniz IR, 1998, REV BIOL TROP, V46, P109; Donoghue MJ, 2014, ANNU REV ECOL EVOL S, V45, P547, DOI 10.1146/annurev-ecolsys-120213-091905; Duellman WE, 1999, PATTERNS DISTRIBUTIO; Eisenberg J.F., 1999, MAMMALS NEOTROPICS V, V3, P13; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; FARRIS JS, 1970, SYST ZOOL, V19, P83, DOI 10.2307/2412028; Fernandes AG, 2000, FITOGEOGRAFIA BRASIL; Fouquet A, 2012, MOL PHYLOGENET EVOL, V65, P547, DOI 10.1016/j.ympev.2012.07.012; Furley PA, 1999, GLOBAL ECOL BIOGEOGR, V8, P223, DOI 10.1046/j.1466-822X.1999.00142.x; FURLEY PA, 1988, J BIOGEOGR, V15, P97, DOI 10.2307/2845050; Gasc A, 2018, BIOL INVASIONS, V20, P1099, DOI 10.1007/s10530-017-1612-0; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Gorochov A. V., 2014, ZOOSYSTEMATICA ROSSICA, V23, P7; Gwynne DT, 2002, NATURWISSENSCHAFTEN, V89, P125, DOI 10.1007/s00114-002-0298-y; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J., 1987, Oxford Monographs on Biogeography, P105; Hemp A, 2018, GLOBAL CHANGE BIOL, V24, P3499, DOI 10.1111/gcb.14078; Hemp C, 2019, SYST ENTOMOL, V44, P408, DOI 10.1111/syen.12332; Hovenkamp P, 1997, CLADISTICS, V13, P67, DOI 10.1111/j.1096-0031.1997.tb00241.x; Johnson M. A., 1999, Revista Brasileira de Biologia, V59, P421, DOI 10.1590/S0034-71081999000300006; Klein AL., 2002, EUGEN WARMING CERRAD; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; LEDRU MP, 1993, QUATERNARY RES, V39, P90, DOI 10.1006/qres.1993.1011; Lehmann CER, 2011, NEW PHYTOL, V191, P197, DOI 10.1111/j.1469-8137.2011.03689.x; Lovejoy, 1985, AMAZON; Maddison WP., 2019, CHROMASEQ MESQUITE P; MANTOVANI W, 2003, PATRIMONIO AMBIENTAL; Matzke N.J., 2013, BIOGEOBEARS BIOGEOGR; Matzke NJ, 2014, SYST BIOL, V63, P951, DOI 10.1093/sysbio/syu056; Mayr E., 1954, P157; Méio Beatriz B., 2003, Braz. J. Bot., V26, P437, DOI 10.1590/S0100-84042003000400002; MESA A, 1985, Revista Brasileira de Entomologia, V29, P199; Mesa A, 1998, T AM ENTOMOL SOC, V124, P43; Mittermeier RA, 2005, CONSERV BIOL, V19, P601, DOI 10.1111/j.1523-1739.2005.00709.x; MORI SA, 1981, BRITTONIA, V33, P233, DOI 10.2307/2806330; MULLER E, 1973, ADV CHEM SER, P1; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nihei SS, 2007, SYST ENTOMOL, V32, P477, DOI 10.1111/j.1365-3113.2006.00376.x; Nimer E, 1979, CLIMATOLOGIA BRASIL; Nixon K.C., 2002, WINCLADA VER 1 00 08; NIXON KC, 1993, CLADISTICS, V9, P413, DOI 10.1111/j.1096-0031.1993.tb00234.x; Nixon Kevin C., 1992, P119; Nogueira C, 2005, STUD NEOTROP FAUNA E, V40, P105, DOI 10.1080/01650520500129901; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Oliveira PS, 2002, CERRADOS BRAZIL ECOL; Oliveira-Filho A. T., 1995, Edinburgh Journal of Botany, V52, P141; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Otte, 1967, EVOLUTION GENITALIA, P1; Parker TA, 1993, LOWLAND DRY FORESTS; Parker TA III, 1996, NEOTROPICAL BIRDS EC; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pinheiro MHO, 2010, BRAZ J BIOL, V70, P95, DOI 10.1590/S1519-69842010000100013; PRADO DE, 1993, ANN MO BOT GARD, V80, P902, DOI 10.2307/2399937; Prado R, 2006, NEOTROP ENTOMOL, V35, P452, DOI 10.1590/S1519-566X2006000400005; Prado Rogilene Aparecida, 2005, Iheringia, Sér. Zool., V95, P83, DOI 10.1590/S0073-47212005000100012; QGIS Development Team, 2018, QGIS GEOGR INF SYST; RATTER JA, 1973, PHILOS T R SOC B, V266, P449, DOI DOI 10.1098/RSTB.1973.0053; REDFORD KH, 1986, BIOTROPICA, V18, P126, DOI 10.2307/2388755; Ribeiro JF., 1998, FITOFISIONOMIAS BIOM; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ridgely RS., 2016, WILDLIFE CONSERVATIO, V1st edn.; Rizzini CT, 1979, TRATADO FITOGEOGRAFI; Robillard T, 2005, INSECT SYST EVOL, V35, P411; Arias JS, 2017, J BIOGEOGR, V44, P2225, DOI 10.1111/jbi.13024; Santos, 1991, THREATENED ENDEMIC M; Sereno PC, 2007, CLADISTICS, V23, P565, DOI 10.1111/j.1096-0031.2007.00161.x; Sobral-Souza T, 2015, EVOL ECOL, V29, P643, DOI 10.1007/s10682-015-9780-9; Sociedade Brasileira de Diabetes (SBD), 2015, SBD, V1, P72, DOI DOI 10.1016/J.CELS.2015.01.001; Ruiz MS, 2020, HERPETOL J, V30, P53, DOI 10.33256/hj30.2.5368; Souza-Dias PGB, 2015, FLA ENTOMOL, V98, P547, DOI 10.1653/024.098.0223; SWOFFORD DL, 1987, MATH BIOSCI, V87, P199, DOI 10.1016/0025-5564(87)90074-5; Templeton AR, 2008, BIOESSAYS, V30, P470, DOI 10.1002/bies.20745; Tilman D., 1982, Monographs in Population Biology, pi; Vasconcelos TS, 2016, ECOL RES, V31, P913, DOI 10.1007/s11284-016-1401-8; Vogel HF, 2009, REV SAUDE BIO, V4, P24; Whitman Douglas W., 2008, Journal of Orthoptera Research, V17, P117, DOI 10.1665/1082-6467-17.2.117; Whitmore T. C., 1987, BIOGEOGRAPHY QUATERN; Willis Edwin O., 1992, Ornitologia Neotropical, V3, P1; Winterhalter Wade E., 2008, Journal of Orthoptera Research, V17, P347, DOI 10.1665/1082-6467-17.2.347	122	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245325	10.1371/journal.pone.0245325	http://dx.doi.org/10.1371/journal.pone.0245325			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449941	Green Published, gold			2022-12-26	WOS:000609991600001
J	Farah, AM; Nour, TY; Endris, BS; Gebreyesus, SH				Farah, Alinoor Mohamed; Nour, Tahir Yousuf; Endris, Bilal Shikur; Gebreyesus, Seifu Hagos			Concurrence of stunting and overweight/obesity among children: Evidence from Ethiopia	PLOS ONE			English	Article							EXCESS BODY-WEIGHT; DUAL BURDEN; GESTATIONAL-AGE; BIRTH-WEIGHT; LOW-INCOME; NUTRITION TRANSITION; CHILDHOOD OBESITY; UNDER-NUTRITION; RAPID GROWTH; MALNUTRITION	Background Nutrition transition in many low- and middle-income countries (LMICs) has led to shift in childhood nutritional outcomes from a predominance of undernutrition to a double burden of under- and overnutrition. Yet, policies that address undernutrition often times do not include overnutrition nor do policies on overweight, obesity reflect the challenges of undernutrition. It is therefore crucial to assess the prevalence and determinants of concurrence stunting and overweight/obesity to better inform nutrition programs in Ethiopia and beyond. Methods We analyzed anthropometric, sociodemographic and dietary data of children under five years of age from 2016 Ethiopian Demographic and Health Survey (EDHS). A total of 8,714 children were included in the current study. Concurrence of stunting and overweight/obesity (CSO) prevalence was estimated by basic, underlying and immediate factors. To identify factors associated with CSO, we conducted hierarchical logistic regression analyses. Results The overall prevalence of CSO was 1.99% (95% CI, 1.57-2.53). The odds of CSO was significantly higher in children in agrarian region compared to their counter parts in the pastoralist region (AOR = 1.51). Other significant factors included; not having improved toilet facility (AOR = 1.94), being younger than 12 months (AOR = 4.22), not having history of infection (AOR = 1.83) and not having taken deworming tablet within the previous six months (AOR = 1.49). Conclusion Our study provided evidence on the co-existence of stunting and overweight/obesity among infants and young children in Ethiopia. Therefore, identifying children at risk of growth flattering and excess weight gain provides nutrition policies and programs in Ethiopia and beyond with an opportunity of earlier interventions through improving sanitation, dietary quality by targeting children under five years of age and those living in Agrarian regions of Ethiopia.	[Farah, Alinoor Mohamed; Nour, Tahir Yousuf] Jigjiga Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Jigjiga, Ethiopia; [Endris, Bilal Shikur; Gebreyesus, Seifu Hagos] Addis Ababa Univ, Dept Reprod Hlth & Hlth Serv Management, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia	Addis Ababa University	Farah, AM (corresponding author), Jigjiga Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Jigjiga, Ethiopia.	alinuriana@yahoo.com	Yousuf, Tahir/CAF-7685-2022; Farah, Alinoor Mohamed/CAA-1039-2022; Nour, Tahir/GZA-3755-2022	Yousuf, Tahir/0000-0001-6406-5821; Mohamed, Alinoor/0000-0001-8557-7084				Adel E, 2008, LIBYAN J MED, V3, P13, DOI 10.4176/071006; Aguayo VM, 2016, MATERN CHILD NUTR, V12, P3, DOI 10.1111/mcn.12283; Atsu BK, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0928-3; BENDEL RB, 1977, J AM STAT ASSOC, V72, P46, DOI 10.2307/2286904; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Cattaneo A, 2008, PUBLIC HEALTH NUTR, V11, P1209, DOI 10.1017/S1368980008003261; CHEN SJ, 1993, J PEDIATR-US, V123, P132, DOI 10.1016/S0022-3476(05)81556-2; Chomtho S, 2008, AM J CLIN NUTR, V87, P1776, DOI 10.1093/ajcn/87.6.1776; Christian P, 2013, INT J EPIDEMIOL, V42, P1340, DOI 10.1093/ije/dyt109; Conference Outcome Documents, 2014, HLTH PROMOT INT S1, V29, pi19; COOPER E, 1991, T ROY SOC TROP MED H, V85, P168, DOI 10.1016/0035-9203(91)90009-N; CSA I, 2016, ETH DEM HLHT SURV AD; CSA-Ethiopia I., 2012, INT ETH DEM HLHT SUR; Danaei G, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002164; Darapheak Chau, 2013, Int Arch Med, V6, P29, DOI 10.1186/1755-7682-6-29; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dearden KA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4033-1; Dennison BA, 2006, OBESITY, V14, P491, DOI 10.1038/oby.2006.64; Doak CM, 2005, INT J OBESITY, V29, P129, DOI 10.1038/sj.ijo.0802824; Dror DK, 2011, FOOD NUTR BULL, V32, P227, DOI 10.1177/156482651103200307; Druet C, 2012, PAEDIATR PERINAT EP, V26, P19, DOI 10.1111/j.1365-3016.2011.01213.x; Elsmen E, 2004, ACTA PAEDIATR, V93, P529, DOI 10.1080/08035250410024998; Farah AM, 2019, BMC NUTR, V5, DOI 10.1186/s40795-019-0281-z; Fernald LC, 2007, EUR J CLIN NUTR, V61, P623, DOI 10.1038/sj.ejcn.1602558; Ferreira HD, 2010, REV SAUDE PUBL, V44, P377, DOI 10.1590/S0034-89102010005000001; Fongar A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7882-y; Freire WB, 2014, AM J CLIN NUTR, V100, p1636S, DOI 10.3945/ajcn.114.083766; Gardner K, 2011, CHILD CARE HLTH DEV, V37, P143, DOI 10.1111/j.1365-2214.2010.01154.x; Garrett James L., 2005, Food and Nutrition Bulletin, V26, P209; Gebrie Alemu, 2018, BMC Obes, V5, P19, DOI 10.1186/s40608-018-0198-0; Ghattas H, 2020, MATERN CHILD NUTR, V16, DOI 10.1111/mcn.12923; GREEN MS, 1992, INT J EPIDEMIOL, V21, P381, DOI 10.1093/ije/21.2.381; Hassen K, 2017, FOOD NUTR BULL, V38, P196, DOI 10.1177/0379572117701660; Jafar TH, 2008, ARCH DIS CHILD, V93, P373, DOI 10.1136/adc.2007.125641; Jehn M, 2009, ECON HUM BIOL, V7, P28, DOI 10.1016/j.ehb.2009.01.007; Jelenkovic A, 2016, SCI REP-UK, V6, DOI 10.1038/srep28496; Jinabhai CC, 2005, ANN TROP PAEDIATR, V25, P3, DOI 10.1179/146532805X23290; Kavle JA, 2016, MATERN CHILD NUTR, V12, P139, DOI 10.1111/mcn.12213; Khor GL, 2003, ASIA PAC J CLIN NUTR, V12, P427; Kilbride H W, 1998, J Perinatol, V18, P102; Kimani-Murage EW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129943; Kimani-Murage EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-158; Kosaka S, 2017, BRIT J NUTR, V117, P1118, DOI 10.1017/S0007114517000812; Kramer MS, 2014, AM J CLIN NUTR, V100, P176, DOI 10.3945/ajcn.113.079590; Kroker-Lobos MF, 2014, AM J CLIN NUTR, V100, p1652S, DOI 10.3945/ajcn.114.083832; Kuhle S, 2017, J PEDIATR-US, V182, P99, DOI 10.1016/j.jpeds.2016.11.067; Martorell R, 2012, PAEDIATR PERINAT EP, V26, P302, DOI 10.1111/j.1365-3016.2012.01298.x; Melaku YA, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0316-3; Mercer, 1993, GROWTH PROMOTION CHI; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Mohammed SH, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0436-4; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Motlagh ME, 2011, PUBLIC HEALTH NUTR, V14, P605, DOI 10.1017/S1368980010002399; Okihiro M, 2012, ETHNIC DIS, V22, P439; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Provo A. M., 2013, Sight and Life Magazine, V27, P40; Reinhardt Kristina, 2014, Front Nutr, V1, P13, DOI 10.3389/fnut.2014.00013; Sahoo Krushnapriya, 2015, J Family Med Prim Care, V4, P187, DOI 10.4103/2249-4863.154628; Saibul N, 2009, ASIA PAC J CLIN NUTR, V18, P412; Said-Mohamed R, 2009, ANN HUM BIOL, V36, P146, DOI 10.1080/03014460802660526; Sanchez M, 2015, INT J ENV RES PUB HE, V12, P162, DOI 10.3390/ijerph120100162; Sarmiento OL, 2014, AM J CLIN NUTR, V100, p1628S, DOI 10.3945/ajcn.114.083816; Sidik Sherina Mohd, 2009, Asia Pac Fam Med, V8, P2, DOI 10.1186/1447-056X-8-2; Slining MM, 2013, J DEV ORIG HLTH DIS, V4, P56, DOI 10.1017/S2040174412000554; Sommerfelt A.E., 1993, DEMOGRAPHIC HLTH SUR; Sorrie MB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182511; SYNNES AR, 1994, J PEDIATR-US, V125, P952, DOI 10.1016/S0022-3476(05)82015-3; Taveras EM, 2009, PEDIATRICS, V123, P1177, DOI 10.1542/peds.2008-1149; Tchoubi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143215; The Lancet HIV, 2016, LANCET HIV, V3, pe191; Tzioumis E, 2016, PUBLIC HEALTH NUTR, V19, P1375, DOI 10.1017/S1368980016000276; UNICEF WHO and World Bank, 2015, LEV TRENDS CHILD MAL; Urke HB, 2014, PUBLIC HEALTH NUTR, V17, P2407, DOI 10.1017/S1368980014000275; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Victora CG, 2001, INT J EPIDEMIOL, V30, P217, DOI 10.1093/ije/30.2.217; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wamani H., 2007, BMC Pediatrics, V7; Wang XL, 2009, PUBLIC HEALTH NUTR, V12, P1991, DOI 10.1017/S1368980009990796; Weldearegay HG, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4752-8; Wells JC, 2020, LANCET, V395, P75, DOI 10.1016/S0140-6736(19)32472-9; WHO, 2013, GLOB NUTR POL REV DO; WHO, 2017, DOUBL DUT ACT NUTR P; World Health Organization, 2015, GLOB PREV AN 2011, V<bold>48</bold>; World Health Organization, 2010, WHO ANTHR PERS COMP; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401; Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x; Zhang C, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0157000, 10.1371/journal.pone.0162830, 10.1371/journal.pone.0158119]	89	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245456	10.1371/journal.pone.0245456	http://dx.doi.org/10.1371/journal.pone.0245456			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449970	gold, Green Published			2022-12-26	WOS:000609991600011
J	Parvaiz, N; Ahmad, F; Yu, WB; MacKerell, AD; Azam, SS				Parvaiz, Nousheen; Ahmad, Faisal; Yu, Wenbo; MacKerell, Alexander D., Jr.; Azam, Syed Sikander			Discovery of beta-lactamase CMY-10 inhibitors for combination therapy against multi-drug resistant Enterobacteriaceae	PLOS ONE			English	Article							COMPETITIVE SATURATION SILCS; GENERAL FORCE-FIELD; SITE-IDENTIFICATION; DYNAMICS; EXPRESSION; EXTENSION; EFFICIENT	beta-lactam antibiotics are the most widely used antimicrobial agents since the discovery of benzylpenicillin in the 1920s. Unfortunately, these life-saving antibiotics are vulnerable to inactivation by continuously evolving beta-lactamase enzymes that are primary resistance determinants in multi-drug resistant pathogens. The current study exploits the strategy of combination therapeutics and aims at identifying novel beta-lactamase inhibitors that can inactivate the beta-lactamase enzyme of the pathogen while allowing the beta-lactam antibiotic to act against its penicillin-binding protein target. Inhibitor discovery applied the Site-Identification by Ligand Competitive Saturation (SILCS) technology to map the functional group requirements of the beta-lactamase CMY-10 and generate pharmacophore models of active site. SILCS-MC, Ligand-grid Free Energy (LGFE) analysis and Machine-learning based random-forest (RF) scoring methods were then used to screen and filter a library of 700,000 compounds. From the computational screens 74 compounds were subjected to experimental validation in which beta-lactamase activity assay, in vitro susceptibility testing, and Scanning Electron Microscope (SEM) analysis were conducted to explore their antibacterial potential. Eleven compounds were identified as enhancers while 7 compounds were recognized as inhibitors of CMY-10. Of these, compound 11 showed promising activity in beta-lactamase activity assay, in vitro susceptibility testing against ATCC strains (E. coli, E. cloacae, E. agglomerans, E. alvei) and MDR clinical isolates (E. cloacae, E. alvei and E. agglomerans), with synergistic assay indicating its potential as a beta-lactam enhancer and beta-lactamase inhibitor. Structural similarity search against the active compound 11 yielded 28 more compounds. The majority of these compounds also exhibited beta-lactamase inhibition potential and antibacterial activity. The non-beta-lactam-based beta-lactamase inhibitors identified in the current study have the potential to be used in combination therapy with lactam-based antibiotics against MDR clinical isolates that have been found resistant against last-line antibiotics.	[Parvaiz, Nousheen; Ahmad, Faisal; Azam, Syed Sikander] Quaid I Azam Univ, Natl Ctr Bioinformat, Computat Biol Lab, Islamabad, Pakistan; [Yu, Wenbo; MacKerell, Alexander D., Jr.] Univ Maryland, Sch Pharm, Comp Aided Drug Design Ctr, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	Quaid I Azam University; University System of Maryland; University of Maryland Baltimore	Azam, SS (corresponding author), Quaid I Azam Univ, Natl Ctr Bioinformat, Computat Biol Lab, Islamabad, Pakistan.; MacKerell, AD (corresponding author), Univ Maryland, Sch Pharm, Comp Aided Drug Design Ctr, Dept Pharmaceut Sci, Baltimore, MD 21201 USA.	alex@outerbanks.umaryland.edu; syedazam2008@gmail.com		MacKerell, Alex/0000-0001-8287-6804	Pakistan-United States Science and Technology Cooperation Program [US/2017/360]; USA National Institutes of Health [GM131710]	Pakistan-United States Science and Technology Cooperation Program; USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the Pakistan-United States Science and Technology Cooperation Program SSA and ADM (US/2017/360) and the USA National Institutes of Health to ADM (GM131710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrar S, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0309-1; Ali SR, 2018, ACS APPL BIO MATER, V1, P967, DOI 10.1021/acsabm.8b00105; Allen M.P., 2017, COMPUTER SIMULATION, P1, DOI [10.1093/oso/9780198803195.001.0001, DOI 10.1093/OSO/9780198803195.001.0001]; Barnaud G, 2001, FEMS MICROBIOL LETT, V195, P185, DOI 10.1111/j.1574-6968.2001.tb10519.x; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; Coates WJ, 1996, COMPREHENSIVE HETERO, V6, P1, DOI [10.1016/B978-008096518-5.00117-9, DOI 10.1016/B978-008096518-5.00117-9]; Das JK, 2018, AM J TROP MED HYG, V99, P48, DOI 10.4269/ajtmh.18-0145; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; DURELL SR, 1994, J PHYS CHEM-US, V98, P2198, DOI 10.1021/j100059a038; Guvench O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000435; Hanson ND, 1999, CURR PHARM DESIGN, V5, P881; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; IACG, 2019, NO TIM WAIT SEC FUT, P28; Jabeen K, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1673-1; Kim JY, 2006, MOL MICROBIOL, V60, P907, DOI 10.1111/j.1365-2958.2006.05146.x; King DT, 2015, ACS INFECT DIS, V1, P175, DOI 10.1021/acsinfecdis.5b00007; Koes DR, 2011, J CHEM INF MODEL, V51, P1307, DOI 10.1021/ci200097m; Lakkaraju SK, 2014, J CHEM THEORY COMPUT, V10, P2281, DOI 10.1021/ct500201y; Lalitha MK, 1997, INDIAN J MED RES, V106, P500; LEVITT M, 1969, J MOL BIOL, V46, P269, DOI 10.1016/0022-2836(69)90421-5; Li F, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3579832; Lim CLL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-523; Lin FY, 2017, J PHYS CHEM B, V121, P6813, DOI 10.1021/acs.jpcb.7b04198; Lomonaco S, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.00500-19; Macias AT, 2005, J CHEM INF MODEL, V45, P1759, DOI 10.1021/ci050225z; Murtey M.D., 2016, MODERN ELECT MICROSC, P161, DOI DOI 10.5772/61720; Na JH, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00098-17, 10.1128/aac.00098-17]; Nisar M, 2017, FOOD CONTROL, V80, P327, DOI 10.1016/j.foodcont.2017.03.048; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Powers RA, 1999, PROTEIN SCI, V8, P2330; Raman EP, 2013, J CHEM INF MODEL, V53, P3384, DOI 10.1021/ci4005628; Raman EP, 2011, J CHEM INF MODEL, V51, P877, DOI 10.1021/ci100462t; Saleem Z, 2019, INT J CLIN PHARM-NET, V41, P1348, DOI 10.1007/s11096-019-00875-7; Sambrook J., 2001, MOL CLONING LAB MANU; Santajit S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2475067; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Tomar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043522; Tondi D, 2005, J AM CHEM SOC, V127, P4632, DOI 10.1021/ja042984o; Ustach VD, 2019, J CHEM INF MODEL, V59, P3018, DOI 10.1021/acs.jcim.9b00210; Vakulenko SB, 2002, ANTIMICROB AGENTS CH, V46, P1966, DOI 10.1128/AAC.46.6.1966-1970.2002; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wang RX, 2001, J CHEM INF COMP SCI, V41, P1422, DOI 10.1021/ci010025x; Weinstein, 2018, PERFORMANCE STANDARD; Wojcikowski M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46710; Yu WB, 2015, J CHEM INF MODEL, V55, P407, DOI 10.1021/ci500691p; Yu WB, 2014, J COMPUT AID MOL DES, V28, P491, DOI 10.1007/s10822-014-9728-0; Yu WB, 2012, J COMPUT CHEM, V33, P2451, DOI 10.1002/jcc.23067	51	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0244967	10.1371/journal.pone.0244967	http://dx.doi.org/10.1371/journal.pone.0244967			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449932	Green Published			2022-12-26	WOS:000609991600017
J	Sartayev, Y; Takahashi, J; Gutevich, A; Hayashida, N				Sartayev, Yesbol; Takahashi, Jumpei; Gutevich, Alexander; Hayashida, Naomi			Screening for the Cs-137 body burden owing to the Chernobyl accident in Zhytomyr region, Ukraine: 2009-2018	PLOS ONE			English	Article							BRYANSK REGION; RADIATION-EXPOSURE; INHABITANTS; RUSSIA; POPULATION; CESIUM; OBLAST	The Chernobyl Nuclear Power Plant accident released vast amounts of various fission products, of which I-131 and Cs-137 are considered the most important because they are a major source of radiation exposure to the general public. Cs-137, unlike I-131, has a 30-year half-life that continues to expose people internally and externally for several decades after being deposited into the ground. Cs-137 can be easily transmitted to the body through the intake of products and wild forest foodstuffs produced in contaminated areas. In the early phase, external exposure to Cs-137 was predominant; however, it gradually diminished, mostly owing to horizontal and vertical distribution, and internal exposure started gaining dominance. Prior studies have shown that people in the affected areas have been constantly subjected to the inevitable low-grade internal exposure, which in turn has led to high anxiety and concern regarding the potential health effects. The present 10-year study assessed the latest status of the body burden among residents of the contaminated parts of the Zhytomyr region of Ukraine by measuring the internal concentration of Cs-137 using the whole-body counter installed at the Medical Center of Korosten city. Almost 110 000 examinees from eight different districts were screened between 2009 and 2018. The study area was situated to the west of Chernobyl, which experienced a significant fallout of Cs-137 and I-131 from the Chernobyl Nuclear Power Plant. We analyzed the data for internal exposure to Cs-137 by obtaining the actual magnitude, pace, and pattern of change for each year. During the study, the average Cs-137 concentration in residents fell from 21.6 Bq/kg at the beginning of the study to 3.0 Bq/kg at the end of the study. The proportion of examinees with detectable levels had also fallen rapidly, from 45% to 11%. We found a weaker seasonal effect and a significantly higher Bq/kg concentration in adolescents than in other age groups.	[Sartayev, Yesbol; Hayashida, Naomi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiat & Environm Hlth Effects, Nagasaki, Japan; [Takahashi, Jumpei] Nagasaki Univ, Ctr Int Collaborat Res, Nagasaki, Japan; [Gutevich, Alexander] Zhytomyr Interarea Med Diagnost Ctr, Korosten, Ukraine; [Hayashida, Naomi] Nagasaki Univ, Atom Bomb Dis Inst, Div Strateg Collaborat Res, Nagasaki, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Hayashida, N (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiat & Environm Hlth Effects, Nagasaki, Japan.; Hayashida, N (corresponding author), Nagasaki Univ, Atom Bomb Dis Inst, Div Strateg Collaborat Res, Nagasaki, Japan.	naomin@nagasaki-u.ac.jp			Program of the Network-type Joint Usage/Research Center for Radiation Disaster Medical Science; Atomic Bomb Disease Institute of Nagasaki University	Program of the Network-type Joint Usage/Research Center for Radiation Disaster Medical Science; Atomic Bomb Disease Institute of Nagasaki University	This research was supported by financial support from the Program of the Network-type Joint Usage/Research Center for Radiation Disaster Medical Science (URL: https://home.hiroshima-u.ac.jp/housai/index-e.html) and the Atomic Bomb Disease Institute of Nagasaki University (URL: https://www-sdc.med.nagasaki-u.ac.jp/abdi/index.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, Ann ICRP, V21, P1; [Anonymous], 1996, MED MALADIES INFECT, V26, P1; Balonov M. I., 1999, Journal of Radiological Protection, V19, P261, DOI 10.1088/0952-4746/19/3/304; Bernhardsson C, 2011, SCI TOTAL ENVIRON, V409, P4811, DOI 10.1016/j.scitotenv.2011.07.066; Chobotko H M, 2018, Probl Radiac Med Radiobiol, V23, P216, DOI 10.33145/2304-8336-2018-23-216-228; Fesenko SV, 2000, RADIAT ENVIRON BIOPH, V39, P291; Hayashida N, 2011, J RADIAT RES, V52, P629, DOI 10.1269/jrr.11017; Hoshi M, 2000, HEALTH PHYS, V79, P182, DOI 10.1097/00004032-200008000-00011; Hosokawa Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174549; International Atomic Energy Agency, 2006, ENV CONS CHERN ACC T; International Atomic Energy Agency, 2006, CHERN LEG HLTH ENV S; Jelin BA, 2016, J EXPO SCI ENV EPID, V26, P546, DOI 10.1038/jes.2015.6; Jesko T, 2000, RADIAT PROT DOSIM, V89, P179, DOI 10.1093/oxfordjournals.rpd.a033061; Kimura Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139007; Kravets AP, 2008, RADIAT ENVIRON BIOPH, V47, P213, DOI 10.1007/s00411-008-0156-1; Sekitani Y, 2010, RADIAT PROT DOSIM, V141, P36, DOI 10.1093/rpd/ncq137; Skuterud L., 2012, P 13 INT C RAD PROT, DOI [10.13140/2.1.3603.5848, DOI 10.13140/2.1.3603.5848]; Skuterud L, 2015, ENVIRON SCI TECHNOL, V49, P3145, DOI 10.1021/es506244n; Thornberg C, 2005, RADIAT ENVIRON BIOPH, V44, P97, DOI 10.1007/s00411-005-0007-2; Travnikova IG, 2001, RADIAT PROT DOSIM, V93, P331, DOI 10.1093/oxfordjournals.rpd.a006445; Warshawsky-Livne L, 2014, ADV HEALTH ECON HEAL, V24, P123, DOI 10.1108/S0731-219920140000024003	21	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245491	10.1371/journal.pone.0245491	http://dx.doi.org/10.1371/journal.pone.0245491			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449945	Green Published, gold			2022-12-26	WOS:000609991600024
J	Wirth, S; Krause, K; Kunert, M; Broska, S; Paetz, C; Boland, W; Kothe, E				Wirth, Sophia; Krause, Katrin; Kunert, Maritta; Broska, Selina; Paetz, Christian; Boland, Wilhelm; Kothe, Erika			Function of sesquiterpenes from Schizophyllum commune in interspecific interactions	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; HYPHOLOMA-FASCICULARE; ROT FUNGI; BROWN-ROT; WOOD; METABOLITES; BACTERIAL	Wood is a habitat for a variety of organisms, including saprophytic fungi and bacteria, playing an important role in wood decomposition. Wood inhabiting fungi release a diversity of volatiles used as signaling compounds to attract or repel other organisms. Here, we show that volatiles of Schizophyllum commune are active against wood-decay fungi and bacteria found in its mycosphere. We identified sesquiterpenes as the biologically active compounds, that inhibit fungal growth and modify bacterial motility. The low number of cultivable wood inhabiting bacteria prompted us to analyze the microbial community in the mycosphere of S. commune using a culture-independent approach. Most bacteria belong to Actinobacteria and Proteobacteria, including Pseudomonadaceae, Sphingomonadaceae, Erwiniaceae, Yersiniaceae and Mariprofundacea as the dominating families. In the fungal community, the phyla of ascomycetes and basidiomycetes were well represented. We propose that fungal volatiles might have an important function in the wood mycosphere and could meditate interactions between microorganisms across domains and within the fungal kingdom.	[Wirth, Sophia; Krause, Katrin; Broska, Selina; Kothe, Erika] Friedrich Schiller Univ Jena, Inst Microbiol, Microbial Commun, Jena, Germany; [Kunert, Maritta; Boland, Wilhelm] Max Planck Inst Chem Ecol, Bioorgan Chem, Jena, Germany; [Paetz, Christian] Max Planck Inst Chem Ecol, Res Grp Biosynth NMR, Jena, Germany	Friedrich Schiller University of Jena; Max Planck Society; Max Planck Society	Krause, K (corresponding author), Friedrich Schiller Univ Jena, Inst Microbiol, Microbial Commun, Jena, Germany.	katrin.krause@uni-jena.de	Boland, Wilhelm/K-7762-2012	Boland, Wilhelm/0000-0001-6784-2534	SW Jena School for Microbial Communication KK Friedrich Schiller University Jena EK Friedrich Schiller University Jena	SW Jena School for Microbial Communication KK Friedrich Schiller University Jena EK Friedrich Schiller University Jena	This study was supported by: SW Jena School for Microbial Communication KK Friedrich Schiller University Jena EK Friedrich Schiller University Jena.	Almsi E, 2019, NEW PHYTOL, V224, P902, DOI 10.1111/nph.16032; BeltranGarcia MJ, 1997, J AGR FOOD CHEM, V45, P4049, DOI 10.1021/jf960876i; Boddy L, 2018, FUNGAL KINGDOM, P293, DOI 10.1128/microbiolspec.FUNK-0019-2016; Brown ME, 2014, CURR OPIN CHEM BIOL, V19, P1, DOI 10.1016/j.cbpa.2013.11.015; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Dickschat JS, 2017, NAT PROD REP, V34, P310, DOI 10.1039/c7np00003k; DONATH J, 1995, PHYTOCHEMISTRY, V39, P785, DOI 10.1016/0031-9422(95)00082-I; El Ariebi N, 2016, FUNGAL ECOL, V20, P144, DOI 10.1016/j.funeco.2015.12.013; Evans JA, 2008, FUNGAL ECOL, V1, P57, DOI 10.1016/j.funeco.2008.06.001; Folman LB, 2008, FEMS MICROBIOL ECOL, V63, P181, DOI 10.1111/j.1574-6941.2007.00425.x; Fowler TJ, 2000, GENETICS, V156, P1585; Freihorst D, 2018, FUNGAL GENET BIOL, V112, P2, DOI 10.1016/j.fgb.2016.08.007; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Herve V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147100; Hung R, 2015, APPL MICROBIOL BIOT, V99, P3395, DOI 10.1007/s00253-015-6494-4; Hynes J, 2007, J CHEM ECOL, V33, P43, DOI 10.1007/s10886-006-9209-6; Kamei I, 2012, CURR MICROBIOL, V64, P173, DOI 10.1007/s00284-011-0050-y; Kazemi M, 2015, INT J FOOD PROP, V18, P1784, DOI 10.1080/10942912.2014.939660; Kielak AM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00231; KOVATS E, 1958, HELV CHIM ACTA, V41, P1915, DOI 10.1002/hlca.19580410703; Kramer R, 2012, PHYTOCHEM REV, V11, P15, DOI 10.1007/s11101-011-9216-2; Krause K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232145; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Mackie AE, 1999, SOIL BIOL BIOCHEM, V31, P375, DOI 10.1016/S0038-0717(98)00140-0; Menezes RC, 2015, ANAL BIOANAL CHEM, V407, P2273, DOI 10.1007/s00216-014-8383-6; Minerdi D, 2009, ENVIRON MICROBIOL, V11, P844, DOI 10.1111/j.1462-2920.2008.01805.x; Monrroy M, 2011, ENZYME MICROB TECH, V49, P472, DOI 10.1016/j.enzmictec.2011.08.004; Muller A, 2013, FUNGAL GENET BIOL, V54, P25, DOI 10.1016/j.fgb.2013.02.005; Noll M, 2010, INT BIODETER BIODEGR, V64, P629, DOI 10.1016/j.ibiod.2010.07.002; Pandey KK, 2003, INT BIODETER BIODEGR, V52, P151, DOI 10.1016/S0964-8305(03)00052-0; Schalchli H, 2011, CHEM ECOL, V27, P503, DOI 10.1080/02757540.2011.596832; Schmidt R, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01495; SCHWALB MN, 1967, AM J BOT, V54, P440, DOI 10.2307/2440834; Sethupathy S, 2016, J APPL PHYCOL, V28, P1987, DOI 10.1007/s10811-015-0717-z; Shanks RMQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057634; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Strobel GA, 2001, MICROBIOL-SGM, V147, P2943, DOI 10.1099/00221287-147-11-2943; Valaskova V, 2009, ISME J, V3, P1218, DOI 10.1038/ismej.2009.64; Van P., 2009, J STAT MECH THEORY E, V2009, pP0254; Wilkins K, 2000, CHEMOSPHERE, V41, P437, DOI 10.1016/S0045-6535(99)00273-8; Wirth S, 2018, ENVIRON MICROBIOL, V20, P3684, DOI 10.1111/1462-2920.14369; Woo HL, 2014, SYST APPL MICROBIOL, V37, P60, DOI 10.1016/j.syapm.2013.10.001; Ziegenbein FC, 2006, FLAVOUR FRAG J, V21, P813, DOI 10.1002/ffj.1732	45	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245623	10.1371/journal.pone.0245623	http://dx.doi.org/10.1371/journal.pone.0245623			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449959	Green Published, gold			2022-12-26	WOS:000609991600031
J	Reddy, K; Bekker, A; Whitelaw, AC; Esterhuizen, TM; Dramowski, A				Reddy, Kessendri; Bekker, Adrie; Whitelaw, Andrew C.; Esterhuizen, Tonya M.; Dramowski, Angela			A retrospective analysis of pathogen profile, antimicrobial resistance and mortality in neonatal hospital-acquired bloodstream infections from 2009-2018 at Tygerberg Hospital, South Africa	PLOS ONE			English	Article							CARE-ASSOCIATED INFECTIONS; ANTIBIOTIC-RESISTANCE; SEPSIS; UNIT; SURVEILLANCE	Background Analysis of hospital-acquired bloodstream infection (HA-BSI) trends is important to monitor emerging antimicrobial resistance (AMR) threats and guide empiric antibiotic choices. Methods A retrospective 10-year review of neonatal HA-BSI was performed at Tygerberg Hospital's neonatal unit in Cape Town, South Africa. Neonatal clinical and laboratory data from 2014 to 2018 (Period 2) was compared with published data from 2009 to 2013 (Period 1). Results The neonatal unit's HA-BSI rate declined between periods from 3.9/1000 inpatient-days in Period 1 to 3.3/1000 inpatient-days in Period 2 (p = 0.002). Pathogen yield and blood culture contamination rate were unchanged (11.0% to 10.4%, p = 0.233; 5.1% to 5.3%, p = 0.636 respectively). Gram-negative pathogens predominated (1047/1636; 64.0%); Klebsiella species, Staphylococcus aureus, Serratia marcescens, Enterococcus species and Acinetobacter baumannii were the most frequent pathogens. Extended spectrum beta-lactamase production was observed in 319/432 (73.8%) of Klebsiella species, methicillin resistance in 171/246 (69.5%) of Staphylococcus aureus and extensive drug resistance in 115/137 (83.9%) of Acinetobacter species (2009-2018). The crude mortality rate of neonatal HA-BSI episodes increased from Period 1 to Period 2 from 139/717 (19.4%) to 179/718 (24.9%) (p = 0.014), but HA-BSI attributable mortality remained unchanged (97/139 [69.8%] vs 118/179 [65.9%], p = 0.542). The in-vitro activity of piperacillin-tazobactam and amikacin declined during Period 2 (74.6% to 61.4%; p<0.001). Conclusion Although HA-BSI rates declined in the neonatal unit, antimicrobial resistance rates in BSI pathogens remained high. Continuous BSI surveillance is a valuable tool to detect changes in pathogen and AMR profiles and inform empiric antibiotic recommendations for neonatal units in resource-limited settings.	[Reddy, Kessendri; Whitelaw, Andrew C.] Stellenbosch Univ, Div Med Microbiol & Immunol, Dept Pathol, Fac Med & Hlth Sci, Cape Town, South Africa; [Bekker, Adrie] Stellenbosch Univ, Div Neonatol, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, Cape Town, South Africa; [Esterhuizen, Tonya M.] Stellenbosch Univ, Div Epidemiol & Biostat, Dept Global Hlth, Fac Med & Hlth Sci, Cape Town, South Africa; [Dramowski, Angela] Stellenbosch Univ, Div Paediat Infect Dis, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, Cape Town, South Africa	Stellenbosch University; University of Cape Town; Stellenbosch University; Stellenbosch University; Stellenbosch University	Reddy, K (corresponding author), Stellenbosch Univ, Div Med Microbiol & Immunol, Dept Pathol, Fac Med & Hlth Sci, Cape Town, South Africa.	kessendri@yahoo.com		Whitelaw, Andrew/0000-0001-9070-5247; Reddy, Kessendri/0000-0002-6701-9764	National Health Laboratory Services Tygerberg; US National Institutes of Health (NIH) Fogarty Emerging Global Leader Award [K43 TW010682]; South African Medical Research Council	National Health Laboratory Services Tygerberg; US National Institutes of Health (NIH) Fogarty Emerging Global Leader Award; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	No funding was specifically sought for the purposes of this study. This study was supported by National Health Laboratory Services Tygerberg. AD is supported by a US National Institutes of Health (NIH) Fogarty Emerging Global Leader Award K43 TW010682 and receives funding for neonatal infection research from the South African Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Taiar A, 2013, ARCH DIS CHILD-FETAL, V98, pF249, DOI 10.1136/archdischild-2012-301767; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; [Anonymous], 2012, REC MAN COMM CHILDH; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; Bianchi-Jassir F, 2020, VACCINE, V38, P6682, DOI 10.1016/j.vaccine.2020.08.052; Boghossian NS, 2013, J PEDIATR-US, V162, P1120, DOI 10.1016/j.jpeds.2012.11.089; Cailes B, 2018, ARCH DIS CHILD-FETAL, V103, pF474, DOI 10.1136/archdischild-2017-313238; Centre for Disease Control and Prevention and the National Healthcare Safety Network, 2017, CDC NHSN BLOODSTREAM; Chik, 2020, SUSTAINABLE DEV GOAL; Dorrington R, 2012, POPULATION PROJECTIO; Dramowski A, 2015, PAEDIATR INT CHILD H, V35, P265, DOI 10.1179/2046905515Y.0000000029; Giannoni E, 2018, J PEDIATR-US, V201, P106, DOI 10.1016/j.jpeds.2018.05.048; Gkentzi D, 2019, ARCH DIS CHILD-FETAL, V104, pF293, DOI 10.1136/archdischild-2018-315024; Gowda H, 2017, PEDIATR INFECT DIS J, V36, P883, DOI 10.1097/INF.0000000000001568; Guo JF, 2019, MED SCI MONITOR, V25, P2296, DOI 10.12659/MSM.912375; Hammoud MS, 2017, INT J INFECT DIS, V55, P125, DOI 10.1016/j.ijid.2017.01.006; Humphries RM, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/jcm.00203-19, 10.1128/JCM.00203-19]; Kabwe M, 2016, PEDIATR INFECT DIS J, V35, pE191, DOI 10.1097/INF.0000000000001154; Kayange N, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-39; Kishk Rania Mohammed, 2014, Int J Microbiol, V2014, P276873, DOI 10.1155/2014/276873; Korang SK, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-1207-1; Labi AK, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1913-4; Lim N L, 1995, Med J Malaysia, V50, P59; Madide A, 2016, SAMJ S AFR MED J, V106, P36, DOI [10.7196/SAMJ.2016.v106i4.10206, 10.7196/samj.2016.v106i4.10206]; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Magobo RE, 2017, MYCOSES, V60, P320, DOI 10.1111/myc.12596; Malik A, 2001, Indian Pediatr, V38, P68; Nouetchognou Julienne Stephanie, 2016, BMC Res Notes, V9, P94, DOI 10.1186/s13104-016-1923-8; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Ogundare E, 2019, AFR HEALTH SCI, V19, P2390, DOI 10.4314/ahs.v19i3.12; Orsi GB, 2009, AM J INFECT CONTROL, V37, P201, DOI 10.1016/j.ajic.2008.05.009; Paul H, 2008, RETHINK HIST, V12, P75, DOI 10.1080/13642520701838884; Ramirez MS, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.PLAS-0016-2013; Rothe C, 2013, J HOSP INFECT, V85, P257, DOI 10.1016/j.jhin.2013.09.008; Sankar MJ, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5314; Shane AL, 2017, LANCET, V390, P1770, DOI 10.1016/S0140-6736(17)31002-4; Snyman Y, 2020, INT J INFECT DIS, V91, P94, DOI 10.1016/j.ijid.2019.11.021; Softic Izeta, 2017, Acta Med Acad, V46, P7, DOI 10.5644/ama2006-124.181; Thomas R, 2018, J INFECT DEV COUNTR, V12, P211, DOI 10.3855/jidc.9543; Tiskumara R, 2009, ARCH DIS CHILD-FETAL, V94, pF144, DOI 10.1136/adc.2008.139865; Tsai MH, 2014, PEDIATR INFECT DIS J, V33, pE7, DOI 10.1097/INF.0b013e3182a72ee0; United Nations, 2019, LEV TRENDS CHILD MOR; van der Zwet WC, 2005, J HOSP INFECT, V61, P300, DOI 10.1016/j.jhin.2005.03.014; van Schalkwyk E, 2019, EMERG INFECT DIS, V25, P1698, DOI 10.3201/eid2509.190040; Verstraete EH, 2016, EUR J PEDIATR, V175, P943, DOI 10.1007/s00431-016-2726-6; Wasserman S, 2017, SAMJ S AFR MED J, V107, P405, DOI [10.7196/SAMJ.2017.v107i5.12370, 10.7196/samj.2017.v107i5.12370]; WHO, 2011, WHO LIB CAT PUBL DAT; Wu JH, 2009, PEDIATR NEONATOL, V50, P88, DOI 10.1016/S1875-9572(09)60042-5; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X; Zea-Vera A, 2015, J TROP PEDIATRICS, V61, P1, DOI 10.1093/tropej/fmu079; Zingg W, 2008, CURR OPIN INFECT DIS, V21, P228, DOI 10.1097/QCO.0b013e3282fcec5f	51	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245089	10.1371/journal.pone.0245089	http://dx.doi.org/10.1371/journal.pone.0245089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444334	Green Published, gold			2022-12-26	WOS:000609988100059
J	Rout, AK; Acharya, V; Maharana, D; Dehury, B; Udgata, SR; Jena, R; Behera, B; Parida, PK; Behera, BK				Rout, Ajaya Kumar; Acharya, Varsha; Maharana, Diptimayee; Dehury, Budheswar; Udgata, Sheela Rani; Jena, Rajkumar; Behera, Bhaskar; Parida, Pranaya Kumar; Behera, Bijay Kumar			Insights into structure and dynamics of extracellular domain of Toll-like receptor 5 in Cirrhinus mrigala (mrigala): A molecular dynamics simulation approach	PLOS ONE			English	Article							RECOGNITION; FISH; EXPRESSION; LIGANDS; CLONING; EVOLUTION; FLAGELLIN; PROTEINS; BACTERIA; BINDING	The toll-like receptor 5 (TLR5) is the most conserved important pattern recognition receptors (PRRs) often stimulated by bacterial flagellins and plays a major role in the first-line defense against invading pathogenic bacteria and in immune homeostasis. Experimental crystallographic studies have shown that the extracellular domain (ECD) of TLR5 recognizes flagellin of bacteria and functions as a homodimer in model organism zebrafish. However, no structural information is available on TLR5 functionality in the major carp Cirrhinus mrigala (mrigala) and its interaction with bacterial flagellins. Therefore, the present study was undertaken to unravel the structural basis of TLR5-flagellin recognition in mrigala using structural homodimeric TLR5-flagellin complex of zebrafish as reference. Integrative structural modeling and molecular dynamics simulations were employed to explore the structural and mechanistic details of TLR5 recognition. Results from structural snapshots of MD simulation revealed that TLR5 consistently formed close interactions with the three helices of the D1 domain in flagellin on its lateral side mediated by several conserved amino acids. Results from the intermolecular contact analysis perfectly substantiate with the findings of per residue-free energy decomposition analysis. The differential recognition mediated by flagellin to TLR5 in mrigala involves charged residues at the interface of binding as compared to the zebrafish complex. Overall our results shows TLR5 of mrigala involved in innate immunity specifically recognized a conserved site on flagellin which advocates the scientific community to explore host-specific differences in receptor activation.	[Rout, Ajaya Kumar; Acharya, Varsha; Maharana, Diptimayee; Parida, Pranaya Kumar; Behera, Bijay Kumar] ICAR Cent Inland Fisheries Res Inst, Aquat Environm Biotechnol & Nanotechnol AEBN Div, Kolkata, W Bengal, India; [Dehury, Budheswar] Tech Univ Denmark, Dept Chem, Lyngby, Denmark; [Udgata, Sheela Rani] Odisha Univ Agr & Technol, Dept Bioinformat, Bhubaneswar, Odisha, India; [Jena, Rajkumar; Behera, Bhaskar] Fakir Mohan Univ, Dept Biosci & Biotechnol, Balasore, Odisha, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Inland Fisheries Research Institute; Technical University of Denmark; Orissa University of Agriculture & Technology; Fakir Mohan University	Parida, PK; Behera, BK (corresponding author), ICAR Cent Inland Fisheries Res Inst, Aquat Environm Biotechnol & Nanotechnol AEBN Div, Kolkata, W Bengal, India.	pranayaparida@gmail.com; beherabk18@yahoo.co.in	Behera, Bijay Kumar/AAU-3873-2021; Rout, Ajaya Kumar/ABE-8780-2021; Jena, Rajkumar/AAZ-8812-2021; Behera, Bijay Kumar/AGZ-8213-2022	Behera, Bijay Kumar/0000-0003-4960-9768; Rout, Ajaya Kumar/0000-0002-4128-9133; Behera, Bijay Kumar/0000-0003-4960-9768; Jena, Rajkumar/0000-0002-3242-5746				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alegre R, 2007, MOL IMMUNOL, V44, P2426, DOI 10.1016/j.molimm.2006.10.017; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Andersen-Nissen E, 2007, J EXP MED, V204, P393, DOI 10.1084/jem.20061400; Beatson SA, 2006, TRENDS MICROBIOL, V14, P151, DOI 10.1016/j.tim.2006.02.008; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chang JS, 2009, VET IMMUNOL IMMUNOP, V127, P94, DOI 10.1016/j.vetimm.2008.09.026; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Das BK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40323-0; David CC, 2014, METHODS MOL BIOL, V1084, P193, DOI 10.1007/978-1-62703-658-0_11; Dehury B, 2021, J CELL BIOCHEM, V122, P69, DOI 10.1002/jcb.29832; Dehury B, 2021, J BIOMOL STRUCT DYN, V39, P7231, DOI 10.1080/07391102.2020.1802348; Dehury B, 2020, J BIOMOL STRUCT DYN, V38, P3196, DOI 10.1080/07391102.2019.1655481; Dehury B, 2017, J MOL GRAPH MODEL, V71, P154, DOI 10.1016/j.jmgm.2016.11.012; Dehury B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097852; Dikhit MR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32040-x; Dikhit MR, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01763; Dubey PK, 2012, J APPL ANIM RES, V40, P17, DOI 10.1080/09712119.2011.620247; Faber E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29371-0; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Hollingsworth SA, 2018, NEURON, V99, P1129, DOI 10.1016/j.neuron.2018.08.011; Huang KF, 2020, NANOSCALE, V12, P10737, DOI 10.1039/c9nr10638c; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang SD, 2010, FISH SHELLFISH IMMUN, V29, P630, DOI 10.1016/j.fsi.2010.06.011; Ishii A, 2007, J IMMUNOL, V178, P397, DOI 10.4049/jimmunol.178.1.397; Ivicak-Kocjan K, 2013, BIOCHEM BIOPH RES CO, V435, P40, DOI 10.1016/j.bbrc.2013.04.030; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kongchum P, 2011, FISH SHELLFISH IMMUN, V30, P361, DOI 10.1016/j.fsi.2010.11.012; Kumar R, 2019, EUR J MED CHEM, V182, DOI 10.1016/j.ejmech.2019.111602; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Leifer CA, 2014, IMMUNOL LETT, V162, P3, DOI 10.1016/j.imlet.2014.07.017; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Liang YS, 2018, FISH SHELLFISH IMMUN, V74, P309, DOI 10.1016/j.fsi.2017.12.054; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Maharana J, 2014, MOL BIOSYST, V10, P2942, DOI 10.1039/c4mb00212a; Maki-Yonekura S, 2010, NAT STRUCT MOL BIOL, V17, P417, DOI 10.1038/nsmb.1774; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Mikami T, 2012, GENE, V503, P235, DOI 10.1016/j.gene.2012.04.007; Ng ACY, 2011, P NATL ACAD SCI USA, V108, P4631, DOI 10.1073/pnas.1000093107; Palti Y, 2011, DEV COMP IMMUNOL, V35, P1263, DOI 10.1016/j.dci.2011.03.006; Rogerson P, 2011, J MATH CHEM, V49, P1493, DOI 10.1007/s10910-011-9825-4; Rout AK, 2019, J CELL BIOCHEM, V120, P12534, DOI 10.1002/jcb.28519; Rout AK, 2020, J BIOMOL STRUCT DYN, V38, P3687, DOI 10.1080/07391102.2019.1666742; Rout AK, 2019, J CELL BIOCHEM, V120, P9437, DOI 10.1002/jcb.28219; Rout AK, 2018, J MOL GRAPH MODEL, V81, P175, DOI 10.1016/j.jmgm.2018.02.002; Roy P, 2019, INT J BIOL MACROMOL, V136, P1258, DOI [10.1016/j.ijbiomac.2019.06.161, 10.1016/j.ijbiomac2019.06.161]; Sahoo BR, 2020, INT J BIOL MACROMOL, V161, P1602, DOI 10.1016/j.ijbiomac.2020.07.293; Samanta M, 2014, APPL BIOCHEM BIOTECH, V174, P309, DOI 10.1007/s12010-014-1058-0; Samanta M, 2012, FISH SHELLFISH IMMUN, V32, P411, DOI 10.1016/j.fsi.2011.11.029; Sepulcre MP, 2009, J IMMUNOL, V182, P1836, DOI 10.4049/jimmunol.0801755; Sharma V, 2020, MOL BIOL EVOL, V37, P1847, DOI 10.1093/molbev/msaa058; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Song WS, 2017, SCI REP-UK, V7, DOI 10.1038/srep40878; Tahoun A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17935-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Uenishi H, 2009, DEV COMP IMMUNOL, V33, P353, DOI 10.1016/j.dci.2008.06.001; Voogdt CGP, 2018, P NATL ACAD SCI USA, V115, pE3221, DOI 10.1073/pnas.1719245115; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wang EC, 2019, CHEM REV, V119, P9478, DOI 10.1021/acs.chemrev.9b00055; Wang YJ, 2016, DEV COMP IMMUNOL, V61, P25, DOI 10.1016/j.dci.2016.03.005; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yonekura K, 2002, RES MICROBIOL, V153, P191, DOI 10.1016/S0923-2508(02)01308-6; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584; Zhang J, 2014, FISH SHELLFISH IMMUN, V41, P380, DOI 10.1016/j.fsi.2014.09.022	73	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245358	10.1371/journal.pone.0245358	http://dx.doi.org/10.1371/journal.pone.0245358			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444377	Green Published, gold			2022-12-26	WOS:000609988100086
J	Watts, BD; Truitt, BR				Watts, Bryan D.; Truitt, Barry R.			Influence of introduced peregrine falcons on the distribution of red knots within a spring staging site	PLOS ONE			English	Article							SEMIPALMATED SANDPIPERS; RAPTOR PREDATION; ATLANTIC COAST; BODY STORES; POPULATION; MIGRATION; SHOREBIRDS; DECLINE; RECRUITMENT; DYNAMICS	Predator recovery driven by single-species management approaches may lead to conservation conflicts between recovered predators and prey species of conservation concern. As part of an aggressive recovery plan, the Eastern Peregrine Falcon Recovery Team released (1975-1985) 307 captive-reared peregrine falcons (Falco peregrinus) and successfully established a breeding population within the mid-Atlantic Coastal Plain, a physiographic region with no historic breeding population and a critical spring staging area for migratory shorebirds. We examined the influence of resident falcons on the distribution of foraging red knots during spring migration. We conducted weekly aerial surveys (2006-2009) along the Virginia barrier islands during the spring staging period (25 April- 6 June) to map foraging red knots (Calidris canutus) and evaluated the influence of proximity (0-3, 3-6, >6 km) of beaches to active peregrine falcon nests on knot density (birds/km). Accumulated use of beaches throughout the season by red knots was significantly influenced by proximity of beaches to active falcon nests such that mean density was more than 6 fold higher on beaches that were >6 km compared to beaches that were only 0-3 km from active eyries. Whether or not an eyrie was used in a given year had a significant influence on the use of associated close (0-3 km) beaches. From 6.5 to 64 fold more knots used beaches when associated eyries were not active compared to when they were active depending on the specific site. Historically, red knots and other migratory shorebirds would have enjoyed a peregrine-free zone within this critical staging site. The establishment of a dense breeding population of falcons within the area represents a new hazard for the knot population.	[Watts, Bryan D.] William & Mary, Ctr Conservat Biol, Williamsburg, VA 23185 USA; [Truitt, Barry R.] Virginia Coast Reserve, Nat Conservancy Virginia, Nassawadox, VA USA	Nature Conservancy	Watts, BD (corresponding author), William & Mary, Ctr Conservat Biol, Williamsburg, VA 23185 USA.	bdwatt@wm.edu		Watts, Bryan/0000-0001-8244-6951	Virginia Department of Game & Inland Fisheries [755311, 755741, 756121, 756441]	Virginia Department of Game & Inland Fisheries	B.W. was awarded contracts #755311, #755741, #756121 and #756441 to monitor peregrine falcon population (2006-2009) by the Virginia Department of Game & Inland Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, CMS APP 1; [Anonymous], 1969, PEREGRINE FALCON POP; Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; Barclay J.H., 1988, P549; Berger D. D., 1969, P165; BIJLSMA RG, 1990, ARDEA, V78, P75; Boettcher R, 2016, J RAPTOR RES, V50, P313, DOI 10.3356/JRR-15-72.1; Bollengier Jr. RM, 1979, E PEREGRINE FALCON R; Burger J, 2013, URBAN ECOSYST, V16, P657, DOI 10.1007/s11252-012-0269-9; Burger J, 2012, CONDOR, V114, P302, DOI 10.1525/cond.2012.110077; Cade TJ, 2003, RETURN PEREGRINE N A, P73; Cardoso RS, 2003, MAR BIOL, V142, P153, DOI 10.1007/s00227-002-0926-2; Clark K, 2018, PEREGRINE FALCON RES; CLARK KE, 1993, CONDOR, V95, P694, DOI 10.2307/1369612; Cohen JB, 2009, J WILDLIFE MANAGE, V73, P939, DOI 10.2193/2008-042; COSEWIC, 2011, CAN WILDL SPEC RISK; CRESSWELL W, 1994, IBIS, V136, P223, DOI 10.1111/j.1474-919X.1994.tb01088.x; Dekker D, 2011, WATERBIRDS, V34, P195, DOI 10.1675/063.034.0208; Dolan J, 1988, J COASTAL RES, V3, P245; DOLAN R, 1979, GEOLOGY, V7, P602, DOI 10.1130/0091-7613(1979)7<602:SERATM>2.0.CO;2; Dunne P., 1982, RECORDS NEW JERSEY B, V8, P68; Harrington Brian, 1996, FLIGHT RED KNOT; Heller EL, 2020, THESIS; Jenkins AR, 1998, J RAPTOR RES, V32, P90; Lank DB, 2003, OIKOS, V103, P303, DOI 10.1034/j.1600-0706.2003.12314.x; Lissimore Darren, 1999, Wader Study Group Bulletin, V88, P55; Long E. C., 2009, THESIS; MacKinnon CM, 2008, CAN FIELD NAT, V122, P274, DOI 10.22621/cfn.v122i3.616; Marshall KN, 2016, CONSERV LETT, V9, P70, DOI 10.1111/conl.12186; Middleton AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0870; Morrison RIG, 2007, J AVIAN BIOL, V38, P479, DOI 10.1111/j.2007.0908-8857.03934.x; Morrison RIG, 2004, AUK, V121, P333, DOI 10.1642/0004-8038(2004)121[0333:UOBSIS]2.0.CO;2; Morrison RIG, 2004, CONDOR, V106, P60; Nebel S, 2005, BEHAV ECOL SOCIOBIOL, V59, P44, DOI 10.1007/s00265-005-0007-x; NEWELL RIE, 1982, BIOL BULL, V162, P299, DOI 10.2307/1540985; Niles LJ., 2008, STUD AVIAN BIOL, V36, P1; PAGE G, 1975, CONDOR, V77, P73, DOI 10.2307/1366760; Piersma T, 2003, IBIS, V145, P565, DOI 10.1046/j.1474-919X.2003.00178.x; Pomeroy AC, 2008, AVIAN CONSERV ECOL, V3; Porri F, 2006, J EXP MAR BIOL ECOL, V332, P178, DOI 10.1016/j.jembe.2005.11.008; Quinn JL, 1997, IBIS, V139, P170, DOI 10.1111/j.1474-919X.1997.tb04517.x; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; SLOCOMBE DS, 1993, BIOSCIENCE, V43, P612, DOI 10.2307/1312148; Slocombe DS, 1998, ENVIRON MANAGE, V22, P483, DOI 10.1007/s002679900121; Smith F.M, 2008, CTR CONSERVATION BIO; Smith FM, 2014, CTR CONSERVATION BIO, VCCBTR-14-04; STEIDL R. J., 1997, NO WILDLIFE, V52, P11; Thirgood S, 2000, CONSERV BIOL, V14, P95, DOI 10.1046/j.1523-1739.2000.99013.x; U.S. Fish and Wildlife Service, 2020, SPEC STAT ASS REP RU; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; van den Hout PJ, 2017, BEHAV ECOL, V28, P419, DOI 10.1093/beheco/arw173; Watts BD, 2017, WADER STUDY, V124, P1; Watts BD, 2001, THE RAVEN, V71, P1; Watts BD, 2018, CTR CONSERVATION BIO, VCCBTR-18-14; Watts Bryan D., 2018, Ornis Hungarica, V26, P104; Watts BD, 2015, J RAPTOR RES, V49, P359, DOI 10.3356/rapt-49-04-359-366.1; Watts BD, 2015, J WILDLIFE MANAGE, V79, P288, DOI 10.1002/jwmg.828; Watts BD, 2011, WATERBIRDS, V34, P347, DOI 10.1675/063.034.0308; Williams R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026738; Ydenberg RC, 2004, P ROY SOC B-BIOL SCI, V271, P1263, DOI 10.1098/rspb.2004.2713; Ydenberg RC, 2002, J AVIAN BIOL, V33, P47, DOI 10.1034/j.1600-048X.2002.330108.x; Ydenberg RC, 2007, J AVIAN BIOL, V38, P523, DOI 10.1111/j.2007.0908-8857.04202.x; Ydenberg RC, 2017, OECOLOGIA, V183, P1101, DOI 10.1007/s00442-017-3835-2; Ydenberg Ronald C., 2010, BMC Ecology, V10, P1, DOI 10.1186/1472-6785-10-1	64	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0244459	10.1371/journal.pone.0244459	http://dx.doi.org/10.1371/journal.pone.0244459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444364	gold, Green Published			2022-12-26	WOS:000609988100029
J	Lednicky, J; Salemi, M; Subramaniam, K; Waltzek, TB; Sabo-Attwood, T; Loeb, JC; Hentschel, S; Tagliamonte, MS; Marini, S; Alam, MM; Stephenson, CJ; Elbadry, M; Morris, JG				Lednicky, John; Salemi, Marco; Subramaniam, Kuttichantran; Waltzek, Thomas B.; Sabo-Attwood, Tara; Loeb, Julia C.; Hentschel, Shannon; Tagliamonte, Massimiliano S.; Marini, Simone; Alam, Md. Mahbubul; Stephenson, Caroline J.; Elbadry, Maha; Morris, J. Glenn, Jr.			Earliest detection to date of SARS-CoV-2 in Florida: Identification together with influenza virus on the main entry door of a university building, February 2020	PLOS ONE			English	Article							CONTAMINATION	In February and March, 2020, environmental surface swab samples were collected from the handle of the main entry door of a major university building in Florida, as part of a pilot surveillance project screening for influenza. Samples were taken at the end of regular classroom hours, between the dates of February 1-5 and February 19-March 4, 2020. Influenza A(H1N1)pdm09 virus was isolated from the door handle on four of the 19 days sampled. Both SARS-CoV-2 and A(H1N1)pdm09 virus were detected in a sample collected on February 21, 2020. Based on sequence analysis, the Florida SARS-CoV-2 strain (designated UF-11) was identical to strains being identified in Washington state during the same time period, while the earliest similar sequences were sampled in China/Hubei between Dec 30(th) 2019 and Jan 5(th) 2020. The first human case of COVID-19 was not officially reported in Florida until March 1(st). In an analysis of sequences from COVID-19 patients in this region of Florida, there was only limited evidence of subsequent dissemination of the UF-11 strain. Identical or highly similar strains, possibly related through a common transmission chain, were detected with increasing frequency in Washington state between end of February and beginning of March. Our data provide further documentation of the rapid early spread of SARS-CoV-2 and underscore the likelihood that closely related strains were cryptically circulating in multiple U.S. communities before the first "official" cases were recognized.	[Lednicky, John; Salemi, Marco; Subramaniam, Kuttichantran; Waltzek, Thomas B.; Sabo-Attwood, Tara; Loeb, Julia C.; Hentschel, Shannon; Tagliamonte, Massimiliano S.; Marini, Simone; Alam, Md. Mahbubul; Stephenson, Caroline J.; Elbadry, Maha; Morris, J. Glenn, Jr.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Lednicky, John; Sabo-Attwood, Tara; Loeb, Julia C.; Hentschel, Shannon; Alam, Md. Mahbubul; Stephenson, Caroline J.; Elbadry, Maha] Univ Florida, Dept Environm & Global Hlth, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Salemi, Marco; Tagliamonte, Massimiliano S.; Marini, Simone] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Subramaniam, Kuttichantran; Waltzek, Thomas B.] Univ Florida, Coll Vet Med, Dept Infect Dis & Immunol, Gainesville, FL USA; [Marini, Simone] Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Morris, J. Glenn, Jr.] Univ Florida, Coll Med, Dept Med, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Morris, JG (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.; Morris, JG (corresponding author), Univ Florida, Coll Med, Dept Med, Gainesville, FL 32611 USA.	jgmorris@epi.ufl.edu	Waltzek, Thomas/AHD-3209-2022	Subramaniam, Kuttichantran/0000-0002-2752-4467; Tagliamonte, Massimiliano/0000-0003-2699-7331; Marini, Simone/0000-0002-5704-3533; Sabo-Attwood, Tara/0000-0002-1968-6802	Clinical and Translational Science Institute, University of Florida	Clinical and Translational Science Institute, University of Florida	Work was funded in part by an internal grant from the Clinical and Translational Science Institute, University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shmuel A, 2020, CLIN MICROBIOL INFEC, V26, P1658, DOI 10.1016/j.cmi.2020.09.004; D'accolti M, 2020, EUR REV MED PHARMACO, V24, P9202, DOI 10.26355/eurrev_202009_22872; European Centre for Disease Prevention and Control, 2020, INFL VIR CHAR SUMM E; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Iovine NM, 2015, EMERG INFECT DIS, V21, P664, DOI 10.3201/eid2104.141375; Jorden MA, 2020, MMWR-MORBID MORTAL W, V69, P680, DOI 10.15585/mmwr.mm6922e1; Lednicky JA, 2020, AEROSOL AIR QUAL RES, V20, P1167, DOI [10.4209/aaqr.2020.05.0202, 10.4209/aaqr.2020.02.0202]; Lednickya JA, 2020, INT J INFECT DIS, V100, P476, DOI [10.1016/j.ijid.2020.09.025, 10.1101/2020.08.03.20167395]; Liu Y-C, BIOMEDICAL J, DOI 10/1016/j/bj.2020.04.007; Memish ZA, 2014, AM J INFECT CONTROL, V42, P1266, DOI 10.1016/j.ajic.2014.07.027; Nakamura T, 2018, BIOINFORMATICS, V34, P2490, DOI 10.1093/bioinformatics/bty121; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Pastorino B, 2020, EMERG INFECT DIS, V26, P2256, DOI 10.3201/eid2609.201788; Rife Magalis B, DIFFERING IMPACTS GL; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; U.S. Centers for Disease Control, DUR IS PREC AD COVID; U.S. Centers for Disease Control, US VIR SURV WEEK 14; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; World Health Organization, PROT 1 WHO COLL CTR; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	21	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0245352	10.1371/journal.pone.0245352	http://dx.doi.org/10.1371/journal.pone.0245352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439885	Green Published, gold, Green Submitted			2022-12-26	WOS:000609985300048
J	Lenz, OK; Riegel, W; Wilde, V				Lenz, Olaf K.; Riegel, Walter; Wilde, Volker			Greenhouse conditions in lower Eocene coastal wetlands?-Lessons from Schoningen, Northern Germany	PLOS ONE			English	Article							PALEOCENE THERMAL MAXIMUM; MIDDLE EOCENE; VEGETATION DYNAMICS; CARBON INJECTION; PEAT SWAMP; LAND-USE; BOUNDARY; PALEOECOLOGY; CHARCOAL; ORIGIN	The Paleogene succession of the Helmstedt Lignite Mining District in Northern Germany includes coastal peat mire records from the latest Paleocene to the middle Eocene at the southern edge of the Proto-North Sea. Therefore, it covers the different long- and short-term climate perturbations of the Paleogene greenhouse. 56 samples from three individual sections of a lower Eocene seam in the record capture the typical succession of the vegetation in a coastal wetland during a period that was not affected by climate perturbation. This allows facies-dependent vegetational changes to be distinguished from those that were climate induced. Cluster analyses and NMDS of well-preserved palynomorph assemblages reveal four successional stages in the vegetation during peat accumulation: (1) a coastal vegetation, (2) an initial mire, (3) a transitional mire, and (4) a terminal mire. Biodiversity measures show that plant diversity decreased significantly in the successive stages. The highly diverse vegetation at the coast and in the adjacent initial mire was replaced by low diversity communities adapted to wet acidic environments and nutrient deficiency. The palynomorph assemblages are dominated by elements such as Alnus (Betulaceae) or Sphagnum (Sphagnaceae). Typical tropical elements which are characteristic for the middle Eocene part of the succession are missing. This indicates that a more warm-temperate climate prevailed in northwestern Germany during the early lower Eocene.	[Lenz, Olaf K.] Senckenberg Soc Nat Res, Gen Directorate, Frankfurt, Germany; [Riegel, Walter; Wilde, Volker] Senckenberg Res Inst, Dept Palaeontol & Hist Geol, Frankfurt, Germany; [Riegel, Walter; Wilde, Volker] Nat Hist Museum, Frankfurt, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN)	Lenz, OK (corresponding author), Senckenberg Soc Nat Res, Gen Directorate, Frankfurt, Germany.	olaf.lenz@senckenberg.de		Lenz, Olaf K./0000-0002-0958-7982	Deutsche Forschungsgemeinschaft [DFG LE 2376/4-1]; Open Access Fund of the Leibniz Association	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Fund of the Leibniz Association	This study was supported by the Deutsche Forschungsgemeinschaft in the form of a grant (DFG LE 2376/4-1, https://www.dfg.de/) awarded to OL. This study was also supported in the form of funding by the Open Access Fund of the Leibniz Association.	AHRENDT H., 1995, Z DTSCH GEOLOGISCHEN, V146, P450, DOI DOI 10.1127/ZDGG/146/1995/450; [Anonymous], 2012, NEUROGASTROENTEROL M, V24, pe147; [Anonymous], 2007, C2 SOFTWARE ECOLOGIC; [Anonymous], 1977, PALAEONTOGR ABT B; [Anonymous], 2020, LANCET MICROBE, V1, pe99, DOI 10.1016/S2666-5247(20)30054-9; [Anonymous], 1962, P YORKSHIRE GEOLOGIC, DOI DOI 10.1144/PYGS.33.4.423; [Anonymous], 1999, REVUE DROIT PUBLIC S, V2, P315; Bains S, 2000, NATURE, V407, P171, DOI 10.1038/35025035; Baldschuhn R., 1996, GEOL JB A, V153, P1; Beck J, 2013, METHODS ECOL EVOL, V4, P370, DOI 10.1111/2041-210x.12023; Benson Doug, 2012, Cunninghamia, V12, P267, DOI 10.7751/cunninghamia.2012.12.021; Birks HJB, 2016, REV PALAEOBOT PALYNO, V228, P1, DOI 10.1016/j.revpalbo.2015.12.011; Blumenstengel H., 2008, GEOLOGIE SACHSEN ANH, P267; BORSCH T, 2000, POLLEN SPORES MORPHO, P285; Bowen GJ, 2002, SCIENCE, V295, P2062, DOI 10.1126/science.1068700; Box EO, 2015, BASICS METHODS CASE, P225; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Broothaerts N, 2014, QUATERNARY SCI REV, V102, P96, DOI 10.1016/j.quascirev.2014.08.006; Bujak JP, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P277; Campbell E. O., 1983, ECOSYSTEMS WORLD MIR, V4B, P153; Campbell EO, 1964, T ROYAL SOC NZ, V2, P219; Campbell EO, 1975, P NZ ECOLOGICAL SOC, V22, P57; Clark JS, 1998, HOLOCENE, V8, P19, DOI 10.1191/095968398672501165; CLARK JS, 1988, QUATERNARY RES, V30, P67, DOI 10.1016/0033-5894(88)90088-9; Clarkson BR, 2004, WETLANDS, V24, P133, DOI 10.1672/0277-5212(2004)024[0133:VAPCIT]2.0.CO;2; Clyde WC, 1998, GEOLOGY, V26, P1011, DOI 10.1130/0091-7613(1998)026<1011:MCRTTL>2.3.CO;2; CLYMO RS, 1984, PHILOS T R SOC B, V303, P605, DOI 10.1098/rstb.1984.0002; Cohen A. D., 1975, GEOSCI MAN, V11, P123, DOI [10.1080/00721395.1975.9989761, DOI 10.1080/00721395.1975.9989761]; COHEN AD, 1974, J SEDIMENT PETROL, V44, P716; Cohen AD, 1974, SE GEOLOGY, V15, P141; Cohen AD, 1984, OKEFENOKEE SWAMP ITS, P493; Collinson M.E., 2003, GEOLOGICAL SOC AM SP, V369, P333, DOI DOI 10.1130/0-8137-2369-8.333; Collinson ME, 2009, GRANA, V48, P38, DOI 10.1080/00173130802707980; Collinson ME, 1983, FIELD GUIDES FOSSILS, V1; Colwell R. K., 2013, ESTIMATESS STAT ESTI; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Cottam G., 1978, ORDINATION PLANT COM, V5 -2, P185, DOI [10.1007/978-94-009-7989-5_7, DOI 10.1007/978-94-009-7989-5_7]; Cramer BS, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000909; Crouch EM, 2001, GEOLOGY, V29, P315, DOI 10.1130/0091-7613(2001)029<0315:GDEAWT>2.0.CO;2; CYPERT EUGENE, 1961, AMER MIDLAND NAT, V66, P485, DOI 10.2307/2423049; Dai SF, 2020, INT J COAL GEOL, V219, DOI 10.1016/j.coal.2019.103383; Daly RJ, 2015, PALAEOGEOGR PALAEOCL, V418, P141, DOI 10.1016/j.palaeo.2014.10.014; Daubenmire RF., 1978, PLANT GEOGRAPHY SPEC; Dickens GR, 2001, GEOL SOC SPEC PUBL, V183, P293, DOI 10.1144/GSL.SP.2001.183.01.14; Eldrett JS, 2014, CLIM PAST, V10, P759, DOI 10.5194/cp-10-759-2014; Ellison AM, 2010, ECOLOGY, V91, P1962, DOI 10.1890/09-1692.1; Ewel K.C., 1990, P281; Fairfax R, 2019, MIRES PEAT, V24, DOI 10.19189/MaP.2018.OMB.369; Fralish JS, 2002, EXCLUDING MEXICO SUB; Garel S, 2013, PALAEOGEOGR PALAEOCL, V376, P184, DOI 10.1016/j.palaeo.2013.02.035; Gastaldo R.A., 1994, SEDIMENTATION ORGANI, P103; Gastaldo RA, 1999, PALAEOGEOGR PALAEOCL, V149, P1, DOI 10.1016/S0031-0182(98)00188-6; Gastaldo RA, 1993, MODERN ANCIENT COAL, V286, P107; GAUCH HG, 1980, VEGETATIO, V40, P147; Ghilardi B, 2013, BOREAS, V42, P623, DOI 10.1111/j.1502-3885.2012.00292.x; Gotelli N. J., 2010, BIOL DIVERSITY FRONT; GRAMANN F, 1975, Newsletters on Stratigraphy, V4, P71; GREENWOOD DR, 1994, REV PALAEOBOT PALYNO, V81, P83, DOI 10.1016/0034-6667(94)90128-7; Grimsson F, 2016, GRANA, V55, P101, DOI 10.1080/00173134.2015.1096566; Gurs K, 2005, NEWSL STRATIGR, V41, P313, DOI 10.1127/0078-0421/2005/0041-0313; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; Hamilton DB, 1984, OKEFENOKEE SWAMP ITS, P86; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hammer-Schiemann G., 1998, THESIS; Haq B. U., 1988, SOC ECON PALEONT MIN, V42, P71, DOI DOI 10.2110/PEC.88.01.0071; Harrington G. J., 2003, GEOLOGICAL SOC AM SP, P381, DOI DOI 10.1130/0-8137-2369-8.381; Harrington GJ, 2001, PALAIOS, V16, P266, DOI 10.2307/3515604; Harrington GJ, 2007, J GEOL SOC LONDON, V164, P323, DOI 10.1144/0016-76492006-027; HEILMANN-CLAUSEN C, 1985, Bulletin of the Geological Society of Denmark, V33, P287; Heilmann-Clausen C, 2020, P GEOLOGIST ASSOC, V131, P450, DOI 10.1016/j.pgeola.2018.06.001; Hofmann Christa-Charlotte, 2001, Palaeontographica Abteilung B Palaeophytologie, V259, P47; Holdgate G, 2016, INT J COAL GEOL, V166, P47, DOI 10.1016/j.coal.2016.05.010; Houston DT, 2016, EUROPEAN ATLAS FORES, pe01ff87; Iakovleva AI, 2001, PALAEOGEOGR PALAEOCL, V172, P243, DOI 10.1016/S0031-0182(01)00300-5; Inglis GN, 2017, EARTH PLANET SC LETT, V460, P86, DOI 10.1016/j.epsl.2016.12.009; Inglis GN, 2015, PALAEOGEOGR PALAEOCL, V438, P245, DOI 10.1016/j.palaeo.2015.08.001; Innes JB, 2000, PALAEOGEOGR PALAEOCL, V164, P151, DOI 10.1016/S0031-0182(00)00184-X; Ivanov D., 1999, ACTA PALAEOBOT S, V2, P307; Iversen J, 1989, J BIOGEOGR; Izlar RL, 1984, OKEFENOKEE SWAMP ITS, P70; Jaramillo C, 2010, SCIENCE, V330, P957, DOI 10.1126/science.1193833; Jardine PE, 2008, PALYNOLOGY, V32, P183; Kaiser ML, 1974, GEOLOGISCHES JB, V25, P85; Keen HF, 2014, PALAEOGEOGR PALAEOCL, V408, P48, DOI 10.1016/j.palaeo.2014.05.001; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Korasidis VA, 2020, PALAIOS, V35, P22, DOI 10.2110/palo.2019.073; Korasidis VA, 2019, PALAEOGEOGR PALAEOCL, V516, P35, DOI 10.1016/j.palaeo.2018.11.023; Kothe A., 2003, REV PALEOBIOLOGIE, V22, P895; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Krutzsch W., 1976, ABHANDLUNGEN ZENTRAL, V26, P47; Kurtz AC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000908; Laskar J, 2011, ASTRON ASTROPHYS, V532, DOI [10.1051/0004-6361/201116836, 10.1051/0004-6361/201117504]; Lenz OK, 2005, PALAEONTOGR ABT B, V271, P1; Lenz OK, 2001, FACIES, V45, P177, DOI 10.1007/BF02668111; Lenz O, 2021, GRANA, V60, P97, DOI 10.1080/00173134.2020.1808697; Lenz OK, 2018, PALEOBIOLOGY, V44, P709, DOI 10.1017/pab.2018.25; Loftin CS, 2018, WETLANDS, V38, P819, DOI 10.1007/s13157-018-1033-6; Lourens LJ, 2005, NATURE, V435, P1083, DOI 10.1038/nature03814; Mai DH., 1995, TERTI RE VEGETATIONS; Mander L, 2010, P NATL ACAD SCI USA, V107, P15351, DOI 10.1073/pnas.1004207107; Manger G, 1952, MITTEILUNGEN GEOLOGI, V21, P7; Methner K, 2019, CLIM PAST, V15, P1741, DOI 10.5194/cp-15-1741-2019; MINCHIN PR, 1987, VEGETATIO, V69, P89, DOI 10.1007/BF00038690; Moore EA, 2008, PALAEOGEOGR PALAEOCL, V267, P147, DOI 10.1016/j.palaeo.2008.06.010; Moore P. D., 1987, GEOL SOC SPEC PUBL, V32, P7, DOI DOI 10.1144/GSL.SP.1987.032.01.02; Moshayedi M, 2020, PALAEOBIO PALAEOENV, V100, P951, DOI 10.1007/s12549-020-00425-4; Natlandsmyr B, 2016, FOREST ECOL MANAG, V372, P78, DOI 10.1016/j.foreco.2016.03.049; Nichols DJ, 1994, SEDIMENTATION ORGANI, P217; Nichols GJ, 2000, PALAEOGEOGR PALAEOCL, V164, P43, DOI 10.1016/S0031-0182(00)00174-7; Nickel B., 1996, MAINZ NATURWISS AR B, V18, P1; Oksanen J, 2005, MULTIVARIATE ANAL EC; Page SE, 2006, DEV EARTH S, V9, P145, DOI 10.1016/S0928-2025(06)09007-9; Page SE, 1999, PHILOS T R SOC B, V354, P1885, DOI 10.1098/rstb.1999.0529; Pflug H. D., 1986, NORDWESTDEUTSCHLAND, V18, P567; PFLUG HANS, 1952, PALAEONTOL ZEITSCHR, V26, P112; Phillips S, 1997, PALAEOGEOGR PALAEOCL, V128, P301, DOI 10.1016/S0031-0182(97)81129-7; Punt W, 2003, REV PALAEOBOT PALYNO, V123, P99, DOI 10.1016/S0034-6667(02)00157-4; Riegel W., 1999, ACTA PALAEOBOT, V2, P349; Riegel W, 2016, INT J COAL GEOL, V159, P57, DOI 10.1016/j.coal.2016.03.021; Riegel W, 2015, PALAIOS, V30, P304, DOI 10.2110/palo.2014.005; Riegel W, 2012, AUSTRIAN J EARTH SCI, V105, P88; Robson BE, 2015, PALAEOGEOGR PALAEOCL, V437, P53, DOI 10.1016/j.palaeo.2015.07.016; Rohl U, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001784; Rohl U, 2000, GEOLOGY, V28, P927, DOI 10.1130/0091-7613(2000)28<927:NCFTLP>2.0.CO;2; ROHL U, 2005, GEOL SOC AM ABSTR, V37, P264; Schneck T, 2006, THESIS; Scott AC, 2007, INT J COAL GEOL, V70, P53, DOI 10.1016/j.coal.2006.02.009; Scott AC, 2010, PALAEOGEOGR PALAEOCL, V291, P11, DOI 10.1016/j.palaeo.2009.12.012; Simpson MJA, 1996, ECON BOT, V50, P122, DOI 10.1007/BF02862118; Skene KR, 2000, J ECOL, V88, P1079, DOI 10.1046/j.1365-2745.2000.00522.x; Sluijs A, 2009, BIOGEOSCIENCES, V6, P1755, DOI 10.5194/bg-6-1755-2009; Sluijs A, 2006, NATURE, V441, P610, DOI 10.1038/nature04668; Sluijs A, 2007, NATURE, V450, P1218, DOI 10.1038/nature06400; Sluijs A, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004224; Sluijs A, 2009, NAT GEOSCI, V2, P777, DOI 10.1038/NGEO668; Smith A.H.V., 1968, COAL COAL BEARING ST, P31; Smith AHV, 1957, GEOLOGICAL MAGAZINE, V94, P345; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Spackman W, 1969, ENV COALD DEPOSITION, V114, P1; Standke G, 2008, Z DTSCH GES GEOWISS, V159, P81, DOI 10.1127/1860-1804/2008/0159-0081; TEICHMULLER M, 1989, INT J COAL GEOL, V12, P1, DOI 10.1016/0166-5162(89)90047-5; Teichmuller M, 1958, FORTSCHRITTE GEOLOGI, V2, P539; Ter Braak C. J. F., 1995, P29; THIELE-PFEIFFER H, 1988, Palaeontographica Abteilung B Palaeophytologie, V211, P1; THOMSON P. W., 1953, PALAEONTOGRAPHICA, V94 B., P1; Turner SK, 2014, NAT GEOSCI, V7, P748, DOI [10.1038/NGEO2240, 10.1038/ngeo2240]; VANBREEMEN N, 1995, TRENDS ECOL EVOL, V10, P270, DOI 10.1016/0169-5347(95)90007-1; Vogt W, 1981, FORTSCHRITTE GEOLOGI, V29, P73; Weijers JWH, 2007, EARTH PLANET SC LETT, V261, P230, DOI 10.1016/j.epsl.2007.06.033; Westerhold T, 2017, CLIM PAST, V13, P1129, DOI 10.5194/cp-13-1129-2017; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; Wilde V, 2008, TERRA NOSTRA, V2, P306; Willard DA, 2001, REV PALAEOBOT PALYNO, V113, P213, DOI 10.1016/S0034-6667(00)00042-7; Williams GL, 2015, PALYNOLOGY, V39, P289, DOI 10.1080/01916122.2014.993888; Wing S.L., 2000, WARM CLIMATES EARTH, P197; Wing SL, 2013, AM J BOT, V100, P1234, DOI 10.3732/ajb.1200554; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zachos JC, 2010, EARTH PLANET SC LETT, V299, P242, DOI 10.1016/j.epsl.2010.09.004; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110; Zeebe RE, 2019, SCIENCE, V365, P926, DOI 10.1126/science.aax0612; Zetter R., 2001, OSTERREICHISCHE AKAD, V14, P473; Ziegler P. A., 1990, GEOLOGICAL ATLAS W C	165	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0232861	10.1371/journal.pone.0232861	http://dx.doi.org/10.1371/journal.pone.0232861			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439859	Green Published, gold, Green Submitted			2022-12-26	WOS:000609985300021
J	Vatsyayan, A; Sharma, P; Gupta, S; Sandhu, S; Venu, SL; Sharma, V; Badaoui, B; Azedine, K; Youssef, S; Rajab, A; Fayez, A; Madinur, S; Ranawat, A; Pandhare, K; Ramachandran, S; Sivasubbu, S; Scaria, V				Vatsyayan, Aastha; Sharma, Parul; Gupta, Shrey; Sandhu, Sumiti; Venu, Seetha Lakshmi; Sharma, Vandana; Badaoui, Bouabid; Azedine, Kaidi; Youssef, Serti; Rajab, Anna; Fayez, Alaaeldin; Madinur, Seema; Ranawat, Anop; Pandhare, Kavita; Ramachandran, Srinivasan; Sivasubbu, Sridhar; Scaria, Vinod			DALIA- a comprehensive resource of Disease Alleles in Arab population	PLOS ONE			English	Article							GENETIC-DISORDERS; GENOME PROJECT; DATABASE	The Arab population encompasses over 420 million people characterized by genetic admixture and a consequent rich genetic diversity. A number of genetic diseases have been reported for the first time from the population. Additionally a high prevalence of some genetic diseases including autosomal recessive disorders such as hemoglobinopathies and familial mediterranean fever have been found in the population and across the region. There is a paucity of databases cataloguing genetic variants of clinical relevance from the population. The availability of such a catalog could have implications in precise diagnosis, genetic epidemiology and prevention of disease. To fill in the gap, we have compiled DALIA, a comprehensive compendium of genetic variants reported in literature and implicated in genetic diseases reported from the Arab population. The database aims to act as an effective resource for population-scale and sub-population specific variant analyses, enabling a ready reference aiding clinical interpretation of genetic variants, genetic epidemiology, as well as facilitating rapid screening and a quick reference for evaluating evidence on genetic diseases.	[Vatsyayan, Aastha; Ranawat, Anop; Pandhare, Kavita; Ramachandran, Srinivasan; Sivasubbu, Sridhar; Scaria, Vinod] CSIR, Inst Genom & Integrat Biol CSIR IGIB, Delhi, India; [Vatsyayan, Aastha] Amity Univ, Noida, India; [Sharma, Parul; Gupta, Shrey] Indraprastha Inst Informat Technol Delhi IIIT D, Delhi, India; [Sandhu, Sumiti] Amity Univ, Jaipur, Rajasthan, India; [Venu, Seetha Lakshmi] ACBR, Delhi, India; [Sharma, Vandana] Univ Delhi, Kalindi Coll, New Delhi, India; [Badaoui, Bouabid; Azedine, Kaidi; Youssef, Serti] Mohammed V Univ, Rabat, Morocco; [Rajab, Anna] Minist Hlth, Natl Genet Ctr, Muscat, Oman; [Fayez, Alaaeldin] Natl Res Ctr, Human Genet & Genome Res Div, Ctr Excellence Human Genet, Cairo, Egypt; [Ramachandran, Srinivasan; Sivasubbu, Sridhar; Scaria, Vinod] Acad Sci & Innovat Res AcSIR, Ghaziabad, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Amity University Noida; Indraprastha Institute of Information Technology Delhi; University of Delhi; Mohammed V University in Rabat; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Academy of Scientific & Innovative Research (AcSIR)	Scaria, V (corresponding author), CSIR, Inst Genom & Integrat Biol CSIR IGIB, Delhi, India.; Scaria, V (corresponding author), Acad Sci & Innovat Res AcSIR, Ghaziabad, India.	vinods@igib.in	Scaria, Vinod/AAS-3151-2021; Badaoui, Bouabid/AAV-8968-2021; Fayez, Alaaeldin/N-7181-2018	Scaria, Vinod/0000-0001-7644-7181; Fayez, Alaaeldin/0000-0003-3433-3033	Council of Scientific and Industrial Research, India; Indian Council for Medical Research	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Indian Council for Medical Research(Indian Council of Medical Research (ICMR))	The work was funded by the Council of Scientific and Industrial Research, India [RareGen Grant]. The funding body had no role in the preparation of the manuscript or decision to publish. AV acknowledges a Senior Research Fellowship from the Indian Council for Medical Research.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Al Rajeh S, 2001, SEIZURE-EUR J EPILEP, V10, P410, DOI 10.1053/seiz.2001.0602; Al-Ali M, 2018, J HUM GENET, V63, P533, DOI 10.1038/s10038-017-0402-y; Al-Dewik N, 2019, AM J MED GENET A, V179, P927, DOI 10.1002/ajmg.a.61126; Al-Gazali L, 2006, BMJ-BRIT MED J, V333, P831, DOI 10.1136/bmj.38982.704931.AE; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2020, ARAB COUNTRIES; [Anonymous], 2019, TR2195 3GPP; Danial-Farran N, 2018, EUR J HUM GENET, V26, P1840, DOI 10.1038/s41431-018-0218-z; El-Hazmi Mohsen A F, 2011, Indian J Med Res, V134, P597, DOI 10.4103/0971-5916.90984; Fakhro Khalid A, 2016, Hum Genome Var, V3, P16016, DOI 10.1038/hgv.2016.16; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hariprakash JM, 2018, DATABASE-OXFORD, DOI 10.1093/database/bay080; Jithesh PV, 2017, PERS MED, V14, DOI 10.2217/pme-2017-0048; Karczewski K.J., 2019, GENOMICS, DOI [10.1101/531210, DOI 10.1101/531210]; Klomek AB, 2016, SOC PSYCH PSYCH EPID, V51, P869, DOI 10.1007/s00127-016-1219-2; Koshy R, 2017, J HUM GENET, V62, P889, DOI 10.1038/jhg.2017.67; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Mokdad AH, 2014, LANCET, V383, P309, DOI 10.1016/S0140-6736(13)62189-3; Nakouzi G, 2015, J COMMUN GENET, V6, P83, DOI 10.1007/s12687-014-0203-3; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Rani J, 2015, J BIOSCIENCES, V40, P671, DOI 10.1007/s12038-015-9552-2; Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, pD886, DOI 10.1093/nar/gky1016; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Saudi Genome Project Team, 2015, IEEE PULSE, V6, P22, DOI 10.1109/MPUL.2015.2476541; Scott EM, 2016, NAT GENET, V48, P1071, DOI 10.1038/ng.3592; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sivadas A, 2018, PHARMACOGENOMICS J, V18, P590, DOI 10.1038/s41397-018-0022-8; Tadmouri GO, 2006, NUCLEIC ACIDS RES, V34, pD602, DOI 10.1093/nar/gkj015; Tadmouri Ghazi O, 2014, Glob Cardiol Sci Pract, V2014, P394, DOI 10.5339/gcsp.2014.54; Tadmouri Ghazi O, 2009, Reprod Health, V6, P17, DOI 10.1186/1742-4755-6-17; Teebi AS, 2002, HUM MUTAT, V19, P615, DOI 10.1002/humu.10082; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; Yousri NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-01972-9; Zayed H, 2016, INT J CLIN PRACT, V70, P832, DOI 10.1111/ijcp.12871	36	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0244567	10.1371/journal.pone.0244567	http://dx.doi.org/10.1371/journal.pone.0244567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439861	Green Published, gold			2022-12-26	WOS:000609985300011
J	Kamieniarz, A; Michalska, J; Marszalek, W; Stania, M; Slomka, KJ; Gorzkowska, A; Juras, G; Okun, MS; Christou, EA				Kamieniarz, Anna; Michalska, Justyna; Marszalek, Wojciech; Stania, Magdalena; Slomka, Kajetan J.; Gorzkowska, Agnieszka; Juras, Grzegorz; Okun, Michael S.; Christou, Evangelos A.			Detection of postural control in early Parkinson's disease: Clinical testing vs. modulation of center of pressure	PLOS ONE			English	Article							SWAY; INDIVIDUALS; INSTABILITY; MOBILITY; ENTROPY; SCALE; STATE; RISK; GO	Introduction Little is known about the early stage balance changes in PD. Many clinicians assume that there are no postural issues in early PD because of failure to identify them on bedside and clinical testing. Here, we quantify balance changes in early and moderate stage PD and compared these values to healthy controls (HC) using clinical assessments of balance and posturography. Methods We compared 15 HC with 15 early PD (PD-II; Hoehn and Yahr stage II) and 15 moderate PD (PD-III; H&Y stage III). Participants performed various clinical tests of balance and a standing postural task on a force platform. We quantified the spatiotemporal parameters of the center of pressure (COP), the sample entropy and power spectral density (PSD) of the COP. Results The PSD of the COP differentiated PD-II from HC from 0-0.5 Hz and PD-II from PD-III from 0.5-1 Hz. Specifically, PD-II and PD-III manifested greater power than HC from 0-0.5 Hz, whereas PD-III exhibited greater power than PD-II and HC from 0.5-1.0 Hz (p<0.05). However, there were no significant differences between PD-II and HC in all clinical tests and in spatiotemporal parameters of the COP (p>0.05). Although the sample entropy was significantly lower in the PD groups (p<0.05), entropy failed to differentiate PD-II from PD-III. Conclusion The low-frequency modulation of the COP in this small cohort differentiated early PD from HC and from moderate PD. Clinicians should be aware that there are early balance deficits in PD. A larger sample size is needed to confirm these findings.	[Kamieniarz, Anna; Michalska, Justyna; Marszalek, Wojciech; Stania, Magdalena; Slomka, Kajetan J.; Juras, Grzegorz] Acad Phys Educ, Inst Sport Sci, Katowice, Poland; [Gorzkowska, Agnieszka] Med Univ Silesia, Fac Med Sci Katowice, Dept Neurorehabil, Katowice, Poland; [Okun, Michael S.; Christou, Evangelos A.] Univ Florida, Dept Neurol, Norman Fixel Inst Neurol Dis, Gainesville, FL USA; [Christou, Evangelos A.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA	Medical University Silesia; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kamieniarz, A (corresponding author), Acad Phys Educ, Inst Sport Sci, Katowice, Poland.	a.kamieniarz@awf.katowice.pl	Słomka, Kajetan J/W-5167-2018	Słomka, Kajetan J/0000-0001-8447-4251; Kamieniarz, Anna/0000-0002-2678-8436; Michalska, Justyna/0000-0001-8650-0484; Marszalek, Wojciech/0000-0003-3780-1090; Okun, Michael/0000-0002-6247-9358; Juras, Grzegorz/0000-0001-8081-8854	Institute of Sport Science, Academy of Physical Education in Katowice	Institute of Sport Science, Academy of Physical Education in Katowice	The study was supported by the statutory funds of Institute of Sport Science, Academy of Physical Education in Katowice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkin AL, 2003, MOVEMENT DISORD, V18, P496, DOI 10.1002/mds.10396; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; Barbieri FA, 2016, HUM MOVEMENT SCI, V46, P96, DOI 10.1016/j.humov.2015.12.009; Behrman AL, 2002, ARCH PHYS MED REHAB, V83, P538, DOI 10.1053/apmr.2002.30934; BERG K, 1989, Physiotherapy Canada, V41, P304; Beuter A, 2008, CAN J NEUROL SCI, V35, P65, DOI 10.1017/S0317167100007575; Blaszczyk JW, 2007, EXP BRAIN RES, V183, P107, DOI 10.1007/s00221-007-1024-y; BLASZCZYK JW, 1993, GAIT POSTURE, V1, P211, DOI 10.1016/0966-6362(93)90048-6; Borg FG, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-38; Chastan N, 2008, MOVEMENT DISORD, V23, P366, DOI 10.1002/mds.21840; Demura S, 2008, PERCEPT MOTOR SKILL, V106, P307, DOI 10.2466/PMS.106.1.307-316; DICHGANS J, 1976, AGRESSOLOGIE, V17, P15; Donker SF, 2008, EXP BRAIN RES, V184, P363, DOI 10.1007/s00221-007-1105-y; Ferdjallah M, 1999, GAIT POSTURE, V10, P129, DOI 10.1016/S0966-6362(99)00023-5; Ferrazzoli D, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/520128; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox EJ, YOUNG, V25, P30; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Kamieniarz A, 2018, CLIN INTERV AGING, V13, P2301, DOI 10.2147/CIA.S180894; Kanekar N, 2014, J NEUROSCI METH, V222, P91, DOI 10.1016/j.jneumeth.2013.10.020; Kegelmeyer DA, 2007, PHYS THER, V87, P1369, DOI 10.2522/ptj.20070007; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; MARTINEZMARTIN P, 1994, MOVEMENT DISORD, V9, P76, DOI 10.1002/mds.870090112; Mirahmadi M, 2018, EUR NEUROL, V80, P261, DOI 10.1159/000497041; Morris M, 2000, GAIT POSTURE, V12, P205, DOI 10.1016/S0966-6362(00)00076-X; NJIOKIKTJIEN C, 1978, AGRESSOLOGIE, V19, P87; Nnodim J.O., 2015, J GERIATR MED GERONT, V1, DOI [10.23937/2469-5858/1510003, DOI 10.23937/2469-5858/1510003]; Oppenheim U, 1999, DIABETES CARE, V22, P328, DOI 10.2337/diacare.22.2.328; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Rezvanian S, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18041102; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rocchi L, 2006, NEUROSCI LETT, V394, P140, DOI 10.1016/j.neulet.2005.10.020; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Stylianou AP, 2011, INT J NEUROSCI, V121, P614, DOI 10.3109/00207454.2011.602807; Thenganatt MA, 2014, JAMA NEUROL, V71, P499, DOI 10.1001/jamaneurol.2013.6233; TINETTI ME, 1986, AM J MED, V80, P429, DOI 10.1016/0002-9343(86)90717-5; Vieira TMM, 2009, BRAZ J MED BIOL RES, V42, P665, DOI 10.1590/S0100-879X2009000700012; Watanabe T, 2019, GAIT POSTURE, V68, P187, DOI 10.1016/j.gaitpost.2018.11.026; Zampieri C, 2010, J NEUROL NEUROSUR PS, V81, P171, DOI 10.1136/jnnp.2009.173740; Zirek E, 2018, NEUROL SCI, V39, P2151, DOI 10.1007/s10072-018-3564-2	43	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245353	10.1371/journal.pone.0245353	http://dx.doi.org/10.1371/journal.pone.0245353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434235	Green Published, gold			2022-12-26	WOS:000609979700041
J	Seeland, M; Mader, P				Seeland, Marco; Maeder, Patrick			Multi-view classification with convolutional neural networks	PLOS ONE			English	Article								Humans' decision making process often relies on utilizing visual information from different views or perspectives. However, in machine-learning-based image classification we typically infer an object's class from just a single image showing an object. Especially for challenging classification problems, the visual information conveyed by a single image may be insufficient for an accurate decision. We propose a classification scheme that relies on fusing visual information captured through images depicting the same object from multiple perspectives. Convolutional neural networks are used to extract and encode visual features from the multiple views and we propose strategies for fusing these information. More specifically, we investigate the following three strategies: (1) fusing convolutional feature maps at differing network depths; (2) fusion of bottleneck latent representations prior to classification; and (3) score fusion. We systematically evaluate these strategies on three datasets from different domains. Our findings emphasize the benefit of integrating information fusion into the network rather than performing it by post-processing of classification scores. Furthermore, we demonstrate through a case study that already trained networks can be easily extended by the best fusion strategy, outperforming other approaches by large margin.	[Seeland, Marco; Maeder, Patrick] Tech Univ Ilmenau, Inst Comp & Syst Engn, Ilmenau, Germany	Technische Universitat Ilmenau	Seeland, M (corresponding author), Tech Univ Ilmenau, Inst Comp & Syst Engn, Ilmenau, Germany.	marco.seeland@tu-ilmenau.de	Mäder, Patrick/A-1848-2018	Mäder, Patrick/0000-0001-6871-2707	German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB) [3514685C19, 3519685]; German Ministry of Education and Research (BMBF) [01LC1319, 01IS20062]; Stiftung Naturschutz Thuringen (SNT) [SNT-082-248-03/2014]; Open Access Publication Fund of the Technische Universitat Ilmenau; Thuringian Ministry for Environment, Energy and Nature Conservation grant [68678]	German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Stiftung Naturschutz Thuringen (SNT); Open Access Publication Fund of the Technische Universitat Ilmenau; Thuringian Ministry for Environment, Energy and Nature Conservation grant	We are funded by the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB) grants: 3514685C19, 3519685; the German Ministry of Education and Research (BMBF) grants: 01LC1319, 01IS20062; the Thuringian Ministry for Environment, Energy and Nature Conservation grant: 68678; and the Stiftung Naturschutz Thuringen (SNT) grant: SNT-082-248-03/2014. We acknowledge support for the publication costs by the Open Access Publication Fund of the Technische Universitat Ilmenau.	Abadi M, 2016, ACM SIGPLAN NOTICES, V51, P1, DOI [10.1145/2951913.2976746, 10.1145/3022670.2976746]; Barbosa A, 2020, P IEEE CVF C COMP VI; Boho D, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03920-9; California Academy of Sciences, 2019, ANTWEB; Chollet F, 2016, KERAS, DOI DOI 10.1038/NATURE083580; Dolata P, 2017, APPL ARTIF INTELL, V31, P643, DOI 10.1080/08839514.2018.1428491; Feichtenhofer C, 2016, PROC CVPR IEEE, P1933, DOI 10.1109/CVPR.2016.213; Feng YF, 2018, PROC CVPR IEEE, P264, DOI 10.1109/CVPR.2018.00035; Geras K. J., 2017, 170307047 ARXIV, P1; Goeau H., 2016, P CLEF C LABS EVALUA, P428; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hofmann M, 2019, INT J COMPUT VISION, V127, P207, DOI 10.1007/s11263-018-1093-3; Juocas L, 2019, INT J ADV MANUF TECH, V102, P3217, DOI 10.1007/s00170-019-03407-9; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee SH, 2018, IEEE T IMAGE PROCESS, V27, P4287, DOI 10.1109/TIP.2018.2836321; Li S, 2018, PATTERN RECOGN, V81, P294, DOI 10.1016/j.patcog.2018.03.035; Li YM, 2019, IEEE T KNOWL DATA EN, V31, P1863, DOI 10.1109/TKDE.2018.2872063; Lin CH, 2018, PATTERN RECOGN, V83, P314, DOI 10.1016/j.patcog.2018.05.004; Lin M, 2013, COMPUT SCI; Marques ACR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192011; Muzammil SR, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10110904; Ortega E., 2020, CASENT0281563; Polap D, 2019, IEEE ACCESS, V7, P149355, DOI 10.1109/ACCESS.2019.2947354; Polap D, 2018, INF TECHNOL CONTROL, V47, P691, DOI 10.5755/j01.itc.47.4.21602; Razavian AS, 2014, IEEE COMPUT SOC CONF, P512, DOI 10.1109/CVPRW.2014.131; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Seeland M, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-018-2474-x; Setio AAA, 2016, IEEE T MED IMAGING, V35, P1160, DOI 10.1109/TMI.2016.2536809; Su H, 2015, IEEE I CONF COMP VIS, P945, DOI 10.1109/ICCV.2015.114; Do TB, 2017, INT CONF KNOWL SYS, P191, DOI 10.1109/KSE.2017.8119457; Waldchen J, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005993; Wang AR, 2015, IEEE I CONF COMP VIS, P1125, DOI 10.1109/ICCV.2015.134; Yang LJ, 2015, PROC CVPR IEEE, P3973, DOI 10.1109/CVPR.2015.7299023; Zemgulys J, 2020, J AMB INTEL HUM COMP, V11, P979, DOI 10.1007/s12652-019-01209-1; Zoph B, 2018, PROC CVPR IEEE, P8697, DOI 10.1109/CVPR.2018.00907	36	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245230	10.1371/journal.pone.0245230	http://dx.doi.org/10.1371/journal.pone.0245230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434208	gold, Green Published			2022-12-26	WOS:000609979700039
J	Gamage, SD; Ross, N; Kralovic, SM; Simbartl, LA; Roselle, GA; Berkelman, RL; Chamberlain, AT				Gamage, Shantini D.; Ross, Natasha; Kralovic, Stephen M.; Simbartl, Loretta A.; Roselle, Gary A.; Berkelman, Ruth L.; Chamberlain, Allison T.			Health after Legionnaires' disease: A description of hospitalizations up to 5 years after Legionella pneumonia	PLOS ONE			English	Article								Background and objectives Research on Legionnaires' Disease (LD) suggests there may be long-term health complications, but data are limited. This study investigated whether Intensive Care Unit (ICU) admission during LD hospitalization may be associated with adverse health outcomes and characterized subsequent discharge diagnoses in patients with LD up to 5 years post-LD. Methods We conducted a retrospective case series study with follow up for 5 years among patients hospitalized at a Department of Veterans Affairs (VA) Medical Center between 2005 and 2010 with LD. Data were collected from medical records on health history, LD severity (including ICU admission), and discharge diagnoses for 5 years post-LD or until death. We used ordinal logistic regression to explore associations between ICU admission and hospitalizations post-LD. Frequency counts were used to determine the most prevalent discharge diagnoses in the 5 years post-LD. Results For the 292 patients with laboratory-confirmed LD, those admitted to the ICU during LD hospitalization were more likely to have a greater number of hospitalizations within 5 years compared to non-ICU patients (ORHosp 1.92 CI95% 1.25, 2.95). Fifty-five percent (161/292) had >= 1 hospitalization within 5 years post-LD. After accounting for pre-existing diagnosis codes in patients with at least one hospitalization in the 2 years prior to LD (n = 77/161 patients, 47.8%), three of the four most frequent new diagnoses in the 5 years post-LD were non-chronic conditions: acute renal failure (n = 22, 28.6%), acute respiratory failure (n = 17, 22.1%) and unspecified pneumonia (n = 15, 19.5%). Conclusions Our findings indicate that LD requiring ICU admission is associated with more subsequent hospitalizations, a factor that could contribute to poorer future health for people with severe LD. In addition to chronic conditions prevalent in this study population, we found new diagnoses in the 5-year post-LD period including acute renal failure. With LD incidence increasing, more research is needed to understand conditions and factors that influence long term health after LD.	[Gamage, Shantini D.; Kralovic, Stephen M.; Simbartl, Loretta A.; Roselle, Gary A.] US Dept Vet Affairs, Natl Infect Dis Serv, Specialty Care Serv, Vet Hlth Adm, Washington, DC USA; [Gamage, Shantini D.; Kralovic, Stephen M.; Roselle, Gary A.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Infect Dis, Cincinnati, OH USA; [Ross, Natasha; Berkelman, Ruth L.; Chamberlain, Allison T.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Kralovic, Stephen M.; Roselle, Gary A.] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH USA; [Ross, Natasha] Emory Healthcare, Off Qual, Atlanta, GA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Ohio; University of Cincinnati; Emory University; Rollins School Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Emory University	Chamberlain, AT (corresponding author), Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	Allison.chamberlain@emory.edu		Chamberlain, Allison/0000-0001-6009-537X				Ajayi OO, 2017, AM J MED SCI, V353, P445, DOI 10.1016/j.amjms.2017.03.002; Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; Amodeo MR, 2010, CLIN MICROBIOL INFEC, V16, P1405, DOI 10.1111/j.1469-0691.2009.03125.x; BAKER PCH, 1981, J NEUROL NEUROSUR PS, V44, P1054, DOI 10.1136/jnnp.44.11.1054; Brown SH, 2003, INT J MED INFORM, V69, P135, DOI 10.1016/S1386-5056(02)00131-4; Buxbaum JD, 2019, HEALTH SERV RES, V54, P1326, DOI 10.1111/1475-6773.13207; CARLIER B, 1981, ACTA CLIN BELG, V36, P12; Cassini A, IMPACT INFECT DIS PO; Centers for Disease Control and Prevention, 2019, NAT NOT DIS SURV SYS; CHASTRE J, 1987, CHEST, V91, P57, DOI 10.1378/chest.91.1.57; Cho J, 2016, J AM GERIATR SOC, V64, P1250, DOI 10.1111/jgs.14161; Coronel D, 2016, THER APHER DIAL, V20, P686, DOI 10.1111/1744-9987.12421; Cunha BA, 2016, LANCET, V387, P376, DOI 10.1016/S0140-6736(15)60078-2; Daumas Aurelie, 2012, J Med Case Rep, V6, P100, DOI 10.1186/1752-1947-6-100; Department of Veterans Affairs Office of Inspector General, 2013, HEALTHC INSP PREV LE; Gamage SD, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0230; Gupta Samir, 2018, EGEMS (Wash DC), V6, P4, DOI 10.5334/egems.198; Hellwege JN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11704-w; Hicks Lauri A., 2011, Morbidity and Mortality Weekly Report, V60, P1083; Hou JK, 2014, DIGEST DIS SCI, V59, P2406, DOI 10.1007/s10620-014-3174-7; Jonkers RE, 2004, CLIN INFECT DIS, V38, P605, DOI 10.1086/381199; Kheirbek RE, 2017, J AM GERIATR SOC, V65, P2100, DOI 10.1111/jgs.14900; Lettinga KD, 2002, CLIN INFECT DIS, V35, P11, DOI 10.1086/340738; National Academies of Sciences Engineering and Medicine, 2019, MANAGEMENT LEGIONELL, DOI [10.17226/25474, DOI 10.17226/25474]; Neil K, 2008, CLIN INFECT DIS, V47, P591, DOI 10.1086/590557; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; PEARSON SB, 1981, POSTGRAD MED J, V57, P109, DOI 10.1136/pgmj.57.664.109; Peterson R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132664; POULTER N, 1981, CLIN NEPHROL, V15, P216; RELMAN AS, 1978, NEW ENGL J MED, V298, P1014, DOI 10.1056/NEJM197805042981810; Sutarjono B, 2019, BMJ CASE REP, V12, DOI 10.1136/bcr-2019-229243; Sutton SS, 2019, CTS-CLIN TRANSL SCI, V12, P698, DOI 10.1111/cts.12676; Thakar CV, 2009, CRIT CARE MED, V37, P2552, DOI 10.1097/CCM.0b013e3181a5906f; Valley TS, 2015, JAMA-J AM MED ASSOC, V314, P1272, DOI 10.1001/jama.2015.11068; van Loenhout JAF, 2014, J INFECTION, V68, P527, DOI 10.1016/j.jinf.2014.01.004; Viasus D, 2013, MEDICINE, V92, P51, DOI 10.1097/MD.0b013e31827f6104; Villa P, 2016, J AM GERIATR SOC, V64, P536, DOI 10.1111/jgs.14031; Wilson NJ, 1997, HEALTH AFFAIR, V16, P200, DOI 10.1377/hlthaff.16.4.200; Wingfield T, 2013, CLIN MED, V13, P152, DOI 10.7861/clinmedicine.13-2-152; Yende S, 2007, J AM GERIATR SOC, V55, P518, DOI 10.1111/j.1532-5415.2007.01100.x; Yogarajah Meera, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-208367	41	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0245262	10.1371/journal.pone.0245262	http://dx.doi.org/10.1371/journal.pone.0245262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY4UJ	33428684	gold, Green Published			2022-12-26	WOS:000630036100049
J	Garneret, P; Coz, E; Martin, E; Manuguerra, JC; Brient-Litzler, E; Enouf, V; Obando, DFG; Olivo-Marin, JC; Monti, F; van der Werf, S; Vanhomwegen, J; Tabeling, P				Garneret, Pierre; Coz, Etienne; Martin, Elian; Manuguerra, Jean-Claude; Brient-Litzler, Elodie; Enouf, Vincent; Obando, Daniel Felipe Gonzalez; Olivo-Marin, Jean-Christophe; Monti, Fabrice; van der Werf, Sylvie; Vanhomwegen, Jessica; Tabeling, Patrick			Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification	PLOS ONE			English	Article							PAPER; DEVICE; BLOOD; DNA	To respond to the urgent need for COVID-19 testing, countries perform nucleic acid amplification tests (NAAT) for the detection of SARS-CoV-2 in centralized laboratories. Real-time RT-PCR (Reverse transcription-Polymerase Chain Reaction), used to amplify and detect the viral RNA., is considered, as the current gold standard for diagnostics. It is an efficient process, but the complex engineering required for automated RNA extraction and temperature cycling makes it incompatible for use in point of care settings [1]. In the present work, by harnessing progress made in the past two decades in isothermal amplification and paper microfluidics, we created a portable test, in which SARS-CoV-2 RNA is extracted, amplified isothermally by RT-LAMP (Loop-mediated Isothermal Amplification), and detected using intercalating dyes or fluorescent probes. Depending on the viral load in the tested samples, the detection takes between twenty minutes and one hour. Using a set of 16 pools of nasopharyngal swab eluates, we estimated a limit of detection comparable to real-time RT-PCR (i.e. 1 genome copies per microliter of clinical sample) and no cross-reaction with eight major respiratory viruses currently circulating in Europe. We designed and fabricated an easy-to-use portable device called "COVIDISC" to carry out the test at the point of care. The low cost of the materials along with the absence of complex equipment will expedite the widespread dissemination of this device. What is proposed here is a new efficient tool to help managing the pandemics.	[Garneret, Pierre; Coz, Etienne; Martin, Elian; Monti, Fabrice; Tabeling, Patrick] IPGG, CBI, ESPCI PSL, Paris, France; [Manuguerra, Jean-Claude; Brient-Litzler, Elodie; Enouf, Vincent; Obando, Daniel Felipe Gonzalez; Olivo-Marin, Jean-Christophe; van der Werf, Sylvie; Vanhomwegen, Jessica] Inst Pasteur, Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tabeling, P (corresponding author), IPGG, CBI, ESPCI PSL, Paris, France.	patrick.tabeling@espci.fr		Gonzalez Obando, Daniel Felipe/0000-0002-5964-3057	IPGG platform [ANR-10-EQPX-34]; Carnot Pasteur Maladies Infectieuses program [ANR 11-CARN 017-01, ANR20-COVI-000]; FONDS ESPCI	IPGG platform; Carnot Pasteur Maladies Infectieuses program; FONDS ESPCI	IPGG platform (ANR-10-EQPX-34) (PT, PG,EC,EM), Carnot Pasteur Maladies Infectieuses program (ANR 11-CARN 017-01) (JV,JCM), ANR20-COVI-000 (EB,JV,JCM,PT,EM,C), FONDS ESPCI (EC). he funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball CS, 2016, ANAL CHEM, V88, P3562, DOI 10.1021/acs.analchem.5b04054; Bartolone SN, 2018, JOVE-J VIS EXP, DOI 10.3791/58436; Bhadra S, 2020, HIGH SURETY ISOTHERM; Bhakta SA, 2014, ANAL CHIM ACTA, V809, P117, DOI 10.1016/j.aca.2013.11.044; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Carrilho E, 2009, ANAL CHEM, V81, P7091, DOI 10.1021/ac901071p; Carter C, 2017, J VIROL METHODS, V244, P32, DOI 10.1016/j.jviromet.2017.02.013; Connelly JT, 2015, ANAL CHEM, V87, P7595, DOI 10.1021/acs.analchem.5b00411; Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432; Gonzales JL, 2020, REVERSE TRANSCRIPTIO; Govindarajan AV, 2012, LAB CHIP, V12, P174, DOI 10.1039/c1lc20622b; Lamb LE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234682; Linnes JC, 2014, RSC ADV, V4, P42245, DOI 10.1039/c4ra07911f; Magro L, 2017, LAB CHIP, V17, P2347, DOI 10.1039/c7lc00013h; Magro L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00758-9; Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817; McFall SM, 2015, J VIROL METHODS, V214, P37, DOI 10.1016/j.jviromet.2015.01.005; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; OptiGene, 2017, LAMP USER GUIDE MAST; Pollock NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075616; Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778; Rabe BA, 2020, SARS COV 2 DETECTION, V23, P2020; Reboud J, 2019, P NATL ACAD SCI USA, V116, P4834, DOI 10.1073/pnas.1812296116; Tang RH, 2017, LAB CHIP, V17, P1270, DOI 10.1039/c6lc01586g; Uehara M, 2016, ANAL SCI, V32, P371, DOI 10.2116/analsci.32.371; Vella SJ, 2012, ANAL CHEM, V84, P2883, DOI 10.1021/ac203434x; WHO Coronavirus disease, WHO CORONAVIRUS DIS; World Health Organization (WHO), PROT REAL TIM RT PCR; Xu GL, 2016, ANGEW CHEM INT EDIT, V55, P15250, DOI 10.1002/anie.201606060; Yu L, 2020, ILACO MEDRXIV	32	17	18	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0243712	10.1371/journal.pone.0243712	http://dx.doi.org/10.1371/journal.pone.0243712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428641	Green Published, gold			2022-12-26	WOS:000630036100013
J	Wang, X; Ma, QJ				Wang, Xin; Ma, Qingjun			Wzb of Vibrio vulnificus represents a new group of low-molecular-weight protein tyrosine phosphatases with a unique insertion in the W-loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PHOSPHOTYROSYL PHOSPHATASE; MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; PHOSPHORYLATION; REFINEMENT; INSIGHTS; KINASES; MPTPA	Protein tyrosine phosphorylation regulates the production of capsular polysaccharide, an essential virulence factor of the deadly pathogen Vibrio vulnificus. The process requires the protein tyrosine kinase Wzc and its cognate phosphatase Wzb, both of which are largely uncharacterized. Herein, we report the structures of Wzb of V. vulnificus (VvWzb) in free and ligand-bound forms. VvWzb belongs to the low-molecular-weight protein tyrosine phosphatase (LMWPTP) family. Interestingly, it contains an extra four-residue insertion in the W-loop, distinct from all known LMWPTPs. The W-loop of VvWzb protrudes from the protein body in the free structure, but undergoes significant conformational changes to fold toward the active site upon ligand binding. Deleting the four-residue insertion from the W-loop severely impaired the enzymatic activity of VvWzb, indicating its importance for optimal catalysis. However, mutating individual residues or even substituting the whole insertion with four alanine residues only modestly decreased the enzymatic activity, suggesting that the contribution of the insertion to catalysis is not determined by the sequence specificity. Furthermore, inserting the four residues into Escherichia coli Wzb at the corresponding position enhanced its activity as well, indicating that the four-residue insertion in the W-loop can act as a general activity enhancing element for other LMWPTPs. The novel W-loop type and phylogenetic analysis suggested that VvWzb and its homologs should be classified into a new group of LMWPTPs. Our study sheds new insight into the catalytic mechanism and structural diversity of the LMWPTP family and promotes the understanding of the protein tyrosine phosphorylation system in prokaryotes.	[Wang, Xin; Ma, Qingjun] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Wang, Xin; Ma, Qingjun] Pilot Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Wang, Xin; Ma, Qingjun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ma, Qingjun] Chinese Acad Sci, Ctr Ocean Megasci, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Ma, QJ (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.; Ma, QJ (corresponding author), Pilot Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Ma, QJ (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Ma, QJ (corresponding author), Chinese Acad Sci, Ctr Ocean Megasci, Qingdao, Peoples R China.	qma@qdio.ac.cn			Qingdao Innovation Leadership Program [18-1-2-12-zhc]; "Aoshan Talents Program" of the Pilot National Laboratory for Marine Science and Technology [2015ASTP]	Qingdao Innovation Leadership Program; "Aoshan Talents Program" of the Pilot National Laboratory for Marine Science and Technology	This work was supported by "Qingdao Innovation Leadership Program" (No. 18-1-2-12-zhc) and "Aoshan Talents Program" of the Pilot National Laboratory for Marine Science and Technology (No. 2015ASTP) to Q. M.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Baker-Austin C, 2018, ENVIRON MICROBIOL, V20, P423, DOI 10.1111/1462-2920.13955; Bechet E, 2009, AMINO ACIDS, V37, P499, DOI 10.1007/s00726-009-0237-8; Caselli A, 2016, BBA-PROTEINS PROTEOM, V1864, P1339, DOI 10.1016/j.bbapap.2016.07.001; Chao JD, 2014, J BIOL CHEM, V289, P9463, DOI 10.1074/jbc.R113.520015; Chatterjee S, 2019, BBA-PROTEINS PROTEOM, V1867, P114, DOI 10.1016/j.bbapap.2018.11.003; Chatzidaki-Livanis M, 2006, J BACTERIOL, V188, P1987, DOI 10.1128/JB.188.5.1987-1998.2006; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esser D, 2012, J PROTEOME RES, V11, P4823, DOI 10.1021/pr300190k; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fanzani L, 2015, CURR MED CHEM, V22, P3110, DOI 10.2174/0929867322666150812150036; Fouz B, 2006, J FISH DIS, V29, P285, DOI 10.1111/j.1365-2761.2006.00719.x; Getz LJ, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00205-19; Grangeasse C, 1997, GENE, V204, P259, DOI 10.1016/S0378-1119(97)00554-4; Grangeasse C, 2007, TRENDS BIOCHEM SCI, V32, P86, DOI 10.1016/j.tibs.2006.12.004; Hagelueken G, 2009, J MOL BIOL, V392, P678, DOI 10.1016/j.jmb.2009.07.026; Hansen AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003403; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hunter T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020644; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim R, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-24; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ku B, 2016, BIOCHEM BIOPH RES CO, V478, P1217, DOI 10.1016/j.bbrc.2016.08.097; Kumagai T, 2009, BIOCHEM BIOPH RES CO, V385, P534, DOI 10.1016/j.bbrc.2009.05.091; Lescop E, 2006, J BIOL CHEM, V281, P19570, DOI 10.1074/jbc.M601263200; Lori G, 2018, CANCER MED-US, V7, P1933, DOI 10.1002/cam4.1435; Madhurantakam C, 2005, J BACTERIOL, V187, P2175, DOI 10.1128/JB.187.6.2175-2181.2005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nadler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037984; Nath S, 2014, BIOCHEM BIOPH RES CO, V450, P390, DOI 10.1016/j.bbrc.2014.05.129; Petrova OE, 2012, P NATL ACAD SCI USA, V109, P16690, DOI 10.1073/pnas.1207832109; Pettis GS, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093259; Phippen BL, 2015, INFECT IMMUN, V83, P551, DOI 10.1128/IAI.02559-14; Raugei G, 2002, CELL MOL LIFE SCI, V59, P941, DOI 10.1007/s00018-002-8481-z; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sachdeva S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00070; Salomone-Stagni M, 2016, ACTA CRYSTALLOGR F, V72, P903, DOI 10.1107/S2053230X16018781; Sanchez-Rodriguez R, 2020, ARCH BIOCHEM BIOPHYS, V681, DOI 10.1016/j.abb.2020.108277; Schwechheimer C, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008745; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Stanford SM, 2017, NAT CHEM BIOL, V13, P624, DOI 10.1038/nchembio.2344; Stehle T, 2012, J BIOL CHEM, V287, P34569, DOI 10.1074/jbc.M112.399261; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Studer RA, 2013, BIOCHEM J, V449, P581, DOI 10.1042/BJ20121221; SU XD, 1994, NATURE, V370, P575, DOI 10.1038/370575a0; Tailor P, 1997, J BIOL CHEM, V272, P5371, DOI 10.1074/jbc.272.9.5371; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wan Y, 2019, J BIOL CHEM, V294, P11391, DOI 10.1074/jbc.RA119.008280; Wang SS, 2000, BIOCHEMISTRY-US, V39, P1903, DOI 10.1021/bi991348d; Wang ZJ, 2016, J SYNCHROTRON RADIAT, V23, P1323, DOI 10.1107/S160057751601451X; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Whitmore SE, 2012, INT J ORAL SCI, V4, P1, DOI 10.1038/ijos.2012.6; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wright AC, 2001, INFECT IMMUN, V69, P6893, DOI 10.1128/IAI.69.11.6893-6901.2001; Zabell APR, 2006, J BIOL CHEM, V281, P6520, DOI 10.1074/jbc.M506285200; Zang K, 2018, J BIOL CHEM, V293, P1088, DOI [10.1074/jbc.M117.815266, 10.1074/jbc.m117.815266]; ZHANG M, 1994, BIOCHEMISTRY-US, V33, P11097, DOI 10.1021/bi00203a006; Zhang M, 1998, J BIOL CHEM, V273, P21714, DOI 10.1074/jbc.273.34.21714; Zhang M, 1997, BIOCHEMISTRY-US, V36, P15, DOI 10.1021/bi961804n; Zhang WZ, 2019, NUCL SCI TECH, V30, DOI 10.1007/s41365-019-0683-2	64	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100280	10.1016/j.jbc.2021.100280	http://dx.doi.org/10.1016/j.jbc.2021.100280			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33450227	gold, Green Published			2022-12-26	WOS:000672866400256
J	Wilson, T; Mourino, S; Wilks, A				Wilson, Tyree; Mourino, Susana; Wilks, Angela			The heme-binding protein PhuS transcriptionally regulates the Pseudomonas aeruginosa tandem sRNA prrF1,F2 locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON HOMEOSTASIS; FUR REGULATOR; OXYGENASE; ALGR; SYSTEM; RYHB; PHOSPHORYLATION; TRAFFICKING; HOMOLOGS; REVEALS	Pseudomonas aeruginosa is an opportunistic pathogen requiring iron for its survival and virulence. P. aeruginosa can acquire iron from heme via the nonredundant heme assimilation system and Pseudomonas heme uptake (Phu) systems. Heme transported by either the heme assimilation system or Phu system is sequestered by the cytoplasmic protein PhuS. Furthermore, PhuS has been shown to specifically transfer heme to the iron-regulated heme oxygenase HemO. As the PhuS homolog ShuS from Shigella dysenteriae was observed to bind DNA as a function of its heme status, we sought to further determine if PhuS, in addition to its role in regulating heme flux through HemO, functions as a DNA-binding protein. Herein, through a combination of chromatin immunoprecipitation-PCR, EMSA, and fluorescence anisotropy, we show that apo-PhuS but not holo-PhuS binds upstream of the tandem iron-responsive sRNAs prrF1,F2. Previous studies have shown the PrrF sRNAs are required for sparing iron for essential proteins during iron starvation. Furthermore, under certain conditions, a heme-dependent read through of the prrF1 terminator yields the longer PrrH transcript. Quantitative PCR analysis of P. aeruginosa WT and Delta phuS strains shows that loss of PhuS abrogates the heme-dependent regulation of PrrF and PrrH levels. Taken together, our data show that PhuS, in addition to its role in extracellular heme metabolism, also functions as a transcriptional regulator by modulating PrrF and PrrH levels in response to heme. This dual function of PhuS is central to integrating extracellular heme utilization into the PrrF/PrrH sRNA regulatory network that is critical for P. aeruginosa adaptation and virulence within the host.	[Wilson, Tyree; Mourino, Susana; Wilks, Angela] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Wilks, A (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA.	awilks@rx.umaryland.edu		MOURINO, SUSANA/0000-0003-3707-1139	National Institutes of Health [R01 AI134886]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant R01 AI134886 (to A. W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agriesti F, 2014, NUCLEIC ACIDS RES, V42, P3138, DOI 10.1093/nar/gkt1258; Barker KD, 2012, J BIOL CHEM, V287, P18342, DOI 10.1074/jbc.M112.359265; Carpenter BM, 2010, J BACTERIOL, V192, P5037, DOI 10.1128/JB.00198-10; Cody WL, 2009, J BACTERIOL, V191, P2993, DOI 10.1128/JB.01156-08; Contreras H, 2014, CURR OPIN CHEM BIOL, V19, P34, DOI 10.1016/j.cbpa.2013.12.014; Cournac A, 2013, J BACTERIOL, V195, P1109, DOI 10.1128/JB.02038-12; Dent AT, 2020, J BIOL CHEM, V295, P10456, DOI 10.1074/jbc.RA120.014081; Dent AT, 2019, J BIOL CHEM, V294, P2771, DOI 10.1074/jbc.RA118.006185; Deredge DJ, 2017, P NATL ACAD SCI USA, V114, P3421, DOI 10.1073/pnas.1606931114; Fuhrhop J. H., 1975, PORPHYRINS METALLOPO, P804; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Huang WL, 2017, ANNU REV BIOCHEM, V86, P799, DOI 10.1146/annurev-biochem-060815-014214; Jacques JF, 2006, MOL MICROBIOL, V62, P1181, DOI 10.1111/j.1365-2958.2006.05439.x; Johnson EE, 2012, MICROBES INFECT, V14, P207, DOI 10.1016/j.micinf.2011.10.001; Kaur AP, 2007, BIOCHEMISTRY-US, V46, P2994, DOI 10.1021/bi061722r; Kaur AP, 2009, J BIOL CHEM, V284, P56, DOI 10.1074/jbc.M806068200; Kong WN, 2015, NUCLEIC ACIDS RES, V43, P8268, DOI 10.1093/nar/gkv747; Lansky IB, 2006, J BIOL CHEM, V281, P13652, DOI 10.1074/jbc.M600824200; Leclerc JM, 2013, MICROBIOL-SGM, V159, P591, DOI 10.1099/mic.0.064329-0; Letoffe S, 2004, J BACTERIOL, V186, P4067, DOI 10.1128/JB.186.13.4067-4074.2004; Little AS, 2018, MBIO, V9, DOI 10.1128/mBio.02318-17; Marvig RL, 2014, MBIO, V5, DOI 10.1128/mBio.00966-14; Mascher T, 2013, CURR OPIN MICROBIOL, V16, P148, DOI 10.1016/j.mib.2013.02.001; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; MOHR CD, 1994, MOL GEN GENET, V242, P177, DOI 10.1007/BF00391011; Morici LA, 2007, J BACTERIOL, V189, P7752, DOI 10.1128/JB.01797-06; Mourino S, 2016, J BIOL CHEM, V291, P20503, DOI 10.1074/jbc.M116.728527; Murphy ER, 2007, INFECT IMMUN, V75, P3470, DOI 10.1128/IAI.00112-07; Nguyen AT, 2014, J BACTERIOL, V196, P2265, DOI 10.1128/JB.01491-14; O'Neill MJ, 2013, ACS CHEM BIOL, V8, P1794, DOI 10.1021/cb400165b; O'Neill MJ, 2012, P NATL ACAD SCI USA, V109, P5639, DOI 10.1073/pnas.1121549109; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200; Oglesby-Sherrouse AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009930; Okkotsu Y, 2013, J BACTERIOL, V195, P5499, DOI 10.1128/JB.00726-13; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; Reinhart AA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00764-16; Reinhart AA, 2015, INFECT IMMUN, V83, P863, DOI 10.1128/IAI.02707-14; Roncarati D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12593; Smith AD, 2015, J BIOL CHEM, V290, P7756, DOI 10.1074/jbc.M114.633495; Whitchurch CB, 2002, J BACTERIOL, V184, P4544, DOI 10.1128/JB.184.16.4544-4554.2002; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101	45	5	5	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100275	10.1016/j.jbc.2021.100275	http://dx.doi.org/10.1016/j.jbc.2021.100275			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33428928	gold, Green Published			2022-12-26	WOS:000672866400251
J	Neave, HW; Webster, JR; Zobel, G				Neave, Heather W.; Webster, James R.; Zobel, Gosia			Anticipatory behaviour as an indicator of the welfare of dairy calves in different housing environments	PLOS ONE			English	Article							NEGATIVE CONTRAST; ANIMAL-WELFARE; REWARD; COGNITION; FOOD; SENSITIVITY; SUBSTRATE; STATE; RATS; BIAS	Anticipatory behaviour occurs in the period before a reward or other positive event is presented and has been interpreted as an indicator of the welfare and emotional state of animals. The use of this indicator has received limited attention in dairy calves. Therefore, we investigated how anticipatory behaviour is affected by housing environment and reward quality, and if anticipatory behaviour changes when reward quality changes unexpectedly. Sixteen pairs of calves were assigned to treatments in a 2 x 2 factorial design (two housing environment and two reward quality combinations). Housing was either basic (2 m(2)/calf, river stone surface) or enriched (5 m(2)/calf, woodchip, and enrichment items), and the reward was access to either an additional basic or enriched pen. Calves were conditioned to anticipate reward pen access; anticipatory behaviour toward receiving the reward pen was measured. Signaling reward access increased the frequency of transitions between behaviours and duration of touching and looking at the signal and exit door. Basic-housed calves showed more anticipatory behaviour (increased frequency of transitions between behaviours) and decreased latency to access the reward compared to enriched-housed calves, but the reward pen quality had no effect on anticipatory behaviour. When the reward pen quality changed from enriched to basic unexpectedly, resulting in sudden reward loss, basic-housed calves decreased, while enriched-housed calves increased, anticipatory behaviour. However, there was no change in anticipatory behaviour during reward gain (change from basic to enriched reward pen). Our findings align with previous work showing that animals in basic housing show more anticipation for a reward, and demonstrate suppressed behavioural response when experiencing reward loss, suggesting greater sensitivity to reward. Sensitivity to reward has associations with mood state; thus, calves in basic environments may experience a more negative emotional state, and thus reduced welfare, compared to calves in enriched environments.	[Neave, Heather W.; Webster, James R.; Zobel, Gosia] AgResearch Ltd, Anim Behav & Welf, Ruakura Res Ctr, Hamilton, New Zealand; [Neave, Heather W.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC, Canada	AgResearch - New Zealand; University of British Columbia	Zobel, G (corresponding author), AgResearch Ltd, Anim Behav & Welf, Ruakura Res Ctr, Hamilton, New Zealand.	gosia.zobel@agresearch.co.nz			AgResearch Core funding [A19041]; Natural Science and Engineering Research Council Canada Graduate Scholarship; Michael Smith Foreign Study Supplement	AgResearch Core funding; Natural Science and Engineering Research Council Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foreign Study Supplement(Canadian Institutes of Health Research (CIHR)Social Sciences and Humanities Research Council of Canada (SSHRC)Natural Sciences and Engineering Research Council of Canada (NSERC))	The study funding was provided by AgResearch Core funding (A19041). At the time of study completion, author HN was supported by the Natural Science and Engineering Research Council Canada Graduate Scholarship and the Michael Smith Foreign Study Supplement. Furthermore, the study funders provided support in the form of salaries for author GZ but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the `author contributions' section.	Anderson C, 2020, ANIM WELFARE, V29, P231, DOI 10.7120/09627286.29.3.231; Anderson C, 2015, BEHAV PROCESS, V113, P152, DOI 10.1016/j.beproc.2015.02.003; Annicchiarico I, 2016, BEHAV PROCESS, V129, P54, DOI 10.1016/j.beproc.2016.06.006; Baciadonna L, 2020, APPL ANIM BEHAV SCI, V225, DOI 10.1016/j.applanim.2020.104968; Boissy A, 2007, ANIM WELFARE, V16, P37; Burgdorf J, 2006, NEUROSCI BIOBEHAV R, V30, P173, DOI 10.1016/j.neubiorev.2005.06.001; Burman OHP, 2008, BIOL LETTERS, V4, P330, DOI 10.1098/rsbl.2008.0113; Cantor MC, 2019, TRANSL ANIM SCI, V3, P549, DOI 10.1093/tas/txy144; Clegg ILK, 2018, APPL ANIM BEHAV SCI, V202, P85, DOI 10.1016/j.applanim.2018.01.015; Clegg ILK, 2018, ZOO BIOL, V37, P67, DOI 10.1002/zoo.21400; Costa JHC, 2016, J DAIRY SCI, V99, P2453, DOI 10.3168/jds.2015-10144; Daros RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098429; Flaherty CF, 1998, ANIM LEARN BEHAV, V26, P397, DOI 10.3758/BF03199232; Fraser D, 1997, ANIM WELFARE, V6, P187; Greiveldinger L, 2011, PSYCHONEUROENDOCRINO, V36, P806, DOI 10.1016/j.psyneuen.2010.11.002; Hernandez CE, 2015, APPL ANIM BEHAV SCI, V163, P135, DOI 10.1016/j.applanim.2014.12.002; Imfeld-Mueller S, 2012, APPL ANIM BEHAV SCI, V137, P23, DOI 10.1016/j.applanim.2012.01.012; Luo L, 2020, ANIM COGN, V23, P121, DOI 10.1007/s10071-019-01322-w; Makowska IJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147595; McGrath N, 2016, APPL ANIM BEHAV SCI, V184, P80, DOI 10.1016/j.applanim.2016.08.010; Mitchell EN, 2012, BEHAV BRAIN RES, V234, P155, DOI 10.1016/j.bbr.2012.06.016; Modlinska K, 2019, BEHAV PROCESS, V164, P78, DOI 10.1016/j.beproc.2019.04.015; Moe RO, 2009, APPL ANIM BEHAV SCI, V121, P171, DOI 10.1016/j.applanim.2009.10.002; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Peters SM, 2012, APPL ANIM BEHAV SCI, V138, P60, DOI 10.1016/j.applanim.2012.01.018; PIJNENBURG AJJ, 1976, EUR J PHARMACOL, V35, P45, DOI 10.1016/0014-2999(76)90299-5; Riemer S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35056-5; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Spruijt BM, 2001, APPL ANIM BEHAV SCI, V72, P145, DOI 10.1016/S0168-1591(00)00204-5; Suarez AB, 2017, DEV PSYCHOBIOL, V59, P118, DOI 10.1002/dev.21430; Sutherland MA, 2014, J DAIRY SCI, V97, P4455, DOI 10.3168/jds.2013-7822; Van den Berg CL, 1999, BEHAV BRAIN RES, V106, P133, DOI 10.1016/S0166-4328(99)00099-6; van der Harst JE, 2003, BEHAV BRAIN RES, V142, P151, DOI 10.1016/S0166-4328(02)00403-5; Van Der Harst JE, 2003, ANIM BEHAV, V66, P493, DOI 10.1006/anbe.2003.2201; Vinke CM, 2004, APPL ANIM BEHAV SCI, V89, P145, DOI 10.1016/j.applanim.2004.06.002; Von Frijtag JC, 2000, BEHAV BRAIN RES, V117, P137, DOI 10.1016/S0166-4328(00)00300-4; Watters JV, 2014, ZOO BIOL, V33, P251, DOI 10.1002/zoo.21144; Webster JR, 2015, NEW ZEAL VET J, V63, P31, DOI 10.1080/00480169.2014.958117; Wichman A, 2012, APPL ANIM BEHAV SCI, V140, P62, DOI 10.1016/j.applanim.2012.05.006; Yeates JW, 2011, ANIM WELFARE, V20, P397; Zimmerman PH, 2011, ANIM BEHAV, V81, P569, DOI 10.1016/j.anbehav.2010.11.028; Zobel G, 2017, ANIMALS, V7, DOI 10.3390/ani7110084	42	3	3	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245742	10.1371/journal.pone.0245742	http://dx.doi.org/10.1371/journal.pone.0245742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM1OE	33471865	gold, Green Published			2022-12-26	WOS:000639428800036
J	Maruyama, H; Hanada, K; Shimizu, A; Minami, T; Hirano, N; Hino, F; Abe, T; Amano, H; Fujiwara, Y				Maruyama, Hirotsugu; Hanada, Keiji; Shimizu, Akinori; Minami, Tomoyuki; Hirano, Naomiti; Hino, Fumiaki; Abe, Tomoyuki; Amano, Hironobu; Fujiwara, Yasuhiro			Value of endoscopic ultrasonography in the observation of the remnant pancreas after pancreatectomy	PLOS ONE			English	Article							DIAGNOSIS; LESIONS; CANCER; EUS	Background Endoscopic ultrasonography (EUS) is proven to be a more specific and sensitive method for detecting pancreatic lesions. However, usefulness of EUS after pancreatectomy has not been reported. This study aimed to evaluate the observational capability of EUS for the remnant pancreas (RP) after pancreatectomy. Patient and methods This single-center, retrospective study enrolled 395 patients who underwent pancreatectomy at Onomichi General Hospital between December 2002 and March 2016, 45 patients who underwent EUS for RP were included for analysis. We evaluated the usefulness of EUS for RP using logistic regression analysis. Results Complete observation of the RP was done in 42 patients (93%). In the initial surgical procedure, 21 patients underwent pancreaticoduodenectomy (PD), and 24 patients underwent distal pancreatectomy (DP). PD and DP were observed in 85% (18/21) and 100% (24/24) cases, respectively. A comparison of the detection capability of EUS and contrast-enhanced computed tomography (CT) or magnetic resonance imaging (MRI) showed that EUS was significantly superior to contrast-enhanced CT or MRI (p < 0.01). Eight of the 45 patients showed recurrence lesions in the RP. The median recurrence period was 33 months. Predictive factors for recurrence in the univariate and multivariate analyses were significantly different in space occupying lesion with EUS findings (p < 0.01) and elevated CA19-9(p < 0.01). Conclusions EUS was able to observe the RP in almost all cases. In addition, the detection capability of EUS was significantly superior to those of CT or MRI. We recommend that all patients with RP should undergo EUS, and a longer follow-up must be performed.	[Maruyama, Hirotsugu; Hanada, Keiji; Shimizu, Akinori; Minami, Tomoyuki; Hirano, Naomiti; Hino, Fumiaki] Onomichi Gen Hosp, Dept Gastroenterol, Onomichi, Japan; [Maruyama, Hirotsugu; Fujiwara, Yasuhiro] Osaka City Univ, Dept Gastroenterol, Grad Sch Med, Osaka, Japan; [Abe, Tomoyuki; Amano, Hironobu] Onomichi Gen Hosp, Dept Surg, Onomichi, Japan	Osaka Metropolitan University	Maruyama, H (corresponding author), Onomichi Gen Hosp, Dept Gastroenterol, Onomichi, Japan.; Maruyama, H (corresponding author), Osaka City Univ, Dept Gastroenterol, Grad Sch Med, Osaka, Japan.	hiromaruyama99@gmail.com						Akabori H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-224; Ballehaninna UK, 2012, J GASTROINTEST ONCOL, V3, P105, DOI 10.3978/j.issn.2078-6891.2011.021; Canto MI, 2012, GASTROENTEROLOGY, V142, P796, DOI 10.1053/j.gastro.2012.01.005; Helmstaedter L, 2008, LANGENBECK ARCH SURG, V393, P923, DOI 10.1007/s00423-007-0275-1; Ikemoto J, 2017, GASTROENTEROLOGICAL, V59, P1638; Ikemoto J, 2018, PANCREAS, V47, P482, DOI 10.1097/MPA.0000000000001021; Kamata K, 2018, DIGEST ENDOSC, V30, P659, DOI 10.1111/den.13176; LEPANTO L, 1994, AM J ROENTGENOL, V163, P841, DOI 10.2214/ajr.163.4.7916530; Miyazaki M, 2014, SURGERY, V155, P58, DOI 10.1016/j.surg.2013.06.050; NCCN (National Comprehensive Cancer Network), 2016, CLIN PRACT GUID ONC; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Shin EJ, 2015, GASTROINTEST ENDOSC, V82, P812, DOI 10.1016/j.gie.2015.02.028; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tamm EP, 2007, ABDOM IMAGING, V32, P660, DOI 10.1007/s00261-007-9298-x	14	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245447	10.1371/journal.pone.0245447	http://dx.doi.org/10.1371/journal.pone.0245447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465138	Green Published, gold			2022-12-26	WOS:000611969200003
J	Ronnberg, C; Lugaajju, A; Nyman, A; Hammar, U; Bottai, M; Lautenbach, MJ; Sundling, C; Kironde, F; Persson, KEM				Ronnberg, Caroline; Lugaajju, Allan; Nyman, Anna; Hammar, Ulf; Bottai, Matteo; Lautenbach, Maximilian Julius; Sundling, Christopher; Kironde, Fred; Persson, Kristina E. M.			A longitudinal study of plasma BAFF levels in mothers and their infants in Uganda, and correlations with subsets of B cells	PLOS ONE			English	Article							ACTIVATING FACTOR BAFF; PLASMODIUM-FALCIPARUM; PLACENTAL MALARIA; CORD BLOOD; PREGNANCY; EXPRESSION; MEMORY; ANTIBODIES; SURVIVAL; EXPOSURE	Malaria is a potentially life-threatening disease with approximately half of the world's population at risk. Young children and pregnant women are hit hardest by the disease. B cells and antibodies are part of an adaptive immune response protecting individuals continuously exposed to the parasite. An infection with Plasmodium falciparum can cause dysregulation of B cell homeostasis, while antibodies are known to be key in controlling symptoms and parasitemia. BAFF is an instrumental cytokine for the development and maintenance of B cells. Pregnancy alters the immune status and renders previously clinically immune women at risk of severe malaria, potentially due to altered B cell responses associated with changes in BAFF levels. In this prospective study, we investigated the levels of BAFF in a malaria-endemic area in mothers and their infants from birth up to 9 months. We found that BAFF-levels are significantly higher in infants than in mothers. BAFF is highest in cord blood and then drops rapidly, but remains significantly higher in infants compared to mothers even at 9 months of age. We further correlated BAFF levels to P. falciparum-specific antibody levels and B cell frequencies and found a negative correlation between BAFF and both P. falciparum-specific and total proportions of IgG(+) memory B cells, as well as CD27(-) memory B cells, indicating that exposure to both malaria and other diseases affect the development of B-cell memory and that BAFF plays a part in this. In conclusion, we have provided new information on how natural immunity against malaria is formed.	[Ronnberg, Caroline; Lugaajju, Allan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Ronnberg, Caroline; Lautenbach, Maximilian Julius; Sundling, Christopher] Karolinska Inst, Dept Med Solna, Div Infect Dis, Stockholm, Sweden; [Ronnberg, Caroline; Lautenbach, Maximilian Julius; Sundling, Christopher] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Lugaajju, Allan; Kironde, Fred] Makerere Univ, Kampala, Uganda; [Nyman, Anna; Persson, Kristina E. M.] Lund Univ, Skane Univ Hosp, Dept Lab Med, Lund, Sweden; [Hammar, Ulf; Bottai, Matteo] Karolinska Inst, Inst Environm Med, Div Biostat, Stockholm, Sweden; [Lautenbach, Maximilian Julius; Sundling, Christopher] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Kironde, Fred] Islamic Univ Uganda IUIU, Habib Med Sch, Mbale, Uganda	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Makerere University; Lund University; Skane University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Persson, KEM (corresponding author), Lund Univ, Skane Univ Hosp, Dept Lab Med, Lund, Sweden.	kristina.persson@med.lu.se	Sundling, Christopher/H-7707-2019	Sundling, Christopher/0000-0002-6138-690X; Persson, Kristina E M/0000-0003-2661-3115; Lugaajju, Allan/0000-0003-4841-0538; Lautenbach, Maximilian Julius/0000-0001-5763-6964	Stockholms lans landsting; Sida; Anna Lisa och Sven-Erik Lundgrens Stiftelse for Medicinsk Forskning, ALF (Region Skane) - Office of the Director, National Institutes of Health (OD) [D43TW010132]; National Institute of Dental & Craniofacial Research (NIDCR); National Institute of Neurological Disorders and Stroke (NINDS); National Heart, Lung, and Blood Institute (NHLBI); Fogarty International Center (FIC); National Institute on Minority Health and Health Disparities (NIMHD); Vetenskapsradet	Stockholms lans landsting; Sida; Anna Lisa och Sven-Erik Lundgrens Stiftelse for Medicinsk Forskning, ALF (Region Skane) - Office of the Director, National Institutes of Health (OD); National Institute of Dental & Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute on Minority Health and Health Disparities (NIMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Vetenskapsradet(Swedish Research Council)	Funding was provided from Stockholms lans landsting, Sida, Anna Lisa och Sven-Erik Lundgrens Stiftelse for Medicinsk Forskning, ALF (Region Skane), grant number D43TW010132, supported by Office of the Director, National Institutes of Health (OD), National Institute of Dental & Craniofacial Research (NIDCR), National Institute of Neurological Disorders and Stroke (NINDS), National Heart, Lung, and Blood Institute (NHLBI), Fogarty International Center (FIC), and National Institute on Minority Health and Health Disparities (NIMHD) and Vetenskapsradet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bienertova-Vasku J, 2015, J REPROD IMMUNOL, V109, P89, DOI 10.1016/j.jri.2014.12.003; Carter MJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00630; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Darce JR, 2007, J IMMUNOL, V179, P7276, DOI 10.4049/jimmunol.179.11.7276; Donati D, 2004, INFECT IMMUN, V72, P5412, DOI 10.1128/IAI.72.9.5412-5418.2004; Duchamp M, 2014, IMMUN INFLAMM DIS, V2, P131, DOI 10.1002/iid3.26; Esteve-Sole A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00201; Fontaine J, 2011, BLOOD, V117, P145, DOI 10.1182/blood-2010-08-301887; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Giha HA, 1999, INFECT IMMUN, V67, P4092, DOI 10.1128/IAI.67.8.4092-4098.1999; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Illingworth J, 2013, J IMMUNOL, V190, P1038, DOI 10.4049/jimmunol.1202438; Kessel A, 2006, CLIN EXP IMMUNOL, V145, P563, DOI 10.1111/j.1365-2249.2006.03170.x; Kreuzaler M, 2012, J IMMUNOL, V188, P497, DOI 10.4049/jimmunol.1102321; Kumsiri R, 2010, ACTA TROP, V116, P217, DOI 10.1016/j.actatropica.2010.08.012; Langat DL, 2008, AM J PATHOL, V172, P1303, DOI 10.2353/ajpath.2008.071139; Liu XQ, 2012, EUR J IMMUNOL, V42, P3291, DOI 10.1002/eji.201242689; Lugaajju A, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1697-z; Lugaajju A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0911-0; Lundell AC, 2015, J ALLERGY CLIN IMMUN, V136, P1074, DOI 10.1016/j.jaci.2015.03.022; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Mackay F, 2010, IMMUNOL REV, V237, P205, DOI 10.1111/j.1600-065X.2010.00944.x; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Muehlenbachs A, 2007, J IMMUNOL, V179, P557, DOI 10.4049/jimmunol.179.1.557; Naradikian MS, 2015, CURR OPIN IMMUNOL, V34, P126, DOI 10.1016/j.coi.2015.03.005; Ndam NT, 2015, EMERG INFECT DIS, V21, P813, DOI 10.3201/eid2105.141626; Nduati E, 2011, J INFECT DIS, V204, P962, DOI 10.1093/infdis/jir438; Nicoletti AM, 2016, J PHARMACOL EXP THER, V359, P37, DOI 10.1124/jpet.116.236075; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Portugal S, 2015, ELIFE, V4, DOI 10.7554/eLife.07218; Requena P, 2014, J IMMUNOL, V193, P2971, DOI 10.4049/jimmunol.1401037; Rodig SJ, 2005, HUM PATHOL, V36, P1113, DOI 10.1016/j.humpath.2005.08.005; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Rogerson SJ, 2018, LANCET INFECT DIS, V18, pE107, DOI 10.1016/S1473-3099(18)30066-5; Sakai J, 2017, CLIN MICROBIOL REV, V30, P991, DOI 10.1128/CMR.00046-17; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Scholz JL, 2008, P NATL ACAD SCI USA, V105, P15517, DOI 10.1073/pnas.0807841105; Scholzen A, 2014, J IMMUNOL, V192, P3719, DOI 10.4049/jimmunol.1302960; Scholzen A, 2013, TRENDS PARASITOL, V29, P252, DOI 10.1016/j.pt.2013.03.002; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Sullivan RT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004894; Sundling C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126492; Team RC, 2020, R LANG ENV STAT COMP; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; WHO, 2019, WORLD MALARIA REPORT; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Yeo KT, 2019, J IMMUNOL, V202, P1465, DOI 10.4049/jimmunol.1801024; Yman V, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1255-3	52	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245431	10.1371/journal.pone.0245431	http://dx.doi.org/10.1371/journal.pone.0245431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465125	gold, Green Published			2022-12-26	WOS:000611969200032
J	Kang, W; Zhang, JL; Huang, TT; Zhou, YH; Wong, CC; Chan, RCK; Dong, YJ; Wu, F; Zhang, B; Wu, WKK; Chan, MWY; Cheng, ASL; Yu, J; Wong, N; Lo, KW; To, KF				Kang, Wei; Zhang, Jinglin; Huang, Tingting; Zhou, Yuhang; Wong, Chi Chun; Chan, Ronald C. K.; Dong, Yujuan; Wu, Feng; Zhang, Bin; Wu, William K. K.; Chan, Michael W. Y.; Cheng, Alfred S. L.; Yu, Jun; Wong, Nathalie; Lo, Kwok Wai; To, Ka Fai			NOTCH3, a crucial target of miR-491-5p/miR-875-5p, promotes gastric carcinogenesis by upregulating PHLDB2 expression and activating Akt pathway	ONCOGENE			English	Article							GAMMA SECRETASE INHIBITOR; SIGNALING PATHWAY; MICRORNA EXPRESSION; PHASE-II; CANCER; RO4929097; GROWTH; TUMORIGENESIS; ONCOGENE; INVASION	Aberrant Notch activation has been implicated in multiple malignancies and the identification of NOTCH receptors and related pathways is critical for targeted therapy. In this study, we aim to delineate the most prominent dysregulated NOTCH receptor and comprehensively reveal its deregulation in gastric cancer (GC). In the four Notch members, NOTCH3 was found uniformly upregulated and associated with poor clinical outcomes in multiple GC datasets. siRNA-mediated NOTCH3 knockdown demonstrated antitumor effects by suppressing cell proliferation, inhibiting monolayer formation, and impairing cell invasion abilities. Its depletion also induced early and late apoptosis. NOTCH3 was confirmed to be a direct target of two tumor suppressor microRNAs (miRNAs), namely miR-491-5p and miR-875-5p. The activation of NOTCH3 is partly due to the silence of these two miRNAs. Through RNA-seq profiling and functional validation, PHLDB2 was identified as a potent functional downstream modulator for NOTCH3 in gastric carcinogenesis. PHLDB2 expression demonstrated a positive correlation with NOTCH3, but was negatively correlated with miR-491-5p. Akt-mTOR was revealed as the downstream signaling of PHLDB2. The NOTCH3-PHLDB2-Akt co-activation was found in 33.7% GC patients and the activation of this axis predicted poor clinical outcome. GC cells treated with siNOTCH3, siPHLDB2, miR-491-5p, miR-875-5p, were more sensitive to Cisplatin and 5-FU. Taken together, the NOTCH3-PHLDB2-Akt cascade plays oncogenic role in gastric carcinogenesis and serves as a therapeutic target. Our study provided insights into Notch-mediated underlying molecular mechanisms and implied translational potential.	[Kang, Wei; Zhang, Jinglin; Huang, Tingting; Zhou, Yuhang; Chan, Ronald C. K.; Wu, Feng; Wong, Nathalie; Lo, Kwok Wai; To, Ka Fai] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, State Key Lab Translat Oncol, Hong Kong, Peoples R China; [Kang, Wei; Zhang, Jinglin; Huang, Tingting; Zhou, Yuhang; Wong, Chi Chun; Dong, Yujuan; Yu, Jun; To, Ka Fai] Chinese Univ Hong Kong, Inst Digest Dis, State Key Lab Digest Dis, Hong Kong, Peoples R China; [Kang, Wei; Zhang, Jinglin; Huang, Tingting; Zhou, Yuhang; Wong, Nathalie; Lo, Kwok Wai; To, Ka Fai] Chinese Univ Hong Kong, Sir YK Pao Canc Ctr, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China; [Zhang, Bin] Nanjing Univ, Med Sch, Dept Gastroenterol, Affiliated Drum Tower Hosp, Nanjing, Peoples R China; [Wu, William K. K.] Chinese Univ Hong Kong, Dept Anaesthesia & Intens Care, Hong Kong, Peoples R China; [Chan, Michael W. Y.] Natl Chung Cheng Univ, Dept Life Sci, Chiayi, Taiwan; [Cheng, Alfred S. L.] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Yu, Jun] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Nanjing University; Chinese University of Hong Kong; National Chung Cheng University; Chinese University of Hong Kong; Chinese University of Hong Kong	Kang, W (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, State Key Lab Translat Oncol, Hong Kong, Peoples R China.; Kang, W (corresponding author), Chinese Univ Hong Kong, Inst Digest Dis, State Key Lab Digest Dis, Hong Kong, Peoples R China.; Kang, W (corresponding author), Chinese Univ Hong Kong, Sir YK Pao Canc Ctr, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China.	weikang@cuhk.edu.hk	wu, william/HII-5817-2022; Wu, William K.K./A-3277-2009; huang, ting/GRR-3141-2022; KANG, Wei/C-5451-2016; Dong, Yujuan/AAS-3467-2021	Wu, William K.K./0000-0002-5662-5240; KANG, Wei/0000-0002-4651-677X; Wong, Chi Chun/0000-0003-1362-3541	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK 14100019, 14118518]; CUHK Direct Grant for Research from The Chinese University of Hong Kong [2019.001]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); CUHK Direct Grant for Research from The Chinese University of Hong Kong	The manuscript is under support of Research Grants Council of the Hong Kong Special Administrative Region, China [Project No.: CUHK 14100019 and 14118518 (for GRF projects)], and CUHK Direct Grant for Research (2019.001) from The Chinese University of Hong Kong.	Andersson ER, 2014, NAT REV DRUG DISCOV, V13, P359, DOI 10.1038/nrd4252; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bauer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044566; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Capaccione KM, 2013, CARCINOGENESIS, V34, P1420, DOI 10.1093/carcin/bgt127; Chen G, 2017, BIOCHEM BIOPH RES CO, V487, P90, DOI 10.1016/j.bbrc.2017.04.023; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; De Jesus-Acosta A, 2014, INVEST NEW DRUG, V32, P739, DOI 10.1007/s10637-014-0083-8; Denoyelle C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.389; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fernandez-Majada V, 2007, P NATL ACAD SCI USA, V104, P276, DOI 10.1073/pnas.0606476104; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gong FC, 2016, AM J TRANSL RES, V8, P485; Guo LY, 2012, WORLD J GASTROENTERO, V18, P7262, DOI 10.3748/wjg.v18.i48.7262; He PY, 2017, ONCOL REP, V38, P3554, DOI 10.3892/or.2017.6037; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hsu KW, 2012, CARCINOGENESIS, V33, P1459, DOI 10.1093/carcin/bgs165; Huang TT, 2015, ONCOTARGET, V6, P18012, DOI 10.18632/oncotarget.4000; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Ji DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085116; Kang H, 2012, HISTOPATHOLOGY, V61, P576, DOI 10.1111/j.1365-2559.2012.04274.x; Kang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033919; Kang W, 2011, CLIN CANCER RES, V17, P2130, DOI 10.1158/1078-0432.CCR-10-2467; Kim SJ, 2016, ONCOGENE, V35, P251, DOI 10.1038/onc.2015.80; Kimura K, 2007, CANCER SCI, V98, P155, DOI 10.1111/j.1349-7006.2006.00369.x; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luistro L, 2009, CANCER RES, V69, P7672, DOI 10.1158/0008-5472.CAN-09-1843; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; Molaei Fatemeh, 2018, Iranian Biomedical Journal, V22, P217, DOI 10.22034/ibj.22.4.217; Nair JS, 2013, ANTICANCER RES, V33, P1307; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Ozawa T, 2014, ANN SURG ONCOL, V21, P2650, DOI 10.1245/s10434-014-3659-9; Pasto A, 2014, CANCER RES, V74, P2106, DOI 10.1158/0008-5472.CAN-13-2022; Piazzi G, 2012, CELL CYCLE, V11, P4323, DOI 10.4161/cc.22388; Pine SR, 2008, DIS MARKERS, V24, P257, DOI 10.1155/2008/396281; Polkowski W, 1999, ANN SURG ONCOL, V6, P290, DOI 10.1007/s10434-999-0290-2; Qian CJ, 2015, MOL CELL BIOCHEM, V401, P165, DOI 10.1007/s11010-014-2304-z; Qian ZL, 2014, GENE CHROMOSOME CANC, V53, P883, DOI 10.1002/gcc.22196; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; Serafin V, 2011, J PATHOL, V224, P448, DOI 10.1002/path.2895; Strosberg JR, 2012, EUR J CANCER, V48, P997, DOI 10.1016/j.ejca.2012.02.056; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Takebe N, 2014, PHARMACOL THERAPEUT, V141, P140, DOI 10.1016/j.pharmthera.2013.09.005; Tolcher AW, 2012, J CLIN ONCOL, V30, P2348, DOI 10.1200/JCO.2011.36.8282; Vilimas T, 2007, NAT MED, V13, P70, DOI 10.1038/nm1524; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Wu WKK, 2010, CANCER LETT, V295, P144, DOI 10.1016/j.canlet.2010.04.025; Yeh TS, 2009, CANCER RES, V69, P5039, DOI 10.1158/0008-5472.CAN-08-4021; Yuan X, 2015, CANCER LETT, V369, P20, DOI 10.1016/j.canlet.2015.07.048; Zhang H, 2014, BRIT J CANCER, V110, P2283, DOI 10.1038/bjc.2014.135; Zhang TN, 2016, ONCOTARGET, V7, P42225, DOI 10.18632/oncotarget.9944; Zhao Q, 2015, ONCOL REP, V34, P979, DOI 10.3892/or.2015.4013; Zhou QOL, 2010, J BIOL CHEM, V285, P27581, DOI 10.1074/jbc.M110.146886	59	14	15	2	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2021	40	9					1578	1594		10.1038/s41388-020-01579-3	http://dx.doi.org/10.1038/s41388-020-01579-3		JAN 2021	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QR9UA	33452458	hybrid, Green Published			2022-12-26	WOS:000607998600006
J	Sabah, A; Tiun, S; Sani, NS; Ayob, M; Taha, AY				Sabah, Ali; Tiun, Sabrina; Sani, Nor Samsiah; Ayob, Masri; Taha, Adil Yaseen			Enhancing web search result clustering model based on multiview multirepresentation consensus cluster ensemble (mmcc) approach	PLOS ONE			English	Article								Existing text clustering methods utilize only one representation at a time (single view), whereas multiple views can represent documents. The multiview multirepresentation method enhances clustering quality. Moreover, existing clustering methods that utilize more than one representation at a time (multiview) use representation with the same nature. Hence, using multiple views that represent data in a different representation with clustering methods is reasonable to create a diverse set of candidate clustering solutions. On this basis, an effective dynamic clustering method must consider combining multiple views of data including semantic view, lexical view (word weighting), and topic view as well as the number of clusters. The main goal of this study is to develop a new method that can improve the performance of web search result clustering (WSRC). An enhanced multiview multirepresentation consensus clustering ensemble (MMCC) method is proposed to create a set of diverse candidate solutions and select a high-quality overlapping cluster. The overlapping clusters are obtained from the candidate solutions created by different clustering methods. The framework to develop the proposed MMCC includes numerous stages: (1) acquiring the standard datasets (MORESQUE and Open Directory Project-239), which are used to validate search result clustering algorithms, (2) preprocessing the dataset, (3) applying multiview multirepresentation clustering models, (4) using the radius-based cluster number estimation algorithm, and (5) employing the consensus clustering ensemble method. Results show an improvement in clustering methods when multiview multirepresentation is used. More importantly, the proposed MMCC model improves the overall performance of WSRC compared with all single-view clustering models.	[Sabah, Ali; Tiun, Sabrina; Sani, Nor Samsiah; Ayob, Masri; Taha, Adil Yaseen] Univ Kebangsaan Malaysia, Ctr Artificial Intelligence Technol CAIT, Fac Informat Sci & Technol, Bangi, Selangor, Malaysia	Universiti Kebangsaan Malaysia	Tiun, S (corresponding author), Univ Kebangsaan Malaysia, Ctr Artificial Intelligence Technol CAIT, Fac Informat Sci & Technol, Bangi, Selangor, Malaysia.	sabrinatiun@ukm.edu.my	Sani, Nor Samsiah/AAV-9808-2020; Saadi, Ali Sabah AL-/AAQ-4768-2021	Sani, Nor Samsiah/0000-0001-5802-5946; Saadi, Ali Sabah AL-/0000-0002-7148-4976; tiun, sabrina/0000-0002-1134-973X	Universiti Kebangsaan Malaysia [GUP-2020-063]	Universiti Kebangsaan Malaysia	This research was funded by the Universiti Kebangsaan Malaysia (Grant code: GUP-2020-063). This grant was received by Dr Sabrina Tiun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi MT, 2018, MALAYS J COMPUT SCI, V31, P15, DOI 10.22452/mjcs.sp2018no1.2; Abdulameer Ali Sabah, 2015, Journal of Theoretical and Applied Information Technology, V81, P621; Abdulameer AS, 2020, J KING SAUD U COMPUT; Abu-Jamous B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056432; Abu-Jamous B, 2012, EUR SIGNAL PR CONF, P2193; Acharya Sudipta, 2014, P COLING 2014 25 INT, P99; Alam M, 2013, ADV COMPUTING INFORM, P153; Alam M, 2015, WEB SEARCH RESULT CL; [Anonymous], 2015, INT J ADV SOFT COMPU; Bickel S, 2004, FOURTH IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P19, DOI 10.1109/ICDM.2004.10095; Blei D., 2009, TEXT MINING CLASSIFI, P71, DOI [DOI 10.1145/1143844.1143859, DOI 10.1201/9781420059458.CH4]; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Boongoen T, 2018, COMPUT SCI REV, V28, P1, DOI 10.1016/j.cosrev.2018.01.003; Cao XC, 2015, PROC CVPR IEEE, P586, DOI 10.1109/CVPR.2015.7298657; Carpineto C, 2010, SIGIR 2010: PROCEEDINGS OF THE 33RD ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH DEVELOPMENT IN INFORMATION RETRIEVAL, P170; Chao GQ, 2019, INFORM SCIENCES, V494, P278, DOI 10.1016/j.ins.2019.04.039; Chen K., 2013, ADV NEURAL INF PROCE, V26, P3111, DOI DOI 10.5555/2999792.2999959; Dai H, 2019, 2019 IEEE 4TH INTERNATIONAL CONFERENCE ON CLOUD COMPUTING AND BIG DATA ANALYSIS (ICCCBDA), P333, DOI 10.1109/ICCCBDA.2019.8725648; Feng T, 2013, CYCLODEXTRIN CHEMISTRY: PREPARATION AND APPLICATION, P183; Fraj M, 2019, LECT NOTES ARTIF INT, V11683, P219, DOI 10.1007/978-3-030-28377-3_18; Gao J., 2013, SIAM, P252, DOI [10.1137/1.9781611972832.28, DOI 10.1137/1.9781611972832.28]; Goldberg Y, 2014, ARXIV PREPRINT ARXIV; HANSEN LK, 1990, IEEE T PATTERN ANAL, V12, P993, DOI 10.1109/34.58871; Hussain SF, 2014, J INTELL INF SYST, V43, P81, DOI 10.1007/s10844-014-0307-6; Ibrahim R, 2019, ADV SCI TECHNOL ENG, V4, P115; Jiang Y, 2012, INT C PATT RECOG, P2997; Karaa WB, 2016, INTEL SYST REF LIBR, V96, P267, DOI 10.1007/978-3-319-21212-8_12; Larsen B, 1999, P 5 ACM SIGKDD INT C, P16, DOI DOI 10.1145/312129.312186; Law MHC, 2004, PROC CVPR IEEE, P424; LUHN HP, 1957, IBM J RES DEV, V1, P309, DOI 10.1147/rd.14.0309; Marx A, 2016, GENOM PROTEOM BIOINF, V14, P55, DOI 10.1016/j.gpb.2015.11.004; Mazarura J, 2016, 2016 PATTERN RECOGNITION ASSOCIATION OF SOUTH AFRICA AND ROBOTICS AND MECHATRONICS INTERNATIONAL CONFERENCE (PRASA-ROBMECH); Mojahed A, 2017, KNOWL INF SYST, V50, P27, DOI 10.1007/s10115-016-0930-3; Moreno Jesus, 2014, 2014 IEEE Frontiers in Education Conference (FIE). Proceedings, P1, DOI 10.1109/FIE.2014.7044055; Moreno JG, 2014, SIGIR'14: PROCEEDINGS OF THE 37TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P777, DOI 10.1145/2600428.2609583; Navigli R., 2010, P 2010 C EMP METH NA, V2010, P116; Petkos Georgios, 2014, MultiMedia Modeling. 20th Anniversary International Conference, MMM 2014. Proceedings: LNCS 8325, P146, DOI 10.1007/978-3-319-04114-8_13; Petkos G, 2012, P 2 ACM INT C MULT, P1; Rahman MA, 2014, KNOWL-BASED SYST, V71, P345, DOI 10.1016/j.knosys.2014.08.011; Sadeghian AH, 2015, 2015 INTERNATIONAL SYMPOSIUM ON ARTIFICIAL INTELLIGENCE AND SIGNAL PROCESSING (AISP), P240, DOI 10.1109/AISP.2015.7123481; Saha S, 2018, ACM T KNOWL DISCOV D, V12, DOI 10.1145/3182181; Samangooei S, SOCIAL EVENT DETECTI; Sangaiah AK, 2019, CLUSTER COMPUT, V22, pS4535, DOI 10.1007/s10586-018-2084-4; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Sun JY, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.096014; Tan AC, 2003, P 1 AS PAC BIOINF C, V19, P219; Teng G, 2016, APPL SOFT COMPUT, V43, P35, DOI 10.1016/j.asoc.2016.01.043; Tiun S, 2020, LECT NOTES ELECTR EN, V603, P435, DOI 10.1007/978-981-15-0058-9_42; Vega-Pons S, 2011, INT J PATTERN RECOGN, V25, P337, DOI 10.1142/S0218001411008683; Vijitha C., 2014, INT J COMPUTER SCI I, V5, P5987; Wahid A, 2015, IEEE C EVOL COMPUTAT, P1696, DOI 10.1109/CEC.2015.7257091; Wang Y., 2016, PROC INT JOINT C ART, P2153; Wei C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146672; Wei Wang, 2010, Proceedings of the 2010 International Conference on Machine Vision and Human-Machine Interface (MVHI 2010), P604, DOI 10.1109/MVHI.2010.72; Yang Y., 2018, BIG DATA MINING ANAL, V1, P83; Yin JH, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P233, DOI 10.1145/2623330.2623715; Zaw MM, 2012, T GIGAKU SCOPE POLIC; Zhang LS, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS (ROBIO), P757, DOI 10.1109/ROBIO.2015.7418860; Zhang YJ, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0055-0; Zhou Z., 2015, ENCY BIOMETRICS, V2nd, P411, DOI DOI 10.1007/978-1-4899-7488-4_293; Zhu DC, 2016, 2016 IEEE INFORMATION TECHNOLOGY, NETWORKING, ELECTRONIC AND AUTOMATION CONTROL CONFERENCE (ITNEC), P1060, DOI 10.1109/ITNEC.2016.7560526	61	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245264	10.1371/journal.pone.0245264	http://dx.doi.org/10.1371/journal.pone.0245264			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449949	Green Published, gold			2022-12-26	WOS:000609991600036
J	Foo, VHX; Liu, YC; Ong, HS; Ang, M; Mehta, JS				Foo, Valencia Hui Xian; Liu, Yu-Chi; Ong, Hon Shing; Ang, Marcus; Mehta, Jodhbir S.			The effects of laser displacement on femtosecond laser-assisted conjunctival autograft preparation for pterygium surgery	PLOS ONE			English	Article								Aims To evaluate the effects of no-suction femtosecond laser (FSL) stability on conjunctival autograft (CAG) dissection in pterygium surgery. Methods Prospective analysis of 35 eyes from 34 subjects who underwent femtosecond laser-assisted pterygium surgery with the Ziemer Z8 laser (Ophthalmic Systems AG, Switzerland). Intraoperative absolute FSL displacements were measured and correlated with the duration and ease of CAG peel, CAG thickness, measured with intraoperative optical coherence tomography, and deviation from intended graft thickness. Results The median absolute FSL displacement was 22 mu m (interquartile range [IQR] 14.7 to 60.8), while median vertical FSL displacement was 14.7 mu m (IQR 7.3 to 44) and median horizontal FSL displacement was 22.0 mu m (IQR 14.7 to 44). 65.7% had a grade 1 peel, 11.4% had grade 2 peel, 14.3% had grade 3 peel and 8.6% had grade 4 peel. The median duration of CAG peel was 5.4 seconds (IQR 3 to 21.4). The median CAG thickness was 69 mu m (IQR 60.3 to 78.5), and the median deviation from targeted graft thickness was 9 mu m (IQR 1 to 16). Eyes with more difficult peels and longer duration of CAG peels had significantly greater vertical FSL displacements (p = 0.04 and 0.02 respectively), but not horizontal displacement, age, ethnicity, CAG thickness or deviation from original thickness, compared to those with better quality and shorter duration peels. 1 eye (2.9%) had an incomplete CAG peel with a buttonhole and 2 eyes had graft tears (5.7%). Conclusion Micro-displacements during the suction-free CAG preparation are common but they did not affect the quality of the CAG peel, duration of peel, or CAG thickness. However, vertical globe displacement during FSL-assisted CAG creation was significantly associated with a more difficult and longer CAG peel duration. This highlights the importance of the cornea traction suture fixation to ensure stability of the eye during FSL application.	[Foo, Valencia Hui Xian; Liu, Yu-Chi; Ong, Hon Shing; Ang, Marcus; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Foo, Valencia Hui Xian; Liu, Yu-Chi; Ong, Hon Shing; Ang, Marcus; Mehta, Jodhbir S.] Singapore Eye Res Inst, Singapore, Singapore; [Liu, Yu-Chi; Ong, Hon Shing; Ang, Marcus; Mehta, Jodhbir S.] Duke Natl Univ Singapore, Ophthalmol & Visual Sci Acad Clin Res Program, Grad Med Sch, Singapore, Singapore	Singapore National Eye Center; National University of Singapore; Singapore National Eye Center; National University of Singapore	Mehta, JS (corresponding author), Singapore Natl Eye Ctr, Singapore, Singapore.; Mehta, JS (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.; Mehta, JS (corresponding author), Duke Natl Univ Singapore, Ophthalmol & Visual Sci Acad Clin Res Program, Grad Med Sch, Singapore, Singapore.	jodhbir.mehta@singhealth.com.sg		Foo, Valencia/0000-0002-2840-8134; Ong, Hon Shing/0000-0001-5475-8712				Ang M, 2012, OPHTHALMOLOGY, V119, P1509, DOI 10.1016/j.ophtha.2012.02.009; [Anonymous], 2016, J LARGE SCALE RES FA, V2, pA49; Binder PS, 2010, EYE CONTACT LENS, V36, P282, DOI 10.1097/ICL.0b013e3181ee2d11; Callou TP, 2016, CLIN OPHTHALMOL, V10, P697, DOI 10.2147/OPTH.S99741; Chung SH, 2009, J BIOPHOTONICS, V2, P557, DOI 10.1002/jbio.200910053; DETELS R, 1967, ARCH OPHTHALMOL-CHIC, V78, P485; Fuest M, 2017, CORNEA, V36, P889, DOI 10.1097/ICO.0000000000001230; Fuest M, 2017, OCUL SURF, V15, P211, DOI 10.1016/j.jtos.2016.12.001; Grewal DS, 2016, SURV OPHTHALMOL, V61, P103, DOI 10.1016/j.survophthal.2015.09.002; Howlett J, 2014, J Curr Glaucoma Pract, V8, P63, DOI 10.5005/jp-journals-10008-1163; Khaw PT, 2012, DEV OPHTHALMOL, V50, P1, DOI 10.1159/000334776; Kuo MX, 2015, CORNEA, V34, P824, DOI 10.1097/ICO.0000000000000461; Kymionis GD, 2012, J REFRACT SURG, V28, P912, DOI 10.3928/1081597X-20121116-01; LARUCHE G, 1992, ANN DERMATOL VENER, V119, P567; Liu YC, 2019, AM J OPHTHALMOLOGY; Liu YC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59586-z; Mohammed I, 2011, ANN AFR MED, V10, P197, DOI 10.4103/1596-3519.84695; MORAN DJ, 1984, BRIT J OPHTHALMOL, V68, P343, DOI 10.1136/bjo.68.5.343; Pajic B, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17061429; TAYLOR HR, 1992, ARCH OPHTHALMOL-CHIC, V110, P99, DOI 10.1001/archopht.1992.01080130101035; Ti SE, 2000, BRIT J OPHTHALMOL, V84, P385, DOI 10.1136/bjo.84.4.385; WELSH NH, 1970, BRIT J OPHTHALMOL, V54, P594, DOI 10.1136/bjo.54.9.594; Williams GP, 2015, SCI REP-UK, V5, DOI 10.1038/srep14742; Wu KL, 1999, EPIDEMIOLOGICAL CHAR, V7, P17; Zhang XR, 2013, INVEST OPHTH VIS SCI, V54, P4705, DOI 10.1167/iovs.12-11003	25	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245223	10.1371/journal.pone.0245223	http://dx.doi.org/10.1371/journal.pone.0245223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444405	Green Published, gold			2022-12-26	WOS:000609988100084
J	Habib, MA; Dayyab, FM; Iliyasu, G; Habib, AG				Habib, Maryam Abdulrazaq; Dayyab, Farouq Muhammad; Iliyasu, Garba; Habib, Abdulrazaq G.			Knowledge, attitude and practice survey of COVID-19 pandemic in Northern Nigeria	PLOS ONE			English	Article								Background A pandemic of coronavirus disease 2019 (COVID-19) emerged and affected most of the world in early 2020. To inform effective public health measures we conducted a knowledge, attitude and practice (KAP) survey among a Hausa Muslim society in Nigeria in March 2020. Methods The study is an analytic cross-sectional survey with questionnaires administered to the general population including Health Care Workers (HCW) in Kano, Nigeria. Participants were recruited by convenience sampling following informed consent. The percentage of KAP scores were categorized as good and poor. Independent predictors of good knowledge of COVID 19 were ascertained using a binary logistic regression model. Results The questionnaire was administered among urban 32.8%, peri-urban dwellers 32.4%, and to online participants 34.8%. The peri-urban and urban participants were given paper questionnaires. There were 886 study participants with mean age 28.58yrs [SD:10.25] (Interquartile range [IQR]:22yrs-32yrs), males 55.4% with 57.3% having had or were in tertiary education. Most participants were students 40% and civil servants 20%. The overall mean [standard deviation (SD)] for knowledge, attitude and practice scores expressed in percentage was 65.38%[SD15.90], 71.45% [SD14.10], and 65.04% [SD17.02] respectively. Out of the respondents, 270(30.47%) had good knowledge (GK), 158(17.8%) had good attitude (GA), and 230(25.96%) had good practice (GP) using cut-off scores of 75%, 86.5%, and 75% respectively. Over 48% did not agree COVID-19 originated from animals while 60% perceived the pandemic to be due to God's punishment. Also, 36% thought it was a man-made virus. When rating fear, most respondents [63.5%] had marked fear i.e. >= 7 out of 10 and 56% admitted to modifying their habits recently in fear of contracting the virus. As regards attitude to religious norms, 77.77% agreed on cancellation of the lesser pilgrimage as a measure to curb the spread of the disease while 23.64% admitted that greater pilgrimage (Hajj) should proceed despite the persistence of the ongoing pandemic. About 50% of the respondents insisted on attending Friday congregational prayers despite social distancing. One in four people still harbored stigma towards a person who has recovered from the virus. 28% felt some races are more at risk of the disease though 66% mentioned always practicing social distancing from persons coughing or sneezing. Almost 70% of respondents said they were willing to accept a vaccine with 39% saying they would be willing to pay for it if not publicly funded. In univariate analysis increasing age and having been ever married were associated with GK while tertiary education was associated with GA [Odds Ratio; 95% Confidence Interval] 2.66(1.79-3.95). Independent positive predictors of GK were those who were or had ever been married, those who had marked fear of COVID-19, and had modified their habits in the last three months. Those who had non-tertiary education and had the questionnaire administered as paper rather than online version had GK but age was not a predictor. Conclusion Knowledge of transmission and preventive measures should be improved in the general population cognizant of cultural norms and Islamic practices. The study highlights the importance of considering belief systems and perception in developing control measures against COVID-19.	[Habib, Maryam Abdulrazaq] Murtala Mohammed Specialist Hosp, Dept Internal Med, Kano, Kano State, Nigeria; [Dayyab, Farouq Muhammad] Infect Dis Hosp, Kano, Kano State, Nigeria; [Iliyasu, Garba; Habib, Abdulrazaq G.] Bayero Univ, Coll Hlth Sci, Infect & Trop Dis Unit, Kano, Kano State, Nigeria	Bayero University	Habib, MA (corresponding author), Murtala Mohammed Specialist Hosp, Dept Internal Med, Kano, Kano State, Nigeria.	abdulrazaqmaryam18@gmail.com		Habib, Maryam/0000-0002-4904-4237; Dayyab, Farouq/0000-0001-8920-6483				Abir T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145252; Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217; [Anonymous], 2020, NAT MED, V26, P1, DOI 10.1038/s41591-019-0740-8; [Anonymous], COR DIS COVID 2019 R; Berman M, 2020, ANN BEHAV MED, V54, P728, DOI 10.1093/abm/kaaa074; Center for Disease Control and Prevention (CDC), COVID 19 WHAT YOU SH; Centers for Disease Control and Prevention, PREV COVID 19 SPREAD; Centers for Disease Control and Prevention, COR DIS 2019 COVID 1, DOI DOI 10.1016/S0140-6736(20)30211-7; Centers for Disease Control and Prevention (CDC), INT CLIN GUID MAN PA; Consolo U, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103459; Cummins E, 2020, MEDSCAPE; Deng SQ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020575; Du Toit LC, 2020, 9 POPULAR MYTHS DOIN; European Center for Disease Control and Prevention (ECDC), COVID 19 SIT UPD WOR; Hager E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236918; Iliyasu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135955; Latifat O, 2020, DAILY TRUST 0228; Li WG, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-3312; Maclean R., 2020, NY TIMES; Mallhi TH, 2018, PEERJ, V6, DOI 10.7717/peerj.5481; Mbah F, 2020, AL JAZEERA; Oyeyemi SO, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6178; Papagiannis D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144925; Peng YL, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09392-z; Puspitasari IM, 2020, J MULTIDISCIP HEALTH, V13, P727, DOI 10.2147/JMDH.S265527; Sallam M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144915; Temsah MH, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001958; Tesfaye ZT, 2020, INTEGR PHARM RES PRA, V9, P105, DOI 10.2147/IPRP.S261275; UNICEF, SOC STIGM ASS COVID; Usman IM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00340; Zanin GM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093024	31	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245176	10.1371/journal.pone.0245176	http://dx.doi.org/10.1371/journal.pone.0245176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444360	gold, Green Published			2022-12-26	WOS:000609988100015
J	Matsuoka, Y; Al-Shareef, H; Kogo, M; Nakahara, H				Matsuoka, Yudai; Al-Shareef, Hani; Kogo, Mikihiko; Nakahara, Hirokazu			Effects of decreased Rac activity and malignant state on oral squamous cell carcinoma in vitro	PLOS ONE			English	Article							N-TERMINAL KINASE; RHO GTPASES; APOPTOSIS; ACTIVATION; SUPPRESSION; INHIBITION; BINDING; CDC42	Rac proteins, members of the Rho family of small GTP-binding proteins, have been implicated in transducing a number of signals for various biological mechanisms, including cell cytoskeleton organization, transcription, proliferation, migration, and cancer cell motility. Among human cancers, Rac proteins are highly activated by either overexpression of the genes, up-regulation of the protein, or by mutations that allow the protein to elude normal regulatory signaling pathways. Rac proteins are involved in controlling cell survival and apoptosis. The effects of Rac inhibition by the Rac-specific small molecule inhibitor NSC23766 or by transfection of dominant negative Rac (Rac-DN) were examined on three human-derived oral squamous cell carcinoma cell lines that exhibit different malignancy grades, OSC-20 (grade 3), OSC-19 (grade 4C), and HOC313 (grade 4D). Upon suppression of Rac, OSC-19 and HOC313 cells showed significant decreases in Rac activity and resulted in condensation of the nuclei and up-regulation of c-Jun N-terminal kinase (JNK), leading to caspase-dependent apoptosis. In contrast, OSC-20 cells showed only a slight decrease in Rac activity, which resulted in slight activation of JNK and no change in the nuclei. Fibroblasts treated with NSC23766 also showed only a slight decrease in Rac activity with no change in the nuclei or JNK activity. Our results indicated that apoptosis elicited by the inhibition of Rac depended on the extent of decreased Rac activity and the malignant state of the squamous cell carcinoma. In addition, activation of JNK strongly correlated with apoptosis. Rac inhibition may represent a novel therapeutic approach for cancer treatment.	[Matsuoka, Yudai; Kogo, Mikihiko; Nakahara, Hirokazu] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, Suita, Osaka, Japan; [Al-Shareef, Hani; Nakahara, Hirokazu] Osaka City Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Osaka, Osaka, Japan	Osaka University; Osaka Metropolitan University	Nakahara, H (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, Suita, Osaka, Japan.; Nakahara, H (corresponding author), Osaka City Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Osaka, Osaka, Japan.	nakahara.hirokazu@med.osaka-cu.ac.jp	Al-Shareef, Hani/L-6891-2018	Al-Shareef, Hani/0000-0002-8050-0667	Japan Society for the Promotion of Science (JSPS) [20592328]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Hirokazu Nakahara Japan Society for the Promotion of Science (JSPS) grant (grant no. 20592328). http://www.jsps.go.jp/english/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aznar S, 2001, CANCER LETT, V165, P1, DOI 10.1016/S0304-3835(01)00412-8; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Coleman ML, 2002, CELL DEATH DIFFER, V9, P493, DOI 10.1038/sj.cdd.4400987; Gallagher ED, 2002, J BIOL CHEM, V277, P45785, DOI 10.1074/jbc.M207702200; Guo F, 2008, BLOOD, V112, P1767, DOI 10.1182/blood-2008-01-132068; Imamura H, 1998, MOL BIOL CELL, V9, P2561, DOI 10.1091/mbc.9.9.2561; Jin S, 2008, AM J PHYSIOL-GASTR L, V294, pG928, DOI 10.1152/ajpgi.00219.2007; Joiakim A, 2003, DRUG METAB DISPOS, V31, P1279, DOI 10.1124/dmd.31.11.1279; Kamai T, 2004, CLIN CANCER RES, V10, P4799, DOI 10.1158/1078-0432.CCR-0436-03; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Li H, 2014, BIOFACTORS, V40, P226, DOI 10.1002/biof.1155; Matsuoka Y, 2008, ORAL SCI INT, V5, P52, DOI 10.1016/S1348-8643(08)80006-7; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Senger DL, 2002, CANCER RES, V62, P2131; Stankiewicz TR, 2015, J BIOL CHEM, V290, P9363, DOI 10.1074/jbc.M114.575217; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Wang RA, 2013, J CELL MOL MED, V17, P205, DOI 10.1111/j.1582-4934.2012.01663.x; Wang Wei, 2004, Zhonghua Zhongliu Zazhi, V26, P279; YAMAMOTO E, 1983, CANCER, V51, P2175, DOI 10.1002/1097-0142(19830615)51:12<2175::AID-CNCR2820511205>3.0.CO;2-M; Zhang BL, 2004, MOL CELL BIOL, V24, P6205, DOI 10.1128/MCB.24.14.6205-6214.2004	22	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0212323	10.1371/journal.pone.0212323	http://dx.doi.org/10.1371/journal.pone.0212323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444335	Green Published, gold, Green Submitted			2022-12-26	WOS:000609988100066
J	Vediappan, RS; Bennett, C; Cooksley, C; Finnie, J; Trochsler, M; Quarrington, RD; Jones, CF; Bassiouni, A; Moratti, S; Psaltis, AJ; Maddern, G; Vreugde, S; Wormald, PJ				Vediappan, Rajan Sundaresan; Bennett, Catherine; Cooksley, Clare; Finnie, John; Trochsler, Markus; Quarrington, Ryan D.; Jones, Claire F.; Bassiouni, Ahmed; Moratti, Stephen; Psaltis, Alkis J.; Maddern, Guy; Vreugde, Sarah; Wormald, P. J.			Prevention of adhesions post-abdominal surgery: Assessing the safety and efficacy of Chitogel with Deferiprone in a rat model	PLOS ONE			English	Article							CHITOSAN-DEXTRAN GEL; ENDOSCOPIC SINUS SURGERY; PERITONEAL ADHESIONS; GALLIUM-PROTOPORPHYRIN; UNITED-STATES; SHEEP MODEL; OBSTRUCTION; HEMOSTASIS; HYDROGEL; BARRIERS	Introduction Adhesions are often considered to be an inevitable consequence of abdominal and pelvic surgery, jeopardizing the medium and long-term success of these procedures. Numerous strategies have been tested to reduce adhesion formation, however, to date, no surgical or medical therapeutic approaches have been successful in its prevention. This study demonstrates the safety and efficacy of Chitogel with Deferiprone and/or antibacterial Gallium Protoporphyrin in different concentrations in preventing adhesion formation after abdominal surgery. Materials and methods 112 adult (8-10 week old) male Wistar albino rats were subjected to midline laparotomy and caecal abrasion, with 48 rats having an additional enterotomy and suturing. Kaolin (0.005g/ml) was applied to further accelerate adhesion formation. The abrasion model rats were randomized to receive saline, Chitogel, or Chitogel plus Deferiprone (5, 10 or 20 mM), together with Gallium Protoporphyrin (250 mu g/mL). The abrasion with enterotomy rats were randomised to receive saline, Chitogel or Chitogel with Deferiprone (1 or 5 mM). At day 21, rats were euthanised, and adhesions graded macroscopically and microscopically; the tensile strength of the repaired caecum was determined by an investigator blinded to the treatment groups. Results Chitogel with Deferiprone 5 mM significantly reduced adhesion formation (p<0.01) when pathologically assessed in a rat abrasion model. Chitogel with Deferiprone 5 mM and 1 mM also significantly reduced adhesions (p<0.05) after abrasion with enterotomy. Def-Chitogel 1mM treatment did not weaken the enterotomy site with treated sites having significantly better tensile strength compared to control saline treated enterotomy rats. Conclusions Chitogel with Deferiprone 1 mM constitutes an effective preventative anti-adhesion barrier after abdominal surgery in a rat model. Moreover, this therapeutic combination of agents is safe and does not weaken the healing of the sutured enterotomy site.	[Vediappan, Rajan Sundaresan; Bennett, Catherine; Cooksley, Clare; Bassiouni, Ahmed; Psaltis, Alkis J.; Vreugde, Sarah; Wormald, P. J.] Univ Adelaide, Dept Surg Otolaryngol Head & Neck Surg, Adelaide, SA, Australia; [Finnie, John] Univ Adelaide, SA Pathol & Adelaide Med Sch, Adelaide, SA, Australia; [Trochsler, Markus; Maddern, Guy] Univ Adelaide, Dept Surg, Adelaide, SA, Australia; [Quarrington, Ryan D.; Jones, Claire F.] Univ Adelaide, Adelaide Med Sch, Adelaide Spinal Res Grp, Ctr Orthopaed & Trauma Res, Adelaide, SA, Australia; [Jones, Claire F.] Univ Adelaide, Sch Mech Engn, Adelaide, SA, Australia; [Moratti, Stephen] Univ Otago, Dept Chem, Dunedin, New Zealand	University of Adelaide; SA Pathology; University of Adelaide; University of Adelaide; University of Adelaide; University of Adelaide; University of Otago	Wormald, PJ (corresponding author), Univ Adelaide, Dept Surg Otolaryngol Head & Neck Surg, Adelaide, SA, Australia.	peterj.wormald@adelaide.edu.au	Quarrington, Ryan/R-6132-2019; Jones, Claire Frances/C-4942-2012	Quarrington, Ryan/0000-0002-0633-2482; Jones, Claire Frances/0000-0002-0995-1182; Bassiouni, Ahmed/0000-0002-5545-0194; Vediappan, Rajan Sundaresan/0000-0001-5370-8262	NHMRC [APP1171756]; Hospital Research Foundation; University of Adelaide under Australian Government Research Training Program Scholarship	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Hospital Research Foundation; University of Adelaide under Australian Government Research Training Program Scholarship	This project is supported by an NHMRC Development grant APP1171756 awarded to SM, SV, GM and MT. RSV was supported by The Hospital Research Foundation and The University of Adelaide under Australian Government Research Training Program Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S., 2016, ACHIEVEMENTS LIFE SC, V10, P27, DOI 10.1016/j; [Anonymous], 2020, BMC PEDIATR, V20, P1, DOI DOI 10.1016/J.CLAE.2020.04.011; Athanasiadis T, 2008, LARYNGOSCOPE, V118, P1088, DOI 10.1097/MLG.0b013e31816ba576; Cabral JD, 2015, J BIOMED MATER RES A, V103, P2611, DOI 10.1002/jbm.a.35395; Cabral JD, 2014, J MATER SCI-MATER M, V25, P2743, DOI 10.1007/s10856-014-5292-3; Carney MJ, 2017, AM J SURG, V214, P287, DOI 10.1016/j.amjsurg.2017.01.001; Davey AK, 2007, J MINIM INVAS GYN, V14, P15, DOI 10.1016/j.jmig.2006.07.013; diZerega GSe, 2000, SPRINGERLINK PERITON; diZeregal GS, 2001, HUM REPROD UPDATE, V7, P547, DOI 10.1093/humupd/7.6.547; Giles D, 2019, SHACKELFORDS SURG AL, P1005; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Ha T, 2018, INT FORUM ALLERGY RH, V8, P435, DOI 10.1002/alr.22057; Kennedy R, 1996, SURGERY, V120, P866, DOI 10.1016/S0039-6060(96)80096-1; Lauder CIW, 2012, J SURG RES, V176, P448, DOI 10.1016/j.jss.2011.10.029; Lauder CIW, 2011, J SURG RES, V171, P877, DOI 10.1016/j.jss.2010.06.028; Mais V, 2014, WORLD J GASTROENTERO, V20, P4917, DOI 10.3748/wjg.v20.i17.4917; Correa-Rovelo JM, 2015, CIR CIR, V83, P345, DOI 10.1016/j.circir.2015.05.024; Menzies D, 2001, ANN ROY COLL SURG, V83, P40; Munireddy S, 2010, SURG CLIN N AM, V90, P1227, DOI 10.1016/j.suc.2010.08.002; Okabayashi K, 2014, SURG TODAY, V44, P405, DOI 10.1007/s00595-013-0591-8; Ong SY, 2008, BIOMATERIALS, V29, P4323, DOI 10.1016/j.biomaterials.2008.07.034; Ooi ML, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00917; Paramasivan S, 2014, AM J RHINOL ALLERGY, V28, P361, DOI 10.2500/ajra.2014.28.4069; Ramezanpour M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38902-2; Ray NF, 1998, J AM COLL SURGEONS, V186, P1, DOI 10.1016/S1072-7515(97)00127-0; Richter K, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00481-17; Richter K, 2016, INT FORUM ALLERGY RH, V6, P737, DOI 10.1002/alr.21735; Sikirica V, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-13; ten Broek RPG, 2014, LANCET, V383, P48, DOI 10.1016/S0140-6736(13)61687-6; ten Broek RPG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5588; Ha TN, 2013, INT FORUM ALLERGY RH, V3, P573, DOI 10.1002/alr.21136; Trochsler M, 2014, LANCET, V383, P8, DOI 10.1016/S0140-6736(13)62002-4; Vakalopoulos KA, 2013, J SURG RES, V180, P290, DOI 10.1016/j.jss.2012.12.043; Valentine R, 2010, AM J RHINOL ALLERGY, V24, P70, DOI 10.2500/ajra.2010.24.3422; Valentine R, 2009, AM J RHINOL ALLERGY, V23, P71, DOI 10.2500/ajra.2009.23.3266; Vediappan RS, 2020, FRONT SURG, V7, DOI 10.3389/fsurg.2020.00012; Vediappan RS, 2020, J CLIN NEUROSCI, V72, P378, DOI 10.1016/j.jocn.2019.12.042; Venables WN., 2002, MODERN APPL STAT S 4	38	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0244503	10.1371/journal.pone.0244503	http://dx.doi.org/10.1371/journal.pone.0244503			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444337	Green Published, gold			2022-12-26	WOS:000609988100042
J	Silva, MHME; Garlet, J; Silva, FL; Paula, CD				Martins e Silva, Marcus Henrique; Garlet, Juliana; Silva, Fernando Luiz; Paula, Carla da Silva			Coleoborers (Curculionidae: Scolytinae) in native and homogeneous systems of Brazil nut (Bertholletia excelsa bonpl.) in the Southern Amazon, Brazil	PLOS ONE			English	Article								Brazil nut is one of the most important species of the Amazon due to its socioeconomic importance. Especially in homogeneous production systems, it may be susceptible to damage by wood-boring insects, as by the subfamily Scolytinae (Coleoptera: Curculionidae); thus, inadequate management conditions can cause economic damage. Therefore, the objective of the present work is to evaluate the occurrence of wood-boring insects (Curculionidae: Scolytinae) in native and homogeneous systems of Brazil nut in the Meridional Amazonian, Brazil. The study was conducted in three environments: Brazil Nut Native Anthropized, Homogeneous Brazil Nut and Brazil Nut Native Preserved. Twelve ethanol (96 degrees GL) traps were installed in each environment during four sampling periods. The data were submitted to entomofaunistic analysis, Pearson ' s correlation analysis and cluster analysis. A total of 2,243 individuals from 31 species were sampled, of which 23 were from the Brazil Nut Native Anthropized nut, 24 from the Homogeneous Brazil Nut and 26 from the Brazil Nut Native Preserved. Some species are restricted to a specific environment, such as Corthylocurus vernaculus Wood & Bright, 1992 and Xyleborus biconicus Eggers, 1928, in relation to Brazil Nut Native Anthropized, Xyleborus tolimanus Eggers, 1928 that occurred only in Homogeneous Brazil Nut and Corthylus antennarius Schedl and Hypothenus bolivianus Wood & Bright, 1992 verified only in Brazil Nut Native Preserved. In the faunistic analysis, we highlight the species Xyleborus affinis (Eichhoff, 1868), which was the most representative one in the three environments and a super-dominant species in all four sampling periods. Among the species considered indicator due to their high representativeness in the sampling, only Premnobius cavipennis Eichhoff, 1878 showed a significant negative correlation between its abundance and the minimum temperature for environments Homogeneous Brazil Nut and Brazil Nut Native Preserved. There was a greater similarity between the Brazil Nut Native Anthropized and the Brazil Nut Native Preserved; these two environments showed dissimilarity with the Homogeneous Brazil Nut. Monitoring wood-boring insects in Brazil nut agroecosystems is fundamental for the establishment of integrated pest management strategies.	[Martins e Silva, Marcus Henrique; Silva, Fernando Luiz] Fed Inst Mato Grosso, Campus Alta Floresta, Alta Floresta, Brazil; [Garlet, Juliana] Estate Univ Mato Grosso, Fac Biol & Agr Sci, Campus Alta Floresta, Alta Floresta, Brazil; [Paula, Carla da Silva] Fed Univ Para, Belem, Para, Brazil; [Martins e Silva, Marcus Henrique] Inst Mato Grosso, Campus Alta Floresta, Alta Floresta, Mato Grosso, Brazil; [Garlet, Juliana] Univ Estado Mato Grosso, Campus Alta Floresta, Alta Floresta, Mato Grosso, Brazil	Instituto Federal de Mato Grosso (IFMT); Universidade Federal do Para; Universidade do Estado de Mato Grosso	Silva, MHME (corresponding author), Fed Inst Mato Grosso, Campus Alta Floresta, Alta Floresta, Brazil.; Silva, MHME (corresponding author), Inst Mato Grosso, Campus Alta Floresta, Alta Floresta, Mato Grosso, Brazil.	marcus.silva@alf.ifmt.edu.br		Paula, Carla/0000-0002-6328-5395; Silva, Fernando Luiz/0000-0002-7897-0395; MARTINS E SILVA, MARCUS HENRIQUE/0000-0002-9446-1064				Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; [Anonymous], 2014, B MUS E GOELDI CIENC, DOI DOI 10.46357/BCNATURAIS.V9I2.534; Baker WL, 1972, E FOREST INSECTS MIS, V1175; Caioni C, 2014, ENCICLOPEDIA BIOSFER, V10, P2656; Cajaiba Reinaldo Lucas, 2018, Neotropical Biology and Conservation, V13, P10, DOI 10.4013/nbc.2018.131.02; Ciesla WM, 2011, FOREST ENTOMOLOGY: A GLOBAL PERSPECTIVE, P173; DORVAL A, 2012, MULTITEMAS       JUL, P21; Flechtmann CAH, 2019, ATENA EDITORA, P15; GARLET J, 2012, PESQUISA FLORESTAL B, V32, P115, DOI [DOI 10.4336/2012.PFB.32.69.115, 10.4336/2012.pfb.32.69.115]; Gomes FB, 2015, BIOSCI J, V31, P1708, DOI 10.14393/BJ-v31n6a2015-29433; Gumier-Costa F., 1 RECORD COFFEE BERR; Gusmao RS., 2011, AN FAUN SCOL COL COL; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Homma A. K. O., 2014, Boletim do Museu Paraense Emilio Goeldi, Ciencias Naturais, V9, P293; HOMMA A. K. O, 2014, EXTRATIVISMO VEGETAL; Hulcr J, 2017, ANNU REV ENTOMOL, V62, P285, DOI 10.1146/annurev-ento-031616-035105; Jorge, 2017, ESPACIOS, V38, P28; Jorge VC, 2016, ESPACIOS, V37, P27; Lunzi AM, 2011, CIENC RURAL, V41, P2101, DOI 10.1590/S0103-84782011001200011; Machado LM, 2017, CIENC FLOREST, V27, P669, DOI 10.5902/1980509827751; Meurer E., 2013, ACTA BIOL PARANA, V42, P195, DOI DOI 10.5380/ABPR.V42I1-4.35214; Monteiro M, 2019, BIOSCI J, V35, P826, DOI 10.14393/BJ-v35n3a2019-41992; Monteiro M, 2018, CIENC FLOREST, V28, P913, DOI 10.5902/1980509833355; Moraes RCB, 2003, SCCONTR BIOL SAO PED; Peres Filho O., 2007, Floresta e Ambiente, V14, P45; Pimentel LD, 2007, INFORM EC, V37, P26; Pinheiro A, 2018, COMPORTAMENTO VOO FL; Pires EM, 2017, SCI ELECT ARCH, V10, P1; Pires EM, 2018, SCI ELECT ARCH, V11, P57; Pires EM, 2019, FLA ENTOMOL, V102, P76, DOI 10.1653/024.102.0111; Pires EM, 2018, FLA ENTOMOL, V101, P684, DOI 10.1653/024.101.0407; Rocha WD, 2015, FLORESTA AMBIENTE, V22, P88, DOI 10.1590/2179-8087.0049; Rockwell CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135464; Rodriguez CS, 2017, ENVIRON ENTOMOL, V46, P1254, DOI 10.1093/ee/nvx160; Silva J. M. da, 2018, Journal of Agricultural Science (Toronto), V10, P457, DOI 10.5539/jas.v10n8p457; Silveira-Neto S., 1976, MANUAL ECOLOGIA INSE; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stilwell AR, 2014, J ECON ENTOMOL, V107, P675, DOI 10.1603/EC13559; Tonini H, 2019, CIENC FLOREST, V29, P607, DOI 10.5902/1980509822112; Wood S. L., 1982, The bark and ambrosia beetles of North and Central America (Coleoptera : Scolytidae), a taxonomic monograph.; Wood S.L., 2007, BARK AMBROSIA BEETLE; Wood SL, 1986, GREAT BASIN NAT MEM, V48, P188; Wratten SD, 1981, ECOLOGIA INTERACO EN	43	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0234287	10.1371/journal.pone.0234287	http://dx.doi.org/10.1371/journal.pone.0234287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428621	Green Published, Green Submitted, gold			2022-12-26	WOS:000630036100001
J	Yoshida, Y; Takashima, R; Yano, R				Yoshida, Yuko; Takashima, Risa; Yano, Rika			Is skin disinfection before subcutaneous injection necessary? The reasoning of Certified Nurses in Infection Control in Japan	PLOS ONE			English	Article								Nurses continue to disinfect the skin before administering subcutaneous injections as a standard process in clinical settings; despite evidence that disinfection is not necessary. To implement evidence-based practice, it is critical to explore why this gap between "evidence" and "practice" exists. This study aimed to describe the reasons offered by Certified Nurses in Infection Control (CNIC) in Japan for performing skin disinfection before subcutaneous injection. Adopting an inductive qualitative design, interviews were conducted with 10 CNIC in 2013. According to the participants, skin disinfection before subcutaneous injection: (a) was common practice; (b) may have been beneficial if it was omitted; (c) adhered to hospital norms; (d) prevented persistent suspicion of infection; (e) had no detrimental effect; (f) was an ingrained custom; and (g) involved a tacit approval for not disinfecting in home care settings. The themes (c) and (g) were cited as the main reasons affecting decision-making. The CNIC administered injections following skin disinfection in hospitals in accordance with hospital norms. On the contrary, outside the hospital, they administered subcutaneous injections without skin disinfection. All themes except (b) and (g) reflect the barriers and resistance to omitting skin disinfection, while (g) shows that it is already partly implemented in home care settings. It is necessary to create a guideline for skin disinfection before subcutaneous injection that considers the quality of life of patients at home, their physical conditions, and the surrounding environment at the time of injection, in addition to the guidelines applicable in hospitals.	[Yoshida, Yuko; Yano, Rika] Hokkaido Univ, Fac Hlth Sci, Dept Fundamental Nursing, Sapporo, Hokkaido, Japan; [Takashima, Risa] Hokkaido Univ, Fac Hlth Sci, Dept Functioning & Disabil, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Yoshida, Y (corresponding author), Hokkaido Univ, Fac Hlth Sci, Dept Fundamental Nursing, Sapporo, Hokkaido, Japan.	yuko790402@hs.hokudai.ac.jp		Yoshida, Yuko/0000-0001-7494-888X	Japan Society for the Promotion of Science, Tokyo, Japan (KAKENHI) [JP26861850]	Japan Society for the Promotion of Science, Tokyo, Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion of Science, Tokyo, Japan (KAKENHI Grant Number JP26861850).	American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS106; Argemi X, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051215; Australian Diabetes Educators Association, 2017, CLIN GUID PRINC SUB; Bardsley Alison, 2015, Br J Community Nurs, V20, P166, DOI 10.12968/bjcn.2015.20.4.166; Blanco M, 2013, Diabetes Metab, V39, P445, DOI 10.1016/j.diabet.2013.05.006; Burnard P, 1991, Nurse Educ Today, V11, P461, DOI 10.1016/0260-6917(91)90009-Y; DANN TC, 1969, LANCET, V2, P96; Dunleavy K, 2017, DRUG ALCOHOL DEPEN, V174, P91, DOI 10.1016/j.drugalcdep.2017.01.020; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Ercole FF, 2013, REV LAT-AM ENFERM, V21, P459, DOI 10.1590/S0104-11692013000100023; Fleming DR, 1997, DIABETES CARE, V20, P244, DOI 10.2337/diacare.20.3.244; Forum for Injection Technique UK, 2016, UK INJ INF TECHN REC, V4th ed., DOI [14/7946/3482/FIT_UK_Recommendations_4th_Edition.pdf, DOI 14/7946/3482/FIT_UK_RECOMMENDATIONS_4TH_EDITION.PDF]; Frid AH, 2016, MAYO CLIN PROC, V91, P1231, DOI 10.1016/j.mayocp.2016.06.010; Gangawane AK, 2016, J DIABETES METAB, V7, DOI 10.4172/2155-6156.1000644; Hope VD, 2014, INT J DRUG POLICY, V25, P303, DOI 10.1016/j.drugpo.2013.11.012; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hutin Y, 2003, B WORLD HEALTH ORGAN, V81, P491; Japan Ministry of Health Labour and Welfare, 2019, TEIKISESSHUJISSIYOUR; Karkos B, 2006, J NURS ADMIN, V36, P377, DOI 10.1097/00005110-200607000-00011; Khawaja RA, 2013, J LIAQUAT UNIV MED H, V12, P109; KOIVISTO VA, 1978, LANCET, V1, P1072; Lexico.com, PERCEPTION; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; MCCARTHY JA, 1993, DIABETES CARE, V16, P402, DOI 10.2337/diacare.16.1.402a; Merriam-Webster, 2020, EXPERIENCE; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; Potter PA, 2017, FUNDAMENTALS NURSING, V9th, DOI [10.1186/s12912-017-0213-7, DOI 10.1186/S12912-017-0213-7]; Pozzuoli GM, 2018, ACTA DIABETOL, V55, P67, DOI 10.1007/s00592-017-1066-y; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Schoonover H, 2009, J NURSES PROF DEV, V25, P199, DOI 10.1097/NND.0b013e3181ae145f; Sexson Kathryn, 2017, Am J Nurs, V117, pS7, DOI 10.1097/01.NAJ.0000516387.89892.ba; Tandon Nikhil, 2017, Indian J Endocrinol Metab, V21, P600, DOI 10.4103/ijem.IJEM_97_17; Theofanidis Dimitrios, 2017, Diabetes Spectr, V30, P175, DOI 10.2337/ds16-0001; Upvall MJ, 2018, NURS FORUM, V53, P376, DOI 10.1111/nuf.12256; Vaccine Administration Taskforce Association of Occupational Health Nurse Practitioners British Travel Health Association Community Practitioners' and Health Visitors' Association. Royal College of General Practitioners Royal College of Nursing (Great Britain), 2001, UK GUID BEST PRACT V; World Health Organization, 2009, WHO GUID HAND HYG HL; World Health Organization, 2010, WHO BEST PRACT INJ R; Yoshida Y, 2020, J COMPREH NURS RES, V19; Yoshida Y., 2014, JPN J NURS ART SCI, V13, P140, DOI [10.18892/jsnas.13.2_140, DOI 10.18892/JSNAS.13.2_140, 10.18892/jsnas.13. 2_140]	39	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0245202	10.1371/journal.pone.0245202	http://dx.doi.org/10.1371/journal.pone.0245202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY4OF	33418557	Green Published, gold			2022-12-26	WOS:000630020100022
J	Li, J; Ma, XL; Banerjee, S; Baruah, S; Schnicker, NJ; Roh, E; Ma, WY; Liu, KD; Bode, AM; Dong, ZG				Li, Jian; Ma, Xinli; Banerjee, Surajit; Baruah, Sankar; Schnicker, Nicholas J.; Roh, Eunmiri; Ma, Weiya; Liu, Kangdong; Bode, Ann M.; Dong, Zigang			Structural basis for multifunctional roles of human Ints3 C-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEINS; DOUBLE-STRAND BREAKS; DNA-DAMAGE; MODULAR RECOGNITION; CRYSTAL-STRUCTURE; COMPLEX; HSSB1; INTEGRATOR; REPAIR; PARTICIPATE	Proper repair of damaged DNA is critical for the maintenance of genome stability. A complex composed of Integrator subunit 3 (Ints3), single-stranded DNA-binding protein 1 (SSB1), and SSB-interacting protein 1 (SSBIP1) is required for efficient homologous recombination-dependent repair of double-strand breaks (DSBs) and ataxia-telangiectasia mutated (ATM)-dependent signaling pathways. It is known that in this complex the Ints3 N-terminal domain scaffolds SSB1 and SSBIP1. However, the molecular basis for the function of the Ints3 C-terminal domain remains unclear. Here, we present the crystal structure of the Ints3 C-terminal domain, uncovering a HEAT-repeat superhelical fold. Using structure and mutation analysis, we show that the C-terminal domain exists as a stable dimer. A basic groove and a cluster of conserved residues on two opposite sides of the dimer bind single-stranded RNA/DNA (ssRNA/ssDNA) and Integrator complex subunit 6 (Ints6), respectively. Dimerization is required for nucleic acid binding, but not for Ints6 binding. Additionally, in vitro experiments using HEK 293T cells demonstrate that Ints6 interaction is critical for maintaining SSB1 protein level. Taken together, our findings establish the structural basis of a multifunctional Ints3 C-terminal module, allowing us to propose a novel mode of nucleic acid recognition by helical repeat protein and paving the way for future mechanistic studies.	[Li, Jian; Ma, Xinli; Roh, Eunmiri; Ma, Weiya; Bode, Ann M.] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Li, Jian; Ma, Xinli; Liu, Kangdong; Dong, Zigang] China US Henan Hormel Canc Inst, Zhengzhou, Henan, Peoples R China; [Banerjee, Surajit] Cornell Univ, Northeastern Collaborat Access Team, Adv Photon Source, Lemont, IL USA; [Baruah, Sankar; Schnicker, Nicholas J.] Univ Iowa, Carver Coll Med, Prot & Crystallog Facil, Iowa City, IA USA; [Roh, Eunmiri] Kwangju Womens Univ, Dept Cosmet Sci, Gwangju, South Korea; [Liu, Kangdong; Dong, Zigang] Zhengzhou Univ, Coll Med, Zhengzhou, Henan, Peoples R China	University of Minnesota System; United States Department of Energy (DOE); Argonne National Laboratory; University of Iowa; Zhengzhou University	Dong, ZG (corresponding author), China US Henan Hormel Canc Inst, Zhengzhou, Henan, Peoples R China.; Dong, ZG (corresponding author), Zhengzhou Univ, Coll Med, Zhengzhou, Henan, Peoples R China.	dongzg@zzu.edu.cn		Li, Jian/0000-0002-7532-1728; Dong, Zigang/0000-0002-4174-4028; Liu, Kangdong/0000-0002-4425-5625	National Institute of General Medical Sciences from the National Institutes of Health [P30 GM124165]; NIH-ORIP HEI grant [S10 RR029205]; Hormel Foundation	National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NIH-ORIP HEI grant; Hormel Foundation	This work is supported by The Hormel Foundation and is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P30 GM124165). The Pilatus 6M detector on 24-ID-C beam line is funded by a NIH-ORIP HEI grant (S10 RR029205). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albrecht TR, 2018, NUCLEIC ACIDS RES, V46, P4241, DOI 10.1093/nar/gky100; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Ashton NW, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-9; Bader AS, 2020, BRIT J CANCER, V122, P613, DOI 10.1038/s41416-019-0624-1; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Ben-Shaul A, 2015, BIOPHYS J, V108, P14, DOI 10.1016/j.bpj.2014.11.010; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Buchan DWA, 2019, NUCLEIC ACIDS RES, V47, pW402, DOI 10.1093/nar/gkz297; Chatterjee N, 2017, ENVIRON MOL MUTAGEN, V58, P235, DOI 10.1002/em.22087; Chen JD, 2012, RNA, V18, P2148, DOI 10.1261/rna.035725.112; Corley M, 2020, MOL CELL, V78, P9, DOI 10.1016/j.molcel.2020.03.011; Dickey TH, 2013, STRUCTURE, V21, P1074, DOI 10.1016/j.str.2013.05.013; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ezzeddine N, 2011, MOL CELL BIOL, V31, P328, DOI 10.1128/MCB.00943-10; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Holm L, 2019, BIOINFORMATICS, V35, P5326, DOI 10.1093/bioinformatics/btz536; Huang J, 2009, MOL CELL, V35, P384, DOI 10.1016/j.molcel.2009.06.011; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Ke JY, 2013, NAT STRUCT MOL BIOL, V20, P1377, DOI 10.1038/nsmb.2710; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim MS, 2015, NATURE, V518, P507, DOI 10.1038/nature14174; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li YJ, 2009, J BIOL CHEM, V284, P23525, DOI 10.1074/jbc.C109.039586; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liu Q, 2011, ACTA CRYSTALLOGR D, V67, P45, DOI 10.1107/S0907444910046573; Liu YF, 2001, P NATL ACAD SCI USA, V98, P6877, DOI 10.1073/pnas.121013398; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ni ZY, 2014, NAT STRUCT MOL BIOL, V21, P686, DOI 10.1038/nsmb.2853; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paull TT, 2015, ANNU REV BIOCHEM, V84, P711, DOI 10.1146/annurev-biochem-060614-034335; Ren WD, 2014, CELL REP, V6, P982, DOI 10.1016/j.celrep.2014.02.020; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Richard DJ, 2011, NUCLEIC ACIDS RES, V39, P3643, DOI 10.1093/nar/gkq1340; Richard DJ, 2011, NUCLEIC ACIDS RES, V39, P1692, DOI 10.1093/nar/gkq1098; Rubinson EH, 2012, CURR OPIN STRUC BIOL, V22, P101, DOI 10.1016/j.sbi.2011.11.005; SHAMOO Y, 1995, NUCLEIC ACIDS RES, V23, P725, DOI 10.1093/nar/23.5.725; Skaar JR, 2009, J CELL BIOL, V187, P25, DOI 10.1083/jcb.200907026; Syed A, 2018, ANNU REV BIOCHEM, V87, P263, DOI 10.1146/annurev-biochem-062917-012415; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vidhyasagar V, 2018, BIOCHEM J, V475, P45, DOI 10.1042/BCJ20170351; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wernimont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005094; Williams RM, 2020, CURR OPIN STRUC BIOL, V61, P98, DOI 10.1016/j.sbi.2019.12.010; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang SH, 2013, EMBO J, V32, P126, DOI 10.1038/emboj.2012.314; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; Yoshimura SH, 2016, J CELL SCI, V129, P3963, DOI 10.1242/jcs.185710; Zhang F, 2013, J CELL SCI, V126, P4850, DOI 10.1242/jcs.132514; Zhang F, 2009, J BIOL CHEM, V284, P30408, DOI 10.1074/jbc.M109.039404	55	5	5	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100112	10.1074/jbc.RA120.016393	http://dx.doi.org/10.1074/jbc.RA120.016393			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33434574	Green Published, gold			2022-12-26	WOS:000672866400092
J	Liu, J; Li, ML; Kong, LH; Cao, MW; Zhang, ML; Wang, YH; Song, CC; Fang, XT; Chen, H; Zhang, CL				Liu, Jia; Li, MengLu; Kong, LingHao; Cao, MengWen; Zhang, MoLan; Wang, YanHong; Song, ChengChuang; Fang, XingTang; Chen, Hong; Zhang, ChunLei			CircARID1A regulates mouse skeletal muscle regeneration by functioning as a sponge of miR-6368	FASEB JOURNAL			English	Article						circARID1A; miR&#8208; 6368; proliferation and differentiation; regeneration	PROMOTES MYOBLAST PROLIFERATION; CIRCULAR RNAS; DIFFERENTIATION; EXPRESSION; REVEALS; TARGETS; GENES; CELLS; TLR4; MICRORNAS	The noncoding RNAs play important role in growth and development of mammalian skeletal muscle. Recent work has shown that circRNAs are abundant in skeletal muscle tissue, with significant changes in their expression patterns during muscle development and aging. We identified a novel circRNA called circARID1A that is highly expressed in mice skeletal muscle compare to its linear transcript. Experiments shown that circARID1A significantly inhibited the process of C2C12 cell proliferation and promoted its differentiation. Interactions between circRNA and miRNA were screened by miRNA gene chip sequencing. The results indicated that circARID1A can sponge miR-6368, which was further verified by miRNA sensor and other experiments. Besides, miR-6368 is a commonly expressed miRNA that regulates the expression of several target genes including Tlr4. A mouse model of skeletal muscle injury was successfully established to explore the role of circARID1A in skeletal muscle development and regeneration in vivo. Moreover, we found the overexpression of circARID1A significantly promoted the regeneration of skeletal muscle. The results of our study suggest that circARID1A may regulate skeletal muscle cell development and regeneration by sponging miR-6368.	[Liu, Jia; Li, MengLu; Kong, LingHao; Cao, MengWen; Zhang, MoLan; Wang, YanHong; Song, ChengChuang; Fang, XingTang; Chen, Hong; Zhang, ChunLei] Jiangsu Normal Univ, Sch Life Sci, Inst Cellular & Mol Biol, Xuzhou 221116, Jiangsu, Peoples R China	Jiangsu Normal University	Wang, YH; Zhang, CL (corresponding author), Jiangsu Normal Univ, Sch Life Sci, Inst Cellular & Mol Biol, Xuzhou 221116, Jiangsu, Peoples R China.	7096871@163.com; clzhang@jsnu.edu.cn	Wang, Yuan/HHC-1520-2022; Wang, Yu/GZL-9655-2022; wang, yi/GVT-8516-2022; Wang, Yanbo/HFZ-8018-2022; Wang, Yin/HCI-9352-2022; wangwangwang, yuanyaun/HHN-6432-2022; wang, yan/GSE-6489-2022					Abdelmohsen K, 2015, AGING-US, V7, P903, DOI 10.18632/aging.100834; Agnieszka RW., 2016, MOL CELL, V58, P1; Cao Y, 2018, ASIAN AUSTRAL J ANIM, V31, P1550, DOI 10.5713/ajas.17.0563; Chen JN, 2018, ONCOTARGET, V9, P1524, DOI 10.18632/oncotarget.23290; Chen XL, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7110199; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Dudekulay DB, 2016, RNA BIOL, V13, P34, DOI 10.1080/15476286.2015.1128065; Glazar P, 2014, RNA, V20, P1666, DOI 10.1261/rna.043687.113; Greco S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113454; Guardiola O, 2017, JOVE-J VIS EXP, V119, pe54515; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Horak M, 2016, DEV BIOL, V410, P1, DOI 10.1016/j.ydbio.2015.12.013; Hosokawa T, 2015, J PEDIATR SURG, V50, P1352, DOI 10.1016/j.jpedsurg.2014.12.028; Iotzova-Weiss G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185668; Jakub OW., 2014, CELL REP, V9, P1; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; KOZARSKY KF, 1993, CURR OPIN GENET DEV, V3, P499, DOI 10.1016/0959-437X(93)90126-A; Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017; Li CY, 2017, ONCOTARGET, V8, P97165, DOI 10.18632/oncotarget.21835; Li H, 2018, J CELL PHYSIOL, V233, P4643, DOI 10.1002/jcp.26230; Li XY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060616; Liu YL, 2016, AM J PHYSIOL-REG I, V311, pR365, DOI 10.1152/ajpregu.00043.2016; Martineau Y, 2013, ONCOGENE, V32, P671, DOI 10.1038/onc.2012.116; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Nakajima H., 2014, NEUROPROTECTION REGE, V1, P193; Nicolas FE, 2011, METHODS MOL BIOL, V732, P139, DOI 10.1007/978-1-61779-083-6_11; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Ouyang HJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00172; Ouyang HJ, 2018, DNA RES, V25, P71, DOI 10.1093/dnares/dsx039; OWNBY CL, 1993, TOXICON, V31, P697, DOI 10.1016/0041-0101(93)90376-T; Paul JS., 2019, INT J MOL SCI, V20, P5273; Qin XY, 2016, CELL CYCLE, V15, P781, DOI 10.1080/15384101.2016.1151581; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Schiedner G, 1998, NAT GENET, V18, P180, DOI 10.1038/ng0298-180; Sikalidis AK., 2013, J AMINO ACIDS, V2013, P864757, DOI DOI 10.1155/2013/864757; Sun P, 2010, DEVELOPMENT, V137, P2461, DOI 10.1242/dev.051466; Sun QL, 2008, MOL IMMUNOL, V45, P2929, DOI 10.1016/j.molimm.2008.01.025; Surono A, 1999, HUM MOL GENET, V8, P493, DOI 10.1093/hmg/8.3.493; Tang CM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40342; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Wang LS, 2018, J AGR FOOD CHEM, V66, P6308, DOI 10.1021/acs.jafc.8b01753; Wang YH, 2019, INT J BIOL MACROMOL, V121, P1308, DOI 10.1016/j.ijbiomac.2018.09.039; Wei XF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.541; Wilusz JE, 2013, SCIENCE, V340, P440, DOI 10.1126/science.1238522; Xiao YW, 2020, J CELL BIOCHEM, V121, P394, DOI 10.1002/jcb.29194; Yang J, 2012, MOL BIOL REP, V39, P3361, DOI 10.1007/s11033-011-1106-6; You XT, 2015, NAT NEUROSCI, V18, P603, DOI 10.1038/nn.3975; Yue BL, 2019, INT J BIOCHEM CELL B, V117, DOI 10.1016/j.biocel.2019.105621; Zhang CL, 2016, J DAIRY SCI, V99, P4750, DOI 10.3168/jds.2015-10381; Zhang CL, 2014, J NUTR, V144, P1142, DOI 10.3945/jn.114.192575; Zhang GH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02347-2; Zhang PP, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080885; Zhang Y., 2018, BIOMED RES INT, V2018, P1; Zhang Y, 2016, CELL REP, V15, P611, DOI 10.1016/j.celrep.2016.03.058	57	10	10	7	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21324	10.1096/fj.202001992R	http://dx.doi.org/10.1096/fj.202001992R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33421208				2022-12-26	WOS:000647789600075
J	Bortone, B; Jackson, C; Hsia, Y; Bielicki, J; Magrini, N; Sharland, M				Bortone, Barbara; Jackson, Charlotte; Hsia, Yingfen; Bielicki, Julia; Magrini, Nicola; Sharland, Mike			High global consumption of potentially inappropriate fixed dose combination antibiotics: Analysis of data from 75 countries	PLOS ONE			English	Article							COMMUNITY; SALES	Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antimicrobial resistance (AMR) and toxicity. We used a pharmaceutical database, IQVIA-Multinational Integrated Data Analysis System (IQVIA-MIDAS (R)), to estimate sales of antibiotic FDCs from 75 countries in 2015. Antibiotic consumption was estimated using standard units (SU), defined by IQVIA as a single tablet, capsule, ampoule, vial or 5ml oral suspension. For each FDC antibiotic, the approval status was assessed by either registration with the United States Food and Drug Administration (US FDA) or inclusion on the World Health Organization (WHO) Essential Medicines List (EML). A total of 119 antibiotic FDCs were identified, contributing 16.7 x 10(9) SU, equalling 22% of total antibiotic consumption in 2015. The most sold antibiotic FDCs were amoxicillin-clavulanic acid followed by trimethoprim/sulfamethoxazole and ampicillin/cloxacillin. The category with the highest consumption volume was aminopenicillin/beta -lactamase inhibitor +/- other agents. The majority of antibiotic FDCs (92%; 110/119) were not approved by the US FDA. Of these, the most sold were ampicillin/cloxacillin, cefixime/ofloxacin and metronidazole/spiramycin. More than 80% (98/119) of FDC antibiotics were not compatible with the 2017 WHO EML. The countries with the highest numbers of FDC antibiotics were India (80/119), China (25/119) and Vietnam (19/119). There is high consumption of FDC antibiotics globally, particularly in middle-income countries. The majority of FDC antibiotic were not approved by either US FDA or WHO EML. International initiatives such as clear guidance from the WHO EML on which FDCs are not appropriate may help to regulate the manufacturing and sales of these antibiotics.	[Bortone, Barbara] Meyer Childrens Univ Hosp, Paediat Infect Dis Div, Florence, Italy; [Jackson, Charlotte; Hsia, Yingfen; Bielicki, Julia; Sharland, Mike] St Georges Univ London, Paediat Infect Dis Res Grp, Inst Infect & Immun, London, England; [Hsia, Yingfen] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Bielicki, Julia] Univ Basel Childrens Hosp, Paediat Pharmacol & Paediat Infect Dis, Basel, Switzerland; [Magrini, Nicola] WHO, Expert Comm Select & Use Essential Med, Geneva, Switzerland	University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; St Georges University London; Queens University Belfast; World Health Organization	Hsia, Y (corresponding author), St Georges Univ London, Paediat Infect Dis Res Grp, Inst Infect & Immun, London, England.; Hsia, Y (corresponding author), Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland.	Y.Hsia@qub.ac.uk		Hsia, Yingfen/0000-0002-7955-852X	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 1960, NEW ENGL J MED, V262, P255; Bakthavatchalam YD, 2017, J APPL MICROBIOL, V123, P615, DOI 10.1111/jam.13522; Central drugs standard control organization, REP EXP COMM EV CAS; Dalal K, 2016, J CLIN DIAGN RES, V10, pFC5, DOI 10.7860/JCDR/2016/17856.7691; Faruqui DAA., 2012, INDIAN J BASIC APPL, V1, P296; Gautam CS, 2008, BRIT J CLIN PHARMACO, V65, P795, DOI 10.1111/j.1365-2125.2007.03089.x; Gong YH, 2020, B WORLD HEALTH ORGAN, V98, P449, DOI 10.2471/BLT.19.242370; Goodman L.S., 2011, GOODMAN GILMANS PHAR, V13th ed.; Goswami Nimit, 2013, Perspect Clin Res, V4, P130, DOI 10.4103/2229-3485.111797; Haffajee Anne D, 2003, Ann Periodontol, V8, P115, DOI 10.1902/annals.2003.8.1.115; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Nguyen HH, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7812-z; Hsia Y, 2019, LANCET INFECT DIS, V19, P67, DOI 10.1016/S1473-3099(18)30547-4; IQVIA, 2018, ACTS IQVIA QUAL ASS; Klein EY, 2018, P NATL ACAD SCI USA, V115, pE3463, DOI 10.1073/pnas.1717295115; McGettigan P, 2019, BRIT J CLIN PHARMACO, V85, P59, DOI 10.1111/bcp.13503; Mehta KC, 2014, J CLIN DIAGN RES, V8, pME5, DOI 10.7860/JCDR/2014/8778.4489; Poudel AP., 2008, GANDAKI MED J, V1, P61; Poudel Arjun, 2017, Glob Health Res Policy, V2, P14, DOI 10.1186/s41256-017-0033-z; Poulet PP, 2005, J ANTIMICROB CHEMOTH, V55, P347, DOI 10.1093/jac/dki013; Richa, 2015, INDIAN J MED MICROBI, V33, P393, DOI 10.4103/0255-0857.158564; Sakeena MHF, 2018, INT J ANTIMICROB AG, V52, P771, DOI 10.1016/j.ijantimicag.2018.09.022; Sharma K, 2014, J CLIN DIAGN RES, V8, pZC49, DOI 10.7860/JCDR/2014/10273.5294; Srinivasaraghavan R, 2016, INDIAN PEDIATR, V53, P1032; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Veeraraghavan B, 2018, FUTUR SCI OA, V4, DOI 10.4155/fsoa-2018-0003; WHO, 2017, WHO GUID ETH ISS PUB; WHO, 2005, TECHNICAL REPORT SER; WHO Collaborating Centre for Drug Statistics Methodology, J01 ANT SYST US AN T; Wirtz VJ, 2010, REV PANAM SALUD PUBL, V27, P219, DOI 10.1590/S1020-49892010000300009; World Bank, WORLD DATABANK WORLD; World Health Organization, 2017, ESSE MED LIST; Wright H, 2017, CLIN MICROBIOL INFEC, V23, P704, DOI 10.1016/j.cmi.2017.09.001	33	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0241899	10.1371/journal.pone.0241899	http://dx.doi.org/10.1371/journal.pone.0241899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471786	Green Accepted, gold, Green Published			2022-12-26	WOS:000639428800026
J	de Oliveira, RR; Zuanon, J; Py-Daniel, LHR; Birindelli, JLO; Sousa, LM				de Oliveira, Renildo Ribeiro; Zuanon, Jansen; Py-Daniel, Lucia H. Rapp; Birindelli, Jose L. O.; Sousa, Leandro M.			Taxonomic revision of Hopliancistrus Isbrucker & Nijssen, 1989 (Siluriformes, Loricariidae) with redescription of Hopliancistrus tricornis and description of four new species	PLOS ONE			English	Article								Hopliancistrus is an Ancistrini genus diagnosed by having few and very strong cheek odontodes on interopercular area, and a patch of strong and stiff odontodes on the antero-lateral border of the snout. The type species is herein redescribed based on types and recently collected specimens. In addition, four new congeneric species are described based on specimens collected in other parts of the Rio Xingu and Rio Tapajos basins. Hopliancistrus tricornis is distributed in the lower Rio Tapajos and is diagnosed by the possession of four branched anal-fin rays and relatively large white to yellow spots on trunk and pectoral and pelvic fins, and dark brown spots on dorsal, caudal and anal fins. Hopliancistrus munduruku is described based on specimens from Rio Jamanxim (Rio Tapajos basin) and Rio Curua (Rio Xingu basin) and is diagnosed by the possession of five branched anal-fin rays and large yellow blotches on trunk and dark brown to black spots over the fins. Hopliancistrus wolverine is distributed in the rapids of the lower and middle Rio Xingu and is diagnosed by the possession of five branched anal-fin rays and conspicuous small yellow dots on head, trunk and fins. Hopliancistrus xikrin is distributed in medium- to small-sized tributaries of the lower portion of Rio Xingu basin, and is diagnosed by absence of contact between the transverse process of the first dorsal-fin pterygiophore and the transverse process of the second pterygiophore. Hopliancistrus xavante is distributed in the tributaries of upper Rio Xingu basin, and is diagnosed by having a thick skin covering the nuchal plate; by having large white spots on trunk and fins; and by the possession of five branched anal-fin rays. An osteological description and a key for species identification are also provided.	[de Oliveira, Renildo Ribeiro; Zuanon, Jansen; Py-Daniel, Lucia H. Rapp] Inst Nacl Pesquisas Amazonia INPA, Coordenacao Biodiversidade COBIO, Manaus, AM, Brazil; [Birindelli, Jose L. O.] Univ Estadual Londrina, Dept Biol Anim & Vegetal, Londrina, PR, Brazil; [Sousa, Leandro M.] Univ Fed Para, Lab Ictiol Altamira, Altamira, PA, Brazil	Institute Nacional de Pesquisas da Amazonia; Universidade Estadual de Londrina; Universidade Federal do Para	de Oliveira, RR (corresponding author), Inst Nacl Pesquisas Amazonia INPA, Coordenacao Biodiversidade COBIO, Manaus, AM, Brazil.	deoliveirarr@gmail.com	Birindelli, José L.O./AAS-7096-2020; de Sousa, Leandro Melo/I-6108-2012; Sousa, Leandro/AAX-2811-2021; Rapp-Py-Daniel, Lucia H./D-9021-2019; Zuanon, Jansen A. S./E-5791-2013	Birindelli, José L.O./0000-0001-9646-9636; de Sousa, Leandro Melo/0000-0002-0793-9737; Sousa, Leandro/0000-0002-0793-9737; Rapp-Py-Daniel, Lucia H./0000-0002-0954-7366; Zuanon, Jansen A. S./0000-0001-8354-2750; Ribeiro de Oliveira, Renildo/0000-0001-6611-0833	CNPq [302872/2018-3, 313183/2014-7, 309392/2011-0, 309815/2017-7, 486376/2013-3, 474236/2004-8]; iXingu Project [NSF DEB-1257813]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); iXingu Project	1. JLOB, JZ, LRP and LMS receive grants from CNPq (302872/2018-3, 313183/2014-7, 309392/2011-0 and 309815/2017-7 respectively). 2. Research supported in part by iXingu Project (NSF DEB-1257813, PI M.H. Sabaj). 3. CNPq process 486376/2013-3 (PI L.M. Sousa). 4. We also benefited from material acquired with financial support from CNPq (Edital Universal, #474236/2004-8).	Armbruster J, 2017, FAMILY LORICARIIDAE, P253; Armbruster JW, 2008, ZOOTAXA, P1; Armbruster JW, 2004, ZOOL J LINN SOC-LOND, V141, P1, DOI 10.1111/j.1096-3642.2004.00109.x; Bemis WE, 2004, COPEIA, P603; Boeseman M., 1968, Zoologische Verhandelingen, VNo. 99, P1; Camargo M, 2009, ENTRE TERRA GUAS OS; Camargo M., 2013, LORICARIIDS MIDDLE R; Castilhos ZC, 2011, ECORREGI O AQU TICA; Datz. Alle L-Nummern: Lebensraume, PFLEGE ERN HRUNG DAT; Fisch-Muller Sonia, 2001, Ichthyological Exploration of Freshwaters, V12, P289; Fricke R, SPECIES FAMILYSUBFAM; Isbrucker IJH., 1989, ICHTHYOLOGIE, V42, P541; Lima FCT, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P145; Lucena CAS, 2013, B SOC BRAS ICTIOL, V105, P20; Lujan NK, 2015, MOL PHYLOGENET EVOL, V82, P269, DOI 10.1016/j.ympev.2014.08.020; Lundberg J.G., 1982, Miscellaneous Publications Museum of Zoology University of Michigan, V163, P1; Lundberg J.G., 1969, American Museum Novitates, VNo. 2398, P1; LUNDBERG JG, 1998, STAGE NEOTROPICAL FI, P13; Nelson J.S., 2016, FISHES WORLD, DOI 10.1002/9781119174844; Roxo FF, 2019, MOL PHYLOGENET EVOL, V135, P148, DOI 10.1016/j.ympev.2019.02.017; SCHAEFER S A, 1987, Contributions in Science (Los Angeles), P1; Schaefer SA, 1997, P ACAD NAT SCI PHILA, V148, P1; Schraml E., 2004, AQUALOG LORICARIIDAE; Seidel I, 2005, WELS ATLAS BAND 2 HY; Seidel I., 2008, BACK NATURE GUIDE L; Stawikowski R., 2008, AQUARIENUND TERRARIE, V62, P35; Stawikowski R., 1994, AQUARIENUND TERRARIE, V47, P533; Stawikowski R, 1996, AQUARIENUND TERRARIE, V49, P480; Stawikowski R., 1989, AQUARIENUND TERRARIE, V38, P173; TAYLOR W R, 1985, Cybium, V9, P107; Werner A., 2004, AQUARIENUND TERRARIE, V57, P60	31	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0244894	10.1371/journal.pone.0244894	http://dx.doi.org/10.1371/journal.pone.0244894			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471818	Green Published, gold			2022-12-26	WOS:000639428800049
J	Yoshimoto, T; Sakurai, H; Ohmichi, Y; Ohmichi, M; Morimoto, A; Ushida, T; Sato, J				Yoshimoto, Takahiko; Sakurai, Hiroki; Ohmichi, Yusuke; Ohmichi, Mika; Morimoto, Atsuko; Ushida, Takahiro; Sato, Jun			Changes in cardiovascular parameters in rats exposed to chronic widespread mechanical allodynia induced by hind limb cast immobilization	PLOS ONE			English	Article							REGIONAL PAIN SYNDROME; REFLEX SYMPATHETIC DYSTROPHY; SKIN BLOOD-FLOW; HEART-RATE-VARIABILITY; NERVE ACTIVITY; UP-REGULATION; CRPS-I; ALPHA(1)-ADRENOCEPTORS; NOREPINEPHRINE; HYPERALGESIA	To elucidate the relationship between chronic pain conditions with cast immobilization and autonomic function, we investigated the functional changes of the autonomic nervous system in conscious rats with chronic post-cast pain (CPCP) induced by a two-week cast immobilization of one hind limb. We telemetrically examined the time courses of systolic arterial blood pressure (SBP), heart rate (HR), and the middle-frequency (MF) component obtained from the power spectral analysis of SBP variability as a vasomotor sympathetic index. We also investigated the baroreflex sensitivity to phentolamine, an alpha-adrenoceptor antagonist, and the SBP and HR responses to a low ambient temperature (LT; 9.0 +/- 0.2 degrees C) exposure, a sympathetic stimulant. Rats exposed to cast immobilization exhibited mechanical allodynia lasting for at least 10 weeks after cast removal in the calf area (skin and muscle) of the bilateral hind limbs. Under resting conditions, the SBP, HR, and MF components were significantly increased during cast immobilization (all p < 0.001). Following cast removal, these parameters gradually decreased and within 1 week reached lower than baseline levels, lasting for over 10 weeks. Phentolamine administration (10 mg/kg, intraperitoneally) significantly decreased the SBP before and during cast immobilization (before, p < 0.001; during, p = 0.001) but did not lower the SBP after cast removal. The baroreflex gain after phentolamine administration, calculated as the HR increase divided by the SBP reduction, was significantly increased after cast removal (p = 0.002). The SBP increase on LT exposure was significantly greater after cast removal than that before cast immobilization, suggesting hypersensitivity to sympathetic neurotransmitters. These results revealed that, in the CPCP model, sympathetic activation was augmented during cast immobilization, which then decreased after cast removal and remained below normal levels with persisting pain behaviors. Additionally, the responsiveness of the autonomic nervous system was impaired in the CPCP model.	[Yoshimoto, Takahiko] Showa Univ, Dept Hyg Publ Hlth & Prevent Med, Sch Med, Shinagawa Ku, Tokyo, Japan; [Sakurai, Hiroki; Ohmichi, Yusuke; Morimoto, Atsuko; Ushida, Takahiro; Sato, Jun] Aichi Med Univ, Multidisciplinary Pain Ctr, Nagakute, Aichi, Japan; [Sakurai, Hiroki] Tokoha Univ, Fac Hlth Sci, Hamamatsu, Shizuoka, Japan; [Ohmichi, Yusuke; Ohmichi, Mika] Aichi Med Univ, Dept Anat, Nagakute, Aichi, Japan; [Sato, Jun] Chubu Univ, Coll Life & Hlth Sci, Dept Phys Therapy, Kasugai, Aichi, Japan	Showa University; Aichi Medical University; Aichi Medical University; Chubu University	Sato, J (corresponding author), Aichi Med Univ, Multidisciplinary Pain Ctr, Nagakute, Aichi, Japan.; Sato, J (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Phys Therapy, Kasugai, Aichi, Japan.	jsato@isc.chubu.ac.jp		Ohmichi, Yusuke/0000-0002-9503-8022	KAKENHI from the Japan Society for the Promotion of Science [18613020, 20602009]; KAKENHI [18613020, 20602009]; Daiko Foundation [5476]; Research Foundation for Oriental Medicine [07-07]	KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Daiko Foundation(Daiko Foundation); Research Foundation for Oriental Medicine	The Research Budget (2002-2008) of the Department of Algesiology, Aichi Medical University. This funding was awarded to TY, HS, YO, MO, AM. Grant number: None. URL of funder website: None. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Grants-in-Aid for Scientific Research (C) (KAKENHI No. 18613020, 20602009) from the Japan Society for the Promotion of Science. This funding was awarded to TY, HS, YO, MO, AM. Grant number: KAKENHI No. 18613020, 20602009. URL of funder website: https://www.jsps.go.jp/english/index.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Daiko Foundation (2007). This funding was awarded to TY. Grant number: 5476. URL of funder website: http://www1.s3.starcat.ne.jp/daiko-f/jyosei_07.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Research Foundation for Oriental Medicine (2007). This funding was awarded to TY. Grant number: 07-07. URL of funder website: http://www.disclo-koeki.org/07a/00928/index.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD JMO, 1993, ANN INTERN MED, V118, P619, DOI 10.7326/0003-4819-118-8-199304150-00008; Baron R, 1996, PAIN, V67, P317, DOI 10.1016/0304-3959(96)03136-3; Birklein F, 1998, PAIN, V75, P93, DOI 10.1016/S0304-3959(97)00209-1; Birklein F, 2000, ACTA NEUROL SCAND, V101, P262, DOI 10.1034/j.1600-0404.2000.101004262x./; BROWN DR, 1994, AM J PHYSIOL-REG I, V267, pR1378, DOI 10.1152/ajpregu.1994.267.5.R1378; Bruehl S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h2730; Cannon WB, 1949, LAW DENERVATION; CASALE R, 1992, J AUTONOM NERV SYST, V41, P215, DOI 10.1016/0165-1838(92)90061-K; D'Angelo G, 2005, HYPERTENSION, V46, P806, DOI 10.1161/01.HYP.0000182697.39687.34; Drummond ES, 2014, NEUROSCIENCE, V281, P99, DOI 10.1016/j.neuroscience.2014.09.046; DRUMMOND PD, 1991, BRAIN, V114, P2025, DOI 10.1093/brain/114.5.2025; Drummond PD, 2018, PAIN, V159, P2296, DOI 10.1097/j.pain.0000000000001335; Drummond PD, 2014, PAIN, V155, P606, DOI 10.1016/j.pain.2013.12.021; Finch PM, 2014, PAIN MED, V15, P1945, DOI 10.1111/pme.12548; Gemes G, 2009, PAIN, V146, P293, DOI 10.1016/j.pain.2009.07.040; Harden RN, 2007, PAIN MED, V8, P326, DOI 10.1111/j.1526-4637.2006.00169.x; HARDEN RN, 1994, CLIN J PAIN, V10, P324, DOI 10.1097/00002508-199412000-00014; Jin Y, 2008, PAIN, V135, P221, DOI 10.1016/j.pain.2007.05.020; Knudsen LF, 2019, CLIN AUTON RES, V29, P457, DOI 10.1007/s10286-019-00612-0; Kurvers HAJM, 1996, NEUROSCIENCE, V74, P935, DOI 10.1016/0306-4522(96)00178-9; Kurvers HAJM, 1997, J AUTONOM NERV SYST, V63, P19, DOI 10.1016/S0165-1838(96)00127-0; Loria A, 2007, AM J PHYSIOL-RENAL, V293, pF506, DOI 10.1152/ajprenal.00066.2007; Ohmichi Y, 2012, EUR J PAIN, V16, P338, DOI 10.1002/j.1532-2149.2011.00026.x; Ohmichi Y, 2020, PAIN, V161, P1808, DOI 10.1097/j.pain.0000000000001867; Oliveira LR, 2012, AUTON NEUROSCI-BASIC, V167, P45, DOI 10.1016/j.autneu.2011.12.004; Pagani M, 1997, CIRCULATION, V95, P1441; Sabharwal R, 2016, PAIN, V157, P387, DOI 10.1097/j.pain.0000000000000330; SATO J, 1991, SCIENCE, V251, P1608, DOI 10.1126/science.2011742; Schurmann M, 2000, AUTON NEUROSCI-BASIC, V86, P127, DOI 10.1016/S1566-0702(00)00250-2; Stanton-Hicks MD, 2019, REGION ANESTH PAIN M, V44, P376, DOI 10.1136/rapm-2018-100064; Sumitani M, 2010, PAIN, V150, P243, DOI 10.1016/j.pain.2010.03.032; Taneyama C, 2013, CLIN J PAIN, V29, P962, DOI 10.1097/AJP.0b013e31827da343; Terkelsen AJ, 2008, ANESTHESIOLOGY, V109, P297, DOI 10.1097/ALN.0b013e31817f4c9d; Terkelsen AJ, 2012, ANESTHESIOLOGY, V116, P133, DOI 10.1097/ALN.0b013e31823bbfb0; Tripovic D, 2010, BRIT J PHARMACOL, V159, P142, DOI 10.1111/j.1476-5381.2009.00520.x; Vogel T, 2010, CLIN J PAIN, V26, P128, DOI 10.1097/AJP.0b013e3181b5effc; Wasner G, 2001, BRAIN, V124, P587, DOI 10.1093/brain/124.3.587; Xanthos DN, 2008, PAIN, V137, P640, DOI 10.1016/j.pain.2007.10.031; Yoshimoto T, 2011, J PHYSIOL SCI, V61, P373, DOI 10.1007/s12576-011-0158-7	39	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245544	10.1371/journal.pone.0245544	http://dx.doi.org/10.1371/journal.pone.0245544			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465131	Green Published, gold			2022-12-26	WOS:000611969200021
J	Sirisha, A; Gaur, GS; Pal, P; Bobby, Z; Balakumar, B; Pal, GK				Sirisha, Allampalli; Gaur, Girwar Singh; Pal, Pravati; Bobby, Zachariah; Balakumar, Bharathi; Pal, Gopal Krushna			Effect of honey and insulin treatment on oxidative stress and nerve conduction in an experimental model of diabetic neuropathy Wistar rats	PLOS ONE			English	Article							NATURAL HONEY; BODY-WEIGHT; ANTIOXIDANT; SUPPLEMENTATION; GLUCOSE; PLASMA; FRAP; AGE	Diabetic neuropathy is the most common complication affecting more than 50% of patients with longstanding diabetes. Till date, there are no reports to explain the scientific basis of alternative medicine as an adjunct therapy for treating diabetic neuropathy. Hence, we studied the effect of honey and insulin treatment on hyperglycemia, dyslipidemia, oxidant and anti-oxidant status and nerve conduction in experimental diabetic neuropathy Wistar rats. In this experimental study, forty healthy male Wistar albino rats of 10-12 weeks age, weighing between 150 to 200g were obtained from our institute central animal house. After acclimatization, the rats were divided into control (n = 8) and experimental (n = 32) groups randomly. In the experimental group, type 2 diabetic neuropathy was induced with high fat and high sugar diet for 8 weeks followed by streptozotocin at a dose of 35 mg/kg body weight. Three days after streptozotocin injection, blood glucose levels of rats were measured from fasting samples to confirm diabetes. After the development of diabetes, rats were given standard rodent chow and allowed four more weeks to remain diabetic and to develop neuropathy. Every second week, nerve conduction study was done to confirm neuropathy. All the diabetic rats of experimental group developed neuropathy after 4 weeks of developing diabetes, which was confirmed by significant reduction in conduction velocity of sensory and motor nerve when compared to non-diabetic control group. After the development of neuropathy, these rats were randomly divided into diabetic neuropathy with no treatment group (n = 8) and three treatment groups (n = 8, each). The rats of treatment group were administered with either honey or insulin or honey+insulin for six weeks. After six-weeks of intervention, there was significant decrease in blood glucose and lipids in honey, insulin and honey+insulin treated neuropathy rats, when compared with no treatment group. Malondialdehyde was reduced and total anti-oxidant status improved in all the three treatment groups. There was no significant increase in conduction velocity of sciatic tibial motor nerve in treatment groups when compared with no treatment group. However, the sensory nerve conduction velocity improved significantly in honey+insulin treated neuropathy rats. In conclusion, six-week honey treatment helped in reducing dyslipidemia and oxidative stress. Honey given along with insulin for six-weeks improved sensory nerve conduction velocity in experimental diabetic neuropathy Wistar rats.	[Sirisha, Allampalli; Gaur, Girwar Singh; Pal, Pravati; Balakumar, Bharathi; Pal, Gopal Krushna] Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Dept Physiol, Pondicherry, India; [Bobby, Zachariah] Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Dept Biochem, Pondicherry, India	Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research	Gaur, GS (corresponding author), Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Dept Physiol, Pondicherry, India.	drgsgaur@yahoo.com		, Allampalli Sirisha/0000-0002-0574-8857	JIPMER	JIPMER	Our institute (JIPMER) provided intramural fund for conducting PhD thesis as part of protocol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluko E. O., 2013, British Journal of Medicine and Medical Research, V3, P2214; Andreollo NA, 2012, ABCD-ARQ BRAS CIR DI, V25, P49, DOI 10.1590/S0102-67202012000100011; Anju M, 2020, DIABETES METAB SYND, V14, P1061, DOI 10.1016/j.dsx.2020.06.065; [Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], DIAB DIET S; [Anonymous], 2011, BRIT MED J; Aslan I, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-54; Azman KF, 2018, J TAIBAH UNIV SCI, V12, P273, DOI 10.1080/16583655.2018.1465275; Bahrami M, 2009, INT J FOOD SCI NUTR, V60, P618, DOI 10.3109/09637480801990389; Balk EM, 2007, DIABETES CARE, V30, P2154, DOI 10.2337/dc06-0996; Barriere DA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18896-5; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; CAMERON NE, 1994, DIABETOLOGIA, V37, P449, DOI 10.1007/s001250050131; Coppey LJ, 2003, FREE RADICAL RES, V37, P33, DOI 10.1080/1071576021000028442; Dang JK, 2014, PAIN MED, V15, P637, DOI 10.1111/pme.12387_1; Dobiasova M, 2006, Vnitr Lek, V52, P64; Dobiasova M, 2000, Vnitr Lek, V46, P152; Dudonne S, 2009, J AGR FOOD CHEM, V57, P1768, DOI 10.1021/jf803011r; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Erejuwa OO, 2012, INT J BIOL SCI, V8, P913, DOI 10.7150/ijbs.3697; Erejuwa OO, 2011, INT J BIOL SCI, V7, P244, DOI 10.7150/ijbs.7.244; Hosseini A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/168039; International Diabetes Federation,, 2019, IDF DIABETES ATLAS; Li JB, 2013, DIABETES CARE, V36, P3405, DOI 10.2337/dc13-0590; Mijnhout GS, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/456279; Nasrolahi O, 2012, AVICENNA J PHYTOMEDI, V2, P212; Okpoghono J., 2018, INT J VET SCI MED, V6, P117, DOI DOI 10.1016/j.ijvsm.2018.03.006; Omotayo EO, 2010, INT J VITAM NUTR RES, V80, P74, DOI 10.1024/0300-9831/a000008; Polcyn Rachel, 2017, Neuroimmunol Neuroinflamm, V4, P254, DOI 10.20517/2347-8659.2017.59; Rana S, 2018, PROG NUTR, V20, P5, DOI 10.23751/pn.v20i1-S.6394; Rao PVLNS, 2015, J ANTIOXIDANT ACTIVI, V1, P22, DOI DOI 10.14302/ISSN.2471-2140.JAA-14-617; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Smith AG, 2013, J DIABETES COMPLICAT, V27, P436, DOI 10.1016/j.jdiacomp.2013.04.003; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Sullivan KA, 2007, NEUROBIOL DIS, V28, P276, DOI 10.1016/j.nbd.2007.07.022; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Tungmunnithum Duangjai, 2018, Medicines (Basel), V5, DOI 10.3390/medicines5030093; Vallianou G.N., 2014, GEN MED OPEN ACCESS, V2, DOI [10.4172/2327-5146.1000132, DOI 10.4172/2327-5146.1000132]; Vincent AM, 2009, DIABETES, V58, P2376, DOI 10.2337/db09-0047; Wang DQ, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/282383; Warne JP, 2006, ENDOCRINOLOGY, V147, P5443, DOI 10.1210/en.2006-0702; Wendel A, 1981, Methods Enzymol, V77, P325; Yaghoobi N, 2008, THESCIENTIFICWORLDJO, V8, P463, DOI 10.1100/tsw.2008.64; YAGI K, 1984, METHOD ENZYMOL, V105, P328; Yagihashi S, 2011, J DIABETES INVEST, V2, P18, DOI 10.1111/j.2040-1124.2010.00070.x	47	2	2	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245395	10.1371/journal.pone.0245395	http://dx.doi.org/10.1371/journal.pone.0245395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449943	gold, Green Published			2022-12-26	WOS:000609991600053
J	Yajima, T; Yajima, K; Takahashi, H				Yajima, Takahiro; Yajima, Kumiko; Takahashi, Hiroshi			Association of the erythropoiesis-stimulating agent resistance index and the geriatric nutritional risk index with cardiovascular mortality in maintenance hemodialysis patients	PLOS ONE			English	Article							EPOETIN-ALPHA; INFLAMMATION; ANEMIA; HYPORESPONSIVENESS; MALNUTRITION; PREDICTORS; DISEASE; MARKER	Objective Hyporesponsiveness to erythropoiesis-stimulating agent (ESA) may be associated with protein-energy wasting. We investigated the relationship of the ESA resistance index (ERI) and the geriatric nutritional risk index (GNRI) for cardiovascular mortality in hemodialysis (HD) patients. Methods A total of 180 maintenance HD patients were enrolled. The patients were stratified by the GNRI of 91.2, a previously reported cut-off value, and the ERI of 13.7 (IU/week/kg/g/dL), a cut-off value for predicting cardiovascular-specific mortality, and they were classified into four groups (group 1[G1]: higher GNRI and lower ERI, G2: higher GNRI and higher ERI, G3: lower GNRI and lower ERI, G4: lower GNRI and higher ERI). Results The ERI was independently associated with the GNRI (beta = -0.271, p = 0.0005). During a median follow-up of 4.6 years, higher ERI and lower GNRI were independently associated with cardiovascular mortality, respectively (adjusted hazard ratio [aHR], 3.10; 95% confidence interval [CI], 1.31-7.34, and aHR, 6.64; 95%CI, 2.60-16.93, respectively). The 7-year survival rates were 96.1%, 70.3%, 77.3%, and 50.1% in G1, G2, G3, and G4, respectively. The aHR values for G4 versus G1 were 12.63 (95%CI, 3.58-44.59). With regards to model discrimination, adding the GNRI alone, the ERI alone, and both to the traditional risk model significantly improved the net reclassification improvement by 0.421, 0.662, and 0.671, respectively. Similar results were obtained for all-cause mortality. Conclusion The ERI was independently associated with the GNRI, and could predict cardiovascular mortality in HD patients. Moreover, the combination of GNRI and ERI could improve the predictability for cardiovascular mortality.	[Yajima, Takahiro] Matsunami Gen Hosp, Dept Nephrol, Gifu, Japan; [Yajima, Kumiko] Matsunami Gen Hosp, Dept Internal Med, Gifu, Japan; [Takahashi, Hiroshi] Fujita Hlth Univ, Sch Med, Div Med Stat, Toyoake, Aichi, Japan	Fujita Health University	Yajima, T (corresponding author), Matsunami Gen Hosp, Dept Nephrol, Gifu, Japan.	yajima5639@gmail.com						[Anonymous], 2015, ICC DISPUTE RESOLUTI, V1, DOI DOI 10.21476/PP.2015.1129; Bailie GR, 2015, KIDNEY INT, V87, P162, DOI 10.1038/ki.2014.275; Bonafont X, 2009, CLIN KIDNEY J, V2, P347, DOI 10.1093/ndtplus/sfp097; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777, DOI 10.1093/ajcn/82.4.777; Brookhart MA, 2013, J AM SOC NEPHROL, V24, P1151, DOI 10.1681/ASN.2012121164; Cremieux PY, 2006, CURR MED RES OPIN, V22, P2329, DOI 10.1185/030079906X154024; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Eriguchi R, 2015, J NEPHROL, V28, P217, DOI 10.1007/s40620-014-0121-9; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Gonzalez-Ortiz A, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1457-0; Kalantar-Zadeh K, 2004, NEPHROL DIAL TRANSPL, V19, P1507, DOI 10.1093/ndt/gfh143; Kalantar-Zadeh K, 2009, AM J KIDNEY DIS, V53, P823, DOI 10.1053/j.ajkd.2008.12.040; Kanbay M, 2010, BLOOD PURIFICAT, V29, P1, DOI 10.1159/000245041; Kausz AT, 2005, AM J KIDNEY DIS, V45, P136, DOI 10.1053/j.ajkd.2004.08.042; Kilpatrick RD, 2008, CLIN J AM SOC NEPHRO, V3, P1077, DOI 10.2215/CJN.04601007; Kobayashi I, 2010, NEPHROL DIAL TRANSPL, V25, P3361, DOI 10.1093/ndt/gfq211; Kuragano T, 2014, KIDNEY INT, V86, P845, DOI 10.1038/ki.2014.114; Okazaki M, 2014, BLOOD PURIFICAT, V37, P106, DOI 10.1159/000358215; Panichi V, 2011, NEPHROL DIAL TRANSPL, V26, P2641, DOI 10.1093/ndt/gfq802; Pecoits R, 2003, NEPHROL DIAL TRANSPL, V18, P1042, DOI 10.1093/ndt/gfg111; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Qureshi AR, 2002, J AM SOC NEPHROL, V13, pS28; Rattanasompattikul M, 2013, NEPHROL DIAL TRANSPL, V28, P1936, DOI 10.1093/ndt/gfs368; Sibbel SP, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0138-x; Stenvinkel P, 2002, SEMIN DIALYSIS, V15, P329, DOI 10.1046/j.1525-139X.2002.00083.x; Takahashi H, 2017, J RENAL NUTR, V27, P201, DOI 10.1053/j.jrn.2016.12.005; Takahashi H, 2014, J CARDIOL, V64, P32, DOI 10.1016/j.jjcc.2013.10.018; Xiong JC, 2018, KIDNEY BLOOD PRESS R, V43, P1878, DOI 10.1159/000495999; Yajima T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113333; Yajima T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112659; Yajima T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211988; Yajima T, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040480; Yamada K, 2008, AM J CLIN NUTR, V87, P106, DOI 10.1093/ajcn/87.1.106; Zhang Y, 2004, AM J KIDNEY DIS, V44, P866, DOI 10.1053/j.ajkd.2004.08.002; Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x	35	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245625	10.1371/journal.pone.0245625	http://dx.doi.org/10.1371/journal.pone.0245625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449974	gold, Green Published			2022-12-26	WOS:000609991600032
J	Nabwera, HM; Wang, DM; Tongo, OO; Andang'o, PEA; Abdulkadir, I; Ezeaka, CV; Ezenwa, BN; Fajolu, IB; Imam, ZO; Mwangome, MK; Umoru, DD; Akindolire, AE; Otieno, W; Nalwa, GM; Talbert, AW; Abubakar, I; Embleton, ND; Allen, SJ				Nabwera, Helen M.; Wang, Dingmei; Tongo, Olukemi O.; Andang'o, Pauline E. A.; Abdulkadir, Isa; Ezeaka, Chinyere V.; Ezenwa, Beatrice N.; Fajolu, Iretiola B.; Imam, Zainab O.; Mwangome, Martha K.; Umoru, Dominic D.; Akindolire, Abimbola E.; Otieno, Walter; Nalwa, Grace M.; Talbert, Alison W.; Abubakar, Ismaela; Embleton, Nicholas D.; Allen, Stephen J.		Neonatal Nutr Network NeoNuNet	Burden of disease and risk factors for mortality amongst hospitalized newborns in Nigeria and Kenya	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; NEONATAL-MORTALITY; UNIVERSITY	Objective To describe the patient population, priority diseases and outcomes in newborns admitted Study design In a network of seven secondary and tertiary level neonatal units in Nigeria and Kenya, we captured anonymised data on all admissions Results 2280 newborns were admitted. Mean birthweight was 2.3 kg (SD 0.9); 57.0% (1214/2128) infants were low birthweight (LBW; <2.5kg) and 22.6% (480/2128) were very LBW (VLBW; <1.5 kg). Median gestation was 36 weeks (interquartile range 32, 39) and 21.6% (483/2236) infants were very preterm (gestation <32 weeks). The most common morbidities were jaundice (987/2262, 43.6%), suspected sepsis (955/2280, 41.9%), respiratory conditions (817/2280, 35.8%) and birth asphyxia (547/2280, 24.0%). 18.7% (423/2262) newborns died; mortality was very high amongst VLBW (222/472, 47%) and very preterm infants (197/483, 40.8%). Factors independently associated with mortality were gestation <28 weeks (adjusted odds ratio 11.58; 95% confidence interval 4.73-28.39), VLBW (6.92; 4.06-11.79), congenital anomaly (4.93; 2.42-10.05), abdominal condition (2.86; 1.40-5.83), birth asphyxia (2.44; 1.52-3.92), respiratory condition (1.46; 1.08-2.28) and maternal antibiotics within 24 hours before or after birth (1.91; 1.28-2.85). Mortality was reduced if mothers received a partial (0.51; 0.28-0.93) or full treatment course (0.44; 0.21-0.92) of dexamethasone before preterm delivery. Conclusion Greater efforts are needed to address the very high burden of illnesses and mortality in hospitalized newborns in sub-Saharan Africa. Interventions need to address priority issues during pregnancy and delivery as well as in the newborn.	[Nabwera, Helen M.; Abubakar, Ismaela; Allen, Stephen J.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Nabwera, Helen M.; Allen, Stephen J.] Alder Hey Childrens Hosp NHS Trust, Liverpool, Merseyside, England; [Wang, Dingmei] Fudan Univ, Childrens Hosp, Shanghai, Peoples R China; [Tongo, Olukemi O.; Akindolire, Abimbola E.] Univ Coll Hosp, Ibadan, Nigeria; [Andang'o, Pauline E. A.; Otieno, Walter; Nalwa, Grace M.] Maseno Univ, Maseno, Kenya; [Abdulkadir, Isa] Ahmadu Bello Univ Teaching Hosp, Zaria, Nigeria; [Ezeaka, Chinyere V.; Ezenwa, Beatrice N.; Fajolu, Iretiola B.] Lagos Univ Teaching Hosp, Lagos, Nigeria; [Imam, Zainab O.] Massey St Childrens Hosp, Lagos, Nigeria; [Mwangome, Martha K.; Talbert, Alison W.] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Umoru, Dominic D.] Maitama Dist Hosp, Abuja, Nigeria; [Otieno, Walter; Nalwa, Grace M.] Jaramogi Oginga Odinga Teaching & Referral Hosp, Jomo Kenyatta Highway Kaloleni Kisumu KE, Central, Kenya; [Embleton, Nicholas D.] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England; [Embleton, Nicholas D.] Newcastle Upon Tyne Hosp NHS Fdn Trust, High Heaton, Newcastle Upon Tyne, Tyne & Wear, England	Liverpool School of Tropical Medicine; Alder Hey Children's NHS Foundation Trust; Fudan University; University of Ibadan; University College Hospital, Ibadan; Maseno University; Ahmadu Bello University; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Nabwera, HM (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.; Nabwera, HM (corresponding author), Alder Hey Childrens Hosp NHS Trust, Liverpool, Merseyside, England.	helen.nabwera@lstmed.ac.uk	Fajolu, Iretiola Bamikeolu/P-5759-2019; Nabwera, Helen/GRJ-3507-2022; Ezenwa, Beatrice Nkolika/H-8687-2018	Fajolu, Iretiola Bamikeolu/0000-0003-3045-9616; Ezenwa, Beatrice Nkolika/0000-0001-7437-3211; Nabwera, Helen/0000-0003-1056-729X; Mwangome, Martha/0000-0003-4806-1307; Ezeaka, Veronica Chinyere/0000-0003-1880-4616; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	MRC Confidence in Global Nutrition and Health Research scheme [MC_PC_MR/R019789/1]; MRC [MC_PC_MR/R019789/1] Funding Source: UKRI	MRC Confidence in Global Nutrition and Health Research scheme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was completed as part of the Neonatal Nutrition Network, funded by a grant from the MRC Confidence in Global Nutrition and Health Research scheme, awarded to SJA (grant reference MC_PC_MR/R019789/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedokun ST, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2242-6; Adeyi O, 2016, HEALTH SYST REFORM, V2, P285, DOI 10.1080/23288604.2016.1224023; Akindolire AE, 2016, J INFECT DEV COUNTR, V10, P1338, DOI 10.3855/jidc.7830; Alganabi Mashriq, 2019, F1000Res, V8, DOI 10.12688/f1000research.17228.1; Aluvaala J, 2015, ARCH DIS CHILD, V100, P42, DOI 10.1136/archdischild-2014-306423; [Anonymous], 2019, LANCET GLOB HEALTH; [Anonymous], 2017, DAT CAUS CHILD MORT; Ballot DE, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0337-4; Ballot DE, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-30; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Boerma T, 2018, LANCET, V391, P1538, DOI 10.1016/S0140-6736(18)30104-1; Demisse AG, 2017, PEDIATR HEALTH MED T, V8, P57, DOI 10.2147/PHMT.S130309; Desalew A, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-02051-7; Dewez JE, 2017, TROP DOCT, V47, P19, DOI 10.1177/0049475516630210; Elizabeth IU, 2015, J NURS HLTH SCI, V4, P62; English M, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0556-z; Engwa Godwill Azeh, 2017, BMC Res Notes, V10, P721, DOI 10.1186/s13104-017-3051-5; Enweronu-Laryea CC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204410; Gitobu CM, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1708-2; Kihuba E, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24859; Kintiraki E, 2015, HORM-INT J ENDOCRINO, V14, P211, DOI 10.14310/horm.2002.1582; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lee ACC, 2019, LANCET GLOB HEALTH, V7, pE2, DOI 10.1016/S2214-109X(18)30484-4; Lehtonen L, 2017, SEMIN FETAL NEONAT M, V22, P153, DOI 10.1016/j.siny.2017.02.006; Lippi G, 2020, ACTA HAEMATOL-BASEL, V143, P196, DOI 10.1159/000502434; Medvedev MM, 2020, LANCET CHILD ADOLESC, V4, P299, DOI 10.1016/S2352-4642(20)30021-3; Ministry of Health K, 2016, BAS PAED PROT AG 5 Y, VFourth; Murphy GAV, 2019, J CLIN NURS, V28, P882, DOI 10.1111/jocn.14695; National Population Commission N ICF, 2019, NIG DEM HLTH SURV; Ndombo PK, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-017-0369-5; Noubiap JJ, 2019, J CLIN HYPERTENS, V21, P479, DOI 10.1111/jch.13514; Ntoimo OF, 2018, INT J WOMENS HEALTH, V10, P69, DOI 10.2147/IJWH.S151784; Nunes Marta C, 2018, F1000Res, V7, P122, DOI 10.12688/f1000research.12473.1; Olusanya BO, 2018, LANCET CHILD ADOLESC, V2, P610, DOI 10.1016/S2352-4642(18)30139-1; Olusanya BO, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1471; Orsido TT, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2227-5; Osuorah CDI, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1174-z; Owa J A, 1990, West Afr J Med, V9, P252; Owusu BA, 2018, AFR HEALTH SCI, V18, P369, DOI 10.4314/ahs.v18i2.22; Rosenberg RE, 2009, J HEALTH POPUL NUTR, V27, P332; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Shah S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000792; Slusher TM, 2017, BMJ PAEDIATR OPEN, V1, DOI 10.1136/bmjpo-2017-000105; Tekleab AM, 2016, RES REP NEONATOL, V6, P17, DOI 10.2147/RRN.S95455; The Lancet, 2020, LANCET PLANET HLTH, V4, pe168; (UNDP) UNDP, 2018, HUM DEV IND IND 2018; Unger H, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-018-2128-z; United Nations Inter-agency Group for Child Mortality Estimation (UN IGME), 2021, LEVELS TRENDS CHILD; Upadhyay RP, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020384; Vojtek I, 2018, ANN MED, V50, P193, DOI 10.1080/07853890.2017.1421320; WHO UNICEF, 2018, PROGR REP REACH EV N; Worku B, 2012, ETHIOP J HEALTH DEV, V26, P200; World Health Organization, 2015, WHO REC PREV TRE MAT; World Health Organization, 2014, EV NEWB ACT PLAN END; World Health Organization (WHO), 2016, STANDARDS IMPROVING	55	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0244109	10.1371/journal.pone.0244109	http://dx.doi.org/10.1371/journal.pone.0244109			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444346	gold, Green Published, Green Accepted			2022-12-26	WOS:000609988100044
J	Heffernan, A; Ma, YL; Nayagam, S; Chan, PL; Chen, ZD; Cooke, GS; Guo, Y; Liu, CT; Thursz, M; Zhang, WY; Zhang, XB; Zhang, XJ; Jia, MH; Hallett, TB				Heffernan, Alastair; Ma, Yanling; Nayagam, Shevanthi; Chan, Polin; Chen, Zhongdan; Cooke, Graham S.; Guo, Yan; Liu, Chuntao; Thursz, Mark; Zhang, Wanyue; Zhang, Xiaobing; Zhang, Xiujie; Jia, Manhong; Hallett, Timothy B.			Economic and epidemiological evaluation of interventions to reduce the burden of hepatitis C in Yunnan province, China	PLOS ONE			English	Article							COST-EFFECTIVENESS; DRUGS; HIV	Background The paradigm shift in hepatitis C virus (HCV) treatment options in the last five years has raised the prospect of eliminating the disease as a global health threat. This will require a step-change in the number being treated with the new direct-acting antivirals (DAAs). Given constrained budgets and competing priorities, policy makers need information on how to scale-up access to HCV treatment. To inform such decisions, we examined the cost effectiveness of screening and treatment interventions in Yunnan, China. Methods and findings We simulated the HCV epidemic using a previously published model of HCV transmission and disease progression, calibrated to Yunnan data, and implemented a range of treatment and screening interventions from 2019. We incorporated treatment, diagnosis, and medical costs (expressed in 2019 US Dollars, USD) to estimate the lifetime benefits and costs of interventions. Using this model, we asked: is introducing DAAs cost effective from a healthcare sector perspective; what is the optimal combination of screening interventions; and what is the societal return on investment of intervention? The incremental cost-effectiveness ratio (ICER) of switching to DAAs with a median cost of 7,400 USD (50,000 Chinese Yuan) per course is 500 USD/disability adjusted life year (DALY) averted; at a threshold of 50% of Yunnan gross domestic product (2,600 USD), switching to DAAs is cost effective 94% of the time. At this threshold, the optimal, cost-effective intervention comprises screening people who inject drugs, those in HIV care, men who have sex with men, and ensuring access to DAAs for all those newly diagnosed with HCV. For each USD invested in this intervention, there is an additional 0 center dot 80 USD (95% credible interval: 0 center dot 17-1 center dot 91) returned through reduced costs of disease or increased productivity. Returns on investment are lower (and potentially negative) if a sufficiently long-term horizon, encompassing the full stream of future benefits, is not adopted. The study had two key limitations: costing data were not always specific to Yunnan province but were taken from China-level studies; and modelled interventions may require more operational research to ensure they can be effectively and efficiently rolled-out to the entire province. Conclusions Introducing DAAs is cost effective, the optimal package of screening measures is focussed on higher risk groups, and there are likely to be positive returns from investing in such HCV interventions. Our analysis shows that targeted investment in HCV interventions will have net benefits to society; these benefits will only increase as DAA costs fall.	[Heffernan, Alastair; Nayagam, Shevanthi; Cooke, Graham S.; Thursz, Mark; Hallett, Timothy B.] Imperial Coll London, Sch Publ Hlth, London, England; [Ma, Yanling; Guo, Yan; Liu, Chuntao; Zhang, Wanyue; Zhang, Xiaobing; Zhang, Xiujie; Jia, Manhong] Yunnan Ctr Dis Control & Prevent, Kunming, Yunnan, Peoples R China; [Chan, Polin; Chen, Zhongdan] World Hlth Org, Western Pacific Reg Off, Manila, Philippines	Imperial College London; World Health Organization	Hallett, TB (corresponding author), Imperial Coll London, Sch Publ Hlth, London, England.; Jia, MH (corresponding author), Yunnan Ctr Dis Control & Prevent, Kunming, Yunnan, Peoples R China.	jiamanhong@yncdc.cn; timothy.hallett@imperial.ac.uk	MA, YAN/HHN-2912-2022	Heffernan, Alastair/0000-0002-8077-6823; Thursz, Mark/0000-0002-8218-192X; Chan, Polin/0000-0003-1708-5170; Hallett, Timothy/0000-0002-9681-0424	Wellcome Trust [105268/Z/14/Z]; MRC [MR/P025064/1, MR/R015600/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AH was supported by the Wellcome Trust (https://wellcome.ac.uk), grant number 105268/Z/14/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, DUBL DRUG POL SUMM R; [Anonymous], 2017, EPLASTY, V17, pic25; Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Chen GF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155934; Chen H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175189; Chung RT, 2018, CLIN INFECT DIS; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Claxton K.P., 2014, GATES REFERENCE CASE; Cooke GS, 2019, LANCET GASTROENTEROL, V4, P135, DOI 10.1016/S2468-1253(18)30270-X; de Vries LM, 2019, PHARMACOECONOMICS, V37, P119, DOI 10.1007/s40273-018-0749-8; Degenhardt L, 2017, LANCET GLOB HEALTH, V5, pE1192, DOI 10.1016/S2214-109X(17)30375-3; Hecht R, 2018, HEALTH POLICY PLANN, V33, P528, DOI 10.1093/heapol/czy018; Heffernan A, 2019, LANCET; Heffernan A, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofx252; Hiebert L, 2019, VALUE HEALTH REG ISS, V18, P112, DOI 10.1016/j.vhri.2018.12.005; Hu M, 2009, VALUE HEALTH, V12, pS89, DOI 10.1111/j.1524-4733.2009.00636.x; Li Jianhua, 2012, B WHO HUMAN RESOURCE; Liu YC, 2018, CLIN DRUG INVEST, V38, P427, DOI 10.1007/s40261-018-0621-9; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Lu Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195117; Lyttleton C, 2004, DEV CHANGE, V35, P909, DOI 10.1111/j.1467-7660.2004.00386.x; Manos MM, 2013, J MANAGE CARE PHARM, V19, P438, DOI 10.18553/jmcp.2013.19.6.438; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; O TM, 2018, OTOLARYNGOL CLIN N A, V51, pxvii; ofx.com, YEARL AV RAT; Platt L, 2018, ADDICTION, V113, P545, DOI 10.1111/add.14012; Raftery AE, 2010, BIOMETRICS, V66, P1162, DOI 10.1111/j.1541-0420.2010.01399.x; Statista, CHIN UN RAT 2012 202; The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; WHO, 2017, WHO PUBLISHES LIST B; Wikipedia, 2018, YUNN PAG 2017 GDP ST; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015; Woods B, 2016, VALUE HEALTH, V19, P929, DOI 10.1016/j.jval.2016.02.017; World Health Organization, 2018, GUID CAR TREATM PERS; World Health Organization, 2018, STAT ACC REP 2018 TI; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhang GB, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00256; Zhou YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042937	41	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0245288	10.1371/journal.pone.0245288	http://dx.doi.org/10.1371/journal.pone.0245288			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4UT	33439903	Green Published, gold			2022-12-26	WOS:000609985300006
J	Yen, YH; Cheng, YF; Wang, JH; Lin, CC; Wang, CC				Yen, Yi-Hao; Cheng, Yu-Fan; Wang, Jing-Houng; Lin, Chih-Che; Wang, Chih-Chi			Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: When East meets West	PLOS ONE			English	Article							FATTY LIVER-DISEASE; AMERICAN ASSOCIATION; UNITED-STATES; HEPATITIS-C; MANAGEMENT; DIAGNOSIS; VALIDATION; PATTERNS; FIBROSIS; THERAPY	Background/Aims A recent study from the United States reported that nearly 12% of hepatocellular carcinomas (HCCs) occurred in patients without cirrhosis. Non-alcoholic fatty liver disease (NAFLD) was the most common liver disease in these patients. We aim to evaluate the characteristics, etiologies, and outcomes of cases of non-cirrhotic HCC in East Asia, where there is a higher prevalence of hepatitis B virus (HBV)-associated non-cirrhotic HCC. Methods This retrospective study consecutively enrolled de novo HCC patients managed at our institution from 2011 to 2017. The presence of cirrhosis was assessed by histology; if histology was not available, it was assessed by image study. Results 2055 patients with HCC were enrolled in this study. Among them, 529 (25.7%) were non-cirrhotic. The non-cirrhotic patients were younger (60.9 vs. 62.5 years, p = 0.006), included a greater proportion of males (78.1% vs. 71.3%, p = 0.002), and had a lower body mass index (24.3 vs. 25.3 kg/m(2), p<0.001) than the cirrhotic patients. Among the non-cirrhotic patients, HBV was the most common liver disease (49.0%). The patients with non-cirrhotic HCC had larger tumors (5.9 vs. 4.7 cm, p<0.001), underwent liver resection at a higher rate (66.0% vs. 17.4%, p<0.001), and had better overall survival than the cirrhotic HCC patients (median 5.67 vs. 2.83 years, p<0.001). Conclusions Nearly 26% of the HCCs occurred in patients without cirrhosis. HBV was the most common liver disease in these patients, and the survival was better in the non-cirrhotic patients than the cirrhotic patients.	[Yen, Yi-Hao; Wang, Jing-Houng] Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [Yen, Yi-Hao; Wang, Jing-Houng] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Cheng, Yu-Fan] Chang Gung Univ, Liver Transplantat Ctr, Dept Diagnost Radiol, Kaohsiung Chang Gung Mem Hosp,Coll Med, Kaohsiung, Taiwan; [Lin, Chih-Che; Wang, Chih-Chi] Kaohsiung Chang Gung Mem Hosp, Liver Transplantat Ctr, Kaohsiung, Taiwan; [Lin, Chih-Che; Wang, Chih-Chi] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yen, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Kaohsiung, Taiwan.; Yen, YH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.	cassellyen@yahoo.com.tw			Kaohsiung Chang Gung Memorial Hospital, Taiwan [CMRPG8J1281]	Kaohsiung Chang Gung Memorial Hospital, Taiwan	This study was supported by Grant CMRPG8J1281 from the Kaohsiung Chang Gung Memorial Hospital, Taiwan. Grant Recipient is YiHao Yen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bengtsson B, 2019, LIVER INT, V39, P1098, DOI 10.1111/liv.14087; Bertot LC, 2019, EXPERT REV GASTROENT, V13, P179, DOI 10.1080/17474124.2019.1549989; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Degasperi E, 2016, LANCET GASTROENTEROL, V1, P156, DOI 10.1016/S2468-1253(16)30018-8; Edge SB, 2010, AM JOINT COMMITTEE C, P175; European Assoc Study Liver, 2018, J HEPATOL, V69, P154, DOI 10.1016/j.jhep.2018.03.018; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; Everhart JE, 2010, HEPATOLOGY, V51, P585, DOI 10.1002/hep.23315; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gawrieh S, 2019, ALIMENT PHARM THER, V50, P809, DOI 10.1111/apt.15464; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Kanwal F, 2018, GASTROENTEROLOGY, V155, P1828, DOI 10.1053/j.gastro.2018.08.024; Kee KM, 2007, INT J CANCER, V120, P2650, DOI 10.1002/ijc.22616; Kuang XJ, 2018, J VIRAL HEPATITIS, V25, P1026, DOI 10.1111/jvh.12905; Kudo M, 2015, LIVER CANCER, V4, P39, DOI 10.1159/000367727; Li J, 2019, LANCET GASTROENTEROL, V4, P389, DOI 10.1016/S2468-1253(19)30039-1; Marrero JA, 2018, HEPATOLOGY, V68, P723, DOI 10.1002/hep.29913; Mittal S, 2016, CLIN GASTROENTEROL H, V14, P124, DOI 10.1016/j.cgh.2015.07.019; Omata M, 2017, HEPATOL INT, V11, P317, DOI 10.1007/s12072-017-9799-9; Park JW, 2015, LIVER INT, V35, P2155, DOI 10.1111/liv.12818; Piscaglia F, 2016, HEPATOLOGY, V63, P827, DOI 10.1002/hep.28368; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Shen YC, 2010, J HEPATOL, V52, P889, DOI 10.1016/j.jhep.2009.12.041; Shiha G, 2017, HEPATOL INT, V11, P1, DOI 10.1007/s12072-016-9760-3; Tsigos C, 2008, OBESITY FACTS, V1, P106, DOI 10.1159/000126822; Vitale A, 2015, J HEPATOL, V62, P617, DOI 10.1016/j.jhep.2014.10.037; Wang CK, 2018, J FORMOS MED ASSOC, V117, P381, DOI 10.1016/j.jfma.2017.09.007; Wong JSW, 2011, ALIMENT PHARM THER, V33, P1104, DOI 10.1111/j.1365-2036.2011.04634.x; Wong VWS, 2018, J GASTROEN HEPATOL, V33, P70, DOI 10.1111/jgh.13857; Xiao GQ, 2017, HEPATOLOGY, V66, P1486, DOI 10.1002/hep.29302; Yang HI, 2011, LANCET ONCOL, V12, P568, DOI 10.1016/S1470-2045(11)70077-8; Younossi ZM, 2015, HEPATOLOGY, V62, P1723, DOI 10.1002/hep.28123	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0244939	10.1371/journal.pone.0244939	http://dx.doi.org/10.1371/journal.pone.0244939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439893	Green Published, gold			2022-12-26	WOS:000609985300057
J	Melendez, DM; Marti, S; Haley, DB; Schwinghamer, TD; Schwartzkopf-Genswein, KS				Melendez, Daniela M.; Marti, Sonia; Haley, Derek B.; Schwinghamer, Timothy D.; Schwartzkopf-Genswein, Karen S.			Effects of conditioning, source, and rest on indicators of stress in beef cattle transported by road	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; BOVINE RESPIRATORY-DISEASE; LONG-DISTANCE TRANSPORT; FEED WITHDRAWAL; CALVES; BEHAVIOR; PERFORMANCE; HEALTH; GROWTH; RESPONSES	Consumers are increasingly concerned about the welfare of farm animals, especially during transportation. The Canadian transport regulations state that weaned cattle require an 8 h rest after 36 h of transport. There are, however, only a few studies that assess the effect of rest on the welfare of beef cattle. The aim of this study was to assess the effect of conditioning, source and rest on indicators of welfare in 7-8-month-old beef calves during long-distance transport. Treatments consisted of a 2 x 2 x 2 factorial design where the main factors were conditioning: conditioned (C; n = 160) or non-conditioned (N; n = 160); source: auction market (A; n = 160) or ranch direct (R; n = 160); and rest: 0 h (0 h; n = 160) or 8 h (8 h; n = 160). Means of non-esterified fatty acids (NEFA), serum amyloid-A, haptoglobin, creatine kinase (CK), and percentage of time standing from N calves were greater than C calves (all p <= 0.05). Means of percentage of time standing and CK of R calves were greater than A calves (both p <= 0.05). The mean of NEFA of 0 h calves was greater than the 8 h calves (p < 0.01), while the percentage of time standing of 0 h calves was less than 8 h calves (p < 0.01). Statistically significant differences between means of NEFA and standing percentage, were observed between 0 h and 8h calves. Few and inconsistent indicators of reduced welfare were observed between auction market and ranch direct calves, while non-conditioning was associated with greater physiological and behavioural indicators of reduced welfare. Based on these results, conditioning should be implemented as a management practice to improve the welfare of transported calves.	[Melendez, Daniela M.; Schwinghamer, Timothy D.; Schwartzkopf-Genswein, Karen S.] Agr & Agri Food Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB, Canada; [Marti, Sonia] IRTA, Dept Ruminant Prod, Barcelona, Spain; [Haley, Derek B.] Univ Guelph, Dept Populat Med, Guelph, ON, Canada	Agriculture & Agri Food Canada; IRTA; University of Guelph	Schwartzkopf-Genswein, KS (corresponding author), Agr & Agri Food Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB, Canada.	karen.genswein@canada.ca		Melendez, Daniela/0000-0002-0153-9708; Schwinghamer, Timothy/0000-0001-7727-7284	Agriculture and Agri-Food Canada; Beef Cattle Research Council through the Canadian Beef Cattle Industry Science Cluster [ANH.06.17 AIP-CL01]; Canadian Beef Cattle Industry Science Cluster [ANH.06.17 AIP-CL01]; CERCA program from Generalitat de Catalunya	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Beef Cattle Research Council through the Canadian Beef Cattle Industry Science Cluster; Canadian Beef Cattle Industry Science Cluster; CERCA program from Generalitat de Catalunya	Funding was provided by Agriculture and Agri-Food Canada (http://www.agr.gc.ca/eng/home/?id=1395690825741) and the Beef Cattle Research Council (http://www.beefresearch.ca/) through the Canadian Beef Cattle Industry Science Cluster (ANH.06.17 AIP-CL01). The co-author Sonia Marti was partly supported by the CERCA program from Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, REC COD PRACT CAR HA; Arthington JD, 2003, J ANIM SCI, V81, P1120; Bailey E. A., 2015, Professional Animal Scientist, V31, P20; Bernardini D, 2012, J ANIM SCI, V90, P1183, DOI 10.2527/jas.2011-4113; BLAIR-WEST J R, 1989, American Journal of Physiology, V257, pR1212; Blokhuis HJ, 2003, ANIM WELFARE, V12, P445; Buddle EA, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8100171; Burrow H.M., 1988, P AUST SOC ANIM PROD, V17, P154; CANFAX, 2013, MARK CALV CULLS; Carroll JA, 2009, J ANIM SCI, V87, P4167, DOI 10.2527/jas.2009-2016; CCAC, 2009, CCAC GUID AN US PROT; Ceciliani F, 2012, J PROTEOMICS, V75, P4207, DOI 10.1016/j.jprot.2012.04.004; Cooke RF, 2013, J ANIM SCI, V91, P5448, DOI 10.2527/jas.2013-6357; Dewell G., FEEDLOT HLTH MANAGEM; Duff GC, 2007, J ANIM SCI, V85, P823, DOI 10.2527/jas.2006-501; Edwards TA, 2010, VET CLIN N AM-FOOD A, V26, P273, DOI 10.1016/j.cvfa.2010.03.005; Enriquez D, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-28; Fisher AD, 2014, J DAIRY RES, V81, P297, DOI 10.1017/S0022029914000193; GONYOU HW, 1979, APPL ANIM ETHOL, V5, P113, DOI 10.1016/0304-3762(79)90083-X; Gonzalez LA, 2012, J ANIM SCI, V90, P3618, DOI 10.2527/jas.2011-4771; Grandin T, 1997, J ANIM SCI, V75, P249; Gummow B, 2000, PREV VET MED, V43, P29, DOI 10.1016/S0167-5877(99)00071-9; Haley DB, 2005, J ANIM SCI, V83, P2205; Hickey MC, 2003, J ANIM SCI, V81, P2847; HIGUCHI H, 1994, AM J VET RES, V55, P1080; KARREN DB, 1987, CAN J ANIM SCI, V67, P327, DOI 10.4141/cjas87-031; KENT JE, 1983, BRIT VET J, V139, P228, DOI 10.1016/S0007-1935(17)30489-X; Kim MH, 2011, J VET SCI, V12, P151, DOI 10.4142/jvs.2011.12.2.151; Knowles TG, 2014, LIVESTOCK HANDLING AND TRANSPORT, 4TH EDITION, P399, DOI 10.1079/9781780643212.0399; Lay DC, 1998, APPL ANIM BEHAV SCI, V56, P109, DOI 10.1016/S0168-1591(97)00103-2; Lynch E, 2019, J APPL ANIM RES, V47, P167, DOI 10.1080/09712119.2019.1594825; Macartney JE, 2003, J AM VET MED ASSOC, V223, P677, DOI 10.2460/javma.2003.223.677; MacKenzie AM, 1997, RES VET SCI, V63, P227, DOI 10.1016/S0034-5288(97)90025-4; Marques RS, 2019, J ANIM SCI, V97, P398, DOI 10.1093/jas/sky397; Marti S, 2017, J ANIM SCI, V95, P636, DOI 10.2527/jas.2016.0739; MCVEIGH JM, 1982, J ANIM SCI, V54, P790, DOI 10.2527/jas1982.544790x; Melendez DM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228492; North American Meat Institute, N AM MEAT I MOB SCOR; NRC (National Research Council), 2016, NUTR REQ BEEF CATTL; O'Loughlin A, 2014, RES VET SCI, V97, P458, DOI 10.1016/j.rvsc.2014.06.003; Penicaud L, 2000, NUTRITION, V16, P903, DOI 10.1016/S0899-9007(00)00427-5; Petersen HH, 2004, VET RES, V35, P163, DOI 10.1051/vetres:2004002; Petherick JC, 2009, APPL ANIM BEHAV SCI, V120, P28, DOI 10.1016/j.applanim.2009.05.009; Petherick JC, 2002, AUST J EXP AGR, V42, P389, DOI 10.1071/EA01084; Price EO, 2003, J ANIM SCI, V81, P116; Radostits O, 2000, ALBERTA FEEDLOT MANA; RIBBLE CS, 1995, J AM VET MED ASSOC, V207, P616; Robert BD, 2011, AM J VET RES, V72, P467, DOI 10.2460/ajvr.72.4.467; Roland L, 2014, J VET DIAGN INVEST, V26, P592, DOI 10.1177/1040638714546490; Sahlin K, 1998, ACTA PHYSIOL SCAND, V162, P261, DOI 10.1046/j.1365-201X.1998.0298f.x; Schwartzkopf-Genswein K, 2018, WELFARE CATTLE, P216; Schwartzkopf-Genswein KS, 2007, APPL ANIM BEHAV SCI, V108, P12, DOI 10.1016/j.applanim.2006.11.012; Schwartzkopf-Genswein KS, 2003, CAN J ANIM SCI, V83, P29, DOI 10.4141/A02-027; Smith BM., 1973, THESIS, P6271; Smith BP, 2008, LARGE ANIMAL INTERNA, V4th, DOI [10.2169/internalmedicine.47.0773, DOI 10.2169/INTERNALMEDICINE.47.0773]; Sowell BF, 1998, APPL ANIM BEHAV SCI, V59, P277, DOI 10.1016/S0168-1591(98)00110-5; Step DL, 2008, J ANIM SCI, V86, P3146, DOI 10.2527/jas.2008-0883; Svorc P, 2018, AUTONOMIC NERVOUS SY, P4; TARRANT PV, 1992, LIVEST PROD SCI, V30, P223, DOI 10.1016/0301-6226(92)90071-B; Taylor JD, 2010, CAN VET J, V51, P1351; Taylor JD, 2010, CAN VET J, V51, P1095; Vogel KD, 2011, J ANIM SCI, V89, P538, DOI 10.2527/jas.2009-2675; Voisinet BD, 1997, J ANIM SCI, V75, P892; VOLFINGER L, 1994, AM J PHYSIOL, V266, pR434, DOI 10.1152/ajpregu.1994.266.2.R434; Wallimann T, 1998, BIOFACTORS, V8, P229, DOI 10.1002/biof.5520080310; WARRISS PD, 1995, VET REC, V136, P319, DOI 10.1136/vr.136.13.319; WIERINGA FL, 1974, CAN VET J, V15, P309; Zhang S, 2013, J ANIM SCI, V91, P1696, DOI 10.2527/jas.2012-5774	68	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0244854	10.1371/journal.pone.0244854	http://dx.doi.org/10.1371/journal.pone.0244854			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434915	Green Published, gold			2022-12-26	WOS:000609979700026
J	Bridgland, VME; Moeck, EK; Green, DM; Swain, TL; Nayda, DM; Matson, LA; Hutchison, NP; Takarangi, MKT				Bridgland, Victoria M. E.; Moeck, Ella K.; Green, Deanne M.; Swain, Taylor L.; Nayda, Diane M.; Matson, Lucy A.; Hutchison, Nadine P.; Takarangi, Melanie K. T.			Why the COVID-19 pandemic is a traumatic stressor	PLOS ONE			English	Article							DEPRESSION; ANXIETY; SAMPLE	The COVID-19 pandemic does not fit into prevailing Post-traumatic Stress Disorder (PTSD) models, or diagnostic criteria, yet emerging research shows traumatic stress symptoms as a result of this ongoing global stressor. Current pathogenic event models focus on past, and largely direct, trauma exposure to certain kinds of life-threatening events. Yet, traumatic stress reactions to future, indirect trauma exposure, and non-Criterion A events exist, suggesting COVID-19 is also a traumatic stressor which could lead to PTSD symptomology. To examine this idea, we asked a sample of online participants (N = 1,040), in five western countries, to indicate the COVID-19 events they had been directly exposed to, events they anticipated would happen in the future, and other forms of indirect exposure such as through media coverage. We then asked participants to complete the Posttraumatic Stress Disorder Checklist-5, adapted to measure pre/peri/post-traumatic reactions in relation to COVID-19. We also measured general emotional reactions (e.g., angry, anxious, helpless), well-being, psychosocial functioning, and depression, anxiety, and stress symptoms. We found participants had PTSD-like symptoms for events that had not happened and when participants had been directly (e.g., contact with virus) or indirectly exposed to COVID-19 (e.g., via media). Moreover, 13.2% of our sample were likely PTSD-positive, despite types of COVID-19 "exposure" (e.g., lockdown) not fitting DSM-5 criteria. The emotional impact of "worst" experienced/anticipated events best predicted PTSD-like symptoms. Taken together, our findings support emerging research that COVID-19 can be understood as a traumatic stressor event capable of eliciting PTSD-like responses and exacerbating other related mental health problems (e.g., anxiety, depression, psychosocial functioning, etc.). Our findings add to existing literature supporting a pathogenic event memory model of traumatic stress.	[Bridgland, Victoria M. E.; Moeck, Ella K.; Green, Deanne M.; Swain, Taylor L.; Nayda, Diane M.; Matson, Lucy A.; Hutchison, Nadine P.; Takarangi, Melanie K. T.] Flinders Univ S Australia, Coll Educ Psychol & Social Work, Adelaide, SA, Australia; [Moeck, Ella K.] Monash Univ, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia	Flinders University South Australia; Monash University	Takarangi, MKT (corresponding author), Flinders Univ S Australia, Coll Educ Psychol & Social Work, Adelaide, SA, Australia.	melanie.takarangi@flinders.edu.au	Moeck, Ella/GLR-2235-2022	Hutchison, Nadine/0000-0002-5301-3484; Takarangi, Melanie/0000-0002-6006-8045	College of Education, Psychology and Social Work at Flinders University	College of Education, Psychology and Social Work at Flinders University	MKTT and EKM received funding for this research from the College of Education, Psychology and Social Work at Flinders University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2020, REV PHILOS PSYCHOL, V11, P233, DOI 10.1007/s13164-020-00470-0; American psychiatric association, 1980, DIAGNOSTIC STAT MANU; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, DOI DOI 10.1176/APPI.BOOKS.9780890425596; American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU, V4th; Arpaci I, 2020, PERS INDIV DIFFER, V164, DOI 10.1016/j.paid.2020.110108; Bai H., 2018, EVIDENCE LARGE AMOUN; Bech P, 1996, PSYCHOTHER PSYCHOSOM, V65, P183, DOI 10.1159/000289073; Berinsky AJ, 2014, AM J POLIT SCI, V58, P739, DOI 10.1111/ajps.12081; Berntsen D, 2015, CLIN PSYCHOL SCI, V3, P663, DOI 10.1177/2167702614551766; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Brickman P., 1971, ADAPTATION LEVEL THE, P287, DOI DOI 10.3389/FPSYG.2018.01158; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Chao M, 2020, J ANXIETY DISORD, V74, DOI 10.1016/j.janxdis.2020.102248; Clark DM, 1999, BEHAV RES THER, V37, pS5, DOI 10.1016/S0005-7967(99)00048-0; Cooke JE, 2020, PSYCHIAT RES, V292, DOI 10.1016/j.psychres.2020.113347; Cordova MJ, 2017, LANCET PSYCHIAT, V4, P330, DOI 10.1016/S2215-0366(17)30014-7; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Friedman MJ, 2013, J TRAUMA STRESS, V26, P548, DOI 10.1002/jts.21840; Funder DC, 2019, ADV METH PRACT PSYCH, V2, P156, DOI 10.1177/2515245919847202; Galea S, 2008, J TRAUMA STRESS, V21, P357, DOI 10.1002/jts.20355; Gilliland G, 1998, DEATH STUD, V22, P541; Gold SD, 2005, J ANXIETY DISORD, V19, P687, DOI 10.1016/j.janxdis.2004.06.002; Goutaudier N, 2019, J REPROD INFANT PSYC, V37, P44, DOI 10.1080/02646838.2018.1504284; Hauser DJ, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015584617; Hauser DJ, 2016, BEHAV RES METHODS, V48, P400, DOI 10.3758/s13428-015-0578-z; Holman EA, 2014, P NATL ACAD SCI USA, V111, P93, DOI 10.1073/pnas.1316265110; Horesh D, 2020, PSYCHOL TRAUMA-US, V12, P331, DOI 10.1037/tra0000592; Liang LL, 2020, J HEALTH PSYCHOL, V25, P1164, DOI 10.1177/1359105320937057; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Marx B.P., 2019, BRIEF INVENTORY PSYC; McNally Richard J., 2003, REMEMBERING TRAUMA; Mellis AM, 2020, ADDICTION, V115, P1960, DOI 10.1111/add.15032; Mertens G, 2020, J ANXIETY DISORD, V74, DOI 10.1016/j.janxdis.2020.102258; Molla R, 2020, IT DIDNT WORK, DOI 1048116/tech-companies-time-well-spent-mobile-phone-usage-dat; Moss A., 2018, BOT SCARE UNDERSTAND; Park A, 2020, STRESS FUNCTIONING C; Peer E, 2017, J EXP SOC PSYCHOL, V70, P153, DOI 10.1016/j.jesp.2017.01.006; Ren ZJ, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09723-0; Rubin DC, 2008, J EXP PSYCHOL GEN, V137, P591, DOI 10.1037/a0013165; Rubin DC, 2015, PSYCHOL REV, V122, P1, DOI 10.1037/a0037907; Rubin DC, 2014, J EXP PSYCHOL GEN, V143, P612, DOI 10.1037/a0032638; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Schonbrodt FD, 2013, J RES PERS, V47, P609, DOI 10.1016/j.jrp.2013.05.009; Shapiro DN, 2013, CLIN PSYCHOL SCI, V1, P213, DOI 10.1177/2167702612469015; Sinclair SJ, 2012, EVAL HEALTH PROF, V35, P259, DOI 10.1177/0163278711424282; Stokel-Walker C., 2018, NEW SCI; Taylor S, 2020, DEPRESS ANXIETY, V37, P706, DOI 10.1002/da.23071; Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Weathers F. W., 2013, PTSD CHECKLIST DSM 5, DOI DOI 10.1037/T02622-000; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; World Health Organisation,, 2020, MENT HLTH PSYCH CONS; Zachar P, 2017, VAGUENESS PSYCHIAT, P169, DOI [10.1093/ med/9780198722373.001.0001/med-9780198722373-chapter-9, DOI 10.1093/MED/9780198722373.001.0001/MED-9780198722373-CHAPTER-9]; Zhang Q, 2020, IEEE GLOB COMM CONF, DOI 10.1109/GLOBECOM42002.2020.9348075	59	153	155	15	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0240146	10.1371/journal.pone.0240146	http://dx.doi.org/10.1371/journal.pone.0240146			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY4UJ	33428630	Green Published, gold, Green Submitted			2022-12-26	WOS:000630036100005
J	Ganguly, E; Kirschenman, R; Spaans, F; Holody, CD; Phillips, TEJ; Case, CP; Cooke, CLM; Murphy, MP; Lemieux, H; Davidge, ST				Ganguly, Esha; Kirschenman, Raven; Spaans, Floor; Holody, Claudia D.; Phillips, Thomas E. J.; Case, C. Patrick; Cooke, Christy-Lynn M.; Murphy, Michael P.; Lemieux, Helene; Davidge, Sandra T.			Nanoparticle-encapsulated antioxidant improves placental mitochondrial function in a sexually dimorphic manner in a rat model of prenatal hypoxia	FASEB JOURNAL			English	Article						mitochondrial function; nMitoQ; placenta; prenatal hypoxia	INTRAUTERINE GROWTH RESTRICTION; HIGH-FAT DIET; OXIDATIVE STRESS; S-NITROSYLATION; RESPIRATION; FISSION; DRP1; PHOSPHORYLATION; PREECLAMPSIA; ADAPTATIONS	Pregnancy complications associated with prenatal hypoxia lead to increased placental oxidative stress. Previous studies suggest that prenatal hypoxia can reduce mitochondrial respiratory capacity and mitochondrial fusion, which could lead to placental dysfunction and impaired fetal development. We developed a placenta-targeted treatment strategy using a mitochondrial antioxidant, MitoQ, encapsulated into nanoparticles (nMitoQ) to reduce placental oxidative stress and (indirectly) improve fetal outcomes. We hypothesized that, in a rat model of prenatal hypoxia, nMitoQ improves placental mitochondrial function and promotes mitochondrial fusion in both male and female placentae. Pregnant rats were treated with saline or nMitoQ on gestational day (GD) 15 and exposed to normoxia (21% O-2) or hypoxia (11% O-2) from GD15-21. On GD21, male and female placental labyrinth zones were collected for mitochondrial respirometry assessments, mitochondrial content, and markers of mitochondrial biogenesis, fusion and fission. Prenatal hypoxia reduced complex IV activity and fusion in male placentae, while nMitoQ improved complex IV activity in hypoxic male placentae. In female placentae, prenatal hypoxia decreased respiration through the S-pathway (complex II) and increased N-pathway (complex I) respiration, while nMitoQ increased fusion in hypoxic female placentae. No changes in mitochondrial content, biogenesis or fission were found. In conclusion, nMitoQ improved placental mitochondrial function in male and female placentae from fetuses exposed to prenatal hypoxia, which may contribute to improved placental function. However, the mechanisms (ie, changes in mitochondrial respiratory capacity and mitochondrial fusion) were distinct between the sexes. Treatment strategies targeted against placental oxidative stress could improve placental mitochondrial function in complicated pregnancies.	[Ganguly, Esha; Davidge, Sandra T.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Ganguly, Esha; Kirschenman, Raven; Spaans, Floor; Cooke, Christy-Lynn M.; Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynaecol, Edmonton, AB, Canada; [Ganguly, Esha; Kirschenman, Raven; Spaans, Floor; Holody, Claudia D.; Cooke, Christy-Lynn M.; Lemieux, Helene; Davidge, Sandra T.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Holody, Claudia D.] Univ Alberta, Dept Paediat, Edmonton, AB, Canada; [Holody, Claudia D.] Univ Alberta, Fac St Jean, Edmonton, AB, Canada; [Phillips, Thomas E. J.] Cardiff Univ, Dementia Res Inst, Cardiff, Wales; [Case, C. Patrick] Univ Bristol, Musculoskeletal Res Unit, Bristol, Avon, England; [Murphy, Michael P.] Univ Cambridge, MRC Mitochondrial Biol Unit, Keith Peters Bldg, Cambridge, England; [Lemieux, Helene] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; Cardiff University; University of Bristol; University of Cambridge; University of Alberta	Davidge, ST (corresponding author), Univ Alberta, Canada Res Chair Maternal & Perinatal Cardiovasc, 232 HMRC, Edmonton, AB T6G 2S2, Canada.	sandra.davidge@ualberta.ca	Phillips, Thomas/AAJ-5804-2021	Phillips, Thomas/0000-0002-4709-2550; Davidge, Sandra/0000-0002-5559-4905; Holody, Claudia/0000-0003-1479-3809	Canadian Institutes of Health Research [CIHR FS 154313]; Women and Children's Health Research Institute (WCHRI) through Stollery Children's Hospital Foundation; Lois Hole Hospital for Women; Natural Sciences and Engineering Research Council of Canada [RGPIN 402636]; Faculty of Medicine & Dentistry 75th Anniversary Awards; WCHRI Graduate Studentship Program; University of Alberta	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Women and Children's Health Research Institute (WCHRI) through Stollery Children's Hospital Foundation; Lois Hole Hospital for Women; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Faculty of Medicine & Dentistry 75th Anniversary Awards; WCHRI Graduate Studentship Program; University of Alberta(University of Alberta)	This research was funded by grants from the Canadian Institutes of Health Research (CIHR FS 154313) and the Women and Children's Health Research Institute (WCHRI) through the generosity of the Stollery Children's Hospital Foundation and supporters of the Lois Hole Hospital for Women supporting the laboratory of SD. SD is a Canada Research Chair in Maternal and Perinatal Cardiovascular Health and a Distinguished University Professor at the University of Alberta. HL was supported by a discovery grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN 402636). EG was supported by Faculty of Medicine & Dentistry 75th Anniversary Awards, WCHRI Graduate Studentship Program and Dean's Doctoral Award from the University of Alberta.	Aljunaidy MM, 2018, PHARMACOL RES, V134, P332, DOI 10.1016/j.phrs.2018.05.006; Ausman J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0360-0; Baker MJ, 2014, EMBO J, V33, P578, DOI 10.1002/embj.201386474; Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010; Biri A, 2007, GYNECOL OBSTET INVES, V64, P187, DOI 10.1159/000106488; Bossy B, 2010, J ALZHEIMERS DIS, V20, pS513, DOI 10.3233/JAD-2010-100552; Burton GJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0066; Carter AM, 2000, PLACENTA, V21, pS31, DOI 10.1053/plac.1999.0513; Chandel NS, 1997, J BIOL CHEM, V272, P18808, DOI 10.1074/jbc.272.30.18808; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chaudhari HN, 2014, FREE RADICAL RES, V48, P587, DOI 10.3109/10715762.2014.896003; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Colleoni F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055194; Fisher JJ, 2020, CLIN EXP PHARMACOL P, V47, P176, DOI 10.1111/1440-1681.13172; Ganguly E, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104836; Ganguly E, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00562; Gnaiger E., 2014, MITOCHONDRIAL PATHWA, V4th; Han WH, 2017, INVEST OPHTH VIS SCI, V58, P3826, DOI 10.1167/iovs.17-21929; Hinkle PC, 2005, BBA-BIOENERGETICS, V1706, P1, DOI 10.1016/j.bbabio.2004.09.004; Holland O, 2017, PLACENTA, V54, P2, DOI 10.1016/j.placenta.2016.12.012; Holland OJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1190-9; Hu CX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010144; Jahani-Asl A, 2007, EMBO REP, V8, P912, DOI 10.1038/sj.embor.7401077; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kim H, 2009, MACROMOL BIOSCI, V9, P842, DOI 10.1002/mabi.200800367; Koopman WJH, 2007, AM J PHYSIOL-CELL PH, V293, pC22, DOI 10.1152/ajpcell.00194.2006; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lemieux H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02789-8; Lemieux H, 2011, INT J BIOCHEM CELL B, V43, P1729, DOI 10.1016/j.biocel.2011.08.008; Lemieux H, 2010, J GERONTOL A-BIOL, V65, P1157, DOI 10.1093/gerona/glq141; Longtine MS, 2011, SEMIN REPROD MED, V29, P187, DOI 10.1055/s-0031-1275515; MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186; Mayeur S, 2013, AM J PHYSIOL-ENDOC M, V304, pE14, DOI 10.1152/ajpendo.00332.2012; Muralimanoharan S, 2012, PLACENTA, V33, P816, DOI 10.1016/j.placenta.2012.07.002; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Nuzzo AM, 2018, AM J PATHOL, V188, P2704, DOI 10.1016/j.ajpath.2018.07.027; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Pesta D, 2011, AM J PHYSIOL-REG I, V301, pR1078, DOI 10.1152/ajpregu.00285.2011; Phillips TJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06300-1; Plecita-Hlavata L, 2009, INT J BIOCHEM CELL B, V41, P1697, DOI 10.1016/j.biocel.2009.02.015; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Raijmakers MTM, 2004, HYPERTENSION, V44, P374, DOI 10.1161/01.HYP.0000141085.98320.01; Rueda-Clausen CF, 2011, DIABETES, V60, P507, DOI 10.2337/db10-1239; Rueda-Clausen CF, 2009, CARDIOVASC RES, V81, P713, DOI 10.1093/cvr/cvn341; Schneider J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228710; Sferruzzi-Perri AN, 2019, P NATL ACAD SCI USA, V116, P1621, DOI 10.1073/pnas.1816056116; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Song H, 2019, BIOL REPROD, V100, P208, DOI 10.1093/biolre/ioy167; Vaughan OR, 2016, REPROD DOMEST ANIM, V51, P25, DOI 10.1111/rda.12797; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Vishnyakova PA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32410; Wang Y, 2018, ADV SUSTAIN SYST, V2, DOI 10.1002/adsu.201700119; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; Zhang S, 2015, NUTRIENTS, V7, P360, DOI 10.3390/nu7010360; Zhou XB, 2017, EXP CELL RES, V359, P195, DOI 10.1016/j.yexcr.2017.07.029	57	8	8	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21338	10.1096/fj.202002193R	http://dx.doi.org/10.1096/fj.202002193R		JAN 2021	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33428278				2022-12-26	WOS:000607203800001
J	Tamene, A; Afework, A				Tamene, Aiggan; Afework, Abel			Exploring barriers to the adoption and utilization of improved latrine facilities in rural Ethiopia: An Integrated Behavioral Model for Water, Sanitation and Hygiene (IBM-WASH) approach	PLOS ONE			English	Article							LED TOTAL SANITATION; PIT LATRINES; COMMUNITY; COVERAGE; DISTRICT; CHALLENGES; MANAGEMENT; HOUSEHOLDS; HEALTH	Background Even though evidence shows that access to and use of improved latrines is related to healthful families and the public, obstacles to the adoption and use of improved latrine facilities remain. Globally, not many inquiries appear to have been carried out to satisfactorily inform us regarding the multi-level barriers influencing the adoption and utilization of improved latrines facilities. Related studies in Ethiopia are even fewer. Methods Two qualitative data gathering methods, viz., key informant interviews and focus group discussions, were employed to collect data for this study. A total of fifteen focus group discussions were conducted with members of the community in the rural Wonago district of Ethiopia. Similarly, ten key informant interviews were conducted with water, sanitation, and hygiene officers, and health extension workers responsible for coordinating sanitation and hygiene activities. Open code software 4.03 was used for thematic analysis. Result Barriers to adoption and use of improved latrine facilities were categorized into Contextual factors (e.g. Gender, educational status, personal preference for using the field, limited space, population density, the status of land ownership), Psychosocial factors (Culture, beliefs, attitudes, and perceptions of minimal health threat from children's feces), and Technological factors (inconveniences in acquiring materials and cost of constructing a latrine). Conclusion There are a series of multi-leveled barriers to the sustained adoption and use of latrines. Providing funding opportunities for the underprivileged and offering training on the engineering skills of latrine construction at the community level based on the contextual soil circumstances could expand the latrine coverage and use. Similarly, taking into account the variability in motivations for adopting and using latrines among our study in Ethiopia and other studies, we implore public health experts to recognize behaviors and norms in their target communities in advance of implementing sanitation interventions.	[Tamene, Aiggan] Wachemo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Environm Hlth Unit, Hosaena, Ethiopia; [Afework, Abel] Dilla Univ, Dilla Univ Hosp, Coll Med & Hlth Sci, Infect Prevent & Patient Safety Unit, Dilla, Ethiopia	Dilla University	Tamene, A (corresponding author), Wachemo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Environm Hlth Unit, Hosaena, Ethiopia.	apublic22@gmail.com	Afework, Abel/GNO-9194-2022; Tamene, Aiggan/ABB-7893-2021	Afework, Abel/0000-0002-9828-7446; Tamene, Aiggan/0000-0001-5504-0905				Adane M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182783; Aiemjoy K, 2017, AM J TROP MED HYG, V96, P65, DOI 10.4269/ajtmh.16-0541; Alemu F, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4717-6; Alhassan S, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070749; Aluko OO, 2017, BMC PUBLIC HEALTH, V17, DOI [10.1186/s12889-017-4078-1, 10.1186/s12889-017-4078-1`]; Andres H, 2013, WATER POLICY, V2013, P15, DOI [10.2166/wp.2012.198, DOI 10.2166/WP.2012.198]; Antwi-Agyei P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124528; Armah FA, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00931; Awoke W, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-99; Azage M, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03828; Bartram J, 2014, INT J ENV RES PUB HE, V11, P8137, DOI 10.3390/ijerph110808137; Bauza V, 2019, AM J TROP MED HYG, V100, P1013, DOI 10.4269/ajtmh.18-0840; Belachew A B, 2018, J Prev Med Hyg, V59, pE219, DOI 10.15167/2421-4248/jpmh2018.59.3.826; Beyene A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1804-4; Bhatt N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219246; Budhathoki Shyam Sundar, 2017, BMC Res Notes, V10, P209, DOI 10.1186/s13104-017-2539-3; Carolini GY, 2012, AM J PUBLIC HEALTH, V102, P256, DOI 10.2105/AJPH.2011.300399; Crocker J, 2016, ENVIRON SCI TECHNOL, V50, P6517, DOI 10.1021/acs.est.6b01021; Cronin AA, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0709-5; Dreibelbis R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1015; Federal Democratic Republic of Ethiopia, 2012, NAT PLAN ACT INCL PE; Gebremariam B, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4519-2; Grimason AM, 2000, J R SOC PROMO HEALTH, V120, P175, DOI 10.1177/146642400012000307; Guo A, 2017, AM J TROP MED HYG, V97, P1033, DOI 10.4269/ajtmh.17-0208; Huda TMN, 2018, AM J TROP MED HYG, V98, P967, DOI 10.4269/ajtmh.16-0724; Hyun C, 2019, ANNU REV ENV RESOUR, V44, P287, DOI 10.1146/annurev-environ-101718-033327; Kayser GL, 2019, B WORLD HEALTH ORGAN, V97, P438, DOI 10.2471/BLT.18.223305; Kumwenda Save, 2017, BMC Res Notes, V10, P200, DOI 10.1186/s13104-017-2519-7; Leshargie CT, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5798-6; Mai VQ, 2020, ENVIRON HEALTH INSIG, V14, DOI 10.1177/1178630220938396; Mara D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000363; Meier BM, 2014, SCI ENG ETHICS, V20, P833, DOI 10.1007/s11948-013-9504-x; Miller-Petrie MK, 2016, AM J TROP MED HYG, V94, P456, DOI 10.4269/ajtmh.15-0423; Oswald WE, 2016, AM J TROP MED HYG, V95, P709, DOI 10.4269/ajtmh.15-0895; Pruss-Ustun A, 2019, INT J HYG ENVIR HEAL, V222, P765, DOI 10.1016/j.ijheh.2019.05.004; Sibiya JE, 2013, INT J ENV RES PUB HE, V10, P2282, DOI 10.3390/ijerph10062282; Sinha A, 2017, INT J HYG ENVIR HEAL, V220, P906, DOI 10.1016/j.ijheh.2017.05.004; Tessema RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175233; Tsinda A, 2013, INT J ENV RES PUB HE, V10, P6939, DOI 10.3390/ijerph10126939; Yimam YT, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.334.4206; Zeleke DA, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4066-x	41	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0245289	10.1371/journal.pone.0245289	http://dx.doi.org/10.1371/journal.pone.0245289			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY4UJ	33428677	Green Published, gold			2022-12-26	WOS:000630036100053
J	Khaled, M; Moustafa, AS; El-Khazragy, N; Ahmed, MI; Abd Elkhalek, MA; El-Salahy, EM				Khaled, Mai; Moustafa, Amr S.; El-Khazragy, Nashwa; Ahmed, Maha Imam; Abd Elkhalek, Marwa Ali; El-Salahy, Eman M.			CRISPR/Cas9 mediated knock-out of VPREB1 gene induces a cytotoxic effect in myeloma cells	PLOS ONE			English	Article							PATIENT-DERIVED IPSCS; GENOME; CAS9	Background Multiple Myeloma (MM) is a heterogeneous, hematological neoplasm that accounts 2% of all cancers. Although, autologous stem cell transplantation and chemotherapy are currently the most effective therapy, it carries a notable hazards, in addition for being non curative. Recently, the Clustered Regular Interspaced Short Palindromic Repeats (CRISPR-cas9) has been successfully tried at the experimental level, for the treatment of several hematological malignancies. Objectives We aimed to investigate the in-vitro effect of CRISPR-cas9-mediated knock-out of V-set pre B-cell surrogate light chain 1"VPREB1" gene on the malignant proliferation of primary cultured myeloma cells. Methods Bioinformatics' analysis was performed to explore the gene expression profile of MM, and the VPREB1 gene was selected as a target gene for this study. We knocked-out the VPREB1 gene in primary cultured myeloma cells using CRISPR-cas9, the VPREB1 gene editing efficacy was verified by determining VPREB1 gene expression at both the mRNA and protein levels by qPCR and immunofluorescence, respectively. Furthermore, the cytotoxic effect on primary myeloma cells proliferation was evaluated using cytotoxicity assay. Results There was a statistically significant reduction of both VPREB1 mRNA and protein expression levels (p<0.01). knock-out of VPREB1 gene in myeloma cell line resulted in a statistically significant reduction of myeloma cell proliferation. Conclusion CRISPR-cas9-mediated knock-out of VPREB1 gene is effective for inhibiting the proliferation of primary myeloma cells. This would provide a basis for a promising therapeutic strategy for patients with multiple myeloma.	[Khaled, Mai; Moustafa, Amr S.; Ahmed, Maha Imam; Abd Elkhalek, Marwa Ali; El-Salahy, Eman M.] Ain Shams Univ, Fac Med, Dept Med Biochem & Mol Biol, Cairo, Egypt; [El-Khazragy, Nashwa] Ain Shams Univ, Fac Med, Clin Pathol Hematol & AinShams Med Res Inst MASRI, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams University	El-Khazragy, N (corresponding author), Ain Shams Univ, Fac Med, Clin Pathol Hematol & AinShams Med Res Inst MASRI, Cairo, Egypt.	nashwaelkhazragy@med.asu.edu.eg	El-Khazragy, Nashwa/AAC-3207-2020	El-Khazragy, Nashwa/0000-0001-6646-4674; Moustafa, Amr/0000-0003-2155-9842; Imam, Maha/0000-0003-3271-5759				Aiba Y, 2008, BLOOD, V111, P1497, DOI 10.1182/blood-2007-08-109769; Alateeq S, 2018, APL BIOENG, V2, DOI 10.1063/1.5048625; Bakker CE, 2013, EXP CELL RES, V313, P244, DOI [10.1126/science.1232033RNA-Guided, DOI 10.1126/SCIENCE.1232033RNA-GUIDED]; Barwick BG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01121; Bejar R, 2014, BLOOD, V124, P2705, DOI 10.1182/blood-2014-06-582809; Chen DF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162638; Collins JE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r84; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Foundation IM. International Myeloma Working Group (IMWG), 2019, MOL CLASS MULT MYEL; Gonzalez-Romero E, 2019, HAEMATOLOGICA, V104, P881, DOI 10.3324/haematol.2018.211359; Gundry MC, 2017, EXP HEMATOL, V54, P4, DOI 10.1016/j.exphem.2017.07.006; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Kiyokawa N, 2004, MODERN PATHOL, V17, P423, DOI 10.1038/modpathol.3800079; Lino CA, 2018, DRUG DELIV, V25, P1234, DOI 10.1080/10717544.2018.1474964; Liu ZP, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0174-2; Lu Y, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.3050; Lucas D, 2017, EXP HEMATOL, V54, P1, DOI 10.1016/j.exphem.2017.06.006; Martensson IL, 2010, FEBS LETT, V584, P2572, DOI 10.1016/j.febslet.2010.04.057; MILLAR BC, 1988, BRIT J HAEMATOL, V69, P197, DOI 10.1111/j.1365-2141.1988.tb07622.x; Moreau P, 2017, ANN ONCOL, V28, P52, DOI 10.1093/annonc/mdx096; Moreau P, 2019, BLOOD CANCER J, V9, DOI 10.1038/s41408-019-0200-1; Morstadt L, 2008, PROTEIN SCI, V17, P458, DOI 10.1110/ps.073269808; Park CY, 2019, STEM CELL REP, V12, P1242, DOI 10.1016/j.stemcr.2019.04.016; Park CY, 2015, CELL STEM CELL, V17, P213, DOI 10.1016/j.stem.2015.07.001; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rossi B, 2006, J IMMUNOL, V177, P796, DOI 10.4049/jimmunol.177.2.796; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Terpos E, 2015, HAEMATOLOGICA, V100, P1254, DOI 10.3324/haematol.2014.117176; Tian XL, 2019, NPJ PRECIS ONCOL, V3, DOI 10.1038/s41698-019-0080-7; Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170; Wattanapanitch M, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0779-3; Winkler TH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02423; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Yu X, 2016, BIOTECHNOL LETT, V38, P919, DOI 10.1007/s10529-016-2064-9; Zhan T, 2019, SEMIN CANCER BIOL; Zhang NY, 2016, BLOOD, V127, P675, DOI 10.1182/blood-2015-10-675751; Zhao C, 2018, MOL THER-NUCL ACIDS, V13, P208, DOI 10.1016/j.omtn.2018.08.022	37	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0245349	10.1371/journal.pone.0245349	http://dx.doi.org/10.1371/journal.pone.0245349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4OF	33418558	gold, Green Published			2022-12-26	WOS:000630020100028
J	Devkota, S; Williams, TD; Wolfe, MS				Devkota, Sujan; Williams, Todd D.; Wolfe, Michael S.			Familial Alzheimer's disease mutations in amyloid protein precursor alter proteolysis by gamma-secretase to increase amyloid beta-peptides of >= 45 residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMEMBRANE CLEAVAGE; TERMINAL FRAGMENT; A-BETA; PRESENILIN-1; MECHANISM; A-BETA-40; DRIVEN; DOMAIN	Production of amyloid beta-protein (A beta) is carried out by the membrane-embedded gamma-secretase complex. Mutations in the transmembrane domain of amyloid beta-protein precursor (APP) associated with early-onset familial Alzheimer's disease (FAD) can alter the ratio of aggregation-prone 42-residue A beta (A beta 42) to 40-residue A beta (A beta 40). However, APP substrate is proteolyzed processively by gamma-secretase along two pathways: A beta 49 -> A beta 46 -> A beta 43 -> A beta 40 and A beta 48 -> A beta 45 -> A beta 42 -> A beta 38. Effects of FAD mutations on each proteolytic step are unknown, largely due to difficulties in detecting and quantifying longer A beta peptides. To address this, we carried out systematic and quantitative analyses of all tri- and tetrapeptide coproducts from proteolysis of wild-type and 14 FAD-mutant APP substrates by purified gamma-secretase. These small peptides, including FAD-mutant forms, were detected by tandem mass spectrometry and quantified by establishing concentration curves for each of 32 standards. APP intracellular domain (AICD) coproducts were quantified by immunoblot, and the ratio of AICD products corresponding to A beta 48 and A beta 49 was determined by mass spectrometry. Levels of individual A beta peptides were determined by subtracting levels of peptide coproducts associated with degradation from those associated with production. This method was validated for A beta 40 and A beta 42 by specific ELISAs and production of equimolar levels of A beta and AICD. Not all mutant substrates led to increased A beta 42/40. However, all 14 disease-causing mutations led to inefficient processing of longer forms of A beta >= 45 residues. In addition, the effects of certain mutations provided insight into the mechanism of processive proteolysis: intermediate A beta peptides apparently remain bound for subsequent trimming and are not released and reassociated.	[Devkota, Sujan; Wolfe, Michael S.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Williams, Todd D.] Univ Kansas, Mass Spectrometry Lab, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Wolfe, MS (corresponding author), Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA.	mswolfe@ku.edu		Wolfe, Michael/0000-0002-5721-9092	U.S. National Institutes of Health [GM122894, AG66986]	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was support by grants GM122894 and AG66986 from the U.S. National Institutes of Health to M. S. W. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Bolduc DM, 2017, METHOD ENZYMOL, V584, P295, DOI 10.1016/bs.mie.2016.10.026; Bolduc DM, 2016, ELIFE, V5, DOI 10.7554/eLife.17578; Bolduc DM, 2016, P NATL ACAD SCI USA, V113, pE509, DOI 10.1073/pnas.1512952113; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Dickey SW, 2013, CELL, V155, P1270, DOI 10.1016/j.cell.2013.10.053; Dimitrov M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3246; Fernandez MA, 2016, BIOCHEMISTRY-US, V55, P5675, DOI 10.1021/acs.biochem.6b00718; Fernandez MA, 2014, J BIOL CHEM, V289, P31043, DOI 10.1074/jbc.M114.581165; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kamp F, 2015, BIOPHYS J, V108, P1229, DOI 10.1016/j.bpj.2014.12.045; Kretner B, 2016, EMBO MOL MED, V8, P458, DOI 10.15252/emmm.201505952; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Quintero-Monzon O, 2011, BIOCHEMISTRY-US, V50, P9023, DOI 10.1021/bi2007146; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Sun LF, 2017, P NATL ACAD SCI USA, V114, pE476, DOI 10.1073/pnas.1618657114; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tanzi RE, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006296; Veugelen S, 2016, NEURON, V90, P410, DOI 10.1016/j.neuron.2016.03.010; Wolfe MS, 2019, BIOCHEMISTRY-US, V58, P2953, DOI 10.1021/acs.biochem.9b00401; Yin YI, 2007, J BIOL CHEM, V282, P23639, DOI 10.1074/jbc.M704601200	28	16	16	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100281	10.1016/j.jbc.2021.100281	http://dx.doi.org/10.1016/j.jbc.2021.100281			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33450230	gold, Green Published			2022-12-26	WOS:000672866400257
J	Hamano, F; Kuribayashi, H; Iwagawa, T; Tsuhako, A; Nagata, K; Sagara, H; Shimizu, T; Shindou, H; Watanabe, S				Hamano, Fumie; Kuribayashi, Hiroshi; Iwagawa, Toshiro; Tsuhako, Asano; Nagata, Katsuyuki; Sagara, Hiroshi; Shimizu, Takao; Shindou, Hideo; Watanabe, Sumiko			Mapping membrane lipids in the developing and adult mouse retina under physiological and pathological conditions using mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; DOCOSAHEXAENOIC ACID; ELOVL4; NRL; PHOSPHATIDYLCHOLINE; HOMEOSTASIS; METABOLISM; DISEASE; HEALTH; AGE	Membrane phospholipids play pivotal roles in various cellular processes, and their levels are tightly regulated. In the retina, phospholipids had been scrutinized because of their distinct composition and requirement in visual transduction. However, how lipid composition changes during retinal development remains unclear. Here, we used liquid chromatography-mass spectrometry (LC-MS) to assess the dynamic changes in the levels of two main glycerophospholipids, phosphatidylcholine (PC) and phosphatidyl-ethanolamine (PE), in the developing mouse retina under physiological and pathological conditions. The total levels of PC and PE increased during retinal development, and individual lipid species exhibited distinct level changes. The amount of very-long-chain PC and PE increased dramatically in the late stages of retinal development. The mRNA levels of Elovl2 and Elovl4, genes encoding enzymes essential for the synthesis of very-long-chain polyunsaturated fatty acids, increased in developing photoreceptors. Cell sorting based on CD73 expression followed by LC-MS revealed distinct changes in PC and PE levels in CD73-positive rod photoreceptors and CD73-negative retinal cells. Finally, using the NaIO3-induced photoreceptor degeneration model, we identified photoreceptor-specific changes in PC and PE levels from 1 day after NaIO3 administration, before the outer segment of photoreceptors displayed morphological impairment. In conclusion, our findings provide insight into the dynamic changes in PC and PE levels in the developing and adult mouse retina under physiological and pathological conditions. Furthermore, we provide evidence that cell sorting followed by LC-MS is a promising approach for investigating the relevance of lipid homeostasis in the function of different retinal cell types.	[Hamano, Fumie; Nagata, Katsuyuki; Shimizu, Takao; Shindou, Hideo] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Shinjuku Ku, Tokyo, Japan; [Hamano, Fumie] Univ Tokyo, Grad Sch Med, Life Sci Core Facil, Bunkyo Ku, Tokyo, Japan; [Kuribayashi, Hiroshi; Iwagawa, Toshiro; Tsuhako, Asano; Watanabe, Sumiko] Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Minato Ku, Tokyo, Japan; [Sagara, Hiroshi] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo, Japan; [Shindou, Hideo] Univ Tokyo, Grad Sch Med, Dept Lipid Sci, Bunkyo Ku, Tokyo, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Watanabe, S (corresponding author), Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Minato Ku, Tokyo, Japan.	sumiko@ims.u-tokyo.ac.jp	Sagara, Hiroshi/GRX-7740-2022	Sagara, Hiroshi/0000-0001-8456-8362; Watanabe, Sumiko/0000-0003-4497-5750	Joint Research Project of the Institute of Medical Science, University of Tokyo; Agency for Medical Research and Development (AMED)-Core Research for Evolutional Science and Technology [19gm0910011]; Takeda Science Foundation	Joint Research Project of the Institute of Medical Science, University of Tokyo; Agency for Medical Research and Development (AMED)-Core Research for Evolutional Science and Technology(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work is supported by the grants from the Joint Research Project of the Institute of Medical Science, University of Tokyo (S. W., H. Sagara, H. Shindou) and Agency for Medical Research and Development (AMED)-Core Research for Evolutional Science and Technology 19gm0910011 (S. W., H. Sagara, H. Shindou); the Takeda Science Foundation.	Agbaga MP, 2010, J LIPID RES, V51, P1624, DOI 10.1194/jlr.R005025; Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; AVELDANO MI, 1987, J BIOL CHEM, V262, P1172; Barragan I, 2005, INT J MOL MED, V16, P1163; Brooks MJ, 2019, STEM CELL REP, V13, P891, DOI 10.1016/j.stemcr.2019.09.009; Carter JM, 2008, J BIOL CHEM, V283, P202, DOI 10.1074/jbc.M706531200; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Deak F, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00428; Enzmann V, 2006, EXP EYE RES, V82, P441, DOI 10.1016/j.exer.2005.08.002; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Harayama T, 2020, J LIPID RES, V61, P1150, DOI 10.1194/jlr.R120000800; Hopiavuori BR, 2017, J LIPID RES, V58, P668, DOI 10.1194/jlr.M070714; Iida A, 2011, INVEST OPHTH VIS SCI, V52, P3008, DOI 10.1167/iovs.10-6428; Iwagawa T, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.3.7; Iwagawa T, 2019, NEUROSCI RES, V138, P43, DOI 10.1016/j.neures.2018.09.010; Kim JW, 2016, CELL REP, V17, P2460, DOI 10.1016/j.celrep.2016.10.074; Koso H, 2009, INVEST OPHTH VIS SCI, V50, P5411, DOI 10.1167/iovs.08-3246; LAVAIL MM, 1973, J CELL BIOL, V58, P650, DOI 10.1083/jcb.58.3.650; Lenis TL, 2018, P NATL ACAD SCI USA, V115, pE11120, DOI 10.1073/pnas.1802519115; Mandal MNA, 2004, GENOMICS, V83, P626, DOI 10.1016/j.ygeno.2003.09.020; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; MARTIN RE, 1992, J NEUROCHEM, V59, P318, DOI 10.1111/j.1471-4159.1992.tb08906.x; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Molday RS, 2009, BBA-MOL CELL BIOL L, V1791, P573, DOI 10.1016/j.bbalip.2009.02.004; NEURINGER M, 1988, ANNU REV NUTR, V8, P517, DOI 10.1146/annurev.nu.08.070188.002505; Pauter AM, 2014, J LIPID RES, V55, P718, DOI 10.1194/jlr.M046151; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; SCOTT BL, 1987, EXP EYE RES, V44, P101, DOI 10.1016/S0014-4835(87)80029-5; SCOTT BL, 1988, J NEUROSCI RES, V20, P202, DOI 10.1002/jnr.490200209; Shindou H, 2017, J BIOL CHEM, V292, P12054, DOI [10.1074/jbc.M117.790568, 10.1074/jbc.m117.790568]; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tanna P, 2017, BRIT J OPHTHALMOL, V101, P25, DOI 10.1136/bjophthalmol-2016-308823; Ueno K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29264; van der Veen JN, 2017, BBA-BIOMEMBRANES, V1859, P1558, DOI 10.1016/j.bbamem.2017.04.006; Wu J, 2017, OPHTHALMOLOGY, V124, P634, DOI 10.1016/j.ophtha.2016.12.033; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817	37	6	6	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100303	10.1016/j.jbc.2021.100303	http://dx.doi.org/10.1016/j.jbc.2021.100303			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33465374	Green Published, gold			2022-12-26	WOS:000672866400277
J	Yu, BB; Liu, YA; Luo, HG; Fu, JY; Li, Y; Shao, C				Yu, Bingbing; Liu, Yanan; Luo, Haoge; Fu, Jiaying; Li, Yang; Shao, Chen			Androgen receptor splicing variant 7 (ARV7) inhibits docetaxel sensitivity by inactivating the spindle assembly checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; MITOTIC CHECKPOINT; RESISTANCE; SLIPPAGE; MECHANISMS; AR-V7	The clinical efficacy of docetaxel (DTX) in prostate cancer treatment is barely satisfactory due to diverse responses of the patients, including the development of resistance. Recently, aberrant androgen receptor (AR) signaling, including expression of the constitutively active ARV7, was reported to contribute to DTX resistance. However, the underlying molecular mechanism remains largely unknown. Of note, previous studies have highlighted that ARV7, unlike its parental AR, potentially favors the expression of some genes involved in cell cycle progression. Since DTX mainly targets microtubule dynamics and mitosis, we wanted to test whether ARV7 plays a specific role in mitotic regulation and whether this activity is involved in DTX resistance. In the present study, we found that ARV7 mediates DTX sensitivity through inactivating the spindle assembly checkpoint (SAC) and promoting mitotic slippage. By shifting the balance to the slippage pathway, ARV7-expressing cells are more likely to escape from mitotic death induced by acute DTX treatment. Furthermore, we also identified E2 enzyme UBE2C as the primary downstream effector of ARV7 in promoting the SAC inactivation and premature degradation of cyclin B1. Moreover, we showed that combination treatment of DTX and an inhibitor of mitotic exit can exert synergistic effect in high ARV7-expressing prostate cancer cells. In sum, our work identified a novel role of ARV7 in promoting DTX resistance and offering a potential path to combat DTX resistance related to abnormal activation of the AR signaling and mitotic dysregulation.	[Yu, Bingbing; Liu, Yanan; Luo, Haoge; Fu, Jiaying; Li, Yang; Shao, Chen] Jilin Univ, Coll Basic Med Sci, Dept Pathophysiol, Changchun, Peoples R China	Jilin University	Shao, C (corresponding author), Jilin Univ, Coll Basic Med Sci, Dept Pathophysiol, Changchun, Peoples R China.	shaochen@jlu.edu.cn		, Chen/0000-0001-5008-6912	National Natural Science Foundation of China [81802579]; Jilin University Bethune Plan B Projects [2018B30]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin University Bethune Plan B Projects	This work was supported by the National Natural Science Foundation of China (81802579) and the Jilin University Bethune Plan B Projects (2018B30).	Antonarakis ES, 2015, JAMA ONCOL, V1, P582, DOI 10.1001/jamaoncol.2015.1341; Bastos DA, 2018, EXPERT REV MOL DIAGN, V18, P155, DOI 10.1080/14737159.2018.1427068; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Cao B, 2014, ONCOTARGET, V5, P1646, DOI 10.18632/oncotarget.1802; Cheng B, 2017, ENDOCR-RELAT CANCER, V24, pT97, DOI 10.1530/ERC-17-0147; Ciccarese C, 2016, CANCER TREAT REV, V43, P27, DOI 10.1016/j.ctrv.2015.12.003; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3; Dai C, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a030452; Fu YF, 2007, GYNECOL ONCOL, V105, P66, DOI 10.1016/j.ygyno.2006.10.061; Han JS, 2013, MOL CELL, V51, P92, DOI 10.1016/j.molcel.2013.05.019; Hao ZL, 2012, TUMOR BIOL, V33, P723, DOI 10.1007/s13277-011-0291-1; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Haschka M, 2018, EMBO REP, V19, DOI 10.15252/embr.201745440; He YD, 2018, NUCLEIC ACIDS RES, V46, P1895, DOI 10.1093/nar/gkx1306; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Komura K, 2016, P NATL ACAD SCI USA, V113, P6259, DOI 10.1073/pnas.1600420113; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lu J, 2015, J UROLOGY, V193, P690, DOI 10.1016/j.juro.2014.08.043; Ma HT, 2012, J BIOL CHEM, V287, P21561, DOI 10.1074/jbc.M112.364356; Nakazawa M, 2014, HORM CANCER-US, V5, P265, DOI 10.1007/s12672-014-0190-1; Pienta KJ, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.26892; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Shao C, 2019, LIFE SCI, V234, DOI 10.1016/j.lfs.2019.116768; Sharp A, 2019, J CLIN INVEST, V129, P192, DOI 10.1172/JCI122819; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sloss O, 2016, ONCOTARGET, V7, P5176, DOI 10.18632/oncotarget.6894; Tagawa ST, 2019, CLIN CANCER RES, V25, P1880, DOI 10.1158/1078-0432.CCR-18-0320; Thadani-Mulero M, 2014, CANCER RES, V74, P2270, DOI 10.1158/0008-5472.CAN-13-2876; van Ree JH, 2010, J CELL BIOL, V188, P83, DOI 10.1083/jcb.200906147; Wadosky KM, 2017, ONCOTARGET, V8, P18550, DOI 10.18632/oncotarget.14537; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Xie CL, 2014, INT J BIOCHEM CELL B, V47, P113, DOI 10.1016/j.biocel.2013.11.023; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zasadil LM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007965; Zhan Y, 2017, MOL CANCER RES, V15, P59, DOI 10.1158/1541-7786.MCR-16-0236; Zhang GY, 2015, ONCOTARGET, V6, P23358, DOI 10.18632/oncotarget.4396	41	6	6	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100276	10.1016/j.jbc.2021.100276	http://dx.doi.org/10.1016/j.jbc.2021.100276			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33428943	Green Published, gold			2022-12-26	WOS:000672866400252
J	Glasgow, EM; Kemna, EI; Bingman, CA; Ing, NL; Deng, K; Bianchetti, CM; Takasuka, TE; Northen, TR; Fox, BG				Glasgow, Evan M.; Kemna, Elias, I; Bingman, Craig A.; Ing, Nicole L.; Deng, Kai; Bianchetti, Christopher M.; Takasuka, Taichi E.; Northen, Trent R.; Fox, Brian G.			A structural and kinetic survey of GH5_4 endoglucanases reveals determinants of broad substrate specificity and opportunities for biomass hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; substrate specificity; polysaccharide; cellulase; bioenergy; endoglucanase; GH5; xyloglucanase	BIOCHEMICAL-CHARACTERIZATION; RUMINOCOCCUS-FLAVEFACIENS; GLYCOSYL HYDROLASES; TRICHODERMA-REESEI; GENOME SEQUENCE; XYLOGLUCAN; BINDING; RECOGNITION; CELLULASE; IDENTIFICATION	Broad-specificity glycoside hydrolases (GHs) contribute to plant biomass hydrolysis by degrading a diverse range of polysaccharides, making them useful catalysts for renewable energy and biocommodity production. Discovery of new GHs with improved kinetic parameters or more tolerant substrate-binding sites could increase the efficiency of renewable bioenergy production even further. GH5 has over 50 subfamilies exhibiting selectivities for reaction with beta-(1,4)-linked oligo- and polysaccharides. Among these, subfamily 4 (GH5_4) contains numerous broad-selectivity endoglucanases that hydrolyze cellulose, xyloglucan, and mixed-linkage glucans. We previously surveyed the whole subfamily and found over 100 new broad-specificity endoglucanases, although the structural origins of broad specificity remained unclear. A mechanistic understanding of GH5_4 substrate specificity would help inform the best protein design strategies and the most appropriate industrial application of broad-specificity endoglucanases. Here we report structures of 10 new GH5_4 enzymes from cellulolytic microbes and characterize their substrate selectivity using normalized reducing sugar assays and MS. We found that GH5_4 enzymes have the highest catalytic efficiency for hydrolysis of xyloglucan, glucomannan, and soluble beta-glucans, with opportunistic secondary reactions on cellulose, mannan, and xylan. The positions of key aromatic residues determine the overall reaction rate and breadth of substrate tolerance, and they contribute to differences in oligosaccharide cleavage patterns. Our new composite model identifies several critical structural features that confer broad specificity and may be readily engineered into existing industrial enzymes. We demonstrate that GH5_4 endoglucanases can have broad specificity without sacrificing high activity, making them a valuable addition to the biomass deconstruction toolset.	[Glasgow, Evan M.; Kemna, Elias, I; Bingman, Craig A.; Bianchetti, Christopher M.; Fox, Brian G.] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA; [Glasgow, Evan M.; Bingman, Craig A.; Bianchetti, Christopher M.; Fox, Brian G.] Great Lakes Bioenergy Res Ctr, Madison, WI 53726 USA; [Ing, Nicole L.; Deng, Kai; Northen, Trent R.] Joint BioEnergy Inst, Emeryville, CA USA; [Ing, Nicole L.; Deng, Kai] Sandia Natl Labs, Livermore, CA USA; [Takasuka, Taichi E.] Hokkaido Univ, Sapporo, Hokkaido, Japan; [Northen, Trent R.] Lawrence Berkeley Natl Lab, Berkeley, CA USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Sandia National Laboratories; Hokkaido University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Fox, BG (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.; Fox, BG (corresponding author), Great Lakes Bioenergy Res Ctr, Madison, WI 53726 USA.	bgfox@biochem.wisc.edu	Takasuka, Taichi/AAF-9441-2020; Bingman, Craig/F-1711-2019	Takasuka, Taichi/0000-0002-4413-2924; Glasgow, Evan/0000-0002-6542-781X; Kemna, Elias/0000-0002-9527-7189; Ing, Nicole/0000-0003-4264-9679; Bingman, Craig/0000-0002-3073-5089	United States Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-SC0018409, DE-FC02-07ER64494, DE-AC02-05CH11231]; National Institutes of Health [5 T32 GM008349]	United States Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the United States Department of Energy, Office of Science, Office of Biological and Environmental Research under Awards DE-SC0018409, DE-FC02-07ER64494, and DE-AC02-05CH11231. E. M. G. was supported by National Institutes of Health Grant 5 T32 GM008349 (UW-Madison Biotechnology Training Program). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Andric P, 2010, BIOTECHNOL ADV, V28, P308, DOI 10.1016/j.biotechadv.2010.01.003; Annamalai N, 2016, BIOFUEL BIOREFIN TEC, V3, P37, DOI 10.1007/978-3-319-43679-1_3; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Attia MA, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1039-6; Badieyan S, 2012, BIOTECHNOL BIOENG, V109, P31, DOI 10.1002/bit.23280; Bianchetti CM, 2013, J MOL BIOL, V425, P4267, DOI 10.1016/j.jmb.2013.05.030; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; Chandel AK, 2018, BIORESOURCE TECHNOL, V264, P370, DOI 10.1016/j.biortech.2018.06.004; Chassard C, 2012, INT J SYST EVOL MICR, V62, P138, DOI 10.1099/ijs.0.027375-0; Chen ZW, 2012, J BIOL CHEM, V287, P25335, DOI 10.1074/jbc.M112.362640; Couturier M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079800; Dai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040430; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Deng K, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00165; Deng K, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00153; Deng K, 2014, ACS CHEM BIOL, V9, P1470, DOI 10.1021/cb5000289; Desvaux M, 2005, FEMS MICROBIOL REV, V29, P741, DOI 10.1016/j.femsre.2004.11.003; Diederichs K, 2003, ACTA CRYSTALLOGR D, V59, P903, DOI 10.1107/S0907444903006516; Dorival J, 2018, BIOCHEM J, V475, P3609, DOI 10.1042/BCJ20180486; dos Santos CR, 2015, BIOCHEMISTRY-US, V54, P1930, DOI 10.1021/acs.biochem.5b00011; DUCROS V, 1995, STRUCTURE, V3, P939, DOI 10.1016/S0969-2126(01)00228-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FIEROBE HP, 1991, J BACTERIOL, V173, P7956, DOI 10.1128/jb.173.24.7956-7962.1991; Findley SD, 2011, APPL ENVIRON MICROB, V77, P8106, DOI 10.1128/AEM.05925-11; Fort S, 2001, CHEMBIOCHEM, V2, P319; Fox Brian G, 2009, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0523s56; FREIER D, 1988, APPL ENVIRON MICROB, V54, P204, DOI 10.1128/AEM.54.1.204-211.1988; Gao DH, 2013, P NATL ACAD SCI USA, V110, P10922, DOI 10.1073/pnas.1213426110; Garcia-Vallve S, 2000, MOL BIOL EVOL, V17, P352, DOI 10.1093/oxfordjournals.molbev.a026315; Glasgow EM, 2019, J MOL BIOL, V431, P1217, DOI 10.1016/j.jmb.2019.01.024; Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200; Goldman AD, 2016, J MOL EVOL, V82, P17, DOI 10.1007/s00239-015-9722-8; Gorrec F, 2016, DRUG DISCOV TODAY, V21, P819, DOI 10.1016/j.drudis.2016.03.008; Harjunpaa V, 1996, EUR J BIOCHEM, V240, P584, DOI 10.1111/j.1432-1033.1996.0584h.x; Himmel ME, 1999, CURR OPIN BIOTECH, V10, P358, DOI 10.1016/S0958-1669(99)80065-2; Hudson KL, 2015, J AM CHEM SOC, V137, P15152, DOI 10.1021/jacs.5b08424; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Julliand V, 1999, APPL ENVIRON MICROB, V65, P3738; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; Lan PTN, 2006, INT J SYST EVOL MICR, V56, P2853, DOI 10.1099/ijs.0.64517-0; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Liberato MV, 2016, SCI REP-UK, V6, DOI 10.1038/srep36428; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lo Leggio L, 2002, FEBS LETT, V523, P103, DOI 10.1016/S0014-5793(02)02954-X; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Asensio JL, 2013, ACCOUNTS CHEM RES, V46, P946, DOI 10.1021/ar300024d; Matsuzawa T, 2016, TRENDS GLYCOSCI GLYC, V28, pE63, DOI 10.4052/tigg.1510.1E; McGregor N, 2016, J BIOL CHEM, V291, P1175, DOI 10.1074/jbc.M115.691659; Meng DD, 2017, BIOCHEM J, V474, P3373, DOI 10.1042/BCJ20170328; Naas AE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11666; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; Northrop DB, 1998, J CHEM EDUC, V75, P1153, DOI 10.1021/ed075p1153; Oke MA, 2016, BIOENERG RES, V9, P1189, DOI 10.1007/s12155-016-9765-8; Omelchenko MV, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-31; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page R, 2003, ACTA CRYSTALLOGR D, V59, P1028, DOI 10.1107/S0907444903007790; Peng XW, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0509-y; Rahikainen JL, 2013, ENZYME MICROB TECH, V53, P315, DOI 10.1016/j.enzmictec.2013.07.003; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; Srivastava N, 2018, RENEW SUST ENERG REV, V82, P2379, DOI 10.1016/j.rser.2017.08.074; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Tamaru Y, 2010, J BACTERIOL, V192, P901, DOI 10.1128/JB.01450-09; Tatko C, 2008, NAT CHEM BIOL, V4, P586, DOI 10.1038/nchembio1008-586; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Tseng CW, 2011, ACTA CRYSTALLOGR F, V67, P1189, DOI 10.1107/S1744309111032428; VAREL VH, 1989, ARCH MICROBIOL, V152, P209, DOI 10.1007/BF00409652; Venditto I, 2016, P NATL ACAD SCI USA, V113, P7136, DOI 10.1073/pnas.1601558113; Venditto I, 2015, J BIOL CHEM, V290, P10572, DOI 10.1074/jbc.M115.637827; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Wong DDWS, 2010, APPL MICROBIOL BIOT, V86, P1463, DOI 10.1007/s00253-009-2364-2; Wu TH, 2011, BBA-PROTEINS PROTEOM, V1814, P1832, DOI 10.1016/j.bbapap.2011.07.020; Xue SS, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0378-9; Yuan SF, 2015, J BIOL CHEM, V290, P5739, DOI 10.1074/jbc.M114.604454	81	6	6	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17752	17769		10.1074/jbc.RA120.015328	http://dx.doi.org/10.1074/jbc.RA120.015328			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454012	Green Published, hybrid			2022-12-26	WOS:000603272300028
J	Schafer, CT; Shumate, A; Farrens, DL				Schafer, Christopher T.; Shumate, Anthony; Farrens, David L.			Novel fluorescent GPCR biosensor detects retinal equilibrium binding to opsin and active G protein and arrestin signaling conformations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); G protein; arrestin; biosensor; fluorescence; conformational change; rhodopsin; drug discovery; protein engineering	ROD OUTER SEGMENTS; CRYSTAL-STRUCTURE; TRANSMEMBRANE HELICES; METARHODOPSIN-II; RHODOPSIN; SITE; ACTIVATION; INSIGHTS; DYNAMICS; SPECTROSCOPY	Rhodopsin is a canonical class A photosensitive G protein-coupled receptor (GPCR), yet relatively few pharmaceutical agents targeting this visual receptor have been identified, in part due to the unique characteristics of its light-sensitive, covalently bound retinal ligands. Rhodopsin becomes activated when light isomerizes 11-cis-retinal into an agonist, all-trans-retinal (ATR), which enables the receptor to activate its G protein. We have previously demonstrated that, despite being covalently bound, ATR can display properties of equilibrium binding, yet how this is accomplished is unknown. Here, we describe a new approach for both identifying compounds that can activate and attenuate rhodopsin and testing the hypothesis that opsin binds retinal in equilibrium. Our method uses opsin-based fluorescent sensors, which directly report the formation of active receptor conformations by detecting the binding of G protein or arrestin fragments that have been fused onto the receptor's C terminus. We show that these biosensors can be used to monitor equilibrium binding of the agonist, ATR, as well as the noncovalent binding of beta-ionone, an antagonist for G protein activation. Finally, we use these novel biosensors to observe ATR release from an activated, unlabeled receptor and its subsequent transfer to the sensor in real time. Taken together, these data support the retinal equilibrium binding hypothesis. The approach we describe should prove directly translatable to other GPCRs, providing a new tool for ligand discovery and mutant characterization.	[Schafer, Christopher T.; Shumate, Anthony; Farrens, David L.] Oregon Hlth & Sci Univ, Dept Chem Physiol & Biochem, Portland, OR 97201 USA	Oregon Health & Science University	Farrens, DL (corresponding author), Oregon Hlth & Sci Univ, Dept Chem Physiol & Biochem, Portland, OR 97201 USA.	farrensd@ohsu.edu		Schafer, Christopher/0000-0001-9907-295X	National Institutes of Health [R01EY029343, R21EY027959, R21DA043001, F31DA049438, T32 EY023211, T32 GM071338]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY029343, R21EY027959, and R21DA043001 (to D. L. F.); F31DA049438 (to A. D. S.), and T32 EY023211 and T32 GM071338 (to C. T. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya S, 1997, J BIOL CHEM, V272, P6519, DOI 10.1074/jbc.272.10.6519; Alexiev U, 2014, BBA-BIOENERGETICS, V1837, P694, DOI 10.1016/j.bbabio.2013.10.008; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Brunette AMJ, 2014, BIOCHEMISTRY-US, V53, P6290, DOI 10.1021/bi500493r; Buczylko J, 1996, J BIOL CHEM, V271, P20621, DOI 10.1074/jbc.271.34.20621; Chen CH, 2017, J BIOL CHEM, V292, P19356, DOI 10.1074/jbc.M117.795187; DAEMEN FJM, 1978, NATURE, V276, P847, DOI 10.1038/276847a0; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; DRATZ EA, 1993, NATURE, V363, P276, DOI 10.1038/363276a0; Eichel K, 2016, NAT CELL BIOL, V18, P303, DOI 10.1038/ncb3307; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fay JF, 2015, P NATL ACAD SCI USA, V112, P8469, DOI 10.1073/pnas.1500895112; Garcia-Nafria J, 2019, MOL CELL ENDOCRINOL, V488, P1, DOI 10.1016/j.mce.2019.02.006; Goncalves JA, 2010, P NATL ACAD SCI USA, V107, P19861, DOI 10.1073/pnas.1009405107; Han M, 1997, P NATL ACAD SCI USA, V94, P13442, DOI 10.1073/pnas.94.25.13442; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; Huang WJ, 2020, NATURE, V579, P303, DOI 10.1038/s41586-020-1953-1; Isayama T, 2006, VISUAL NEUROSCI, V23, P899, DOI 10.1017/S0952523806230256; Isayama T, 2009, VISUAL NEUROSCI, V26, P267, DOI 10.1017/S0952523809090105; Janz JM, 2004, J BIOL CHEM, V279, P29767, DOI 10.1074/jbc.M402567200; Janz JM, 2003, VISION RES, V43, P2991, DOI 10.1016/j.visres.2003.08.010; Jastrzebska B, 2013, FASEB J, V27, P1572, DOI 10.1096/fj.12-225383; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kefalov VJ, 1999, J GEN PHYSIOL, V113, P491, DOI 10.1085/jgp.113.3.491; Kobayashi H, 2019, NAT PROTOC, V14, P1084, DOI 10.1038/s41596-019-0129-7; Kono M, 2008, BIOCHEMISTRY-US, V47, P7567, DOI 10.1021/bi800357b; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Maeda R, 2018, J PHYS CHEM B, V122, P4838, DOI 10.1021/acs.jpcb.8b02819; Mansoor SE, 2006, P NATL ACAD SCI USA, V103, P3060, DOI 10.1073/pnas.0511010103; Mansoor SE, 2004, BIOCHEMISTRY-US, V43, P9426, DOI 10.1021/bi036259m; Mansoor SE, 2010, BIOCHEMISTRY-US, V49, P9722, DOI 10.1021/bi100907m; MATSUMOTO H, 1975, NATURE, V258, P523, DOI 10.1038/258523a0; Nguyen AH, 2019, NAT STRUCT MOL BIOL, V26, P1123, DOI 10.1038/s41594-019-0330-y; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Pulvermuller A, 2000, J BIOL CHEM, V275, P37679, DOI 10.1074/jbc.M006776200; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; RESEK JF, 1993, BIOCHEMISTRY-US, V32, P12025, DOI 10.1021/bi00096a012; Sato S, 2019, J NEUROSCI, V39, P212, DOI 10.1523/JNEUROSCI.1980-18.2018; Schafer CT, 2016, P NATL ACAD SCI USA, V113, P11961, DOI 10.1073/pnas.1606347113; Schafer CT, 2015, J BIOL CHEM, V290, P4304, DOI 10.1074/jbc.M114.603134; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Seifert R, 1999, TRENDS PHARMACOL SCI, V20, P383, DOI 10.1016/S0165-6147(99)01368-1; Shukla AK, 2014, TRENDS BIOCHEM SCI, V39, P594, DOI 10.1016/j.tibs.2014.10.001; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Sinha A, 2014, BIOCHEMISTRY-US, V53, P3294, DOI 10.1021/bi401534y; Smith JS, 2018, NAT REV DRUG DISCOV, V17, P243, DOI 10.1038/nrd.2017.229; Sommer ME, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2000; Staus DP, 2020, NATURE, V579, P297, DOI 10.1038/s41586-020-1954-0; Steen A, 2013, J BIOL CHEM, V288, P12511, DOI 10.1074/jbc.M112.449587; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; Tesmer JJG, 2016, NAT REV MOL CELL BIO, V17, P439, DOI 10.1038/nrm.2016.36; Tian H, 2017, BIOPHYS J, V112, P153, DOI 10.1016/j.bpj.2016.12.005; Tsukamoto H, 2013, J BIOL CHEM, V288, P28207, DOI 10.1074/jbc.M113.472464; Unal H, 2012, TRENDS PHARMACOL SCI, V33, P79, DOI 10.1016/j.tips.2011.09.007; Van Eps N, 2010, BIOCHEMISTRY-US, V49, P6877, DOI 10.1021/bi100846c; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; Wingler LM, 2019, CELL, V176, P468, DOI 10.1016/j.cell.2018.12.005; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Yin WC, 2019, CELL RES, V29, P971, DOI 10.1038/s41422-019-0256-2; Zhou XE, 2017, CELL, V170, P457, DOI 10.1016/j.cell.2017.07.002	68	0	0	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17486	17496		10.1074/jbc.RA120.014631	http://dx.doi.org/10.1074/jbc.RA120.014631			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453993	Green Published, hybrid			2022-12-26	WOS:000603272300009
J	Matta, R; Yousafzai, MS; Murrell, M; Gonzalez, AL				Matta, Rita; Yousafzai, Muhammad Sulaiman; Murrell, Michael; Gonzalez, Anjelica L.			Endothelial cell secreted metalloproteinase-2 enhances neural stem cell N-cadherin expression, clustering, and migration	FASEB JOURNAL			English	Article						cell clustering; cell migration; N&#8208; cadherin; neural stem cell	STREAM; GROWTH; TISSUE; NICHE; NEUROGENESIS; INHIBITION; SCAFFOLDS; QUIESCENT; NEURONS; INJURY	Neuroblasts have a clustered phenotype critical for their unidirectional migration, which in part is dependent on signaling from microvascular endothelial cells (EC) and pericytes (PC). Diffusible signals secreted by vascular cells have been demonstrated to increase survival, proliferation, and differentiation of subventricular zone resident neural stem cells (NSC); however, the signals that promote the necessary initiating step of NSC clustering are undefined. To investigate the role of vascular cells in promoting NSC clustering and directing migration, we created a 3-D hydrogel that mimics the biomechanics, biochemistry, and architectural complexity of brain tissue. We demonstrate that EC, and not PC, have a crucial role in NSC clustering and migration, further verified through microfluidic chamber systems and traction force microscopy. Ablation of the extended NSC aggregate arm halts aggregate movement, suggesting that clustering is a prerequisite for migration. When cultured with EC, NSC clustering occurs and NSC coincidentally increase their expression of N-cadherin, as compared to NSC cultured alone. NSC-presented N-cadherin expression was increased following exposure to EC secreted metalloproteinase-2 (MMP2). We demonstrate that inhibition of MMP2 prevented NSC N-cadherin surface expression and subsequent NSC clustering, even when NSC were in direct contact with EC. Furthermore, with exogenous activation of EGFR, which serves as a downstream activator of N-cadherin cleavage, NSC form clusters. Our results suggest that EC secretion of MMP2 promotes NSC clustering through N-cadherin expression. The insight gained about the mechanisms by which EC promote NSC migration may enhance NSC therapeutic response to sites of injury.	[Matta, Rita; Yousafzai, Muhammad Sulaiman; Murrell, Michael; Gonzalez, Anjelica L.] Yale Univ, Biomed Engn Dept, New Haven, CT USA; [Yousafzai, Muhammad Sulaiman; Murrell, Michael] Yale Univ, Syst Biol Inst, West Haven, CT USA; [Murrell, Michael] Yale Univ, Phys Dept, New Haven, CT USA	Yale University; Yale University; Yale University	Gonzalez, AL (corresponding author), 55 Prospect St, New Haven, CT 06511 USA.	anjelica.gonzalez@yale.edu			NIBIB NIH HHS [R01 EB016629] Funding Source: Medline	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Auler M, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2247; Azevedo PO, 2017, NEUROSCIENCE, V363, P62, DOI 10.1016/j.neuroscience.2017.08.059; Borrell V, 2006, NAT NEUROSCI, V9, P1284, DOI 10.1038/nn1764; Bressan RB, 2017, DEVELOPMENT, V144, P635, DOI 10.1242/dev.140855; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Conant K, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0827-4; Corbel M, 2001, J PATHOL, V193, P538, DOI 10.1002/path.826; Crapo PM, 2014, TISSUE ENG PT A, V20, P313, DOI [10.1089/ten.tea.2013.0186, 10.1089/ten.TEA.2013.0186]; Rosario LVD, 2020, ANTICANCER RES, V40, P2725, DOI 10.21873/anticanres.14244; Fang TH, 2004, MICROELECTRON J, V35, P595, DOI 10.1016/j.mejo.2004.02.004; Felling RJ, 2006, J NEUROSCI, V26, P4359, DOI 10.1523/JNEUROSCI.1898-05.2006; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Ghuman H, 2017, ACTA BIOMATER, V63, P50, DOI 10.1016/j.actbio.2017.09.011; Gonzalez AL, 2004, TISSUE ENG, V10, P1775, DOI 10.1089/ten.2004.10.1775; Her GJ, 2013, ACTA BIOMATER, V9, P5170, DOI 10.1016/j.actbio.2012.10.012; HERMAN IM, 1987, TISSUE CELL, V19, P197, DOI 10.1016/0040-8166(87)90005-X; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Klingener M, 2014, J NEUROSCI, V34, P9590, DOI 10.1523/JNEUROSCI.3699-13.2014; Lauridsen HM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171386; Leroux A, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00656-0; Marins M, 2009, DEV NEUROBIOL, V69, P715, DOI 10.1002/dneu.20737; Matta R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54167-1; McBride RA, 2003, J MATER CHEM, V13, P1196, DOI 10.1039/b211723c; Miragall F, 1997, CELL TISSUE RES, V287, P243; Pellowe AS, 2017, JOVE-J VIS EXP, DOI 10.3791/56384; Prado AF, 2018, REDOX BIOL, V18, P181, DOI 10.1016/j.redox.2018.07.005; Prontera C, 1999, INT J CANCER, V81, P761, DOI 10.1002/(SICI)1097-0215(19990531)81:5<761::AID-IJC16>3.0.CO;2-1; Rammensee S, 2017, STEM CELLS, V35, P497, DOI 10.1002/stem.2489; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shin Y, 2014, ADV HEALTHC MATER, V3, P1457, DOI 10.1002/adhm.201300569; Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0; Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027; Thomas RC, 2017, ACS BIOMATER SCI ENG, V3, P1451, DOI 10.1021/acsbiomaterials.7b00002; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Wittko IM, 2009, J NEUROSCI, V29, P8704, DOI 10.1523/JNEUROSCI.5527-08.2009; Yang HKC, 2004, J NEUROSCI RES, V76, P282, DOI 10.1002/jnr.20071; Zhang HX, 2003, J CELL BIOL, V163, P1375, DOI 10.1083/jcb.200308040; Zhang PZ, 2013, NEUROSCI LETT, V534, P101, DOI 10.1016/j.neulet.2012.11.018	42	0	0	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21311	10.1096/fj.202002302RR	http://dx.doi.org/10.1096/fj.202002302RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33417253				2022-12-26	WOS:000647789600046
J	Doubleday, A; Choe, Y; Isaksen, TB; Miles, S; Errett, NA				Doubleday, Annie; Choe, Youngjun; Isaksen, Tania Busch; Miles, Scott; Errett, Nicole A.			How did outdoor biking and walking change during COVID-19?: A case study of three US cities	PLOS ONE			English	Article								A growing body of literature suggests that restrictive public health measures implemented to control COVID-19 have had negative impacts on physical activity. We examined how Stay Home orders in Houston, New York City, and Seattle impacted outdoor physical activity patterns, measured by daily bicycle and pedestrian count data. We assessed changes in activity levels between the period before and during Stay Home orders. Across all three cities, we found significant changes in bicycle and pedestrian counts from the period before to the period during Stay Home orders. The direction of change varied by location, likely due to differing local contexts and outbreak progression. These results can inform policy around the use of outdoor public infrastructure as the COVID-19 pandemic continues.	[Doubleday, Annie; Isaksen, Tania Busch; Errett, Nicole A.] Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Choe, Youngjun] Univ Washington, Dept Ind & Syst Engn, Seattle, WA 98195 USA; [Isaksen, Tania Busch; Errett, Nicole A.] Univ Washington, Sch Publ Hlth, Dept Hlth Serv, Seattle, WA 98195 USA; [Miles, Scott] Univ Washington, Dept Human Centered Design & Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Doubleday, A (corresponding author), Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	doubleda@uw.edu		Choe, Youngjun/0000-0002-7702-521X; Busch Isaksen, Tania/0000-0001-8180-6054; Doubleday, Annie/0000-0002-6600-8668				Ammar A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061583; [Anonymous], BIKE COUNTERS TRANSP; [Anonymous], 2020, NYC DOT BICYCLISTS B; Espinosa E, 2020, PRESS RELEASE MAYOR; Harris County Public Health, 2020, 2019 NOV COR; Hu W., 2020, NEW YORK TIMES; Lesser IA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113899; Lotan Meir, 2005, Int J Adolesc Med Health, V17, P23; Martinez-Ferran M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061549; Moore SA, 2020, INT J BEHAV NUTR PHY, V17, DOI 10.1186/s12966-020-00987-8; NYC DOT, OP STREETS; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pecanha T, 2020, AM J PHYSIOL-HEART C, V318, pH1441, DOI [10.1152/ajpheart.00268.2020, 10.1152/ajpheart.00268.2020.]; Schulkin R, 2020, SEATTLE PARKS RECREA; Seattle Department of Transportation, 2018, SEATTLE STREETS; Tison GH, 2020, ANN INTERN MED, V173, P767, DOI 10.7326/M20-2665; Underground W Weather Underground, 2020, WEATH HIST DAT ARCH; White MP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44097-3; Zhang X, 2017, NAT COMMUN, V8, P1, DOI [10.1038/s41467-017-01968-5, 10.1038/ncomms14542, 10.1038/s41467-017-00321-0]; Zhang Y, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103722	20	27	27	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245514	10.1371/journal.pone.0245514	http://dx.doi.org/10.1371/journal.pone.0245514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471858	Green Published, gold			2022-12-26	WOS:000639428800057
J	Qu, XS; Qu, CX; Ma, T; Yin, P; Zhao, N; Xia, YM; Qu, SG				Qu, Xishuai; Qu, Chenxi; Ma, Tao; Yin, Peng; Zhao, Ning; Xia, Yumeng; Qu, Shengguan			Effects of an industrial passive assistive exoskeleton on muscle activity, oxygen consumption and subjective responses during lifting tasks	PLOS ONE			English	Article							LOW-BACK-PAIN; DEVICE PLAD; BODY; MOMENTS; BELT; RISK; EMG; AID	The purpose of this study was to evaluate the effects of an industrial passive assisted exoskeleton (IPAE) with simulated lifting tasks on muscle activity, oxygen consumption, perceived level of exertion, local perceived pressure, and systemic usability. Eight workers were required to complete two lifting tasks with and without the IPAE, that were single lifting tasks (repeated 5 times) and 15 min repeated lifting tasks respectively. Both of the tasks required subjects to remove a toolbox from the ground to the waist height. The test results showed that IPAE significantly reduced the muscle activity of the lumbar erector spinae, thoracic erector spinae, middle deltoid and labrum-biceps muscles; the reduction effect during the 15 min lifting task was reached 21%, 12%, 32% and 38% respectively. The exoskeleton did not cause significant differences in oxygen consumption and the perceived level of exertion, but local perceived pressure on the shoulders, thighs, wrists, and waist of the subjects could be produced. 50% of the subjects rated the usability of the equipment as acceptable. The results illustrate the good potential of the exoskeleton to reduce the muscle activity of the low back and upper arms. However, there is still a concern for the obvious contact pressure.	[Qu, Xishuai; Yin, Peng; Qu, Shengguan] South China Univ Technol, Sch Mech & Automot Engn, Guangzhou, Peoples R China; [Qu, Chenxi] Univ Manchester, Sch Mech Aerosp & Civil Engn, Manchester, Lancs, England; [Ma, Tao; Zhao, Ning; Qu, Shengguan] Inner Mongolia First Machinery Grp Co Ltd, State Key Lab Smart Mfg Special Vehicles & Transm, Baotou, Peoples R China; [Xia, Yumeng] China North Adv Technol Generalizat Inst, Beijing, Peoples R China	South China University of Technology; University of Manchester	Qu, SG (corresponding author), South China Univ Technol, Sch Mech & Automot Engn, Guangzhou, Peoples R China.; Qu, SG (corresponding author), Inner Mongolia First Machinery Grp Co Ltd, State Key Lab Smart Mfg Special Vehicles & Transm, Baotou, Peoples R China.	qusg@scut.edu.cn			Inner Mongolia First Machinery Group Co., Ltd.; State Key Laboratory of Special Vehicles and Drive Systems Intelligent Manufacturing Project Open Project [GZ2019KF001, GZ2019KF007]	Inner Mongolia First Machinery Group Co., Ltd.; State Key Laboratory of Special Vehicles and Drive Systems Intelligent Manufacturing Project Open Project	This research was funded by the Inner Mongolia First Machinery Group Co., Ltd. State Key Laboratory of Special Vehicles and Drive Systems Intelligent Manufacturing Project Open Project (GZ2019KF001; GZ2019KF007). Visualization: T. M.;project administration: N.Z.	Abdoli-E M, 2008, CLIN BIOMECH, V23, P372, DOI 10.1016/j.clinbiomech.2007.10.012; Abdoli-E M, 2006, CLIN BIOMECH, V21, P456, DOI 10.1016/j.clinbiomech.2005.12.021; Alonso-Garcia M, 2020, SPINE, V45, pE1026, DOI 10.1097/BRS.0000000000003476; Baltrusch SJ, 2020, HUM FACTORS, V62, P365, DOI 10.1177/0018720819885788; Baltrusch SJ., 2018, EFFECT PASSIVE TRUNK, P229; Bangor A, 2009, J USABILITY STUD, V4, P114; Bosch T, 2016, APPL ERGON, V54, P212, DOI 10.1016/j.apergo.2015.12.003; Chen YL, 2003, INT J IND ERGONOM, V31, P111, DOI 10.1016/S0169-8141(02)00179-8; Cholewicki J, 1999, EUR SPINE J, V8, P388, DOI 10.1007/s005860050192; Colombo G, 2000, J REHABIL RES DEV, V37, P693; de Looze MP, 2016, ERGONOMICS, V59, P671, DOI 10.1080/00140139.2015.1081988; De Luca CJ, 1997, J APPL BIOMECH, V13, P135, DOI 10.1123/jab.13.2.135; Drake JDM, 2006, J ELECTROMYOGR KINES, V16, P175, DOI 10.1016/j.jelekin.2005.07.003; Edlich Richard F, 2004, J Long Term Eff Med Implants, V14, P521; Granata KP, 2004, J BIOMECH, V37, P241, DOI 10.1016/S0021-9290(03)00249-5; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Huysamen K, 2018, APPL ERGON, V68, P125, DOI 10.1016/j.apergo.2017.11.004; Kagawa T., ROBOT HUMAN INTERACT, P546; Kukichi T., INTELLIGENT ROBOTS S, P2959; Lavender SA, 2000, SPINE, V25, P1569, DOI 10.1097/00007632-200006150-00018; Lotz CA, 2009, J ELECTROMYOGR KINES, V19, P331, DOI 10.1016/j.jelekin.2007.08.006; Luo ZG, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION (ICMA), P230, DOI 10.1109/ICMA.2013.6617923; Nilsson A, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-92; Pistolesi F, 2020, IEEE T IND INFORM, V16, P7199, DOI 10.1109/TII.2020.2992984; Pons JL., WEARABLE ROBOTS BIOM; Roberts B, INVENTORBACK MOUNTED; Sankai Y, 2010, SPRINGER TRAC ADV RO, V66, P25; Seki S, AUTOMATION SYSTEMS 1, P2002; Shiiba T., INTELLIGENT ROBOTS S, P3624; VANDERGRINTEN MP, 1992, ADV IND ERG, V4, P311; Whitfield BH, 2014, INT J IND ERGONOM, V44, P39, DOI 10.1016/j.ergon.2013.10.002; Wu AM, 2019, PAIN, V160, P237, DOI 10.1097/j.pain.0000000000001396; Zoss A, 2005, 2005 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P3132, DOI 10.1109/IROS.2005.1545453; Zurada J, 2012, EXPERT SYST APPL, V39, P11125, DOI 10.1016/j.eswa.2012.03.043	34	5	5	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245629	10.1371/journal.pone.0245629	http://dx.doi.org/10.1371/journal.pone.0245629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM1OE	33471870	Green Published, gold			2022-12-26	WOS:000639428800076
J	Suwono, B; Eckmanns, T; Kaspar, H; Merle, R; Zacher, B; Kollas, C; Weiser, AA; Noll, I; Feig, M; Tenhagen, BA				Suwono, Beneditta; Eckmanns, Tim; Kaspar, Heike; Merle, Roswitha; Zacher, Benedikt; Kollas, Chris; Weiser, Armin A.; Noll, Ines; Feig, Marcel; Tenhagen, Bernd-Alois			Cluster analysis of resistance combinations in Escherichia coli from different human and animal populations in Germany 2014-2017	PLOS ONE			English	Article							PUBLIC-HEALTH; LIVESTOCK; CATTLE; FOOD	Recent findings on Antibiotic Resistance (AR) have brought renewed attention to the comparison of data on AR from human and animal sectors. This is however a major challenge since the data is not harmonized. This study performs a comparative analysis of data on resistance combinations in Escherichia coli (E. coli) from different routine surveillance and monitoring systems for human and different animal populations in Germany. Data on E. coli isolates were collected between 2014 and 2017 from human clinical isolates, non-clinical animal isolates from food-producing animals and food, and clinical animal isolates from food-producing and companion animals from national routine surveillance and monitoring for AR in Germany. Sixteen possible resistance combinations to four antibiotics-ampicillin, cefotaxime, ciprofloxacin and gentamicin-for these populations were used for hierarchical clustering (Euclidian and average distance). All analyses were performed with the software R 3.5.1 (Rstudio 1.1.442). Data of 333,496 E. coli isolates and forty-one different human and animal populations were included in the cluster analysis. Three main clusters were detected. Within these three clusters, all human populations (intensive care unit (ICU), general ward and outpatient care) showed similar relative frequencies of the resistance combinations and clustered together. They demonstrated similarities with clinical isolates from different animal populations and most isolates from pigs from both non-clinical and clinical isolates. Isolates from healthy poultry demonstrated similarities in relative frequencies of resistance combinations and clustered together. However, they clustered separately from the human isolates. All isolates from different animal populations with low relative frequencies of resistance combinations clustered together. They also clustered separately from the human populations. Cluster analysis has been able to demonstrate the linkage among human isolates and isolates from various animal populations based on the resistance combinations. Further analyses based on these findings might support a better one-health approach for AR in Germany.	[Suwono, Beneditta; Kollas, Chris; Weiser, Armin A.; Tenhagen, Bernd-Alois] German Fed Inst Risk Assessment, Dept Biol Safety, Unit Epidemiol Zoonoses & Antimicrobial Resistanc, Berlin, Germany; [Suwono, Beneditta; Eckmanns, Tim; Zacher, Benedikt; Noll, Ines; Feig, Marcel] Robert Koch Inst, Dept Infect Dis Epidemiol, Unit Healthcare Associated Infect, Surveillance Antibiot Resistance & Consumpt, Berlin, Germany; [Kaspar, Heike] Fed Off Consumer Protect & Food Safety, Unit Antibiot Resistance Monitoring, Berlin, Germany; [Merle, Roswitha] Free Univ Berlin, Inst Vet Epidemiol & Biostat, Dept Vet Med, Working Grp Appl Epidemiol, Berlin, Germany	Federal Institute for Risk Assessment; Robert Koch Institute; Free University of Berlin	Tenhagen, BA (corresponding author), German Fed Inst Risk Assessment, Dept Biol Safety, Unit Epidemiol Zoonoses & Antimicrobial Resistanc, Berlin, Germany.	Bernd-Alois.Tenhagen@bfr.bund.de		Suwono, Beneditta/0000-0001-5021-6510; Merle, Roswitha/0000-0002-8688-2926	German Federal Institute for Risk Assessment [1322-687]; German Federal Institute for Risk Assessment	German Federal Institute for Risk Assessment; German Federal Institute for Risk Assessment	This study was funded by the German Federal Institute for Risk Assessment in the framework of the German One Health Initiative (GOHI) (Grant No. 1322-687). The funders had no role in study design, data collection and analysis and preparation of the manuscript. As funding was part of the common budget of the German Federal Institute for Risk Assessment, the institute is involved in the decision to publish.	Abu Sin M, 2018, BUNDESGESUNDHEITSBLA, V61, P507, DOI 10.1007/s00103-018-2722-2; Aerts M, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5709; [Anonymous], 2013, EFSA J, V11, P3129, DOI DOI 10.2903/J.EFSA.2015.3991; [Anonymous], VERABREICHUNG ANTIBI; [Anonymous], ZOONOSEN MONITORING; [Anonymous], BUNDESINISTITUT RISI; Arnold KE, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0137; Aust V, 2013, J ANIM PHYSIOL AN N, V97, P1091, DOI 10.1111/jpn.12019; Autoriteit Diergeneesmiddelen (SDA), 2019, US ANT AGR LIV NETH; Berge ACB, 2007, FOODBORNE PATHOG DIS, V4, P397, DOI 10.1089/fpd.2007.0009; Berry EA, 2002, J DAIRY SCI, V85, P112, DOI 10.3168/jds.S0022-0302(02)74059-9; Botner A, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1667; Brown E, 2019, FOODBORNE PATHOG DIS, V16, P441, DOI 10.1089/fpd.2019.2662; Bundesamt fur Verbrauchschutz und Lebensmittelsicherheit (BVL), 2017, RES KLIN WICHT TIERP; Bundesamt fur Verbrauchschutz und Lebensmittelsicherheit (BVL), 2016, RES KLIN WICHT TIERP; Bundesamt fur Verbrauchschutz und Lebensmittelsicherheit (BVL), 2018, RES KLIN WICHT TIERP; Bundesamt fur Verbrauchschutz und Lebensmittelsicherheit (BVL) Bundesinstitut fur Risikobewertung (BfR)., 2017, ZOON MON 201; Bundesamt fur Verbrauchschutz und Lebensmittelsicherheit (BVL) Bundesinstitut fur Risikobewertung (BfR)., 2016, ZOON MON 2014; Bundesministerium fur Gesundheit, DART 2020 ANT RES BE; Burow E, 2019, PREV VET MED, V165, P52, DOI 10.1016/j.prevetmed.2019.02.008; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; Ciccolini M, 2014, P NATL ACAD SCI USA, V111, P2271, DOI 10.1073/pnas.1308062111; de Verdier K, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-2; Dell'Orco F, 2019, RES VET SCI, V123, P77, DOI 10.1016/j.rvsc.2018.12.011; Donker T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035002; Donker T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000715; Dorado-Garcia A, 2018, J ANTIMICROB CHEMOTH, V73, P339, DOI 10.1093/jac/dkx397; European Ctr Dis Prevention, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4872; European Ctr Dis Prevention Contro, 2015, EFSA J, V13, DOI [10.2903/j.efsa.2015.4006, 10.2903/j.efsa.20Y15.4204]; European Food Safety Authority, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5598; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4329; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Friedrich AW, 2019, WIEN MED WOCHENSCHR, V169, pS25, DOI 10.1007/s10354-018-0676-5; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Hegde NV., 2016, VET ANIM SCI; Irrgang A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02256; Jaspers S., 2016, EFSA SUPP PUBL, V13, p1084E; Karkman A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07992-3; Kromker V, 2017, REPROD DOMEST ANIM, V52, P21, DOI 10.1111/rda.13032; Laube H, 2013, APPL ENVIRON MICROB, V79, P4815, DOI 10.1128/AEM.00856-13; Lee S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43280-w; Martin NH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01549; Matuschek E, 2014, CLIN MICROBIOL INFEC, V20, pO255, DOI 10.1111/1469-0691.12373; Merle R, 2013, BERL MUNCH TIERARZTL, V126, P318, DOI 10.2376/0005-9366-126-318; Mo SS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198019; Much P, 2019, PREV VET MED, V171, DOI 10.1016/j.prevetmed.2019.104755; Munk P, 2018, NAT MICROBIOL, V3, P898, DOI 10.1038/s41564-018-0192-9; Murphy D, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4666; Noll I, 2012, BUNDESGESUNDHEITSBLA, V55, P1370, DOI 10.1007/s00103-012-1559-3; Pantoja JCF, 2011, J DAIRY SCI, V94, P2680, DOI 10.3168/jds.2010-3721; Parnanen KMM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau9124; Pietsch M, 2017, VET MICROBIOL, V200, P130, DOI 10.1016/j.vetmic.2015.11.028; Ricci A, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4665; Roth N, 2019, POULTRY SCI, V98, P1791, DOI 10.3382/ps/pey539; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Schmid A, 2013, APPL ENVIRON MICROB, V79, P3027, DOI 10.1128/AEM.00204-13; Schwaiger K, 2008, ZOONOSES PUBLIC HLTH, V55, P331, DOI 10.1111/j.1863-2378.2008.01151.x; Shang Y, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00254; Swift BMC, 2019, SCI TOTAL ENVIRON, V649, P12, DOI 10.1016/j.scitotenv.2018.08.180; Szmolka A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00258; van Hoek AHAM, 2016, VET MICROBIOL, V194, P55, DOI 10.1016/j.vetmic.2016.04.008; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WHO, 2017, INT SURV ANT RES FOO	63	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0244413	10.1371/journal.pone.0244413	http://dx.doi.org/10.1371/journal.pone.0244413			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471826	Green Published, gold, Green Submitted			2022-12-26	WOS:000639428800038
J	Premoli, M; Baggi, D; Bianchetti, M; Gnutti, A; Bondaschi, M; Mastinu, A; Migliorati, P; Signoroni, A; Leonardi, R; Memo, M; Bonini, SA				Premoli, Marika; Baggi, Daniele; Bianchetti, Marco; Gnutti, Alessandro; Bondaschi, Marco; Mastinu, Andrea; Migliorati, Pierangelo; Signoroni, Alberto; Leonardi, Riccardo; Memo, Maurizio; Bonini, Sara Anna			Automatic classification of mice vocalizations using Machine Learning techniques and Convolutional Neural Networks	PLOS ONE			English	Article							ULTRASONIC VOCALIZATIONS; MOUSE MODEL; ABNORMALITIES; TOOL; DEFICITS	Ultrasonic vocalizations (USVs) analysis is a well-recognized tool to investigate animal communication. It can be used for behavioral phenotyping of murine models of different disorders. The USVs are usually recorded with a microphone sensitive to ultrasound frequencies and they are analyzed by specific software. Different calls typologies exist, and each ultrasonic call can be manually classified, but the qualitative analysis is highly time-consuming. Considering this framework, in this work we proposed and evaluated a set of supervised learning methods for automatic USVs classification. This could represent a sustainable procedure to deeply analyze the ultrasonic communication, other than a standardized analysis. We used manually built datasets obtained by segmenting the USVs audio tracks analyzed with the Avisoft software, and then by labelling each of them into 10 representative classes. For the automatic classification task, we designed a Convolutional Neural Network that was trained receiving as input the spectrogram images associated to the segmented audio files. In addition, we also tested some other supervised learning algorithms, such as Support Vector Machine, Random Forest and Multilayer Perceptrons, exploiting informative numerical features extracted from the spectrograms. The performance showed how considering the whole time/frequency information of the spectrogram leads to significantly higher performance than considering a subset of numerical features. In the authors' opinion, the experimental results may represent a valuable benchmark for future work in this research field.	[Premoli, Marika; Mastinu, Andrea; Memo, Maurizio; Bonini, Sara Anna] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Baggi, Daniele; Bianchetti, Marco; Gnutti, Alessandro; Bondaschi, Marco; Migliorati, Pierangelo; Signoroni, Alberto; Leonardi, Riccardo] Univ Brescia, Dept Informat Engn, Brescia, Italy	University of Brescia; University of Brescia	Premoli, M (corresponding author), Univ Brescia, Dept Mol & Translat Med, Brescia, Italy.	m.premoli002@unibs.it		SIGNORONI, Alberto/0000-0002-8383-3766	University of Brescia	University of Brescia	This work was supported by the research grant from the University of Brescia.	Abadi M., 2016, TENSORFLOW LARGE SCA; Bonini SA, 2016, CEREB CORTEX, V26, P2832, DOI 10.1093/cercor/bhw037; Branchi I, 2001, BEHAV BRAIN RES, V125, P49, DOI 10.1016/S0166-4328(01)00277-7; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chollet F., 2015, KERAS; Coffey KR, 2019, NEUROPSYCHOPHARMACOL, V44, P859, DOI 10.1038/s41386-018-0303-6; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; D'Amato FR, 2005, BEHAV GENET, V35, P103, DOI 10.1007/s10519-004-0860-9; Fischer J, 2011, GENES BRAIN BEHAV, V10, P17, DOI 10.1111/j.1601-183X.2010.00610.x; Gaudissard J, 2017, AUTISM RES, V10, P1584, DOI 10.1002/aur.1814; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Ivanenko A, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007918; Leonardi R, 2002, IEEE MULTIMEDIA, V9, P44, DOI 10.1109/93.998057; MAGGIO JC, 1985, J COMP PSYCHOL, V99, P420, DOI 10.1037/0735-7036.99.4.420; Mastinu A, 2018, NEUROPHARMACOLOGY, V133, P366, DOI 10.1016/j.neuropharm.2018.02.007; Oddi D, 2015, NEUROPSYCHOPHARMACOL, V40, P1113, DOI 10.1038/npp.2014.291; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Premoli M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52378-0; Reno JM, 2013, J NEUROSCI METH, V219, P155, DOI 10.1016/j.jneumeth.2013.06.006; Rosenblatt F., 1961, PRINCIPLES NEURODYNA, DOI DOI 10.1001/ARCHPSYC.1962.01720030064010; Sainburg T., 2019, LATENT SPACE VISUALI, V870311, DOI [10.1101/870311, DOI 10.1101/870311]; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Scattoni ML, 2010, HDB MAMMALIAN VOCALI, P88; Scholkopf B, 2001, ADV NEUR IN, V13, P301; Sungur AO, 2016, AUTISM RES, V9, P696, DOI 10.1002/aur.1564; Van Segbroeck M, 2017, NEURON, V94, P465, DOI 10.1016/j.neuron.2017.04.005; Vogel AP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44221-3; Wohr M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00073; ZIPPELIUS HM, 1956, NATURWISSENSCHAFTEN, V43, P501	33	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0244636	10.1371/journal.pone.0244636	http://dx.doi.org/10.1371/journal.pone.0244636			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465075	gold, Green Published			2022-12-26	WOS:000611969200004
J	Guo, YW; Tocchini, C; Ciosk, R				Guo, Yanwu; Tocchini, Cristina; Ciosk, Rafal			CLK-2/TEL2 is a conserved component of the nonsense-mediated mRNA decay pathway	PLOS ONE			English	Article							IDENTIFICATION; PROTEIN; GENOME; TEL2; NMD; SURVEILLANCE; TERMINATION; BINDING; GENE; DEGRADATION	Nonsense-mediated mRNA decay (NMD) controls eukaryotic mRNA quality, inducing the degradation of faulty transcripts. Key players in the NMD pathway were originally identified, through genetics, in Caenorhabditis elegans as smg (suppressor with morphological effect on genitalia) genes. Using forward genetics and fluorescence-based NMD reporters, we reexamined the genetic landscape underlying NMD. Employing a novel strategy for mapping sterile mutations, Het-Map, we identified clk-2, a conserved gene previously implicated in DNA damage signaling, as a player in the nematode NMD. We find that CLK-2 is expressed predominantly in the germline, highlighting the importance of auxiliary factors in tissue-specific mRNA decay. Importantly, the human counterpart of CLK-2/TEL2, TELO2, has been also implicated in the NMD, suggesting a conserved role of CLK-2/TEL2 proteins in mRNA surveillance. Recently, variants of TELO2 have been linked to an intellectual disability disorder, the You-Hoover-Fong syndrome, which could be related to its function in the NMD.	[Guo, Yanwu; Ciosk, Rafal] Univ Oslo, Dept Biosci, Oslo, Norway; [Tocchini, Cristina] Univ Basel, Biozentrum, Basel, Switzerland; [Ciosk, Rafal] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland	University of Oslo; University of Basel; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Ciosk, R (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.; Ciosk, R (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.	rafal.ciosk@ibv.uio.no		Tocchini, Cristina/0000-0002-6213-0287; Ciosk, Rafal/0000-0003-2234-6216	Foundation for Polish Science [POIR.04.04.00-00-203A/16]; European Union under the European Regional Development Fund; EMBO Installation Grant [3615]; Research Council of Norway [FRIMEDBIO-286499]; NIH Office of Research Infrastructure Programs [P40 OD010440]	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union under the European Regional Development Fund; EMBO Installation Grant; Research Council of Norway(Research Council of Norway); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The project POIR.04.04.00-00-203A/16 was carried out within the Team program of the Foundation for Polish Science (www.fnp.org.pl), co-financed by the European Union under the European Regional Development Fund. RC was also supported by the EMBO Installation Grant (www.embo.org/funding-awards) No. 3615 and the Research Council of Norway (www.forskningsradet.no) grant FRIMEDBIO-286499. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Ahn S, 2013, BBA-GENE REGUL MECH, V1829, P1047, DOI 10.1016/j.bbagrm.2013.06.002; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Anders KR, 2003, EMBO J, V22, P641, DOI 10.1093/emboj/cdg056; Anderson CM, 2008, GENE DEV, V22, P854, DOI 10.1101/gad.1646208; Andrews S, FASTQC QUALITY CONTR; Arnold A, 2014, NUCLEIC ACIDS RES, V42, P13353, DOI 10.1093/nar/gku1077; Azzalin CM, 2006, CURR BIOL, V16, P433, DOI 10.1016/j.cub.2006.01.018; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588; Benard C, 2001, DEVELOPMENT, V128, P4045; BRENNER S, 1974, GENETICS, V77, P71; Cali BM, 1999, GENETICS, V151, P605; Casadio A, 2015, EMBO REP, V16, P71, DOI 10.15252/embr.201439183; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Crespo MV, 2010, BIOCHEM SOC T, V38, P1500, DOI 10.1042/BST0381500; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; CUI Y, 1995, GENE DEV, V9, P423, DOI 10.1101/gad.9.4.423; Del-Prado-Sanchez C, 2020, OPHTHALMIC GENET, V41, P656, DOI 10.1080/13816810.2020.1821382; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doitsidou M, 2016, GENETICS, V204, P451, DOI 10.1534/genetics.115.186197; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Edgley Mark L, 2006, WormBook, P1; Fatscher T, 2014, RNA, V20, P1579, DOI 10.1261/rna.044933.114; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gonzalez-Huici V, 2017, GENETICS, V206, P1853, DOI 10.1534/genetics.117.203414; Habacher C, 2016, DEV CELL, V39, P359, DOI 10.1016/j.devcel.2016.09.018; He F, 2015, ANNU REV GENET, V49, P339, DOI 10.1146/annurev-genet-112414-054639; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Hurov KE, 2010, GENE DEV, V24, P1939, DOI 10.1101/gad.1934210; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Izumi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000468; Jaffrey SR, 2018, NAT REV NEUROSCI, V19, P715, DOI 10.1038/s41583-018-0079-z; Jiang N, 2003, J BIOL CHEM, V278, P21678, DOI 10.1074/jbc.M300286200; Johns L, 2007, MOL CELL BIOL, V27, P5630, DOI 10.1128/MCB.00410-07; Karam R, 2015, EMBO REP, V16, P599, DOI 10.15252/embr.201439696; Kebaara BW, 2009, NUCLEIC ACIDS RES, V37, P2771, DOI 10.1093/nar/gkp146; Kurosaki T, 2019, NAT REV MOL CELL BIO, V20, P406, DOI 10.1038/s41580-019-0126-2; Kurosaki T, 2016, J CELL SCI, V129, P461, DOI 10.1242/jcs.181008; Kurosaki T, 2013, P NATL ACAD SCI USA, V110, P3357, DOI 10.1073/pnas.1219908110; Lehrbach Nicolas J, 2017, Curr Protoc Mol Biol, V117, DOI 10.1002/cpmb.27; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Longman D, 2007, GENE DEV, V21, P1075, DOI 10.1101/gad.417707; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Menck CFM, 2014, GENET MOL BIOL, V37, P220, DOI 10.1590/S1415-47572014000200008; Moosa S, 2017, MOL GENET GENOM MED, V5, P580, DOI 10.1002/mgg3.287; Moser SC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000451; Nguyen LS, 2013, HUM MOL GENET, V22, P1816, DOI 10.1093/hmg/ddt035; Nickless A, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0153-7; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Runge KW, 1996, MOL CELL BIOL, V16, P3094; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Tocchini C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004533; Xu YJ, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00175-19; You J, 2016, AM J HUM GENET, V98, P909, DOI 10.1016/j.ajhg.2016.03.014; Zuryn S, 2010, GENETICS, V186, P427, DOI 10.1534/genetics.110.119230	56	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0244505	10.1371/journal.pone.0244505	http://dx.doi.org/10.1371/journal.pone.0244505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444416	gold, Green Published			2022-12-26	WOS:000609988100043
J	Niraula, PM; Zhang, XF; Jeremic, D; Lawrence, KS; Klink, VP				Niraula, Prakash M.; Zhang, Xuefeng; Jeremic, Dragica; Lawrence, Katherine S.; Klink, Vincent P.			Xyloglucan endotransglycosylase/hydrolase increases tightly-bound xyloglucan and chain number but decreases chain length contributing to the defense response that Glycine max has to Heterodera glycines	PLOS ONE			English	Article							OLIGOMERIC GOLGI-COMPLEX; PRIMARY-CELL WALLS; GENE-EXPRESSION; MOLECULAR-WEIGHT; MATRIX POLYSACCHARIDES; ARABIDOPSIS; ROOT; PROTEIN; PLANTS; GROWTH	The Glycine max xyloglucan endotransglycosylase/hydrolase (EC 2.4.1.207), GmXTH43, has been identified through RNA sequencing of RNA isolated through laser microdissection of Heterodera glycines-parasitized root cells (syncytia) undergoing the process of defense. Experiments reveal that genetically increasing XTH43 transcript abundance in the H. glycines-susceptible genotype G. max([Williams 82/PI 518671]) decreases parasitism. Experiments presented here show decreasing XTH43 transcript abundance through RNA interference (RNAi) in the H. glycines-resistant G. max([Peking/PI 548402]) increases susceptibility, but it is unclear what role XTH43 performs. The experiments presented here show XTH43 overexpression decreases the relative length of xyloglucan (XyG) chains, however, there is an increase in the amount of those shorter chains. In contrast, XTH43 RNAi increases XyG chain length. The experiments show that XTH43 has the capability to function, when increased in its expression, to limit XyG chain extension. This outcome would likely impair the ability of the cell wall to expand. Consequently, XTH43 could provide an enzymatically-driven capability to the cell that would allow it to limit the ability of parasitic nematodes like H. glycines to develop a feeding structure that, otherwise, would facilitate parasitism. The experiments presented here provide experimentally-based proof that XTHs can function in ways that could be viewed as being able to limit the expansion of the cell wall.	[Niraula, Prakash M.; Klink, Vincent P.] Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA; [Zhang, Xuefeng; Jeremic, Dragica] Mississippi State Univ, Dept Sustainable Bioprod, Mississippi State, MS 39762 USA; [Lawrence, Katherine S.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Klink, Vincent P.] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Klink, Vincent P.] Ctr Computat Sci High Performance Comp Collaborat, Mississippi State, MS 39762 USA; [Niraula, Prakash M.] Texas A&M Univ, Dept Plant Pathol & Microbiol, Texas A&M AgriLife Res & Extens Ctr, Weslaco, TX USA	Mississippi State University; Auburn University System; Auburn University; Mississippi State University; Mississippi State University; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas A&M University Kingsville	Klink, VP (corresponding author), Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA.; Klink, VP (corresponding author), Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA.; Klink, VP (corresponding author), Ctr Computat Sci High Performance Comp Collaborat, Mississippi State, MS 39762 USA.	heartwood27@hotmail.com	ZHANG, XUEFENG/D-9685-2018	ZHANG, XUEFENG/0000-0003-1654-3969; Lawrence, Kathy/0000-0002-5358-2011	Department of Biological Sciences; Mississippi Soybean Promotion Board [18-2013]; College of Arts and Sciences, Mississippi State University, College of Arts and Sciences [(CAS)2018-1]	Department of Biological Sciences; Mississippi Soybean Promotion Board; College of Arts and Sciences, Mississippi State University, College of Arts and Sciences	Funding was provided by the Department of Biological Sciences in the form of Teaching Assistantships to PMN, URL: https://www.biology.msstate.edu/.Additional funding was kindly provided by the Mississippi Soybean Promotion Board grant number grant number 18-2013 to VK, URL: https://www.mssoy.org.Additional funding was also kindly provided by the College of Arts and Sciences, Mississippi State University, College of Arts and Sciences (CAS)2018-1], URL: https://www.cas.msstate.edu/] to VK.	Albert M, 2004, PLANT BIOLOGY, V6, P402, DOI 10.1055/s-2004-817959; Aljaafri WAR, 2017, PLANT PHYSIOL BIOCH, V121, P161, DOI 10.1016/j.plaphy.2017.10.004; Alshehri HA, 2019, BIOINFORMATION, V15, P338, DOI 10.6026/97320630015338; [Anonymous], 2012, J ENDOCRIMOL META, V17, pS1; Antosiewicz DM, 1997, PLANT PHYSIOL, V115, P1319, DOI 10.1104/pp.115.4.1319; Austin HW, 2019, J PLANT INTERACT, V14, P276, DOI 10.1080/17429145.2019.1622043; Baik YS, 2007, B KOR CHEM SOC, V28, P847; BANFIELD DK, 1995, NATURE, V375, P806, DOI 10.1038/375806a0; Bhattacharyya S, 2002, VIRUS RES, V90, P47, DOI 10.1016/S0166-0934(02)00146-5; Blanc G, 2000, PLANT CELL, V12, P1093, DOI 10.1105/tpc.12.7.1093; Bourquin V, 2002, PLANT CELL, V14, P3073, DOI 10.1105/tpc.007773; Campbell P, 1998, PLANT J, V15, P553, DOI 10.1046/j.1365-313X.1998.00239.x; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Cavalier DM, 2008, PLANT CELL, V20, P1519, DOI 10.1105/tpc.108.059873; Chevalier L, 2010, PLANT J, V64, P977, DOI 10.1111/j.1365-313X.2010.04388.x; Cocuron JC, 2007, P NATL ACAD SCI USA, V104, P8550, DOI 10.1073/pnas.0703133104; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Davis J, 2010, PLANT J, V64, P1028, DOI 10.1111/j.1365-313X.2010.04392.x; Dwivany FM, 2009, MOL PLANT, V2, P1025, DOI 10.1093/mp/ssp064; Eklof JM, 2010, PLANT PHYSIOL, V153, P456, DOI 10.1104/pp.110.156844; FINN GA, 1982, PLANT PHYSIOL, V69, P327, DOI 10.1104/pp.69.2.327; FRY SC, 1992, BIOCHEM J, V282, P821, DOI 10.1042/bj2820821; FRY SC, 1989, PHYSIOL PLANTARUM, V75, P532, DOI 10.1111/j.1399-3054.1989.tb05620.x; FRY SC, 1989, J EXP BOT, V40, P1, DOI 10.1093/jxb/40.1.1; Fry SC, 1997, PHARMACIA, V708, P699, DOI [10.1042/bj3270699, DOI 10.1042/BJ3270699]; Fry SC, 2008, PLANT J, V55, P240, DOI 10.1111/j.1365-313X.2008.03504.x; Fry SC, 2011, ANNU PLANT REV, V41, P1, DOI 10.1002/9781444391015.ch1; Gaborieau M, 2011, ANAL BIOANAL CHEM, V399, P1413, DOI 10.1007/s00216-010-4221-7; Genovesi V, 2008, J EXP BOT, V59, P875, DOI 10.1093/jxb/ern013; GIDLEY MJ, 1991, CARBOHYD RES, V214, P299, DOI 10.1016/0008-6215(91)80037-N; GOLDEN A. M., 1970, Plant Disease Reporter, V54, P544; HAYASHI T, 1994, PLANT CELL PHYSIOL, V35, P893; HAYASHI T, 1989, ANNU REV PLANT PHYS, V40, P139, DOI 10.1146/annurev.pp.40.060189.001035; HAYASHI T, 1984, PLANT PHYSIOL, V76, P739, DOI 10.1104/pp.76.3.739; Hayashi T, 2011, MOL PLANT, V4, P17, DOI 10.1093/mp/ssq063; Henriksson H, 2003, BIOCHEM J, V375, P61, DOI 10.1042/BJ20030485; Herbers K, 2001, PLANTA, V212, P279, DOI 10.1007/s004250000393; Hoffman M, 2005, CARBOHYD RES, V340, P1826, DOI 10.1016/j.carres.2005.04.016; Hyodo H, 2003, PLANT MOL BIOL, V52, P473, DOI 10.1023/A:1023904217641; Jan A, 2004, PLANT PHYSIOL, V136, P3670, DOI 10.1104/pp.104.052274; Jia ZH, 2005, CARBOHYD RES, V340, P1818, DOI 10.1016/j.carres.2005.04.015; Kallas AM, 2005, BIOCHEM J, V390, P105, DOI 10.1042/BJ20041749; Kerr EM, 2003, PLANTA, V217, P327, DOI 10.1007/s00425-003-1027-2; Kim SJ, 2016, GLYCOBIOLOGY, V26, P940, DOI 10.1093/glycob/cww044; Klink VP, 2009, PLANTA, V230, P53, DOI 10.1007/s00425-009-0926-2; Klink VP, 2005, PLANT MOL BIOL, V59, P965, DOI 10.1007/s11103-005-2416-7; Kohnke T, 2011, BIOMACROMOLECULES, V12, P2633, DOI 10.1021/bm200437m; KOOIMAN P, 1957, NATURE, V179, P107, DOI 10.1038/179107a0; Lawaju BR, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.564495; Liu YB, 2007, PLANTA, V226, P1547, DOI 10.1007/s00425-007-0591-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lund CH, 2015, J EXP BOT, V66, P85, DOI 10.1093/jxb/eru401; Lupashin VV, 1997, MOL BIOL CELL, V8, P2659, DOI 10.1091/mbc.8.12.2659; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Maris A, 2009, J EXP BOT, V60, P3959, DOI 10.1093/jxb/erp229; Mastuda K, 1980, PLANT CELL PHYSL, P1405; Matsye PD, 2012, PLANT MOL BIOL, V80, P131, DOI 10.1007/s11103-012-9932-z; Matsye PD, 2011, PLANT MOL BIOL, V77, P513, DOI 10.1007/s11103-011-9828-3; McNeece BT, 2019, PLANT PHYSIOL BIOCH, V137, P25, DOI 10.1016/j.plaphy.2019.01.018; McNeece BT, 2017, PLANT PHYSIOL BIOCH, V114, P60, DOI 10.1016/j.plaphy.2017.02.022; Mellerowicz EJ, 2008, ANN BOT-LONDON, V102, P659, DOI 10.1093/aob/mcn170; Miedes E, 2011, J PLANT PHYSIOL, V168, P196, DOI 10.1016/j.jplph.2010.06.029; Muller F, 2011, BIOMACROMOLECULES, V12, P3330, DOI 10.1021/bm200881x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mustafa G, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00627; Muszynski A, 2015, PLANTA, V242, P1123, DOI 10.1007/s00425-015-2344-y; Niraula PM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241678; Nishikubo N, 2011, PLANT PHYSIOL, V155, P399, DOI 10.1104/pp.110.166934; O'Neill EM, 2018, P NATL ACAD SCI USA, V115, pE9514, DOI 10.1073/pnas.1803779115; Ochoa-Villarreal M, 2012, POLYMERIZATION, P64, DOI [DOI 10.5772/46094, 10.5772/46094]; Ostertag M, 2013, MOL PLANT PATHOL, V14, P230, DOI 10.1111/j.1364-3703.2012.00846.x; Pant SR, 2014, PLANT MOL BIOL, V85, P107, DOI 10.1007/s11103-014-0172-2; Park YB, 2015, PLANT CELL PHYSIOL, V56, P180, DOI 10.1093/pcp/pcu204; Pauly M, 2013, PLANTA, V238, P627, DOI 10.1007/s00425-013-1921-1; Pena MJ, 2012, PLANT CELL, V24, P4511, DOI 10.1105/tpc.112.103390; Popper ZA, 2005, ANN BOT-LONDON, V96, P91, DOI 10.1093/aob/mci153; Rodrigues EP, 2012, GENET MOL BIOL, V35, P348, DOI 10.1590/S1415-47572012000200016; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; ROSS J. P., 1958, PHYTOPATH, V48, P578; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Sharma K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72126-z; Sharma K, 2016, J PLANT INTERACT, V11, P74, DOI 10.1080/17429145.2016.1195891; Shestakova A, 2007, J CELL BIOL, V179, P1179, DOI 10.1083/jcb.200705145; Shin YK, 2006, PLANTA, V224, P32, DOI 10.1007/s00425-005-0189-5; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Stratilova E, 2010, PLANT PHYSIOL BIOCH, V48, P207, DOI 10.1016/j.plaphy.2010.01.016; Takeda T, 2002, P NATL ACAD SCI USA, V99, P9055, DOI 10.1073/pnas.132080299; TALBOTT LD, 1992, PLANT PHYSIOL, V98, P369, DOI 10.1104/pp.98.1.369; TEPFER D, 1984, CELL, V37, P959, DOI 10.1016/0092-8674(84)90430-6; Tokumoto H, 2002, PLANT CELL PHYSIOL, V43, P411, DOI 10.1093/pcp/pcf048; Toyooka K, 2009, PLANT SIGNAL BEHAV, V4, P1196, DOI 10.4161/psb.4.12.10075; Toyooka K, 2009, PLANT CELL, V21, P1212, DOI 10.1105/tpc.108.058933; Tucker ML, 2011, PLANT PHYSIOL, V156, P319, DOI 10.1104/pp.110.170357; Umemura M, 2009, CELLULOSE, V16, P361, DOI 10.1007/s10570-009-9278-0; Van Sandt VST, 2007, PLANT BIOLOGY, V9, P142, DOI 10.1055/s-2006-924661; Van Sandt VST, 2006, J EXP BOT, V57, P2909, DOI 10.1093/jxb/erl064; Vanzin GF, 2002, P NATL ACAD SCI USA, V99, P3340, DOI 10.1073/pnas.052450699; Vissenberg K, 2001, PLANT PHYSIOL, V127, P1125, DOI 10.1104/pp.010295; WARD TC, 1981, J CHEM EDUC, V58, P867, DOI 10.1021/ed058p867; Wulff C, 2000, PLANT PHYSIOL, V122, P867, DOI 10.1104/pp.122.3.867; Yokoyama R, 2004, PLANT PHYSIOL, V134, P1088, DOI 10.1104/pp.103.035261; Yokoyama R, 2001, PLANT CELL PHYSIOL, V42, P292, DOI 10.1093/pcp/pce034; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhu XF, 2012, PLANT CELL, V24, P4731, DOI 10.1105/tpc.112.106039	104	9	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0244305	10.1371/journal.pone.0244305	http://dx.doi.org/10.1371/journal.pone.0244305			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444331	Green Published, gold			2022-12-26	WOS:000609988100088
J	Wardyn, PM; de Broucker, V; Chenivesse, C; Sobaszek, A; Van Bulck, R; Perez, T; Edme, JL; Hulo, S				Wardyn, Pierre-Marie; de Broucker, Virginie; Chenivesse, Cecile; Sobaszek, Annie; Van Bulck, Richard; Perez, Thierry; Edme, Jean-Louis; Hulo, Sebastien			Assessing the applicability of the new Global Lung Function Initiative reference values for the diffusing capacity of the lung for carbon monoxide in a large population set	PLOS ONE			English	Article							STANDARDIZATION; EQUATIONS	Background The single-breath diffusing capacity of the lung for carbon monoxide (D-LCO) interpretation needs the comparison of measured values to reference values. In 2017, the Global Lung Function Initiative published new reference values (GLI-2017) for D-LCO, alveolar volume (V-A) and transfer coefficient of the lung for carbon monoxide (K-CO). We aimed to assess the applicability of GLI-2017 reference values for D-LCO on a large population by comparing them to the European Community of Steel and Coal equations of 1993 (ECSC-93) widely used. Methods In this retrospective study, spirometric indices, total lung capacity, D-LCO, V-A and K-CO were measured in adults classified in 5 groups (controls, asthma, chronic bronchitis, cystic fibrosis, and interstitial lung diseases (ILD)). Statistical analysis comparing the 2 equations sets were stratified by sex. Results 4180 tests were included. GLI-2017 z-scores of the 3 D-LCO indices of the controls (n = 150) are nearer to 0 (expected value in a normal population) than ECSC-93 z-scores. All groups combined, in both genders, D-LCO GLI-2017 z-scores and %predicted are significantly higher than ECSC z-scores and %predicted. In the ILD group, differences between the 2 equation sets depend on the D-LCO impairment severity: GLI-2017 z-scores are higher than ECSC z-scores in patients with no or "mild" decrease in D-LCO, but are lower in "moderate" or "severe" decrease. Conclusion GLI-2017 reference values for D-LCO are more suitable to our population and influence the diagnostic criteria and severity definition of several lung diseases.	[Wardyn, Pierre-Marie; de Broucker, Virginie; Van Bulck, Richard; Perez, Thierry; Edme, Jean-Louis; Hulo, Sebastien] CHU Lille, Serv Explorat Fonct Resp, Lille, France; [de Broucker, Virginie; Sobaszek, Annie; Edme, Jean-Louis; Hulo, Sebastien] Univ Lille, EA IMPECS IMPact Environm Chim Sante Humaine 4483, Lille, France; [Chenivesse, Cecile] CHU Lille, Ctr Reference Constitutif Malad Pulm Rares, Serv Pneumol & Immunoallergol, Lille, France; [Chenivesse, Cecile; Perez, Thierry] CIIL Center Infect & Immun Lille, Inst Pasteur Lille, CNRS, INSERM,U1019,UMR 8204, Lille, France; [Chenivesse, Cecile] Univ Lille, Lille, France; [Sobaszek, Annie] CHU Lille, Serv Med Travail, Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Hulo, S (corresponding author), CHU Lille, Serv Explorat Fonct Resp, Lille, France.; Hulo, S (corresponding author), Univ Lille, EA IMPECS IMPact Environm Chim Sante Humaine 4483, Lille, France.	sebastien.hulo@univ-lille.fr		WARDYN, Pierre-Marie/0000-0002-8884-7462				[Anonymous], 2017, PNEUMOLOGIE, V71, P9; [Anonymous], EUR RESPIR J; Brazzale DJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01905-2019; COTES JE, 1993, EUR RESPIR J, V6, P41, DOI 10.1183/09041950.041s1693; Culver BH, 2017, AM J RESP CRIT CARE, V196, P1463, DOI 10.1164/rccm.201710-1981ST; de Broucker V, 2019, REV MAL RESPIR, V36, P287, DOI 10.1016/j.rmr.2018.12.005; Graham BL, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00016-2016; Hulo S, 2016, EUR RESPIR J, V48, P1779, DOI 10.1183/13993003.00606-2016; International Organization for Standardization, 1989, 28591 ISO; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Oostveen E, 2019, RESP MED, V146, P113, DOI 10.1016/j.rmed.2018.12.005; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Polgar G, 1971, PULMONARY FUNCTION T; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; QUANJER PH, 1983, B EUR PHYSIOPATH RES, V19, P1; Quanjer PH, 2016, EUR RESPIR J, V48, P1782, DOI 10.1183/13993003.01757-2016; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Riem B, 2018, 1 ER JANVIER 2016 2; Stanojevic S, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00010-2017; Wan ES, 2018, AM J RESP CRIT CARE, V198, P1397, DOI 10.1164/rccm.201804-0663OC; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Wapenaar M, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01895-2018; Weinberger SE, 2019, PRINCIPLES PULMONARY, VSeventh, P132, DOI [10.1016/B978-0-323-52371-4.00012-X, DOI 10.1016/B978-0-323-52371-4.00012-X]	24	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245434	10.1371/journal.pone.0245434	http://dx.doi.org/10.1371/journal.pone.0245434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33445178	Green Published, gold			2022-12-26	WOS:000609988100039
J	Jain, M; Caplan, Y; Ramesh, BM; Isac, S; Anand, P; Engl, E; Halli, S; Kemp, H; Blanchard, J; Gothalwal, V; Namasivayam, V; Kumar, P; Sgaier, SK				Jain, Mokshada; Caplan, Yael; Ramesh, B. M.; Isac, Shajy; Anand, Preeti; Engl, Elisabeth; Halli, Shiva; Kemp, Hannah; Blanchard, James; Gothalwal, Vikas; Namasivayam, Vasanthakumar; Kumar, Pankaj; Sgaier, Sema K.			Understanding drivers of family planning in rural northern India: An integrated mixed-methods approach	PLOS ONE			English	Article							PERCEPTIONS; HEALTH	Background Family planning is a key means to achieving many of the Sustainable Development Goals. Around the world, governments and partners have prioritized investments to increase access to and uptake of family planning methods. In Uttar Pradesh, India, the government and its partners have made significant efforts to increase awareness, supply, and access to modern contraceptives. Despite progress, uptake remains stubbornly low. This calls for systematic research into understanding the 'why'-why people are or aren't using modern methods, what drives their decisions, and who influences them. Methods We use a mixed-methods approach, analyzing three existing quantitative data sets to identify trends and geographic variation, gaps and contextual factors associated with family planning uptake and collecting new qualitative data through in-depth immersion interviews, journey mapping, and decision games to understand systemic and individual-level barriers to family planning use, household decision making patterns and community level barriers. Results We find that reasons for adoption of family planning are complex-while access and awareness are critical, they are not sufficient for increasing uptake of modern methods. Although awareness is necessary for uptake, we found a steep drop-off (59%) between high awareness of modern contraceptive methods and its intention to use, and an additional but smaller drop-off from intention to actual use (9%). While perceived access, age, education and other demographic variables partially predict modern contraceptive intention to use, the qualitative data shows that other behavioral drivers including household decision making dynamics, shame to obtain modern contraceptives, and high-risk perception around side-effects also contribute to low intention to use modern contraceptives. The data also reveals that strong norms and financial considerations by couples are the driving force behind the decision to use and when to use family planning methods. Conclusion The finding stresses the need to shift focus towards building intention, in addition to ensuring access of trained staff, and commodities drugs and equipment, and building capacities of health care providers.	[Jain, Mokshada; Caplan, Yael; Engl, Elisabeth; Kemp, Hannah; Sgaier, Sema K.] Surgo Fdn, Washington, DC 20001 USA; [Ramesh, B. M.; Isac, Shajy; Anand, Preeti; Halli, Shiva; Blanchard, James; Gothalwal, Vikas; Namasivayam, Vasanthakumar] Univ Manitoba, Dept Community Hlth Sci, Ctr Global Publ Hlth, Winnipeg, MB, Canada; [Isac, Shajy] India Hlth Act Trust, Delhi, India; [Anand, Preeti; Gothalwal, Vikas] India Hlth Act Trust, Lucknow, Uttar Pradesh, India; [Kumar, Pankaj] Govt Uttar Pradesh, Natl Hlth Mission, Lucknow, Uttar Pradesh, India; [Sgaier, Sema K.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Sgaier, Sema K.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	University of Manitoba; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle	Sgaier, SK (corresponding author), Surgo Fdn, Washington, DC 20001 USA.; Sgaier, SK (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.; Sgaier, SK (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	semasgaier@surgofoundation.org		Blanchard, James/0000-0002-4701-590X; Isac, Shajy/0000-0002-4272-7748; Namasivayam, Vasanthakumar/0000-0001-7905-0155	Surgo Foundation	Surgo Foundation	This study was funded by Surgo Foundation, a non-profit organization. The funder provided support in the form of salaries for authors [MJ, YC, EE, HK, SS], and senior leadership at the funding organization were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The funder provided grants to the University of Manitoba [BR, SH, JB, VG, VN] which operates the India Health Action Trust [SI, PA, VG] for support with design of research instruments, implementation, and data analysis. The specific roles of all authors are articulated in the `author contributions' section.	Agha S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-450; Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; [Anonymous], 2017, FP2020 WAY AHEAD 201; Ariely D, 2009, PREDICATABLY IRRATIO; Bajwa SK, 2012, ASIA-PAC J PUBLIC HE, V24, P1002, DOI 10.1177/1010539511411473; Booth-Kewley S, 1994, J Pers, V62, P281, DOI 10.1111/j.1467-6494.1994.tb00298.x; Bourdieu P., 1977, OUTLINE THEORY OFPRA; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Char A, 2010, REPROD HEALTH MATTER, V18, P154, DOI 10.1016/S0968-8080(10)35497-8; Diamond-Smith N, 2012, CULT HEALTH SEX, V14, P421, DOI 10.1080/13691058.2012.664659; Dockalova BLK, 2016, SUSTAINABLE DEV GOAL; Engl E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214922; FOlstad A, 2013, CUSTOMER JOURNEY MEA; Fotso JC, 2013, J BIOSOC SCI, V45, P779, DOI 10.1017/S0021932012000570; Government of India, 2017, FAM PLANN 2020 COMM; Government of India International Institute for Population Sciences (IIPS) and ICF, 2022, NATL FAMILY HLTH SUR; Huang VS, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002340; Huber D, 2010, B WORLD HEALTH ORGAN, V88, P227, DOI 10.2471/BLT.08.059410; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; International Institute for Population Sciences (IIPS) and ICF, 2017, NAT FAM HLTH SURV NF; Lopez LM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006964.pub3; Mission NRH, 2013, GUIDANCE NOTE IMPLEM; Muttreja Poonam, 2018, Indian J Med Res, V148, pS1, DOI 10.4103/ijmr.IJMR_2067_17; Mwaikambo L, 2011, STUD FAMILY PLANN, V42, P67, DOI 10.1111/j.1728-4465.2011.00267.x; Nte AR, 2009, NIGER J CLIN PRACT, V12, P306; Office of the Registrar General and Census Commissioner India, 2011, ANN HLTH SURV B 2010; Office of the Registrar General and Census Commissioner India, 2012, ANN HLTH SURV B 2011; Office of the Registrar General & Census Commissioner I, 2013, ANN HLTH SURV B 2012; Panda AK, 2016, 1102322016FP MIN HLT; Raj A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153190; Rogers EM, 1999, STUD FAMILY PLANN, V30, P193, DOI 10.1111/j.1728-4465.1999.00193.x; Sedgh G., 2016, UNMET NEED CONTRACEP; Sgaier SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181411; Sgaier SK, 2018, STANFORD SOCIAL INNO; Starbird E, 2016, GLOB HEALTH-SCI PRAC, V4, P191, DOI 10.9745/GHSP-D-15-00374; Steiner MJ, 2006, AM J OBSTET GYNECOL, V195, P85, DOI 10.1016/j.ajog.2005.12.053; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wambui T, 2009, INT NURS REV, V56, P340, DOI 10.1111/j.1466-7657.2009.00726.x; Withers M, 2015, CULT HEALTH SEX, V17, P1132, DOI 10.1080/13691058.2015.1043144; Yzer MC, 2012, HLTH COMMUNICATION M, P21	41	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0243854	10.1371/journal.pone.0243854	http://dx.doi.org/10.1371/journal.pone.0243854			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4UT	33439888	Green Published, gold			2022-12-26	WOS:000609985300043
J	Rawling, M; Leclercq, E; Foey, A; Castex, M; Merrifield, D				Rawling, Mark; Leclercq, Eric; Foey, Andrew; Castex, Mathieu; Merrifield, Daniel			A novel dietary multi-strain yeast fraction modulates intestinal toll-like-receptor signalling and mucosal responses of rainbow trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							YERSINIA-RUCKERI; INFLAMMATORY RESPONSE; EXPRESSION ANALYSIS; CANDIDA-ALBICANS; IMMUNE-RESPONSE; CELLS; FISH; AQUACULTURE; GENE; INTERLEUKIN-12	This study was conducted to evaluate the mucosal immune responses of rainbow trout when supplementing an experimental formulated feed with multi-strain yeast fraction product (Saccharomyces cerevisiae and Cyberlindnera jardinii). In total, 360 fish (initial BW 23.1 +/- 0.2 g) were randomly allotted into three dietary treatments in an 8-week feeding trial. The dietary treatments included basal diet (control) and control + 1.5 g/kg multi-strain yeast fraction product (MsYF) fed continuously and pulsed every two weeks between control and MsYF diet. No negative effects on growth performance of feeding the MsYF supplemented diet were observed. SGR and FCR averaged 2.30 +/- 0.03%/day and 1.03 +/- 0.03, respectively, across experimental groups. Muscularis thickness in the anterior intestine after 8 weeks of feeding was significantly elevated by 44.3% in fish fed the MsYF continuously, and by 14.4% in fish fed the MsYF pulsed (P < 0.02). Significant elevations in goblet cell density in the anterior and posterior (>50% increase) intestine were observed after 8 weeks of feeding the MsYF supplemented diet (P< 0.03). In contrast, lamina propria width was significantly lower in fish fed the experimental diets (>10% reduction). The gene expression analysis of the intestine revealed significant elevations in expression of tlr2, il1r1, irak4, and tollip2 after 4 weeks of feeding the MsYF. Significant elevations in effector cytokines tnf alpha, il10 and tgf beta were observed after 4 weeks of feeding the MsYF regime. After 8 weeks significant elevations in the gene expression levels of il1 beta, ifn gamma, and il12 were observed in fish fed the MsYF. Likewise, the expression of the transcription factor gata3 was significantly elevated (P<0.01). Supplementation of the multi-strain yeast fraction product positively modulates the intestinal mucosal response of rainbow trout through interaction with toll-like receptor two signalling pathway and potential for increased capacity of delivery of antigens to the underlying mucosal associated lymphoid tissue.	[Rawling, Mark; Merrifield, Daniel] Univ Plymouth, Sch Biol & Marine Sci, Plymouth, Devon, England; [Leclercq, Eric; Castex, Mathieu] Lallemand SAS, Blagnac, France; [Foey, Andrew] Univ Plymouth, Sch Biomed Sci, Plymouth, Devon, England	University of Plymouth; Lallemand - France; University of Plymouth	Rawling, M (corresponding author), Univ Plymouth, Sch Biol & Marine Sci, Plymouth, Devon, England.	mark.rawling@plymouth.ac.uk	Merrifield, Daniel/B-3747-2011	Merrifield, Daniel/0000-0002-1790-2217	Lallemand SAS	Lallemand SAS	The study was supported financially by Lallemand SAS. Authors Dr Mathieu Castex and Dr Eric Leclercq provided funding for the study but also made a significant contribution to the experimental design and writing of the study. The funder provided support in the form of salaries for author (MR); they did have a significant role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contribution' section.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Akhter N, 2015, FISH SHELLFISH IMMUN, V45, P733, DOI 10.1016/j.fsi.2015.05.038; Al-Shaghdali K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214681; [Anonymous], 2004, LANCET ONCOL, V5, P1; AOAC, 2007, 200704 AOAC; Bassity E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033196; Bekatorou A, 2006, FOOD TECHNOL BIOTECH, V44, P407; Brietzke A, 2014, FISH SHELLFISH IMMUN, V36, P206, DOI 10.1016/j.fsi.2013.11.005; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carson WE, 2000, BLOOD, V96, P1465, DOI 10.1182/blood.V96.4.1465.h8001465_1465_1473; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Dawood MAO, 2016, AQUACULTURE, V454, P243, DOI 10.1016/j.aquaculture.2015.12.033; Dimitroglou A, 2009, J ANIM SCI, V87, P3226, DOI 10.2527/jas.2008-1428; Dos Anjos CM, 2019, LIVEST SCI, V223, P39, DOI 10.1016/j.livsci.2019.02.018; Erwig LP, 2016, NAT REV MICROBIOL, V14, P163, DOI 10.1038/nrmicro.2015.21; Garcia-Rubio R, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02993; Goodridge Helen S., 2008, V183, P87; Grayfer L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01105; Guerreiro I, 2018, REV AQUACULT, V10, P800, DOI 10.1111/raq.12201; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Harun NO, 2011, VACCINE, V29, P4388, DOI 10.1016/j.vaccine.2011.04.003; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Hodgkinson Jordan W., 2015, Biology-Basel, V4, P881, DOI 10.3390/biology4040881; Holland JW, 2003, PARASITOLOGY, V126, pS95, DOI 10.1017/S0031182003003767; Hoseinifar SH, 2015, FISH SHELLFISH IMMUN, V45, P27, DOI 10.1016/j.fsi.2015.03.029; Huising MO, 2004, DEV COMP IMMUNOL, V28, P395, DOI 10.1016/j.dci.2003.09.005; Jenkins P. G., 1991, Fish & Shellfish Immunology, V1, P279, DOI 10.1016/S1050-4648(05)80066-X; Jouault T, 2003, J INFECT DIS, V188, P165, DOI 10.1086/375784; Khimmakthong U, 2013, MICROB PATHOGENESIS, V59-60, P33, DOI 10.1016/j.micpath.2013.03.001; Knoop KA, 2015, MUCOSAL IMMUNOL, V8, P198, DOI 10.1038/mi.2014.58; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lauwerys BR, 1999, CYTOKINE, V11, P822, DOI 10.1006/cyto.1999.0501; Leclercq E, 2020, AQUACULTURE, V529, DOI 10.1016/j.aquaculture.2020.735701; Lokka G, 2014, DEV COMP IMMUNOL, V47, P77, DOI 10.1016/j.dci.2014.07.005; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Mohan K, 2019, AQUACULTURE, V500, P250, DOI 10.1016/j.aquaculture.2018.10.023; Mukherjee PK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003996; Nasiri AH, 2019, ANIM FEED SCI TECH, V251, P112, DOI 10.1016/j.anifeedsci.2019.03.007; National Research Council, 2011, NUTR REQ FISH; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Ozinsky A, 2000, J ENDOTOXIN RES, V6, P393, DOI 10.1179/096805100101532333; Patin E, 2018, NAT IMMUNOL, V19, P302, DOI 10.1038/s41590-018-0049-7; Person-Le Ruyet J, 2008, AQUAT LIVING RESOUR, V21, P185, DOI 10.1051/alr:2008024; Petit J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00280; Petit J, 2016, DEV COMP IMMUNOL, V64, P93, DOI 10.1016/j.dci.2016.03.003; Rasmussen RO, 2001, TRANSPORT RES REC, P26, DOI 10.3141/1778-04; Rawling MD, 2019, J WORLD AQUACULT SOC, V50, P1108, DOI 10.1111/jwas.12591; RCore Team, 2020, R LANG ENV STAT COMP; Rebl A, 2010, VET IMMUNOL IMMUNOP, V134, P139, DOI 10.1016/j.vetimm.2009.09.021; Rohmel J, 1996, BIOMETRICAL J, V38, P977, DOI 10.1002/bimj.4710380810; Rombout JHWM, 2011, FISH SHELLFISH IMMUN, V31, P616, DOI 10.1016/j.fsi.2010.09.001; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Skall HF, 2005, J FISH DIS, V28, P509, DOI 10.1111/j.1365-2761.2005.00654.x; Smith IM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167410; Smith IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096595; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Smythies LE, 2010, J BIOL CHEM, V285, P19593, DOI 10.1074/jbc.M109.069955; Tobback E, 2009, DIS AQUAT ORGAN, V84, P219, DOI 10.3354/dao02057; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vallejos-Vidal E, 2016, FISH SHELLFISH IMMUN, V56, P34, DOI 10.1016/j.fsi.2016.06.028; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verma A, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a019612; Wang TH, 2010, FISH SHELLFISH IMMUN, V29, P705, DOI 10.1016/j.fsi.2010.06.016; Wiegertjes GF, 2016, MOL IMMUNOL, V69, P146, DOI 10.1016/j.molimm.2015.09.026; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Xu KM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00045; Zanello G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018573; Zhou ZX, 2018, FISH SHELLFISH IMMUN, V75, P32, DOI 10.1016/j.fsi.2018.01.036; Zou J, 2004, EUR J BIOCHEM, V271, P1913, DOI 10.1111/j.1432-1033.2004.04101.x	71	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245021	10.1371/journal.pone.0245021	http://dx.doi.org/10.1371/journal.pone.0245021			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434201	gold, Green Published			2022-12-26	WOS:000609979700030
J	Epelboin, Y; Wang, LJ; Gianetto, QG; Choumet, V; Gaborit, P; Issaly, J; Guidez, A; Douche, T; Chaze, T; Matondo, M; Dusfour, I				Epelboin, Yanouk; Wang, Lanjiao; Gianetto, Quentin Giai; Choumet, Valerie; Gaborit, Pascal; Issaly, Jean; Guidez, Amandine; Douche, Thibaut; Chaze, Thibault; Matondo, Mariette; Dusfour, Isabelle			CYP450 core involvement in multiple resistance strains of Aedes aegypti from French Guiana highlighted by proteomics, molecular and biochemical studies	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; INSECTICIDE RESISTANCE; PYRETHROID RESISTANCE; TEMEPHOS RESISTANCE; DIPTERA-CULICIDAE; STEGOMYIA-AEGYPTI; CROSS-RESISTANCE; POINT MUTATIONS; KDR MUTATIONS; MECHANISMS	Insecticide resistance is a worldwide threat for vector control around the world, and Aedes aegypti, the main vector of several arboviruses, is a particular concern. To better understand the mechanisms of resistance, four isofemale strains originally from French Guiana were isolated and analysed using combined approaches. The activity of detoxification enzymes involved in insecticide resistance was assayed, and mutations located at positions 1016 and 1534 of the sodium voltage-gated channel gene, which have been associated with pyrethroid resistance in Aedes aegypti populations in Latin America, were monitored. Resistance to other insecticide families (organophosphates and carbamates) was evaluated. A large-scale proteomic analysis was performed to identify proteins involved in insecticide resistance. Our results revealed a metabolic resistance and resistance associated with a mutation of the sodium voltage-gated channel gene at position 1016. Metabolic resistance was mediated through an increase of esterase activity in most strains but also through the shifts in the abundance of several cytochrome P450 (CYP450s). Overall, resistance to deltamethrin was linked in the isofemale strains to resistance to other class of insecticides, suggesting that cross- and multiple resistance occur through selection of mechanisms of metabolic resistance. These results give some insights into resistance to deltamethrin and into multiple resistance phenomena in populations of Ae. aegypti.	[Epelboin, Yanouk; Wang, Lanjiao; Gaborit, Pascal; Issaly, Jean; Guidez, Amandine; Dusfour, Isabelle] Inst Pasteur, Unite Entomol Med, Cayenne, French Guiana; [Gianetto, Quentin Giai; Douche, Thibaut; Chaze, Thibault; Matondo, Mariette] Inst Pasteur, Mass Spectrometry Biol Unit, Prote Platform, USR CNRS 2000, Paris, France; [Gianetto, Quentin Giai] Inst Pasteur, Computat Biol Dept, Bioinformat & Biostat Hub, USR CNRS 3756, Paris, France; [Choumet, Valerie] Inst Pasteur, Environm & Infect Risks Unit, Paris, France; [Dusfour, Isabelle] Inst Pasteur, Global Hlth Dept, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Dusfour, I (corresponding author), Inst Pasteur, Unite Entomol Med, Cayenne, French Guiana.; Dusfour, I (corresponding author), Inst Pasteur, Global Hlth Dept, Paris, France.	isabelle.dusfour@pasteur.fr	Matondo, Mariette/AAA-4163-2020	Matondo, Mariette/0000-0003-3958-7710; Douche, Thibaut/0000-0001-8627-6726; Dusfour, Isabelle/0000-0002-5265-8432; Amandine, Guidez/0000-0003-2821-6447; Wang, Lanjiao/0000-0002-5699-1443	European Funds for Regional Development; CNES under FEDER "CONTROLE" [GY0010695]; Investissement d'Avenir grant of the Agence Nationale de la Recherche" [CEBA: ANR-10-LABX25-01]; Institut Pasteur de la Guyane	European Funds for Regional Development(European Commission); CNES under FEDER "CONTROLE"; Investissement d'Avenir grant of the Agence Nationale de la Recherche"(French National Research Agency (ANR)); Institut Pasteur de la Guyane	This study was funded by the European Funds for Regional Development and CNES under FEDER "CONTROLE", project n omicron Synergie: GY0010695 awarded to YE, LW, PG, JI, AG, and ID. This study was also funded by "an Investissement d'Avenir grant of the Agence Nationale de la Recherche" (CEBA: ANR-10-LABX25-01) in which the Institut Pasteur de la Guyane is partner awarded to YE, LW, PG, JI, AG, and ID.	[Anonymous], 2016, WORLD HLTH ORG TECHN, DOI [10.1021/jp052915b, DOI 10.1021/JP052915B]; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25; Bisset J A, 2001, Rev Cubana Med Trop, V53, P37; Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410; Cattel J, 2020, EVOL APPL, V13, P303, DOI 10.1111/eva.12867; Clements A. N., 1999, BIOL MOSQUITOES, V1; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429; DEVONSHIRE AL, 1991, BIOCHEM SOC T, V19, P755, DOI 10.1042/bst0190755; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Du YZ, 2016, INSECTS, V7, DOI 10.3390/insects7040060; Dusfour I, PLOS NEGL TROP DIS; Dusfour I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004226; Dusfour I, 2011, MEM I OSWALDO CRUZ, V106, P346, DOI 10.1590/S0074-02762011000300015; Edi CV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004236; Epelboin Y, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170398; Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x; Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115; Flores AE, 2006, J AM MOSQUITO CONTR, V22, P672, DOI 10.2987/8756-971X(2006)22[672:MOIRIF]2.0.CO;2; Flores AE, 2013, J ECON ENTOMOL, V106, P959, DOI 10.1603/EC12284; Giai Gianetto Q., 2019, IMP4P IMPUTATION PRO; Gianetto QG, 2016, PROTEOMICS, V16, P29, DOI 10.1002/pmic.201500189; Gnanguenon V, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0833-2; Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x; Haddi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46549; Hamid PH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2215-4; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2; Jirakanjanakit N, 2007, J ECON ENTOMOL, V100, P545, DOI 10.1603/0022-0493(2007)100[545:IRSIAS]2.0.CO;2; Juntarajumnong W, 2012, J AM MOSQUITO CONTR, V28, P30, DOI 10.2987/11-6203.1; Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Li CX, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0933-z; Li YJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2581-y; Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5; Macoris MD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006390; Maestre-Serrano R, 2019, PEST MANAG SCI, V75, P1681, DOI 10.1002/ps.5287; Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; Milesi P, 2013, BIORSSAY R SCRIPT BI; Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625; Murataliev MB, 2008, INSECT BIOCHEM MOLEC, V38, P1008, DOI 10.1016/j.ibmb.2008.08.007; Murcia O, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3309-y; Otali D, 2014, B ENTOMOL RES, V104, P323, DOI 10.1017/S0007485314000091; Pauchet Y, 2008, J PROTEOME RES, V7, P1629, DOI 10.1021/pr7006208; Penning TM, 2015, CHEM-BIOL INTERACT, V234, P236, DOI 10.1016/j.cbi.2014.09.024; Pinto J, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3739-6; Plernsub S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1713-0; Polson KA, 2011, ACTA TROP, V117, P31, DOI 10.1016/j.actatropica.2010.09.005; Pounds S, 2006, BIOINFORMATICS, V22, P1979, DOI 10.1093/bioinformatics/btl328; Poupardin R, INSECT MOL BIOL; Poupardin R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002743; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodríguez María Magdalena, 2003, Rev Cubana Med Trop, V55, P105; Rodriguez MM, 2002, J MED ENTOMOL, V39, P882, DOI 10.1603/0022-2585-39.6.882; Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x; Seixas G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005799; Silva APB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-450; Smith LB, 2019, PESTIC BIOCHEM PHYS, V160, P119, DOI 10.1016/j.pestbp.2019.07.011; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soderlund DM, 2012, ARCH TOXICOL, V86, P165, DOI 10.1007/s00204-011-0726-x; Srisawat R, 2010, APPL ENTOMOL ZOOL, V45, P275, DOI 10.1303/aez.2010.275; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Swenson TL, 2013, TOXICOL SCI, V133, P22, DOI 10.1093/toxsci/kft066; Tahir M, 2009, RESPONSE CULEX QUINQ; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Valle D, QUANTIFICATION METHO; Viana-Medeiros PF, 2017, MED VET ENTOMOL, V31, P340, DOI 10.1111/mve.12241; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, P11033, DOI 10.1093/nar/gkw880; Wang LQ, 2006, CURR DRUG METAB, V7, P83, DOI 10.2174/138920006774832596; WHO, 1981, INSTRUCTIONS DETERMI; Wieczorek S, 2017, BIOINFORMATICS, V33, P135, DOI 10.1093/bioinformatics/btw580; Wirth MC, 1999, J AM MOSQUITO CONTR, V15, P315; Wu C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112829; Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x	82	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0243992	10.1371/journal.pone.0243992	http://dx.doi.org/10.1371/journal.pone.0243992			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428654	Green Published, gold			2022-12-26	WOS:000630036100015
J	Shaibu, JO; Onwuamah, CK; James, AB; Okwuraiwe, AP; Amoo, OS; Salu, OB; Ige, FA; Liboro, G; Odewale, E; Okoli, LC; Ahmed, RA; Achanya, D; Adesesan, A; Amuda, OA; Sokei, J; Oyefolu, BAO; Salako, BL; Omilabu, SA; Audu, RA				Shaibu, Joseph Ojonugwa; Onwuamah, Chika K.; James, Ayorinde Babatunde; Okwuraiwe, Azuka Patrick; Amoo, Olufemi Samuel; Salu, Olumuyiwa B.; Ige, Fehintola A.; Liboro, Gideon; Odewale, Ebenezer; Okoli, Leona Chika; Ahmed, Rahaman A.; Achanya, Dominic; Adesesan, Adesegun; Amuda, Oyewunmi Abosede; Sokei, Judith; Oyefolu, Bola A. O.; Salako, Babatunde Lawal; Omilabu, Sunday Aremu; Audu, Rosemary Ajuma			Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria	PLOS ONE			English	Article								In an outbreak, effective detection of the aetiological agent(s) involved using molecular techniques is key to efficient diagnosis, early prevention and management of the spread. However, sequencing is necessary for mutation monitoring and tracking of clusters of transmission, development of diagnostics and for vaccines and drug development. Many sequencing methods are fast evolving to reduce test turn-around-time and to increase through-put compared to Sanger sequencing method; however, Sanger sequencing remains the gold standard for clinical research sequencing with its 99.99% accuracy This study sought to generate sequence data of SARS-CoV-2 using Sanger sequencing method and to characterize them for possible site(s) of mutations. About 30 pairs of primers were designed, synthesized, and optimized using endpoint PCR to generate amplicons for the full length of the virus. Cycle sequencing using BigDye Terminator v.3.1 and capillary gel electrophoresis on ABI 3130xl genetic analyser were performed according to the manufacturers' instructions. The sequence data generated were assembled and analysed for variations using DNASTAR Lasergene 17 SeqMan Ultra. Total length of 29,760bp of SARS-CoV-2 was assembled from the sample analysed and deposited in GenBank with accession number: MT576584. Blast result of the sequence assembly shows a 99.97% identity with the reference sequence. Variations were noticed at positions: nt201, nt2997, nt14368, nt16535, nt20334, and nt28841-28843, which caused amino acid alterations at the S (aa614) and N (aa203-204) regions. The mutations observed at S and N-gene in this study may be indicative of a gradual changes in the genetic coding of the virus hence, the need for active surveillance of the viral genome.	[Shaibu, Joseph Ojonugwa; Onwuamah, Chika K.; Okwuraiwe, Azuka Patrick; Amoo, Olufemi Samuel; Ige, Fehintola A.; Liboro, Gideon; Odewale, Ebenezer; Okoli, Leona Chika; Ahmed, Rahaman A.; Achanya, Dominic; Sokei, Judith; Omilabu, Sunday Aremu; Audu, Rosemary Ajuma] Nigerian Inst Med Res, Ctr Human Virol & Genom, Microbiol Dept, Lagos, Nigeria; [James, Ayorinde Babatunde] Nigerian Inst Med Res, Biochem Dept, Lagos, Nigeria; [Salu, Olumuyiwa B.; Omilabu, Sunday Aremu] Lagos Univ Teaching Hosp, Coll Med, Ctr Human & Zoonot Virol, Dept Med Microbiol & Parasitol, Lagos, Nigeria; [Ahmed, Rahaman A.] Univ Lagos, Dept Cell Biol & Genet, Lagos, Nigeria; [Adesesan, Adesegun; Amuda, Oyewunmi Abosede] Nigerian Inst Med Res, Ctr TB Res, Lagos, Nigeria; [Oyefolu, Bola A. O.] Lagos State Univ, Dept Microbiol, Virol Res Grp, Lagos, Nigeria; [Salako, Babatunde Lawal] Nigerian Inst Med Res, Lagos, Nigeria	University of Lagos; Lagos State University	Shaibu, JO (corresponding author), Nigerian Inst Med Res, Ctr Human Virol & Genom, Microbiol Dept, Lagos, Nigeria.	josephshaibu2013@gmail.com	Onwuamah, Chika Kingsley/ABB-9926-2020; Amoo, Olufemi/GVR-9974-2022	Onwuamah, Chika Kingsley/0000-0002-5111-1822; Amoo, Olufemi/0000-0003-1076-7910; Salu, Olumuyiwa Babalola/0000-0003-2683-3521; SHAIBU, JOSEPH/0000-0001-7829-6591; Sokei, Judith/0000-0003-2206-557X	Nigerian Institute of Medical Research	Nigerian Institute of Medical Research	This project was financially supported by Nigerian Institute of Medical Research in response to SARS-CoV-2 outbreak in Nigeria.	Bajaj A, 2020, INDIAN J MICROBIOL, V60, P398, DOI 10.1007/s12088-020-00869-4; Deng YM, 2015, J CLIN VIROL, V68, P43, DOI 10.1016/j.jcv.2015.04.019; Domingo E, 2000, VIROLOGY, V270, P251, DOI 10.1006/viro.2000.0320; Duffy S, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000003; Khailany RA, 2020, GENE REP, V19, DOI 10.1016/j.genrep.2020.100682; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kuo L, 2014, J VIROL, V88, P4451, DOI 10.1128/JVI.03866-13; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Maurier F, 2019, VIROLOGY, V531, P141, DOI 10.1016/j.virol.2019.03.006; Molenkamp R, 1997, VIROLOGY, V239, P78, DOI 10.1006/viro.1997.8867; Nakamura T, 2018, BIOINFORMATICS, V34, P2490, DOI 10.1093/bioinformatics/bty121; Pachetti M, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02344-6; Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126; Qiang XL, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00649-8; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Verheije MH, 2010, J VIROL, V84, P11575, DOI 10.1128/JVI.00569-10; Wang CT, 2020, J MED VIROL, V92, P667, DOI 10.1002/jmv.25762; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	20	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0243271	10.1371/journal.pone.0243271	http://dx.doi.org/10.1371/journal.pone.0243271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428634	Green Published, gold			2022-12-26	WOS:000630036100009
J	Varona, L; Gonzales, JR				Varona, Luis; Gonzales, Jorge R.			Dynamics of the impact of COVID-19 on the economic activity of Peru	PLOS ONE			English	Article								Background The COVID-19 virus impacts human health and the world economy, causing in Peru, more than 800 thousand infected and a strong recession expressed in a drop of -12% in its economic growth rate for 2020. In this context, the objective of the study is to analyze the dynamics of the short-term behavior of economic activity, as well as to explain the causal relationships in a Pandemic context based on the basic number of spread (Re) of COVID-19 per day. Methods An Autoregressive Distributed Lags (ARDL) model was used. Results A negative and statistically significant impact of the COVID-19 shock was found on the level of economic activity and a long-term Cointegration relationship with an error correction model (CEM), with the expected sign and statistically significant at 1%. Conclusion The Pandemic has behaved as a systemic shock of supply and aggregate demand at the macroeconomic level, which together have an impact on the recession or level of economic activity. The authors propose changing public health policy from an indiscriminate suppression strategy to a targeted, effective and intelligent mitigation strategy that minimizes the risk of human life costs and socioeconomic costs, in a context of uncertainty about the end of the Pandemic and complemented by economic, fiscal and monetary policies that mitigate the economic recession, considering the underlying structural characteristics of the Peruvian economy.	[Varona, Luis] Comillas Pontifical Univ Madrid, Madrid, Spain; [Gonzales, Jorge R.] Univ Nacl Autonoma Mexico, Castillo, Peru	Comillas Pontifical University	Varona, L (corresponding author), Comillas Pontifical Univ Madrid, Madrid, Spain.	luvar8@hotmail.com		Varona Castillo, Luis/0000-0002-0394-2584; GONZALES CASTILLO, JORGE RICARDO/0000-0001-7632-8457				Acemoglu D., 2020, NBER WORKING PAPERS; Alvarez F. E., 2020, 26981 NBER; [Anonymous], 2020, MEF PUBL LIST 71553; ARROW KJ, 1962, REV ECON STUD, V29, P155, DOI 10.2307/2295952; Atkeson A., 2020, 26867 NAT BUR EC RES, DOI [10.3386/w26867, DOI 10.3386/W26867]; Baldwin R., 2020, MITIGATING COVID EC, P227; Barrios S, 2010, REV ECON STAT, V92, P350, DOI 10.1162/rest.2010.11212; BARRO RJ, 1990, J POLIT ECON, V98, pS103, DOI 10.1086/261726; BARRO RJ, 1984, Q J ECON, V99, P817, DOI 10.2307/1883127; Barro Robert, 2020, NBER WORKING PAPERS; BCRP, 2020, RES INF SEM, P16; BCRP, 2020, REP INFL PAN ACT PRO, P152; BCRP, 2020, REV MONEDA, V182, P86; BCRP El Banco Central de Reserva del Peru, 2020, BANC CENTR RES PER R, P1; Bloom DE, 1998, BROOKINGS PAP ECO AC, P207, DOI 10.2307/2534695; Bukhari Q., 2020, SSRN; Caballero R.J., 2020, 27044 NBER; Casella F, 2020, ARXIV200306967; CEPAL, 2020, DIM EF COVID 19 PENS, V2, P21; CEPAL, 2020, COVID 10 RESP, P213; Chiu APY, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0185004, 10.1371/journal.pone.]; Coibion O., 2020, 27141 NBER, V20, P1; COSTELLO DM, 1993, J POLIT ECON, V101, P207, DOI 10.1086/261873; De Urgencia Decreto, 2020, SALUD AFRONTAR PANDE, V19; Dell M, 2012, AM ECON J-MACROECON, V4, P66, DOI 10.1257/mac.4.3.66; Diewert W.E., 2020, 27144 NBER; Domar ED, 1946, ECONOMETRICA, V14, P137, DOI 10.2307/1905364; Eichenauer V., 2020, KOF WORKING PAPERS; Eichenbaum M.S., 2020, NBER WP 27430; Everett T., 2010, DEP ENV FOOD RURAL A, P52; Ferguson N., 2020, 9 IMP COLL LOND, P1, DOI DOI 10.25561/77482; Gali J, 2008, MONETARY POLICY, INFLATION, AND THE BUSINESS CYCLE: AN INTRODUCTION TO THE NEW KEYNESIAN FRAMEWORK, P1; Gali J, 2018, J ECON PERSPECT, V32, P87, DOI 10.1257/jep.32.3.87; Gluskin RT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002713; Gotz TB, 2019, INT J FORECASTING, V35, P45, DOI 10.1016/j.ijforecast.2018.08.001; Gonzales J.R., WORKING PAPER CRECED; Gonzales-Castillo J.R., 2020, REV SALUD P BLICA, V22, P1, DOI [10.15446/rsap.v22n2.87373, DOI 10.15446/RSAP.V22N2.87373]; Greenwood J, 2019, ECONOMETRICA, V87, P1081, DOI 10.3982/ECTA11530; Gujarati D., 2010, ECONOMETRIA, V5ta; Harrod RF, 1939, ECON J, V49, P14, DOI 10.2307/2225181; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; IDB, 2020, PUBL POL TACKL COV 1; IMF, 2020, WORLD EC OUTLOOK LON, P204; IMF, 2020, WORLD EC OUTL UPD, P20; Jones C.J., 2020, 26984 NBER; Kahn M.E, 2019, 26167 NBER; KALDOR N, 1957, ECON J, V67, P586; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Lavado P., 2016, PRODUCTIVIDAD PERU M, V2; Legislativo Decreto, 1276, QUE APRUEBA MARCO RE; Loayza N., 2020, WORLD BANK RES POLIC; Loayza N.V., 2020, COSTS TRADE OFFS FIG; LUCAS RE, 1988, J MONETARY ECON, V22, P3, DOI 10.1016/0304-3932(88)90168-7; MANKIW NG, 1995, BROOKINGS PAP ECO AC, P275; Masters W.A., 2000, CID WORKING PAPER SE, V48; Menebo MM, 2020, SCI TOTAL ENVIRON, V737, DOI 10.1016/j.scitotenv.2020.139659; Narayan P., 2004, REFORMULATING CRITIC, V2; Narayan PK, 2005, APPL ECON, V37, P1979, DOI 10.1080/00036840500278103; Narita F., 2018, SEARCH INFORM USE GO; Pesaran B., 2009, TIME SERIES ECONOMET; Pesaran M.H., 1997, EC EC THEOR 20 CENT, DOI [10.1017/ccol0521633230.011, DOI 10.1017/CCOL0521633230.011]; Pesaran M.H., 1998, EC SOC MONOGR, V31, P371, DOI DOI 10.1017/CCOL521633230.011; Pesaran MH, 2001, J APPL ECONOMET, V16, P289, DOI 10.1002/jae.616; REBELO S, 1991, J POLIT ECON, V99, P500, DOI 10.1086/261764; Rebelo S., 2020, 26882 NBER; ROMER PM, 1986, J POLIT ECON, V94, P1002, DOI 10.1086/261420; ROMER PM, 1990, J POLIT ECON, V98, pS71, DOI 10.1086/261725; Sajadi Mohammad M, 2020, SSRN, P3550308, DOI 10.2139/ssrn.3550308; SAMUELSON PA, 1958, J POLIT ECON, V66, P467, DOI 10.1086/258100; Sangkhaphan S, 2020, ECONOMIES, V8, DOI 10.3390/economies8010001; Seminario B, 2020, OJO PUBLICO; Seminario B., 2012, CUANDO DESPERTEMOS 2; Shin SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32920; SOLOW RM, 1957, REV ECON STAT, V39, P312, DOI 10.2307/1926047; SOLOW RM, 1956, Q J ECON, V70, P65, DOI 10.2307/1884513; Spence M., 2020, ON POINT; Stiglitz J.E., 2015, EC PUBLIC SECTOR 4 I, DOI [10.1177/1071100714555713, DOI 10.1177/1071100714555713]; Thirlwall AP, 2011, PSL Q REV, V64, P429; Topcu M, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101691; Varona L., 2018, WORKING PAPER CRECED; Varona L, 2020, PROBLEMAS DESARROLLO, P69636; Walker PGT, 2020, SCIENCE, V369, P413, DOI 10.1126/science.abc0035; Wang J., 2020, SSRN; Woodford M, 2003, INTEREST AND PRICES: FOUNDATIONS OF A THEORY OF MONETARY POLICY, P1; Wooldrige J., 2003, ENFOQUE MODERNO; Yang P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236857	86	21	22	12	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0244920	10.1371/journal.pone.0244920	http://dx.doi.org/10.1371/journal.pone.0244920			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY4OF	33417613	gold, Green Published			2022-12-26	WOS:000630020100015
J	Zhang, YL; Kong, Y; Ma, Y; Ni, SL; Wikerholmen, T; Xi, KY; Zhao, FH; Zhao, ZM; Wang, JP; Huang, B; Chen, AJ; Yao, Z; Han, MZ; Feng, ZC; Hu, YT; Thorsen, F; Wang, J; Li, XG				Zhang, Yulin; Kong, Yang; Ma, Yuan; Ni, Shilei; Wikerholmen, Tobias; Xi, Kaiyan; Zhao, Feihu; Zhao, Zhimin; Wang, Junpeng; Huang, Bin; Chen, Anjing; Yao, Zhong; Han, Mingzhi; Feng, Zichao; Hu, Yaotian; Thorsen, Frits; Wang, Jian; Li, Xingang			Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines	ONCOGENE			English	Article							IRON; CANCER; METABOLISM; DEATH; TEMOZOLOMIDE; DEGRADATION; COATOMER; FERRITIN; BIOLOGY; SCREEN	Dysregulated iron metabolism is a hallmark of many cancers, including glioblastoma (GBM). However, its role in tumor progression remains unclear. Herein, we identified coatomer protein complex subunit zeta 1 (COPZ1) as a therapeutic target candidate which significantly dysregulated iron metabolism in GBM cells. Overexpression of COPZ1 was associated with increasing tumor grade and poor prognosis in glioma patients based on analysis of expression data from the publicly available database The Cancer Genome Atlas (P < 0.001). Protein levels of COPZ1 were significantly increased in GBM compared to non-neoplastic brain tissue samples in immunohistochemistry and western blot analysis. SiRNA knockdown of COPZ1 suppressed proliferation of U87MG, U251 and P3#GBM in vitro. Stable expression of a COPZ1 shRNA construct in U87MG inhibited tumor growth in vivo by similar to 60% relative to controls at day 21 after implantation (P < 0.001). Kaplan-Meier analysis of the survival data demonstrated that the overall survival of tumor bearing animals increased from 20.8 days (control) to 27.8 days (knockdown, P < 0.05). COPZ1 knockdown also led to the increase in nuclear receptor coactivator 4 (NCOA4), resulting in the degradation of ferritin, and a subsequent increase in the intracellular levels of ferrous iron and ultimately ferroptosis. These data demonstrate that COPZ1 is a critical mediator in iron metabolism. The COPZ1/NCOA4/FTH1 axis is therefore a novel therapeutic target for the treatment of human GBM.	[Zhang, Yulin; Kong, Yang; Ma, Yuan; Ni, Shilei; Xi, Kaiyan; Zhao, Feihu; Zhao, Zhimin; Wang, Junpeng; Huang, Bin; Chen, Anjing; Yao, Zhong; Feng, Zichao; Hu, Yaotian; Thorsen, Frits; Wang, Jian; Li, Xingang] Shandong Univ, Dept Neurosurg, Qilu Hosp, Cheeloo Coll Med, 107 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Zhang, Yulin; Kong, Yang; Ma, Yuan; Ni, Shilei; Xi, Kaiyan; Zhao, Feihu; Zhao, Zhimin; Wang, Junpeng; Huang, Bin; Chen, Anjing; Yao, Zhong; Feng, Zichao; Hu, Yaotian; Thorsen, Frits; Wang, Jian; Li, Xingang] Shandong Univ, Dept Neurosurg, Inst Brain & Brain Inspired Sci, Cheeloo Coll Med, 107 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Zhang, Yulin; Kong, Yang; Ma, Yuan; Ni, Shilei; Xi, Kaiyan; Zhao, Feihu; Zhao, Zhimin; Wang, Junpeng; Huang, Bin; Chen, Anjing; Yao, Zhong; Feng, Zichao; Hu, Yaotian; Wang, Jian; Li, Xingang] Shandong Key Lab Brain Funct Remodeling, 107 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Zhang, Yulin; Kong, Yang; Wikerholmen, Tobias; Han, Mingzhi; Thorsen, Frits; Wang, Jian] Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway; [Thorsen, Frits] Univ Bergen, Dept Biomed, Mol Imaging Ctr, Jonas Lies Vei 91, N-5009 Bergen, Norway	Shandong University; Shandong University; University of Bergen; University of Bergen	Thorsen, F; Wang, J; Li, XG (corresponding author), Shandong Univ, Dept Neurosurg, Qilu Hosp, Cheeloo Coll Med, 107 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.; Thorsen, F; Wang, J; Li, XG (corresponding author), Shandong Univ, Dept Neurosurg, Inst Brain & Brain Inspired Sci, Cheeloo Coll Med, 107 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.; Wang, J; Li, XG (corresponding author), Shandong Key Lab Brain Funct Remodeling, 107 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.; Thorsen, F; Wang, J (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway.; Thorsen, F (corresponding author), Univ Bergen, Dept Biomed, Mol Imaging Ctr, Jonas Lies Vei 91, N-5009 Bergen, Norway.	Frits.Thorsen@uib.no; Jian.Wang@uib.no; lixg@sdu.edu.cn	Huang, Bin/AAT-4514-2021; Chen, Anjing/GYE-2355-2022	Wikerholmen, Tobias/0000-0002-2925-6144; Zhang, Yulin/0000-0002-0031-1808	National Natural Science Foundation of China [81972351, 81874082, 82073219, 81702474]; Department of Science & Technology of Shandong Province [2017CXGC1502, 2018GSF118094, 2018CXGC1503]; Special Foundation for Taishan Scholars [tshw201502056, ts20110814, tsqn201909173]; China Postdoctoral Science Foundation [2018M642666]; Jinan Science and Technology Bureau of Shandong Province [2019GXRC006, 201821049]; Shandong Research Institute of Industrial Technology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science & Technology of Shandong Province; Special Foundation for Taishan Scholars; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jinan Science and Technology Bureau of Shandong Province; Shandong Research Institute of Industrial Technology	This work was supported by the National Natural Science Foundation of China (81972351, 81874082, 82073219, and 81702474), the Department of Science & Technology of Shandong Province (2017CXGC1502, 2018GSF118094 and 2018CXGC1503), the Special Foundation for Taishan Scholars (tshw201502056, ts20110814 and tsqn201909173), the China Postdoctoral Science Foundation (2018M642666), the Jinan Science and Technology Bureau of Shandong Province (2019GXRC006 and 201821049) and the Shandong Research Institute of Industrial Technology.	Anania MC, 2017, CANCER LETT, V410, P201, DOI 10.1016/j.canlet.2017.09.024; Angeli JPF, 2019, NAT REV CANCER, V19, P405, DOI 10.1038/s41568-019-0149-1; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Chen JJ, 2018, TRENDS CELL BIOL, V28, P77, DOI 10.1016/j.tcb.2017.11.007; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Cooper MS, 2019, BRAIN, V142, DOI 10.1093/brain/awz183; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Dowdle WE, 2014, NAT CELL BIOL, V16, P1069, DOI 10.1038/ncb3053; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Gao MH, 2019, MOL CELL, V73, P354, DOI 10.1016/j.molcel.2018.10.042; Gao MH, 2016, CELL RES, V26, P1021, DOI 10.1038/cr.2016.95; Han MZ, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201910924; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassannia B, 2019, CANCER CELL, V35, P830, DOI 10.1016/j.ccell.2019.04.002; Hou W, 2016, AUTOPHAGY, V12, P1425, DOI 10.1080/15548627.2016.1187366; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Legendre C, 2015, TRENDS ENDOCRIN MET, V26, P322, DOI 10.1016/j.tem.2015.03.008; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Madsen E, 2007, ANNU REV NEUROSCI, V30, P317, DOI 10.1146/annurev.neuro.30.051606.094232; Mancias JD, 2015, ELIFE, V4, DOI 10.7554/eLife.10308; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mleczko-Sanecka K, 2017, HAEMATOLOGICA, V102, P1173, DOI 10.3324/haematol.2016.162917; Mleczko-Sanecka K, 2014, BLOOD, V123, P1574, DOI 10.1182/blood-2013-07-515957; Murphy MP, 2018, NAT CELL BIOL, V20, P1104, DOI 10.1038/s41556-018-0209-x; Pignatello JJ, 2006, CRIT REV ENV SCI TEC, V36, P1, DOI 10.1080/10643380500326564; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Ryu MS, 2017, J CLIN INVEST, V127, P1786, DOI 10.1172/JCI90519; Salvador GA, 2010, BIOFACTORS, V36, P103, DOI 10.1002/biof.80; Schoenfeld JD, 2017, CANCER CELL, V31, P487, DOI 10.1016/j.ccell.2017.02.018; Shin D, 2020, REDOX BIOL, V30, DOI 10.1016/j.redox.2019.101418; Shtutman M, 2011, P NATL ACAD SCI USA, V108, P12449, DOI 10.1073/pnas.1103842108; Simon T, 2020, ONCOGENE, V39, P4477, DOI 10.1038/s41388-020-1308-2; Sosa V, 2013, AGEING RES REV, V12, P376, DOI 10.1016/j.arr.2012.10.004; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sukseree S, 2020, AUTOPHAGY, V16, P1851, DOI 10.1080/15548627.2019.1709764; Sun X, 2015, ONCOGENE, V34, P5617, DOI 10.1038/onc.2015.32; Teng J, 2018, NEURO-ONCOLOGY, V20, P642, DOI 10.1093/neuonc/nox198; Theil EC, 2004, ANNU REV NUTR, V24, P327, DOI 10.1146/annurev.nutr.24.012003.132212; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; van Swelm RPL, 2020, NAT REV NEPHROL, V16, P77, DOI 10.1038/s41581-019-0197-5; Wang YF, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010095; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Zhang YL, 2020, ACS APPL MATER INTER, V12, P43408, DOI 10.1021/acsami.0c12042; Zhang ZL, 2018, AUTOPHAGY, V14, P2083, DOI 10.1080/15548627.2018.1503146	47	42	43	6	32	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2021	40	8					1425	1439		10.1038/s41388-020-01622-3	http://dx.doi.org/10.1038/s41388-020-01622-3		JAN 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QM6NM	33420375	hybrid, Green Published			2022-12-26	WOS:000607346000013
J	Molstad, DHH; Mattson, AM; Begun, DL; Westendorf, JJ; Bradley, EW				Molstad, David H. H.; Mattson, Anna M.; Begun, Dana L.; Westendorf, Jennifer J.; Bradley, Elizabeth W.			Hdac3 regulates bone modeling by suppressing osteoclast responsiveness to RANKL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NF-&#954; B; acetylation; Sphk1; sphingosine-1-phosphate; bone resorption; sphingosine-1-phosphate (S1P); sphingosine kinase (SphK); bone; NF-kB transcription factor	HISTONE DEACETYLASE 3; ESTROGEN-RECEPTOR; DELETION; ACTIVATION; EXPRESSION; RESORPTION; PERIOSTEUM; PROMOTION; MASS; AGE	Hdac3 is a lysine deacetylase that removes acetyl groups from histones and additional proteins. Although Hdac3 functions within mesenchymal lineage skeletal cells are defined, little is known about Hdac3 activities in bone-resorbing osteoclasts. In this study we conditionally deleted Hdac3 within Ctsk-expressing cells and examined the effects on bone modeling and osteoclast differentiation in mice. Hdac3 deficiency reduced femur and tibia periosteal circumference and increased cortical periosteal osteoclast number. Trabecular bone was likewise reduced and was accompanied by increased osteoclast number per trabecular bone surface. We previously showed that Hdac3 deacetylates the p65 subunit of the NF-kappa B transcriptional complex to decrease DNA-binding and transcriptional activity. Hdac3-deficient osteoclasts demonstrate increased K310 NF-kappa B acetylation and NF-kappa B transcriptional activity. Hdac3-deficient osteoclast lineage cells were hyper-responsive to RANKL and showed elevated ex vivo osteoclast number and size and enhanced bone resorption in pit formation assays. Osteoclast-directed Hdac3 deficiency decreased cortical and trabecular bone mass parameters, suggesting that Hdac3 regulates coupling of bone resorption and bone formation. We surveyed a panel of osteoclast-derived coupling factors and found that Hdac3 suppression diminished sphingosine-1-phosphate production. Osteoclast-derived sphingosine-1-phosphate acts in paracrine to promote bone mineralization. Mineralization of WT bone marrow stromal cells cultured with conditioned medium from Hdac3-deficient osteoclasts was markedly reduced. Expression of alkaline phosphatase, type 1a1 collagen, and osteocalcin was also suppressed, but no change in Runx2 expression was observed. Our results demonstrate that Hdac3 controls bone modeling by suppressing osteoclast lineage cell responsiveness to RANKL and coupling to bone formation.	[Molstad, David H. H.; Bradley, Elizabeth W.] Univ Minnesota, Dept Orthoped, Minneapolis, MN 55455 USA; [Bradley, Elizabeth W.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Mattson, Anna M.; Begun, Dana L.; Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA; [Westendorf, Jennifer J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic	Bradley, EW (corresponding author), Univ Minnesota, Dept Orthoped, Minneapolis, MN 55455 USA.; Bradley, EW (corresponding author), Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA.	ebradle1@umn.edu		Bradley, Elizabeth/0000-0002-8814-5524; Westendorf, Jennifer J/0000-0002-4464-6108	National Institutes of Health [AR065397, AR072634]; Mayo Clinic Center for Biomedical Discovery; Mayo Clinic Foundation; University of Minnesota Board of Regents	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Biomedical Discovery; Mayo Clinic Foundation; University of Minnesota Board of Regents	This work was supported by National Institutes of Health Grants AR065397 and AR072634 and by funds from the Mayo Clinic Center for Biomedical Discovery, the Mayo Clinic Foundation, and the University of Minnesota Board of Regents. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen MR, 2004, BONE, V35, P1003, DOI 10.1016/j.bone.2004.07.014; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; BONJOUR JP, 1994, OSTEOPOROSIS INT, V4, P7; Boyce BF, 2015, ENDOCRINOL METAB, V30, P35, DOI 10.3803/EnM.2015.30.1.35; Bradley EW, 2008, J CELL PHYSIOL, V217, P752, DOI 10.1002/jcp.21550; Bradley EW, 2008, J CELL BIOCHEM, V104, P1439, DOI 10.1002/jcb.21719; Bradley EW, 2008, J BIOL CHEM, V283, P8055, DOI 10.1074/jbc.M709500200; Bradley EW, 2013, J BIOL CHEM, V288, P9572, DOI 10.1074/jbc.M112.423723; Bradley Elizabeth W., 2008, V455, P19, DOI 10.1007/978-1-59745-104-8_2; Carpio LR, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf3273; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chiu WSM, 2004, GENESIS, V39, P178, DOI 10.1002/gene.20041; Debnath S, 2018, NATURE, V562, P133, DOI 10.1038/s41586-018-0554-8; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Feigenson M, 2017, J BONE MINER RES, V32, P2453, DOI 10.1002/jbmr.3236; Greene Warner C, 2004, Novartis Found Symp, V259, P208; Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Jepsen KJ, 2010, J BONE MINER RES, V25, P1581, DOI 10.1002/jbmr.41; Kanisicak O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12260; Keller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6215; Khosla S, 2013, J GERONTOL A-BIOL, V68, P1226, DOI 10.1093/gerona/gls163; Pham L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216853; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Liu P, 2008, CANCER RES, V68, P10290, DOI 10.1158/0008-5472.CAN-08-2038; Liu XF, 2004, J BIOL CHEM, V279, P15050, DOI 10.1074/jbc.M311932200; Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; McGee-Lawrence ME, 2013, BONE, V52, P296, DOI 10.1016/j.bone.2012.10.015; McGee-Lawrence ME, 2011, BONE, V48, P1117, DOI 10.1016/j.bone.2011.01.007; MILGROM C, 1989, J BIOMECH, V22, P1243, DOI 10.1016/0021-9290(89)90226-1; Miyazaki Y, 2016, J NEUROIMMUNOL, V298, P24, DOI 10.1016/j.jneuroim.2016.06.007; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Orwoll ES, 2003, J BONE MINER RES, V18, P949, DOI 10.1359/jbmr.2003.18.6.949; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Quint P, 2013, J BIOL CHEM, V288, P5398, DOI 10.1074/jbc.M112.413583; Rantalainen T, 2016, BONE, V93, P71, DOI 10.1016/j.bone.2016.09.015; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Riggs BL, 2004, J BONE MINER RES, V19, P1945, DOI 10.1359/JBMR.040916; Ruiz P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36201; Schoenbuchner SM, 2017, J BONE MINER RES, V32, P2355, DOI 10.1002/jbmr.3279; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; Smith LM, 2014, BONE, V67, P130, DOI 10.1016/j.bone.2014.06.035; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Winkeler CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042005; Yang WT, 2013, NATURE, V499, P491, DOI 10.1038/nature12396	46	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17713	17723		10.1074/jbc.RA120.013573	http://dx.doi.org/10.1074/jbc.RA120.013573			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454009	hybrid, Green Published			2022-12-26	WOS:000603272300025
J	Ziegler, N; Bader, E; Epanchintsev, A; Margerie, D; Kannt, A; Schmoll, D				Ziegler, Nicole; Bader, Erik; Epanchintsev, Alexey; Margerie, Daniel; Kannt, Aimo; Schmoll, Dieter			AMPK beta 1 and AMPK beta 2 define an isoform-specific gene signature in human pluripotent stem cells, differentially mediating cardiac lineage specification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMPK; isoforms; stem cells; gene expression; differentiation; mesoderm; lineage decision; cardiomyocyte; AMP-activated kinase; energy metabolism; cardiac development; cell differentiation; induced pluripotent stem cell; iPSC	ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; IN-VITRO; TRANSCRIPTION; SUBUNIT; PHOSPHORYLATION; CARDIOMYOCYTES; EXPRESSION; STRESS; LOCALIZATION	AMP-activated protein kinase (AMPK) is a key regulator of energy metabolism that phosphorylates a wide range of proteins to maintain cellular homeostasis. AMPK consists of three subunits: alpha, beta, and gamma. AMPK alpha and beta are encoded by two genes, the gamma subunit by three genes, all of which are expressed in a tissue-specific manner. It is not fully understood, whether individual isoforms have different functions. Using RNA-Seq technology, we provide evidence that the loss of AMPK beta 1 and AMPK beta 2 lead to different gene expression profiles in human induced pluripotent stem cells (hiPSCs), indicating isoform-specific function. The knockout of AMPK beta 2 was associated with a higher number of differentially regulated genes than the deletion of AMPK beta 1, suggesting that AMPK beta 2 has a more comprehensive impact on the transcriptome. Bioinformatics analysis identified cell differentiation as one biological function being specifically associated with AMPK beta 2. Correspondingly, the two isoforms differentially affected lineage decision toward a cardiac cell fate. Although the lack of PRKAB1 impacted differentiation into cardiomyocytes only at late stages of cardiac maturation, the availability of PRKAB2 was indispensable for mesoderm specification as shown by gene expression analysis and histochemical staining for cardiac lineage markers such as cTnT, GATA4, and NKX2.5. Ultimately, the lack of AMPK beta 1 impairs, whereas deficiency of AMPK beta 2 abrogates differentiation into cardiomyocytes. Finally, we demonstrate that AMPK affects cellular physiology by engaging in the regulation of hiPSC transcription in an isoform-specific manner, providing the basis for further investigations elucidating the role of dedicated AMPK subunits in the modulation of gene expression.	[Ziegler, Nicole; Epanchintsev, Alexey; Kannt, Aimo; Schmoll, Dieter] Sanofi Aventis Deutschland GmbH, Res & Dev, Frankfurt, Germany; [Bader, Erik] Sanofi Aventis Deutschland GmbH, Integrated Drug Discovery, Frankfurt, Germany; [Margerie, Daniel] Sanofi Aventis Deutschland GmbH, Digital Data Sci, Res & Dev, Frankfurt, Germany	Sanofi-Aventis; Sanofi-Aventis; Sanofi-Aventis	Ziegler, N; Schmoll, D (corresponding author), Sanofi Aventis Deutschland GmbH, Res & Dev, Frankfurt, Germany.	Nicole.Ziegler@unimedizin-mainz.de; Dieter.Schmoll@sanofi.com		Kannt, Aimo/0000-0002-5197-2286				Alfar EA, 2018, CARDIOVASC RES, V114, P779, DOI 10.1093/cvr/cvy065; Anderson DJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03714-x; Andre E, 2019, STEM CELLS DEV, V28, P1498, DOI 10.1089/scd.2019.0129; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Birket MJ, 2013, STEM CELL REP, V1, P560, DOI 10.1016/j.stemcr.2013.11.008; Breckwoldt K, 2017, NAT PROTOC, V12, P1177, DOI 10.1038/nprot.2017.033; Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241; Carvajal K, 2007, AM J PHYSIOL-HEART C, V292, pH3136, DOI 10.1152/ajpheart.00683.2006; Chen S, 2014, LIFE SCI, V98, P75, DOI 10.1016/j.lfs.2014.01.006; Chiu WT, 2014, DEVELOPMENT, V141, P4537, DOI 10.1242/dev.107227; Churko JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07333-4; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Dasgupta B, 2012, MOL CELL BIOL, V32, P2837, DOI 10.1128/MCB.05853-11; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Dubois-Deruy E, 2015, CARDIOVASC RES, V107, P56, DOI 10.1093/cvr/cvv136; Dzeja PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019300; Estaras C, 2017, GENE DEV, V31, P2250, DOI 10.1101/gad.307512.117; Fu JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027417; Fuerstenau-Sharp M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126596; Funa NS, 2015, CELL STEM CELL, V16, P639, DOI 10.1016/j.stem.2015.03.008; Gaarenstroom T, 2014, SEMIN CELL DEV BIOL, V32, P107, DOI 10.1016/j.semcdb.2014.01.009; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Gelinas R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02795-4; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Holmes BF, 2005, AM J PHYSIOL-ENDOC M, V289, pE1071, DOI 10.1152/ajpendo.00606.2004; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Hsu HT, 2018, STEM CELL REP, V11, P1357, DOI 10.1016/j.stemcr.2018.10.013; Hu DJ, 2018, CIRC RES, V123, P1066, DOI 10.1161/CIRCRESAHA.118.313249; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kay M, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1249-2; Keil S, 2010, J MED CHEM, V53, P8679, DOI 10.1021/jm101179e; Kim EK, 2012, J CELL PHYSIOL, V227, P1680, DOI 10.1002/jcp.22892; Kim M, 2012, J MOL CELL CARDIOL, V52, P1066, DOI 10.1016/j.yjmcc.2012.01.016; Koay A, 2010, FEBS LETT, V584, P3499, DOI 10.1016/j.febslet.2010.07.015; Kodiha M, 2007, AM J PHYSIOL-CELL PH, V293, pC1427, DOI 10.1152/ajpcell.00176.2007; Kuppusamy KT, 2015, P NATL ACAD SCI USA, V112, pE2785, DOI 10.1073/pnas.1424042112; Li XX, 2008, ARTERIOSCL THROM VAS, V28, P1789, DOI 10.1161/ATVBAHA.108.172452; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Ling X, 2017, ONCOTARGET, V8, P84403, DOI 10.18632/oncotarget.21218; Malizia AP, 2011, WIRES SYST BIOL MED, V3, P183, DOI 10.1002/wsbm.111; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; McGee SL, 2003, DIABETES, V52, P926, DOI 10.2337/diabetes.52.4.926; Mills RJ, 2017, P NATL ACAD SCI USA, V114, pE8372, DOI 10.1073/pnas.1707316114; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Olivier S, 2018, BIOCHEM PHARMACOL, V153, P147, DOI 10.1016/j.bcp.2018.01.049; Peng CM, 2017, MOL CELL, V68, P591, DOI 10.1016/j.molcel.2017.10.010; Poon E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077784; Ross FA, 2016, FEBS J, V283, P2987, DOI 10.1111/febs.13698; Rubio T, 2013, MOL BIOL CELL, V24, P1801, DOI 10.1091/mbc.E12-11-0806; Salminen A, 2016, CELL SIGNAL, V28, P887, DOI 10.1016/j.cellsig.2016.03.009; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Salt IP, 2017, CIRC RES, V120, P1825, DOI 10.1161/CIRCRESAHA.117.309633; Sarikhani M, 2020, STEM CELL REP, V15, P498, DOI 10.1016/j.stemcr.2020.06.012; Shen XP, 2016, P NATL ACAD SCI USA, V113, P9551, DOI 10.1073/pnas.1608256113; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Song CC, 2019, STEM CELL REP, V13, P338, DOI 10.1016/j.stemcr.2019.06.003; Steinberg GR, 2019, NAT REV DRUG DISCOV, V18, P527, DOI 10.1038/s41573-019-0019-2; Steinberg GR, 2010, J BIOL CHEM, V285, P37198, DOI 10.1074/jbc.M110.102434; Sung MM, 2015, CARDIOVASC RES, V107, P235, DOI 10.1093/cvr/cvv166; Suzuki A, 2007, MOL CELL BIOL, V27, P4317, DOI 10.1128/MCB.02222-06; Thomson DM, 2008, J APPL PHYSIOL, V104, P429, DOI 10.1152/japplphysiol.00900.2007; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Wang Q, 2016, TOXICOL SCI, V149, P346, DOI 10.1093/toxsci/kfv246; Wang YG, 2016, SCI REP-UK, V6, DOI 10.1038/srep32771; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Wilson KD, 2010, CIRC-CARDIOVASC GENE, V3, P426, DOI 10.1161/CIRCGENETICS.109.934281; Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200; Young NP, 2016, GENE DEV, V30, P535, DOI 10.1101/gad.274142.115; Zhu WZ, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011260	73	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17659	17671		10.1074/jbc.RA120.013990	http://dx.doi.org/10.1074/jbc.RA120.013990			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454005	hybrid, Green Published			2022-12-26	WOS:000603272300021
J	Orlando, V; Rea, F; Savare, L; Guarino, I; Mucherino, S; Perrella, A; Trama, U; Coscioni, E; Menditto, E; Corrao, G				Orlando, Valentina; Rea, Federico; Savare, Laura; Guarino, Ilaria; Mucherino, Sara; Perrella, Alessandro; Trama, Ugo; Coscioni, Enrico; Menditto, Enrica; Corrao, Giovanni			Development and validation of a clinical risk score to predict the risk of SARS-CoV-2 infection from administrative data: A population-based cohort study from Italy	PLOS ONE			English	Article								Background The novel coronavirus (SARS-CoV-2) pandemic spread rapidly worldwide increasing exponentially in Italy. To date, there is lack of studies describing clinical characteristics of the people at high risk of infection. Hence, we aimed (i) to identify clinical predictors of SARS-CoV-2 infection risk, (ii) to develop and validate a score predicting SARS-CoV-2 infection risk, and (iii) to compare it with unspecific scores. Methods Retrospective case-control study using administrative health-related database was carried out in Southern Italy (Campania region) among beneficiaries of Regional Health Service aged over than 30 years. For each person with SARS-CoV-2 confirmed infection (case), up to five controls were randomly matched for gender, age and municipality of residence. Odds ratios and 90% confidence intervals for associations between candidate predictors and risk of infection were estimated by means of conditional logistic regression. SARS-CoV-2 Infection Score (SIS) was developed by generating a total aggregate score obtained from assignment of a weight at each selected covariate using coefficients estimated from the model. Finally, the score was categorized by assigning increasing values from 1 to 4. Discriminant power was used to compare SIS performance with that of other comorbidity scores. Results Subjects suffering from diabetes, anaemias, Parkinson's disease, mental disorders, cardiovascular and inflammatory bowel and kidney diseases showed increased risk of SARS-CoV-2 infection. Similar estimates were recorded for men and women and younger and older than 65 years. Fifteen conditions significantly contributed to the SIS. As SIS value increases, risk progressively increases, being odds of SARS-CoV-2 infection among people with the highest SIS value (SIS = 4) 1.74 times higher than those unaffected by any SIS contributing conditions (SIS = 1). Conclusion Conditions and diseases making people more vulnerable to SARS-CoV-2 infection were identified by the current study. Our results support decision-makers in identifying high-risk people and adopting of preventive measures to minimize the spread of further epidemic waves.	[Orlando, Valentina; Guarino, Ilaria; Mucherino, Sara; Menditto, Enrica] Univ Naples Federico II, Ctr Drug Utilizat & Pharmacoecon, CIRFF, Naples, Italy; [Orlando, Valentina; Mucherino, Sara; Menditto, Enrica] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Rea, Federico; Savare, Laura; Corrao, Giovanni] Univ Milano Bicocca, Natl Ctr Healthcare Res & Pharmacoepidemiol, Milan, Italy; [Rea, Federico; Savare, Laura; Corrao, Giovanni] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Lab Healthcare Res & Pharmacoepidemiol, Unit Biostat Epidemiol & Publ Hlth, Milan, Italy; [Perrella, Alessandro] AORN Antonio Cardarelli, Infect Dis Healthcare Direct, Naples, Italy; [Trama, Ugo] Reg Pharmaceut Unit, Naples, Campania Region, Italy; [Coscioni, Enrico] AOU San Giovanni di Dio & Ruggi dAragona, Div Cardiac Surg, Salerno, Italy	University of Naples Federico II; University of Naples Federico II; University of Milano-Bicocca; University of Milano-Bicocca	Savare, L (corresponding author), Univ Milano Bicocca, Natl Ctr Healthcare Res & Pharmacoepidemiol, Milan, Italy.; Savare, L (corresponding author), Univ Milano Bicocca, Dept Stat & Quantitat Methods, Lab Healthcare Res & Pharmacoepidemiol, Unit Biostat Epidemiol & Publ Hlth, Milan, Italy.	laura.savare@unimib.it		Mucherino, Sara/0000-0003-3357-5655; Savare, Laura/0000-0001-9030-7011; REA, FEDERICO/0000-0001-7988-5101				Aghagoli G, 2020, J CARDIAC SURG, V35, P1302, DOI 10.1111/jocs.14538; Andersson NW, 2016, INT J EPIDEMIOL, V45, P131, DOI 10.1093/ije/dyv333; Bargagli AM, 2016, J NEUROL, V263, P751, DOI 10.1007/s00415-016-8049-8; Bezzini D, 2016, NEUROEPIDEMIOLOGY, V46, P37, DOI 10.1159/000441567; Burstyn I., 2020, REDUCTION BIAS EPIDE, DOI [10.1101/2020.04.08.20057661, DOI 10.1101/2020.04.08.20057661]; Burstyn I, 2014, INT J ENV RES PUB HE, V11, P10951, DOI 10.3390/ijerph111010951; Canova C, 2019, EPIDEMIOL PREV, V43, P62, DOI 10.19191/EP19.4.S2.P062.093; Carey IM, 2018, DIABETES CARE, V41, P513, DOI 10.2337/dc17-2131; Casula M, 2014, AM J MANAG CARE, V20, pE138; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005; Chini F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-688; Chowdhury SF, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00306; Christensen DM, 2020, J GEN INTERN MED, V35, P2801, DOI 10.1007/s11606-020-05991-z; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Corrao G, 2020, EUR J PUBLIC HEALTH, V30, P916, DOI 10.1093/eurpub/ckaa063; Corrao G, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-019503; de Leon-Rendon JL, 2020, REV GASTROENTEROL ME, V85, P295, DOI 10.1016/j.rgmx.2020.05.001; De Vito A, 2020, EUR REV MED PHARMACO, V24, P7861, DOI 10.26355/eurrev_202007_22291; Diao Bo, 2020, DIAGNOSIS ACUTE RESP, DOI [DOI 10.1161/CIRCULATIONAHA.104.510461, 10.1101/2020.03.04.20031120]; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Favalli EG, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102523; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; Guerriero F, 2017, CLINICOECONOMIC OUTC, V9, P741, DOI 10.2147/CEOR.S147558; Haimovich A., 2020, ANN EMERG MED, DOI [10.1101/2020.05.07.20094573, DOI 10.1101/2020.05.07.20094573]; Iolascon G, 2013, AGING CLIN EXP RES, V25, pS137, DOI 10.1007/s40520-013-0127-5; Italian Data Protection Authority, GEN AUTH PROC PERS D, DOI [10.1094/PDIS-11-11-0999-PDN., DOI 10.1094/PDIS-11-11-0999-PDN]; Jiang T, 2019, EPIDEMIOLOGY, V30, P911, DOI 10.1097/EDE.0000000000001071; Li Q, 2020, IEEE WIREL COMMUN, V27, P118, DOI 10.1109/MWC.001.1900335; Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033; Maio Vittorio, 2005, J Health Serv Res Policy, V10, P232, DOI 10.1258/135581905774414259; Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923; Menditto E, 2018, PATIENT PREFER ADHER, V12, P1975, DOI 10.2147/PPA.S164819; Juste AM, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00870; O'Shea M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-23; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Orlando V, 2020, RISK MANAG HEALTHC P, V13, P63, DOI 10.2147/RMHP.S223042; Orlando V, 2016, CURR DIABETES REV, V12, P100, DOI 10.2174/1573399811666150701120408; Orlo V., DRUG UTILISATION PRO, DOI [10.21203/rs.3.rs-31829/v, DOI 10.21203/RS.3.RS-31829/V]; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; Perico L, 2020, NEPHRON, V144, P213, DOI 10.1159/000507305; Pratt NL, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021122; Russo V, 2018, CLINICOECONOMIC OUTC, V10, DOI 10.2147/CEOR.S161299; Seminog OO, 2013, THORAX, V68, P171, DOI 10.1136/thoraxjnl-2012-202480; Sharma Garima, 2020, JACC Case Rep, V2, P1407, DOI 10.1016/j.jaccas.2020.04.027; Sun YXH, 2020, CLIN INFECT DIS, V71, P786, DOI 10.1093/cid/ciaa322; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Vaira LA, 2020, HEAD NECK-J SCI SPEC, V42, P1560, DOI 10.1002/hed.26269; Vaira LA, 2020, HEAD NECK-J SCI SPEC, V42, P1252, DOI 10.1002/hed.26204; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G; Vultaggio A, 2020, J ALLER CL IMM-PRACT, V8, P2575, DOI 10.1016/j.jaip.2020.06.013; Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000; Wang BX, 2020, OPEN HEART, V7, DOI 10.1136/openhrt-2020-001310; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Xie J., 2020, DEV EXTERNAL VALIDAT, DOI [10.1101/2020.03.28.20045997, DOI 10.1101/2020.03.28.20045997, 10.2139/ssrn.3562456]; Xu H, 2019, STAT MED, V38, P437, DOI 10.1002/sim.7986; Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021	61	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0237202	10.1371/journal.pone.0237202	http://dx.doi.org/10.1371/journal.pone.0237202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471809	gold, Green Published, Green Submitted			2022-12-26	WOS:000639428800050
J	Sekizawa, Y; Konishi, Y				Sekizawa, Yoichi; Konishi, Yoko			Are consumer confidence and asset value expectations positively associated with length of daylight?: An exploration of psychological mediators between length of daylight and seasonal asset price transitions	PLOS ONE			English	Article							AFFECTIVE-DISORDER; DEPRESSIVE SYMPTOMS; HALLOWEEN INDICATOR; STOCK RETURNS; SENTIMENT; ANXIETY; SELL; GO	Many economists claim that asset price transitions, particularly stock price transitions, have a seasonal cycle affected by length of daylight. Although they claim that the seasonal affective disorder (SAD) is a mediator between the length of daylight and asset price transitions, recent studies in psychology have been inconclusive about the existence of SAD, and some economics studies disagree regarding the involvement of SAD in seasonal stock price transitions. The purpose of the present study is to examine if there is any psychological mediator linking length of daylight and seasonal asset price transitions as an alternative or supplement to SAD. As a possible mediator, we examined Japan's consumer confidence index (CCI) and asset value expectations (AVE), which indicate people's optimism for future economy and are generated from a monthly household survey by the Japanese government. We analyzed individual longitudinal data from this survey between 2004 and 2018 and estimated four fixed-effects regression models to control for time-invariant unobserved heterogeneity across individual households. The results revealed that, (i) there was a seasonal cycle of CCI and AVE; the trough occurred in December and the peak in early summer; (ii) the length of daylight time was positively associated with CCI and AVE; and (iii) the higher the latitude, the larger the seasonal cycle of CCI and AVE became. These findings suggest that the length of the daylight may affect asset price transitions through the cycle of optimism/pessimism for future economy exemplified by the CCI and AVE.	[Sekizawa, Yoichi; Konishi, Yoko] Res Inst Econ Trade & Ind, Tokyo, Japan		Sekizawa, Y (corresponding author), Res Inst Econ Trade & Ind, Tokyo, Japan.	sekizawa-yoichi@rieti.go.jp		Sekizawa, Yoichi/0000-0001-6563-6358				Aggarwal R, 2014, INT REV FINANC ANAL, V32, P179, DOI 10.1016/j.irfa.2013.07.018; [Anonymous], 2016, BEHAV INTERACTIONS; Barnett, 2010, ANAL SEASONAL HLTH D; Bergsma K, 2016, FINANC MANAGE, V45, P3, DOI 10.1111/fima.12094; Bouman S, 2002, AM ECON REV, V92, P1618, DOI 10.1257/000282802762024683; Brosch T, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13786; Chau F, 2016, INT REV FINANC ANAL, V48, P221, DOI 10.1016/j.irfa.2016.10.003; Coelho MP, 2010, J BUS PSYCHOL, V25, P397, DOI 10.1007/s10869-009-9146-9; Dohmen TJ, WILLINGNESS TAKE RIS; Dolvin SD, 2014, VENTUR CAP, V16, P51, DOI 10.1080/13691066.2013.863066; Dolvin SD, 2007, REV ACCOUNT FINANC, V6, P214, DOI 10.1108/14757700710750865; Duxbury D, 2020, EUR J FINANC, V26, P1417, DOI 10.1080/1351847X.2020.1742758; Frijters P, 2012, J ECON BEHAV ORGAN, V81, P159, DOI 10.1016/j.jebo.2011.09.007; Frydman C, 2016, TRENDS COGN SCI, V20, P661, DOI 10.1016/j.tics.2016.07.003; Gunasekara FI, 2014, INT J EPIDEMIOL, V43, P264, DOI 10.1093/ije/dyt221; Hirshleifer D, 2020, J FINANC ECON, V137, P272, DOI 10.1016/j.jfineco.2020.02.003; Jacobsen B, 2008, J BANK FINANC, V32, P526, DOI 10.1016/j.jbankfin.2007.08.004; Jacobsen B, 2009, J BANK FINANC, V33, P583, DOI 10.1016/j.jbankfin.2008.09.011; Kamstra MJ, 2015, CRIT FINANC REV, V4, P45, DOI 10.1561/104.00000021; Kamstra MJ, 2003, AM ECON REV, V93, P324, DOI 10.1257/000282803321455322; Kaplanski G, 2012, J EMPIR FINANC, V19, P123, DOI 10.1016/j.jempfin.2011.11.004; KATONA G, 1974, J CONSUM RES, V1, P1, DOI 10.1086/208575; Keef SP, 2015, J NEUROSCI PSYCHOL E, V8, P78, DOI 10.1037/npe0000037; Keef SP, 2011, J SOCIO-ECON, V40, P959, DOI 10.1016/j.socec.2011.08.012; Kelly PJ, 2010, J BANK FINANC, V34, P1308, DOI 10.1016/j.jbankfin.2009.11.027; Kerr DCR, 2013, J AFFECT DISORDERS, V151, P837, DOI 10.1016/j.jad.2013.07.019; Kliger D, 2015, J BEHAV EXP ECON, V59, P74, DOI 10.1016/j.socec.2015.10.003; Knight J, 2010, WORLD DEV, V38, P113, DOI 10.1016/j.worlddev.2009.03.002; Lemmon M, 2006, REV FINANC STUD, V19, P1499, DOI 10.1093/rfs/hhj038; Lerner JS, 2015, ANNU REV PSYCHOL, V66, P799, DOI 10.1146/annurev-psych-010213-115043; LoBello SG, 2019, J BEHAV THER EXP PSY, V62, P72, DOI 10.1016/j.jbtep.2018.09.003; Lyall LM, 2018, J AFFECT DISORDERS, V229, P296, DOI 10.1016/j.jad.2017.12.106; MacLeod AK, 1996, J ABNORM PSYCHOL, V105, P286, DOI 10.1037/0021-843X.105.2.286; Meesters Y, 2016, PSYCHOL RES BEHAV MA, V9, P317, DOI 10.2147/PRBM.S114906; Miloyan B, 2017, GERONTOLOGIST, V57, P619, DOI 10.1093/geront/gnv695; Miranda R, 2007, COGNITIVE THER RES, V31, P71, DOI 10.1007/s10608-006-9063-4; Murgea A, 2016, ECON RES-EKON ISTRAZ, V29, P177, DOI 10.1080/1331677X.2016.1164924; Overland S, 2020, EPIDEMIOL PSYCH SCI, V29, DOI 10.1017/S2045796019000209; Rojo-Suarez J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241318; ROSENTHAL NE, 1986, J NEURAL TRANSM, P257; Senik C, 2008, J ECON BEHAV ORGAN, V68, P140, DOI 10.1016/j.jebo.2008.03.004; Shephard RJ, 2009, EUR J APPL PHYSIOL, V107, P251, DOI 10.1007/s00421-009-1127-1; Skrinjaric T, 2018, RISKS, V6, DOI 10.3390/risks6040140; Smoski MJ, 2008, J BEHAV THER EXP PSY, V39, P567, DOI 10.1016/j.jbtep.2008.01.004; Stewart AE, 2014, MED HYPOTHESES, V83, P517, DOI 10.1016/j.mehy.2014.09.010; Thaler, 1987, J ECON PERSPECT, V1, P197, DOI [10.1257/jep.1.1.197, DOI 10.1257/JEP.1.1.197]; Traffanstedt MK, 2016, CLIN PSYCHOL SCI, V4, P825, DOI 10.1177/2167702615615867; van Giesen RI, 2019, J ECON PSYCHOL, V70, P109, DOI 10.1016/j.joep.2018.12.004; Weinstock E, 2014, J ECON BEHAV ORGAN, V108, P236, DOI 10.1016/j.jebo.2014.10.002; Winlder D, 2017, J AFFECT DISORDERS, V208, P54, DOI 10.1016/j.jad.2016.08.041; Winthorst WH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239033; Wirz-Justice A, 2019, EUR ARCH PSY CLIN N, V269, P833, DOI 10.1007/s00406-018-0921-3; Zhang CY, 2021, J INT MONEY FINANC, V110, DOI 10.1016/j.jimonfin.2020.102268	53	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245520	10.1371/journal.pone.0245520	http://dx.doi.org/10.1371/journal.pone.0245520			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM1OE	33471850	gold, Green Published			2022-12-26	WOS:000639428800017
J	Shukla, S; Husak, G; Turner, W; Davenport, F; Funk, C; Harrison, L; Krell, N				Shukla, Shraddhanand; Husak, Greg; Turner, William; Davenport, Frank; Funk, Chris; Harrison, Laura; Krell, Natasha			A slow rainy season onset is a reliable harbinger of drought in most food insecure regions in Sub-Saharan Africa	PLOS ONE			English	Article							SOUTHERN AFRICA; INTERANNUAL VARIABILITY; WEST-AFRICA; RAINFALL; NDVI; VEGETATION; PHENOLOGY; CESSATION; SCIENCE; GEOGLAM	Since 2015, Sub-Saharan Africa (SSA) has experienced an unprecedented rise in acute food insecurity (AFI), and current projections for the year 2020 indicate that more than 100 million Africans are estimated to receive emergency food assistance. Climate-driven drought is one of the main contributing factors to AFI, and timely and appropriate actions can be taken to mitigate impacts of AFI on lives and livelihoods through early warning systems. To support this goal, we use observations of peak Normalized Difference Vegetation Index (NDVI) as an indicator of seasonal drought conditions following a rainy season to show that delays in the onset of the rainy season (onset date) can be an effective early indicator of seasonal drought conditions. The core of this study is an evaluation of the relationship of the onset dates and peak NDVI, stratified by AFI risks, calculated using AFI reports by the United States Agency of International Development (USAID)-funded Famine Early Warning Systems Network (FEWS NET). Several parts of SSA, mostly located in East Africa (EA), reported the "Crisis" phase of AFI-requiring emergency food assistance-at least one-third of the time between April 2011 to present. The results show that the onset date can effectively explain much of the interannual variability in peak NDVI in the regions with the highest AFI risk level, particularly in EA where the median of correlation (across all the Administrative Unit 2) varies between -0.42 to -0.68. In general, an onset date delay of at least 1 dekad (10 days) increases the likelihood of seasonal drought conditions. In the regions with highest risks of AFI, an onset delay of just 1 dekad doubles the chance of the standardized anomaly of peak NDVI being below -1, making a -1 anomaly the most probable outcome. In those regions, a 2-dekads delay in the onset date is associated with a very high probability (50%) of seasonal drought conditions (-1 standardized anomaly of NDVI). Finally, a multivariate regression analysis between standardized anomaly and onset date anomaly further substantiates the negative impacts of delay in onset date on NDVI anomaly. This relationship is statistically significant over the SSA as a whole, particularly in the EA region. These results imply that the onset date can be used as an additional critical tool to provide alerts of seasonal drought development in the most food-insecure regions of SSA. Early warning systems using onset date as a tool can help trigger effective mid-season responses to save human lives, livestock, and livelihoods, and, therefore, mitigate the adverse impacts of drought hazards.	[Shukla, Shraddhanand; Husak, Greg; Turner, William; Davenport, Frank; Funk, Chris; Harrison, Laura] Univ Calif Santa Barbara, Dept Geog, Climate Hazards Ctr, Santa Barbara, CA 93106 USA; [Krell, Natasha] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Shukla, S (corresponding author), Univ Calif Santa Barbara, Dept Geog, Climate Hazards Ctr, Santa Barbara, CA 93106 USA.	sshukla@ucsb.edu	Krell, Natasha/AFS-5319-2022	Krell, Natasha/0000-0001-6308-5580	NASA Harvest Consortium [80NSSC18M0039]; United States Agency for International Development (USAID) [72DFFP19CA00001]; USGS Drivers of Drought program; NASA Precipitation Monitoring Mission grant [80NSSC19K0686]; Defense Advanced Research Projects Agency (DARPA) World Modelers Program under Army Research Office (ARO) [W911NF-18-1-0018]; NASA SERVIR [80NSSC20K0159]	NASA Harvest Consortium; United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); USGS Drivers of Drought program; NASA Precipitation Monitoring Mission grant; Defense Advanced Research Projects Agency (DARPA) World Modelers Program under Army Research Office (ARO)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NASA SERVIR	SS supported by #80NSSC18M0039 from the NASA Harvest Consortium, GH, WT, LH supported by #72DFFP19CA00001 from the United States Agency for International Development (USAID) cooperative agreement, CF received support from the USGS Drivers of Drought program and the NASA Precipitation Monitoring Mission grant 80NSSC19K0686, SS and FD received support from W911NF-18-1-0018 by the Defense Advanced Research Projects Agency (DARPA) World Modelers Program under Army Research Office (ARO). FD supported by #80NSSC20K0159 from NASA SERVIR.	Adole T, 2018, APPL GEOGR, V90, P187, DOI 10.1016/j.apgeog.2017.12.006; [Anonymous], 2020, 2020 GLOB REP FOOD C; [Anonymous], GLOB FOOD ASS OUTL B; [Anonymous], RAP REAL TIM REV DFI; [Anonymous], SOM DROUGHT IMP NEED; Archer ERM, 2017, CLIM RISK MANAG, V16, P22, DOI 10.1016/j.crm.2017.03.006; Arsenault KR, 2020, B AM METEOROL SOC, V101, pE1007, DOI 10.1175/BAMS-D-18-0264.1; Becker-Reshef I, 2018, INT GEOSCI REMOTE SE, P8155; Becker-Reshef I, 2019, GLOB FOOD SECUR-AGR, V23, P173, DOI 10.1016/j.gfs.2019.04.010; Begue A, 2014, INT J APPL EARTH OBS, V31, P167, DOI 10.1016/j.jag.2014.03.024; Bester CA, 2011, J ECONOMETRICS, V165, P137, DOI 10.1016/j.jeconom.2011.01.007; Brown JF, 2008, GISCI REMOTE SENS, V45, P16, DOI 10.2747/1548-1603.45.1.16; Brown ME, 2008, REMOTE SENS ENVIRON, V112, P2261, DOI 10.1016/j.rse.2007.10.008; Camberlin P, 2003, CLIMATE RES, V23, P159, DOI 10.3354/cr023159; Camberlin P, 2009, THEOR APPL CLIMATOL, V98, P237, DOI 10.1007/s00704-009-0113-1; Cameron AC, 2006, T0327 NAT BUR EC RES, pT0327, DOI [10.3386/t0327, DOI 10.3386/T0327]; Davenport F, 2017, PAP REG SCI, V96, pS155, DOI 10.1111/pirs.12178; Davenport F, 2015, APPL GEOGR, V63, P136, DOI 10.1016/j.apgeog.2015.06.010; Davenport FM, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab5ccd; Dunning CM, 2016, J GEOPHYS RES-ATMOS, V121, P11405, DOI 10.1002/2016JD025428; Funk CC, 2006, REMOTE SENS ENVIRON, V101, P249, DOI 10.1016/j.rse.2005.12.014; Funk C, 2009, REMOTE SENS ENVIRON, V113, P115, DOI 10.1016/j.rse.2008.08.015; Funk C, 2019, B AM METEOROL SOC, V100, P1011, DOI 10.1175/BAMS-D-17-0233.1; Funk C, 2019, B AM METEOROL SOC, V100, pS55, DOI 10.1175/BAMS-D-18-0108.1; Funk C, 2018, Q J ROY METEOR SOC, V144, P360, DOI 10.1002/qj.3266; Funk C, 2018, B AM METEOROL SOC, V99, pS91, DOI [10.1175/bams-d-17-0112.1, 10.1175/BAMS-D-17-0112.1]; Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.66; Hamill TM, 2006, B AM METEOROL SOC, V87, P33, DOI 10.1175/BAMS-87-1-33; Hansen JW, 2011, EXP AGR, V47, P205, DOI 10.1017/S0014479710000876; Hastenrath S, 2004, INT J CLIMATOL, V24, P1333, DOI 10.1002/joc.1070; Heumann BW, 2007, REMOTE SENS ENVIRON, V108, P385, DOI 10.1016/j.rse.2006.11.025; Hillbruner C, 2012, GLOB FOOD SECUR-AGR, V1, P20, DOI 10.1016/j.gfs.2012.08.001; Ibrahim YZ, 2015, REMOTE SENS-BASEL, V7, P5471, DOI 10.3390/rs70505471; IPC, 2020, IPC AC FOOD INS CLAS; Jenkerson C.B., 2010, EMODIS USER FRIENDLY, DOI [10.3133/ofr20101055, DOI 10.3133/OFR20101055]; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; Kawabata A, 2001, INT J REMOTE SENS, V22, P1377, DOI 10.1080/01431160119381; Kirtman BP, 2014, B AM METEOROL SOC, V95, P585, DOI 10.1175/BAMS-D-12-00050.1; Laux P, 2008, INT J CLIMATOL, V28, P329, DOI 10.1002/joc.1542; McNally A, 2019, WATER-SUI, V11, DOI 10.3390/w11101968; McNally A, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.12; NEWEY WK, 1987, ECONOMETRICA, V55, P703, DOI 10.2307/1913610; Omotosho JB, 2000, INT J CLIMATOL, V20, P865, DOI [10.1002/1097-0088(20000630)20:8<865::AID-JOC505>3.0.CO;2-R, 10.1002/1097-0088(20000630)20:8&lt;865::AID-JOC505&gt;3.0.CO;2-R]; Pegion K., B AM METEOROL SOC; Reason CJC, 2005, INT J CLIMATOL, V25, P1835, DOI 10.1002/joc.1228; Rojas O, 2011, REMOTE SENS ENVIRON, V115, P343, DOI 10.1016/j.rse.2010.09.006; SADC, 2016, RELIEFWEB; Setchell H., 2018, ECMWF; Shukla S, 2014, HYDROL EARTH SYST SC, V18, P3907, DOI 10.5194/hess-18-3907-2014; Shukla S, 2020, NAT HAZARD EARTH SYS, V20, P1187, DOI 10.5194/nhess-20-1187-2020; Shukla S, 2019, CLIM DYNAM, V53, P7411, DOI 10.1007/s00382-016-3296-z; SIVAKUMAR MVK, 1988, AGR FOREST METEOROL, V42, P295, DOI 10.1016/0168-1923(88)90039-1; Sultan B, 2003, J CLIMATE, V16, P3407, DOI 10.1175/1520-0442(2003)016&lt;3407:TWAMDP&gt;2.0.CO;2; Tadross MA, 2005, J CLIMATE, V18, P3356, DOI 10.1175/JCLI3423.1; Trambauer P, 2013, PHYS CHEM EARTH, V66, P16, DOI 10.1016/j.pce.2013.07.003; Verdin J, 2005, PHILOS T R SOC B, V360, P2155, DOI 10.1098/rstb.2005.1754; Verdin J, 2002, HYDROL PROCESS, V16, P1617, DOI 10.1002/hyp.1025; Vrieling A, 2016, REMOTE SENS ENVIRON, V174, P44, DOI 10.1016/j.rse.2015.12.003; Vrieling A, 2008, PROC SPIE, V7104, DOI 10.1117/12.799824; Vrieling A, 2011, CLIMATIC CHANGE, V109, P455, DOI 10.1007/s10584-011-0049-1; World Food Programme, 2019, 2019 STATE FOOD SECU; Yuan X, 2013, J HYDROMETEOROL, V14, P1706, DOI 10.1175/JHM-D-13-054.1	62	13	13	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0242883	10.1371/journal.pone.0242883	http://dx.doi.org/10.1371/journal.pone.0242883			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM1OE	33471787	Green Published, gold			2022-12-26	WOS:000639428800071
J	Chen, LP; Zhang, QH; Yi, GY; He, WQ				Chen, Li-Pang; Zhang, Qihuang; Yi, Grace Y.; He, Wenqing			Model-based forecasting for Canadian COVID-19 data	PLOS ONE			English	Article								Background Since March 11, 2020 when the World Health Organization (WHO) declared the COVID-19 pandemic, the number of infected cases, the number of deaths, and the number of affected countries have climbed rapidly. To understand the impact of COVID-19 on public health, many studies have been conducted for various countries. To complement the available work, in this article we examine Canadian COVID-19 data for the period of March 18, 2020 to August 16, 2020 with the aim to forecast the dynamic trend in a short term. Method We focus our attention on Canadian data and analyze the four provinces, Ontario, Alberta, British Columbia, and Quebec, which have the most severe situations in Canada. To build predictive models and conduct prediction, we employ three models, smooth transition autoregressive (STAR) models, neural network (NN) models, and susceptible-infected-removed (SIR) models, to fit time series data of confirmed cases in the four provinces separately. In comparison, we also analyze the data of daily infections in two states of USA, Texas and New York state, for the period of March 18, 2020 to August 16, 2020. We emphasize that different models make different assumptions which are basically difficult to validate. Yet invoking different models allows us to examine the data from different angles, thus, helping reveal the underlying trajectory of the development of COVID-19 in Canada. Finding The examinations of the data dated from March 18, 2020 to August 11, 2020 show that the STAR, NN, and SIR models may output different results, though the differences are small in some cases. Prediction over a short term period incurs smaller prediction variability than over a long term period, as expected. The NN method tends to outperform other two methods. All the methods forecast an upward trend in all the four Canadian provinces for the period of August 12, 2020 to August 23, 2020, though the degree varies from method to method. This research offers model-based insights into the pandemic evolvement in Canada.	[Chen, Li-Pang; Zhang, Qihuang; Yi, Grace Y.; He, Wenqing] Univ Western Ontario, Dept Stat & Actuarial Sci, London, ON, Canada; [Yi, Grace Y.] Univ Western Ontario, Dept Comp Sci, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Yi, GY (corresponding author), Univ Western Ontario, Dept Stat & Actuarial Sci, London, ON, Canada.; Yi, GY (corresponding author), Univ Western Ontario, Dept Comp Sci, London, ON, Canada.	gyi5@uwo.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) [GY: Canada Research Chairs program]. The funders (NSERC) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayyurt L, 2020, MEDRXIV, DOI [10.1101/2020.04.17.20069237, DOI 10.1101/2020.04.17.20069237]; Chatfield C., 2019, ANAL TIME SERIES INT; Chatfield C, 2001, INT SERIES OPERATION, V30, DOI [10.1007/978-0-306-47630-3_21, DOI 10.1007/978-0-306-47630-3_21]; Dijk D. van, 2002, ECONOMET REV, V21, P1, DOI [10.1081/ETC-120008723, DOI 10.1081/ETC-120008723]; Efimov D., 2020, FFHAL02517866V6; Fanelli D, 2020, CHAOS SOLITON FRACT, V134, DOI 10.1016/j.chaos.2020.109761; He W., 2020, J MED VIROLOGY, DOI [10.1101/2020.04.28.20083758, DOI 10.1101/2020.04.28.20083758]; Hyndman R. J., 2018, FORECASTING PRINCIPL; Knighton T., 2020, STATC COVID 19 DAT I; Liu D., 2020, INT J STAT PROBABILI, V9, P23, DOI [10.5539/ijsp.v9n5p23, DOI 10.5539/IJSP.V9N5P23]; McCaw J., 2006, USING MATH MODELS AS; Messacar D., 2020, WORK INTERRUPTIONS F; Moriarty LF, 2020, MMWR-MORBID MORTAL W, V69, P347, DOI 10.15585/mmwr.mm6912e3; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; Petropoulos F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231236; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Siedner MJ, 2020, PLOS MED; Tandon H, 2020, ARXIV200407859; Tuite AR, 2020, CAN MED ASSOC J, V192, pE497, DOI 10.1503/cmaj.200476; Uppal, 2020, SOCIAL EC CONCERNS I; Wall K, 2020, COVID 19 PANDEMIC FI	21	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0244536	10.1371/journal.pone.0244536	http://dx.doi.org/10.1371/journal.pone.0244536			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465142	gold, Green Published			2022-12-26	WOS:000611969200048
J	Davies, LE; Kingston, A; Todd, A; Hanratty, B				Davies, Laurie E.; Kingston, Andrew; Todd, Adam; Hanratty, Barbara			Characterising polypharmacy in the very old: Findings from the Newcastle 85+Study	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; SEX-DIFFERENCES; HEALTH INEQUALITIES; ADVANCED AGE; PRESCRIPTION; PATTERNS; MEDICATIONS; NATIONWIDE; PEOPLE; LIFE	Background Polypharmacy is potentially harmful and under-researched amongst the fastest growing subpopulation, the very old (aged >= 85). We aimed to characterise polypharmacy using data from the Newcastle 85+ Study-a prospective cohort of people born in 1921 who turned 85 in 2006 (n = 845). Methods The prevalence of polypharmacy at baseline (mean age 85.5) was examined using cut-points of 0, 1, 2-4, 5-9 and >= 10 medicines-so-called 'no polypharmacy', 'monotherapy', 'minor polypharmacy', 'polypharmacy' and 'hyperpolypharmacy.' Cross-tabulations and upset plots identified the most frequently prescribed medicines and medication combinations within these categories. Mixed-effects models assessed whether gender and socioeconomic position were associated with prescribing changes over time (mean age 85.5-90.5). Participant characteristics were examined through descriptive statistics. Results Complex multimorbidity (44.4%, 344/775) was widespread but hyperpolypharmacy was not (16.0%, 135/845). The median medication count was six (interquartile range 4-8). Preventative medicines were common to all polypharmacy categories, and prescribing regimens were diverse. Nitrates and oral anticoagulants were more frequently prescribed for men, whereas bisphosphonates, non-opioid analgesics and antidepressants were more common in women. Cardiovascular medicines, including loop diuretics, tended to be more frequently prescribed for socioeconomically disadvantaged people (<25(th) centile Index of Multiple Deprivation (IMD)), despite no difference in the prevalence of cardiovascular disease (p = 0.56) and diabetes (p = 0.92) by IMD. Conclusion Considering their complex medical conditions, prescribing is relatively conservative amongst 85-year-olds living in North East England. Prescribing shows significant gender and selected socioeconomic differences. More support for managing preventative medicines, of uncertain benefit, might be helpful in this population.	[Davies, Laurie E.; Kingston, Andrew; Hanratty, Barbara] Newcastle Univ, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Todd, Adam] Newcastle Univ, Sch Pharm, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Davies, LE (corresponding author), Newcastle Univ, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England.	L.E.Davies2@newcastle.ac.uk		Todd, Adam/0000-0003-1496-9341; Davies, Laurie/0000-0003-4931-3270; Kingston, Andrew/0000-0003-4211-7007; Hanratty, Barbara/0000-0002-3122-7190	National Institute for Health Research School for Primary Care Research (NIHR SPCR) [SPCR-2014-10043]; Medical Research Council; Dunhill Medical Trust; National Institute for Health Research School for Primary Care Research; British Heart Foundation; Unilever Corporate Research; Newcastle University; NHS North of Tyne (Newcastle Primary Care Trust); Biotechnology and Biological Sciences Research Council; MRC [MR/J50001X/1, G0500997] Funding Source: UKRI	National Institute for Health Research School for Primary Care Research (NIHR SPCR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dunhill Medical Trust(Dunhill Medical Trust); National Institute for Health Research School for Primary Care Research; British Heart Foundation(British Heart Foundation); Unilever Corporate Research(Unilever); Newcastle University; NHS North of Tyne (Newcastle Primary Care Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This paper presents independent research funded by the National Institute for Health Research School for Primary Care Research (NIHR SPCR) [SPCR-2014-10043]. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. The Newcastle 85+ Study has been funded by the Medical Research Council, Biotechnology and Biological Sciences Research Council, the Dunhill Medical Trust and the National Institute for Health Research School for Primary Care Research. Parts of the work have also been funded by the British Heart Foundation, Unilever Corporate Research, Newcastle University, NHS North of Tyne (Newcastle Primary Care Trust). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBER N, 1995, BRIT MED J, V310, P923, DOI 10.1136/bmj.310.6984.923; Beijer HJM, 2002, PHARM WORLD SCI, V24, P46, DOI 10.1023/A:1015570104121; Bjerrum L, 1997, EUR J CLIN PHARMACOL, V53, P7, DOI 10.1007/s002280050329; Brannstrom J, 2011, DRUG AGING, V28, P993, DOI 10.2165/11594730-000000000-00000; *BRIT MED ASS, 2009, BRIT NAT FORM; Brittain K, 2017, AGEING SOC, V37, P39, DOI 10.1017/S0144686X15001142; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Cohen A, 2006, ARCH GEN PSYCHIAT, V63, P50, DOI 10.1001/archpsyc.63.1.50; Collerton Joanna, 2007, BMC Geriatr, V7, P14, DOI 10.1186/1471-2318-7-14; Collerton J, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8745670; Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; Conway JR, 2017, BIOINFORMATICS, V33, P2938, DOI 10.1093/bioinformatics/btx364; Dahlgren G, 1991, POLICIES STRATEGIES; Davies K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108370; Davies K, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-64; Davies LE, 2020, J AM MED DIR ASSOC, V21, P181, DOI 10.1016/j.jamda.2019.10.022; Department of Health and Social Security England, 1980, IN HLTH REP RES WORK; Duncan R, 2011, AGE AGEING, V40, P752, DOI 10.1093/ageing/afr105; Eachus J, 1999, J EPIDEMIOL COMMUN H, V53, P603, DOI 10.1136/jech.53.10.603; Gandhi M, 2004, ANNU REV PHARMACOL, V44, P499, DOI [10.1146/annurev.pharmtox.44.101802.121453, 10.2165/00003088-200948030-00001]; Giron MST, 1999, CLIN DRUG INVEST, V17, P389; Gnjidic D, 2012, CLIN PHARMACOL THER, V91, P521, DOI 10.1038/clpt.2011.258; GRIFFIN JP, 1993, J ROY COLL PHYS LOND, V27, P121; Guthrie B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0322-7; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hofer-Duckelmann Christina, 2012, Handb Exp Pharmacol, P169, DOI 10.1007/978-3-642-30726-3_9; Holmes HM, 2006, ARCH INTERN MED, V166, P605, DOI 10.1001/archinte.166.6.605; Holmes HM, 2013, DRUG AGING, V30, P655, DOI 10.1007/s40266-013-0095-7; Hovstadius Bo, 2010, BMC Clin Pharmacol, V10, P16, DOI 10.1186/1472-6904-10-16; Hughes LD, 2013, AGE AGEING, V42, P62, DOI 10.1093/ageing/afs100; Ilango S, 2017, INTERN MED J, V47, P1019, DOI 10.1111/imj.13526; Johnell K, 2018, EXPERT REV CLIN PHAR, V11, P825, DOI 10.1080/17512433.2018.1510313; Jorgensen T, 2001, ANN PHARMACOTHER, V35, P1004, DOI 10.1345/aph.10351; Jyrkka J, 2009, DRUG AGING, V26, P493, DOI 10.2165/00002512-200926060-00006; Kalache A, 1997, WORLD HEALTH, V50, P4, DOI DOI 10.1007/S10534-014-9784-X; Kerse N, 2015, INT J EPIDEMIOL, V44, P1823, DOI 10.1093/ije/dyv103; Kingston A, 2015, ARCH GERONTOL GERIAT, V60, P405, DOI 10.1016/j.archger.2015.02.006; Kingston A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088016; Kingston A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031665; Lagerin A, 2017, SCAND J PUBLIC HLTH; Linjakumpu T, 2002, J CLIN EPIDEMIOL, V55, P809, DOI 10.1016/S0895-4356(02)00411-0; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Mangin D, 2007, BMJ-BRIT MED J, V335, P285, DOI 10.1136/bmj.39241.630741.BE1; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Martin-Ruiz C, 2011, MECH AGEING DEV, V132, P496, DOI 10.1016/j.mad.2011.08.001; McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4; Morin L, 2017, AM J MED, V130, P927, DOI [10.1016/amjmed.2017.02.028, 10.1016/j.amjmed.2017.02.028]; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; National Institute for Health and Care Excellence, 2010, CLOP MOD REL REL DIP; Nobili A, 2011, PHARMACOEPIDEM DR S, V20, P488, DOI 10.1002/pds.2108; O'Rand AM, 2002, CUMULATIVE ADVANTAGE; Office for National Statistics, 2018, LIV LONG OUR POP CHA; Oksuzyan A, 2008, AGING CLIN EXP RES, V20, P91; Onder G, 2016, J AM MED DIR ASSOC, V17, P168, DOI 10.1016/j.jamda.2015.08.009; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Rawle MJ, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0795-2; Royal College of Physicians, 2016, NAT CLIN GUID STROK; Royal College of Physicians, 2014, WHY ASTHM STILL KILL; Teh R, 2014, NEW ZEAL MED J, V127; Teh RO, 2018, AGE AGEING, V47, P261, DOI 10.1093/ageing/afx184; Tsoi Christopher S, 2014, BMC Res Notes, V7, P340, DOI 10.1186/1756-0500-7-340; van Kraaij DJW, 1998, BRIT J CLIN PHARMACO, V46, P403, DOI 10.1046/j.1365-2125.1998.00793.x; VERBRUGGE LM, 1985, J HEALTH SOC BEHAV, V26, P156, DOI 10.2307/2136750; Wagert PV, 2006, AGING CLIN EXP RES, V18, P116; Wastesson JW, 2017, PHARMACOEPIDEM DR S, V26, P152, DOI 10.1002/pds.4120; Wastesson JW, 2012, AGE AGEING, V41, P218, DOI 10.1093/ageing/afr144; WINGARD DL, 1984, ANNU REV PUBL HEALTH, V5, P433, DOI 10.1146/annurev.pu.05.050184.002245; Woodward MC., 2003, J PHARM PRACT RES, V33, P323, DOI [10.1002/jppr2003334323, DOI 10.1002/JPPR2003334323]; World Health Organization, 2010, SOCIAL DETERMINANTS, DOI DOI 10.13016/17CR-AQB9; Yadegarfar ME, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019218	70	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245648	10.1371/journal.pone.0245648	http://dx.doi.org/10.1371/journal.pone.0245648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PY3TH	33465141	Green Published, gold			2022-12-26	WOS:000611969200038
J	Matzek, V; Wilson, KA				Matzek, Virginia; Wilson, Kerrie A.			Public support for restoration: Does including ecosystem services as a goal engage a different set of values and attitudes than biodiversity protection alone?	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; ECOLOGICAL RESTORATION; ENVIRONMENTAL CONCERN; VALUE ORIENTATIONS; TRADE-OFFS; MANAGEMENT; PREFERENCES; DISSERVICES; VALUATION; CONSEQUENCES	The ecosystem services concept has come into wide use in conservation and natural resource management, partly due to its appeal as an anthropocentric rationale for protecting and restoring nature. Proponents of the ecosystem services concept expect that presenting these arguments alongside biodiversity arguments should lead to a broader base of support for conservation. This raises the question of whether support for activities that ensure ecosystem service provision relates to different sets of core values, or environmental attitudes, than support for biodiversity protection. We surveyed adult Australians to evaluate the influence of values and attitudes on willingness to pay for different habitat restoration outcomes. We hypothesized that when restoration is framed with an anthropocentric rationale (such as ecosystem service provision), support for restoration would align more strongly with anthropocentric or self-centered values and attitudes. Specifically, we tested if preference for ecosystem service benefits over biodiversity attributes, as indicated by willingness to pay in different restoration scenarios, is more strongly associated with self-enhancing (Egoistic) than self-transcending (Altruistic and Biospheric) values, and more associated with a pro-use attitude towards nature (Utilization) than an anti-use attitude (Preservation). We found that support for habitat restoration is generally based on ecocentric values and attitudes, but that positive associations between pro-environmental behavior and Egoistic values emerge when emphasis is placed on ecosystem service outcomes. Individuals scoring higher on Egoistic/Utilization metrics were also more likely to anticipate disservices from restoration. Attitudes predicted behavioral intention (willingness to pay) better than core values. Our results support the notion that the ecosystem services concept garners nontraditional backers and broadens the appeal of ecological restoration.	[Matzek, Virginia] Santa Clara Univ, Dept Environm Studies & Sci, Santa Clara, CA 95053 USA; [Wilson, Kerrie A.] Queensland Univ Technol, Brisbane, Qld, Australia	Santa Clara University; Queensland University of Technology (QUT)	Matzek, V (corresponding author), Santa Clara Univ, Dept Environm Studies & Sci, Santa Clara, CA 95053 USA.	vmatzek@scu.edu			US National Science Foundation [IIA-1427595]; Australian Research Council Future Fellowship	US National Science Foundation(National Science Foundation (NSF)); Australian Research Council Future Fellowship(Australian Research Council)	The US National Science Foundation awarded grant IIA-1427595 to VM. https://www.nsf.gov KW worked under the auspices of an Australian Research Council Future Fellowship during the period of this research. https://www.arc.gov.au/grants/discovery-program/futurefellowships The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame MF, 2015, CONSERV BIOL, V29, P493, DOI 10.1111/cobi.12391; Allan JD, 2015, FRONT ECOL ENVIRON, V13, P418, DOI 10.1890/140328; [Anonymous], 2014, J ORTHOP RES S1, V32, pS158; Armsworth PR, 2007, CONSERV BIOL, V21, P1383, DOI 10.1111/j.1523-1739.2007.00821.x; Becerra TA, 2013, RANGELAND ECOL MANAG, V66, P529, DOI 10.2111/REM-D-12-00174.1; Bengston DN, 1999, ENVIRON BEHAV, V31, P514, DOI 10.1177/00139169921972218; Blignaut J, 2014, ECOL ENG, V65, P54, DOI 10.1016/j.ecoleng.2013.09.003; Bolderdijk JW, 2013, NAT CLIM CHANGE, V3, P413, DOI [10.1038/NCLIMATE1767, 10.1038/nclimate1767]; Borrie WT, 2002, HUMAN ECOLOGY REV, P41; Brancalion PHS, 2014, RESTOR ECOL, V22, P65, DOI 10.1111/rec.12025; Bright AD, 2000, WILDLIFE SOC B, V28, P218; BROWN TC, 1984, LAND ECON, V60, P231, DOI 10.2307/3146184; Buckley MC, 2008, CONSERV BIOL, V22, P1118, DOI 10.1111/j.1523-1739.2008.01027.x; Buijs AE, 2009, J ENVIRON MANAGE, V90, P2680, DOI 10.1016/j.jenvman.2009.02.006; Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011; Clewell AF, 2006, CONSERV BIOL, V20, P420, DOI 10.1111/j.1523-1739.2006.00340.x; Dallimer M, 2015, BIOSCIENCE, V65, P33, DOI 10.1093/biosci/biu187; Dallimer M, 2014, CONSERV BIOL, V28, P404, DOI 10.1111/cobi.12215; de Groot JIM, 2007, J CROSS CULT PSYCHOL, V38, P318, DOI 10.1177/0022022107300278; Diekmann A, 2003, RATION SOC, V15, P441, DOI 10.1177/1043463103154002; Dietz T, 2005, ANNU REV ENV RESOUR, V30, P335, DOI 10.1146/annurev.energy.30.050504.144444; Fu BJ, 2011, ECOL COMPLEX, V8, P284, DOI 10.1016/j.ecocom.2011.07.003; Fulton D.C., 1996, HUMAN DIMENSIONS WIL, V1, P24, DOI DOI 10.1080/10871209609359060; Funk JL, 2014, BIOSCIENCE, V64, P58, DOI 10.1093/biosci/bit004; Goldman RL, 2008, P NATL ACAD SCI USA, V105, P9445, DOI 10.1073/pnas.0800208105; Hansla A, 2008, J ENVIRON PSYCHOL, V28, P1, DOI 10.1016/j.jenvp.2007.08.004; Hein L, 2006, ECOL ECON, V57, P209, DOI 10.1016/j.ecolecon.2005.04.005; Hicks CC, 2015, CONSERV BIOL, V29, P1471, DOI 10.1111/cobi.12550; HOMER PM, 1988, J PERS SOC PSYCHOL, V54, P638, DOI 10.1037/0022-3514.54.4.638; Howley P, 2011, ECOL ECON, V72, P161, DOI 10.1016/j.ecolecon.2011.09.026; Hurst M, 2013, J ENVIRON PSYCHOL, V36, P257, DOI 10.1016/j.jenvp.2013.09.003; Ives CD, 2014, J ENVIRON MANAGE, V144, P67, DOI 10.1016/j.jenvman.2014.05.013; Johansson M, 2011, SOC NATUR RESOUR, V24, P717, DOI 10.1080/08941920903530925; Kaltenborn BP, 2002, LANDSCAPE URBAN PLAN, V59, P1, DOI 10.1016/S0169-2046(01)00243-2; Klockner CA, 2013, GLOBAL ENVIRON CHANG, V23, P1028, DOI 10.1016/j.gloenvcha.2013.05.014; Lapointe M, 2019, BIOSCIENCE, V69, P108, DOI 10.1093/biosci/biy151; Larson KL, 2019, ECOL SOC, V24, DOI 10.5751/ES-10888-240207; Layden PC, 2003, WILDLIFE SOC B, V31, P174; Limburg KE, 2010, J GREAT LAKES RES, V36, P86, DOI 10.1016/j.jglr.2009.11.007; Lopez-Santiago CA, 2014, ECOL SOC, V19, DOI 10.5751/ES-06401-190227; Lyytimaki J, 2009, URBAN FOR URBAN GREE, V8, P309, DOI 10.1016/j.ufug.2009.09.003; Martin A, 2008, PAYING ENV SERVICES; Martin-Lopez B, 2014, ECOL INDIC, V37, P220, DOI 10.1016/j.ecolind.2013.03.003; Milfont TL, 2013, PERS SOC PSYCHOL B, V39, P1127, DOI 10.1177/0146167213490805; Milfont TL, 2010, J ENVIRON PSYCHOL, V30, P80, DOI 10.1016/j.jenvp.2009.09.001; Narloch U, 2012, WORLD DEV, V40, P2096, DOI 10.1016/j.worlddev.2012.03.014; Nassauer JI, 2004, WETLANDS, V24, P756, DOI 10.1672/0277-5212(2004)024[0756:MTSOMW]2.0.CO;2; Nielsen-Pincus M, 2010, EC EMPLOYMENT IMPACT; Nordlund A, 2011, FORESTS, V2, P30, DOI 10.3390/f2010030; Nunnally J., 1978, PSYCHOMETRIC THEORY; Ojea E, 2007, ECOL ECON, V63, P807, DOI 10.1016/j.ecolecon.2007.02.003; Olivero-Lora S, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12010117; Pastorella F, 2017, J FOREST RES-JPN, V22, P36, DOI 10.1080/13416979.2017.1279708; Pate J, 1997, ECOL ECON, V20, P199, DOI 10.1016/S0921-8009(96)00080-8; R Core Team, 2021, R LANGUAGE ENV STAT; Raymond CM, 2016, ECOSYST SERV, V21, P241, DOI 10.1016/j.ecoser.2016.07.018; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Reyers B, 2012, BIOSCIENCE, V62, P503, DOI 10.1525/bio.2012.62.5.12; Rode J, 2015, ECOL ECON, V117, P270, DOI 10.1016/j.ecolecon.2014.11.019; Rowe RD, 1996, J ENVIRON ECON MANAG, V31, P178, DOI 10.1006/jeem.1996.0039; Sagie H, 2013, J ARID ENVIRON, V97, P38, DOI 10.1016/j.jaridenv.2013.05.007; Schroter M, 2014, CONSERV LETT, V7, P514, DOI 10.1111/conl.12091; Schultz PW, 2005, J CROSS CULT PSYCHOL, V36, P457, DOI 10.1177/0022022105275962; Schultz PW, 2001, J ENVIRON PSYCHOL, V21, P327; Seymour E, 2010, AUSTRALAS J ENV MAN, V17, P142, DOI 10.1080/14486563.2010.9725261; Shackleton CM, 2016, ECOSYSTEMS, V19, P587, DOI 10.1007/s10021-015-9952-z; Shin YH, 2017, J HOSP TOUR MANAG, V33, P113, DOI 10.1016/j.jhtm.2017.10.010; Skroch M, 2010, CONSERV BIOL, V24, P325, DOI 10.1111/j.1523-1739.2009.01416.x; Spash CL, 2009, ECOL ECON, V68, P955, DOI 10.1016/j.ecolecon.2006.09.013; Stern P. C., 1999, HUMAN ECOLOGY REVIEW, V6, P81, DOI DOI 10.2307/2083693; Stern PC, 2000, J SOC ISSUES, V56, P407, DOI 10.1111/0022-4537.00175; STERN PC, 1994, J SOC ISSUES, V50, P65, DOI 10.1111/j.1540-4560.1994.tb02420.x; STOKOLS D, 1990, AM PSYCHOL, V45, P641, DOI 10.1037/0003-066X.45.5.641; SUTHERLAND RJ, 1985, LAND ECON, V61, P281, DOI 10.2307/3145843; Trainor SF, 2006, ENVIRON VALUE, V15, P3, DOI 10.3197/096327106776678951; Treves A, 2013, CONSERV BIOL, V27, P315, DOI 10.1111/cobi.12009; van Riper CJ, 2017, ECOL INDIC, V72, P278, DOI 10.1016/j.ecolind.2016.07.029; Van Riper CJ, 2014, J ENVIRON MANAGE, V145, P374, DOI 10.1016/j.jenvman.2014.06.014; Vatn A, 2010, ECOL ECON, V69, P1245, DOI 10.1016/j.ecolecon.2009.11.018; Venkatachalam L, 2004, ENVIRON IMPACT ASSES, V24, P89, DOI 10.1016/S0195-9255(03)00138-0; Vining Joanne, 2000, P143; von Dohren P, 2015, ECOL INDIC, V52, P490, DOI 10.1016/j.ecolind.2014.12.027; Willott E, 2004, RESTOR ECOL, V12, P147, DOI 10.1111/j.1061-2971.2004.00392.x	83	7	8	9	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245074	10.1371/journal.pone.0245074	http://dx.doi.org/10.1371/journal.pone.0245074			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PY3TH	33465097	Green Published, gold			2022-12-26	WOS:000611969200056
J	Yan, XX; Han, XT; Wu, CF; Shang, XW; Zhang, L; He, MG				Yan, Xixi; Han, Xiaotong; Wu, Changfan; Shang, Xianwen; Zhang, Lei; He, Mingguang			Effect of physical activity on reducing the risk of diabetic retinopathy progression: 10-year prospective findings from the 45 and Up Study	PLOS ONE			English	Article							BODY-MASS INDEX; PARTICIPANTS; ASSOCIATION; INACTIVITY; EXERCISE; OBESITY; DISEASE; ADULTS	Objective To examine the association of physical activities (PA) with diabetic retinopathy (DR) progression based on a 10-year follow-up of a large cohort of working-aged diabetic populations in Australia. Methods Nine thousand and eighteen working-aged diabetic patients were enrolled from the baseline of the 45 and Up Study from New South Wales, Australia. Self-reported PA collected by questionnaire at baseline in 2006 was graded into low (<5 sessions/week), medium (>= 5-14), and high (>= 14) levels. Retinal photocoagulation (RPC) treatment during the follow-up period was used as a surrogate for DR progression and was tracked through the Medicare Benefits Schedule, which was available from 2004 to 2016. Cox regression was used to estimate the association between PA and RPC incidence. Results In the fully adjusted model, higher PA level was significantly associated with a lower risk of RPC incident (Cox-regression, p-value for trend = 0.002; medium vs. low, hazard ratio (HR) = 0.78, 95% Confidence Interval (CI): 0.61-0.98; high vs. low, HR = 0.61, 95%CI: 0.36-0.84. In addition, gender, body mass index, insulin treatment, family history of diabetes, history of cardiovascular disease were significant effect modifiers for the association between PA and RPC. Conclusions Higher PA level was independently associated with a lower risk of DR progression among working-aged diabetic populations in this large cohort study.	[Yan, Xixi] Wuhan Univ, Renmin Hosp, Eye Ctr, Eye Inst, Wuhan, Peoples R China; [Yan, Xixi; Han, Xiaotong; Wu, Changfan; Shang, Xianwen; Zhang, Lei; He, Mingguang] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Dept Surg, Ctr Eye Res Australia,Ophthalmol, Melbourne, Vic, Australia; [Han, Xiaotong; He, Mingguang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Peoples R China; [Wu, Changfan] Wannan Med Coll, Dept Ophthalmol, Yijishan Hosp, Wuhu, Peoples R China; [Zhang, Lei] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Zhang, Lei] Monash Univ, Cent Clin Sch, Fac Med, Melbourne, Vic, Australia; [Zhang, Lei] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian, Shaanxi, Peoples R China	Wuhan University; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Sun Yat Sen University; Wannan Medical College; Monash University; Xi'an Jiaotong University	Zhang, L; He, MG (corresponding author), Univ Melbourne, Royal Victorian Eye & Ear Hosp, Dept Surg, Ctr Eye Res Australia,Ophthalmol, Melbourne, Vic, Australia.; He, MG (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Peoples R China.; Zhang, L (corresponding author), Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.; Zhang, L (corresponding author), Monash Univ, Cent Clin Sch, Fac Med, Melbourne, Vic, Australia.; Zhang, L (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian, Shaanxi, Peoples R China.	lei.zhang1@monash.edu; mingguang.he@unimelb.edu.au	Zhang, Lei/D-4039-2011	Zhang, Lei/0000-0003-2343-084X; He, Mingguang/0000-0002-6912-2810; Shang, Xianwen/0000-0001-6143-9349	University of Melbourne at Research Accelerator Program; CERA Foundation; Victorian State Government; Australia China Research Accelerator Program at CERA; Fundamental Research Funds of the State Key Laboratory in Ophthalmology, National Natural Science Foundation of China [81420108008]	University of Melbourne at Research Accelerator Program; CERA Foundation; Victorian State Government; Australia China Research Accelerator Program at CERA; Fundamental Research Funds of the State Key Laboratory in Ophthalmology, National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Professor Mingguang He receives support from the University of Melbourne at Research Accelerator Program and the CERA Foundation. The Centre for Eye Research Australia (CERA) receives Operational Infrastructure Support from the Victorian State Government. The specific project is funded by Australia China Research Accelerator Program at CERA. Professor Mingguang He is also supported by the Fundamental Research Funds of the State Key Laboratory in Ophthalmology, National Natural Science Foundation of China (81420108008). The sponsor or funding organization had no role in the design or conduct of this research.	Australian Institute of Health and Welfare, 2019, INS PHYS ACT; Australian Institute of Health and Wellfare (AIHW), 2003, ACT AUSTR SURV GUID; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Banks E, 2011, PUBLIC HEALTH NUTR, V14, P34, DOI 10.1017/S1368980010000674; Brown WJ, 2004, J SCI MED SPORT, V7, P205, DOI 10.1016/S1440-2440(04)80010-0; Chimen M, 2012, DIABETOLOGIA, V55, P542, DOI 10.1007/s00125-011-2403-2; Chudyk A, 2011, DIABETES CARE, V34, P1228, DOI 10.2337/dc10-1881; Ciolac EG, 2010, HYPERTENS RES, V33, P836, DOI 10.1038/hr.2010.72; Colberg SR, 2016, DIABETES CARE, V39, P2065, DOI 10.2337/dc16-1728; Comino EJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-481; CRUICKSHANKS KJ, 1992, DIABETES CARE, V15, P1267, DOI 10.2337/diacare.15.10.1267; CRUICKSHANKS KJ, 1995, OPHTHALMOLOGY, V102, P1177, DOI 10.1016/S0161-6420(95)30893-7; Dirani M, 2014, CLIN EXP OPHTHALMOL, V42, P574, DOI 10.1111/ceo.12306; Elosua R, 2003, ATHEROSCLEROSIS, V167, P327, DOI 10.1016/S0021-9150(03)00018-2; Heesch KC, 2011, J SCI MED SPORT, V14, P233, DOI 10.1016/j.jsams.2010.11.004; Hemmingsson E, 2007, INT J OBESITY, V31, P663, DOI 10.1038/sj.ijo.0803458; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Janevic MR, 2013, CHRONIC ILLN, V9, P251, DOI 10.1177/1742395313475461; Kuwata H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172890; LAPORTE RE, 1986, PEDIATRICS, V78, P1027; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee R, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0026-2; Ng SP, 2011, AUST NZ J PUBL HEAL, V35, P557, DOI 10.1111/j.1753-6405.2011.00742.x; Praidou A, 2017, J DIABETES COMPLICAT, V31, P456, DOI 10.1016/j.jdiacomp.2016.06.027; Riley L, 2016, AM J PUBLIC HEALTH, V106, P74, DOI 10.2105/AJPH.2015.302962; Sabanayagam C, 2019, LANCET DIABETES ENDO, V7, P140, DOI 10.1016/S2213-8587(18)30128-1; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Stitt AW, 2016, PROG RETIN EYE RES, V51, P156, DOI 10.1016/j.preteyeres.2015.08.001; Tarr Joanna M, 2013, ISRN Ophthalmol, V2013, P343560, DOI 10.1155/2013/343560; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Xu F, 2012, DIABETIC MED, V29, P593, DOI 10.1111/j.1464-5491.2011.03495.x; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	32	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0239214	10.1371/journal.pone.0239214	http://dx.doi.org/10.1371/journal.pone.0239214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444338	Green Published, gold			2022-12-26	WOS:000609988100024
J	Zhu, FD; Chen, Y; Yu, YX; Xie, YY; Zhu, HH; Wang, HM				Zhu, Fudong; Chen, Yao; Yu, Yunxian; Xie, Yanyi; Zhu, Haihua; Wang, Huiming			Caries prevalence of the first permanent molars in 6-8 years old children	PLOS ONE			English	Article							ORAL-HEALTH KNOWLEDGE; ATTITUDES; BEHAVIOR	Dental caries is one of the most common infectious diseases affecting 6-8-year-old children, especially their first permanent molars (FPMs). This study explored the prevalence of dental caries on FPMs by analyzing the oral health status of 1,423,720 children aged 6-8 years in Zhejiang Province, China. The data were extracted from the dental electronic records of the schoolchildren attending the Oral Health Promotion Project (OHPP), conducted during 2013-2017 in Zhejiang Province. Multiple logistic regression models were used to determine the factors affecting dental caries. Boys and girls accounted for 53.2% and 46.8% of the subjects, respectively. From 2013 to 2017, the prevalence of dental caries on FPMs increased: 2013: 20.4%; 2014: 25.3%; 2015: 24.5%; 2016: 27.0%; and 2017: 29.0%, despite the OHPP conducted. Based on multiple logistic regression model, girls had a significantly higher risk of FPM caries compared to boys (OR = 1.38, 95% CI: 1.37-1.39, p < 0.0001); compared with the caries rates in urban areas, the caries risk was significantly higher in rural areas (OR = 1.15, 95% CI: 1.14-1.16, p < 0.0001). In terms of geographic location in Zhejiang Province, the odds ratios of the caries risk of the east, south, west, and north were 1.35 (1.33-1.36), 1.3 (1.28-1.31), 0.81 (0.8-0.83), and 0.82 (0.81-0.84), respectively (p < 0.0001), by considering the central region as a reference. The caries prevalence of FPMs was high, with an increasing tendency and gender, social, cultural, and environmental factors affecting the caries prevalence.	[Zhu, Fudong; Chen, Yao; Xie, Yanyi; Zhu, Haihua; Wang, Huiming] Zhejiang Univ, Sch Stomatol, Affiliated Hosp Stomatol, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Zhu, Fudong; Chen, Yao; Xie, Yanyi; Zhu, Haihua; Wang, Huiming] Key Lab Oral Biomed Res Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Yu, Yunxian] Zhejiang Univ, Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhu, HH; Wang, HM (corresponding author), Zhejiang Univ, Sch Stomatol, Affiliated Hosp Stomatol, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Zhu, HH; Wang, HM (corresponding author), Key Lab Oral Biomed Res Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China.	zhuhh403@zju.edu.cn; whmwhm@zju.edu.cn	wang, hui/GRS-4730-2022; wang, huimin/HDM-8421-2022	ZHU, Haihua/0000-0003-4735-8459	Health Commission of Zhejiang Province	Health Commission of Zhejiang Province	This project was sponsored by the Health Commission of Zhejiang Province, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADA Division of Communications, 2006, J Am Dent Assoc, V137, P127; [Anonymous], 2009, LANCET, V373, P1, DOI 10.1016/S0140-6736(08)61933-9; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; BECK D. J., 1966, N Z DENT J, V62, P279; Du MQ, 2007, QUINTESSENCE INT, V38, P143; Jain Mitali, 2015, J Dent Res Dent Clin Dent Prospects, V9, P115, DOI 10.15171/joddd.2014.023; Kwon Ho-Kwen, 1997, Yonsei Medical Journal, V38, P101; Lu HX, 2018, CHIN J DENT RES, V21, P161, DOI 10.3290/j.cjdr.a41079; Lukacs JR, 2011, CLIN ORAL INVEST, V15, P649, DOI 10.1007/s00784-010-0445-3; Mattila ML, 2000, J DENT RES, V79, P875, DOI 10.1177/00220345000790031501; Nazir MA, 2019, J CLIN DIAGN RES, V13, pZC36, DOI 10.7860/JCDR/2019/38167.12509; Noronha J C, 1999, Braz Dent J, V10, P99; Ou R, 2001, J PREVENTION TREATME, V9, P248; Popkin BM, 2014, OBES REV, V15, P60, DOI 10.1111/obr.12120; Satcher D, 2017, AM J PUBLIC HEALTH, V107, pS32, DOI 10.2105/AJPH.2017.303687; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Shu L, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0303-0; Sun XY, 2018, CHIN J DENT RES, V21, P285, DOI 10.3290/j.cjdr.a41087; Thomson WM, 2004, COMMUNITY DENT ORAL, V32, P345, DOI 10.1111/j.1600-0528.2004.00173.x; Wang H, 2019, J MANUF SCI E-T ASME, V141, DOI 10.1115/1.4043308; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th; Zhen SH, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0372-8; Zhu L, 2005, INT DENT J, V55, P231, DOI 10.1111/j.1875-595X.2005.tb00321.x; Zhu L, 2003, INT DENT J, V53, P289, DOI 10.1111/j.1875-595X.2003.tb00762.x; Ziller S, 2006, INT DENT J, V56, P29	25	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0245345	10.1371/journal.pone.0245345	http://dx.doi.org/10.1371/journal.pone.0245345			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439883	Green Published, gold			2022-12-26	WOS:000609985300030
J	Xiao, YN; Jin, L; Deng, CL; Guan, Y; Kalogera, E; Ray, U; Thirusangu, P; Staub, J; Bhattacharya, SS; Xu, HT; Fang, XL; Shridhar, V				Xiao, Yinan; Jin, Ling; Deng, Chaolin; Guan, Ye; Kalogera, Eleftheria; Ray, Upasana; Thirusangu, Prabhu; Staub, Julie; Bhattacharya, Sayantani Sarkar; Xu, Haotian; Fang, Xiaoling; Shridhar, Viji			Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer	ONCOGENE			English	Article							PHASE-II; THERAPEUTIC TARGET; OVARIAN-CANCER; TUMOR-GROWTH; AUTOPHAGY; GLYCOLYSIS; COMBINATION; METASTASIS; EXPRESSION; INDUCTION	The advanced or recurrent endometrial cancer (EC) has a poor prognosis because of chemoresistance. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3), a glycolytic enzyme, is overexpressed in a variety of human cancers and plays important roles in promoting tumor cell growth. Here, we showed that high expression of PFKFB3 in EC cell lines is associated with chemoresistance. Pharmacological inhibition of PFKFB3 with PFK158 and or genetic downregulation of PFKFB3 dramatically suppressed cell proliferation and enhanced the sensitivity of EC cells to carboplatin (CBPt) and cisplatin (Cis). Moreover, PFKFB3 inhibition resulted in reduced glucose uptake, ATP production, and lactate release. Notably, we found that PFK158 with CBPt or Cis exerted strong synergistic antitumor activity in chemoresistant EC cell lines, HEC-1B and ARK-2 cells. We also found that the combination of PFK158 and CBPt/Cis induced apoptosis- and autophagy-mediated cell death through inhibition of the Akt/mTOR signaling pathway. Mechanistically, we found that PFK158 downregulated the CBPt/Cis-induced upregulation of RAD51 expression and enhanced CBPt/Cis-induced DNA damage as demonstrated by an increase in gamma-H2AX levels in HEC-1B and ARK-2 cells, potentially revealing a means to enhance PFK158-induced chemosensitivity. More importantly, PFK158 treatment, either as monotherapy or in combination with CBPt, led to a marked reduction in tumor growth in two chemoresistant EC mouse xenograft models. These data suggest that PFKFB3 inhibition alone or in combination with standard chemotherapy may be used as a novel therapeutic strategy for improved therapeutic efficacy and outcomes of advanced and recurrent EC patients.	[Xiao, Yinan; Jin, Ling; Ray, Upasana; Thirusangu, Prabhu; Staub, Julie; Bhattacharya, Sayantani Sarkar; Shridhar, Viji] Mayo Clin, Dept Expt Pathol, Rochester, MN 55905 USA; [Xiao, Yinan; Fang, Xiaoling] Cent South Univ, Xiangya Hosp 2, Dept Obstet & Gynecol, Changsha, Hunan, Peoples R China; [Deng, Chaolin] Mayo Clin, Dept Gastroenterol & Hepatol, Rochester, MN USA; [Guan, Ye] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Kalogera, Eleftheria] Mayo Clin, Div Gynecol Oncol, Rochester, MN USA; [Xu, Haotian] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA	Mayo Clinic; Central South University; Mayo Clinic; University of Michigan System; University of Michigan; Mayo Clinic; Wayne State University	Shridhar, V (corresponding author), Mayo Clin, Dept Expt Pathol, Rochester, MN 55905 USA.	shridhar.vijayalakshmi@mayo.edu	Sarkar Bhattacharya, Sayantani/AAG-6222-2020	Sarkar Bhattacharya, Sayantani/0000-0001-8971-7566; Xiao, Yinan/0000-0003-3873-9444; Ray, Upasana/0000-0002-9804-6888	National Institutes of Health [P50CA136393]; Department of Experimental Pathology and Laboratory Medicine; Mayo Clinic; China Scholarship Council (CSC)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Experimental Pathology and Laboratory Medicine; Mayo Clinic; China Scholarship Council (CSC)(China Scholarship Council)	We would like to thank Dr. Gottfried E. Konecny (UCLA Medical Center, Santa Monica), who provided the EC cell lines used in this study; Dr. Daniel Billadeau (Mayo Clinic, Rochester, MN) for providing the RFP-GFP-LC3B plasmid; Dr. Scott Kaufmann (Mayo Clinic, Rochester, MN) for providing the DR-GFP and I-SceI plasmids; the contributions of the Pathology Research Core laboratory, the Microscopy Core laboratory, and the Flow Cytometry Facility, Mayo Clinic, Rochester, MN. This work is supported in part by the National Institutes of Health P50CA136393 and the Department of Experimental Pathology and Laboratory Medicine and the Mayo Clinic (VS). The support provided by China Scholarship Council (CSC) during a visit of YX to Mayo Clinic is acknowledged.	Arend RC, 2018, GYNECOL ONCOL, V150, P569, DOI 10.1016/j.ygyno.2018.05.015; Atsumi T, 2002, CANCER RES, V62, P5881; Bhattacharya SS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1916-3; Bobarykina AY, 2006, ACTA BIOCHIM POL, V53, P789, DOI 10.18388/abp.2006_3308; Cantelmo AR, 2016, CANCER CELL, V30, P968, DOI 10.1016/j.ccell.2016.10.006; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Clem BF, 2013, MOL CANCER THER, V12, P1461, DOI 10.1158/1535-7163.MCT-13-0097; Cortez MA, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.47; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Emons G, 2016, GYNECOL ONCOL, V140, P450, DOI 10.1016/j.ygyno.2015.12.025; Farkas T, 2009, AUTOPHAGY, V5, P1018, DOI 10.4161/auto.5.7.9443; Galluzzi L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.428; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Guan Y, 2018, ELIFE, V7, DOI 10.7554/eLife.33549; Gustafsson NMS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06287-x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ngo H, 2015, MOL BIOL REP, V42, P825, DOI 10.1007/s11033-014-3764-7; Hong KJ, 2015, AM J CANCER RES, V5, P2422; Huang Z, 2016, INT J CANCER, V139, P23, DOI 10.1002/ijc.29990; Ji MM, 2015, AUTOPHAGY, V11, P2160, DOI 10.1080/15548627.2015.1082024; Jia WZ, 2018, ONCOGENE, V37, P1685, DOI 10.1038/s41388-017-0072-4; Jones NL, 2017, INT J CANCER, V140, P1396, DOI 10.1002/ijc.30537; Jung DB, 2015, ONCOTARGET, V6, P4992, DOI 10.18632/oncotarget.3214; Kessler R, 2008, J NEURO-ONCOL, V86, P257, DOI 10.1007/s11060-007-9471-7; Khurana A, 2015, ONCOTARGET, V6, P36354, DOI 10.18632/oncotarget.5632; Kim YC, 2015, J CLIN INVEST, V125, P25, DOI 10.1172/JCI73939; Li HM, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-016-0481-1; Liu Y, 2020, ONCOGENE, V39, P6190, DOI 10.1038/s41388-020-01422-9; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Minchenko OH, 2005, BIOCHIMIE, V87, P1005, DOI 10.1016/j.biochi.2005.04.007; Mondal S, 2019, INT J CANCER, V144, P178, DOI 10.1002/ijc.31868; Morice P, 2016, LANCET, V387, P1094, DOI 10.1016/S0140-6736(15)00130-0; Moxley KM, 2010, ONCOLOGIST, V15, P1026, DOI 10.1634/theoncologist.2010-0087; Myers AP, 2020, INT J CANCER, V147, P413, DOI 10.1002/ijc.32783; Nagathihalli NS, 2011, BBA-REV CANCER, V1816, P209, DOI 10.1016/j.bbcan.2011.07.004; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Ray-Coquard I, 2013, BRIT J CANCER, V108, P1771, DOI 10.1038/bjc.2013.183; Roncolato F, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012160.pub2; ROY D, 2017, SCI REP UK, V7; Rozengurt E, 2014, MOL CANCER THER, V13, P2477, DOI 10.1158/1535-7163.MCT-14-0330; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; Shafer A, 2010, INT J CANCER, V126, P1144, DOI 10.1002/ijc.24837; Shi LL, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.44; Shi WK, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0435-y; Shteingauz A, 2015, CANCER RES, V75, P3946, DOI 10.1158/0008-5472.CAN-15-0037; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Slomovitz BM, 2012, CLIN CANCER RES, V18, P5856, DOI 10.1158/1078-0432.CCR-12-0662; Tsoref D, 2014, GYNECOL ONCOL, V135, P184, DOI 10.1016/j.ygyno.2014.06.033; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward A, 2015, CANCER TREAT REV, V41, P35, DOI 10.1016/j.ctrv.2014.10.006; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Yan SY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215415; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	53	16	16	3	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2021	40	8					1409	1424		10.1038/s41388-020-01621-4	http://dx.doi.org/10.1038/s41388-020-01621-4		JAN 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QM6NM	33420377	hybrid, Green Published			2022-12-26	WOS:000607346000014
J	Essawy, A; Jo, S; Beetch, M; Lockridge, A; Gustafson, E; Alejandro, EU				Essawy, Ahmad; Jo, Seokwon; Beetch, Megan; Lockridge, Amber; Gustafson, Eric; Alejandro, Emilyn U.			O-linked N-acetylglucosamine transferase (OGT) regulates pancreatic alpha-cell function in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; GLCNAC TRANSFERASE; NEURONS; GLYCOSYLATION; PROGLUCAGON; ANTIBODIES; ISLETS; FOXA1; MASS	The nutrient sensor O-GlcNAc transferase (OGT) catalyzes posttranslational addition of O-GlcNAc onto target proteins, influencing signaling pathways in response to cellular nutrient levels. OGT is highly expressed in pancreatic glucagon-secreting cells (alpha-cells), which secrete glucagon in response to hypoglycemia. The objective of this study was to determine whether OGT is necessary for the regulation of alpha-cell mass and function in vivo. We utilized genetic manipulation to produce two alpha-cell specific OGT-knockout models: a constitutive glucagon-Cre (alpha OGT(KO)) and an inducible glucagon-Cre (i-alpha OGT(KO)), which effectively delete OGT in alpha-cells. Using approaches including immunoblotting, immunofluorescent imaging, and metabolic phenotyping in vivo, we provide the first insight on the role of O-GlcNAcylation in alpha-cell mass and function. alpha OGT(KO) mice demonstrated normal glucose tolerance and insulin sensitivity but displayed significantly lower glucagon levels during both fed and fasted states. alpha OGT(KO) mice exhibited significantly lower alpha-cell glucagon content and alpha-cell mass at 6 months of age. In fasting, alpha OGT(KO) mice showed impaired pyruvate stimulated gluconeogenesis in vivo and reduced glucagon secretion in vitro. i-alpha OGT(KO) mice showed similarly reduced blood glucagon levels, defective in vitro glucagon secretion, and normal alpha-cell mass. Interestingly, both alpha OGT(KO) and i-alpha OGT(KO) mice had no deficiency in maintaining blood glucose homeostasis under fed or fasting conditions, despite impairment in alpha-cell mass and function, and glucagon content. In conclusion, these studies provide a first look at the role of OGT signaling in the alpha-cell, its effect on alpha-cell mass, and its importance in regulating glucagon secretion in hypoglycemic conditions.	[Essawy, Ahmad; Jo, Seokwon; Beetch, Megan; Lockridge, Amber; Gustafson, Eric; Alejandro, Emilyn U.] Univ Minnesota, Med Sch, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Alejandro, EU (corresponding author), Univ Minnesota, Med Sch, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA.	ealejand@umn.edu		Jo, Seokwon/0000-0002-8989-4893; Alejandro, Emilyn/0000-0002-7941-8439; Lockridge, Amber/0000-0003-1122-6286	National Institutes of Health Grant NIDDK [R21DK112144, R01DK115720, T32 DK007203]; National Institutes of Health Grant NIDDK (IBP start-up funds)	National Institutes of Health Grant NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health Grant NIDDK (IBP start-up funds)	This work was supported by National Institutes of Health Grant NIDDK (R21DK112144, R01DK115720, and IBP start-up funds to E.U. A. and T32 DK007203 for M. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akimoto Y, 1999, DIABETES, V48, P2407, DOI 10.2337/diabetes.48.12.2407; Albrechtsen NJW, 2016, BIOMARK MED, V10, P1141, DOI 10.2217/bmm-2016-0090; Alejandro EU, 2015, CELL REP, V13, P2527, DOI 10.1016/j.celrep.2015.11.020; Alejandro EU, 2014, J CLIN INVEST, V124, P4395, DOI 10.1172/JCI74237; Baumann D, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.186643; Bozadjieva N, 2017, J CLIN INVEST, V127, P4379, DOI 10.1172/JCI90004; Cork SC, 2015, MOL METAB, V4, P718, DOI 10.1016/j.molmet.2015.07.008; D'Alessio D, 2011, DIABETES OBES METAB, V13, P126, DOI 10.1111/j.1463-1326.2011.01449.x; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; DRUCKER DJ, 1988, J BIOL CHEM, V263, P13475; Folli F, 2018, DIABETES OBES METAB, V20, P137, DOI 10.1111/dom.13380; Forma E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198351; Gloster TM, 2010, CURR SIGNAL TRANSD T, V5, P74, DOI 10.2174/157436210790226537; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Ida S, 2017, DIABETOLOGIA, V60, P1761, DOI 10.1007/s00125-017-4327-y; Jo S, 2019, J BIOL CHEM, V294, P13040, DOI 10.1074/jbc.RA119.008670; Lagerlof O, 2016, SCIENCE, V351, P1293, DOI 10.1126/science.aad5494; Larsen PJ, 1997, NEUROSCIENCE, V77, P257, DOI 10.1016/S0306-4522(96)00434-4; Liu YB, 2017, BIOCHEM BIOPH RES CO, V487, P755, DOI 10.1016/j.bbrc.2017.04.135; Llewellyn-Smith IJ, 2011, NEUROSCIENCE, V180, P111, DOI 10.1016/j.neuroscience.2011.02.023; Lockridge A, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107609; Lockridge AD, 2016, ISLETS, V8, P195, DOI 10.1080/19382014.2016.1260797; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Lund A, 2012, CURR DIABETES REP, V14, P555, DOI 10.1007/s11892-014-0555-4; Masson MH, 2014, ENDOCRINOLOGY, V155, P3781, DOI 10.1210/en.2013-1843; McGirr R, 2013, J ENDOCRINOL, V217, P229, DOI 10.1530/JOE-12-0468; Ong QX, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00599; POITOUT V, 1995, DIABETES, V44, P306, DOI 10.2337/diabetes.44.3.306; POWERS AC, 1990, DIABETES, V39, P406, DOI 10.2337/diabetes.39.4.406; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Ruan HB, 2014, CELL, V159, P306, DOI 10.1016/j.cell.2014.09.010; Shiota C, 2017, DIABETOLOGIA, V60, P2399, DOI 10.1007/s00125-017-4425-x; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; Tashima Y, 2014, J BIOL CHEM, V289, P11132, DOI 10.1074/jbc.M113.492512; Thorel F, 2011, DIABETES, V60, P2872, DOI 10.2337/db11-0876; Vasconcelos-dos-Santos A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00138; Wang AC, 2016, P NATL ACAD SCI USA, V113, P15120, DOI 10.1073/pnas.1606899113; Xavier GD, 2018, J CLIN MED, V7, DOI 10.3390/jcm7030054; Zachara N.E., 2022, ESSENTIALS GLYCOBIOL, DOI [10.1101/9781621824213, DOI 10.1101/9781621824213]; Zhao M, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708736	43	7	7	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100297	10.1016/j.jbc.2021.100297	http://dx.doi.org/10.1016/j.jbc.2021.100297			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33460647	Green Published, gold			2022-12-26	WOS:000672866400271
J	Nandi, S; Razzaghi, M; Srivastava, D; Dey, M				Nandi, Suparno; Razzaghi, Mortezaali; Srivastava, Dhiraj; Dey, Mishtu			Structural basis for allosteric regulation of pyruvate kinase M2 by phosphorylation and acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pyruvate kinase muscle isoform 2; glycolysis; allosteric regulation; post-translational modification; phosphorylation; acetylation; crystal structure; enzyme kinetics; fluorescence binding; cancer metabolism; oligomerization; pyruvate kinase; protein structure; protein phosphorylation; post-translational modification (PTM); crystal structure; oligomerization; glycolysis; allosteric regulation; enzyme kinetics; acetylation	NA+/H+ EXCHANGER; PH DYNAMICS; ISOFORM M2; PKM2; CANCER; PROMOTES; MECHANISM; IDENTIFICATION; INHIBITORS; TARGETS	Pyruvate kinase muscle isoform 2 (PKM2) is a key glycolytic enzyme and transcriptional coactivator and is critical for tumor metabolism. In cancer cells, native tetrameric PKM2 is phosphorylated or acetylated, which initiates a switch to a dimeric/monomeric form that translocates into the nucleus, causing oncogene transcription. However, it is not known how these post-translational modifications (PTMs) disrupt the oligomeric state of PKM2. We explored this question via crystallographic and biophysical analyses of PKM2 mutants containing residues that mimic phosphorylation and acetylation. We find that the PTMs elicit major structural reorganization of the fructose 1,6-bisphosphate (FBP), an allosteric activator, binding site, impacting the interaction with FBP and causing a disruption in oligomerization. To gain insight into how these modifications might cause unique outcomes in cancer cells, we examined the impact of increasing the intracellular pH (pH(i)) from similar to 7.1 (in normal cells) to similar to 7.5 (in cancer cells). Biochemical studies of WT PKM2 (wtPKM2) and the two mimetic variants demonstrated that the activity decreases as the pH is increased from 7.0 to 8.0, and wtPKM2 is optimally active and amenable to FBP-mediated allosteric regulation at pH(i) 7.5. However, the PTM mimetics exist as a mixture of tetramer and dimer, indicating that physiologically dimeric fraction is important and might be necessary for the modified PKM2 to translocate into the nucleus. Thus, our findings provide insight into how PTMs and pH regulate PKM2 and offer a broader understanding of its intricate allosteric regulation mechanism by phosphorylation or acetylation.	[Nandi, Suparno; Razzaghi, Mortezaali; Srivastava, Dhiraj; Dey, Mishtu] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA	University of Iowa	Dey, M (corresponding author), Univ Iowa, Dept Chem, Iowa City, IA 52242 USA.	mishtu-dey@uiowa.edu	Srivastava, Dhiraj/GLQ-8896-2022	Nandi, Suparno/0000-0002-3534-8002; Dey, Mishtu/0000-0003-4763-2921; Srivastava, Dhiraj/0000-0002-1460-1646	National Science Foundation [CLP 1506181]	National Science Foundation(National Science Foundation (NSF))	M. D. was supported by National Science Foundation Grant CLP 1506181 (to M. D.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alfarouk Khalid O, 2014, Oncoscience, V1, P777; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bollenbach TJ, 1999, BIOCHEMISTRY-US, V38, P9137, DOI 10.1021/bi990690n; Bond CJ, 2000, BIOCHEMISTRY-US, V39, P15333, DOI 10.1021/bi001443i; Brummett AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127288; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chen TJ, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0343-4; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Damaghi M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00370; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; DOMINGO M, 1992, J HISTOCHEM CYTOCHEM, V40, P665, DOI 10.1177/40.5.1374093; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; GREGORY RB, 1983, BIOCHEM J, V209, P413, DOI 10.1042/bj2090413; Harguindey S, 2005, BBA-REV CANCER, V1756, P1, DOI 10.1016/j.bbcan.2005.06.004; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Israelsen WJ, 2015, SEMIN CELL DEV BIOL, V43, P43, DOI 10.1016/j.semcdb.2015.08.004; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalaiarasan P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120469; Keller KE, 2014, MOL CELL, V53, P700, DOI 10.1016/j.molcel.2014.02.015; Keller KE, 2012, SCIENCE, V338, P1069, DOI 10.1126/science.1224409; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12431; Liu VM, 2020, FEBS LETT, V594, P646, DOI 10.1002/1873-3468.13648; Lv L, 2013, MOL CELL, V52, P340, DOI 10.1016/j.molcel.2013.09.004; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Macpherson JA, 2019, ELIFE, V8, DOI 10.7554/eLife.45068; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morgan HP, 2013, P NATL ACAD SCI USA, V110, P5881, DOI 10.1073/pnas.1217157110; Nandi S, 2020, J BIOL CHEM, V295, P5390, DOI 10.1074/jbc.RA120.013030; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; Schnicker NJ, 2016, J BIOL CHEM, V291, P13360, DOI 10.1074/jbc.M116.725432; Spoden GA, 2008, INT J CANCER, V123, P312, DOI 10.1002/ijc.23512; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Srivastava D, 2019, BIOCHEMISTRY-US, V58, P3669, DOI 10.1021/acs.biochem.9b00349; Srivastava D, 2017, BIOCHEMISTRY-US, V56, P6517, DOI 10.1021/acs.biochem.7b01013; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; Wang HZ, 2017, NATURE, V546, P426, DOI 10.1038/nature22797; Wang P, 2015, PROTEIN CELL, V6, P275, DOI 10.1007/s13238-015-0132-x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong Nicholas, 2013, Int J Cell Biol, V2013, P242513, DOI 10.1155/2013/242513; Wu SF, 2013, ACTA BIOCH BIOPH SIN, V45, P27, DOI 10.1093/abbs/gms106; Yamada E, 1999, BIOCHEM BIOPH RES CO, V256, P257, DOI 10.1006/bbrc.1999.0228; Yan M, 2016, BIOCHEMISTRY-US, V55, P4731, DOI 10.1021/acs.biochem.6b00658; Yang JX, 2016, J CHEM INF MODEL, V56, P1184, DOI 10.1021/acs.jcim.6b00115; Yang WW, 2015, J CELL SCI, V128, P1655, DOI 10.1242/jcs.166629; Yang WW, 2013, CELL CYCLE, V12, P3154, DOI 10.4161/cc.26182; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zhang TB, 2015, INT J CLIN EXP MED, V8, P2423; Zwerschke W, 1999, P NATL ACAD SCI USA, V96, P1291, DOI 10.1073/pnas.96.4.1291	57	8	8	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17425	17440		10.1074/jbc.RA120.015800	http://dx.doi.org/10.1074/jbc.RA120.015800			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453989	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000603272300005
J	Teng, FY; Wang, TT; Guo, HL; Xin, BG; Sun, B; Dou, SX; Xi, XG; Hou, XM				Teng, Fang-Yuan; Wang, Ting-Ting; Guo, Hai-Lei; Xin, Ben-Ge; Sun, Bo; Dou, Shuo-Xing; Xi, Xu-Guang; Hou, Xi-Miao			The HRDC domain oppositely modulates the unwinding activity of E. coli RecQ helicase on duplex DNA and G-quadruplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; E; coli; RecQ; G-quadruplex; helicase; unwinding; single-molecule	BLOOMS SYNDROME HELICASE; SINGLE-MOLECULE; CRYSTAL-STRUCTURE; REVEALS; BINDING; REPAIR; RECOMBINATION; MECHANISM; EFFICIENT; HAIRPIN	RecQ family helicases are highly conserved from bacteria to humans and have essential roles in maintaining genome stability. Mutations in three human RecQ helicases cause severe diseases with the main features of premature aging and cancer predisposition. Most RecQ helicases shared a conserved domain arrangement which comprises a helicase core, an RecQ C-terminal domain, and an auxiliary element helicase and RNaseD C-terminal (HRDC) domain, the functions of which are poorly understood. In this study, we systematically characterized the roles of the HRDC domain in E. coli RecQ in various DNA transactions by single-molecule FRET. We found that RecQ repetitively unwinds the 3 '-partial duplex and fork DNA with a moderate processivity and periodically patrols on the ssDNA in the 5 '-partial duplex by translocation. The HRDC domain significantly suppresses RecQ activities in the above transactions. In sharp contrast, the HRDC domain is essential for the deep and long-time unfolding of the G4 DNA structure by RecQ. Based on the observations that the HRDC domain dynamically switches between RecA core- and ssDNA-binding modes after RecQ association with DNA, we proposed a model to explain the modulation mechanism of the HRDC domain. Our findings not only provide new insights into the activities of RecQ on different substrates but also highlight the novel functions of the HRDC domain in DNA metabolisms.	[Teng, Fang-Yuan; Wang, Ting-Ting; Guo, Hai-Lei; Xin, Ben-Ge; Xi, Xu-Guang; Hou, Xi-Miao] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Teng, Fang-Yuan; Wang, Ting-Ting; Guo, Hai-Lei; Xin, Ben-Ge; Xi, Xu-Guang; Hou, Xi-Miao] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Teng, Fang-Yuan] Southwest Med Univ, Affiliated Hosp, Expt Med Ctr, Luzhou, Sichuan, Peoples R China; [Teng, Fang-Yuan] Southwest Med Univ, Dept Endocrinol & Metab, Luzhou, Sichuan, Peoples R China; [Teng, Fang-Yuan] Southwest Med Univ, Cardiovasc & Metab Dis Key Lab Luzhou, Luzhou, Sichuan, Peoples R China; [Teng, Fang-Yuan] Southwest Med Univ, Sichuan Clin Res Ctr Nephropathy & Academician Ex, Luzhou, Sichuan, Peoples R China; [Sun, Bo] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Dou, Shuo-Xing] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing, Peoples R China; [Dou, Shuo-Xing] Chinese Acad Sci, Lab Soft Matter Phys Inst Phys, Beijing, Peoples R China; [Xi, Xu-Guang] Ecole Normale Super Paris Saclay, LBPA, CNRS, Gif Sur Yvette, France	Northwest A&F University - China; Northwest A&F University - China; Southwest Medical University; Southwest Medical University; Southwest Medical University; Southwest Medical University; ShanghaiTech University; Chinese Academy of Sciences; Chinese Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Xi, XG; Hou, XM (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Xi, XG; Hou, XM (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.; Xi, XG (corresponding author), Ecole Normale Super Paris Saclay, LBPA, CNRS, Gif Sur Yvette, France.	xxi01@ens-cachan.fr; houximiao@nwsuaf.edu.cn	teng, fang-yuan/S-9833-2018	teng, fang-yuan/0000-0002-9564-0961; Dou, Shuo-Xing/0000-0002-7201-2081; Sun, Bo/0000-0002-4590-7795	National Natural Science Foundation of China [32071225, 31870788, 32071291]; Affiliated Hospital of Southwest Medical University [18102]; Luzhou-Southwest Medical University [2019LZXNYDJ06, 2018-ZRZD-003]; Chinese Universities Scientific Fund [Z109021718]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Affiliated Hospital of Southwest Medical University; Luzhou-Southwest Medical University; Chinese Universities Scientific Fund	This work was supported by the National Natural Science Foundation of China Grants 32071225, 31870788, and 32071291, the Research Startup Funding of the Affiliated Hospital of Southwest Medical University Grant 18102, Scientific Research Funding of Luzhou-Southwest Medical University Grants 2019LZXNYDJ06 and 2018-ZRZD-003, and the Chinese Universities Scientific Fund Grant Z109021718. The research was conducted within the context of the International Associated Laboratory "Helicase-mediated G-quadruplex DNA unwinding and Genome Stability."	Bagchi D, 2018, NUCLEIC ACIDS RES, V46, P8500, DOI 10.1093/nar/gky647; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Bernstein DA, 2005, STRUCTURE, V13, P1173, DOI 10.1016/j.str.2005.04.018; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Cahoon LA, 2013, J BACTERIOL, V195, P2255, DOI 10.1128/JB.02217-12; Chatterjee S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6556; Chen MC, 2018, NATURE, V558, P465, DOI 10.1038/s41586-018-0209-9; Choi S, 2019, NUCLEIC ACIDS RES, V47, P9708, DOI 10.1093/nar/gkz708; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Dou SX, 2004, J BIOL CHEM, V279, P6354, DOI 10.1074/jbc.M311272200; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; Harami GM, 2017, P NATL ACAD SCI USA, V114, pE466, DOI 10.1073/pnas.1615439114; Harami GM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11091; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; Hou XM, 2017, NUCLEIC ACIDS RES, V45, P11401, DOI 10.1093/nar/gkx766; Hou XM, 2015, BIOCHEM J, V466, P189, DOI 10.1042/BJ20140997; Kaplan OI, 2016, NUCLEIC ACIDS RES, V44, P9083, DOI 10.1093/nar/gkw769; Kim YM, 2010, NUCLEIC ACIDS RES, V38, P7764, DOI 10.1093/nar/gkq586; Kitano K, 2007, J BIOL CHEM, V282, P2717, DOI 10.1074/jbc.M610142200; Klaue D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3024; Kocsis ZS, 2014, J BIOL CHEM, V289, P5938, DOI 10.1074/jbc.M113.530741; Larsen NB, 2013, ADV EXP MED BIOL, V973, P161, DOI 10.1007/978-1-4614-5037-5_8; Lee M, 2018, NUCLEIC ACIDS RES, V46, P4689, DOI 10.1093/nar/gky272; Li N, 2010, J BIOL CHEM, V285, P6922, DOI 10.1074/jbc.M109.069286; Liu Z, 1999, STRUCTURE, V7, P1557, DOI 10.1016/S0969-2126(00)88346-X; Manthei KA, 2015, P NATL ACAD SCI USA, V112, P4292, DOI 10.1073/pnas.1416746112; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Markiewicz RP, 2012, NUCLEIC ACIDS RES, V40, P7975, DOI 10.1093/nar/gks523; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Newman JA, 2015, NUCLEIC ACIDS RES, V43, P5221, DOI 10.1093/nar/gkv373; Sato A, 2010, J BIOCHEM, V148, P517, DOI 10.1093/jb/mvq097; Swan MK, 2014, ACTA CRYSTALLOGR D, V70, P1465, DOI 10.1107/S139900471400501X; Teng FY, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.586450; Teng FY, 2017, FEBS J, V284, P4051, DOI 10.1111/febs.14290; Tippana R, 2016, P NATL ACAD SCI USA, V113, P8448, DOI 10.1073/pnas.1603724113; Vindigni A, 2010, BIOPHYS CHEM, V149, P67, DOI 10.1016/j.bpc.2010.03.012; Vindigni A, 2009, HFSP J, V3, P153, DOI 10.2976/1.3079540; Voter AF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06751-8; Wang S, 2015, NUCLEIC ACIDS RES, V43, P3736, DOI 10.1093/nar/gkv209; Wu CG, 2016, NUCLEIC ACIDS RES, V44, P8742, DOI 10.1093/nar/gkw574; Wu WQ, 2019, NEW PHYTOL, V223, P508, DOI 10.1111/nph.15928; Wu WQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43954; Wu WQ, 2015, NUCLEIC ACIDS RES, V43, P4614, DOI 10.1093/nar/gkv361; Xu HQ, 2003, J BIOL CHEM, V278, P34925, DOI 10.1074/jbc.M303581200; Yodh JG, 2009, EMBO J, V28, P405, DOI 10.1038/emboj.2008.298; Zhang B, 2016, NUCLEIC ACIDS RES, V44, P8385, DOI 10.1093/nar/gkw669; Zhang XD, 2006, J BIOL CHEM, V281, P12655, DOI 10.1074/jbc.M513089200; Zhou RB, 2014, ELIFE, V3, DOI 10.7554/eLife.02190	50	6	6	4	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17646	17658		10.1074/jbc.RA120.015492	http://dx.doi.org/10.1074/jbc.RA120.015492			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454004	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000603272300020
J	Belfort, MB; Qureshi, F; Litt, J; Enlow, MB; De Vivo, I; Gregory, K; Tiemeier, H				Belfort, Mandy Brown; Qureshi, Farah; Litt, Jonathan; Enlow, Michelle Bosquet; De Vivo, Immaculata; Gregory, Katherine; Tiemeier, Henning			Telomere length shortening in hospitalized preterm infants: A pilot study	PLOS ONE			English	Article							YOUNG-ADULTS; BORN PRETERM; BIRTH; OUTCOMES; RISK; CHILDREN; DISEASE; AGE; METAANALYSIS; PREMATURITY	Leukocyte telomere length is a biomarker of aging-related health risks. Hospitalized preterm infants frequently experience elevated oxidative stress and inflammation, both of which contribute to telomere shortening. Our aim was to examine changes in telomere length during neonatal intensive care unit (NICU) hospitalization in a cohort of preterm infants <32 weeks' gestation. We conducted a longitudinal study of 10 infants (mean gestational age 27 weeks, range 23.5 to 29, at birth). We isolated DNA from dried blood spots and used Real Time Quantitative PCR to measure relative leukocyte telomere length in triplicate at three time points for each participant. From birth to discharge, infants experienced an average decline in relative telomere length of 0.021 units per week (95% CI -0.040, -0.0020; p = 0.03), after adjustment for gestational age at birth. Our results suggest a measurable decline in telomere length during NICU hospitalization. We speculate that telomere length change may convey information about NICU exposures that carry short- and long-term health risks.	[Belfort, Mandy Brown; Gregory, Katherine] Brigham & Womens Hosp, Dept Pediat Newborn Med, 75 Francis St, Boston, MA 02115 USA; [Belfort, Mandy Brown; Litt, Jonathan; Enlow, Michelle Bosquet; Gregory, Katherine] Harvard Med Sch, Boston, MA 02115 USA; [Qureshi, Farah; Litt, Jonathan; Tiemeier, Henning] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Litt, Jonathan] Beth Israel Deaconess Med Ctr, Dept Neonatol, Boston, MA 02215 USA; [Enlow, Michelle Bosquet] Boston Childrens Hosp, Dept Psychiat, Boston, MA USA; [De Vivo, Immaculata] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Belfort, MB (corresponding author), Brigham & Womens Hosp, Dept Pediat Newborn Med, 75 Francis St, Boston, MA 02115 USA.; Belfort, MB (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	mbelfort@bwh.harvard.edu	Tiemeier, Henning/H-6534-2019	Tiemeier, Henning/0000-0002-4395-1397; Belfort, Mandy/0000-0001-8799-3313; Gregory, Katherine/0000-0002-0610-5386; De Vivo, Immaculata/0000-0002-7185-7402; Qureshi, Farah/0000-0002-9092-8085				Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Akkad A, 2006, BJOG-INT J OBSTET GY, V113, P318, DOI 10.1111/j.1471-0528.2005.00839.x; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389; Brydges CR, 2018, DEV MED CHILD NEUROL, V60, P452, DOI 10.1111/dmcn.13685; Casavant SG, 2019, EARLY HUM DEV, V131, P63, DOI 10.1016/j.earlhumdev.2019.03.003; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cheong JL, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2016.4805; Crump C, 2019, JAMA PEDIATR, V173, P736, DOI 10.1001/jamapediatrics.2019.1327; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; DeJong F, 2011, AM HEART ASS JOINT C; Delgado DA, 2019, HUM GENET, V138, P49, DOI 10.1007/s00439-018-1964-2; Eidelman AI, 2012, PEDIATRICS, V129, pE827, DOI 10.1542/peds.2011-3552; Elizabeth CL, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0547-4; Enlow MB, 2020, PSYCHONEUROENDOCRINO, V115, DOI 10.1016/j.psyneuen.2020.104602; Factor-Litvak P, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3927; Fyhrquist F, 2013, NAT REV CARDIOL, V10, P274, DOI 10.1038/nrcardio.2013.30; Gu BW, 2011, AGING CELL, V10, P338, DOI 10.1111/j.1474-9726.2011.00674.x; Hadchouel A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136123; He H, 2015, AM J RESP CRIT CARE, V192, P520, DOI 10.1164/rccm.201503-0522LE; Horbar JD, 2016, 2015 MANUAL OPERAT 2; Hovi P, 2016, HYPERTENSION, V68, P880, DOI 10.1161/HYPERTENSIONAHA.116.08167; Kuban KCK, 2015, PEDIATR NEUROL, V52, P42, DOI 10.1016/j.pediatrneurol.2014.10.005; Li S, 2014, OBES REV, V15, P804, DOI 10.1111/obr.12214; Moore TA, 2018, BIOL RES NURS, V20, P497, DOI 10.1177/1099800418791028; Moreira RS, 2014, J PEDIAT-BRAZIL, V90, P119, DOI 10.1016/j.jped.2013.05.010; Niu ZZ, 2019, J PEDIATR-US, V215, P64, DOI 10.1016/j.jpeds.2019.08.040; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Pascal A, 2018, DEV MED CHILD NEUROL, V60, P342, DOI 10.1111/dmcn.13675; Pettker CM, 2017, OBSTET GYNECOL, V129, pE150, DOI 10.1097/AOG.0000000000002046; Prescott J, 2012, HUM REPROD, V27, P3622, DOI 10.1093/humrep/des314; Provenzi L, 2019, EARLY HUM DEV, V129, P1, DOI 10.1016/j.earlhumdev.2018.12.002; Provenzi L, 2018, PSYCHONEUROENDOCRINO, V89, P113, DOI 10.1016/j.psyneuen.2018.01.009; Provenzi L, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00295; Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608; Ridout KK, 2018, MOL PSYCHIATR, V23, P858, DOI 10.1038/mp.2017.26; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Savran O, 2018, INT J CHRONIC OBSTR, V13, P683, DOI 10.2147/COPD.S153555; Scarabino D, 2017, EXP GERONTOL, V98, P143, DOI 10.1016/j.exger.2017.08.025; Sipola-Leppanen M, 2015, AM J EPIDEMIOL, V181, P861, DOI 10.1093/aje/kwu443; Smeets CCJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143951; Song LL, 2019, ENVIRON HEALTH PERSP, V127, DOI [10.1289/EHP4492, 10.1289/ehp4492]; Sperling MA, 2004, NEW ENGL J MED, V351, P2229, DOI 10.1056/NEJMe048274; Stroustrup A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193835; Turner KJ, 2014, BIOMARK MED, V8, P485, DOI 10.2217/bmm.14.13; Vasu V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180082; Vohr BR, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0269; vom Hove M, 2014, J PEDIATR-US, V164, P40, DOI 10.1016/j.jpeds.2013.07.045; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wang H, 2008, MOVEMENT DISORD, V23, P302, DOI 10.1002/mds.21867; Wang Q, 2018, AGEING RES REV, V48, P11, DOI 10.1016/j.arr.2018.09.002; Wong JYY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087348; Yeh JK, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090058	55	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0243468	10.1371/journal.pone.0243468	http://dx.doi.org/10.1371/journal.pone.0243468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471805	Green Published, gold			2022-12-26	WOS:000639428800004
J	Pham, TTH; Huang, WY; Chen, CS; Chiu, WT; Chuang, HS				Thi Thanh Huong Pham; Huang, Wan-Ying; Chen, Chang-Shi; Chiu, Wen-Tai; Chuang, Han-Sheng			Effects of electrotactic exercise and antioxidant EUK-134 on oxidative stress relief in Caenorhabditis elegans	PLOS ONE			English	Article							ALZHEIMERS-DISEASE BRAIN; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; PROTEIN OXIDATION; PHYSICAL-ACTIVITY; ROS FUNCTION; LIFE-SPAN; OVEREXPRESSION; EXPRESSION; EXTENSION	Antioxidant uptake and regular exercise are two well-acknowledged measures used for rejuvenation and oxidative stress elimination. Previous studies have revealed that moderate exercise mildly increases intracellular signaling oxidant levels and strengthens the ability of an organism to deal with escalating oxidative stress by upregulating antioxidant enzymes, such as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase. Antioxidant supplementation directly scavenges intracellular reactive oxygen species (ROS) to reduce oxidative stress. However, research to understand the impacts of these enzymes on mitigating oxidative stress from the perspective of simple animals is limited. Herein, we show that exercise combined with antioxidant supplementation ameliorates the physiological phenotypes and markers of aging in wild-type and SOD/CAT-deficient Caenorhabditis elegans. We discovered that treated wild-type and gene-deficient worms show better survivorship, reproduction, and motility compared with their control counterparts. Assays of biochemical indices revealed that variations in sod-3 expression under different stress levels imply an inducible enzyme response resulting from exercise training and antioxidant supplementation. In addition, induced ROS resistance obtained from any type of treatment could persist for several days even after treatment cessation, thus suggesting a potential long-term antioxidative stress effect. Our findings confirm that exercise, antioxidant supplementation, and their combination could significantly improve the ability of C. elegans to withstand adverse stress. Our observations provide promising insights into future therapies of anti-oxidative stress in higher animals.	[Thi Thanh Huong Pham; Huang, Wan-Ying; Chiu, Wen-Tai; Chuang, Han-Sheng] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan; [Chen, Chang-Shi] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Tainan, Taiwan; [Chuang, Han-Sheng] Natl Cheng Kung Univ, Ctr Micro Nano Sci & Technol, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Chuang, HS (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan.; Chuang, HS (corresponding author), Natl Cheng Kung Univ, Ctr Micro Nano Sci & Technol, Tainan, Taiwan.	oswaldchuang@mail.ncku.edu.tw	Chuang, Han-Sheng/ABH-3992-2020; Chen, Chang-Shi/B-9251-2009	Chuang, Han-Sheng/0000-0002-7257-6565; Chen, Chang-Shi/0000-0002-8201-3635	Taiwan Ministry of Science and Technology [108-2628-E-006-002-MY3]; Taiwan Ministry of Education; Higher Education Sprout Project, Ministry of Education	Taiwan Ministry of Science and Technology; Taiwan Ministry of Education(Ministry of Education, Taiwan); Higher Education Sprout Project, Ministry of Education	This research was supported by the Taiwan Ministry of Science and Technology in the form of a grant awarded to HSC (108-2628-E-006-002-MY3), the Taiwan Ministry of Education in the form of a grant awarded to HSC (TEEP@Asia), and in part by the Higher Education Sprout Project, Ministry of Education to the Headquarters of University Advancement at National Cheng Kung University (NCKU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves AJ, 2016, WORLD J CARDIOL, V8, P575, DOI 10.4330/wjc.v8.i10.575; Aprioku Jonah Sydney, 2013, J Reprod Infertil, V14, P158; Back P, 2012, FREE RADICAL BIO MED, V52, P850, DOI 10.1016/j.freeradbiomed.2011.11.037; Bartholome A, 2010, ARCH BIOCHEM BIOPHYS, V501, P58, DOI 10.1016/j.abb.2010.05.024; Boyd WA, 2010, TOXICOL APPL PHARM, V245, P153, DOI 10.1016/j.taap.2010.02.014; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; Chuang HS, 2016, SCI REP-UK, V6, DOI 10.1038/srep28064; Clarkson PM, 2000, AM J CLIN NUTR, V72, p637S, DOI 10.1093/ajcn/72.2.637S; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Declercq L., 2004, International Journal of Cosmetic Science, V26, P255, DOI 10.1111/j.1467-2494.2004.00234.x; Gabel CV, 2007, J NEUROSCI, V27, P7586, DOI 10.1523/JNEUROSCI.0775-07.2007; Gechev T, 2002, CELL MOL LIFE SCI, V59, P708, DOI 10.1007/s00018-002-8459-x; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Gruber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019444; Halliwell B, 2005, AM J CLIN NUTR, V81, p268S, DOI 10.1093/ajcn/81.1.268S; Hancock JT, 2001, BIOCHEM SOC T, V29, P345, DOI 10.1042/BST0290345; He F, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00486; Hsu PC, 1998, TOXICOLOGY, V128, P169, DOI 10.1016/S0300-483X(98)00068-7; Hunter T, 1997, J BIOL CHEM, V272, P28652, DOI 10.1074/jbc.272.45.28652; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Kandola K, 2015, INT J COSMETIC SCI, V37, P1, DOI 10.1111/ics.12287; Katiki LM, 2011, VET PARASITOL, V182, P264, DOI 10.1016/j.vetpar.2011.05.020; Kawashima A, 2015, REPROD SCI, V22, P783, DOI 10.1177/1933719114561561; Knoefler D, 2012, MOL CELL, V47, P767, DOI 10.1016/j.molcel.2012.06.016; Kondo M, 2005, MECH AGEING DEV, V126, P642, DOI 10.1016/j.mad.2004.11.012; Kumsta C, 2011, ANTIOXID REDOX SIGN, V14, P1023, DOI 10.1089/ars.2010.3203; Kuo WJ, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4872061; Laranjeiro R, 2019, P NATL ACAD SCI USA, V116, P23829, DOI 10.1073/pnas.1909210116; Lobo V, 2010, Pharmacogn Rev, V4, P118, DOI 10.4103/0973-7847.70902; Maniere X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016637; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Miranda-Vizuete A, 2017, REDOX BIOL, V11, P708, DOI 10.1016/j.redox.2016.12.020; Petriv OI, 2004, J BIOL CHEM, V279, P19996, DOI 10.1074/jbc.M400207200; Powers SK, 2004, J SPORT SCI, V22, P81, DOI 10.1080/0264041031000140563; Rezai P, 2010, LAB CHIP, V10, P220, DOI 10.1039/b917486a; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Sakamoto T, 2017, J BIOL CHEM, V292, P14804, DOI 10.1074/jbc.M117.788901; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; SOKOL RJ, 1988, ANNU REV NUTR, V8, P351, DOI 10.1146/annurev.nu.08.070188.002031; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Urso ML, 2003, TOXICOLOGY, V189, P41, DOI 10.1016/S0300-483X(03)00151-3; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; Victor VM, 2004, INT IMMUNOPHARMACOL, V4, P327, DOI 10.1016/j.intimp.2004.01.020; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Yanase S, 2009, J GERONTOL A-BIOL, V64, P530, DOI 10.1093/gerona/glp020; Zuo L, 2015, ACTA PHYSIOL, V214, P329, DOI 10.1111/apha.12515; Zuo L, 2014, AM J PHYSIOL-REG I, V306, pR75, DOI 10.1152/ajpregu.00425.2013; Zuo L, 2011, J APPL PHYSIOL, V111, P898, DOI 10.1152/japplphysiol.00398.2011	53	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245474	10.1371/journal.pone.0245474	http://dx.doi.org/10.1371/journal.pone.0245474			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471830	Green Published, gold			2022-12-26	WOS:000639428800066
J	Zheng, DD; Loewenstein, DA; Christ, SL; Feaster, DJ; Lam, BL; McCollister, KE; Curiel-Cid, RE; Lee, DJ				Zheng, D. Diane; Loewenstein, David A.; Christ, Sharon L.; Feaster, Daniel J.; Lam, Byron L.; McCollister, Kathryn E.; Curiel-Cid, Rosie E.; Lee, David J.			Multimorbidity patterns and their relationship to mortality in the US older adult population	PLOS ONE			English	Article							MULTIPLE CHRONIC CONDITIONS; LATENT CLASS ANALYSIS; ALL-CAUSE MORTALITY; COGNITIVE IMPAIRMENT; RISK-FACTORS; PREVALENCE; COMMUNITY; MORBIDITY; DEMENTIA; IMPACT	Background Understanding patterns of multimorbidity in the US older adult population and their relationship with mortality is important for reducing healthcare utilization and improving health. Previous investigations measured multimorbidity as counts of conditions rather than specific combination of conditions. Methods This cross-sectional study with longitudinal mortality follow-up employed latent class analysis (LCA) to develop clinically meaningful subgroups of participants aged 50 and older with different combinations of 13 chronic conditions from the National Health Interview Survey 2002-2014. Mortality linkage with National Death Index was performed through December 2015 for 166,126 participants. Survival analyses were conducted to assess the relationships between LCA classes and all-cause mortality and cause specific mortalities. Results LCA identified five multimorbidity groups with primary characteristics: "healthy" (51.5%), "age-associated chronic conditions" (33.6%), "respiratory conditions" (7.3%), "cognitively impaired" (4.3%) and "complex cardiometabolic" (3.2%). Covariate-adjusted survival analysis indicated "complex cardiometabolic" class had the highest mortality with a Hazard Ratio (HR) of 5.30, 99.5% CI [4.52, 6.22]; followed by "cognitively impaired" class (3.34 [2.93, 3.81]); "respiratory condition" class (2.14 [1.87, 2.46]); and "age-associated chronic conditions" class (1.81 [1.66, 1.98]). Patterns of multimorbidity classes were strongly associated with the primary underlying cause of death. The "cognitively impaired" class reported similar number of conditions compared to the "respiratory condition" class but had significantly higher mortality (3.8 vs 3.7 conditions, HR = 1.56 [1.32, 1.85]). Conclusion We demonstrated that LCA method is effective in classifying clinically meaningful multimorbidity subgroup. Specific combinations of conditions including cognitive impairment and depressive symptoms have a substantial detrimental impact on the mortality of older adults. The numbers of chronic conditions experienced by older adults is not always proportional to mortality risk. Our findings provide valuable information for identifying high risk older adults with multimorbidity to facilitate early intervention to treat chronic conditions and reduce mortality.	[Zheng, D. Diane; Loewenstein, David A.; Curiel-Cid, Rosie E.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Ctr Cognit Neurosci & Aging, Miami, FL 33136 USA; [Zheng, D. Diane; Feaster, Daniel J.; McCollister, Kathryn E.; Lee, David J.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Christ, Sharon L.] Purdue Univ, Dept Human Dev & Family Studies & Stat, W Lafayette, IN 47907 USA; [Lam, Byron L.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA	University of Miami; University of Miami; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Bascom Palmer Eye Institute; University of Miami	Zheng, DD (corresponding author), Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Ctr Cognit Neurosci & Aging, Miami, FL 33136 USA.; Zheng, DD (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.	dzheng@med.miami.edu		Zheng, D. Diane/0000-0003-2913-2878	National Eye Institute [F31EY025936]; National Institute on Aging [R01AG061106, R01AG055638]	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported grants from National Eye Institute (F31EY025936 DDZ); and National Institute on Aging (R01AG061106 DAL and R01AG055638 REC). The organization that provided funding had no role in the design and conduct of the study; management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Ahmadi SF, 2015, J AM MED DIR ASSOC, V16, P933, DOI 10.1016/j.jamda.2015.07.014; Anderson G, 2010, CHRONIC CARE MAKING; Asparouhov T, 2014, STRUCT EQU MODELING, V21, P329, DOI 10.1080/10705511.2014.915181; Asparouhov T, 2015, STRUCT EQU MODELING, V22, P169, DOI 10.1080/10705511.2014.935844; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bassuk SS, 2000, AM J EPIDEMIOL, V151, P676; Bauman M., 2017, MULTIPLE CHRONIC CON; Bernstein AB, 2007, GERONTOLOGIST, V47, P350, DOI 10.1093/geront/47.3.350; BOTMAN SL, 1995, STAT MED, V14, P669, DOI 10.1002/sim.4780140523; Boyle PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043647; Christ SL, 2007, J GERONTOL B-PSYCHOL, V62, pS399, DOI 10.1093/geronb/62.6.S399; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Dewey ME, 2001, INT J GERIATR PSYCH, V16, P751, DOI 10.1002/gps.397.abs; Gerteis J, 2014, MULTIPLE CHRONIC CON; Gilman SE, 2017, CAN MED ASSOC J, V189, pE1304, DOI 10.1503/cmaj.170125; Goodman RA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120239; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kingston A, 2018, AGE AGEING, V47, P374, DOI 10.1093/ageing/afx201; Landi F, 2010, J CLIN EPIDEMIOL, V63, P752, DOI 10.1016/j.jclinepi.2009.09.007; Larsen FB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169426; Li YS, 2020, CLIN EPIDEMIOL, V12, P1171, DOI 10.2147/CLEP.S279075; Luo HB, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.170338; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Marengoni A, 2009, J INTERN MED, V265, P288, DOI 10.1111/j.1365-2796.2008.02017.x; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Menotti A, 2001, J CLIN EPIDEMIOL, V54, P680, DOI 10.1016/S0895-4356(00)00368-1; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; National Center for Health Statistics, 2019, NCHS DAT LINK NDI MO; National Center for Health Statistics, 2019, PUBL US LINK MORT FI; Nunes BP, 2016, ARCH GERONTOL GERIAT, V67, P130, DOI 10.1016/j.archger.2016.07.008; Office of the Assistant Secretary for Health, 2015, US DEP HLTH HUM SERV; Olaya B, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0586-1; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Park B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216259; Parsons V. L., 2014, DESIGN ESTIMATION NA; Plassman BL, 2008, ANN INTERN MED, V148, P427, DOI 10.7326/0003-4819-148-6-200803180-00005; Salive ME, 2013, EPIDEMIOL REV, V35, P75, DOI 10.1093/epirev/mxs009; St John PD, 2014, CAN FAM PHYSICIAN, V60, pE272; The National Center for Health Statistics, NATL HLTH INTERVIEW; United Nations DoE Social Affairs PD, 2015, STESASERA390; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; Wang CY, 2009, MED CARE, V47, P813, DOI 10.1097/MLR.0b013e318197929c; Weissman J.S., 2015, SERIOUS PSYCHOL DIST; Whitson HE, 2016, J AM GERIATR SOC, V64, P1668, DOI 10.1111/jgs.14201; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Woo J, 2014, AGE, V36, P923, DOI 10.1007/s11357-013-9590-3; Zheng DD, 2020, PREV MED, V136, DOI 10.1016/j.ypmed.2020.106102; Zheng DD, 2020, JAMA OPHTHALMOL, V138, P387, DOI 10.1001/jamaophthalmol.2020.0052	49	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245053	10.1371/journal.pone.0245053	http://dx.doi.org/10.1371/journal.pone.0245053			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM1OE	33471812	gold, Green Published			2022-12-26	WOS:000639428800025
J	L'Ecuyer-Sauvageau, C; Dupras, J; He, J; Auclair, J; Kermagoret, C; Poder, TG				L'Ecuyer-Sauvageau, Chloe; Dupras, Jerome; He, Jie; Auclair, Jeoffrey; Kermagoret, Charlene; Poder, Thomas G.			The economic value of Canada's National Capital Green Network	PLOS ONE			English	Article							MAPPING ECOSYSTEM SERVICES; WILLINGNESS-TO-PAY; SUPPLY-AND-DEMAND; DECISION-MAKING; URBAN SPRAWL; WETLANDS; QUEBEC; LAND; VALUATION; BENEFITS	The lack of information on the value of ecosystems contributing to human well-being in urban and peri-urban setting is known to contribute to the degradation of natural capital and ecosystem services (ES). The purpose of this study was to determine the economic value of ES in Canada's Capital Region (Ottawa-Gatineau region), so that these values can be integrated in future planning decisions. Using the valuation methods of market pricing, cost replacement, and two benefit transfer approaches (with adjustment and with meta-analysis), the value of 13 ES from five ecosystems (forests, wetlands, croplands, prairies and grasslands, and freshwater systems) was measured. The annual economic value of these 13 ES amounts to an average of 332 million dollars, and to a total economic value of over 5 billion dollars, annualized over 20 years. The largest part of this value is generated by nonmarket ES, indicating that much more emphasis should be put on the management, preservation, and understanding of processes that make up these types of ES. The work generated as part of this study is a first step towards operationalizing the concept of ES in planning. More specifically, these results can be used to raise awareness, but also as a stepping stone to improve ecosystem-wide planning in the Canada's Capital Region.	[L'Ecuyer-Sauvageau, Chloe; Dupras, Jerome; Auclair, Jeoffrey; Kermagoret, Charlene] Univ Quebec Outaouais, Dept Sci Nat, Ripon, PQ, Canada; [He, Jie] Univ Sherbrooke, Dept Decon, Ecole Gest, Sherbrooke, PQ, Canada; [Poder, Thomas G.] Univ Montreal, Dept Gest Evaluat & Polit Sante, Ecole Sante Publ, Montreal, PQ, Canada; [Poder, Thomas G.] Ctr Rech Inst Univ Sante Mentale Montreal, CIUSSS Est Ile Montreal, Montreal, PQ, Canada	University of Quebec; University Quebec Outaouais; University of Sherbrooke; Universite de Montreal	L'Ecuyer-Sauvageau, C (corresponding author), Univ Quebec Outaouais, Dept Sci Nat, Ripon, PQ, Canada.	lecc23@uqo.ca			National Capital Commission (NCC); Social Sciences and Humanities Research Council of Canada; Guangzhou Natural Science Fund	National Capital Commission (NCC); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Guangzhou Natural Science Fund	The study was funded by the National Capital Commission (NCC) and by the Social Sciences and Humanities Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Jie He thanks the financial support from Guangzhou Natural Science Fund (201904010189). The financial support from the Guangzhou Natural Science Fund did not influence the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agriculture and Agri-Food Canada, 2014, LAND COV INV DAT TEM; Agriculture and Agri-Food Canada (AAC), 2017, STAT OV CAN HON BEE; Albert C, 2014, LANDSCAPE ECOL, V29, P1301, DOI [10.1007/s10980-014-9990-5, 10.1007/s10980-014-0085-0]; Alvarez-Farizo B., 1999, Journal of Environmental Planning and Management, V42, P23, DOI 10.1080/09640569911280; [Anonymous], 2013, U VERMONT HIST REV, VXXIV, P1; Arcand A., 2014, METROPOLITAN OUTOOK; Bagnall J., 2014, OTTAWA CITIZEN; Baro F, 2017, ECOSYST SERV, V24, P147, DOI 10.1016/j.ecoser.2017.02.021; Bastian CT, 2002, ECOL ECON, V40, P337, DOI 10.1016/S0921-8009(01)00278-6; BATEMAN I., 2002, EC VALUATION STATED; Boardman AE, 2011, J BENEFIT-COST ANAL, V2, DOI 10.2202/2152-2812.1050; Bowker J. M., 1994, Agricultural and Resource Economics Review, V23, P218; BOXALL PC, 1995, CAN J AGR ECON, V43, P119, DOI 10.1111/j.1744-7976.1995.tb00111.x; BREAUX A, 1995, J ENVIRON MANAGE, V44, P285, DOI 10.1006/jema.1995.0046; Breuste J., 2013, Ecosystem services in agricultural and urban landscapes, P83; Brunette V, 2008, C AGR RESP ENV TOUT; Butler D, 2016, OTTAWA CITIZEN; Butler D, 2016, OTTAWA SUN 1206; Bystrom O, 2000, ENVIRON RESOUR ECON, V16, P347, DOI 10.1023/A:1008316619355; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Centre de reference en agriculture et agroalimentaire du Quebec (CRAAQ), 2011, 142821A CRAAQ AGDEX; Centre de reference en agriculture et agroalimentaire du Quebec (CRAAQ), 2014, 232281 CRAAQ AGDEX; Centre de reference en agriculture et agroalimentaire du Quebec (CRAAQ), 2014, 121821 CRAAQ AGDEX; Chichilnisky G, 1998, NATURE, V391, P629, DOI 10.1038/35481; Compton JE, 2011, ECOL LETT, V14, P804, DOI 10.1111/j.1461-0248.2011.01631.x; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Croitoru L, 2007, FOREST POLICY ECON, V9, P536, DOI 10.1016/j.forpol.2006.04.001; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Del Degan Masse, 2010, GAT PARK EC CONS PLA; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Dunderdale JAL, 1997, J CHART INST WATER E, V11, P423; Dupras J, 2013, OURANOS, V218; Dupras J, 2014, EVALUATION EC SERVIC; Dupras J, 2018, LANDSCAPE RES, V43, P679, DOI 10.1080/01426397.2017.1332172; Dupras J, 2015, PLAN PRACT RES, V30, P355, DOI 10.1080/02697459.2015.1058073; Dupras J, 2016, LAND USE POLICY, V51, P66, DOI 10.1016/j.landusepol.2015.11.005; Dupras J, 2015, CAN GEOGR-GEOGR CAN, V59, P93, DOI 10.1111/cag.12138; Dupras J, 2015, J ENVIRON POL PLAN, V17, P180, DOI 10.1080/1523908X.2014.927755; Environics Research, 2017, REP PRES NAT CAP COM; Environment and Climate Change Canada, 2016, TECHN UPD ENV CLIM C; Ewing R, 1997, J AM PLANN ASSOC, V63, P107, DOI 10.1080/01944369708975728; Farber S, 1996, CONTEMP ECON POLICY, V14, P92, DOI 10.1111/j.1465-7287.1996.tb00606.x; Fetridge ED, 2008, ANN ENTOMOL SOC AM, V101, P1067, DOI 10.1603/0013-8746-101.6.1067; Folke C, 1991, ECOLOGY EC ENV, V1, P141; FOX G, 1990, CAN J AGR ECON, V38, P23, DOI 10.1111/j.1744-7976.1990.tb03447.x; Garneau M., 2016, SYNTHESE VALEUR REPA; Garrod GD, 1997, ECOL ECON, V21, P45, DOI 10.1016/S0921-8009(96)00092-4; Gordon D., 2008, URBAN GREEN BELTS 21, P129; Guerry AD, 2015, P NATL ACAD SCI USA, V112, P7348, DOI 10.1073/pnas.1503751112; Hansen R, 2015, ECOSYST SERV, V12, P228, DOI 10.1016/j.ecoser.2014.11.013; Hayha T, 2015, ECOSYST SERV, V14, P12, DOI 10.1016/j.ecoser.2015.03.001; He J, 2017, J ENVIRON ECON POLIC, V6, P51, DOI 10.1080/21606544.2016.1199976; He J, 2015, WETL ECOL MANAG, V23, P707, DOI 10.1007/s11273-015-9414-6; Hein L, 2011, ECOL SOC, V16; Hirabayashi S., 2014, I TREE CANOPY AIR PO; Howard E., 1898, TOMORROW PEACEFUL PA; Jenkins WA, 2010, ECOL ECON, V69, P1051, DOI 10.1016/j.ecolecon.2009.11.022; Johnson MP, 2001, ENVIRON PLANN A, V33, P717, DOI 10.1068/a3327; Jones L, 2016, LAND USE POLICY, V52, P151, DOI 10.1016/j.landusepol.2015.12.014; Kniivila M., 2002, Journal of Forest Economics, V8, P131, DOI 10.1078/1104-6899-00008; Knowler DJ, 2003, J ENVIRON MANAGE, V69, P261, DOI 10.1016/j.jenvman.2003.09.001; Kosz M, 1996, ECOL ECON, V16, P109, DOI 10.1016/0921-8009(95)00058-5; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Kurz WA, 1999, ECOL APPL, V9, P526, DOI 10.1890/1051-0761(1999)009[0526:AYRAOC]2.0.CO;2; La Financiere Agricole Quebec (FADQ), 2015, ORG JANV DEC 2013 CO; La Financiere Agricole Quebec (FADQ), 2015, MAIS JANV DEC 2013 C; La Financiere Agricole Quebec (FADQ), 2015, SOYA JANV DEC 2013 C; La Financiere Agricole Quebec (FADQ), 2015, BLE AL HUM JANV DEC; La Financiere Agricole Quebec (FADQ), 2015, AV JANV DEC 2013 COU; Lafleur PM, 2001, J GEOPHYS RES-ATMOS, V106, P3071, DOI 10.1029/2000JD900588; Laurans Y, 2013, J ENVIRON MANAGE, V119, P208, DOI 10.1016/j.jenvman.2013.01.008; Loomis J, 1998, ECOL ECON, V27, P29, DOI 10.1016/S0921-8009(97)00126-2; Mace GM, 2015, J APPL ECOL, V52, P641, DOI 10.1111/1365-2664.12431; Maes J, 2012, ECOSYST SERV, V1, P31, DOI 10.1016/j.ecoser.2012.06.004; Martinez-Harms MJ, 2015, BIOL CONSERV, V184, P229, DOI 10.1016/j.biocon.2015.01.024; MEA, 2005, EC HUM WELL BEING SY, DOI DOI 10.1119/1.2344558; Meyerhoff J., 2007, European Environment, V17, P18, DOI 10.1002/eet.439; Ministere du Developpement durable de l'Environnement et de la Lutte contre les changements climatiques, 2015, SUMM PROF RIV OUT WA; Mitchell MGE, 2013, ECOSYSTEMS, V16, P894, DOI 10.1007/s10021-013-9647-2; Morri E, 2014, ECOL INDIC, V37, P210, DOI 10.1016/j.ecolind.2013.08.016; Mueller H, 2016, ECOSYST SERV, V22, P370, DOI 10.1016/j.ecoser.2016.02.037; National Capital Commission, 2014 2015 ANN REP; National Capital Commission and Del Degan Masse (NCC), 2005, GAT PARK MAST PLAN; National Capital Commission (NCC), 2013, CAN CAP GREENB MAST; National Capital Commission (NCC), PRIOR PLANS CAP; Nelson NM, 2015, ECOL ECON, V118, P1, DOI 10.1016/j.ecolecon.2015.06.013; Nikodinoska N, 2018, ECOL MODEL, V368, P411, DOI 10.1016/j.ecolmodel.2017.10.013; Ninan KN, 2013, ECOSYST SERV, V5, pE78, DOI 10.1016/j.ecoser.2013.02.006; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Olden JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110458; Ontario Ministry of Agriculture Food and Rural Affairs (OMAFRA)., 2012, 2014 GRAIN OILS METR; Ontario Ministry of Agriculture Food and Rural Affairs (OMAFRA)., 2015, 2016 FIELD CROP BUDG; Orfield M., 1999, FORUM SOCIAL EC, V28, P33; Ovando P, 2016, LAND USE POLICY, V50, P479, DOI 10.1016/j.landusepol.2015.10.015; Pate J, 1997, ECOL ECON, V20, P199, DOI 10.1016/S0921-8009(96)00080-8; Pendall R, 1999, ENVIRON PLANN B, V26, P555, DOI 10.1068/b260555; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Poder T, 2015, VALEUR EC CEINTURE T; Potschin M., 2008, ENGLANDS TERRESTRIAL; Pretty JN, 2003, ENVIRON SCI TECHNOL, V37, P201, DOI 10.1021/es020793k; PTCEC, 1998, REP PENNS 21 CENT EN; Rands SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025971; Remme RP, 2015, ECOL ECON, V112, P116, DOI 10.1016/j.ecolecon.2015.02.015; Roesch-McNally GE, 2016, ENVIRON MANAGE, V57, P585, DOI 10.1007/s00267-015-0641-7; Sabourin B, 2017, LE DROIT; Sandhu HS, 2008, ECOL ECON, V64, P835, DOI 10.1016/j.ecolecon.2007.05.007; Sattler C, 2013, ECOSYST SERV, V6, P2, DOI 10.1016/j.ecoser.2013.09.009; Scarpa R, 2000, ECOL ECON, V33, P237, DOI 10.1016/S0921-8009(99)00143-3; Schomers S, 2013, ECOSYST SERV, V6, P16, DOI 10.1016/j.ecoser.2013.01.002; Siikamaki J, 2007, LAND ECON, V83, P539, DOI 10.3368/le.83.4.539; Smith WN, 2001, CAN J SOIL SCI, V81, P221, DOI 10.4141/S00-033; Statistics Canada, 2016, TABL 111 0009 FAM CH; Statistics Canada, 2017, QUEB CENS SUBD QUEB; Statistics Canada, 2016, TABL 051 0056 EST PO; Tammi I, 2017, ECOSYST SERV, V26, P329, DOI 10.1016/j.ecoser.2016.11.008; TAYLOR J, 1995, LANDSCAPE URBAN PLAN, V33, P47, DOI 10.1016/0169-2046(94)02013-6; The Sierra Club, 1998, DARK SID AM DREAM CO; Troy A, 2006, ECOL ECON, V60, P435, DOI 10.1016/j.ecolecon.2006.04.007; Tuttle CM, 2015, RESOUR ENERGY ECON, V39, P1, DOI 10.1016/j.reseneeco.2014.11.001; U.S. Department of Housing and Urban Development, 1999, STAT CIT 1999; United Nations, 2014, 2014 REV WORLD URB P; Value of Nature to Canadians Study Taskforce, 2017, COMPL US EC SERV ASS; Van der Ploeg S., 2010, TEEB VALUATION DATAB; Van Houtven G, 2014, ECOL ECON, V99, P40, DOI 10.1016/j.ecolecon.2013.12.018; WALSH RG, 1984, LAND ECON, V60, P14, DOI 10.2307/3146089; Whitehead JC, 2008, J ECON SURV, V22, P872, DOI 10.1111/j.1467-6419.2008.00552.x; Wilson S. J., 2008, ONTARIOS WEALTH CANA; Winfree R, 2011, ECOL ECON, V71, P80, DOI 10.1016/j.ecolecon.2011.08.001; Xue D, 2001, BIODIVERS CONSERV, V10, P467, DOI 10.1023/A:1016630825913; Yoo J, 2014, ECOL ECON, V97, P74, DOI 10.1016/j.ecolecon.2013.11.001; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Zhang CW, 2010, ECOL ECON, V70, P394, DOI 10.1016/j.ecolecon.2010.09.011	132	1	1	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245045	10.1371/journal.pone.0245045	http://dx.doi.org/10.1371/journal.pone.0245045			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PY3TH	33465112	gold, Green Published			2022-12-26	WOS:000611969200007
J	Presta, V; Paraboschi, F; Marsella, F; Lucarini, V; Galli, D; Mirandola, P; Banchini, A; Marchesi, C; Galuppo, L; Vitale, M; Tonna, M; Gobbi, G				Presta, Valentina; Paraboschi, Francesca; Marsella, Filippo; Lucarini, Valeria; Galli, Daniela; Mirandola, Prisco; Banchini, Antonio; Marchesi, Carlo; Galuppo, Laura; Vitale, Marco; Tonna, Matteo; Gobbi, Giuliana			Posture and gait in the early course of schizophrenia	PLOS ONE			English	Article							SWAY; RISK; DISTURBANCES; INDIVIDUALS; PARAMETERS; DISORDERS; ONSET	While correlations between postural stability deficits and schizophrenia are well documented, information on dynamic motor alterations in schizophrenia are still scarce, and no data on their onset are available yet. Therefore, the aim of this study was i) to measure gait pattern(s) in patients with schizophrenia; ii) to identify posture and gait alterations which could potentially be used as a predictive clinical tool of the onset of the disorder. Body composition, posture and gait parameters were assessed in a group of 30 patients with schizophrenia and compared to 25 healthy subjects. Sway area was significantly higher in the schizophrenia group compared to controls regardless of whether the participants were in eyes open or eyes closed condition. Gait cadence and speed were significantly lower in patients with schizophrenia, while stride length was similar. We concluded that the combination of an increased sway area (independent from eye closure) and a gait cadence reduction-in the presence of normal gait speed and stride length-might be considered peculiar postural and gait profile characteristic of early schizophrenia.	[Presta, Valentina; Galli, Daniela; Mirandola, Prisco; Banchini, Antonio; Vitale, Marco; Gobbi, Giuliana] Univ Parma, Dept Med & Surg Human Anat, Parma, Italy; [Presta, Valentina] Univ Parma, Dept Med & Surg, Human Anat, Parma, Italy; [Paraboschi, Francesca; Tonna, Matteo] Local Hlth Serv, Dept Mental Hlth, Parma, Italy; [Marsella, Filippo; Lucarini, Valeria; Marchesi, Carlo] Univ Parma, Dept Neurosci, Psychiat Unit, Parma, Italy; [Galuppo, Laura] AUSL Reggio Emilia, Reggio Emilia, Italy; [Vitale, Marco] Parma Univ Hosp, Movement Anal Lab LAM, Parma, Italy	University of Parma; University of Parma; University of Parma; University of Parma; University Hospital of Parma	Vitale, M (corresponding author), Univ Parma, Dept Med & Surg Human Anat, Parma, Italy.; Vitale, M (corresponding author), Parma Univ Hosp, Movement Anal Lab LAM, Parma, Italy.	marco.vitale@unipr.it		Lucarini, Valeria/0000-0002-3553-8818; Presta, Valentina/0000-0003-0820-9135	Cariparma [VITALE_2017_FONDCARIPR]; National Research Program - Italian Ministry of the University and Research, MIUR [2017RS5M44]	Cariparma; National Research Program - Italian Ministry of the University and Research, MIUR(Ministry of Education, Universities and Research (MIUR))	This study was supported by Cariparma to MV [grant number VITALE_2017_FONDCARIPR]; and the National Research Program -Italian Ministry of the University and Research, MIUR [grant number 2017RS5M44]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen NC, 2005, AM J PSYCHIAT, V162, P441, DOI 10.1176/appi.ajp.162.3.441; [Anonymous], 2006, INT J SYSTEMATIC THE, V8.1, P8; Apthorp D, 2019, SCHIZOPHRENIA BULL, V45, P512, DOI 10.1093/schbul/sby141; Chan RCK, 2018, EUR ARCH PSY CLIN N, V268, P49, DOI 10.1007/s00406-017-0828-4; Chern Jen-Suh, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P2329, DOI 10.1109/EMBC.2018.8512870; Cristiano VB, 2017, INT J PSYCHIAT CLIN, V21, P104, DOI 10.1080/13651501.2016.1249892; Dean DJ, 2015, SCHIZOPHR RES, V162, P86, DOI 10.1016/j.schres.2014.12.039; First MB, 2002, PSYCHOPATHOLOGY, V35, P67, DOI 10.1159/000065121; Fujino H, 2015, PSYCHIAT QUART, V86, P603, DOI 10.1007/s11126-015-9355-5; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Herz MI, 1997, AM J PSYCHIAT, V154, P1; Hirjak D, 2018, NEUROSCI BIOBEHAV R, V87, P87, DOI 10.1016/j.neubiorev.2018.01.011; Huang Ji-Jer, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P4245, DOI 10.1109/EMBC.2018.8513305; Ikai S, 2016, ASIAN J PSYCHIATR, V19, P14, DOI 10.1016/j.ajp.2015.11.008; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kendler KS, 2016, JAMA PSYCHIAT, V73, P1082, DOI 10.1001/jamapsychiatry.2016.1976; Kent JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041808; Kim T, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00286; Lallart E, 2012, PSYCHIAT RES, V198, P366, DOI 10.1016/j.psychres.2011.12.013; Lemay JF, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-8; Marvel CL, 2004, SCHIZOPHR RES, V68, P363, DOI 10.1016/j.schres.2003.09.003; Matsuura Y, 2015, GAIT POSTURE, V41, P847, DOI 10.1016/j.gaitpost.2015.03.006; Newton R, 2018, NPJ SCHIZOPHR, V4, DOI 10.1038/s41537-018-0063-7; Owen MJ, 2016, LANCET, V388, P86, DOI 10.1016/S0140-6736(15)01121-6; Ozbulut O, 2013, PSYCHIAT RES, V210, P806, DOI 10.1016/j.psychres.2013.09.015; Parnas J, 2005, PSYCHOPATHOLOGY, V38, P236, DOI 10.1159/000088441; Putzhammer A, 2005, PSYCHIAT CLIN NEUROS, V59, P303, DOI 10.1111/j.1440-1819.2005.01375.x; Putzhammer A, 2004, SCHIZOPHR RES, V69, P159, DOI 10.1016/S0920-9964(03)00090-2; Quednow BB, 2008, BIOL PSYCHIAT, V64, P766, DOI 10.1016/j.biopsych.2008.04.019; Sadowska D, 2015, J APPL BIOMECH, V31, P318, DOI 10.1123/jab.2014-0228; Sanders Richard D, 2010, Psychiatry (Edgmont), V7, P38; Schmahmann JD, 2007, CEREBELLUM, V6, P254, DOI 10.1080/14734220701490995; Stensdotter AK, 2013, GAIT POSTURE, V38, P918, DOI 10.1016/j.gaitpost.2013.04.017; Stensdotter AK, 2013, J MOTOR BEHAV, V45, P279, DOI 10.1080/00222895.2013.791241; Strassnig M, 2017, EARLY INTERV PSYCHIA, V11, P229, DOI 10.1111/eip.12225; Teng YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158219; Tonna M, 2014, CEREBELLUM, V13, P531, DOI 10.1007/s12311-014-0561-8; Tsai MT, 2018, SCHIZOPHR RES, V197, P138, DOI 10.1016/j.schres.2018.01.023; Walther S, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0856-9	39	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245661	10.1371/journal.pone.0245661	http://dx.doi.org/10.1371/journal.pone.0245661			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PY3TH	33465166	Green Published, gold			2022-12-26	WOS:000611969200027
J	Andrew-Peter-Leon, MT; Ramchander, S; Kumar, KK; Muthamilarasan, M; Pillai, MA				Andrew-Peter-Leon, M. T.; Ramchander, S.; Kumar, K. K.; Muthamilarasan, Mehanathan; Pillai, M. Arumugam			Assessment of efficacy of mutagenesis of gamma-irradiation in plant height and days to maturity through expression analysis in rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GIBBERELLIN METABOLISM; GENETIC-VARIABILITY; HEADING DATE; MILLED-RICE; MUTANTS; QTLS; IDENTIFICATION; POPULATION; REGION	Introduction of semi-dwarfism and early maturity in rice cultivars is important to achieve improved plant architecture, lodging resistance and high yield. Gamma rays induced mutations are routinely used to achieve these traits. We report the development of a semi-dwarf, early maturing and high-yielding mutant of rice cultivar 'Improved White Ponni', a popular cosmopolitan variety in south India preferred for its superior grain quality traits. Through gamma rays induced mutagenesis, several mutants were developed and subjected to selection up to six generations (M-6) until the superior mutants were stabilized. In the M-6 generation, significant reduction in days to flowering (up to 11.81% reduction) and plant height (up to 40% reduction) combined with an increase in single plant yield (up to 45.73% increase) was observed in the mutant population. The cooking quality traits viz., linear elongation ratio, breadthwise expansion ratio, gel consistency and gelatinization temperature of the mutants were similar to the parent variety Improved White Ponni. The genetic characterization with SSR markers showed variability between the semi-dwarf-early mutants and the Improved White Ponni. Gibberellin responsiveness study and quantitative real-time PCR showed a faulty gibberellin pathway and epistatic control between the genes such as OsKOL4 and OsBRD2 causing semi-dwarfism in a mutant. These mutants have potential as new rice varieties and can be used as new sources of semi-dwarfism and earliness for improving high grain quality rice varieties.	[Andrew-Peter-Leon, M. T.; Pillai, M. Arumugam] Tamil Nadu Agr Univ, Dept Plant Breeding & Genet, Agr Coll & Res Inst, Tuticorin, Tamil Nadu, India; [Ramchander, S.] Int Crops Res Inst Semi Arid Trop, IRRI South Asia Hub, Patancheru, Andhra Pradesh, India; [Kumar, K. K.] Tamil Nadu Agr Univ, Ctr Plant Mol Biol & Biotechnol, Coimbatore, Tamil Nadu, India; [Muthamilarasan, Mehanathan] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad, Telangana, India	Tamil Nadu Agricultural University; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Tamil Nadu Agricultural University; University of Hyderabad	Pillai, MA (corresponding author), Tamil Nadu Agr Univ, Dept Plant Breeding & Genet, Agr Coll & Res Inst, Tuticorin, Tamil Nadu, India.	mapillai1@hotmail.com	Pillai, Arumugam/AAD-6317-2022; Pillai, Arumugam M/A-1526-2010; leon, Andrew peter/AAV-3845-2021; Ramchander, S./AGR-8818-2022	Ramchander, S./0000-0002-1734-1288; PILLAI, ARUMUGAM/0000-0002-4383-2574				Aach H, 1997, PLANTA, V202, P211, DOI 10.1007/s004250050121; Alvarado G., 2016, CIMMYT RES DATA SOFT, V20, P2017; [Anonymous], 1986, ALN, V11, P244; [Anonymous], 2005, CULTURAL GEOGRAPHIES, V12, P151; [Anonymous], 1967, JAPANESE J BREEDING; Bughio, 2006, PLANT MUTATION REPOR, V1, P13; Burton G.W., 1952, P 6 INT GRASSLAND C, V1, P227; Chern CG, 2007, PLANT MOL BIOL, V65, P427, DOI 10.1007/s11103-007-9218-z; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Dalrymple D. G., 1986, Development and spread of high-yielding rice varieties in developing countries.; Fang YX, 2015, PLANT GROWTH REGUL, V77, P157, DOI 10.1007/s10725-015-0047-9; Fu HW, 2007, ISR J PLANT SCI, V55, P201, DOI 10.1560/IJPS.55.2.201; Fu HW, 2008, MOL BREEDING, V22, P281, DOI 10.1007/s11032-008-9173-7; Fujino K, 2008, BREEDING SCI, V58, P367, DOI 10.1270/jsbbs.58.367; Gao DY, 2009, PLANT CELL TISS ORG, V98, P187, DOI 10.1007/s11240-009-9551-9; Han Y, 2019, 3 BIOTECH, V9, DOI 10.1007/s13205-019-1919-x; Hedden P, 2015, J PLANT GROWTH REGUL, V34, P740, DOI 10.1007/s00344-015-9546-1; Helliwell CA, 2001, P NATL ACAD SCI USA, V98, P2065, DOI 10.1073/pnas.041588998; Hori K, 2012, BREEDING SCI, V62, P223, DOI 10.1270/jsbbs.62.223; IRRI, 2006, BREED GRAIN QUAL MAN; IRRI, 2013, STAND EV SYST SES RI; Ishikawa S, 2005, PLANT CELL PHYSIOL, V46, P79, DOI 10.1093/pcp/pci022; JOHNSON HERBERT W., 1955, AGRON JOUR, V47, P477; JULIANO BO, 1971, CEREAL SCI TODAY, V16, P334; JULIANO BO, 1984, J CEREAL SCI, V2, P281, DOI 10.1016/S0733-5210(84)80016-8; Kadambari G, 2018, PLANT CELL REP, V37, P677, DOI 10.1007/s00299-018-2260-2; Kanbe T, 2008, PLANT PROD SCI, V11, P447, DOI 10.1626/pps.11.447; Kebriyaee D., 2012, Notulae Scientia Biologicae, V4, P116; Lapitan VC, 2009, CROP SCI, V49, P1620, DOI 10.2135/cropsci2008.11.0655; Liang YS, 2011, RICE SCI, V18, P265, DOI 10.1016/S1672-6308(12)60004-3; LIN Y, 2011, BIOINFORMATICS, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUSH J. L., 1940, Record of Proceedings. American Society of Animal Production, P293; Marathi B, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-137; Miclea C, 2007, ROM J INF SCI TECH, V10, P243; Moncada P, 2001, THEOR APPL GENET, V102, P41, DOI 10.1007/s001220051616; Nguyen Thi Hong, 2015, International Journal of Agricultural Technology, V11, P1793; Nirmaladevi G, 2015, SABRAO J BREED GENET, V47, P424; Oladosu Y, 2015, AGROCIENCIA-MEXICO, V49, P249; Padron E, 2020, DEV NEW SEMIDWARF SO; Panse V.G., 1964, STAT METHODS AGR WOR, V2nd Edn; Perrier X., 2006, DARWIN SOFTWARE; Qiao F, 2011, PLANT MOL BIOL REP, V29, P952, DOI 10.1007/s11105-011-0309-2; R Core Team, 2018, R LANG ENV STAT COMP; Rabiei B., 2007, Journal of Agricultural Science and Technology, V9, P235; Rajendran R, 2014, HINDU; Ramchander S., 2015, Biochemical and Cellular Archives, V15, P171; Ramchander S., 2015, Indian Journal of Agricultural Research, V49, P24, DOI 10.5958/0976-058X.2015.00003.7; Rao DMR, 1997, EUPHYTICA, V95, P45, DOI 10.1023/A:1002970021399; Rutger J. N, 1992, MUTATION BREEDING RE; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Sangodele E A, 2014, INT J CURR RES ACAD, V2, P108; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Shobha Rani N, 2007, ORYZA, V44, P212; Subudhi PK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20324-1; Takeuchi Y, 2008, BREEDING SCI, V58, P437, DOI 10.1270/jsbbs.58.437; The Gene Ontology Consortium, 2008, NUCL ACIDS RES, V36, pD440; Tong JP, 2007, GENET RES, V89, P221, DOI 10.1017/S0016672307009020; Tong JP, 2016, G3-GENES GENOM GENET, V6, P1491, DOI 10.1534/g3.116.028720; Trinh Hoang Khai, 2005, Omonrice, P121; TUANH T, 2018, AGRICULTURE-LONDON, V8, P30; van Zanten L, 1998, GLOBAL ACHIEVEMENTS; Vikash Kumar, 2012, International Journal of Plant Breeding and Genetics, V6, P195; Wang L, 2009, PLANT J, V57, P498, DOI 10.1111/j.1365-313X.2008.03707.x; Wei T, 2017, R PACKAGE CORRPLOT V; Wu X, 2000, BREEDING SCI, V50, P17, DOI 10.1270/jsbbs.50.17; Wu ZGG, 2018, J EXP BOT, V69, P4703, DOI 10.1093/jxb/ery243; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yao XY, 2016, J INTEGR AGR, V15, P2437, DOI [10.1016/S2095-3119(15)61311-9, 10.1016/s2095-3119(15)61311-9]; Zhao XQ, 2016, THEOR APPL GENET, V129, P141, DOI 10.1007/s00122-015-2616-8; Zhu SF, 2005, PLANT PHYSIOL, V139, P1935, DOI 10.1104/pp.105.072306	72	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245603	10.1371/journal.pone.0245603	http://dx.doi.org/10.1371/journal.pone.0245603			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449977	gold, Green Published			2022-12-26	WOS:000609991600003
J	Fujii, S; Muranaka, T; Matsubayashi, J; Yamada, S; Yoneyama, A; Takakuwa, T				Fujii, Sena; Muranaka, Taiga; Matsubayashi, Jun; Yamada, Shigehito; Yoneyama, Akio; Takakuwa, Tetsuya			Bronchial tree of the human embryo: Categorization of the branching mode as monopodial and dipodial	PLOS ONE			English	Article								Some human organs are composed of bifurcated structures. Two simple branching modes-monopodial and dipodial-have been proposed. With monopodial branching, child branches extend from the sidewall of the parent branch. With dipodial branching, the tip of the bronchus bifurcates. However, the branching modes of the human bronchial tree have not been elucidated precisely. A total of 48 samples between Carnegie stage (CS) 15 and CS23 belonging to the Kyoto Collection were used to acquire imaging data with phase-contrast X-ray computed tomography. Bronchial trees of all samples were three-dimensionally reconstructed from the image data. We analyzed the lobar bronchus, segmental bronchus, and subsegmental bronchus. After calculating each bronchus length, we categorized the branching mode of the analyzed bronchi based on whether the parent bronchus was divided after generation of the analyzed bronchi. All lobar bronchi were formed with monopodial branching. Twenty-five bifurcations were analyzed to categorize the branching mode of the segmental and subsegmental bronchi; 22 bifurcations were categorized as monopodial branching, two bifurcations were not categorized as any branching pattern, and the only lingular bronchus that bifurcated from the left superior lobar bronchus was categorized as dipodial branching. The left superior lobar bronchus did not shorten during the period from CS17 or CS18, when the child branch was generated, to CS23. All analyzed bronchi that could be categorized, except for one, were categorized as monopodial branching. The branching modes of the lobar bronchus and segmental bronchus were similar in the mouse lung and human lung; however, the modes of the subsegmental bronchi were different. Furthermore, remodeling, such as shrinkage of the bronchus, was not observed during the analysis period. Our three-dimensional reconstructions allowed precise calculation of the bronchus length, thereby improving the knowledge of branching morphogenesis in the human embryonic lung.	[Fujii, Sena; Muranaka, Taiga; Matsubayashi, Jun; Yamada, Shigehito; Takakuwa, Tetsuya] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan; [Yamada, Shigehito] Kyoto Univ, Grad Sch Med, Congenital Anomaly Res Ctr, Kyoto, Japan; [Yoneyama, Akio] SAGA Light Source, Saga, Japan	Kyoto University; Kyoto University	Takakuwa, T (corresponding author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan.	tez@hs.med.kyoto-u.ac.jp	Yamada, Shigehito/G-2061-2010	Yamada, Shigehito/0000-0002-8194-6927; Matsubayashi, Jun/0000-0003-4104-6833; Yoneyama, Akio/0000-0001-6925-6723; Takakuwa, Tetsuya/0000-0002-9660-9384	Japan Society for the Promotion of Science [JP16K15535, JP17H05294, JP18K07876, JP26220004]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Society for the Promotion of Science, Grant/Award Number: JP16K15535, JP17H05294, JP18K07876 and JP26220004 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOYDEN EA, 1948, AM J ANAT, V82, P27, DOI 10.1002/aja.1000820103; BOYDEN EA, 1946, AM J ANAT, V79, P321, DOI 10.1002/aja.1000790302; BOYDEN EA, 1951, J THORAC SURG, V21, P172; Fujii S, 2020, J ANAT, V237, P311, DOI 10.1111/joa.13199; Huang M, 2019, SURG RADIOL ANAT, V41, P335, DOI 10.1007/s00276-019-02199-7; Lindstrom NO, 2015, J ANAT, V226, P13, DOI 10.1111/joa.12239; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; NISHIMURA H, 1968, TERATOLOGY, V1, P281, DOI 10.1002/tera.1420010306; O'Rahilly R., 1987, DEV STAGES HUMAN EMB, P1; Onuma K, 2001, TOHOKU J EXP MED, V194, P157, DOI 10.1620/tjem.194.157; PALMER DWIGHT M., 1936, OHIO JOUR SCI, V36, P69; SHIOTA K, 1991, Congenital Anomalies, V31, P67, DOI 10.1111/j.1741-4520.1991.tb00360.x; Streeter George L., 1948, CONTRIBUTIONS TO EMBRYOLOGY [CARNEGIE INST OF WASHINGTON PUBL], V32, P133; Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025; WELLS LJ, 1954, AM J ANAT, V95, P163, DOI 10.1002/aja.1000950202; Yamashita H, 1978, ROENTGENOLOGIC ANATO, P91; Yoneyama A, 2011, ADVANCED BIOMEDICAL ENGINEERING-BOOK, P107	17	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245558	10.1371/journal.pone.0245558	http://dx.doi.org/10.1371/journal.pone.0245558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449967	Green Published, gold			2022-12-26	WOS:000609991600047
J	Reeve, S; Sheaves, B; Freeman, D				Reeve, Sarah; Sheaves, Bryony; Freeman, Daniel			Excessive sleepiness in patients with psychosis: An initial investigation	PLOS ONE			English	Article							PERSECUTORY DELUSIONS; DAYTIME SLEEPINESS; UNITED-STATES; SCHIZOPHRENIA; HYPERSOMNIA; FATIGUE; DEPRESSION; EXPERIENCE; DISORDERS; CLOZAPINE	Clinical experience indicates that excessive sleepiness and hypersomnia may be a common issue for patients with psychosis. Excessive sleepiness is typically ascribed to the sedating effects of antipsychotic medications but there may be other potential contributors such as sleep disorders and depression. Furthermore, the impact of excessive sleepiness itself on patients' symptoms and general wellbeing is yet to be examined. The current study reports an exploratory cross-sectional between-groups comparison of patients with early psychosis fulfilling criteria assessed in a diagnostic interview for problematic excessive sleepiness (n = 14), compared with those not reporting excessive sleepiness (n = 46). There were no differences between the groups in diagnosis, medication type, or antipsychotic medication dosage. There were no significant group differences in sleep duration. Significantly lower activity levels were found in the excessive sleepiness group. Insomnia and nightmares were common in those reporting excessive sleepiness. No significant differences were found in psychiatric symptoms, although data did indicate more severe cognitive disorganisation and grandiosity, but less severe paranoia and hallucinations, in the excessive sleepiness group. Wide confidence intervals and small sample size mean that care should be taken interpreting these results. Overall, this study indicates that excessive sleepiness may not be solely related to medication but also to low levels of activity and other sleep disorders. This is a novel finding that, if replicated, could indicate routes of intervention for this clinical issue. Future research should aim to disentangle directions of effect amongst sleepiness, mood, activity, and psychotic symptoms and investigate possible interventions for excessive sleepiness in psychosis.	[Reeve, Sarah] UCL, Dept Clin Educ & Hlth Psychol, London, England; [Sheaves, Bryony; Freeman, Daniel] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Sheaves, Bryony; Freeman, Daniel] Warneford Hosp, Oxford Hlth NHS Fdn Trust, Oxford, England	University of London; University College London; University of Oxford	Reeve, S (corresponding author), UCL, Dept Clin Educ & Hlth Psychol, London, England.	sarah.reeve.18@ucl.ac.uk		Sheaves, Bryony/0000-0002-2995-193X; Reeve, Sarah/0000-0002-9374-0950	Medical Research Council Doctoral Studentship; Balliol College Dervorguilla Scholarship (University of Oxford); NIHR clinical doctoral fellowship [ICA-CDRF-2017-03-088]; NIHR Research Professorship [NIHR-RP-2014-05-003]; NIHR Oxford Health Biomedical Research Centre	Medical Research Council Doctoral Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Balliol College Dervorguilla Scholarship (University of Oxford); NIHR clinical doctoral fellowship; NIHR Research Professorship; NIHR Oxford Health Biomedical Research Centre	This research was supported by a Medical Research Council Doctoral Studentship and a Balliol College Dervorguilla Scholarship (University of Oxford) to S.R., B.S. is supported by an NIHR clinical doctoral fellowship (ICA-CDRF-2017-03-088), and D.F. is supported by an NIHR Research Professorship (NIHR-RP-2014-05-003). This study was supported by the NIHR Oxford Health Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	AASS, 2014, INT CLASSIFICATION S; Afonso P, 2014, WORLD J BIOL PSYCHIA, V15, P517, DOI 10.3109/15622975.2012.756987; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, DOI DOI 10.1176/APPI.BOOKS.9780890425596.893619; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; BILLIARD M, 1994, J PSYCHOSOM RES, V38, P41, DOI 10.1016/0022-3999(94)90134-1; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Carney CE, 2012, SLEEP, V35, P287, DOI 10.5665/sleep.1642; Dauvilliers Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-78; Fang F, 2016, CNS DRUGS, V30, P845, DOI 10.1007/s40263-016-0352-5; Faulkner S, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1329-8; Freeman D, 2016, LANCET PSYCHIAT, V3, P685, DOI 10.1016/S2215-0366(16)00066-3; Harvey AG, 2012, PSYCHOL BULL, V138, P77, DOI 10.1037/a0025730; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; IBM Corp, 2011, REL IBM SPSS STAT WI; ICSD-3, 2014, ICSD 3 INT CLASS SLE, DOI [10.1111/febs.12678, DOI 10.1111/FEBS.12678]; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaplan KA, 2015, PSYCHOL MED, V45, P1751, DOI 10.1017/S0033291714002918; Kaplan KA, 2009, SLEEP MED REV, V13, P275, DOI 10.1016/j.smrv.2008.09.001; Kluge M, 2012, SCHIZOPHR RES, V135, P123, DOI 10.1016/j.schres.2011.12.017; Leucht S, 2016, SCHIZOPHRENIA BULL, V42, pS90, DOI 10.1093/schbul/sbv167; Lovibond SH., 1995, MANUAL DEPRESSION AN, V56; Martin J, 2001, SCHIZOPHR RES, V47, P77, DOI 10.1016/S0920-9964(00)00029-3; Maslowsky J, 2014, J ADOLESCENT HEALTH, V54, P691, DOI 10.1016/j.jadohealth.2013.10.201; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Merikangas KR, 2014, SLEEP MED, V15, P530, DOI 10.1016/j.sleep.2013.10.011; Miller Del D, 2004, Prim Care Companion J Clin Psychiatry, V6, P3; Morrison P, 2015, INT J MENT HEALTH NU, V24, P253, DOI 10.1111/inm.12110; NOFZINGER EA, 1991, AM J PSYCHIAT, V148, P1177; Parkes JD, 1998, J SLEEP RES, V7, P41, DOI 10.1046/j.1365-2869.1998.00093.x; Poulin J, 2010, PSYCHIAT RES, V179, P274, DOI 10.1016/j.psychres.2009.08.009; Perdigues SR, 2016, EUR NEUROPSYCHOPHARM, V26, P156, DOI 10.1016/j.euroneuro.2015.11.006; Reeve S, 2019, SCHIZOPHRENIA BULL, V45, P287, DOI 10.1093/schbul/sby129; Ronald A, 2014, SCHIZOPHRENIA BULL, V40, P868, DOI 10.1093/schbul/sbt106; Sharma P, 2016, J CLIN DIAGN RES, V10, pVC6, DOI 10.7860/JCDR/2016/21272.8627; Sheaves B, 2021, PSYCHOL PSYCHOTHER-T, V94, P341, DOI 10.1111/papt.12303; Sheaves B, 2018, BEHAV COGN PSYCHOTH, V46, P661, DOI 10.1017/S1352465817000789; Shen JH, 2006, SLEEP MED REV, V10, P63, DOI 10.1016/j.smrv.2005.05.004; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Stein KD, 2004, J PAIN SYMPTOM MANAG, V27, P14, DOI 10.1016/j.jpainsymman.2003.06.003; Stubbs B, 2016, SCHIZOPHR RES, V171, P103, DOI 10.1016/j.schres.2016.01.034; Tandon R, 2020, ANN GEN PSYCHIATR, V19, DOI 10.1186/s12991-020-00292-5; Trotti LM, 2017, SLEEP MED REV, V35, P76, DOI 10.1016/j.smrv.2016.08.005; Vgontzas AN, 2000, PSYCHOSOM MED, V62, P220, DOI 10.1097/00006842-200003000-00013; Vorontsova N, 2013, J ABNORM PSYCHOL, V122, P1121, DOI 10.1037/a0034952; Waite F, 2016, PSYCHOL PSYCHOTHER-T, V89, P181, DOI 10.1111/papt.12073; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; World Health Organisation, 2017, DEF DAIL DOS DDD DEF	48	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245301	10.1371/journal.pone.0245301	http://dx.doi.org/10.1371/journal.pone.0245301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4XD	33449971	Green Published, gold, Green Accepted			2022-12-26	WOS:000609991600041
J	Baek, MS; Cha, MJ; Kim, MC; Chung, JW; Kim, WY; Choi, H; Choi, SH				Baek, Moon Seong; Cha, Min Jae; Kim, Min-Chul; Chung, Jin-Won; Kim, Won-Young; Choi, Hyewon; Choi, Seong-Ho			Clinical and radiological findings of adult hospitalized patients with community-acquired pneumonia from SARS-CoV-2 and endemic human coronaviruses	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; DISEASE 2019 COVID-19; THIN-SECTION CT	Endemic human coronaviruses (HCoVs) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are members of the family Coronaviridae. Comparing the findings of the infections caused by these viruses would help reveal the novel characteristics of SARS-CoV-2 and provide insight into the unique pathogenesis of SARS-CoV-2 infection. This study aimed to compare the clinical and radiological characteristics of SARS-CoV-2 and endemic HCoVs infection in adult hospitalized patients with community-acquired pneumonia (CAP). This study was performed at a university-affiliated tertiary hospital in the Republic of Korea, between January 1, 2015, and July 31, 2020. A total of 109 consecutive patients who were over 18 years of age with confirmed SARS-CoV-2 and endemic HCoVs were enrolled. Finally, 19 patients with SARS-CoV-2 CAP were compared to 40 patients with endemic HCoV CAP. Flu-like symptoms such as cough, sore throat, headache, myalgia, and prolonged fever were more common in SARS-CoV-2 CAP, whereas clinical findings suggestive of bacterial pneumonia such as dyspnea, leukocytosis with left shift, and increased C-reactive protein were more common in endemic HCoV CAP. Bilateral peripherally distributed ground-glass opacities (GGOs) were typical radiologic findings in SARS-CoV-2 CAP, whereas mixed patterns of GGOs, consolidations, micronodules, and pleural effusion were observed in endemic HCoV CAP. Coinfection was not observed in patients with SARS-CoV-2 CAP, but was observed in more than half of the patients with endemic HCoV CAP. There were distinctive differences in the clinical and radiologic findings between SARS-CoV-2 and endemic HCoV CAP. Further investigations are required to elucidate the mechanism underlying this difference. Follow-up observations are needed to determine if the presentation of SARS-CoV-2 CAP changes with repeated infection.	[Baek, Moon Seong; Kim, Won-Young] Chung Ang Univ, Chung Ang Univ Hosp, Dept Internal Med, Coll Med, Seoul, South Korea; [Cha, Min Jae; Choi, Hyewon] Chung Ang Univ Hosp, Dept Radiol, Seoul, South Korea; [Kim, Min-Chul; Chung, Jin-Won; Choi, Seong-Ho] Chung Ang Univ, Chung Ang Univ Hosp, Dept Infect Dis, Dept Internal Med,Coll Med, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital	Choi, SH (corresponding author), Chung Ang Univ, Chung Ang Univ Hosp, Dept Infect Dis, Dept Internal Med,Coll Med, Seoul, South Korea.	tobeservant@cau.ac.kr	Kim, Won-Young/AHE-5670-2022	Kim, Won-Young/0000-0002-6038-9818; Baek, Moon Seong/0000-0001-6455-0376; Choi, Seong-Ho/0000-0001-8108-2412; Cha, Min Jae/0000-0001-6358-8081	National Research Foundation of Korea - Korea Government (MSIP) [2019R1C1C1006417]	National Research Foundation of Korea - Korea Government (MSIP)	Seong-Ho Choi was supported by the National Research Foundation of Korea grant funded by the Korea Government (MSIP) (2019R1C1C1006417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; Bai HX, 2020, RADIOLOGY, V296, pE46, DOI 10.1148/radiol.2020200823; Bernheim A, 2020, RADIOLOGY, V295, P685, DOI 10.1148/radiol.2020200463; Das KM, 2015, AM J ROENTGENOL, V204, P736, DOI 10.2214/AJR.14.13671; Di Castelnuovo A, 2020, VASC PHARMACOL, V135, DOI 10.1016/j.vph.2020.106805; Di Castelnuovo A, 2020, NUTR METAB CARDIOVAS, V30, P1899, DOI 10.1016/j.numecd.2020.07.031; Galante O, 2016, AM J RESP CRIT CARE, V193, P100, DOI 10.1164/rccm.201506-1239LE; Gussow Ayal B, 2020, bioRxiv, DOI 10.1101/2020.04.05.026450; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hong KH, 2020, ANN LAB MED, V40, P351, DOI 10.3343/alm.2020.40.5.351; Kanwar A, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx052; Kaur N, 2021, INFECT GENET EVOL, V89, DOI 10.1016/j.meegid.2020.104490; Koo HJ, 2020, RADIOGRAPHICS, V40, pE8, DOI 10.1148/rg.2020200097; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Ooi GC, 2004, RADIOLOGY, V230, P836, DOI 10.1148/radiol.2303030853; Pene F, 2003, CLIN INFECT DIS, V37, P929, DOI 10.1086/377612; Schnell D, 2010, RESP MED, V104, P1050, DOI 10.1016/j.rmed.2010.01.021; Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4; Walsh EE, 2013, J INFECT DIS, V208, P1634, DOI 10.1093/infdis/jit393; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Wong KT, 2003, RADIOLOGY, V228, P395, DOI 10.1148/radiol.2283030541; Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196	23	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245547	10.1371/journal.pone.0245547	http://dx.doi.org/10.1371/journal.pone.0245547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444422	gold, Green Published			2022-12-26	WOS:000609988100027
J	Chattopadhyay, S; Arnold, JD; Malayil, L; Hittle, L; Mongodin, EF; Marathe, KS; Gomez-Lobo, V; Sapkota, AR				Chattopadhyay, Suhana; Arnold, Justin D.; Malayil, Leena; Hittle, Lauren; Mongodin, Emmanuel F.; Marathe, Kalyani S.; Gomez-Lobo, Veronica; Sapkota, Amy R.			Potential role of the skin and gut microbiota in premenarchal vulvar lichen sclerosus: A pilot case-control study	PLOS ONE			English	Article							HIDRADENITIS SUPPURATIVA; STAPHYLOCOCCUS-AUREUS; ATOPIC-DERMATITIS; DISEASE; COLONIZATION; ASSOCIATION; MARKER	The etiology of vulvar lichen sclerosus (LS) remains unclear; however, alterations in cutaneous and gut microbiota may be contributing to the pathogenesis of this inflammatory condition. To explore this hypothesis, we conducted a pilot case-control study, obtaining dermal swab and stool samples from prepubertal girls with vulvar LS (n = 5), girls with nonspecific vulvovaginitis (n = 5), and healthy controls (n = 3). Samples (n = 56) were subjected to total DNA extractions. Resulting DNA was purified, subjected to PCR (targeting the V3V4 region of the 16S rRNA gene), sequenced, and analyzed using QIIME, MetagenomeSeq, and DESeq2 software packages. Our findings showed that there were significant differences in the cutaneous and gut microbiotas of girls with LS compared to controls. On the skin, girls with LS had a statistically significantly higher relative abundance of Porphyromonas spp., Parvimonas spp., Peptoniphilus spp., Prevotella spp., Dialister spp., and Peptostreptococcus spp., but a lower relative abundance of Cornyebacterium compared to the control group. In the gut samples, girls with LS had a significantly higher relative abundance of Dialister spp., Clostridiales spp., Paraprevotella spp., Escherichia coli, Bifidobacterium adolescentis, and Akkermansia muciniphila, and a lower relative abundance of Roseburia faecis and Ruminococcus bromii compared to controls. These results suggest a potential association between cutaneous and gut dysbiosis and pediatric vulvar LS. Future studies involving larger samples sizes are warranted to further evaluate this association.	[Chattopadhyay, Suhana; Malayil, Leena; Sapkota, Amy R.] Univ Maryland, Maryland Inst Appl Environm Hlth, Sch Publ Hlth, College Pk, MD 20742 USA; [Arnold, Justin D.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Hittle, Lauren; Mongodin, Emmanuel F.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Marathe, Kalyani S.] Childrens Natl Hlth Syst, Div Dermatol, Washington, DC USA; [Marathe, Kalyani S.] Univ Cincinnati, Dept Dermatol, Cincinnati, OH USA; [Gomez-Lobo, Veronica] MedStar Washington Hosp Ctr, Pediat & Adolescent Obstet & Gynecol, Childrens Natl Hlth Syst, Washington, DC USA; [Gomez-Lobo, Veronica] NICHHD, Pediat & Adolescent Gynecol, Bethesda, MD USA	University System of Maryland; University of Maryland College Park; George Washington University; University System of Maryland; University of Maryland Baltimore; Children's National Health System; University System of Ohio; University of Cincinnati; Children's National Health System; MedStar Washington Hospital Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Sapkota, AR (corresponding author), Univ Maryland, Maryland Inst Appl Environm Hlth, Sch Publ Hlth, College Pk, MD 20742 USA.	ars@umd.edu	Malayil, Leena/AAK-4679-2021; Chattopadhyay, Suhana/HHC-2870-2022	Malayil, Leena/0000-0002-8864-2678				Ananthakrishnan AN, 2012, GASTROENTEROLOGY, V142, P482, DOI 10.1053/j.gastro.2011.11.040; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang HW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0533-1; Chen LP, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000051; Chopyk J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00358; Cooper SM, 2008, ARCH DERMATOL, V144, P1432, DOI 10.1001/archderm.144.11.1432; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FRIEDRICH EG, 1984, NEW ENGL J MED, V310, P488, DOI 10.1056/NEJM198402233100803; Geoghegan JA, 2018, TRENDS MICROBIOL, V26, P484, DOI 10.1016/j.tim.2017.11.008; Gong JQ, 2006, BRIT J DERMATOL, V155, P680, DOI 10.1111/j.1365-2133.2006.07410.x; Guet-Revillet H, 2017, CLIN INFECT DIS, V65, P282, DOI 10.1093/cid/cix285; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hajishengallis G, 2014, TRENDS IMMUNOL, V35, P3, DOI 10.1016/j.it.2013.09.001; Holm JB, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00029-19; Kambura AK, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0748-x; Langan EA, 2019, BRIT J DERMATOL, V181, P1254, DOI 10.1111/bjd.17989; Lee A, 2015, JAMA DERMATOL, V151, P1061, DOI 10.1001/jamadermatol.2015.0643; Lewis DJ, 2019, CLIN DERMATOL, V37, P160, DOI 10.1016/j.clindermatol.2019.01.011; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Machiels K, 2014, GUT, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meisel JS, 2016, J INVEST DERMATOL, V136, P947, DOI 10.1016/j.jid.2016.01.016; Meylan P, 2017, J INVEST DERMATOL, V137, P2497, DOI 10.1016/j.jid.2017.07.834; Miheller P, 2009, INFLAMM BOWEL DIS, V15, P1656, DOI 10.1002/ibd.20947; O'Neill CA, 2016, BIOESSAYS, V38, P1167, DOI 10.1002/bies.201600008; Pannaraj PS, 2017, JAMA PEDIATR, V171, P647, DOI 10.1001/jamapediatrics.2017.0378; Venegas DP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01486; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Popadiak K, 2007, J IMMUNOL, V178, P7242, DOI 10.4049/jimmunol.178.11.7242; Potempa M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000316; Ring HC, 2017, JAMA DERMATOL, V153, P897, DOI 10.1001/jamadermatol.2017.0904; Ronger S, 2003, J Drugs Dermatol, V2, P23; Salem I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01459; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Tamanai-Shacoori Z, 2017, FUTURE MICROBIOL, V12, P157, DOI 10.2217/fmb-2016-0130; Tito RY, 2017, ARTHRITIS RHEUMATOL, V69, P114, DOI 10.1002/art.39802; Wallace H J, 1971, Trans St Johns Hosp Dermatol Soc, V57, P9; Waterhouse M, 2019, EUR J NUTR, V58, P2895, DOI 10.1007/s00394-018-1842-7; Weisberg P, 2004, AM J CLIN NUTR, V80, p1697S, DOI 10.1093/ajcn/80.6.1697S; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wolf B, 2017, GYNECOL ONCOL REP, V20, P73, DOI 10.1016/j.gore.2017.03.003	42	7	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245243	10.1371/journal.pone.0245243	http://dx.doi.org/10.1371/journal.pone.0245243			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444404	gold, Green Published			2022-12-26	WOS:000609988100058
J	Deme, S; Yeung, LY; Sun, T; Lee, CTA				Deme, Samiksha; Yeung, Laurence Y.; Sun, Tao; Lee, Cin-Ty A.			Stable isotope (C, N, O, and H) study of a comprehensive set of feathers from two Setophaga citrina	PLOS ONE			English	Article							DELTA-O-18 MEASUREMENTS; DRINKING-WATER; HYDROGEN; CARBON; NITROGEN; VALUES; RATIOS; C-13	Oxygen, hydrogen, carbon and nitrogen stable isotopes were measured on a comprehensive sampling of feathers from two spring Hooded Warblers (Setophaga citrina) in Texas to evaluate isotopic variability between feathers and during molt. Isotopic homogeneity within each bird was found across all four isotopic systems, supporting the hypothesis that molt in these neotropical migrants is fully completed on the breeding grounds. This homogeneity suggests that the isotopic composition of a single feather is may be representative of the whole songbird. However, each bird was found to have one or two outlier feathers, which could signify regrowth of lost feathers after prebasic molt.	[Deme, Samiksha; Yeung, Laurence Y.; Sun, Tao; Lee, Cin-Ty A.] Rice Univ, Dept Earth Environm & Planetary Sci, Houston, TX 77251 USA	Rice University	Deme, S (corresponding author), Rice Univ, Dept Earth Environm & Planetary Sci, Houston, TX 77251 USA.	srd8@rice.edu	Lee, Cin-Ty/AAV-8155-2021	Lee, Cin-Ty/0000-0002-3586-0110; Deme, Samiksha/0000-0001-9760-6524; Sun, Tao/0000-0001-6266-3350				Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; Bontempo L, 2014, METHODS ECOL EVOL, V5, P363, DOI 10.1111/2041-210X.12165; Bowen GJ, 2010, ANNU REV EARTH PL SC, V38, P161, DOI 10.1146/annurev-earth-040809-152429; Bridge ES, 2011, CONDOR, V113, P1, DOI 10.1525/cond.2011.100228; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Chiver I, 2011, HOODED WARBLER SETOP; English PA, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00014; Evans KL, 2012, OIKOS, V121, P634, DOI 10.1111/j.1600-0706.2011.19722.x; Gat J.R., 1980, HDB ENV ISOTOPE GEOC, V1, P21; Gordo O, 2020, J ORNITHOL, V161, P381, DOI 10.1007/s10336-019-01729-9; Graves GR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193486; Hobson KA, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00018.1; Hobson KA, 1999, CONDOR, V101, P799, DOI 10.2307/1370067; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Hobson KA, 2004, OECOLOGIA, V141, P477, DOI 10.1007/s00442-004-1671-7; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 2015, ECOL EVOL, V5, P799, DOI 10.1002/ece3.1383; Hobson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035137; Holmes RL, 2017, PACIFISM: A PHILOSOPHY OF NONVIOLENCE, P3; Howell S.N.G., 2010, MOLT N AM BIRDS; Hyodo F, 2015, ENTOMOL SCI, V18, P295, DOI 10.1111/ens.12128; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kendall C, 2001, HYDROL PROCESS, V15, P1363, DOI 10.1002/hyp.217; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Lachniet MS, 2009, EARTH PLANET SC LETT, V284, P435, DOI 10.1016/j.epsl.2009.05.010; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; MIZUTANI H, 1992, ECOLOGY, V73, P1391, DOI 10.2307/1940684; Perkins MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093281; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Soto DX, 2017, RAPID COMMUN MASS SP, V31, P1193, DOI 10.1002/rcm.7893; Still CJ, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P179, DOI 10.1007/978-90-481-3354-3_9; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wolf N, 2013, AUK, V130, P323, DOI 10.1525/auk.2013.12075; Wolf N, 2012, J EXP BIOL, V215, P1915, DOI 10.1242/jeb.065219; Wolf N, 2011, J EXP BIOL, V214, P98, DOI 10.1242/jeb.050211	35	0	0	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0236536	10.1371/journal.pone.0236536	http://dx.doi.org/10.1371/journal.pone.0236536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444336	Green Published, gold, Green Submitted			2022-12-26	WOS:000609988100064
J	Rodpai, R; Sanpool, O; Thanchomnang, T; Wangwiwatsin, A; Sadaow, L; Phupiewkham, W; Boonroumkaew, P; Intapan, PM; Maleewong, W				Rodpai, Rutchanee; Sanpool, Oranuch; Thanchomnang, Tongjit; Wangwiwatsin, Arporn; Sadaow, Lakkhana; Phupiewkham, Weeraya; Boonroumkaew, Patcharaporn; Intapan, Pewpan M.; Maleewong, Wanchai			Investigating the microbiota of fermented fish products (Pla-ra) from different communities of northeastern Thailand	PLOS ONE			English	Article							SP-NOV.; STARTER CULTURE; LACTOBACILLUS; SAUCE; IMPROVEMENT; WEISSELLA; BACTERIA	DNA-sequencing was performed on the V3-V4 regions of 16S rRNA genes to investigate the microbial diversity of five samples of fermented freshwater fish (pla-ra) from three provinces in northeastern Thailand. The samples had salt concentrations ranging from 7 to 10%, pH values from 4.83 to 7.15, and D-/L-lactic acid concentrations of 90 to 450 mg/l. A total of 598 operational taxonomic units were annotated at various taxonomic ranks based on the SILVA Database. The lactic-acid and halophilic genera Tetragenococcus, Halanaerobium and Lactobacillus were among the dominant taxa of bacteria. The top 20 non-redundant taxa were considered in more detail. In two pla-ra samples, Tetragenococcus muriaticus was commonly identified. Halanaerobium fermentans was the most abundant species in a third sample and co-dominant in another sample. Lactobacillus rennini was dominant in the pla-ra sample from Roi Et Province. Additionally, other beneficial bacteria were detected including Staphylococcus nepalensis, Lactobacillus sakei, Lactobacillus pentosus, Weissella confusa, and Bifidobacterium bifidum. Differences between samples may be due to use of different raw materials, salt concentrations, recipes, processes and fermentation periods. The microbial communities in pla-ra provide a better understanding of the production outcomes of traditional products. Further optimization of the fermentation process, for example by using dominant bacterial taxa in starter cultures, may improve processes of food fermentation, food quality and flavor control, providing useful guidelines for industrial applications.	[Rodpai, Rutchanee; Sanpool, Oranuch; Sadaow, Lakkhana; Phupiewkham, Weeraya; Boonroumkaew, Patcharaporn; Intapan, Pewpan M.; Maleewong, Wanchai] Khon Kaen Univ, Dept Parasitol, Fac Med, Khon Kaen, Thailand; [Rodpai, Rutchanee; Sanpool, Oranuch; Thanchomnang, Tongjit; Sadaow, Lakkhana; Phupiewkham, Weeraya; Boonroumkaew, Patcharaporn; Intapan, Pewpan M.; Maleewong, Wanchai] Mekong Hlth Sci Res Inst, Fac Med, Khon Kaen, Thailand; [Thanchomnang, Tongjit] Mahasarakram Univ, Fac Med, Mahasarakram, Thailand; [Wangwiwatsin, Arporn] Khon Kaen Univ, Dept Biol, Fac Sci, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University	Maleewong, W (corresponding author), Khon Kaen Univ, Dept Parasitol, Fac Med, Khon Kaen, Thailand.; Maleewong, W (corresponding author), Mekong Hlth Sci Res Inst, Fac Med, Khon Kaen, Thailand.	wanch_ma@kku.ac.th	Phupiewkham, Weeraya/AAZ-4802-2021	Rodpai, Rutchanee/0000-0003-0281-2101; Phupiewkham, Weeraya/0000-0001-5635-0171; Maleewong, Wanchai/0000-0002-6726-3759; Wangwiwatsin, Arporn/0000-0003-4536-4492; Thanchomnang, Tongjit/0000-0003-2604-0281; Sanpool, Oranuch/0000-0003-0451-0756	Thailand Research Fund [DPG6280002]; Khon Kaen University, Thailand [I62-00-24-11, PD2563-08]; Faculty of Medicine, Khon Kaen University [DR63101]	Thailand Research Fund(Thailand Research Fund (TRF)); Khon Kaen University, Thailand; Faculty of Medicine, Khon Kaen University	This study was supported by the Thailand Research Fund (grant no. DPG6280002) awarded toWMand PMI, the Khon Kaen University, Thailand (grant nos. I62-00-24-11 awarded toWM and PMI and PD2563-08 awarded toWMand RR) and the Faculty of Medicine, Khon Kaen University grant awarded to RR, OS andWM(DR63101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Please modify these sentences in financial disclosure.	Adams M. R., 1985, Tropical Science, V25, P61; An C, 2010, J SCI FOOD AGR, V90, P1796, DOI 10.1002/jsfa.4015; [Anonymous], 2017, J TELECOMMUNICATION, V9, P7; Ayeni FA, 2011, INT J FOOD MICROBIOL, V147, P97, DOI 10.1016/j.ijfoodmicro.2011.03.014; Behera SS, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9361614; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bintsis T, 2017, AIMS MICROBIOL, V3, P529, DOI 10.3934/microbiol.2017.3.529; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardinali F, 2018, INT J FOOD MICROBIOL, V278, P61, DOI 10.1016/j.ijfoodmicro.2018.04.032; Chenoll E, 2006, INT J SYST EVOL MICR, V56, P449, DOI 10.1099/ijs.0.64021-0; Chotechuang N, 2012, J NUTR FOOD SCI S, VS10, DOI [10.4172/2155-9600.S10-004, DOI 10.4172/2155-9600.S10-004]; Du FM, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7090371; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fukami K, 2004, FISHERIES SCI, V70, P916, DOI 10.1111/j.1444-2906.2004.00887.x; Fukami K, 2004, J FOOD SCI, V69, pM45; Gupta AK, 2011, INT J SYST EVOL MICR, V61, P1360, DOI 10.1099/ijs.0.018622-0; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hayek S. A., 2013, Food and Nutrition Sciences, V4, P73; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Hill D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02107; Igbinosa EO, 2010, INT J ENV RES PUB HE, V7, P3628, DOI 10.3390/ijerph7103628; Jung JY, 2013, FOOD MICROBIOL, V34, P360, DOI 10.1016/j.fm.2013.01.009; Jung SY, 2005, INT J SYST EVOL MICR, V55, P577, DOI 10.1099/ijs.0.63398-0; Kobayashi T, 2000, INT J SYST EVOL MICR, V50, P1621, DOI 10.1099/00207713-50-4-1621; Kurilshikov A, 2017, TRENDS IMMUNOL, V38, P633, DOI 10.1016/j.it.2017.06.003; Lofblom J, 2017, APPL MICROBIOL BIOT, V101, P8293, DOI 10.1007/s00253-017-8528-6; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marui Junichiro, 2015, Biosci Microbiota Food Health, V34, P45, DOI 10.12938/bmfh.2014-018; Miyashita M, 2012, MICROBIOL CULT COLL, V28, P1; Namwong S, 2005, INT J SYST EVOL MICR, V55, P315, DOI 10.1099/ijs.0.63272-0; National Bureau of Agricultural Commodity and Food Standards Ministry of Agriculture and Cooperatives, 2018, 70232018 TAS PLARA; Nychas GJE, 2008, MEAT SCI, V78, P77, DOI 10.1016/j.meatsci.2007.06.020; Papizadeh M, 2017, MICROB PATHOGENESIS, V111, P118, DOI 10.1016/j.micpath.2017.08.021; Phewpan A, 2020, J AGR FOOD CHEM, V68, P10345, DOI 10.1021/acs.jafc.9b06107; Phithakpol B., 1993, FISH FERMENTATION TE, P155; Quinto EJ, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8040208; Saeb ATM, 2017, EVOL BIOINFORM, V12, DOI 10.1177/1176934316686072; Sangjindavong M., 2008, Kasetsart Journal, Natural Sciences, V42, P129; Sarowska J, 2019, GUT PATHOG, V11, DOI 10.1186/s13099-019-0290-0; Satomi M, 1997, INT J SYST BACTERIOL, V47, P832, DOI 10.1099/00207713-47-3-832; Song D, 2012, PROBIOTICS; Tamang JP, 2020, COMPR REV FOOD SCI F, V19, P184, DOI 10.1111/1541-4337.12520; Tanasupawat S, 1998, J GEN APPL MICROBIOL, V44, P193, DOI 10.2323/jgam.44.193; Tanasupawat S, 2000, INT J SYST EVOL MICR, V50, P1479, DOI 10.1099/00207713-50-4-1479; Thongsanit J., 2002, JPN J LACTIC ACID BA, V13, P46, DOI [DOI 10.4109/JSLAB1997.13.46, 10.4109/jslab1997.13.46]; Udomsil N, 2011, J AGR FOOD CHEM, V59, P8401, DOI 10.1021/jf201953v; Wilaipun P, 2008, BIOSCI BIOTECH BIOCH, V72, P2232, DOI 10.1271/bbb.80239; Yongsawatdigul J, 2007, J FOOD SCI, V72, pM382, DOI 10.1111/j.1750-3841.2007.00532.x; Yoshida Y, 1998, FOOD REV INT, V14, P213, DOI 10.1080/87559129809541158; Zagorec M, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5030056; Zhang H, 2015, J FOOD SCI, V80, pM776, DOI 10.1111/1750-3841.12818	53	9	9	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245227	10.1371/journal.pone.0245227	http://dx.doi.org/10.1371/journal.pone.0245227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444386	Green Published, gold			2022-12-26	WOS:000609988100078
J	Mele, A; Mantuano, P; Fonzino, A; Rana, F; Capogrosso, RF; Sanarica, F; Rolland, JF; Cappellari, O; De Luca, A				Mele, Antonietta; Mantuano, Paola; Fonzino, Adriano; Rana, Francesco; Capogrosso, Roberta Francesca; Sanarica, Francesca; Rolland, Jean-Francois; Cappellari, Ornella; De Luca, Annamaria			Ultrasonography validation for early alteration of diaphragm echodensity and function in the mdx mouse model of Duchenne muscular dystrophy	PLOS ONE			English	Article							QUANTITATIVE MUSCLE ULTRASOUND; DISEASE PROGRESSION; SKELETAL-MUSCLE; IN-VIVO; MICE; EXERCISE; MODULATION; PHENOTYPE; COMPOUND; CHANNELS	The mdx mouse model of Duchenne muscular dystrophy is characterized by functional and structural alterations of the diaphragm since early stages of pathology, closely resembling patients' condition. In recent years, ultrasonography has been proposed as a useful longitudinal non-invasive technique to assess mdx diaphragm dysfunction and evaluate drug efficacy over time. To date, only a few preclinical studies have been conducted. Therefore, an independent validation of this method by different laboratories is needed to increase results reliability and reduce biases. Here, we performed diaphragm ultrasonography in 3- and 6-month-old mdx mice, the preferred age-window for pharmacology studies. The alteration of diaphragm function over time was measured as diaphragm ultrasound movement amplitude. At the same time points, a first-time assessment of diaphragm echodensity was performed, as an experimental index of progressive loss of contractile tissue. A parallel evaluation of other in vivo and ex vivo dystrophy-relevant readouts was carried out. Both 3- and 6-month-old mdx mice showed a significant decrease in diaphragm amplitude compared to wild type (wt) mice. This index was well-correlated either with in vivo running performance or ex vivo isometric tetanic force of isolated diaphragm. In addition, diaphragms from 6-month-old dystrophic mice were also highly susceptible to eccentric contraction ex vivo. Importantly, we disclosed an age-dependent increase in echodensity in mdx mice not observed in wt animals, which was independent from abdominal wall thickness. This was accompanied by a notable increase of pro-fibrotic TGF-beta 1 levels in the mdx diaphragm and of non-muscle tissue amount in diaphragm sections stained by hematoxylin & eosin. Our findings corroborate the usefulness of diaphragm ultrasonography in preclinical drug studies as a powerful tool to monitor mdx pathology progression since early stages.	[Mele, Antonietta; Mantuano, Paola; Fonzino, Adriano; Rana, Francesco; Capogrosso, Roberta Francesca; Sanarica, Francesca; Cappellari, Ornella; De Luca, Annamaria] Univ Bari Aldo Moro, Pharmacol Sect, Dept Pharm Drug Sci, Bari, Italy; [Rolland, Jean-Francois] Axxam SpA, Milan, Italy	Universita degli Studi di Bari Aldo Moro	De Luca, A (corresponding author), Univ Bari Aldo Moro, Pharmacol Sect, Dept Pharm Drug Sci, Bari, Italy.	annamaria.deluca@uniba.it		Rolland, Jean-Francois/0000-0002-7420-8272; Mantuano, Paola/0000-0001-6339-2222; Cappellari, Ornella/0000-0002-1882-3502	PRIN-MIUR (Research Projects of National Interest - Ministry of Education, University and Research) [2015MJBEM2_005, 2017FJSM9S_005]; Dutch Duchenne Parent Project (DPP NL)	PRIN-MIUR (Research Projects of National Interest - Ministry of Education, University and Research)(Ministry of Education, Universities and Research (MIUR)); Dutch Duchenne Parent Project (DPP NL)	This work was supported by PRIN-MIUR (Research Projects of National Interest - Ministry of Education, University and Research; grant n.2015MJBEM2_005 and grant n.2017FJSM9S_005) and by The Dutch Duchenne Parent Project (DPP NL; grant 2015) to Annamaria De Luca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In quality of expert in the field, author J.F.R. has been involved in reviewing and editing of our manuscript, as articulated in the 'author contributions' section. For this role, no salary was provided to the author by his affiliation Axxam S.p.A.	Amin VR., 1989, THESIS IOWA STATE U; Betts CA, 2015, SCI REP-UK, V5, DOI 10.1038/srep11632; Burdi R, 2006, NEUROMUSCULAR DISORD, V16, P237, DOI 10.1016/j.nmd.2006.01.013; Burdi R, 2009, J APPL PHYSIOL, V106, P1311, DOI 10.1152/japplphysiol.90985.2008; Burns DP, 2017, J PHYSIOL-LONDON, V595, P6653, DOI 10.1113/JP274792; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Capogrosso RF, 2018, FASEB J, V32, P1025, DOI 10.1096/fj.201700182RRR; Capogrosso RF, 2017, J APPL PHYSIOL, V122, P828, DOI 10.1152/japplphysiol.00776.2015; Cappellari O, 2013, DEV CELL, V24, P586, DOI 10.1016/j.devcel.2013.01.022; Conte E, 2017, J CACHEXIA SARCOPENI, V8, P386, DOI 10.1002/jcsm.12185; De Bellis M, 2017, ONCOTARGET, V8, P14279, DOI 10.18632/oncotarget.15263; De Luca Annamaria, 2012, Acta Myol, V31, P40; Ding LJ, 2001, PATTERN RECOGN, V34, P721, DOI 10.1016/S0031-3203(00)00023-6; Fayssoil A, 2019, J NEUROMUSCULAR DIS, V6, P55, DOI 10.3233/JND-180326; Fayssoil A, 2013, J ULTRAS MED, V32, P757, DOI 10.7863/ultra.32.5.757; Gamberi T, 2018, J PROTEOMICS, V170, P43, DOI 10.1016/j.jprot.2017.09.009; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; Harish P, 2019, J CACHEXIA SARCOPENI, V10, P1016, DOI 10.1002/jcsm.12438; Heier CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112477; Henry CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183853; Ishizaki M, 2008, NEUROMUSCULAR DISORD, V18, P342, DOI 10.1016/j.nmd.2008.02.002; Jansen M, 2012, NEUROMUSCULAR DISORD, V22, P306, DOI 10.1016/j.nmd.2011.10.020; Kim JH, 2012, FREE RADICAL BIO MED, V52, P1597, DOI 10.1016/j.freeradbiomed.2012.01.015; Labyed Y, 2010, J ACOUST SOC AM, V128, P3232, DOI 10.1121/1.3483739; Laviola M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200582; LOUBOUTIN JP, 1993, NEUROMUSCULAR DISORD, V3, P463, DOI 10.1016/0960-8966(93)90098-5; Maffioletti SM, 2018, CELL REP, V23, P899, DOI 10.1016/j.celrep.2018.03.091; Mantuano P, 2018, BIOCHEM PHARMACOL, V154, P89, DOI 10.1016/j.bcp.2018.04.022; Mele A, 2019, TRANSL RES, V204, P82, DOI 10.1016/j.trsl.2018.09.004; Mele A, 2016, SCI REP-UK, V6, DOI 10.1038/srep20061; Menegon A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44843; Muller J, 2001, J MUSCLE RES CELL M, V22, P133, DOI 10.1023/A:1010305801236; Pierno S, 2007, NEUROPATH APPL NEURO, V33, P344, DOI 10.1111/j.1365-2990.2007.00798.x; Pillen S, 2009, ULTRASOUND MED BIOL, V35, P443, DOI 10.1016/j.ultrasmedbio.2008.09.016; Rolland JF, 2006, NEUROBIOL DIS, V24, P466, DOI 10.1016/j.nbd.2006.08.010; Sanarica F, 2019, PHARMACOL RES, V145, DOI 10.1016/j.phrs.2019.104260; Sarwal A, 2014, MUSCLE NERVE, V50, P607, DOI 10.1002/mus.24294; Serrano E, 2017, IEEE ACM INT SYMP, P830, DOI 10.1109/CCGRID.2017.56; Shirokova N, 2013, J MOL CELL CARDIOL, V58, P217, DOI 10.1016/j.yjmcc.2012.12.009; Smith LR, 2016, MUSCLE NERVE, V54, P71, DOI 10.1002/mus.24998; Smith LR, 2014, AM J PHYSIOL-CELL PH, V306, pC889, DOI 10.1152/ajpcell.00383.2013; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Tricarico D, 2012, J PHARMACOL EXP THER, V340, P266, DOI 10.1124/jpet.111.185835; Vohra R, 2017, AM J PATHOL, V187, P2060, DOI 10.1016/j.ajpath.2017.05.010; Wacker SJ, 2012, CHEMMEDCHEM, V7, P1775, DOI 10.1002/cmdc.201100600; Whitehead NP, 2016, J PHYSIOL-LONDON, V594, P7215, DOI 10.1113/JP272707; Willmann Raffaella, 2015, J Neuromuscul Dis, V2, P113; Willmann R, 2012, NEUROMUSCULAR DISORD, V22, P43, DOI 10.1016/j.nmd.2011.04.012; Zaidman CM, 2017, ANN NEUROL, V81, P633, DOI 10.1002/ana.24904; Zhao J, 2013, HEALTH INF SCI SYST, V1, DOI 10.1186/2047-2501-1-5	50	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245397	10.1371/journal.pone.0245397	http://dx.doi.org/10.1371/journal.pone.0245397			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434240	gold, Green Published			2022-12-26	WOS:000609979700042
J	Laskowski, M; Schioler, L; Gustafsson, H; Wennberg, AM; Aberg, M; Toren, K				Laskowski, Marta; Schioler, Linus; Gustafsson, Helena; Wennberg, Ann-Marie; Aberg, Maria; Toren, Kjell			Cardiorespiratory fitness in late adolescence and long-term risk of psoriasis and psoriatic arthritis among Swedish men	PLOS ONE			English	Article								Background Psoriasis is a chronic immune-mediated disease and psoriatic arthritis is a common coexisting condition. Cardiorespiratory fitness is the overall capacity to perform exertion exercise. Low levels of cardiorespiratory fitness are associated with negative health outcomes. Individuals with psoriasis have lower cardiorespiratory fitness compared with individuals without psoriasis. There are no previous studies exploring the association between cardiorespiratory fitness and new-onset psoriasis and psoriatic arthritis. Methods With the objective to investigate whether low cardiorespiratory fitness in late adolescence increases the risk for onset of psoriasis and psoriatic arthritis, a cohort of Swedish men in compulsory military service between 1968 and 2005 was created using data from the Swedish Military Service Conscription Register. Cardiorespiratory fitness, estimated by maximum capacity cycle ergometer testing at conscription, was divided into three groups: high, medium, and low. Diagnoses were obtained using the Swedish National Patient Register and cohort members were followed from conscription until an event, new-onset psoriasis or psoriatic arthritis, occurred, or at the latest until 31 December 2016. Cox regression models adjusted for confounders at conscription were used to obtain hazard ratios with 95% confidence intervals for incident psoriasis and psoriatic arthritis. Results During the follow-up period (median follow-up time 31 years, range 0-48 years), 20,679 cases of incident psoriasis and 6,133 cases of incident psoriatic arthritis were found among 1,228,562 men (mean age at baseline 18.3 years). There was a significant association between low cardiorespiratory fitness and incident psoriasis and psoriatic arthritis (hazard ratio 1.35 (95% confidence interval 1.26-1.44) and 1.44 (95% confidence interval 1.28-1.63), respectively). Conclusions These novel findings suggest that low cardiorespiratory fitness at an early age is associated with increased risk of incident psoriasis and psoriatic arthritis among men, and highlight the importance of assessing cardiorespiratory fitness early in life.	[Laskowski, Marta; Wennberg, Ann-Marie] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Dermatol & Venereol, Gothenburg, Sweden; [Laskowski, Marta; Gustafsson, Helena; Wennberg, Ann-Marie] Sahlgrens Univ Hosp, Dept Dermatol & Venereol, Reg Vastra Gotaland, Gothenburg, Sweden; [Schioler, Linus; Toren, Kjell] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Sch Publ Hlth & Community Med,Occupat & Environm, Gothenburg, Sweden; [Gustafsson, Helena] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden; [Aberg, Maria] Univ Gothenburg, Sahlgrenska Acad, Sch Publ Hlth & Community Med Primary Hlth Care, Inst Med, Gothenburg, Sweden; [Aberg, Maria] Reg Vastra Gotaland, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg; University of Gothenburg	Laskowski, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Dermatol & Venereol, Gothenburg, Sweden.; Laskowski, M (corresponding author), Sahlgrens Univ Hosp, Dept Dermatol & Venereol, Reg Vastra Gotaland, Gothenburg, Sweden.	marta.laskowski@vgregion.se		Laskowski, Marta/0000-0001-9056-2207	Psoriasis Fund (Psoriasisfonden); Sahlgrenska University Hospital Funds (SUfonderna) [SU-786171]; Wilhelm and Martina Lundgren Science Fund (Wilhelm och Martina Lundgrens Vetenskapsfond) [2019-3016]; Royal and Hvitfeldts' Foundation (Kungliga och Hvitfeldtska stiftelsen); Swedish Council for Working Life, Health, and Welfare (FORTE); Government of Sweden [ALFGBG-74570]; County Councils [ALFGBG-74570]	Psoriasis Fund (Psoriasisfonden); Sahlgrenska University Hospital Funds (SUfonderna); Wilhelm and Martina Lundgren Science Fund (Wilhelm och Martina Lundgrens Vetenskapsfond); Royal and Hvitfeldts' Foundation (Kungliga och Hvitfeldtska stiftelsen); Swedish Council for Working Life, Health, and Welfare (FORTE); Government of Sweden; County Councils	ML and HG report grants from The Psoriasis Fund (Psoriasisfonden, www.psoriasisforbundet.se), grants from The Sahlgrenska University Hospital Funds (SUfonderna, SU-786171, www.researchweb.org), grants from The Wilhelm and Martina Lundgren Science Fund (Wilhelm och Martina Lundgrens Vetenskapsfond, 2019-3016, https://wmlundgren.se), grants from The Royal and Hvitfeldts' Foundation (Kungliga och Hvitfeldtska stiftelsen, www.hvitfeldtskastiftelsen.se), during the conduct of the study; LS and KT report grants from The Swedish Council for Working Life, Health, and Welfare (FORTE, https://forte.se), grants from The Swedish State under the ALF agreement between the Government of Sweden and the County Councils (ALFGBG-74570, www.alfvastragotaland.se), during the conduct of the study; A-MW and MA have nothing to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg MAI, 2014, PSYCHOL MED, V44, P779, DOI 10.1017/S0033291713001207; Aberg MAI, 2009, P NATL ACAD SCI USA, V106, P20906, DOI 10.1073/pnas.0905307106; Ali SM, 2009, SCAND J PUBLIC HEALT, V37, P146, DOI 10.1177/1403494808100274; Asgari MM, 2013, PHARMACOEPIDEM DR S, V22, P842, DOI 10.1002/pds.3447; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Bouchard C, 1998, MED SCI SPORT EXER, V30, P252, DOI 10.1097/00005768-199802000-00013; Bouchard C, 2015, MAYO CLIN PROC, V90, P1533, DOI 10.1016/j.mayocp.2015.08.005; Brooke HL, 2017, EUR J EPIDEMIOL, V32, P765, DOI 10.1007/s10654-017-0316-1; Celis-Morales CA, 2017, EUR HEART J, V38, P116, DOI 10.1093/eurheartj/ehw249; Davidson T, 2018, AM HEART J, V196, P156, DOI 10.1016/j.ahj.2017.08.022; de Oliveira RG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168503; Eder L, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-017-1497-4; Edwards MK, 2016, PHYSICIAN SPORTSMED, V44, P223, DOI 10.1080/00913847.2016.1221751; Ekblom-Bak E, 2019, SCAND J MED SCI SPOR, V29, P232, DOI 10.1111/sms.13328; Frankel HC, 2012, ARCH DERMATOL, V148, P918, DOI 10.1001/archdermatol.2012.943; Haligur BD, 2012, INT J DERMATOL, V51, P557, DOI 10.1111/j.1365-4632.2011.05111.x; Hautala AJ, 2009, NEUROSCI BIOBEHAV R, V33, P107, DOI 10.1016/j.neubiorev.2008.04.009; Henriksson M, 2018, J EPIDEMIOL COMMUN H, V72, P582, DOI 10.1136/jech-2018-210461; Icen M, 2008, J AM ACAD DERMATOL, V59, P981, DOI 10.1016/j.jaad.2008.08.034; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Lee DC, 2011, BRIT J SPORT MED, V45, P504, DOI 10.1136/bjsm.2009.066209; LOCHEN ML, 1992, J EPIDEMIOL COMMUN H, V46, P103, DOI 10.1136/jech.46.2.103; Lofvendahl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098024; Love TJ, 2012, ANN RHEUM DIS, V71, P1273, DOI 10.1136/annrheumdis-2012-201299; Ludvigsson JF, 2019, EUR J EPIDEMIOL, V34, P423, DOI 10.1007/s10654-019-00511-8; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; McAuley PA, 2014, PROG CARDIOVASC DIS, V56, P434, DOI 10.1016/j.pcad.2013.09.006; Michalek IM, 2017, J EUR ACAD DERMATOL, V31, P205, DOI 10.1111/jdv.13854; Myers J, 2004, AM J MED, V117, P912, DOI 10.1016/j.amjmed.2004.06.047; Nordesjo LO, 1974, SWEDISH J DEFENCE ME, V10, P11; Pezzolo E, 2019, EXPERT REV CLIN IMMU, V15, P41, DOI 10.1080/1744666X.2019.1543591; Prizment AE, 2011, CANCER CAUSE CONTROL, V22, P1003, DOI 10.1007/s10552-011-9773-0; Proietti I, 2014, DRUG DEVELOP RES, V75, pS81, DOI 10.1002/ddr.21204; Ritchlin CT, 2017, NEW ENGL J MED, V376, P957, DOI 10.1056/NEJMra1505557; Ross R, 2003, INT J OBESITY, V27, P204, DOI 10.1038/sj.ijo.802222; Ross R, 2016, CIRCULATION, V134, pE653, DOI 10.1161/CIR.0000000000000461; de Oliveira MDSP, 2015, AN BRAS DERMATOL, V90, P9, DOI 10.1590/abd1806-4841.20153038; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Scotti L, 2018, SEMIN ARTHRITIS RHEU, V48, P28, DOI 10.1016/j.semarthrit.2018.01.003; Sharif K, 2018, AUTOIMMUN REV, V17, P53, DOI 10.1016/j.autrev.2017.11.010; Snekvik I, 2019, BRIT J DERMATOL, V180, P94, DOI 10.1111/bjd.16885; Williams PT, 2001, MED SCI SPORT EXER, V33, P754, DOI 10.1097/00005768-200105000-00012; Wilson PB, 2012, J EUR ACAD DERMATOL, V26, P1345, DOI 10.1111/j.1468-3083.2012.04494.x; Wilson PB, 2016, J PHYS ACT HEALTH, V13, P771, DOI 10.1123/jpah.2015-0150; Wu SW, 2015, J RHEUMATOL, V42, P835, DOI 10.3899/jrheum.140808	47	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0243348	10.1371/journal.pone.0243348	http://dx.doi.org/10.1371/journal.pone.0243348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428629	Green Published, gold			2022-12-26	WOS:000630036100011
J	Martinez-Llorens, S; Peruzzi, S; Falk-Petersen, IB; Godoy-Olmos, S; Ulleberg, LO; Tomas-Vidal, A; Puvanendran, V; Odei, DK; Hagen, O; Fernandes, JMO; Jobling, M				Martinez-Llorens, Silvia; Peruzzi, Stefano; Falk-Petersen, Inger-Britt; Godoy-Olmos, Sergio; Ulleberg, Lars Olav; Tomas-Vidal, Ana; Puvanendran, Velmurugu; Odei, Derrick Kwame; Hagen, Orjan; Fernandes, Jorge M. O.; Jobling, Malcolm			Digestive tract morphology and enzyme activities of juvenile diploid and triploid Atlantic salmon (Salmo salar) fed fishmeal-based diets with or without fish protein hydrolysates	PLOS ONE			English	Article								Triploid, sterile Atlantic salmon (Salmo salar) could make a contribution to the development of the farming industry, but uncertainties about the performance and welfare of triploids have limited their adoption by farmers. In this study, we compared the ontogeny of digestive tract morphology and enzyme activities (pepsin, trypsin, chymotrypsin, alkaline phosphatase and aminopeptidase) of diploid and triploid Atlantic salmon. Fish were fed diets based on fishmeal (STD) or a mix of fishmeal and hydrolysed fish proteins (HFM) whilst being reared at low temperature from start-feeding to completion of the parr-smolt transformation. Fish weights for each ploidy and feed combination were used to calculate thermal growth coefficients (TGCs) that spanned this developmental period, and the data were used to examine possible relationships between enzyme activities and growth. At the end of the experiment, faeces were collected and analyzed to determine the apparent digestibility coefficients (ADCs) of the dietary amino acids (AAs). Digestive tract histo-morphology did not differ substantially between ploidies and generally reflected organ maturation and functionality. There were no consistent differences in proteolytic enzyme activities resulting from the inclusion of HFM in the diet, nor was there improved digestibility and AA bioavailability of the HFM feed in either diploid or triploid fish. The triploid salmon had lower ADCs than diploids for most essential and non-essential AAs in both diets (STD and HFM), but without there being any indication of lower intestinal protease activity in triploid fish. When trypsin-to-chymotrypsin activity and trypsin and alkaline phosphatase (ALP) ratios (T:C and T:ALP, respectively) were considered in combination with growth data (TGC) low T:C and T:ALP values coincided with times of reduced fish growth, and vice versa, suggesting that T:C and T:ALP may be used to predict recent growth history and possible growth potential.	[Martinez-Llorens, Silvia; Godoy-Olmos, Sergio; Tomas-Vidal, Ana] Univ Politecn Valencia, Inst Sci & Anim Technol ICTA, Aquaculture & Biodivers Res Grp, Valencia, Spain; [Peruzzi, Stefano; Falk-Petersen, Inger-Britt; Ulleberg, Lars Olav; Odei, Derrick Kwame; Jobling, Malcolm] UiT Arctic Univ Norway, Fac Biosci Fisheries & Econ, Tromso, Norway; [Puvanendran, Velmurugu] Nofima AS, Prod Biol, Tromso, Norway; [Hagen, Orjan; Fernandes, Jorge M. O.] Nord Univ, Fac Biosci & Aquaculture, Bodo, Norway	Universitat Politecnica de Valencia; UiT The Arctic University of Tromso; Nofima; Nord University	Peruzzi, S (corresponding author), UiT Arctic Univ Norway, Fac Biosci Fisheries & Econ, Tromso, Norway.	stefano.peruzzi@uit.no	Puvanendran, Velmurugu/AAN-7205-2020; peruzzi, Stefano/A-2634-2008; Peruzzi, Stefano/O-5009-2019; TOMAS VIDAL, ANA/L-8254-2014	peruzzi, Stefano/0000-0002-9043-7438; Peruzzi, Stefano/0000-0002-9043-7438; MARTINEZ LLORENS, SILVIA/0000-0002-9824-3267; TOMAS VIDAL, ANA/0000-0002-2985-9324	Norwegian Research Council [248028]; Norwegian College of Fishery Science, University of Tromso; Arctic University of Norway; UiT, the Arctic University of Norway	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian College of Fishery Science, University of Tromso; Arctic University of Norway; UiT, the Arctic University of Norway	This work was supported by the Norwegian Research Council, Regional Research Fund-RFF-NORD-https://www.regionaleforskningsfond.no/-(Grant no. 248028, VP at Nofima as project coordinator) and the Norwegian College of Fishery Science, University of Tromso, (UiT) the Arctic University of Norway. The funder provided support in the form of salary for one author [VP] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this and other authors are articulated in the `author contributions' section. Publication charges for the article were provided by the Open Access publication fund of UiT, the Arctic University of Norway.	Anderson B.G., 1974, ATLAS TROUT HISTOLOG; Anson ML, 1938, J GEN PHYSIOL, V22, P79, DOI 10.1085/jgp.22.1.79; Benfey TJ, 2016, REV AQUACULT, V8, P264, DOI 10.1111/raq.12092; Benfey Tillmann J., 1999, Reviews in Fisheries Science, V7, P39, DOI 10.1080/10641269991319162; Benhaim D, 2020, APPL ANIM BEHAV SCI, V229, DOI 10.1016/j.applanim.2020.105031; Blank R, 1999, J ANIM SCI, V77, P2974; Blier PU, 2007, COMP BIOCHEM PHYS A, V146, P174, DOI 10.1016/j.cbpa.2006.10.012; Blier PU, 2002, AQUACULTURE, V209, P379, DOI 10.1016/S0044-8486(01)00807-9; Bodin N, 2012, AQUACULTURE, V356, P105, DOI 10.1016/j.aquaculture.2012.05.030; Bosch L, 2006, J CHROMATOGR B, V831, P176, DOI 10.1016/j.jchromb.2005.12.002; Bucking C, 2009, AQUACULT NUTR, V15, P282, DOI 10.1111/j.1365-2095.2008.00593.x; Cahu C, 2004, AQUACULTURE, V238, P295, DOI 10.1016/j.aquaculture.2004.04.013; Cantas L, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-71; Chen KT, 2011, DIGEST DIS SCI, V56, P1020, DOI 10.1007/s10620-010-1396-x; CHO CY, 1992, AQUACULTURE, V100, P107, DOI 10.1016/0044-8486(92)90353-M; Clarkson M, 2017, BRIT J NUTR, V118, P17, DOI 10.1017/S0007114517001842; Diaz-Lopez M, 1998, COMP BIOCHEM PHYS B, V121, P369, DOI 10.1016/S0305-0491(98)10123-2; Ditlecadet D, 2009, J FISH BIOL, V75, P2695, DOI 10.1111/j.1095-8649.2009.02468.x; Engrola S, 2007, AQUAC RES, V38, P696, DOI 10.1111/j.1365-2109.2007.01701.x; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; Espe M, 1999, AQUACULTURE, V174, P119, DOI 10.1016/S0044-8486(98)00502-X; Estruch G, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1626-6; Fawley J, 2016, J SURG RES, V202, P225, DOI 10.1016/j.jss.2015.12.008; Fernandez I, 2008, AQUACULTURE, V283, P102, DOI 10.1016/j.aquaculture.2008.06.037; Fjelldal PG, 2016, AQUACULT NUTR, V22, P72, DOI 10.1111/anu.12238; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Hardy R.W., 1991, P AQ FEED PROC NUTR, P109; Kolkovski S, 2000, AQUACULT NUTR, V6, P11; Korovina JM, 1981, J ICHTHYOL+, V21, P106; Krogdahl A, 1999, AQUACULT NUTR, V5, P121; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Krogdahl A, 2015, AQUACULTURE, V449, P27, DOI 10.1016/j.aquaculture.2015.02.032; Lalles JP, 2020, REV AQUACULT, V12, P555, DOI 10.1111/raq.12340; Lazo JP, 2007, AQUACULTURE, V265, P194, DOI 10.1016/j.aquaculture.2007.01.043; Lemieux H, 1999, FISH PHYSIOL BIOCHEM, V20, P293, DOI 10.1023/A:1007791019523; Lijalad M, 2009, AQUACULTURE, V290, P145, DOI 10.1016/j.aquaculture.2009.01.039; Lokka G, 2013, J MORPHOL, V274, P859, DOI 10.1002/jmor.20142; Marquez L, 2013, AQUACULTURE, V384, P46, DOI 10.1016/j.aquaculture.2012.12.008; Maxime V, 2008, FISH FISH, V9, P67, DOI 10.1111/j.1467-2979.2007.00269.x; Moldal T, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-60; Montoya A, 2010, AQUACULTURE, V306, P315, DOI 10.1016/j.aquaculture.2010.06.023; Moyano FJ, 1996, FISH PHYSIOL BIOCHEM, V15, P121, DOI 10.1007/BF01875591; Nikolopoulou D, 2011, COMP BIOCHEM PHYS A, V158, P406, DOI 10.1016/j.cbpa.2010.11.021; Nolasco-Soria H, 2020, REV AQUACULT; OLIVATELES A, 1990, J FISH BIOL, V37, P125, DOI 10.1111/j.1095-8649.1990.tb05934.x; Olsen RL, 2017, TRENDS FOOD SCI TECH, V66, P93, DOI 10.1016/j.tifs.2017.06.003; Peruzzi S, 2013, J APPL ICHTHYOL, V29, P1104, DOI 10.1111/jai.12210; Peruzzi S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194340; Peruzzi S, 2015, AQUACULT INT, V23, P1105, DOI 10.1007/s10499-014-9867-2; Piferrer F, 2009, AQUACULTURE, V293, P125, DOI 10.1016/j.aquaculture.2009.04.036; Refstie S, 2004, AQUACULTURE, V239, P331, DOI 10.1016/j.aquaculture.2004.06.015; Ribeiro L, 2015, AQUACULTURE, V447, P116, DOI 10.1016/j.aquaculture.2014.12.017; Ronnestad I, 2013, REV AQUACULT, V5, pS59, DOI 10.1111/raq.12010; Rungruangsak-Torrissen K, 2006, FISH PHYSIOL BIOCHEM, V32, P7, DOI 10.1007/s10695-005-0630-5; Rungruangsak-Torrissen K, 1999, FISH PHYSIOL BIOCHEM, V21, P223, DOI 10.1023/A:1007804823932; Rungruangsak-Torrissen K, 2000, FISH PHYSIOL BIOCHEM, V22, P337, DOI 10.1023/A:1007864413112; Rungruangsak-Torrissen K, 2007, J FOOD BIOCHEM, V31, P509, DOI 10.1111/j.1745-4514.2007.00127.x; Rungruangsak-Torrissen K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216030; Rust MB, 2002, NUTR PHYSL FISH NUTR; Sahlmann C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124179; Sambraus F, 2020, J FISH BIOL, V97, P137, DOI 10.1111/jfb.14338; Sanden M, 2005, J FISH DIS, V28, P317, DOI 10.1111/j.1365-2761.2005.00618.x; Santigosa E, 2008, AQUACULTURE, V282, P68, DOI 10.1016/j.aquaculture.2008.06.007; Savoie A, 2011, COMP BIOCHEM PHYS A, V158, P525, DOI 10.1016/j.cbpa.2010.12.017; Savoie A, 2008, AQUAC RES, V39, P382, DOI 10.1111/j.1365-2109.2007.01797.x; Siddik MAB, 2021, REV AQUACULT, V13, P406, DOI 10.1111/raq.12481; Smedley MA, 2018, AQUACULTURE, V490, P329, DOI 10.1016/j.aquaculture.2018.02.049; Smedley MA, 2016, AQUACULTURE, V451, P357, DOI 10.1016/j.aquaculture.2015.10.001; Sunde J, 2004, AQUACULT NUTR, V10, P261, DOI 10.1111/j.1365-2095.2004.00300.x; Sunde J, 2001, FISH PHYSIOL BIOCHEM, V25, P335, DOI 10.1023/A:1023233024001; Swanepoel JC, 2018, AQUACULTURE, V496, P262, DOI 10.1016/j.aquaculture.2018.06.084; Taylor JF, 2015, AQUACULT NUTR, V21, P18, DOI 10.1111/anu.12130; Taylor JF, 2019, COMP BIOCHEM PHYS B, V227, P106, DOI 10.1016/j.cbpb.2018.10.004; Uran PA, 2009, AQUACULT NUTR, V15, P492, DOI 10.1111/j.1365-2095.2008.00615.x; VANDENINGH TSGAM, 1991, AQUACULTURE, V94, P297, DOI 10.1016/0044-8486(91)90174-6; Vera LM, 2019, COMP BIOCHEM PHYS B, V237, DOI 10.1016/j.cbpb.2019.110327; Verdi LG, 2005, QUIM NOVA, V28, P85, DOI 10.1590/S0100-40422005000100017; Verdile N, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10040745; Walter H., 1984, 2 15 2 METHOD HAEMOG, P3; Yufera M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033687; Zamani A, 2006, IRAN SCI FISH J, V15, P29	81	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0245216	10.1371/journal.pone.0245216	http://dx.doi.org/10.1371/journal.pone.0245216			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33429419	Green Published, gold			2022-12-26	WOS:000630036100042
J	Murata, M; Konno, K; Wasano, N; Mochizuki, A; Mitsuhara, I				Murata, Mika; Konno, Kotaro; Wasano, Naoya; Mochizuki, Atsushi; Mitsuhara, Ichiro			Expression of a gene for an MLX56 defense protein derived from mulberry latex confers strong resistance against a broad range of insect pests on transgenic tomato lines	PLOS ONE			English	Article							SUGAR-MIMIC ALKALOIDS; VECTOR; TRANSMISSION; MANAGEMENT; VIRUS; ERI	Insect pests cause serious damage in crop production, and various attempts have been made to produce insect-resistant crops, including the expression of genes for proteins with anti-herbivory activity, such as Bt (Bacillus thuringiensis) toxins. However, the number of available genes with sufficient anti-herbivory activity is limited. MLX56 is an anti-herbivory protein isolated from the latex of mulberry plants, and has been shown to have strong growth-suppressing activity against the larvae of a variety of lepidopteran species. As a model of herbivore-resistant plants, we produced transgenic tomato lines expressing the gene for MLX56. The transgenic tomato lines showed strong anti-herbivory activities against the larvae of the common cutworm, Spodoptera litura. Surprisingly, the transgenic tomato lines also exhibited strong activity against the attack of western flower thrips, Frankliniera occidentalis. Further, growth of the hadda beetle, Henosepilachna vigintioctopunctata, fed on leaves of transgenic tomato was significantly retarded. The levels of damage caused by both western flower thrips and hadda beetles were negligible in the high-MLX56-expressing tomato line. These results indicate that introduction of the gene for MLX56 into crops can enhance crop resistance against a wide range of pest insects, and that MLX56 can be utilized in developing genetically modified (GM) pest-resistant crops.	[Murata, Mika] Natl Agr & Food Res Org NARO, Inst Vegetable & Floriculture Sci, Tsu, Mie, Japan; [Konno, Kotaro; Mitsuhara, Ichiro] NARO, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Wasano, Naoya] Kyushu Univ, Fac Agr, Inst Biol Control, Fukuoka, Fukuoka, Japan; [Mochizuki, Atsushi] NARO, Inst Agroenvironm Sci, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; Kyushu University; National Agriculture & Food Research Organization - Japan	Konno, K; Mitsuhara, I (corresponding author), NARO, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan.	konno@affrc.go.jp; mithuhara@affrc.go.jp	Murata, Mika/AAX-8746-2021					Barik S, 2020, J ENTOMOL ZOOL STUD, V8, P297; Cannon RJC, 2007, CROP PROT, V26, P1089, DOI 10.1016/j.cropro.2006.10.023; Elanchezhyan K., 2008, Journal of Biopesticides, V1, P113; Gao YL, 2012, PEST MANAG SCI, V68, P1111, DOI 10.1002/ps.3305; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; GASSMANN AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI DOI 10.1073/pnas.1317179111; Ghosh S. K., 2012, Journal of Biopesticides, V5, P151; Hilder VA, 1999, CROP PROT, V18, P177, DOI 10.1016/S0261-2194(99)00028-9; Hirayama C, 2007, INSECT BIOCHEM MOLEC, V37, P1348, DOI 10.1016/j.ibmb.2007.09.001; Kawazu K, 2012, PLANT BIOTECHNOL-NAR, V29, P495, DOI 10.5511/plantbiotechnology.12.0711a; Kitajima S, 2012, PLANTA, V235, P589, DOI 10.1007/s00425-011-1533-6; Kitajima S, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-6; Konno K, 2006, P NATL ACAD SCI USA, V103, P1337, DOI 10.1073/pnas.0506944103; Konno K, 2019, J INSECT PHYSIOL, V117, DOI 10.1016/j.jinsphys.2019.103912; Konno K, 2018, PHYTOCHEMISTRY, V147, P211, DOI 10.1016/j.phytochem.2018.01.005; Konno K, 2011, PHYTOCHEMISTRY, V72, P1510, DOI 10.1016/j.phytochem.2011.02.016; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; Oerke EC., 1994, CROP PRODUCTION CROP; Ohtsubo N, 1999, PLANT CELL PHYSIOL, V40, P808, DOI 10.1093/oxfordjournals.pcp.a029609; Peterson JA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01794; R Development Core Team, R LANG ENV STAT COMP; Sakurai T, 2004, APPL ENTOMOL ZOOL, V39, P71, DOI 10.1303/aez.2004.71; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Sun HJ, 2006, PLANT CELL PHYSIOL, V47, P426, DOI 10.1093/pcp/pci251; Terra WR, 2019, ADV INSECT PHYSIOL, V56, P117, DOI 10.1016/bs.aiip.2019.01.004; Wang ZL, 2017, J ECON ENTOMOL, V110, P2084, DOI 10.1093/jee/tox207; Wasano N, 2009, PHYTOCHEMISTRY, V70, P880, DOI 10.1016/j.phytochem.2009.04.014; Whitfield AE, 2015, VIROLOGY, V479, P278, DOI 10.1016/j.virol.2015.03.026; WIJKAMP I, 1993, J GEN VIROL, V74, P341, DOI 10.1099/0022-1317-74-3-341	29	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0239958	10.1371/journal.pone.0239958	http://dx.doi.org/10.1371/journal.pone.0239958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428626	Green Published, Green Submitted, gold			2022-12-26	WOS:000630036100004
J	Assafiri, O; Song, AAL; Tan, GH; Hanish, I; Hashim, AM; Yusoff, K				Assafiri, Omar; Song, Adelene Ai-Lian; Tan, Geok Hun; Hanish, Irwan; Hashim, Amalie Mohd; Yusoff, Khatijah			Klebsiella virus UPM2146 lyses multiple drugresistant Klebsiella pneumoniae in vitro and in vivo	PLOS ONE			English	Article							ZEBRAFISH LARVAE	Klebsiella pneumoniae are opportunistic bacteria found in the gut. In recent years they have been associated with nosocomial infections. The increased incidence of multiple drug-resistant K. pneumoniae makes it necessary to find new alternatives to treat the disease. In this study, phage UPM2146 was isolated from a polluted lake which can lyse its host K. pneumoniae ATCC BAA-2146. Observation from TEM shows that UPM2146 belongs to Caudoviriales (Order) based on morphological appearance. Whole genome analysis of UPM2146 showed that its genome comprises 160,795 bp encoding for 214 putative open reading frames (ORFs). Phylogenetic analysis revealed that the phage belongs to Ackermannviridae (Family) under the Caudoviriales. UPM2146 produces clear plaques with high titers of 1010 PFU/ml. The phage has an adsorption period of 4 min, latent period of 20 min, rise period of 5 min, and releases approximately 20 PFU/bacteria at Multiplicity of Infection (MOI) of 0.001. UPM2146 has a narrow host-range and can lyse 5 out of 22 K. pneumoniae isolates (22.72%) based on spot test and efficiency of plating (EOP). The zebrafish larvae model was used to test the efficacy of UPM2146 in lysing its host. Based on colony forming unit counts, UPM2146 was able to completely lyse its host at 10 hours onwards. Moreover, we show that the phage is safe to be used in the treatment against K. pneumoniae infections in the zebrafish model.	[Assafiri, Omar; Song, Adelene Ai-Lian; Hanish, Irwan; Hashim, Amalie Mohd; Yusoff, Khatijah] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Microbiol, Serdang, Selangor, Malaysia; [Tan, Geok Hun] Univ Putra Malaysia, Fac Agr, Dept Agr Technol, Serdang, Selangor, Malaysia; [Tan, Geok Hun; Yusoff, Khatijah] Univ Putra Malaysia, Inst Biosci, Serdang, Selangor, Malaysia; [Hashim, Amalie Mohd] Univ Putra Malaysia, Halal Prod Res Inst, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Yusoff, K (corresponding author), Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Microbiol, Serdang, Selangor, Malaysia.; Yusoff, K (corresponding author), Univ Putra Malaysia, Inst Biosci, Serdang, Selangor, Malaysia.	kyusoff@upm.edu.my	Hashim, Amalia Mohd/AAT-5403-2021; Assafiri, Omar/HGE-6082-2022	Hashim, Amalia Mohd/0000-0002-8320-0141; assafiri, omar/0000-0002-7626-3099	Universiti Putra Malaysia [GP/IPS/2018/9602400]	Universiti Putra Malaysia	Universiti Putra Malaysia grant number GP/IPS/2018/9602400.	Abedon Stephen T, 2011, Bacteriophage, V1, P46, DOI 10.4161/bact.1.1.13980; Adriaenssens EM, 2018, ARCH VIROL, V163, P1125, DOI 10.1007/s00705-018-3723-z; Al Zubidi M, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00512-19; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Bao J, 2020, EMERG MICROBES INFEC, V9, P771, DOI 10.1080/22221751.2020.1747950; Born Y, ARCH VIROL; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Cao F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/752930; Cheepurupalli L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00614; Chhibber S, 2008, J MED MICROBIOL, V57, P1508, DOI 10.1099/jmm.0.2008/002873-0; Ciacci N, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090482; D'Andrea MM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02788-9; da Cunha BR, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8020045; FARRIS JS, 1972, AM NAT, V106, P645, DOI 10.1086/282802; Foo RQ, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.555122; Goker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006319; Goodridge L, 2003, APPL ENVIRON MICROB, V69, P5364, DOI 10.1128/AEM.69.9.5364-5371.2003; Hamdi S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40349; Haq IU, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-9; Helmi UM, 2016, TROP BIOMED, V33, P109; Herridge WP, 2020, J MED MICROBIOL, V69, P176, DOI 10.1099/jmm.0.001141; Hudson CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099209; Hung CH, 2011, ANTIMICROB AGENTS CH, V55, P1358, DOI 10.1128/AAC.01123-10; Hurwitz BL, 2013, ENVIRON MICROBIOL, V15, P1428, DOI 10.1111/j.1462-2920.2012.02836.x; Hyman P, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12010035; Hyman Paul, 2009, V501, P175, DOI 10.1007/978-1-60327-164-6_18; Jackman SD, 2017, GENOME RES, V27, P768, DOI 10.1101/gr.214346.116; Kropinski Andrew M., 2009, V501, P69, DOI 10.1007/978-1-60327-164-6_7; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lefkowitz EJ, NUCLEIC ACIDS RES; Lefort V, 2015, MOL BIOL EVOL, V32, P2798, DOI 10.1093/molbev/msv150; Lin Derek M, 2017, World J Gastrointest Pharmacol Ther, V8, P162, DOI 10.4292/wjgpt.v8.i3.162; Lin W, 2016, SCI REP-UK, V6, P1; Marcoleta AE, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00030; McNair K, 2012, BIOINFORMATICS, V28, P614, DOI 10.1093/bioinformatics/bts014; Meier-Kolthoff JP, 2017, BIOINFORMATICS, V33, P3396, DOI 10.1093/bioinformatics/btx440; Meier-Kolthoff JP, 2014, STAND GENOMIC SCI, V9, DOI [10.1186/1944-3277-9-2, 10.4056/sigs.4207886]; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Mirzaei MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118557; Paczosa MK, 2016, MICROBIOL MOL BIOL R, V80, P629, DOI 10.1128/MMBR.00078-15; Pan YJ, 2019, MICROB BIOTECHNOL, V12, P472, DOI 10.1111/1751-7915.13370; Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/eri.13.12, 10.1586/ERI.13.12]; Rajnovic D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216292; Rambaut A, FIGTREE VERSION 1 4; Rodriguez-Rubio L, 2016, APPL ENVIRON MICROB, V82, P4975, DOI 10.1128/AEM.00446-16; Ross A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01352; Sambrook J., 2006, COMMONLY USED TECHNI, DOI 10.1101/pdb.prot4455; Shahbaaz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084263; Silva YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114197; Taj MK, 2014, J ANIM PLANT SCI, V24, P1252; Varas M, 2017, J MICROBIOL METH, V135, P20, DOI 10.1016/j.mimet.2017.01.020; Vinodkumar C. S., 2005, Journal of Communicable Diseases, V37, P18; Walker PJ, 2019, ARCH VIROL, V164, P2417, DOI 10.1007/s00705-019-04306-w; Wittebole X, 2014, VIRULENCE, V5, P226, DOI 10.4161/viru.25991; Zeman M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46319	58	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0245354	10.1371/journal.pone.0245354	http://dx.doi.org/10.1371/journal.pone.0245354			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4OF	33418559	Green Published, gold			2022-12-26	WOS:000630020100029
J	Chen, H; Bian, AW; Yang, LF; Yin, X; Wang, J; Ti, CW; Miao, Y; Peng, SH; Xu, SF; Liu, MY; Qiu, WW; Yi, ZF				Chen, Huang; Bian, Aiwu; Yang, Lian-fang; Yin, Xuan; Wang, Jie; Ti, Chaowen; Miao, Ying; Peng, Shihong; Xu, Shifen; Liu, Mingyao; Qiu, Wen-Wei; Yi, Zhengfang			Targeting STAT3 by a small molecule suppresses pancreatic cancer progression	ONCOGENE			English	Article							TRANSCRIPTION FACTOR STAT3; SIGNAL TRANSDUCER; MITOCHONDRIAL STAT3; HUMAN BREAST; INHIBITOR; ACTIVATION; GROWTH; TOFACITINIB; SUPPORTS; PATHWAY	Pancreatic cancer is lethal in over 90% of cases since it is resistant to current therapeutic strategies. The key role of STAT3 in promoting pancreatic cancer progression has been proven, but effective interventions that suppress STAT3 activities are limited. The development of novel anticancer agents that directly target STAT3 may have potential clinical benefits for pancreatic cancer treatment. Here, we report a new small-molecule inhibitor (N4) with potent antitumor bioactivity, which inhibits multiple oncogenic processes in pancreatic cancer. N4 blocked STAT3 and phospho-tyrosine (pTyr) peptide interactions in fluorescence polarization (FP) assay, specifically abolished phosphor-STAT3 (Tyr705), and suppressed expression of STAT3 downstream genes. The mechanism involved the direct binding of N4 to the STAT3 SH2 domain, thereby, the STAT3 dimerization, STAT3-EGFR, and STAT3-NF-kappa B cross-talk were efficiently inhibited. In animal models of pancreatic cancer, N4 was well tolerated, suppressed tumor growth and metastasis, and significantly prolonged survival of tumor-bearing mice. Our results offer a preclinical proof of concept for N4 as a candidate therapeutic compound for pancreatic cancer.	[Chen, Huang; Bian, Aiwu; Ti, Chaowen; Miao, Ying; Peng, Shihong; Liu, Mingyao; Yi, Zhengfang] East China Normal Univ, Shanghai 200241, Peoples R China; [Chen, Huang; Bian, Aiwu; Ti, Chaowen; Miao, Ying; Peng, Shihong; Liu, Mingyao; Yi, Zhengfang] East China Normal Univ, Shanghai Fengxian Dist Cent Hosp Joint Ctr Transl, Shanghai Key Lab Regulatory Biol Inst Biomed Sci, Shanghai 200241, Peoples R China; [Chen, Huang; Bian, Aiwu; Ti, Chaowen; Miao, Ying; Peng, Shihong; Liu, Mingyao; Yi, Zhengfang] East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Yang, Lian-fang; Wang, Jie; Qiu, Wen-Wei; Yi, Zhengfang] East China Normal Univ, Shanghai Engn Res Ctr Mol Therapeut & New Drug De, Sch Chem & Mol Engn, Shanghai 200241, Peoples R China; [Yin, Xuan; Xu, Shifen] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, Shanghai, Peoples R China	East China Normal University; East China Normal University; East China Normal University; East China Normal University; Shanghai University of Traditional Chinese Medicine	Liu, MY; Yi, ZF (corresponding author), East China Normal Univ, Shanghai 200241, Peoples R China.; Liu, MY; Yi, ZF (corresponding author), East China Normal Univ, Shanghai Fengxian Dist Cent Hosp Joint Ctr Transl, Shanghai Key Lab Regulatory Biol Inst Biomed Sci, Shanghai 200241, Peoples R China.; Liu, MY; Yi, ZF (corresponding author), East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China.; Qiu, WW; Yi, ZF (corresponding author), East China Normal Univ, Shanghai Engn Res Ctr Mol Therapeut & New Drug De, Sch Chem & Mol Engn, Shanghai 200241, Peoples R China.	myliu@bio.ecnu.edu.cn; wwqiu@chem.ecnu.edu.cn; zfyi@bio.ecnu.edu.cn		chen, huang/0000-0003-2507-5044	National Natural Science Foundation of China [82073310, 81773204, 81830083, 81802970]; Science and Technology Commission of Shanghai Municipality [20JC1417900, 11DZ2260300]; National Key R&D Program of China [2018YFA0507001]; Innovation program of Shanghai Municipal Education Commission [2017-01-07-00-05-E00011]; Shanghai Science and Technology Council [18ZR1411200]; Shenzhen Municipal Government of China [KQTD20170810160226082]; ECNU Construction Fund of Innovation and Entrepreneurship Laboratory [44400-20201-532300/021]; ECNU Public Platform for Innovation [011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Key R&D Program of China; Innovation program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Shanghai Science and Technology Council; Shenzhen Municipal Government of China; ECNU Construction Fund of Innovation and Entrepreneurship Laboratory; ECNU Public Platform for Innovation	This study was supported by National Natural Science Foundation of China (82073310, 81773204, 81830083, and 81802970), The Science and Technology Commission of Shanghai Municipality (20JC1417900, 11DZ2260300), National Key R&D Program of China (2018YFA0507001), Innovation program of Shanghai Municipal Education Commission (2017-01-07-00-05-E00011), Shanghai Science and Technology Council (18ZR1411200), Shenzhen Municipal Government of China (KQTD20170810160226082), ECNU Construction Fund of Innovation and Entrepreneurship Laboratory (44400-20201-532300/021), and ECNU Public Platform for Innovation (011).	Ahmad R, 2008, CANCER RES, V68, P2920, DOI 10.1158/0008-5472.CAN-07-3036; Bharadwaj U, 2016, ONCOTARGET, V7, P26307, DOI 10.18632/oncotarget.8368; Brambilla L, 2015, MOL ONCOL, V9, P1194, DOI 10.1016/j.molonc.2015.02.012; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Furtek SL, 2016, ACS CHEM BIOL, V11, P308, DOI 10.1021/acschembio.5b00945; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Genini D, 2017, P NATL ACAD SCI USA, V114, pE4924, DOI 10.1073/pnas.1615730114; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; He YD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13122; Houg DS, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0842-9; Huang C, 2012, CYTOKINE GROWTH F R, V23, P25, DOI 10.1016/j.cytogfr.2012.01.003; Huynh J, 2019, NAT REV CANCER, V19, P82, DOI 10.1038/s41568-018-0090-8; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jung KH, 2017, CLIN CANCER RES, V23, P5537, DOI 10.1158/1078-0432.CCR-16-2253; Kleeff J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.22; Lai PS, 2015, EXPERT OPIN THER PAT, V25, P1397, DOI 10.1517/13543776.2015.1086749; Lee JW, 2019, NATURE, V567, P249, DOI 10.1038/s41586-019-1004-y; Lee JY, 2005, BIOCHEM BIOPH RES CO, V334, P764, DOI 10.1016/j.bbrc.2005.06.162; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Miklossy G, 2013, NAT REV DRUG DISCOV, V12, P611, DOI 10.1038/nrd4088; Nagathihalli NS, 2016, ONCOTARGET, V7, P65982, DOI 10.18632/oncotarget.11786; Scholz A, 2003, GASTROENTEROLOGY, V125, P891, DOI 10.1016/S0016-5085(03)01064-3; Schwartz DM, 2017, NAT REV DRUG DISCOV, V16, P843, DOI 10.1038/nrd.2017.201; Shao H, 2003, CANCER RES, V63, P3923; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tolcher A, 2018, ONCOLOGIST, V23, P658, DOI 10.1634/theoncologist.2017-0325; Toyonaga T, 2003, CANCER LETT, V201, P107, DOI 10.1016/S0304-3835(03)00482-8; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wilkinson B, 2014, NEW ENGL J MED, V371, P1164, DOI 10.1056/NEJMc1408607; Wong ALA, 2017, EXPERT OPIN INV DRUG, V26, P883, DOI 10.1080/13543784.2017.1351941; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zhang B, 2019, CELL, V176, P636, DOI 10.1016/j.cell.2019.01.003; Zhang T, 2017, ONCOGENE, V36, P6627, DOI 10.1038/onc.2017.270; Zhang XL, 2013, CANCER RES, V73, P1922, DOI 10.1158/0008-5472.CAN-12-3175; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109; Zhao W, 2010, J BIOL CHEM, V285, P35855, DOI 10.1074/jbc.M110.154088	42	15	15	5	16	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2021	40	8					1440	1457		10.1038/s41388-020-01626-z	http://dx.doi.org/10.1038/s41388-020-01626-z		JAN 2021	18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QM6NM	33420372	hybrid, Green Published			2022-12-26	WOS:000607346000003
J	Huang, ZB; Chen, KM; Chi, YL; Jin, H; Li, L; Zhang, WQ; Xu, J; Zhang, YY				Huang, Zhibin; Chen, Kemin; Chi, Yali; Jin, Hao; Li, Li; Zhang, Wenqing; Xu, Jin; Zhang, Yiyue			Runx1 regulates zebrafish neutrophil maturation via synergistic interaction with c-Myb	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; MYELOPEROXIDASE; DIFFERENTIATION; MACROPHAGES; C/EBP; AML1; LOCALIZATION; GRANULOCYTES; MUTATIONS; PEBP2/CBF	Neutrophils play an essential role in the innate immune defense system in vertebrates. During hematopoiesis, the full function of neutrophils involves maturation of granules and related enzymes. Yet, transcription regulators that promote neutrophil maturation remain largely undefined. Here, two hematopoiesis-defective zebrafish mutants, runx1(w84x) and c-myb(hkz3), were used to investigate the in vivo roles of Runx1 in cooperation with c-Myb in regulating neutrophil maturation. Loss of runx1 impairs primitive neutrophil development. Additional regulation of c-myb(+/-) and c-myb(-/-) induces a more severe phenotypes suggesting a synergistic genetic interaction between c-myb and runx1 in neutrophil maturation. Further studies revealed that the two transcription factors act cooperatively to control neutrophil maturation processes via transactivating a series of neutrophil maturation-related genes. These data reveal the in vivo roles of Runx1 in regulating primitive neutrophil maturation while also indicating a novel genetic and molecular orchestration of Runx1 and c-Myb in myeloid cell development. The study will provide new evidence on the regulation of neutrophil maturation during hematopoiesis.	[Huang, Zhibin; Chen, Kemin; Zhang, Wenqing; Xu, Jin; Zhang, Yiyue] South China Univ Technol, Sch Med, Div Cell Dev & Integrat Biol, Guangzhou, Peoples R China; [Chi, Yali] Southern Med Univ, Sch Basic Med Sci, Dept Dev Biol, Guangzhou, Peoples R China; [Jin, Hao] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Hong Kong, Peoples R China; [Li, Li] Southwest Univ, Sch Life Sci, State Key Lab Breeding Base Ecoenvironm & Bioreso, Key Lab Freshwater Fish Reprod & Dev,Minist Educ, Chongqing, Peoples R China	South China University of Technology; Southern Medical University - China; Hong Kong University of Science & Technology; Southwest University - China	Zhang, YY (corresponding author), South China Univ Technol, Sch Med, Div Cell Dev & Integrat Biol, Guangzhou, Peoples R China.	mczhangyy@scut.edu.cn	zhang, wenqing/GYA-0786-2022; Xu, Jin/N-6576-2018	Huang, Zhibin/0000-0003-4286-4002; Chen, Kemin/0000-0003-4881-8584; ZHANG, Yiyue/0000-0002-9402-3523; Xu, Jin/0000-0002-6840-1359	National Key R&D Program of China [2018YFA0800200, 2018YFA0801000]; National Natural Science Foundation of China [31922023]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Fundamental Research Funds for the Central Universities [2019ZD54]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Key R&D Program of China (2018YFA0800200 and 2018YFA0801000), the National Natural Science Foundation of China (31922023), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2019), and the Fundamental Research Funds for the Central Universities (2019ZD54).	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Austin GE, 1998, LEUKEMIA RES, V22, P1037, DOI 10.1016/S0145-2126(98)00105-2; Bellissimo DC, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00111; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Brightman DS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30355-3; Chi YL, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180043; Cuartero S, 2018, NAT IMMUNOL, V19, P932, DOI 10.1038/s41590-018-0184-1; De Braekeleer E, 2011, FUTURE ONCOL, V7, P77, DOI [10.2217/fon.10.158, 10.2217/FON.10.158]; Eaves CJ, 2015, BLOOD, V125, P2605, DOI 10.1182/blood-2014-12-570200; Ezoe S, 2004, CELL CYCLE, V3, P314; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Friedman AD, 1996, CURR TOP MICROBIOL, V211, P149; Friedman AD, 2015, INT J HEMATOL, V101, P330, DOI 10.1007/s12185-015-1764-6; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Hart DO, 2007, NATURE, V450, P1082, DOI 10.1038/nature06349; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Huang M, 2002, NAT CELL BIOL, V4, P774, DOI 10.1038/ncb855; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Jin H, 2016, BLOOD, V128, P415, DOI 10.1182/blood-2015-12-686147; Jin H, 2012, BLOOD, V119, P5239, DOI 10.1182/blood-2011-12-398362; Jin H, 2009, DEVELOPMENT, V136, P647, DOI 10.1242/dev.029637; Kitaguchi T, 2009, MECH DEVELOP, V126, P314, DOI 10.1016/j.mod.2009.02.007; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Mangan James K., 2011, Critical Reviews in Oncogenesis, V16, P77; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Ng KP, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.41; Niemann CU, 2007, BLOOD, V109, P4478, DOI 10.1182/blood-2006-02-001719; Niemann CU, 2004, J LEUKOCYTE BIOL, V76, P406, DOI 10.1189/jlb.1003502; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Veldhoen M, 2015, NAT MED, V21, P709, DOI 10.1038/nm.3894; Wang K, 2015, FISH SHELLFISH IMMUN, V44, P109, DOI 10.1016/j.fsi.2015.01.038; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Zhang DE, 1996, CURR TOP MICROBIOL, V211, P137; Zhang YY, 2011, BLOOD, V118, P4093, DOI 10.1182/blood-2011-03-342501	43	2	2	4	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100272	10.1016/j.jbc.2021.100272	http://dx.doi.org/10.1016/j.jbc.2021.100272			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33434583	Green Published, gold			2022-12-26	WOS:000672866400248
J	Lopusna, K; Nowialis, P; Opavska, J; Abraham, A; Riva, A; Haney, SL; Opavsky, R				Lopusna, Katarina; Nowialis, Pawel; Opavska, Jana; Abraham, Ajay; Riva, Alberto; Haney, Staci L.; Opavsky, Rene			Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; DE-NOVO METHYLATION; DNA METHYLATION; GENE; MYC; EXPRESSION; TCL1; TUMORIGENESIS; TRANSCRIPTION; INSTABILITY	DNA methylation regulates gene transcription and is involved in various physiological processes in mammals, including development and hematopoiesis. It is catalyzed by DNA methyltransferases including Dnmt1, Dnmt3a, and Dnmt3b. For Dnmt3b, its effects on transcription can result from its own DNA methylase activity, the recruitment of other Dnmts to mediate methylation, or transcription repression in a methylation-independent manner. Low-frequency mutations in human DNMT3B are found in hematologic malignancies including cutaneous T-cell lymphomas, hairy cell leukemia, and diffuse large B-cell lymphomas. Moreover, Dnmt3b is a tumor suppressor in oncogene-driven lymphoid and myeloid malignancies in mice. However, it is poorly understood how the different Dnmt3b activities contribute to these outcomes. We modulated Dnmt3b activity in vivo by generating Dnmt3b(+/-) mice expressing one wild-type allele as well as Dnmt3b(+/CI) and Dnmt3b(CI/CI) mice where one or both alleles express catalytically inactive Dnmt3b(CI). We show that 43% of Dnmt3b(+/-) mice developed T-cell lymphomas, chronic lymphocytic leukemia, and myeloproliferation over 18 months, thus resembling phenotypes previously observed in Dnmt3a(+/-) mice, possibly through regulation of shared target genes. Interestingly, Dnmt3b(+/CI) and Dnmt3b(CI/CI) mice survived postnatal development and were affected by B-cell rather than T-cell malignancies with decreased penetrance. Genome-wide hypomethylation, increased expression of oncogenes such as Jdp2, STAT1, and Trip13, and p53 downregulation were major events contributing to Dnmt3b(+/-) lymphoma development. We conclude that Dnmt3b catalytic activity is critical to prevent B-cell transformation in vivo, whereas accessory and methylation-independent repressive functions are important to prevent T-cell transformation.	[Lopusna, Katarina; Nowialis, Pawel; Opavska, Jana; Abraham, Ajay; Opavsky, Rene] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32611 USA; [Riva, Alberto] Univ Florida, ICBR Bioinformat Canc & Genet Res Complex, Gainesville, FL USA; [Haney, Staci L.] Univ Nebraska Med Ctr, Dept Internal Med, Nebraska Med Ctr 985950, Omaha, NE USA; [Abraham, Ajay] Univ Texas Austin, Dell Med Sch, Dept Oncol, 1601 Trinity St,Bldg B, Austin, TX 78712 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Nebraska System; University of Nebraska Medical Center; University of Texas System; University of Texas Austin	Opavsky, R (corresponding author), Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32611 USA.	ropavsky@ufl.edu	Abraham, Ajay/AAK-8454-2020; Lopusna, Katarina/AAO-7437-2020	Abraham, Ajay/0000-0003-4094-2476; Lopusna, Katarina/0000-0002-9887-8422	NIH/NCI [1R01CA188561-01A1]	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH/NCI grant 1R01CA188561-01A1 (R.O.).	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Avalle Lidia, 2012, JAKSTAT, V1, P65, DOI 10.4161/jkst.20045; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Barau J, 2016, SCIENCE, V354, P909, DOI 10.1126/science.aah5143; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Blanco-Betancourt CE, 2004, BLOOD, V103, P2683, DOI 10.1182/blood-2003-08-2632; Celik H, 2016, INT J HEMATOL, V103, P617, DOI 10.1007/s12185-016-1957-7; Cole CB, 2017, J CLIN INVEST, V127, P3657, DOI 10.1172/JCI93041; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DONEHOWER LA, 1995, MOL CARCINOGEN, V14, P16, DOI 10.1002/mc.2940140105; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Duymich CE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11453; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; FRANCESCHINI P, 1995, EUR J PEDIATR, V154, P840, DOI 10.1007/BF01959794; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Gao TS, 2016, BIOINFORMATICS, V32, P3543, DOI 10.1093/bioinformatics/btw495; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Haney SL, 2015, ONCOGENE, V34, P5436, DOI 10.1038/onc.2014.472; Haney SL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006334; Haney SL, 2016, CELL REP, V15, P1190, DOI 10.1016/j.celrep.2016.04.004; Herling M, 2006, LEUKEMIA, V20, P280, DOI 10.1038/sj.leu.2404017; Hlady RA, 2012, J CLIN INVEST, V122, P163, DOI 10.1172/JCI57292; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Juhling F, 2016, GENOME RES, V26, P256, DOI 10.1101/gr.196394.115; Kiel MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9470; King AD, 2016, CELL REP, V17, P289, DOI 10.1016/j.celrep.2016.08.083; Kovacic B, 2006, CANCER CELL, V10, P77, DOI 10.1016/j.ccr.2006.05.025; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Lu S, 2019, COMPUT STRUCT BIOTEC, V17, P854, DOI 10.1016/j.csbj.2019.06.005; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Neri F, 2017, NATURE, V543, P72, DOI 10.1038/nature21373; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Nowialis P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12355-7; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Palamarchuk A, 2012, P NATL ACAD SCI USA, V109, P2555, DOI 10.1073/pnas.1200003109; Peters SL, 2014, LEUKEMIA, V28, P1138, DOI 10.1038/leu.2013.364; Peters SL, 2013, MOL CELL BIOL, V33, P4321, DOI 10.1128/MCB.00776-13; Poole CJ, 2017, ONCOTARGET, V8, P76898, DOI 10.18632/oncotarget.20176; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rice KL, 2007, ONCOGENE, V26, P6697, DOI 10.1038/sj.onc.1210755; Shah MY, 2010, CANCER RES, V70, P5840, DOI 10.1158/0008-5472.CAN-10-0847; Sterlin D, 2016, J CLIN IMMUNOL, V36, P149, DOI 10.1007/s10875-016-0240-2; Stratikopoulos E, 2008, P NATL ACAD SCI USA, V105, P19378, DOI 10.1073/pnas.0809223105; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ueda Y, 2006, DEVELOPMENT, V133, P1183, DOI 10.1242/dev.02293; Upchurch GM, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00182; van der Weyden L, 2013, ONCOGENE, V32, P397, DOI 10.1038/onc.2012.56; Vasanthakumar A, 2013, BLOOD, V121, P2059, DOI 10.1182/blood-2012-04-421065; Wierda RJ, 2010, J CELL MOL MED, V14, P1225, DOI 10.1111/j.1582-4934.2010.01022.x; Xiao H, 2019, EPIGENETICS-US, V14, P837, DOI 10.1080/15592294.2019.1625670; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yuille MR, 2001, GENE CHROMOSOME CANC, V30, P336, DOI 10.1002/gcc.1099; Zhang TY, 2015, EMBO REP, V16, P1467, DOI 10.15252/embr.201540945; Zhang YY, 2018, ELIFE, V7, DOI 10.7554/eLife.40757; Zheng Y, 2016, LEUKEMIA, V30, P2373, DOI 10.1038/leu.2016.112	63	2	2	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100285	10.1016/j.jbc.2021.100285	http://dx.doi.org/10.1016/j.jbc.2021.100285			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33450231	gold, Green Published			2022-12-26	WOS:000672866400261
J	Dadousis, C; Cecchi, F; Ablondi, M; Fabbri, MC; Stella, A; Bozzi, R				Dadousis, Christos; Cecchi, Francesca; Ablondi, Michela; Fabbri, Maria Chiara; Stella, Alessandra; Bozzi, Riccardo			Keep Garfagnina alive. An integrated study on patterns of homozygosity, genomic inbreeding, admixture and breed traceability of the Italian Garfagnina goat breed	PLOS ONE			English	Article							GENETIC-RESOURCES; POPULATIONS; DOMESTICATION; SIGNATURES; MUTATIONS; SELECTION; RUNS; TOOL	The objective of this study was to investigate the genetic diversity of the Garfagnina (GRF) goat, a breed that currently risks extinction. For this purpose, 48 goats were genotyped with the Illumina CaprineSNP50 BeadChip and analyzed together with 214 goats belonging to 9 other Italian breeds (similar to 25 goats/breed), whose genotypes were available from the AdaptMap project [Argentata (ARG), Bionda dell'Adamello (BIO), Ciociara Grigia (CCG), Di Teramo (DIT), Garganica (GAR), Girgentana (GGT), Orobica (ORO), Valdostana (VAL) and Valpassiria (VSS)]. Comparative analyses were conducted on i) runs of homozygosity (ROH), ii) admixture ancestries and iii) the accuracy of breed traceability via discriminant analysis on principal components (DAPC) based on cross-validation. ROH analyses was used to assess the genetic diversity of GRF, while admixture and DAPC to evaluate its relationship to the other breeds. For GRF, common ROH (more than 45% in GRF samples) was detected on CHR 12 at, roughly 50.25-50.94Mbp (ARS1 assembly), which spans the CENPJ (centromere protein) and IL17D (interleukin 17D) genes. The same area of common ROH was also present in DIT, while a broader region (similar to 49.25-51.94Mbp) was shared among the ARG, CCG, and GGT. Admixture analysis revealed a small region of common ancestry from GRF shared by BIO, VSS, ARG and CCG breeds. The DAPC model yielded 100% assignment success for GRF. Overall, our results support the identification of GRF as a distinct native Italian goat breed. This work can contribute to planning conservation programmes to save GRF from extinction and will improve the understanding of the socio-agro-economic factors related with the farming of GRF.	[Dadousis, Christos; Fabbri, Maria Chiara; Bozzi, Riccardo] Univ Firenze, Dipartimento Sci & Tecnol Agr Alimentari Ambienta, Florence, Italy; [Cecchi, Francesca] Univ Pisa, Dipartimento Sci Vet, Pisa, Italy; [Ablondi, Michela] Univ Parma, Dipartimento Sci Med Vet, Parma, Italy; [Stella, Alessandra] CNR, Ist Biol & Biotecnol Agr, Milan, Italy	University of Florence; University of Pisa; University of Parma; Consiglio Nazionale delle Ricerche (CNR)	Dadousis, C (corresponding author), Univ Firenze, Dipartimento Sci & Tecnol Agr Alimentari Ambienta, Florence, Italy.	christos.dadousis@unipr.it	Fabbri, Maria Chiara/AAP-2814-2020; stella, Alessandra/AAG-6401-2021; Ablondi, Michela/AAA-3031-2019; stella, Alessandra/ABB-1952-2021	Fabbri, Maria Chiara/0000-0002-3224-745X; stella, Alessandra/0000-0003-2850-3964; stella, Alessandra/0000-0003-2850-3964; Ablondi, Michela/0000-0003-3700-1042; CECCHI, FRANCESCA/0000-0001-5483-6354; DADOUSIS, CHRISTOS/0000-0002-7689-6443	University of Pisa; University of Firenze [RICCARDOBOZZIRICATEN19]	University of Pisa; University of Firenze	This work was supported by grants of the University of Pisa (PRA 2016) and grants of the University of Firenze (RICCARDOBOZZIRICATEN19).	Ablondi M, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10061005; Alexander D., ADMIXTURE VERSION 1; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bertolini F, 2018, GENET SEL EVOL, V50, DOI 10.1186/s12711-018-0424-8; Bertolini F, 2018, GENET SEL EVOL, V50, DOI 10.1186/s12711-018-0421-y; Bertolini F, 2016, MAMM GENOME, V27, P144, DOI 10.1007/s00335-016-9623-1; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Cecchi F, 2019, TROP ANIM HEALTH PRO, V51, P729, DOI 10.1007/s11250-018-1728-y; Cecchi F, 2018, J APPL ANIM RES, V46, P879, DOI 10.1080/09712119.2017.1417129; Cecchi F, 2017, TROP ANIM HEALTH PRO, V49, P1135, DOI 10.1007/s11250-017-1306-8; Curone G, 2018, RES VET SCI, V116, P88, DOI 10.1016/j.rvsc.2017.11.020; Ding WY, 2019, J NEUROSCI, V39, P1994, DOI 10.1523/JNEUROSCI.1849-18.2018; Domestic Animal Diversity Information System (DAD-IS), 2019, DOM AN DIV INF SYST; Duerinckx S, 2018, SEMIN CELL DEV BIOL, V76, P76, DOI 10.1016/j.semcdb.2017.09.015; Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4; Feng YP, 2009, ACTA BIOCH BIOPH SIN, V41, P285, DOI 10.1093/abbs/gmp012; Food and Agriculture Organization of the United Nations, GLOB PLAN ACT AN GEN; Food and Agriculture Organization of the United Nations, FAOSTAT INT; Gomez-Raya L, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0153-1; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kim ES, 2016, HEREDITY, V116, P255, DOI 10.1038/hdy.2015.94; Lamartine J, 2000, NAT GENET, V26, P142, DOI 10.1038/79851; Lovreglio R, 2014, IFOREST, V7, P260, DOI 10.3832/ifor1112-007; Marras G, 2015, ANIM GENET, V46, P110, DOI 10.1111/age.12259; Martini M, 2010, J DAIRY SCI, V93, P4659, DOI 10.3168/jds.2010-3207; Mastrangelo S, 2016, ANIMAL, V10, P746, DOI 10.1017/S1751731115002943; McIntyre RE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003022; Naderi S, 2008, P NATL ACAD SCI USA, V105, P17659, DOI 10.1073/pnas.0804782105; Naveed M, 2018, GENET RES, V100, DOI 10.1017/S0016672318000046; Paiva SR, 2016, LIVEST SCI, V193, P32, DOI 10.1016/j.livsci.2016.09.010; Pandya A, 2003, GENET MED, V5, P295, DOI 10.1097/01.GIM.0000078026.01140.68; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Ribeiro NL, 2016, SMALL RUMINANT RES, V144, P236, DOI 10.1016/j.smallrumres.2016.10.001; Salari F, 2016, ITAL J ANIM SCI, V15, P568, DOI 10.1080/1828051X.2016.1247658; Samori P, 2019, ADV MATER TECHNOL-US, V4, DOI 10.1002/admt.201900303; Schiavo G, 2020, ANIMAL, V14, P910, DOI 10.1017/S175173111900332X; Silversides FG, 2012, BRIT POULTRY SCI, V53, P599, DOI 10.1080/00071668.2012.727383; Sponenberg DP, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11100177; Stella A, 2018, GENET SEL EVOL, V50, DOI 10.1186/s12711-018-0427-5; Tosser-Klopp G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086227; Villanueva B, 2004, BSAS PUBL, V30, P113, DOI 10.1017/S0263967X00041987; Wimmer V, 2012, BIOINFORMATICS, V28, P2086, DOI 10.1093/bioinformatics/bts335; Windig JJ, 2008, ANIMAL, V2, P1733, DOI 10.1017/S1751731108003029; Woolliams JA, 2015, J ANIM BREED GENET, V132, P89, DOI 10.1111/jbg.12148; Woolliams J, 2007, UTILISATION AND CONSERVATION OF FARM ANIMAL GENETIC RESOURCES, P55; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254; Zomerdijk F, 2020, BIOPRESERV BIOBANK, V18, P244, DOI 10.1089/bio.2019.0128	50	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0232436	10.1371/journal.pone.0232436	http://dx.doi.org/10.1371/journal.pone.0232436			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449925	Green Published, Green Submitted, gold			2022-12-26	WOS:000609991600042
J	Zilli, J; Kressin, M; Schanzer, A; Kampschulte, M; Schmidt, MJ				Zilli, Jessica; Kressin, Monika; Schanzer, Anne; Kampschulte, Marian; Schmidt, Martin J.			Partial cortico-hippocampectomy in cats, as therapy for refractory temporal epilepsy: A descriptive cadaveric study	PLOS ONE			English	Article							SPATIAL DELAYED-RESPONSES; LOBE EPILEPSY; SELECTIVE AMYGDALOHIPPOCAMPECTOMY; LOBECTOMY; SCLEROSIS; LESIONS; FEATURES; DOG; AMYGDALA; SEIZURE	Cats, similar to humans, are known to be affected by hippocampal sclerosis (HS), potentially causing antiepileptic drug (AED) resistance. HS can occur as a consequence of chronic seizure activity, trauma, inflammation, or even as a primary disease. In humans, temporal lobe resection is the standardized therapy in patients with refractory temporal lobe epilepsy (TLE). The majority of TLE patients are seizure free after surgery. Therefore, the purpose of this prospective cadaveric study is to establish a surgical technique for hippocampal resection in cats as a treatment for AED resistant seizures. Ten cats of different head morphology were examined. Pre-surgical magnetic resonance imaging (MRI) and computed tomography (CT) studies of the animals' head were carried out to complete 3D reconstruction of the head, brain, and hippocampus. The resected hippocampal specimens and the brains were histologically examined for tissue injury adjacent to the hippocampus. The feasibility of the procedure, as well as the usability of the removed specimen for histopathological examination, was assessed. Moreover, a micro-CT (mCT) examination of the brain of two additional cats was performed in order to assess temporal vasculature as a reason for possible intraoperative complications. In all cats but one, the resection of the temporal cortex and the hippocampus were successful without any evidence of traumatic or vascular lesions in the surrounding neurovascular structures. In one cat, the presence of mechanical damage (a fissure) of the thalamic surface was evident in the histopathologic examination of the brain post-resection. All hippocampal fields and the dentate gyrus were identified in the majority of the cats via histological examination. The study describes a new surgical approach (partial temporal cortico-hippocampectomy) offering a potential treatment for cats with clinical and diagnostic evidence of temporal epilepsy which do not respond adequately to the medical therapy.	[Zilli, Jessica; Schmidt, Martin J.] Justus Liebig Univ, Small Anim Clin, Dept Vet Clin Sci, Giessen, Germany; [Kressin, Monika] Justus Liebig Univ, Inst Vet Anat Histol & Embryol, Giessen, Germany; [Schanzer, Anne] Justus Liebig Univ, Inst Neuropathol, Giessen, Germany; [Kampschulte, Marian] Justus Liebig Univ, Dept Radiol, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Zilli, J (corresponding author), Justus Liebig Univ, Small Anim Clin, Dept Vet Clin Sci, Giessen, Germany.	Jessica.Zilli@vetmed.uni-giessen.de		Zilli, Jessica/0000-0003-4112-6518				ADAMEC RE, 1983, PROG NEURO-PSYCHOPH, V7, P505, DOI 10.1016/0278-5846(83)90017-9; ANDY OJ, 1967, J COMP PHYSIOL PSYCH, V64, P516, DOI 10.1037/h0025193; [Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01; [Anonymous], 2015, TRANSPLANTATION DIRE, V1, pe2, DOI 10.1097/TXD.0000000000000509; Bate H, 2007, EUR J NEUROL, V14, P90, DOI 10.1111/j.1468-1331.2006.01565.x; Blumcke I, 2013, EPILEPSIA, V54, P1315, DOI 10.1111/epi.12220; Brini E, 2004, J FELINE MED SURG, V6, P377, DOI 10.1016/j.jfms.2003.12.007; BROWN TS, 1969, BRAIN RES, V12, P86, DOI 10.1016/0006-8993(69)90057-2; Bujarski KA, 2013, J NEUROSURG, V119, P16, DOI 10.3171/2013.3.JNS12714; Cheung LK, 1996, J ORAL MAXIL SURG, V54, P1439, DOI 10.1016/S0278-2391(96)90261-X; Classen AC, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0788-3; DELGADO JM, 1961, ELECTROEN CLIN NEURO, V13, P722, DOI 10.1016/0013-4694(61)90104-3; Ekenstedt KJ, 2012, MAMM GENOME, V23, P28, DOI 10.1007/s00335-011-9362-2; Ellenberger W., 1977, HDB VERGLEICHENDEN A, V18; Fors S, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0127-x; Forterre F, 2009, J FELINE MED SURG, V11, P510, DOI 10.1016/j.jfms.2008.11.002; GAMBARYAN LS, 1979, ZH VYSSH NERV DEYAT+, V29, P56; GASTAUT H, 1959, J NEUROPATH EXP NEUR, V18, P270, DOI 10.1097/00005072-195904000-00004; GILLILAN LA, 1976, AM J ANAT, V146, P237, DOI 10.1002/aja.1001460303; Goetzen Bogdan, 1992, Neuropatologia Polska, V30, P173; Hamamoto Y, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00172; Hasegawa D, 2016, VET J, V215, P64, DOI 10.1016/j.tvjl.2016.03.005; Heller HB, 2018, VET CLIN N AM-SMALL, V48, P31, DOI 10.1016/j.cvsm.2017.08.011; Helmstaedter C, 2004, J NEUROL NEUROSUR PS, V75, P323; Hu WH, 2013, J NEUROSURG, V119, P1089, DOI 10.3171/2013.8.JNS121854; JARRARD LE, 1973, PSYCHOL BULL, V79, P1, DOI 10.1037/h0033792; Kitz S, 2017, J VET INTERN MED, V31, P633, DOI 10.1111/jvim.14699; KOWALSKA DM, 1992, ACTA NEUROBIOL EXP, V52, P119; Kowalska DM, 1999, ACTA NEUROBIOL EXP, V59, P303; Kowalska DM, 2000, PROG NEURO-PSYCHOPH, V24, P855, DOI 10.1016/S0278-5846(00)00110-X; KOWALSKA DM, 1995, HIPPOCAMPUS, V5, P363, DOI 10.1002/hipo.450050409; Loiselle M, 2012, NEUROPSYCHOLOGIA, V50, P630, DOI 10.1016/j.neuropsychologia.2011.12.023; Long S, 2014, J VET INTERN MED, V28, P189, DOI 10.1111/jvim.12235; Martle V, 2014, VET J, V199, P332, DOI 10.1016/j.tvjl.2013.09.055; MILLER LA, 1994, J NEUROL NEUROSUR PS, V57, P1099, DOI 10.1136/jnnp.57.9.1099; Mizoguchi S, 2014, EPILEPSY RES, V108, P1940, DOI 10.1016/j.eplepsyres.2014.09.009; Muzumdar D, 2016, INT J SURG, V36, P411, DOI 10.1016/j.ijsu.2016.10.027; Nascimento FA, 2016, ARQ NEURO-PSIQUIAT, V74, P35, DOI 10.1590/0004-282X20150188; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST, V3; Nilges RG, 1944, J COMP NEUROL, V80, P177, DOI 10.1002/cne.900800203; Olivier A, 2012, TECHNIQUES IN EPILEPSY SURGERY: THE MNI APPROACH, P1, DOI 10.1017/CBO9781139021951; Paglioli E, 2006, J NEUROSURG, V104, P70, DOI 10.3171/jns.2006.104.1.70; Pakozdy A, 2015, ANAT HISTOL EMBRYOL, V44, P422, DOI 10.1111/ahe.12153; Pakozdy A, 2014, J VET INTERN MED, V28, P255, DOI 10.1111/jvim.12297; Pakozdy A, 2017, MODELS OF SEIZURES AND EPILEPSY, 2ND EDITION, P399, DOI 10.1016/B978-0-12-804066-9.00029-8; Pakozdy A, 2014, EPILEPTIC DISORD, V16, P116, DOI 10.1684/epd.2014.0635; Polley Martin, 2000, CONTEMP BR HIST, V14, P100; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; Rusbridge C, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0466-x; Salanova V, 2002, EPILEPSIA, V43, P170, DOI 10.1046/j.1528-1157.2002.33800.x; Schmidt MJ, 2017, J VET INTERN MED, V31, P1487, DOI 10.1111/jvim.14805; Schmied O, 2008, VET RADIOL ULTRASOUN, V49, P343, DOI 10.1111/j.1740-8261.2008.00377.x; Schober W., 1974, Handbuch der Zoologie, V8, P1; Shihab N, 2014, VET SURG, V43, P877, DOI 10.1111/j.1532-950X.2014.12246.x; Shores A, 2017, CURRENT TECHNIQUES C; Shouse MN, 2004, BRAIN RES, V1027, P126, DOI 10.1016/j.brainres.2004.08.047; Sloviter RS, 2008, EPILEPSIA, V49, P85, DOI 10.1111/j.1528-1167.2008.01931.x; Snider RS, 1961, STEREOTAXIC ATLAS CA, DOI [10.1001/archinte.1961.03620120081011, DOI 10.1001/ARCHINTE.1961.03620120081011]; Tanaka T, 1989, No To Shinkei, V41, P1239; Tartygin NA, 1996, SOV PSYCHOL, V5, P38; TEITELBAUM H, 1964, EXP NEUROL, V9, P452, DOI 10.1016/0014-4886(64)90053-6; Vanhaesebrouck AE, 2012, J FELINE MED SURG, V14, P932, DOI 10.1177/1098612X12454419; WADA JA, 1975, EPILEPSIA, V16, P503, DOI 10.1111/j.1528-1157.1975.tb06080.x; Wagner E, 2014, BRAIN PATHOL, V24, P607, DOI 10.1111/bpa.12147; Wendling AS, 2013, EPILEPSY RES, V104, P94, DOI 10.1016/j.eplepsyres.2012.09.007; Wininger F, 2014, VET CLIN N AM-SMALL, V44, P1235, DOI 10.1016/j.cvsm.2014.07.015; Wouters EGH, 2011, VET COMP ORTHOPAED, V24, P72, DOI 10.3415/VCOT-10-02-0018; Yu Y, 2018, AM J VET RES, V79, P324, DOI 10.2460/ajvr.79.3.324	68	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0244892	10.1371/journal.pone.0244892	http://dx.doi.org/10.1371/journal.pone.0244892			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449929	Green Published, gold			2022-12-26	WOS:000609991600038
J	Maguire, M; Kase, JA; Roberson, D; Muruvanda, T; Brown, EW; Allard, M; Musser, SM; Gonzalez-Escalona, N				Maguire, Meghan; Kase, Julie A.; Roberson, Dwayne; Muruvanda, Tim; Brown, Eric W.; Allard, Marc; Musser, Steven M.; Gonzalez-Escalona, Narjol			Precision long-read metagenomics sequencing for food safety by detection and assembly of Shiga toxin-producing Escherichia coli in irrigation water	PLOS ONE			English	Article							UNITED-STATES; FRESH PRODUCE; FOODBORNE PATHOGENS; SURVEILLANCE; INFECTIONS; ILLNESS; RESISTANCE; OUTBREAKS; GENOMICS; BACTERIA	Shiga toxin-producing Escherichia coli (STEC) contamination of agricultural water might be an important factor to recent foodborne illness and outbreaks involving leafy greens. Closed bacterial genomes from whole genome sequencing play an important role in source tracking. We aimed to determine the limits of detection and classification of STECs by qPCR and nanopore sequencing using 24 hour enriched irrigation water artificially contaminated with E. coli O157:H7 (EDL933). We determined the limit of STEC detection by qPCR to be 30 CFU/reaction, which is equivalent to 10(5) CFU/ml in the enrichment. By using Oxford Nanopore's EPI2ME WIMP workflow and de novo assembly with Flye followed by taxon classification with a k-mer analysis software (Kraken2), E. coli O157:H7 could be detected at 10(3) CFU/ml (68 reads) and a complete fragmented E. coli O157:H7 metagenome-assembled genome (MAG) was obtained at 10(5)-10(8) CFU/ml. Using a custom script to extract the E. coli reads, a completely closed MAG was obtained at 10(7)-10(8) CFU/ml and a complete, fragmented MAG was obtained at 10(5)-10(6) CFU/ml. In silico virulence detection for E. coli MAGs for 10(5)-10(8) CFU/ml showed that the virulotype was indistinguishable from the spiked E. coli O157:H7 strain. We further identified the bacterial species in the un-spiked enrichment, including antimicrobial resistance genes, which could have important implications to food safety. We propose this workflow provides proof of concept for faster detection and complete genomic characterization of STECs from a complex microbial sample compared to current reporting protocols and could be applied to determine the limit of detection and assembly of other foodborne bacterial pathogens.	[Maguire, Meghan; Kase, Julie A.; Roberson, Dwayne; Muruvanda, Tim; Brown, Eric W.; Allard, Marc; Musser, Steven M.; Gonzalez-Escalona, Narjol] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA	US Food & Drug Administration (FDA)	Gonzalez-Escalona, N (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.	narjol.gonzalez-escalona@fda.hhs.gov		Gonzalez-Escalona, Narjol/0000-0003-4568-0022; Kase, Julie/0000-0002-5094-7492	MCMi Challenge Grants Program [2018-646]; FDA Foods Program Intramural Funds	MCMi Challenge Grants Program; FDA Foods Program Intramural Funds	NGE research was supported by funding from the MCMi Challenge Grants Program Proposal #2018-646 and the FDA Foods Program Intramural Funds. MM was supported by funding from the MCMi Challenge Grants Program Proposal #2018-646. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Alcock BP, 2020, NUCLEIC ACIDS RES, V48, pD517, DOI 10.1093/nar/gkz935; Allard MW, 2018, CURR OPIN BIOTECH, V49, P224, DOI 10.1016/j.copbio.2017.11.002; Allende A, 2015, INT J ENV RES PUB HE, V12, P7457, DOI 10.3390/ijerph120707457; Allos BM, 2004, CLIN INFECT DIS, V38, pS115, DOI 10.1086/381577; Archer DL, 2018, CURR OPIN FOOD SCI, V20, P64, DOI 10.1016/j.cofs.2018.03.007; Bergholz TM, 2014, TRENDS MICROBIOL, V22, P275, DOI 10.1016/j.tim.2014.01.006; Bertrand D, 2019, NAT BIOTECHNOL, V37, P937, DOI 10.1038/s41587-019-0191-2; Beutin L, 2012, J FOOD PROTECT, V75, P408, DOI 10.4315/0362-028X.JFP-11-452; Bottichio L, 2020, CLIN INFECT DIS, V71, pE323, DOI 10.1093/cid/ciz1182; Boykin LM, 2019, GENES-BASEL, V10, DOI 10.3390/genes10090632; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Cooper RM, 2017, ELIFE, V6, DOI 10.7554/eLife.25950; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Fischer M, 2015, OUTBREAK ALERT 2015; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Gigliucci F, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00025; Gonzalez-Escalona N, 2019, FOOD MICROBIOLOGY, 5 EDITION, P289, DOI 10.1128/9781555819972.ch11; Gonzalez-Escalona N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220494; Gonzalez-Escalona N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214620; Gonzalez-Escalona N, 2016, APPL ENVIRON MICROB, V82, P3900, DOI 10.1128/AEM.00498-16; Grutzke J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01805; Gu GY, 2020, INT J FOOD MICROBIOL, V318, DOI 10.1016/j.ijfoodmicro.2019.108458; Holzel CS, 2018, FOODBORNE PATHOG DIS, V15, P671, DOI 10.1089/fpd.2018.2501; Hoffmann M, 2016, J INFECT DIS, V213, P502, DOI 10.1093/infdis/jiv297; Juul S., 2015, BIORXIV, DOI [10.1101/030742, DOI 10.1101/030742]; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karp BE, 2017, FOODBORNE PATHOG DIS, V14, P545, DOI 10.1089/fpd.2017.2283; Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116; Kolmogorov M, 2019, NAT BIOTECHNOL, V37, P540, DOI 10.1038/s41587-019-0072-8; Kovac J, 2017, TRAC-TREND ANAL CHEM, V96, P52, DOI 10.1016/j.trac.2017.06.001; Leaman S, 2014, AGR WATER; Leonard SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167870; Leonard SR, 2015, APPL ENVIRON MICROB, V81, P8183, DOI 10.1128/AEM.02601-15; Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/nmeth.3444]; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Monaghan JM, 2012, J APPL MICROBIOL, V112, P1007, DOI 10.1111/j.1365-2672.2012.05269.x; Moss EL, 2020, NAT BIOTECHNOL, V38, P701, DOI 10.1038/s41587-020-0422-6; Nicholls SM, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz043; Olaimat AN, 2012, FOOD MICROBIOL, V32, P1, DOI 10.1016/j.fm.2012.04.016; Oliveira M, 2012, INT J FOOD MICROBIOL, V156, P133, DOI 10.1016/j.ijfoodmicro.2012.03.014; Ottesen A, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-019-4747-z; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Sekse C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02029; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Steele M, 2004, J FOOD PROTECT, V67, P2839, DOI 10.4315/0362-028X-67.12.2839; Suttner B, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.02525-19; Tack DM, 2020, MMWR-MORBID MORTAL W, V69, P509, DOI 10.15585/mmwr.mm6917a1; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Thakur S, 2019, AM J TROP MED HYG, V100, P227, DOI 10.4269/ajtmh.18-0973; The Lancet Global Health, 2018, LANCET GLOB HLTH, V6, pE593; Uyttendaele M, 2015, COMPR REV FOOD SCI F, V14, P336, DOI 10.1111/1541-4337.12133; Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0	55	10	10	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245172	10.1371/journal.pone.0245172	http://dx.doi.org/10.1371/journal.pone.0245172			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444384	Green Published, Green Submitted, gold			2022-12-26	WOS:000609988100022
J	Zhen, XX; Zheng, NM; Yu, JL; Bi, CY; Xu, F				Zhen, Xiaoxi; Zheng, Naimeng; Yu, Jinlei; Bi, Congyuan; Xu, Fan			Autophagy mediates grain yield and nitrogen stress resistance by modulating nitrogen remobilization in rice	PLOS ONE			English	Article							USE EFFICIENCY; ARABIDOPSIS SEEDLINGS; MONITORING METHODS; PROTEIN; SENESCENCE; ATG8; IDENTIFICATION; GENES; OVEREXPRESSION; ASSIMILATION	Autophagy, a conserved cellular process in eukaryotes, has evolved to a sophisticated process to dispose of intracellular constituents and plays important roles in plant development, metabolism, and efficient nutrients remobilization under suboptimal nutrients conditions. Here, we show that OsATG8b, an AUTOPHAGY-RELATED8 (ATG8) gene in rice, was highly induced by nitrogen (N) starvation. Elevated expression of OsATG8b significantly increased ATG8 lipidation, autophagic flux, and grain yield in rice under both sufficient and deficient N conditions. Overexpressing of OsATG8b could greatly increase the activities of enzymes related to N metabolism. Intriguingly, the N-15-labeling assay further revealed that more N was remobilized to seeds in OsATG8b-overexpressing rice, which significantly increased the N remobilization efficiency (NRE), N harvest index, N utilization efficiency (NUE), and N uptake efficiency (NUpE). Conversely, the osatg8b knock-out mutants had the opposite results on these characters. The substantial transcriptional changes of the overexpressed transgenic lines indicated the presence of complex signaling to developmental, metabolic process, and hormone, etc. Excitingly, the transgenic rice under different backgrounds all similarly be boosted in yield and NUE with OsATG8b overexpression. This work provides an excellent candidate gene for improving N remobilization, utilization, and yield in crops simultaneously.	[Zhen, Xiaoxi; Zheng, Naimeng; Yu, Jinlei; Bi, Congyuan; Xu, Fan] Shenyang Agr Univ, Key Lab Northeast Rice Biol & Genet & Breeding, Key Lab Northern Japon Rice Genet & Breeding, Minist Educ & Liaoning Prov,Minist Agr,Rice Res I, Shenyang, Peoples R China; [Zhen, Xiaoxi] Shanxi Agr Univ, Coll Agr, Taigu, Peoples R China	Ministry of Agriculture & Rural Affairs; Shenyang Agricultural University; Shanxi Agricultural University	Xu, F (corresponding author), Shenyang Agr Univ, Key Lab Northeast Rice Biol & Genet & Breeding, Key Lab Northern Japon Rice Genet & Breeding, Minist Educ & Liaoning Prov,Minist Agr,Rice Res I, Shenyang, Peoples R China.	celiafanfan@163.com			National Key Research and Development Program of China [2018YFD0300300]; National Natural Science Foundation of China [31401298]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Research and Development Program of China (grant number 2018YFD0200200), the National Natural Science Foundation of China (grant number 31401298) and the National Key Research and Development Program of China (grant number 2018YFD0300300).	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Avin-Wittenberg T, 2018, J EXP BOT, V69, P1335, DOI 10.1093/jxb/ery069; Avin-Wittenberg T, 2015, PLANT CELL, V27, P306, DOI 10.1105/tpc.114.134205; Bertipaglia C, 2016, EMBO REP, V17, P1044, DOI 10.15252/embr.201541960; Cai HM, 2009, PLANT CELL REP, V28, P527, DOI 10.1007/s00299-008-0665-z; Chardon F, 2012, J EXP BOT, V63, P3401, DOI 10.1093/jxb/err353; Chen QW, 2019, PLANT CELL PHYSIOL, V60, P343, DOI 10.1093/pcp/pcy214; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Chung T, 2009, PLANT PHYSIOL, V149, P220, DOI 10.1104/pp.108.126714; Cock J., 1976, LAB MANUAL PHYSL STU; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; Eguchi M, 2017, SOIL SCI PLANT NUTR, V63, P342, DOI 10.1080/00380768.2017.1360750; Perez-Perez ME, 2010, PLANT PHYSIOL, V152, P1874, DOI 10.1104/pp.109.152520; Fan T, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00588; Fan XR, 2016, P NATL ACAD SCI USA, V113, P7118, DOI 10.1073/pnas.1525184113; Gallavotti A, 2013, J EXP BOT, V64, P2593, DOI 10.1093/jxb/ert141; Guiboileau A, 2013, NEW PHYTOL, V199, P683, DOI 10.1111/nph.12307; Guiboileau A, 2012, NEW PHYTOL, V194, P732, DOI 10.1111/j.1469-8137.2012.04084.x; Hafren A, 2017, P NATL ACAD SCI USA, V114, pE2026, DOI 10.1073/pnas.1610687114; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hu B, 2015, NAT GENET, V47, P834, DOI 10.1038/ng.3337; Izumi M, 2015, PLANT PHYSIOL, V167, P1307, DOI 10.1104/pp.114.254078; Jia M, 2019, NAT PLANTS, V5, P212, DOI 10.1038/s41477-018-0348-x; Kellner R, 2017, TRENDS PLANT SCI, V22, P204, DOI 10.1016/j.tplants.2016.11.015; Krapp A, 2015, CURR OPIN PLANT BIOL, V25, P115, DOI 10.1016/j.pbi.2015.05.010; Li FQ, 2015, PLANT CELL, V27, P1389, DOI 10.1105/tpc.15.00158; Li FQ, 2012, TRENDS PLANT SCI, V17, P526, DOI 10.1016/j.tplants.2012.05.006; Li H, 2017, J EXP BOT, V68, P2477, DOI 10.1093/jxb/erx101; Li WW, 2015, BIOCHEM BIOPH RES CO, V468, P800, DOI 10.1016/j.bbrc.2015.11.035; Li WW, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3113-4; Liu YM, 2012, ANNU REV PLANT BIOL, V63, P215, DOI 10.1146/annurev-arplant-042811-105441; Marshall RS, 2018, ANNU REV PLANT BIOL, V69, P173, DOI 10.1146/annurev-arplant-042817-040606; Masclaux-Daubresse C, 2017, CURR OPIN PLANT BIOL, V39, P8, DOI 10.1016/j.pbi.2017.05.001; Masclaux-Daubresse C, 2014, PLANT CELL, V26, P1857, DOI 10.1105/tpc.114.124677; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; McLoughlin F, 2018, NAT PLANTS, V4, P1056, DOI 10.1038/s41477-018-0299-2; Merkulova EA, 2014, PLANT CELL PHYSIOL, V55, P715, DOI 10.1093/pcp/pcu041; Minina EA, 2018, J EXP BOT, V69, P1415, DOI 10.1093/jxb/ery010; Popelka H, 2015, FEBS J, V282, P3474, DOI 10.1111/febs.13356; Ren CX, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00301; Reyes FC, 2011, PLANT CELL, V23, P769, DOI 10.1105/tpc.110.082156; Seo E, 2016, AUTOPHAGY, V12, P2054, DOI 10.1080/15548627.2016.1217373; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Slavikova S, 2008, J EXP BOT, V59, P4029, DOI 10.1093/jxb/ern244; Su W, 2006, MOL BIOL REP, V33, P273, DOI 10.1007/s11033-006-9011-0; Suttangkakul A, 2011, PLANT CELL, V23, P3761, DOI 10.1105/tpc.111.090993; Svenning S, 2011, AUTOPHAGY, V7, P993, DOI 10.4161/auto.7.9.16389; Tasaki M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00172; Thompson AR, 2005, PLANT PHYSIOL, V138, P2097, DOI 10.1104/pp.105.060673; Tong HN, 2018, TRENDS PLANT SCI, V23, P1016, DOI 10.1016/j.tplants.2018.08.007; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Wada S, 2015, PLANT PHYSIOL, V168, P60, DOI 10.1104/pp.15.00242; Wang P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00720; Wang Y, 2013, PLANT CELL, V25, P1383, DOI 10.1105/tpc.112.108993; Wang Y, 2019, PLANT PHYSIOL, V179, P671, DOI 10.1104/pp.18.01028; Wingenter K, 2010, PLANT PHYSIOL, V154, P665, DOI 10.1104/pp.110.162040; Wurzer B, 2015, ELIFE, V4, DOI 10.7554/eLife.08941; Xia KF, 2011, DNA RES, V18, P363, DOI 10.1093/dnares/dsr024; Xia TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037217; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xiong Y, 2005, PLANT J, V42, P535, DOI 10.1111/j.1365-313X.2005.02397.x; Xu GH, 2012, ANNU REV PLANT BIOL, V63, P153, DOI 10.1146/annurev-arplant-042811-105532; Yoshimoto K, 2009, PLANT CELL, V21, P2914, DOI 10.1105/tpc.109.068635; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu JL, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00584; Zhen XX, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194956; Zhen XX, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223011; Zhou XM, 2015, DNA RES, V22, P245, DOI 10.1093/dnares/dsv012; Zientara-Rytter K, 2011, AUTOPHAGY, V7, P1145, DOI 10.4161/auto.7.10.16617	70	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0244996	10.1371/journal.pone.0244996	http://dx.doi.org/10.1371/journal.pone.0244996			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444362	Green Published, gold			2022-12-26	WOS:000609988100004
J	Tsegaw, SA; Dawed, YA; Amsalu, ET				Tsegaw, Shambel Aychew; Ali Dawed, Yeshimebet; Tadesse Amsalu, Erkihun			Exploring the determinants of exclusive breastfeeding among infants under-six months in Ethiopia using multilevel analysis	PLOS ONE			English	Article							EPIDEMIOLOGY	Introduction Exclusive breastfeeding (EBF) is the safest and healthiest option of feeding among infants in the first 6 months throughout the world. Thus, the promotion of EBF is essential to prevent complex infant health problems even at the adulthood level. But the majority of previous studies focused on individual- level determinants of EBF by using basic regression models in localized areas. This study aimed to identify the determinants of EBF at the individual and community level which would be helpful to design appropriate strategies for improving the practice of EBF. Methods It is a secondary data analysis using the 2016 Ethiopian Demographic and Health Survey (EDHS) data. A total of 1185 infants under 6 months of age were included in the analysis. A Multilevel logistic regression model was employed to investigate factors significantly associated with EBF among under-six infants in Ethiopia. Adjusted odds ratio (AOR) with 95% confidence interval (CI) was used to measure the association of variables whereas Intracluster correlation (ICC), median odds ratio (MOR), and proportional change in variance (PCV) were used to measure random effects (variation). Result In multilevel logistic regression; 4-5 months age infant (AOR = 0.04, 95%CI:0.02-0.07), female infants (AOR = 2.51, 95%CI:1.61-3.91), infant comorbidities (AOR = 0.35, 95%CI: 0.21-0.57), richest household wealth index (AOR = 10.34, 95%CI: 3.14-34.03) and antenatal care (AOR = 2.25, 95%CI:1.32-3.82) were individual- level determinants significantly associated with exclusive breastfeeding. Whereas, contextual region (AOR = 0.30, 95%CI: 0.10-0.87), community- level of postnatal visit (AOR = 2.77, 95%CI: 1.26-6.58) and community -level of maternal employment (AOR = 2.8, 95%CI: 1.21-6.47) were community level determinants significantly associated with EBF. The full model showed that46.8% of the variation of exclusive breastfeeding was explained by the combined factors at the individual and community levels. Similarly, it showed that the variation in exclusive breastfeeding across communities remained statistically significant (ICC = 8.77% and variance = 0.32 with P<0.001). Conclusion and recommendation Our study showed that both individual and community level determinants were significantly associated with EBF practice among under 6 infants. Based on our findings, it is recommended to promote and enhance antenatal and postnatal care services utilization of mothers to improve exclusive breastfeeding practice and more emphasis should be given to infants with comorbid conditions and those who were living in the pastoralist regions.	[Tsegaw, Shambel Aychew] Dessie Hlth Sci Coll, Dept Publ Hlth, Dessie, Ethiopia; [Ali Dawed, Yeshimebet] Wollo Univ, Sch Publ Hlth, Dept Nutr, Coll Med & Hlth Sci, Dessie, Ethiopia; [Tadesse Amsalu, Erkihun] Wollo Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Dessie, Ethiopia	University of Gondar; University of Gondar	Amsalu, ET (corresponding author), Wollo Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Dessie, Ethiopia.	brhaneyared07@gmail.com	Tadesse, Erkihun/AAS-1819-2021	Tadesse, Erkihun/0000-0003-0677-7315				Adugna B, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0137-6; [Anonymous], 2016, LANCET, V387, P404, DOI 10.1016/S0140-6736(16)00210-5; [Anonymous], 2017, J19 J 19 CENTURY AM, V5, P55; [Anonymous], 2017, EXPERT OPIN THER PAT, V27, P1, DOI DOI 10.1017/S0959270917000065; [Anonymous], 2017, DRUG SAF UPDATE, DOI DOI 10.1186/s13104-016-2345-3; [Anonymous], 2019, IRISH EC SOCIAL HIST, V46, P62; [Anonymous], 2017, AETHIOPICA, V20, P70; Azeze GA, 2019, INT J PEDIAT, V2019, DOI 10.1155/2019/1483024; Bazie E., 2019, INT J HOMEOPAT NAT M, V5, P42; Belachew AB, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0117-0; Dalcastagne SV, 2018, SAO PAULO MED J, V136, P533, DOI 10.1590/1516-3180.2018.0262161118; Egenti NB, 2018, INT J MED RES HEALTH, V7, P57; Endoscopy CSoD, 2017, CHINESE J GASTROINTE, V4, P145; FDRE Pacc, 2008, SUMM STAT REP 2007 P; FMoH, NAT NUTR PROGR 2 201, P20; Hanieh S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2431-9; Horn IOD, 2017, UNICEF ANN REPORT 20, P1; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Hussein Tamara H, 2019, Int J MCH AIDS, V8, P32, DOI 10.21106/ijma.258; ICF C, 2016, ETH DEM HLTH SURV 20, pDF; Indongo N, 2017, INT J SCI, V36, P159; Issaka AI, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014145; Kandeel W, 2018, OPEN ACCESS MACED J; Lenja A, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0091-8; Manyeh AK, 2020, INT BREASTFEED J, V15, DOI 10.1186/s13006-020-0253-6; Meng CS, 2017, 25TH ACM SIGSPATIAL INTERNATIONAL CONFERENCE ON ADVANCES IN GEOGRAPHIC INFORMATION SYSTEMS (ACM SIGSPATIAL GIS 2017), DOI 10.1145/3139958.3139984; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Mututho LN, 2017, FACTORS ASS EXCLUSIV, V4, P4358, DOI [10.18203/2394-6040.ijcmph20175305, DOI 10.18203/2394-6040.IJCMPH20175305]; Nkoka O, 2019, INT BREASTFEED J, V14, DOI 10.1186/s13006-019-0232-y; Nussbaumer-Streit B, 2019, WHO GUIDELINE COUNSE; Ogbo FA, 2019, INT BREASTFEED J, V14, DOI 10.1186/s13006-019-0214-0; Raman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111900; Ruan Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223251; Tambe BA, 2018, DETERMINANTS EXCLUSI; Tariku A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179056; Tesfahunegn A, 2019, INDIVIDUAL COMMUNITY; Thomas JV, 2016, BARRIERS EXCLUSIVE B; United Nations Children's Fund (UNICEF), 2018, INF YOUNG CHILD FEED; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; WHO U, 2019, INCR COMM BREASTF FU; World Health Organization, 2017, PROTECTING PROMOTING	41	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0245034	10.1371/journal.pone.0245034	http://dx.doi.org/10.1371/journal.pone.0245034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439886	Green Published, gold			2022-12-26	WOS:000609985300051
J	Goelz, N; Eekels, JJM; Pantic, M; Kamber, CT; Speer, O; Franzoso, FD; Schmugge, M				Goelz, Nadine; Eekels, Julia J. M.; Pantic, Milica; Kamber, Christoph T.; Speer, Oliver; Franzoso, Francesca D.; Schmugge, Markus			Platelets express adaptor proteins of the extrinsic apoptosis pathway and can activate caspase-8	PLOS ONE			English	Article							DJ-1	Background Apoptotic pathways in platelets are important for their survival and function. Platelet apoptosis may be involved in the pathogenesis of immune thrombocytopenia (ITP), an autoimmune-mediated disease. In contrast to the intrinsic apoptosis pathway, not much is known about the extrinsic pathway mechanisms in platelets. Objectives To investigate the expression of proteins involved in the extrinsic apoptosis pathway, including the death receptors, adaptor and regulator proteins in human platelets. To determine a possible trigger of the extrinsic apoptosis pathway in platelets. Methods To investigate the expression of key markers of the extrinsic pathway we used targeted immunofluorescence and flow cytometry assays. To study their expression and interaction we performed Western blotting and co-immunoprecipitation. Treated platelets with different apoptosis triggers were subjected to flow cytometry. Results We could identify the protein expression of the pro-apoptotic proteins TRADD (Tumor Necrosis Factor Receptor type 1-Associated DEATH Domain protein), TRAF2/5, (TNF Associated Factor) and DEDAF (Death Effector Domain-Associated Factor), FADD (Fas-Associated protein with death domain) as well as the anti-apoptotic proteins DJ-1 (Degly-case 1) and c-FLIP in human platelets. ABT-737 treatment induced a disruption in the colocalization of DJ-1 with FADD. Platelets treated with ABT-737 showed an activation in caspase-3 and -8. The exposure to TNF (Tumor Necrosis Factor), FasL (Fas ligand), and TWEAK or to plasma derived from ITP patients, did not lead to changes in caspase-3 and -8 activation in platelets. Conclusions Human platelets express some proteins of the extrinsic apoptosis pathway which can be modulated only by ABT-737 treatment. However so far, no other apoptosis trigger or interaction with an external receptor have been yet identified.	[Goelz, Nadine; Pantic, Milica; Kamber, Christoph T.; Franzoso, Francesca D.; Schmugge, Markus] Univ Childrens Hosp Zurich, Div Haematol, Zurich, Switzerland; [Goelz, Nadine; Pantic, Milica; Kamber, Christoph T.; Franzoso, Francesca D.; Schmugge, Markus] Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland; [Eekels, Julia J. M.] Univ Hosp Greifswald, Div Transfus Med, Greifswald, Germany; [Speer, Oliver] Hosp Thurgau AG, Inst Lab Med, Munsterlingen, Switzerland	University Children's Hospital Zurich; University Children's Hospital Zurich	Schmugge, M (corresponding author), Univ Childrens Hosp Zurich, Div Haematol, Zurich, Switzerland.; Schmugge, M (corresponding author), Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland.	markus.schmugge@kispi.uzh.ch		Schmugge, Markus/0000-0003-4745-8572	Swiss National Fond (SNF); Children's Research Center Zurich	Swiss National Fond (SNF)(Swiss National Science Foundation (SNSF)); Children's Research Center Zurich	This work was supported by the Swiss National Fond (SNF) (to MS), and the Children's Research Center Zurich (to MS).	Deng G, 2017, HEMATOLOGY, V22, P155, DOI 10.1080/10245332.2016.1237004; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fu K, 2012, ONCOGENE, V31, P1311, DOI 10.1038/onc.2011.315; Goette NP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160563; Ishiwatari S, 2015, ARCH DERMATOL RES, V307, P925, DOI 10.1007/s00403-015-1605-8; Lev N, 2006, J MOL NEUROSCI, V29, P215, DOI 10.1385/JMN:29:3:215; Leytin V, 2006, J THROMB HAEMOST, V4, P2656, DOI 10.1111/j.1538-7836.2006.02200.x; Leytin V, 2012, BLOOD REV, V26, P51, DOI 10.1016/j.blre.2011.10.002; Li JZ, 2000, TRANSFUSION, V40, P1320, DOI 10.1046/j.1537-2995.2000.40111320.x; Mutlu A, 2012, BRIT J HAEMATOL, V159, P565, DOI 10.1111/bjh.12066; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Plenchette S, 2001, LEUKEMIA, V15, P1572, DOI 10.1038/sj.leu.2402231; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Schleicher RI, 2015, BLOOD, V126, P1483, DOI 10.1182/blood-2013-12-544445; Schoenwaelder SM, 2009, BLOOD, V114, P663, DOI 10.1182/blood-2009-01-200345; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Vogler M, 2011, BLOOD, V117, P7145, DOI 10.1182/blood-2011-03-344812; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Winkler J, 2013, THROMB HAEMOSTASIS, V109, P532, DOI 10.1160/TH12-06-0404; Winkler J, 2012, BRIT J HAEMATOL, V156, P508, DOI 10.1111/j.1365-2141.2011.08973.x; Wolf BB, 1999, BLOOD, V94, P1683, DOI 10.1182/blood.V94.5.1683.417k37_1683_1692; Wu LS, 2019, J INT MED RES, V47, P962, DOI 10.1177/0300060518820785; Zhang F, 2006, EUR J HAEMATOL, V76, P427, DOI 10.1111/j.1600-0609.2005.00622.x	23	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0244848	10.1371/journal.pone.0244848	http://dx.doi.org/10.1371/journal.pone.0244848			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428668	Green Accepted, Green Published, gold			2022-12-26	WOS:000630036100024
J	Assiri, AS				Assiri, Adel Saad			On the performance improvement of Butterfly Optimization approaches for global optimization and Feature Selection	PLOS ONE			English	Article							ALGORITHM THEORY; SEARCH	Butterfly Optimization Algorithm (BOA) is a recent metaheuristics algorithm that mimics the behavior of butterflies in mating and foraging. In this paper, three improved versions of BOA have been developed to prevent the original algorithm from getting trapped in local optima and have a good balance between exploration and exploitation abilities. In the first version, Opposition-Based Strategy has been embedded in BOA while in the second Chaotic Local Search has been embedded. Both strategies: Opposition-based & Chaotic Local Search have been integrated to get the most optimal/near-optimal results. The proposed versions are compared against original Butterfly Optimization Algorithm (BOA), Grey Wolf Optimizer (GWO), Moth-flame Optimization (MFO), Particle warm Optimization (PSO), Sine Cosine Algorithm (SCA), and Whale Optimization Algorithm (WOA) using CEC 2014 benchmark functions and 4 different real-world engineering problems namely: welded beam engineering design, tension/compression spring, pressure vessel design, and Speed reducer design problem. Furthermore, the proposed approches have been applied to feature selection problem using 5 UCI datasets. The results show the superiority of the third version (CLSOB-BOA) in achieving the best results in terms of speed and accuracy.	[Assiri, Adel Saad] King Khalid Univ, Coll Business, Dept Management Informat Syst, Abha, Saudi Arabia	King Khalid University	Assiri, AS (corresponding author), King Khalid Univ, Coll Business, Dept Management Informat Syst, Abha, Saudi Arabia.	adaseri@kku.edu.sa			King Khalid University	King Khalid University	King Khalid University.	Abualigah L, 2021, APPL INTELL, V51, P2353, DOI 10.1007/s10489-020-01947-2; Alatas B, 2010, EXPERT SYST APPL, V37, P5682, DOI 10.1016/j.eswa.2010.02.042; Arora J.S, 2004, INTRO OPTIMUM DESIGN; Arora S, 2018, INT J COMPUT MAT SCI, V7, DOI 10.1142/S2047684118500215; Arora S, 2019, SOFT COMPUT, V23, P715, DOI 10.1007/s00500-018-3102-4; Arora S, 2019, EXPERT SYST APPL, V116, P147, DOI 10.1016/j.eswa.2018.08.051; Assiri AS, 2020, IEEE ACCESS, V8, P77746, DOI 10.1109/ACCESS.2020.2990338; Aygul K, 2019, ENERG SOURCE PART A, DOI 10.1080/15567036.2019.1677818; Basturk B., 2006, IEEE SWARM INTELLIGE; Cheng MY, 2014, COMPUT STRUCT, V139, P98, DOI 10.1016/j.compstruc.2014.03.007; Coello CAC, 2000, COMPUT IND, V41, P113, DOI 10.1016/S0166-3615(99)00046-9; Dhiman G, 2019, KNOWL-BASED SYST, V165, P169, DOI 10.1016/j.knosys.2018.11.024; Dhiman G, 2018, KNOWL-BASED SYST, V159, P20, DOI 10.1016/j.knosys.2018.06.001; Dorigo M., 1999, Proceedings of the 1999 Congress on Evolutionary Computation-CEC99 (Cat. No. 99TH8406), P1470, DOI 10.1109/CEC.1999.782657; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Fister I., 2013, CUCKOO SEARCH FIREFL, P27, DOI [10.1007/978-3-319-02141-6_2, DOI 10.1007/978-3-319-02141-6_2]; Fister I, 2015, INT J BIO-INSPIR COM, V7, P36, DOI 10.1504/IJBIC.2015.067989; Gandomi AH, 2013, NEURAL COMPUT APPL, V22, P1239, DOI 10.1007/s00521-012-1028-9; Guo YJ, 2021, J EXP THEOR ARTIF IN, V33, P127, DOI 10.1080/0952813X.2020.1725651; Gupta S, 2019, J EXP THEOR ARTIF IN, V31, P751, DOI 10.1080/0952813X.2018.1554712; Hasegawa M, 2002, EUR J OPER RES, V139, P543, DOI 10.1016/S0377-2217(01)00189-8; Hashim FA, 2019, FUTURE GENER COMP SY, V101, P646, DOI 10.1016/j.future.2019.07.015; Hassanien Aboul Ella, 2017, 2017 8 INT C INT COM; Heidari AA, 2019, FUTURE GENER COMP SY, V97, P849, DOI 10.1016/j.future.2019.02.028; HOLLAND JH, 1992, SCI AM, V267, P66, DOI 10.1038/scientificamerican0792-66; Hussien A. G., 2020, IEEE ACCESS; Hussien Abdelazim, 2019, RECENT TRENDS SIGNAL, P79; Hussien AG, 2020, J EXP THEOR ARTIF IN, V32, P705, DOI 10.1080/0952813X.2020.1737246; Hussien AG, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8101821; Hussien AG, 2020, ENG OPTIMIZ, V52, P945, DOI 10.1080/0305215X.2019.1624740; Jain M, 2019, SWARM EVOL COMPUT, V44, P148, DOI 10.1016/j.swevo.2018.02.013; KANNAN BK, 1994, J MECH DESIGN, V116, P405, DOI 10.1115/1.2919393; Karaboga D, 2007, J GLOBAL OPTIM, V39, P459, DOI 10.1007/s10898-007-9149-x; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lal D. K., 2019, P 2019 2 INT C ADV C, P1; Li GC, 2019, SYMMETRY-BASEL, V11, DOI 10.3390/sym11081049; Li SM, 2020, FUTURE GENER COMP SY, V111, P300, DOI 10.1016/j.future.2020.03.055; Li XT, 2014, NEURAL COMPUT APPL, V24, P1867, DOI 10.1007/s00521-013-1433-8; Luenberger D. G., 1984, LINEAR NONLINEAR PRO, V2; Malisia AR, 2007, 2007 IEEE SWARM INTELLIGENCE SYMPOSIUM, P182, DOI 10.1109/SIS.2007.368044; Meng HJ, 2004, CONF CYBERN INTELL S, P367; Mirjalili S, 2017, ADV ENG SOFTW, V114, P163, DOI 10.1016/j.advengsoft.2017.07.002; Mirjalili S, 2016, ADV ENG SOFTW, V95, P51, DOI 10.1016/j.advengsoft.2016.01.008; Mirjalili S, 2016, NEURAL COMPUT APPL, V27, P1053, DOI 10.1007/s00521-015-1920-1; Mirjalili S, 2014, ADV ENG SOFTW, V69, P46, DOI 10.1016/j.advengsoft.2013.12.007; Rahnamayan S, 2008, APPL SOFT COMPUT, V8, P906, DOI 10.1016/j.asoc.2007.07.010; Rashedi E, 2009, INFORM SCIENCES, V179, P2232, DOI 10.1016/j.ins.2009.03.004; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Saremi S, 2017, ADV ENG SOFTW, V105, P30, DOI 10.1016/j.advengsoft.2017.01.004; Shareef H, 2015, APPL SOFT COMPUT, V36, P315, DOI 10.1016/j.asoc.2015.07.028; Sharma S., 2019, SOFT COMPUT, P1; Simon D, 2008, IEEE T EVOLUT COMPUT, V12, P702, DOI 10.1109/TEVC.2008.919004; SIMPSON AR, 1994, J WATER RES PL-ASCE, V120, P423, DOI 10.1061/(ASCE)0733-9496(1994)120:4(423); Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Sun G., 2020, IEEE ACCESS; Tizhoosh HR, 2006, International Conference on Computational Intelligence for Modelling, Control & Automation Jointly with International Conference on Intelligent Agents, Web Technologies & Internet Commerce, Vol 1, Proceedings, P695, DOI 10.1109/cimca.2005.1631345; Toktas A, 2020, IEEE T ANTENN PROPAG, V68, P5602, DOI 10.1109/TAP.2020.2981728; Wang GG, 2015, 2015 3RD INTERNATIONAL SYMPOSIUM ON COMPUTATIONAL AND BUSINESS INTELLIGENCE (ISCBI 2015), P1, DOI 10.1109/ISCBI.2015.8; Wang Z., 2020, ENG COMPUT-GERMANY; Wei Z., IEEE ACCESS; Wilcoxon F., 1992, SPRINGER SERIES STAT, V1, P196, DOI DOI 10.2307/3001968; Yang XS, 2009, WOR CONG NAT BIOL, P210, DOI 10.1109/nabic.2009.5393690; Zhang B, 2020, IEEE ACCESS, V8, P67799, DOI 10.1109/ACCESS.2020.2985986; Zou F, 2015, APPL SOFT COMPUT, V37, P725, DOI 10.1016/j.asoc.2015.08.047	66	13	13	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0242612	10.1371/journal.pone.0242612	http://dx.doi.org/10.1371/journal.pone.0242612			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4OF	33417606	gold, Green Published			2022-12-26	WOS:000630020100002
J	Chen, DJ; Parker, TM; Bhat-Nakshatri, P; Chu, XN; Liu, YL; Wang, Y; Nakshatri, H				Chen, Duojiao; Parker, Taylor M.; Bhat-Nakshatri, Poornima; Chu, Xiaona; Liu, Yunlong; Wang, Yue; Nakshatri, Harikrishna			Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression	ONCOGENE			English	Article							PIONEER TRANSCRIPTION FACTORS; BREAST-CANCER; ER-ALPHA; TAMOXIFEN RESISTANCE; DNA-BINDING; FOXA1; ENHANCERS; REVEALS; RECRUITMENT; REPRESSION	Chromatin accessibility is central to basal and inducible gene expression. Through ATAC-seq experiments in estrogen receptor-positive (ER+) breast cancer cell line MCF-7 and integration with multi-omics data, we found estradiol (E2) induced chromatin accessibility changes in a small number of breast cancer-relevant E2-regulated genes. As expected, open chromatin regions associated with E2-inducible gene expression showed enrichment of estrogen response element (ERE) and those associated with E2-repressible gene expression were enriched for ERE, PBX1, and PBX3. While a significant number of open chromatin regions showed pioneer factor FOXA1 occupancy in the absence of E2, E2-treatment further enhanced FOXA1 occupancy suggesting that ER-E2 enhances chromatin occupancy of FOXA1 to a subset of E2-regulated genes. Surprisingly, promoters of 80% and enhancers of 60% of E2-inducible genes displayed closed chromatin configuration both in the absence and presence of E2. Integration of ATAC-seq data with ER alpha ChIP-seq data revealed that similar to 40% ER alpha binding sites in the genome are found in chromatin regions that are not accessible as per ATAC-seq. Such ER alpha binding regions were enriched for binding sites of multiple nuclear receptors including ER, ESRRB, ERR gamma, COUP-TFII (NR2F2), RAR alpha, EAR2 as well as traditional pioneer factors FOXA1 and GATA3. Similar data were also obtained when ER alpha ChIP-seq data were integrated with MNase-seq and DNase-seq data sets. In summation, our results reveal complex mechanisms of ER-E2 interaction with nucleosomes. Notably, "closed chromatin" configuration as defined by ATAC-seq or by other techniques is not necessarily associated with lack of gene expression and technical limitations may preclude ATAC-seq to demonstrate accessibility of chromatin regions that are bound by ER alpha.	[Chen, Duojiao; Chu, Xiaona; Liu, Yunlong; Wang, Yue] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Parker, Taylor M.; Bhat-Nakshatri, Poornima; Nakshatri, Harikrishna] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA; [Nakshatri, Harikrishna] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Nakshatri, Harikrishna] Roudebush VA Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Wang, Y (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.; Nakshatri, H (corresponding author), Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA.; Nakshatri, H (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.; Nakshatri, H (corresponding author), Roudebush VA Med Ctr, Indianapolis, IN 46202 USA.	yuewang@iu.edu; hnakshat@iupui.edu	Chen, Duojiao/GRY-2410-2022	Wang, Yue/0000-0003-4671-8547; Nakshatri, Harikrishna/0000-0001-8876-0052	Susan G Komen for the Cure [SAC110025]	Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation)	Susan G Komen for the Cure (SAC110025 to HN) supported this work. We also thank the members of the Medical Genomics core for sequencing and help with data analyses.	Abba MC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-37; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Andersson R, 2020, NAT REV GENET, V21, P71, DOI 10.1038/s41576-019-0173-8; Bhat-Nakshatri P, 2008, MOL CELL BIOL, V28, P7487, DOI 10.1128/MCB.00799-08; Brambati A, 2020, MUTAT RES-REV MUTAT, V784, DOI 10.1016/j.mrrev.2020.108300; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Castellano-Pozo M, 2013, MOL CELL, V52, P583, DOI 10.1016/j.molcel.2013.10.006; Cheung E, 2010, ANNU REV PHYSIOL, V72, P191, DOI 10.1146/annurev-physiol-021909-135840; Chung CY, 2019, CELL REP, V29, P495, DOI 10.1016/j.celrep.2019.08.089; Cocce KJ, 2019, CELL REP, V29, P889, DOI 10.1016/j.celrep.2019.09.032; Costantino L, 2015, CURR OPIN CELL BIOL, V34, P39, DOI 10.1016/j.ceb.2015.04.008; D'Souza AD, 2018, BBA-GENE REGUL MECH, V1861, P158, DOI 10.1016/j.bbagrm.2017.12.008; De Bosscher K, 2020, NAT REV ENDOCRINOL, V16, P363, DOI 10.1038/s41574-020-0349-5; Drouin J, 2014, MOL ENDOCRINOL, V28, P989, DOI 10.1210/me.2014-1084; Dumelie JG, 2017, ELIFE, V6, DOI 10.7554/eLife.28306; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Pham D, 2019, CELL REP, V29, P1203, DOI 10.1016/j.celrep.2019.09.064; Esnault C, 2017, MOL CELL, V65, P1081, DOI 10.1016/j.molcel.2017.02.005; Fleming JD, 2013, GENOME RES, V23, P1195, DOI 10.1101/gr.148080.112; Gao TS, 2020, NUCLEIC ACIDS RES, V48, pD58, DOI 10.1093/nar/gkz980; Glont SE, 2019, CELL REP, V26, P2558, DOI 10.1016/j.celrep.2019.02.036; Goswami CP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-970; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; Guertin MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004613; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Iwafuchi-Doi M, 2016, MOL CELL, V62, P79, DOI 10.1016/j.molcel.2016.03.001; Jiang GJ, 2019, THERANOSTICS, V9, P6501, DOI 10.7150/thno.34874; Jozwik KM, 2012, NAT REV CANCER, V12, P381, DOI 10.1038/nrc3263; Liu Z, 2018, J CELL BIOL, V217, P1181, DOI 10.1083/jcb.201710038; Liu ZJ, 2014, CELL, V159, P358, DOI 10.1016/j.cell.2014.08.027; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Magnani L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002368; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; Meers MP, 2019, MOL CELL, V75, P562, DOI 10.1016/j.molcel.2019.05.025; Mueller B, 2017, GENE DEV, V31, P451, DOI 10.1101/gad.293118.116; Murakami S, 2019, MOL CANCER RES, V17, P2356, DOI 10.1158/1541-7786.MCR-19-0393; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Nardone V, 2017, BBA-GENE REGUL MECH, V1860, P571, DOI 10.1016/j.bbagrm.2016.09.006; Oldfield AJ, 2014, MOL CELL, V55, P708, DOI 10.1016/j.molcel.2014.07.005; Paakinaho V, 2019, CELL REP, V28, P3523, DOI 10.1016/j.celrep.2019.08.039; Sato S, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190116; Stork CT, 2016, ELIFE, V5, DOI 10.7554/eLife.17548; Swinstead EE, 2018, ENDOCR-RELAT CANCER, V25, pR385, DOI 10.1530/ERC-18-0033; Swinstead EE, 2016, CELL, V165, P593, DOI 10.1016/j.cell.2016.02.067; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Wu YM, 2018, CANCER RES, V78, P671, DOI 10.1158/0008-5472.CAN-17-1327; Yang F, 2017, MOL CELL, V66, P321, DOI 10.1016/j.molcel.2017.03.019; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhu C, 2019, MOL CELL, V75, P791, DOI 10.1016/j.molcel.2019.06.010; Zhuang T, 2015, ONCOTARGET, V6, P43853, DOI 10.18632/oncotarget.6081	55	3	3	2	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2021	40	7					1332	1346		10.1038/s41388-020-01607-2	http://dx.doi.org/10.1038/s41388-020-01607-2		JAN 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QK0LS	33420376				2022-12-26	WOS:000607346000007
J	Eesmaa, A; Yu, LY; Goos, H; Noges, K; Kovaleva, V; Hellman, M; Zimmermann, R; Jung, M; Permi, P; Varjosalo, M; Lindholm, P; Saarma, M				Eesmaa, Ave; Yu, Li-Ying; Goos, Helka; Noges, Kristofer; Kovaleva, Vera; Hellman, Maarit; Zimmermann, Richard; Jung, Martin; Permi, Perttu; Varjosalo, Markku; Lindholm, Paivi; Saarma, Mart			The cytoprotective protein MANF promotes neuronal survival independently from its role as a GRP78 cofactor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; NEUROTROPHIC FACTOR MANF; ER-STRESS; COMPREHENSIVE RESOURCE; BIP; BINDING; ATF6; ATP; DISSOCIATION; IRE1-ALPHA	Mesencephalic astrocyte-derived neurotrophic factor (MANF) is an endoplasmic reticulum (ER)-stress-regulated protein exhibiting cytoprotective properties through a poorly understood mechanism in various in vitro and in vivo models of neuronal and non-neuronal damage. Although initially characterized as a secreted neurotrophic factor for midbrain dopamine neurons, MANF has recently gained more interest for its intracellular role in regulating the ER homeostasis, including serving as a cofactor of the chaperone glucose-regulated protein 78 (GRP78). We aimed for a better understanding of the neuroprotective mechanisms of MANF. Here we show for the first time that MANF promotes the survival of ER-stressed neurons in vitro as a general unfolded protein response (UPR) regulator, affecting several UPR pathways simultaneously. Interestingly, MANF does not affect naive neurons. We hypothesize that MANF regulates UPR signaling toward a mode more compatible with neuronal survival. Screening of MANF interacting proteins from two mammalian cell lines revealed a conserved interactome of 15 proteins including several ER chaperones such as GRP78, GRP170, protein disulfide isomerase family A member 1, and protein disulfide isomerase family A member 6. Further characterization confirmed previously published finding that MANF is a cofactor of GRP78 interacting with its nucleotide binding domain. Using microscale thermophoresis and nuclear magnetic resonance spectroscopy, we discovered that MANF is an ATP binding protein and that ATP blocks the MANF-GRP78 interaction. Interestingly, functional analysis of the antiapoptotic properties of MANF mutants in cultured neurons revealed divergent roles of MANF as a GRP78 cofactor and as an antiapoptotic regulator of UPR. We conclude that the co-factor type interaction with GRP78 is dispensable for the survival-promoting activity of MANF in neurons.	[Eesmaa, Ave; Yu, Li-Ying; Goos, Helka; Noges, Kristofer; Kovaleva, Vera; Varjosalo, Markku; Lindholm, Paivi; Saarma, Mart] Univ Helsinki, Inst Biotechnol, HiLIFE, Helsinki, Finland; [Hellman, Maarit; Permi, Perttu] Univ Jyvaskyla, Nanosci Ctr, Dept Chem, Jyvaskyla, Finland; [Zimmermann, Richard; Jung, Martin] Saarland Univ, Med Biochem & Mol Biol, Homburg, Germany; [Permi, Perttu] Univ Jyvaskyla, Nanosci Ctr, Dept Biol & Environm Sci, Jyvaskyla, Finland	University of Helsinki; University of Jyvaskyla; Universitatsklinikum des Saarlandes; University of Jyvaskyla	Lindholm, P; Saarma, M (corresponding author), Univ Helsinki, Inst Biotechnol, HiLIFE, Helsinki, Finland.	paivi.pulkkila@helsinki.fi; mart.saarma@helsinki.fi	Jung, Martin/AAM-4547-2021; Varjosalo, Markku/K-6424-2015	Jung, Martin/0000-0002-1482-7020; Varjosalo, Markku/0000-0002-1340-9732; Eesmaa, Ave/0000-0002-3397-3330; Goos, Helka/0000-0002-6175-4872; Kovaleva, Vera/0000-0001-7597-0480; Pulkkila, Paivi/0000-0003-3022-5035	Jane and Aatos Erkko Foundation; Academy of Finland [1310891]; European Union H2020 project "TreatER" [732386]	Jane and Aatos Erkko Foundation; Academy of Finland(Academy of Finland); European Union H2020 project "TreatER"	This work was funded by Jane and Aatos Erkko Foundation, Academy of Finland (grant 1310891) and European Union H2020 project "TreatER" (No 732386).	Airavaara M, 2009, J COMP NEUROL, V515, P116, DOI 10.1002/cne.22039; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Awad W, 2008, P NATL ACAD SCI USA, V105, P1164, DOI 10.1073/pnas.0702132105; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Bai MR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03355-0; Bergmann TJ, 2018, J BIOL CHEM, V293, P5600, DOI 10.1074/jbc.RA117.001484; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bies C, 1999, BIOL CHEM, V380, P1175, DOI 10.1515/BC.1999.149; Bonora M, 2012, PURINERG SIGNAL, V8, P343, DOI 10.1007/s11302-012-9305-8; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Carrara M, 2015, ELIFE, V4, DOI 10.7554/eLife.03522; Chen LJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08133; CLAIRMONT CA, 1992, J BIOL CHEM, V267, P3983; Compostella F, 2012, CR CHIM, V15, P37, DOI 10.1016/j.crci.2011.09.011; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Danilova T, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00765; Danilova T, 2019, DIABETES, V68, P66, DOI 10.2337/db17-1149; Dudek J, 2009, CELL MOL LIFE SCI, V66, P1556, DOI 10.1007/s00018-009-8745-y; Eletto D, 2014, MOL CELL, V53, P562, DOI 10.1016/j.molcel.2014.01.004; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Glembotski CC, 2012, J BIOL CHEM, V287, P25893, DOI 10.1074/jbc.M112.356345; Gorasia DG, 2016, BBA-PROTEINS PROTEOM, V1864, P715, DOI 10.1016/j.bbapap.2016.03.002; Grinberg AV, 2004, MOL CELL BIOL, V24, P4294, DOI 10.1128/MCB.24.10.4294-4308.2004; Hakonen E, 2018, DIABETOLOGIA, V61, P2202, DOI 10.1007/s00125-018-4687-y; Hartley CL, 2013, HUM MOL GENET, V22, P5262, DOI 10.1093/hmg/ddt383; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hellman M, 2011, J BIOL CHEM, V286, P2675, DOI 10.1074/jbc.M110.146738; Hellman M, 2010, BIOMOL NMR ASSIGN, V4, P215, DOI 10.1007/s12104-010-9251-8; Henderson MJ, 2013, J BIOL CHEM, V288, P4209, DOI 10.1074/jbc.M112.400648; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hong F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169260; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang JW, 2016, CELL BIOL INT, V40, P803, DOI 10.1002/cbin.10621; Ikeda J, 1997, BIOCHEM BIOPH RES CO, V230, P94, DOI 10.1006/bbrc.1996.5890; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Jung TW, 2018, J PHARMACOL EXP THER, V365, P485, DOI 10.1124/jpet.117.246686; Karagoz GE, 2017, ELIFE, V6, DOI 10.7554/eLife.30700; Kim Y, 2016, J AM SOC NEPHROL, V27, P2974, DOI 10.1681/ASN.2014100986; Klein MC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06003-9; Kovaleva V., 2020, MANF REGULATES UNFOL, DOI [10.1101/2020.09.22.307744, DOI 10.1101/2020.09.22.307744]; Latge C, 2015, J BIOL CHEM, V290, P20527, DOI 10.1074/jbc.M115.662254; Latge C, 2013, BIOMOL NMR ASSIGN, V7, P101, DOI 10.1007/s12104-012-9388-8; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lindahl M, 2017, NEUROBIOL DIS, V97, P90, DOI 10.1016/j.nbd.2016.07.009; Lindahl M, 2014, CELL REP, V7, P366, DOI 10.1016/j.celrep.2014.03.023; Lindholm P, 2008, MOL CELL NEUROSCI, V39, P356, DOI 10.1016/j.mcn.2008.07.016; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Lindstrom R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151550; Lindstrom R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073928; Liu JQ, 2018, BIOCHEM BIOPH RES CO, V497, P564, DOI 10.1016/j.bbrc.2018.02.095; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Matlik K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.371; Matlik K, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap8957; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; MCKAY DB, 1993, ADV PROTEIN CHEM, V44, P67, DOI 10.1016/S0065-3233(08)60564-1; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Michalak M, 2009, TRENDS CELL BIOL, V19, P253, DOI 10.1016/j.tcb.2009.03.006; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; Neves J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf3646; Oikawa D, 2009, EXP CELL RES, V315, P2496, DOI 10.1016/j.yexcr.2009.06.009; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pakarinen E, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0477-19.2019; Palgi M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-134; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Parkash V, 2009, PROTEIN ENG DES SEL, V22, P233, DOI 10.1093/protein/gzn080; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Prins D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004069; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Schindler AJ, 2009, P NATL ACAD SCI USA, V106, P17775, DOI 10.1073/pnas.0910342106; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Silla T, 2005, J VIROL, V79, P15277, DOI 10.1128/JVI.79.24.15277-15288.2005; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; Takahashi T, 2012, J LIPID RES, V53, P1437, DOI 10.1194/jlr.R026682; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Thomas H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh144; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Varjosalo M, 2013, CELL REP, V3, P1306, DOI 10.1016/j.celrep.2013.03.027; Varjosalo M, 2013, NAT METHODS, V10, P307, DOI [10.1038/NMETH.2400, 10.1038/nmeth.2400]; Vishnu N, 2014, MOL BIOL CELL, V25, P368, DOI 10.1091/mbc.E13-07-0433; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weitzmann A, 2007, FEBS J, V274, P5175, DOI 10.1111/j.1742-4658.2007.06039.x; Wu YB, 2013, CELL PHYSIOL BIOCHEM, V32, P367, DOI 10.1159/000354444; Yagi T, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101810; Yan YH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08450-4; Yang S, 2014, NEURON, V81, P349, DOI 10.1016/j.neuron.2013.12.002; Zhao M, 2017, ONCOTARGET, V8, P77061, DOI 10.18632/oncotarget.20352	103	10	10	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100295	10.1016/j.jbc.2021.100295	http://dx.doi.org/10.1016/j.jbc.2021.100295			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33460650	Green Published, gold			2022-12-26	WOS:000672866400269
J	Guengerich, FP; McCarty, KD; Chapman, JG				Guengerich, F. Peter; McCarty, Kevin D.; Chapman, Jesse G.			Kinetics of cytochrome P450 3A4 inhibition by heterocyclic drugs defines a general sequential multistep binding process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM-BASED INACTIVATION; LIGAND-BINDING; P450 REDUCTASE; ACTIVE-SITE; METABOLISM; RITONAVIR; CYP3A4; ITRACONAZOLE; OXIDATION; ENZYMES	Cytochrome P450 (P450) 3A4 is the enzyme most involved in the metabolism of drugs and can also oxidize numerous steroids. This enzyme is also involved in one-half of pharmacokinetic drug-drug interactions, but details of the exact mechanisms of P450 3A4 inhibition are still unclear in many cases. Ketoconazole, clotrimazole, ritonavir, indinavir, and itraconazole are strong inhibitors; analysis of the kinetics of reversal of inhibition with the model substrate 7-benzoyl quinoline showed lag phases in several cases, consistent with multiple structures of P450 3A4 inhibitor complexes. Lags in the onset of inhibition were observed when inhibitors were added to P450 3A4 in 7-benzoyl quinoline O-debenzylation reactions, and similar patterns were observed for inhibition of testosterone 6 beta-hydroxylation by ritonavir and indinavir. Upon mixing with inhibitors, P450 3A4 showed rapid binding as judged by a spectral shift with at least partial high-spin iron character, followed by a slower conversion to a low-spin iron-nitrogen complex. The changes were best described by two intermediate complexes, one being a partial high-spin form and the second another intermediate, with half-lives of seconds. The kinetics could be modeled in a system involving initial loose binding of inhibitor, followed by a slow step leading to a tighter complex on a multisecond time scale. Although some more complex possibilities cannot be dismissed, these results describe a system in which conformationally distinct forms of P450 3A4 bind inhibitors rapidly and two distinct P450-inhibitor complexes exist en route to the final enzyme-inhibitor complex with full inhibitory activity.	[Guengerich, F. Peter; McCarty, Kevin D.; Chapman, Jesse G.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37235 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37235 USA.	f.guengerich@vanderbilt.edu		Chapman, Jesse G/0000-0002-3104-1310	National Institutes of Health [R01 GM118122]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by National Institutes of Health grant R01 GM118122 (F. P. G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABELES RH, 1976, ACCOUNTS CHEM RES, V9, P313, DOI 10.1021/ar50105a001; Barr JT, 2020, DRUG METAB DISPOS, V48, P508, DOI 10.1124/dmd.119.089813; BRUGNARA C, 1995, J PHARMACOL EXP THER, V273, P266; Cheong EJY, 2020, J PHARMACOL EXP THER, V374, P438, DOI 10.1124/jpet.120.265868; Chiba M, 1996, DRUG METAB DISPOS, V24, P307; Child SA, 2020, J MED CHEM, V63, P6513, DOI 10.1021/acs.jmedchem.9b01849; Chuo SW, 2019, BIOCHEMISTRY-US, V58, P3903, DOI 10.1021/acs.biochem.9b00620; Chuo SW, 2019, BIOCHEMISTRY-US, V58, P2353, DOI 10.1021/acs.biochem.9b00192; Correia M. A., 2015, CYTOCHROME P450 STRU, V4th, P177, DOI [10.1007/978-3-319-12108-6_5, DOI 10.1007/978-3-319-12108-6_5]; Dabrowski MJ, 2002, J AM CHEM SOC, V124, P11866, DOI 10.1021/ja027552x; Dalvie DK, 2002, CHEM RES TOXICOL, V15, P269, DOI 10.1021/tx015574b; Daniels F., 1966, PHYS CHEM, V3rd, P330; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Ernest CS, 2005, J PHARMACOL EXP THER, V312, P583, DOI 10.1124/jpet.104.075416; Furge LL, 1997, BIOCHEMISTRY-US, V36, P6475, DOI 10.1021/bi9627267; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; Greenblatt DJ, 2010, XENOBIOTICA, V40, P713, DOI 10.3109/00498254.2010.506224; GRIFFIN BW, 1972, BIOCHEMISTRY-US, V11, P4740, DOI 10.1021/bi00775a017; Guengerich F. P, 2006, METHODS MOL BIOL, V320, P31; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich F. P., 2020, ACS CATAL, DOI 10, 5008-5022; Guengerich F. P., 2021, ACS CATAL, V11, P639; Guengerich FP, 2019, J BIOL CHEM, V294, P10928, DOI 10.1074/jbc.RA119.009305; Guengerich FP, 2019, J BIOL CHEM, V294, P10028, DOI 10.1074/jbc.RA119.008860; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; GUENGERICH FP, 1986, J BIOL CHEM, V261, P5051; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; GUENGERICH FP, 1990, CHEM RES TOXICOL, V3, P363, DOI 10.1021/tx00016a015; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; GUTHEIL WG, 1994, ANAL BIOCHEM, V223, P13, DOI 10.1006/abio.1994.1539; Hakkola J, 2020, ARCH TOXICOL, V94, P3671, DOI 10.1007/s00204-020-02936-7; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Isin EM, 2007, J BIOL CHEM, V282, P6863, DOI 10.1074/jbc.M610346200; Isoherranen N, 2004, DRUG METAB DISPOS, V32, P1121, DOI 10.1124/dmd.104.000315; Johnson K. A., 2019, KINETIC ANAL NEW ENZ, V1st; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Kalgutkar AS, 2020, J MED CHEM, V63, P6276, DOI 10.1021/acs.jmedchem.9b00917; Krauser JA, 2005, J BIOL CHEM, V280, P19496, DOI 10.1074/jbc.M501854200; Kumar GN, 1996, J PHARMACOL EXP THER, V277, P423; LAVRIJSEN K, 1987, XENOBIOTICA, V17, P45, DOI 10.3109/00498258709047174; Lee YT, 2011, BIOCHEMISTRY-US, V50, P693, DOI 10.1021/bi101726d; Li F, 2011, CHEM RES TOXICOL, V24, P2109, DOI 10.1021/tx2004147; Lin HL, 2013, DRUG METAB DISPOS, V41, P1813, DOI 10.1124/dmd.113.053108; Liou SH, 2020, BIOCHEMISTRY-US, V59, P2012, DOI 10.1021/acs.biochem.0c00294; Lu P, 2001, DRUG METAB DISPOS, V29, P1473; MANSUY D, 1979, J AM CHEM SOC, V101, P3971, DOI 10.1021/ja00508a048; Mast N, 2013, J BIOL CHEM, V288, P4613, DOI 10.1074/jbc.M112.438754; MAYER RT, 1990, BIOCHEM PHARMACOL, V40, P1645, DOI 10.1016/0006-2952(90)90467-Y; Montane E, 2018, BRIT J CLIN PHARMACO, V84, P542, DOI 10.1111/bcp.13471; Murarka VC, 2020, BIOCHEMISTRY-US, V59, P2743, DOI 10.1021/acs.biochem.0c00366; Ortiz de Montellano P. R, 2015, CYTOCHROME P450 STRU, V4th; PAULSENSORMAN UB, 1984, J MED CHEM, V27, P342, DOI 10.1021/jm00369a018; Pearson JT, 2006, BIOCHEMISTRY-US, V45, P6341, DOI 10.1021/bi0600042; Peng CC, 2012, DRUG METAB DISPOS, V40, P426, DOI 10.1124/dmd.111.042739; POHL LR, 1984, MOL PHARMACOL, V25, P318; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; Rock BM, 2014, MOL PHARMACOL, V86, P665, DOI 10.1124/mol.114.094862; RODRIGUES AD, 1987, BIOCHEM PHARMACOL, V36, P4277, DOI 10.1016/0006-2952(87)90670-8; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Segel I. H, 1975, 3 SIMPLE INHIBITION, P109; Sevrioukova IF, 2012, ARCH BIOCHEM BIOPHYS, V520, P108, DOI 10.1016/j.abb.2012.02.018; Sevrioukova IF, 2012, J BIOL CHEM, V287, P3510, DOI 10.1074/jbc.M111.317081; Sevrioukova IF, 2010, P NATL ACAD SCI USA, V107, P18422, DOI 10.1073/pnas.1010693107; Shaw PM, 1997, ARCH BIOCHEM BIOPHYS, V348, P107, DOI 10.1006/abbi.1997.0378; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; SHOU M, 1994, BIOCHEMISTRY-US, V33, P6450, DOI 10.1021/bi00187a009; SILVERMAN RB, 1995, METHOD ENZYMOL, V249, P240; Sun G, 2020, MOL MED REP, V22, P1576, DOI 10.3892/mmr.2020.11235; Ueng YF, 1997, BIOCHEMISTRY-US, V36, P370, DOI 10.1021/bi962359z; von Moltke LL, 2000, EUR J CLIN PHARMACOL, V56, P259, DOI 10.1007/s002280000125; WALSH CT, 1979, ENZYMATIC REACTION M; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yamazaki H, 1996, J BIOL CHEM, V271, P27438, DOI 10.1074/jbc.271.44.27438; Yamazaki H, 2001, J BIOL CHEM, V276, P30885, DOI 10.1074/jbc.M105011200; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Yu JJ, 2018, DRUG METAB DISPOS, V46, P835, DOI 10.1124/dmd.117.078691; Zimmerlin A, 2011, DRUG METAB DISPOS, V39, P1039, DOI 10.1124/dmd.110.037911	79	4	4	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100223	10.1074/jbc.RA120.016855	http://dx.doi.org/10.1074/jbc.RA120.016855			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33449875	gold, Green Published			2022-12-26	WOS:000672866400201
J	Koay, TW; Osterhof, C; Orlando, IMC; Keppner, A; Andre, D; Yousefian, S; Alonso, MS; Correia, M; Markworth, R; Schodel, J; Hankeln, T; Hoogewijs, D				Koay, Teng Wei; Osterhof, Carina; Orlando, Ilaria M. C.; Keppner, Anna; Andre, Daniel; Yousefian, Schayan; Alonso, Maria Suarez; Correia, Miguel; Markworth, Robert; Schoedel, Johannes; Hankeln, Thomas; Hoogewijs, David			Androglobin gene expression patterns and FOXJ1-dependent regulation indicate its functional association with ciliogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBIN; DISTAL; CILIA; FOXJ1; INDUCTION	Androglobin (ADGB) represents the latest addition to the globin superfamily in metazoans. The chimeric protein comprises a calpain domain and a unique circularly permutated globin domain. ADGB expression levels are most abundant in mammalian testis, but its cell-type-specific expression, regulation, and function have remained unexplored. Analyzing bulk and single-cell mRNA-Seq data from mammalian tissues, we found that-in addition to the testes-ADGB is prominently expressed in the female reproductive tract, lungs, and brain, specifically being associated with cell types forming motile cilia. Correlation analysis suggested coregulation of ADGB with FOXJ1, a crucial transcription factor of ciliogenesis. Investigating the transcriptional regulation of the ADGB gene, we characterized its promoter using epigenomic datasets, exogenous promoter-dependent luciferase assays, and CRISPR/dCas9-VPR-mediated activation approaches. Reporter gene assays revealed that FOXJ1 indeed substantially enhanced luciferase activity driven by the ADGB promoter. ChIP assays confirmed binding of FOXJ1 to the endogenous ADGB promoter region. We dissected the minimal sequence required for FOXJ1-dependent regulation and fine mapped the FOXJ1 binding site to two evolutionarily conserved regions within the ADGB promoter. FOXJ1 overexpression significantly increased endogenous ADGB mRNA levels in HEK293 and MCF-7 cells. Similar results were observed upon RFX2 overexpression, another key transcription factor in ciliogenesis. The complex transcriptional regulation of the ADGB locus was illustrated by identifying a distal enhancer, responsible for synergistic regulation by RFX2 and FOXJ1. Finally, cell culture studies indicated an ADGB-dependent increase in the number of ciliated cells upon overexpression of the full-length protein, confirming a ciliogenesis-associated role of ADGB in mammals.	[Koay, Teng Wei; Orlando, Ilaria M. C.; Keppner, Anna; Alonso, Maria Suarez; Correia, Miguel; Hoogewijs, David] Univ Fribourg, Dept Endocrinol Metab & Cardiovasc Syst, Sect Med, Fribourg, Switzerland; [Osterhof, Carina; Andre, Daniel; Yousefian, Schayan; Hankeln, Thomas] Johannes Gutenberg Univ Mainz, Fac Biol, Inst Organism & Mol Evolut, Mol Genet & Genome Anal, Mainz, Germany; [Markworth, Robert] Univ Duisburg Essen, Inst Physiol, Duisburg, Germany; [Schoedel, Johannes] Univ Klinikum Erlangen, Dept Nephrol & Hypertens, Erlangen, Germany; [Schoedel, Johannes] Friedrich Alexander Univ Erlangen Nurnberg, Dept Nephrol & Hypertens, Erlangen, Germany	University of Fribourg; Johannes Gutenberg University of Mainz; University of Duisburg Essen; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Hoogewijs, D (corresponding author), Univ Fribourg, Dept Endocrinol Metab & Cardiovasc Syst, Sect Med, Fribourg, Switzerland.	david.hoogewijs@unifr.ch		Osterhof, Carina/0000-0002-1699-7410; Keppner, Anna/0000-0002-7880-3810; Schodel, Johannes/0000-0002-3587-8839; Koay, Teng Wei/0000-0002-7053-6359	Swiss National Science Foundation [31003A_173000]; German Research Foundation [HO 5837/1-1, HA 2103/9-1, SFB 1350]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Foundation(German Research Foundation (DFG))	This work was supported by the Swiss National Science Foundation to D. H. (grant 31003A_173000) and the German Research Foundation to D. H. (HO 5837/1-1), T. H. (HA 2103/9-1) and J. S. (Projektnummer 387509280; SFB 1350).	ACTON AB, 1966, J CELL BIOL, V29, P366, DOI 10.1083/jcb.29.2.366; Altmae S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10098-3; Barton BE, 2020, REPRODUCTION, V159, pR125, DOI 10.1530/REP-19-0189; Blatt EN, 1999, AM J RESP CELL MOL, V21, P168, DOI 10.1165/ajrcmb.21.2.3691; Bracke A, 2018, ANAL BIOCHEM, V543, P62, DOI 10.1016/j.ab.2017.11.027; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2006, FEBS J, V273, P468, DOI 10.1111/j.1742-4658.2005.05073.x; Burmester T, 2014, ACTA PHYSIOL, V211, P501, DOI 10.1111/apha.12312; Burmester T, 2018, J INSECT PHYSIOL, V106, P224, DOI 10.1016/j.jinsphys.2017.06.003; Campbell EP, 2016, DEVELOPMENT, V143, P4654, DOI 10.1242/dev.143859; Campbell JN, 2017, NAT NEUROSCI, V20, P484, DOI 10.1038/nn.4495; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Cheneby J, 2018, NUCLEIC ACIDS RES, V46, pD267, DOI 10.1093/nar/gkx1092; Choksi SP, 2014, DEVELOPMENT, V141, P3410, DOI 10.1242/dev.108209; Choksi SP, 2014, DEVELOPMENT, V141, P1427, DOI 10.1242/dev.074666; Comer MT, 1998, HUM REPROD, V13, P3114, DOI 10.1093/humrep/13.11.3114; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; FERENCZY A, 1972, SCIENCE, V175, P783, DOI 10.1126/science.175.4023.783; Fishilevich S, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax028; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gleixner E, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-34; Haider S, 2019, ENDOCRINOLOGY, V160, P2282, DOI 10.1210/en.2019-00314; Hoogewijs D, 2004, IUBMB LIFE, V56, P697, DOI 10.1080/15216540500037562; Hoogewijs D, 2016, HYPOXIA, V4, P91, DOI 10.2147/HP.S97681; Hoogewijs D, 2012, MOL BIOL EVOL, V29, P1105, DOI 10.1093/molbev/msr246; Hoogewijs D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-279; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Huang B, 2014, INT J CLIN EXP PATHO, V7, P2179; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; JAMIESON B G M, 1991, Memoirs of the Queensland Museum, V31, P109; Keppner A, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101687; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kistler WS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005368; Kowal TJ, 2015, CELL BIOL INT, V39, P1341, DOI 10.1002/cbin.10500; Lauer V, 2020, J BIOL CHEM, V295, P4065, DOI 10.1074/jbc.RA119.009827; Lewis M, 2021, SEMIN CELL DEV BIOL, V110, P51, DOI 10.1016/j.semcdb.2020.04.007; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lukassen S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24725-0; Mirzadeh Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13759; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Mukherjee I, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00023; NELSON GA, 1982, J CELL BIOL, V92, P121, DOI 10.1083/jcb.92.1.121; Nemajerova A, 2016, GENE DEV, V30, P1300, DOI 10.1101/gad.279836.116; Orlando IMC, 2020, HAEMATOLOGICA, V105, P2774, DOI 10.3324/haematol.2019.236406; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Quigley IK, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006538; Randi EB, 2020, ANTIOXID REDOX SIGN, V32, P1155, DOI 10.1089/ars.2019.7868; Schorg A, 2015, NUCLEIC ACIDS RES, V43, P5810, DOI 10.1093/nar/gkv506; Schuster H, 2017, P NATL ACAD SCI USA, V114, pE9942, DOI 10.1073/pnas.1707658114; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Sigg MA, 2017, DEV CELL, V43, P744, DOI 10.1016/j.devcel.2017.11.014; Spassky N, 2017, NAT REV MOL CELL BIO, V18, P423, DOI 10.1038/nrm.2017.21; Stauber M, 2017, DEV BIOL, V423, P170, DOI 10.1016/j.ydbio.2016.11.019; Storti F, 2014, HAEMATOLOGICA, V99, pE45, DOI 10.3324/haematol.2013.102707; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tang ZM, 2013, NATURE, V502, P254, DOI 10.1038/nature12606; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van Dam TJP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216705; Weidemann M, 2016, DEVELOPMENT, V143, P4736, DOI 10.1242/dev.139626; Whitfield M, 2019, AM J HUM GENET, V105, P198, DOI 10.1016/j.ajhg.2019.04.015; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263	65	11	11	3	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100291	10.1016/j.jbc.2021.100291	http://dx.doi.org/10.1016/j.jbc.2021.100291			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33453283	gold, Green Published			2022-12-26	WOS:000672866400265
J	Mukai, S; Mizokami, A; Otani, T; Sano, T; Matsuda, M; Chishaki, S; Gao, J; Kawakubo-Yasukochi, T; Tang, RH; Kanematsu, T; Takeuchi, H; Jimi, E; Hirata, M				Mukai, Satoru; Mizokami, Akiko; Otani, Takahito; Sano, Tomomi; Matsuda, Miho; Chishaki, Sakura; Gao, Jing; Kawakubo-Yasukochi, Tomoyo; Tang, Ronghao; Kanematsu, Takashi; Takeuchi, Hiroshi; Jimi, Eijiro; Hirata, Masato			Adipocyte-specific GPRC6A ablation promotes diet-induced obesity by inhibiting lipolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; HORMONE-SENSITIVE LIPASE; BETA-CELL; OSTEOCALCIN; EXPRESSION; INSULIN; RECEPTOR; PROTEIN; INFLAMMATION; MICE	The G protein-coupled receptor GPRC6A regulates various physiological processes in response to its interaction with multiple ligands, such as extracellular basic amino acids, divalent cations, testosterone, and the uncarboxylated form of osteocalcin (GluOC). Global ablation of GPRC6A increases the susceptibility of mice to diet-induced obesity and related metabolic disorders. However, given that GPRC6A is expressed in many tissues and responds to a variety of hormonal and nutritional signals, the cellular and molecular mechanisms underlying the development of metabolic disorders in conventional knockout mice have remained unclear. On the basis of our previous observation that long-term oral administration of GluOC markedly reduced adipocyte size and improved glucose tolerance in WT mice, we examined whether GPRC6A signaling in adipose tissue might be responsible for prevention of metabolic disorders. We thus generated adipocyte-specific GPRC6A knockout mice, and we found that these animals manifested increased adipose tissue weight, adipocyte hypertrophy, and adipose tissue inflammation when fed a high-fat and high-sucrose diet compared with control mice. These effects were associated with reduced lipolytic activity because of downregulation of lipolytic enzymes such as adipose triglyceride lipase and hormone-sensitive lipase in adipose tissue of the conditional knockout mice. Given that, among GPR6CA ligands tested, GluOC and ornithine increased the expression of adipose triglyceride lipase in cultured 3T3-L1 adipocytes in a manner dependent on GPRC6A, our results suggest that the constitutive activation of GPRC6A signaling in adipocytes by GluOC or ornithine plays a key role in adipose lipid handling and the prevention of obesity and related metabolic disorders.	[Mukai, Satoru; Mizokami, Akiko; Chishaki, Sakura; Kawakubo-Yasukochi, Tomoyo; Jimi, Eijiro] Kyushu Univ, Fac Dent Sci, OBT Res Ctr, Fukuoka, Japan; [Mukai, Satoru] Univ East Asia, Fac Allied Hlth Sci, Dept Hlth & Nutr Care, Shimonoseki, Yamaguchi, Japan; [Otani, Takahito] Fukuoka Dent Coll, Dept Morphol Biol, Div Funct Struct, Fukuoka, Japan; [Sano, Tomomi; Kanematsu, Takashi] Kyushu Univ, Fac Dent Sci, Dept Cell Biol & Pharmacol, Fukuoka, Japan; [Matsuda, Miho; Chishaki, Sakura; Gao, Jing; Tang, Ronghao; Jimi, Eijiro] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka, Japan; [Takeuchi, Hiroshi] Kyushu Dent Univ, Div Appl Pharmacol, Kitakyushu, Fukuoka, Japan; [Hirata, Masato] Fukuoka Dent Coll, Oral Med Res Ctr, Fukuoka, Japan	Kyushu University; Fukuoka Dental College (FDC); Kyushu University; Kyushu University; Kyushu Dental University; Fukuoka Dental College (FDC)	Mizokami, A (corresponding author), Kyushu Univ, Fac Dent Sci, OBT Res Ctr, Fukuoka, Japan.; Hirata, M (corresponding author), Fukuoka Dent Coll, Oral Med Res Ctr, Fukuoka, Japan.	akiko-k@dent.kyushu-u.ac.jp; hirata@college.fdcnet.ac.jp	Mizokami, Akiko/ABC-5448-2021	Mizokami, Akiko/0000-0002-7490-5190; Tang, Ronghao/0000-0002-0219-3366; Otani, Takahito/0000-0003-2103-6873	Japan Society for the Promotion of Science KAKENHI [18K09521, 17K19766, 17H01595, 20H03854]; Lotte Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Lotte Foundation	This work was supported by Japan Society for the Promotion of Science KAKENHI grants (18K09521 to A. M. and 17K19766, 17H01595, and 20H03854 to M. H.) as well as by grants from the Lotte Foundation to A. M.	Allison DB, 2008, OBESITY, V16, P1161, DOI 10.1038/oby.2008.231; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Benoit SC, 2002, J NEUROSCI, V22, P9048; Chakrabarti P, 2009, J BIOL CHEM, V284, P13296, DOI 10.1074/jbc.C800241200; Clemmensen C, 2014, BRIT J PHARMACOL, V171, P1129, DOI 10.1111/bph.12365; Clemmensen C, 2013, J ENDOCRINOL, V217, P151, DOI 10.1530/JOE-12-0550; Eguchi J, 2008, CELL METAB, V7, P86, DOI 10.1016/j.cmet.2007.11.002; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Hayasaka S, 2011, BRIT J NUTR, V106, P801, DOI 10.1017/S0007114511003291; Hong J, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-11; Large V, 1999, J LIPID RES, V40, P2059; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Martinelli D, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0242-9; Mizokami A, 2016, BIOSCI BIOTECH BIOCH, V80, P2176, DOI 10.1080/09168451.2016.1214530; Mizokami A, 2014, BONE, V69, P68, DOI 10.1016/j.bone.2014.09.006; Mizokami A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057375; Otani T, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1257-7; Otani T, 2015, CELL SIGNAL, V27, P532, DOI 10.1016/j.cellsig.2014.12.018; Oue K, 2016, J BIOL CHEM, V291, P4185, DOI 10.1074/jbc.M115.705723; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Oya M, 2013, J BIOL CHEM, V288, P4513, DOI 10.1074/jbc.M112.402677; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pi M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64384-8; Pi M, 2017, MOL METAB, V6, DOI 10.1016/j.molmet.2016.12.006; Pi M, 2011, J BONE MINER RES, V26, P1680, DOI 10.1002/jbmr.390; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Snel M, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/983814; Wei JW, 2014, DIABETES, V63, P1021, DOI 10.2337/db13-0887; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003; Wellendorph P, 2009, J MOL ENDOCRINOL, V42, P215, DOI 10.1677/JME-08-0149; Yasutake Y, 2016, AM J PHYSIOL-ENDOC M, V310, pE662, DOI 10.1152/ajpendo.00334.2015; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	39	6	7	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100274	10.1016/j.jbc.2021.100274	http://dx.doi.org/10.1016/j.jbc.2021.100274			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33428938	Green Published, gold			2022-12-26	WOS:000672866400250
J	Cizmecioglu, NT; Huang, JL; Keskin, EG; Wang, XF; Esen, I; Chen, F; Orkin, SH				Cizmecioglu, Nihal Terzi; Huang, Jialiang; Keskin, Ezgi G.; Wang, Xiaofeng; Esen, Idil; Chen, Fei; Orkin, Stuart H.			ARID4B is critical for mouse embryonic stem cell differentiation towards mesoderm and endoderm, linking epigenetics to pluripotency exit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; cell differentiation; epigenetics; gene expression; chromatin modification; embryonic stem cell	CHROMATIN REMODELING COMPLEX; HISTONE DEACETYLASE; SELF-RENEWAL; DEVELOPMENTAL REGULATORS; H3K4 TRIMETHYLATION; SUPER-ENHANCERS; GENE-EXPRESSION; RBP1 RECRUITS; RNAI SCREEN; POLYCOMB	Distinct cell types emerge from embryonic stem cells through a precise and coordinated execution of gene expression programs during lineage commitment. This is established by the action of lineage specific transcription factors along with chromatin complexes. Numerous studies have focused on epigenetic factors that affect embryonic stem cells (ESC) self-renewal and pluripotency. However, the contribution of chromatin to lineage decisions at the exit from pluripotency has not been as extensively studied. Using a pooled epigenetic shRNA screen strategy, we identified chromatin-related factors critical for differentiation toward mesodermal and endodermal lineages. Here we reveal a critical role for the chromatin protein, ARID4B. Arid4b-deficient mESCs are similar to WT mESCs in the expression of pluripotency factors and their self-renewal. However, ARID4B loss results in defects in up-regulation of the meso/endodermal gene expression program. It was previously shown that Arid4b resides in a complex with SIN3A and HDACS 1 and 2. We identified a physical and functional interaction of ARID4B with HDAC1 rather than HDAC2, suggesting functionally distinct Sin3a subcomplexes might regulate cell fate decisions Finally, we observed that ARID4B deficiency leads to increased H3K27me3 and a reduced H3K27Ac level in key developmental gene loci, whereas a subset of genomic regions gain H3K27Ac marks. Our results demonstrate that epigenetic control through ARID4B plays a key role in the execution of lineage-specific gene expression programs at pluripotency exit.	[Cizmecioglu, Nihal Terzi; Keskin, Ezgi G.] Middle East Tech Univ, Fac Arts & Sci, Dept Biol Sci, Ankara, Turkey; [Huang, Jialiang; Chen, Fei] Xiamen Univ, Innovat Ctr Cell Signaling Network, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Wang, Xiaofeng] Dartmouth Coll, Geisel Sch Med, Hanover, NH USA; [Esen, Idil; Orkin, Stuart H.] Harvard Med Sch, Dept Pediat, Howard Hughes Med Inst, Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA 02115 USA	Middle East Technical University; Xiamen University; Dartmouth College; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Cizmecioglu, NT (corresponding author), Middle East Tech Univ, Fac Arts & Sci, Dept Biol Sci, Ankara, Turkey.; Orkin, SH (corresponding author), Harvard Med Sch, Dept Pediat, Howard Hughes Med Inst, Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA 02115 USA.	nterzi@metu.edu.tr; Stuart_Orkin@dfci.harvard.edu	Cizmecioglu, Nihal Terzi/D-4803-2019	Stuart, Orkin/0000-0002-0313-152X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Baltus GA, 2009, J BIOL CHEM, V284, P6998, DOI 10.1074/jbc.M807670200; Baymaz HI, 2015, BBA-GENE REGUL MECH, V1849, P1051, DOI 10.1016/j.bbagrm.2015.06.012; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Bledau AS, 2014, DEVELOPMENT, V141, P1022, DOI 10.1242/dev.098152; Bonev B, 2017, CELL, V171, P557, DOI 10.1016/j.cell.2017.09.043; Boward B, 2016, STEM CELLS, V34, P1427, DOI 10.1002/stem.2345; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Cao JN, 2001, J NATL CANCER I, V93, P1159, DOI 10.1093/jnci/93.15.1159; Collinson A, 2016, CELL REP, V17, P2700, DOI 10.1016/j.celrep.2016.11.032; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Creech AL, 2015, METHODS, V72, P57, DOI 10.1016/j.ymeth.2014.10.033; Dalton S, 2015, TRENDS CELL BIOL, V25, P592, DOI 10.1016/j.tcb.2015.07.007; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Das PP, 2014, MOL CELL, V53, P32, DOI 10.1016/j.molcel.2013.11.011; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; Dawlaty MM, 2014, DEV CELL, V29, P102, DOI 10.1016/j.devcel.2014.03.003; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Denissov S, 2014, DEVELOPMENT, V141, P526, DOI 10.1242/dev.102681; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fraser J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156492; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Goldberger N, 2013, CANCER RES, V73, P2671, DOI 10.1158/0008-5472.CAN-12-3513; Gong WB, 2012, J BIOL CHEM, V287, P8531, DOI 10.1074/jbc.M111.299149; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hu G, 2012, CELL STEM CELL, V10, P497, DOI 10.1016/j.stem.2012.04.011; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Huang JL, 2016, DEV CELL, V36, P9, DOI 10.1016/j.devcel.2015.12.014; Icardi L, 2012, P NATL ACAD SCI USA, V109, P12058, DOI 10.1073/pnas.1206458109; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Lai A, 1999, ONCOGENE, V18, P2091, DOI 10.1038/sj.onc.1202520; Laj A, 1999, MOL CELL BIOL, V19, P6632; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Li VC, 2014, P NATL ACAD SCI USA, V111, P9503, DOI 10.1073/pnas.1408638111; Li VC, 2012, P NATL ACAD SCI USA, V109, P12550, DOI 10.1073/pnas.1206740109; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; Mas G, 2018, NAT GENET, V50, P1452, DOI 10.1038/s41588-018-0218-5; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Morey L, 2015, MOL CELL BIOL, V35, P2716, DOI 10.1128/MCB.00266-15; Nitarska J, 2016, CELL REP, V17, P1683, DOI 10.1016/j.celrep.2016.10.022; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Pile LA, 2003, J BIOL CHEM, V278, P37840, DOI 10.1074/jbc.M305996200; Reynolds N, 2013, DEVELOPMENT, V140, P505, DOI 10.1242/dev.083105; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Ruiz-Roig C, 2010, MOL MICROBIOL, V76, P1049, DOI 10.1111/j.1365-2958.2010.07167.x; Saha N, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2428-5; Saunders A, 2017, CELL REP, V18, P1713, DOI 10.1016/j.celrep.2017.01.055; Sen P, 2017, CELL REP, V18, P2135, DOI 10.1016/j.celrep.2017.02.017; Seruggia D, 2019, MOL CELL, V74, P1148, DOI 10.1016/j.molcel.2019.03.025; Shao Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r16; Streubel G, 2017, EMBO J, V36, P2216, DOI 10.15252/embj.201696307; Terzi N, 2011, MOL CELL BIOL, V31, P3569, DOI 10.1128/MCB.05590-11; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; van Oevelen C, 2010, MOL CELL BIOL, V30, P5686, DOI 10.1128/MCB.00975-10; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wang K, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-23; Wang XF, 2017, NAT GENET, V49, P289, DOI 10.1038/ng.3746; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95; Wilson BG, 2014, MOL CELL BIOL, V34, P1136, DOI 10.1128/MCB.01372-13; Winter SF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002735; Wu MY, 2008, JNCI-J NATL CANCER I, V100, P1247, DOI 10.1093/jnci/djn253; Wu MY, 2006, GENE DEV, V20, P2859, DOI 10.1101/gad.1452206; Wu RC, 2017, STEM CELLS, V35, P1554, DOI 10.1002/stem.2597; Wu RC, 2015, MOL ENDOCRINOL, V29, P1334, DOI 10.1210/me.2015-1089; Wu RC, 2013, P NATL ACAD SCI USA, V110, P4616, DOI 10.1073/pnas.1218318110; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu FG, 2018, NUCLEIC ACIDS RES, V46, P6026, DOI 10.1093/nar/gky347; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	103	6	6	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17738	17751		10.1074/jbc.RA120.015534	http://dx.doi.org/10.1074/jbc.RA120.015534			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454011	Green Published, hybrid			2022-12-26	WOS:000603272300027
J	Fahrig-Kamarauskait, J; Wurth-Roderer, K; Thorbjornsrud, HV; Mailand, S; Krengel, U; Kast, P				Fahrig-Kamarauskait, Jurate; Wuerth-Roderer, Kathrin; Thorbjornsrud, Helen, V; Mailand, Susanne; Krengel, Ute; Kast, Peter			Evolving the naturally compromised chorismate mutase from Mycobacterium tuberculosis to top performance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						catalytic efficiency; conformational change; crystal structure; directed evolution; enzyme catalysis; enzyme mutation; molecular evolution; protein structure; structure-activity relationship; X-ray crystallography	ALLOSTERIC REGULATION; DIRECTED EVOLUTION; TRANSITION-STATE; COMBINATORIAL MUTAGENESIS; CRYSTAL-STRUCTURE; ACTIVE-SITE; ENZYME; SELECTION; OPTIMIZATION; STABILITY	Chorismate mutase (CM), an essential enzyme at the branch-point of the shikimate pathway, is required for the biosynthesis of phenylalanine and tyrosine in bacteria, archaea, plants, and fungi. MtCM, the CM from Mycobacterium tuberculosis, has less than 1% of the catalytic efficiency of a typical natural CM and requires complex formation with 3-deoxy-d-arabino-heptulosonate 7-phosphate synthase for high activity. To explore the full potential of MtCM for catalyzing its native reaction, we applied diverse iterative cycles of mutagenesis and selection, thereby raising k(cat)/K-m 270-fold to 5 x 10(5) m(-1)s(-1), which is even higher than for the complex. Moreover, the evolutionarily optimized autonomous MtCM, which had 11 of its 90 amino acids exchanged, was stabilized compared with its progenitor, as indicated by a 9 degrees C increase in melting temperature. The 1.5 angstrom crystal structure of the top-evolved MtCM variant reveals the molecular underpinnings of this activity boost. Some acquired residues (e.g. Pro(52) and Asp(55)) are conserved in naturally efficient CMs, but most of them lie beyond the active site. Our evolutionary trajectories reached a plateau at the level of the best natural enzymes, suggesting that we have exhausted the potential of MtCM. Taken together, these findings show that the scaffold of MtCM, which naturally evolved for mediocrity to enable inter-enzyme allosteric regulation of the shikimate pathway, is inherently capable of high activity.	[Fahrig-Kamarauskait, Jurate; Wuerth-Roderer, Kathrin; Mailand, Susanne; Kast, Peter] Swiss Fed Inst Technol, Lab Organ Chem, Zurich, Switzerland; [Thorbjornsrud, Helen, V; Krengel, Ute] Univ Oslo, Dept Chem, Oslo, Norway	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oslo	Kast, P (corresponding author), Swiss Fed Inst Technol, Lab Organ Chem, Zurich, Switzerland.; Krengel, U (corresponding author), Univ Oslo, Dept Chem, Oslo, Norway.	ute.krengel@kjemi.uio.no; kast@org.chem.ethz.ch		Kast, Peter/0000-0002-0209-8975; Wurth-Roderer, Kathrin/0000-0002-0233-9863	University of Oslo; ETH Zurich; Norwegian Research Council [216625, 247730]; Swiss National Science Foundation [31003A-116475, 31003A-135651, 31003A-156453, 310030M_182648]	University of Oslo; ETH Zurich(ETH Zurich); Norwegian Research Council(Research Council of NorwayEuropean Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was financed by funds from the University of Oslo (position of H. V. T.), the ETH Zurich (to P. K.), the Norwegian Research Council Grants 216625 and 247730 (to U. K.), and the Swiss National Science Foundation Grants 31003A-116475, 31003A-135651, 31003A-156453, and 310030M_182648 (to P. K.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ADDADI L, 1983, BIOCHEMISTRY-US, V22, P4494, DOI 10.1021/bi00288a022; Bai Y, 2019, J BIOL CHEM, V294, P4828, DOI 10.1074/jbc.RA118.005220; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; BARTLETT PA, 1985, J AM CHEM SOC, V107, P7792, DOI 10.1021/ja00311a111; BENNER SA, 1989, CHEM REV, V89, P789, DOI 10.1021/cr00094a004; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bershtein S, 2008, CURR OPIN CHEM BIOL, V12, P151, DOI 10.1016/j.cbpa.2008.01.027; BLACKLOW SC, 1988, BIOCHEMISTRY-US, V27, P1158, DOI 10.1021/bi00404a013; BLACKLOW SC, 1990, BIOCHEMISTRY-US, V29, P4099, DOI 10.1021/bi00469a012; Blackmore NJ, 2015, J BIOL CHEM, V290, P18187, DOI 10.1074/jbc.M115.638700; Burschowsky D, 2018, BIOCHEMISTRY-US, V57, P557, DOI 10.1021/acs.biochem.7b01018; Butz M, 2011, BIOCHEMISTRY-US, V50, P8594, DOI 10.1021/bi2011338; Diaz-Lopez T, 2003, J BIOL CHEM, V278, P18606, DOI 10.1074/jbc.M212024200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fan YF, 2018, P NATL ACAD SCI USA, V115, P3006, DOI 10.1073/pnas.1717621115; FANGMAN WL, 1964, J BIOL CHEM, V239, P1839; Gamper M, 2000, BIOCHEMISTRY-US, V39, P14087, DOI 10.1021/bi0016570; Grisostomi C, 1997, BIOORG CHEM, V25, P297, DOI 10.1006/bioo.1997.1073; GUILFORD WJ, 1987, J AM CHEM SOC, V109, P5013, DOI 10.1021/ja00250a041; Gustin DJ, 1999, J AM CHEM SOC, V121, P1756, DOI 10.1021/ja9841759; Haslam E., 1993, SHIKIMIC ACID METABO; Hecky J, 2005, BIOCHEMISTRY-US, V44, P12640, DOI 10.1021/bi0501885; Hecky J, 2007, METH MOL B, V352, P275; Helmstaedt K, 2004, ARCH MICROBIOL, V181, P195, DOI 10.1007/s00203-003-0639-z; Helmstaedt K, 2002, P NATL ACAD SCI USA, V99, P6631, DOI 10.1073/pnas.092130899; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Hoskins JR, 2006, P NATL ACAD SCI USA, V103, P909, DOI 10.1073/pnas.0509154103; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; Jiao WT, 2020, J BIOL CHEM, V295, P6252, DOI 10.1074/jbc.RA120.012605; Jiao W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180052; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kast P, 1996, P NATL ACAD SCI USA, V93, P5043, DOI 10.1073/pnas.93.10.5043; KAST P, 1994, GENE, V138, P109, DOI 10.1016/0378-1119(94)90790-0; KAST P, 1991, J MOL BIOL, V222, P99, DOI 10.1016/0022-2836(91)90740-W; Kast P, 1996, PURE APPL CHEM, V68, P2017, DOI 10.1351/pac199668112017; Kim SK, 2008, FEBS J, V275, P4824, DOI 10.1111/j.1742-4658.2008.06621.x; Kiss C, 2009, PROTEIN ENG DES SEL, V22, P313, DOI 10.1093/protein/gzp006; Ladner JE, 2000, ACTA CRYSTALLOGR D, V56, P673, DOI 10.1107/S0907444900004625; LEE AY, 1995, J AM CHEM SOC, V117, P3627, DOI 10.1021/ja00117a038; Light SH, 2013, PROTEIN SCI, V22, P395, DOI 10.1002/pro.2233; Liu DR, 1996, J AM CHEM SOC, V118, P1789, DOI 10.1021/ja953151o; MacBeath G, 1998, BIOTECHNIQUES, V24, P789, DOI 10.2144/98245st02; MacBeath G, 1998, BIOCHEMISTRY-US, V37, P10062, DOI 10.1021/bi980449t; MacBeath G, 1998, PROTEIN SCI, V7, P1757, DOI 10.1002/pro.5560070810; Mandal A, 2003, J AM CHEM SOC, V125, P5598, DOI 10.1021/ja029447t; Mattei P, 1999, EUR J BIOCHEM, V261, P25, DOI 10.1046/j.1432-1327.1999.00169.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCullum EO, 2010, METHODS MOL BIOL, V634, P103, DOI 10.1007/978-1-60761-652-8_7; Moore JC, 1996, NAT BIOTECHNOL, V14, P458, DOI 10.1038/nbt0496-458; Munack S, 2016, J MOL BIOL, V428, P1237, DOI 10.1016/j.jmb.2016.01.001; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nazmi AR, 2016, J BIOL CHEM, V291, P21836, DOI 10.1074/jbc.M116.741637; Newton MS, 2018, CURR OPIN STRUC BIOL, V48, P110, DOI 10.1016/j.sbi.2017.11.007; Okvist M, 2006, J MOL BIOL, V357, P1483, DOI 10.1016/j.jmb.2006.01.069; Pervushin K, 2007, NAT STRUCT MOL BIOL, V14, P1202, DOI 10.1038/nsmb1325; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Renata H, 2015, ANGEW CHEM INT EDIT, V54, P3351, DOI 10.1002/anie.201409470; RICHMOND MH, 1962, BACTERIOL REV, V26, P398, DOI 10.1128/MMBR.26.4.398-420.1962; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Roderer K., 2012, THESIS; Roderer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116234; Roderer K, 2009, CHIMIA, V63, P313, DOI 10.2533/chimia.2009.313; Russ WP, 2020, SCIENCE, V369, P440, DOI 10.1126/science.aba3304; Sambrook J., 2001, MOL CLONING LAB MANU; Sasso S, 2005, FEBS J, V272, P375, DOI 10.1111/j.1742-4658.2004.04478.x; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Schnappauf G, 1997, P NATL ACAD SCI USA, V94, P8491, DOI 10.1073/pnas.94.16.8491; SMITH WW, 1993, J ORG CHEM, V58, P7308, DOI 10.1021/jo00077a070; Speck J, 2012, BIOCHEMISTRY-US, V51, P4850, DOI 10.1021/bi2018738; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Sterritt OW, 2018, BIOCHEMISTRY-US, V57, P2667, DOI 10.1021/acs.biochem.8b00082; Strater N, 1997, STRUCTURE, V5, P1437, DOI 10.1016/S0969-2126(97)00294-3; Studer S, 2018, SCIENCE, V362, P1285, DOI 10.1126/science.aau3744; Taylor SV, 2001, ANGEW CHEM INT EDIT, V40, P3310, DOI 10.1002/1521-3773(20010917)40:18<3310::AID-ANIE3310>3.0.CO;2-P; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Westfall CS, 2014, J BIOL CHEM, V289, P28619, DOI 10.1074/jbc.M114.591123; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; XUE YF, 1994, P NATL ACAD SCI USA, V91, P10814, DOI 10.1073/pnas.91.23.10814; Zhang HJ, 2005, ARCH BIOCHEM BIOPHYS, V441, P123, DOI 10.1016/j.abb.2005.07.006; Zhang S, 1996, BIOORGAN MED CHEM, V4, P1015, DOI 10.1016/0968-0896(96)00099-5	84	1	1	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17514	17534		10.1074/jbc.RA120.014924	http://dx.doi.org/10.1074/jbc.RA120.014924			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453995	Green Published, hybrid			2022-12-26	WOS:000603272300011
J	Mears, HV; Sweeney, TR				Mears, Harriet, V; Sweeney, Trevor R.			Mouse Ifit1b is a cap1-RNA-binding protein that inhibits mouse coronavirus translation and is regulated by complexing with Ifit1c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA-binding protein; mRNA; translation control; innate immunity; viral immunology; mouse; interferon-induced proteins with tetratricopeptide repeats (IFIT)	DOUBLE-STRANDED-RNA; SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURE; INTERFERON; INDUCTION; BINDING; RECOGNITION; EXPRESSION; ELEMENTS; REVEALS	Knockout mouse models have been extensively used to study the antiviral activity of IFIT (interferon-induced protein with tetratricopeptide repeats). Human IFIT1 binds to cap0 (m7GpppN) RNA, which lacks methylation on the first and second cap-proximal nucleotides (cap1, m7GpppNm, and cap2, m7GpppNmNm, respectively). These modifications are signatures of "self" in higher eukaryotes, whereas unmodified cap0-RNA is recognized as foreign and, therefore, potentially harmful to the host cell. IFIT1 inhibits translation at the initiation stage by competing with the cap-binding initiation factor complex, eIF4F, restricting infection by certain viruses that possess "nonself" cap0-mRNAs. However, in mice and other rodents, the IFIT1 orthologue has been lost, and the closely related Ifit1b has been duplicated twice, yielding three paralogues: Ifit1, Ifit1b, and Ifit1c. Although murine Ifit1 is similar to human IFIT1 in its cap0-RNA-binding selectivity, the roles of Ifit1b and Ifit1c are unknown. Here, we found that Ifit1b preferentially binds to cap1-RNA, whereas binding is much weaker to cap0- and cap2-RNA. In murine cells, we show that Ifit1b can modulate host translation and restrict WT mouse coronavirus infection. We found that Ifit1c acts as a stimulatory cofactor for both Ifit1 and Ifit1b, promoting their translation inhibition. In this way, Ifit1c acts in an analogous fashion to human IFIT3, which is a cofactor to human IFIT1. This work clarifies similarities and differences between the human and murine IFIT families to facilitate better design and interpretation of mouse models of human infection and sheds light on the evolutionary plasticity of the IFIT family.	[Mears, Harriet, V; Sweeney, Trevor R.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Cambridge, England	Addenbrooke's Hospital; University of Cambridge	Mears, HV; Sweeney, TR (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Cambridge, England.	hym30@cam.ac.uk; ts629@cam.ac.uk		Mears, Harriet/0000-0003-0300-0885; Sweeney, Trevor/0000-0003-4016-7326	Royal Society/Wellcome Trust Sir Henry Dale Fellowship [202471/Z/16/Z]; University of Cambridge, Department of Pathology Ph.D. Studentship	Royal Society/Wellcome Trust Sir Henry Dale Fellowship; University of Cambridge, Department of Pathology Ph.D. Studentship	This work was funded by Royal Society/Wellcome Trust Sir Henry Dale Fellowship 202471/Z/16/Z (to T. R. S.). H. V. M. was supported by a University of Cambridge, Department of Pathology Ph.D. Studentship.	Abbas Y.M., 2017, CONSERVED HOMODIMERI, DOI [10.1101/152850, DOI 10.1101/152850]; Abbas YM, 2017, P NATL ACAD SCI USA, V114, pE2106, DOI 10.1073/pnas.1612444114; Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; BLUYSSEN HAR, 1994, EUR J BIOCHEM, V220, P395, DOI 10.1111/j.1432-1033.1994.tb18636.x; Butchi NB, 2014, J VIROL, V88, P1051, DOI 10.1128/JVI.02272-13; Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243; Coley SE, 2005, J VIROL, V79, P3097, DOI 10.1128/JVI.79.5.3097-3106.2005; Cook G., 2018, BIORXIV, DOI [10.1101/292979, DOI 10.1101/292979]; Cowling VH, 2010, BIOCHEM J, V425, P295, DOI 10.1042/BJ20091352; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Daugherty MD, 2016, ELIFE, V5, DOI 10.7554/eLife.14228; Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feng F, 2013, CELL RES, V23, P1055, DOI 10.1038/cr.2013.80; Fensterl V, 2015, J VIROL, V89, P2462, DOI 10.1128/JVI.02744-14; Fleith RC, 2018, NUCLEIC ACIDS RES, V46, P5269, DOI 10.1093/nar/gky191; Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739; Goodsell DS, 2019, STRUCTURE, V27, P1716, DOI 10.1016/j.str.2019.08.011; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo JJ, 2000, VIROLOGY, V267, P209, DOI 10.1006/viro.1999.0135; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; Habjan M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003663; Hou ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26150; Huang X, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2475; Hyde JL, 2014, SCIENCE, V343, P783, DOI 10.1126/science.1248465; Irigoyen N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005473; Johnson B, 2018, IMMUNITY, V48, P487, DOI 10.1016/j.immuni.2018.01.014; Katibah GE, 2014, P NATL ACAD SCI USA, V111, P12025, DOI 10.1073/pnas.1412842111; Katibah GE, 2013, MOL CELL, V49, P743, DOI 10.1016/j.molcel.2012.12.015; Kumar P, 2014, NUCLEIC ACIDS RES, V42, P3228, DOI 10.1093/nar/gkt1321; Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12; Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066859; Liu ZQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02460-2; Mears Harriet V, 2019, Wellcome Open Res, V4, P82, DOI 10.12688/wellcomeopenres.15223.1; Mears HV, 2018, J GEN VIROL, V99, P1463, DOI 10.1099/jgv.0.001149; Menachery VD, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00346-17; Menachery VD, 2014, J VIROL, V88, P4251, DOI 10.1128/JVI.03571-13; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; PERRY RP, 1976, CELL, V8, P433, DOI 10.1016/0092-8674(76)90156-2; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Pidugu VK, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00148; Reolon LW, 2019, NUCLEIC ACIDS RES, V47, P5973, DOI 10.1093/nar/gkz339; Reynaud JM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004863; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Smith JB, 1996, ARCH BIOCHEM BIOPHYS, V330, P290, DOI 10.1006/abbi.1996.0256; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; STURMAN LS, 1972, INFECT IMMUN, V6, P501, DOI 10.1128/IAI.6.4.501-507.1972; Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698; Tamassia N, 2008, J IMMUNOL, V181, P6563, DOI 10.4049/jimmunol.181.9.6563; Terenzi F, 2005, VIROLOGY, V340, P116, DOI 10.1016/j.virol.2005.06.011; Terenzi F, 2007, J VIROL, V81, P8656, DOI 10.1128/JVI.00322-07; Tumescheit C., 2020, BIORXIV, DOI [10.1101/2020.09.14.291484, DOI 10.1101/2020.09.14.291484]; van Pesch V, 2004, J VIROL, V78, P8219, DOI 10.1128/JVI.78.15.8219-8228.2004; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; Wang J, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz751; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Yang ZL, 2012, CELL RES, V22, P1328, DOI 10.1038/cr.2012.111; Zamudio JR, 2006, EUKARYOT CELL, V5, P905, DOI 10.1128/EC.00080-06; Zamudio JR, 2009, MOL MICROBIOL, V72, P1100, DOI 10.1111/j.1365-2958.2009.06696.x; Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	66	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17781	17801		10.1074/jbc.RA120.014695	http://dx.doi.org/10.1074/jbc.RA120.014695			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454014	hybrid, Green Published			2022-12-26	WOS:000603272300030
J	Golubtsov, AS; Korostelev, NB; Levin, BA				Golubtsov, Alexander S.; Korostelev, Nikolai B.; Levin, Boris A.			Monsters with a shortened vertebral column: A population phenomenon in radiating fish Labeobarbus (Cyprinidae)	PLOS ONE			English	Article							LAKE TANA ETHIOPIA; SALMON SALMO-SALAR; LARGE BARBS BARBUS; ATLANTIC SALMON; SPECIES FLOCK; GENETIC-VARIATION; MORPHOLOGICAL DIVERGENCE; CYPRINIFORMES CYPRINIDAE; ECOLOGICAL OPPORTUNITY; SKELETAL DEFORMITIES	The phenomenon of a massive vertebral deformity was recorded in the radiating Labeobarbus assemblage from the middle reaches of the Genale River (south-eastern Ethiopia, East Africa). Within this sympatric assemblage, five trophic morphs-generalized, lipped, piscivorous and two scraping feeders-were reported between 1993 and 2019. In 2009, a new morph with prevalence of similar to 10% was discovered. The new morph, termed 'short', had an abnormally shortened vertebral column and a significantly deeper body. This type of deformity is common in farmed Atlantic salmon and other artificially reared fish, but is rare in nature. In the Genale Labeobarbus assemblage, the deformity was present exclusively within the generalized and lipped morphs. The short morph had between seven and 36 deformed (compressed and/or fused) vertebrae. Their body depth was positively correlated with number of deformed vertebrae. In another collection in 2019, the short morph was still present at a frequency of 11%. Various environmental and genetic factors could contribute to the development of this deformity in the Genale Labeobarbus, but based on the available data, it is impossible to confidently identify the key factor(s). Whether the result of genetics, the environment, or both, this deep-bodied phenotype is assumed to be an anti-predator adaptation, as there is evidence of its selective advantage in the generalized morph. The Genale monstrosity is the first reported case of a massive deformity of the vertebral column in a natural population of African fishes.	[Golubtsov, Alexander S.; Korostelev, Nikolai B.] Russian Acad Sci, Severtsov Inst Ecol & Evolut, Moscow, Russia; [Levin, Boris A.] Russian Acad Sci, Papanin Inst Biol Inland Waters, Borok, Russia; [Levin, Boris A.] Cherepovets State Univ, Cherepovets, Russia	Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; Papanin Institute for Biology of Inland Waters; Russian Academy of Sciences; Cherepovets State University	Levin, BA (corresponding author), Russian Acad Sci, Papanin Inst Biol Inland Waters, Borok, Russia.; Levin, BA (corresponding author), Cherepovets State Univ, Cherepovets, Russia.	borislyovin@gmail.com	Levin, Boris A./F-8287-2013; Golubtsov, Alexander/K-8612-2018	Levin, Boris A./0000-0002-4044-2036; Golubtsov, Alexander/0000-0002-8317-7527	Russian Science Foundation [BAL 19-14-00218]	Russian Science Foundation(Russian Science Foundation (RSF))	ASG, BAL 19-14-00218 Russian Science Foundation https://rscf.ru/en/NO.	Ackerly KL, 2016, J EXP ZOOL PART A, V325, P25, DOI 10.1002/jez.1993; Aida T, 1930, GENETICS, V15, P1; AL-HASSAN L A J, 1986, Indian Journal of Fisheries, V33, P237; Alekseyev SS, 1996, FOLIA ZOOL, V45, P85; Alekseyev SS, 2016, THESIS MOSCOW STATE; Banister KE., 1973, B BR MUS NAT HIS Z, V26, P1, DOI 10.5962/bhl.part.204; BARAHONAFERNANDES MH, 1982, J FISH BIOL, V21, P239, DOI 10.1111/j.1095-8649.1982.tb02830.x; Bensimon-Brito A, 2010, J APPL ICHTHYOL, V26, P235, DOI 10.1111/j.1439-0426.2010.01412.x; Bensimon-Brito A, 2012, EVOL DEV, V14, P116, DOI 10.1111/j.1525-142X.2011.00526.x; Berhanu B., 2014, SURFACE WATER GROUND, P97, DOI [10.1007/978-3-319-02720-3_6, DOI 10.1007/978-3-319-02720]; Berrebi P, 1998, BIOL J LINN SOC, V64, P369; Beshera KA, 2014, J FISH BIOL, V85, P228, DOI 10.1111/jfb.12408; Beshera KA, 2016, ZOOTAXA, V4093, P363, DOI 10.11646/zootaxa.4093.3.4; Bini G., 1940, REALE ACCADEMIA DITA, V3, P137; Boglione C, 2013, REV AQUACULT, V5, pS121, DOI 10.1111/raq.12016; Bogutskaya NG, 2011, J FISH BIOL, V79, P991, DOI 10.1111/j.1095-8649.2011.03078.x; Bolotovskiy AA, 2018, J APPL ICHTHYOL, V34, P449, DOI 10.1111/jai.13659; Brunelli G., 1940, B CHIMICA BIOLOGIA R, V3, P207; CAMPBELL WB, 1995, J FISH BIOL, V46, P717, DOI 10.1111/j.1095-8649.1995.tb01106.x; Cataudella S, 1996, INT WORKSHOP SEA BAS, P45; Comtois D, 2018, **DATA OBJECT**; Corral WDR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219677; Cunningham ME, 2005, ENVIRON BIOL FISH, V73, P9, DOI 10.1007/s10641-004-3153-5; Darwin C., 1860, ORIGIN SPECIES MEANS; DAWSON C. E., 1966, GULF RES REP, V2, P169; DAWSON C. E., 1964, GULF RES REPTS, V1, P308; DAWSON C E, 1976, Gulf Research Reports, V5, P35; Dawson C.E., 1971, Publ Gulf Coast Res Lab Mus (Ocean Springs Miss), V3, P215; de Graaf M, 2005, J FISH BIOL, V66, P1214, DOI 10.1111/j.0022-1112.2005.00671.x; De Graaf M, 2000, NETH J ZOOL, V50, P215, DOI 10.1163/156854200505955; de Graaf M, 2008, MAR FRESHWATER RES, V59, P391, DOI 10.1071/MF07123; De Graaf M, 2007, ANIM BIOL, V57, P39, DOI 10.1163/157075607780002069; de Graaf M, 2010, ANIM BIOL, V60, P183, DOI 10.1163/157075610X491725; de Graaf M, 2010, MOL PHYLOGENET EVOL, V54, P336, DOI 10.1016/j.ympev.2009.10.029; Dgebuadze YY, 1999, J FISH BIOL, V54, P417, DOI 10.1006/jfbi.1998.0875; Dimmick WW, 2001, COPEIA, P1123; Domenici P, 2008, P ROY SOC B-BIOL SCI, V275, P195, DOI 10.1098/rspb.2007.1088; DUNHAM RA, 1991, PROG FISH CULT, V53, P101, DOI 10.1577/1548-8640(1991)053&lt;0101:LOIOSA&gt;2.3.CO;2; Dzerzhinskii KF., 2007, J ICHTHYOL+, V47, P639, DOI 10.1134/S0032945207080103; Evans KM, 2018, COPEIA, V106, P130, DOI 10.1643/CI-17-598; Fjelldal PG, 2012, J APPL ICHTHYOL, V28, P433, DOI 10.1111/j.1439-0426.2012.01980.x; Fjelldal PG, 2006, AQUACULTURE, V261, P715, DOI 10.1016/j.aquaculture.2006.08.008; Fjelldal PG, 2021, J FISH BIOL, V98, P1049, DOI 10.1111/jfb.14337; Fjelldal PG, 2009, AQUACULTURE, V296, P36, DOI 10.1016/j.aquaculture.2009.08.020; Fraser TWK, 2021, J FISH BIOL, V98, P1059, DOI 10.1111/jfb.14353; FRASER-BRUNNER A., 1951, BULL BRIT MUS [NAT HIST] ZOOL, V1, P87; Friendly MM, 2020, PACKAGE CANDISC; Gavaia PJ, 2002, AQUACULTURE, V211, P305, DOI 10.1016/S0044-8486(02)00167-9; Gistelinck C, 2018, P NATL ACAD SCI USA, V115, pE8037, DOI 10.1073/pnas.1722200115; Gjerde B, 2005, AQUACULTURE, V244, P77, DOI 10.1016/j.aquaculture.2004.12.002; Golubtsov A.S., 1993, Cahiers d'Ethologie, V13, P227; Golubtsov A. S., 1995, ARTIFICIAL KEY FISH; GOLUBTSOV AS, 1993, J FISH BIOL, V42, P445, DOI 10.1111/j.1095-8649.1993.tb00347.x; Golubtsov AS, 2002, BIO INL WAT, P167; Golubtsov AS., 2017, ETHIOP J BIOL SCI, V16, P45; Gorman KF, 2007, COMP BIOCHEM PHYS C, V145, P28, DOI 10.1016/j.cbpc.2006.10.004; GUEGAN JF, 1995, J FISH BIOL, V47, P192, DOI 10.1111/j.1095-8649.1995.tb01888.x; Hansen T, 2010, J APPL ICHTHYOL, V26, P355, DOI 10.1111/j.1439-0426.2010.01434.x; HILGER I, 1992, DIS AQUAT ORGAN, V13, P83, DOI 10.3354/dao013083; HUBBS C, 1959, ECOLOGY, V40, P154, DOI 10.2307/1929941; Jawad Laith A., 2015, Travaux du Museum National d'Histoire Naturelle Grigore Antipa, V57, P127, DOI 10.1515/travmu-2015-0006; Johnson GD, 2005, J MORPHOL, V266, P11, DOI 10.1002/jmor.10242; Krysanov EY, 1996, FOLIA ZOOL, V45, P67; Kvellestad A, 2000, DIS AQUAT ORGAN, V39, P97, DOI 10.3354/dao039097; Levin BA., 2012, J ICHTHYOL, V52, P908, DOI [10.1134/S0032945212110069, DOI 10.1134/S0032945212110069]; Levin BA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64350-4; Levin BA, 2019, FRESHWATER BIOL, V64, P1721, DOI 10.1111/fwb.13364; Levin BA, 2013, AFR ZOOL, V48, P400, DOI 10.3377/004.048.0208; LODI E, 1978, GENETICA, V48, P197, DOI 10.1007/BF00155570; Madsen L, 2001, AQUAC RES, V32, P235, DOI 10.1046/j.1365-2109.2001.00552.x; Martini A, 2021, J FISH BIOL, V98, P971, DOI 10.1111/jfb.14272; MCKAY LR, 1986, AQUACULTURE, V52, P263, DOI 10.1016/0044-8486(86)90369-8; Mina M.V., 2005, J ICHTHYOL+, V45, P284, DOI 10.1134/S0032945206020056; Mina MV, 1996, FOLIA ZOOL, V45, P109; Mina MV, 1996, J FISH BIOL, V48, P383, DOI 10.1111/j.1095-8649.1996.tb01435.x; Mina MV, 2004, ENVIRON BIOL FISH, V70, P315, DOI 10.1023/B:EBFI.0000033346.86973.17; Mina MV, 1998, ITAL J ZOOL, V65, P9, DOI 10.1080/11250009809386789; Mina MV, 2001, ENVIRON BIOL FISH, V61, P241, DOI 10.1023/A:1010952108081; MOLLER H, 1984, HELGOLANDER MEERESUN, V37, P389, DOI 10.1007/BF01989319; Moller H., 1983, Bulletin of the European Association of Fish Pathologists, V3, P7; Moritz T, 2019, CYBIUM, V43, P137, DOI 10.26028/cybium/2019-423-011; MYERS GS, 1960, EVOLUTION, V14, P323, DOI 10.2307/2405975; Nagelkerke LAJ, 2015, J FISH BIOL, V87, P1191, DOI 10.1111/jfb.12779; NAGELKERKE LAJ, 1994, ENVIRON BIOL FISH, V39, P1, DOI 10.1007/BF00004751; Nagelkerke LAJ, 2000, NETH J ZOOL, V50, P179, DOI 10.1163/156854200505946; Nagelkerke LAJ, 1996, J FISH BIOL, V49, P1244; Nagelkerke LAJ, 1995, NETH J ZOOL, V45, P431; NAGELKERKE LAJ, 1995, BIOSCIENCE, V45, P772, DOI 10.2307/1312629; Nagelkerke Leo A.J., 1997, P105; Naran D, 2007, AFR ZOOL, V42, P254, DOI 10.3377/1562-7020(2007)42[254:KOTEHS]2.0.CO;2; Naseka A.M., 1996, Publicaciones Especiales Instituto Espanol de Oceanografia, V21, P149; Nelson J.S., 2016, FISHES WORLD, DOI 10.1002/9781119174844; Nilsson PA, 2000, OIKOS, V88, P539, DOI 10.1034/j.1600-0706.2000.880310.x; OELLERMANN LK, 1990, J FISH BIOL, V37, P105, DOI 10.1111/j.1095-8649.1990.tb05932.x; OGAWA NM, 1965, EMBRYOLOGIA, V9, P13, DOI 10.1111/j.1440-169X.1965.tb00212.x; Ogle D., 2017, CRAN REPOS, P1; Paugy D, 2010, HYDROBIOLOGIA, V649, P301, DOI 10.1007/s10750-010-0273-0; Pavlov DS., 2010, CURRENT PROBLEMS ICH, P96; Pohlert T., 2018, PACKAGE PMCMRR PACKA; Pope EC, 2010, REV FISH BIOL FISHER, V20, P471, DOI 10.1007/s11160-009-9155-9; Powell MD, 2009, DIS AQUAT ORGAN, V85, P59, DOI 10.3354/dao02056; Prestinicola L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055736; RStudio Team, 2020, RSTUDIO INTEGRATED D; Schultz RJ., 1963, COPEIA, P325; Shkil FN, 2018, J APPL ICHTHYOL, V34, P465, DOI 10.1111/jai.13665; Shkil FN, 2015, RUSS J DEV BIOL+, V46, P294, DOI 10.1134/S1062360415050069; Shkil FN, 2012, J APPL ICHTHYOL, V28, P398, DOI 10.1111/j.1439-0426.2012.01992.x; Shkil FN, 2010, J APPL ICHTHYOL, V26, P315, DOI 10.1111/j.1439-0426.2010.01428.x; Sibbing FA, 2001, REV FISH BIOL FISHER, V10, P393; Sibbing Ferdinand A., 1998, Aquatic Ecology, V32, P217, DOI 10.1023/A:1009920522235; Smirnov S.V., 2006, J ICHTHYOL+, V46, P129, DOI 10.1134/S0032945206010176; Steffens W., 1980, KARPFEN, V5; Stroud JT, 2016, ANNU REV ECOL EVOL S, V47, P507, DOI 10.1146/annurev-ecolsys-121415-032254; Sullivan M, 2007, J FISH DIS, V30, P753, DOI 10.1111/j.1365-2761.2007.00888.x; TAVE D, 1982, J FISH DIS, V5, P487, DOI 10.1111/j.1365-2761.1982.tb00508.x; Tave Douglas, 2011, Fisheries and Aquatic Sciences, V14, P148; THOMERSON JE, 1966, COPEIA, P878; Torres-Dowdall J, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0197; TYLER JC, 1970, P ACAD NAT SCI PHILA, V122, P249; Vagsholm I, 1998, J FISH DIS, V21, P47, DOI 10.1046/j.1365-2761.1998.00069.x; Villeneuve DL, 2005, ENVIRON SCI TECHNOL, V39, P3495, DOI 10.1021/es048570c; Vreven EJWMN, 2019, ZOOL J LINN SOC-LOND, V186, P414, DOI 10.1093/zoolinnean/zly049; Vreven EJWMN, 2016, ZOOL J LINN SOC-LOND, V177, P231, DOI 10.1111/zoj.12366; Wargelius A, 2005, DEV GENES EVOL, V215, P350, DOI 10.1007/s00427-005-0482-0; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Witten PE, 2016, J FISH BIOL, V88, P690, DOI 10.1111/jfb.12870; Witten PE, 2006, AQUACULTURE, V258, P164, DOI 10.1016/j.aquaculture.2006.05.005; Witten PE, 2009, AQUACULTURE, V295, P6, DOI 10.1016/j.aquaculture.2009.06.037; Witten PE, 2005, DIS AQUAT ORGAN, V64, P237, DOI 10.3354/dao064237; WUNDER W, 1971, HELGOLAND WISS MEER, V22, P201, DOI 10.1007/BF01609461; WUNDER WILHELM, 1949, WILHELM ROUX ARCH ENTWICKLUNGSMECH ORGAN, V144, P1, DOI 10.1007/BF00575291; YAMAMOTO T, 1963, JPN J GENET, V38, P36, DOI 10.1266/jjg.38.36; Yang L, 2015, MOL PHYLOGENET EVOL, V85, P97, DOI 10.1016/j.ympev.2015.01.014; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x; Zworykin DD., 2006, J ICHTHYOL+, V46, P661, DOI 10.1134/S0032945206080133	135	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0239639	10.1371/journal.pone.0239639	http://dx.doi.org/10.1371/journal.pone.0239639			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471803	gold, Green Published, Green Submitted			2022-12-26	WOS:000639428800075
J	Kumar, P; Akhter, T; Bhardwaj, P; Kumar, R; Bhardwaj, U; Mazumdar-Leighton, S				Kumar, Pawan; Akhter, Tabasum; Bhardwaj, Parul; Kumar, Rakesh; Bhardwaj, Usha; Mazumdar-Leighton, Sudeshna			Consequences of 'no-choice, fixed time' reciprocal host plant switches on nutrition and gut serine protease gene expression in Pieris brassicae L. (Lepidoptera: Pieridae)	PLOS ONE			English	Article							DIETARY PROTEINASE-INHIBITORS; TROPAEOLUM-MAJUS; AGROTIS-IPSILON; HELICOVERPA-ZEA; TRYPSIN; PERFORMANCE; GROWTH; SPECIALIST; ADAPTATION; LARVAE	Rapid adaptive responses were evident from reciprocal host-plant switches on performance, digestive physiology and relative gene expression of gut serine proteases in larvae of crucifer pest P. brassicae transferred from cauliflower (CF, Brassica oleracea var. botrytis, family Brassicaceae) to an alternate host, garden nasturtium, (GN, Tropaeolum majus L., family Tropaeolaceae) and vice-versa under laboratory conditions. Estimation of nutritional indices indicated that larvae of all instars tested consumed the least food and gained less weight on CF-GN diet (significant at p <= 0.05) as compared to larvae feeding on CF-CF, GN-GN and GN-CF diets suggesting that the switch to GN was nutritionally less favorable for larval growth. Nevertheless, these larvae, especially fourth instars, were adroit in utilizing and digesting GN as a new host plant type. In vitro protease assays conducted to understand associated physiological responses within twelve hours indicated that levels and properties of gut proteases were significantly influenced by type of natal host-plant consumed, change in diet as well as larval age. Activities of gut trypsins and chymotrypsins in larvae feeding on CF-GN and GN-CF diets were distinct, and represented shifts toward profiles observed in larvae feeding continuously on GN-GN and CF-CF diets respectively. Results with diagnostic protease inhibitors like TLCK, STI and SBBI in these assays and gelatinolytic zymograms indicated complex and contrasting trends in gut serine protease activities in different instars from CF-GN diet versus GN-CF diet, likely due to ingestion of plant protease inhibitors present in the new diet. Cloning and sequencing of serine protease gene fragments expressed in gut tissues of fourth instar P. brassicae revealed diverse transcripts encoding putative trypsins and chymotrypsins belonging to at least ten lineages. Sequences of members of each lineage closely resembled lepidopteran serine protease orthologs including uncharacterized transcripts from Pieris rapae. Differential regulation of serine protease genes (Pbr1-Pbr5) was observed in larval guts of P. brassicae from CF-CF and GN-GN diets while expression of transcripts encoding two putative trypsins (Pbr3 and Pbr5) were significantly different in larvae from CF-GN and GN-CF diets. These results suggested that some gut serine proteases that were differentially expressed in larvae feeding on different species of host plants were also involved in rapid adaptations to dietary switches. A gene encoding nitrile-specifier protein (nsp) likely involved in detoxification of toxic products from interactions of ingested host plant glucosinolates with myrosinases was expressed to similar levels in these larvae. Taken together, these snapshots reflected contrasts in physiological and developmental plasticity of P. brassicae larvae to nutritional challenges from wide dietary switches in the short term and the prominent role of gut serine proteases in rapid dietary adaptations. This study may be useful in designing novel management strategies targeting candidate gut serine proteases of P. brassicae using RNA interference, gene editing or crops with transgenes encoding protease inhibitors from taxonomically-distant host plants.	[Kumar, Pawan; Akhter, Tabasum; Bhardwaj, Parul; Kumar, Rakesh; Bhardwaj, Usha; Mazumdar-Leighton, Sudeshna] Univ Delhi, Fac Sci, Dept Bot, Delhi, India; [Kumar, Rakesh] Indian Chem Council, New Delhi, India; [Bhardwaj, Usha] CUNY, Dept Chem, New York, NY 10021 USA	University of Delhi; City University of New York (CUNY) System	Mazumdar-Leighton, S (corresponding author), Univ Delhi, Fac Sci, Dept Bot, Delhi, India.	smceres21@yahoo.co.in	Kumar, Pawan/GXF-7072-2022	Bhardwaj, Usha/0000-0003-1830-5059; Mazumdar-Leighton, Sudeshna/0000-0002-7869-452X	Delhi University; University Grants Commission, Government of India	Delhi University; University Grants Commission, Government of India(University Grants Commission, India)	This work was supported in part by Delhi University Research and Development Grant (2014-2017) to SML. The University Grants Commission, Government of India provided senior research fellowships to PK, TA and PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2003, J CHEM ECOL, V29, P1403, DOI 10.1023/A:1024265420375; Ansari MS, 2012, B ENTOMOL RES, V102, P231, DOI 10.1017/S000748531100054X; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Badenes-Perez FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095766; Bhardwaj U, 2014, ARCH INSECT BIOCHEM, V85, P13, DOI 10.1002/arch.21140; BROADWAY RM, 1992, J CHEM ECOL, V18, P1009, DOI 10.1007/BF00980059; BROADWAY RM, 1995, J INSECT PHYSIOL, V41, P107, DOI 10.1016/0022-1910(94)00101-L; Broadway RM, 1996, ARCH INSECT BIOCHEM, V32, P39, DOI 10.1002/(SICI)1520-6327(1996)32:1&lt;39::AID-ARCH3&gt;3.0.CO;2-S; Celorio-Mancera MD, 2013, MOL ECOL, V22, P4884, DOI 10.1111/mec.12440; Chew F.S., 1995, P214; Courtier-Orgogozo V, 2017, EMBO REP, V18, P1481, DOI 10.15252/embr.201744822; Cui J, 2017, PLANT GROWTH REGUL, V81, P543, DOI 10.1007/s10725-016-0231-6; DAVIES CR, 1985, OECOLOGIA, V67, P278, DOI 10.1007/BF00384299; Davis SL, 2014, BIOL INVASIONS, V16, P1941, DOI 10.1007/s10530-013-0637-2; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dunaevsky Ya. E., 2005, Molecular Biology (New York), V39, P608, DOI 10.1007/s11008-005-0076-y; Edger PP, 2015, P NATL ACAD SCI USA, V112, P8362, DOI 10.1073/pnas.1503926112; Erlandson MA, 2010, ARCH INSECT BIOCHEM, V75, P70, DOI 10.1002/arch.20381; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Fei MH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081263; Feller C., 1995, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V47, P193; Friberg M, 2015, OECOLOGIA, V178, P1181, DOI 10.1007/s00442-015-3286-6; Gatehouse JA, 2011, CURR PROTEIN PEPT SC, V12, P409; GREER J, 1990, PROTEINS, V7, P317, DOI 10.1002/prot.340070404; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; HUANG XP, 1995, J CHEM ECOL, V21, P1601, DOI 10.1007/BF02035155; Hwang SY, 2008, BIOCHEM SYST ECOL, V36, P505, DOI 10.1016/j.bse.2008.03.001; Janz N, 2011, ANNU REV ECOL EVOL S, V42, P71, DOI 10.1146/annurev-ecolsys-102710-145024; Keller M, 1996, INSECT BIOCHEM MOLEC, V26, P365, DOI 10.1016/0965-1748(95)00102-6; Kleinwachter M, 2008, J APPL BOT FOOD QUAL, V82, P55; Knolhoff LM, 2014, ANNU REV ENTOMOL, V59, P263, DOI 10.1146/annurev-ento-011613-161945; Kumar R, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00095; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuwar SS, 2015, INSECT BIOCHEM MOLEC, V59, P18, DOI 10.1016/j.ibmb.2015.01.016; Lazarevic J, 2015, ENTOMOL EXP APPL, V157, P123, DOI 10.1111/eea.12349; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XL, 2017, HORTIC ENVIRON BIOTE, V58, P195, DOI 10.1007/s13580-017-0188-z; Mazumdar-Leighton S, 2001, INSECT BIOCHEM MOLEC, V31, P645, DOI 10.1016/S0965-1748(00)00169-7; Mazumdar-Leighton S, 2001, INSECT BIOCHEM MOLEC, V31, P633, DOI 10.1016/S0965-1748(00)00168-5; Mazumdar-Leighton S, 2000, INSECT BIOCHEM MOLEC, V30, P57, DOI 10.1016/S0965-1748(99)00097-1; Mendonca EG, 2020, ARCH INSECT BIOCHEM, V103, DOI 10.1002/arch.21637; Meng FL, 2017, FLA ENTOMOL, V100, P607, DOI 10.1653/024.100.0319; Metspalu L., 2003, Agronomy Research, V1, P85; Michaud D, 1998, ANAL CHIM ACTA, V372, P173, DOI 10.1016/S0003-2670(98)00349-3; Muller C, 2017, MOL ECOL, V26, P6370, DOI 10.1111/mec.14349; Nallu S, 2018, NAT ECOL EVOL, V2, P1418, DOI 10.1038/s41559-018-0629-9; Nishio N, 1997, PLANT PHYSIOL, V115, P841, DOI 10.1104/pp.115.2.841; Oberlander J, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1943-3; Okamura Y, 2019, MOL ECOL, V28, P4958, DOI 10.1111/mec.15268; Okamura Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43703-8; Okamura Y, 2019, J INSECT SCI, V19, DOI 10.1093/jisesa/iez035; Oppert B, 2005, COMP BIOCHEM PHYS C, V140, P53, DOI 10.1016/j.cca.2005.01.006; Ortego F, 1998, J INSECT PHYSIOL, V44, P95, DOI 10.1016/S0022-1910(97)00103-0; Poelman EH, 2008, ENTOMOL EXP APPL, V127, P218, DOI 10.1111/j.1570-7458.2008.00700.x; Renwick JAA, 2002, ENTOMOL EXP APPL, V104, P35, DOI 10.1023/A:1021231732022; Rodriguez-Cabrera L, 2010, ENVIRON MICROBIOL, V12, P2894, DOI 10.1111/j.1462-2920.2010.02259.x; Saikia M, 2011, INSECT MOL BIOL, V20, P1, DOI 10.1111/j.1365-2583.2010.01048.x; Schluter U, 2010, J EXP BOT, V61, P4169, DOI 10.1093/jxb/erq166; Schoonhoven L. M., 2005, Insect-plant biology; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; SCRIBER JM, 1981, ANNU REV ENTOMOL, V26, P183, DOI 10.1146/annurev.en.26.010181.001151; Sharifloo A, 2018, B ENTOMOL RES, V108, P501, DOI [10.1017/S0007485317001067, 10.1017/s0007485317001067]; Sikkink KL, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3787-2; SLANSKY F, 1977, ECOL MONOGR, V47, P209, DOI 10.2307/1942617; Smallegange RC, 2007, J CHEM ECOL, V33, P1831, DOI 10.1007/s10886-007-9350-x; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; Souza TP, 2016, COMP BIOCHEM PHYS B, V196, P67, DOI 10.1016/j.cbpb.2016.02.007; Terra WR, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P365, DOI 10.1016/B978-0-12-384747-8.10011-X; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1; Wittstock U, 2004, P NATL ACAD SCI USA, V101, P4859, DOI 10.1073/pnas.0308007101; Woods HA, 1999, ARCH INSECT BIOCHEM, V42, P74, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;74::AID-ARCH8&gt;3.0.CO;2-S; Wu YR, 1997, MOL BREEDING, V3, P371, DOI 10.1023/A:1009681323131; Xiang M, 2018, ARCH INSECT BIOCHEM, V97, DOI 10.1002/arch.21427; Zalucki MP, 2002, ANNU REV ENTOMOL, V47, P361, DOI 10.1146/annurev.ento.47.091201.145220; Zhao AP, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01963; Zhou DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062252; Zhu-Salzman K, 2015, ANNU REV ENTOMOL, V60, P233, DOI 10.1146/annurev-ento-010814-020816	78	3	3	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245649	10.1371/journal.pone.0245649	http://dx.doi.org/10.1371/journal.pone.0245649			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471847	Green Published, gold			2022-12-26	WOS:000639428800010
J	Labrecque, MP; Brown, LG; Coleman, IM; Nguyen, HM; Lin, DW; Corey, E; Nelson, PS; Morrissey, C				Labrecque, Mark P.; Brown, Lisha G.; Coleman, Ilsa M.; Nguyen, Holly M.; Lin, Daniel W.; Corey, Eva; Nelson, Peter S.; Morrissey, Colm			Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; KINASE INHIBITOR; PHASE-II; AMG 337; HYPOXIA; MET; GENE; CELLS; IDENTIFICATION; ANGIOGENESIS	With the advent of potent second-line anti-androgen therapy, we and others have observed an increased incidence of androgen receptor (AR)-null small cell or neuroendocrine prostate cancer (SCNPC) in metastatic castration-resistant prostate cancer (mCRPC). Our study was designed to determine the effect of cabozantinib, a multi-targeted tyrosine kinase inhibitor that inhibits VEGFR2, MET and RET on SCNPC. Transcriptome analysis of the University of Washington rapid autopsy and SU2C mCRPC datasets revealed upregulated MET and RET expression in SCNPCs relative to adenocarcinomas. Additionally, increased MET expression correlated with attenuated AR expression and activity. In vitro treatment of SCNPC patient-derived xenograft (PDX) cells with the MET inhibitor AMG-337 had no impact on cell viability in LuCaP 93 (MET+/RET+) and LuCaP 173.1 (MET-/RET-), whereas cabozantinib decreased cell viability of LuCaP 93, but not LuCaP 173.1. Notably, MET+/RET+ LuCaP 93 and MET-/RET- LuCaP 173.1 tumor volumes were significantly decreased with cabozantinib treatment in vivo, and this activity was independent of MET or RET expression in LuCaP 173.1. Tissue analysis indicated that cabozantinib did not inhibit tumor cell proliferation (Ki67), but significantly decreased microvessel density (CD31) and increased hypoxic stress and glycolysis (HK2) in LuCaP 93 and LuCaP 173.1 tumors. RNA-Seq and gene set enrichment analysis revealed that hypoxia and glycolysis pathways were increased in cabozantinib-treated tumors relative to control tumors. Our data suggest that the most likely mechanism of cabozantinib-mediated tumor growth suppression in SCNPC PDX models is through disruption of the tumor vasculature. Thus, cabozantinib may represent a potential therapy for patients with metastatic disease in tumor phenotypes that have a significant dependence on the tumor vasculature for survival and proliferation.	[Labrecque, Mark P.; Brown, Lisha G.; Nguyen, Holly M.; Lin, Daniel W.; Corey, Eva; Morrissey, Colm] Univ Washington, Sch Med, Dept Urol, Seattle, WA 98195 USA; [Coleman, Ilsa M.; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA; [Lin, Daniel W.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Nelson, Peter S.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Morrissey, C (corresponding author), Univ Washington, Sch Med, Dept Urol, Seattle, WA 98195 USA.	cmorriss@uw.edu	Labrecque, Mark/GPP-4575-2022	Labrecque, Mark/0000-0001-7887-7599; Corey, Eva/0000-0002-9244-3807	NCI NIH HHS [P50 CA097186] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abhinand CS, 2016, J CELL COMMUN SIGNAL, V10, P347, DOI 10.1007/s12079-016-0352-8; Abida W, 2019, P NATL ACAD SCI USA, V116, P11428, DOI 10.1073/pnas.1902651116; Armstrong K, 2011, BRIT J CANCER, V105, P1362, DOI 10.1038/bjc.2011.367; Ban KC, 2017, CLIN CANCER RES, V23, P4885, DOI 10.1158/1078-0432.CCR-17-0528; Basch EM, 2019, EUR UROL, V75, P929, DOI 10.1016/j.eururo.2018.11.033; Beltran H, 2019, CLIN CANCER RES, V25, P6916, DOI 10.1158/1078-0432.CCR-19-1423; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Bluemn EG, 2017, CANCER CELL, V32, P474, DOI 10.1016/j.ccell.2017.09.003; Boezio AA, 2016, J MED CHEM, V59, P2328, DOI 10.1021/acs.jmedchem.5b01716; Choueiri TK, 2016, LANCET ONCOL, V17, P917, DOI 10.1016/S1470-2045(16)30107-3; Dai JL, 2014, CLIN CANCER RES, V20, P617, DOI 10.1158/1078-0432.CCR-13-0839; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Han HJ, 2020, J MATER CHEM B, V8, P5143, DOI 10.1039/d0tb00874e; Hughes PE, 2016, MOL CANCER THER, V15, P1568, DOI 10.1158/1535-7163.MCT-15-0871; Jan YH, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0698-5; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kluin RJC, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2353-5; Koinis F, 2020, CANCERS, V12, DOI 10.3390/cancers12010244; Labrecque MP, 2019, J CLIN INVEST, V129, P4492, DOI 10.1172/JCI128212; Labrecque MP, 2016, ONCOTARGET, V7, P24284, DOI 10.18632/oncotarget.8301; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Le Jan S, 2006, FEBS LETT, V580, P3395, DOI 10.1016/j.febslet.2006.05.011; Lieu C, 2011, CLIN CANCER RES, V17, P6130, DOI 10.1158/1078-0432.CCR-11-0659; Mathupala SP, 2001, J BIOL CHEM, V276, P43407, DOI 10.1074/jbc.M108181200; Minchenko A, 2002, J BIOL CHEM, V277, P6183, DOI 10.1074/jbc.M110978200; Morrissey C, 2008, CLIN EXP METASTAS, V25, P377, DOI 10.1007/s10585-007-9116-4; Morrissey C, 2010, PROSTATE, V70, P1799, DOI 10.1002/pros.21216; Nguyen HM, 2017, PROSTATE, V77, P654, DOI 10.1002/pros.23313; Nguyen HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078881; Ouiddir A, 1999, AM J RESP CELL MOL, V21, P710, DOI 10.1165/ajrcmb.21.6.3751; Qiao YY, 2016, NEOPLASIA, V18, P1, DOI 10.1016/j.neo.2015.11.009; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ryan CJ, 2013, CLIN CANCER RES, V19, P215, DOI 10.1158/1078-0432.CCR-12-2605; Smith DC, 2013, J CLIN ONCOL, V31, P412, DOI 10.1200/JCO.2012.45.0494; Smith M, 2016, J CLIN ONCOL, V34, P3005, DOI 10.1200/JCO.2015.65.5597; Smith NR, 2013, CLIN CANCER RES, V19, P6943, DOI 10.1158/1078-0432.CCR-13-1637; Sonpavde GP, 2020, EUR UROL ONCOL, V3, P540, DOI 10.1016/j.euo.2018.11.006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tazuke SI, 1998, P NATL ACAD SCI USA, V95, P10188, DOI 10.1073/pnas.95.17.10188; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; VanDeusen HR, 2020, MOL CANCER RES, V18, P1176, DOI 10.1158/1541-7786.MCR-19-1245; Vargas-Leal V, 2005, J IMMUNOL, V175, P2301, DOI 10.4049/jimmunol.175.4.2301; Varkaris A, 2016, CLIN CANCER RES, V22, P107, DOI 10.1158/1078-0432.CCR-15-0235; Vlachostergios PJ, 2017, CURR ONCOL REP, V19, DOI 10.1007/s11912-017-0593-6; Voellenkle C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24141; Yakes FM, 2011, MOL CANCER THER, V10, P2298, DOI 10.1158/1535-7163.MCT-11-0264; Zhang XL, 2020, J OPHTHALMOL, V2020, DOI 10.1155/2020/5905269; Zhang Y, 2010, IDRUGS, V13, P112	48	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245602	10.1371/journal.pone.0245602	http://dx.doi.org/10.1371/journal.pone.0245602			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471819	Green Published, gold			2022-12-26	WOS:000639428800001
J	Tsigebrhan, R; Fekadu, A; Medhin, G; Newton, CR; Prince, MJ; Hanlon, C				Tsigebrhan, Ruth; Fekadu, Abebaw; Medhin, Girmay; Newton, Charles R.; Prince, Martin J.; Hanlon, Charlotte			Comorbid mental disorders and quality of life of people with epilepsy attending primary health care clinics in rural Ethiopia	PLOS ONE			English	Article							SEIZURE SEVERITY; COMMUNITY SURVEY; SOCIAL SUPPORT; DEPRESSION; POPULATION; IMPACT; ADULTS; SCHIZOPHRENIA; DISTRESS; DISTRICT	Background Evidence from high-income countries demonstrates that co-morbid mental disorders in people with epilepsy adversely affect clinical and social outcomes. However, evidence from low-income countries is lacking. The objective of this study was to measure the association between co-morbid mental disorders and quality of life and functioning in people with epilepsy. Methods A facility-based, community ascertained cross-sectional survey was carried out in selected districts of the Gurage Zone, Southern Ethiopia. Participants were identified in the community and referred to primary health care (PHC) clinics. Those diagnosed by PHC workers were recruited. Co-morbid mental disorders were measured using a standardised, semi-structured clinical interview administered by mental health professionals. The main outcome, quality of life, was measured using the Quality of Life in Epilepsy questionnaire (QOLIE-10p). The secondary outcome, functional disability, was assessed using the 12-item World Health Organization Disability Assessment Schedule (WHODAS-2). Results The prevalence of comorbid mental disorders was 13.9%. Comorbid mental disorders were associated with poorer quality of life (Adjusted (Adj.) beta -13.27; 95% CI -23.28 to-3.26) and greater disability (multiplier of WHODAS-2 score 1.62; 95% CI 1.05, 2.50) after adjusting for hypothesised confounding factors. Low or very low relative wealth (Adj. beta = -12.57, 95% CI -19.94 to-5.20), higher seizure frequency (Adj.beta coef. = -1.92, 95% CI -2.83 to -1.02), and poor to intermediate social support (Adj. beta coef. = -9.66, 95% CI -16.51 to -2.81) were associated independently with decreased quality of life. Higher seizure frequency (multiplier of WHODAS-2 score 1.11; 95% CI 1.04, 1.19) was associated independently with functional disability. Conclusion Co-morbid mental disorders were associated with poorer quality of life and impairment, independent of level of seizure control. Integrated and comprehensive psychosocial care is required for better health and social outcomes of people with epilepsy.	[Tsigebrhan, Ruth; Fekadu, Abebaw; Medhin, Girmay; Hanlon, Charlotte] Addis Ababa Univ, Coll Hlth Sci, Ctr Innovat Drug Dev & Therapeut Trials Africa CD, Addis Ababa, Ethiopia; [Fekadu, Abebaw; Hanlon, Charlotte] Addis Ababa Univ, Dept Psychiat, WHO Collaborating Ctr Mental Hlth Res & Capac Bld, Sch Med,Coll Hlth Sci, Addis Ababa, Ethiopia; [Fekadu, Abebaw] Brighton & Sussex Med Sch, Dept Global Hlth & Infect, Brighton, E Sussex, England; [Medhin, Girmay] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Newton, Charles R.] Univ Oxford, Warneford Hosp, Dept Psychiat, Warneford Lane, Oxford, England; [Prince, Martin J.; Hanlon, Charlotte] Kings Coll London, Ctr Global Mental Hlth, Hlth Serv & Populat Res Dept, Inst Psychiat Psychol & Neurosci, London, England	Addis Ababa University; Addis Ababa University; University of Brighton; University of Sussex; Addis Ababa University; University of Oxford; University of London; King's College London	Tsigebrhan, R (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Ctr Innovat Drug Dev & Therapeut Trials Africa CD, Addis Ababa, Ethiopia.	r_tessera@yahoo.com		Tsigebrhan, Ruth/0000-0002-4957-5820; Medhin, Girmay/0000-0003-2146-4261	Wellcome Trust [104023/Z/14/A]; CDT-Africa; UK Department for International Development (DfID) [201446]; National Institute of Health Research (NIHR) Global Health Research Unit on Health System Strengthening in SubSaharan Africa, King's College London [GHRU 16/136/54]; AMARI as part of the DELTAS Africa Initiative [DEL-15-01]; MRC [MR/M025470/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); CDT-Africa; UK Department for International Development (DfID); National Institute of Health Research (NIHR) Global Health Research Unit on Health System Strengthening in SubSaharan Africa, King's College London(National Institute for Health Research (NIHR)); AMARI as part of the DELTAS Africa Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was conducted as part of a Wellcome Trust fellowship for RT (Grant Number 104023/Z/14/A) and a PhD fellowship from CDTAfrica The study was nested within the PRogramme for Improving Mental health carE (PRIME). PRIME was funded by the UK Department for International Development (DfID) [201446]. The views expressed in this article do not necessarily reflect the UK Government's official policies. CH is supported by the National Institute of Health Research (NIHR) Global Health Research Unit on Health System Strengthening in SubSaharan Africa, King's College London (GHRU 16/136/54). The views expressed are those of the author and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. CH additionally receives support from AMARI as part of the DELTAS Africa Initiative [DEL-15-01].	Adams G, 2004, J CLIN EPIDEMIOL, V57, P785, DOI 10.1016/j.jclinepi.2003.12.013; Adebayo PB, 2014, ACTA NEUROL SCAND, V129, P102, DOI 10.1111/ane.12146; Adebayo PB, 2014, ACTA NEUROL SCAND, V130, P387, DOI 10.1111/ane.12281; Alem A, 2009, SCHIZOPHRENIA BULL, V35, P646, DOI 10.1093/schbul/sbn029; [Anonymous], 2019, LANCET NEUROL; Baker GA, 1997, EPILEPSIA, V38, P353, DOI 10.1111/j.1528-1157.1997.tb01128.x; Boen H, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-27; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Cramer JA, 1996, EPILEPSIA, V37, P577, DOI 10.1111/j.1528-1157.1996.tb00612.x; Cramer JA, 2000, EPILEPSY RES, V41, P29, DOI 10.1016/S0920-1211(00)00127-3; CSA, 2007, SUMM STAT REP 2007 P; Dalgard OS, 2006, SOC PSYCH PSYCH EPID, V41, P444, DOI 10.1007/s00127-006-0051-5; Fawale MB, 2014, EPILEPSY BEHAV, V32, P9, DOI 10.1016/j.yebeh.2013.12.026; Fekadu A, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0628-y; Fekadu A, 2016, BRIT J PSYCHIAT, V208, pS4, DOI 10.1192/bjp.bp.114.153676; Fekadu A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-194; Fiest KM, 2017, NEUROLOGY, V88, P296, DOI 10.1212/WNL.0000000000003509; Garin O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-51; Hanlon C, 2020, EPIDEMIOL PSYCH SCI, V29, DOI 10.1017/S2045796019000398; Hanlon C, 2008, SOC PSYCH PSYCH EPID, V43, P653, DOI 10.1007/s00127-008-0342-0; Hanlon C, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1191-x; Hanlon C, 2015, J AFFECT DISORDERS, V186, P32, DOI 10.1016/j.jad.2015.07.015; Hermann B, 2009, EPILEPSY BEHAV, V15, pS11, DOI 10.1016/j.yebeh.2009.03.029; Jacobsson L., 2006, ETHIOP J HEALTH DEV, V20, P170; Jacoby A, 2008, EPILEPSY BEHAV, V12, P557, DOI 10.1016/j.yebeh.2007.11.013; Jehi L, 2011, EPILEPSY BEHAV, V22, P723, DOI 10.1016/j.yebeh.2011.08.039; Josephson CB., 2017, INT REV PSYCHIATR, V29, P409, DOI [10.1080/09540261.2017.1302412, DOI 10.1080/09540261.2017.1302412]; Kanner AM, 2017, SEIZURE-EUR J EPILEP, V49, P79, DOI 10.1016/j.seizure.2017.04.007; Lund C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001359; Mbewe EK, 2013, AM J TROP MED HYG, V89, P873, DOI 10.4269/ajtmh.13-0062; Mogga S, 2006, BRIT J PSYCHIAT, V189, P241, DOI 10.1192/bjp.bp.105.013417; Molenaar J, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02646-5; Mosaku KS, 2006, INT J PSYCHIAT MED, V36, P469, DOI 10.2190/R80G-580X-X1H2-6936; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Mwangala PN, 2018, EPILEPSY BEHAV, V85, P45, DOI 10.1016/j.yebeh.2018.05.032; Newton CR, 2012, LANCET, V380, P1193, DOI 10.1016/S0140-6736(12)61381-6; Olley B O, 2004, Afr J Med Med Sci, V33, P39; Organization WH, 2010, MHGAP INTERVENTION G; Rucker J, 2011, BRIT J PSYCHIAT, V199, P151, DOI 10.1192/bjp.bp.110.082925; Sajobi TT, 2015, EPILEPSIA, V56, P1463, DOI 10.1111/epi.13102; Sartorius N, 1996, SOC PSYCH PSYCH EPID, V31, P55, DOI 10.1007/BF00801901; Scott AJ, 2017, EPILEPSIA, V58, P973, DOI 10.1111/epi.13769; Senturk V, 2012, J AFFECT DISORDERS, V136, P340, DOI 10.1016/j.jad.2011.11.028; Shibre T, 2002, INT J SOC PSYCHIATR, V48, P200, DOI 10.1177/002076402128783244; Skevington SM, 2009, J COMMUNITY APPL SOC, V19, P33, DOI 10.1002/casp.978; Swinkels WAM, 2005, EPILEPSY BEHAV, V7, P37, DOI 10.1016/j.yebeh.2005.04.012; Tegegne MT., 2014, SCI J PUBLIC HLTH, V2, P378; Ustun T. B., 2010, Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0); Yildirim Z, 2018, EPILEPSY BEHAV, V78, P1, DOI 10.1016/j.yebeh.2017.10.030	49	3	3	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0238137	10.1371/journal.pone.0238137	http://dx.doi.org/10.1371/journal.pone.0238137			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM1OE	33471799	Green Published, gold			2022-12-26	WOS:000639428800051
J	Kimura, S; Sekiguchi, M; Watanabe, K; Hiwatarai, M; Seki, M; Yoshida, K; Isobe, T; Shiozawa, Y; Suzuki, H; Hoshino, N; Hayashi, Y; Oka, A; Miyano, S; Ogawa, S; Takita, J				Kimura, Shunsuke; Sekiguchi, Masahiro; Watanabe, Kentaro; Hiwatarai, Mitsuteru; Seki, Masafumi; Yoshida, Kenichi; Isobe, Tomoya; Shiozawa, Yusuke; Suzuki, Hiromichi; Hoshino, Noriko; Hayashi, Yasuhide; Oka, Akira; Miyano, Satoru; Ogawa, Seishi; Takita, Junko			Association of high-risk neuroblastoma classification based on expression profiles with differentiation and metabolism	PLOS ONE			English	Article							ACTIVATING MUTATIONS; ALK KINASE; CATECHOLAMINES; INHIBITION; DIAGNOSIS; DELETIONS; GENOMICS; THERAPY; PROLINE; DISEASE	Neuroblastoma, the most common extracranial solid malignancy among children, originates from undifferentiated neural crest cells (NCC). Despite recent intensified treatment, high-risk patients still have a high mortality rate. To explore a new therapeutic strategy, we performed an integrated genomic and transcriptomic analysis of 30 high-risk neuroblastoma cases. Based on the expression profiling of RNA sequencing, neuroblastoma was classified into Mesenchymal (MES; n = 5) and Noradrenergic (ADRN; n = 25) clusters, as previously reported in the super-enhancer landscape. The expression patterns in MES-cluster cases were similar to normal adrenal glands, with enrichment in secretion-related pathways, suggesting chromaffin cell-like features built from NCC-derived Schwann cell precursors (SCPs). In contrast, neuron-related pathways were enriched in the ADRN-cluster, indicating sympathoblast features reported to originate from NCC but not via SCPs. Thus, MES- and ADRN-clusters were assumed to be corresponding to differentiation pathways through SCP and sympathoblast, respectively. ADRN-cluster cases were further classified into MYCN- and ATRX-clusters, characterized by genetic alterations, MYCN amplifications and ATRX alterations, respectively. MYCN-cluster cases showed high expression of ALDH18A1, encoding P5CS related to proline production. As reported in other cancers, this might cause reprogramming of proline metabolism leading to tumor specific proline vulnerability candidate for a target therapy of metabolic pathway. In ATRX-cluster, SLC18A2 (VMAT2), an enzyme known to prevent cell toxicity due to the oxidation of dopamine, was highly expressed and VMAT2 inhibitor (GZ-793A) represented significant attenuation of cell growth in NB-69 cell line (high SLC18A2 expression, no MYCN amplification) but not in IMR-32 cell line (MYCN amplification). In addition, the correlation of VMAT2 expression with metaiodobenzylguanidine (MIBG) avidity suggested a combination of VMAT2 inhibitor and MIBG radiation for a novel potential therapeutic strategy in ATRX-cluster cases. Thus, targeting the characteristics of unique neuroblastomas may prospectively improve prognosis.	[Kimura, Shunsuke; Sekiguchi, Masahiro; Watanabe, Kentaro; Hiwatarai, Mitsuteru; Seki, Masafumi; Isobe, Tomoya; Hoshino, Noriko; Oka, Akira; Takita, Junko] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo, Japan; [Kimura, Shunsuke] Hiroshima Univ, Grad Sch Biomed Sci, Dept Pediat, Hiroshima, Japan; [Yoshida, Kenichi; Shiozawa, Yusuke; Suzuki, Hiromichi; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan; [Hayashi, Yasuhide] Jobu Univ, Inst Physiol & Med, Gunma, Japan; [Miyano, Satoru] Univ Tokyo, Human Genome Ctr Inst Med Sci, Tokyo, Japan; [Takita, Junko] Kyoto Univ, Dept Pediat, Kyoto, Japan	University of Tokyo; Hiroshima University; Kyoto University; University of Tokyo; Kyoto University	Takita, J (corresponding author), Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo, Japan.; Takita, J (corresponding author), Kyoto Univ, Dept Pediat, Kyoto, Japan.	jtakita@kuhp.kyoto-u.ac.jp	Seki, Masafumi/AAN-1025-2021; Kimura, Shunsuke/O-2037-2019; HIWATARI, Mitsuteru/HDM-0869-2022; Suzuki, Hiromichi/AAO-4664-2021	Seki, Masafumi/0000-0003-4671-7026; Kimura, Shunsuke/0000-0002-2158-467X; Suzuki, Hiromichi/0000-0002-8858-0294; Sekiguchi, Masahiro/0000-0002-7941-9319; Isobe, Tomoya/0000-0002-3487-3307; Hiwatari, Mitsuteru/0000-0003-3683-4472	Japan Society for the Promotion of Science (KAKENHI) [JP20H00528, JP26221308, JP19H05656]; Project for Cancer Research and Therapeutic Evolution (P-CREATE) from Japan Agency for Medical Research and Development (AMED) [JP18cm0106509h9903, JP19cm0106509h9904]; Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) from Japan Agency for Medical Research and Development (AMED) [JP20cm0106501h0005]; Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development (AMED) [JP19ck0106468h0001]; Princess Takamatsu Cancer Research Fund	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Project for Cancer Research and Therapeutic Evolution (P-CREATE) from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Princess Takamatsu Cancer Research Fund	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (KAKENHI; grant nos. JP20H00528 to J.T. and JP26221308 and JP19H05656 to S.O.); Project for Cancer Research and Therapeutic Evolution (P-CREATE; grant no. JP18cm0106509h9903 and JP19cm0106509h9904 to J.T.), Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT; grant no. JP20cm0106501h0005 to S.O.), and Practical Research for Innovative Cancer Control (grant no. JP19ck0106468h0001 to J.T.) from Japan Agency for Medical Research and Development (AMED) and Princess Takamatsu Cancer Research Fund (grant to J.T.). The other authors received no specific funding for this work.	Ackermann S, 2018, SCIENCE, V362, P1165, DOI 10.1126/science.aat6768; Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Boeva V, 2017, NAT GENET, V49, P1408, DOI 10.1038/ng.3921; Bresler SC, 2014, CANCER CELL, V26, P682, DOI 10.1016/j.ccell.2014.09.019; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Furlan A, 2017, SCIENCE, V357, P46, DOI 10.1126/science.aal3753; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Harenza JL, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.33; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; Kimura S, 2019, ONCOL LETT, V17, P3323, DOI 10.3892/ol.2019.9985; Ladenstein R, 2017, LANCET ONCOL, V18, P500, DOI 10.1016/S1470-2045(17)30070-0; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Loayza-Puch F, 2016, NATURE, V530, P490, DOI 10.1038/nature16982; Lonergan GJ, 2002, RADIOGRAPHICS, V22, P911, DOI 10.1148/radiographics.22.4.g02jl15911; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Maser T, 2017, CANCER MED-US, V6, P1341, DOI 10.1002/cam4.1065; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Mayor R, 2013, DEVELOPMENT, V140, P2247, DOI 10.1242/dev.091751; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Munoz P, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/920953; Mylonas E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13892-x; Peaston RT, 2004, ANN CLIN BIOCHEM, V41, P17, DOI 10.1258/000456304322664663; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saint-Andre V, 2016, GENOME RES, V26, P385, DOI 10.1101/gr.197590.115; Schleiermacher G, 2012, BRIT J CANCER, V107, P1418, DOI 10.1038/bjc.2012.375; Schleiermacher G, 2010, J CLIN ONCOL, V28, P3122, DOI 10.1200/JCO.2009.26.7955; Seki M, 2017, NAT GENET, V49, P1274, DOI 10.1038/ng.3900; Sekiguchi M, 2020, NPJ PRECIS ONCOL, V4, DOI 10.1038/s41698-020-0125-y; Shiraishi Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt126; Spitz R, 2003, CLIN CANCER RES, V9, P52; Takagi M, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/.inci/djx062; Temple W, 2016, EUR J NUCL MED MOL I, V43, P474, DOI 10.1007/s00259-015-3179-2; Tolbert VP, 2017, CURR OPIN GENET DEV, V42, P81, DOI 10.1016/j.gde.2017.03.008; Valentijn LJ, 2015, NAT GENET, V47, P1411, DOI 10.1038/ng.3438; van Groningen T, 2017, NAT GENET, V49, P1261, DOI 10.1038/ng.3899; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Volavka J, 2004, ANN NY ACAD SCI, V1036, P393, DOI 10.1196/annals.1330.023; Yoshizato T, 2017, BLOOD, V129, P2347, DOI 10.1182/blood-2016-12-754796	45	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245526	10.1371/journal.pone.0245526	http://dx.doi.org/10.1371/journal.pone.0245526			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465163	Green Published, gold			2022-12-26	WOS:000611969200040
J	Ojha, SK; Dimov, LD; Tadesse, W				Ojha, Santosh K.; Dimov, Luben D.; Tadesse, Wubishet			Growth, proportion, and distribution pattern of longleaf pine across southeastern forests and disturbance types: A change assessment for the period 1997-2018	PLOS ONE			English	Article							STAND; FIRE; DYNAMICS	The long-term decline of longleaf pine-dominated forests has received considerable attention among land managers and conservation professionals in the last few decades. The objective of this study was to investigate the change in and the variation of the proportion, density, growth, and dominance of longleaf pine across the longleaf pine ecosystems for the 1997-2018 period. We used two sets of measurements of 1,432 plots from the Forest Inventory and Analysis (FIA) dataset covering the entire current longleaf pine range. The relationship between disturbances and longleaf pine basal area ratio and basal area growth were analyzed using linear mixed modeling. Change detection maps were produced using the Inverse Distance Weighted (IDW) interpolation method. The total basal area and aboveground biomass per hectare increased in 64% and 72%, but decreased in 30% and 28% of the study area, respectively, between the first and last inventory intervals. Species richness and diversity generally decreased across the studied plots. Longleaf pine tree density and importance value percent increased during the period. However, longleaf basal area ratio and aboveground biomass ratio in the stands decreased on average by 5% during the period, although these ratios increased in some locations in southwest Georgia and near the west coast of Florida. The longleaf pine basal area ratio and aboveground biomass ratio decreased equally in 37%, and increased in 19% and 21% of the study area, respectively. There was about 79% variation in the ratio of longleaf pine basal area among plots. When compared to the natural control of no disturbance, fire disturbance was significantly associated with greater longleaf pine basal area ratio and basal area growth. Understanding the change in growth and distribution patterns of longleaf pine across its range over time is vital to restore these critical ecosystems.	[Ojha, Santosh K.; Tadesse, Wubishet] Alabama A&M Univ, Dept Biol & Environm Sci, Normal, AL 35762 USA; [Dimov, Luben D.] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT USA	Alabama A&M University; University of Vermont	Ojha, SK (corresponding author), Alabama A&M Univ, Dept Biol & Environm Sci, Normal, AL 35762 USA.	santosh.ojha@aamu.edu			Agriculture and Food Research Initiative (AFRI) Education and Workforce Development from the United States Department of Agriculture National Institute of Food and Agriculture [2019-67012-29700, 1019406]; "Modeling the Impacts of Climate Change, Population Growth, and Land Use Change on Water Availability in Tennessee River Basin" USDA-NIFA Evans-Allen Project [1008993]	Agriculture and Food Research Initiative (AFRI) Education and Workforce Development from the United States Department of Agriculture National Institute of Food and Agriculture; "Modeling the Impacts of Climate Change, Population Growth, and Land Use Change on Water Availability in Tennessee River Basin" USDA-NIFA Evans-Allen Project	This work was supported by the Agriculture and Food Research Initiative (AFRI) Education and Workforce Development, grant no. 2019-67012-29700/project accession no.number 1019406, from the United States Department of Agriculture National Institute of Food and Agriculture (SKO and LDD). We acknowledge the support for publication from "Modeling the Impacts of Climate Change, Population Growth, and Land Use Change on Water Availability in Tennessee River Basin" USDA-NIFA Evans-Allen Project, Accession #number 1008993 (WT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Anderson J., 2013, CLIMATE SE US VARIAB, P165; Bailey RG., 1980, DESCRIPTION ECOREGIO; Bechtold WA, 2005, USDA GEN TECH REP, DOI 10.1371/journal.pone.0044795; Bell BA, 2013, INTERMEDIATE PRIMER; Bell BA, 2013, MULTILEVEL MODEL PRI, P1; Bianchette TA, 2009, J COASTAL RES, P1622; Boyer W. D., 1998, General Technical Report - Southern Research Station, USDA Forest Service, P92; Boyer W.D., 1987, P 4 BIENN SO SILV RE P 4 BIENN SO SILV RE, P73; Brockway DG, 2005, IN ST WA MA, V3, P501; Brockway DG, 2005, RESTORATION LONGLEAF, P34; Burrill E. A, 2017, FOREST INVENTORY ANA; Carey JH, 1992, FIRE EFFECTS INFORM; Cartwright JM, 2016, ECOSYSTEM VULNERABIL, P4, DOI [10.3133/fs20163052, DOI 10.3133/FS20163052]; Costanza J, 2016, ASSESSING CLIMATE SE, P278, DOI [10.3133/ofr20161073, DOI 10.3133/OFR20161073]; Croker TC., 1975, REGENERATING LONGLEA; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; Fenneman N.M., 1946, PHYSIOGRAPHIC DIVISI; Florida Forest Service, 2019, FLOR FOR SERV REP SY; Gilliam FS, 1999, PLANT ECOL, V140, P15, DOI 10.1023/A:1009776020438; Guldin, 2012, CUMULATIVE WATERSHED, P7; Hammond DH, 2016, FOREST ECOL MANAG, V364, P154, DOI 10.1016/j.foreco.2015.12.029; Hogland J, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11151803; Iverson LR, 2019, FORESTS, V10, DOI 10.3390/f10110989; Jenkins JC, 2003, FOREST SCI, V49, P12; Johnsen KH, 2009, SOUTH J APPL FOR, V33, P178, DOI 10.1093/sjaf/33.4.178; JOSE S., 2007, LONGLEAF PINE ECOSYS; Kalivas DP, 2013, GEO-SPAT INF SCI, V16, P100, DOI 10.1080/10095020.2013.766398; Kush JS, 2006, STAND DYNAMICS LONGL, P90; LANDERS JL, 1995, J FOREST, V93, P39; McCarl BA, 2000, CLIMATE RES, V15, P195, DOI 10.3354/cr015195; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; MCMINN JW, 1992, CAN J FOREST RES, V22, P1179, DOI 10.1139/x92-156; McNab W.H., 2007, DESCRIPTION ECOLOGIC; Nowell HK, 2018, GEOPHYS RES LETT, V45, P7874, DOI 10.1029/2018GL078679; NRCS, 2020, LONGL PIN RANG; Ojha SK, 2020, FOREST SCI, V66, P242, DOI 10.1093/forsci/fxz072; Ojha SK, 2019, FOREST ECOL MANAG, V438, P151, DOI 10.1016/j.foreco.2019.02.013; Oswalt CM, 2012, HIST CURRENT CONDITI, P51, DOI [10.1016/j.pedhc.2010.06.014, DOI 10.1016/J.PEDHC.2010.06.014]; Outcalt KW, 2010, FOREST ECOL MANAG, V259, P1615, DOI 10.1016/j.foreco.2010.01.039; Peet RK, 2006, SPRINGER SER ENV MAN, P51; Ruark G. A., 1991, Southern Journal of Applied Forestry, V15, P73; Smith WB, 2002, ENVIRON POLLUT, V116, pS233, DOI 10.1016/S0269-7491(01)00255-X; US Census Bureau, 2010, GEOGR CART BOUND SHA; Vanderwel MC, 2013, GLOBAL CHANGE BIOL, V19, P1504, DOI 10.1111/gcb.12152; Wade DD, 2000, US FOR SERV RMRS-P, P53; Waldrop T.A., 1987, SE45 USDA FOR SERV S, P45; Way A, 2019, NEW GEORGIA ENCY; Woodall CW, 2009, FOREST ECOL MANAG, V257, P1434, DOI 10.1016/j.foreco.2008.12.013	48	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245218	10.1371/journal.pone.0245218	http://dx.doi.org/10.1371/journal.pone.0245218			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465105	Green Published, gold			2022-12-26	WOS:000611969200013
J	Shi, HD; Song, YL; Song, Z; Huang, C				Shi, Huadi; Song, Yuling; Song, Zhi; Huang, Chun			CKMT1B is a potential prognostic biomarker and associated with immune infiltration in Lower-grade glioma	PLOS ONE			English	Article							MITOCHONDRIAL CREATINE-KINASE; POOR-PROGNOSIS; MAST-CELLS; CANCER; EXPRESSION; TUMORS	Background Lower-grade glioma (LGG) is the most common histology identified in glioma. CKMT1B has not been investigated in glioma. The purpose of this research was to investigate the prognostic value of CKMT1B and its correlation with immune infiltration in LGG. Methods We used Gene Expression Profiling Interactive Analysis (GEPIA) to analyze the expression of CKMT1B in LGG. Univariate and multivariate Cox regression analyses were used to assess the effect of CKMT1B expression and screened variables on survival. The correlation between CKMT1B and immune infiltration was evaluated by TIMER and CIBERSORT. Moreover, the possible biological functions of CKMT1B were studied by GSEA. The statistical analysis was conducted by R software. Results The expression of CKMT1B was significantly lower than the normal samples in LGG. Low expression of CKMT1B predicts a worse prognosis. Multivariate Cox analyses revealed that CKMT1B might be an independent favorable prognostic indicator. TIMER analysis revealed that CKMT1B expression level was related to immune infiltration. CIBERSORT analysis showed that CKMT1B expression was positively related to the infiltration level of activated mast cells and negatively related to macrophage M2 in LGG. Moreover, GESA showed that multiple cancer-related and immune-related gene sets were enriched in the low-CKMT1B group in the top 5 of the most significant differences. Conclusion CKMT1B is a prognostic biomarker with potential applications and associated with immune infiltration in Lower-grade glioma.	[Shi, Huadi; Song, Yuling; Song, Zhi; Huang, Chun] Guangdong Med Univ, Zhanjiang Cent Hosp, Dept Internal Med, Zhanjiang, Guangdong, Peoples R China; [Shi, Huadi] Guangdong Med Univ, Dept Oncol, Zhanjiang, Guangdong, Peoples R China	Guangdong Medical University; Guangdong Medical University	Song, YL (corresponding author), Guangdong Med Univ, Zhanjiang Cent Hosp, Dept Internal Med, Zhanjiang, Guangdong, Peoples R China.	song_yuling1985@163.com			Science and Technology Project of Zhanjiang City [190712174542055]	Science and Technology Project of Zhanjiang City	This work was supported by the Science and Technology Project of Zhanjiang City (No. 190712174542055).	Ali HR, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002194; Amamoto R, 2016, J CANCER, V7, P50, DOI 10.7150/jca.13207; Bense RD, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw192; Blum A, 2018, CELL, V173, P530, DOI 10.1016/j.cell.2018.03.059; Chen YL, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0408-0; Cimpean AM, 2017, CRIT REV ONCOL HEMAT, V115, P23, DOI 10.1016/j.critrevonc.2017.04.009; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Kekelidze T, 2001, J NEUROSCI RES, V66, P866, DOI 10.1002/jnr.10060; Komi DEA, 2020, CLIN REV ALLERG IMMU, V58, P313, DOI 10.1007/s12016-019-08753-w; Lan R L, 2018, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V53, P524, DOI 10.3760/cma.j.issn.1673-0860.2018.07.008; Li LF, 2016, INT J CANCER, V139, P2261, DOI 10.1002/ijc.30289; Li PP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10101-7; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Liu XY, 2017, BIOMED PHARMACOTHER, V95, P55, DOI 10.1016/j.biopha.2017.08.003; Longo V, 2018, CLIN EXP MED, V18, P319, DOI 10.1007/s10238-018-0493-6; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma RH, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1118599; Martin KR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15816; Meurette O, 2020, ADV EXP MED BIOL, V1223, P1, DOI 10.1007/978-3-030-35582-1_1; Najafi M, 2019, J CELL BIOCHEM, V120, P2756, DOI 10.1002/jcb.27646; Nechushtan H, 2010, INT J BIOCHEM CELL B, V42, P551, DOI 10.1016/j.biocel.2009.12.015; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Onda T, 2006, BRIT J CANCER, V94, P698, DOI 10.1038/sj.bjc.6602986; Pencik J, 2016, CYTOKINE, V87, P26, DOI 10.1016/j.cyto.2016.06.017; Petty AJ, 2019, J CLIN INVEST, V129, P5151, DOI 10.1172/JCI128644; Pouratian N, 2010, CURR NEUROL NEUROSCI, V10, P224, DOI 10.1007/s11910-010-0105-7; Qian XL, 2012, BIOCHEM BIOPH RES CO, V427, P60, DOI 10.1016/j.bbrc.2012.08.147; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Uranbileg B, 2014, INT J CANCER, V134, P2189, DOI 10.1002/ijc.28547; Viaccoz A, 2012, CURR OPIN ONCOL, V24, P694, DOI 10.1097/CCO.0b013e328357f503; Wang D, 2019, CANCER LETT, V452, P244, DOI 10.1016/j.canlet.2019.03.040; Wang HY, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1122157; Yang L, 2019, INT J CANCER, V145, P1099, DOI 10.1002/ijc.32151; Yang L, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0430-2; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	37	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245524	10.1371/journal.pone.0245524	http://dx.doi.org/10.1371/journal.pone.0245524			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465115	gold, Green Published			2022-12-26	WOS:000611969200037
J	Chan, CS; Sarvet, AL; Basu, A; Koenen, K; Keyes, KM				Chan, Caitlin S.; Sarvet, Aaron L.; Basu, Archana; Koenen, Karestan; Keyes, Katherine M.			Associations of intimate partner violence and financial adversity with familial homelessness in pregnant and postpartum women: A 7-year prospective study of the ALSPAC cohort	PLOS ONE			English	Article							HOUSING INSTABILITY; MEDIATING ROLE; UNITED-STATES; HEALTH; PREVALENCE; MOTHERS; ABUSE; RISK	Objective To determine whether emotional and physical intimate partner violence (IPV) and financial adversity increase risk of incident homelessness in pregnancy and the post-partum period. Study design Data were drawn from the Avon Longitudinal Study of Parents and Children, which starting in 1990 mailed questionnaires to 14,735 mothers in the UK, over 7 years from pregnancy onwards. Marginal structural models and multiple imputation were used to address time-varying confounding of the primary variables, testing for interaction between concurrent emotional/physical IPV and financial adversity, and adjusted for baseline age, ethnicity, education, partner's alcohol use, parity, depression, and social class. Results Emotional IPV (HR 1.44 (1.13,1.84)), physical IPV (HR 2.05 (1.21,3.49)), and financial adversity (HR 1.59 (1.44,1.77)) each predicted a multiplicative increase in the discrete-time hazard of incident homelessness. We identified joint effects for concurrent emotional IPV and financial adversity (HR 2.09 (1.35,3.22)) and concurrent physical IPV and financial adversity (HR 2.79 (1.21,6.44)). We further identified a temporary decline in self-reported physical IPV among mothers during pregnancy and up to 8 months post-partum. Conclusions Emotional and physical IPV and financial adversity independently and jointly increase the risk of incident homelessness. The effects of emotional and physical IPV are comparable to or greater than the risk of financial adversity. Homelessness prevention policies should consider IPV victims as high-risk, regardless of financial status. Furthermore, self-reported physical IPV declines temporarily during pregnancy and up to 8 months post-partum. Screening for IPV in this period may miss high-risk individuals.	[Chan, Caitlin S.; Sarvet, Aaron L.; Basu, Archana; Koenen, Karestan] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Keyes, Katherine M.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; Columbia University	Chan, CS (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	cac115@mail.harvard.edu	Chan, Caitlin/GPK-6180-2022; Chan, Caitlin/GPC-6128-2022	Chan, Caitlin/0000-0001-8979-3112	UK Medical Research Council [217065/Z/19/Z]; Wellcome [217065/Z/19/Z]; Wellcome Trust [WT092830/Z/10/Z]; NIMH [U01MH110925, T32 MH 017119]; MRC [MC_PC_19009] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome; Wellcome Trust(Wellcome TrustEuropean Commission); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and Caitlin Chan will serve as guarantor for the contents of this paper. A comprehensive list of grants funding is available on the ALSPAC website. This research was specifically funded by Wellcome Trust (Grant ref: WT092830/Z/10/Z Funder URL: https://wellcome.org/grant-funding) This study was supported in part by NIMH grants U01MH110925 (AB and KCK) and T32 MH 017119 (ALS) (Funder URL: https://www.nimh.nih.gov/index.shtml) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AE, 2012, VIOLENCE AGAINST WOM, V18, P1345, DOI 10.1177/1077801212474294; Agrawal A, 2014, MATERN CHILD HLTH J, V18, P1985, DOI 10.1007/s10995-014-1444-9; [Anonymous], 2018, TABL 782 HOUS TYP TE; Bassuk E, 2004, VIOLENCE WOMEN FAMIL; BASSUK EL, 1988, AM J PUBLIC HEALTH, V78, P783, DOI 10.2105/AJPH.78.7.783; BASSUK EL, 1993, AM J ORTHOPSYCHIAT, V63, P340, DOI 10.1037/h0079443; Bowen E, 2005, BJOG-INT J OBSTET GY, V112, P1083, DOI 10.1111/j.1471-0528.2005.00653.x; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Budig MJ, 2001, AM SOCIOL REV, V66, P204, DOI 10.2307/2657415; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Charles P, 2007, J FAM VIOLENCE, V22, P609, DOI 10.1007/s10896-007-9112-0; Cochran T, 2007, HUNG HOM SURV; COX J, 1994, PERINATAL PSYCHIATRY, P115; Daoud N, 2016, WOMEN HEALTH, V56, P208, DOI 10.1080/03630242.2015.1086465; Dillon G, 2016, VIOLENCE AGAINST WOM, V22, P1597, DOI 10.1177/1077801216628689; Evans ML, 2020, NEW ENGL J MED, V383, P2302, DOI 10.1056/NEJMp2024046; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Golombok S, 2003, DEV PSYCHOL, V39, P20, DOI 10.1037//0012-1649.39.1.20; Goodman LA, 2009, TRAUMA VIOLENCE ABUS, V10, P306, DOI 10.1177/1524838009339754; Groves AK, 2015, MATERN CHILD HLTH J, V19, P487, DOI 10.1007/s10995-014-1528-6; Harrykissoon SD, 2002, ARCH PEDIAT ADOL MED, V156, P325, DOI 10.1001/archpedi.156.4.325; Heise L, 2002, INT J GYNECOL OBSTET, V78, pS5, DOI 10.1016/S0020-7292(02)00038-3; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Homelessness USICo, 2018, FOC FAM CHILDR; Kuijpers KF, 2012, J TRAUMA STRESS, V25, P179, DOI 10.1002/jts.21676; Long SM, 2015, J COMMUNITY PSYCHOL, V43, P1019, DOI 10.1002/jcop.21729; Martin SL, 2001, JAMA-J AM MED ASSOC, V285, P1581, DOI 10.1001/jama.285.12.1581; Mazza M, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113046; Meyer S, 2016, GLOB PUBLIC HEALTH, V11, P198, DOI 10.1080/17441692.2015.1047390; Montgomery AE, 2018, AM J PREV MED, V54, P584, DOI 10.1016/j.amepre.2018.01.020; Pavao J, 2007, AM J PREV MED, V32, P143, DOI 10.1016/j.amepre.2006.10.008; Petrosky E, 2017, MMWR-MORBID MORTAL W, V66, P741, DOI 10.15585/mmwr.mm6628a1; Rees S, 2011, JAMA-J AM MED ASSOC, V306, P513, DOI 10.1001/jama.2011.1098; Robins JM, 1999, SYNTHESE, V121, P151, DOI 10.1023/A:1005285815569; Sacco LN, 2019, VIOLENCE WOMEN ACT V; Silva EP, 2011, REV SAUDE PUBL, V45, P1044, DOI [10.1590/S0034-89102011005000017, 10.1590/s0034-89102011005000074, 10.1590/S0034-89102011005000074]; Tjaden P, 2000, EXTENT NATURE CONSEQ; UCLA A, 2016, INT SAS; von Hippel PT, 2009, SOCIOL METHODOL, V39, P265, DOI 10.1111/j.1467-9531.2009.01215.x; Wolper Andrea, 1995, WOMENS RIGHTS HUMAN, P126	41	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245507	10.1371/journal.pone.0245507	http://dx.doi.org/10.1371/journal.pone.0245507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4XD	33449965	Green Published, gold			2022-12-26	WOS:000609991600034
J	D'Aquila, PS; Galistu, A				D'Aquila, Paolo S.; Galistu, Adriana			Further characterization of the effect of the prototypical antidepressant imipramine on the microstructure of licking for sucrose	PLOS ONE			English	Article							REUPTAKE INHIBITOR PAROXETINE; RATS LICKING; BEHAVIORAL ACTIVATION; D2-LIKE RECEPTORS; DOPAMINE D1-LIKE; RESPONSES; PIMOZIDE; MODEL; TERM	We previously reported that treatment with the prototypical antidepressant imipramine induced a dose-dependent reduction of the ingestion of a 10% sucrose solution, due to reduction of the licking burst number, thus suggesting reduced motivation and/or increased satiation. Importantly, the experimental sessions were performed in an alternate order, either 1-h or 24-h after imipramine administration. The observation that imipramine effect was more pronounced in the "1-h after-treatment" sessions, i.e. at the time of the brain drug C-max, led us to suggest that it was likely related to brain drug levels at testing time. However, such an experimental design does not allow to rule out the alternative possibility that the observed effect might be due to post-session administration, as previously observed with memantine. To determine whether imipramine-induced decrease of sucrose ingestion could be observed even in absence of post-session administration, we examined the effect of a daily 22 day treatment with imipramine (5, 10 and 20 mg/kg). In the first half of the treatment period all behavioural tests were performed 1-h after administration. In the second half of the treatment period, tests were performed alternatively either 1-h or 24-h after imipramine administration. The results confirm that imipramine reduces sucrose ingestion due to a reduction of the licking burst number. Most importantly, these results demonstrate that this effect does not require imipramine post-session administration, since it was present before the beginning of post-session administrations. This supports the interpretation of the reduction of sucrose ingestion as a consequence of reduced motivation and/or increased satiation. Thus, these findings, taken together with the results of our previous study, might be relevant in explaining the effects of imipramine in models of drug-seeking and in body weight gain reduction in rats, but not in accounting for the antidepressant therapeutic effect. At variance with the results of our previous study, an increase in burst size was present in the first half of the treatment period, which might be interpreted as a prohedonic effect and/or as a compensatory effect.	[D'Aquila, Paolo S.; Galistu, Adriana] Univ Sassari, Dipartimento Sci Biomed, Sassari, Italy	University of Sassari	D'Aquila, PS (corresponding author), Univ Sassari, Dipartimento Sci Biomed, Sassari, Italy.	dsfpaolo@uniss.it	D'Aquila, Paolo S./H-5389-2011	D'Aquila, Paolo S./0000-0002-7885-9988	Fondazione di Sardegna [U500.2013/AI.424]; University of Sassari	Fondazione di Sardegna(Fondazione Banco di Sardegna); University of Sassari	This work was supported by the Fondazione di Sardegna (U500.2013/AI.424.MGB to PSD) and by the University of Sassari Research Fund 2020 (PSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthurs J, 2017, PHYSIOL BEHAV, V180, P39, DOI 10.1016/j.physbeh.2017.08.005; ASIN KE, 1992, PSYCHOPHARMACOLOGY, V109, P415, DOI 10.1007/BF02247717; Baird JP, 2005, BEHAV NEUROSCI, V119, P983, DOI 10.1037/0735-7044.119.4.983; Berridge KC, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01647; Collu M, 1994, POL J PHARMACOL, V46, P315; Collu M, 1996, BEHAV PHARMACOL, V7, P18; D'Aquila PS, 2020, PHYSIOL BEHAV, V224, DOI 10.1016/j.physbeh.2020.113032; D'Aquila PS, 2019, PSYCHOPHARMACOLOGY, V236, P3497, DOI 10.1007/s00213-019-05317-w; D'Aquila PS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177705; D'Aquila PS, 2012, PHARMACOL BIOCHEM BE, V101, P99, DOI 10.1016/j.pbb.2011.12.004; D'Aquila PS, 2010, NEUROPHARMACOLOGY, V58, P1085, DOI 10.1016/j.neuropharm.2010.01.017; D'Aquila PS, 2000, EUR J PHARMACOL, V405, P365, DOI 10.1016/S0014-2999(00)00566-5; D'Aquila PS, 2006, BEHAV PHARMACOL, V17, P101, DOI 10.1097/01.fbp.0000190682.92607.0c; D'Aquila PS, 2001, EUR J PHARMACOL, V416, P107, DOI 10.1016/S0014-2999(01)00876-7; DAVIS JD, 1992, BEHAV NEUROSCI, V106, P217, DOI 10.1037/0735-7044.106.1.217; Duman CH, 2015, NEUROSCI LETT, V601, P20, DOI 10.1016/j.neulet.2015.01.022; Dwyer DM, 2012, Q J EXP PSYCHOL, V65, P371, DOI 10.1080/17470218.2011.652969; FIBIGER HC, 1981, SCIENCE, V214, P683, DOI 10.1126/science.7197394; FOWLER SC, 1992, BEHAV NEUROSCI, V106, P386, DOI 10.1037/0735-7044.106.2.386; Galistu A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239270; Galistu A, 2020, PSYCHOPHARMACOLOGY, V237, P103, DOI 10.1007/s00213-019-05348-3; Galistu A, 2011, PSYCHOPHARMACOLOGY, V216, P411, DOI 10.1007/s00213-011-2237-0; GRAMLING SE, 1986, PHARMACOL BIOCHEM BE, V25, P219, DOI 10.1016/0091-3057(86)90256-X; GRAMLING SE, 1984, PHARMACOL BIOCHEM BE, V21, P617, DOI 10.1016/S0091-3057(84)80047-7; Higgs S, 1998, PSYCHOPHARMACOLOGY, V139, P342, DOI 10.1007/s002130050725; Higgs S, 2011, PSYCHOPHARMACOLOGY, V214, P941, DOI 10.1007/s00213-010-2106-2; Hoflich A, 2019, INT J NEUROPSYCHOPH, V22, P105, DOI 10.1093/ijnp/pyy081; Jastrzebska J, 2017, BRAIN RES, V1673, P30, DOI 10.1016/j.brainres.2017.07.016; Johnson AW, 2018, INT J DEV NEUROSCI, V64, P38, DOI 10.1016/j.ijdevneu.2017.06.012; KOE BK, 1990, J CLIN PSYCHIAT, V51, P13; Liao R M, 1995, Chin J Physiol, V38, P65; Mathes CM, 2013, CHEM SENSES, V38, P211, DOI 10.1093/chemse/bjs096; Mathes CM, 2011, CHEM SENSES, V36, P515, DOI 10.1093/chemse/bjr011; Menard C, 2016, NEUROSCIENCE, V321, P138, DOI 10.1016/j.neuroscience.2015.05.053; O'Donnell JM, 2017, GOODMAN GILMANS PHAR, P267; PAPP M, 1988, PHARMACOL BIOCHEM BE, V30, P889, DOI 10.1016/0091-3057(88)90115-3; Robbins TW, 2007, PSYCHOPHARMACOLOGY, V191, P433, DOI 10.1007/s00213-006-0528-7; SATO Y, 1994, BRIT J PHARMACOL, V112, P625, DOI 10.1111/j.1476-5381.1994.tb13120.x; Smith GP, 2001, APPETITE, V36, P84, DOI 10.1006/appe.2000.0371; Spector AC, 1998, BEHAV NEUROSCI, V112, P678, DOI 10.1037/0735-7044.112.3.678; Upton G., 2006, DICT STAT; Willner P, 2017, NEUROBIOL STRESS, V6, P78, DOI 10.1016/j.ynstr.2016.08.002; Winer BJ, 1971, STAT PRINCIPLES EXPT	43	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245559	10.1371/journal.pone.0245559	http://dx.doi.org/10.1371/journal.pone.0245559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449955	Green Published, gold			2022-12-26	WOS:000609991600051
J	Bueno, GD; Gatto, KP; Gazolla, CB; Leivas, PT; Struett, MM; Moura, M; Bruschi, DP				Bueno, Gislayne de Paula; Gatto, Kaleb Pretto; Gazolla, Camilla Borges; Leivas, Peterson T.; Struett, Michelle M.; Moura, Mauricio; Bruschi, Daniel Pacheco			Cytogenetic characterization and mapping of the repetitive DNAs in Cycloramphus bolitoglossus (Werner, 1897): More clues for the chromosome evolution in the genus Cycloramphus (Anura, Cycloramphidae)	PLOS ONE			English	Article							5S RIBOSOMAL-RNA; NUCLEOLUS ORGANIZER REGIONS; SATELLITE DNA; MICROSATELLITE DISTRIBUTION; MOLECULAR-ORGANIZATION; MULTIGENE FAMILIES; DEATH EVOLUTION; ATLANTIC FOREST; RDNA; CHARACIFORMES	Cycloramphus bolitoglossus (Werner, 1897) is a rare species with a low population density in the Serra do Mar region of Parana and Santa Catarina, in southern Brazil. Currently, it has been assigned to the Near Threatened (NT) category in the Brazilian List of Endangered Animal Species. Here, we described the karyotype of this species for the first time and investigated the patterns of some repetitive DNA classes in the chromosomes using molecular cytogenetic approaches. We isolated, sequenced and mapped the 5S rDNA and the satellite DNA PcP190 of C. bolitoglossus, as well as mapped the telomeric sequences and seven microsatellites motifies [(GA)(15), (CA)(15), (GACA)(4), (GATA)(8), (CAG)(10), (CGC)(10), and (GAA)](10). Cycloramphus bolitoglossus has 2n = 26 chromosomes and a fundamental number (FN) equal to 52, with a highly conserved karyotype compared to other genus members. Comparative cytogenetic under the phylogenetic context of genus allowed evolutionary interpretations of the morphological changes in the homologs of pairs 1, 3, and 6 along with the evolutionary history of Cycloramphus. Two subtypes of 5S rDNA type II were isolated in C. bolitoglossus genome, and several comparative analysis suggests mixed effects of concerted and birth-and-death evolution acting in this repetitive DNA. The 5S rDNA II subtype "a" and "b" was mapped on chromosome 1. However, their different position along chromosome 1 provide an excellent chromosome marker for future studies. PcP190 satellite DNA, already reported for species of the families Hylidae, Hylodidae, Leptodactylidae, and Odontophrynidae, is scattered throughout the C. bolitoglossus genome, and even non-heterochromatic regions showed hybridization signals using the PcP190 probe. Molecular analysis suggests that PcP190 satellite DNA exhibit a high-level of homogenization of this sequence in the genome of C. bolitoglossus. The PcP190 satDNA from C. bolitoglossus represents a novel sequence group, compared to other anurans, based on its hypervariable region. Overall, the present data on repetitive DNA sequences showed pseudogenization evidence and corroborated the hypothesis of the emergence of satDNA from rDNA 5S clusters. These two arguments that reinforced the importance of the birth-and-death evolutionary model to explain 5S rDNA patterns found in anuran genomes.	[Bueno, Gislayne de Paula; Gazolla, Camilla Borges; Bruschi, Daniel Pacheco] Univ Fed Parana UFPR, Dept Genet, Setor Ciencias Biol, Curitiba, Parana, Brazil; [Gatto, Kaleb Pretto] Univ Estadual Paulista, Inst Biociencias, Dept Biodivers, UNESP, Rio Claro, SP, Brazil; [Gatto, Kaleb Pretto] Univ Estadual Paulista, Inst Biociencias, Ctr Aquicultura, UNESP, Rio Claro, SP, Brazil; [Leivas, Peterson T.] Univ Posit UP, Curso Ciencias Biol, Curitiba, Parana, Brazil; [Struett, Michelle M.; Moura, Mauricio] Univ Fed Parana UFPR, Dept Zool, Setor Ciencias Biol, Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Positivo; Universidade Federal do Parana	Bruschi, DP (corresponding author), Univ Fed Parana UFPR, Dept Genet, Setor Ciencias Biol, Curitiba, Parana, Brazil.	danielpachecobruschi@gmail.com	Gatto, Kaleb Pretto/ABH-1420-2021; Bueno, Gislayne/GYU-8725-2022; Moura, Mauricio O/B-1063-2013	Moura, Mauricio O/0000-0001-7948-2986; Struett, Michelle Micarelli/0000-0001-8862-0957; Pretto Gatto, Kaleb/0000-0002-2261-229X				Bardella VB, 2018, GENE, V646, P153, DOI 10.1016/j.gene.2017.12.030; BECAK ML, 1970, CYTOGENETICS, V9, P225, DOI 10.1159/000130093; Bruschi DP, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-70; Sassi FDC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20122944; Cazaux B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-124; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Chistiakov DA, 2006, AQUACULTURE, V255, P1, DOI 10.1016/j.aquaculture.2005.11.031; Cholak LR, 2020, GENET MOL BIOL, V43, DOI [10.1590/1678-4685-gmb-2019-0364, 10.1590/1678-4685-GMB-2019-0364]; da Silva MJ, 2020, CYTOGENET GENOME RES, V160, P141, DOI 10.1159/000506531; de Sa FP, 2020, EVOLUTION, V74, P459, DOI 10.1111/evo.13879; DENARO L, 1972, Journal of Herpetology, V6, P71, DOI 10.2307/1563095; Dimarco E, 2012, GENE, V508, P21, DOI 10.1016/j.gene.2012.07.067; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Dover G, 2002, TRENDS GENET, V18, P587, DOI 10.1016/S0168-9525(02)02789-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eirin-Lopez JM, 2012, GENOME DYNAM, V7, P170, DOI 10.1159/000337119; Ernetti JR, 2019, GENET MOL BIOL, V42, DOI [10.1590/1678-4685-GMB-2019-0151, 10.1590/1678-4685-gmb-2019-0151]; Fedoriw AM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002468; Feliciello I, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005466; Feliciello I, 2015, GENOME BIOL EVOL, V7, P228, DOI 10.1093/gbe/evu280; Frederiksen S, 1997, CYTOGENET CELL GENET, V76, P101, DOI 10.1159/000134523; Freire R, 2010, J MOL EVOL, V70, P413, DOI 10.1007/s00239-010-9341-3; Frost D.R., 2020, AMPHIBIAN SPECIES WO, DOI [10.5531/db.vz.0001, DOI 10.5531/DB.VZ.0001]; Gatto KP, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00301; Gatto KP, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020160; Gatto KP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156176; Green D. M, 1991, AMPHIBIAN CYTOGENETI, P431, DOI [DOI 10.1016/B978-0-12-297880-7.50021-4, 10.1016/B978-0-12-297880-7.50021-4]; Guedes Jhonny J.M., 2019, Herpetology Notes, V12, P113; Guerra M, 2012, CITOGENETICA MOL PRO; Guo WJ, 2009, GENOMICS, V93, P323, DOI 10.1016/j.ygeno.2008.12.009; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HEYER WR, 1988, BIOTROPICA, V20, P230, DOI 10.2307/2388238; Heyer WR, 2004, CYCLORAMPHUS BOLITOG, DOI [10.2305/IUCN.UK.2004.RLTS.T56359A11452397.en, DOI 10.2305/IUCN.UK.2004.RLTS.T56359A11452397.EN]; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; ICMBio, 2018, LISTA VERMELHA DAS E; KING M, 1976, CHROMOSOMA, V54, P75, DOI 10.1007/BF00331835; Kirov I, 2017, COMP CYTOGENET, V11, P747, DOI 10.3897/CompCytogen.v11i4.20830; Kubat Z, 2008, GENOME, V51, P350, DOI 10.1139/G08-024; Kuhn GCS, 2012, MOL BIOL EVOL, V29, P7, DOI 10.1093/molbev/msr173; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kumke K, 2016, CYTOGENET GENOME RES, V148, P68, DOI 10.1159/000444873; Lima AMX, 2010, J HERPETOL, V44, P360, DOI 10.1670/08-185.1; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Lopez-Flores I, 2012, GENOME DYNAM, V7, P1, DOI 10.1159/000337118; Martins C, 2002, CYTOGENET GENOME RES, V98, P78, DOI 10.1159/000068542; Martins C, 2001, GENETICA, V111, P439, DOI 10.1023/A:1013799516717; Martins Cesar, 2004, P335; Martins C, 2006, GENETICA, V127, P133, DOI 10.1007/s10709-005-2674-y; Merlo MA, 2013, J MOL EVOL, V76, P83, DOI 10.1007/s00239-013-9541-8; Nascimento J, 2010, GENETICA, V138, P1127, DOI 10.1007/s10709-010-9501-9; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Noleto RB, 2011, ZOOL ANZ, V250, P205, DOI 10.1016/j.jcz.2011.04.001; Pasolini P, 2006, J MOL EVOL, V62, P564, DOI 10.1007/s00239-005-0118-z; PENDAS AM, 1994, CYTOGENET CELL GENET, V67, P31, DOI 10.1159/000133792; PETERSON RC, 1980, CELL, V20, P131, DOI 10.1016/0092-8674(80)90241-X; Pinhal D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-151; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Pucci MB, 2016, CYTOGENET GENOME RES, V149, P182, DOI 10.1159/000447959; Rebordinos L, 2013, CYTOGENET GENOME RES, V141, P103, DOI 10.1159/000354871; Rodrigues DS, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-17; Ruiz-Ruano FJ, 2015, CHROMOSOMA, V124, P221, DOI 10.1007/s00412-014-0492-7; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scacchetti PC, 2015, CYTOGENET GENOME RES, V146, P136, DOI 10.1159/000437165; SCHMID M, 1978, CHROMOSOMA, V66, P361, DOI 10.1007/BF00328536; Schmid M, 2015, CYTOGENET GENOME RES, V145, P201, DOI 10.1159/000433481; Silva Ana Paula Zampieri, 2001, Revista Brasileira de Zoologia, V18, P111; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Targueta CP, 2018, ESSENTIAL GUIDE CYTO, P1; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Travenzoli NM, 2019, CYTOGENET GENOME RES, V158, P213, DOI 10.1159/000501754; Vierna J, 2013, HEREDITY, V111, P410, DOI 10.1038/hdy.2013.63; Vittorazzi SE, 2011, CYTOGENET GENOME RES, V134, P101, DOI 10.1159/000325540; Vittorazzi SE, 2016, COMP CYTOGENET, V10, P311, DOI 10.3897/CompCytogen.v10i2.9319; Vittorazzi SE, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0111-x	75	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0245128	10.1371/journal.pone.0245128	http://dx.doi.org/10.1371/journal.pone.0245128			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439901	Green Published, gold			2022-12-26	WOS:000609985300004
J	Karthik, D; Suresh, J; Reddy, YR; Sharma, GRK; Ramana, JV; Gangaraju, G; Reddy, YPK; Yasaswini, D; Adegbeye, MJ; Reddy, PRK				Karthik, D.; Suresh, J.; Reddy, Y. Ravindra; Sharma, G. R. K.; Ramana, J. V.; Gangaraju, G.; Pradeep Kumar Reddy, Y.; Yasaswini, D.; Adegbeye, M. J.; Reddy, P. Ravi Kanth			Farming systems in sheep rearing: Impact on growth and reproductive performance, nutrient digestibility, disease incidence and heat stress indices	PLOS ONE			English	Article							ERYTHROCYTE OSMOTIC FRAGILITY; FEED-INTAKE; PARAMETERS; CURVE; CATTLE; TEMPERATURE; CONCENTRATE; RESPONSES; DISTRICT; TRAITS	The experiment was conducted with an intent to know the effect of different farming systems on the growth performance, nutrient digestibility coefficients, reproductive traits, disease incidence, heat stress indices, and cost economics of Nellore sheep. The study includes two parallel trials to prevent the influence of age on heat stress indices (panting score and erythrocyte osmotic fragility (EOF)). One hundred and twenty lambs (60 ram-lambs and 60 ewe-lambs) were allotted in a randomized block design under extensive, semi-intensive, and intensive systems for trial I, whereas trial II include eighteen rams assigned to the three respective farming systems in a completely randomised design. Both, season (summer) and grazing practice increased the panting score and EOF. The heat stress indices were positively correlated (P<0.01) with dry-bulb temperature and temperature-humidity index (THI) and inversely correlated (P<0.01) to relative humidity. Allotting the sheep to intensive system increased (P<0.001) weight gain and average daily gain with higher effect in males compared to females. The parameters of asymptotic weight (A), integration constant (B), and maturation rate were higher for intensive males. The male Nellore lambs had higher asymptotic weight and lower maturity rate than females, irrespective of the rearing system. Intensive sheep revealed a higher dry matter intake, digestibility coefficients, feed conversion ratio. The instantaneous bite mass (IBM) was higher for Commelina benghalensis, while instantaneous bite frequency (IBF), instantaneous intake rate (IIR) were higher for Cyanodon dactylon and amaranthus viridis, respectively. The proportion of intakes were highest for Stylo hemata followed by Cynodon dactylon and Tridax procumbens species. No differences were observed for the weight at puberty, oestrus cycle length, oestrus duration, conception percent, gestation period, and lambing percent in three rearing systems; however, the age at puberty was lower (P<0.001) and the birth weight was higher (P<0.001) for sheep reared under intensive farming system. Highest disease incidence was observed in rainy and winter seasons, particularly in sheep reared under extensive system. The capital expenditure was same for the three rearing systems, while the recurring expenditure was higher for Intensive farming system. The gross income and net income were higher for intensive system on account of higher weight gains. However, the higher returns per rupee of expenditure project the extensive farming as an ideal rearing system for small farmers and entrepreneurs with a low initial capital.	[Karthik, D.; Reddy, Y. Ravindra] Sri Venkateswara Vet Univ, Dept Livestock Prod Management, Coll Vet Sci, Tirupati, Andhra Pradesh, India; [Suresh, J.; Pradeep Kumar Reddy, Y.] Sri Venkateswara Vet Univ, Coll Vet Sci, Ctr Continuing Vet Educ & Commun, Tirupati, Andhra Pradesh, India; [Sharma, G. R. K.] Sri Venkateswara Vet Univ, Dept Vet & Anim Husb Extens Educ, Coll Vet Sci, Tirupati, Andhra Pradesh, India; [Ramana, J. V.] Sri Venkateswara Vet Univ, Coll Vet Sci, Examinat, Tirupati, Andhra Pradesh, India; [Gangaraju, G.] Sri Venkateswara Vet Univ, Livestock Res Stn, Palamaner, India; [Yasaswini, D.] Sri Venkateswara Vet Univ, Dept Vet Med, Coll Vet Sci, Tirupati, Andhra Pradesh, India; [Adegbeye, M. J.] Joseph Ayo Babalola Univ, Dept Anim Sci & Livestock Prod, Coll Agr & Nat Sci, Ilesha, Osun State, Nigeria; [Reddy, P. Ravi Kanth] Vet Dispensary, Anim Husb Dept, Taticherla, Andhra Pradesh, India	Sri Venkateswara Veterinary University; Sri Venkateswara Veterinary University; Sri Venkateswara Veterinary University; Sri Venkateswara Veterinary University; Sri Venkateswara Veterinary University; Sri Venkateswara Veterinary University	Reddy, PRK (corresponding author), Vet Dispensary, Anim Husb Dept, Taticherla, Andhra Pradesh, India.	ravi.nutrition001@gmail.com	POONOORU, RAVIKANTH REDDY/AAU-5144-2020	POONOORU, RAVIKANTH REDDY/0000-0003-2451-2783; Adegbeye, Moyosore/0000-0001-6485-2489; Yasaswini, Duvvuru/0000-0003-1348-270X				Abbas Meamarbashi, 2013, Asian Journal of Experimental Biological Sciences, V4, P322; Abegaz S, 2010, ARCH TIERZUCHT, V53, P85, DOI 10.5194/aab-53-85-2010; Adegbeye MJ, 2020, J CLEAN PROD, V242, DOI 10.1016/j.jclepro.2019.118319; Adenkola A. Y., 2011, Journal of Animal and Plant Sciences (JAPS), V11, P1474; Agreil C, 2005, APPL ANIM BEHAV SCI, V91, P35, DOI 10.1016/j.applanim.2004.08.029; [Anonymous], 2017, J ANIMAL RES NUTR; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2007, J ART PSYCHOTHERAPY, V3, P83; AOAC, 1990, OFFICIAL METHODS ANA; Aslani MR, 2003, VET RES COMMUN, V27, P53, DOI 10.1023/A:1022010707704; Bharambe V Y, 2012, INDIAN J HILL FARMIN, V25, P44; Bonnet OJF, 2015, ANIM PROD SCI, V55, P339, DOI 10.1071/AN14540; Brown-Brandl TM, 2006, LIVEST SCI, V105, P57, DOI 10.1016/j.livsci.2006.04.025; Carnovale F, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10040694; Carrasco S, 2008, J MEAT SCI, V80, P239; Chaturvedi O. H., 2010, Indian Journal of Small Ruminants, V16, P97; Chellapandian M., 2003, Indian Journal of Small Ruminants, V9, P71; Chien-Ho Wang, 2019, Sustainability, V11, DOI 10.3390/su11030744; Chinnamani K, 2018, J ENTOMOLOGY ZOOLOGI, V6, P86; Dass G, 2007, INDIAN J ANIM SCI, V77, P763; El-Hag F. M., 2007, Tropical Science, V47, P26, DOI 10.1002/ts.188; Habibu B, 2014, VET MED-CZECH, V59, P479, DOI 10.17221/7778-VETMED; Habibu B, 2017, ARCH ANIM BREED, V60, P33, DOI 10.5194/aab-60-33-2017; Hassan M. R., 2010, Bangladesh Veterinarian, V27, P26, DOI 10.3329/bvet.v27i1.5912; Herrero M., 2019, IPCC SPECIAL REPORT; Hojjati F, 2018, J APPL ANIM RES, V46, P499, DOI 10.1080/09712119.2017.1348949; Hossein-Zadeh NG, 2015, SMALL RUMINANT RES, V130, P60, DOI 10.1016/j.smallrumres.2015.07.014; Hyder I, 2017, SHEEP PRODUCTION ADA; IBM Corp, REL 2015 IBM SPSS ST; Kabir MHB, 2011, AFR J MICROBIOL RES, V5, P346; Kopuzlu S, 2014, J APPL ANIM RES, V42, P228, DOI 10.1080/09712119.2013.842479; Kotb A R, 1972, Nutr Abstr Rev, V42, P813; Kuldeep Porwal, 2006, Indian Journal of Small Ruminants, V12, P67; Lacy Brian E, 2011, Gastroenterol Hepatol (N Y), V7, P729; Lees AM, 2019, INT J BIOMETEOROL, V63, P973, DOI 10.1007/s00484-019-01711-3; Li CQ, 2015, ANIM NUTR, V1, P324, DOI 10.1016/j.aninu.2015.11.004; Malhado CHM, 2009, SMALL RUMINANT RES, V84, P16, DOI 10.1016/j.smallrumres.2009.04.006; Marai IFM, 2007, SMALL RUMINANT RES, V71, P1, DOI 10.1016/j.smallrumres.2006.10.003; Marai IFM, 2001, TROP ANIM HEALTH PRO, V33, P451, DOI 10.1023/A:1012772311177; Mekibib Berhanu, 2019, J Vet Med, V2019, P5169040, DOI 10.1155/2019/5169040; Mohammadi Y, 2019, SMALL RUMINANT RES, V177, P117, DOI 10.1016/j.smallrumres.2019.06.012; Mohanty A., 2016, J NANOMEDICINE RES, V2, P1; Munoz CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218603; Naqvi SMK, 2001, SMALL RUMINANT RES, V39, P199, DOI 10.1016/S0921-4488(00)00200-5; Nasrullah, 2013, PAK J ZOOL, V45, P107; Nejad JG, 2017, J ANIM SCI TECHNOL, V59, DOI 10.1186/s40781-017-0140-x; Padua JT, 1997, LIVESTOCK ENVIRONMENT V, VOLS I AND II, P809; Papanastasiou DK, INT C AGR ENG AGENG; Patel Geeta, 2013, Journal of Parasitic Diseases, V37, P173, DOI 10.1007/s12639-012-0154-8; Patel K. M., 2004, International Journal of Agriculture and Biology, V6, P860; Pereira DH, 2008, ANIM FEED SCI TECH, V140, P52, DOI 10.1016/j.anifeedsci.2007.02.012; Raineri C, 2015, ASIAN AUSTRAL J ANIM, V28, P1209, DOI 10.5713/ajas.14.0585; Rajendran D, 2012, ANIM NUTR FEED TECHN, V12, P63; Rana M., 2014, J BANGLADESH AGRIC U, V12, P91, DOI 10.3329/jbau.v12i1.21253; Ravagnolo O, 2000, J DAIRY SCI, V83, P2120, DOI 10.3168/jds.S0022-0302(00)75094-6; Reddy PRK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220252; Reddy PR, 2022, BIOL RHYTHM RES, V53, P234, DOI 10.1080/09291016.2019.1629087; SAS, 2013, SAS US GUID VERS 9 4; Savage DB, 2008, AUST J EXP AGR, V48, P1044, DOI 10.1071/EA08056; Sejian V, 2010, INT J BIOMETEOROL, V54, P653, DOI 10.1007/s00484-010-0341-1; Singh N. P., 2003, Indian Journal of Small Ruminants, V9, P142; Souza JD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219343; Stegelmeier BL, 2013, HASCHEK AND ROUSSEAUX'S HANDBOOK OF TOXICOLOGIC PATHOLOGY, VOL 1-3, 3RD EDITION, P1259, DOI 10.1016/B978-0-12-415759-0.00040-6; Sundaram SM, 2002, INDIAN J ANIM SCI, V72, P904; Tadesse D, 2019, J APPL ANIM RES, V47, P492, DOI 10.1080/09712119.2019.1674658; Tekleyohannes Berhanu, 2013, Kasetsart Journal, Natural Science, V47, P74; TILLEY J. M. A., 1963, JOUR BRIT GRASSLAND SOC, V18, P104; Yaqub LS, 2014, J EQUINE VET SCI, V34, P1324, DOI 10.1016/j.jevs.2014.09.015; Yiakoulaki MD, 1997, ANIM FEED SCI TECH, V67, P163, DOI 10.1016/S0377-8401(96)01134-0; Zohara BF, 2014, IOSR J AGR VET SCI, V7, P64	70	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0244922	10.1371/journal.pone.0244922	http://dx.doi.org/10.1371/journal.pone.0244922			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439900	Green Published, gold			2022-12-26	WOS:000609985300016
J	Dagenais, P; Aegerter, CM				Dagenais, Paule; Aegerter, Christof M.			Hydrodynamic stress maps on the surface of a flexible fin-like foil	PLOS ONE			English	Article							PARTICLE TRACKING VELOCIMETRY; PRESSURE FIELD; FLOW-FIELDS; CAUDAL FIN; LOCOMOTOR FUNCTION; LARVAL ZEBRAFISH; BOUNDARY-LAYER; RAINBOW-TROUT; WAKE DYNAMICS; CHUB MACKEREL	We determine the time dependence of pressure and shear stress distributions on the surface of a pitching and deforming hydrofoil from measurements of the three dimensional flow field. Period-averaged stress maps are obtained both in the presence and absence of steady flow around the foil. The velocity vector field is determined via volumetric three-component particle tracking velocimetry and subsequently inserted into the Navier-Stokes equation to calculate the total hydrodynamic stress tensor. In addition, we also present a careful error analysis of such measurements, showing that local evaluations of stress distributions are possible. The consistency of the force time-dependence is verified using a control volume analysis. The flapping foil used in the experiments is designed to allow comparison with a small trapezoidal fish fin, in terms of the scaling laws that govern the oscillatory flow regime. As a complementary approach, unsteady Euler-Bernoulli beam theory is employed to derive instantaneous transversal force distributions on the flexible hydrofoil from its deflection and the results are compared to the spatial distributions of hydrodynamic stresses obtained from the fluid velocity field.	[Dagenais, Paule; Aegerter, Christof M.] Univ Zurich, Phys Inst, Zurich, Switzerland	University of Zurich	Aegerter, CM (corresponding author), Univ Zurich, Phys Inst, Zurich, Switzerland.	aegerter@physik.uzh.ch		Aegerter, Christof/0000-0002-7200-7987	swiss national science foundation (SNF) as part of a Sinergia grant; CanDoc fellowship of the Forschungskredit of the University of Zurich (UZH)	swiss national science foundation (SNF) as part of a Sinergia grant(Swiss National Science Foundation (SNSF)); CanDoc fellowship of the Forschungskredit of the University of Zurich (UZH)	This work was funded by the swiss national science foundation (SNF) as part of a Sinergia grant awarded to CMA as well as a CanDoc fellowship of the Forschungskredit of the University of Zurich (UZH) to PD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alben S, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4709477; Anderson EJ, 2001, J EXP BIOL, V204, P81; Anderson JM, 1998, J FLUID MECH, V360, P41, DOI 10.1017/S0022112097008392; [Anonymous], 2016, J ELECTROMYOGRAPHY K, V27, pI; [Anonymous], [No title captured]; [Anonymous], 2018, J VASC INTERV RADIOL, V29, pS105; Aris R, 1990, DOVER BOOKS MATH; BAINBRIDGE R, 1958, J EXP BIOL, V35, P109; Batchelor G.K., 2000, INTRO FLUID DYNAMICS, DOI DOI 10.1017/CBO9780511800955; Baur T, 1999, 3 INT WORKSH PIV SAN, P101; Bhattacharya S, 2020, EXP FLUIDS, V61, DOI 10.1007/s00348-020-03021-6; Bin Asad SMS, 2019, WATER-SUI, V11, DOI 10.3390/w11040650; BLICKHAN R, 1992, NATURWISSENSCHAFTEN, V79, P220, DOI 10.1007/BF01227131; Bohl DG, 2009, J FLUID MECH, V620, P63, DOI 10.1017/S0022112008004734; Boushaki T, 2017, FLOW MEAS INSTRUM, V54, P46, DOI 10.1016/j.flowmeasinst.2016.12.003; Budick SA, 2000, J EXP BIOL, V203, P2565; Charonko JJ, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/10/105401; Cheng B, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0984; Cheng B, 2013, EXP FLUIDS, V54, DOI 10.1007/s00348-012-1423-0; Dabiri J. O., J EXPT BIOL, V217; Dabiri JO, 2006, J FLUID MECH, V547, P105, DOI 10.1017/S0022112005007585; Dabiri JO, 2005, J EXP BIOL, V208, P3519, DOI 10.1242/jeb.01813; Dabiri JO, 2006, J EXP BIOL, V209, P2025, DOI 10.1242/jeb.02242; Dagenais P, 2020, J FLUID MECH, V901, DOI 10.1017/jfm.2020.489; Dai H, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4764047; David L, 2012, EXP FLUIDS, V52, P857, DOI 10.1007/s00348-011-1148-5; David MJ, 2017, J FLUID MECH, V828, P70, DOI 10.1017/jfm.2017.491; de Kat R, 2013, MEAS SCI TECHNOL, V24, DOI 10.1088/0957-0233/24/2/024002; de Kat R, 2012, EXP FLUIDS, V52, P1089, DOI 10.1007/s00348-011-1237-5; de Kat R., 2010, 15 INT S APPL LAS TE; Dewey PA, 2013, J FLUID MECH, V732, P29, DOI 10.1017/jfm.2013.384; Dewey PA, 2012, J FLUID MECH, V691, P245, DOI 10.1017/jfm.2011.472; Dickinson MH, 1996, AM ZOOL, V36, P537; Dickinson MH, 1996, J EXP BIOL, V199, P2085; Donley JM, 2000, J EXP BIOL, V203, P3103; Dracos TH, 1996, ERCOFTAC SER, V4, P155; Drucker EG, 1999, J EXP BIOL, V202, P2393; Drucker EG, 2005, J EXP BIOL, V208, P4479, DOI 10.1242/jeb.01922; Drucker EG, 2001, J EXP BIOL, V204, P2943; Elsinga GE, 2006, EXP FLUIDS, V41, P933, DOI 10.1007/s00348-006-0212-z; Esposito CJ, 2012, J EXP BIOL, V215, P56, DOI 10.1242/jeb.062711; Flammang BE, 2011, P ROY SOC B-BIOL SCI, V278, P3670, DOI 10.1098/rspb.2011.0489; Flammang BE, 2011, BIOL LETTERS, V7, P695, DOI 10.1098/rsbl.2011.0282; Fujisawa N, 2008, J VISUAL-JAPAN, V11, P281, DOI 10.1007/BF03182195; Fujisawa N, 2006, MICROFLUID NANOFLUID, V2, P447, DOI 10.1007/s10404-006-0088-5; Gemmell BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9790; Ghaemi S., EXPT FLUIDS, V53; Godoy-Diana R, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016308; Green MA, 2011, J FLUID MECH, V685, P117, DOI 10.1017/jfm.2011.286; Hefetz D., 1999, 3 INT WORKSH PART IM, P671; Hong Y, 2008, J AIRCRAFT, V45, P1206, DOI 10.2514/1.34100; Inman J. D., 2013, ENG VIBRATIONS, V4th; Jakobsen ML, 1997, MEAS SCI TECHNOL, V8, P1502, DOI 10.1088/0957-0233/8/12/013; Jardin T, 2009, EXP FLUIDS, V46, P847, DOI 10.1007/s00348-009-0632-7; JAYNE BC, 1995, J EXP BIOL, V198, P585; Joshi P, 2014, J FLUID MECH, V748, P36, DOI 10.1017/jfm.2014.147; Kancharala AK, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/3/036011; Kang CK, 2011, J FLUID MECH, V689, P32, DOI 10.1017/jfm.2011.428; Kefayati S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098209; Kenney J. F., 1962, MATH STAT 1, V3rd, P32; Khodarahmi I, 2010, IEEE ENG MED BIO, P2594, DOI 10.1109/IEMBS.2010.5626676; Kim D, 2010, EXP FLUIDS, V49, P329, DOI 10.1007/s00348-010-0872-6; Konig D, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00227; KOOCHESFAHANI MM, 1989, AIAA J, V27, P1200, DOI 10.2514/3.10246; Kopman V, 2013, PROCEEDINGS OF THE ASME 2013 DYNAMIC SYSTEMS AND CONTROL CONFERENCE (DSCC2013), VOL. 1, DOI 10.1115/DSCC2013-3787; Koschatzky V, 2011, EXP FLUIDS, V50, P863, DOI 10.1007/s00348-010-0935-8; Koschatzky V., 2012, 16 INT S APPL LAS TE; Kunze S, 2011, EXP FLUIDS, V50, P747, DOI 10.1007/s00348-010-0981-2; Laskari A, 2016, EXP FLUIDS, V57, DOI 10.1007/s00348-016-2129-5; Lauder GV, 2007, EXP FLUIDS, V43, P641, DOI 10.1007/s00348-007-0357-4; Lauder GV, 2000, AM ZOOL, V40, P101, DOI 10.1668/0003-1569(2000)040[0101:FOTCFD]2.0.CO;2; Leftwich MC, 2012, J EXP BIOL, V215, P416, DOI 10.1242/jeb.061440; Liu X., 2016, INSTANTANEOUS PRESSU, DOI [10.2514/6.2016-1049, DOI 10.2514/6.2016-1049]; Liu X., PHYS FLUIDS PHYS FLU, V20; Liu XF, 2006, EXP FLUIDS, V41, P227, DOI 10.1007/s00348-006-0152-7; Liu XF, 2020, MEAS SCI TECHNOL, V31, DOI 10.1088/1361-6501/ab6c28; Liu XF, 2018, AIAA J, V56, P3897, DOI 10.2514/1.J056168; Liu XF, 2013, J FLUID MECH, V728, P417, DOI 10.1017/jfm.2013.275; Lorenzoni V., 2009, AEROACOUSTIC ANAL RO; Losilevskii G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163517; Lucas KN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189225; MAAS HG, 1993, EXP FLUIDS, V15, P133, DOI 10.1007/BF00190953; Marais C., J FLUID MECH, V710; Masoud H, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056304; McClure J., EXPT FLUIDS, V58; McHenry MJ, 2005, J EXP BIOL, V208, P2289, DOI 10.1242/jeb.01642; Michelin S, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3177356; Milne-Thomson L. M., 1973, DOVER BOOKS AERONAUT; Muller UK, 2008, J EXP BIOL, V211, P196, DOI 10.1242/jeb.005629; Muir RE, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170077; Muller UK, 2006, FISH FISH, V7, P84, DOI 10.1111/j.1467-2979.2006.00210.x; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; Muller UK, 1997, J EXP BIOL, V200, P2893; Muller UK, 2001, J EXP BIOL, V204, P2751; Muller UK, 2000, J EXP BIOL, V203, P193; Murai Y, 2007, MEAS SCI TECHNOL, V18, P2491, DOI 10.1088/0957-0233/18/8/026; Mwaffo V, 2017, PEERJ, V5, DOI 10.7717/peerj.4041; Nauen JC, 2002, J EXP BIOL, V205, P3271; Nauen JC, 2002, J EXP BIOL, V205, P1709; Noca F, FM965 GALCIT; Palstra AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014483; Panciroli R, 2013, EXP FLUIDS, V54, DOI 10.1007/s00348-013-1630-3; Paraz F, 2016, PHYS FLUIDS, V28, DOI 10.1063/1.4939499; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Peng JF, 2007, J EXP BIOL, V210, P685, DOI 10.1242/jeb.02692; Pereira F. J. A., 2008, 14 INT S APPL LAS TE; Pereira F, 2006, MEAS SCI TECHNOL, V17, P1680, DOI 10.1088/0957-0233/17/7/006; Prandtl L., 1952, ESSENTIALS FLUID DYN; Puri S., 2018, THESIS; Puri S, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.171777; Quinn DB, 2015, J FLUID MECH, V767, P430, DOI 10.1017/jfm.2015.35; Raffel M., 2018, PARTICLE IMAGE VELOC; Raffel M., 1998, EXP FLUID MECH; Ragni D, 2012, EXP FLUIDS, V52, P463, DOI 10.1007/s00348-011-1236-6; Ragni D, 2011, EXP FLUIDS, V51, P361, DOI 10.1007/s00348-011-1057-7; Ragni D, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/1/017003; Ragni D, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/7/074005; Ramananarivo S, 2011, P NATL ACAD SCI USA, V108, P5964, DOI 10.1073/pnas.1017910108; Ren ZY, 2016, INT J ADV ROBOT SYST, V13, DOI 10.5772/63571; Ren ZY, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/1/016008; Rival D, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/1/016008; Rosic MLN, 2017, BIOINSPIR BIOMIM, V12, DOI 10.1088/1748-3190/aa5113; Sambilay V. C. J., INTERRELATIONSHIPS S, V8; Schnipper T, 2009, J FLUID MECH, V633, P411, DOI 10.1017/S0022112009007964; Sfakianakis DG, 2011, ENVIRON BIOL FISH, V90, P421, DOI 10.1007/s10641-010-9751-5; Shinde SY, 2014, J FLUID MECH, V757, P231, DOI 10.1017/jfm.2014.480; Singleman C, 2014, ZEBRAFISH, V11, P396, DOI 10.1089/zeb.2014.0976; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Spagnolie SE, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3383215; STAMHUIS EJ, 1995, J EXP BIOL, V198, P283; Suryadi A., EXPT FLUIDS EXP FLUI, V51; Tangorra JL, 2010, J EXP BIOL, V213, P4043, DOI 10.1242/jeb.048017; Tangorra JL, 2007, IEEE J OCEANIC ENG, V32, P533, DOI 10.1109/JOE.2007.903362; Taylor GK, 2003, NATURE, V425, P707, DOI 10.1038/nature02000; Triantafyllou MS, 2000, ANNU REV FLUID MECH, V32, P33, DOI 10.1146/annurev.fluid.32.1.33; Triantafyllou MS, 2004, IEEE J OCEANIC ENG, V29, P585, DOI 10.1109/JOE.2004.833216; Tronchin T, 2015, EXP FLUIDS, V56, DOI 10.1007/s00348-014-1870-x; Tytell ED, 2006, J EXP BIOL, V209, P1516, DOI 10.1242/jeb.02154; Tytell ED, 2004, J EXP BIOL, V207, P3265, DOI 10.1242/jeb.01139; Tytell ED, 2008, J EXP BIOL, V211, P187, DOI 10.1242/jeb.008128; Unal MF, 1997, J FLUID STRUCT, V11, P965, DOI 10.1006/jfls.1997.0111; Van der Kindere JW, 2019, EXP FLUIDS, V60, DOI 10.1007/s00348-019-2678-5; van Leeuwen JL, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0479; van Oudheusden BW, 2008, EXP FLUIDS, V45, P657, DOI 10.1007/s00348-008-0546-9; van Oudheusden BW, 2007, EXP FLUIDS, V43, P153, DOI 10.1007/s00348-007-0261-y; van Oudheusden BW, 2006, EXP FLUIDS, V40, P988, DOI 10.1007/s00348-006-0149-2; van Oudheusden BW, 2013, MEAS SCI TECHNOL, V24, DOI 10.1088/0957-0233/24/3/032001; Violato D, 2011, EXP FLUIDS, V50, P1057, DOI 10.1007/s00348-010-1011-0; Voesenek CJ, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.149583; Wang J, 2019, EXP FLUIDS, V60, DOI 10.1007/s00348-019-2700-y; Wang ZJ, 2013, INT J ADV ROBOT SYST, V10, DOI 10.5772/56801; Wang ZY, 2017, J PHYS CONF SER, V822, DOI 10.1088/1742-6596/822/1/012055; Wang ZY, 2016, EXP FLUIDS, V57, DOI 10.1007/s00348-016-2189-6; Whitaker S., 1968, INTRO FLUID MECH; Windsor P.S, 2008, THESIS; Windsor SP, 2010, J EXP BIOL, V213, P3819, DOI 10.1242/jeb.040741; Zhang C, 2017, J FLUID MECH, V823, P345, DOI 10.1017/jfm.2017.299; Zhu R., 2017, PROPULSIVE PERFORMAN, DOI [10.2514/6.2017-3980, DOI 10.2514/6.2017-3980]	159	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0244674	10.1371/journal.pone.0244674	http://dx.doi.org/10.1371/journal.pone.0244674			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434237	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000609979700011
J	Knapp, GC; Alatise, O; Olopade, B; Samson, M; Olasehinde, O; Wuraola, F; Odujoko, OO; Komolafe, AO; Arije, OO; Castle, PE; Smith, JJ; Weiser, MR; Kingham, TP				Knapp, Gregory C.; Alatise, Olusegun; Olopade, Bolatito; Samson, Marguerite; Olasehinde, Olalekan; Wuraola, Funmilola; Odujoko, Oluwole O.; Komolafe, Akinwunmi O.; Arije, Olujide O.; Castle, Philip E.; Smith, J. Joshua; Weiser, Martin R.; Kingham, T. Peter			Feasibility and performance of the fecal immunochemical test (FIT) for average-risk colorectal cancer screening in Nigeria	PLOS ONE			English	Article							DIAGNOSTIC-ACCURACY; COLONOSCOPY; POLYPS; ADENOMAS	Introduction There is a paucity of prospective data on the performance of the fecal immunochemical test (FIT) for colorectal cancer (CRC) screening in sub-Saharan Africa. The aim of this exploratory analysis was to evaluate the feasibility and performance of FIT in Nigeria. Methods This was a prospective, single-arm study. A convenience sample of asymptomatic, average-risk individuals between 40-75 years of age were enrolled at Obafemi Awolowo University Teaching Hospital. Study participants returned in 48 hours with a specimen for ova and parasite (O&P) and qualitative FIT (50ug/g) testing. Participants with a positive FIT had follow-up colonoscopy and those with intestinal parasites were provided treatment. Results Between May-June 2019, 379 individuals enrolled with a median age of 51 years (IQR 46-58). In total, 87.6% (n = 332) returned for FIT testing. FIT positivity was 20.5% (95% CI = 16.3%-25.2%). Sixty-one (89.7%) of participants with a positive FIT had a follow-up colonoscopy (n = 61), of whom 9.8% (95%CI:3.7-20.2%) had an adenoma and 4.9% (95%CI:1.0-13.7%) had advanced adenomas. Presence of intestinal parasites was inversely related to FIT positivity (6.5% with vs. 21.1% without parasites, p = 0.05). Eighty-two percent of participants found the FIT easy to use and 100% would recommend the test to eligible family or friends if available. Conclusions Asymptomatic, FIT-based CRC screening was feasible and well tolerated in this exploratory analysis. However, the high FIT positivity and low positive predictive value for advanced neoplasia raises concerns about its practicality and cost effectiveness in a low-resource setting such as Nigeria.				knappg@pm.me	Olasehinde, Olalekan/AFK-8552-2022; Arije, Olujide/J-6002-2016	Knapp, Gregory/0000-0002-9305-1709; Arije, Olujide/0000-0001-5192-3698				Abdulkareem FB, 2012, HISTOPATHOLOGY, V61, P74; Alatise O, 2019, NIGERIAN J GASTRO HE, V11, P42; Alatise OI, 2014, NIGER J CLIN PRACT, V17, P756, DOI 10.4103/1119-3077.144391; Alatise OI, 2018, CANCER-AM CANCER SOC, V124, P2766, DOI 10.1002/cncr.31399; Calderwood AH, 2016, WORLD J GASTRO ONCOL, V8, P826, DOI 10.4251/wjgo.v8.i12.826; Chang LC, 2017, CLIN GASTROENTEROL H, V15, P872, DOI 10.1016/j.cgh.2016.07.029; Cubiella J, 2014, UNITED EUR GASTROENT, V2, P522, DOI 10.1177/2050640614553285; Duduyemi, 2020, AM J MED BIOL RES, V1, P145, DOI [10.12691/ajmbr-1-4-7, DOI 10.12691/AJMBR-1-4-7]; Graham Alice, 2012, J Glob Health, V2, P020404, DOI 10.7189/jogh.02.020204; Health FMo, 2018, INT CANC CONTR PARTN; Irabor David O, 2017, Niger Med J, V58, P87, DOI 10.4103/0300-1652.234076; Irabor DO, 2017, ANTICANCER RES, V37, P2649, DOI 10.21873/anticanres.11612; Ismaila BO, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.22.1865; Knapp GC, 2019, WORLD J SURG, V43, P2674, DOI 10.1007/s00268-019-05100-0; Labaeka EO, 2020, JCO GLOB ONCOL, V6, P525, DOI 10.1200/JGO.19.00340; Laiyemo AO, 2016, INT J CANCER, V138, P1033, DOI 10.1002/ijc.29843; Lee JK, 2014, ANN INTERN MED, V160, P171, DOI 10.7326/M13-1484; Lopes Gilberto, 2019, J Glob Oncol, V5, P1, DOI 10.1200/JGO.18.00213; MABOGUNJE OA, 1978, DIS COLON RECTUM, V21, P474, DOI 10.1007/BF02586730; Ng SC, 2013, ALIMENT PHARM THER, V38, P835, DOI 10.1111/apt.12446; Olokoba Abdulfatai Bamidele, 2013, Niger Med J, V54, P111, DOI 10.4103/0300-1652.110044; Oluyemi A, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.333.9434; Quintero E, 2014, GASTROENTEROLOGY, V147, P1021, DOI 10.1053/j.gastro.2014.08.004; Rex DK, 2015, AM J GASTROENTEROL, V110, P72, DOI 10.1038/ajg.2014.385; Robertson DJ, 2017, GASTROINTEST ENDOSC, V85, P2, DOI 10.1016/j.gie.2016.09.025; Saluja S, 2014, SURGERY, V156, P305, DOI 10.1016/j.surg.2014.03.036; Sharp L, 2012, BRIT J CANCER, V106, P805, DOI 10.1038/bjc.2011.580; van Doorn SC, 2015, ENDOSCOPY, V47, P1011, DOI 10.1055/s-0034-1392412; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; Winawer SJ, 2011, J CLIN GASTROENTEROL, V45, P297, DOI 10.1097/MCG.0b013e3182098e07; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	31	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0243587	10.1371/journal.pone.0243587	http://dx.doi.org/10.1371/journal.pone.0243587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434195	Green Published, gold			2022-12-26	WOS:000609979700001
J	Ninomiya, K; Arimura, H; Chan, WY; Tanaka, K; Mizuno, S; Gowdh, NFM; Yaakup, NA; Liam, CK; Chai, CS; Ng, KH				Ninomiya, Kenta; Arimura, Hidetaka; Chan, Wai Yee; Tanaka, Kentaro; Mizuno, Shinichi; Gowdh, Nadia Fareeda Muhammad; Yaakup, Nur Adura; Liam, Chong-Kin; Chai, Chee-Shee; Ng, Kwan Hoong			Robust radiogenomics approach to the identification of EGFR mutations among patients with NSCLC from three different countries using topologically invariant Betti numbers	PLOS ONE			English	Article							CELL LUNG-CANCER; RISK-FACTORS; RADIOMICS; FEATURES; CT; ADENOCARCINOMA; CLASSIFICATION; PREDICTION; TEXTURE	Objectives To propose a novel robust radiogenomics approach to the identification of epidermal growth factor receptor (EGFR) mutations among patients with non-small cell lung cancer (NSCLC) using Betti numbers (BNs). Materials and methods Contrast enhanced computed tomography (CT) images of 194 multi-racial NSCLC patients (79 EGFR mutants and 115 wildtypes) were collected from three different countries using 5 manufacturers' scanners with a variety of scanning parameters. Ninety-nine cases obtained from the University of Malaya Medical Centre (UMMC) in Malaysia were used for training and validation procedures. Forty-one cases collected from the Kyushu University Hospital (KUH) in Japan and fifty-four cases obtained from The Cancer Imaging Archive (TCIA) in America were used for a test procedure. Radiomic features were obtained from BN maps, which represent topologically invariant heterogeneous characteristics of lung cancer on CT images, by applying histogram- and texture-based feature computations. A BN-based signature was determined using support vector machine (SVM) models with the best combination of features that maximized a robustness index (RI) which defined a higher total area under receiver operating characteristics curves (AUCs) and lower difference of AUCs between the training and the validation. The SVM model was built using the signature and optimized in a five-fold cross validation. The BN-based model was compared to conventional original image (OI)- and wavelet-decomposition (WD)-based models with respect to the RI between the validation and the test. Results The BN-based model showed a higher RI of 1.51 compared with the models based on the OI (RI: 1.33) and the WD (RI: 1.29). Conclusion The proposed model showed higher robustness than the conventional models in the identification of EGFR mutations among NSCLC patients. The results suggested the robustness of the BN-based approach against variations in image scanner/scanning parameters.	[Ninomiya, Kenta] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Div Med Quantum Sci, Fukuoka, Japan; [Arimura, Hidetaka] Kyushu Univ, Fac Med Sci, Dept Hlth Sci, Div Med Quantum Sci, Fukuoka, Japan; [Chan, Wai Yee; Gowdh, Nadia Fareeda Muhammad; Yaakup, Nur Adura; Ng, Kwan Hoong] Univ Malaya, Fac Med, Dept Biomed Imaging, Kuala Lumpur, Malaysia; [Tanaka, Kentaro] Kyushu Univ Hosp, Dept Resp Med, Fukuoka, Japan; [Mizuno, Shinichi] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Div Med Sci & Technol, Fukuoka, Japan; [Liam, Chong-Kin] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Chai, Chee-Shee] Univ Malaysia Sarawak, Fac Med & Hlth Sci, Dept Med, Sarawak, Malaysia	Kyushu University; Kyushu University; Universiti Malaya; Kyushu University; Kyushu University; Universiti Malaya; University of Malaysia Sarawak	Arimura, H (corresponding author), Kyushu Univ, Fac Med Sci, Dept Hlth Sci, Div Med Quantum Sci, Fukuoka, Japan.; Chan, WY (corresponding author), Univ Malaya, Fac Med, Dept Biomed Imaging, Kuala Lumpur, Malaysia.	arimurah@med.kyushu-u.ac.jp; waiyeec@ummc.edu.my	Liam, Chong-Kin/AAC-8475-2022; yee, chan wai/X-6470-2018; muhammad gowdh, nadia/ABH-0270-2022; YAAKUP, NUR ADURA/B-9409-2010	yee, chan wai/0000-0002-2718-3797; muhammad gowdh, nadia/0000-0002-1534-6034; YAAKUP, NUR ADURA/0000-0002-2863-3681; Liam, Chong-Kin/0000-0002-3639-9231; Ninomiya, Kenta/0000-0002-9566-4875	Center for Clinical and Translational Research of Kyushu University Hospital; JSPS KAKENHI [20K08084]	Center for Clinical and Translational Research of Kyushu University Hospital; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from Center for Clinical and Translational Research of Kyushu University Hospital and JSPS KAKENHI Grant Number 20K08084. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Angulo B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043842; Arimura H, 2018, J RADIAT RES, V59, P1, DOI [10.1093/jrr/rrx047, DOI 10.1093/JRR/RRX047]; Bakr S, 2017, CANC IMAG ARCH, DOI [10.7937/K9/TCIA.2017.7hs46-rv, DOI 10.7937/K9/TCIA.2017.7HS46-RV]; Bakr S, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.202; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chalkidou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124165; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Goldstraw P, 2016, J THORAC ONCOL, V11, P39, DOI 10.1016/j.jtho.2015.09.009; Han BH, 2017, LUNG CANCER, V113, P37, DOI 10.1016/j.lungcan.2017.08.021; HERMAN GT, 1992, IEEE COMPUT GRAPH, V12, P69, DOI 10.1109/38.135915; Hirsch FR, 2009, LANCET ONCOL, V10, P432, DOI 10.1016/S1470-2045(09)70110-X; Kaczynski T., 2004, COMPUTATIONAL HOMOLO; Kadoya N, 2020, MED PHYS, V47, P2197, DOI 10.1002/mp.14104; Kalpathy-Cramer J, 2017, TCIA MULTISEGMENTATI; Kalpathy-Cramer J, 2016, TOMOGRAPHY, V2, P430, DOI 10.18383/j.tom.2016.00235; Kalpathy-Cramer J, 2016, J DIGIT IMAGING, V29, P476, DOI 10.1007/s10278-016-9859-z; Kerr KM, 2014, ANN ONCOL, V25, P1681, DOI 10.1093/annonc/mdu145; Kohno T, 2015, TRANSL LUNG CANCER R, V4, P156, DOI 10.3978/j.issn.2218-6751.2014.11.11; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lawson P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36798-y; Li Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19131-x; Liu Y, 2016, RADIOLOGY, V280, P271, DOI 10.1148/radiol.2016151455; Mackin D, 2015, INVEST RADIOL, V50, P757, DOI 10.1097/RLI.0000000000000180; Manhire A, 2003, THORAX, V58, P920, DOI 10.1136/thorax.58.11.920; Meng LW, 2021, IEEE J BIOMED HEALTH, V25, P755, DOI 10.1109/JBHI.2020.3002805; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Nakane K, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0244-x; Ninomiya K, 2020, PHYS MEDICA, V69, P90, DOI 10.1016/j.ejmp.2019.11.026; Nishio M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210720; Novello S, 2016, ANN ONCOL, V27, pv1, DOI 10.1093/annonc/mdw326; Oyama A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45283-z; Pei GT, 2014, J THORAC DIS, V6, P1230, DOI 10.3978/j.issn.2072-1439.2014.07.23; Shen C, 2017, TRANSL ONCOL, V10, P886, DOI 10.1016/j.tranon.2017.08.007; Soufi M, 2018, MED PHYS, V45, P5116, DOI 10.1002/mp.13202; Stahl David L, 2015, Int J Crit Illn Inj Sci, V5, P189, DOI 10.4103/2229-5151.164995; Tu WT, 2019, LUNG CANCER, V132, P28, DOI 10.1016/j.lungcan.2019.03.025; Vallieres M, 2015, PHYS MED BIOL, V60, P5471, DOI 10.1088/0031-9155/60/14/5471; Wang S, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.00986-2018; Wieduwilt MJ, 2008, CELL MOL LIFE SCI, V65, P1566, DOI 10.1007/s00018-008-7440-8; Wu CC, 2011, AM J ROENTGENOL, V196, pW678, DOI 10.2214/AJR.10.4659; Yang JZ, 2016, COMPUT MED IMAG GRAP, V48, P1, DOI 10.1016/j.compmedimag.2015.12.001; Yang XG, 2019, ONCOLOGIST, V24, pE1156, DOI 10.1634/theoncologist.2018-0706; Yang Y, 2015, LUNG CANCER, V87, P272, DOI 10.1016/j.lungcan.2014.12.016	44	5	6	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0244354	10.1371/journal.pone.0244354	http://dx.doi.org/10.1371/journal.pone.0244354			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428651	Green Accepted, gold, Green Published			2022-12-26	WOS:000630036100018
J	Wang, HB; Lu, J; Chen, XG; Schwalbe, M; Gorka, JE; Mandel, JA; Wang, JL; Goetzman, ES; Ranganathan, S; Dobrowolski, SF; Prochownik, EV				Wang, Huabo; Lu, Jie; Chen, Xiaoguang; Schwalbe, Marie; Gorka, Joanna E.; Mandel, Jordan A.; Wang, Jinglin; Goetzman, Eric S.; Ranganathan, Sarangarajan; Dobrowolski, Steven F.; Prochownik, Edward, V			Acquired deficiency of peroxisomal dicarboxylic acid catabolism is a metabolic vulnerability in hepatoblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; CANCER; GLYCOLYSIS; HALLMARKS; CATENIN; ALPHA; TUMOR	Metabolic reprogramming provides transformed cells with proliferative and/or survival advantages. Capitalizing on this therapeutically, however, has been only moderately successful because of the relatively small magnitude of these differences and because cancers may further adapt their metabolism to evade metabolic pathway inhibition. Mice lacking the peroxisomal bifunctional enzyme enoyl-CoA hydratase/3-hydroxyacyl CoA dehydrogenase (Ehhadh) and supplemented with the 12-carbon fatty acid lauric acid (C12) accumulate the toxic metabolite dodecanedioic acid (DDDA), which causes acute hepatocyte necrosis and liver failure. We noted that, in a murine model of pediatric hepatoblastoma (HB) and in primary human HBs, downregulation of Ehhadh occurs in association with the suppression of mitochondrial beta- and endosomal/peroxisomal omega-fatty acid oxidation pathways. This suggested that HBs might be more susceptible than normal liver tissue to C12 dietary intervention. Indeed, HB-bearing mice provided with C12- and/or DDDA-supplemented diets survived significantly longer than those on standard diets. In addition, larger tumors developed massive necrosis following short-term DDDA administration. In some HBs, the eventual development of DDDA resistance was associated with 129 transcript differences, similar to 90% of which were downregulated, and approximately two-thirds of which correlated with survival in numerous human cancers. These transcripts often encoded extracellular matrix components, suggesting that DDDA resistance arises from reduced Ehhadh uptake. Lower Ehhadh expression was also noted in murine hepatocellular carcinomas and in subsets of certain human cancers, supporting the likely generality of these results. Our results demonstrate the feasibility of C12 or DDDA dietary supplementation that is nontoxic, inexpensive, and likely compatible with more standard chemotherapies.	[Wang, Huabo; Lu, Jie; Chen, Xiaoguang; Schwalbe, Marie; Gorka, Joanna E.; Mandel, Jordan A.; Wang, Jinglin; Prochownik, Edward, V] UPMC Childrens Hosp Pittsburgh, Div Hematol Oncol, Dept Pediat, Pittsburgh, PA 15224 USA; [Chen, Xiaoguang] Henan Univ Sci & Technol, Sch Anim Sci & Technol, Luoyang, Henan, Peoples R China; [Wang, Jinglin] Cent South Univ, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Goetzman, Eric S.; Dobrowolski, Steven F.] UPMC Childrens Hosp Pittsburgh, Dept Pediat, Div Med Genet, Pittsburgh, PA USA; [Ranganathan, Sarangarajan] Cincinnati Childrens Hosp, Dept Pathol, Cincinnati, OH USA; [Prochownik, Edward, V] Univ Pittsburgh, Hillman Canc Ctr, Med Ctr, Pittsburgh, PA 15260 USA; [Prochownik, Edward, V] Pittsburgh Liver Res Inst, Pittsburgh, PA 15261 USA; [Prochownik, Edward, V] Univ Pittsburgh, Dept Microbiol & Mol Genet, Med Ctr, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Henan University of Science & Technology; Central South University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cincinnati Children's Hospital Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), UPMC Childrens Hosp Pittsburgh, Div Hematol Oncol, Dept Pediat, Pittsburgh, PA 15224 USA.; Prochownik, EV (corresponding author), Univ Pittsburgh, Hillman Canc Ctr, Med Ctr, Pittsburgh, PA 15260 USA.; Prochownik, EV (corresponding author), Pittsburgh Liver Res Inst, Pittsburgh, PA 15261 USA.; Prochownik, EV (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Med Ctr, Pittsburgh, PA 15260 USA.	procev@chp.edu		Goetzman, Eric/0000-0001-9476-309X; Gorka, Joanna/0000-0001-9871-7664; Ranganathan, Sarangarajan/0000-0001-6214-9167; WANG, HUABO/0000-0003-2551-3243	National Institutes of Health [RO1CA174713, DK090242]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants RO1CA174713 to E. V. P. and DK090242 to E. S. G.	Akins NS, 2018, CURR TOP MED CHEM, V18, P494, DOI 10.2174/1568026618666180523111351; Allen BG, 2014, REDOX BIOL, V2, P963, DOI 10.1016/j.redox.2014.08.002; Altman BJ, 2016, NAT REV CANCER, V16, P749, DOI 10.1038/nrc.2016.114; Ambrosetti D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193477; Ashton TM, 2018, CLIN CANCER RES, V24, P2482, DOI 10.1158/1078-0432.CCR-17-3070; Bandari SK, 2018, MATRIX BIOL, V65, P104, DOI 10.1016/j.matbio.2017.09.001; Bell Danielle, 2017, Gene Expression, V17, P141, DOI 10.3727/105221616X693639; Brandhorst S, 2016, RECENT RESULTS CANC, V207, P241, DOI 10.1007/978-3-319-42118-6_12; Byrne FL, 2014, CANCER RES, V74, P5832, DOI 10.1158/0008-5472.CAN-14-0254; Chen GA, 2003, P NATL ACAD SCI USA, V100, P13537, DOI 10.1073/pnas.2233850100; Choi S, 2018, NUCL MED MOLEC IMAG, V52, P453, DOI 10.1007/s13139-018-0555-4; Chung HH, 2016, J GYNECOL ONCOL, V27, DOI 10.3802/jgo.2016.27.e15; Czauderna P, 2014, CURR OPIN PEDIATR, V26, P19, DOI 10.1097/MOP.0000000000000046; Deshmukh A, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0555-x; Di Francesco A, 2018, SCIENCE, V362, P770, DOI 10.1126/science.aau2095; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; DiNardo CD, 2018, NEW ENGL J MED, V378, P2386, DOI 10.1056/NEJMoa1716984; Ding J, 2013, CELL REP, V5, P248, DOI 10.1016/j.celrep.2013.08.032; Dolezal JM, 2017, J BIOL CHEM, V292, P10068, DOI 10.1074/jbc.M117.782052; Edmunds LR, 2016, ONCOTARGET, V7, P30379, DOI 10.18632/oncotarget.8856; Fan TWM, 2019, J BIOL CHEM, V294, P13464, DOI 10.1074/jbc.RA119.008743; Fendt SM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00150; Fransen M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061126; Goetzman ES, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00129; Guerra F, 2017, BBA-BIOENERGETICS, V1858, P686, DOI 10.1016/j.bbabio.2017.01.012; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; Harisi R, 2015, ONCOTARGETS THER, V8, P1387, DOI 10.2147/OTT.S48883; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirata E, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026781; Holle AW, 2016, ADV DRUG DELIVER REV, V97, P270, DOI 10.1016/j.addr.2015.10.007; Hooks KB, 2018, HEPATOLOGY, V68, P89, DOI 10.1002/hep.29672; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Jackson LE, 2017, CANCER RES, V77, P5795, DOI 10.1158/0008-5472.CAN-17-1325; Jin L, 2016, ONCOGENE, V35, P3619, DOI 10.1038/onc.2015.447; Kanarek N, 2020, NATURE, V579, P507, DOI 10.1038/s41586-020-2124-0; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Kulkarni S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182705; Kumar SN, 2011, J AGR FOOD CHEM, V59, P13050, DOI 10.1021/jf203182d; Lao-On U, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2019.165656; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Lee CH, 2010, CANCER RES, V70, P1564, DOI 10.1158/0008-5472.CAN-09-3228; Li T, 2018, ADV EXP MED BIOL, V1063, P13, DOI 10.1007/978-3-319-77736-8_2; Lucarelli G, 2015, ONCOTARGET, V6, P13371, DOI 10.18632/oncotarget.3823; Luengo A, 2017, CELL CHEM BIOL, V24, P1161, DOI 10.1016/j.chembiol.2017.08.028; Mandel J, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-06756-x; Mandel J, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5851-6; Marusyk A, 2020, CANCER CELL, V37, P471, DOI 10.1016/j.ccell.2020.03.007; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Montalban-Bravo G, 2018, FUTURE ONCOL, V14, P979, DOI 10.2217/fon-2017-0523; Morrow G, 2017, ADV EXP MED BIOL, V959, P9, DOI 10.1007/978-3-319-55780-9_2; Muir A, 2017, ELIFE, V6, DOI 10.7554/eLife.27713; Nencioni A, 2018, NAT REV CANCER, V18, P707, DOI 10.1038/s41568-018-0061-0; Norsworthy KJ, 2019, CLIN CANCER RES, V25, P3205, DOI 10.1158/1078-0432.CCR-18-3749; Palm W, 2017, NATURE, V546, P234, DOI 10.1038/nature22379; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Phannasil P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129848; Placencio VR, 2015, CANCER RES, V75, P2969, DOI 10.1158/0008-5472.CAN-15-0876; Qi C, 1999, J BIOL CHEM, V274, P15775, DOI 10.1074/jbc.274.22.15775; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769; Schuurbiers OCJ, 2014, J THORAC ONCOL, V9, P1485, DOI 10.1097/JTO.0000000000000286; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Sharma D, 2017, SEMIN DIAGN PATHOL, V34, P192, DOI 10.1053/j.semdp.2016.12.015; Sullivan MR, 2019, CRIT REV BIOCHEM MOL, V54, P193, DOI 10.1080/10409238.2019.1611733; Tao JY, 2014, GASTROENTEROLOGY, V147, P690, DOI 10.1053/j.gastro.2014.05.004; Torrence ME, 2018, ANNU REV CANC BIOL, V2, P251, DOI 10.1146/annurev-cancerbio-030617-050329; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Waitkus MS, 2018, CANCER CELL, V34, P186, DOI 10.1016/j.ccell.2018.04.011; Wang HB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218186; Wang HB, 2018, J BIOL CHEM, V293, P14740, DOI 10.1074/jbc.RA118.004099; Wang HB, 2016, J BIOL CHEM, V291, P26241, DOI 10.1074/jbc.M116.754218; Zhang WQ, 2019, J BIOL CHEM, V294, P17524, DOI 10.1074/jbc.RA119.009979; Zhu JJ, 2019, NAT REV MOL CELL BIO, V20, P436, DOI 10.1038/s41580-019-0123-5	74	3	3	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100283	10.1016/j.jbc.2021.100283	http://dx.doi.org/10.1016/j.jbc.2021.100283			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33450224	gold, Green Published			2022-12-26	WOS:000672866400259
J	Shao, L; Jiang, GT; Yang, XL; Zeng, ML; Cheng, JJ; Kong, S; Dong, X; Chen, TX; Han, S; Yin, J; Liu, WH; He, XH; He, CJ; Peng, BW				Shao, Lin; Jiang, Guang-tong; Yang, Xing-liang; Zeng, Meng-liu; Cheng, Jing-jing; Kong, Shuo; Dong, Xin; Chen, Tao-xiang; Han, Song; Yin, Jun; Liu, Wan-hong; He, Xiao-hua; He, Chunjiang; Peng, Bi-wen			Silencing of circIgf1r plays a protective role in neuronal injury via regulating astrocyte polarization during epilepsy	FASEB JOURNAL			English	Article						astrocyte; circRNA; epilepsy; neuronal damage	CIRCULAR RNAS; REACTIVE ASTROCYTES; SEIZURE ACTIVITY; ACTIVATION; NEURODEGENERATION; 4-AMINOPYRIDINE; GLUTAMATE; BRAIN; ANTIEPILEPTOGENESIS; INFLAMMATION	Epilepsy is a common brain disorder, repeated seizures of epilepsy may lead to a series of brain pathological changes such as neuronal or glial damage. However, whether circular RNAs are involved in neuronal injury during epilepsy is not fully understood. Here, we screened circIgf1r in the status epilepticus model through circRNA sequencing, and found that it was upregulated after the status epilepticus model through QPCR analysis. Astrocytes polarizing toward neurotoxic A1 phenotype and neurons loss were observed after status epilepticus. Through injecting circIgf1r siRNA into the lateral ventricle, it was found that knocking down circIgf1r in vivo would induce the polarization of astrocytes to phenotype A2 and reduce neuronal loss. The results in vitro further confirmed that inhibiting the expression of circIgf1r in astrocytes could protect neurons by converting reactive astrocytes from A1 to the protective A2. In addition, knocking down circIgf1r in astrocytes could functionally promote astrocyte autophagy and relieve the destruction of 4-AP-induced autophagy flux. In terms of mechanism, circIgf1r promoted the polarization of astrocytes to phenotype A1 by inhibiting autophagy. Taken together, our results reveal circIgf1r may serve as a potential target for the prevention and treatment of neuron damage after epilepsy.	[Shao, Lin; Jiang, Guang-tong; Yang, Xing-liang; Zeng, Meng-liu; Cheng, Jing-jing; Kong, Shuo; Chen, Tao-xiang; He, Chunjiang; Peng, Bi-wen] Wuhan Univ, Sch Basic Med Sci, Dept Physiol, Hubei Prov Key Lab Dev Originated Dis, Donghu Rd185, Wuhan 430071, Hubei, Peoples R China; [Dong, Xin; Han, Song; Yin, Jun; He, Xiao-hua] Wuhan Univ, Sch Basic Med Sci, Dept Pathophysiol, Wuhan, Peoples R China; [Liu, Wan-hong] Wuhan Univ, Sch Basic Med Sci, Dept Immunol, Wuhan, Peoples R China; [He, Chunjiang] Huazhong Agr Univ, Coll Biomed & Hlth, Wuhan 430070, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Huazhong Agricultural University	Peng, BW (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Physiol, Hubei Prov Key Lab Dev Originated Dis, Donghu Rd185, Wuhan 430071, Hubei, Peoples R China.; He, CJ (corresponding author), Huazhong Agr Univ, Coll Biomed & Hlth, Wuhan 430070, Peoples R China.; He, CJ (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Physiol, Donghu Rd185, Wuhan 430071, Hubei, Peoples R China.	che@whu.edu.cn; pengbiwen@whu.edu.cn	He, Chunjiang/N-4316-2016	He, Chunjiang/0000-0002-4868-331X; /0000-0002-5599-6779; Han, Song/0000-0003-4659-4388				Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Aronica E, 2007, NEUROBIOL DIS, V26, P497, DOI 10.1016/j.nbd.2007.01.015; Aronica E, 2011, EPILEPSIA, V52, P26, DOI 10.1111/j.1528-1167.2011.03033.x; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bonifati DM, 2007, MOL IMMUNOL, V44, P999, DOI 10.1016/j.molimm.2006.03.007; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Danelon V, 2016, MOL CELL NEUROSCI, V75, P81, DOI 10.1016/j.mcn.2016.07.002; Dube U, 2019, NAT NEUROSCI, V22, P1903, DOI 10.1038/s41593-019-0501-5; Duncan JS, 2002, NEUROLOGY, V59, pS15, DOI 10.1212/WNL.59.9_suppl_5.S15; Erlandsson MC, 2017, BBA-MOL BASIS DIS, V1863, P2158, DOI 10.1016/j.bbadis.2017.06.002; Fang W, 2015, BRAIN RES, V1602, P9, DOI 10.1016/j.brainres.2014.08.030; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Farrell JS, 2017, ADV NEUROBIOL, V15, P317, DOI 10.1007/978-3-319-57193-5_12; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Feng Z, 2020, BIOCHEM BIOPH RES CO, V522, P388, DOI 10.1016/j.bbrc.2019.11.102; Fu HW, 2019, GENE, V716, DOI 10.1016/j.gene.2019.144031; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; Gao XY, 2020, J CELL MOL MED, V24, P12980, DOI 10.1111/jcmm.15894; Gong GH, 2018, CELL PHYSIOL BIOCHEM, V51, P1399, DOI 10.1159/000495589; Grimaldi M, 2001, J NEUROSCI, V21, P3135, DOI 10.1523/JNEUROSCI.21-09-03135.2001; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Han B, 2018, AUTOPHAGY, V14, P1164, DOI 10.1080/15548627.2018.1458173; Heinemann U, 1999, Adv Neurol, V79, P583; Heuzeroth H, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00677; Hiruma H, 2010, J MOL NEUROSCI, V40, P295, DOI 10.1007/s12031-009-9219-2; Holmes GL, 2002, NEUROLOGY, V59, pS3, DOI 10.1212/WNL.59.9_suppl_5.S3; Huang RR, 2017, AUTOPHAGY, V13, P1722, DOI 10.1080/15548627.2017.1356975; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jiang GH, 2015, CLIN SCI, V129, P1047, DOI 10.1042/CS20150312; Jin MM, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00378; Kalynchuk LE, 2002, BRAIN RES, V935, P118, DOI 10.1016/S0006-8993(02)02459-9; Kobow K, 2012, EPILEPSIA, V53, P1868, DOI 10.1111/j.1528-1167.2012.03716.x; Lasda E, 2014, RNA, V20, P1829, DOI 10.1261/rna.047126.114; Laurino L, 2005, J CELL SCI, V118, P3653, DOI 10.1242/jcs.02490; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lingor P, 2012, CELL TISSUE RES, V349, P289, DOI 10.1007/s00441-012-1362-3; Liu JT, 2018, NEUROTHERAPEUTICS, V15, P1093, DOI 10.1007/s13311-018-0653-0; Loewen JL, 2016, J NEUROPATH EXP NEUR, V75, P366, DOI 10.1093/jnen/nlw008; Lu DC, 2021, J NEUROTRAUM, V38, P1193, DOI 10.1089/neu.2011.2114; Lu YJ, 2019, NEUROSCI BULL, V35, P877, DOI 10.1007/s12264-019-00361-0; Luhmann HJ, 2000, EUR J NEUROSCI, V12, P2757, DOI 10.1046/j.1460-9568.2000.00156.x; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Naegele JR, 2007, EPILEPSIA, V48, P107, DOI 10.1111/j.1528-1167.2007.01071.x; Neukomm LJ, 2014, TRENDS CELL BIOL, V24, P515, DOI 10.1016/j.tcb.2014.04.003; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Pitkanen A, 2002, NEUROLOGY, V59, pS27, DOI 10.1212/WNL.59.9_suppl_5.S27; Pitkanen A, 2016, LANCET NEUROL, V15, P843, DOI 10.1016/S1474-4422(16)00112-5; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Shao YY, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00249; Shapiro LA, 2008, EPILEPSIA, V49, P33, DOI 10.1111/j.1528-1167.2008.01491.x; Shinozaki Y, 2017, CELL REP, V19, P1151, DOI 10.1016/j.celrep.2017.04.047; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; SZENTE M, 1987, BRAIN RES, V413, P368, DOI 10.1016/0006-8993(87)91031-6; TAPIA R, 1982, BRAIN RES, V250, P291, DOI 10.1016/0006-8993(82)90423-1; Thijs RD, 2019, LANCET, V393, P689, DOI 10.1016/S0140-6736(18)32596-0; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Wang HQ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4971; Wang XQ, 2003, J PHARMACOL EXP THER, V305, P502, DOI 10.1124/jpet.102.045013; Wani A, 2019, AUTOPHAGY, V15, P1810, DOI 10.1080/15548627.2019.1596476; Xiao AY, 2002, J NEUROSCI, V22, P1350, DOI 10.1523/JNEUROSCI.22-04-01350.2002; Xu XT, 2019, J CELL PHYSIOL, V234, P904, DOI 10.1002/jcp.26918; Xu ZY, 2020, THORAC CANCER, V11, P875, DOI 10.1111/1759-7714.13329; YAMAGUCHI S, 1992, EPILEPSY RES, V11, P9, DOI 10.1016/0920-1211(92)90016-M; You XT, 2015, NAT NEUROSCI, V18, P603, DOI 10.1038/nn.3975; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	69	14	14	5	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21330	10.1096/fj.202001737RR	http://dx.doi.org/10.1096/fj.202001737RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33417289				2022-12-26	WOS:000647789600010
J	Adhikari, A; Kim, W; Davie, J				Adhikari, Abhinav; Kim, William; Davie, Judith			Myogenin is required for assembly of the transcription machinery on muscle genes during skeletal muscle differentiation	PLOS ONE			English	Article							HELIX-LOOP-HELIX; FACT COMPLEX; MYOD; ELONGATION; MECHANISMS; DISTINCT	Skeletal muscle gene expression is governed by the myogenic regulatory family (MRF) which includes MyoD (MYOD1) and myogenin (MYOG). MYOD1 and MYOG are known to regulate an overlapping set of muscle genes, but MYOD1 cannot compensate for the absence of MYOG in vivo. In vitro, late muscle genes have been shown to be bound by both factors, but require MYOG for activation. The molecular basis for this requirement was unclear. We show here that MYOG is required for the recruitment of TBP and RNAPII to muscle gene promoters, indicating that MYOG is essential in assembling the transcription machinery. Genes regulated by MYOD1 and MYOG include genes required for muscle fusion, myomaker and myomerger, and we show that myomaker is fully dependent on activation by MYOG. We also sought to determine the role of MYOD1 in MYOG dependent gene activation and unexpectedly found that MYOG is required to maintain Myod1 expression. However, we also found that exogenous MYOD1 was unable to compensate for the loss of Myog and activate muscle gene expression. Thus, our results show that MYOD1 and MYOG act in a feed forward loop to maintain each other's expression and also show that it is MYOG, and not MYOD1, that is required to load TBP and activate gene expression on late muscle gene promoters bound by both factors.	[Adhikari, Abhinav; Davie, Judith] Southern Illinois Univ, Dept Biochem & Mol Biol, Sch Med, Carbondale, IL 62901 USA; [Adhikari, Abhinav] Massachusetts Gen Hosp, Res Inst, Mol Pathol Unit, Charlestown, MA USA; [Adhikari, Abhinav] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Charlestown, MA USA; [Adhikari, Abhinav] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Adhikari, Abhinav] Harvard Stem Cell Inst, Cambridge, MA USA; [Kim, William] Southern Illinois Univ, Coll Sci, Carbondale, IL USA	Southern Illinois University System; Southern Illinois University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Southern Illinois University System; Southern Illinois University	Davie, J (corresponding author), Southern Illinois Univ, Dept Biochem & Mol Biol, Sch Med, Carbondale, IL 62901 USA.	jdavie@siumed.edu		Adhikari, Abhinav/0000-0002-9228-480X	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [RAR068622]	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	JKD was supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number RAR068622. https://www.niams.nih.gov/The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ATCHLEY WR, 1994, P NATL ACAD SCI USA, V91, P11522, DOI 10.1073/pnas.91.24.11522; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Biswas D, 2005, MOL CELL BIOL, V25, P5812, DOI 10.1128/MCB.25.14.5812-5822.2005; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Davie JK, 2007, DEV BIOL, V311, P650, DOI 10.1016/j.ydbio.2007.08.014; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Garcia H, 2011, ONCOTARGET, V2, P783; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hernandez-Hernandez M, 2017, SEMIN CELL DEV BIOL, V72, P10, DOI 10.1016/j.semcdb.2017.11.010; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; Jeronimo C, 2019, CELL REP, V28, P1206, DOI 10.1016/j.celrep.2019.06.097; Knapp JR, 2006, DEVELOPMENT, V133, P601, DOI 10.1242/dev.02249; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; LeRoy G, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aay3068; Lolis AA, 2013, J BIOL CHEM, V288, P7676, DOI 10.1074/jbc.M112.426718; Londhe P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004633; Londhe P, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-14; Malpas J, 1997, AUSTRALAS J PHILOS, V75, P1, DOI 10.1080/00048409712347641; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Millay DP, 2014, GENE DEV, V28, P1641, DOI 10.1101/gad.247205.114; Miller JB, 1999, CURR TOP DEV BIOL, V43, P191; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Myer A, 2001, DEV BIOL, V229, P340, DOI 10.1006/dbio.2000.9985; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; Sen R, 2016, MOL CELL BIOL, V36, P1691, DOI 10.1128/MCB.01112-15; STOCKDALE FE, 1992, DEV BIOL, V154, P284, DOI 10.1016/0012-1606(92)90068-R; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Winkler DD, 2011, J BIOL CHEM, V286, P18369, DOI 10.1074/jbc.R110.180778; Wyzykowski JC, 2002, MOL CELL BIOL, V22, P6199, DOI 10.1128/MCB.22.17.6199-6208.2002; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024	38	10	11	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245618	10.1371/journal.pone.0245618	http://dx.doi.org/10.1371/journal.pone.0245618			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465133	gold, Green Published			2022-12-26	WOS:000611969200051
J	He, JJ; Wu, XM; Li, JX; He, SX				He, Jianjia; Wu, Xiumeng; Li, Junxiang; He, Shengxue			Multi-energy conversion based on game theory in the industrial interconnection	PLOS ONE			English	Article							CHINA ENERGY-CONSUMPTION; DISTRIBUTION NETWORK; OPTIMAL-DESIGN; OPERATION; STORAGE; SYSTEM; ALGORITHM; STRATEGY	The multi-energy conversion system (MCS) plays an important role in improving the utilization of energy resources and realizing the energy transition. With the application of the new generation of information technologies, the new MCS can realize real-time information interaction, multi-energy collaboration, and real-time demand response, in which energy suppliers can intelligently motivate consumers' energy use behavior. In this paper, an MCS coupled with a cloud platform is proposed to address information explosion and data security issues. Due to the development of Internet technology, the increasing energy data, and the serious energy coupling, it is difficult for traditional optimization methods to deal with the interaction between participants of the MCS. Therefore, the non-cooperative game is used to formulate the interactions between participants with the aim of maximizing the energy suppliers' profit and minimizing the customers' cost. It is proved that the game model is an ordinary game with one Nash equilibrium. The simulation was performed with a gradient projection algorithm and the results show that the proposed MCS improves energy utilization efficiency through energy conversion while ensuring consumer satisfaction, and benefits both the customers and suppliers by reducing the energy consumption cost and the peak load demand, which effectively improve the supply quality and enrich the energy consumption patterns.	[He, Jianjia; Wu, Xiumeng; Li, Junxiang; He, Shengxue] Univ Shanghai Sci & Technol, Business Sch, Shanghai, Peoples R China; [He, Jianjia; Li, Junxiang] Super Network Res Ctr China, Shanghai, Peoples R China	University of Shanghai for Science & Technology	He, JJ (corresponding author), Univ Shanghai Sci & Technol, Business Sch, Shanghai, Peoples R China.; He, JJ (corresponding author), Super Network Res Ctr China, Shanghai, Peoples R China.	hejianjia@usst.edu.cn			national natural science foundation of China [71871144, 71572113]; Science and Technology Development Program of Shanghai University for Science and Technology [2020KJFZ046]	national natural science foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Program of Shanghai University for Science and Technology	The study has been supported by the national natural science foundation of China (Project No.: 71871144, 71572113), Science and Technology Development Program of Shanghai University for Science and Technology (Project No.: 2020KJFZ046).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, Drug Ther Bull, V55, P33, DOI 10.1136/dtb.2017.3.0463; Boyd S., 2004, CONVEX OPTIMIZATION; Chen XP, 2017, APPL ENERG, V208, P132, DOI 10.1016/j.apenergy.2017.10.065; Clegg S, 2019, ENERGY, V184, P191, DOI 10.1016/j.energy.2018.02.078; Delgado BM, 2018, BUILD RES INF, V46, P668, DOI 10.1080/09613218.2017.1327279; Dong YS, 2014, SCI WORLD J, DOI [10.1155/2014/259139, 10.1155/2014/862019]; Gabrielli P, 2018, APPL ENERG, V221, P557, DOI 10.1016/j.apenergy.2018.03.149; Gao Y, 2019, INT J ELEC POWER, V107, P273, DOI 10.1016/j.ijepes.2018.11.033; Huang ZS, 2018, ENERGY, V150, P109, DOI 10.1016/j.energy.2018.02.091; Islam S, 2018, ENERG CONVERS MANAGE, V156, P746, DOI 10.1016/j.enconman.2017.09.039; Ke MT, 2017, APPL ENERG, V188, P497, DOI 10.1016/j.apenergy.2016.12.034; Kienzle F, 2011, IEEE T SUSTAIN ENERG, V2, P194, DOI 10.1109/TSTE.2011.2106228; Liang JB, 2019, IEEE ACCESS, V7, P77649, DOI 10.1109/ACCESS.2019.2922322; Lin SL, 2018, INT CONF SMART GR C, P84, DOI 10.1109/ICSGCE.2018.8556829; Liu NA, 2018, IEEE T IND ELECTRON, V65, P6740, DOI 10.1109/TIE.2018.2793181; Liu XZ, 2019, APPL ENERG, V248, P256, DOI 10.1016/j.apenergy.2019.04.106; Mi ZF, 2018, EARTHS FUTURE, V6, P1007, DOI 10.1029/2018EF000840; Monderer D, 1996, GAME ECON BEHAV, V14, P124, DOI 10.1006/game.1996.0044; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Papin Vladimir V., 2018, Materials Science Forum, V931, P933, DOI 10.4028/www.scientific.net/MSF.931.933; Qian C, 2019, J CLEAN PROD, V241, DOI 10.1016/j.jclepro.2019.118379; Sobhani SO, 2020, ENERGY, V206, DOI 10.1016/j.energy.2020.118017; Sun JS, 2018, STRUCT CHANGE ECON D, V47, P57, DOI 10.1016/j.strueco.2018.07.007; Sun YH, 2017, INTELL AUTOM SOFT CO, V23, P555, DOI 10.1080/10798587.2017.1316073; Tang JQ, 2021, INT J NEUROSCI, V131, P239, DOI 10.1080/00207454.2020.1738429; Tang JJ, 2018, PHYSICA A, V512, P745, DOI 10.1016/j.physa.2018.08.017; Tseng YC, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8060531; van Goor H, 2014, ENERGY, V72, P126, DOI 10.1016/j.energy.2014.05.016; Wang QH, 2019, IEEE ACCESS, V7, P127839, DOI 10.1109/ACCESS.2019.2939913; Wang YQ, 2019, ENERGY, V167, P275, DOI 10.1016/j.energy.2018.10.177; Wang Y, 2020, TRANSPORT RES E-LOG, V143, DOI 10.1016/j.tre.2020.102118; Wang Y, 2020, J CLEAN PROD, V258, DOI 10.1016/j.jclepro.2020.120590; Wang Y, 2017, APPL SOFT COMPUT, V56, P143, DOI 10.1016/j.asoc.2017.02.025; Wang Y, 2017, J CLEAN PROD, V144, P203, DOI 10.1016/j.jclepro.2017.01.001; Xu X, 2015, ADV INTELL SYST, V370, P427, DOI 10.1007/978-3-319-21206-7_36; Zhang B, 2019, ENERG CONVERS MANAGE, V202, DOI 10.1016/j.enconman.2019.112199; Zheng T, 2019, PROCESSES, V7, DOI 10.3390/pr7090570; Zhu XY, 2020, RENEW ENERG, V146, P2700, DOI 10.1016/j.renene.2019.07.011	38	0	0	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245622	10.1371/journal.pone.0245622	http://dx.doi.org/10.1371/journal.pone.0245622			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465129	Green Published, gold			2022-12-26	WOS:000611969200047
J	Kim, HJ; Kim, JY; Jung, CW; Lee, YS; An, JY; Kim, EH; Kim, KH; Lee, SP; Park, JY; Park, MJ				Kim, Hee-Jin; Kim, Jeong-Yub; Jung, Chan-Woong; Lee, Young-Sun; An, Joon-Yong; Kim, Eun Ho; Kim, Ki-Hong; Lee, Sang Pyung; Park, Jae-Yong; Park, Myung-Jin			ANO1 regulates the maintenance of stemness in glioblastoma stem cells by stabilizing EGFRvIII	ONCOGENE			English	Article							CHLORIDE CHANNEL TMEM16A; GROWTH-FACTOR RECEPTOR; TUMOR-GROWTH; CANCER; EXPRESSION; PROTEIN; CONTRIBUTES; GLIOMA; IDENTIFICATION; CONCOMITANT	Glioblastoma multiforme (GBM) or glioblastoma is the most deadly malignant brain tumor in adults. GBM is difficult to treat mainly due to the presence of glioblastoma stem cells (GSCs). Epidermal growth factor receptor variant III (EGFRvIII) has been linked to stemness and malignancy of GSCs; however, the regulatory mechanism of EGFRvIII is largely unknown. Here, we demonstrated that Anoctamin-1 (ANO1), a Ca2+-activated Cl- channel, interacts with EGFRvIII, increases its protein stability, and supports the maintenance of stemness and tumor progression in GSCs. Specifically, shRNA-mediated knockdown and pharmacological inhibition of ANO1 suppressed the self-renewal, invasion activities, and expression of EGFRvIII and related stem cell factors, including NOTCH1, nestin, and SOX2 in GSCs. Conversely, ANO1 overexpression enhanced the above phenomena. Mechanistically, ANO1 protected EGFRvIII from proteasomal degradation by directly binding to it. ANO1 knockdown significantly increased survival in mice and strongly suppressed local invasion of GSCs in an in vivo intracranial mouse model. Collectively, these results suggest that ANO1 plays a crucial role in the maintenance of stemness and invasiveness of GSCs by regulating the expression of EGFRvIII and related signaling molecules, and can be considered a promising therapeutic target for GBM treatment.	[Kim, Hee-Jin; Kim, Jeong-Yub; Jung, Chan-Woong; Park, Myung-Jin] Korea Inst Radiol & Med Sci, Radiat Therapeut Dev Team, Div Radiat Canc Sci, Seoul, South Korea; [Kim, Hee-Jin; Lee, Young-Sun; An, Joon-Yong; Park, Jae-Yong] Korea Univ, Sch Biosyst & Biomed Sci, Coll Hlth Sci, Seoul, South Korea; [Jung, Chan-Woong] Korea Univ, Dept Life Sci, Seoul, South Korea; [Kim, Eun Ho] Daegu Catholic Univ, Sch Med, Dept Biochem, Daegu, South Korea; [Kim, Ki-Hong] Daegu Catholic Univ, Dept Neurosurg, Sch Med, Daegu, South Korea; [Lee, Sang Pyung] Halla Gen Hosp, Dept Neurosurg, Jeju, South Korea	Korea Institute of Radiological & Medical Sciences; Korea University; Korea University; Catholic University of Daegu; Catholic University of Daegu	Park, MJ (corresponding author), Korea Inst Radiol & Med Sci, Radiat Therapeut Dev Team, Div Radiat Canc Sci, Seoul, South Korea.; Park, JY (corresponding author), Korea Univ, Sch Biosyst & Biomed Sci, Coll Hlth Sci, Seoul, South Korea.	jaeyong68@korea.ac.kr; mjpark@kirams.re.kr	Kim, Heejin/HII-8568-2022	An, Joon-Yong/0000-0001-8839-6297	National Research Foundation of Korea [NRF-2017M3A9C4092979]; Korea Institute of Radiological and Medical Sciences (KIRAMS) - Ministry of Science and ICT (MSIT), the Republic of Korea [50531-2019]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Institute of Radiological and Medical Sciences (KIRAMS) - Ministry of Science and ICT (MSIT), the Republic of Korea	This work was supported by the Bio-Synergy Research Project (NRF-2017M3A9C4092979 to JYP) of the National Research Foundation of Korea, and by a grant from the Korea Institute of Radiological and Medical Sciences (KIRAMS), funded by the Ministry of Science and ICT (MSIT), the Republic of Korea (No. 50531-2019 to MJP).	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bill A, 2015, ONCOTARGET, V6, P9173, DOI 10.18632/oncotarget.3277; Bill A, 2014, J BIOL CHEM, V289, P11029, DOI 10.1074/jbc.M114.549188; Bleeker FE, 2012, J NEURO-ONCOL, V108, P11, DOI 10.1007/s11060-011-0793-0; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; Carneiro A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-98; Cheng L, 2011, BIOCHEM BIOPH RES CO, V406, P643, DOI 10.1016/j.bbrc.2011.02.123; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Crottes D, 2019, CELL CALCIUM, V82, DOI 10.1016/j.ceca.2019.06.004; Crottes D, 2019, P NATL ACAD SCI USA, V116, P13026, DOI 10.1073/pnas.1900703116; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; de la Iglesia N, 2009, CURR MOL MED, V9, P580; Del Vecchio CA, 2013, ONCOGENE, V32, P2670, DOI 10.1038/onc.2012.280; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Emlet DR, 2014, CANCER RES, V74, P1238, DOI 10.1158/0008-5472.CAN-13-1407; Eskilsson E, 2016, NEURO-ONCOLOGY, V18, P1644, DOI 10.1093/neuonc/now113; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gallego O, 2015, CURR ONCOL, V22, pE273, DOI 10.3747/co.22.2436; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Hatanpaa KJ, 2010, NEOPLASIA, V12, P675, DOI 10.1593/neo.10688; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Huang X, 2002, P NATL ACAD SCI USA, V99, P11369, DOI 10.1073/pnas.172285799; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Ji QS, 2019, J CELL PHYSIOL, V234, P7856, DOI 10.1002/jcp.27865; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Katoh M, 2003, INT J ONCOL, V22, P1375; Lee YS, 2016, BIOCHEM BIOPH RES CO, V475, P216, DOI 10.1016/j.bbrc.2016.05.077; Lee YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep26413; Liu F, 2015, ONCOTARGET, V6, P11585, DOI 10.18632/oncotarget.3412; Liu J, 2014, MOL MED REP, V9, P1068, DOI 10.3892/mmr.2014.1888; Liu W, 2012, CANCER LETT, V326, P41, DOI 10.1016/j.canlet.2012.07.015; Ma MM, 2017, HYPERTENSION, V69, P892, DOI 10.1161/HYPERTENSIONAHA.116.08874; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Oh U, 2016, PFLUG ARCH EUR J PHY, V468, P443, DOI 10.1007/s00424-016-1790-0; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Sauter DRP, 2015, PFLUG ARCH EUR J PHY, V467, P1495, DOI 10.1007/s00424-014-1598-8; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shiwarski DJ, 2014, CLIN CANCER RES, V20, P4673, DOI 10.1158/1078-0432.CCR-14-0363; Simon S, 2013, CANCER RES, V73, P3661, DOI 10.1158/0008-5472.CAN-12-3839; Singh SK, 2003, CANCER RES, V63, P5821; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sui YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115443; Wang H, 2019, CANCER LETT, V455, P48, DOI 10.1016/j.canlet.2019.04.027; Wang H, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0720-x; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yin J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002152	50	3	3	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2021	40	8					1490	1502		10.1038/s41388-020-01612-5	http://dx.doi.org/10.1038/s41388-020-01612-5		JAN 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QM6NM	33452454				2022-12-26	WOS:000607998600007
J	Liu, PI; Chang, AC; Lai, JL; Lin, TH; Tsai, CH; Chen, PC; Jiang, YJ; Lin, LW; Huang, WC; Yang, SF; Tang, CH				Liu, Po-, I; Chang, An-Chen; Lai, Jiun-Lin; Lin, Tien-Huang; Tsai, Chun-Hao; Chen, Po-Chun; Jiang, Ya-Jing; Lin, Liang-Wei; Huang, Wei-Chien; Yang, Shun-Fa; Tang, Chih-Hsin			Melatonin interrupts osteoclast functioning and suppresses tumor-secreted RANKL expression: implications for bone metastases	ONCOGENE			English	Article							PROSTATE-CANCER; PLUS MELATONIN; CELLS; ANGIOGENESIS; CHEMOTHERAPY; METAANALYSIS; METABOLISM; MODULATION; MECHANISMS; STRATEGIES	Cancer-related bone erosion occurs frequently in bone metastasis and is associated with severe complications such as chronic bone pain, fractures, and lower survival rates. In recognition of the fact that the darkness hormone melatonin is capable of regulating bone homeostasis, we explored its therapeutic potential in bone metastasis. We found that melatonin directly reduces osteoclast differentiation, bone resorption activity and promotes apoptosis of mature osteoclasts. We also observed that melatonin inhibits RANKL production in lung and prostate cancer cells by downregulating the p38 MAPK pathway, which in turn prevents cancer-associated osteoclast differentiation. In lung and prostate bone metastasis models, twice-weekly melatonin treatment markedly reduced tumor volumes and numbers of osteolytic lesions. Melatonin also substantially lowered the numbers of TRAP-positive osteoclasts in tibia bone marrow and RANKL expression in tumor tissue. These findings show promise for melatonin in the treatment of bone metastases.	[Liu, Po-, I; Lai, Jiun-Lin; Jiang, Ya-Jing; Huang, Wei-Chien; Tang, Chih-Hsin] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Liu, Po-, I] Asia Univ Hosp, Dept Gen Thorac Surg, Taichung, Taiwan; [Chang, An-Chen; Chen, Po-Chun] Shin Kong Wu Ho Su Mem Hosp, Translat Med Ctr, Taipei, Taiwan; [Lin, Tien-Huang] Buddhist Tzu Chi Gen Hosp, Dept Urol, Taichung Branch, Taichung, Taiwan; [Lin, Tien-Huang] Tzu Chi Univ, Sch Postbaccalaureate Chinese Med, Hualien, Taiwan; [Tsai, Chun-Hao] China Med Univ Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Tsai, Chun-Hao; Lin, Liang-Wei; Tang, Chih-Hsin] China Med Univ, Sch Med, Taichung, Taiwan; [Chen, Po-Chun] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Po-Chun; Tang, Chih-Hsin] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Chinese Med Res Ctr, Taichung, Taiwan	China Medical University Taiwan; Shin Kong Wu Ho Su Memorial Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan	Tang, CH (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.; Tang, CH (corresponding author), China Med Univ, Sch Med, Taichung, Taiwan.; Tang, CH (corresponding author), Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan.; Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Yang, SF (corresponding author), Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan.; Tang, CH (corresponding author), China Med Univ, Chinese Med Res Ctr, Taichung, Taiwan.	ysf@csmu.edu.tw; chtang@mail.cmu.edu.tw	Chang, An-Chen/ABB-6915-2021; Yang, Shun-Fa/AAN-1519-2020; Huang, Wei-Chien/D-1740-2012	Yang, Shun-Fa/0000-0002-0365-7927; Chang, An-Chen/0000-0002-9544-9980; Huang, Wei-Chien/0000-0001-6467-8716	Taiwan's Ministry of Science and Technology [MOST 108-2320-B-039-026-, MOST 109-2320-B-341-002-]; China Medical University Hospital [DMR-110-102]; Shin Kong Wu Ho-Su Memorial Hospital [2020SKHBND001]; China Medical University under the Higher Education Sprout Project, Ministry of Education, Taiwan [CMRCCHM-3-1]; Asia University Hospital [10951002]; Chung Shan Medical University Hospital, Taiwan [CSH-2020-E-001-Y3]	Taiwan's Ministry of Science and Technology; China Medical University Hospital; Shin Kong Wu Ho-Su Memorial Hospital; China Medical University under the Higher Education Sprout Project, Ministry of Education, Taiwan; Asia University Hospital; Chung Shan Medical University Hospital, Taiwan	This study was supported by grants from Taiwan's Ministry of Science and Technology (MOST 108-2320-B-039-026-, MOST 109-2320-B-341-002-), China Medical University Hospital (DMR-110-102), Shin Kong Wu Ho-Su Memorial Hospital (2020SKHBND001), China Medical University under the Higher Education Sprout Project, Ministry of Education, Taiwan (CMRCCHM-3-1), Asia University Hospital (10951002) and Chung Shan Medical University Hospital, Taiwan (CSH-2020-E-001-Y3).	Anderson G, 2015, MULT SCLER RELAT DIS, V4, P112, DOI 10.1016/j.msard.2014.12.001; [Anonymous], 2018, Nat Rev Dis Primers, V4, P18002, DOI 10.1038/nrdp.2018.2; Arendt J, 2006, CHRONOBIOL INT, V23, P21, DOI 10.1080/07420520500464361; Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Bang J, 2012, RHEUMATOL INT, V32, P379, DOI 10.1007/s00296-010-1641-9; Benjamin Biju, 2016, Osteoporos Sarcopenia, V2, P77, DOI 10.1016/j.afos.2016.03.003; Bi HD, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00234; Boafo A, 2019, NAT SCI SLEEP, V11, P1, DOI 10.2147/NSS.S181365; Brown JE, 2005, JNCI-J NATL CANCER I, V97, P59, DOI 10.1093/jnci/dji002; Chang AC, 2018, CANCER LETT, V426, P47, DOI 10.1016/j.canlet.2018.03.050; Chao CC, 2019, CLIN SCI, V133, P709, DOI 10.1042/CS20180945; Chen PC, 2013, CARCINOGENESIS, V34, P1669, DOI 10.1093/carcin/bgt103; Chen Q, 2002, INT IMMUNOPHARMACOL, V2, P1443, DOI 10.1016/S1567-5769(02)00088-7; Chin Hong, 2015, Fed Pract, V32, P24; Chuang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078022; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Cordoba-Moreno MO, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61652-5; Cutando A, 2014, ONCOL LETT, V7, P923, DOI 10.3892/ol.2014.1813; Dauchy RT, 2014, CANCER RES, V74, P4099, DOI 10.1158/0008-5472.CAN-13-3156; do Amaral FG, 2018, ARCH ENDOCRIN METAB, V62, P472, DOI 10.20945/2359-3997000000066; Farach-Carson MC, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00163; Fowler TW, 2015, J CELL SCI, V128, P683, DOI 10.1242/jcs.157834; Golan K, 2019, EXP HEMATOL, V78, P1, DOI 10.1016/j.exphem.2019.08.008; Golan K, 2018, CELL STEM CELL, V23, P572, DOI 10.1016/j.stem.2018.08.002; Guise TA, 2003, CLIN ORTHOP RELAT R, pS32, DOI 10.1097/01.blo.0000093055.96273.69; Guise TA, 2006, CLIN CANCER RES, V12, p6213S, DOI 10.1158/1078-0432.CCR-06-1007; Hall CL, 2005, CANCER RES, V65, P7554, DOI 10.1158/0008-5472.CAN-05-1317; Han Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06304-x; Huang CC, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12560; Jahanban-Esfahlan R, 2018, BRIT J PHARMACOL, V175, P3230, DOI 10.1111/bph.13898; Jung B, 2006, CANCER RES, V66, P9789, DOI 10.1158/0008-5472.CAN-06-1776; Kim HJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061142; Kim Jung Ha, 2016, Chonnam Med J, V52, P12, DOI 10.4068/cmj.2016.52.1.12; Kim TK, 2013, FASEB J, V27, P2742, DOI 10.1096/fj.12-224691; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Koyama H, 2002, J BONE MINER RES, V17, P1219, DOI 10.1359/jbmr.2002.17.7.1219; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; Leaw B, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00199; Lee HP, 2020, FOOD AGR IMMUNOL, V31, P193, DOI 10.1080/09540105.2020.1713055; Lee HP, 2019, FOOD AGR IMMUNOL, V30, P1033, DOI 10.1080/09540105.2019.1660623; Lee HP, 2019, J FUNCT FOODS, V52, P537, DOI 10.1016/j.jff.2018.11.040; Leja-Szpak A, 2018, PHARMACOL REP, V70, P1079, DOI 10.1016/j.pharep.2018.05.007; Li Y, 2017, ONCOTARGET, V8, P39896, DOI 10.18632/oncotarget.16379; LISSONI P, 1995, BRIT J CANCER, V71, P854, DOI 10.1038/bjc.1995.164; LISSONI P, 1994, TUMORI, V80, P464, DOI 10.1177/030089169408000611; Liu JB, 2016, ANNU REV PHARMACOL, V56, P361, DOI 10.1146/annurev-pharmtox-010814-124742; Liu JF, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091491; Lopez-Canul M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102452; Lv JW, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12557; Lyu HC, 2019, J CLIN ENDOCR METAB, V104, P1753, DOI 10.1210/jc.2018-02236; Macedo F, 2017, ONCOL REV, V11, P43, DOI 10.4081/oncol.2017.321; Maria S, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12465; Markus RP, 2018, BRIT J PHARMACOL, V175, P3239, DOI 10.1111/bph.14083; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Menendez-Menendez J, 2018, INT J ENDOCRINOL, V2018, DOI 10.1155/2018/3271948; Meng XT, 2018, MOL MED REP, V17, P7202, DOI 10.3892/mmr.2018.8729; Nakashima T, 2000, BIOCHEM BIOPH RES CO, V275, P768, DOI 10.1006/bbrc.2000.3379; Otto S, 2018, CANCER TREAT REV, V69, P177, DOI 10.1016/j.ctrv.2018.06.007; Pandi-Perumal SR, 2013, NEUROTOX RES, V23, P267, DOI 10.1007/s12640-012-9337-4; Roth JA, 1999, J BIOL CHEM, V274, P22041, DOI 10.1074/jbc.274.31.22041; Rouach V, 2018, J BONE ONCOL, V12, P91, DOI 10.1016/j.jbo.2018.07.011; Schmid-Alliana A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010148; Seely D, 2012, INTEGR CANCER THER, V11, P293, DOI 10.1177/1534735411425484; Shupp AB, 2018, CANCERS, V10, DOI 10.3390/cancers10060182; Singh VA, 2014, SINGAP MED J, V55, P539, DOI 10.11622/smedj.2014138; Slominski AT, 2018, J INVEST DERMATOL, V138, P490, DOI 10.1016/j.jid.2017.10.025; Slominski AT, 2017, CELL MOL LIFE SCI, V74, P3913, DOI 10.1007/s00018-017-2617-7; Slominski AT, 2017, EXP DERMATOL, V26, P563, DOI 10.1111/exd.13208; Slominski RM, 2012, MOL CELL ENDOCRINOL, V351, P152, DOI 10.1016/j.mce.2012.01.004; Palmer ACS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231379; Steger Guenther G, 2011, Ther Adv Med Oncol, V3, P233, DOI 10.1177/1758834011412656; Svensson E, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016022; Tordjman S, 2017, CURR NEUROPHARMACOL, V15, P434, DOI 10.2174/1570159X14666161228122115; van Dam PA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092183; Wang B, 2019, J CELL PHYSIOL, V234, P1008, DOI 10.1002/jcp.27090; Wang MF, 2019, BIOCHEM PHARMACOL, V166, P23, DOI 10.1016/j.bcp.2019.05.005; Wang Y, 2018, ONCOTARGETS THER, V11, P7895, DOI 10.2147/OTT.S174100; Watanabe M, 2008, J OBSTET GYNAECOL RE, V34, P567, DOI 10.1111/j.1447-0756.2008.00818.x; Watkins LR, 2020, GENES-BASEL, V11, DOI 10.3390/genes11060694; Wu MH, 2012, J CELL PHYSIOL, V227, P3016, DOI 10.1002/jcp.23043; Wutzl A, 2006, WIEN KLIN WOCHENSCHR, V118, P473, DOI 10.1007/s00508-006-0644-8; Yang YC, 2019, ENVIRON TOXICOL, V34, P203, DOI 10.1002/tox.22674	82	13	13	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2021	40	8					1503	1515		10.1038/s41388-020-01613-4	http://dx.doi.org/10.1038/s41388-020-01613-4		JAN 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QM6NM	33452455				2022-12-26	WOS:000607998600005
J	Ali, M; Khalil, A; Ijaz, M; Saeed, N				Ali, Muhammad; Khalil, Alamgir; Ijaz, Muhammad; Saeed, Noor			Alpha-Power Exponentiated Inverse Rayleigh distribution and its applications to real and simulated data	PLOS ONE			English	Article							GENERATING FAMILIES; MODEL	The main goal of the current paper is to contribute to the existing literature of probability distributions. In this paper, a new probability distribution is generated by using the Alpha Power Family of distributions with the aim to model the data with non-monotonic failure rates and provides a better fit. The proposed distribution is called Alpha Power Exponentiated Inverse Rayleigh or in short APEIR distribution. Various statistical properties have been investigated including they are the order statistics, moments, residual life function, mean waiting time, quantiles, entropy, and stress-strength parameter. To estimate the parameters of the proposed distribution, the maximum likelihood method is employed. It has been proved theoretically that the proposed distribution provides a better fit to the data with monotonic as well as non-monotonic hazard rate shapes. Moreover, two real data sets are used to evaluate the significance and flexibility of the proposed distribution as compared to other probability distributions.	[Ali, Muhammad; Khalil, Alamgir; Ijaz, Muhammad; Saeed, Noor] Univ Peshawar, Dept Stat, Peshawar, Khyber Pakhtunk, Pakistan	University of Peshawar	Ijaz, M (corresponding author), Univ Peshawar, Dept Stat, Peshawar, Khyber Pakhtunk, Pakistan.	ijaz.statistics@gmail.com		Ijaz, Dr.Muhammad/0000-0003-1403-7093				Ahmad A., 2014, MATH THEORY MODEL, V4, P90; Alzaatreh A, 2013, METRON, V71, P63, DOI 10.1007/s40300-013-0007-y; [Anonymous], 2014, NEUROUROL URODYN S, V33, pS1; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Chen F, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060609; Dey S, 2017, OZONE-SCI ENG, V39, P273, DOI 10.1080/01919512.2017.1308817; Dina A., 2018, INT J COMPUTER APPL, V181, P6, DOI [10.5120/ijca2018917657, DOI 10.5120/IJCA2018917657]; Dong B., 2018, J ADV TRANSPORT, V2018, DOI [10.1155/2018/7905140, DOI 10.1155/2018/7905140]; Eugene N, 2002, COMMUN STAT-THEOR M, V31, P497, DOI 10.1081/STA-120003130; Gupta RD, 2001, BIOMETRICAL J, V43, P117, DOI 10.1002/1521-4036(200102)43:1<117::AID-BIMJ117>3.0.CO;2-R; Hassan A.S., 2018, J NONLINEAR SCI APP, V12, P239, DOI [10.22436/jnsa.012.04.05, DOI 10.22436/JNSA.012.04.05]; Jones M., 2009, STAT METHODOL, V6, P70, DOI [10.1016/j.stamet.2008.04.001, DOI 10.1016/J.STAMET.2008.04.001]; Lee C, 2013, WIRES COMPUT STAT, V5, P219, DOI 10.1002/wics.1255; Lemonte AJ, 2014, COMMUN STAT-THEOR M, V43, P2066, DOI 10.1080/03610926.2013.766343; Mahdavi A, 2017, COMMUN STAT-THEOR M, V46, P6543, DOI 10.1080/03610926.2015.1130839; Merovci F., 2015, APPL MATH INFORM SCI, V9, P2127; Nassar M, 2017, COMMUN STAT-THEOR M, V46, P10236, DOI 10.1080/03610926.2016.1231816; Raqab M., 2011, GEN RAYLEIGH DISTRIB, P599; Rehman S., 2015, THESIS U PUNJAB LAHO; ShuaibKhan M., 2014, INT J COMPUTER APPL, V87, P28, DOI [10.5120/15270-3868, DOI 10.5120/15270-3868]; Voda V. Gh., 1972, Reports of Statistical Application Research, Union of Japanese Scientists and Engineers, V19, P13; Wen HY, 2019, ACCIDENT ANAL PREV, V132, DOI 10.1016/j.aap.2019.07.025; ZeinEldin R. A., 2018, J NONLINEAR SCI APP, V11, P1099; Zeng Q, 2022, J TRANSP SAF SECUR, V14, P323, DOI 10.1080/19439962.2020.1779422; Zeng Q, 2017, ACCIDENT ANAL PREV, V99, P184, DOI 10.1016/j.aap.2016.11.018	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245253	10.1371/journal.pone.0245253	http://dx.doi.org/10.1371/journal.pone.0245253			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444340	Green Published, gold			2022-12-26	WOS:000609988100070
J	Chon, C; Chon, G; Matsui, Y; Zeng, HQ; Lai, ZC; Liu, AM				Chon, Cristin; Chon, Grace; Matsui, Yurika; Zeng, Huiqing; Lai, Zhi-Chun; Liu, Aimin			Efficient multiplexed genome engineering with a polycistronic tRNA and CRISPR guide-RNA reveals an important role of detonator in reproduction of Drosophila melanogaster	PLOS ONE			English	Article							WIDE ASSOCIATION; DISEASES; MOUSE	Genome association studies in human and genetic studies in mouse implicated members of the transmembrane protein 132 (TMEM132) family in multiple conditions including panic disorder, hearing loss, limb and kidney malformation. However, the presence of five TMEM132 paralogs in mammalian genomes makes it extremely challenging to reveal the full requirement for these proteins in vivo. In contrast, there is only one TMEM132 homolog, detonator (dtn), in the genome of fruit fly Drosophila melanogaster, enabling straightforward research into its in vivo function. In the current study, we generate multiple loss-of-function dtn mutant fly strains through a polycistronic tRNA-gRNA approach, and show that most embryos lacking both maternal and paternal dtn fail to hatch into larvae, indicating an essential role of dtn in Drosophila reproduction.	[Chon, Cristin; Chon, Grace; Matsui, Yurika; Zeng, Huiqing; Lai, Zhi-Chun; Liu, Aimin] Penn State Univ, Huck Inst Life Sci, Ctr Cellular Dynam, Dept Biol,Eberly Coll Sci, State Coll, PA 16801 USA; [Chon, Cristin; Chon, Grace; Matsui, Yurika; Zeng, Huiqing; Lai, Zhi-Chun; Liu, Aimin] Penn State Univ, Huck Inst Life Sci, Ctr Cellular & Mol Invest Neurol Dis, Dept Biol,Eberly Coll Sci, State Coll, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Liu, AM (corresponding author), Penn State Univ, Huck Inst Life Sci, Ctr Cellular Dynam, Dept Biol,Eberly Coll Sci, State Coll, PA 16801 USA.	AXL25@psu.edu		Matsui, Yurika/0000-0003-0731-2499; Liu, Aimin/0000-0003-0099-0879	NASA PA Space Consortium Research Internship Program; Eberly College of Science of the Penn State University; A Penn State University new lab start up fund	NASA PA Space Consortium Research Internship Program; Eberly College of Science of the Penn State University; A Penn State University new lab start up fund	This work was supported by a NASA PA Space Consortium Research Internship Program and Undergraduate Research Support grant from the Eberly College of Science of the Penn State University for C. C. and G. C. and A Penn State University new lab start up fund for A. L.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bier E, 2018, GENETICS, V208, P1, DOI 10.1534/genetics.117.1113; Briggs MD, 2015, INT J MOL MED, V35, P1483, DOI 10.3892/ijmm.2015.2158; Cicek MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038175; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dong FP, 2017, BIOCHEM BIOPH RES CO, V482, P889, DOI 10.1016/j.bbrc.2016.11.129; Erhardt A, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.85; Erhardt A, 2011, MOL PSYCHIATR, V16, P647, DOI 10.1038/mp.2010.41; Farlow JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121104; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Haaker J, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.1; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Honjo K, 2016, CELL REP, V16, P295, DOI 10.1016/j.celrep.2016.06.003; Howe AS, 2016, MOL PSYCHIATR, V21, P665, DOI 10.1038/mp.2015.138; Kobayashi M, 2006, P NATL ACAD SCI USA, V103, P14417, DOI 10.1073/pnas.0606571103; Krauchunas AR, 2012, DEV BIOL, V370, P125, DOI 10.1016/j.ydbio.2012.07.024; Lane JM, 2017, NAT GENET, V49, P274, DOI 10.1038/ng.3749; Li JX, 2015, HUM MUTAT, V36, P98, DOI 10.1002/humu.22712; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; Port F, 2016, NAT METHODS, V13, P852, DOI 10.1038/nmeth.3972; Quast C, 2012, AM J MED GENET B, V159B, P896, DOI 10.1002/ajmg.b.32096; Shimada-Sugimoto Mihoko, 2016, Hum Genome Var, V3, P16001, DOI 10.1038/hgv.2016.1; Son HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139716; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Yang CJ, 2015, RNA BIOL, V12, P1109, DOI 10.1080/15476286.2015.1085150; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825	26	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245454	10.1371/journal.pone.0245454	http://dx.doi.org/10.1371/journal.pone.0245454			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444382	Green Published, gold			2022-12-26	WOS:000609988100021
J	Guha, S; Herman, A; Carr, IA; Porter, D; Natu, R; Berman, S; Myers, MR				Guha, Suvajyoti; Herman, Alexander; Carr, Ian A.; Porter, Daniel; Natu, Rucha; Berman, Shayna; Myers, Matthew R.			Comprehensive characterization of protective face coverings made from household fabrics	PLOS ONE			English	Article							SIZE DISTRIBUTION; CORONAVIRUS; FACEMASKS; QUANTITY; MASKS	Background Face coverings constitute an important strategy for containing pandemics, such as COVID-19. Infection from airborne respiratory viruses including Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can occur in at least three modes; tiny and/or dried aerosols (typically < 1.0 mu m) generated through multiple mechanisms including talking, breathing, singing, large droplets (> 0.5 mu m) generated during coughing and sneezing, and macro drops transmitted via fomites. While there is a growing number of studies looking at the performance of household materials against some of these situations, to date, there has not been any systematic characterization of household materials against all three modes. Methods A three-step methodology was developed and used to characterize the performance of 21 different household materials with various material compositions (e.g. cotton, polyester, polypropylene, cellulose and blends) using submicron sodium chloride aerosols, water droplets, and mucous mimicking macro droplets over an aerosol-droplet size range of similar to 20 nm to 0.6 cm. Results Except for one thousand-thread-count cotton, most single-layered materials had filtration efficiencies < 20% for sub-micron solid aerosols. However, several of these materials stopped > 80% of larger droplets, even at sneeze-velocities of up to 1700 cm/s. Three or four layers of the same material, or combination materials, would be required to stop macro droplets from permeating out or into the face covering. Such materials can also be boiled for reuse. Conclusion Four layers of loosely knit or woven fabrics independent of the composition (e.g. cotton, polyester, nylon or blends) are likely to be effective source controls. One layer of tightly woven fabrics combined with multiple layers of loosely knit or woven fabrics in addition to being source controls can have sub-micron filtration efficiencies > 40% and may offer some protection to the wearer. However, the pressure drop across such fabrics can be high (> 100 Pa).	[Guha, Suvajyoti; Herman, Alexander; Carr, Ian A.; Porter, Daniel; Natu, Rucha; Berman, Shayna; Myers, Matthew R.] US FDA, Div Appl Mech, Off Sci & Engn Labs, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Guha, S (corresponding author), US FDA, Div Appl Mech, Off Sci & Engn Labs, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA.	Suvajyoti.Guha@fda.hhs.gov	Herman, Alexander/AAD-2113-2021; Porter, Daniel/I-2720-2018	Herman, Alexander/0000-0002-8378-8184; Porter, Daniel/0000-0002-4219-3782; Guha, Suvajyoti/0000-0002-7622-2721	U.S. Food and Drug Administration	U.S. Food and Drug Administration	This study was funded by the U.S. Food and Drug Administration.	Aboubakr HA, 2021, TRANSBOUND EMERG DIS, V68, P296, DOI 10.1111/tbed.13707; Alsved M, 2020, AEROSOL SCI TECH, V54, P1245, DOI 10.1080/02786826.2020.1812502; Anderson Christopher J., 2020, LSE COVID 19 BLOG; [Anonymous], 2007, DETERMINATION PARTIC; Bagheri MH, 2020, FILTRATION EFFICIENC; Bar-On YM, 2020, ELIFE, V9, DOI 10.7554/eLife.57309; Bryce E, 2008, J HOSP INFECT, V68, P241, DOI 10.1016/j.jhin.2007.12.007; CDC, 2019, CDC TEB APR STP; CDC, 2020, US MASKS HELP SLOW S; CDC, 2019, DET PART FILT EFF LE; Cook TM, 2020, ANAESTHESIA, V75, P920, DOI 10.1111/anae.15071; Davies Anna, 2013, Disaster Med Public Health Prep, V7, P413, DOI 10.1017/dmp.2013.43; Desai Angel N, 2020, JAMA, V323, P2103, DOI 10.1001/jama.2020.6437; Fischer EP, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd3083; Gandhi M, 2020, J GEN INTERN MED, V35, P3063, DOI 10.1007/s11606-020-06067-8; Guha S, 2017, J OCCUP ENVIRON HYG, V14, P214, DOI 10.1080/15459624.2016.1237029; Guha S, 2015, AM J INFECT CONTROL, V43, P871, DOI 10.1016/j.ajic.2015.03.032; HALL GJL, 1971, BRIT J PREV SOC MED, V25, P109; Jayaweera M, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109819; Jonathan J.Y, 2020, J HEAD FACE PAIN, V60, P864; Jung H, 2014, AEROSOL AIR QUAL RES, V14, P991, DOI 10.4209/aaqr.2013.06.0201; Kim JH, 2015, INT J OCCUP MED ENV, V28, P71, DOI 10.13075/ijomeh.1896.00153; Konda A, 2020, ACS NANO, V14, P6339, DOI 10.1021/acsnano.0c03252; KYOKAME K, 1980, J CHEM ENG JAPAN, V14, P54; Lee J, 2019, AEROSOL AIR QUAL RES, V19, P840, DOI 10.4209/aaqr.2018.01.0031; Lindsley WG, 2012, J OCCUP ENVIRON HYG, V9, P443, DOI 10.1080/15459624.2012.684582; Lustig SR, 2020, ACS NANO, V14, P7651, DOI 10.1021/acsnano.0c03972; Mainelis G, 2001, J AEROSOL SCI, V32, P1087, DOI 10.1016/S0021-8502(01)00039-8; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Morawska Lidia, 2020, CLIN INFECT DIS; Munyard P, 1996, ARCH DIS CHILD, V74, P531, DOI 10.1136/adc.74.6.531; Nikitin N, 2014, ADV VIROL, V2014, DOI 10.1155/2014/859090; O'Kelly E., 2020, ABILITY FABRIC FACEM; Picard A., 2020, GLOBE MAIL, DOI DOI 10.1352/1934-9556-58.6.486; Pyankov OV, 2018, J AEROSOL SCI, V115, P158, DOI 10.1016/j.jaerosci.2017.09.009; Rengasamy S, 2017, J OCCUP ENVIRON HYG, V14, P92, DOI 10.1080/15459624.2016.1225157; Rengasamy S, 2010, ANN OCCUP HYG, V54, P789, DOI 10.1093/annhyg/meq044; Rodriguez-Palacios A, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00260; RODRIGUEZPALACIOS, 2020, FRONT MED-LAUSANNE, V7, DOI DOI 10.3389/FMED.2020.00260; Saif MTA., 2020, PERFORMANCE FABRICS, DOI [10.1101/2020.04.19.20071779, DOI 10.1101/2020.04.19.20071779]; Staymates M, 2020, MY STAY HOME LAB SHO; Tang JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059970; Verma S, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0016018; Wang WK, 2004, EMERG INFECT DIS, V10, P1213, DOI 10.3201/eid1007.031113; Wathore R, 2020, SCI TOTAL ENVIRON, V749, DOI 10.1016/j.scitotenv.2020.141486; WebMD, BIOT PBF MOUTHW ART; World Health Organization, 2020, GUIDING PRINCIPLES I; Yang W, 2011, J R SOC INTERFACE, V8, P1176, DOI 10.1098/rsif.2010.0686; Zangmeister C, 2020, ACS NANO; Zhao M, 2020, NANO LETT, V20, P5544, DOI 10.1021/acs.nanolett.0c02211	50	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0244626	10.1371/journal.pone.0244626	http://dx.doi.org/10.1371/journal.pone.0244626			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439878	Green Published, gold			2022-12-26	WOS:000609985300046
J	Muslim, A; Lim, YAL; Sofian, SM; Shaari, SA; Zain, ZM				Muslim, Azdayanti; Lim, Yvonne Ai-Lian; Mohd Sofian, Sakinah; Shaari, Syahrul Azlin; Mohd Zain, Zaini			Nutritional status, hemoglobin level and their associations with soil-transmitted helminth infections between Negritos (indigenous) from the inland jungle village and resettlement at town peripheries	PLOS ONE			English	Article							ORANG ASLI CHILDREN; CHILDHOOD MALNUTRITION; ASCARIS-LUMBRICOIDES; ABORIGINES; MALAYSIA; DISEASE; ANEMIA	This study compared the current nutritional status, hemoglobin levels and their associations with soil-transmitted helminth (STH) infections between two categories of Negritos (indigenous): (i) Inland Jungle Villages (IJV) (ii) and Resettlement Plan Scheme (RPS) near town peripheries, decades after redevelopment and demarginalization. A total of 416 Negritos (IJV: 149; RPS: 267) was included for nutritional profiling based on anthropometric analysis. However, only 196 (IJV: 64; RPS: 132) individuals consented to blood taking for the hemoglobin (Hb) measurements. Subsequently, the association of undernutrition and anemia with STH infections were determined based on univariate and multivariate logistic regression analyses. The overall prevalence of stunting, wasting, and underweight amongst children and adolescents (n = 343) were 45.8%, 42.3% and 59.1%, respectively. In adults (n = 73), the prevalence of underweight was low (6.8%) but overweight and obese was prominent (26.0%). For anemia (n = 196), an overall prevalence rate of 68.4% were observed with 80% and 70.4% of children aged 2-6 y/o and aged 7-12 y/o, respectively being anemic. Comparatively, the prevalence of underweight (WAZ) was significantly higher in the RPS versus the IJV (P = 0.03) In the IJV, children aged <= 6 y/o and having STH poly-parasitism were associated with underweight (P = 0.01) and moderate-severe T. trichiura infection was associated with anemia. Whilst in the RPS, underweight was highly associated with only T. trichiura infection (P = 0.04). Wasting was significantly associated with young children aged <= 10 in both IJV (P = 0.004) and RPS (P = 0.02). Despite efforts in improving provision of facilities and amenities among the indigenous, this study highlighted a high magnitude of nutritional issues among the Negritos especially those in the RPS and their likely association with STH infections and decades of demarginalization. Joint nutritional intervention strategies with mass anti-helminthic treatment are imperative and urgently needed to reduce the undernutrition problems especially among indigenous children.	[Muslim, Azdayanti; Lim, Yvonne Ai-Lian] Univ Malaya, Dept Parasitol, Fac Med, Kuala Lumpur, Malaysia; [Muslim, Azdayanti; Shaari, Syahrul Azlin; Mohd Zain, Zaini] Univ Teknol MARA, Dept Med Microbiol & Parasitol, Fac Med, Sungai Buloh, Selangor, Malaysia; [Lim, Yvonne Ai-Lian] Univ Malaya, Ctr Malaysian Indigenous Studies CMIS, Kuala Lumpur, Malaysia; [Lim, Yvonne Ai-Lian] Univ Malaya, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia; [Mohd Sofian, Sakinah] Univ Teknol MARA, Inst Med Mol Biotechnol IMMB, Fac Med, Sungai Buloh, Selangor, Malaysia	Universiti Malaya; Universiti Teknologi MARA; Universiti Malaya; Universiti Malaya; Universiti Teknologi MARA	Muslim, A; Lim, YAL (corresponding author), Univ Malaya, Dept Parasitol, Fac Med, Kuala Lumpur, Malaysia.; Muslim, A (corresponding author), Univ Teknol MARA, Dept Med Microbiol & Parasitol, Fac Med, Sungai Buloh, Selangor, Malaysia.; Lim, YAL (corresponding author), Univ Malaya, Ctr Malaysian Indigenous Studies CMIS, Kuala Lumpur, Malaysia.; Lim, YAL (corresponding author), Univ Malaya, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia.	azdayanti@salam.uitm.edu.my; limailian@um.edu.my	Muslim, Azdayanti/ABB-1333-2020; LIM, YVONNE AL/B-5276-2010	LIM, YVONNE AL/0000-0003-4050-6332; Muslim, Azdayanti/0000-0003-1351-2526	Fundamental Research Grant Scheme (FRGS), Ministry of Higher Education, Malaysia [FRGS 1/2015/SKK 11/UiTM/03/1, FP004-2017A]	Fundamental Research Grant Scheme (FRGS), Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	This research was funded by the Fundamental Research Grant Scheme (FRGS), Ministry of Higher Education, Malaysia [FRGS 1/2015/SKK 11/UiTM/03/1 and FP004-2017A].	Aghakhanian F, 2015, GENOME BIOL EVOL, V7, P1206, DOI 10.1093/gbe/evv065; Ahmed A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-119; Al-Mekhlafi HMS, 2005, ASIA PAC J CLIN NUTR, V14, P188; Al-Mekhlafi MH, 2008, T ROY SOC TROP MED H, V102, P1046, DOI 10.1016/j.trstmh.2008.05.012; Al-Mekhlafi MSH, 2005, T ROY SOC TROP MED H, V99, P686, DOI 10.1016/j.trstmh.2005.02.006; [Anonymous], 2006, PREV CHEM HUM HELM C; Aziz TATA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2848-9; Baer A., 1999, HLTH DIS SURVIVAL BI; BENDEL RB, 1977, J AM STAT ASSOC, V72, P46, DOI 10.2307/2286904; Blo''ssner M., 2005, MALNUTRITION QUANTIF; BOLTON JM, 1972, AM J CLIN NUTR, V25, P789; BREARLEY A, 1970, Medical Journal of Malaya, V24, P183; BURNSCOX CJ, 1970, AM HEART J, V80, P718, DOI 10.1016/0002-8703(70)90022-0; BURNSCOX CJ, 1972, BRIT HEART J, V34, P953, DOI 10.1136/hrt.34.9.953; Decruyenaere A, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0206-y; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Department of Statistics, 2016, HOUS INC BAS AM SURV; Dunn F. L., 1968, MAN HUNTER, P221; DUNN FL, 1972, B WORLD HEALTH ORGAN, V46, P99; EGGER RJ, 1990, TROP GEOGR MED, V42, P312; Ey Chua E Y, 2012, Malays J Nutr, V18, P1; Geik OP, 2016, PAK J NUTR, V15, P133; Gendrel D, 2003, FUND CLIN PHARMACOL, V17, P189, DOI 10.1046/j.1472-8206.2003.00169.x; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; Herrador Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105880; JHEOA, 2010, PEC PEND OR ASL MENG; Khara T., 2016, FIELD EXCH, V50, P23; Lan WS, 2008, STUDY 5 DEATHS MALAY, P37; Leng C O, 1974, Med J Malaysia, V28, P267; Lin Khor Geok, 1994, PERTANIKA J SOC SCI, V2, P123; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Moktar N, 2004, ASIA PAC J CLIN NUTR, P13; Muslim A, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007331; National Health and Morbidity Survey, 2016, 2016 MAT CHILD HLTH, DOI [10.1177/1363459315595846, DOI 10.1177/1363459315595846]; Navarro C, 2006, ADULT MALNUTRITION E; Ngui R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001550; Panter-Brick C, 2001, HUNTER GATHERERS INT, DOI [10.1079/bjn2000225, DOI 10.1079/BJN2000225]; Papier K, 2014, CLIN INFECT DIS, V59, P234, DOI 10.1093/cid/ciu211; ROBSON P, 1973, AM J CLIN NUTR, V26, P95, DOI 10.1093/ajcn/26.1.95; Saibul N, 2009, ASIA PAC J CLIN NUTR, V18, P412; Shrimpton R., 2012, DOUBLE BURDEN MALNUT; STEPHENSON LS, 1993, J NUTR, V123, P1036; STEPHENSON LS, 1980, PARASITOLOGY, V81, P221, DOI 10.1017/S0031182000055177; Tariku EZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206659; Wang H, 2007, WORKS POSIT NAVIGAT, P1; WHO, 2001, AN DEF; *WHO, 2004, INH WORLD ATL CHILDR; Wong CY, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2058-x; Wong WK, 2016, CAN J INFECT DIS MED, V2016, DOI 10.1155/2016/1326085; Zerdo Z., 2017, TRANSL BIOMED, V8, P2; 2010, J ROYAL ANTHR I, V16	51	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0245377	10.1371/journal.pone.0245377	http://dx.doi.org/10.1371/journal.pone.0245377			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439889	gold, Green Published			2022-12-26	WOS:000609985300020
J	Reisberg, K; Riso, EM; Jurimae, J				Reisberg, Kirkke; Riso, Eva-Maria; Jurimae, Jaak			Physical fitness in preschool children in relation to later body composition at first grade in school	PLOS ONE			English	Article							CHILDHOOD OVERWEIGHT; OBESITY; STRENGTH; ADOLESCENCE; ASSOCIATION; BALANCE; IMPACT; RISK	Background This study aimed to investigate whether better physical fitness in kindergarten predicts later healthier body composition in first grade at school. Methods Body composition was assessed by skinfold thickness measurements. Physical fitness tests included 20 m shuttle run test, handgrip strength test, standing long jump test, 4x10 m shuttle run test as part of PREFIT fitness test battery, and one-leg stance test from EUROFIT test battery. The participants of this study were 147 Estonian children (51% boys) aged 6-8 years, who were measured in the transition from kindergarten to school. Results After adjusting for maternal body mass index, educational attainment, child's sex, age at the measurements, greater cardiovascular and motor fitness, relative lower body strength, static balance at 6.6 yr were associated with lower fat mass index, fat mass percentage at 12-month follow-up. The relative lower body strength above the median at 6.6 yr were related to lower fat mass index and fat mass percentage at 12-month follow-up, while the static balance test results demonstrated the opposite associations. Improvements in the 4x10 m shuttle run test results during the 12-month follow-up period were associated with the most beneficial changes in body composition status, such as increases in fat-free mass index and decreases in fat mass index, fat mass percentage, waist-to-height ratio after adjusting for maternal body mass index, educational attainment, child's sex, age, at the measurements and baseline values of exposures. Conclusion Better physical fitness tests results at 6.6 yr in kindergarten generally predicted lower body fat parameters in children at 7.6 yr in first grade at school.	[Reisberg, Kirkke; Riso, Eva-Maria; Jurimae, Jaak] Tartu Univ, Inst Sports Sci & Physiotherapy, Tartu, Estonia; [Reisberg, Kirkke] Tartu Healthcare Coll, Tartu, Estonia	University of Tartu	Reisberg, K (corresponding author), Tartu Univ, Inst Sports Sci & Physiotherapy, Tartu, Estonia.; Reisberg, K (corresponding author), Tartu Healthcare Coll, Tartu, Estonia.	kirkkereisberg@nooruse.ee	Reisberg, Kirkke/AAG-5928-2021	Reisberg, Kirkke/0000-0002-7616-7195	Estonian Ministry of Education and Science [IUT 20-58]	Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia)	Jaak Jurimae received funding from IUT 20-58 grant from the Estonian Ministry of Education and Science.	Abdelmoula A, 2012, APPL PHYSIOL NUTR ME, V37, P269, DOI [10.1139/h2012-010, 10.1139/H2012-010]; Artero EG, 2012, J SPORT MED PHYS FIT, V52, P263; Brady TM, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00197; Browne Allen F, 2017, Gastrointest Endosc Clin N Am, V27, P313, DOI 10.1016/j.giec.2017.01.003; Burns Ryan D, 2017, Prev Med Rep, V5, P21; Cadenas-Sanchez C, 2019, J SCI MED SPORT, V22, P430, DOI 10.1016/j.jsams.2018.09.227; Cadenas-Sanchez C, 2016, J SCI MED SPORT, V19, P910, DOI 10.1016/j.jsams.2016.02.003; Cicek B, 2014, J PAK MED ASSOC, V64, P1154; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Moraes FB, 2018, REV BRAS MED ESPORTE, V24, P361, DOI 10.1590/1517-869220182405156640; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Ervin RB, 2014, PEDIATRICS, V134, pE782, DOI 10.1542/peds.2014-0794; Fjortoft I, 2000, PEDIATR EXERC SCI, V12, P424, DOI 10.1123/pes.12.4.424; French SA, 2018, OBESITY, V26, P1467, DOI 10.1002/oby.22273; Gandhi M, 2010, ANTHROPOLOGIST, V12, P35, DOI 10.1080/09720073.2010.11891129; Grant-Guimaraes J, 2016, GASTROENTEROL CLIN N, V45, P715, DOI 10.1016/j.gtc.2016.07.007; Henriksson P, 2019, J SCI MED SPORT, V22, P574, DOI 10.1016/j.jsams.2018.11.024; Hussain Z, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004194; Jimenez-Pavon D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-667; Kakebeeke TH, 2017, OBESITY FACTS, V10, P420, DOI 10.1159/000477406; Leppanen MH, 2017, MED SCI SPORT EXER, V49, P2078, DOI 10.1249/MSS.0000000000001313; Lloyd LJ, 2012, INT J OBESITY, V36, P1, DOI 10.1038/ijo.2011.186; Marfell-Jones M, 2006, INT STANDARDS ANTHRO, DOI [10.1016/s1286-0115(06)74505-2, DOI 10.1016/S1286-0115(06)74505-2]; Martin A, 2017, CURR OBES REP, V6, P297, DOI 10.1007/s13679-017-0272-9; McGavock JM, 2009, OBESITY, V17, P1802, DOI 10.1038/oby.2009.59; McGuine TA, 2000, CLIN J SPORT MED, V10, P239, DOI 10.1097/00042752-200010000-00003; Mehta SK, 2015, CLIN PEDIATR, V54, P652, DOI 10.1177/0009922814557784; Muller MJ, 2012, OBES REV, V13, P6, DOI 10.1111/j.1467-789X.2012.01033.x; Must A, 2012, J PEDIATR-US, V160, P743, DOI 10.1016/j.jpeds.2011.10.037; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Ortega FB, 2011, MED SCI SPORT EXER, V43, P1891, DOI 10.1249/MSS.0b013e3182190d71; PERUSSE L, 1988, CAN J SPORT SCI, V13, P8; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Reisberg K, 2020, SCAND J MED SCI SPOR, V30, P2251, DOI 10.1111/sms.13784; Riso EM, 2019, ACTA PAEDIATR, V108, P1624, DOI 10.1111/apa.14750; Riso EM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218901; Riso EM, 2018, INT HANDB QUALITY, P365, DOI 10.1007/978-3-319-75529-8_21; Riso EM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5406-9; Riso EM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3000-6; Rodrigues LP, 2016, J SCI MED SPORT, V19, P87, DOI 10.1016/j.jsams.2015.01.002; Rodrigues LP, 2013, J SCI MED SPORT, V16, P118, DOI 10.1016/j.jsams.2012.06.008; Sartorio A, 2002, J ENDOCRINOL INVEST, V25, P431, DOI 10.1007/BF03344033; Schmutz EA, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00039; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Steffl M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177006; Sutaria S, 2019, ARCH DIS CHILD, V104, P64, DOI 10.1136/archdischild-2017-314608; Tomlinson DJ, 2016, BIOGERONTOLOGY, V17, P467, DOI 10.1007/s10522-015-9626-4; Weber David R, 2012, Pediatr Endocrinol Rev, V10, P130; World Health Organization, 2011, GLOB REC PHYS ACT HL	49	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0244603	10.1371/journal.pone.0244603	http://dx.doi.org/10.1371/journal.pone.0244603			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439898	gold, Green Published			2022-12-26	WOS:000609985300015
J	Lv, QQ; Tian, YS; Zhou, JL; Ren, HW; Wang, GH; Sarafraz, M				Lv, Qing Q.; Tian, Yong S.; Zhou, Jun L.; Ren, Hua W.; Wang, Guang H.; Sarafraz, Mohsen			A comprehensive investigation of the reaction behaviorial features of coke with different CRIs in the simulated cohesive zone of a blast furnace	PLOS ONE			English	Article							REDUCTION	The reaction characteristics and mechanism of coke with different coke reactivity indices (CRIs) in the high-temperature zone of a blast furnace should be fully understood to correctly evaluate the coke quality and optimize ironmaking. In this work, low-CRI coke (coke A) and high-CRI coke (coke B) were charged into a thermogravimetric analyzer to separately study their microstructural changes, gasification characteristics, and reaction mechanism under simulated cohesive zone conditions in a blast furnace. The results show that both coke A and coke B underwent pyrolysis, polycondensation, and graphitization during the heat treatment. The pyrolysis, polycondensation, gasification speed, and dissolution speed rates of coke B were higher than those of coke A. Direct and indirect reduction between sinter and coke occurred in the cohesive zone and had different stages. The consumption rate of coke B was faster than that of coke A during the coke-sinter reduction. The carbon molecules of coke A must absorb more energy to break away from the skeleton than those of coke B.	[Lv, Qing Q.; Tian, Yong S.; Wang, Guang H.; Sarafraz, Mohsen] Wuhan Univ Sci & Technol, Sch Chem & Chem Engn, Wuhan, Peoples R China; [Lv, Qing Q.; Tian, Yong S.; Wang, Guang H.; Sarafraz, Mohsen] Key Lab Hubei Prov Coal Convers & New Carbon Mat, Wuhan, Peoples R China; [Zhou, Jun L.] Iron & Steel Res Inst Shasteel, Zhangjiagang, Jiangsu, Peoples R China; [Ren, Hua W.] Xingtai Risun Sci & Technol Co Ltd, Coking Div, Xingtai, Hebei, Peoples R China	Wuhan University of Science & Technology	Wang, GH (corresponding author), Wuhan Univ Sci & Technol, Sch Chem & Chem Engn, Wuhan, Peoples R China.; Wang, GH (corresponding author), Key Lab Hubei Prov Coal Convers & New Carbon Mat, Wuhan, Peoples R China.	wghwang@263.net			National Key RAMP;D Program of China [2017YFB0304300, 2017YFB0304303]; National Key RAMP;D Program of China	National Key RAMP;D Program of China; National Key RAMP;D Program of China	This work was financially Supported by National Key R&D Program of China (2017YFB0304300&2017YFB0304303). The funder is National Key R&D Program of China. And no sponsors of funder play any role in the study design, data dollection and analysis, desision to publish, or preparation of the manuscript. The National Key R&D program provided support in the form of salaries for authors [QQL, YST, JLZ, HWR and GHW]. The Key Laboratory of Hubei Province for Coal Conversion and New Carbon Materials provided support for this study in the form of salary for authors YST and GHW. Iron and Steel Research Institute of Shasteel provided support in the form of salary for author JLZ. Zhangjiagang and Xingtai Risun Science and Technology Co., Ltd. provided support in the form of salary for author HWR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Barde AA, 2016, INT J HYDROGEN ENERG, V41, P10103, DOI 10.1016/j.ijhydene.2015.12.129; Bertling H, 1999, ISIJ INT, V39, P617, DOI 10.2355/isijinternational.39.617; Chapman MW, 2011, METALL MATER TRANS B, V42, P642, DOI 10.1007/s11663-011-9519-0; Chen K, 2019, FUEL, V246, P60, DOI 10.1016/j.fuel.2019.02.096; Dong S, 2009, ENERG FUEL, V23, P1651, DOI 10.1021/ef800961g; Fang Zhan, 2012, Shanghai Metals, V34, P31; Fehse F, 2017, FUEL, V203, P915, DOI 10.1016/j.fuel.2017.05.002; FERNANDEZ AM, 2012, FUEL, V95, P642; Filatov S. V., 2014, Steel in Translation, V44, P746, DOI 10.3103/S0967091214100040; Flores BD, 2017, FUEL PROCESS TECHNOL, V164, P13, DOI 10.1016/j.fuproc.2017.04.015; Gasparini VM, 2017, J MATER RES TECHNOL, V6, P220, DOI 10.1016/j.jmrt.2016.12.001; Guo R, 2012, IRONMAKING, V31, P45; Gupta S, 2013, FUEL, V113, P77, DOI 10.1016/j.fuel.2013.05.074; Harris PJF, 2005, CRIT REV SOLID STATE, V30, P235, DOI 10.1080/10408430500406265; IGUCHI Y, 1993, TETSU TO HAGANE, V79, P431, DOI 10.2355/tetsutohagane1955.79.4_431; Kawakami M, 2006, ISIJ INT, V46, P1165, DOI 10.2355/isijinternational.46.1165; [孔德文 Kong Dewen], 2011, [钢铁, Iron and Steel], V46, P15; Kurunov IF, 2007, METALLURGIST+, V51, P644, DOI 10.1007/s11015-007-0116-z; Lan CC, 2019, FUEL PROCESS TECHNOL, V193, P180, DOI 10.1016/j.fuproc.2019.05.012; Li KJ, 2016, METALL MATER TRANS B, V47, P811, DOI 10.1007/s11663-015-0574-9; Liu ZL, 2009, THEORY TECHNOLOGY IR; Lyalyuk VP, 2011, COKE CHEM, V54, P47, DOI [10.3103/S1068364X11020050, 10.3103/S1068364X11080059]; Mohanty A, 2019, FUEL, V249, P411, DOI 10.1016/j.fuel.2019.03.108; Monaghan BJ, 2008, IRONMAK STEELMAK, V35, P38, DOI 10.1179/030192307X233377; Sahajwalla V, 2002, ACTA MATER, V50, P663, DOI 10.1016/S1359-6454(01)00398-6; Sahajwalla V, 2000, METALL MATER TRANS B, V31, P1517, DOI 10.1007/s11663-000-0036-9; Shen LL, 2013, RES IRON STEEL, V41, P6; Song, 2009, THEORY OPERATION BLA; Sun, 2013, BAOSTEEL TECHNOL, V6, P6; SUNAHARA K, 1993, ISIJ INT, V33, P275, DOI 10.2355/isijinternational.33.275; Tong ZF, 2017, ISIJ INT, V57, P245, DOI 10.2355/isijinternational.ISIJINT-2016-414; Ubando AT, 2019, ENERGY, V180, P968, DOI 10.1016/j.energy.2019.05.149; Wang HT, 2018, POWDER TECHNOL, V328, P318, DOI 10.1016/j.powtec.2018.01.027; Wang Q, 2016, FUEL, V182, P879, DOI 10.1016/j.fuel.2016.05.101; Wang W, 2017, FUEL PROCESS TECHNOL, V159, P118, DOI 10.1016/j.fuproc.2017.01.039; Xing X, 2019, FUEL, V237, P775, DOI 10.1016/j.fuel.2018.10.069; Xu BX, 2003, PRACTICAL HDB NEW CO; Ye ZZ, 2013, ISIJ INT, V53, P181, DOI 10.2355/isijinternational.53.181; Yu XB, 2020, POWDER TECHNOL, V361, P124, DOI 10.1016/j.powtec.2019.10.012; Zhang S., 2013, COAL COAL CHEM; Zhang WJ, 2019, FUEL, V251, P218, DOI 10.1016/j.fuel.2019.04.057; Zhao HB, 2013, J IRON STEEL RES INT, V20, P6, DOI 10.1016/S1006-706X(13)60074-6; Zhou SY, 2005, COKING COAL PROPERTY; Zhu XQ, 2016, BIORESOURCE TECHNOL, V207, P85, DOI 10.1016/j.biortech.2016.01.105; Zhu ZZ, 2006, J IRON STEEL RES INT, V13, P14, DOI 10.1016/S1006-706X(06)60053-8	45	0	0	9	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0245124	10.1371/journal.pone.0245124	http://dx.doi.org/10.1371/journal.pone.0245124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428653	Green Published, gold			2022-12-26	WOS:000630036100034
J	Wada, Y; Iyoda, M; Matsumoto, K; Suzuki, T; Tachibana, S; Kanazawa, N; Honda, H				Wada, Yukihiro; Iyoda, Masayuki; Matsumoto, Kei; Suzuki, Taihei; Tachibana, Shohei; Kanazawa, Nobuhiro; Honda, Hirokazu			Reno-protective effect of IL-34 inhibition on cisplatin-induced nephrotoxicity in mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; WISTAR-KYOTO RATS; GROWTH-FACTOR; LANGERHANS CELLS; KIDNEY; RECEPTOR; CSF-1; MACROPHAGES; CYTOKINE; SURVIVAL	Introduction Interleukin-34 (IL-34) shares a receptor (cFMS) with colony stimulating factor-1 (CSF-1), and these two ligands mediate macrophage proliferation. However, in contrast to CSF-1, the influence of IL-34 on tubular epithelial cells (TECs) injury remains unclear. We investigated the physiological effects of IL-34 on TEC damage caused by cisplatin nephrotoxicity (CP-N). Methods Mice were administered anti-mouse IL-34 antibody (anti-IL-34 Ab; 400 ng/kg) or vehicle from 1 day before and up to 2 days after CP-N induction. In vitro, mouse renal proximal TECs (MRPTEpiC) were cultured to analyze the inhibitory effects of IL-34 on CP-induced TEC apoptosis. Results Compared to vehicle treatment, anti-IL-34 Ab treatment significantly suppressed the intrarenal expression of IL-34 and its two receptors, cFMS and PTP-zeta, and significantly improved renal function, ameliorated tubulointerstitial injury, suppressed macrophage infiltration, and reduced apoptotic cell numbers in CP-N mice. It also significantly reduced the renal transcript levels of Kim-1, MIP-1/CCL3, TNF-alpha, and Bax in CP-N mice. Furthermore, anti-IL-34 Ab-treated CP-N mice showed less renal infiltration of F4/80(+) TNF-alpha(+) cells. In vitro, stimulation with CP induced the expression of IL-34 and its two receptors in MRPTEpiC. Anti-IL-34 Ab treatment significantly suppressed CP-induced Bax expression with the degradation of ERK1/2 phosphorylation in damaged MRPTEpiC. Conclusions IL-34 secreted from damaged TECs appeared to be involved in the progression of CP-N. Inhibition of IL-34 with neutralizing antibody directly prevented CP-induced TEC apoptosis by inhibiting the phosphorylation of ERK 1/2. Blocking of IL-34 appears to suppress the proliferation of cytotoxic macrophages, which indirectly attenuates CP-N. Thus, IL-34 represents a potential therapeutic target for TEC injury, and the inhibition of IL-34 might have a reno-protective effect.	[Wada, Yukihiro; Iyoda, Masayuki; Suzuki, Taihei; Tachibana, Shohei; Kanazawa, Nobuhiro; Honda, Hirokazu] Showa Univ, Dept Med, Div Nephrol, Sch Med, Tokyo, Japan; [Iyoda, Masayuki] Showa Univ, Dept Microbiol & Immunol, Sch Med, Tokyo, Japan; [Matsumoto, Kei] Showa Univ, Dept Med, Div Nephrol, Koto Toyosu Hosp, Tokyo, Japan	Showa University; Showa University; Showa University	Wada, Y (corresponding author), Showa Univ, Dept Med, Div Nephrol, Sch Med, Tokyo, Japan.	yukihiro@med.showa-u.ac.jp		Wada, Yukihiro/0000-0001-5996-8735	Japan Society for the Promotion of Science KAKENHI [19K08734]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion of Science KAKENHI (Grant number 19K08734).	Azalaru DL, 2016, NEPHROL DIAL TRANSPL, V31, P1781, DOI 10.1093/ndt/gfw083; Baek JH, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01016; Baek JH, 2015, J CLIN INVEST, V125, P3198, DOI 10.1172/JCI81166; Baghdadi M, 2016, CANCER RES, V76, P6030, DOI 10.1158/0008-5472.CAN-16-1170; Bezie S, 2015, J CLIN INVEST, V125, P3952, DOI 10.1172/JCI81227; Boulakirba S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18433-4; BYRNE PV, 1981, J CELL BIOL, V91, P848, DOI 10.1083/jcb.91.3.848; Cohen S, 2012, J IMMUNOL, V188, P259, DOI 10.4049/jimmunol.1101468; Day YJ, 2005, AM J PHYSIOL-RENAL, V288, pF722, DOI 10.1152/ajprenal.00378.2004; Sanchez-Nino MD, 2016, NEPHROL DIAL TRANSPL, V31, P1409, DOI 10.1093/ndt/gfw026; Fan Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep39324; Ferenbach DA, 2012, KIDNEY INT, V82, P928, DOI 10.1038/ki.2012.207; Foucher ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056045; Ge Y, 2019, INT J BIOL SCI, V15, P1835, DOI 10.7150/ijbs.35070; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Guilliams M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00406; Hirai Y, 2012, AM J PHYSIOL-RENAL, V302, pF244, DOI 10.1152/ajprenal.00113.2011; Huen SC, 2015, J AM SOC NEPHROL, V26, P1334, DOI 10.1681/ASN.2014060612; Iseri K, 2016, AM J PHYSIOL-RENAL, V310, pF1182, DOI 10.1152/ajprenal.00165.2016; Iwata Y, 2012, J IMMUNOL, V188, P4568, DOI 10.4049/jimmunol.1102154; Iyoda M, 2011, J AM SOC NEPHROL, V22, P1486, DOI 10.1681/ASN.2010111158; Iyoda M, 2009, KIDNEY INT, V75, P1060, DOI 10.1038/ki.2009.43; Jo SK, 2005, KIDNEY INT, V67, P458, DOI 10.1111/j.1523-1755.2005.67102.x; Kanazawa N, 2020, KIDNEY BLOOD PRESS R, V45, P391, DOI 10.1159/000506286; Lee H, 2010, KIDNEY INT, V78, P1100, DOI 10.1038/ki.2010.139; Li JZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23975; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Masteller EL, 2014, DRUG DISCOV TODAY, V19, P1212, DOI 10.1016/j.drudis.2014.05.016; Meng XM, 2014, NAT REV NEPHROL, V10, P493, DOI 10.1038/nrneph.2014.114; Menke J, 2012, CANCER RES, V72, P187, DOI 10.1158/0008-5472.CAN-11-1232; Menke J, 2009, J CLIN INVEST, V119, P2330, DOI 10.1172/JCI39087; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Nandi S, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.442731; Ortiz A, 1995, Adv Nephrol Necker Hosp, V24, P53; Ozkok A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/967826; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Perse M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1462802; Rogers NM, 2014, NAT REV NEPHROL, V10, P625, DOI 10.1038/nrneph.2014.170; Shi MJ, 2018, LAB INVEST, V98, P1105, DOI 10.1038/s41374-018-0063-2; Sorensen OE, 2006, J CLIN INVEST, V116, P1878, DOI 10.1172/JCI28422; Tachibana S, 2019, NEPHROL DIAL TRANSPL, V34, P774, DOI 10.1093/ndt/gfy201; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; van den Boorn JG, 2014, MOL THER, V22, P1577, DOI 10.1038/mt.2014.150; van Kooten C, 1999, KIDNEY INT, V56, P41, DOI 10.1046/j.1523-1755.1999.00514.x; Wada Y, 2019, J AM SOC NEPHROL, V30, P244, DOI 10.1681/ASN.2018090901; Wada Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206865; Wada Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111728; Wang YM, 2016, EUR J IMMUNOL, V46, P552, DOI 10.1002/eji.201545917; Wang YM, 2014, EUR J IMMUNOL, V44, P1575, DOI 10.1002/eji.201344365; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; WUTHRICH RP, 1990, KIDNEY INT, V37, P783, DOI 10.1038/ki.1990.46; Yamamoto Y, 2018, NEPHROL DIAL TRANSPL, V33, P598, DOI 10.1093/ndt/gfx264; Zhang MZ, 2012, J CLIN INVEST, V122, P4519, DOI 10.1172/JCI60363; Zilbermintz L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13476	55	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0245340	10.1371/journal.pone.0245340	http://dx.doi.org/10.1371/journal.pone.0245340			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428678	Green Published, gold			2022-12-26	WOS:000630036100059
J	Hayashi, I				Hayashi, Ikuko			The C-terminal region of the plasmid partitioning protein TubY is a tetramer that can bind membranes and DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						TubZ; crystal structure; bacteria; plasmid partitioning; DNA segregation; segrosome; MerR; amphipathic helix; plasmid; DNA binding protein; cytoskeleton; plasmid partioning	TUBULIN HOMOLOG TUBZ; COMPLEXES; SEQUENCE; REVEAL; DOMAIN; PARM; MIND; P53; REPLICATION; STABILITY	Bacterial low-copy-number plasmids require partition (par) systems to ensure their stable inheritance by daughter cells. In general, these systems consist of three components: a centromeric DNA sequence, a centromere-binding protein and a nucleotide hydrolase that polymerizes and functions as a motor. Type III systems, however, segregate plasmids using three proteins: the FtsZ/tubulin-like GTPase TubZ, the centromere-binding protein TubR and the MerR-like transcriptional regulator TubY. Although the TubZ filament is sufficient to transport the TubR-centromere complex in vitro, TubY is still necessary for the stable maintenance of the plasmid. TubY contains an N-terminal DNA-binding helix-turn-helix motif and a C-terminal coiled-coil followed by a cluster of lysine residues. This study determined the crystal structure of the C-terminal domain of TubY from the Bacillus cereus pXO1-like plasmid and showed that it forms a tetrameric parallel four-helix bundle that differs from the typical MerR family proteins with a dimeric anti-parallel coiled-coil. Biochemical analyses revealed that the C-terminal tail with the conserved lysine cluster helps TubY to stably associate with the TubR-centromere complex as well as to nonspecifically bind DNA. Furthermore, this C-terminal tail forms an amphipathic helix in the presence of lipids but must oligomerize to localize the protein to the membrane in vivo. Taken together, these data suggest that TubY is a component of the nucleoprotein complex within the partitioning machinery, and that lipid membranes act as mediators of type III systems.	[Hayashi, Ikuko] Yokohama City Univ, Dept Med Life Sci, Yokohama, Kanagawa, Japan	Yokohama City University	Hayashi, I (corresponding author), Yokohama City Univ, Dept Med Life Sci, Yokohama, Kanagawa, Japan.	ihay@yokohama-cu.ac.jp		Hayashi, Ikuko/0000-0003-4784-8933	MEXT, Japan Society for the Promotion of Science (JSPS) [15H01326, 19K05774]	MEXT, Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by MEXT, Japan Society for the Promotion of Science (JSPS) Grants 15H01326 and 19K05774 (to I. H.).	Aylett CHS, 2012, P NATL ACAD SCI USA, V109, P16522, DOI 10.1073/pnas.1210899109; Baxter JC, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.PLAS-0023-2014; Bharat TAM, 2015, NATURE, V523, P106, DOI 10.1038/nature14356; Brooks AC, 2017, PLASMID, V91, P37, DOI 10.1016/j.plasmid.2017.03.004; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; DAVIS MA, 1988, EMBO J, V7, P1881, DOI 10.1002/j.1460-2075.1988.tb03021.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Duman R, 2013, P NATL ACAD SCI USA, V110, pE4601, DOI 10.1073/pnas.1313978110; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fink G, 2015, P NATL ACAD SCI USA, V112, pE1845, DOI 10.1073/pnas.1423746112; Friedler A, 2005, STRUCTURE, V13, P629, DOI 10.1016/j.str.2005.01.020; FUNNELL BE, 1988, P NATL ACAD SCI USA, V85, P6657, DOI 10.1073/pnas.85.18.6657; Gayathri P, 2012, SCIENCE, V338, P1334, DOI 10.1126/science.1229091; Ge Y, 2014, J BACTERIOL, V196, P4304, DOI 10.1128/JB.01855-14; Ge Y, 2014, MICROBIOL-SGM, V160, P1112, DOI 10.1099/mic.0.075465-0; Gimenez-Andres M, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8030045; Hayashi I, 2018, J MOL BIOL, V430, P5015, DOI 10.1016/j.jmb.2018.11.001; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hofbauer HF, 2018, J CELL BIOL, V217, P3109, DOI 10.1083/jcb.201802027; Hoshino S, 2012, J BIOL CHEM, V287, P32103, DOI 10.1074/jbc.M112.373803; Hu ZL, 2003, MOL MICROBIOL, V47, P345, DOI 10.1046/j.1365-2958.2003.03321.x; Jain SS, 2008, NAT PROTOC, V3, P1092, DOI 10.1038/nprot.2008.72; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Laptenko O, 2016, TRENDS BIOCHEM SCI, V41, P1022, DOI 10.1016/j.tibs.2016.08.011; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Lee PS, 2006, MOL MICROBIOL, V60, P853, DOI 10.1111/j.1365-2958.2006.05140.x; Lewis PJ, 1999, GENE, V227, P101, DOI 10.1016/S0378-1119(98)00580-0; Martin-Garcia B, 2018, NUCLEIC ACIDS RES, V46, P5704, DOI 10.1093/nar/gky370; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Montabana EA, 2014, P NATL ACAD SCI USA, V111, P3407, DOI 10.1073/pnas.1318339111; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ni LS, 2010, P NATL ACAD SCI USA, V107, P11763, DOI 10.1073/pnas.1003817107; Oliva MA, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00051; Oliva MA, 2012, P NATL ACAD SCI USA, V109, P7711, DOI 10.1073/pnas.1121546109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008; Schumacher MA, 2005, NATURE, V438, P516, DOI 10.1038/nature04149; Schumacher MA, 2015, GENE DEV, V29, P451, DOI 10.1101/gad.254714.114; Szeto TH, 2003, J BIOL CHEM, V278, P40050, DOI 10.1074/jbc.M306876200; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Tang MJ, 2006, APPL ENVIRON MICROB, V72, P6948, DOI 10.1128/AEM.00976-06; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tinsley E, 2006, J BACTERIOL, V188, P2829, DOI 10.1128/JB.188.8.2829-2835.2006; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vecchiarelli AG, 2014, P NATL ACAD SCI USA, V111, P4880, DOI 10.1073/pnas.1401025111	50	1	1	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17770	17780		10.1074/jbc.RA120.014705	http://dx.doi.org/10.1074/jbc.RA120.014705			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454013	Green Published, hybrid			2022-12-26	WOS:000603272300029
J	Kim, YY; Um, JH; Shin, DJ; Jeong, DJ; Hong, YB; Yun, JH				Kim, Young Yeon; Um, Jee-Hyun; Shin, Dong Jin; Jeong, Dae Jin; Hong, Young Bin; Yun, Jeanho			p53-mediated regulation of mitochondrial dynamics plays a pivotal role in the senescence of various normal cells as well as cancer cells	FASEB JOURNAL			English	Article						cellular senescence; Drp1; mitochondrial dynamics; p53; PKA	GIANT MITOCHONDRIA; ONCOGENIC RAS; LIFE-SPAN; P53; PHOSPHORYLATION; DRP1; TRANSLOCATION; TRANSCRIPTION; INVOLVEMENT; DYSFUNCTION	The tumor suppressor p53 is known as a critical mediator of many cellular processes, including cellular senescence, but its role in mitochondrial dynamics is not fully understood. We have previously shown that p53 regulates mitochondrial dynamics via the PKA-Drp1 pathway to induce cellular senescence. In this study, to further understand the role of p53-dependent regulation of mitochondrial dynamics, the effect of p53 expression on mitochondrial morphology was examined in various cancer cell lines and normal human cells. We found that p53 induced remarkable mitochondrial elongation and cellular senescence in various cancer cells regardless of their p53 status. p53 also induced mitochondrial elongation in various human primary normal cells, suggesting that p53-mediated mitochondrial elongation is a general phenomenon. Moreover, we found that p53 plays an essential role in mitochondrial elongation in H-Ras-induced cellular senescence and in the replicative senescence of normal human cells. Treatment with the MDM-2 antagonist Nutlin-3a also induced mitochondrial elongation through the PKA-Drp1 pathway in IMR90 normal human cells. Furthermore, the inhibition of PKA activity in late-passage normal cells significantly reduced both mitochondrial elongation and cellular senescence, suggesting that the p53-PKA pathway is essential for maintaining the senescence phenotype in normal cells. Together, these results further confirm the direct regulation of mitochondrial dynamics by p53 and the important role of p53-mediated mitochondrial elongation in cellular senescence.	[Kim, Young Yeon; Um, Jee-Hyun; Shin, Dong Jin; Jeong, Dae Jin; Hong, Young Bin; Yun, Jeanho] Dong A Univ, Peripheral Neuropathy Res Ctr, Coll Med, Busan, South Korea; [Kim, Young Yeon; Um, Jee-Hyun; Shin, Dong Jin; Jeong, Dae Jin; Hong, Young Bin; Yun, Jeanho] Dong A Univ, Dept Biochem, Coll Med, Busan 49201, South Korea; [Shin, Dong Jin; Jeong, Dae Jin; Hong, Young Bin; Yun, Jeanho] Dong A Univ, Grad Sch, Dept Translat Biomed Sci, Busan, South Korea	Dong A University; Dong A University; Dong A University	Kim, YY; Yun, JH (corresponding author), Dong A Univ, Dept Biochem, Coll Med, Busan 49201, South Korea.; Kim, YY; Yun, JH (corresponding author), Dong A Univ, Grad Sch, Busan 49201, South Korea.	kyy8191@dau.ac.kr; yunj@dau.ac.kr		Yun, Jeanho/0000-0001-7700-5123				Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chan DC, 2020, ANNU REV PATHOL-MECH, V15, P235, DOI 10.1146/annurev-pathmechdis-012419-032711; Chiao YA, 2020, ELIFE, V9, DOI 10.7554/eLife.55513; COLEMAN R, 1987, GERONTOLOGY, V33, P34, DOI 10.1159/000212851; Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862; Desdin-Mico G, 2020, SCIENCE, V368, P1371, DOI 10.1126/science.aax0860; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Kim MA, 2007, EXP MOL MED, V39, P205, DOI 10.1038/emm.2007.23; Kim YY, 2020, FASEB J, V34, P2451, DOI 10.1096/fj.201901747RR; Kim YY, 2017, AGING CELL, V16, P1094, DOI 10.1111/acel.12639; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; MURAKOSHI M, 1985, Tokai Journal of Experimental and Clinical Medicine, V10, P531; Park JH, 2016, FEBS LETT, V590, P924, DOI 10.1002/1873-3468.12061; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Rana A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00525-4; Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110; Saleem A, 2015, AM J PHYSIOL-CELL PH, V308, pC319, DOI 10.1152/ajpcell.00253.2014; SATO T, 1975, ACTA PATHOL JAPON, V25, P403; Sebastian D, 2017, TRENDS MOL MED, V23, P201, DOI 10.1016/j.molmed.2017.01.003; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Seo KS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00552; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Stockl P, 2006, EXP GERONTOL, V41, P674, DOI 10.1016/j.exger.2006.04.009; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vizioli MG, 2020, GENE DEV, V34, P428, DOI 10.1101/gad.331272.119; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wiley CD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20000-4; Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Yun J, 1999, J BIOL CHEM, V274, P29677, DOI 10.1074/jbc.274.42.29677; Yun JH, 2003, J BIOL CHEM, V278, P36966, DOI 10.1074/jbc.M305178200; Zhou S, 2003, MUTAGENESIS, V18, P287, DOI 10.1093/mutage/18.3.287	46	4	4	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21319	10.1096/fj.202002007R	http://dx.doi.org/10.1096/fj.202002007R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33433933				2022-12-26	WOS:000647789600060
J	Stanfield, BA; Purves, T; Palmer, S; Sullenger, B; Welty-Wolf, K; Haines, K; Agarwal, S; Kasotakis, G				Stanfield, Brent A.; Purves, Todd; Palmer, Scott; Sullenger, Bruce; Welty-Wolf, Karen; Haines, Krista; Agarwal, Suresh; Kasotakis, George			IL-10 and class 1 histone deacetylases act synergistically and independently on the secretion of proinflammatory mediators in alveolar macrophages	PLOS ONE			English	Article							NF-KAPPA-B; RESPIRATORY-DISTRESS-SYNDROME; TOLL-LIKE RECEPTORS; POSTTRANSCRIPTIONAL REGULATION; SIGNAL-TRANSDUCTION; EXPRESSION; INTERLEUKIN-10; INHIBITION; LIPOPOLYSACCHARIDE; PATTERN	Introduction Anti-inflammatory cytokine IL-10 suppresses pro-inflammatory IL-12b expression after Lipopolysaccharide (LPS) stimulation in colonic macrophages, as part of the innate immunity Toll-Like Receptor (TLR)-NF-kappa B activation system. This homeostatic mechanism limits excess inflammation in the intestinal mucosa, as it constantly interacts with the gut flora. This effect is reversed with Histone Deacetylase 3 (HDAC3), a class I HDAC, siRNA, suggesting it is mediated through HDAC3. Given alveolar macrophages' prominent role in Acute Lung Injury (ALI), we aim to determine whether a similar regulatory mechanism exists in the typically sterile pulmonary microenvironment. Methods Levels of mRNA and protein for IL-10, and IL-12b were determined by qPCR and ELISA/Western Blot respectively in naive and LPS-stimulated alveolar macrophages. Expression of the NF-kappa B intermediaries was also similarly assessed. Experiments were repeated with AS101 (an IL-10 protein synthesis inhibitor), MS-275 (a selective class 1 HDAC inhibitor), or both. Results LPS stimulation upregulated all proinflammatory mediators assayed in this study. In the presence of LPS, inhibition of IL-10 and/or class 1 HDACs resulted in both synergistic and independent effects on these signaling molecules. Quantitative reverse-transcriptase PCR on key components of the TLR4 signaling cascade demonstrated significant diversity in IL-10 and related gene expression in the presence of LPS. Inhibition of IL-10 secretion and/or class 1 HDACs in the presence of LPS independently affected the transcription of MyD88, IRAK1, Rela and the NF-kappa B p50 subunit. Interestingly, by quantitative ELISA inhibition of IL-10 secretion and/or class 1 HDACs in the presence of LPS independently affected the secretion of not only IL-10, IL-12b, and TNF alpha, but also proinflammatory mediators CXCL2, IL-6, and MIF. These results suggest that IL-10 and class 1 HDAC activity regulate both independent and synergistic mechanisms of proinflammatory cytokine/chemokine signaling. Conclusions Alveolar macrophages after inflammatory stimulation upregulate both IL-10 and IL-12b production, in a highly class 1 HDAC-dependent manner. Class 1 HDACs appear to help maintain the balance between the pro- and anti-inflammatory IL-12b and IL-10 respectively. Class 1 HDACs may be considered as targets for the macrophage-initiated pulmonary inflammation in ALI in a preclinical setting.	[Stanfield, Brent A.; Purves, Todd; Palmer, Scott; Sullenger, Bruce; Welty-Wolf, Karen; Haines, Krista; Agarwal, Suresh; Kasotakis, George] Duke Univ, Med Ctr, Durham, NC 27708 USA; [Stanfield, Brent A.; Purves, Todd; Sullenger, Bruce; Haines, Krista; Agarwal, Suresh; Kasotakis, George] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Stanfield, Brent A.; Haines, Krista; Agarwal, Suresh; Kasotakis, George] Duke Univ, Div Trauma Acute & Crit Care Surg, Med Ctr, Durham, NC 27708 USA; [Purves, Todd] Duke Univ, Med Ctr, Div Urol, Durham, NC USA; [Palmer, Scott; Welty-Wolf, Karen] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Palmer, Scott] Duke Clin Res Inst, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Kasotakis, G (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.; Kasotakis, G (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.; Kasotakis, G (corresponding author), Duke Univ, Div Trauma Acute & Crit Care Surg, Med Ctr, Durham, NC 27708 USA.	george.kasotakis@duke.edu	Stanfield, Brent/CAG-1570-2022; Stanfield, Brent/A-3266-2019	Haines, Krista/0000-0002-2056-1820; Stanfield, Brent/0000-0002-0966-9662; Kasotakis, George/0000-0002-7630-0742; Purves, J/0000-0001-9689-2047				Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; BERNARD GR, 1987, NEW ENGL J MED, V317, P1565, DOI 10.1056/NEJM198712173172504; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Brodsky M, 2007, J INTERF CYTOK RES, V27, P453, DOI 10.1089/jir.2007.0168; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chanteux H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-71; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Christoffersson G, 2012, BLOOD, V120, P4653, DOI 10.1182/blood-2012-04-421040; Du X, 1999, BLOOD CELL MOL DIS, V25, P328, DOI 10.1006/bcmd.1999.0262; Eppensteiner J, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127925; Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200; Hammer M, 2005, EUR J IMMUNOL, V35, P2991, DOI 10.1002/eji.200526192; Han SH, 2015, J IMMUNOL, V194, P855, DOI 10.4049/jimmunol.1402513; Harris J, 2019, TRENDS IMMUNOL, V40, P447, DOI 10.1016/j.it.2019.03.002; Hayun M, 2006, BIOCHEM PHARMACOL, V72, P1423, DOI 10.1016/j.bcp.2006.06.015; Hoogerwerf JJ, 2008, AM J RESP CRIT CARE, V178, P34, DOI 10.1164/rccm.200708-1261OC; Hoshino K, 1999, J IMMUNOL, V162, P3749; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Huang SP, 2013, CELL SIGNAL, V25, P1228, DOI 10.1016/j.cellsig.2013.02.009; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Jeyaseelan S, 2005, INFECT IMMUN, V73, P1754, DOI 10.1128/IAI.73.3.1754-1763.2005; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Johnson CA, 2002, J BIOL CHEM, V277, P9590, DOI 10.1074/jbc.M107942200; Kobayashi T, 2012, J IMMUNOL, V189, P1792, DOI 10.4049/jimmunol.1200042; Kor DJ, 2016, JAMA-J AM MED ASSOC, V315, P2406, DOI 10.1001/jama.2016.6330; Kuzmich NN, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5040034; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Ma Xiaojing, 2015, F1000Res, V4, DOI 10.12688/f1000research.7010.1; Malinina A, 2020, AGING CELL, V19, DOI 10.1111/acel.13130; McAuley DF, 2014, NEW ENGL J MED, V371, P1695, DOI 10.1056/NEJMoa1403285; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Moumne L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031080; OPP MR, 1995, J NEUROIMMUNOL, V60, P165, DOI 10.1016/0165-5728(95)00066-B; Place RF, 2005, BIOCHEM PHARMACOL, V70, P394, DOI 10.1016/j.bcp.2005.04.030; Powell MJ, 2000, J IMMUNOL, V165, P292, DOI 10.4049/jimmunol.165.1.292; Robles AJ, 2018, J TRAUMA ACUTE CARE, V85, P148, DOI 10.1097/TA.0000000000001926; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Sharma A, 2009, P NATL ACAD SCI USA, V106, P5761, DOI 10.1073/pnas.0808743106; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Strassmann G, 1997, CELL IMMUNOL, V176, P180, DOI 10.1006/cimm.1997.1087; Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520; Varma TK, 2001, INFECT IMMUN, V69, P5249, DOI 10.1128/IAI.69.9.5249-5263.2001; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wan Y, 2018, GENE DEV, V32, P1309, DOI 10.1101/gad.316257.118; Wang KS, 2000, BLOOD, V95, P3183, DOI 10.1182/blood.V95.10.3183.010k36_3183_3190; Xia C, 2020, J VIROL, V94, DOI 10.1128/JVI.01572-19; Zerfaoui M, 2010, J IMMUNOL, V185, P1894, DOI 10.4049/jimmunol.1000646; Zhong XC, 2018, FASEB J, V32, P5312, DOI 10.1096/fj.201800223R	66	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245169	10.1371/journal.pone.0245169	http://dx.doi.org/10.1371/journal.pone.0245169			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471802	Green Published, gold			2022-12-26	WOS:000639428800016
J	Yin, XL; Ma, D; Zhu, KJ; Li, DY				Yin, Xiling; Ma, Dan; Zhu, Kejing; Li, Deyun			Identifying intentional injuries among children and adolescents based on Machine Learning	PLOS ONE			English	Article							SELF-INJURY; METAANALYSIS; PREVALENCE; BURDEN; ABUSE	Background Compared to other studies, the injury monitoring of Chinese children and adolescents has captured a low level of intentional injuries on account of self-harm/suicide and violent attacks. Intentional injuries in children and adolescents have not been apparent from the data. It is possible that there has been a misclassification of existing intentional injuries, and there is a lack of research literature on the misclassification of intentional injuries. This study aimed to discuss the feasibility of discriminating the intention of injury based on Machine Learning (ML) modelling and provided ideas for understanding whether there was a misclassification of intentional injuries. Methods Information entropy was used to determine the correlation between variables and the intention of injury, and Naive Bayes (NB), Decision Tree (DT), Random Forest (RF), Adaboost algorithms and Deep Neural Networks (DNN) were used to create an intention of injury discrimination model. The models were compared by comprehensively testing the discrimination effect to determine stability and consistency. Results For the area under the ROC curve with different intentions of injuries, the NB model was 0.891, 0.880, and 0.897, respectively; the DT model was 0.870, 0.803, and 0.871, respectively; the RF model was 0.850, 0.809, and 0.845, respectively; the Adaboost model was 0.914, 0.846, and 0.914, respectively; the DNN model was 0.927, 0.835, and 0.934, respectively. In a comprehensive comparison of the five models, DNN and Adaboost models had higher values for the determination of the intention of injury. A discrimination of cases with unclear intentions of injury showed that on average, unintentional injuries, violent attacks, and self-harm/suicides accounted for 86.57%, 6.81%, and 6.62%, respectively. Conclusion It was feasible to use the ML algorithm to determine the injury intention of children and adolescents. The research suggested that the DNN and Adaboost models had higher values for the determination of the intention of injury. This study could build a foundation for transforming the model into a tool for rapid diagnosis and excavating potential intentional injuries of children and adolescents by widely collecting the influencing factors, extracting the influence variables characteristically, reducing the complexity and improving the performance of the models in the future.	[Yin, Xiling; Ma, Dan; Zhu, Kejing; Li, Deyun] Ctr Dis Control & Prevent Zhuhai City, Dept Publ Hlth & Hlth Res, Zhuhai, Guangdong, Peoples R China		Li, DY (corresponding author), Ctr Dis Control & Prevent Zhuhai City, Dept Publ Hlth & Hlth Res, Zhuhai, Guangdong, Peoples R China.	ljdycn@163.com						Amanullah S, 2014, PEDIATRICS, V133, P254, DOI 10.1542/peds.2013-2155; Bousema S, 2016, BURNS, V42, P1287, DOI 10.1016/j.burns.2016.01.009; Cunningham RM, 2018, NEW ENGL J MED, V379, P2468, DOI 10.1056/NEJMsr1804754; Gallaher JR, 2016, INJURY, V47, P837, DOI 10.1016/j.injury.2015.10.072; Gordon AR, 2018, J SCHOOL HEALTH, V88, P306, DOI 10.1111/josh.12606; Han Hyejin, 2018, J Prev Med Public Health, V51, P163, DOI 10.3961/jpmph.18.027; Hillis S, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4079; Hughes K, 2017, LANCET PUBLIC HEALTH, V2, pE356, DOI 10.1016/S2468-2667(17)30118-4; Khan UR, 2015, BMC EMERG MED, V15, DOI 10.1186/1471-227X-15-S2-S6; Kim PT, 2017, J PEDIATR SURG, V52, P1827, DOI 10.1016/j.jpedsurg.2017.02.014; Klinke M, 2018, KLIN PADIATR, V230, P61, DOI 10.1055/s-0043-119416; Kyu HH, 2016, JAMA PEDIATR, V170, P267, DOI 10.1001/jamapediatrics.2015.4276; Liu NT, 2017, SHOCK, V48, P504, DOI 10.1097/SHK.0000000000000898; Madea Burkhard, 2015, Arch Kriminol, V236, P11; Paek SH, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013724; Peng Lin, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P1245; Somer O, 2015, SOC PSYCH PSYCH EPID, V50, P1163, DOI 10.1007/s00127-015-1060-z; Stoltenborgh M, 2013, INT J PSYCHOL, V48, P81, DOI 10.1080/00207594.2012.697165; Stoltenborgh M, 2011, CHILD MALTREATMENT, V16, P79, DOI 10.1177/1077559511403920; Stylianou N, 2015, BURNS, V41, P925, DOI 10.1016/j.burns.2015.03.016; Ulseth Elisabeth Tallaksen, 2019, Tidsskr Nor Laegeforen, V139, DOI 10.4045/tidsskr.17.1116; Vallmuur K, 2016, INJURY PREV, V22, P34, DOI 10.1136/injuryprev-2015-041813; Wang YL, 2019, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02672; Yuan W., 2016, CHIN J DIS CONTROL P, V20, P670, DOI [10.16462/j.cnki.zhjbkz.2016.07.007, DOI 10.16462/J.CNKI.ZHJBKZ.2016.07.007]; Zainum K, 2017, FORENSIC SCI MED PAT, V13, P115, DOI 10.1007/s12024-017-9860-y	25	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245437	10.1371/journal.pone.0245437	http://dx.doi.org/10.1371/journal.pone.0245437			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM1OE	33471800	Green Published, gold			2022-12-26	WOS:000639428800058
J	Nooij, SAE; Bockisch, CJ; Bulthoff, HH; Straumann, D				Nooij, Suzanne A. E.; Bockisch, Christopher J.; Bulthoff, Heinrich H.; Straumann, Dominik			Beyond sensory conflict: The role of beliefs and perception in motion sickness	PLOS ONE			English	Article							SELF-MOTION; SPATIAL ORIENTATION; CIRCULAR VECTION; VISUAL-FIELD; SUSCEPTIBILITY; SUPPRESSION; ROTATION	Illusory self-motion often provokes motion sickness, which is commonly explained in terms of an inter-sensory conflict that is not in accordance with previous experience. Here we address the influence of cognition in motion sickness and show that such a conflict is not provocative when the observer believes that the motion illusion is indeed actually occurring. Illusory self-motion and motion sickness were elicited in healthy human participants who were seated on a stationary rotary chair inside a rotating optokinetic drum. Participants knew that both chair and drum could rotate but were unaware of the actual motion stimulus. Results showed that motion sickness was correlated with the discrepancy between participants' perceived self-motion and participants' beliefs about the actual motion. Together with the general motion sickness susceptibility, this discrepancy accounted for 51% of the variance in motion sickness intensity. This finding sheds a new light on the causes of visually induced motion sickness and suggests that it is not governed by an inter-sensory conflict per se, but by beliefs concerning the actual self-motion. This cognitive influence provides a promising tool for the development of new countermeasures.	[Nooij, Suzanne A. E.; Bulthoff, Heinrich H.] Max Planck Inst Biol Cybernet, Dept Human Percept Act & Cognit, Tubingen, Germany; [Nooij, Suzanne A. E.] TNO Soesterberg, Soesterberg, Netherlands; [Bockisch, Christopher J.; Straumann, Dominik] Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland; [Bockisch, Christopher J.; Straumann, Dominik] Univ Zurich, Zurich, Switzerland; [Bockisch, Christopher J.] Univ Hosp Zurich, Dept Ophthalmol, Zurich, Switzerland; [Bockisch, Christopher J.] Univ Hosp, Dept Otorhinolaryngol, Zurich, Switzerland; [Bockisch, Christopher J.; Straumann, Dominik] Univ Hosp Zurich, Interdisciplinary Ctr Vertigo & Neurol Visual Dis, Zurich, Switzerland; [Bockisch, Christopher J.; Straumann, Dominik] Univ Hosp Zurich, Clin Neurosci Ctr, Zurich, Switzerland; [Straumann, Dominik] Swiss Concuss Ctr, Zurich, Switzerland	Max Planck Society; Netherlands Organization Applied Science Research; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Nooij, SAE (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Act & Cognit, Tubingen, Germany.; Nooij, SAE (corresponding author), TNO Soesterberg, Soesterberg, Netherlands.	suzanne.nooij@tubingen.mpg.de		Bockisch, Christopher/0000-0003-1054-2578				Becker W, 2002, EXP BRAIN RES, V144, P554, DOI 10.1007/s00221-002-1104-y; BEHRENS F, 1992, VISION RES, V32, P889, DOI 10.1016/0042-6989(92)90031-D; Bertolini G, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00014; Bos JE, 2008, DISPLAYS, V29, P47, DOI 10.1016/j.displa.2007.09.002; Claremont CA, 1931, PSYCHE, V11, P86; Clemens IAH, 2011, J NEUROSCI, V31, P5365, DOI 10.1523/JNEUROSCI.6472-10.2011; Cohen J., 1983, APPL MULTIPLE REGRES; CRAMPTON GH, 1953, J COMP PHYSIOL PSYCH, V46, P451, DOI 10.1037/h0058423; DICHGANS J, 1973, ACTA OTO-LARYNGOL, V76, P339, DOI 10.3109/00016487309121519; Diels C, 2016, APPL ERGON, V53, P374, DOI 10.1016/j.apergo.2015.09.009; Ellis AW, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00286; Ellis AW, 2017, J NEUROL, V264, pS74, DOI 10.1007/s00415-017-8471-6; Ellis AW, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00138; Faugloire E, 2007, EXP BRAIN RES, V177, P520, DOI 10.1007/s00221-006-0700-7; Feenstra PJ, 2011, DISPLAYS, V32, P194, DOI 10.1016/j.displa.2010.11.002; Golding JF, 1998, BRAIN RES BULL, V47, P507, DOI 10.1016/S0361-9230(98)00091-4; Golding JF, 2006, PERS INDIV DIFFER, V41, P237, DOI 10.1016/j.paid.2006.01.012; Griffin MJ, 2004, AVIAT SPACE ENVIR MD, V75, P739; GUEDRY F E JR, 1978, Aviation Space and Environmental Medicine, V49, P29; HU SQ, 1989, AVIAT SPACE ENVIR MD, V60, P411; Ji JTT, 2009, HUM FACTORS, V51, P739, DOI 10.1177/0018720809349708; Karmali F, 2012, J NEUROPHYSIOL, V108, P390, DOI 10.1152/jn.00883.2011; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Keshavarz B, 2011, HUM FACTORS, V53, P415, DOI 10.1177/0018720811403736; Lackner JR, 2014, EXP BRAIN RES, V232, P2493, DOI 10.1007/s00221-014-4008-8; Lamb S, 2013, J WIND ENG IND AEROD, V119, P1, DOI 10.1016/j.jweia.2013.05.004; Laurens J, 2007, BIOL CYBERN, V96, P389, DOI 10.1007/s00422-006-0133-1; LEPECQ JC, 1995, PERCEPTION, V24, P435, DOI 10.1068/p240435; MacNeilage PR, 2008, J NEUROPHYSIOL, V100, P2981, DOI 10.1152/jn.90677.2008; Mast FW, 2015, MULTISENS RES, V28, P443, DOI 10.1163/22134808-00002503; Mast FW, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00044; Mertz S, 2000, ACTA PSYCHOL, V105, P57, DOI 10.1016/S0001-6918(00)00048-2; Nigmatullina Y, 2015, NEUROSCIENCE, V291, P46, DOI 10.1016/j.neuroscience.2015.01.021; Nooij SAE, 2018, EXP BRAIN RES, V236, P3031, DOI 10.1007/s00221-018-5340-1; Nooij SAE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175305; OMAN CM, 1990, CAN J PHYSIOL PHARM, V68, P294, DOI 10.1139/y90-044; REASON JT, 1978, J ROY SOC MED, V71, P819, DOI 10.1177/014107687807101109; Reason JT., 1975, MOTION SICKNESS; Riecke BE, 2008, APGV 2008: PROCEEDINGS OF THE SYMPOSIUM ON APPLIED PERCEPTION IN GRAPHICS AND VISUALIZATION, P147; ROLNICK A, 1991, ERGONOMICS, V34, P867, DOI 10.1080/00140139108964831; Stern RM, 1987, GASTROENTEROLOGY, V92, P92, DOI 10.1016/0016-5085(87)90843-2; Welsch R, 1980, REGRESSION DIAGNOSTI; Wertheim AH, 2001, PERCEPTION, V30, P733, DOI 10.1068/p3092; Wright WG, 2006, J VESTIBUL RES-EQUIL, V16, P23	45	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245295	10.1371/journal.pone.0245295	http://dx.doi.org/10.1371/journal.pone.0245295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PY3TH	33465124	Green Accepted, Green Published, gold			2022-12-26	WOS:000611969200014
J	Kyei, S; Obeng, PA; Kwarteng, MA; Assiamah, F				Kyei, Samuel; Obeng, Patience Asantewaa; Kwarteng, Michael Agyemang; Assiamah, Frank			Epidemiology and clinical presentation of glaucoma in a referral facility in Ghana: Any lessons for public health intervention?	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; SICKLE-CELL-DISEASE; PREVALENCE; PEOPLE	The purpose of this study was to evaluate the epidemiological and clinical profile of patients living with glaucoma and receiving care in a tertiary eye center in Ghana. This was a hospital-based retrospective study of clinical records of glaucoma patients from January 2010 to December 2019. The study involved collating demographic information of patients, clinical presentation, and the management of glaucoma. A total of nineteen thousand (19,000) charts were retrieved from the eye center's archives. Out of these, 660 (3.5%) records of patients qualified for the study and were analyzed. There were 398 (60.3%) males and 262 (39.7%) females. Their ages ranged from 9 to 86 years (mean age = 47.30; SD +/- 16.86 years). The averages of ocular parameters of 1,320 eyes (660 patients) were visual acuity = 0.26 +/- 0.55 logMAR; intraocular pressure: 17.31 +/- 6.11 mmHg; cup-to-disc ratios: 0.67 +/- 0.17 D; and the average retinal nerve fibers thickness was 95.03 +/- 21.74 mu m. The mainstay of treatment was the sole use of medication. Males were the major group receiving glaucoma care at the tertiary level. Glaucoma cases included juveniles but the mean age suggests most were of adult-onset. Socio-demographic characteristics affected the diagnosis and management of glaucoma among patients receiving care at a referral center. Public health, stakeholders, and policymakers' interventions can help identify individuals with glaucoma.	[Kyei, Samuel; Obeng, Patience Asantewaa; Assiamah, Frank] Univ Cape Coast, Sch Allied Hlth Sci, Dept Optometry & Vis Sci, Coll Hlth & Allied Sci, Cape Coast, Ghana; [Kwarteng, Michael Agyemang] Bindura Univ Sci Educ, Fac Sci & Engn, Dept Optometry, Bindura, Zimbabwe	University of Cape Coast	Kyei, S (corresponding author), Univ Cape Coast, Sch Allied Hlth Sci, Dept Optometry & Vis Sci, Coll Hlth & Allied Sci, Cape Coast, Ghana.	skyei@ucc.edu.gh	Kwarteng, Michael Agyemang/AAY-5399-2020; Kyei, Samuel/ABD-5389-2020	Kwarteng, Michael Agyemang/0000-0003-1072-315X; Kyei, Samuel/0000-0003-2568-8246; ASSIAMAH, FRANK/0000-0002-3548-6114				Ackuaku EM, 2000, GHANA MED J, V34, P24; AlHamdan NA, 2007, GENET MED, V9, P372, DOI 10.1097/GIM.0b013e318065a9e8; Alswaidi FM, 2009, J MED SCREEN, V16, P22, DOI 10.1258/jms.2008.008029; Boadi-Kusi Samuel Bert, 2016, J Optom, V9, P54, DOI 10.1016/j.optom.2015.06.004; Bowling B, 2016, KANSKIS CLIN OPHTHAL, V8th, P319; Budenz DL, 2013, JAMA OPHTHALMOL, V131, P651, DOI 10.1001/jamaophthalmol.2013.1686; Carpenter CR, 2010, CAN J EMERG MED, V12, P431; Clayton JA, 2015, CURR EYE RES, V40, P102, DOI 10.3109/02713683.2014.986333; Faal Hannah, 2012, Community Eye Health, V25, P41; Faiq Muneeb, 2013, J Curr Glaucoma Pract, V7, P66, DOI 10.5005/jp-journals-10008-1140; Flodgren G, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000125.pub4, 10.1002/14651858.CD000125]; Gebru M.K., 2017, INT J PEACE DEV STUD, V8, P15, DOI [https://doi.org/10.5897/IJPDS2016.0289, DOI 10.5897/IJPDS2016.0289]; Griffiths AJF, 1999, HUMAN PEDIGREE ANAL; Guzek J P, 2005, Ghana Med J, V39, P55; Gyasi M E, 2014, Ghana Med J, V48, P143, DOI 10.4314/gmj.v48i3.4; He M, 2006, EYE, V20, P3, DOI 10.1038/sj.eye.6701797; Herndon LW, 2002, J GLAUCOMA, V11, P421, DOI 10.1097/00061198-200210000-00009; Khandekar R, 2009, INDIAN J OPHTHALMOL, V57, P443, DOI 10.4103/0301-4738.57153; Kingman S, 2004, B WORLD HEALTH ORGAN, V82, P887; Kyari Fatima, 2013, Middle East Afr J Ophthalmol, V20, P111, DOI 10.4103/0974-9233.110605; Locock L, 2001, SOC SCI MED, V53, P745, DOI 10.1016/S0277-9536(00)00387-7; Melamed C, 2010, 1 AFR GLAUC SUMM AUG, V2010; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Mohammadi Seyed-Farzad, 2014, J Ophthalmic Vis Res, V9, P3; Nelson-Ayifah D, 2020, AFR VIS EYE HEALTH J, V79, DOI 10.4102/aveh.v79i1.521; Neyhouser C, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0890-3; Ntim-Amponsah CT, 2004, EYE, V18, P491, DOI 10.1038/sj.eye.6700674; Ocansey S, 2020, J OPHTHALMOL, V2020, DOI 10.1155/2020/7150673; Ocansey S, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1528-x; Ofosu A, 2018, AFR VIS EYE HEALTH J, V77, DOI 10.4102/aveh.v77i1.426; Otabil KB, 2013, RUSS OPEN MED J, V2, DOI 10.15275/rusomj.2013.0310; Peden M., 2014, WORLD REPORT ROAD TR; Poeze M, 2019, J ETHN MIGR STUD, V45, P3065, DOI 10.1080/1369183X.2018.1547019; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Serjeant GR, 2017, J COMMUN GENET, V8, P133, DOI 10.1007/s12687-017-0294-8; Shalev SA, 2019, CLIN GENET, V95, P3, DOI 10.1111/cge.13231; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; Varma R, 2004, OPHTHALMOLOGY, V111, P1439, DOI 10.1016/j.ophtha.2004.01.025; VERREY JD, 1990, EYE, V4, P115, DOI 10.1038/eye.1990.14; Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30; Wiggs JL, 2017, HUM MOL GENET, V26, pR21, DOI 10.1093/hmg/ddx184; World Health Organization, 2019, PRIOR EYE DIS; World Health Organization, 2009, GLOB STAT REP ROAD S; World Health Organization (WHO), 2013, PED SAF ROAD SAF MAN	46	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245486	10.1371/journal.pone.0245486	http://dx.doi.org/10.1371/journal.pone.0245486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449975	Green Published, gold			2022-12-26	WOS:000609991600007
J	Xiong, YY; Ju, LG; Yuan, LS; Chen, L; Wang, G; Xu, HM; Peng, TC; Luo, YW; Xiao, Y; Wang, XH				Xiong, Yaoyi; Ju, Lingao; Yuan, Lushun; Chen, Liang; Wang, Gang; Xu, Huimin; Peng, Tianchen; Luo, Yongwen; Xiao, Yu; Wang, Xinghuan			KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer	ONCOGENE			English	Article							PI3K/AKT PATHWAY; THERAPY; TARGET	KNSTRN is a component of the mitotic spindle, which was rarely investigated in tumorigenesis. AKT plays an essential role in tumorigenesis by modulating the phosphorylation of various substrates. The activation of AKT is regulated by PTEN and PIP3. Here, we prove KNSTRN is positively correlated with malignancy of bladder cancer and KNSTRN activates AKT phosphorylation at Thr308 and Ser473. More importantly, our study reveals that both KNSTRN and PTEN interact with PH domain of AKT at cell membrane. The amount of KNSTRN interacted with AKT is negatively related to PTEN. Furthermore, PIP3 pull-down assay proves that KNSTRN promoted AKT movement to PIP3. These data suggest KNSTRN may activate AKT phosphorylation by promoting AKT movement to PIP3 and alleviating PTEN suppression. Based on the activation of AKT phosphorylation, our study demonstrates that KNSTRN promotes bladder cancer metastasis and gemcitabine resistance in vitro and in vivo. Meanwhile, the effect of KNSTRN on tumorigenesis and gemcitabine resistance could be restored by AKT specific inhibitor MK2206 or AKT overexpression. In conclusion, we identify an oncogene KNSTRN that promotes tumorigenesis and gemcitabine resistance by activating AKT phosphorylation and may serve as a therapeutic target in bladder cancer.	[Xiong, Yaoyi; Chen, Liang; Xu, Huimin; Peng, Tianchen; Luo, Yongwen; Xiao, Yu; Wang, Xinghuan] Wuhan Univ, Zhongnan Hosp, Dept Urol, Wuhan, Peoples R China; [Ju, Lingao; Wang, Gang; Xiao, Yu] Wuhan Univ, Zhongnan Hosp, Dept Biol Repositories, Wuhan, Peoples R China; [Ju, Lingao; Wang, Gang; Xiao, Yu] Human Genet Resource Preservat Ctr Hubei Prov, Wuhan, Peoples R China; [Ju, Lingao; Wang, Gang; Xiao, Yu; Wang, Xinghuan] Chinese Acad Med Sci, Res Ctr Wuhan Infect Dis & Canc, Wuhan, Peoples R China; [Yuan, Lushun] Leiden Univ Med Ctr, Dept Internal Med, Div Nephrol, Leiden, Netherlands; [Chen, Liang] Natl Inst Environm Hlth Sci, Signal Transduct Lab, Durham, NC USA; [Xiao, Yu] Wuhan Univ, Zhongnan Hosp, Lab Precis Med, Wuhan, Peoples R China; [Wang, Xinghuan] Wuhan Univ, Med Res Inst, Wuhan, Peoples R China	Wuhan University; Wuhan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Leiden University; Leiden University Medical Center (LUMC); Wuhan University; Wuhan University	Xiao, Y; Wang, XH (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Urol, Wuhan, Peoples R China.; Xiao, Y (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Biol Repositories, Wuhan, Peoples R China.; Xiao, Y (corresponding author), Human Genet Resource Preservat Ctr Hubei Prov, Wuhan, Peoples R China.; Xiao, Y; Wang, XH (corresponding author), Chinese Acad Med Sci, Res Ctr Wuhan Infect Dis & Canc, Wuhan, Peoples R China.; Xiao, Y (corresponding author), Wuhan Univ, Zhongnan Hosp, Lab Precis Med, Wuhan, Peoples R China.; Wang, XH (corresponding author), Wuhan Univ, Med Res Inst, Wuhan, Peoples R China.	yu.xiao@whu.edu.cn; wangxinghuan@whu.edu.cn	Xiao, Yu/AGA-4786-2022; Ju, Lingao/ADP-8482-2022	Xiao, Yu/0000-0003-1377-9685; Ju, Lingao/0000-0003-0813-3628	Improvement Project for Theranostic ability on Difficulty miscellaneous disease (Tumor) from National Health Commission of China [ZLYNXM202006]; National Natural Science Foundation of China [81772730, 31900902, 81902603]	Improvement Project for Theranostic ability on Difficulty miscellaneous disease (Tumor) from National Health Commission of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors wish to acknowledge thank Dr Xiaoling Li from NIEHS for critical editing during the preparation of this paper. The excellent technical assistance of Ms Yayun Fang and Ms Danni Shan is gratefully acknowledged. We would like to acknowledge the the TCGA databases for free use. This work was supported by the Improvement Project for Theranostic ability on Difficulty miscellaneous disease (Tumor) from National Health Commission of China (ZLYNXM202006) and National Natural Science Foundation of China to XW (81772730), LJ (31900902) and GW (81902603).	Albers P, 2011, ANN ONCOL, V22, P288, DOI 10.1093/annonc/mdq398; Bergman AM, 2002, DRUG RESIST UPDATE, V5, P19, DOI 10.1016/S1368-7646(02)00002-X; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cao DL, 2019, CANCER RES, V79, P2604, DOI 10.1158/0008-5472.CAN-18-3842; Choo Z, 2016, ONCOTARGET, V7, P34229, DOI 10.18632/oncotarget.8748; Chu N, 2018, CELL, V174, P897, DOI 10.1016/j.cell.2018.07.003; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Daizumoto K, 2018, CANCER RES, V78, P2233, DOI 10.1158/0008-5472.CAN-17-2528; Delaloge S, 2017, LANCET ONCOL, V18, P1293, DOI 10.1016/S1470-2045(17)30514-4; Dunsch AK, 2011, J CELL BIOL, V192, P959, DOI 10.1083/jcb.201008023; Friese A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11407; Gao X, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2530-0; Houede N, 2015, PHARMACOL THERAPEUT, V145, P1, DOI 10.1016/j.pharmthera.2014.06.004; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kern DM, 2017, ELIFE, V6, DOI 10.7554/eLife.26866; Kern DM, 2016, J CELL BIOL, V213, P315, DOI 10.1083/jcb.201510117; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee CS, 2014, NAT GENET, V46, P1060, DOI 10.1038/ng.3091; Li WJ, 2019, CELL DEATH DIFFER, V26, P1379, DOI 10.1038/s41418-018-0211-7; Liu BL, 2019, ONCOL REP, V41, P2168, DOI 10.3892/or.2019.7019; LoRusso PM, 2016, J CLIN ONCOL, V34, P3803, DOI 10.1200/JCO.2014.59.0018; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Martini M, 2014, ANN MED, V46, P372, DOI 10.3109/07853890.2014.912836; Mayer IA, 2016, ANNU REV MED, V67, P11, DOI 10.1146/annurev-med-062913-051343; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; Miyamoto DT, 2018, LANCET ONCOL, V19, pE683, DOI 10.1016/S1470-2045(18)30693-4; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Qin B, 2016, SCI REP-UK, V6, DOI 10.1038/srep38791; Shelley MD, 2012, BJU INT, V109, P496, DOI 10.1111/j.1464-410X.2011.10880.x; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toker A, 2015, CANCER CELL, V28, P143, DOI 10.1016/j.ccell.2015.07.010; van der Vos KE, 2011, ANTIOXID REDOX SIGN, V14, P579, DOI 10.1089/ars.2010.3419; van Rhijn BWG, 2009, EUR UROL, V56, P430, DOI 10.1016/j.eururo.2009.06.028; Wang GH, 2019, NAT CELL BIOL, V21, P214, DOI 10.1038/s41556-018-0266-1; Webb AE, 2014, TRENDS BIOCHEM SCI, V39, P159, DOI 10.1016/j.tibs.2014.02.003; Wong K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08081-1; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang PZ, 2017, NAT MED, V23, P1055, DOI 10.1038/nm.4379	41	13	13	4	24	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2021	40	9					1595	1608		10.1038/s41388-020-01634-z	http://dx.doi.org/10.1038/s41388-020-01634-z		JAN 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QR9UA	33452459				2022-12-26	WOS:000607998600008
J	Kunc, V; Klema, J				Kunc, Vladimir; Klema, Jiri			On transformative adaptive activation functions in neural networks for gene expression inference	PLOS ONE			English	Article							TRAINABLE AMPLITUDE; ENSEMBLE METHODS; DEEP	Gene expression profiling was made more cost-effective by the NIH LINCS program that profiles only similar to 1, 000 selected landmark genes and uses them to reconstruct the whole profile. The D-GEX method employs neural networks to infer the entire profile. However, the original D-GEX can be significantly improved. We propose a novel transformative adaptive activation function that improves the gene expression inference even further and which generalizes several existing adaptive activation functions. Our improved neural network achieves an average mean absolute error of 0.1340, which is a significant improvement over our reimplementation of the original D-GEX, which achieves an average mean absolute error of 0.1637. The proposed transformative adaptive function enables a significantly more accurate reconstruction of the full gene expression profiles with only a small increase in the complexity of the model and its training procedure compared to other methods.	[Kunc, Vladimir; Klema, Jiri] Czech Tech Univ, Fac Elect Engn, Dept Comp Sci, Prague, Czech Republic	Czech Technical University Prague	Kunc, V (corresponding author), Czech Tech Univ, Fac Elect Engn, Dept Comp Sci, Prague, Czech Republic.	kuncvlad@fel.cvut.cz	Kunc, Vladimír/AAM-2421-2020	Kunc, Vladimír/0000-0002-5130-4384	Czech Science Foundation [20-19162S]; Research Center for Informatics [CZ.02.1.01/0.0/0.0/16_019/0000765]	Czech Science Foundation(Grant Agency of the Czech Republic); Research Center for Informatics	This study was supported by the Czech Science Foundation (GACR -https://gacr.cz/en/) in the form of a grant awarded to JK (20-19162S) and the Research Center for Informatics (https://ec.europa.eu/) in the form of a grant awarded to JK (CZ.02.1.01/0.0/0.0/16_019/0000765). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M., 2016, TENSORFLOW LARGE SCA; Angermueller C, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156651; Nguyen AT, 2019, NEURAL COMPUT, V31, P555, DOI 10.1162/neco_a_01166; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bai YP, 2009, CHAOS SOLITON FRACT, V40, P69, DOI 10.1016/j.chaos.2007.07.033; Baldi P, 2014, ARXIV14126830; Bostrom H., 2008, 2008 11 INT C INF FU, P1; Campolucci P, 1996, IEEE MEDITERR ELECT, P1442, DOI 10.1109/MELCON.1996.551220; Castelli Ilaria, 2012, Partially Supervised Learning: First IAPR TC3 Workshop (PSL 2011). Revised Selected Papers, P52, DOI 10.1007/978-3-642-28258-4_6; Castelli Ilaria, 2012, Partially Supervised Learning: First IAPR TC3 Workshop (PSL 2011). Revised Selected Papers, P62, DOI 10.1007/978-3-642-28258-4_7; Castelli I, 2014, PATTERN RECOGN LETT, V37, P178, DOI 10.1016/j.patrec.2013.06.013; Chen CT, 1996, NEURAL NETWORKS, V9, P627, DOI 10.1016/0893-6080(96)00006-8; Chen YF, 2016, BIOINFORMATICS, V32, P1832, DOI 10.1093/bioinformatics/btw074; Chollet F., 2015, KERAS; Clevert D.-A., 2015, P 4 INT C LEARNING R; Dawson MRW, 1994, BIENN C CAN SOC COMP; Dizaji KG, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P1435, DOI 10.1145/3219819.3220114; Dozat T., 2015, INCORPORATING NESTER; Edsgard D, 2018, NAT METHODS, V15, P339, DOI 10.1038/nmeth.4634; Flennerhag, 2018, ABS180508574 CORR; Freeman DC, 2017, 5 INT C LEARN REPR; Freund Y., 1996, P 13 INT C MACH LEAR, V96, P148, DOI DOI 10.5555/3091696.3091715; Glorot Xavier, 2010, P MACHINE LEARNING R, P249; Goh SL, 2003, NEURAL NETWORKS, V16, P1095, DOI 10.1016/S0893-6080(03)00139-4; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Guarnieri S, 1999, IEEE T NEURAL NETWOR, V10, P672, DOI 10.1109/72.761726; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Hou L, 2017, PR MACH LEARN RES, V54, P430; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ismail A, 2013, ENG APPL ARTIF INTEL, V26, P1540, DOI 10.1016/j.engappai.2012.12.011; Johnson M, 2018, IEEE IJCNN; Jones E., 2001, SCIPY OPEN SOURCE SC; Karniadakis GE, 2019, ABS190912228 CORR; Kuncheva L., 2014, COMBINING PATTERN CL; Lancashire LJ, 2009, BRIEF BIOINFORM, V10, P315, DOI 10.1093/bib/bbp012; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee WC, 2018, MODERN PATHOL, V31, P947, DOI 10.1038/s41379-018-0029-3; Leshchyns'ka I, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6427537; Li W, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01077; Lin M, 2013, COMPUT SCI; Maas A.L., 2013, INT C MACHINE LEARNI, V30, P3, DOI DOI 10.1016/0010-0277(84)90022-2; McKinney W., 2010, 9 PYTHON SCI C, V445, P51; MEDLER DA, 1994, PSYCHOL RES-PSYCH FO, V57, P54, DOI 10.1007/BF00452996; Min S, 2017, BRIEF BIOINFORM, V18, P851, DOI 10.1093/bib/bbw068; Nielsen JB, 2018, NAT GENET, V50, P1234, DOI 10.1038/s41588-018-0171-3; Nigam I, 2018, IEEE WINT CONF APPL, P1499, DOI 10.1109/WACV.2018.00168; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Piazza, 1992, P INT JOINT C NEUR N; Qian S, 2018, NEUROCOMPUTING, V272, P204, DOI 10.1016/j.neucom.2017.06.070; Nguyen Q, 2017, PR MACH LEARN RES, V70; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Rokach L, 2009, COMPUT STAT DATA AN, V53, P4046, DOI 10.1016/j.csda.2009.07.017; Safran I, 2016, PR MACH LEARN RES, V48; Scardapane S., 2019, WIRN 2017 2017, V102, P73, DOI [10.1007/978-3-319-95098-3_7, DOI 10.1007/978-3-319-95098-3_7, 10.1007/978- 3-319-95098-3_7]; Solazzi M, 2000, IEEE IJCNN, P471, DOI 10.1109/IJCNN.2000.861352; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Stojanova D, 2010, ECOL INFORM, V5, P256, DOI 10.1016/j.ecoinf.2010.03.004; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Tagkopoulos, 2018, BIOINFORMATICS; Tiwari Arvind Kumar, 2014, Int J Proteomics, V2014, P845479, DOI 10.1155/2014/845479; Trentin E, 2001, NEURAL NETWORKS, V14, P471, DOI 10.1016/S0893-6080(01)00028-4; Valentini, 2003, IEEE INT JOINT C NEU, DOI [10.1109/IJCNN.2003.1223688, DOI 10.1109/IJCNN.2003.1223688]; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Vecci L, 1998, NEURAL NETWORKS, V11, P259, DOI 10.1016/S0893-6080(97)00118-4; Vinyals O, 2017, IEEE T PATTERN ANAL, V39, P652, DOI 10.1109/TPAMI.2016.2587640; Wang HQ, 2019, J BIOINF COMPUT BIOL, V17, DOI 10.1142/S0219720019500227; Wang XQ, 2018, BIOINFORMATICS, V34, P603, DOI 10.1093/bioinformatics/bty563; Wang YQ, 2018, GENET MED, V20, P927, DOI 10.1038/gim.2017.224; YAMADA T, 1992, IEEE T NEURAL NETWOR, V3, P595, DOI 10.1109/72.143373; Yang PY, 2010, CURR BIOINFORM, V5, P296, DOI 10.2174/157489310794072508; Yu, 2002, 2002 IEEE REG 10 C C, DOI [10.1109/tencon.2002.1181357, DOI 10.1109/TENC0N.2002.1181357]; Zhang M, 2000, P IEEE INNS ENNS INT, DOI [10.1109/ijcnn.2000.861351, DOI 10.1109/IJCNN.2000.861351]	74	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0243915	10.1371/journal.pone.0243915	http://dx.doi.org/10.1371/journal.pone.0243915			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444316	Green Published, gold, Green Submitted			2022-12-26	WOS:000609988100038
J	Marrella, A; Fedi, A; Varani, G; Vaccari, I; Fato, M; Firpo, G; Guida, P; Aceto, N; Scaglione, S				Marrella, Alessandra; Fedi, Arianna; Varani, Gabriele; Vaccari, Ivan; Fato, Marco; Firpo, Giuseppe; Guida, Patrizia; Aceto, Nicola; Scaglione, Silvia			High blood flow shear stress values are associated with circulating tumor cells cluster disaggregation in a multi-channel microfluidic device	PLOS ONE			English	Article							CANCER; EXTRAVASATION; METASTASIS; MIGRATION; FORCES	Metastasis represents a dynamic succession of events involving tumor cells which disseminate through the organism via the bloodstream. Circulating tumor cells (CTCs) can flow the bloodstream as single cells or as multicellular aggregates (clusters), which present a different potential to metastasize. The effects of the bloodstream-related physical constraints, such as hemodynamic wall shear stress (WSS), on CTC clusters are still unclear. Therefore, we developed, upon theoretical and CFD modeling, a new multichannel microfluidic device able to simultaneously reproduce different WSS characterizing the human circulatory system, where to analyze the correlation between SS and CTC clusters behavior. Three physiological WSS levels (i.e. 2, 5, 20 dyn/cm(2)) were generated, reproducing values typical of capillaries, veins and arteries. As first validation, triple-negative breast cancer cells (MDA-MB-231) were injected as single CTCs showing that higher values of WSS are correlated with a decreased viability. Next, the SS-mediated disaggregation of CTC clusters was computationally investigated in a vessels-mimicking domain. Finally, CTC clusters were injected within the three different circuits and subjected to the three different WSS, revealing that increasing WSS levels are associated with a raising clusters disaggregation after 6 hours of circulation. These results suggest that our device may represent a valid in vitro tool to carry out systematic studies on the biological significance of blood flow mechanical forces and eventually to promote new strategies for anticancer therapy.	[Marrella, Alessandra; Fedi, Arianna; Varani, Gabriele; Vaccari, Ivan; Scaglione, Silvia] Natl Res Council CNR, Inst Elect Comp & Telecommun IEIIT, Genoa, Italy; [Fedi, Arianna; Fato, Marco] Univ Genoa, Dept Comp Sci Bioengn Robot & Syst Engn, Genoa, Italy; [Firpo, Giuseppe; Guida, Patrizia] Univ Genoa, Dept Phys, Genoa, Italy; [Aceto, Nicola] Univ Basel, Dept Biomed, Canc Metastasis Lab, Basel, Switzerland; [Aceto, Nicola] Univ Hosp Basel, Basel, Switzerland	University of Genoa; University of Genoa; University of Basel; University of Basel	Scaglione, S (corresponding author), Natl Res Council CNR, Inst Elect Comp & Telecommun IEIIT, Genoa, Italy.	silvia.scaglione@ieiit.cnr.it	Vaccari, Ivan/AAG-2956-2019; scaglione, silvia/K-5378-2019	Vaccari, Ivan/0000-0001-7721-5737; scaglione, silvia/0000-0002-9464-3554; FATO, MARCO MASSIMO/0000-0001-8085-2438	European Union's Horizon 2020 research and innovation programme [801159]	European Union's Horizon 2020 research and innovation programme	This work was supported by the European Union's Horizon 2020 research and innovation programme under grant agreement No 801159.	Abhyankar VV, 2008, LAB CHIP, V8, P1507, DOI 10.1039/b803533d; Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; [Anonymous], 2019, FRONTIERS PLANT SCI; Au SH, 2016, P NATL ACAD SCI USA, V113, P4947, DOI 10.1073/pnas.1524448113; Barnes JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050973; Bersini S, 2014, BIOMATERIALS, V35, P2454, DOI 10.1016/j.biomaterials.2013.11.050; Follain G, 2019, NAT REV CANCER, P1, DOI DOI 10.1038/S41568-018-0093-5; Follain G, 2018, DEV CELL, V45, P33, DOI 10.1016/j.devcel.2018.02.015; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Fu A, 2016, ONCOTARGET, V7, P50239, DOI 10.18632/oncotarget.10360; Heyden S, 2017, COMPUT METHOD APPL M, V314, P314, DOI 10.1016/j.cma.2016.08.026; Hope JM, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2063-6; Hossain MS, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007952; King MR, 2015, AM J PHYSIOL-CELL PH, V308, pC792, DOI 10.1152/ajpcell.00346.2014; Lee AM, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00108; Lee HJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14122; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Ma SJ, 2018, FREE RADICAL BIO MED, V129, P46, DOI 10.1016/j.freeradbiomed.2018.09.004; Ma SJ, 2017, CANCER LETT, V388, P239, DOI 10.1016/j.canlet.2016.12.001; Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002; Marrella A, 2018, ACS APPL MATER INTER, V10, P41978, DOI 10.1021/acsami.8b15036; Marrella A, 2021, ALTEX-ALTERN ANIM EX, V38, P82, DOI 10.14573/altex.2003131; Marrella A, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0236; Marrella A, 2016, BIOTECHNOL BIOENG, V113, P2286, DOI 10.1002/bit.25994; Mitchell MJ, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00044; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Olsson E, 2007, J COMPUT PHYS, V225, P785, DOI 10.1016/j.jcp.2006.12.027; Ortiz-Otero Nerymar, 2020, Oncotarget, V11, P1037, DOI 10.18632/oncotarget.27510; Phillips KG, 2015, AM J PHYSIOL-CELL PH, V308, pC229, DOI 10.1152/ajpcell.00315.2014; Phillips KG, 2014, AM J PHYSIOL-CELL PH, V306, pC80, DOI 10.1152/ajpcell.00294.2013; Regmi S, 2017, SCI REP-UK, V7, DOI 10.1038/srep39975; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Roy E, 2016, ADVANCES IN MICROFLUIDICS - NEW APPLICATIONS IN BIOLOGY, ENERGY, AND MATERIALS SCIENCES, P335, DOI 10.5772/65773; Senzai T, 2019, LANGMUIR, V35, P9747, DOI 10.1021/acs.langmuir.9b01448; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Shirure VS, 2017, LAB CHIP, V17, P681, DOI 10.1039/c6lc01401a; Sung JH, 2019, APL BIOENG, V3, DOI 10.1063/1.5097675; Sung KE, 2014, ADV DRUG DELIVER REV, V79-80, P68, DOI 10.1016/j.addr.2014.07.002; Trujillo-de Santiago G, 2019, MATERIALS, V12, DOI 10.3390/ma12182945; Vitale C, 2020, POLYMERS-BASEL, V12, DOI 10.3390/polym12112467; Wang P, 2016, SCI REP, V6, P1, DOI DOI 10.1038/s41598-016-0001-8; Weth A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67071-w; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Yesil-Celiktas O, 2018, ADV BIOSYST, V2, DOI 10.1002/adbi.201800109; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Zuchowska A, 2017, BIOMICROFLUIDICS, V11, DOI 10.1063/1.4979104	46	15	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245536	10.1371/journal.pone.0245536	http://dx.doi.org/10.1371/journal.pone.0245536			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444361	Green Published, gold			2022-12-26	WOS:000609988100068
J	Khamis, AG; Ntwenya, JE; Senkoro, M; Mfinanga, SG; Kreppel, K; Mwanri, AW; Bonfoh, B; Kwesigabo, G				Khamis, Ahmed Gharib; Ntwenya, Julius Edward; Senkoro, Mbazi; Mfinanga, Sayoki Godfrey; Kreppel, Katharina; Mwanri, Akwilina Wendelin; Bonfoh, Bassirou; Kwesigabo, Gideon			Association between dietary diversity with overweight and obesity: A cross-sectional study conducted among pastoralists in Monduli District in Tanzania	PLOS ONE			English	Article							NUTRIENT ADEQUACY; RISK-FACTORS; SCORE; ADIPOSITY; VARIETY	Background The prevalence of overweight and obesity is rising at a rapid pace and is associated with negative health consequences like cardiovascular diseases, type 2 diabetes and cancer. Obesity is a multifactorial problem that develops mainly from lifestyle factors including physical inactivity and poor dietary intake. Dietary diversity is a simplified method for assessing the adequacy and quality of diet and is associated with nutritional need and overall health status. Therefore, we conducted this study to synthesize the associations between consumption of a diversified diet and overweight/ obesity among adults living in pastoral communities in Monduli district in Tanzania. Methods This was a cross-sectional study conducted among 510 adults aged >= 18 years old in the Monduli district, Arusha region in Tanzania. We conducted face-to-face interviews to collect information about socio-demographic characteristics, 24-hours dietary recall, and anthropometric measurements. The dietary diversity score (DDS) was constructed and used to determine the diversity of the diet consumed. We performed the multivariate Poisson regressions to determine the prevalence ratio (PR) with 95% confidence intervals (CI). The dependent variables were overweight and general obesity as measured by body mass index (BMI), abdominal obesity measured by waist-hip ratio (WHR) and waist circumference (WC). Results The prevalence of general obesity based on BMI was 20.2% (95%CI; 16.9-23.9), abdominal obesity based on WHR was 37.8% (95%CI; 33.7-42.1), and WC was 29.1% (95%CI; 25.2-33.1). More than half (54.3%) of the participants consumed an adequate dietary diversity (DDS >= 4). After adjustment for potential confounders, the prevalence of abdominal obesity by WHR decreased with higher DDS among male (APR = 0.42; 95% CI, 0.22-0.77) and female participants (APR = 0.63; 95% CI, 0.41-0.94). There were inconsistent positive associations between DDS and prevalence of overweight and general obesity among male and female. There was no association between DDS and abdominal obesity by WC. Conclusion More than half of the pastoralists have consumed an adequate diversified diet. Given the inconsistent findings on associations between dietary diversity and obesity measures, this study suggests that targeting dietary diversity as an overweight/obesity prevention strategy requires careful consideration.	[Khamis, Ahmed Gharib; Kwesigabo, Gideon] Muhimbili Univ Hlth & Allied Sci, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania; [Ntwenya, Julius Edward] Univ Dodoma, Dept Publ Hlth, Dodoma, Tanzania; [Senkoro, Mbazi; Mfinanga, Sayoki Godfrey] Muhimbili Ctr, Natl Inst Med Res, Dar Es Salaam, Tanzania; [Kreppel, Katharina] Nelson Mandela African Inst Sci & Technol, Sch Life Sci & Bioengn, Arusha, Tanzania; [Kreppel, Katharina] Ifakara Hlth Inst, Dept Environm Hlth & Ecol Sci, Dar Es Salaam, Tanzania; [Mwanri, Akwilina Wendelin] Sokoine Univ Agr, Dept Food Technol Nutr & Consumer Sci, Morogoro, Tanzania; [Bonfoh, Bassirou] Ctr Suisse Rech Sci Cote dIvoire, Abidjan, Cote Ivoire	Muhimbili University of Health & Allied Sciences; National Institute of Medical Research; Nelson Mandela African Institution of Science & Technology; Ifakara Health Institute; Sokoine University of Agriculture	Khamis, AG (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania.	ahmadboycd@gmail.com	Khamis, Ahmed Gharib/ABV-4695-2022; Kreppel, Katharina/AAQ-8865-2021	Khamis, Ahmed Gharib/0000-0002-1689-8930; Kreppel, Katharina/0000-0001-7743-6919; Mfinanga, Sayoki/0000-0001-9067-2684; NTWENYA, JULIUS/0000-0002-4719-1970	African Academy of Sciences (AAS); Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency; Wellcome Trust [107753/A/15/Z]; UK government	African Academy of Sciences (AAS); Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency; Wellcome Trust(Wellcome TrustEuropean Commission); UK government	This study was conducted within the framework of the DELTAS Africa Initiative [Afrique One-ASPIRE/DEL-15-008]. Afrique One-ASPIRE is funded by a consortium of donor including the African Academy of Sciences (AAS), Alliance for Accelerating Excellence in Science in Africa (AESA), the New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency, the Wellcome Trust [107753/A/15/Z] and the UK government. The funders had no role in study design, data collection and analysis, decision to publish, or interpretation of the study.	Abris GP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206490; [Anonymous], 2016, CARE SOCIOECONOMIC C; [Anonymous], 2019, INTEL 64 IA 32 ARCHI, V3; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Azadbakht L, 2005, INT J OBESITY, V29, P1361, DOI 10.1038/sj.ijo.0803029; Azadbakht L, 2006, PUBLIC HEALTH NUTR, V9, P728, DOI 10.1079/PHN2005887; Azadbakht L, 2011, PUBLIC HEALTH NUTR, V14, P62, DOI 10.1017/S1368980010000522; Bezerra IN, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-22; FAO, 2018, DIET ASS RES GUID ME; FAO , 2010, GUID MEAS HOUS IND D; Foote JA, 2004, J NUTR, V134, P1779; Ford ND, 2017, ANNU REV PUBL HEALTH, V38, P145, DOI 10.1146/annurev-publhealth-031816-044604; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Galvin KA, 2015, HUM ECOL, V43, P411, DOI 10.1007/s10745-015-9749-x; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Jayawardena R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-314; Joanna Briggs Inst, 2011, NURS HEALTH SCI, V13, P378, DOI 10.1111/j.1442-2018.2011.00617.x; Karimbeiki R, 2018, PUBLIC HEALTH, V157, P127, DOI 10.1016/j.puhe.2018.01.028; Khamis AG, 2020, ARCH PUBLIC HEALTH, V78, DOI 10.1186/s13690-020-00485-0; Kimaro EG, 2018, PASTORALISM, V8, DOI 10.1186/s13570-018-0125-5; Lawson DW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110447; Mayanja M, 2015, ECOL FOOD NUTR, V54, P529, DOI 10.1080/03670244.2015.1041135; Mayega RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047632; Mbwana H. A., 2016, Cogent Food & Agriculture, V2, P1224046, DOI 10.1080/23311932.2016.1224046; Ministry of Health  Community Development  Gender  Elderly and Children (MoHCDGEC) [Tanzania Mainland]  Ministry of Health (MoH) [Zanzibar]  Tanzania Food and Nutrition Centre (TFNC)  National Bureau of Statistics (NBS)  Office of the Chief Government Statistician (OCGS) [Zanzibar] and UNICEF, 2018, TANZ NAT NUTR SURV U; Ng M, 2014, LANCET, V384, P746; Oiye S., 2009, Indigenous peoples' food systems: the many dimensions of culture, diversity and environment for nutrition and health, P231; Otto MCD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141341; Rathnayake Kumari M, 2014, BMC Res Notes, V7, P564, DOI 10.1186/1756-0500-7-564; Rathnayake Kumari Malkanthi, 2012, BMC Res Notes, V5, P469, DOI 10.1186/1756-0500-5-469; Salehi-Abargouei A, 2016, EUR J CLIN NUTR, V70, P1, DOI 10.1038/ejcn.2015.118; The Lancet HIV, 2015, LANCET HIV, V2, pe115; Torheim LE, 2004, EUR J CLIN NUTR, V58, P594, DOI 10.1038/sj.ejcn.1601853; Vadiveloo M, 2013, BRIT J NUTR, V109, P1557, DOI 10.1017/S0007114512006150; Vandevijvere S, 2010, PUBLIC HEALTH NUTR, V13, P1965, DOI 10.1017/S1368980010001606; WHO, 2008, WAIST CIRCUMFERENCE; World Health Organization, 2014, DOUBL BURD MALN; World Health Organization, 2018, GLOB PHYS ACT QUEST; Zhang Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172406	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0244813	10.1371/journal.pone.0244813	http://dx.doi.org/10.1371/journal.pone.0244813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439869	gold, Green Published			2022-12-26	WOS:000609985300028
J	Kowalsky, DB; Rebula, JR; Ojeda, LV; Adamczyk, PG; Kuo, AD				Kowalsky, Daniel B.; Rebula, John R.; Ojeda, Lauro V.; Adamczyk, Peter G.; Kuo, Arthur D.			Human walking in the real world: Interactions between terrain type, gait parameters, and energy expenditure	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; COST; ENERGETICS; BIOMECHANICS; COEFFICIENTS; MECHANICS; BALANCE; LOADS; FOOT	Humans often traverse real-world environments with a variety of surface irregularities and inconsistencies, which can disrupt steady gait and require additional effort. Such effects have, however, scarcely been demonstrated quantitatively, because few laboratory biomechanical measures apply outdoors. Walking can nevertheless be quantified by other means. In particular, the foot's trajectory in space can be reconstructed from foot-mounted inertial measurement units (IMUs), to yield measures of stride and associated variabilities. But it remains unknown whether such measures are related to metabolic energy expenditure. We therefore quantified the effect of five different outdoor terrains on foot motion (from IMUs) and net metabolic rate (from oxygen consumption) in healthy adults (N = 10; walking at 1.25 m/s). Energy expenditure increased significantly (P < 0.05) in the order Sidewalk, Dirt, Gravel, Grass, and Woodchips, with Woodchips about 27% costlier than Sidewalk. Terrain type also affected measures, particularly stride variability and virtual foot clearance (swing foot's lowest height above consecutive footfalls). In combination, such measures can also roughly predict metabolic cost (adjusted R-2 = 0.52, partial least squares regression), and even discriminate between terrain types (10% reclassification error). Body-worn sensors can characterize how uneven terrain affects gait, gait variability, and metabolic cost in the real world.	[Kowalsky, Daniel B.; Rebula, John R.; Ojeda, Lauro V.; Kuo, Arthur D.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Adamczyk, Peter G.] Univ Wisconsin, Dept Mech Engn, Madison, WI 53706 USA; [Kuo, Arthur D.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan	Kuo, AD (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.; Kuo, AD (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	arthur.kuo@ucalgary.ca	Kuo, Arthur/L-3359-2013	Kuo, Arthur/0000-0001-5233-9709	US Department of Defense [W81XWH-09-2-0142]; US National Ins titutes of Health [AG030815]; ETOWL Office of Naval Research	US Department of Defense(United States Department of Defense); US National Ins titutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ETOWL Office of Naval Research(Office of Naval Research)	AK W81XWH-09-2-0142 US Department of Defense https://cdmrp.army.mil PGA and AK: AG030815 US National Ins titutes of Health https://nih.gov AK: ETOWL Office of Naval Research https://www.onr.navy.mil/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk PG, 2006, J EXP BIOL, V209, P3953, DOI 10.1242/jeb.02455; Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; BROCKWAY JM, 1987, HUM NUTR-CLIN NUTR, V41C, P463; Brooks AG, 2005, MED SCI SPORT EXER, V37, P1216, DOI 10.1249/01.mss.0000170074.19649.0e; Bruijn SM, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0816; Burrough P., 1998, PRINCIPLES GEOGRAPHI; Collins SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073597; Crouter SE, 2006, J APPL PHYSIOL, V100, P1324, DOI 10.1152/japplphysiol.00818.2005; Donelan JM, 2001, P ROY SOC B-BIOL SCI, V268, P1985, DOI 10.1098/rspb.2001.1761; Donelan JM, 2002, J EXP BIOL, V205, P3717; ELFTMAN H, 1966, J BONE JOINT SURG AM, VA 48, P363, DOI 10.2106/00004623-196648020-00017; Gates DH, 2012, GAIT POSTURE, V35, P36, DOI 10.1016/j.gaitpost.2011.08.001; Grieve D.W., 1968, BIOMED ENG, V3, P119; Hendelman D, 2000, MED SCI SPORT EXER, V32, pS442, DOI 10.1097/00005768-200009001-00002; HOF AL, 1996, GAIT POSTURE, V4, P222; Huang TWP, 2014, J EXP BIOL, V217, P605, DOI 10.1242/jeb.091587; Kuffel EE, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-92; Kuo AD, 1999, INT J ROBOT RES, V18, P917, DOI 10.1177/02783649922066655; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Lejeune TM, 1998, J EXP BIOL, V201, P2071; Margaria R., 1976, BIOMECHANICS ENERGET; Mariani B, 2012, IEEE T BIO-MED ENG, V59, P3162, DOI 10.1109/TBME.2012.2216263; MONTOYE HJ, 1983, MED SCI SPORT EXER, V15, P403; O'Connor SM, 2012, GAIT POSTURE, V36, P102, DOI 10.1016/j.gaitpost.2012.01.014; O'Connor SM, 2009, J NEUROPHYSIOL, V102, P1411, DOI 10.1152/jn.00131.2009; Ojeda L, 2007, J NAVIGATION, V60, P391, DOI 10.1017/S0373463307004286; Ojeda LV, 2015, MED ENG PHYS, V37, P929, DOI 10.1016/j.medengphy.2015.06.010; PANDOLF KB, 1976, ERGONOMICS, V19, P683, DOI 10.1080/00140137608931583; PANDOLF KB, 1977, J APPL PHYSIOL, V43, P577, DOI 10.1152/jappl.1977.43.4.577; Rebula JR, 2013, GAIT POSTURE, V38, P974, DOI 10.1016/j.gaitpost.2013.05.012; Reimann H., 2018, KINESIOL REV, V7, P18, DOI [10.1123/kr.2017-0053, DOI 10.1123/KR.2017-0053]; Russ JC., 2013, GROUND IMPROVEMENT, V3rd; Seethapathi N, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0486; Snaterse M, 2011, J APPL PHYSIOL, V110, P1682, DOI 10.1152/japplphysiol.00536.2010; SOULE RG, 1969, J APPL PHYSIOL, V27, P687, DOI 10.1152/jappl.1969.27.5.687; SOULE RG, 1978, ERGONOMICS, V21, P373, DOI 10.1080/00140137808931734; SOULE RG, 1972, J APPL PHYSIOL, V32, P706, DOI 10.1152/jappl.1972.32.5.706; Tudor-Locke C, 2002, SPORTS MED, V32, P795, DOI 10.2165/00007256-200232120-00004; Voloshina AS, 2013, J EXP BIOL, V216, P3963, DOI 10.1242/jeb.081711; Wang Y, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0405; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Wu AR, 2015, ENERGETIC TRADEOFFS	42	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0228682	10.1371/journal.pone.0228682	http://dx.doi.org/10.1371/journal.pone.0228682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439858	Green Published, Green Submitted, gold			2022-12-26	WOS:000609985300032
J	Rowland, MA; Pilkiewicz, KR; Mayo, ML				Rowland, Michael A.; Pilkiewicz, Kevin R.; Mayo, Michael L.			Devil in the details: Mechanistic variations impact information transfer across models of transcriptional cascades	PLOS ONE			English	Article							REGULATORY NETWORK; NOISE	The transcriptional network determines a cell's internal state by regulating protein expression in response to changes in the local environment. Due to the interconnected nature of this network, information encoded in the abundance of various proteins will often propagate across chains of noisy intermediate signaling events. The data-processing inequality (DPI) leads us to expect that this intracellular game of "telephone" should degrade this type of signal, with longer chains losing successively more information to noise. However, a previous modeling effort predicted that because the steps of these signaling cascades do not truly represent independent stages of data processing, the limits of the DPI could seemingly be surpassed, and the amount of transmitted information could actually increase with chain length. What that work did not examine was whether this regime of growing information transmission was attainable by a signaling system constrained by the mechanistic details of more complex protein-binding kinetics. Here we address this knowledge gap through the lens of information theory by examining a model that explicitly accounts for the binding of each transcription factor to DNA. We analyze this model by comparing stochastic simulations of the fully nonlinear kinetics to simulations constrained by the linear response approximations that displayed a regime of growing information. Our simulations show that even when molecular binding is considered, there remains a regime wherein the transmitted information can grow with cascade length, but ends after a critical number of links determined by the kinetic parameter values. This inflection point marks where correlations decay in response to an oversaturation of binding sites, screening informative transcription factor fluctuations from further propagation down the chain where they eventually become indistinguishable from the surrounding levels of noise.	[Rowland, Michael A.; Pilkiewicz, Kevin R.; Mayo, Michael L.] US Army Engineer Res & Dev Ctr, Environm Lab, Vicksburg, MS 39180 USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Rowland, MA (corresponding author), US Army Engineer Res & Dev Ctr, Environm Lab, Vicksburg, MS 39180 USA.	Michael.A.Rowland@usace.army.mil		Rowland, Michael/0000-0002-6759-8225	U.S. Army's Installations and Operational Environment Basic Research program	U.S. Army's Installations and Operational Environment Basic Research program	Funding was provided by the U.S. Army's Installations and Operational Environment Basic Research program. The authors express gratitude to Dr. E. Ferguson, Technical Director of the US Army ERDC Installations and Operational Environment Program, for support of this research. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the U.S. Army.	Ahrends R, 2014, SCIENCE, V344, P1384, DOI 10.1126/science.1252079; Allen LJS, 2003, STOCHASTIC PROCESSES; Arsic I, 2005, EUR SIGN PROC C; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bilu Y, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r103; Camp J, 1999, PROC SPIE, V3661, P24, DOI 10.1117/12.348572; Cover T. M., 1991, ELEMENTS INFORM THEO; Danos V, 2004, THEOR COMPUT SCI, V325, P69, DOI 10.1016/j.tcs.2004.03.065; Danos V, 2007, LECT NOTES COMPUT SC, V4703, P17; Daw CS, 2003, REV SCI INSTRUM, V74, P915, DOI 10.1063/1.1531823; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Faeder JR, 2005, COMPLEXITY, V10, P22, DOI 10.1002/cplx.20074; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grima R, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3454685; He X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008155; Kato M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r56; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Ma HW, 2004, NUCLEIC ACIDS RES, V32, P6643, DOI 10.1093/nar/gkh1009; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Mayo M, 2015, BICT 2015, V2016, P148; Parmehr EG, 2013, IEEE IMAGE PROC, P1286, DOI 10.1109/ICIP.2013.6738265; Pilkiewicz KR, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.032412; Ross BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087357; Schaerli Y, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178102; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Steinbock C, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.032301; Suderman R, 2017, P NATL ACAD SCI USA, V114, P5755, DOI 10.1073/pnas.1615660114; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; The Lancet Haematology, 2018, LANCET HAEMATOL, V5, pE127; Van Kampen NG, 1992, STOCHASTIC PROCESSES	32	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0245094	10.1371/journal.pone.0245094	http://dx.doi.org/10.1371/journal.pone.0245094			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439904	Green Published, gold			2022-12-26	WOS:000609985300023
J	Cuberek, R; Janikova, M; Dygryn, J				Cuberek, Roman; Janikova, Marcela; Dygryn, Jan			Adaptation and validation of the Physical Activity Questionnaire for Older Children (PAQ-C) among Czech children	PLOS ONE			English	Article							INTRACLASS CORRELATION-COEFFICIENTS; RELIABILITY; YOUTH; VALIDITY; CALIBRATION; ADULTHOOD; FITNESS; HBSC	The study aimed to adapt the standardized Physical Activity Questionnaire for Older Children (PAQ-C) into the Czech language and assess its psychometric properties. A forwards-and-backwards translation method was carried out to prepare the Czech PAQ-C version (PAQ-C/CZ), followed by adjustments based on socio-cultural aspects. In the next phase, participants (n = 169) wore accelerometers for seven days. On the 8th day, participants completed the PAQ-C/CZ in school so that it was possible to determine the concurrent validity (correlation between the accelerometer and PAQ-C/CZ data, Spearman's r), internal consistency (Cronbach's alpha), item/scale properties (corrected item-total correlations, CITCs), and factor structure (exploratory factor analysis, EFA) for PAQ-C/CZ. In the last phase, participants (n = 63) completed the PAQ-C/CZ twice on two consecutive school days in the morning to determine the test-retest reliability (intraclass correlation coefficient, ICC; independent sample T-test). The PAQ-C/CZ indicated moderate internal consistency (alpha = 0.77), acceptable item/scale properties (CITCs = 0.29-0.61), and good test-retest reliability (ICC = 0.73-0.94). The EFA findings suggested a single factor model (factor load = 0.32-0.73) for PAQ-C/CZ, with items 2, 3, and 4 contributing low to the total score. Results on concurrent validity showed low but significant association (r = 0.28, p < 0.05) between accelerometer and PAQ-C/CZ data. Considering the study results, the PAQ-C/CZ can be recommended as a tool for moderate-to-vigorous physical activity assessment in large-sample research studies only, but with an emphasis on the interpretation of the correct results.	[Cuberek, Roman; Dygryn, Jan] Palacky Univ Olomouc, Inst Act Lifestyle, Fac Phys Culture, Olomouc, Czech Republic; [Janikova, Marcela] Masaryk Univ, Fac Sports Studies, Dept Sport Pedag, Brno, Czech Republic; [Janikova, Marcela] Masaryk Univ, Fac Sports Studies, Res Incubator Sport Sci, Brno, Czech Republic	Palacky University Olomouc; Masaryk University Brno; Masaryk University Brno	Cuberek, R (corresponding author), Palacky Univ Olomouc, Inst Act Lifestyle, Fac Phys Culture, Olomouc, Czech Republic.	roman.cuberek@upol.cz	Cuberek, Roman/E-1810-2016; Dygryn, Jan/E-4760-2017	Cuberek, Roman/0000-0003-1686-835X; Dygryn, Jan/0000-0003-1026-1784; Janikova, Marcela/0000-0003-2053-108X	Masaryk University, Brno, Czechia [MUNI/51/03/2019, ROZV/24/01/FSpS/2018]	Masaryk University, Brno, Czechia	This study was supported by the following grants-The First Stage of PAQ-C and PAQ-A Validation (No. MUNI/51/03/2019) and the Physical Activity, Cognitive Functions, and Physical Fitness in Children Aged 10-11 Years (No. ROZV/24/01/FSpS/2018) provided by the Masaryk University, Brno, Czechia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ActiGraph, 2014, GT3X WGT3X DEV MAN; Aggio D, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0115-2; Aubert S, 2018, J PHYS ACT HEALTH, V15, pS251, DOI 10.1123/jpah.2018-0472; Ben Jemaa H, 2018, ANN NUTR METAB, V73, P234, DOI 10.1159/000492673; Benitez-Porres J, 2016, J SCHOOL HEALTH, V86, P677, DOI 10.1111/josh.12418; Bervoets L, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-47; Biddle SJH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-1; Bussmann JBJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00463; Crocker PRE, 1997, MED SCI SPORT EXER, V29, P1344, DOI 10.1097/00005768-199710000-00011; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Cuberek R, 2019, VYZKUM ORIENTOVANY P, V8, P771; De Vries SI, 2009, MED SCI SPORT EXER, V41, P818, DOI 10.1249/MSS.0b013e31818e5819; Donnelly JE, 2016, MED SCI SPORT EXER, V48, P1197, DOI 10.1249/MSS.0000000000000901; Erdim L, 2019, TURK J MED SCI, V49, P162, DOI 10.3906/sag-1806-212; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Faghihimani Z, 2010, ARYA ATHEROSCLER, V5, P163; Fromel K., 2002, ACTA U PALACKI OLOMU, V32, P11; Gabriel KKP, 2012, J PHYS ACT HEALTH, V9, pS11, DOI 10.1123/jpah.9.s1.s11; Geisinger K., 1994, PSYCHOL ASSESSMENT, V6, P304, DOI [10.1037/1040-3590.6.4.304, DOI 10.1037/1040-3590.6.4.304]; Gobbi E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156354; Hidding LM, 2018, SPORTS MED, V48, P2797, DOI 10.1007/s40279-018-0987-0; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huotari P, 2011, J SPORT SCI, V29, P1135, DOI 10.1080/02640414.2011.585166; Isa T, 2019, CLIN MED INSIGHTS-PE, V13, DOI 10.1177/1179556519835833; Itoh H, 2017, ENVIRON HEALTH PREV, V22, DOI 10.1186/s12199-017-0648-1; Jakubec L., 2020, TELESNA KULT, V42, P62, DOI DOI 10.5507/TK.2020.006; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Janz KF, 2008, MED SCI SPORT EXER, V40, P767, DOI 10.1249/MSS.0b013e3181620ed1; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kalman M, 2015, ACTA GYMNICA, V45, P3, DOI 10.5507/ag.2015.001; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kowalski K. C., 2004, COLL KINESIOLOGY U S, V87, P1, DOI DOI 10.1186/2049-3258-72-47; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P174, DOI 10.1123/pes.9.2.174; Lyden K, 2011, EUR J APPL PHYSIOL, V111, P187, DOI 10.1007/s00421-010-1639-8; Manchola-Gonzalez J.D., 2015, PHYSIOTHERAPY, V101, pe945, DOI [10.1016/j.physio.2015.03.1795, DOI 10.1016/J.PHYSIO.2015.03.1795]; Martin-Bello C, 2020, CULT CIENC DEPORTE, V15, P177; Moore JB, 2007, PEDIATR EXERC SCI, V19, P6, DOI 10.1123/pes.19.1.6; Pelclova J, 2010, J SPORT SCI MED, V9, P490; Qin SS, 2019, QUAL LIFE RES, V28, P1029, DOI 10.1007/s11136-018-2076-0; Saint-Maurice PF, 2017, AM J PREV MED, V52, P880, DOI 10.1016/j.amepre.2016.12.010; Samarzija D. V., 2013, Hrvatski  Sportskomedicinski Vjesnik, V28, P24; Sigmund E, 2017, CENT EUR J PUBL HEAL, V25, pS4, DOI 10.21101/cejph.a4953; Silva KS, 2017, PREV MED, V96, P160, DOI 10.1016/j.ypmed.2016.11.004; Streiner DL., 2015, HLTH MEASUREMENT SCA, DOI [DOI 10.1093/MED/9780199685219.001.0001, 10.1093/med/9780199685219.001.0001]; Telama R, 2005, AM J PREV MED, V28, P267, DOI 10.1016/j.amepre.2004.12.003; Thomas EL, 2014, PSYCHOL SPORT EXERC, V15, P280, DOI 10.1016/j.psychsport.2014.02.002; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Tsang S, 2017, SAUDI J ANAESTH, V11, pS80, DOI 10.4103/sja.SJA_203_17; Voss C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175806; Wang JJ, 2016, BIOMED ENVIRON SCI, V29, P177, DOI 10.3967/bes2016.022; WHO, 2018, PHYS ACTIVITY FACTSH; Zaki NAM., 2016, INT J PUBLIC HLTH RE, V6, P670	52	5	5	8	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245256	10.1371/journal.pone.0245256	http://dx.doi.org/10.1371/journal.pone.0245256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4SP	33434223	gold, Green Published			2022-12-26	WOS:000609979700022
J	Han, MR; Yan, HF; Yang, K; Fan, BY; Liu, PY; Yang, HT				Han, Miaoru; Yan, Haifeng; Yang, Kang; Fan, Boya; Liu, Panying; Yang, Hongtao			Identification of biomarkers and construction of a microRNA-mRNA regulatory network for clear cell renal cell carcinoma using integrated bioinformatics analysis	PLOS ONE			English	Article							R PACKAGE; EXPRESSION; CANCER; GROWTH; MARKER	With the recent research development, the importance of microRNAs (miRNAs) in renal clear cell carcinoma (CCRCC) has become widely known. The purpose of this study is to screen out the potential biomarkers of renal clear cell carcinoma (CCRCC) by microarray analysis. The miRNA chip (GSE16441) and mRNA chip (GSE66270) related to CCRCC were downloaded from the Gene Expression Omnibus (GEO) database. After data filtering and pretreating, R platform and a series of analysis tools (funrich3.1.3, string, Cytoscape_ 3.2.1, David, etc.) were used to analyze chip data and identify the specific and highly sensitive biomarkers. Finally, by constructing the miRNA -mRNA interaction network, it was determined that five miRNAs (hsa-mir-199a-5p, hsa-mir-199b-5p, hsa-mir-532-3p and hsa-mir-429) and two key genes (ETS1 and hapln1) are significantly related to the overall survival rate of patients.	[Han, Miaoru; Yan, Haifeng; Yang, Kang; Fan, Boya; Liu, Panying; Yang, Hongtao] Tianjin Univ Tradit Chinese Med, Dept Nephrol, Teaching Hosp 1, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine	Yang, HT (corresponding author), Tianjin Univ Tradit Chinese Med, Dept Nephrol, Teaching Hosp 1, Tianjin, Peoples R China.	tjtcmht@126.com						Ammirante M, 2014, P NATL ACAD SCI USA, V111, P14776, DOI 10.1073/pnas.1416498111; Atkins MB, 2018, CANCER TREAT REV, V70, P127, DOI 10.1016/j.ctrv.2018.07.009; Campbell S, 2017, J UROLOGY, V198, P520, DOI 10.1016/j.juro.2017.04.100; Chen X, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007209; Chen X, 2019, BRIEF BIOINFORM, V20, P515, DOI 10.1093/bib/bbx130; Chen X, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006418; Chen X, 2018, BIOINFORMATICS, V34, P4256, DOI 10.1093/bioinformatics/bty503; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fan WX, 2016, MOL MED REP, V13, P4800, DOI 10.3892/mmr.2016.5101; Fritz HKM, 2014, EUR J CANCER, V50, P1758, DOI 10.1016/j.ejca.2014.03.281; He YH, 2018, J CELL PHYSIOL, V233, P4458, DOI 10.1002/jcp.26347; Hsieh JJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.9; Ivanova AV, 2009, CLIN CANCER RES, V15, P2602, DOI 10.1158/1078-0432.CCR-08-2755; Liu Z, 2008, INT J MOL SCI, V9, P978, DOI 10.3390/ijms9060978; Ljungberg B, 2015, EUR UROL, V67, P913, DOI 10.1016/j.eururo.2015.01.005; Long KR, 2018, NEURON, V99, P702, DOI 10.1016/j.neuron.2018.07.013; Mebarki S, 2016, ONCOTARGET, V7, P39026, DOI 10.18632/oncotarget.9346; Mercedes, 2015, BIOINFORMATICS OXFOR, V31; Nagarajan A, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00483; Parveen A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030350; Roskoski R, 2017, PHARMACOL RES, V120, P116, DOI 10.1016/j.phrs.2017.03.010; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi HB, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-101; Shinmei S, 2013, INT J UROL, V20, P468, DOI 10.1111/j.1442-2042.2012.03182.x; Sun ZQ, 2016, J CELL BIOL, V215, P445, DOI 10.1083/jcb.201609037; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tarbell JM, 2016, J INTERN MED, V280, P97, DOI 10.1111/joim.12465; Testoni M, 2015, LEUKEMIA LYMPHOMA, V56, P1975, DOI 10.3109/10428194.2014.981670; Villanueva RAM, 2019, MEAS-INTERDISCIP RES, V17, P160, DOI 10.1080/15366367.2019.1565254; Wang JL, 2019, GYNECOL ONCOL, V152, P194, DOI 10.1016/j.ygyno.2018.10.002; Wang S, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00614; Wang ZZ, 2018, ONCOL LETT, V15, P8491, DOI 10.3892/ol.2018.8398; Wirrig EE, 2007, DEV BIOL, V310, P291, DOI 10.1016/j.ydbio.2007.07.041; Xu TB, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109264; Yan Xing-qi, 2008, Chinese Medical Sciences Journal, V23, P202; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yuan HX, 2014, TUMOR BIOL, V35, P12757, DOI 10.1007/s13277-014-2602-9; Zhai W, 2018, BRIT J CANCER, V119, P591, DOI 10.1038/s41416-018-0196-5	42	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0244394	10.1371/journal.pone.0244394	http://dx.doi.org/10.1371/journal.pone.0244394			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434215	Green Published, gold			2022-12-26	WOS:000609979700006
J	Kluwe-Schiavon, B; Viola, TW; Bandinelli, LP; Castro, SCC; Kristensen, CH; da Costa, JC; Grassi-Oliveira, R				Kluwe-Schiavon, Bruno; Viola, Thiago Wendt; Bandinelli, Lucas Poitevin; Coral Castro, Sayra Catalina; Kristensen, Christian Haag; da Costa, Jaderson Costa; Grassi-Oliveira, Rodrigo			A behavioral economic risk aversion experiment in the context of the COVID-19 pandemic	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; MODELS; DELAY	We investigated what degree of risk of infection with COVID-19 is necessary so that people intend to stay home, even when doing so means losing their salary. We conducted an online survey across Brazil during the initial outbreak, in which 8,345 participants answered a questionnaire designed to identify the maximum tolerated risk (k') necessary for them to disregard social distancing recommendations and guarantee their salaries. Generalized linear mixed models, path analysis structural equation, and conditional interference classification tree were performed to further understand how sociodemographic factors impact k' and to establish a predictive model for the risk behavior of leaving home during the pandemic. We found that, on average, people tolerate 38% risk of infection to leave home and earn a full salary, but this number decreased to 13% when the individual risk perception of becoming ill from severe acute respiratory syndrome coronavirus-2 is considered. Furthermore, participants who have a medium-to-high household income and who are older than 35 years are more likely to be part of the risk-taking group who leave home regardless of the potential COVID-19 infection level; while participants over 45 years old and with good financial health are more likely to be part of the risk-averse group, who stay home at the expense of any salary offered. Our findings add to the political and public debate concerning lockdown strategies by showing that, contrary to supposition, people with low socioeconomic status are not more likely to ignore social distancing recommendations due to personal economic matters.	[Kluwe-Schiavon, Bruno; Viola, Thiago Wendt; Bandinelli, Lucas Poitevin; Coral Castro, Sayra Catalina; Kristensen, Christian Haag; Grassi-Oliveira, Rodrigo] Pontificia Univ Catolica Rio Grande do Sul, Sch Med, Dev Cognit Neurosci Lab DCNL, Porto Alegre, RS, Brazil; [Kluwe-Schiavon, Bruno; Viola, Thiago Wendt; da Costa, Jaderson Costa; Grassi-Oliveira, Rodrigo] Pontificia Univ Catolica Rio Grande do Sul, Brain Inst Rio Grande do Sul Brains, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Grassi-Oliveira, R (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Sch Med, Dev Cognit Neurosci Lab DCNL, Porto Alegre, RS, Brazil.; Grassi-Oliveira, R (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Brain Inst Rio Grande do Sul Brains, Porto Alegre, RS, Brazil.	rodrigo.grassi@pucrs.br	DaCosta, Jaderson/C-4968-2015; Grassi-Oliveira, R/G-2623-2012	DaCosta, Jaderson/0000-0001-6776-1515; Grassi-Oliveira, R/0000-0001-9911-5921; Kluwe-Schiavon, Bruno/0000-0002-6529-8667; Bandinelli, Lucas/0000-0001-7258-5771	CAPES	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We would like to thank Prof. Carla Denise Bonan for the support and CAPES for the scholarship cod 001.	Abbasi-Ghahramanloo A, 2018, J RES HEALTH SCI, V18; Ajzenman N, 2020, MORE WORDS LEADERS S; Allen L, 2017, LANCET GLOB HEALTH, V5, pE277, DOI 10.1016/s2214-109x(17)30058-x; Amuedo-Dorantes C, 2020, TIMING IS EVERYTHING, DOI [10.1097/MLR.0000000000001300, DOI 10.1097/MLR.0000000000001300]; Anderson LR, 2008, J HEALTH ECON, V27, P1260, DOI 10.1016/j.jhealeco.2008.05.011; [Anonymous], 2020, CNBC; Berniell L, 2020, JOBS AMENABILITY IS, DOI [10.1016/j.ehb.2020.100901, DOI 10.1016/J.EHB.2020.100901]; Bollen KA, 2011, P NATL ACAD SCI USA, V108, P15639, DOI 10.1073/pnas.1010661108; Branas-Garza P., 2020, PSYARXIV; Branas-Garza P, 2020, MPRA MUNICH PERSONAL; Campos-Mercade P, 2020, PROSOCIALITY PREDICT; CFPB, 2015, MEAS FIN WELL BEING; CFPB, 2017, CFPB FIN WELL BEING; Consumer Financial Protection Bureau (CFPB), 2019, GETT START MEAS FIN; Croda J, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0167-2020; Datafolha, 2020, OP PAND COR; Economics. T, 2020, BARZ CORR RANK TRAND; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Field A., 2012, DISCOVERING STAT USI; Ganem F, 2020, IMPACT EARLY SOCIAL; Glimcher PW, 2013, NEUROECONOMICS DECIS; Griskevicius V, 2011, J PERS SOC PSYCHOL, V100, P1015, DOI 10.1037/a0022403; Guidotti E, 2020, COVID19; Harrison GW, 2002, AM ECON REV, V92, P1606, DOI 10.1257/000282802762024674; Hothorn T., CTREE CONDITIONAL IN; Hothorn T, 2015, J MACH LEARN RES, V16, P3905; Ishii K, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1361-4; Jacques-Avino C, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-044617; Kampfen F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241895; Kirby J, 2020, J BOLSONARO UNDERMIN; Kohn J., 2010, RES BUSINESS EC J; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kumar A, 2021, J POLICY MODEL, V43, P76, DOI 10.1016/j.jpolmod.2020.09.001; Lal A, 2018, AUST NZ J PUBL HEAL, V42, P207, DOI 10.1111/1753-6405.12709; Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037; Leppin A, 2009, INT J BEHAV MED, V16, P7, DOI 10.1007/s12529-008-9002-8; Lindqvist A, 2018, J SOC PSYCHOL, V158, P361, DOI 10.1080/00224545.2017.1357527; Mahoney CT, 2016, BEHAV PROCESS, V125, P13, DOI 10.1016/j.beproc.2016.01.011; Ministry of Health B, 2020, MIN SAUD DECL TRANSM; Papageorge NW, 2020, SOCIODEMOGRAPHIC FAC; Pepper GV, 2017, PEERJ, V5, DOI 10.7717/peerj.3580; Reimers S, 2009, PERS INDIV DIFFER, V47, P973, DOI 10.1016/j.paid.2009.07.026; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; Standl F, 2020, EUR J EPIDEMIOL, V35, P339, DOI 10.1007/s10654-020-00629-0; Stanger C, 2012, EXP CLIN PSYCHOPHARM, V20, P205, DOI 10.1037/a0026543; Story GW, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00076; Thakkar J, 2020, STRUCTURAL EQUATION, V1; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z	48	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245261	10.1371/journal.pone.0245261	http://dx.doi.org/10.1371/journal.pone.0245261			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PY3TH	33465121	Green Published, gold			2022-12-26	WOS:000611969200024
J	Asemahagn, MA; Alene, GD; Yimer, SA				Asemahagn, Mulusew Andualem; Alene, Getu Degu; Yimer, Solomon Abebe			Spatial-temporal clustering of notified pulmonary tuberculosis and its predictors in East Gojjam Zone, Northwest Ethiopia	PLOS ONE			English	Article							CARE; COMMUNITY; BARRIERS; BURDEN	Background Tuberculosis (TB) remains a key health menace in Ethiopia and its districts. This study aimed to assess the spatial-temporal clustering of notified pulmonary TB (PTB) cases in East Gojjam Zone, Northwest Ethiopia. Methods A retrospective study was conducted among all PTB cases reported from 2013-2019. Case notification rates (CNRs) of PTB cases at Kebele (the lowest administrative unit), woreda, and zone levels were estimated. The PTB clustering was done using global Moran's I statistics on Arc GIS 10.6. We used Kulldorff SaTScan 9.6 with a discrete Poisson model to identify statistically significant spatial-temporal clustering of PTB cases at Kebele level. Similarly, a negative binomial regression analysis was used to identify factors associated with the incidence of PTB cases at kebele level. Results A total of 5340 (52%) smear-positive and 4928 (48%) smear-negative PTB cases were analyzed. The overall mean CNR of PTB cases at zone, woreda and Kebele levels were 58(47-69), 82(56-204), and 69(36-347) per 100,000 population, respectively. The purely spatial cluster analysis identified eight most likely clusters (one for overall and one per year for seven reporting years) and 47 secondary clusters. Similarly, the space-time scan analysis identified one most likely and seven secondary clusters. The purely temporal analysis also detected one most likely cluster from 2013-2015. Rural residence, distance from the nearest health facility, and poor TB service readiness were factors (p-value <0.05) to PTB incidence at kebele level. Conclusion The distribution of PTB cases was clustered. The PTB CNR was low and showed a decreasing trend during the reporting periods. Rural residence, distance from the health facilities, and poor facility readiness were factors of PTB incidence. Improving accessibility and readiness of health facilities mainly to rural and hotspot areas is vital to increase case detection and reduce TB transmission.	[Asemahagn, Mulusew Andualem; Alene, Getu Degu] Bahir Dar Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Yimer, Solomon Abebe] Univ Oslo, Dept Microbiol, Unit Genome Dynam, Fac Med, Oslo, Norway; [Yimer, Solomon Abebe] Coalit Epidem Preparedness Innovat CEPI, Oslo, Norway	Bahir Dar University; University of Oslo	Asemahagn, MA (corresponding author), Bahir Dar Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.	muler.hi@gmail.com			Bahir Dar University [RCS/254/09]	Bahir Dar University	Bahir Dar University covered the budget for data collection (Grant No: RCS/254/09), but it has no technical role in all the research processes. The funder provided support in the form of salaries for authors [Mulusew and Getu] and data collection budget, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Ahmad RA, 2013, INT HEALTH, V5, P51, DOI 10.1093/inthealth/ihs002; Alene KA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221027; Alene KA, 2017, GEOSPATIAL HEALTH, V12, P342, DOI 10.4081/gh.2017.575; Alene KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171800; Amenuvegbe Gregory K, 2016, BMC Res Notes, V9, P330, DOI 10.1186/s13104-016-2136-x; Amhara National Regional State Health Bureau, 2019, 2018 19 ANN PERF REP; [Anonymous], 2018, AMH NAT REG STAT; [Anonymous], 2020, BMC PEDIATR, V20, P1, DOI DOI 10.1016/J.CLAE.2020.04.011; Asemahagn MA, 2020, AM J TROP MED HYG, V103, P1455, DOI 10.4269/ajtmh.20-0050; Asemahagn Mulusew Andualem, 2017, Tuberc Res Treat, V2017, P2569598, DOI 10.1155/2017/2569598; Asemahagn MA, 2020, RES REP TROP MED, V11, P3, DOI 10.2147/RRTM.S233052; Asemahagn MA, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0995-3; Asres M, 2017, AM J TROP MED HYG, V96, P1071, DOI 10.4269/ajtmh.16-0892; Awoke N, 2017, TOTAL DELAY TREATMEN, DOI [10.1016/j.scitotenv.2017.07.048, DOI 10.1016/J.SCITOTENV.2017.07.048]; Berju A, 2019, INT J MICROBIOL, V2019, DOI 10.1155/2019/9432469; Cazabon D, 2017, INT J INFECT DIS, V56, P111, DOI 10.1016/j.ijid.2016.10.016; Chen JO, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7993-5; Dabaro Desalegn, 2017, J Clin Tuberc Other Mycobact Dis, V9, P1, DOI 10.1016/j.jctube.2017.08.003; Dangisso MH, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.29443; Dangisso MH, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0126369; Datiko DG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224196; Datiko DG, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6620-9; Deribew A, 2018, ETHIOP J HEALTH SCI, V28, P519, DOI 10.4314/ejhs.v28i5.2; EFMoH, 2018, ETH NAT TUB ANN REP; EPHI FMOH WHO, 2016, ETH SERV AV READ ASS; EPHI FMOH WHO, 2016, ETH HLTH DAT QUAL RE; Ereso BM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226307; Ethiopian Federal Ministry of Health, 2012, ETH STAND FIN MED CL; Gebreegziabher S., 2016, J TUBERC RES, V4, P23, DOI DOI 10.4236/JTR.2016.41004; Gelaw YA, 2019, T ROY SOC TROP MED H, V113, P379, DOI 10.1093/trstmh/trz017; Getnet F, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0551-y; Hamusse SD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-304; Kebede AH, 2014, INT J TUBERC LUNG D, V18, P635, DOI 10.5588/ijtld.13.0417; Kulldorff M., 2018, SATSCANTMUSER GUIDE; Merid Y, 2019, INT J INFECT DIS, V89, P122, DOI 10.1016/j.ijid.2019.10.012; Muttamba W, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4616-2; Republic of Kenya Ministry of Health, 2018, KEN TUB PREV SURV FI; Shaweno D, 2017, INT J TUBERC LUNG D, V21, P79, DOI 10.5588/ijtld.16.0325; Shaweno D, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2759-0; Sinishaw MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141032; Tadesse S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198353; Tadesse T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065022; Tadesse T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-424; Tadesse T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028258; The World Health Organization, 2013, SERV AV READ ASS SAR; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Wubull A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180226; Zhang YJ, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4008-1	48	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245378	10.1371/journal.pone.0245378	http://dx.doi.org/10.1371/journal.pone.0245378			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449953	Green Published, gold			2022-12-26	WOS:000609991600022
J	Plowman, PN; Plowman, CE				Plowman, P. N.; Plowman, C. E.			Onco-ontogeny recapitulates phylogeny - a consideration	ONCOGENE			English	Article							CONSENSUS MOLECULAR SUBTYPES; BRAIN-STEM GLIOMAS; COLORECTAL-CANCER; PATTERNS; MODIFIER; FUMARATE; CELLS	Cancers necessarily rely on the (embryologic) fundamental growth patterning genes to serve their uncontrolled growth. Studying a cancer's behavior, depending on which side of an embryological divide it derives, together with its transcriptome and its relationship to immigrant cells with stem cell potential, intercellular signaling and transducer cascades to transcription factors-all help our understanding of the cancer phenotype. To these can be added the acquired methylome and possibly a "knock-on" metabolome. These aspects are reviewed in the context of Haeckel's law.	[Plowman, P. N.] St Bartholomews Hosp, Dept Clin Oncol, London, England; [Plowman, C. E.] UCL, London, England	University of London; Queen Mary University London; University of London; University College London	Plowman, PN (corresponding author), St Bartholomews Hosp, Dept Clin Oncol, London, England.	nick.plowman1@nhs.net						Aiello NM, 2016, DIS MODEL MECH, V9, P105, DOI 10.1242/dmm.023184; Al-Olabi L, 2018, J CLIN INVEST, V128, P1496, DOI 10.1172/JCI98589; Ashrafian H, 2010, CANCER RES, V70, P9153, DOI 10.1158/0008-5472.CAN-10-1949; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Cohen AL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0345-4; Daoud EV, 2018, J NEUROPATH EXP NEUR, V77, P302, DOI 10.1093/jnen/nly006; Fessler E, 2016, ONCOGENE, V35, P6026, DOI 10.1038/onc.2016.134; Fontana E, 2019, ANN ONCOL, V30, P520, DOI 10.1093/annonc/mdz052; Fromme Julia Elisabeth, 2018, Oncotarget, V9, P32204, DOI 10.18632/oncotarget.25941; Gomez DR, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.19.00201; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Irving C, 2000, DEVELOPMENT, V127, P177; Jiao XM, 2019, CANCER RES, V79, P4801, DOI 10.1158/0008-5472.CAN-19-1167; Kinsler VA, 2020, HARPERS TXB PEDIAT D, P1283; Li HJ, 2012, DEV BIOL, V371, P156, DOI 10.1016/j.ydbio.2012.08.023; Liu J, 2019, J PATHOL, V247, P481, DOI 10.1002/path.5207; Maffeis V, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01255; Makabe T, 2019, CARCINOGENESIS, V40, P611, DOI 10.1093/carcin/bgz046; May CL, 2010, MOL CELL ENDOCRINOL, V323, P70, DOI 10.1016/j.mce.2009.12.009; Mi ZY, 2011, CARCINOGENESIS, V32, P477, DOI 10.1093/carcin/bgr009; Mo J, 2020, CANCER RES TREAT, V52, P74, DOI 10.4143/crt.2019.062; Nishikawa G, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1508-2; Oberheim-Bush NA, 2020, P AM SOC CLIN ONCOL; Padmanaban V, 2019, NATURE, V573, P439, DOI 10.1038/s41586-019-1526-3; Palma DA, 2019, LANCET, V393, P2051, DOI 10.1016/S0140-6736(18)32487-5; Perrone-Capano C, 2000, INT J DEV BIOL, V44, P679; Pinheiro M, 2015, BRIT J CANCER, V113, P686, DOI 10.1038/bjc.2015.281; Plava J, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0960-z; Plowman PN, 2004, BRIT J NEUROSURG, V18, P500, DOI 10.1080/02688690400012400; Schreck KC, 2019, J NEURO-ONCOL, V143, P87, DOI 10.1007/s11060-019-03134-x; Sciacovelli M, 2016, NATURE, V540, DOI 10.1038/nature20144; Sciacovelli M, 2016, NATURE, V537, P544, DOI 10.1038/nature19353; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Sulkowski PL, 2018, NAT GENET, V50, P1086, DOI 10.1038/s41588-018-0170-4; Summerbell ER, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6197; Tapial S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47014-w; Theeler BJ, 2015, J NEUROL SCI, V353, P92, DOI 10.1016/j.jns.2015.04.014; Turajlic S, 2018, CELL, V173, P581, DOI 10.1016/j.cell.2018.03.057; Wallace AS, 2011, WORLD J GASTROENTERO, V17, P4937, DOI 10.3748/wjg.v17.i45.4937; Whitehall VLJ, 2014, EPIGENETICS-US, V9, P1454, DOI 10.4161/15592294.2014.971624; Xu YF, 2007, HUM MOL GENET, V16, pR14, DOI 10.1093/hmg/ddl486	42	0	0	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2021	40	8					1542	1550		10.1038/s41388-020-01624-1	http://dx.doi.org/10.1038/s41388-020-01624-1		JAN 2021	9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QM6NM	33452457				2022-12-26	WOS:000607998600004
J	Abe, MS; Matsumura, K; Yoshii, T; Miyatake, T				Abe, Masato S.; Matsumura, Kentarou; Yoshii, Taishi; Miyatake, Takahisa			Amplitude of circadian rhythms becomes weaken in the north, but there is no cline in the period of rhythm in a beetle	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY RHYTHM; DROSOPHILA-MELANOGASTER; LATITUDINAL CLINE; ECLOSION RHYTHM; POPULATIONS; SELECTION; TEMPERATURE; FLIGHT	Many species show rhythmicity in activity, from the timing of flowering in plants to that of foraging behavior in animals. The free-running periods and amplitude (sometimes called strength or power) of circadian rhythms are often used as indicators of biological clocks. Many reports have shown that these traits are highly geographically variable, and interestingly, they often show latitudinal or longitudinal clines. In many cases, the higher the latitude is, the longer the free-running circadian period (i.e., period of rhythm) in insects and plants. However, reports of positive correlations between latitude or longitude and circadian rhythm traits, including free-running periods, the power of the rhythm and locomotor activity, are limited to certain taxonomic groups. Therefore, we collected a cosmopolitan stored-product pest species, the red flour beetle Tribolium castaneum, in various parts of Japan and examined its rhythm traits, including the power and period of the rhythm, which were calculated from locomotor activity. The analysis revealed that the power was significantly lower for beetles collected in northern areas than southern areas in Japan. However, it is worth noting that the period of circadian rhythm did not show any clines; specifically, it did not vary among the sampling sites, despite the very large sample size (n = 1585). We discuss why these cline trends were observed in T. castaneum.	[Abe, Masato S.] RIKEN, Ctr Adv Intelligence Project, Tokyo, Japan; [Matsumura, Kentarou; Miyatake, Takahisa] Okayama Univ, Grad Sch Environm & Life Sci, Okayama, Japan; [Yoshii, Taishi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan	RIKEN; Okayama University; Okayama University	Miyatake, T (corresponding author), Okayama Univ, Grad Sch Environm & Life Sci, Okayama, Japan.	miyatake@okayama-u.ac.jp			Japan Society for the promotion of Science [16K14810, 18H02510]	Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded from Japan Society for the promotion of Science, Award number 16K14810 and 18H02510.	Arnold PA, 2017, FUNCT ECOL, V31, P653, DOI 10.1111/1365-2435.12772; Bertolini E, 2019, CURR BIOL, V29, P3928, DOI 10.1016/j.cub.2019.09.032; BLACKENHORN WU, 1995, J EVOLUTIONARY BIOL, V8, P21, DOI DOI 10.1046/J.1420-9101.1995.8010021.X; Bloch G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0019; Champ B. R., 1976, FAO PLANT PRODUCTION, V5; COYNE JA, 1987, GENETICS, V117, P727; Drury DW, 2016, ENTOMOL EXP APPL, V158, P269, DOI 10.1111/eea.12401; Endler J.A., 1977, Monographs in Population Biology, pi; Fedina TY, 2008, BIOL REV, V83, P151, DOI 10.1111/j.1469-185X.2008.00037.x; FLEURY F, 1995, BEHAV GENET, V25, P81, DOI 10.1007/BF02197245; Greenham K, 2017, J BIOL RHYTHM, V32, P26, DOI 10.1177/0748730416679307; HALBERG F, 1969, ANNU REV PHYSIOL, V31, P675, DOI 10.1146/annurev.ph.31.030169.003331; Helfrich-Forster C, 2020, EUR J NEUROSCI, V51, P166, DOI 10.1111/ejn.14180; Hut RA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0433; James AC, 1997, GENETICS, V146, P881; Joshi DS, 1999, CAN J ZOOL, V77, P865, DOI 10.1139/cjz-77-6-865; Klarsfeld A, 2003, BEHAV PROCESS, V64, P161, DOI 10.1016/S0376-6357(03)00133-5; Konishi K, 2020, J EVOLUTION BIOL, V33, P1120, DOI 10.1111/jeb.13641; Kyriacou CP, 2008, TRENDS GENET, V24, P124, DOI 10.1016/j.tig.2007.12.003; Kyriacou CP, 2017, CURR BIOL, V27, pR227, DOI 10.1016/j.cub.2017.02.017; LANKINEN P, 1993, HEREDITY, V71, P210, DOI 10.1038/hdy.1993.126; LANKINEN P, 1986, J COMP PHYSIOL A, V159, P123, DOI 10.1007/BF00612503; Matsumura K, 2020, BIOL J LINN SOC, V130, P34, DOI 10.1093/biolinnean/blaa016; Matsumura K, 2019, BEHAV ECOL, V30, P1522, DOI 10.1093/beheco/arz110; Matsumura K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127042; Menegazzi P, 2017, CURR BIOL, V27, P833, DOI 10.1016/j.cub.2017.01.036; Miyatake, BIORXIV, DOI [10.1101/2020.08.10.245431, DOI 10.1101/2020.08.10.245431]; Paolucci S, 2019, BEHAV SCI-BASEL, V9, DOI 10.3390/bs9110115; PITTENDRIGH CS, 1989, J BIOL RHYTHM, V4, P217; PITTENDRIGH CS, 1991, J BIOL RHYTHM, V6, P299, DOI 10.1177/074873049100600402; Pivarciova L, 2016, J BIOL RHYTHM, V31, P568, DOI 10.1177/0748730416671213; R Core Team, 2021, R LANGUAGE ENV STAT; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Ridley AW, 2011, MOL ECOL, V20, P1635, DOI 10.1111/j.1365-294X.2011.05049.x; Saunders DS, 2002, INSECT CLOCKS; Semeao AA, 2012, ENVIRON ENTOMOL, V41, P188, DOI 10.1603/EN11207; Sokoloff A, 1975, BIOL TRIBOLIUM; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; Zhang QZ, 2008, P NATL ACAD SCI USA, V105, P21028, DOI 10.1073/pnas.0810585105; Zonato V, 2018, J BIOL RHYTHM, V33, P15, DOI 10.1177/0748730417742309	41	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245115	10.1371/journal.pone.0245115	http://dx.doi.org/10.1371/journal.pone.0245115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444354	Green Published, Green Submitted, gold			2022-12-26	WOS:000609988100087
J	Finnegan, RN; Orlandini, L; Liao, XF; Yin, J; Lang, JY; Dowling, J; Fontanarosa, D				Finnegan, Robert Neil; Orlandini, Lucia; Liao, Xiongfei; Yin, Jun; Lang, Jinyi; Dowling, Jason; Fontanarosa, Davide			Feasibility of using a novel automatic cardiac segmentation algorithm in the clinical routine of lung cancer patients	PLOS ONE			English	Article							HEART SUBSTRUCTURES; BREAST-CANCER; RADIOTHERAPY; DELINEATION; VALIDATION; DISEASE; MOTION; RISK; CT	Incidental radiation exposure to the heart during lung cancer radiotherapy is associated with radiation-induced heart disease and increased rates of mortality. By considering the respiratory-induced motion of the heart it is possible to create a radiotherapy plan that results in a lower overall cardiac dose. This approach is challenging using current clinical practices: manual contouring of the heart is time consuming, and subject to inter- and intra-observer variability. In this work, we investigate the feasibility of our previously developed, atlas-based, automatic heart segmentation tool to delineate the heart in four-dimensional x-ray computed tomography (4D-CT) images. We used a dataset comprising 19 patients receiving radiotherapy for lung cancer, with 4D-CT imaging acquired at 10 respiratory phases and with a maximum intensity projection image generated from these. For each patient, one of four experienced radiation oncologists contoured the heart on each respiratory phase image and the maximum intensity image. Automatic segmentation of the heart on these same patient image sets was achieved using a leave-one-out approach, where for each patient the remaining 18 were used as an atlas set. The consistency of the automatic segmentation relative to manual contouring was evaluated using the Dice similarity coefficient (DSC) and mean absolute surface-to-surface distance (MASD). The DSC and MASD are comparable to inter-observer variability in clinically acceptable whole heart delineations (average DSC > 0.93 and average MASD < 2.0 mm in all the respiratory phases). The comparison between automatic and manual delineations on the maximum intensity images produced an overall mean DSC of 0.929 and a mean MASD of 2.07 mm. The automatic, atlas-based segmentation tool produces clinically consistent and robust heart delineations and is easy to implement in the routine care of lung cancer patients.	[Finnegan, Robert Neil; Dowling, Jason] Univ Sydney, Inst Med Phys, Sch Phys, Camperdown, NSW, Australia; [Orlandini, Lucia; Liao, Xiongfei; Yin, Jun; Lang, Jinyi] Sichuan Canc Hosp & Inst, Chengdu, Peoples R China; [Orlandini, Lucia; Liao, Xiongfei; Yin, Jun; Lang, Jinyi] Radiat Oncol Key Lab Sichuan Prov, Chengdu, Peoples R China; [Orlandini, Lucia; Liao, Xiongfei; Yin, Jun; Lang, Jinyi] Univ Elect Sci & Technol China UESTC, Sch Med, Chengdu, Peoples R China; [Dowling, Jason] CSIRO, Australian eHlth Res Ctr, Herston, Qld, Australia; [Fontanarosa, Davide] Queensland Univ Technol, Inst Hlth Biomed Innovat, Kelvin Grove, Qld, Australia	University of Sydney; University of Electronic Science & Technology of China; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Queensland University of Technology (QUT)	Yin, J; Lang, JY (corresponding author), Sichuan Canc Hosp & Inst, Chengdu, Peoples R China.; Yin, J; Lang, JY (corresponding author), Radiat Oncol Key Lab Sichuan Prov, Chengdu, Peoples R China.; Yin, J; Lang, JY (corresponding author), Univ Elect Sci & Technol China UESTC, Sch Med, Chengdu, Peoples R China.	scchyinjun@163.com; langjy610@163.com	Dowling, Jason/A-1420-2008	Dowling, Jason/0000-0001-9349-2275; lang, jinyi/0000-0002-5406-8671; Finnegan, Robert/0000-0003-4728-8462; Fontanarosa, Davide/0000-0001-6986-3718				[Anonymous], 2015, PATIENT PERSPECTIVE; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brandner ED, 2017, MED PHYS, V44, P2595, DOI 10.1002/mp.12227; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Choi MS, 2020, RADIOTHER ONCOL; Ciardo D, 2017, BREAST, V32, P44, DOI 10.1016/j.breast.2016.12.010; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; De Ruysscher D, 2017, RADIOTHER ONCOL, V124, P1, DOI 10.1016/j.radonc.2017.06.003; Eldesoky AR, 2016, RADIOTHER ONCOL, V121, P424, DOI 10.1016/j.radonc.2016.09.005; Finnegan R, 2020, RADIOTHER ONCOL; Finnegan RN, 2019, PHYS MED BIOL; Finnegan R, 2019, PHYS MED BIOL, V64, DOI 10.1088/1361-6560/ab0ea6; Ford EC, 2003, MED PHYS, V30, P88, DOI 10.1118/1.1531177; Gagliardi G, 2010, INT J RADIAT ONCOL, V76, pS77, DOI 10.1016/j.ijrobp.2009.04.093; Hoppe BS, 2020, PRACT RADIAT ONCOL, V10, pE147, DOI 10.1016/j.prro.2019.09.015; Jie Liu, 2018, J APPL CLIN MED PHYS; Liu CX, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-295; Lorenzen EL, 2013, RADIOTHER ONCOL, V108, P254, DOI 10.1016/j.radonc.2013.06.025; Martin C, 2020, CLIN LUNG CANCER, V21, pE380, DOI 10.1016/j.cllc.2020.02.014; Martin SP, 2013, J PUBLIC HLTH, V19, P26; McWilliam A, 2020, INT J RADIAT ONCOL, V108, P1073, DOI 10.1016/j.ijrobp.2020.06.031; Mo Y, 2018, INT C MED IM COMP CO; Morris ED, 2020, MED PHYS, V47, P576, DOI 10.1002/mp.13940; Roques TW, 2014, CLIN ONCOL-UK, V26, P353, DOI 10.1016/j.clon.2014.02.013; Schreier J, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00677; Shi Z, 2018, INT C MED IM COMP CO; Stam B, 2017, RADIOTHER ONCOL, V123, P370, DOI 10.1016/j.radonc.2017.04.017; Tsang Yatman, 2019, Tech Innov Patient Support Radiat Oncol, V10, P8, DOI 10.1016/j.tipsro.2019.05.001; van den Bogaard VAB, 2017, J CLIN ONCOL, V35, P1171, DOI 10.1200/JCO.2016.69.8480; van Nimwegen FA, 2016, J CLIN ONCOL, V34, P235, DOI 10.1200/JCO.2015.63.4444; Vansteenkiste J, 2013, ANN ONCOL, V24, P89, DOI 10.1093/annonc/mdt241; Vedam SS, 2003, PHYS MED BIOL, V48, P45, DOI 10.1088/0031-9155/48/1/304; Yang G, 2018, INT WORKSH STAT ATL; Yang G, 2020, FUTURE GENER COMP SY, V107, P215, DOI 10.1016/j.future.2020.02.005; Zhao X, 2014, IEEE IMAGE PROC, P1, DOI 10.1109/ICIP.2014.7024999; Zhou RR, 2017, RADIOTHER ONCOL, V122, P66, DOI 10.1016/j.radonc.2016.11.016; Zhuang XH, 2019, MED IMAGE ANAL, V58, DOI 10.1016/j.media.2019.101537; Zhuang XH, 2015, MED PHYS, V42, P3822, DOI 10.1118/1.4921366	38	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245364	10.1371/journal.pone.0245364	http://dx.doi.org/10.1371/journal.pone.0245364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444379	gold, Green Published			2022-12-26	WOS:000609988100061
J	Zhou, JY; Jiang, YW; Huang, BQ				Zhou, Jianye; Jiang, Yuewen; Huang, Biqing			Source identification of infectious diseases in networks via label ranking	PLOS ONE			English	Article							INFORMATION; EPIDEMIC; SPREAD; RUMORS; SIR	Background Outbreaks of infectious diseases would cause great losses to the human society. Source identification in networks has drawn considerable interest in order to understand and control the infectious disease propagation processes. Unsatisfactory accuracy and high time complexity are major obstacles to practical applications under various real-world situations for existing source identification algorithms. Methods This study attempts to measure the possibility for nodes to become the infection source through label ranking. A unified Label Ranking framework for source identification with complete observation and snapshot is proposed. Firstly, a basic label ranking algorithm with complete observation of the network considering both infected and uninfected nodes is designed. Our inferred infection source node with the highest label ranking tends to have more infected nodes surrounding it, which makes it likely to be in the center of infection subgraph and far from the uninfected frontier. A two-stage algorithm for source identification via semi-supervised learning and label ranking is further proposed to address the source identification issue with snapshot. Results Extensive experiments are conducted on both synthetic and real-world network datasets. It turns out that the proposed label ranking algorithms are capable of identifying the propagation source under different situations fairly accurately with acceptable computational complexity without knowing the underlying model of infection propagation. Conclusions The effectiveness and efficiency of the label ranking algorithms proposed in this study make them be of practical value for infection source identification.	[Zhou, Jianye; Huang, Biqing] Tsinghua Univ, Dept Automat, Beijing, Peoples R China; [Jiang, Yuewen] Hubei Univ Chinese Med, Clin Coll Chinese Med, Wuhan, Hubei, Peoples R China	Tsinghua University; Hubei University of Chinese Medicine	Huang, BQ (corresponding author), Tsinghua Univ, Dept Automat, Beijing, Peoples R China.; Jiang, YW (corresponding author), Hubei Univ Chinese Med, Clin Coll Chinese Med, Wuhan, Hubei, Peoples R China.	workersky1980@hbtcm.edu.cn; hbq@tsinghua.edu.cn			National Science and Technology Major Project of China [2018ZX10201002-004-002]	National Science and Technology Major Project of China	National Science and Technology Major Project of China under grant 2018ZX10201002-004-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Ali S.S., 2020, ONLINE SOC NETWORKS, V17; Ali SS, 2019, PROCEEDINGS OF THE 28TH ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM '19), P891, DOI 10.1145/3357384.3358035; ALLEN LJS, 1994, MATH BIOSCI, V124, P83, DOI 10.1016/0025-5564(94)90025-6; Altarelli F, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.118701; ANDERSON R M, 1991; [Anonymous], 2012, ARXIV12112333; [Anonymous], 1993, KRLEZIJANA, V1, p20b; Antulov-Fantulin N, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.248701; Belkin M, 2004, MACH LEARN, V56, P209, DOI 10.1023/B:MACH.0000033120.25363.1e; Belkin M, 2006, J MACH LEARN RES, V7, P2399; Blum A., 2001, LEARNING LABELED UNL; Brightwell G, 1991, P 23 ANN ACM S THEOR; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Comin CH, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056105; Defferrard M, 2016, ADV NEUR IN, V29; Doer B, 2012, COMMUN ACM, V55, P70, DOI 10.1145/2184319.2184338; Fu L, 2016, EPL-EUROPHYS LETT, V113, DOI 10.1209/0295-5075/113/18006; Gilmer J., 2017, P 34 INT C MACH LEAR; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hu ZL, 2018, PHYS LETT A, V382, P931, DOI 10.1016/j.physleta.2018.01.037; Jiang JJ, 2017, IEEE COMMUN SURV TUT, V19, P465, DOI 10.1109/COMST.2016.2615098; joris, 2014, OE, V1; Kingma DP, 2014, ADV NEUR IN, V27; Kipf T. N., 2017, 5 INT C LEARN REPR; Lokhov AY, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.012801; Louni A, 2018, IEEE T COMPUT SOC SY, V5, P335, DOI 10.1109/TCSS.2018.2801310; Louni A, 2014, IEEE CONF COMPUT, P329, DOI 10.1109/INFCOMW.2014.6849253; Luo WQ, 2014, IEEE J-STSP, V8, P586, DOI 10.1109/JSTSP.2014.2315533; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Nowzari C, 2016, IEEE CONTR SYST MAG, V36, P26, DOI 10.1109/MCS.2015.2495000; Perozzi B, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P701, DOI 10.1145/2623330.2623732; Pinto PC, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.068702; Prakash BA, 2014, KNOWL INF SYST, V38, P35, DOI 10.1007/s10115-013-0671-5; Prakash BA, 2012, P IEEE 12 INT C DAT; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Shah D, 2010, PERF E R SI, V38, P203, DOI 10.1145/1811099.1811063; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Tang J, 2015, PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW 2015), P1067, DOI 10.1145/2736277.2741093; Wang Z, 2017, P 31 AAAI C ART INT; Zang WY, 2015, J COMPUT SCI-NETH, V10, P278, DOI 10.1016/j.jocs.2015.05.002; Zhou DY, 2004, ADV NEUR IN, V16, P321; Zhu K, 2016, IEEE ACM T NETWORK, V24, P408, DOI 10.1109/TNET.2014.2364972; Zhu X., 2003, INT C MACH LEARN ICM, P58; Zhu X.J, 2005, SEMISUPERVISED LEARN	46	1	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245344	10.1371/journal.pone.0245344	http://dx.doi.org/10.1371/journal.pone.0245344			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444390	gold, Green Published			2022-12-26	WOS:000609988100085
J	Arroyo-Marioli, F; Bullano, F; Kucinskas, S; Rondon-Moreno, C				Arroyo-Marioli, Francisco; Bullano, Francisco; Kucinskas, Simas; Rondon-Moreno, Carlos			Tracking R of COVID-19: A new real-time estimation using the Kalman filter	PLOS ONE			English	Article							REPRODUCTION NUMBER; ECONOMICS	We develop a new method for estimating the effective reproduction number of an infectious disease (R) and apply it to track the dynamics of COVID-19. The method is based on the fact that in the SIR model, R is linearly related to the growth rate of the number of infected individuals. This time-varying growth rate is estimated using the Kalman filter from data on new cases. The method is easy to implement in standard statistical software, and it performs well even when the number of infected individuals is imperfectly measured, or the infection does not follow the SIR model. Our estimates of R for COVID-19 for 124 countries across the world are provided in an interactive , and they are used to assess the effectiveness of non-pharmaceutical interventions in a sample of 14 European countries.	[Arroyo-Marioli, Francisco; Bullano, Francisco; Rondon-Moreno, Carlos] Cent Bank Chile, Santiago, Chile; [Kucinskas, Simas] Humboldt Univ, Berlin, Germany	Central Bank of Chile; Humboldt University of Berlin	Kucinskas, S (corresponding author), Humboldt Univ, Berlin, Germany.	simas.kucinskas@hu-berlin.de		Rondon-Moreno, Carlos/0000-0002-6469-0827				Allen LJS, 2008, J DIFFER EQU APPL, V14, P1127, DOI 10.1080/10236190802332308; [Anonymous], 2020, NY TIMES; Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Arroyo-Marioli F., 2020, TRACKING R COVID 19; Atkeson A., 2020, WHAT WILL BE EC IMPA, DOI [10.3386/w26867, DOI 10.3386/W26867]; Bettencourt LMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002185; Brockmann D, 2020, SCIENCE, V4557, P1; Budish E.R, 2020, R 1 EC CPMSTRAINT CA, DOI [10.2139/ssrn.3567068, DOI 10.2139/SSRN.3567068]; CARTER CK, 1994, BIOMETRIKA, V81, P541; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Chowell G., 2009, MATH STAT ESTIMATION, DOI [10.1007/978-90-481-2313-1, DOI 10.1007/978-90-481-2313-1]; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; Commandeur J. J. F., 2007, INTRO STATE SPACE TI; Creal D, 2012, ECONOMET REV, V31, P245, DOI 10.1080/07474938.2011.607333; Dehning J, 2020, SCIENCE, V369, P160, DOI 10.1126/science.abb9789; Delamater PL, 2019, EMERG INFECT DIS, V25, P1, DOI 10.3201/eid2501.171901; Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758; Google,, 2020, COVID 19 COMM MOB RE; Gostic Katelyn M, 2020, PLoS Comput Biol, V16, pe1008409, DOI [10.1101/2020.06.18.20134858, 10.1371/journal.pcbi.1008409]; Guerrieri V., 2020, 26918 NBER; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kruger, 2020, 202043 BECK FRIEDM I; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Leung LB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.20955; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Ma JL, 2020, INFECT DIS MODEL, V5, P129, DOI 10.1016/j.idm.2019.12.009; MacKinlay AC, 1997, J ECON LIT, V35, P13; MUTH JF, 1960, J AM STAT ASSOC, V55, P299; Nishiura H., 2009, MATH STAT ESTIMATION, P103, DOI [DOI 10.1007/978-90-481-2313-1_5, 10.1007/978-90-481-2313-1_5]; Nishiura H, 2020, INT J INFECT DIS, V93, P284, DOI 10.1016/j.ijid.2020.02.060; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; Our World in Data, 2020, COR DIS COVID 19 STA; Park M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040967; Patel Y, 2018, MATER RELIG, V14, P1, DOI 10.1080/17432200.2017.1417215; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Shimer, 2020, NBER WORKING PAPER, P27059; Stevens GA, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002116, 10.1371/journal.pmed.1002056]; Stock J. H., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Streeck H., 2020, INFECT FATALITY RATE, DOI [10.1101/2020.05.04.20090076, DOI 10.1101/2020.05.04.20090076]; Thompson RN, 2019, EPIDEMICS-NETH, V29, DOI 10.1016/j.epidem.2019.100356; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Wang H, 2021, COMPLEX INTELL SYST, V7, P1139, DOI 10.1007/s40747-020-00171-2; Wu P, 2020, IMPACT CHANGING CASE, DOI [10.1101/2020.03.23.20041319, DOI 10.1101/2020.03.23.20041319]; Zhu H, 2020, ESTIMATING NUMBER IN, DOI [10.25561/77731, DOI 10.25561/77731]	49	52	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0244474	10.1371/journal.pone.0244474	http://dx.doi.org/10.1371/journal.pone.0244474			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439880	Green Published, gold			2022-12-26	WOS:000609985300007
J	Baraniuk, JN; Kern, G; Narayan, V; Cheema, A				Baraniuk, James N.; Kern, Grant; Narayan, Vaishnavi; Cheema, Amrita			Exercise modifies glutamate and other metabolic biomarkers in cerebrospinal fluid from Gulf War Illness and Myalgic encephalomyelitis / Chronic Fatigue Syndrome	PLOS ONE			English	Article							INAPPROPRIATE SINUS TACHYCARDIA; SYMPTOMS; ACYLCARNITINE; DISTURBANCES; DEFINITION; CARNITINE; VETERANS; ACID; PAIN	Myalgic encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) and Gulf War Illness (GWI) share many symptoms of fatigue, pain, and cognitive dysfunction that are not relieved by rest. Patterns of serum metabolites in ME/CFS and GWI are different from control groups and suggest potential dysfunction of energy and lipid metabolism. The metabolomics of cerebrospinal fluid was contrasted between ME/CFS, GWI and sedentary controls in 2 sets of subjects who had lumbar punctures after either (a) rest or (b) submaximal exercise stress tests. Postexercise GWI and control subjects were subdivided according to acquired transient postexertional postural tachycardia. Banked cerebrospinal fluid specimens were assayed using Biocrates AbsoluteIDQ (R) p180 kits for quantitative targeted metabolomics studies of amino acids, amines, acylcarnitines, sphingolipids, lysophospholipids, alkyl and ether phosphocholines. Glutamate was significantly higher in the subgroup of postexercise GWI subjects who did not develop postural tachycardia after exercise compared to nonexercise and other postexercise groups. The only difference between nonexercise groups was higher lysoPC a C28:0 in GWI than ME/CFS suggesting this biochemical or phospholipase activities may have potential as a biomarker to distinguish between the 2 diseases. Exercise effects were suggested by elevation of short chain acylcarnitine C5-OH (C3-DC-M) in postexercise controls compared to nonexercise ME/CFS. Limitations include small subgroup sample sizes and absence of postexercise ME/CFS specimens. Mechanisms of glutamate neuroexcitotoxicity may contribute to neuropathology and "neuroinflammation" in the GWI subset who did not develop postural tachycardia after exercise. Dysfunctional lipid metabolism may distinguish the predominantly female ME/CFS group from predominantly male GWI subjects.	[Baraniuk, James N.; Kern, Grant; Narayan, Vaishnavi] Georgetown Univ, Dept Med, Washington, DC 20057 USA; [Cheema, Amrita] Georgetown Univ, Georgetown Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC USA	Georgetown University; Georgetown University	Baraniuk, JN (corresponding author), Georgetown Univ, Dept Med, Washington, DC 20057 USA.	baraniuj@georgetown.edu		Baraniuk, James Nicholas/0000-0002-1866-4177	Department of Defense; National Institute of Neurological Diseases and Stroke;  [W81XWH-15-1-0679];  [W81-XWH-09-1-0526];  [R21NS088138];  [R01NS085131]	Department of Defense(United States Department of Defense); National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ; ; ; 	JNB: W81XWH-15-1-0679, W81-XWH-09-1-0526, R21NS088138, R01NS085131. Department of Defense. https://cdmrp.army.mil/funding National Institute of Neurological Diseases and Stroke. https://www.ninds.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah L, 2016, TOXICOLOGY, V372, P22, DOI 10.1016/j.tox.2016.10.012; Albaugh VL, 2012, SCHIZOPHRENIA BULL, V38, P153, DOI 10.1093/schbul/sbq053; [Anonymous], 2020, LANCET EDITORIAL, V2, pE268, DOI 10.1016/S2589-7500(20)30113-8; Armstrong CW, 2014, ADV CLIN CHEM, V66, P121, DOI 10.1016/B978-0-12-801401-1.00005-0; Armstrong CW, 2012, CLIN CHIM ACTA, V413, P1525, DOI 10.1016/j.cca.2012.06.022; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Baraniuk JN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15383-9; Baraniuk JN, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-22; Baraniuk JN, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-48; Baraniuk JN, 2005, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-58; Boca SM, 2018, PEERJ, V6, DOI 10.7717/peerj.6035; Boca SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153461; Boca SM, 2014, BIOINFORMATICS, V30, P214, DOI 10.1093/bioinformatics/btt633; Carruthers BM, 2007, J CLIN PATHOL, V60, P117, DOI 10.1136/jcp.2006.042754; Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [DOI 10.1300/J092V11N01_02, 10.1300/J092v11n01_02]; Cheema AK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010079; Clarke T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226481; Eldridge Sandra M, 2016, Pilot Feasibility Stud, V2, P64, DOI 10.1136/bmj.i5239; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Emmerich T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176634; Fappiano CM, 2020, MIL MED, V185, pE1120, DOI 10.1093/milmed/usz471; FERY F, 1983, AM J PHYSIOL, V245, pE318, DOI 10.1152/ajpendo.1983.245.4.E318; Fluge O, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89376; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Garner R, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1935-y; Garner RS, 2018, AM J TRANSL RES, V10, P3254; Gaschler MM, 2017, BIOCHEM BIOPH RES CO, V482, P419, DOI 10.1016/j.bbrc.2016.10.086; Germain A, 2017, MOL BIOSYST, V13, P371, DOI 10.1039/c6mb00600k; Holton KF, 2012, CLIN EXP RHEUMATOL, V30, pS10; Holton K, 2016, PAIN MANAG, V6, P317, DOI 10.2217/pmt-2016-0019; Holton KF, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092593; Inst Med, 2015, BEYOND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: REDEFINING AN ILLNESS, P1; Institute of Medicine, 2014, CHRON MULT ILLN GULF, DOI [10.17226/18623, DOI 10.17226/18623, 10.17226/18623.]; Jamieson AR, 2010, MED PHYS, V37, P339, DOI 10.1118/1.3267037; Jones JF, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-57; Jones MG, 2005, CLIN CHIM ACTA, V360, P173, DOI 10.1016/j.cccn.2005.04.029; Kirwan JA, 2018, CLIN CHEM, V64, P1158, DOI 10.1373/clinchem.2018.287045; Koal T, 2015, J ALZHEIMERS DIS, V44, P1193, DOI 10.3233/JAD-142319; Kuratsune H, 1998, INT J MOL MED, V2, P51; KURATSUNE H, 1994, CLIN INFECT DIS, V18, pS62, DOI 10.1093/clinids/18.Supplement_1.S62; Malatji BG, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0863-9; Mandal R, 2012, GENOME MED, V4, DOI 10.1186/gm337; McLean SA, 2006, NEUROPSYCHOPHARMACOL, V31, P2776, DOI 10.1038/sj.npp.1301200; MEYERHOFF JL, 1992, BRAIN RES, V593, P140, DOI 10.1016/0006-8993(92)91276-K; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Nagy-Szakal D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28477-9; Nater UM, 2009, PSYCHOSOM MED, V71, P557, DOI 10.1097/PSY.0b013e31819ea179; Naviaux RK, 2016, P NATL ACAD SCI USA, V113, pE5472, DOI 10.1073/pnas.1607571113; O'Donnell VB, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw2964; Pasaye EH, 2010, NEURORADIOL J, V23, P665, DOI 10.1177/197140091002300604; PLIOPLYS AV, 1995, NEUROPSYCHOBIOLOGY, V32, P132, DOI 10.1159/000119226; Prager JM, 1996, AM J ROENTGENOL, V167, P1289, DOI 10.2214/ajr.167.5.8911197; Provenzano D, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10070456; Provenzano D, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10050319; Provenzano D, 2020, FRONT COMPUT NEUROSC, V14, DOI 10.3389/fncom.2020.00002; Raj S, 2016, ARRHYTH ELECTROPHYSI, V5, P122, DOI 10.15420/AER.2016.7.2; Rayhan RU, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058493, 10.1371/journal.pone.0063903]; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; *RES ADV COMM GULF, 2008, GULF WAR ILLN HLTH G; Reuter SE, 2011, J INTERN MED, V270, P76, DOI 10.1111/j.1365-2796.2010.02341.x; Riley ET, 2002, ANESTHESIOLOGY, V97, P574, DOI 10.1097/00000542-200209000-00009; Riley ET, 2003, ANESTHESIOLOGY, V98, P595, DOI 10.1097/00000542-200209000- 00009; Rodriguez A, 2017, ADV NEUROBIOL, V16, P169, DOI 10.1007/978-3-319-55769-4_8; Romero-Romo JI, 2010, NEURORADIOL J, V23, P671, DOI 10.1177/197140091002300605; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Sheikh Kathryn D, 2011, J Biomol Tech, V22, P1; Sheldon RS, 2015, HEART RHYTHM, V12, pE41, DOI 10.1016/j.hrthm.2015.03.029; Shungu DC, 2012, NMR BIOMED, V25, P1073, DOI 10.1002/nbm.2772; Soetekouw PMMB, 2000, NETH J MED, V57, P20, DOI 10.1016/S0300-2977(00)00030-9; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Stratton SL, 2011, J NUTR, V141, P353, DOI 10.3945/jn.110.135772; Tomas C, 2018, BIOCHEM SOC T, V46, P547, DOI 10.1042/BST20170503; Tomas C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186802; van der Hoek MD, 2020, FASEB J, V34, P11658, DOI 10.1096/fj.202000493R; van der Velpen V, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0551-7; Vary TC, 2006, AM J PHYSIOL-ENDOC M, V290, pE631, DOI 10.1152/ajpendo.00460.2005; Wallis A, 2017, GUT MICROBES, V8, P46, DOI 10.1080/19490976.2016.1256524; Washington SD, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcz039; Yamano E, 2016, SCI REP-UK, V6, DOI 10.1038/srep34990; Zhang J, 2017, EXP PHYSIOL, V102, P48, DOI 10.1113/EP086019	81	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0244116	10.1371/journal.pone.0244116	http://dx.doi.org/10.1371/journal.pone.0244116			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33440400	Green Published, gold			2022-12-26	WOS:000609985300003
J	Krishnamurthi, VR; Niyonshuti, II; Chen, JY; Wang, Y				Krishnamurthi, Venkata Rao; Niyonshuti, Isabelle I.; Chen, Jingyi; Wang, Yong			A new analysis method for evaluating bacterial growth with microplate readers	PLOS ONE			English	Article							NANOPARTICLES; SILVER; RESISTANCE; PARTICLES	Growth curve measurements are commonly used in microbiology, while the use of microplate readers for such measurements provides better temporal resolution and higher throughput. However, evaluating bacterial growth with microplate readers has been hurdled by barriers such as multiple scattering. Here, we report our development of a method based on the time derivatives of the optical density (OD) and/or fluorescence (FL) of bacterial cultures to overcome these barriers. First, we illustrated our method using quantitative models and numerical simulations, which predicted the number of bacteria and the number of fluorescent proteins in time as well as their time derivatives. Then, we systematically investigated how the time derivatives depend on the parameters in the models/simulations, providing a framework for understanding the FL growth curves. In addition, as a demonstration, we applied our method to study the lag time elongation of bacteria subjected to treatment with silver (Ag+) ions and found that the results from our method corroborated well with that from growth curve fitting by the Gompertz model that has been commonly used in the literature. Furthermore, this method was applied to the growth of bacteria in the presence of silver nanoparticles (AgNPs) at various concentrations, where the OD curve measurements failed. We showed that our method allowed us to successfully extract the growth behavior of the bacteria from the FL measurements and understand how the growth was affected by the AgNPs.	[Krishnamurthi, Venkata Rao; Wang, Yong] Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA; [Niyonshuti, Isabelle I.; Chen, Jingyi] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA; [Chen, Jingyi; Wang, Yong] Univ Arkansas, Mat Sci & Engn Program, Fayetteville, AR 72701 USA; [Wang, Yong] Univ Arkansas, Cell & Mol Biol Program, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Wang, Y (corresponding author), Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA.; Wang, Y (corresponding author), Univ Arkansas, Mat Sci & Engn Program, Fayetteville, AR 72701 USA.; Wang, Y (corresponding author), Univ Arkansas, Cell & Mol Biol Program, Fayetteville, AR 72701 USA.	yongwang@uark.edu		Wang, Yong/0000-0002-8601-8302; Krishnamurthi, Venkata Rao/0000-0002-7327-3275	National Science Foundation [1826642]; Arkansas Biosciences Institute [1826642, ABI-0189, ABI-0226, ABI-0277, ABI-0326]	National Science Foundation(National Science Foundation (NSF)); Arkansas Biosciences Institute	YW Grant No. ABI-0189, No. ABI-0226, No. ABI-0277, No. ABI-0326, No. ABI-2021 Arkansas Biosciences Institute https://arbiosciences.org/YW & JC Grant No. 1826642 National Science Foundation https://nsf.gov/awardsearch/showAward?AWD_ID= 1826642&HistoricalAwards=false.	ADAMS SL, 1950, IND ENG CHEM, V42, P1815, DOI 10.1021/ie50489a034; Alonso AA, 2014, APPL ENVIRON MICROB, V80, P5241, DOI 10.1128/AEM.01423-14; Alqahtany M, 2019, NANOTECHNOLOGY, V30, DOI 10.1088/1361-6528/ab2a9f; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Beal J, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01127-5; Begot C, 1996, J MICROBIOL METH, V25, P225, DOI 10.1016/0167-7012(95)00090-9; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Brewster JD, 2003, J MICROBIOL METH, V53, P77, DOI 10.1016/S0167-7012(02)00226-9; Cong Y, 2014, J MATER CHEM B, V2, P3450, DOI 10.1039/c4tb00460d; De Silvestri A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03023; Hamill PG, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62552-4; Haque MA, 2017, RSC ADV, V7, P56173, DOI 10.1039/c7ra10495b; Irwin P, 2010, J NANOBIOTECHNOL, V8, DOI 10.1186/1477-3155-8-34; Ivask A, 2010, ANAL BIOANAL CHEM, V398, P701, DOI 10.1007/s00216-010-3962-7; Ivask A, 2014, ACS NANO, V8, P374, DOI 10.1021/nn4044047; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; Juska A, 2006, BIOCHEM MOL BIOL EDU, V34, P417, DOI 10.1002/bmb.2006.494034062669; Klanjscek T, 2013, ECOTOXICOLOGY, V22, P319, DOI 10.1007/s10646-012-1028-7; Klanjscek T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026955; Klykov SP, 2020, INT J BIOMATH, V13, DOI 10.1142/S1793524520500199; KOCH AL, 1970, ANAL BIOCHEM, V38, P252, DOI 10.1016/0003-2697(70)90174-0; Krisbnamurthi VR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48113-4; Leveau JHJ, 2001, J BACTERIOL, V183, P6752, DOI 10.1128/JB.183.23.6752-6762.2001; Li B, 2016, ANALYST, V141, P3059, DOI 10.1039/c5an02649k; Mahalik S, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0177-1; Mandelstam J., 1982, BIOCH BACTERIAL GROW, V3rd; Niyonshuti II, 2020, ACS APPL MATER INTER, V12, P40067, DOI 10.1021/acsami.0c10517; O'Mahony FC, 2006, APPL ENVIRON MICROB, V72, P1279, DOI 10.1128/AEM.72.2.1279-1287.2006; Reddy C., 2007, METHODS GEN MOL MICR; Robert L, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-17; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; Sadoon AA, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.02479-19; Shiloh MU, 1997, INFECT IMMUN, V65, P3193, DOI 10.1128/IAI.65.8.3193-3198.1997; Stevenson K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38828; Takahashi CN, 2015, ACS SYNTH BIOL, V4, P32, DOI 10.1021/sb500165g; Toprak E, 2013, NAT PROTOC, V8, P555, DOI [10.1038/nprot.2013.021, 10.1038/nprot.nprot.2013.021]; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Zhang QA, 2010, CHEM-EUR J, V16, P10234, DOI 10.1002/chem.201000341; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	41	15	15	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245205	10.1371/journal.pone.0245205	http://dx.doi.org/10.1371/journal.pone.0245205			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434196	Green Published, gold			2022-12-26	WOS:000609979700002
J	Baral, R; Levin, A; Odero, C; Pecenka, C; Tabu, C; Mwendo, E; Bonsu, G; Bawa, J; Dadzie, JF; Charo, J; Antwi-Agyei, KO; Amponsa-Achianou, K; Jalango, RE; Mkisi, R; Gordon, S; Mzengeza, T; Morgan, W; Muhib, F				Baral, Ranju; Levin, Ann; Odero, Chris; Pecenka, Clint; Tabu, Collins; Mwendo, Evans; Bonsu, George; Bawa, John; Dadzie, John Frederick; Charo, Joyce; Antwi-Agyei, Kwadwo Odei; Amponsa-Achianou, Kwame; Jalango, Rose Eddah; Mkisi, Rouden; Gordon, Scott; Mzengeza, Temwa; Morgan, Winthrop; Muhib, Farzana			Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries	PLOS ONE			English	Article							KENYA	Background The RTS,S/ASO1(E) malaria vaccine is being piloted in three countries-Ghana, Kenya, and Malawi-as part of a coordinated evaluation led by the World Health Organization, with support from global partners. This study estimates the costs of continuing malaria vaccination upon completion of the pilot evaluation to inform decision-making and planning around potential further use of the vaccine in pilot areas. Methods We used an activity-based costing approach to estimate the incremental costs of continuing to deliver four doses of RTS,S/ASO1(E) through the existing Expanded Program on Immunization platform, from each government's perspective. The RTS,S/ASO1(E) pilot introduction plans were reviewed and adapted to identify activities for costing. Key informant interviews with representatives from Ministries of Health (MOH) were conducted to inform the activities, resource requirements, and assumptions that, in turn, inform the analysis. Both financial and economic costs per dose, cost of delivery per dose, and cost per fully vaccinated child (FVC) are estimated and reported in 2017 USD units. Results At a vaccine price of $5 per dose and assuming the vaccine is donor-funded, our estimated incremental financial costs range from $1.70 (Kenya) to $2.44 (Malawi) per dose, $0.23 (Malawi) to $0.71 (Kenya) per dose delivered (excluding procurement add-on costs), and $11.50 (Ghana) to $13.69 (Malawi) per FVC. Estimates of economic costs per dose are between three and five times higher than financial costs. Variations in activities used for costing, procurement add-on costs, unit costs of per diems, and allowances contributed to differences in cost estimates across countries. Conclusion Cost estimates in this analysis are meant to inform country decision-makers as they face the question of whether to continue malaria vaccination, should the intervention receive a positive recommendation for broader use. Additionally, important cost drivers for vaccine delivery are highlighted, some of which might be influenced by global and country-specific financing and existing procurement mechanisms. This analysis also adds to the evidence available on vaccine delivery costs for products delivered outside the standard immunization schedule.	[Baral, Ranju; Pecenka, Clint; Gordon, Scott; Muhib, Farzana] PATH, Ctr Vaccine Innovat & Access, Seattle, WA 98121 USA; [Levin, Ann; Morgan, Winthrop] Levin & Morgan LLC, Levin, MD USA; [Odero, Chris] PATH, Ctr Vaccine Innovat & Access, Nairobi, Kenya; [Tabu, Collins; Charo, Joyce; Jalango, Rose Eddah] Minist Hlth, Expanded Program Immunizat, Nairobi, Kenya; [Mwendo, Evans; Mzengeza, Temwa] Minist Hlth, Expanded Program Immunizat, Lilongwe, Malawi; [Bonsu, George; Dadzie, John Frederick; Amponsa-Achianou, Kwame] Minist Hlth, Expanded Program Immunizat, Accra, Ghana; [Bawa, John; Antwi-Agyei, Kwadwo Odei] PATH, Ctr Vaccine Innovat & Access, Accra, Ghana; [Mkisi, Rouden] PATH, Ctr Vaccine Innovat & Access, Lilongwe, Malawi		Baral, R (corresponding author), PATH, Ctr Vaccine Innovat & Access, Seattle, WA 98121 USA.	rbaral@path.org	Morgan, Winthrop/HGB-3956-2022		Bill & Melinda Gates Foundation, Seattle, WA, USA; PATH	Bill & Melinda Gates Foundation, Seattle, WA, USA(Bill & Melinda Gates Foundation); PATH	This work was funded by a grant from the Bill & Melinda Gates Foundation, Seattle, WA, USA to PATH. The funder provided support in the form of salaries for authors [RB, CO, CP, JB, KO, RM, and SG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. PATH funded Levin and Morgan LLC. to develop the costing tool to support the costing analysis in this study.	[Anonymous], 2016, Wkly Epidemiol Rec, V91, P33; Brenzel L., 2013, COMMON APPROACH COST; Galactionova K, 2015, VACCINE, V33, P6710, DOI 10.1016/j.vaccine.2015.10.079; Le Gargasson JB, 2015, VACCINE, V33, pA40, DOI 10.1016/j.vaccine.2014.12.081; Mvundura M, 2015, VACCINE, V33, P2697, DOI 10.1016/j.vaccine.2015.03.084; Pecenka C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190006; Republic of Ghana Ministry of Health (MOH), 2018, MAL VACC IMPL PROGR; Republic of Kenya Ministry of Health (MOH), 2018, MAL VACC IMPL PROGR; WHO, 2011, WORLD MALARIA REPORT 2011, P1; World Health Organization, 2018, Vaccine, V36, P3576, DOI 10.1016/j.vaccine.2016.10.047; World Health organization. Department of Vaccines and Biologicals, 2002, GUID EST COSTS INTR; World Health Organization (WHO), 2016, WELC GLOB HLTH FUND; World Health Organization (WHO), MAL VACC IMPL PROGR; World Health Organization (WHO),, 2014, MINISTRY HLTH GHANA, P12; World Health Organization (WHO),, 2015, MIN HLTH KEN COMPR M; World Health Organization (WHO),, 2015, GOV MAL EPI COMPR MU; World Health Organization (WHO),, 2018, 1 MAL VACC AFR POT N; Yaya Bocoum F, 2019, MED DECISION MAKING, V4, P1	18	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0244995	10.1371/journal.pone.0244995	http://dx.doi.org/10.1371/journal.pone.0244995			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428635	Green Published, gold			2022-12-26	WOS:000630036100030
J	Jiang, LM; Lv, GH; Gong, YM; Li, Y; Wang, HF; Wu, DY				Jiang, Lamei; Lv, Guanghui; Gong, Yanming; Li, Yan; Wang, Hengfang; Wu, Deyan			Characteristics and driving mechanisms of species beta diversity in desert plant communities	PLOS ONE			English	Article							ALTITUDINAL GRADIENT; FLORISTIC VARIATION; DISPERSAL; FOREST; COMPETITION; DISTANCE; TURNOVER; PATTERNS; NICHE; HETEROGENEITY	Species dissimilarity (beta diversity) primarily reflects the spatio-temporal changes in the species composition of a plant community. The correlations between beta diversity and environmental factors and spatial distance can be used to explain the magnitudes of environmental filtering and dispersal. However, little is known about the relative roles and importance of neutral and niche-related factors in the assemblage of plant communities with different life forms in deserts. We found that in desert ecosystems, the beta diversity of herbaceous plants was the highest, followed by that of shrubs and trees. The changes in the beta diversity of herbs and shrubs had stronger correlations with the environment, indicating that community aggregation was strongly affected by niche processes. The soil water content and salt content were the key environmental factors affecting species distributions of the herb and shrub layers, respectively. Spatial distance explained a larger amount of the variation in tree composition, indicating that dispersal limitation was the main factor affecting the construction of the tree layer community. The results suggest that different life forms may determine the association between organisms and the environment. These findings suggest that the spatial patterns of plant community species in the Ebinur Lake desert ecosystem are the result of the combined effects of environmental filtering and dispersal limitation.	[Jiang, Lamei; Lv, Guanghui; Li, Yan; Wang, Hengfang; Wu, Deyan] Xinjiang Univ, Coll Resources & Environm Sci, Urumqi, Peoples R China; [Gong, Yanming] Xinjiang Univ, CAS Key Lab Biogeog & Bioresources Arid Land, Urumqi, Xinjiang, Peoples R China	Xinjiang University; Xinjiang University	Lv, GH (corresponding author), Xinjiang Univ, Coll Resources & Environm Sci, Urumqi, Peoples R China.	guanghui_xju@sina.com			National Natural Science Foundation of China [31560131]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (NO: 31560131).	Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Berdugo M, 2020, SCIENCE, V367, P787, DOI 10.1126/science.aay5958; Bhaskar R, 2014, FUNCT ECOL, V28, P1256, DOI 10.1111/1365-2435.12257; Bhatt A, 2016, J ARID ENVIRON, V128, P73, DOI 10.1016/j.jaridenv.2016.01.008; Blundo C, 2016, PLANT ECOL, V217, P359, DOI 10.1007/s11258-016-0577-x; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Cao MW, 2019, BASIC APPL ECOL, V40, P43, DOI 10.1016/j.baae.2019.08.005; Casas RRD, 2017, NEW PHYTOL, V214, P527; Catano CP, 2017, ECOL LETT, V20, P347, DOI 10.1111/ele.12733; Chain-Guadarrama A, 2012, J TROP ECOL, V28, P463, DOI 10.1017/S0266467412000521; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chen SC, 2020, ECOL LETT, V23, P1635, DOI 10.1111/ele.13595; Chen SC, 2019, FUNCT ECOL, V33, P1469, DOI 10.1111/1365-2435.13353; Coyle JR, 2014, ECOGRAPHY, V37, P814, DOI 10.1111/ecog.00473; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Fattorini S, 2010, J BIOGEOGR, V37, P1061, DOI 10.1111/j.1365-2699.2009.02252.x; Flinn KM, 2010, J ECOL, V98, P1292, DOI 10.1111/j.1365-2745.2010.01708.x; Freestone AL, 2006, ECOLOGY, V87, P2425, DOI 10.1890/0012-9658(2006)87[2425:DLAEHS]2.0.CO;2; Fukami T, 2003, NATURE, V424, P423, DOI 10.1038/nature01785; Gairola S, 2019, PLANT DIVERSITY, V41, P229, DOI 10.1016/j.pld.2019.07.002; Gong YM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07240-6; Green JL, 2003, ECOLOGY, V84, P3090, DOI 10.1890/02-3096; Gremer JR, 2014, ECOL LETT, V17, P380, DOI 10.1111/ele.12241; Gross N, 2013, J ECOL, V101, P637, DOI 10.1111/1365-2745.12063; Guerrero-Meseguer L, 2017, RESTOR ECOL, V25, P453, DOI 10.1111/rec.12438; HONDA C, 1962, J SCI SOIL MANURE, V33, P195; Jabot F, 2011, AM NAT, V178, pE37, DOI 10.1086/660829; Jakovac CC, 2016, J VEG SCI, V27, P1104, DOI 10.1111/jvs.12457; Jiang XM, 2019, ECOL EVOL, V9, P2180, DOI 10.1002/ece3.4913; Jones MM, 2008, OECOLOGIA, V155, P593, DOI 10.1007/s00442-007-0923-8; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; Kristiansen T, 2012, J BIOGEOGR, V39, P1318, DOI 10.1111/j.1365-2699.2012.02689.x; Kula AAR, 2020, PLANT ECOL, V221, P421, DOI 10.1007/s11258-020-01021-4; Lan GY, 2020, GEODERMA, V375, DOI 10.1016/j.geoderma.2020.114505; Lawrence D, 2005, ECOL APPL, V15, P1952, DOI 10.1890/04-0841; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Lessard JP, 2012, P ROY SOC B-BIOL SCI, V279, P266, DOI 10.1098/rspb.2011.0552; [李文静 Li Wenjing], 2019, [生态环境学报, Ecology and Environmental Sciences], V28, P1557; Lohbeck M, 2013, ECOLOGY, V94, P1211, DOI 10.1890/12-1850.1; [马辉英 Ma Huiying], 2017, [生态学报, Acta Ecologica Sinica], V37, P829; MAUN MA, 1994, VEGETATIO, V111, P59; McCain CM, 2016, GLOBAL ECOL BIOGEOGR, V25, P299, DOI 10.1111/geb.12410; Mori AS, 2013, GLOBAL ECOL BIOGEOGR, V22, P878, DOI 10.1111/geb.12058; Munkemuller T, 2012, ECOGRAPHY, V35, P468, DOI 10.1111/j.1600-0587.2011.07259.x; Myers JA, 2013, ECOL LETT, V16, P151, DOI 10.1111/ele.12021; Oksanen J., 2019, R PACKAGE VERSION; Olsen SL, 2016, GLOBAL CHANGE BIOL, V22, P1915, DOI 10.1111/gcb.13241; Pavoine S, 2020, METHODS ECOL EVOL, V11, P1106, DOI 10.1111/2041-210X.13430; POLIS GA, 1991, ECOLOGY DESERT COMMU; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI [DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2, DOI 10.1111/j.1469-8137.2009.02830.x]; Qian H, 2012, GLOBAL ECOL BIOGEOGR, V21, P341, DOI 10.1111/j.1466-8238.2011.00672.x; QUINN JF, 1988, OECOLOGIA, V75, P132, DOI 10.1007/BF00378826; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; RICKLEFS RE, 1992, AM NAT, V139, P1305, DOI 10.1086/285388; Rollinson CR, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00321.1; Schenk HJ, 2002, J ECOL, V90, P480, DOI 10.1046/j.1365-2745.2002.00682.x; Steinbauer MJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P1203, DOI 10.1111/j.1466-8238.2012.00772.x; Stevens MHH, 2002, ECOL LETT, V5, P420, DOI 10.1046/j.1461-0248.2002.00333.x; Svanfeldt K, 2017, J ANIM ECOL, V86, P654, DOI 10.1111/1365-2656.12644; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Ulrich W, 2017, OIKOS, V126, P91, DOI 10.1111/oik.03392; Ulrich W, 2016, PERSPECT PLANT ECOL, V20, P56, DOI 10.1016/j.ppees.2016.04.004; Venable D. Lawrence, 1999, P115; [王长庭 WANG ChangTing], 2008, [生态学报, Acta Ecologica Sinica], V28, P4144; Wang HF, 2019, SCI TOTAL ENVIRON, V697, DOI 10.1016/j.scitotenv.2019.134096; [王琳 Wang Lin], 2014, [生态学报, Acta Ecologica Sinica], V34, P6797; Wang SP, 2012, ECOGRAPHY, V35, P1168, DOI 10.1111/j.1600-0587.2012.00045.x; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; Werden LK, 2018, FUNCT ECOL, V32, P2766, DOI 10.1111/1365-2435.13206; Whitford W., 2002, ECOLOGY DESERT SYSTE; Wu Wei, 2009, Acta Pedologica Sinica, V46, P472; Xing DL, 2019, ECOL LETT, V22, P284, DOI 10.1111/ele.13188; Yang XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109071; Ye XH, 2019, SCI TOTAL ENVIRON, V680, P44, DOI 10.1016/j.scitotenv.2019.05.087; [俞筱押 Yu Xiaoya], 2018, [植物资源与环境学报, Journal of Plant Resources and Environment], V27, P24; Zemunik G, 2016, J ECOL, V104, P792, DOI 10.1111/1365-2745.12546; Zhang H, 2018, FUNCT ECOL, V32, P1379, DOI 10.1111/1365-2435.13079; [张珂 Zhang Ke], 2014, [生态学报, Acta Ecologica Sinica], V34, P6538; Zhang XN, 2018, ARID LAND RES MANAG, V32, P38, DOI 10.1080/15324982.2017.1376004; [张雪妮 Zhang Xueni], 2015, [生态学报, Acta Ecologica Sinica], V35, P5966; Zhang YB, 2020, APPL VEG SCI, V23, P482, DOI 10.1111/avsc.12514	86	2	3	17	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0245249	10.1371/journal.pone.0245249	http://dx.doi.org/10.1371/journal.pone.0245249			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428688	Green Published, gold			2022-12-26	WOS:000630036100046
J	Irmscher, T; Roske, Y; Gayk, I; Dunsing, V; Chiantia, S; Heinemann, U; Barbirz, S				Irmscher, Tobias; Roske, Yvette; Gayk, Igor; Dunsing, Valentin; Chiantia, Salvatore; Heinemann, Udo; Barbirz, Stefanie			Pantoea stewartii WceF is a glycan biofilm-modifying enzyme with a bacteriophage tailspike-like fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAD-BINDING DOMAIN; CRYSTAL-STRUCTURE; CAPSULAR EXOPOLYSACCHARIDE; O-ANTIGEN; PROTEIN; BIOSYNTHESIS; REVEALS; ENDORHAMNOSIDASE; RECOGNITION; AMYLOVORAN	Pathogenic microorganisms often reside in glycan-based biofilms. Concentration and chain length distribution of these mostly anionic exopolysaccharides (EPS) determine the overall biophysical properties of a biofilm and result in a highly viscous environment. Bacterial communities regulate this biofilm state via intracellular small-molecule signaling to initiate EPS synthesis. Reorganization or degradation of this glycan matrix, however, requires the action of extracellular glycosidases. So far, these were mainly described for bacteriophages that must degrade biofilms for gaining access to host bacteria. The plant pathogen Pantoea stewartii (P. stewartii) encodes the protein WceF within its EPS synthesis cluster. WceF has homologs in various biofilm forming plant pathogens of the Erwinia family. In this work, we show that WceF is a glycosidase active on stewartan, the main P. stewartii EPS biofilm component. WceF has remarkable structural similarity with bacteriophage tailspike proteins (TSPs). Crystal structure analysis showed a native trimer of right-handed parallel beta-helices. Despite its similar fold, WceF lacks the high stability found in bacteriophage TSPs. WceF is a stewartan hydrolase and produces oligosaccharides, corresponding to single stewartan repeat units. However, compared with a stewartan-specific glycan hydrolase of bacteriophage origin, WceF showed lectin-like autoagglutination with stewartan, resulting in notably slower EPS cleavage velocities. This emphasizes that the bacterial enzyme WceF has a role in P. stewartii biofilm glycan matrix reorganization clearly different from that of a bacteriophage exopolysaccharide depolymerase.	[Irmscher, Tobias; Gayk, Igor; Barbirz, Stefanie] Univ Potsdam, Phys Biochem, Potsdam, Germany; [Irmscher, Tobias] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany; [Roske, Yvette; Heinemann, Udo] Max Delbruck Ctr Mol Med, Crystallog, Berlin, Germany; [Dunsing, Valentin; Chiantia, Salvatore] Univ Potsdam, Phys Zellbiochem, Potsdam, Germany; [Heinemann, Udo] Freie Univ, Inst Chem & Biochem, Berlin, Germany	University of Potsdam; Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Potsdam; Free University of Berlin	Barbirz, S (corresponding author), Univ Potsdam, Phys Biochem, Potsdam, Germany.; Heinemann, U (corresponding author), Max Delbruck Ctr Mol Med, Crystallog, Berlin, Germany.; Heinemann, U (corresponding author), Freie Univ, Inst Chem & Biochem, Berlin, Germany.	heinemann@mdc-berlin.de; barbirz@uni-potsdam.de	Heinemann, Udo/S-3379-2016; Chiantia, Salvatore/U-6363-2019	Heinemann, Udo/0000-0002-8191-3850; Chiantia, Salvatore/0000-0003-0791-967X; Dunsing, Valentin/0000-0003-2482-1498; Barbirz, Stefanie/0000-0001-6101-9862	Deutsche Forschungsgemeinschaft [BA 4046/1-2]; Max Planck Society grant [IMPRS Multiscale BioSystems]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society grant [IMPRS Multiscale BioSystems]	S.B. was funded by the Deutsche Forschungsgemeinschaft [grant number BA 4046/1-2]. T.I. received a Max Planck Society grant [IMPRS Multiscale BioSystems].	Adriaenssens EM, 2012, ARCH VIROL, V157, P2035, DOI 10.1007/s00705-012-1360-5; Albrecht MT, 2005, J BACTERIOL, V187, P3869, DOI 10.1128/JB.187.11.3869-3872.2005; Andres D, 2010, J BIOL CHEM, V285, P36768, DOI 10.1074/jbc.M110.169003; Baker P, 2015, J BIOL CHEM, V290, P28374, DOI 10.1074/jbc.M115.674929; Bamford NC, 2019, J BIOL CHEM, V294, P13833, DOI 10.1074/jbc.RA119.009910; Bamford NC, 2015, J BIOL CHEM, V290, P27438, DOI 10.1074/jbc.M115.679050; Barbirz S, 2008, MOL MICROBIOL, V69, P303, DOI 10.1111/j.1365-2958.2008.06311.x; Barbirz S, 2009, MACROMOL BIOSCI, V9, P169, DOI 10.1002/mabi.200800278; Bradley P, 2001, P NATL ACAD SCI USA, V98, P14819, DOI 10.1073/pnas.251267298; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Broeker NK, 2019, J BIOL CHEM, V294, P11751, DOI 10.1074/jbc.RA119.008133; Broeker NK, 2017, MOL MICROBIOL, V105, P353, DOI 10.1111/mmi.13729; Broeker NK., 2017, PERSPECT SCI, V11, P45, DOI DOI 10.1016/J.PISC.2016.10.001; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Carlier A, 2009, MOL MICROBIOL, V74, P903, DOI 10.1111/j.1365-2958.2009.06906.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherny KE, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00575-19; Cline K, 2015, J BIOL CHEM, V290, P16530, DOI 10.1074/jbc.R114.626820; Collins RF, 2017, STRUCTURE, V25, P806, DOI 10.1016/j.str.2017.03.017; DANNER M, 1993, EUR J BIOCHEM, V215, P653, DOI 10.1111/j.1432-1033.1993.tb18076.x; Dunsing V, 2019, BIOMACROMOLECULES, V20, P3842, DOI 10.1021/acs.biomac.9b00938; Duran-Pinedo AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028438; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fleming D, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01998-16; Flemming HC, 2016, NAT REV MICROBIOL, V14, P563, DOI 10.1038/nrmicro.2016.94; Greenfield J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43748-9; Hartung J. S., 1988, Molecular Plant-Microbe Interactions, V1, P87, DOI 10.1094/MPMI-1-087; Hengge R, 2019, MOLECULES, V24, DOI 10.3390/molecules24132403; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jenkins J, 1998, J STRUCT BIOL, V122, P236, DOI 10.1006/jsbi.1998.3985; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Latka A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02649; Latka A, 2017, APPL MICROBIOL BIOT, V101, P3103, DOI 10.1007/s00253-017-8224-6; Liston SD, 2018, P NATL ACAD SCI USA, V115, pE4870, DOI 10.1073/pnas.1801336115; Little DJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006998; Lohse MB, 2018, NAT REV MICROBIOL, V16, P19, DOI 10.1038/nrmicro.2017.107; Malinova I, 2014, PLANT PHYSIOL, V164, P907, DOI 10.1104/pp.113.227843; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller S, 1998, PROTEIN SCI, V7, P2223, DOI 10.1002/pro.5560071021; Moradali MF, 2020, NAT REV MICROBIOL, V18, P195, DOI 10.1038/s41579-019-0313-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nimtz M, 1996, CARBOHYD RES, V288, P189, DOI 10.1016/S0008-6215(96)90797-1; Nimtz M, 1996, CARBOHYD RES, V287, P59, DOI 10.1016/0008-6215(96)00070-5; Olsen NMC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080438; Patel KK, 2019, INT J PHARMACEUT, V563, P30, DOI 10.1016/j.ijpharm.2019.03.051; Pestrak MJ, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00234-19, 10.1128/aac.00234-19]; Plattner M, 2019, J MOL BIOL, V431, P3718, DOI 10.1016/j.jmb.2019.07.022; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Roper MC, 2011, MOL PLANT PATHOL, V12, P628, DOI [10.1111/j.1364-3703.2010.00698.x, 10.1111/J.1364-3703.2010.00698.X]; Rumbaugh KP, 2020, NAT REV MICROBIOL, V18, P571, DOI 10.1038/s41579-020-0385-0; Schollmeyer M, 2012, INT J BIOL MACROMOL, V50, P518, DOI 10.1016/j.ijbiomac.2012.01.003; Serra DO, 2014, ENVIRON MICROBIOL, V16, P1455, DOI 10.1111/1462-2920.12483; Seul A, 2014, ACTA CRYSTALLOGR D, V70, P1336, DOI 10.1107/S1399004714002685; Sharon N, 2007, J BIOL CHEM, V282, P2753, DOI 10.1074/JBC.X600004200; Snarr BD, 2017, P NATL ACAD SCI USA, V114, P7124, DOI 10.1073/pnas.1702798114; Sparta KM, 2016, J APPL CRYSTALLOGR, V49, P1085, DOI 10.1107/S1600576716004416; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Steinbacher S, 1997, J MOL BIOL, V267, P865, DOI 10.1006/jmbi.1997.0922; Stewart EJ, 2013, LANGMUIR, V29, P7017, DOI 10.1021/la401322k; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tielen P, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-159; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vidakovic L, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0050-1; Whitfield GB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00471; Witten J, 2017, NANOSCALE, V9, P8080, DOI 10.1039/c6nr09736g; Zhang JC, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00219-18; Zhang YQ, 2011, CARBOHYD POLYM, V85, P554, DOI 10.1016/j.carbpol.2011.03.009; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	70	0	0	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100286	10.1016/j.jbc.2021.100286	http://dx.doi.org/10.1016/j.jbc.2021.100286			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33450228	Green Accepted, Green Published, gold			2022-12-26	WOS:000672866400262
J	Zhou, WJ; Li, YH; Meng, XJ; Liu, A; Mao, Y; Zhu, X; Meng, Q; Jin, Y; Zhang, Z; Tao, WJ				Zhou, Wenjie; Li, Yanhua; Meng, Xiaojing; Liu, An; Mao, Yu; Zhu, Xia; Meng, Qian; Jin, Yan; Zhang, Zhi; Tao, Wenjuan			Switching of delta opioid receptor subtypes in central amygdala microcircuits is associated with anxiety states in pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MU; KAPPA; EXPRESSION; CIRCUITS; AGONIST; NEURONS; ANTAGONIST; MODULATION; LIGANDS; SNC80	Anxiety is often comorbid with pain. Delta opioid receptors (DORs) are promising targets for the treatment of pain and mental disorders with little addictive potential. However, their roles in anxiety symptoms at different stages of pain are unclear. In the current study, mice with inflammatory pain at the fourth hour following complete Freund's adjuvant (CFA) injection displayed significant anxiety-like behavior, which disappeared at the seventh day. Combining electrophysiology, optogenetics, and pharmacology, we found that activation of delta opioid receptor 1 (DOR1) in the central nucleus amygdala (CeA) inhibited both the anxiolytic excitatory input from the basolateral amygdala (BLA) and the anxiogenic excitatory input from the parabrachial nucleus (PBN). In contrast, activation of delta opioid receptor 2 (DOR2) did not affect CeA excitatory synaptic transmission in normal and 4-h CFA mice but inhibited the excitatory projection from the PBN rather than the BLA in 7-day CFA mice. Furthermore, the function of both DOR1 and DOR2 was downregulated to the point of not being detectable in the CeA of mice at the 21st day following CFA injection. Taken together, these results suggest that functional switching of DOR1 and DOR2 is associated with anxiety states at different stages of pain via modulating the activity of specific pathways (BLA-CeA and PBN-CeA).	[Zhou, Wenjie; Li, Yanhua; Mao, Yu; Zhu, Xia; Meng, Qian; Jin, Yan; Zhang, Zhi; Tao, Wenjuan] Univ Sci & Technol China, Dept Biophys & Neurobiol, Hefei Natl Lab Phys Sci Microscale, Hefei, Peoples R China; [Meng, Xiaojing] Anhui Med Univ, Affiliated Psychol Hosp, Dept Sci & Educ, Hefei, Peoples R China; [Liu, An; Mao, Yu; Meng, Qian; Tao, Wenjuan] Anhui Med Univ, Sch Basic Med Sci, Dept Physiol, Hefei, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Anhui Medical University	Zhang, Z; Tao, WJ (corresponding author), Univ Sci & Technol China, Dept Biophys & Neurobiol, Hefei Natl Lab Phys Sci Microscale, Hefei, Peoples R China.; Tao, WJ (corresponding author), Anhui Med Univ, Sch Basic Med Sci, Dept Physiol, Hefei, Peoples R China.	zhizhang@ustc.edu.cn; wjtao01@ahmu.edu.cn			National Natural Science Foundation of China [31600851, 91849119, 32000717, 81870877]; Anhui Medical University [XJ201809]; University of Science and Technology of China Research Funds of the Double First-Class Initiative [YD3460002001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Medical University; University of Science and Technology of China Research Funds of the Double First-Class Initiative	This work was supported by the National Natural Science Foundation of China (31600851, 91849119, 32000717, and 81870877), Grant's for Scientific Research of BSKY (XJ201809) from Anhui Medical University, University of Science and Technology of China Research Funds of the Double First-Class Initiative (YD3460002001).	Ballantyne JC, 2007, PAIN, V129, P235, DOI 10.1016/j.pain.2007.03.028; Bhushan RG, 2004, J MED CHEM, V47, P2969, DOI 10.1021/jm0342358; Bie BH, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-37; Bilsky EJ, 2000, J PHARMACOL EXP THER, V293, P151; Brainin-Mattos J, 2006, PAIN, V122, P174, DOI 10.1016/j.pain.2006.01.032; Cahill CM, 2007, TRENDS PHARMACOL SCI, V28, P23, DOI 10.1016/j.tips.2006.11.003; Cai YQ, 2018, J NEUROSCI, V38, P6340, DOI 10.1523/JNEUROSCI.2780-17.2018; Contet C, 2004, CURR OPIN NEUROBIOL, V14, P370, DOI 10.1016/j.conb.2004.05.005; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Gaveriaux-Ruff C, 2011, PAIN, V152, P1238, DOI 10.1016/j.pain.2010.12.031; Gerrits MMJG, 2014, PAIN, V155, P53, DOI 10.1016/j.pain.2013.09.005; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Han S, 2015, CELL, V162, P363, DOI 10.1016/j.cell.2015.05.057; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Hawker GA, 2011, ARTHRIT CARE RES, V63, P1382, DOI 10.1002/acr.20298; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Ji G, 2008, J NEUROPHYSIOL, V99, P1201, DOI 10.1152/jn.01148.2007; JIANG Q, 1991, J PHARMACOL EXP THER, V257, P1069; Jin Y, 2020, PAIN, V161, P416, DOI 10.1097/j.pain.0000000000001724; Jutkiewicz EM, 2003, BEHAV PHARMACOL, V14, P509, DOI 10.1097/00008877-200311000-00003; Kim J, 2017, NEURON, V93, P1464, DOI 10.1016/j.neuron.2017.02.034; Li JN, 2020, PAIN, V161, P166, DOI 10.1097/j.pain.0000000000001691; Li JN, 2018, J PHYSIOL-LONDON, V596, P6289, DOI 10.1113/JP276935; Lunzer MM, 2007, J PHARMACOL EXP THER, V322, P166, DOI 10.1124/jpet.107.120279; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Margolis EB, 2017, NEUROPHARMACOLOGY, V123, P420, DOI 10.1016/j.neuropharm.2017.06.019; McCullough KM, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0010-18.2018; McWilliams LA, 2003, PAIN, V106, P127, DOI 10.1016/S0304-3959(03)00301-4; Mika J, 2001, EUR J PHARMACOL, V415, P31, DOI 10.1016/S0014-2999(01)00814-7; Nakamura T, 2013, OPEN DENT J, V7, P27, DOI 10.2174/1874210601307010027; Narita M, 2006, NEUROPSYCHOPHARMACOL, V31, P739, DOI 10.1038/sj.npp.1300858; Navratilova E, 2015, J NEUROSCI, V35, P7264, DOI 10.1523/JNEUROSCI.3862-14.2015; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Neugebauer V, 2020, NEUROPHARMACOLOGY, V170, DOI 10.1016/j.neuropharm.2020.108052; Peckys D, 1999, NEUROSCIENCE, V88, P1093, DOI 10.1016/S0306-4522(98)00251-6; Penzo MA, 2015, NATURE, V519, P455, DOI 10.1038/nature13978; Pomrenze MB, 2019, CELL REP, V29, P13, DOI 10.1016/j.celrep.2019.08.083; Pradhan AA, 2011, TRENDS PHARMACOL SCI, V32, P581, DOI 10.1016/j.tips.2011.06.008; Raehal KM, 2011, PHARMACOL REV, V63, P1001, DOI 10.1124/pr.111.004598; Raehal KM, 2005, AAPS J, V7, pE587, DOI 10.1208/aapsj070360; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; Ren WJ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-93; Saitoh A, 2004, J PHARMACOL SCI, V95, P374, DOI 10.1254/jphs.FPJ04014X; Shiwarski DJ, 2017, J NEUROSCI, V37, P3741, DOI 10.1523/JNEUROSCI.2923-16.2017; SIMONIN F, 1994, MOL PHARMACOL, V46, P1015; SOFUOGLU M, 1993, LIFE SCI, V52, P769, DOI 10.1016/0024-3205(93)90240-4; Sugiyama A, 2014, NEUROPHARMACOLOGY, V79, P314, DOI 10.1016/j.neuropharm.2013.11.021; Suzuki T, 1997, EUR J PHARMACOL, V324, P21, DOI 10.1016/S0014-2999(97)00062-9; Suzuki T, 2007, ANESTH ANALG, V104, P1570, DOI 10.1213/01.ane.0000261514.19946.66; Thorat SN, 1997, J PHARMACOL EXP THER, V283, P1185; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Wilson TD, 2019, CELL REP, V29, P332, DOI 10.1016/j.celrep.2019.09.011; Yekkirala AS, 2013, ACS CHEM BIOL, V8, P1412, DOI 10.1021/cb400113d; Yekkirala AS, 2010, ACS CHEM NEUROSCI, V1, P146, DOI 10.1021/cn9000236; Zarrindast MR, 2008, LIFE SCI, V82, P1175, DOI 10.1016/j.lfs.2008.03.020; Zhang Z, 2011, NAT MED, V17, P1448, DOI 10.1038/nm.2442; Zhou WJ, 2019, NAT NEUROSCI, V22, P1649, DOI 10.1038/s41593-019-0468-2; Zhuo M, 2016, TRENDS NEUROSCI, V39, P136, DOI 10.1016/j.tins.2016.01.006	59	5	5	5	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100277	10.1016/j.jbc.2021.100277	http://dx.doi.org/10.1016/j.jbc.2021.100277			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33428940	gold, Green Published			2022-12-26	WOS:000672866400253
J	Gonete, AT; Kassahun, B; Mekonnen, EG; Takele, WW				Gonete, Almaz Tefera; Kassahun, Bogale; Mekonnen, Eskedar Getie; Takele, Wubet Worku			Stunting at birth and associated factors among newborns delivered at the University of Gondar Comprehensive Specialized Referral Hospital	PLOS ONE			English	Article							LINEAR GROWTH; PREGNANCY; WEIGHT; UNDERNUTRITION; DETERMINANTS; CHILDREN; STATURE; INFANTS	Background Stunting at birth is a chronic form of undernutrition majorly attributable to poor prenatal nutrition, which could persist in children's later life and impact their physical and cognitive health. Although multiple studies have been conducted in Ethiopia to show the magnitude of stunting and factors, all are concentrated on children aged between 6 to 59 months. Therefore, this study was done to determine the prevalence and associated factors of stunting at birth among newborns delivered at the University of Gondar Comprehensive Specialized Referral Hospital, Northwest, Ethiopia. Methods An institution-based cross-sectional study was conducted from February 26(th) to April 25(th/)2020. A systematic random sampling technique was used, to select a total of 422 newborn-mother pairs. The binary logistic regression was employed to identify factors associated with stunting and all independent variables were entered into the multivariable logistic regression model to adjust for confounders. Variables that had significant association were identified based on p-value < 0.05 and the adjusted odds ratio with its respective 95% confidence interval was applied to determine the strength as well as the direction of the association. Results About 30.5% (95% CI: 26.3%, 35.1%) of newborns were stunted at birth. Being male [Adjusted odds ratio (AOR) = 2.9(1.62, 5.21)], newborns conceived in Kiremt(rainy season) [AOR = 2.7(1.49, 4.97)], being low birth weight [AOR = 3.1(1.64, 6.06)] were factors associated with stunting at birth. Likewise, newborns born to short stature mothers [AOR = 2.8(1.21, 6.62)] and chronically malnourished mothers [AOR = 15.3(8.12, 29.1)] were at greater risk of being stunted. Conclusion Just under a third of newborns are stunted at birth, implying a pressing public health problem. Newborns born to chronically malnourished and short stature mothers were more stunted. Besides, stunting was prevalently observed among male neonates, newborns conceived in Kiremet, and being low birth weight. Thus, policymakers and nutrition programmers should work on preventing maternal undernutrition through nutrition education to reduce the burden of low birth weight and stunting. Further, paying due attention to newborns conceived in Kiremet season to improve nutritional status is recommended.	[Gonete, Almaz Tefera; Kassahun, Bogale] Univ Gondar, Coll Med & Hlth Sci, Sch Nursing, Dept Pediat & Child Hlth Nursing, Gondar, Ethiopia; [Mekonnen, Eskedar Getie] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Reprod & Child Hlth, Gondar, Ethiopia; [Takele, Wubet Worku] Univ Gondar, Coll Med & Hlth Sci, Sch Nursing, Dept Community Hlth Nursing, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Gonete, AT (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Nursing, Dept Pediat & Child Hlth Nursing, Gondar, Ethiopia.	almazteferag3@gmail.com						ALJEEZRA AI, ALJAZEERA; Arifeen SE, 2000, AM J CLIN NUTR, V72, P1010; Aryastami NK, 2017, BMC NUTR, V3, P16, DOI [10.1186/s40795-017-0130-x, DOI 10.1186/S40795-017-0130-X]; AU C, 2013, COST HUNGER ETHIOPIA; Banerjee Bratati, 2009, Indian J Community Med, V34, P89, DOI 10.4103/0970-0218.51224; Bayu T.Y, 2013, AGROECOLOGICAL ASSES; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Carter KN, 2010, AUST NZ J PUBL HEAL, V34, P602, DOI 10.1111/j.1753-6405.2010.00615.x; CDC, 2018, PREGN COMPL; central stastical Agency (CSA), 2016, CENTR STAT AG CSA ET; Central Statistical Agency (CSA) Ethiopia, ETH DEM HLTH SURV 20; Checkley W, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002408; Christian P, 2013, INT J EPIDEMIOL, V42, P1340, DOI 10.1093/ije/dyt109; Cousens S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4744-3; Dadi AF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215305; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Economists W.L, 2018, POOR COUNTR WORLD; Elly N., 2019, P 1 C INTERPROFESSIO, P328, DOI [10.2991/icihc-18.2019.72, DOI 10.2991/ICIHC-18.2019.72]; Enlow MB, 2019, PSYCHONEUROENDOCRINO, V102, P225, DOI 10.1016/j.psyneuen.2018.12.222; Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995; Ethiopia, 2014, FMOHO NEON INT CAR U; Fite Robera Olana, 2018, BMC Res Notes, V11, P671, DOI 10.1186/s13104-018-3778-7; Galasso E., WORLD BANK POLICY RE; Hayati A.W, 2019, ASIAN J RES MED PHAR, P1; Hills FA, 1996, J ENDOCRINOL, V148, P303, DOI 10.1677/joe.0.1480303; Hospital U.o.G.C.S.R, 2019, ANN DEL REP GOND U C; ICF E.P.H.I.E.E.a, 2019, ETH MIN HLTH SURV 20; Jazeera A.A, AMHARA REGION NOT ON; Khatun W, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081818; Kismul H, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4621-0; Kruger H S, 2005, Curationis, V28, P40; Kuhnt J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017122; Lennox Jessica, 2017, Glob Health Res Policy, V2, P9, DOI 10.1186/s41256-017-0028-9; Leroy JL, 2019, J NUTR, V149, P2219, DOI 10.1093/jn/nxz175; McGovern ME, 2017, INT J EPIDEMIOL, V46, P1171, DOI 10.1093/ije/dyx017; Melamed N, 2013, J ULTRAS MED, V32, P35; Miller AC, 2016, PUBLIC HEALTH NUTR, V19, P1339, DOI 10.1017/S136898001500227X; Neufeld LM, 2004, AM J CLIN NUTR, V79, P646; NP. Commission, 2017, ETH PROGR ER POV INT; Opara EI, 2007, BJOG-INT J OBSTET GY, V114, P1295, DOI 10.1111/j.1471-0528.2007.01435.x; Organization W.H., 2018, RED STUNT CHILDR EQ, V2025; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; PRENTICE AM, 1994, P NUTR SOC, V53, P509, DOI 10.1079/PNS19940061; Ramakrishnan U, 1999, J NUTR, V129, p544S, DOI 10.1093/jn/129.2.544S; Rashad AS, 2019, OXF DEV STUD, V47, P48, DOI 10.1080/13600818.2018.1497589; Ruchayati F, 2012, JURNAL KESEHATAN MAS, V1, P18785; Schmidt MK, 2002, J NUTR, V132, P2202, DOI 10.1093/jn/132.8.2202; Solomons NW, 2015, PUBLIC HEALTH NUTR, V18, P1737, DOI 10.1017/S136898001400264X; Sumarmi S., 2016, MATERNAL SHORT STATU; Svefors P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149700; Tekola-Ayele F, 2019, AGING-US, V11, P5412, DOI 10.18632/aging.102124; The World Bank, 2018, IND ACC FIGHT CHILDH; UNICEF, 2018, MALNUTRITION; UNICEF, 2013, STATE WORLDS CHILDRE; UNICEF World Health Organization World Bank Group, 2020, LEVELS TRENDS CHILD; UoGCSR H., 2020, ANN REP GOND U COMPR; Victora CG, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.1431; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Hoang VN, 2019, APPL ECON, V51, P2001, DOI 10.1080/00036846.2018.1537476; WFP and CSA, 2014, COMPREHENSIVE FOOD S; WHO, 2011, WHO TECH REP SER, V959, P1; WHO, 2015, GLOB TARG TRACK TOOL; WHO, 2005, REP WHO TECHN CONS B; Workicho A, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0448-0; Wulandari R., CORRELATION LOW BIRT; Xie WZ, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1431-5; Orellana JDY, 2019, CIENC SAUDE COLETIVA, V24, P1874, DOI 10.1590/1413-81232018245.17062017	67	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245528	10.1371/journal.pone.0245528	http://dx.doi.org/10.1371/journal.pone.0245528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471862	Green Published, gold			2022-12-26	WOS:000639428800009
J	de Moraes, LR; Delicato, MEA; Cruz, AD; da Silva, HTFNP; Alves, CVBD; Campos, DB; Saraiva, EP; da Costa, FP; Guerra, RR				de Moraes, Lanuza Ribeiro; Delicato, Maria Eduarda Araujo; da Silva Cruz, Andre; Pereira da Silva, Hugo Thyares Fonseca Nascimento; de Vasconcelos Alves, Clara Virginia Batista; Campos, Danila Barreiro; Saraiva, Edilson Paes; Perazzo da Costa, Fernando; Guerra, Ricardo Romao			Methionine supplementing effects on intestine, liver and uterus morphology, and on positivity and expression of Calbindin-D28k and TRPV6 epithelial calcium carriers in laying quail in thermoneutral conditions and under thermal stress	PLOS ONE			English	Article							LOW-PROTEIN-DIET; HEAT-STRESS; VITAMIN-D; EGG-PRODUCTION; ENVIRONMENTAL-TEMPERATURE; SACCHAROMYCES-CEREVISIAE; AMBIENT-TEMPERATURE; EGGSHELL QUALITY; BINDING PROTEIN; PERFORMANCE	This study aimed to provide the performance, localization and expression of the epithelial calcium transporter channels Calbindin-D28k (Calb) and TRPV6, and of the morphology of the digestive and reproductive system of laying quail under heat stress (HS), and with methionine supplementation (MS). This study characterized the positivity (immunohistochemistry) and expression (real-time PCR) of calcium channels in the kidneys, intestine and uterus of 504 laying quails under different MS (100, 110 and 120%) and temperatures (20, 24, 28 and 32 degrees C). The animals under HS (32 degrees C) had lower villus height, villus:crypt ratio, and goblet cell index in the duodenum and jejunum, fewer secondary and tertiary uterine folds, smaller hepatic steatosis, and increased number of distal convoluted renal tubules (CT) positive to Calb, and increased positivity in proximal CTs. Deleterious effects of HS were minimized with MS for: duodenal crypts, number of goblet cells of the jejunum, number of uterine folds, decreased Calb positivity in intestines and kidney, increased positivity of Calb in the uterus and increased TRPV6 gene expression in the kidney (P <= 0.05). Epithelial calcium transporters were altered due to less need for calcium absorption and reabsorption due to more calcium available with the MS, increasing egg production in HS and quality in termoneutrality (P <= 0.05). MS further increased intestinal villus absorption area and height, increased steatosis, decreased Calb positivity in the intestine and kidney, increased uterine positivity of Calb, and increase Calb and TRPV6 expression in the kidney (P <= 0.001) under thermoneutrality. It was concluded that the use of MS (120%) is justifiable in order to partially reverse the deleterious effects of HS on the production, in the epithelial calcium carriers, and in the digestory and reproductive morphology of laying quail.	[de Moraes, Lanuza Ribeiro; Campos, Danila Barreiro; Guerra, Ricardo Romao] Univ Fed Paraiba, Programa Posgrad Ciencia Anim, Areia, Paraiba, Brazil; [Delicato, Maria Eduarda Araujo; da Silva Cruz, Andre; Pereira da Silva, Hugo Thyares Fonseca Nascimento; de Vasconcelos Alves, Clara Virginia Batista] Univ Fed Paraiba, Dept Ciencias Agr, Areia, Paraiba, Brazil; [Saraiva, Edilson Paes; Perazzo da Costa, Fernando; Guerra, Ricardo Romao] Univ Fed Paraiba, Programa Posgrad Zootecnia, Areia, Paraiba, Brazil	Universidade Federal da Paraiba; Universidade Federal da Paraiba; Universidade Federal da Paraiba	Guerra, RR (corresponding author), Univ Fed Paraiba, Programa Posgrad Ciencia Anim, Areia, Paraiba, Brazil.; Guerra, RR (corresponding author), Univ Fed Paraiba, Programa Posgrad Zootecnia, Areia, Paraiba, Brazil.	rromaoguerra@gmail.com	Barreiro Campos, Danila/V-4179-2017	Barreiro Campos, Danila/0000-0003-1426-4392	National Council for Scientific and Technological Development (CNPq-Brazil) [304137/2015-4]; Coordination for the Improvement of Higher Education Personnel (CAPES-Brazil) [881.068412/2014-01]	National Council for Scientific and Technological Development (CNPq-Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES-Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The researcher Guerra, R. R. had a Research Productivity Grant from the National Council for Scientific and Technological Development (CNPq-Brazil), n. 304137/2015-4 and funds through Public Notice 71/2013 PROCAD of the Coordination for the Improvement of Higher Education Personnel (CAPES-Brazil), n. 881.068412/2014-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Only the Coordinator of the research received a grant and funds from federal public agencies that aim to develop research in Brazil.	Alagawany M, 2017, WORLD POULTRY SCI J, V73, P747, DOI 10.1017/S0043933917000782; [Anonymous], 2012, DRUG DISCOV TODAY TE; [Anonymous], 2016, PROD PEC MUN, V44, P29; Araújo Lúcio Francelino, 2006, Cienc. Rural, V36, P1576, DOI 10.1590/S0103-84782006000500037; Bar A, 2008, COMP BIOCHEM PHYS A, V151, P477, DOI [10.1016/j.cbpa.2008.07.006, 10.1016/j.cbpa.2008.11.020]; Barros VRSM, 2014, GALINHAS POEDEIRAS C; Bianco SDC, 2007, J BONE MINER RES, V22, P274, DOI 10.1359/JBMR.061110; Brown AJ, 2005, ARCH BIOCHEM BIOPHYS, V437, P51, DOI 10.1016/j.abb.2005.02.007; Bunchasak C., 2005, International Journal of Poultry Science, V4, P301; Bunchasak C, 1997, ASIAN AUSTRAL J ANIM, V10, P185, DOI 10.5713/ajas.1997.185; Christakos S, 2011, MOL CELL ENDOCRINOL, V347, P25, DOI 10.1016/j.mce.2011.05.038; Cody R., 2015, INTRO SAS U EDITION; CORRADINO RA, 1993, ENDOCRINOLOGY, V132, P193, DOI 10.1210/en.132.1.193; D'Mello JPF, 2003, AMINO ACIDS ANIMAL N, P143; DEANDRADE AN, 1977, POULTRY SCI, V56, P1178, DOI 10.3382/ps.0561178; DEATON JW, 1981, POULTRY SCI, V60, P733, DOI 10.3382/ps.0600733; DONKOH A, 1989, INT J BIOMETEOROL, V33, P259, DOI 10.1007/BF01051087; Ebeid TA, 2012, POULTRY SCI, V91, P2282, DOI 10.3382/ps.2011-01898; EMERY DA, 1984, POULTRY SCI, V63, P2027, DOI 10.3382/ps.0632027; Figueiredo DF, 2003, REV BRAS ZOOTECN, V32, P1321, DOI 10.1590/S1516-35982003000600006; Fleet JC, 2010, CRIT REV CL LAB SCI, V47, P181, DOI 10.3109/10408363.2010.536429; FULLMER CS, 1976, P SOC EXP BIOL MED, V152, P237; HARMS RH, 1993, POULTRY SCI, V72, P1892, DOI 10.3382/ps.0721892; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Klasing K. C., 1998, Comparative avian nutrition.; Lana GRQ, 2000, REV BRAS ZOOTECN, V29, P1117, DOI 10.1590/S1516-35982000000400024; Lin H, 2006, WORLD POULTRY SCI J, V62, P71, DOI 10.1079/WPS200585; Lopes GM, 2014, THESIS; Mack LA, 2013, POULTRY SCI, V92, P285, DOI 10.3382/ps.2012-02589; Marchini CFP, 2009, ARQ BRAS MED VET ZOO, V61, P491, DOI 10.1590/S0102-09352009000200029; Mehaisen GMK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186907; Miller S. C., 1992, Bone biology and skeletal disorders in poultry., P103; MITCHELL MA, 1992, COMP BIOCHEM PHYS A, V101, P137, DOI 10.1016/0300-9629(92)90641-3; Nascimento DCN, 2009, REV BRAS ZOOTECN, V38, P869, DOI 10.1590/S1516-35982009000500013; Nijenhuis T, 2003, J AM SOC NEPHROL, V14, P2731, DOI 10.1097/01.ASN.0000094081.78893.E8; Nyoni NMB, 2019, CLIM DEV, V11, P83, DOI 10.1080/17565529.2018.1442792; PARMENTIER M, 1990, BIOL CELL, V68, P43, DOI 10.1016/0248-4900(90)90285-B; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinheiro SG, 2014, THESIS; Plavnik I, 1998, POULTRY SCI, V77, P870, DOI 10.1093/ps/77.6.870; Plavnik I, 2003, P C AP, P235; Rosa PS, 2005, THESIS; Saki AA, 1997, P AUST POULT SCI, P9; Sandikci M, 2004, REV MED VET-TOULOUSE, V155, P552; Santana MHM, 2014, THESIS; Santos RR, 2015, AVIAN PATHOL, V44, P19, DOI 10.1080/03079457.2014.988122; SIEGEL HS, 1995, BRIT POULTRY SCI, V36, P3, DOI 10.1080/00071669508417748; Sugiyama T, 2007, BRIT POULTRY SCI, V48, P233, DOI 10.1080/00071660701302270; Sugiyama T, 2001, ASIAN AUSTRAL J ANIM, V14, P82; SUMMERS JD, 1991, CAN J ANIM SCI, V71, P211, DOI 10.4141/cjas91-023; TANOR MA, 1984, POULTRY SCI, V63, P304, DOI 10.3382/ps.0630304; Virden WS, 2009, J APPL POULTRY RES, V18, P338, DOI 10.3382/japr.2007-00093; WASSERMA.RH, 1966, SCIENCE, V152, P791, DOI 10.1126/science.152.3723.791; WU JCY, 1993, COMP BIOCHEM PHYS A, V106, P263, DOI 10.1016/0300-9629(93)90510-B; Wu QJ, 2018, POULTRY SCI, V97, P2675, DOI 10.3382/ps/pey123; Yang JH, 2011, BRIT POULTRY SCI, V52, P507, DOI 10.1080/00071668.2011.596994	58	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245615	10.1371/journal.pone.0245615	http://dx.doi.org/10.1371/journal.pone.0245615			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449938	Green Published, Green Submitted, gold			2022-12-26	WOS:000609991600015
J	Feng, J; Wu, RY; Zhang, G; Yang, ZM; Zhang, L				Feng, Jiao; Wu, RuiYang; Zhang, Gang; Yang, ZhiMing; Zhang, Liang			Prognostic importance of numbers of retrieved lymph nodes and positive lymph nodes for ampulla of vater cancer (AVC) in 2347 patients from the Surveillance, Epidemiology, and End Results (SEER) database	PLOS ONE			English	Article							RATIO; RESECTION; ADENOCARCINOMA; RELEVANCE; SURVIVAL; IMPACT	Introduction The numbers of retrieved lymph nodes (RLNs) and positive lymph nodes (PLNs) had a significant impact on the survival of patients with ampulla of vater cancer (AVC), but the optimal numbers of the both were controversial. Objective The cohort study aimed to explore the prognostic value and the optimal point of RLNs and PLNs for AVC. Methods A total of 2347 AVC patients with M0 disease who underwent surgical resection and lymph node dissection from January 2004 to December 2013 were acquired from a prospective database. Results The study found that the optimal cut-off values of RLNs were 18 in the N0 cohort and 16 in N1 or entire cohort due to the highest 5-year overall survival (OS) rate and disease-specific survival (DSS) rate and the separation of survival curves (all P < 0.05). In patients with RLNs >= 16, patients with PLN = 0 demonstrated significantly better 5-year OS and DSS rates (70.9% and 77.1%) compared to those with PLNs = 1-2 (41.6% and 44.7%; all P < 0.001), and patients with PLNs = 1-2 demonstrated significantly better 5-year OS and DSS rates (41.6% and 44.7%) compared to those with PLNs >= 3 (24.3% and 28.0%; all P < 0.001). Conclusions This article recommended that at least 16 lymph nodes will improve the prognosis of AVC patients undergoing surgery. The best cut-off values of PLNs recommended for this study were 0 and 2, which may accurately stratify patients.	[Feng, Jiao] Southwest Med Univ, Dept Gastrointestinal Surg, Affiliated Chengdu Hosp 363, Chengdu, Sichuan, Peoples R China; [Wu, RuiYang; Zhang, Gang] Chengdu Med Coll, Sichuan Prov Hosp Women & Children, Affiliated Women & Childrens Hosp, Dept Gen Surg, Chengdu, Sichuan, Peoples R China; [Wu, RuiYang; Yang, ZhiMing; Zhang, Liang] Chengdu Med Coll, Affiliated Hosp 1, Dept Vasc Surg, Chengdu, Sichuan, Peoples R China	Southwest Medical University; Chengdu Medical College; Chengdu Medical College	Zhang, G (corresponding author), Chengdu Med Coll, Sichuan Prov Hosp Women & Children, Affiliated Women & Childrens Hosp, Dept Gen Surg, Chengdu, Sichuan, Peoples R China.	1419174430@qq.com						Ahn KS, 2018, SURG ONCOL, V27, P82, DOI 10.1016/j.suronc.2017.12.002; Al-Jumayli M, 2019, J ONCOL, V2019, DOI 10.1155/2019/3293509; Albores-Saavedra J, 2009, J SURG ONCOL, V100, P598, DOI 10.1002/jso.21374; Amin MB., 2017, AJCC CANC STAGING MA, V8th; Bourgouin S, 2017, INT J SURG, V42, P103, DOI 10.1016/j.ijsu.2017.04.051; Choi SB, 2011, SCAND J SURG, V100, P92, DOI 10.1177/145749691110000205; Falconi M, 2008, ANN SURG ONCOL, V15, P3178, DOI 10.1245/s10434-008-0099-4; Ha HR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151406; Hsu CH, 2015, MEDICINE, V94, DOI [10.1097/MD.0000000000001859, 10.1097/MD.0000000000002347]; Hurtuk MG, 2009, AM J SURG, V197, P348, DOI 10.1016/j.amjsurg.2008.11.010; Kang HJ, 2014, SURGERY, V155, P74, DOI 10.1016/j.surg.2013.08.004; Kim H, 2019, J HEPATO-BIL-PAN SCI, V26, P179, DOI 10.1002/jhbp.618; Kim Kang Jae, 2011, Korean J Hepatobiliary Pancreat Surg, V15, P171, DOI 10.14701/kjhbps.2011.15.3.171; Lee H, 2016, WORLD J SURG, V40, P967, DOI 10.1007/s00268-015-3316-x; Lino-Silva LS, 2018, J GASTROINTEST ONCOL, V9, P1144, DOI 10.21037/jgo.2018.07.04; Paluri R, 2020, STATPEARLS; Partelli S, 2013, WORLD J SURG, V37, P1397, DOI 10.1007/s00268-013-1995-8; Yeo CJ, 1998, ANN SURG, V227, P821, DOI 10.1097/00000658-199806000-00005; Zheng ZB, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00038; Zhou JG, 2013, CHINESE J CANCER RES, V25, P735, DOI 10.3978/j.issn.1000-9604.2013.12.03	20	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0244987	10.1371/journal.pone.0244987	http://dx.doi.org/10.1371/journal.pone.0244987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449948	gold, Green Published			2022-12-26	WOS:000609991600050
J	Yoda, T; Miyaki, H; Saito, T				Yoda, Tsuyoshi; Miyaki, Hiroshi; Saito, Tomoaki			Effect of container shape on freeze concentration of apple juice	PLOS ONE			English	Article							CHROMATOGRAPHY; PROCYANIDINS	Concentrating fruit juices by freezing supports the maintenance of both nutrients and flavors. Development of the freezing concentration process has introduced equipment such as centrifuge or block freezing systems, which are suitable for large-scale commercial processing. However, the necessary characteristics of freeze concentration methods for juices include simplicity and low cost. This study examined the effects of different container shapes on the processes of freezing and melting. The shape of the container was found to be more important than the melting temperature, across a relatively large scale. Furthermore, the nutrient procyanidin B2 and saccharides were concentrated. The methods concentrated juice components under low cost conditions without complex equipment. This research thus not only offers benefits for commercial juice preparation but also provides new insight into effects of shape differences in concentration technologies.	[Yoda, Tsuyoshi; Miyaki, Hiroshi; Saito, Tomoaki] Aomori Prefectural Ind Technol Res Ctr, Hirosaki Ind Res Inst, Hirosaki, Aomori, Japan		Yoda, T (corresponding author), Aomori Prefectural Ind Technol Res Ctr, Hirosaki Ind Res Inst, Hirosaki, Aomori, Japan.	tsuyoshi_yoda@aomori-itc.or.jp			Aomori Prefectural Industrial Technology Research Center; Shorai Foundation for Science and Technology	Aomori Prefectural Industrial Technology Research Center; Shorai Foundation for Science and Technology	This research was supported by a grant in third term development research funding of the Aomori Prefectural Industrial Technology Research Center. Tsuyoshi Yoda is grateful to financial support from the Shorai Foundation for Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, Japan Patent, Patent No. [P4081514, 4081514]; [Anonymous], 2010, DISTR STAT FRUIT JUI; Gunathilake M, 2014, FOOD SCI TECHNOL RES, V20, P547, DOI 10.3136/fstr.20.547; Hammerstone JF, 1999, J AGR FOOD CHEM, V47, P490, DOI 10.1021/jf980760h; Jelen HH, 2012, ANAL CHIM ACTA, V738, P13, DOI 10.1016/j.aca.2012.06.006; Miyawaki O, 2016, J FOOD ENG, V171, P153, DOI 10.1016/j.jfoodeng.2015.10.022; Nagasako-Akazome Yoko, 2007, J Oleo Sci, V56, P417; Obara M, 2016, FOOD SCI TECHNOL RES, V22, P563, DOI 10.3136/fstr.22.563; Petzold G, 2015, INNOV FOOD SCI EMERG, V30, P192, DOI 10.1016/j.ifset.2015.03.007; Ramos FA, 2005, J FOOD ENG, V69, P291, DOI 10.1016/j.jfoodeng.2004.07.022; Sanchez J, 2010, INNOV FOOD SCI EMERG, V11, P644, DOI 10.1016/j.ifset.2010.06.006; Sanchez J, 2009, FOOD SCI TECHNOL INT, V15, P303, DOI 10.1177/1082013209344267; Shirasawa Seiichi, 2007, J Oleo Sci, V56, P405; Shoji T, 2006, J CHROMATOGR A, V1102, P206, DOI 10.1016/j.chroma.2005.10.065; Shoji T., METHODS DETECTION PR; Suntory, FREEZ CONC METH KOSH; Tabata S, 2004, J FOOD HYG SOC JPN, V45, P245, DOI 10.3358/shokueishi.45.245; Yamazaki S, 2017, STUDY FUNCTIONAL ING; Yee P.L., 2004, JPN J FOOD ENG, V5, P97; YEE PL, 2003, JPN J FOOD ENG, V4, P77, DOI DOI 10.11301/JSFE2000.4.77; Yoshimoto A., 2013, NAKAMURAGAKUENDAIGAK, V45, P183	21	6	6	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245606	10.1371/journal.pone.0245606	http://dx.doi.org/10.1371/journal.pone.0245606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449969	Green Published, gold			2022-12-26	WOS:000609991600004
J	Evangelista, H; Amaral, C; Porto, LC; Goncalves, SJ; Sodre, ED; Nogueira, J; dos Santos, AMG; Cataldo, M; Junger, D				Evangelista, Heitor; Amaral, Cesar; Porto, Luis Cristovao; Goncalves Junior, Sergio J.; Delfino Sodre, Eduardo; Nogueira, Juliana; dos Santos, Angela M. G.; Cataldo, Marcio; Junger, Daniel			Modeling the initial phase of SARS-CoV-2 deposition in the respiratory tract mimicked by the C-11 radionuclide	PLOS ONE			English	Article							ENZYME 2 ACE2; CORONAVIRUS	The knowledge on the deposition and retention of the viral particle of SARS-CoV-2 in the respiratory tract during the very initial intake from the ambient air is of prime importance to understand the infectious process and COVID-19 initial symptoms. We propose to use a modified version of a widely tested lung deposition model developed by the ICRP, in the context of the ICRP Publication 66, that provides deposition patterns of microparticles in different lung compartments. In the model, we mimicked the "environmental decay" of the virus, determined by controlled experiments related to normal speeches, by the radionuclide C-11 that presents comparable decay rates. Our results confirm clinical observations on the high virus retentions observed in the extrathoracic region and the lesser fraction on the alveolar section (in the order of 5), which may shed light on physiopathology of clinical events as well on the minimal inoculum required to establish infection.	[Evangelista, Heitor; Amaral, Cesar; Goncalves Junior, Sergio J.; Delfino Sodre, Eduardo; Nogueira, Juliana; Junger, Daniel] Univ Estado Rio De Janeiro, LARAMG Lab Radioecol & Global Changes, Rio De Janeiro, RJ, Brazil; [Amaral, Cesar] Univ Estado Rio De Janeiro, LDD Lab Diagnost DNA, Rio De Janeiro, RJ, Brazil; [Porto, Luis Cristovao; dos Santos, Angela M. G.] Univ Estado Rio De Janeiro, HLA Lab Histocompatibilidade & Criopreservacao, Rio De Janeiro, RJ, Brazil; [Cataldo, Marcio] Draxos Consultoria & Gestao Ambiental Ltda, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Goncalves, SJ (corresponding author), Univ Estado Rio De Janeiro, LARAMG Lab Radioecol & Global Changes, Rio De Janeiro, RJ, Brazil.	sjrgoncalves@gmail.com	Gonçalves, Sérgio/GQZ-4378-2022; Evangelista, Heitor/C-7561-2013; Amaral, Cesar/AAS-6841-2021	Goncalves Junior, Sergio Jose/0000-0002-1852-0894; Nogueira, Juliana/0000-0003-4858-8774; Athayde Junger de Oliveira, Daniel/0000-0002-5555-7469				Bake B, 2019, RESP RES, V20, DOI 10.1186/s12931-019-0970-9; Bertelli L, 2008, RADIAT PROT DOSIM, V130, P358, DOI 10.1093/rpd/ncn059; Breustedt B, 2018, RADIAT MEAS, V115, P49, DOI 10.1016/j.radmeas.2018.06.013; Casanova LM, 2010, APPL ENVIRON MICROB, V76, P2712, DOI 10.1128/AEM.02291-09; Chan K, 2011, ADV OPTOELECTRON, V2011, DOI [10.1155/2011/734690, 10.1155/2011/196707]; CUDDIHY RG, 1979, TOXICOL APPL PHARM, V49, P179, DOI 10.1016/0041-008X(79)90240-0; Fennelly KP, 2020, LANCET RESP MED, V8, P914, DOI 10.1016/S2213-2600(20)30323-4; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Henricsson F, 2012, RADIONUCLIDES SOURCE; Imai Y, 2008, EXP PHYSIOL, V93, P543, DOI 10.1113/expphysiol.2007.040048; Jia HP, 2016, SHOCK, V46, P239, DOI 10.1097/SHK.0000000000000633; Karame I., 2017, CARBON DIOXIDE CHEM, DOI [10.5772/intechopen.72313, DOI 10.5772/INTECHOPEN.72313]; Kim CS, 2000, PHILOS T ROY SOC A, V358, P2693, DOI 10.1098/rsta.2000.0678; Knight V, 1973, VIRAL MYCOPLASMAL IN, P1; Knight V., 1980, ANN NEW YORK ACAD 5, VPart V, P147; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liu Y, 2020, NATURE, V582, P557, DOI 10.1038/s41586-020-2271-3; Lolli S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73197-8; Madas B. G., 2020, DEPOSITION DISTRIBUT, DOI [10.1101/2020.05.13.20100057, DOI 10.1101/2020.05.13.20100057]; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; OBERDORSTER G, 1986, SCAND J WORK ENV HEA, V12, P523, DOI 10.5271/sjweh.2104; Otahal P, 2011, RADIAT PROT DOSIM, V145, P150, DOI 10.1093/rpd/ncr046; Ratnesar-Shumate S, 2020, J INFECT DIS, V222, P214, DOI 10.1093/infdis/jiaa274; Santarpia J. L., 2020, AEROSOL SURFACE TRAN, DOI [10.1101/2020.03.23.20039446, DOI 10.1101/2020.03.23.20039446]; Saturni S, 2015, ALLERGY ASTHMA IMMUN, V7, P525, DOI 10.4168/aair.2015.7.6.525; Setti L., 2020, SARS COV 2 RNA FOUND, DOI [10.1101/2020.04.15.20065995, DOI 10.1101/2020.04.15.20065995]; Sobral MFF, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138997; Stadnytskyi V, 2020, P NATL ACAD SCI USA, V117, P11875, DOI 10.1073/pnas.2006874117; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Wells WF, 1955, AIRBORNE CONTAGION A, P13; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yagci AK, 2020, INT J INFECT DIS, V101, P160, DOI 10.1016/j.ijid.2020.09.1449	36	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245019	10.1371/journal.pone.0245019	http://dx.doi.org/10.1371/journal.pone.0245019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444356	gold, Green Published, Green Submitted			2022-12-26	WOS:000609988100067
J	Hodeify, R; Chakkour, M; Rida, R; Kreydiyyeh, S				Hodeify, Rawad; Chakkour, Mohamed; Rida, Reem; Kreydiyyeh, Sawsan			PGE2 upregulates the Na+/K+ ATPase in HepG2 cells via EP4 receptors and intracellular calcium	PLOS ONE			English	Article							CA2+ MOBILIZATION; LIVER; NA+,K+-ATPASE; HEPATOCYTES; MECHANISMS	The Na+/K+ ATPase is a key regulator of the hepatocytes ionic homeostasis, which when altered may lead to many liver disorders. We demonstrated recently, a significant stimulation of the Na+/K+ ATPase in HepG2 cells treated with the S1P analogue FTY 720P, that was mediated through PGE2. The mechanism by which the prostaglandin exerts its effect was not investigated, and is the focus of this work. The type of receptors involved was determined using pharmacological inhibitors, while western blot analysis, fluorescence imaging of GFP-tagged Na+/K+ ATPase, and time-lapse imaging on live cells were used to detect changes in membrane abundance of the Na+/K+ ATPase. The activity of the ATPase was assayed by measuring the amount of inorganic phosphate liberated in the presence and absence of ouabain. The enhanced activity of the ATPase was not observed when EP4 receptors were blocked but still appeared in presence inhibitors of EP1, EP2 and EP3 receptors. The involvement of EP4 was confirmed by the stimulation observed with EP4 agonist. The stimulatory effect of PGE2 did not appear in presence of Rp-cAMP, an inhibitor of PKA, and was imitated by db-cAMP, a PKA activator. Chelating intracellular calcium with BAPTA-AM abrogated the effect of db-cAMP as well as that of PGE2, but PGE2 treatment in a calcium-free PBS medium did not, suggesting an involvement of intracellular calcium, that was confirmed by the results obtained with 2-APB treatment. Live cell imaging showed movement of GFP-Na+/K+ ATPase-positive vesicles to the membrane and increased abundance of the ATPase at the membrane after PGE2 treatment. It was concluded that PGE2 acts via EP4, PKA, and intracellular calcium.	[Hodeify, Rawad] Amer Univ Ras Al Khaimah, Sch Arts & Sci, Dept Biotechnol, Ras Al Khaymah, U Arab Emirates; [Chakkour, Mohamed; Rida, Reem; Kreydiyyeh, Sawsan] Amer Univ Beirut, Fac Arts & Sci, Dept Biol, Beirut, Lebanon	American University of Ras Al Khaimah; American University of Beirut	Kreydiyyeh, S (corresponding author), Amer Univ Beirut, Fac Arts & Sci, Dept Biol, Beirut, Lebanon.	Sawkreyd@aub.edu.lb			Lebanese National Council for Scientific Research; American University of Beirut Research Board	Lebanese National Council for Scientific Research; American University of Beirut Research Board	S. Kreydiyyeh received funding from the Lebanese National Council for Scientific Research and the American University of Beirut Research Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APERIA A, 1990, AM J HYPERTENS, V3, pS11, DOI 10.1093/ajh/3.6.11S; Arrebola F, 2005, J CELL PHYSIOL, V204, P500, DOI 10.1002/jcp.20306; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; BURGESS GM, 1991, J BIOL CHEM, V266, P4772; Carranza ML, 1998, J PHYSIOL-LONDON, V511, P235, DOI 10.1111/j.1469-7793.1998.235bi.x; Chakkour Mohamed, 2019, Cell Physiol Biochem, V53, P518, DOI 10.33594/000000155; Colton C. K., 2007, V179, P173; ERLINGER S, 1982, AM J PHYSIOL, V243, pG243, DOI 10.1152/ajpgi.1982.243.4.G243; Graf J, 1996, J HEPATOL, V24, P53; HAJNOCZKY G, 1993, BIOCHEM J, V293, P413, DOI 10.1042/bj2930413; Hatae N, 2002, J BIOCHEM, V131, P781, DOI 10.1093/oxfordjournals.jbchem.a003165; JOSEPH SK, 1993, J BIOL CHEM, V268, P23059; Kihara A, 2008, BBA-MOL CELL BIOL L, V1781, P496, DOI 10.1016/j.bbalip.2008.05.003; Kiroytcheva M, 1999, KIDNEY INT, V55, P1819, DOI 10.1046/j.1523-1755.1999.00414.x; MARTINEZMAS JV, 1995, FEBS LETT, V362, P85, DOI 10.1016/0014-5793(95)00217-W; Micaroni M, 2010, CURR MOL MED, V10, P763, DOI 10.2174/156652410793384204; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Singer B, 2011, INT J CLIN PRACT, V65, P887, DOI 10.1111/j.1742-1241.2011.02721.x; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Tian T, 2016, UNITED EUR GASTROENT, V4, P677, DOI 10.1177/2050640616637968; Wang Shao-yuan, 2015, Yaoxue Xuebao, V50, P1551; Webster CRL, 2016, AM J PHYSIOL-GASTR L, V310, pG865, DOI 10.1152/ajpgi.00253.2015	26	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245400	10.1371/journal.pone.0245400	http://dx.doi.org/10.1371/journal.pone.0245400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444342	Green Published, gold			2022-12-26	WOS:000609988100062
J	Magro, B; Zuccaro, V; Novelli, L; Zileri, L; Celsa, C; Raimondi, F; Gori, M; Camma, G; Battaglia, S; Genova, VG; Paris, L; Tacelli, M; Mancarella, FA; Enea, M; Attanasio, M; Senni, M; Di Marco, F; Lorini, LF; Fagiuoli, S; Bruno, R; Camma, C; Gasbarrini, A				Magro, Bianca; Zuccaro, Valentina; Novelli, Luca; Zileri, Lorenzo; Celsa, Ciro; Raimondi, Federico; Gori, Mauro; Camma, Giulia; Battaglia, Salvatore; Genova, Vincenzo Giuseppe; Paris, Laura; Tacelli, Matteo; Mancarella, Francesco Antonio; Enea, Marco; Attanasio, Massimo; Senni, Michele; Di Marco, Fabiano; Lorini, Luca Ferdinando; Fagiuoli, Stefano; Bruno, Raffaele; Camma, Calogero; Gasbarrini, Antonio			Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use	PLOS ONE			English	Article							COMPETING RISKS; COVID-19	Backgrounds Validated tools for predicting individual in-hospital mortality of COVID-19 are lacking. We aimed to develop and to validate a simple clinical prediction rule for early identification of in-hospital mortality of patients with COVID-19. Methods and findings We enrolled 2191 consecutive hospitalized patients with COVID-19 from three Italian dedicated units (derivation cohort: 1810 consecutive patients from Bergamo and Pavia units; validation cohort: 381 consecutive patients from Rome unit). The outcome was in-hospital mortality. Fine and Gray competing risks multivariate model (with discharge as a competing event) was used to develop a prediction rule for in-hospital mortality. Discrimination and calibration were assessed by the area under the receiver operating characteristic curve (AUC) and by Brier score in both the derivation and validation cohorts. Seven variables were independent risk factors for in-hospital mortality: age (Hazard Ratio [HR] 1.08, 95% Confidence Interval [CI] 1.07-1.09), male sex (HR 1.62, 95%CI 1.30-2.00), duration of symptoms before hospital admission <10 days (HR 1.72, 95%CI 1.39-2.12), diabetes (HR 1.21, 95%CI 1.02-1.45), coronary heart disease (HR 1.40 95% CI 1.09-1.80), chronic liver disease (HR 1.78, 95%CI 1.16-2.72), and lactate dehydrogenase levels at admission (HR 1.0003, 95%CI 1.0002-1.0005). The AUC was 0.822 (95%CI 0.722-0.922) in the derivation cohort and 0.820 (95%CI 0.724-0.920) in the validation cohort with good calibration. The prediction rule is freely available as a web-app (COVID-CALC: https://sites.google.com/community.unipa.it/covid-19riskpredictions/c19-rp). Conclusions A validated simple clinical prediction rule can promptly and accurately assess the risk for in-hospital mortality, improving triage and the management of patients with COVID-19.	[Magro, Bianca; Tacelli, Matteo; Fagiuoli, Stefano] ASST Papa Giovanni XXIII Bergamo, Gastroenterol Hepatol & Transplantat, Bergamo, Italy; [Zuccaro, Valentina; Bruno, Raffaele] IRCCS Fdn Policlin San Matteo, Dept Infect Dis, Pavia, Italy; [Novelli, Luca; Raimondi, Federico; Di Marco, Fabiano] ASST Papa Giovanni XXIII Bergamo, Pneumol Unit, Bergamo, Italy; [Zileri, Lorenzo; Camma, Giulia; Mancarella, Francesco Antonio; Gasbarrini, Antonio] Fdn Policlin Univ A Gemelli IRCCS, UOC Med Interna & Gastroenterol, Dipartimento Sci Gastroenterol Endocrino Metabol, Rome, Italy; [Celsa, Ciro; Camma, Calogero] Univ Palermo, Sect Gastroenterol & Hepatol, Dept Hlth Promot Mother & Child Care, Internal Med & Med Specialties, Palermo, Italy; [Celsa, Ciro] Univ Palermo, Dept Surg Oncol & Oral Sci Di Chir On S, Palermo, Italy; [Gori, Mauro; Senni, Michele] ASST Papa Giovanni XXIII Bergamo, Cardiovasc Dept & Cardiol Unit 1, Bergamo, Italy; [Battaglia, Salvatore; Genova, Vincenzo Giuseppe; Attanasio, Massimo] Univ Palermo, Dept Econ Business & Stat SEAS, Palermo, Italy; [Paris, Laura] ASST Papa Giovanni XXIII Bergamo, Hematol & Bone Marrow Transplant Unit, Bergamo, Italy; [Enea, Marco] Univ Palermo, Dept Hlth Promot Mother & Child Care, Internal Med & Med Specialties, Palermo, Italy; [Lorini, Luca Ferdinando] ASST Papa Giovanni XXIII Bergamo, Emergency & Intens Care Dept, Bergamo, Italy; [Bruno, Raffaele] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy	ASST Papa Giovanni XXIII; IRCCS Fondazione San Matteo; ASST Papa Giovanni XXIII; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Palermo; University of Palermo; ASST Papa Giovanni XXIII; University of Palermo; ASST Papa Giovanni XXIII; University of Palermo; ASST Papa Giovanni XXIII; University of Pavia	Camma, C (corresponding author), Univ Palermo, Sect Gastroenterol & Hepatol, Dept Hlth Promot Mother & Child Care, Internal Med & Med Specialties, Palermo, Italy.	calogero.camma@unipa.it	Genova, Vincenzo Giuseppe/AHE-9808-2022; Bruno, Raffaele/AAB-9491-2022; Novelli, Luca/AFT-6501-2022	Bruno, Raffaele/0000-0002-0235-9207; Novelli, Luca/0000-0002-2705-248X; Raimondi, Federico/0000-0001-9599-6864; Celsa, Ciro/0000-0002-5662-2162; Magro, Bianca/0000-0002-6417-3205; Mancarella, Francesco Antonio/0000-0002-4474-1842; Gasbarrini, Antonio/0000-0003-4863-6924; GENOVA, VINCENZO GIUSEPPE/0000-0002-2196-0153; ENEA, Marco/0000-0002-9281-5746				Al Ghamdi M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1492-4; [Anonymous], 2020, LANCET, V395, P1054; [Anonymous], LANCET, DOI [10.1016/S0140-6736%2820%2930211-7, DOI 10.1016/S0140-6736(20)30211-7]; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Di Castelnuovo A, 2020, LOW DOSE HYDROXYCHLO, DOI [10.1101/2020.11.01.20223958, DOI 10.1101/2020.11.01.20223958]; Dobbin KK, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-31; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fumagalli C, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040729; Gerds TA, 2014, STAT MED, V33, P3191, DOI 10.1002/sim.6152; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Knight SR, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3339; Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033; Mesas AE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241742; Moon AM, 2020, J HEPATOL, V73, P705, DOI 10.1016/j.jhep.2020.05.013; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Putter H, 2020, BIOMETRICAL J, V62, P790, DOI 10.1002/bimj.201800274; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Schoop R, 2011, BIOMETRICAL J, V53, P88, DOI 10.1002/bimj.201000073; Siemieniuk RAC, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2980; Statista, 2020, SHAR POP AR AG 65 YE; Tsui PT, 2003, EMERG INFECT DIS, V9, P1064; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wolbers M, 2014, EUR HEART J, V35, P2936, DOI 10.1093/eurheartj/ehu131; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Yadaw AS, 2020, LANCET DIGIT HEALTH, V2, pE516, DOI 10.1016/S2589-7500(20)30217-X; Zhang ZH, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.07.38	27	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245281	10.1371/journal.pone.0245281	http://dx.doi.org/10.1371/journal.pone.0245281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444411	Green Published, gold			2022-12-26	WOS:000609988100012
J	Wu, YX; Wu, JR; Zhao, CL				Wu, Ya-Xing; Wu, Jian-Rong; Zhao, Chang-Lin			Steccherinum tenuissimum and S. xanthum spp. nov. (Polyporales, Basidiomycota): New species from China	PLOS ONE			English	Article							MORPHOLOGICAL CHARACTERS; TAXONOMY; CLASSIFICATION; PHYLOGENY; DIVERSITY; FAMILY	Two new wood-inhabiting fungal species, Steccherinum tenuissimum and S. xanthum spp. nov. are described based on a combination of morphological features and molecular evidence. Steccherinum tenuissimum is characterized by an annual growth habit, resupinate basidiomata with an odontioid hymenial surface, a dimitic hyphal system with clamped generative hyphae, strongly encrusted cystidia and basidiospores measuring 3-5 x 2-3.5 mu m. Steccherinum xanthum is characterized by odontioid basidiomata and a monomitic hyphal system with generative hyphae bearing clamp connections and covering by crystals, colourless, thin-walled, smooth, IKI-, CB-and has basidiospores measuring 2.7-5.5 x 1.8-4.0 mu m. Sequences of the ITS and nLSU nrRNA gene regions of the studied samples were generated, and phylogenetic analyses were performed with maximum likelihood, maximum parsimony and Bayesian inference methods. The phylogenetic analyses based on molecular data of ITS + nLSU sequences showed that two new Steccherinum species felled into the residual polyporoid clade. Further investigation was obtained for more representative taxa in Steccherinum based on ITS + nLSU sequences, which demonstrated that S. tenuissimum and S. xanthum were sister to S. robustius with high support (100% BP, 100% BS and 1.00 BPP).	[Wu, Ya-Xing; Zhao, Chang-Lin] Southwest Forestry Univ, Key Lab Forest Resources Conservat & Utilizat Sou, Minist Educ, Kunming, Yunnan, Peoples R China; [Wu, Ya-Xing; Wu, Jian-Rong; Zhao, Chang-Lin] Southwest Forestry Univ, Coll Biodivers Conservat, Kunming, Yunnan, Peoples R China	Southwest Forestry University - China; Southwest Forestry University - China	Zhao, CL (corresponding author), Southwest Forestry Univ, Key Lab Forest Resources Conservat & Utilizat Sou, Minist Educ, Kunming, Yunnan, Peoples R China.; Zhao, CL (corresponding author), Southwest Forestry Univ, Coll Biodivers Conservat, Kunming, Yunnan, Peoples R China.	fungichanglinz@163.com			National Natural Science Foundation of China [31700023]; Biodiversity Survey, Observation and Assessment Program (2019-2023) of Ministry of Ecology and Environment of China [1963049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Biodiversity Survey, Observation and Assessment Program (2019-2023) of Ministry of Ecology and Environment of China	The research is supported by the National Natural Science Foundation of China (Project No. 31700023) and the Biodiversity Survey, Observation and Assessment Program (2019-2023) of Ministry of Ecology and Environment of China (Project No. 1963049).	[Anonymous], 1986, ANGELES HERALD  1021, P1; Bernicchia A, 2010, FUNGI EUROPAEI, V12, P1; Binder M, 2005, SYST BIODIVERS, V3, P113, DOI 10.1017/S1477200005001623; Binder M, 2013, MYCOLOGIA, V105, P1350, DOI 10.3852/13-003; Critical Art Ensemble, 2012, TDR-DRAMA REV-J PERF, V56, P49; Cui BK, 2019, FUNGAL DIVERS, V97, P137, DOI 10.1007/s13225-019-00427-4; Dai YC, 2012, MYCOSCIENCE, V53, P49, DOI 10.1007/s10267-011-0134-3; Dai YH, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0592-8; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Floudas D, 2015, FUNGAL BIOL-UK, V119, P679, DOI 10.1016/j.funbio.2015.04.003; Fries E.M, 1821, SYSTEMA MYCOLOGICUM, V1, P1; Guan QX, 2020, PHYTOTAXA, V437, P51, DOI 10.11646/phytotaxa.437.2.1; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; He MQ, 2019, FUNGAL DIVERS, V99, P105, DOI 10.1007/s13225-019-00435-4; Homolka L, 2010, FUNGAL BIOL-UK, V114, P929, DOI 10.1016/j.funbio.2010.08.009; Huang RX, 2020, MYCOL PROG, V19, P753, DOI 10.1007/s11557-020-01591-7; Justo A, 2017, FUNGAL BIOL-UK, V121, P798, DOI 10.1016/j.funbio.2017.05.010; Justo A, 2011, TAXON, V60, P1567, DOI 10.1002/tax.606003; Kim KM, 2007, MYCOLOGIA, V99, P833, DOI 10.3852/mycologia.99.6.833; Larsson KH, 2007, MYCOL RES, V111, P1040, DOI 10.1016/j.mycres.2007.08.001; Ma RX, 2020, PHYTOTAXA, V451, P238, DOI 10.11646/phytotaxa.451.3.7; Miettinen O, 2012, CLADISTICS, V28, P251, DOI 10.1111/j.1096-0031.2011.00380.x; Miettinen O, 2012, MYCOL PROG, V11, P131, DOI 10.1007/s11557-010-0736-8; Miller M. A., 2010, CIPRES PORTALS; Moreno G, 2011, MYCOL PROG, V10, P481, DOI 10.1007/s11557-010-0717-y; Nunez M, 2001, SYNOP FUNGORUM, V14, P165; Nylander J.A.A, 2004, MRMODELTEST V2; Petersen J.H, 1996, DANISH MYCOLOGICAL S, P1; Robledo GL, 2009, MYCOLOGIA, V101, P657, DOI 10.3852/08-040; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryvarden L, 2014, SYN FUNGORUM, V31, P1, DOI DOI 10.5943/MYC0SPHERE/4/4/13; Sjokvist E, 2012, MYCOLOGIA, V104, P1046, DOI 10.3852/11-174; Sun YF, 2020, PERSOONIA, V44, P206, DOI 10.3767/persoonia.2020.44.08; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Tomsovsky M, 2010, FUNGAL BIOL-UK, V114, P350, DOI 10.1016/j.funbio.2010.02.004; Westphalen MC, 2018, PERSOONIA, V41, P130, DOI 10.3767/persoonia.2018.41.07; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yuan HS, 2005, MYCOTAXON, V93, P173; Zhao CL, 2017, MYCOL PROG, V16, P93, DOI 10.1007/s11557-016-1259-8; Zhao CL, 2015, FUNGAL DIVERS, V70, P115, DOI 10.1007/s13225-014-0299-0; Zhao CL, 2014, PHYTOTAXA, V164, P17; Zhou JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159495	42	1	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0244520	10.1371/journal.pone.0244520	http://dx.doi.org/10.1371/journal.pone.0244520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439872	Green Published, gold			2022-12-26	WOS:000609985300019
J	Maroso, F; Gkagkavouzis, K; De Innocentiis, S; Hillen, J; do Prado, F; Karaiskou, N; Taggart, JB; Carr, A; Nielsen, E; Triantafyllidis, A; Bargelloni, L				Maroso, Francesco; Gkagkavouzis, Konstantinos; De Innocentiis, Sabina; Hillen, Jasmien; do Prado, Fernanda; Karaiskou, Nikoleta; Taggart, John Bernard; Carr, Adrian; Nielsen, Einar; Triantafyllidis, Alexandros; Bargelloni, Luca		Aquatrace Consortium	Genome-wide analysis clarifies the population genetic structure of wild gilthead sea bream (Sparus aurata)	PLOS ONE			English	Article							RE-IMPLEMENTATION; TOOL SET; LOCI; FISH; MICROSATELLITES; DIFFERENTIATION; ASSOCIATION; SALMONIDS; SELECTION; SOFTWARE	Gilthead sea bream is an important target for both recreational and commercial fishing in Europe, where it is also one of the most important cultured fish. Its distribution ranges from the Mediterranean to the African and European coasts of the North-East Atlantic. Until now, the population genetic structure of this species in the wild has largely been studied using microsatellite DNA markers, with minimal genetic differentiation being detected. In this geographically widespread study, 958 wild gilthead sea bream from 23 locations within the Mediterranean Sea and Atlantic Ocean were genotyped at 1159 genome-wide SNP markers by RAD sequencing. Outlier analyses identified 18 loci potentially under selection. Neutral marker analyses identified weak subdivision into three genetic clusters: Atlantic, West, and East Mediterranean. The latter group could be further subdivided into an Ionian/Adriatic and an Aegean group using the outlier markers alone. Seascape analysis suggested that this differentiation was mainly due to difference in salinity, this being also supported by preliminary genomic functional analysis. These results are of fundamental importance for the development of proper management of this species in the wild and are a first step toward the study of the potential genetic impact of the sea bream aquaculture industry.	[Maroso, Francesco; Bargelloni, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy; [Gkagkavouzis, Konstantinos; Karaiskou, Nikoleta; Triantafyllidis, Alexandros] Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, Thessaloniki, Macedonia, Greece; [De Innocentiis, Sabina] Inst Environm Protect & Res, ISPRA, Rome, Italy; [Hillen, Jasmien] Univ Leuven, Lab Biodivers & Evolutionary Genom, Leuven, Belgium; [do Prado, Fernanda] Sao Paulo State Univ, Dept Biol Sci, Bauru, SP, Brazil; [Taggart, John Bernard] Univ Stirling, Inst Aquaculture, Stirling, Scotland; [Carr, Adrian] Fios Genom Ltd, Edinburgh, Midlothian, Scotland; [Nielsen, Einar] Tech Univ Denmark, Natl Inst Aquat Resources, Sect Populat Ecol & Genet, Silkeborg, Denmark; [Maroso, Francesco] Univ Ferrara, Dept Life Sci & Biotecnol, Ferrara, Italy	University of Padua; Aristotle University of Thessaloniki; Italian Institute for Environmental Protection & Research (ISPRA); KU Leuven; Universidade Estadual Paulista; University of Stirling; Technical University of Denmark; University of Ferrara	Maroso, F (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy.; Maroso, F (corresponding author), Univ Ferrara, Dept Life Sci & Biotecnol, Ferrara, Italy.	francesco.maroso@gmail.com	Gkagkavouzis, Konstantinos/AAJ-5744-2021; Nielsen, Einar/AAT-1737-2021	Gkagkavouzis, Konstantinos/0000-0001-6967-1361; Nielsen, Einar/0000-0002-7009-9814	7th Framework Programme for research (FP7) under "Knowledge-Based Bio-Economy -KBBE", Theme 2: "Food, Agriculture and Fisheries, and Biotechnologies" Project [311920]; PhD scholarship of Alexander S. Onassis Public Benefit Foundation (GR)	7th Framework Programme for research (FP7) under "Knowledge-Based Bio-Economy -KBBE", Theme 2: "Food, Agriculture and Fisheries, and Biotechnologies" Project; PhD scholarship of Alexander S. Onassis Public Benefit Foundation (GR)	The project is funded by the 7th Framework Programme for research (FP7) under "Knowledge-Based Bio-Economy -KBBE", Theme 2: "Food, Agriculture and Fisheries, and Biotechnologies" Project identifier: FP7-KBBE2012-6-single-stage Grant agreement no.: 311920. Also, Dr Gkagkavouzis was funded by a PhD scholarship of Alexander S. Onassis Public Benefit Foundation (GR). Fios Genomics Ltd. provided support in the form of salaries for authors AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the `author contributions' section.	Alarcon JA, 2004, AQUACULTURE, V230, P65, DOI 10.1016/S0044-8486(03)00434-4; Andrews S., 2010, FASTQC QUALITY CONTR; Arechavala-Lopez P, 2018, REV FISH SCI AQUAC, V26, P214, DOI 10.1080/23308249.2017.1384789; Ben Slimen H, 2004, CYBIUM, V28, P45; Besnier F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070651; Bradbury IR, 2015, MOL ECOL, V24, P5130, DOI 10.1111/mec.13395; Candy JR, 2015, MOL ECOL RESOUR, V15, P1421, DOI 10.1111/1755-0998.12400; Carreras C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43417; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chaoui L, 2009, CR BIOL, V332, P329, DOI 10.1016/j.crvi.2008.11.002; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Coscia I, 2012, HEREDITY, V108, P537, DOI 10.1038/hdy.2011.120; Crawford DL, 2016, BRIEF FUNCT GENOMICS, V15, P342, DOI 10.1093/bfgp/elw008; Crosetti D, 2014, AQUATRACE SPECIES LE; De Innocentiis S, 2004, FISHERIES SCI, V70, P852, DOI 10.1111/j.1444-2906.2004.00879.x; De Mita S, 2013, MOL ECOL, V22, P1383, DOI 10.1111/mec.12182; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO, 2020, SPAR AUR SPEC FACT S; FAO, 1995, COD COND RESP FISH R; Fischer MC, 2011, MOL ECOL, V20, P1450, DOI 10.1111/j.1365-294X.2011.05015.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Forester BR, 2016, MOL ECOL, V25, P104, DOI 10.1111/mec.13476; Franchini P, 2012, ICES J MAR SCI, V69, P41, DOI 10.1093/icesjms/fsr175; Frichot E, 2013, MOL BIOL EVOL, V30, P1687, DOI 10.1093/molbev/mst063; Garcia-Planas M.I., 2016, APPL MATH, P1, DOI [10.21136/AM.2016.0427-15, DOI 10.21136/AM.2016.0427-15]; Gkagkavouzis K, 2019, J FISH BIOL, V94, P606, DOI 10.1111/jfb.13932; Gunther T, 2013, GENETICS, V195, P205, DOI 10.1534/genetics.113.152462; Hohenlohe Paul A, 2012, Methods Mol Biol, V888, P235, DOI 10.1007/978-1-61779-870-2_14; HOUDE ED, 1993, B MAR SCI, V53, P290; International Council for the Exploration of the Sea (ICES), 2006, REPORT WORKING GROUP; Jackson D, 2015, AQUACULTURE, V436, P21, DOI 10.1016/j.aquaculture.2014.10.040; Jeffries DL, 2016, MOL ECOL, V25, P2997, DOI 10.1111/mec.13613; Jombart T., 2013, TUTORIAL DISCRIMINAN; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Keller I, 2013, MOL ECOL, V22, P2848, DOI 10.1111/mec.12083; Limborg MT, 2012, MOL ECOL, V21, P3686, DOI 10.1111/j.1365-294X.2012.05639.x; Manousaki T, 2016, G3-GENES GENOM GENET, V6, P509, DOI 10.1534/g3.115.023432; Muus B.J., 1999, SCANDINAVIAN FISHING; Oksanen J., 2013, PACKAGE VEGAN, V2, P1; Oksanen J., 2007, COMMUNITY ECOLOGY PA, V10, P631; Palaiokostas C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1383-x; Pauletto M, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0122-7; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pecoraro C, REV FISH BIOL FISHER, P1; Peel D., 2004, NEESTIMATOR SOFTWARE; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RCore Team, 2020, R LANG ENV STAT COMP; Rellstab C, 2015, MOL ECOL, V24, P4348, DOI 10.1111/mec.13322; Rodriguez-Ezpeleta N, 2019, FRONT ECOL ENVIRON, V17, P439, DOI 10.1002/fee.2090; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Segvic-Bubic T, 2011, AQUACULTURE, V318, P309, DOI 10.1016/j.aquaculture.2011.06.007; Souche E. L., 2015, BIOL J LINN SOC; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Taslima K, 2020, BMC GENET, V21, DOI 10.1186/s12863-020-00853-3; Triantafyllidis A, 2007, CIESM WORKS MONOGR, P67; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; WAPLES RS, 1991, CAN J FISH AQUAT SCI, V48, P124, DOI 10.1139/f91-311; WAPLES RS, 1994, CAN J FISH AQUAT SCI, V51, P310, DOI 10.1139/f94-318; Waples RS, 2012, GENETIC RISKS ASS MA; Ward RD, 2006, FISH RES, V80, P9, DOI 10.1016/j.fishres.2006.03.009; Zuzul I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51256-z	66	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0236230	10.1371/journal.pone.0236230	http://dx.doi.org/10.1371/journal.pone.0236230			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428622	Green Submitted, gold, Green Published			2022-12-26	WOS:000630036100002
J	Feng, S; Feng, ZB; Ling, C; Chang, C; Feng, ZK				Feng, Shuo; Feng, Zebang; Ling, Chen; Chang, Chen; Feng, Zhongke			Prediction of the COVID-19 epidemic trends based on SEIR and AI models	PLOS ONE			English	Article							SPIKE GLYCOPROTEIN; CORONAVIRUS; VIRUSES; WUHAN	In December 2019, the outbreak of a new coronavirus-caused pneumonia (COVID-19) in Wuhan attracted close attention in China and the world. The Chinese government took strong national intervention measures on January 23 to control the spread of the epidemic. We are trying to show the impact of these controls on the spread of the epidemic. We proposed an SEIR(Susceptible-Exposed-Infectious-Removed) model to analyze the epidemic trend in Wuhan and use the AI model to analyze the epidemic trend in non-Wuhan areas. We found that if the closure was lifted, the outbreak in non-Wuhan areas of mainland China would double in size. Our SEIR and AI model was effective in predicting the COVID-19 epidemic peaks and sizes. The epidemic control measures taken by the Chinese government, especially the city closure measures, reduced the scale of the COVID-19 epidemic.	[Feng, Shuo; Feng, Zebang] Peking Univ, Sch Software & Microelect, Beijing, Peoples R China; [Ling, Chen] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Chang, Chen; Feng, Zhongke] Beijing Forestry Univ, Beijing Key Lab Precis Forestry, Beijing, Peoples R China	Peking University; Harbin Institute of Technology; Beijing Forestry University	Feng, ZK (corresponding author), Beijing Forestry Univ, Beijing Key Lab Precis Forestry, Beijing, Peoples R China.	fengzhongke@126.com			National Natural Science Foundation of China [U1710123]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by: Study on the National Natural Science Foundation of China (U1710123).	[Anonymous], 2020, NAT ECOL EVOL, V4, P283, DOI 10.1038/s41559-020-1150-5; [Anonymous], 2020, CHINA WHO NOVEL CORO; [Anonymous], 2020, CORONAVIRUS 1 3 MONT; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; CUONG L, 2020, NATURE, V20, P408, DOI DOI 10.1016/S1473-3099(20)30111-0; Danese S., 2020, NAT REV GASTRO HEPAT; Falzarano D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01686; Gog J.R., 2020, NAT REV PHYS; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Hsiang S, 2020, NATURE, V584, P262, DOI 10.1038/s41586-020-2404-8; Huang NE, 2020, SCI BULL, V65, P425, DOI 10.1016/j.scib.2020.02.005; JIA JS, 2020, J THORAC DIS, V582, P389, DOI DOI 10.1038/S41586-020-2284-Y; Jiang Q, 2020, SHANGHAI J PREVENTIV, V32, P58; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; Liu SS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08282-6; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Park YJ, 2019, NAT STRUCT MOL BIOL, V26, P1151, DOI 10.1038/s41594-019-0334-7; Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9; Read J. M., 2020, MEDRXIV, DOI 10.1101/2020.01.23.20018549; Sobral MFF, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138997; Tang B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020462; Tapia R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61315-5; Wang HW, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0148-0; Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Wu JM, 2022, CRIT REV FOOD SCI, V62, P783, DOI [10.1080/10408398.2020.1828813, 10.1038/s41591-020-0822-7]; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Yang CH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61133-9; Yang PH, 2020, CELL MOL IMMUNOL, V17, P555, DOI 10.1038/s41423-020-0407-x; YANG Z, 2020, SCIENCE, V12, P165, DOI DOI 10.21037/JTD.2020.02.64; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]	33	21	22	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0245101	10.1371/journal.pone.0245101	http://dx.doi.org/10.1371/journal.pone.0245101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4OF	33417605	gold, Green Submitted, Green Published			2022-12-26	WOS:000630020100018
J	Phintha, A; Prakinee, K; Jaruwat, A; Lawan, N; Visitsatthawong, S; Kantiwiriyawanitch, C; Songsungthong, W; Trisrivirat, D; Chenprakhon, P; Mulholland, A; van Pee, KH; Chitnumsub, P; Chaiyen, P				Phintha, Aisaraphon; Prakinee, Kridsadakorn; Jaruwat, Aritsara; Lawan, Narin; Visitsatthawong, Surawit; Kantiwiriyawanitch, Chadaporn; Songsungthong, Warangkhana; Trisrivirat, Duangthip; Chenprakhon, Pirom; Mulholland, Adrian; van Pee, Karl-Heinz; Chitnumsub, Penchit; Chaiyen, Pimchai			Dissecting the low catalytic capability of flavin-dependent halogenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPTOPHAN 7-HALOGENASE PRNA; ENZYMATIC HALOGENATION; MEDICINAL CHEMISTRY; KINETIC MECHANISM; ELECTRON-TRANSFER; QM/MM METHODS; PROTON; OXYGEN; MONOOXYGENASE; CHLORINATION	Although flavin-dependent halogenases (FDHs) are attractive biocatalysts, their practical applications are limited because of their low catalytic efficiency. Here, we investigated the reaction mechanisms and structures of tryptophan 6-halogenase (Thal) from Streptomyces albogriseolus using stopped-flow, rapid-uench flow, quantum/mechanics molecular mechanics calculations, crystallography, and detection of intermediate (hypohalous acid [HOX]) liberation. We found that the key flavin intermediate, C4a-hydroperoxyflavin (C4aOOH-FAD), formed by Thal and other FDHs (tryptophan 7-halogenase [PrnA] and tryptophan 5-halogenase [PyrH]), can react with I-, Br-, and Cl- but not F- to form C4a-hydroxyflavin and HOX. Our experiments revealed that I- reacts with C4aOOH-FAD the fastest with the lowest energy barrier and have shown for the first time that a significant amount of the HOX formed leaks out as free HOX. This leakage is probably a major cause of low product coupling ratios in all FDHs. Site-saturation mutagenesis of Lys79 showed that changing Lys79 to any other amino acid resulted in an inactive enzyme. However, the levels of liberated HOX of these variants are all similar, implying that Lys79 probably does not form a chloramine or bromamine intermediate as previously proposed. Computational calculations revealed that Lys79 has an abnormally lower pKa compared with other Lys residues, implying that the catalytic Lys may act as a proton donor in catalysis. Analysis of new X-ray structures of Thal also explains why premixing of FDHs with reduced flavin adenine dinucleotide generally results in abolishment of C4aOOH-FAD formation. These findings reveal the hidden factors restricting FDHs capability which should be useful for future development of FDHs applications.	[Phintha, Aisaraphon; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok, Thailand; [Phintha, Aisaraphon; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Ctr Excellence Prot & Enzyme Technol, Bangkok, Thailand; [Phintha, Aisaraphon; Prakinee, Kridsadakorn; Visitsatthawong, Surawit; Kantiwiriyawanitch, Chadaporn; Trisrivirat, Duangthip; Chaiyen, Pimchai] Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn, Rayong, Thailand; [Jaruwat, Aritsara; Songsungthong, Warangkhana; Chitnumsub, Penchit] Natl Ctr Genet Engn & Biotechnol, Biomol Anal & Applicat Res Team, Klongluang, Pathumthani, Thailand; [Lawan, Narin] Chiang Mai Univ, Fac Sci, Dept Chem, Chiang Mai, Thailand; [Chenprakhon, Pirom] Mahidol Univ, Inst Innovat Learning, Salaya, Nakhon Pathom, Thailand; [Mulholland, Adrian] Univ Bristol, Ctr Computat Chem, Sch Chem, Bristol, Avon, England; [van Pee, Karl-Heinz] Tech Univ Dresden, Fac Chem & Food Chem, Gen Biochem, Dresden, Germany	Mahidol University; Mahidol University; Vidyasirimedhi Institute of Science & Technology; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chiang Mai University; Mahidol University; University of Bristol; Technische Universitat Dresden	Chaiyen, P (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Bangkok, Thailand.; Chaiyen, P (corresponding author), Mahidol Univ, Fac Sci, Ctr Excellence Prot & Enzyme Technol, Bangkok, Thailand.; Chaiyen, P (corresponding author), Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn, Rayong, Thailand.; Chitnumsub, P (corresponding author), Natl Ctr Genet Engn & Biotechnol, Biomol Anal & Applicat Res Team, Klongluang, Pathumthani, Thailand.	penchit@biotec.or.th; pimchai.chaiyen@vistec.ac.th		Trisrivirat, Duangthip/0000-0003-0079-4739; Mulholland, Adrian/0000-0003-1015-4567; Phintha, Aisaraphon/0000-0001-6565-998X; Prakinee, Kridsadakorn/0000-0003-2421-1518; Lawan, Narin/0000-0003-0940-9278	Thailand Science Research Innovation; National Research Council of Thailand through grants Royal Golden Jubilee [PHD/0135/2557]; Vidyasirimedhi Institute of Science and Technology (VISTEC); EPSRC [EP/M022609/1, EP/M013219/1]; Chiang Mai University; Program Management Unit-B through Global Partnership grant; BBSRC [BB/L01386X/1] Funding Source: UKRI; EPSRC [EP/J010588/1, EP/M027546/1] Funding Source: UKRI	Thailand Science Research Innovation; National Research Council of Thailand through grants Royal Golden Jubilee; Vidyasirimedhi Institute of Science and Technology (VISTEC); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Chiang Mai University; Program Management Unit-B through Global Partnership grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was financially supported by Thailand Science Research Innovation and National Research Council of Thailand through grants Royal Golden Jubilee PHD/0135/2557 (to A. P.), Program Management Unit-B through Global Partnership grant (to P. C.) and from Vidyasirimedhi Institute of Science and Technology (VISTEC) (to K.P. and P. C.). We thank Ms Waraporn Pinyo and NSTDA Characterization and Testing Center (NCTC, NSTDA Thailand) for X-ray data collection on the single crystal X-ray diffraction D8 venture. A. J. M. thanks EPSRC for funding (grant numbers EP/M022609/1 and EP/M013219/1). This research work was partially supported by Chiang Mai University (to N. L.). We also thank Ms Pornkanok Pongpamorn for analyzing NMR of the products. We thank the Frontier Research Center (FRC) at VISTEC for providing assistance and facilities for NMR and high resolution mass spectrometry for the analysis of the products.	Agarwal V, 2017, CHEM REV, V117, P5619, DOI 10.1021/acs.chemrev.6b00571; Alonso F, 2002, CHEM REV, V102, P4009, DOI 10.1021/cr0102967; Andorfer MC, 2018, ANNU REV BIOCHEM, V87, P159, DOI 10.1146/annurev-biochem-062917-012042; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Belsare KD, 2017, ACS SYNTH BIOL, V6, P416, DOI 10.1021/acssynbio.6b00297; Bitto E, 2008, PROTEINS, V70, P289, DOI 10.1002/prot.21627; BRUICE TC, 1984, ISRAEL J CHEM, V24, P54; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; Cabantous S, 2006, NAT METHODS, V3, P845, DOI 10.1038/nmeth932; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P13856, DOI 10.1021/bi9715122; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P8060, DOI 10.1021/bi970089u; Chitnumsub P, 2004, ACTA CRYSTALLOGR D, V60, P780, DOI 10.1107/S0907444904001544; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; EBERLEIN G, 1983, J AM CHEM SOC, V105, P6685, DOI 10.1021/ja00360a024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Flecks S, 2008, ANGEW CHEM INT EDIT, V47, P9533, DOI 10.1002/anie.200802466; Frese M, 2015, ANGEW CHEM INT EDIT, V54, P298, DOI 10.1002/anie.201408561; Gkotsi DS, 2019, NAT CHEM, V11, P1091, DOI 10.1038/s41557-019-0349-z; Hartwig JF, 2017, ACCOUNTS CHEM RES, V50, P549, DOI 10.1021/acs.accounts.6b00546; Harvey JN, 2004, FARADAY DISCUSS, V127, P165, DOI 10.1039/b314768a; Hernandes MZ, 2010, CURR DRUG TARGETS, V11, P303, DOI 10.2174/138945010790711996; Hertwig RH, 1997, CHEM PHYS LETT, V268, P345, DOI 10.1016/S0009-2614(97)00207-8; Jeschke P, 2010, PEST MANAG SCI, V66, P10, DOI 10.1002/ps.1829; Karabencheva-Christova TG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17789-x; Keller S, 2000, ANGEW CHEM INT EDIT, V39, P2300, DOI 10.1002/1521-3773(20000703)39:13<2300::AID-ANIE2300>3.0.CO;2-I; Kelly BC, 2007, SCIENCE, V317, P236, DOI 10.1126/science.1138275; Lang A, 2011, ANGEW CHEM INT EDIT, V50, P2951, DOI 10.1002/anie.201007896; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Latham J, 2018, CHEM REV, V118, P232, DOI 10.1021/acs.chemrev.7b00032; Mascotti ML, 2016, J MOL BIOL, V428, P3131, DOI 10.1016/j.jmb.2016.07.003; Lawan N, 2019, J MOL GRAPH MODEL, V87, P250, DOI 10.1016/j.jmgm.2018.12.011; Lawan N, 2014, CHEM PHYS LETT, V608, P380, DOI 10.1016/j.cplett.2014.06.010; Lu YX, 2012, EXPERT OPIN DRUG DIS, V7, P375, DOI 10.1517/17460441.2012.678829; Lu YX, 2009, J MED CHEM, V52, P2854, DOI 10.1021/jm9000133; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mori S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09215-9; Moritzer AC, 2019, PROTEIN SCI, V28, P2112, DOI 10.1002/pro.3739; Moritzer AC, 2019, J BIOL CHEM, V294, P2529, DOI 10.1074/jbc.RA118.005393; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Payne JT, 2015, ANGEW CHEM INT EDIT, V54, P4226, DOI 10.1002/anie.201411901; Phintha Aisaraphon, 2020, Enzymes, V47, P327, DOI 10.1016/bs.enz.2020.05.009; Pimviriyakul P, 2017, J BIOL CHEM, V292, P4818, DOI 10.1074/jbc.M116.774448; Poor CB, 2014, CHEMBIOCHEM, V15, P1286, DOI 10.1002/cbic.201300780; Prakash GKS, 2004, J AM CHEM SOC, V126, P15770, DOI 10.1021/ja0465247; Prongjit M, 2009, BIOCHEMISTRY-US, V48, P4170, DOI 10.1021/bi802331r; Ranaghan KE, 2017, J PHYS CHEM B, V121, P9785, DOI 10.1021/acs.jpcb.7b06892; Santos-Aberturas J, 2015, CHEM BIOL, V22, P1406, DOI 10.1016/j.chembiol.2015.08.014; Shah MB, 2017, ACS CHEM BIOL, V12, P1204, DOI 10.1021/acschembio.7b00056; Shepherd SA, 2015, CHEM SCI, V6, P3454, DOI 10.1039/c5sc00913h; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Sullivan B, 2013, ENZYME MICROB TECH, V53, P70, DOI 10.1016/j.enzmictec.2013.02.012; van der Kamp MW, 2010, J PHYS CHEM B, V114, P11303, DOI 10.1021/jp104069t; Visitsatthawong S, 2015, J AM CHEM SOC, V137, P9363, DOI 10.1021/jacs.5b04328; Werner HJ, 2012, WIRES COMPUT MOL SCI, V2, P242, DOI 10.1002/wcms.82; Wilcken R, 2013, J MED CHEM, V56, P1363, DOI 10.1021/jm3012068; Wilcken R, 2012, J AM CHEM SOC, V134, P6810, DOI 10.1021/ja301056a; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wongnate T, 2014, J AM CHEM SOC, V136, P241, DOI 10.1021/ja4088055; Xu B, 2012, WATER AIR SOIL POLL, V223, P4429, DOI 10.1007/s11270-012-1206-5; Xu ZJ, 2014, J CHEM INF MODEL, V54, P69, DOI 10.1021/ci400539q; Xu ZJ, 2011, J MED CHEM, V54, P5607, DOI 10.1021/jm200644r; Yeh E, 2007, BIOCHEMISTRY-US, V46, P1284, DOI 10.1021/bi0621213; Yeh E, 2006, BIOCHEMISTRY-US, V45, P7904, DOI 10.1021/bi060607d; Zhan X, 2008, BIOCHEMISTRY-US, V47, P2221, DOI 10.1021/bi701853w; Zhu XF, 2009, J MOL BIOL, V391, P74, DOI 10.1016/j.jmb.2009.06.008	72	8	8	5	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100068	10.1074/jbc.RA120.016004	http://dx.doi.org/10.1074/jbc.RA120.016004			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33465708	Green Published, gold			2022-12-26	WOS:000672866400049
J	Pilliod, J; Desjardins, A; Pernegre, C; Jamann, H; Larochelle, C; Fon, EA; Leclerc, N				Pilliod, Julie; Desjardins, Alexandre; Pernegre, Camille; Jamann, Helene; Larochelle, Catherine; Fon, Edward A.; Leclerc, Nicole			Clearance of intracellular tau protein from neuronal cells via VAMP8-induced secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						VAMP8; secretion; late endosomes; tau mutants; TIRF microscopy; Tau protein (Tau); endosome; Alzheimer disease; SNARE proteins	MILD COGNITIVE IMPAIRMENT; FRONTOTEMPORAL LOBAR DEGENERATION; MICROTUBULE-ASSOCIATED PROTEINS; ALZHEIMERS-DISEASE; UNCONVENTIONAL SECRETION; NEUROFIBRILLARY TANGLES; REGULATED EXOCYTOSIS; UP-REGULATION; DEMENTIA; GENE	In Alzheimer's disease (AD), tau, a microtubule-associated protein (MAP), becomes hyperphosphorylated, aggregates, and accumulates in the somato-dendritic compartment of neurons. In parallel to its intracellular accumulation in AD, tau is also released in the extracellular space, as revealed by its increased presence in cerebrospinal fluid (CSF). Consistent with this, recent studies, including ours, have reported that neurons secrete tau, and several therapeutic strategies aim to prevent the intracellular tau accumulation. Previously, we reported that late endosomes were implicated in tau secretion. Here, we explore the possibility of preventing intracellular tau accumulation by increasing tau secretion. Using neuronal models, we investigated whether overexpression of the vesicle-associated membrane protein 8 (VAMP8), an R-SNARE found on late endosomes, could increase tau secretion. The overexpression of VAMP8 significantly increased tau secretion, decreasing its intracellular levels in the neuroblastoma (N2a) cell line. Increased tau secretion by VAMP8 was also observed in murine hippocampal slices. The intracellular reduction of tau by VAMP8 overexpression correlated to a decrease of acetylated tubulin induced by tau overexpression in N2a cells. VAMP8 staining was preferentially found on late endosomes in N2a cells. Using total internal reflection fluorescence (TIRF) microscopy, the fusion of VAMP8-positive vesicles with the plasma membrane was correlated to the depletion of tau in the cytoplasm. Finally, overexpression of VAMP8 reduced the intracellular accumulation of tau mutants linked to frontotemporal dementia with parkinsonism and alpha-synuclein by increasing their secretion. Collectively, the present data indicate that VAMP8 could be used to increase tau and alpha-synuclein clearance to prevent their intracellular accumulation.	[Pilliod, Julie; Desjardins, Alexandre; Pernegre, Camille; Jamann, Helene; Larochelle, Catherine; Leclerc, Nicole] Univ Montreal Hosp CRCHUM, Res Ctr, Montreal, PQ, Canada; [Pernegre, Camille; Jamann, Helene; Larochelle, Catherine; Leclerc, Nicole] Univ Montreal, Fac Med, Dept Neurosci, Montreal, PQ, Canada; [Fon, Edward A.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, McGill Parkinson Program, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University	Leclerc, N (corresponding author), Univ Montreal Hosp CRCHUM, Res Ctr, Montreal, PQ, Canada.; Leclerc, N (corresponding author), Univ Montreal, Fac Med, Dept Neurosci, Montreal, PQ, Canada.	Nicole.leclerc@umontreal.ca	Jamann, Hélène/ABD-8456-2021	Jamann, Hélène/0000-0002-3610-3090	Canadian Institute of Health Research (CIHR) [PJT-155993]; CRCHUM internal funds	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CRCHUM internal funds	This work was supported in part by Canadian Institute of Health Research (CIHR) Grant PJT-155993 (to N. L. and E. A. F.) and from CRCHUM internal funds (to N. L.).	Ahmed T, 2014, NEUROBIOL AGING, V35, P2474, DOI 10.1016/j.neurobiolaging.2014.05.005; ALAFUZOFF I, 1987, ACTA NEUROPATHOL, V74, P209, DOI 10.1007/BF00688184; Antonin W, 2000, MOL BIOL CELL, V11, P3289, DOI 10.1091/mbc.11.10.3289; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Barthelemy NR, 2016, J ALZHEIMERS DIS, V51, P1033, DOI 10.3233/JAD-150962; Benskey MJ, 2016, J NEUROCHEM, V137, P331, DOI 10.1111/jnc.13570; BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81, DOI 10.1001/archneur.1995.00540250089017; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bright J, 2015, NEUROBIOL AGING, V36, P693, DOI 10.1016/j.neurobiolaging.2014.09.007; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Congdon EE, 2018, NAT REV NEUROL, V14, P399, DOI 10.1038/s41582-018-0013-z; Diaz-Vera J, 2017, J CELL SCI, V130, P697, DOI 10.1242/jcs.190835; Dujardin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100760; Emmanouilidou E, 2016, BRAIN PATHOL, V26, P398, DOI 10.1111/bpa.12373; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Flach K, 2012, J BIOL CHEM, V287, P43223, DOI 10.1074/jbc.M112.396176; Forrest SL, 2018, BRAIN, V141, P521, DOI 10.1093/brain/awx328; Gao S, 2018, BRAIN, V141, P2711, DOI 10.1093/brain/awy197; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Ghetti B, 2015, NEUROPATH APPL NEURO, V41, P24, DOI 10.1111/nan.12213; Ginsberg SD, 2011, J CHEM NEUROANAT, V42, P102, DOI 10.1016/j.jchemneu.2011.05.012; Ginsberg SD, 2010, J ALZHEIMERS DIS, V22, P631, DOI 10.3233/JAD-2010-101080; Ginsberg SD, 2010, BIOL PSYCHIAT, V68, P885, DOI 10.1016/j.biopsych.2010.05.030; Goedert M, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0298-7; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Gomez-Ramos A, 2009, EUR NEUROPSYCHOPHARM, V19, P708, DOI 10.1016/j.euroneuro.2009.04.006; Hampel H, 2010, EXP GERONTOL, V45, P30, DOI 10.1016/j.exger.2009.10.010; Han PC, 2017, J NEUROPATH EXP NEUR, V76, P44, DOI 10.1093/jnen/nlw105; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iguchi Y, 2016, BRAIN, V139, P3187, DOI 10.1093/brain/aww237; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jadhav S, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0664-z; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kucera Ana, 2016, Commun Integr Biol, V9, pe1204498, DOI 10.1080/19420889.2016.1204498; Kumar-Singh S, 2007, BRAIN PATHOL, V17, P104, DOI 10.1111/j.1750-3639.2007.00055.x; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Le Guennec K, 2017, MOL PSYCHIATR, V22, P1119, DOI 10.1038/mp.2016.226; Lee JG, 2016, NAT CELL BIOL, V18, P765, DOI 10.1038/ncb3372; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUDIN B, 1993, HIPPOCAMPUS, V3, P61; Mandell JW, 1996, PERSPECT DEV NEUROBI, V4, P125; Marshall MR, 2015, J CELL BIOL, V210, P135, DOI 10.1083/jcb.201411093; Mohamed NV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178288; Mohamed NV, 2014, SCI REP-UK, V4, DOI 10.1038/srep05715; Mohamed NV, 2013, EUR J NEUROSCI, V37, P1939, DOI 10.1111/ejn.12229; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Ossenkoppele R, 2016, BRAIN, V139, P1551, DOI 10.1093/brain/aww027; Pernegre C, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00649; Plouffe V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036873; Pontecorvo MJ, 2019, BRAIN, V142, P1723, DOI 10.1093/brain/awz090; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Poorkaj P, 2001, ARCH NEUROL-CHICAGO, V58, P383, DOI 10.1001/archneur.58.3.383; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Rodriguez L, 2017, J NEUROCHEM, V141, P592, DOI 10.1111/jnc.13994; Russell CL, 2017, J ALZHEIMERS DIS, V55, P303, DOI 10.3233/JAD-160633; Schraen-Maschke S, 2004, NEUROBIOL DIS, V15, P449, DOI 10.1016/j.nbd.2003.12.009; Shrivastava AN, 2019, EMBO J, V38, DOI 10.15252/embj.201899871; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; TAKEMURA R, 1992, J CELL SCI, V103, P953; Tang MP, 2019, ADV EXP MED BIOL, V1184, P57, DOI 10.1007/978-981-32-9358-8_5; Tiernan CT, 2016, NEUROBIOL AGING, V42, P80, DOI 10.1016/j.neurobiolaging.2016.02.031; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; Tsunemi T, 2019, J NEUROSCI, V39, P5760, DOI 10.1523/JNEUROSCI.3085-18.2019; Vaz-Silva J, 2018, EMBO J, V37, DOI 10.15252/embj.201899084; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Wang CC, 2007, MOL BIOL CELL, V18, P1056, DOI 10.1091/mbc.E06-10-0974; Wang TL, 2012, J CELL PHYSIOL, V227, P2788, DOI 10.1002/jcp.23023; Wang Y, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-016-0143-y; Xu Y, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0012-7; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Zhu D, 2012, CELL METAB, V16, P238, DOI 10.1016/j.cmet.2012.07.001	82	9	9	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17827	17841		10.1074/jbc.RA120.013553	http://dx.doi.org/10.1074/jbc.RA120.013553			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454017	Green Published, hybrid			2022-12-26	WOS:000603272300033
J	Gonzalez, YIR; Moyer, AL; LeTexier, NJ; Bratti, AD; Feng, SY; Pena, V; Sun, CS; Pulcastro, H; Liu, T; Iyer, SR; Lovering, RM; O'Rourke, B; Wagner, KR				Gonzalez, Yazmin I. Rovira; Moyer, Adam L.; LeTexier, Nicolas J.; Bratti, August D.; Feng, Siyuan; Pena, Vanessa; Sun, Congshan; Pulcastro, Hannah; Liu, Ting; Iyer, Shama R.; Lovering, Richard M.; O'Rourke, Brian; Wagner, Kathryn R.			Mss51 deletion increases endurance and ameliorates histopathology in the mdx mouse model of Duchenne muscular dystrophy	FASEB JOURNAL			English	Article						endurance; fibrosis; mdx; mitochondrial respiration; Mss51; muscular dystrophy	SKELETAL-MUSCLE; ENERGY-METABOLISM; GENE-EXPRESSION; MEMBRANE; MITOCHONDRIA; DEGENERATION; HYPERTROPHY; MECHANISMS; PROTEOMICS; PATHWAYS	Mitochondrial derangement is an important contributor to the pathophysiology of muscular dystrophies and may be among the earliest cellular deficits. We have previously shown that disruption of Mss51, a mammalian skeletal muscle protein that localizes to the mitochondria, results in enhanced muscle oxygen consumption rate, increased endurance capacity, and improved limb muscle strength in mice with wildtype background. Here, we investigate whether Mss51 deletion in the mdx murine model of Duchenne muscular dystrophy (mdx-Mss51 KO) counteracts the muscle pathology and mitochondrial irregularities observed in mdx mice. We found that mdx-Mss51 KO mice had increased myofiber oxygen consumption rates and an amelioration of muscle histopathology compared to mdx counterparts. This corresponded with greater treadmill endurance and less percent fatigue in muscle physiology, but no improvement in forelimb grip strength or limb muscle force production. These findings suggest that although Mss51 deletion ameliorates the skeletal muscle mitochondrial respiration defects in mdx and improves fatigue resistance in vivo, the lack of improvement in force production suggests that this target alone may be insufficient for a therapeutic effect.	[Gonzalez, Yazmin I. Rovira; Moyer, Adam L.; LeTexier, Nicolas J.; Bratti, August D.; Feng, Siyuan; Pena, Vanessa; Sun, Congshan; Pulcastro, Hannah; Wagner, Kathryn R.] Kennedy Krieger Inst, Hugo W Moser Res Inst, Baltimore, MD 21205 USA; [Gonzalez, Yazmin I. Rovira; Moyer, Adam L.] Johns Hopkins Sch Med, Cellular & Mol Med Grad Program, Baltimore, MD USA; [Sun, Congshan; Wagner, Kathryn R.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Sun, Congshan; Wagner, Kathryn R.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA; [Liu, Ting; O'Rourke, Brian] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA; [Iyer, Shama R.; Lovering, Richard M.] Univ Maryland, Sch Med, Dept Orthopaed, Baltimore, MD 21201 USA; [Gonzalez, Yazmin I. Rovira] Shape Therapeut Inc, Dis Biol Div, Seattle, WA USA; [LeTexier, Nicolas J.] Derflan Inc, Bellevue, WA USA; [Bratti, August D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Harvard University	Wagner, KR (corresponding author), Kennedy Krieger Inst, Ctr Genet Muscle Disorders, 707 North Broadway, Baltimore, MD 21205 USA.	wagnerk@kennedykrieger.org		Feng, Siyuan/0000-0003-2374-4769; Rovira Gonzalez, Yazmin/0000-0002-5323-536X	NIAMS, National Institutes of Health (NIH) [R56AR073193] Funding Source: Medline	NIAMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abou-Samra M, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0051-9; ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; Banks GB, 2010, MUSCLE NERVE, V42, P268, DOI 10.1002/mus.21700; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Buyse GM, 2009, EUR HEART J, V30, P116, DOI 10.1093/eurheartj/ehn406; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CARROLL JE, 1985, NEUROLOGY, V35, P96, DOI 10.1212/WNL.35.1.96; Comim CM, 2016, MUSCLE NERVE, V53, P91, DOI 10.1002/mus.24704; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; EVEN PC, 1994, BIOCHEM J, V304, P649, DOI 10.1042/bj3040649; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; Gaglianone RB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38609-4; Gao QQ, 2015, COMPR PHYSIOL, V5, P1223, DOI 10.1002/cphy.c140048; Garcia-Villegas R, 2017, J BIOL CHEM, V292, P10912, DOI 10.1074/jbc.M116.773077; Godin Richard, 2012, J Physiol, V590, P5487, DOI 10.1113/jphysiol.2012.240390; Gonzalez YIR, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122247; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hughes MC, 2019, J CACHEXIA SARCOPENI, V10, P643, DOI 10.1002/jcsm.12405; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Iyer SR, 2016, METHODS MOL BIOL, V1460, P293, DOI 10.1007/978-1-4939-3810-0_20; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kuznetsov AV, 1998, MOL CELL BIOCHEM, V183, P87, DOI 10.1023/A:1006868130002; Kyrychenko V, 2015, CELL CALCIUM, V58, P186, DOI 10.1016/j.ceca.2015.04.006; Latres E, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0060-8; LoMauro A, 2015, THER CLIN RISK MANAG, V11, P1475, DOI 10.2147/TCRM.S55889; Mallouk N, 2000, P NATL ACAD SCI USA, V97, P4950, DOI 10.1073/pnas.97.9.4950; McGreevy JW, 2015, DIS MODEL MECH, V8, P195, DOI 10.1242/dmm.018424; Miao YX, 2015, INT J MOL SCI, V16, P7976, DOI 10.3390/ijms16047976; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Millay DP, 2009, P NATL ACAD SCI USA, V106, P19023, DOI 10.1073/pnas.0906591106; Moore TM, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00690; Moyer Adam L, 2015, J Neuromuscul Dis, V2, P371; Onopiuk M, 2009, BIOCHEM BIOPH RES CO, V386, P463, DOI 10.1016/j.bbrc.2009.06.053; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; Passaquin AC, 2002, NEUROMUSCULAR DISORD, V12, P174, DOI 10.1016/S0960-8966(01)00273-5; Percival JM, 2013, HUM MOL GENET, V22, P153, DOI 10.1093/hmg/dds415; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; Pratt SJP, 2013, J PHYSIOL-LONDON, V591, P559, DOI 10.1113/jphysiol.2012.241679; Rahimov F, 2011, PHYSIOL GENOMICS, V43, P398, DOI 10.1152/physiolgenomics.00223.2010; Ramadasan-Nair R, 2014, J BIOL CHEM, V289, P485, DOI 10.1074/jbc.M113.493270; Rayavarapu S, 2013, MOL CELL PROTEOMICS, V12, P1061, DOI 10.1074/mcp.M112.023127; Schuh RA, 2012, AM J PHYSIOL-REG I, V302, pR712, DOI 10.1152/ajpregu.00229.2011; Selsby JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030063; Sharma N, 2012, J BIOL CHEM, V287, P30455, DOI 10.1074/jbc.M112.354415; Shkryl VM, 2009, PFLUG ARCH EUR J PHY, V458, P915, DOI 10.1007/s00424-009-0670-2; Soto IC, 2012, CELL METAB, V16, P801, DOI 10.1016/j.cmet.2012.10.018; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Sunitha B, 2016, J NEUROCHEM, V138, P174, DOI 10.1111/jnc.13626; Szklarczyk R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r12; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; Vila MC, 2017, CELL DEATH DIFFER, V24, P330, DOI 10.1038/cdd.2016.127; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Welle S, 2009, PHYSIOL GENOMICS, V38, P342, DOI 10.1152/physiolgenomics.00054.2009; Welle S, 2009, AM J PHYSIOL-ENDOC M, V296, pE567, DOI 10.1152/ajpendo.90862.2008; Yucel N, 2018, NPJ REGEN MED, V3, DOI 10.1038/s41536-018-0045-4	55	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21276	10.1096/fj.202002106RR	http://dx.doi.org/10.1096/fj.202002106RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33423297				2022-12-26	WOS:000647789600050
J	Fujii, TG; Ikebuchi, M; Okanoya, K				Fujii, Tomoko G.; Ikebuchi, Maki; Okanoya, Kazuo			Sex differences in the development and expression of a preference for familiar vocal signals in songbirds	PLOS ONE			English	Article							ZEBRA-FINCHES; BENGALESE FINCHES; SONG RECOGNITION; BIRDSONG MEMORY; NEURAL BASES; MECHANISMS; EXPERIENCE; FEMALES; BRAIN; DISSOCIATION	Production and perception of birdsong critically depends on early developmental experience. In species where singing is a sexually dimorphic trait, early life song experience may affect later behavior differently between sexes. It is known that both male and female songbirds acquire a life-long memory of early song experience, though its function remains unclear. In this study, we hypothesized that male and female birds express a preference for their fathers' song, but do so differently depending on the developmental stage. We measured preference for their father's song over an unfamiliar one in both male and female Bengalese finches at multiple time points across ontogeny, using phonotaxis and vocal response as indices of preference. We found that in males, selective approach to their father's song decreased as they developed while in females, it remained stable regardless of age. This may correspond to a higher sensitivity to tutor song in young males while they are learning and a retained sensitivity in females because song is a courtship signal that is used throughout life. In addition, throughout development, males vocalized less frequently during presentation of their father's song compared to unfamiliar song, whereas females emitted more calls to their father's song. These findings contribute to a deeper understanding of why songbirds acquire and maintain such a robust song memory.	[Fujii, Tomoko G.; Okanoya, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan; [Ikebuchi, Maki; Okanoya, Kazuo] RIKEN, Ctr Brain Sci, Behav & Cognit Joint Res Lab, Wako, Saitama, Japan	University of Tokyo; RIKEN	Okanoya, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan.; Okanoya, K (corresponding author), RIKEN, Ctr Brain Sci, Behav & Cognit Joint Res Lab, Wako, Saitama, Japan.	cokanoya@mail.ecc.u-tokyo.ac.jp		Fujii, Tomoko/0000-0003-2360-0001	MEXT/JSPS KAKENHI Grant [17H06380, 17J07023]	MEXT/JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT/JSPS KAKENHI Grant, Numbers 17H06380 to KO & 17J07023 to TGF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (https://www.jsps.go.jp/index.html)	ADRET P, 1993, ANIM BEHAV, V46, P149, DOI 10.1006/anbe.1993.1170; Anderson RC, 2009, BEHAV ECOL SOCIOBIOL, V64, P215, DOI 10.1007/s00265-009-0838-y; Bailey DJ, 2005, BEHAV BRAIN RES, V162, P108, DOI 10.1016/j.bbr.2005.03.016; Bailey DJ, 2003, MOL BRAIN RES, V116, P147, DOI 10.1016/S0169-328X(03)00288-2; Baran NM, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1114; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BATESON P, 1979, ANIM BEHAV, V27, P470, DOI 10.1016/0003-3472(79)90184-2; BATESON P, 1990, PHILOS T ROY SOC B, V329, P125, DOI 10.1098/rstb.1990.0157; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; BOLHUIS JJ, 1991, BIOL REV, V66, P303, DOI 10.1111/j.1469-185X.1991.tb01145.x; Bolhuis JJ, 2015, NEUROSCI BIOBEHAV R, V50, P41, DOI 10.1016/j.neubiorev.2014.11.019; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Catchpole CK., 2008, BIRD SONG BIOLOGICAL, V2nd; Chen YN, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0054; Chen YN, 2016, P NATL ACAD SCI USA, V113, P6641, DOI 10.1073/pnas.1522306113; CLAYTON NS, 1990, ANIM BEHAV, V40, P1009, DOI 10.1016/S0003-3472(05)80169-1; CLAYTON NS, 1988, ANIM BEHAV, V36, P1016, DOI 10.1016/S0003-3472(88)80061-7; Dunning JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089438; Elie JE, 2019, BRAIN BEHAV EVOLUT, V94, P51, DOI 10.1159/000504380; Gobes SMH, 2007, CURR BIOL, V17, P789, DOI 10.1016/j.cub.2007.03.059; Hahnloser RHR, 2010, CURR OPIN NEUROBIOL, V20, P332, DOI 10.1016/j.conb.2010.02.011; Holveck MJ, 2007, ANIM BEHAV, V74, P297, DOI 10.1016/j.anbehav.2006.08.016; Houx BB, 1999, ANIM BEHAV, V57, P837; Ikebuchi M, 2003, ANIM BEHAV, V65, P123, DOI 10.1006/anbe.2002.2012; Kato Y, 2010, J ETHOL, V28, P447, DOI 10.1007/s10164-010-0203-7; Kriengwatana B, 2016, ANIM BEHAV, V116, P99, DOI 10.1016/j.anbehav.2016.03.028; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lauay C, 2004, ANIM BEHAV, V68, P1249, DOI 10.1016/j.anbehav.2003.12.025; MacDougall-Shackleton SA, 1998, NEUROREPORT, V9, P3047, DOI 10.1097/00001756-199809140-00024; MANN NI, 1995, ANIM BEHAV, V49, P811; Martin P., 2007, MEASURING BEHAV INTR, V3rd ed.; MILLER DB, 1979, NATURE, V280, P389, DOI 10.1038/280389a0; Miller-Sims VC, 2014, J NEUROPHYSIOL, V112, P81, DOI 10.1152/jn.00484.2013; Morton Eugene S., 1996, P258; Nagle L, 2002, ETHOLOGY, V108, P463, DOI 10.1046/j.1439-0310.2002.00790.x; Nelson DA, 1997, ANIM BEHAV, V54, P587, DOI 10.1006/anbe.1996.0456; Odom KJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4379; Okanoya K, 2004, ADV STUD BEHAV, V34, P297, DOI 10.1016/S0065-3454(04)34008-8; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; R Core Team, 2020, R LANG ENV STAT COMP; RAJECKI DW, 1973, PSYCHOL BULL, V79, P48, DOI 10.1037/h0033813; Riebel K, 1998, ANIM BEHAV, V56, P1443, DOI 10.1006/anbe.1998.0933; Riebel K, 2002, P ROY SOC B-BIOL SCI, V269, P729, DOI 10.1098/rspb.2001.1930; Rodriguez-Saltos CA, 2017, INTEGR COMP BIOL, V57, P910, DOI 10.1093/icb/icx106; SEARCY WA, 1992, NATO ADV SCI I A-LIF, V228, P175; Seki Y, 2008, J COMP PSYCHOL, V122, P26, DOI 10.1037/0735-7036.122.1.26; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Slater PJB, 2004, J AVIAN BIOL, V35, P289, DOI 10.1111/j.0908-8857.2004.03392.x; Tachibana RO, 2015, J COMP PHYSIOL A, V201, P1157, DOI 10.1007/s00359-015-1046-z; ten Cate C, 1999, ADV STUD BEHAV, V28, P1; Terpstra NJ, 2006, J COMP NEUROL, V494, P784, DOI 10.1002/cne.20831; Terpstra NJ, 2004, J NEUROSCI, V24, P4971, DOI 10.1523/JNEUROSCI.0570-04.2004; Vyas A, 2009, HORM BEHAV, V55, P50, DOI 10.1016/j.yhbeh.2008.08.005; Whaling CS, 1997, P NATL ACAD SCI USA, V94, P12694, DOI 10.1073/pnas.94.23.12694; WILLIAMS H, 1990, ANIM BEHAV, V39, P745, DOI 10.1016/S0003-3472(05)80386-0; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062; Yanagihara S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11946; Yoder KM, 2015, DEV NEUROBIOL, V75, P302, DOI 10.1002/dneu.22231; YONEDA T, 1991, J ETHOL, V9, P41, DOI 10.1007/BF02350206	59	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0243811	10.1371/journal.pone.0243811	http://dx.doi.org/10.1371/journal.pone.0243811			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM1OE	33471804	gold, Green Published			2022-12-26	WOS:000639428800059
J	Karpe, SD; Tiwari, V; Ramanathan, S				Karpe, Snehal Dilip; Tiwari, Vikas; Ramanathan, Sowdhamini			InsectOR-Webserver for sensitive identification of insect olfactory receptor genes from non-model genomes	PLOS ONE			English	Article							HIDDEN MARKOV MODEL; TRANSMEMBRANE TOPOLOGY; ODORANT RECEPTORS; HONEY-BEE; PREDICTION; PROTEINS; SEQUENCE; DATABASE; FAMILY; SUPERFAMILY	Insect Olfactory Receptors (ORs) are diverse family of membrane protein receptors responsible for most of the insect olfactory perception and communication, and hence they are of utmost importance for developing repellents or pesticides. Accurate gene prediction of insect ORs from newly sequenced genomes is an important but challenging task. We have developed a dedicated webserver, 'insectOR', to predict and validate insect OR genes using multiple gene prediction algorithms, accompanied by relevant validations. It is possible to employ this server nearly automatically and perform rapid prediction of the OR gene loci from thousands of OR-protein-to-genome alignments, resolve gene boundaries for tandem OR genes and refine them further to provide more complete OR gene models. InsectOR outperformed the popular genome annotation pipelines (MAKER and NCBI eukaryotic genome annotation) in terms of overall sensitivity at base, exon and locus level, when tested on two distantly related insect genomes. It displayed more than 95% nucleotide level precision in both tests. Finally, given the same input data and parameters, InsectOR missed less than 2% gene loci, in contrast to 55% loci missed by MAKER for Drosophila melanogaster. The webserver is freely available on the web at http://caps.ncbs.res.in/insectOR/ and the basic package can be downloaded from https://github.com/sdk15/insectOR for local use. This tool will allow biologists to perform quick preliminary identification of insect olfactory receptor genes from newly sequenced genomes and also assist in their further detailed annotation. Its usage can also be extended to other divergent gene families.	[Karpe, Snehal Dilip; Tiwari, Vikas; Ramanathan, Sowdhamini] TIFR, Natl Ctr Biol Sci NCBS, Bengaluru, Karnataka, India; [Karpe, Snehal Dilip] Univ Libre Bruxelles, Inst Jules Bordet, Lab Expt Hematol, Brussels, Belgium; [Karpe, Snehal Dilip] Univ Liege, Unit Anim Genom, GIGA, Liege, Belgium	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Institut Jules Bordet; Universite Libre de Bruxelles; University of Liege	Ramanathan, S (corresponding author), TIFR, Natl Ctr Biol Sci NCBS, Bengaluru, Karnataka, India.	mini@ncbs.res.in	Karpe, Snehal/AAM-9841-2020	Karpe, Snehal/0000-0001-6062-7786	Shyama Prasad Mukherjee Fellowship from Council of Scientific and Industrial Research (CSIR), India; Bridging Postdoctoral Fellowship from National Centre for Biological Sciences (Tata Institute of Fundamental Research), India; JC Bose Fellowship from Science and Engineering Research Board, India [SB/S2/JC071/2015]	Shyama Prasad Mukherjee Fellowship from Council of Scientific and Industrial Research (CSIR), India; Bridging Postdoctoral Fellowship from National Centre for Biological Sciences (Tata Institute of Fundamental Research), India; JC Bose Fellowship from Science and Engineering Research Board, India	This work was funded by Shyama Prasad Mukherjee Fellowship from Council of Scientific and Industrial Research (CSIR), India and later Bridging Postdoctoral Fellowship from National Centre for Biological Sciences (Tata Institute of Fundamental Research), India for SDK; and JC Bose Fellowship (JC Bose fellowship (SB/S2/JC071/2015) from Science and Engineering Research Board, India for RS. The authors used the infrastructural facilities of National Centre for Biological Sciences (NCBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Burset M, 1996, GENOMICS, V34, P353, DOI 10.1006/geno.1996.0298; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; DAVIS EE, 1985, J MED ENTOMOL, V22, P237, DOI 10.1093/jmedent/22.3.237; Down TA, 2011, BIOINFORMATICS, V27, P889, DOI 10.1093/bioinformatics/btr020; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Grimmelikhuijzen CJP, 2007, PEST MANAG SCI, V63, P413, DOI 10.1002/ps.1352; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Karpe SD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11098-z; Karpe SD, 2016, GENOME BIOL EVOL, V8, P2879, DOI 10.1093/gbe/evw202; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim J, 2000, BIOINFORMATICS, V16, P767, DOI 10.1093/bioinformatics/16.9.767; Kim J, 2002, J CELL SCI, V115, P1107; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r93; Liu JD, 2014, MOL GENET GENOMICS, V289, P567, DOI 10.1007/s00438-014-0831-7; Miller R, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.5301; Missbach C, 2014, ELIFE, V3, DOI 10.7554/eLife.02115; Mogily S, 2020, CELL TISSUE RES, V379, P131, DOI 10.1007/s00441-019-03078-8; Montagne N, 2015, PROG MOL BIOL TRANSL, V130, P55, DOI 10.1016/bs.pmbts.2014.11.003; Nagarathnam B, 2014, BIOINFORM BIOL INSIG, V8, P147, DOI 10.4137/BBI.S14858; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Oppenheim S, 2020, GENOME BIOL EVOL, V12, P3677, DOI 10.1093/gbe/evz277; PELOSI P, 1990, CHEM SENSES, V15, P205, DOI 10.1093/chemse/15.2.205; Pennisi E., 2017, SCIENCE, DOI [10.1126/science.aal0824, DOI 10.1126/SCIENCE.AAL0824]; Pertea Geo, 2020, F1000Res, V9, P304, DOI 10.12688/f1000research.23297.1; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ray A, 2014, J BIOSCIENCES, V39, P555, DOI 10.1007/s12038-014-9447-7; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Robinson GE, 2011, SCIENCE, V331, P1386, DOI 10.1126/science.331.6023.1386; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Thibaud-Nissen F., 2013, NCBI HDB, V2nd, DOI DOI 10.1093/NAR/GKT1114; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Vizueta J, 2019, BITACORA COMPREHENSI, DOI 10.1101/593889; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107	54	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245324	10.1371/journal.pone.0245324	http://dx.doi.org/10.1371/journal.pone.0245324			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465132	gold, Green Submitted, Green Published			2022-12-26	WOS:000611969200001
J	Silver, D; Silva, TH				Silver, Daniel; Silva, Thiago H.			A Markov model of urban evolution: Neighbourhood change as a complex process	PLOS ONE			English	Article							SPATIAL DYNAMICS; CLASSIFICATION; ECOLOGY	This paper seeks to advance neighbourhood change research and complexity theories of cities by developing and exploring a Markov model of socio-spatial neighbourhood evolution in Toronto, Canada. First, we classify Toronto neighbourhoods into distinct groups using established geodemographic segmentation techniques, a relatively novel application in this geographic setting. Extending previous studies, we pursue a hierarchical approach to classifying neighbourhoods that situates many neighbourhood types within the city's broader structure. Our hierarchical approach is able to incorporate a richer set of types than most past research and allows us to study how neighbourhoods' positions within this hierarchy shape their trajectories of change. Second, we use Markov models to identify generative processes that produce patterns of change in the city's distribution of neighbourhood types. Moreover, we add a spatial component to the Markov process to uncover the extent to which change in one type of neighbourhood depends on the character of nearby neighbourhoods. In contrast to the few studies that have explored Markov models in this research tradition, we validate the model's predictive power. Third, we demonstrate how to use such models in theoretical scenarios considering the impact on the city's predicted evolutionary trajectory when existing probabilities of neighbourhood transitions or distributions of neighbourhood types would hypothetically change. Markov models of transition patterns prove to be highly accurate in predicting the final distribution of neighbourhood types. Counterfactual scenarios empirically demonstrate urban complexity: small initial changes reverberate throughout the system, and unfold differently depending on their initial geographic distribution. These scenarios show the value of complexity as a framework for interpreting data and guiding scenario-based planning exercises.	[Silver, Daniel] Univ Toronto, Sociol, Toronto, ON, Canada; [Silva, Thiago H.] Univ Toronto, Sch Cities, Toronto, ON, Canada; [Silva, Thiago H.] Univ Tecnol Fed Parana, Informat, Curitiba, Parana, Brazil	University of Toronto; University of Toronto; Pontificia Universidade Catolica do Parana; Universidade Federal do Parana; Universidade Tecnologica Federal do Parana	Silver, D (corresponding author), Univ Toronto, Sociol, Toronto, ON, Canada.	dan.silver@utoronto.ca	Silva, Thiago H/AFE-1930-2022	Silva, Thiago H/0000-0001-6994-8076	Connaught Global Challenge Award; School of Cities Urban Challenge Fund; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) [001]; Sao Paulo Research Foundation - FAPESP GoodWeb [2018/23011-1]	Connaught Global Challenge Award; School of Cities Urban Challenge Fund; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation - FAPESP GoodWeb(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	DS is supported by a Connaught Global Challenge Award, and the School of Cities Urban Challenge Fund. THS is supported by Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior Brasil (CAPES) - (Grant -Finance Code 001), https://www.capes.gov.br.THS is supported by Sao Paulo Research Foundation - FAPESP GoodWeb (Grant #2018/23011-1), http://www.fapesp.br.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 1997, SOC FORCES, V75, P1149, DOI 10.2307/2580667; Abdul Qadeer M., 2016, MULTICULTURAL CITIES; Allen J, 2018, CAN GEOGR-GEOGR CAN, V62, P575, DOI 10.1111/cag.12467; [Anonymous], 1996 2016 CENS CAN; Arribas-Bel D, 2018, ENVIRON PLAN B-URBAN, V45, P1142, DOI 10.1177/2399808318783748; Batey P, 1995, GIS BUSINESS SERVICE, P150; Batty M., 2005, CITIES COMPLEXITY UN; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Bergman Peter, 2019, WORKING PAPER SERIES, DOI DOI 10.3386/W26164; Berry B. J. L., 1970, GEOGRAPHIC PERSPECTI; Beveridge AA, 2011, INT STUD POPUL, V9, P185, DOI 10.1007/978-94-007-0068-0_8; Bickenbach F, 2003, INT REGIONAL SCI REV, V26, P363, DOI 10.1177/0160017603253789; Bois D, 2007, PHILADELPHIA NEGRO; Bourne LS, 2004, DELA, P97, DOI [10.4312/dela.21.7.97-107, DOI 10.4312/DELA.21.7.97-107]; Burgess E.W., 1925, CITY, P47; Cornwell B., 2015, SOCIAL SEQUENCE ANAL, V37; Davies W. K. D., 1984, FACTORIAL ECOLOGY; Delmelle E, 2016, ANN REGIONAL SCI, V56, P687, DOI 10.1007/s00168-015-0735-4; Delmelle EC, 2016, ANN AM ASSOC GEOGR, V106, P36, DOI 10.1080/00045608.2015.1096188; Delmelle EC, 2015, APPL GEOGR, V57, P1, DOI 10.1016/j.apgeog.2014.12.002; Delmelle EC, 2014, ENVIRON PLANN A, V46, P867, DOI 10.1068/a46161; Dias F, 2021, GEOGR ANAL, V53, P170, DOI 10.1111/gean.12224; Doering J, 2021, URBAN AFF REV, V57, P911, DOI 10.1177/1078087420940789; Florida R., 2002, RISE CREATIVE CLASS; Florida R., 2014, DIVIDED CITY SHAPE N; Galster GC, 2000, HOUS POLICY DEBATE, V11, P701; Galster GeorgeC., 2019, MAKING OUR NEIGHBORH; Harris R, 2007, POPUL RES POLICY REV, V26, P553, DOI 10.1007/s11113-007-9042-9; Harvey David, 1973, SOCIAL JUSTICE CITY; Hoover E, 1962, ANATOMY METROPOLIS G; Hoyt H, 2000, 100 YEARS LAND VALUE; HUGHES HL, 1993, AM SOCIOL REV, V58, P417, DOI 10.2307/2095909; Hulchanski J. D., 2011, 3 CITIES TORONTO INC; HUNTER AA, 1972, DEMOGRAPHY, V9, P107, DOI 10.2307/2060548; Kang W, 2020, COMPUT ENVIRON URBAN, V81, DOI 10.1016/j.compenvurbsys.2020.101480; Knox P. L., 1994, URBANIZATION INTRO U; Lee ACD, 2015, HABITAT INT, V45, P92, DOI 10.1016/j.habitatint.2014.06.027; MacDonnell S., 2004, POVERTY POSTAL CODE; Marshall S., 2012, COMPLEXITY THEORIES, P191; Mikelbank BA, 2011, URBAN GEOGR, V32, P317, DOI 10.2747/0272-3638.32.3.317; Morenoff JD, 1997, ANN AM ACAD POLIT SS, V551, P59, DOI 10.1177/0002716297551001005; Oksendal Bernt, 2013, SIAM REV; Olson AW, 2021, GEOGR ANAL, V53, P192, DOI 10.1111/gean.12252; Openshaw, 1995, GIS BUSINESS SERVICE, P150; Owens B.R., 2012, AM SOCIOL, V43, P264, DOI [10.1007/s12108-012-9160-7, DOI 10.1007/S12108-012-9160-7]; Park RobertE., 2019, CITY; Penn A, 2017, ENVIRON PLAN B-URBAN, V44, P197, DOI 10.1177/2399808317693478; Perle ED, 1981, URBAN GEOGRAPHY, V2, P237, DOI [10.2747/0272-3638.2.3.237, DOI 10.2747/0272-3638.2.3.237]; Petramala D, 2020, TORONTO NOW FASTEST; Portugali J, 2012, SPRINGER COMPLEXITY; Portugali Juval, 2000, SPRINGER SERIES SYNE; Pumain D., 2012, COMPLEXITY THEORIES, P91, DOI [10.1007/978-3-642-24544-2_6, DOI 10.1007/978-3-642-24544-2_6]; Reibel M, 2011, URBAN GEOGR, V32, P305, DOI 10.2747/0272-3638.32.3.305; Rey SJ, 2001, GEOGR ANAL, V33, P195; Santos FA, 2020, SOCIAL NETWORK ANAL, Vx; Shevky Eshref., 1955, SOCIAL AREA ANAL THE; Sijmons D, 2012, COMPLEXITY THEORIES, P281, DOI DOI 10.1007/978-3-642-24544-2_16; Singleton AD, 2009, APPL GEOGR, V29, P289, DOI 10.1016/j.apgeog.2008.10.006; Tan E., 2012, COMPLEXITY THEORIES, P369, DOI DOI 10.1007/978-3-642-24544-2_20; Tan PN., 2016, INTRO DATA MINING; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vicino TJ, 2008, HOUS POLICY DEBATE, V19, P479, DOI 10.1080/10511482.2008.9521644; Walks A, 2016, INCOME INEQUALITY PO, V238; Walks R. A., 2008, TIMING PATTERNING FO; Walks RA, 2001, URBAN STUD, V38, P407, DOI 10.1080/00420980120027438; Wang Q, 2018, P NATL ACAD SCI USA, V115, P7735, DOI 10.1073/pnas.1802537115; Wei F, 2014, URBAN AFF REV, V50, P459, DOI 10.1177/1078087413501640; Williamson T, 2005, J COMMUNITY APPL SOC, V15, P203, DOI 10.1002/casp.817; Wright EI, 2002, ATLANTA SOCIOLOGICAL, V26; Wyly EK, 1999, ECON GEOGR, V75, P309, DOI 10.2307/144475; Yamu C, 2014, DISP, V50, P43, DOI 10.1080/02513625.2014.1007662; Zamenopoulos T, 2012, AI EDAM, V26, P63, DOI 10.1017/S0890060411000023; Zhang WJ, 2017, COMPUT ENVIRON URBAN, V66, P117, DOI 10.1016/j.compenvurbsys.2017.08.004	74	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245357	10.1371/journal.pone.0245357	http://dx.doi.org/10.1371/journal.pone.0245357			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4XD	33449942	Green Published, gold, Green Submitted			2022-12-26	WOS:000609991600044
J	Freitas, RF; Rocha, JSB; Santos, LI; Pinto, ALDB; Moreira, MHR; de Oliveira, FPSL; Marques, MS; Guerra, GES; Guerra, KDDS; Drummond, AMA; Spelta, JVVB; Trovao, CAM; Franca, DS; Oliveira, LB; Caldeira, AP; D'Angelo, MFSV				Ferreira Freitas, Ronilson; Santos Brant Rocha, Josiane; Ives Santos, Laercio; de Carvalho Braule Pinto, Andre Luiz; Rodrigues Moreira, Maria Helena; Piana Santos Lima de Oliveira, Fernanda; Marques, Maria Suzana; Guerra Junior, Geraldo Edson Souza; de Oliveira Silva Guerra, Kelma Dayana; Araujo Drummond, Andreia Maria; Villas Boas Spelta, Joao Victor; Ananias Meira Trovao, Carolina; Schmidt Franca, Dorothea; Borges Oliveira, Lanuza; Prates Caldeira, Antonio; Silveira Vasconcelos D'Angelo, Marcos Flavio			Validity and precision of the International Physical Activity Questionnaire for climacteric women using computational intelligence techniques	PLOS ONE			English	Article							QUALITY-OF-LIFE; POSITION STATEMENT; COEFFICIENT ALPHA; HEALTH; EXERCISE; MEDICINE; ADULTS	This study aimed to evaluate the validity and precision of the International Physical Activity Questionnaire (IPAQ) for climacteric women using computational intelligence techniques. The instrument was applied to 873 women aged between 40 and 65 years. Considering the proposal to regroup the set of data related to the level of physical activity of climacteric women using the IPAQ, we used 2 algorithms: Kohonen and k-means, and, to evaluate the validity of these clusters, 3 indexes were used: Silhouette, PBM and Dunn. The questionnaire was tested for validity (factor analysis) and precision (Cronbach's alpha). The Random Forests technique was used to assess the importance of the variables that make up the IPAQ. To classify these variables, we used 3 algorithms: Suport Vector Machine, Artificial Neural Network and Decision Tree. The results of the tests to evaluate the clusters suggested that what is recommended for IPAQ, when applied to climacteric women, is to categorize the results into two groups. The factor analysis resulted in three factors, with factor 1 being composed of variables 3 to 6; factor 2 for variables 7 and 8; and factor 3 for variables 1 and 2. Regarding the reliability estimate, the results of the standardized Cronbach's alpha test showed values between 0.63 to 0.85, being considered acceptable for the construction of the construct. In the test of importance of the variables that make up the instrument, the results showed that variables 1 and 8 presented a lesser degree of importance and by the analysis of Accuracy, Recall, Precision and area under the ROC curve, there was no variation when the results were analyzed with all IPAQ variables but variables 1 and 8. Through this analysis, we concluded that the IPAQ, short version, has adequate measurement properties for the investigated population.	[Ferreira Freitas, Ronilson; Santos Brant Rocha, Josiane; Ives Santos, Laercio; Marques, Maria Suzana; de Oliveira Silva Guerra, Kelma Dayana; Schmidt Franca, Dorothea; Borges Oliveira, Lanuza; Prates Caldeira, Antonio; Silveira Vasconcelos D'Angelo, Marcos Flavio] Univ Estadual Montes Claros, Montes Claros, MG, Brazil; [Santos Brant Rocha, Josiane; Piana Santos Lima de Oliveira, Fernanda; Marques, Maria Suzana; Guerra Junior, Geraldo Edson Souza; Ananias Meira Trovao, Carolina; Schmidt Franca, Dorothea; Borges Oliveira, Lanuza; Prates Caldeira, Antonio] Fipmoc Univ Ctr, Montes Claros, MG, Brazil; [de Carvalho Braule Pinto, Andre Luiz] Univ Sao Paulo, Ribeirao Preto, SP, Brazil; [Rodrigues Moreira, Maria Helena] Univ Tras Montes & Alto Douro, Vila Real, Portugal; [Araujo Drummond, Andreia Maria] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Villas Boas Spelta, Joao Victor] Univ Fed Rio Grande do Norte, Natal, RN, Brazil	Universidade Estadual de Montes Claros; Universidade de Sao Paulo; University of Tras-os-Montes & Alto Douro; Universidade Federal de Minas Gerais; Universidade Federal do Rio Grande do Norte	de Oliveira, FPSL (corresponding author), Fipmoc Univ Ctr, Montes Claros, MG, Brazil.	fernandapiana@gmail.com		Piana Santos Lima de Oliveira, Fernanda/0000-0002-8826-6852; Santos Brant Rocha, Josiane/0000-0002-7317-3880; Ives Santos, Laercio/0000-0001-6504-7692; Araujo Drummond, Andreia Maria/0000-0003-4161-5602; Souza Guerra Junior, Geraldo Edson/0000-0001-5755-0968				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Almeida VP, 2019, J BODYW MOV THER, V23, P494, DOI 10.1016/j.jbmt.2018.05.005; American College of Sports Medicine, 1998, REV BRAS MED ESPORTE, V4, P96, DOI [10.1590/S1517-86921998000300005, DOI 10.1590/S1517-86921998000300005, 10.1590/S1517-869219980, DOI 10.1590/S1517-869219980]; American College of Sports Medicine, 2009, ACSMS GUIDELINES EXE; Andrade MV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201723; [Anonymous], 2001, AL ASALA, V6, P5; BARETTA E, 2007, CAD SAUDE PUBLICA, V23, P1595, DOI DOI 10.1590/S0102-311X2007000700010; Beaulieu K, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0473-3; Benedetti T., 2016, REV BRAS ATIV FIS SA, V21, P144, DOI [10.12820/rbafs.v.21n2p144-153, DOI 10.12820/RBAFS.V.21N2P144-153]; Benedetti Tânia R. Bertoldo, 2007, Rev Bras Med Esporte, V13, P11, DOI 10.1590/S1517-86922007000100004; Benedetti TB, 2004, REV BRAS CIENC MOV, V12, P25, DOI DOI 10.18511/RBCM.V12I1.538; Bird Stephen R, 2016, BMJ Open Sport Exerc Med, V2, pe000143, DOI 10.1136/bmjsem-2016-000143; Bishop C.M., 2006, PATTERN RECOGN, V4; Bondarev D, 2018, MENOPAUSE, V25, P1432, DOI 10.1097/GME.0000000000001137; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caputo EL, 2014, REV BRAS REUMATOL, V54, P467, DOI 10.1016/j.rbr.2014.02.008; Colberg SR, 2016, DIABETES CARE, V39, P2065, DOI 10.2337/dc16-1728; Colpani V, 2014, REV SAUDE PUBL, V48, P258, DOI 10.1590/S0034-8910.2014048004765; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dabrowska-Galas M, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55080466; Davis SR, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.4; de Souza IL, 2014, EPIDEMIOL SERV SAUDE, V23, P623, DOI 10.5123/S1679-49742014000400004; Duda R.O., 2000, PATTERN CLASSIFICATI; ESGCT, 2019, HUM GENE THER, V30, pA1; Faceli K., 2011, INTELIGENCIA ARTIFIC; Figueiredo Filho Dalson Brito, 2010, Opin. Publica, V16, P160, DOI 10.1590/S0104-62762010000100007; Furr R. M., 2017, PSYCHOMETRICS INTRO; Garcia LMT, 2013, REV BRAS ATIVIDADE F, V18, P317, DOI [10.12820/RBAFS.V.18N3P317, DOI 10.12820/RBAFS.V.18N3P317]; Guedes Dartagnan Pinto, 2005, Rev Bras Med Esporte, V11, P151, DOI 10.1590/S1517-86922005000200011; Hair J.F., 2010, MULTIVARIANT DATA AN, V7th; Halkidi M, 2002, SIGMOD RECORD, V31, P40, DOI 10.1145/565117.565124; Hallal PC, 2010, J PHYS ACT HEALTH, V7, pS259, DOI 10.1123/jpah.7.s2.s259; Klein SK, 2018, CIENC SAUDE COLETIVA, V23, P1521, DOI 10.1590/1413-81232018235.13432016; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Lima Mario Flávio Cardoso de, 2019, Rev. Bras. Ciênc. Esporte, V41, P233, DOI 10.1016/j.rbce.2018.03.019; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Markus, 2000, REV BRAS CIENC MOV, V8, P23; Marlatt KL, 2018, MATURITAS, V116, P36, DOI 10.1016/j.maturitas.2018.07.014; Martinez-Ferran M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061549; Melanson EL, 1996, CRIT REV FOOD SCI, V36, P385, DOI 10.1080/10408399609527732; Mengesha MM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7465-y; Moilanen JM, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-8; Morardpour F, 2020, MENOPAUSE, V27, P230, DOI 10.1097/GME.0000000000001441; Mostary KF, 2018, BANGLADES MED J, V47, P11, DOI [10.3329/bmj.v47i1.42818, DOI 10.3329/BMJ.V47I1.42818]; Oliveira Daniel Vicentini de, 2019, Fisioter. mov., V32, pe003238, DOI 10.1590/1980-5918.032.ao38; Pakhira MK, 2004, PATTERN RECOGN, V37, P487, DOI 10.1016/j.patcog.2003.06.005; Pardini R, 2001, REV BRAS CIEN MOV, V9, P45, DOI DOI 10.18511/RBCM.V9I3.393; Pasquali, 1997, PSICOMETRIA TEORIAS; Pasquali L, 2009, REV ESC ENFERM USP, V43, P992, DOI 10.1590/S0080-62342009000500002; Pinto Lélia Lessa Teixeira, 2014, Rev. bras. geriatr. gerontol., V17, P819, DOI 10.1590/1809-9823.2014.13204; PRAAGMAN J, 1985, EUR J OPER RES, V19, P144, DOI 10.1016/0377-2217(85)90321-2; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Salas-Gomez D, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00011; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Scarpel Rodrigo Arnaldo, 2007, Pesqui. Oper., V27, P85, DOI 10.1590/S0101-74382007000100005; Schaeffer SE, 2007, COMPUT SCI REV, V1, P27, DOI 10.1016/j.cosrev.2007.05.001; Seidelin K, 2017, MED SCI SPORT EXER, V49, P96, DOI 10.1249/MSS.0000000000001071; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; Silva Glauber dos Santos Ferreira da, 2007, Rev Bras Med Esporte, V13, P39, DOI 10.1590/S1517-86922007000100009; Silvestri R, 2019, MATURITAS, V129, P30, DOI 10.1016/j.maturitas.2019.08.006; Sociedade Norte-Americana da Menopausa (NAMS), 2013, TRAD PEL SOBRAC ASS; Guerra GES, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211617; Sporndly-Nees S, 2017, SLEEP MED, V32, P22, DOI 10.1016/j.sleep.2016.03.017; Sternfeld B, 2011, OBSTET GYN CLIN N AM, V38, P537, DOI 10.1016/j.ogc.2011.05.008; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Sylow L, 2019, CURR OPIN PHYSIOL, V12, P12, DOI 10.1016/j.cophys.2019.04.008; Szwarcwald Célia Landmann, 2008, Rev. bras. epidemiol., V11, P38, DOI 10.1590/S1415-790X2008000500004; Valim MD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005975; Zbinden-Foncea H, 2020, OBESITY, V28, P1378, DOI 10.1002/oby.22849	71	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245240	10.1371/journal.pone.0245240	http://dx.doi.org/10.1371/journal.pone.0245240			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4VV	33444409	gold, Green Published			2022-12-26	WOS:000609988100052
J	Zhang, YQ; Li, H; Wu, HH; Zong, XN				Zhang, Ya-Qin; Li, Hui; Wu, Hua-Hong; Zong, Xin-Nan			Stunting, wasting, overweight and their coexistence among children under 7 years in the context of the social rapidly developing: Findings from a population-based survey in nine cities of China in 2016	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; CHILDHOOD DUAL BURDEN; PHYSICAL GROWTH; PREVALENCE; OBESITY; UNDERNUTRITION; MALNUTRITION; ADOLESCENTS; HEALTH; TRENDS	The prevalence of stunting, wasting, overweight and their coexistence are various in different populations and they also have changed with social developing and environmental improving. In this paper, we aimed to analyze the prevalence of stunting, wasting, overweight and their coexistence in some developed regions of China. Data were collected in a population-based cross-sectional survey by a multi-stage cluster sampling method in nine cities located in the northern, central, and southern region of China in 2016. Children under seven years (n = 110,491) were measured. WHO growth standards were used to assess the growth status. Stunting, underweight, wasting, overweight and obesity were considered as the primary forms of malnutrition (includes undernutrition and overnutrition) for infant or young children at population-levels. The prevalence of stunting, underweight, wasting, and overweight or obesity were respectively 0.7%, 0.6%, 1.2%, and 7.6%. Most of these children (95.4%) suffered from one form of malnutrition, and only 0.2% of them concurrently stunted and wasted, 0.4% concurrently stunted and overweight, 1.7% concurrently stunted and underweight, 2.3% concurrently underweight and wasted. Among stunted children, 91.2% were appropriate body proportion, and only 2.3% were wasted, 6.5% were overweight or obesity. Among overweight or obese children, only 0.6% were stunted, whereas, 15.8% were high stature and 83.6% were the appropriate ranges of stature. Sex, age, urban/suburban, and region were associated with these primary forms of malnutrition in the multivariate logistic analysis. In conclusion, we found that the coexistence of stunting and overweight was not common at both population-level and individual-level. The situation for undernutrition had significantly improved, and overweight may be the leading public health issue for children under seven years in the nine cities of China.	[Zhang, Ya-Qin; Li, Hui; Wu, Hua-Hong; Zong, Xin-Nan] Capital Inst Pediat, Dept Growth & Dev, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP)	Li, H (corresponding author), Capital Inst Pediat, Dept Growth & Dev, Beijing, Peoples R China.	huiligrowth@163.com			National Health Commission of the People's Republic of China	National Health Commission of the People's Republic of China	The survey was supported by National Health Commission of the People's Republic of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atalah E, 2014, AM J CLIN NUTR, V100, p1623S, DOI 10.3945/ajcn.114.083790; Ban L, 2017, INT J PUBLIC HEALTH, V62, P143, DOI 10.1007/s00038-016-0844-6; Bates K, 2017, J EPIDEMIOL COMMUN H, V71, P779, DOI 10.1136/jech-2017-209008; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; de Onis M, 2019, PUBLIC HEALTH NUTR, V22, P175, DOI 10.1017/S1368980018002434; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Hug L., 2020, LEVELS TRENDS CHILD; Initiatives Development, 2018, 2018 GLOB NUTR REP S; Juliusson PB, 2011, ARCH DIS CHILD, V96, P916, DOI 10.1136/adc.2009.166157; Kang Y, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12653; Khara T, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12516; Knai C, 2007, ECON HUM BIOL, V5, P392, DOI 10.1016/j.ehb.2007.08.002; Martorell R, 2000, INT J OBESITY, V24, P959, DOI 10.1038/sj.ijo.0801264; Natale V, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003735; National Bureau of Statistics of China, 2017, CHIN STAT YB 2017; Nshimyiryo A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6504-z; Ogden CL, 2018, JAMA-J AM MED ASSOC, V319, P2410, DOI 10.1001/jama.2018.5158; Rosario AS, 2011, ANN HUM BIOL, V38, P121, DOI 10.3109/03014460.2010.521193; Saaka M, 2016, J NUTR METAB, V2016, DOI 10.1155/2016/4654920; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; Schooling C M, 2013, Hong Kong Med J, V19 Suppl 9, P30; Tzioumis E, 2016, PUBLIC HEALTH NUTR, V19, P1375, DOI 10.1017/S1368980016000276; Tzioumis E, 2014, FOOD NUTR BULL, V35, P230, DOI 10.1177/156482651403500210; Undurraga EA, 2018, AM J HUM BIOL, V30, DOI 10.1002/ajhb.23059; United Nations Children's Fund (Unicef) The World Health Organization The International Bank for Reconstruction and Development/The World Bank, 2018, LEV TRENDS CHILD MAL; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Vonaesch P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182363; Wang XL, 2009, PUBLIC HEALTH NUTR, V12, P1991, DOI 10.1017/S1368980009990796; Williams AM, 2017, PEDIATR CLIN N AM, V64, P755, DOI 10.1016/j.pcl.2017.03.001; Wu HH, 2018, ACTA PAEDIATR, V107, P1555, DOI 10.1111/apa.14302; Yackobovitch-Gavan M, 2017, HORM RES PAEDIAT, V88, P63, DOI 10.1159/000456662; Yokoya M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210265; Yokoya M, 2016, AM J HUM BIOL, V28, P789, DOI 10.1002/ajhb.22867; Yu D M, 2018, Zhonghua Liu Xing Bing Xue Za Zhi, V39, P710, DOI 10.3760/cma.j.issn.0254-6450.2018.06.003; Yu DM, 2016, BIOMED ENVIRON SCI, V29, P165, DOI 10.3967/bes2016.021; Zhang YQ, 2017, AM J PHYS ANTHROPOL, V163, P497, DOI 10.1002/ajpa.23224; Zhang Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204142; Zong XN, 2014, B WORLD HEALTH ORGAN, V92, P555, DOI 10.2471/BLT.13.126243; Zong XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059569; Zong XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046942	43	7	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245455	10.1371/journal.pone.0245455	http://dx.doi.org/10.1371/journal.pone.0245455			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444425	gold, Green Published			2022-12-26	WOS:000609988100020
J	Hasan, ATMH; Das, SC; Islam, MS; Mansur, M; Shawon, MSR; Hassan, R; Chowdhury, MSJH; Mondal, MBA; Mohammad, QD				Hasan, A. T. M. Hasibul; Das, Subir Chandra; Islam, Muhammad Sougatul; Mansur, Mohaimen; Shawon, Md. Shajedur Rahman; Hassan, Rashedul; Chowdhury, Mohammad Shah Jahirul Hoque; Mondal, Md. Badrul Alam; Mohammad, Quazi Deen			Impact of COVID-19 on hospital admission of acute stroke patients in Bangladesh	PLOS ONE			English	Article								Background With the proposed pathophysiologic mechanism of neurologic injury by SARS CoV-2, the frequency of stroke and henceforth the related hospital admissions were expected to rise. This paper investigated this presumption by comparing the frequency of admissions of stroke cases in Bangladesh before and during the pandemic. Methods This is a retrospective analysis of stroke admissions in a 100-bed stroke unit at the National Institute of Neurosciences and Hospital (NINS&H) which is considerably a large stroke unit. All the admitted cases from 1 January to 30 June 2020 were considered. Poisson regression models were used to determine whether statistically significant changes in admission rates can be found before and after 25 March since when there is a surge in COVID-19 infections. Results A total of 1394 stroke patients took admission in the stroke unit during the study period. Half of the patients were older than 60 years, whereas only 2.6% were 30 years old or younger. The male to female ratio is 1.06:1. From January to March 2020, the mean rate of admission was 302.3 cases per month, which dropped to 162.3 cases per month from April to June, with an overall reduction of 46.3% in acute stroke admission per month. In those two periods, reductions in average admission per month for ischemic stroke (IST), intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH) and venous stroke (VS) were 45.5%, 37.2%, 71.4% and 39.0%, respectively. Based on weekly data, results of Poisson regressions confirm that the average number of admissions per week dropped significantly during the last three months of the sample period. Further, in the first three months, a total of 22 cases of hyperacute stroke management were done, whereas, in the last three months, there was an 86.4% reduction in the number of hyperacute stroke patients getting reperfusion treatment. Only 38 patients (2.7%) were later found to be RT-PCR SARS Cov-2 positive based on nasal swab testing. Conclusion This study revealed a more than fifty percent reduction in acute stroke admission during the COVID-19 pandemic. Whether the reduction is related to the fear of getting infected by COVID-19 from hospitalization or the overall restriction on public movement or stay-home measures remains unknown.	[Hasan, A. T. M. Hasibul; Das, Subir Chandra; Chowdhury, Mohammad Shah Jahirul Hoque; Mondal, Md. Badrul Alam; Mohammad, Quazi Deen] Natl Inst Neurosci & Hosp, Dept Neurol, Dhaka, Bangladesh; [Islam, Muhammad Sougatul] BioTED, Dhaka, Bangladesh; [Mansur, Mohaimen] Univ Dhaka, Inst Stat Res & Training, Dhaka, Bangladesh; [Shawon, Md. Shajedur Rahman] UNSW Med, Ctr Big Data Res Hlth, Sydney, NSW, Australia; [Hassan, Rashedul] Green Life Med Coll & Hosp, Dept Med, Dhaka, Bangladesh	University of Dhaka	Hasan, ATMH (corresponding author), Natl Inst Neurosci & Hosp, Dept Neurol, Dhaka, Bangladesh.	parag007us@gmail.com	Mansur, Mohaimen/GVS-8367-2022					Al Saiegh F, 2020, J NEUROL NEUROSUR PS, V91, P846, DOI 10.1136/jnnp-2020-323522; Bersano A, 2020, NEUROLOGY, V94, P905, DOI 10.1212/WNL.0000000000009508; Beyrouti R, 2020, J NEUROL NEUROSUR PS, V91, P889, DOI 10.1136/jnnp-2020-323586; Campiglio L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238159; Cao JL, 2020, CLIN INFECT DIS, V71, P748, DOI 10.1093/cid/ciaa243; Carod-Artal FJ, 2020, REV NEUROLOGIA, V70, P311, DOI 10.33588/rn.7009.2020179; Dhand A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09073-5; Health Services DG, 2020, COR VIR INF 16 AUG 2; Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597; Hoyer C, 2020, STROKE, V51, P2224, DOI 10.1161/STROKEAHA.120.030395; Jillella DV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239443; Majidi S, 2020, STROKE, V51, P2656, DOI 10.1161/STROKEAHA.120.030397; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Mathews P., 2010, SAMPLE SIZE CALCULAT; Muhammad S, 2020, BRAIN BEHAV IMMUN, V87, P150, DOI 10.1016/j.bbi.2020.05.015; Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787; Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187; Qin C, 2020, STROKE, V51, P2219, DOI 10.1161/STROKEAHA.120.030365; Qureshi AI, 2020, INT J STROKE, V15, P540, DOI 10.1177/1747493020923234; Sharifi-Razavi A, 2020, NEW MICROB NEW INFEC, V35, DOI 10.1016/j.nmni.2020.100669; Siepmann T, 2021, EUR J NEUROL, V28, P238, DOI 10.1111/ene.14535; Stohr E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242653; WHO, 2020, 16 WHO; Yaghi S, 2020, STROKE, V51, P2002, DOI 10.1161/STROKEAHA.120.030335	24	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0240385	10.1371/journal.pone.0240385	http://dx.doi.org/10.1371/journal.pone.0240385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439890	Green Submitted, Green Published, gold			2022-12-26	WOS:000609985300054
J	Chen, WJ; Hirwa, H; Ohland, J; Taskesen, T; Mikolajczak, U; Pareek, D; Parisi, J; Gutay, L				Chen, Wenjian; Hirwa, Hippolyte; Ohland, Joerg; Taskesen, Teoman; Mikolajczak, Ulf; Pareek, Devendra; Parisi, Juergen; Guetay, Levent			SiOxNy back-contact barriers for CZTSe thin-film solar cells	PLOS ONE			English	Article							INTERFACE	The formation of molybdenum diselenide (MoSe2) is widely observed at the back-contact interface for copper zinc tin selenide (CZTSe) thin-film solar cells. Depending on individual selenium (Se) supply and thermal conditions for forming CZTSe absorbers on molybdenum (Mo) substrates, the thickness of MoSe2 can vary from a few hundreds of nanometers up to approximate to 1 mu m, which is comparable to the commonly adopted thickness of 1 similar to 1.5 mu m for CZTSe absorbers. In this study, for controlling the thickness of interfacial MoSe2, thin diffusion barrier layers of silicon oxynitride (SiOxNy) are deposited onto Mo layers prior to the growth of CZTSe absorbers in the fabrication process. As a result, a reduction in the thicknesses of MoSe2 layers is achieved. In terms of energy conversion efficiency (eta), CZTSe solar cells grown on Mo/SiOxNy back contacts suffer a deterioration as the SiOxNy layers get thicker. CZTSe solar cells grown on Mo/SiOxNy/Mo back contacts preserve their efficiencies at approximate to 11% with thin 10 nm SiOxNy layers.	[Chen, Wenjian; Hirwa, Hippolyte; Ohland, Joerg; Taskesen, Teoman; Mikolajczak, Ulf; Pareek, Devendra; Parisi, Juergen; Guetay, Levent] Carl von Ossietzky Univ Oldenburg, Inst Phys, Lab Chalcogenide Photovolta, Energy & Semicond Res Lab, Oldenburg, Lower Saxony, Germany	Carl von Ossietzky Universitat Oldenburg	Chen, WJ (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Phys, Lab Chalcogenide Photovolta, Energy & Semicond Res Lab, Oldenburg, Lower Saxony, Germany.	wenjian.chen@uni-oldenburg.de	Pareek, Devendra/T-7646-2018	Pareek, Devendra/0000-0001-7231-6686	German Ministry of Education and Science (BMBF) [03SF0530A]	German Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF))	Wenjian Chen and Teoman Taskesen received funding from German Ministry of Education and Science (BMBF), Grant No. 03SF0530A ("Free-Inca").The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, RHEUMATOLOGY, V54, pii5; Balaji N, 2016, RSC ADV, V6, P70040, DOI 10.1039/c6ra11043f; Brammertz G, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826448; Chen WJ, 2019, RSC ADV, V9, P26850, DOI 10.1039/c9ra02847a; Delbos S, 2012, EPJ PHOTOVOLT, V3, DOI 10.1051/epjpv/2012008; Eisenbarth T, 2010, J APPL PHYS, V107, DOI 10.1063/1.3277043; Freeze J, 2018, PROCEEDINGS OF THE 51ST ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES (HICSS), P913; Grini S, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201900740; Herberholz R, 1998, J APPL PHYS, V83, P318, DOI 10.1063/1.366686; Lancet Global Health, 2019, LANCET GLOBAL HLTH, V7, pe1; Li JJ, 2020, ADV MATER, V32, DOI 10.1002/adma.202005268; Li JJ, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201402178; Liu FY, 2017, NPG ASIA MATER, V9, DOI 10.1038/am.2017.103; Nakamura M, 2019, IEEE J PHOTOVOLT, V9, P1863, DOI 10.1109/JPHOTOV.2019.2937218; Ohland J, 2015, PLASMA CIGS ENTWICKL, P26; Oueslati S, 2015, J PHYS D APPL PHYS, V48, DOI 10.1088/0022-3727/48/3/035103; Schnabel T, 2017, SOL ENERG MAT SOL C, V159, P290, DOI 10.1016/j.solmat.2016.09.029; Shi Y, 2019, MICROMACHINES-BASEL, V10, DOI 10.3390/mi10080552; Shin B, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4740276; Siebentritt S, 2012, PROG PHOTOVOLTAICS, V20, P512, DOI 10.1002/pip.2156; Taskesen T, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201703295; Walter T, 1996, J APPL PHYS, V80, P4411, DOI 10.1063/1.363401; Wang W, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301465; Yan C, 2018, NAT ENERGY, V3, P764, DOI 10.1038/s41560-018-0206-0; Yang KJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10890-x	25	0	0	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245390	10.1371/journal.pone.0245390	http://dx.doi.org/10.1371/journal.pone.0245390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434239	gold, Green Published			2022-12-26	WOS:000609979700047
J	Mailloux, C; Beaulieu, LD; Wideman, TH; Masse-Alarie, H				Mailloux, Catherine; Beaulieu, Louis-David; Wideman, Timothy H.; Masse-Alarie, Hugo			Within-session test-retest reliability of pressure pain threshold and mechanical temporal summation in healthy subjects	PLOS ONE			English	Article							LOW-BACK-PAIN; CENTRAL SENSITIZATION; MODULATION; EXERCISE; SENSITIVITY; INDIVIDUALS; PARAMETERS; HYPOALGESIA; PROTOCOL; PEOPLE	Objective To determine the absolute and relative intra-rater within-session test-retest reliability of pressure pain threshold (PPT) and mechanical temporal summation of pain (TSP) at the low back and the forearm in healthy participants and to test the influence of the number and sequence of measurements on reliability metrics. Methods In 24 participants, three PPT and TSP measures were assessed at four sites (2 at the low back, 2 at the forearm) in two blocks of measurements separated by 20 minutes. The standard error of measurement, the minimal detectable change (MDC) and the intraclass correlation coefficient (ICC) were investigated for five different sequences of measurements (e.g. measurement 1, 1-2, 1-2-3). Results The MDC for the group (MDCgr) for PPT ranged from 28.71 to 50.56 kPa across the sites tested, whereas MDCgr for TSP varied from 0.33 to 0.57 out of 10 (numeric scale). Almost all ICC showed an excellent relative reliability (between 0.80 and 0.97), except when only the first measurement was considered (moderate). Although minimal differences in absolute PPT reliability were present between the different sequences, in general, using only the first measurement increase measurement error. Three TSP measures reduced the measurement error. Discussion We established that two measurements of PPT and three of TSP reduced the measurement error and demonstrated an excellent relative reliability. Our results could be used in future pain research to confirm the presence of true hypo/hyperalgesia for paradigms such as conditioned pain modulation or exercise-induced hypoalgesia, indicated by a change exceeding the measurement variability.	[Mailloux, Catherine; Masse-Alarie, Hugo] Univ Laval, Ctr Interdisciplinaire Rech Readaptat & Integrat, Quebec City, PQ, Canada; [Beaulieu, Louis-David] Univ Quebec Chicoutimi, BioNR Res Lab, Chicoutimi, PQ, Canada; [Wideman, Timothy H.] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada	Laval University; University of Quebec; University of Quebec Chicoutimi; McGill University	Masse-Alarie, H (corresponding author), Univ Laval, Ctr Interdisciplinaire Rech Readaptat & Integrat, Quebec City, PQ, Canada.	hugo.masse-alarie@fmed.ulaval.ca		Masse-Alarie, Hugo/0000-0003-4472-9656	Quebec Pain Research Network (QPRN); Canadian Musculoskeletal Rehab Research Network; Fonds de recherche du Quebec -Sante [281961 - FRQS]; Canadian Institute of Health Research (CIHR); Ordre professionnel de la physiothe rapie du Quebec (OPPQ); Reseau Provincial de Recherche en Adaptation-Readaptation (REPAR)	Quebec Pain Research Network (QPRN); Canadian Musculoskeletal Rehab Research Network; Fonds de recherche du Quebec -Sante(Fonds de la Recherche en Sante du Quebec); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ordre professionnel de la physiothe rapie du Quebec (OPPQ); Reseau Provincial de Recherche en Adaptation-Readaptation (REPAR)	This study is financed by a grant from the Quebec Pain Research Network (QPRN; https://qprn.ca/fr), the Re ' seau Provincial de Recherche en Adaptation-Re ' adaptation (REPAR; https://repar.ca) and the Canadian Musculoskeletal Rehab Research Network (http://mskrehabnet.com).HMA is supported by salary awards from Fonds de recherche du Quebec -Sante (281961 -FRQS; http://www.frqs.gouv.qc.ca).CM received grants from the Canadian Institute of Health Research (CIHR; https://cihr-irsc.gc.ca/e/193.html) and the Ordre professionnel de la physiothe rapie du Quebec (OPPQ; https://oppq.qc.ca).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RJ, 2013, EUR J PAIN, V17, P67, DOI 10.1002/j.1532-2149.2012.00190.x; Aoyagi K, 2019, CLIN J PAIN, V35, P869, DOI 10.1097/AJP.0000000000000755; Arendt-Nielsen L, 2009, J PAIN, V10, P556, DOI 10.1016/j.jpain.2009.02.002; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Balaguier R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160866; Beaulieu LD, 2017, CLIN NEUROPHYSIOL, V128, P1290, DOI 10.1016/j.clinph.2017.04.021; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; BHIVA/ BASHH, 2019, HIV MED S2, V20, ps2; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Coronado RA, 2014, PHYS THER, V94, P1111, DOI 10.2522/ptj.20130372; Correa JB, 2015, EXP BRAIN RES, V233, P2391, DOI 10.1007/s00221-015-4309-6; Crombie KM, 2018, PAIN MED, V19, P118, DOI 10.1093/pm/pnx058; Santos RD, 2018, J PHYSIOL PHARMACOL, V69, P3, DOI 10.26402/jpp.2018.1.01; Damron LA, 2008, J NEUROSCI METH, V173, P121, DOI 10.1016/j.jneumeth.2008.06.001; Falla D, 2014, PAIN, V155, P944, DOI 10.1016/j.pain.2014.01.027; Farasyn A., 2003, J BODYW MOV THER, V7, P53, DOI [10.1016/S1360-8592(02)00050-5, DOI 10.1016/S1360-8592(02)00050-5]; Fingleton C, 2017, CLIN J PAIN, V33, P395, DOI 10.1097/AJP.0000000000000418; Geber C, 2011, PAIN, V152, P548, DOI 10.1016/j.pain.2010.11.013; Gebhart GF, 2004, NEUROSCI BIOBEHAV R, V27, P729, DOI 10.1016/j.neubiorev.2003.11.008; Gehling J, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0650-z; Gierthmuhlen J, 2015, PAIN, V156, P2203, DOI 10.1097/j.pain.0000000000000227; Graven-Nielsen T, 2010, NAT REV RHEUMATOL, V6, P599, DOI 10.1038/nrrheum.2010.107; Harvill L.M., 1991, EDUC MEAS-ISSUES PRA, V10, P33, DOI [DOI 10.1111/J.1745-3992.1991.TB00195.X, 10.1111/j.1745-3992.1991.tb00195.x]; Herrero JF, 2000, PROG NEUROBIOL, V61, P169, DOI 10.1016/S0301-0082(99)00051-9; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Kennedy DL, 2016, PAIN, V157, P2410, DOI 10.1097/j.pain.0000000000000689; Koltyn KF, 2014, J PAIN, V15, P1294, DOI 10.1016/j.jpain.2014.09.006; Kuithan P, 2019, PAIN PRACT, V19, P740, DOI 10.1111/papr.12804; Lacourt TE, 2012, SCAND J PAIN, V3, P31, DOI 10.1016/j.sjpain.2011.10.003; Lexell JE, 2005, AM J PHYS MED REHAB, V84, P719, DOI 10.1097/01.phm.0000176452.17771.20; Marchand S, 2002, PAIN, V95, P201, DOI 10.1016/S0304-3959(01)00399-2; Moseley GL, 2017, EXPLAIN PAIN SUPERCH; Nahman-Averbuch H, 2013, SCAND J PAIN, V4, P10, DOI 10.1016/j.sjpain.2012.08.001; Naugle KM, 2012, J PAIN, V13, P1139, DOI 10.1016/j.jpain.2012.09.006; Neelapala YVR, 2020, CLIN J PAIN, V36, P135, DOI 10.1097/AJP.0000000000000778; Nussbaum EL, 1998, PHYS THER, V78, P160, DOI 10.1093/ptj/78.2.160; O'Neill S, 2014, CLIN J PAIN, V30, P831, DOI 10.1097/AJP.0000000000000042; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Ostrom C, 2017, J PAIN, V18, P295, DOI 10.1016/j.jpain.2016.10.018; Paungmali A, 2018, J MANIP PHYSIOL THER, V41, P181, DOI 10.1016/j.jmpt.2018.01.002; Pigg M, 2010, PAIN, V148, P220, DOI 10.1016/j.pain.2009.10.024; Pogatzki-Zahn EM, 2019, PAIN, V160, P1781, DOI 10.1097/j.pain.0000000000001561; Portney LG, 2009, FDN CLIN RES APPL PR; PRICE DD, 1977, PAIN, V3, P57, DOI 10.1016/0304-3959(77)90035-5; Pud D, 2009, PAIN, V144, P16, DOI 10.1016/j.pain.2009.02.015; Rabey M, 2015, MANUAL THER, V20, P763, DOI 10.1016/j.math.2015.02.011; Rice D, 2019, J PAIN, V20, P1249, DOI 10.1016/j.jpain.2019.03.005; Riley JL, 2014, J PAIN, V15, P272, DOI 10.1016/j.jpain.2013.10.015; Riviere F, 2018, J SPORT HEALTH SCI, V7, P339, DOI 10.1016/j.jshs.2016.08.004; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Schambra HM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00335; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sluka KA, 2018, PAIN, V159, pS91, DOI 10.1097/j.pain.0000000000001235; Sprenger C, 2011, PAIN, V152, P428, DOI 10.1016/j.pain.2010.11.018; Starkweather AR, 2016, APPL NURS RES, V29, P237, DOI 10.1016/j.apnr.2015.03.013; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tour J, 2017, PAIN, V158, P1194, DOI 10.1097/j.pain.0000000000000896; Tousignant-Laflamme Y, 2008, BRAIN RES, V1230, P73, DOI 10.1016/j.brainres.2008.06.120; Vaegter HB, 2017, CLIN J PAIN, V33, P475, DOI 10.1097/AJP.0000000000000428; Vaegter HB, 2019, PAIN MED, V20, P129, DOI 10.1093/pm/pny087; Vaegter HB, 2018, PAIN MED, V19, P2212, DOI 10.1093/pm/pny009; Waller R, 2015, SCAND J PAIN, V9, P38, DOI 10.1016/j.sjpain.2015.05.004; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Yarnitsky D, 2015, EUR J PAIN, V19, P805, DOI 10.1002/ejp.605; Yarnitsky D, 2014, PAIN, V155, P663, DOI 10.1016/j.pain.2013.11.005; Yarnitsky D, 2010, EUR J PAIN, V14, P339, DOI 10.1016/j.ejpain.2010.02.004	66	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245278	10.1371/journal.pone.0245278	http://dx.doi.org/10.1371/journal.pone.0245278			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4SP	33434233	Green Published, gold			2022-12-26	WOS:000609979700045
J	Wang, YS; Wang, RM; Jing, J; Wang, HW				Wang, Yisen; Wang, Ruimin; Jing, Jing; Wang, Huanwei			Implementing a high-efficiency similarity analysis approach for firmware code	PLOS ONE			English	Article								The rapid expansion of the open-source community has shortened the software development cycle, but the spread of vulnerabilities has been accelerated, especially in the field of the Internet of Things. In recent years, the frequency of attacks against connected devices is increasing exponentially; thus, the vulnerabilities are more serious in nature. The state-of-the-art firmware security inspection technologies, such as methods based on machine learning and graph theory, find similar applications depending on the known vulnerabilities but cannot do anything without detailed information about the vulnerabilities. Moreover, model training, which is necessary for the machine learning technologies, requires a significant amount of time and data, resulting in low efficiency and poor extensibility. Aiming at the above shortcomings, a high-efficiency similarity analysis approach for firmware code is proposed in this study. First, the function control flow features and data flow features are extracted from the functions of the firmware and of the vulnerabilities, and the features are used to calculate the SimHash of the functions. The mass storage and fast query capabilities of the SimHash are implemented by the pigeonhole principle. Second, the similarity function pairs are analyzed in detail within and among the basic blocks. Within the basic blocks, the symbolic execution is used to generate the basic block semantic information, and the constraint solver is used to determine the semantic equivalence. Among the basic blocks, the local control flow graphs are analyzed to obtain their similarity. Then, we implemented a prototype and present the evaluation. The evaluation results demonstrate that the proposed approach can implement large-scale firmware function similarity analysis. It can also get the location of the real-world firmware patch without vulnerability function information. Finally, we compare our method with existing methods. The comparison results demonstrate that our method is more efficient and accurate than the Gemini and StagedMethod. More than 90% of the firmware functions can be indexed within 0.1 s, while the search time of 100,000 firmware functions is less than 2 s.	[Wang, Yisen; Wang, Ruimin; Jing, Jing; Wang, Huanwei] State Key Lab Math Engn & Adv Comp, Zhengzhou, Peoples R China; [Wang, Yisen; Wang, Ruimin; Jing, Jing; Wang, Huanwei] Informat Engn Univ China, Zhengzhou, Peoples R China	PLA Information Engineering University	Wang, YS (corresponding author), State Key Lab Math Engn & Adv Comp, Zhengzhou, Peoples R China.; Wang, YS (corresponding author), Informat Engn Univ China, Zhengzhou, Peoples R China.	851067568@qq.com		Wang, Ruimin/0000-0001-8899-2478; Wang, Yisen/0000-0002-0181-2137				[Anonymous], 2016, NETW DISTR SYST SEC; Backes Michael, 2016, ACM SIGSAC C COMP CO; Bayer U., 2009, NDSS; Chandramohan M, 2016, FSE'16: PROCEEDINGS OF THE 2016 24TH ACM SIGSOFT INTERNATIONAL SYMPOSIUM ON FOUNDATIONS OF SOFTWARE ENGINEERING, P678, DOI 10.1145/2950290.2950350; Chen Daming D., 2016, NETW DISTR SYST SEC; David Y, 2018, ACM SIGPLAN NOTICES, V53, P392, DOI [10.1145/3173162.3177157, 10.1145/3296957.3177157]; David Y, 2017, ACM SIGPLAN NOTICES, V52, P79, DOI 10.1145/3062341.3062387; David Y, 2016, ACM SIGPLAN NOTICES, V51, P266, DOI [10.1145/2980983.2908126, 10.1145/2908080.2908126]; Denaro G, 2014, 2014 IEEE SEVENTH INTERNATIONAL CONFERENCE ON SOFTWARE TESTING, VERIFICATION AND VALIDATION (ICST), P71, DOI 10.1109/ICST.2014.18; Duan Yue, 2020, NETW DISTR SYST SEC; Dullien Thomas, 2005, GRAPH BASED COMP EXE; Ferschke O., 2014, P NOTEBOOK PAN CLEF; Fung Benjamin CM, 2019, ASM2VEC BOOSTING STA; Gao DB, 2008, LECT NOTES COMPUT SC, V5308, P238; Gao J, 2018, IEEE INT CONF AUTOM, P896, DOI 10.1145/3238147.3240480; Han ZB, 2017, PROC IEEE INT CONF S, P125, DOI 10.1109/ICSME.2017.52; Huang H, 2017, PROCEEDINGS OF THE 2017 ACM ASIA CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY (ASIA CCS'17), P155, DOI 10.1145/3052973.3052974; Huo X., 2016, P 25 INT JOINT C ART, P1606; Huo X, 2017, PROCEEDINGS OF THE TWENTY-SIXTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1909; Jiang LX, 2007, PROC INT CONF SOFTW, P96; Kamiya T, 2002, IEEE T SOFTWARE ENG, V28, P654, DOI 10.1109/TSE.2002.1019480; Lee Y. J., 2017, P 9 INT C INT ICONI; Liu BC, 2018, IEEE INT CONF AUTOM, P667, DOI 10.1145/3238147.3238199; Luo LN, 2016, 2016 IEEE/ACM 38TH INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING COMPANION (ICSE-C), P481, DOI 10.1145/2889160.2889202; Ming J., 2012, P 15 ANN INT C INF S, P92, DOI [10.1007/978-3-642-37682-58, DOI 10.1007/978-3]; Mitropoulos D., 2014, P 11 WORK C MIN SOFT, P372, DOI DOI 10.1145/2597073.2597123; Mou LL, 2016, AAAI CONF ARTIF INTE, P1287; Muench Marius, 2018, WORKSH BIN AN RES CO, V18; Pewny J, 2015, P IEEE S SECUR PRIV, P709, DOI 10.1109/SP.2015.49; Plate H, 2015, PROC IEEE INT CONF S, P411, DOI 10.1109/ICSM.2015.7332492; Saebjornsen A, 2009, ISSTA 2009: INTERNATIONAL SYMPOSIUM ON SOFTWARE TESTING AND ANALYSIS, P117; Shirani P, 2018, LECT NOTES COMPUT SC, V10885, P114, DOI 10.1007/978-3-319-93411-2_6; Shoshitaishvili Y, 2016, P IEEE S SECUR PRIV, P138, DOI 10.1109/SP.2016.17; Sun YJ, 2007, IEEE T PATTERN ANAL, V29, P1035, DOI 10.1109/TPAMI.2007.1093; Nguyen TD, 2017, PROC INT CONF SOFTW, P438, DOI 10.1109/ICSE.2017.47; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; Viega J, 2000, 16TH ANNUAL COMPUTER SECURITY APPLICATIONS CONFERENCE, PROCEEDINGS, P257, DOI 10.1109/ACSAC.2000.898880; Wang YS, 2019, IEEE ACCESS, V7, P14171, DOI 10.1109/ACCESS.2019.2893733; White Martin, 2017, IEEE INT C SOFTW AN; Wronka Cyprian, 2017, EMBEDDED SOFTWARE DE; Wu C, 2016, 2016 INTERNATIONAL CONFERENCE ON MATERIAL, ENERGY AND ENVIRONMENT ENGINEERING (ICM3E 2016), P480; Xu XJ, 2017, CCS'17: PROCEEDINGS OF THE 2017 ACM SIGSAC CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P363, DOI 10.1145/3133956.3134018; Xu ZZ, 2017, PROC INT CONF SOFTW, P462, DOI 10.1109/ICSE.2017.49; Zaddach Jonas, 2014, NETW DISTR SYST SEC; Zhou W, 2019, IEEE INTERNET THINGS, V6, P1606, DOI 10.1109/JIOT.2018.2847733; Zuo F., 2018, ARXIV PREPRINT ARXIV	47	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245098	10.1371/journal.pone.0245098	http://dx.doi.org/10.1371/journal.pone.0245098			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434199	Green Published, gold			2022-12-26	WOS:000609979700017
J	Songane, M; Grossmann, V				Songane, Mario; Grossmann, Volker			The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value	PLOS ONE			English	Article								Human papillomavirus (HPV) is responsible for almost all of the 570,000 new cases of cervical cancer and approximately 311,000 deaths per year. HPV vaccination is an integral component of the World Health Organization's (WHO) global strategy to fight the disease. However, high vaccine prices enforced through patent protection are limiting vaccine expansion, particularly in low- and middle-income countries. By limiting market power, patent buy-outs could reduce vaccine prices and raise HPV vaccination rates while keeping innovation incentives. We estimate the global patent buyout price as the present discounted value (PDV) of the future profit stream over the remaining patent length for Merck's HPV vaccines (Gardasil-4 and 9), which hold 87% of the global HPV vaccine market, in the range of US$ 15.6-27.7 billion (in 2018 US$). The estimated PDV of the profit stream since market introduction amounts to US$ 17.8-42.8 billion and the estimated R&D cost to US$ 1.05-1.21 billion. Thus, we arrive at a ratio of R&D costs to the patent value of the order of 2.5-6.8%. We relate this figure to typical estimates of the probability of success (POS) for clinical trials of vaccines to discuss if patent protection provides Merck with extraordinarily strong price setting power.	[Songane, Mario; Grossmann, Volker] Univ Fribourg, Dept Econ, Fribourg, Switzerland; [Grossmann, Volker] Inst Study Lab IZA, Bonn, Germany; [Grossmann, Volker] CESifo, Munich, Germany	University of Fribourg; IZA Institute Labor Economics; Ifo Institut	Songane, M; Grossmann, V (corresponding author), Univ Fribourg, Dept Econ, Fribourg, Switzerland.; Grossmann, V (corresponding author), Inst Study Lab IZA, Bonn, Germany.; Grossmann, V (corresponding author), CESifo, Munich, Germany.	mario.songane@unifr.ch; volker.grossmann@unifr.ch		Grossmann, Volker/0000-0001-8917-3503	Swiss Government Excellence Scholarship - Departement federal de l'economie	Swiss Government Excellence Scholarship - Departement federal de l'economie	MS: received a Swiss Government Excellence Scholarship granted by the Departement federal de l'economie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHION P, 1992, ECONOMETRICA, V60, P323, DOI 10.2307/2951599; [Anonymous], 2018, S CHINA MORNING POST; Arbyn M, 2020, LANCET GLOB HEALTH, V8, pE191, DOI 10.1016/S2214-109X(19)30482-6; Bloem P., 2019, HPV VACCINES UPTAKE; Bloem P, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002325; Cazabon D, 2017, J HEAL SPEC, V5, P2; CDC, 2020, IMM SERV DIV; CDC, 2018, VACC IMM; CDC, 2018, ARCH CDC VACC PRIC L; Chandrasekharan S, 2015, VACCINE, V33, P6366, DOI 10.1016/j.vaccine.2015.08.063; Choi YH, 2012, VACCINE, V30, P3383, DOI 10.1016/j.vaccine.2012.03.065; Clendinen C, 2016, VACCINE, V34, P5984, DOI 10.1016/j.vaccine.2016.09.042; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Das M, 2018, LANCET ONCOL, V19, pE84, DOI 10.1016/S1470-2045(18)30018-4; de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716; deSanjose S, VACCINE, V30, pD1; EMA, 2009, GARD; Federal Reserve Bank, 2018, CONS PRIC IND; Frisch M, 2000, CANCER-AM CANCER SOC, V88, P1464, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1464::AID-CNCR26>3.0.CO;2-O; Galasso A, 2016, INT J IND ORGAN, V48, P207, DOI 10.1016/j.ijindorg.2016.06.007; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; GAVI, 2017, SUPPL PROC ROADM HUM; GAVI, 2018, GAV VACC ALL; GAVI, 2020, HUMAN PAPILLOMAVIRUS; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Goldberg PK, 2010, J EUR ECON ASSOC, V8, P326, DOI 10.1111/j.1542-4774.2010.tb00506.x; Goldie SJ, 2008, VACCINE, V26, P4080, DOI 10.1016/j.vaccine.2008.04.053; Gottlieb SD, 2013, MED ANTHROPOL Q, V27, P330, DOI 10.1111/maq.12046; Gouglas D, 2018, LANCET GLOB HEALTH, V6, pE1386, DOI 10.1016/S2214-109X(18)30346-2; GSK, 2014, GSK ANN REP 2013; GSK, 2017, GSK ANN REP 2016; GSK, 2019, GSK ANN REP 2018; GSK, 2011, GSK ANN REP 2010; GSK, 2008, GSK ANN REP 2007; GSK, 2018, ANN REP 2017; Health Canada, 2018, PAT REG DRUG PROD; Hongyu B., 2018, PEOPLES DAILY ONLINE; Insinga RP, 2005, PHARMACOECONOMICS, V23, P1107, DOI 10.2165/00019053-200523110-00004; Kornfield R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055504; Kosen Soewarta, 2017, Asian Pac J Cancer Prev, V18, P2011, DOI 10.22034/APJCP.2017.18.7.2011; Kremer M, 1998, Q J ECON, V113, P1137, DOI 10.1162/003355398555865; Kumar P, 2019, LANCET ONCOL, V20, pE237, DOI 10.1016/S1470-2045(19)30170-6; Lakdawalla DN, 2018, J ECON LIT, V56, P397, DOI 10.1257/jel.20161327; Light DW, 2009, VACCINE, V27, P6627, DOI 10.1016/j.vaccine.2009.07.077; Louie KS, 2009, TROP MED INT HEALTH, V14, P1287, DOI 10.1111/j.1365-3156.2009.02372.x; Ma B, 2010, J FORMOS MED ASSOC, V109, P481, DOI 10.1016/S0929-6646(10)60081-2; MacroTrends, 2019, POUND DOLL EXCH RAT; Mahan V. L., 2014, SYST REV-LONDON, V5, P1374, DOI DOI 10.1186/2046-4053-4-1; McGraw SL, 2014, WORLD J CLIN ONCOL, V5, P744, DOI 10.5306/wjco.v5.i4.744; McKee SJ, 2015, REV MED VIROL, V25, P54, DOI 10.1002/rmv.1824; Medicines Patent Pool, 2020, MPP MED PAT POOL; Merck. Merck & Co, 2009, 2008 ANN REPORT FILE; Merck. Merck & Co, 2008, 2007 ANN REPORT FILE; Merck. Merck & Co, 2017, 2016 ANN REPORT FILE; Merck. Merck & Co. Inc, 2018, 2017 ANN REPORT FILE; Merck. Merck & Co. Inc., 2015, 2014 ANN REPORT FILE; Merck. Merck & Co. Inc., 2012, 2011 ANN REPORT FILE; MSF, 2015, RIGHT SHOT EXT REACH; MSF, 2017, FAIR SHOT VACC AFF; Mueller-Langer F, 2013, HEALTH ECON POLICY L, V8, P185, DOI 10.1017/S1744133112000321; Nguyen A, 2011, HARVARD GLOB EQUITY; Outterson Kevin, 2005, Yale J Health Policy Law Ethics, V5, P193; Padmanabhan S, 2010, NAT BIOTECHNOL, V28, P671, DOI 10.1038/nbt0710-671; PAHO, 2019, PAHO REV FUND; Prasad V, 2017, JAMA INTERN MED, P177; Pronker ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057755; Sabeena S, 2018, J OBSTET GYNAECOL RE, V44, P989, DOI 10.1111/jog.13634; Sagonowsky E, 2018, FIERCEPHARMA; Sankaranarayanan R, 2018, VACCINE, V36, P4783, DOI 10.1016/j.vaccine.2018.02.087; Sertkaya A, 2016, CLIN TRIALS, V13, P117, DOI 10.1177/1740774515625964; Setiawan Didik, 2016, Value Health Reg Issues, V9, P84, DOI 10.1016/j.vhri.2015.10.010; Shamp J., 2019, MERCK ADDING 680M 42; Smith J, 2011, LANCET, V378, P428, DOI 10.1016/S0140-6736(11)60478-9; Tomljenovic L, 2012, J LAW MED ETHICS, V40, P673, DOI 10.1111/j.1748-720X.2012.00698.x; UN, 2018, LDCS GLANC; UNICEF, 2018, HUMAN PAPILLOMAVIRUS; Vicente T, 2011, J INVERTEBR PATHOL, V107, pS42, DOI 10.1016/j.jip.2011.05.004; Wang RJ, 2020, CANCER LETT, V471, P88, DOI 10.1016/j.canlet.2019.11.039; WHO, 2018, GLOB MARK STUD HPV; Wong CH, 2019, BIOSTATISTICS, V20, P273, DOI 10.1093/biostatistics/kxx069; Wouters OJ, 2020, JAMA-J AM MED ASSOC, V323, P844, DOI 10.1001/jama.2020.1166; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064; Yin Y, 2017, LANCET, V390, P1735, DOI 10.1016/S0140-6736(17)32606-5	83	1	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0244722	10.1371/journal.pone.0244722	http://dx.doi.org/10.1371/journal.pone.0244722			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY4UJ	33428667	gold, Green Published, Green Submitted			2022-12-26	WOS:000630036100021
J	Pineau, C; Guschinskaya, N; Goncalves, IR; Ruaudel, F; Robert, X; Gouet, P; Ballut, L; Shevchik, VE				Pineau, Camille; Guschinskaya, Natalia; Goncalves, Isabelle R.; Ruaudel, Florence; Robert, Xavier; Gouet, Patrice; Ballut, Lionel; Shevchik, Vladimir E.			Structure-function analysis of pectate lyase Pel3 reveals essential facets of protein recognition by the bacterial type 2 secretion system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERWINIA-CHRYSANTHEMI; CRYSTAL-STRUCTURE; DOMAIN; ARCHITECTURE; MOLECULE; SEQUENCE; PATHWAY; BINDING; REGION	The type II secretion system (T2SS) transports fully folded proteins of various functions and structures through the outer membrane of Gram-negative bacteria. The molecular mechanisms of substrate recruitment by T2SS remain elusive but a prevailing view is that the secretion determinants could be of a structural nature. The phytopathogenic gamma-proteobacteria, Pectobacterium carotovorum and Dickeya dadantii, secrete similar sets of homologous plant cell wall degrading enzymes, mainly pectinases, by similar T2SSs, called Out. However, the orthologous pectate lyases Pel3 and PelI from these bacteria, which share 67% of sequence identity, are not secreted by the counterpart T2SS of each bacterium, indicating a fine-tuned control of protein recruitment. To identify the related secretion determinants, we first performed a structural characterization and comparison of Pel3 with PelI using X-ray crystallography. Then, to assess the biological relevance of the observed structural variations, we conducted a loop-substitution analysis of Pel3 combined with secretion assays. We showed that there is not one element with a definite secondary structure but several distant and structurally flexible loop regions that are essential for the secretion of Pel3 and that these loop regions act together as a composite secretion signal. Interestingly, depending on the crystal contacts, one of these key secretion determinants undergoes disorder-to-order transitions that could reflect its transient structuration upon the contact with the appropriate T2SS components. We hypothesize that such T2SS-induced structuration of some intrinsically disordered zones of secretion substrates could be part of the recruitment mechanism used by T2SS.	[Pineau, Camille; Guschinskaya, Natalia; Goncalves, Isabelle R.; Ruaudel, Florence; Shevchik, Vladimir E.] Univ Lyon, Microbiol Adaptat & Pathogenie, Univ Lyon 1, UMR5240,CNRS, Villeurbanne, France; [Pineau, Camille; Guschinskaya, Natalia; Shevchik, Vladimir E.] Lyon, Microbiol Adaptat & Pathogenie, INSA Lyon, UMR5240, Villeurbanne, France; [Robert, Xavier; Gouet, Patrice; Ballut, Lionel] Univ Lyon, Mol Microbiol & Struct Biochem, UMR5086, CNRS, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Shevchik, VE (corresponding author), Univ Lyon, Microbiol Adaptat & Pathogenie, Univ Lyon 1, UMR5240,CNRS, Villeurbanne, France.; Shevchik, VE (corresponding author), Lyon, Microbiol Adaptat & Pathogenie, INSA Lyon, UMR5240, Villeurbanne, France.; Ballut, L (corresponding author), Univ Lyon, Mol Microbiol & Struct Biochem, UMR5086, CNRS, Lyon, France.	lionel.ballut@ibcp.fr; vladimir.shevchik@insa-lyon.fr		Shevchik, Vladimir/0000-0002-8031-8638	CNRS (Centre National de la Recherche Scientifique); ANR (Agence Nationale de la Recherche) [SYNERGY_T2SS ANR-19-CE11-0020]	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR))	This research was supported by funding from CNRS (Centre National de la Recherche Scientifique) and a grant from ANR (Agence Nationale de la Recherche) SYNERGY_T2SS ANR-19-CE11-0020.	Akita M, 2001, ACTA CRYSTALLOGR D, V57, P1786, DOI 10.1107/S0907444901014482; Alahuhta M, 2011, ACTA CRYSTALLOGR F, V67, P1498, DOI 10.1107/S1744309111038449; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BORK P, 1992, P NATL ACAD SCI USA, V89, P8990, DOI 10.1073/pnas.89.19.8990; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Castang S, 2004, ACTA CRYSTALLOGR D, V60, P190, DOI 10.1107/S0907444903026222; Chandler PG, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030610; Charkowski AO, 1998, J BACTERIOL, V180, P5211, DOI 10.1128/JB.180.19.5211-5217.1998; Cianciotto NP, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00014-17; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; Creze C, 2008, J BIOL CHEM, V283, P18260, DOI 10.1074/jbc.M709931200; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Ekiert DC, 2017, CELL, V169, P273, DOI 10.1016/j.cell.2017.03.019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filloux A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00155; Filloux A, 2010, J BACTERIOL, V192, P3847, DOI 10.1128/JB.00565-10; Francetic O, 2005, J BACTERIOL, V187, P7045, DOI 10.1128/JB.187.20.7045-7055.2005; Gu S, 2017, BBA-PROTEINS PROTEOM, V1865, P1255, DOI 10.1016/j.bbapap.2017.07.006; Gu S, 2012, J BIOL CHEM, V287, P9072, DOI 10.1074/jbc.M111.300624; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Healey EG, 2015, NAT STRUCT MOL BIOL, V22, P458, DOI 10.1038/nsmb.3016; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HIRST TR, 1987, P NATL ACAD SCI USA, V84, P7418, DOI 10.1073/pnas.84.21.7418; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hugouvieux-Cotte--Pattat N, ELS 2020, DOI [10.1002/9780470015902.a0028932, DOI 10.1002/9780470015902.A0028932]; Hugouvieux-Cotte-Pattat N, 2014, ENV MICROBIOL REP, V6, P427, DOI 10.1111/1758-2229.12166; Jin QL, 2001, SCIENCE, V294, P2556, DOI 10.1126/science.1066397; JOHNSON BH, 1994, BIO-TECHNOL, V12, P1357, DOI 10.1038/nbt1294-1357; Kataeva IA, 2002, APPL ENVIRON MICROB, V68, P4292, DOI 10.1128/AEM.68.9.4292-4300.2002; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kavran JM, 2010, J BIOL CHEM, V285, P24584, DOI 10.1074/jbc.M110.131680; Koide S, 2012, METHOD ENZYMOL, V503, P135, DOI 10.1016/B978-0-12-396962-0.00006-9; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lindeberg M, 1998, J BACTERIOL, V180, P1431, DOI 10.1128/JB.180.6.1431-1437.1998; LITTLE E, 1994, J MOL EVOL, V39, P631, DOI 10.1007/BF00160409; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; Miller SI, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004935; Palomaki T, 2002, MOL MICROBIOL, V43, P585, DOI 10.1046/j.1365-2958.2002.02793.x; Pineau C, 2014, MOL MICROBIOL, V94, P126, DOI 10.1111/mmi.12744; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sherman DJ, 2018, SCIENCE, V359, P798, DOI 10.1126/science.aar1886; Shevchik VE, 1998, MOL MICROBIOL, V29, P1459, DOI 10.1046/j.1365-2958.1998.01028.x; SHEVCHIK VE, 1995, MOL MICROBIOL, V16, P745, DOI 10.1111/j.1365-2958.1995.tb02435.x; Sidar A, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00871; Sikora AE, 2011, J BIOL CHEM, V286, P16555, DOI 10.1074/jbc.M110.211078; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Thomassin JL, 2017, MOL MICROBIOL, V105, P211, DOI 10.1111/mmi.13704; Tsai HH, 2006, STRUCTURE, V14, P1059, DOI 10.1016/j.str.2006.03.015; White RC, 2019, MICROB GENOMICS, V5, DOI 10.1099/mgen.0.000273	57	1	1	4	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100305	10.1016/j.jbc.2021.100305	http://dx.doi.org/10.1016/j.jbc.2021.100305			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33465378	Green Published, gold			2022-12-26	WOS:000672866400279
J	Kasperkiewicz, P; Hempel, A; Janiszewski, T; Kolt, S; Snipas, SJ; Drag, M; Salvesen, GS				Kasperkiewicz, Paulina; Hempel, Anne; Janiszewski, Tomasz; Kolt, Sonia; Snipas, Scott J.; Drag, Marcin; Salvesen, Guy S.			NETosis occurs independently of neutrophil serine proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						activity-based probes; neutrophil extracellular traps; NETosis; pyroptosis; neutrophil; cell death; protease; serine protease; protease inhibitor	GASDERMIN D; CATHEPSIN-G; ELASTASE; PYROPTOSIS; GSDMD; DNA; INHIBITION; CASPASE-11; MECHANISM; SERPINB1	Neutrophils are primary host innate immune cells defending against pathogens. One proposed mechanism by which neutrophils prevent the spread of pathogens is NETosis, the extrusion of cellular DNA resulting in neutrophil extracellular traps (NETs). The protease neutrophil elastase (NE) has been implicated in the formation of NETs through proteolysis of nuclear proteins leading to chromatin decondensation. In addition to NE, neutrophils contain three other serine proteases that could compensate if the activity of NE was neutralized. However, whether they do play such a role is unknown. Thus, we deployed recently described specific inhibitors against all four of the neutrophil serine proteases (NSPs). Using specific antibodies to the NSPs along with our labeled inhibitors, we show that catalytic activity of these enzymes is not required for the formation of NETs. Moreover, the NSPs that decorate NETs are in an inactive conformation and thus cannot participate in further catalytic events. These results indicate that NSPs play no role in either NETosis or arming NETs with proteolytic activity.	[Kasperkiewicz, Paulina; Hempel, Anne; Snipas, Scott J.; Salvesen, Guy S.] NCI Designated Canc Ctr, Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92093 USA; [Kasperkiewicz, Paulina; Janiszewski, Tomasz; Kolt, Sonia; Drag, Marcin] Wroclaw Univ Sci & Technol, Dept Chem Biol & Bioimaging, Wroclaw, Poland	Sanford Burnham Prebys Medical Discovery Institute; Wroclaw University of Science & Technology	Kasperkiewicz, P; Salvesen, GS (corresponding author), NCI Designated Canc Ctr, Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92093 USA.; Kasperkiewicz, P (corresponding author), Wroclaw Univ Sci & Technol, Dept Chem Biol & Bioimaging, Wroclaw, Poland.	paulina.kasperkiewicz@pwr.edu.pl; gsalvesen@sbpdiscovery.org		Kasperkiewicz, Paulina/0000-0002-1291-047X; Snipas, Scott/0000-0002-4239-6862; Kolt, Sonia/0000-0003-4076-0445	National Institutes of Health [R01 GM99040, P30 CA30199]; National Science Centre in Poland [2014/14/M/ST5/00619]; START scholarship from the Foundation for Polish Science	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Centre in Poland(National Science Centre, Poland); START scholarship from the Foundation for Polish Science	This work was supported by National Institutes of Health Grants R01 GM99040 and P30 CA30199 (to G. S. S.) and by National Science Centre Grant 2014/14/M/ST5/00619 in Poland (to M. D.). This work was also supported by a START scholarship from the Foundation for Polish Science (to P. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aglietti RA, 2017, TRENDS IMMUNOL, V38, P261, DOI 10.1016/j.it.2017.01.003; Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Albrengues J, 2018, SCIENCE, V361, P1353, DOI 10.1126/science.aao4227; BELORGEY D, 1995, FEBS LETT, V361, P265, DOI 10.1016/0014-5793(95)00173-7; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Burgener SS, 2019, CELL REP, V27, P3646, DOI 10.1016/j.celrep.2019.05.065; Clancy DM, 2017, FEBS J, V284, P1712, DOI 10.1111/febs.14075; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; DEWALD B, 1975, J EXP MED, V141, P709; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Duranton J, 2000, J BIOL CHEM, V275, P3787, DOI 10.1074/jbc.275.6.3787; Farley K, 2012, J IMMUNOL, V189, P4574, DOI 10.4049/jimmunol.1201167; Frank D, 2019, CELL DEATH DIFFER, V26, P99, DOI 10.1038/s41418-018-0212-6; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Hoppenbrouwers T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176472; Kambara H, 2018, CELL REP, V22, P2924, DOI 10.1016/j.celrep.2018.02.067; Kasperkiewicz P, 2017, J AM CHEM SOC, V139, P10115, DOI 10.1021/jacs.7b04394; Kasperkiewicz P, 2014, P NATL ACAD SCI USA, V111, P2518, DOI 10.1073/pnas.1318548111; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P2653, DOI 10.1016/B978-0-12-382219-2.00587-1; Leshner M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00307; Metzler KD, 2014, CELL REP, V8, P883, DOI 10.1016/j.celrep.2014.06.044; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; O'Donoghue AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075141; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Perera NC, 2012, P NATL ACAD SCI USA, V109, P6229, DOI 10.1073/pnas.1200470109; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Salvesen GS, 2016, FEBS J, V283, P2577, DOI 10.1111/febs.13616; Salvesen GS, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P2661, DOI 10.1016/B978-0-12-382219-2.00588-3; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Vande Walle L, 2016, CURR BIOL, V26, pR568, DOI 10.1016/j.cub.2016.02.019; Wiedow O, 2005, J INTERN MED, V257, P319, DOI 10.1111/j.1365-2796.2005.01476.x; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Zabieglo K, 2015, J LEUKOCYTE BIOL, V98, P99, DOI 10.1189/jlb.4AB1114-543R	40	13	13	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17624	17631		10.1074/jbc.RA120.015682	http://dx.doi.org/10.1074/jbc.RA120.015682			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454002	Green Published, hybrid			2022-12-26	WOS:000603272300018
J	Faruk, M; Ibrahim, S; Aminu, SM; Adamu, A; Abdullahi, A; Suleiman, AM; Rafindadi, AH; Mohammed, A; Iliyasu, Y; Idoko, J; Saidu, R; Randawa, AJ; Musa, HS; Ntekim, A; Shah, KZ; Abubakar, S; Adoke, KU; Manko, M; Awasum, CA				Faruk, Mohammed; Ibrahim, Sani; Aminu, Surajo Mohammed; Adamu, Ahmed; Abdullahi, Adamu; Suleiman, Aishatu Maude; Rafindadi, Abdulmumini Hassan; Mohammed, Abdullahi; Iliyasu, Yawale; Idoko, John; Saidu, Rakiya; Randawa, Abdullahi Jibril; Musa, Halimatu Sadiya; Ntekim, Atara; Shah, Khalid Zahir; Abubakar, Sani; Adoke, Kasimu Umar; Manko, Muhammad; Awasum, Cheh Agustin			Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; IMMUNE CELLS; FOLLOW-UP; APOPTOSIS; TUMOR; INHIBITOR; COLON; FAMILY; LIVIN; CHEMORADIOTHERAPY	Evasion of apoptosis is associated with treatment resistance and metastasis in colorectal cancer (CRC). Various cellular processes are associated with evasion of apoptosis. These include overexpression of pro-apoptotic proteins (including p53 and PD-L1), anti-apoptotic proteins (BIRC7/Livin and Bcl-2), chemokine receptors (including DARC), and dysregulation of DNA mismatch repair proteins (including MSH2 and PMS2). The aim of this study was to determine the effect of folinic acid, 5-FU and oxaliplatin (FOLFOX) as a single agent and aspirin plus FOLFOX in various combinations on the aforementioned proteins in human CRC, SW480 cell line and rat models of N-Methyl-N-Nitrosourea (NMU)-induced CRC. In addition, effects of the NMU-induced CRC and chemotherapeutic regimens on haematological and biochemical parameters in the rat models were studied. Immunohistochemistry, immunofluorescence and immunoblot techniques were used to study the expression pattern of the related proteins in the human CRC cells pre- and post-treatment. Double contrast barium enema, post-mortem examination and histological analyses were used to confirm tumour growth and the effect of the treatment in vivo in rat models. Notably, we found in human mucinous CRC, a significant increase in expression of the BIRC7/Livin post-FOLFOX treatment compared with pre-treatment (p = 0.0001). This increase provides new insights into the prognostic role of BIRC7/Livin in evasion of apoptosis and facilitation of treatment resistance, local recurrence and metastasis particularly among mucinous CRCs post-FOLFOX chemotherapy. These poor prognostic features in the CRC may be further compounded by the significant suppression of DARC, PD-L1, PMS2 and overexpression of MSH2 and anti-apoptotic Bcl-2 and p53 proteins observed in our study (p < 0.05). Importantly, we found a significant reduction in expression of BIRC7/Livin and reactivation of DARC and PD-L1 with a surge in Annexin V expression in rat models of CRC cells post-treatment with a sequential dose of aspirin plus FOLFOX compared with other treatments in vivo (p <0.05). The mechanistic rational of these effects underscores the importance of expanded concept of possible aspirin combination therapy with FOLFOX sequentially in future CRC management. Validation of our findings through randomized clinical trials of aspirin plus FOLFOX sequentially in patients with CRC is therefore warranted.	[Faruk, Mohammed; Rafindadi, Abdulmumini Hassan; Mohammed, Abdullahi; Iliyasu, Yawale; Idoko, John] Ahmadu Bello Univ, Coll Med Sci, Fac Basic Clin Sci, Dept Pathol, Zaria, Nigeria; [Ibrahim, Sani] Ahmadu Bello Univ, Fac Life Sci, Dept Biochem, Zaria, Nigeria; [Aminu, Surajo Mohammed; Suleiman, Aishatu Maude] Ahmadu Bello Univ, Coll Med Sci, Fac Basic Clin Sci, Dept Haematol & Blood Transfus, Zaria, Nigeria; [Adamu, Ahmed] Ahmadu Bello Univ, Coll Med Sci, Fac Basic Clin Sci, Dept Surg, Zaria, Nigeria; [Abdullahi, Adamu] Ahmadu Bello Univ, Coll Med Sci, Fac Basic Clin Sci, Dept Radiotherapy & Oncol, Zaria, Nigeria; [Saidu, Rakiya] Univ Ilorin, Fac Med, Dept Obstet & Gynaecol, Ilorin, Nigeria; [Saidu, Rakiya] Univ Cape Town, Dept Obstet & Gynaecol, Cape Town, South Africa; [Randawa, Abdullahi Jibril] Ahmadu Bello Univ, Coll Med Sci, Fac Clin Sci, Dept Obstet & Gynaecol, Zaria, Nigeria; [Musa, Halimatu Sadiya; Awasum, Cheh Agustin] Ahmadu Bello Univ Zaria, Vet Teaching Hosp, Dept Vet Surg & Radiol, Zaria, Nigeria; [Ntekim, Atara] Univ Ibadan, Coll Med, Dept Radiat Oncol, Ibadan, Nigeria; [Shah, Khalid Zahir] Nova Med Ctr, Lahore, Pakistan; [Abubakar, Sani] Aminu Kano Univ Teaching Hosp, Dept Pathol, Kano, Nigeria; [Adoke, Kasimu Umar] Fed Med Ctr, Dept Pathol, Birnin Kebbi, Nigeria; [Manko, Muhammad] Ahmadu Bello Univ, Coll Med Sci, Fac Clin Sci, Dept Med, Zaria, Nigeria	Ahmadu Bello University; Ahmadu Bello University; Ahmadu Bello University; Ahmadu Bello University; Ahmadu Bello University; University of Ilorin; University of Cape Town; Ahmadu Bello University; Ahmadu Bello University; University of Ibadan; Ahmadu Bello University	Faruk, M (corresponding author), Ahmadu Bello Univ, Coll Med Sci, Fac Basic Clin Sci, Dept Pathol, Zaria, Nigeria.	fmohammed@abu.edu.ng	mohammed, faruk/AGW-5403-2022; Saidu, Rakiya/A-2275-2019	mohammed, faruk/0000-0003-2319-8948; Saidu, Rakiya/0000-0003-4959-8157; Abubakar, Sani Atta/0000-0002-5013-0706; ABDULLAHI, ADAMU/0000-0002-2223-3820; Rafindadi, Abdulmumini/0000-0002-8071-1034				Adams JM, 2018, CELL DEATH DIFFER, V25, P27, DOI 10.1038/cdd.2017.161; [Anonymous], 2017, CANC RES S, V77, pCT030, DOI [10.1158/1538-7445.Am2017-ct030, DOI 10.1158/1538-7445.AM2017-CT030]; Aparicio J, 2005, CLIN COLORECTAL CANC, V5, P263, DOI 10.3816/CCC.2005.n.037; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Ashhab Y, 2001, FEBS LETT, V495, P56, DOI 10.1016/S0014-5793(01)02366-3; Bacso Z, 2000, CANCER RES, V60, P4623; Bashir AIJ, 2019, INT J ONCOL, V54, P1256, DOI 10.3892/ijo.2019.4701; Boland PM, 2017, CANCERS, V9, DOI 10.3390/cancers9050050; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Coyle C, 2016, CURR COLORECT CANC R, V12, P27, DOI 10.1007/s11888-016-0306-9; Deb J, 2011, ONCOL REP, V26, P557, DOI 10.3892/or.2011.1320; Delbridge ARD, 2016, NAT REV CANCER, V16, P99, DOI 10.1038/nrc.2015.17; Dibra HK, 2011, INTECH, V30, P743; Ding ZY, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-281; Drew DA, 2016, NAT REV CANCER, V16, P173, DOI 10.1038/nrc.2016.4; Finn OJ, 2012, ANN ONCOL, V23, P6, DOI 10.1093/annonc/mds256; Fujita M, 2011, CANCER RES, V71, P2664, DOI 10.1158/0008-5472.CAN-10-3055; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada S, 2020, ADV ANAT PATHOL, V27, P20, DOI 10.1097/PAP.0000000000000247; Hardwick JCH, 2004, CARCINOGENESIS, V25, P1293, DOI 10.1093/carcin/bgh118; Hinds MG, 1999, NAT STRUCT BIOL, V6, P648; Hodek M, 2016, STRAHLENTHER ONKOL, V192, P632, DOI 10.1007/s00066-016-0988-6; Holowatyj AN, 2016, J CLIN ONCOL, V34, P2148, DOI 10.1200/JCO.2015.65.0994; Hu Z, 2019, NAT GENET, V51, P1113, DOI 10.1038/s41588-019-0423-x; Hugen N, 2013, ANN ONCOL, V24, P2819, DOI 10.1093/annonc/mdt378; Hugen N, 2016, NAT REV CLIN ONCOL, V13, P361, DOI 10.1038/nrclinonc.2015.140; Hugen N, 2015, J PATHOL CLIN RES, V1, P3, DOI 10.1002/cjp2.1; Jenkins BD, 2019, CANCER EPIDEM BIOMAR, V28, P690, DOI 10.1158/1055-9965.EPI-18-0955; Kasof GM, 2001, J BIOL CHEM, V276, P3238, DOI 10.1074/jbc.M003670200; Kim EM, 2017, CANCER RES, V77, P3092, DOI 10.1158/0008-5472.CAN-16-2098; Kingham TP, 2013, LANCET ONCOL, V14, pE158, DOI 10.1016/S1470-2045(12)70472-2; Koirala P, 2016, SCI REP-UK, V6, DOI 10.1038/srep30093; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Langley RE, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.297; Li YQ, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0539-x; Liang PS, 2020, CLIN TRANSL GASTROEN, V11, DOI 10.14309/ctg.0000000000000155; Liu KP, 2020, AM J CANCER RES, V10, P78; Liu LY, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0512-3; Ma L, 2006, CELL DEATH DIFFER, V13, P2079, DOI 10.1038/sj.cdd.4401959; Mekenkamp LJM, 2012, EUR J CANCER, V48, P501, DOI 10.1016/j.ejca.2011.12.004; Mohelnikova-Duchonova B, 2014, WORLD J GASTROENTERO, V20, P10316, DOI 10.3748/wjg.v20.i30.10316; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Myung DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073262; Negri FV, 2013, ANTICANCER RES, V33, P4611; Oh BY, 2011, WORLD J GASTROENTERO, V17, P2563, DOI 10.3748/wjg.v17.i20.2563; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836; Sharma A, 2020, J SURG ONCOL, V121, P342, DOI 10.1002/jso.25768; Solomon H, 2018, ONCOGENE, V37, P1669, DOI 10.1038/s41388-017-0060-8; Stark LA, 2007, CARCINOGENESIS, V28, P968, DOI 10.1093/carcin/bgl220; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; van Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3; Verbeke H, 2011, CYTOKINE GROWTH F R, V22, P345, DOI 10.1016/j.cytogfr.2011.09.002; Vucic D, 2000, CURR BIOL, V10, P1359, DOI 10.1016/S0960-9822(00)00781-8; Wei YB, 2008, ACTA BIOCH BIOPH SIN, V40, P278, DOI 10.1111/j.1745-7270.2008.00407.x; Williams DS, 2020, MODERN PATHOL, V33, P483, DOI 10.1038/s41379-019-0353-2; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhang XR, 2017, ONCOTARGET, V8, P42602, DOI 10.18632/oncotarget.16645	66	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245581	10.1371/journal.pone.0245581	http://dx.doi.org/10.1371/journal.pone.0245581			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465114	Green Published, gold			2022-12-26	WOS:000611969200050
J	Xie, WX; Patel, A; Boersma, E; Feng, L; Li, M; Gao, RL; Wu, YF				Xie, Wuxiang; Patel, Anushka; Boersma, Eric; Feng, Lin; Li, Min; Gao, Runlin; Wu, Yangfeng			Chronic kidney disease and the outcomes of fibrinolysis for ST-segment elevation myocardial infarction: A real-world study	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; SERUM CREATININE; RENAL-DISEASE; ASSOCIATION; MORTALITY; TRIALS; RISK	Background In low-resource regions, fibrinolytic therapy is often the only option for ST-elevation myocardial infarction (STEMI) patients as primary percutaneous coronary intervention (PCI) is often not available and patients are hardly transferred to a medical center with PCI capacity within the first 120 minutes. Chronic kidney disease (CKD) is one of the most frequently encountered complications of STEMI. However, the evidence for the efficacy of fibrinolytic therapy in STEMI patients with CKD is still limited. The aim of this study is to test whether CKD modifies the association between fibrinolytic therapy and short-term major adverse cardiovascular events (MACEs) among patients with STEMI. Methods and findings This is a real-world study analyzing the data from 9508 STEMI patients (mean age: 64.0 +/- 12.4 years; male: 70.1%) in the third phase of Clinical Pathways in Acute Coronary Syndromes program (CPACS-3), which is a large study of the management of acute coronary syndromes (ACS) in 101 county hospitals without PCI capacity in China. CKD was defined as an estimated glomerular filtration rate of less than 60 mL/min per 1.73 m(2) at the admission. The primary outcome is short-term MACEs, including all-cause death, recurrent myocardial infarction, or nonfatal stroke. Patients were recruited consecutively between October 2011 and November 2014. Out of them, 1282 patients (13.5%) were classified as having CKD. Compared with non-CKD patients, CKD patients were less likely to receive fibrinolytic therapy than non-CKD patients (26.4% vs. 38.9%, P<0.001), more likely to experience a failed fibrinolytic therapy (32.8% vs. 16.9%), and had a higher risk of short-term MACEs (19.7% vs. 5.6%). After full adjustment, use of fibrinolytic therapy was associated with a significantly lower risk of short-term MACEs in non-CKD patients (relative risk [RR] = 0.87, 95% confidence interval [CI]: 0.76-0.99), but not in CKD patients (P for interaction = 0.026). Further analysis stratified by the success of fibrinolysis showed that compared with patients who did not receive fibrinolytic therapy, patients with successful fibrinolysis had a lower risk of short-term MACEs that was similar between patients with (RR = 0.71, 95% CI: 0.55-0.82) and without CKD (RR = 0.67, 95% CI: 0.55-0.92), while patients with unsuccessful fibrinolysis had a similarly higher risk in CKD patients (RR = 1.25, 95% CI: 1.09-1.43) and non-CKD patients (RR = 1.30, 95% CI: 1.13-1.50). Conclusions CKD reduced the likelihood of successful fibrinolysis and increased the risk of short-term MACEs in patients with STEMI. Attention should be paid to how to improve the success rate of fibrinolytic therapy for STEMI patients with CKD.	[Xie, Wuxiang; Feng, Lin; Wu, Yangfeng] Peking Univ, Clin Res Inst, Hosp 1, Beijing, Peoples R China; [Patel, Anushka] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia; [Boersma, Eric] Erasmus Med Coll, Dept Cardiol, Rotterdam, Netherlands; [Feng, Lin; Wu, Yangfeng] Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing, Peoples R China; [Li, Min] Capital Med Univ, Beijing Friendship Hosp, Clin Epidemiol & EBM Ctr, Beijing, Peoples R China; [Gao, Runlin] Chinese Acad Med Sci, Fuwai Hosp, Dept Cardiol, Beijing, Peoples R China; [Gao, Runlin] Peking Union Med Coll, Beijing, Peoples R China; [Wu, Yangfeng] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hlth Sci Ctr, Beijing, Peoples R China	Peking University; George Institute for Global Health; University of New South Wales Sydney; University of Sydney; Erasmus University Rotterdam; Erasmus MC; Peking University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University	Wu, YF (corresponding author), Peking Univ, Clin Res Inst, Hosp 1, Beijing, Peoples R China.; Wu, YF (corresponding author), Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing, Peoples R China.; Wu, YF (corresponding author), Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hlth Sci Ctr, Beijing, Peoples R China.	wuyf@bjmu.edu.cn	Xie, Wuxiang/GYU-3990-2022	Xie, Wuxiang/0000-0001-7527-1022; Wu, Yangfeng/0000-0002-4451-1932; Feng, Lin/0000-0002-6134-4937; Patel, Anushka/0000-0003-3825-4092	Sanofi, China; George Institute for Global Health at PUHSC	Sanofi, China(Sanofi-Aventis); George Institute for Global Health at PUHSC	\Source of funding used to support the research and creation of the article is from Sanofi, China, through an unrestricted research grant. The George Institute for Global Health at PUHSC sponsored the study and owns the data. However, the authors are solely responsible for the design and conduct of this study, all study analyses, the drafting and editing of the manuscript, and its final contents. The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Andersson C, 2012, JAMA-J AM MED ASSOC, V308, P882, DOI 10.1001/2012.jama.10779; [Anonymous], 2004, SAS USERS GROUP INT; Charytan D, 2006, KIDNEY INT, V70, P2021, DOI 10.1038/sj.ki.5001934; China Society of Cardiology of Chinese Medical Association Editorial Board of Chinese Journal of Cardiology, 2015, Zhonghua Xin Xue Guan Bing Za Zhi, V43, P380; Coca SG, 2006, JAMA-J AM MED ASSOC, V296, P1377, DOI 10.1001/jama.296.11.1377; Fox CS, 2010, CIRCULATION, V121, P357, DOI 10.1161/CIRCULATIONAHA.109.865352; Gackler A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212237; Gibson CM, 2003, J AM COLL CARDIOL, V42, P1535, DOI 10.1016/j.jacc.2003.06.001; Hobbach HP, 2003, J THROMB THROMBOLYS, V16, P167, DOI 10.1023/B:THRO.0000024055.13207.50; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Li J, 2015, LANCET, V385, P441, DOI 10.1016/S0140-6736(14)60921-1; Li SS, 2015, AM HEART J, V169, P349, DOI 10.1016/j.ahj.2014.12.005; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Medi C, 2009, JACC-CARDIOVASC INTE, V2, P26, DOI 10.1016/j.jcin.2008.09.010; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Wang HB, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016838; Washam JB, 2015, CIRCULATION, V131, P1123, DOI 10.1161/CIR.0000000000000183; Wu YF, 2019, JAMA CARDIOL, V4, P418, DOI 10.1001/jamacardio.2019.0897; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	22	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245576	10.1371/journal.pone.0245576	http://dx.doi.org/10.1371/journal.pone.0245576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465135	Green Published, gold			2022-12-26	WOS:000611969200017
J	da Fonseca, RD; Santos, PR; Monteiro, MS; Fernandes, LA; Campos, AH; Borges, DL; Rosa, SDRF				da Fonseca, Ronei Delfino; Santos, Paulo Roberto; Monteiro, Melissa Silva; Fernandes, Luciana Alves; Campos, Andreia Henrique; Borges, Dibio L.; Rosa, Suelia De Siqueira Rodrigues Fleury			Parametric evaluation of impedance curve in radiofrequency ablation: A quantitative description of the asymmetry and dynamic variation of impedance in bovine ex vivo model	PLOS ONE			English	Article							TARGET TISSUE NECROSIS; HEPATOCELLULAR-CARCINOMA; LIVER-TUMORS; RF ABLATION; TEMPERATURE; IMPEDIVITY; EFFICACY	Radiofrequency ablation (RFA) is a treatment for liver tumors with advantages over the traditional treatment of surgical resection. This procedure has the shortest recovery time in early stage tumors. The objective of this study is to parameterize the impedance curve of the RFA procedure in an ex vivo model by defining seven parameters (t(1/2), t(minimum), t(end), Z(initial), Z(1/2), Z(minimum) and Z(end)). Based on these parameters, three performance indices are defined: one to identify the magnitude of impedance curve asymmetry (delta), one Drop ratio (DR) describing the percentage of impedance decrease until the minimum impedance point is reached, and Ascent Ratio (AR) describing the magnitude of increase in impedance from the minimum impedance point to its maximum point. Fifty ablations were performed in a bovine ex vivo model to measure and evaluate the proposed parameters and performance index. The results show that the groups had an average delta of 29.02%, DR of 22.41%, and AR of 545.33% for RFA without the use of saline or deionized solutions. The saline solution and deionized water-cooled groups indicated the correlation of performance indices delta, DR, and AR with the obtained final ablation volume. Therefore, by controlling these parameters and indices, lower recurrence is achieved.	[da Fonseca, Ronei Delfino; Santos, Paulo Roberto; Campos, Andreia Henrique] Univ Brasilia, Technol Coll, Dept Mech Engn, Brasilia, DF, Brazil; [Monteiro, Melissa Silva] Univ Brasilia, Biol Inst, Brasilia, DF, Brazil; [Fernandes, Luciana Alves; Rosa, Suelia De Siqueira Rodrigues Fleury] Univ Brasilia, FGA, Post Grad Program Biomed Engn PPGEB, Gama, DF, Brazil; [Borges, Dibio L.] Univ Brasilia, Dept Comp Sci, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia	da Fonseca, RD (corresponding author), Univ Brasilia, Technol Coll, Dept Mech Engn, Brasilia, DF, Brazil.	ronei@unb.br	Fonseca, Ronei/AAD-2026-2021; de Siqueira Rodrigues Fleury Rosa, Suélia/U-5343-2019; Borges, Dibio Leandro/E-9562-2017	Fonseca, Ronei/0000-0001-8835-9031; de Siqueira Rodrigues Fleury Rosa, Suélia/0000-0002-1247-9050; Borges, Dibio Leandro/0000-0002-4868-0629	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil (CAPES); Postgraduate Program in Mechatronics Engineering (PPMEC) of the University of Brasilia; Postgraduate Program in Biomedical (PPGEB) of the University of Brasilia; Institute of Biological Sciences (IB) of the University of Brasilia; Federal Institute of Rondonia (IFRO)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Postgraduate Program in Mechatronics Engineering (PPMEC) of the University of Brasilia; Postgraduate Program in Biomedical (PPGEB) of the University of Brasilia; Institute of Biological Sciences (IB) of the University of Brasilia; Federal Institute of Rondonia (IFRO)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil (CAPES).; The present work was carried out with the support received from the Postgraduate Programs in Mechatronics Engineering (PPMEC), Biomedical (PPGEB), the Institute of Biological Sciences (IB) of the University of Brasilia and the Federal Institute of Rondonia (IFRO).	Arata MA, 2001, J VASC INTERV RADIOL, V12, P455, DOI 10.1016/S1051-0443(07)61884-3; Balogh J, 2016, J HEPATOCELL CARCINO, V3, P41, DOI 10.2147/JHC.S61146; Best J, 2017, ANN GASTROENTEROL, V30, P23, DOI 10.20524/aog.2016.0092; Bhaskaran A, 2016, J CARDIOVASC ELECTR, V27, P351, DOI 10.1111/jce.12893; Bjerkli IH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239783; Burton C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034222; Cole K. S., 1940, Cold Spring Harbor Symposia on Quantitative Biology, V8, P110; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; da Fonseca RD, 2019, IEEE T BIO-MED ENG, V66, P1390, DOI 10.1109/TBME.2018.2873141; Edd JF, 2005, IEEE T BIO-MED ENG, V52, P695, DOI 10.1109/TBME.2005.844042; Fukushima T, 2015, ONCOLOGY-BASEL, V89, P47, DOI 10.1159/000375166; Haukoos JS, 2005, ACAD EMERG MED, V12, P360, DOI 10.1197/j.aem.2004.11.018; Iida H, 2012, WORLD J GASTROENTERO, V18, P5870, DOI 10.3748/wjg.v18.i41.5870; Jiang XY, 2016, CARDIOVASC INTER RAD, V39, P600, DOI 10.1007/s00270-015-1218-9; Jossinet J, 1998, PHYSIOL MEAS, V19, P61, DOI 10.1088/0967-3334/19/1/006; Jossinet J, 1996, MED BIOL ENG COMPUT, V34, P346, DOI 10.1007/BF02520002; Lee, 2015, LIVER ABLATION BEST; Lin YQ, 2019, INT J HYPERTHER, V35, P450, DOI 10.1080/02656736.2018.1507047; Medavaram S, 2018, EXP HEMATOL ONCOL, V7, DOI 10.1186/s40164-018-0109-6; Patel V, 2019, SEMIN INTERVENT RAD, V36, P398, DOI 10.1055/s-0039-1697945; Possebon R, 2018, MED BIOL ENG COMPUT, V56, P385, DOI 10.1007/s11517-017-1699-6; R Core Team, 2013, R LANG ENV STAT COMP; Ramirez-Chavarria RG, 2018, ELECTROCHIM ACTA, V276, P214, DOI 10.1016/j.electacta.2018.04.167; Shirai W, 2005, ANAT HISTOL EMBRYOL, V34, P354, DOI 10.1111/j.1439-0264.2005.00623.x; Team R, 2017, RSTUDIO INT DEV ENV; Trujillo M, 2012, INT J HYPERTHER, V28, P62, DOI 10.3109/02656736.2011.631076; Ullah Waqas, 2017, JACC Clin Electrophysiol, V3, P1080, DOI 10.1016/j.jacep.2017.03.011; University of Brasilia Foundation Center TD, 2017, RAD HEP ABL SYST CON; Wallisch C, 2021, STAT MED, V40, P369, DOI 10.1002/sim.8779; Zaryab M, 2017, PROC SPIE, V10042, DOI 10.1117/12.2251654; Zhang B, 2016, PHYS MEDICA, V32, P961, DOI 10.1016/j.ejmp.2016.07.092; Zhang B, 2014, INT J HYPERTHER, V30, P593, DOI 10.3109/02656736.2014.984000; Ziemlewicz TJ, 2015, J VASC INTERV RADIOL, V26, P62, DOI 10.1016/j.jvir.2014.09.012	33	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245145	10.1371/journal.pone.0245145	http://dx.doi.org/10.1371/journal.pone.0245145			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449951	gold, Green Published			2022-12-26	WOS:000609991600037
J	Shoji, M; Sugimoto, M; Matsuno, K; Fujita, Y; Mii, T; Ayaki, S; Takeuchi, M; Yamaji, S; Tanaka, N; Takahashi, E; Noda, T; Kido, H; Tokuyama, T; Tokuyama, T; Tokuyama, T; Kuzuhara, T				Shoji, Masaki; Sugimoto, Minami; Matsuno, Kosuke; Fujita, Yoko; Mii, Tomohiro; Ayaki, Satomi; Takeuchi, Misa; Yamaji, Saki; Tanaka, Narue; Takahashi, Etsuhisa; Noda, Takeshi; Kido, Hiroshi; Tokuyama, Takaaki; Tokuyama, Takahito; Tokuyama, Takashi; Kuzuhara, Takashi			A novel aqueous extract from rice fermented with Aspergillus oryzae and Saccharomyces cerevisiae possesses an anti-influenza A virus activity	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; ANTIVIRAL AGENTS; PHENOLIC PROFILE; INFLUENZA; PEPTIDE; CELLS; RESISTANCE; MICE	Human influenza virus infections occur annually worldwide and are associated with high morbidity and mortality. Hence, development of novel anti-influenza drugs is urgently required. Rice Power(R) extract developed by the Yushin Brewer Co. Ltd. is a novel aqueous extract of rice obtained via saccharization and fermentation with various microorganisms, such as Aspergillus oryzae, yeast [such as Saccharomyces cerevisiae], and lactic acid bacteria, possessing various biological and pharmacological properties. In our previous experimental screening with thirty types of Rice Power(R) extracts, we observed that the 30(th) Rice Power(R) (Y30) extract promoted the survival of influenza A virus-infected Madin-Darby canine kidney (MDCK) cells. Therefore, to identify compounds for the development of novel anti-influenza drugs, we aimed to investigate whether the Y30 extract exhibits anti-influenza A virus activity. In the present study, we demonstrated that the Y30 extract strongly promoted the survival of influenza A H1N1 Puerto Rico 8/34 (A/PR/8/34), California 7/09, or H3N2 Aichi 2/68 (A/Aichi/2/68) viruses-infected MDCK cells and inhibited A/PR/8/34 or A/Aichi/2/68 viruses infection and growth in the co-treatment and pre-infection experiments. The pre-treatment of Y30 extract on MDCK cells did not induce anti-influenza activity in the cell. The Y30 extract did not significantly affect influenza A virus hemagglutination, and neuraminidase and RNA-dependent RNA polymerase activities. Interestingly, the electron microscopy experiment revealed that the Y30 extract disrupts the integrity of influenza A virus particles by permeabilizing the viral membrane envelope, suggesting that Y30 extract has a direct virucidal effect against influenza A virus. Furthermore, we observed that compared to the ethyl acetate (EtOAc) extract, the water extract of Y30 extract considerably promoted the survival of cells infected with A/PR/8/34 virus. These results indicated that more anti-influenza components were present in the water extract of Y30 extract than in the EtOAc extract. Our results highlight the potential of a rice extract fermented with A. oryzae and S. cerevisiae as an anti-influenza medicine and a drug source for the development of anti-influenza compounds.	[Shoji, Masaki; Sugimoto, Minami; Takeuchi, Misa; Yamaji, Saki; Tanaka, Narue; Kuzuhara, Takashi] Tokushima Bunri Univ, Lab Biochem, Fac Pharmaceut Sci, Yamashiro, Tokushima, Japan; [Matsuno, Kosuke; Mii, Tomohiro; Ayaki, Satomi; Tokuyama, Takaaki; Tokuyama, Takahito; Tokuyama, Takashi] Yushin Brewer Co Ltd, Ayagawa, Kagawa, Japan; [Fujita, Yoko; Noda, Takeshi] Kyoto Univ, Grad Sch Biostudies, Lab Ultrastruct Virol, Sakyo Ku, Shogoin Kawahara Cho, Kyoto, Japan; [Fujita, Yoko; Noda, Takeshi] Kyoto Univ, Inst Frontier Life & Med Sci, Lab Ultrastruct Virol, Sakyo Ku, Shogoin Kawahara Cho, Kyoto, Japan; [Takahashi, Etsuhisa; Kido, Hiroshi] Univ Tokushima, Inst Enzyme Res, Div Pathol & Metabolome Res Infect Dis & Host Def, Kuramoto Cho, Tokushima, Japan	Tokushima Bunri University; Kyoto University; Kyoto University; Tokushima University	Shoji, M; Kuzuhara, T (corresponding author), Tokushima Bunri Univ, Lab Biochem, Fac Pharmaceut Sci, Yamashiro, Tokushima, Japan.	masaki-shoji@ph.bunri-u.ac.jp; kuzuhara@ph.bunri-u.ac.jp		Fujita-Fujiharu, Yoko/0000-0002-2411-5473	Japan Society for the Promotion of Science (JSPS) [18K15173]; Yushin Brewer Co. Ltd.	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yushin Brewer Co. Ltd.	This study was partially supported by the Japan Society for the Promotion of Science (JSPS), Grants-in-Aid for Young Scientists 18K15173 (to MS) and the Grants from Yushin Brewer Co. Ltd. The Yushin Brewer Co. Ltd. provided the Y30 extract, a part of the grant, and support in the form of salaries for authors [KM, TM, SA, TakaaT, TakahT, TakasT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Akaike M, 2020, CURR MICROBIOL, V77, P632, DOI 10.1007/s00284-019-01718-4; Arakawa T, 2009, CURR MED CHEM, V16, P2485, DOI 10.2174/092986709788682065; Boonstra S, 2018, ANNU REV BIOPHYS, V47, P153, DOI 10.1146/annurev-biophys-070317-033018; Bunnoy A, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0624-5; Busath BHaDD, 2019, ADV COMPL ALT MED, V4, P358; Checkmahomed L, 2020, J INFECT DIS, V221, P63, DOI 10.1093/infdis/jiz418; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Di Sotto A, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/5919237; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Furihata C, 1996, CANCER DETECT PREV, V20, P193; Hamauzu Y, 2005, J AGR FOOD CHEM, V53, P928, DOI 10.1021/jf0494635; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; Hayden FG, 2018, NEW ENGL J MED, V379, P913, DOI 10.1056/NEJMoa1716197; Hiasa M, 2013, BRIT J PHARMACOL, V169, P115, DOI 10.1111/bph.12102; Hirai S, 2014, LIFE SCI, V117, P1, DOI 10.1016/j.lfs.2014.08.017; Ho BY, 2010, INTEGR CANCER THER, V9, P204, DOI 10.1177/1534735410365079; Holthausen DJ, 2017, IMMUNITY, V46, P587, DOI 10.1016/j.immuni.2017.03.018; Horie Y, 2016, APPL BIOCHEM BIOTECH, V178, P1599, DOI 10.1007/s12010-015-1970-y; Hurt Aeron C, 2006, Expert Rev Anti Infect Ther, V4, P795, DOI 10.1586/14787210.4.5.795; Ikeda K, 2020, JPN J INFECT DIS, V73, P8, DOI 10.7883/yoken.JJID.2018.522; Itoh M, 2012, PHYTOTHER RES, V26, P1661, DOI 10.1002/ptr.4631; Kim D, 2011, PLANT FOOD HUM NUTR, V66, P285, DOI 10.1007/s11130-011-0243-3; Kiyono T, 2013, J AGR FOOD CHEM, V61, P11660, DOI 10.1021/jf404381w; Kong B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08138-1; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Lee CI, 2013, APPL MICROBIOL BIOT, V97, P1269, DOI 10.1007/s00253-012-4279-6; Lee CL, 2008, APPL MICROBIOL BIOT, V79, P829, DOI 10.1007/s00253-008-1480-8; Li QL, 2011, PEPTIDES, V32, P1518, DOI 10.1016/j.peptides.2011.05.015; Li ZT, 2018, J THORAC DIS, V10, pS2248, DOI 10.21037/jtd.2018.03.169; Lin CP, 2011, J PHARM PHARMACOL, V63, P1587, DOI 10.1111/j.2042-7158.2011.01364.x; Liu Q, 2013, ACTA PHARMACOL SIN, V34, P1075, DOI 10.1038/aps.2013.54; Murakami M, 2005, J GASTROENTEROL, V40, P459, DOI 10.1007/s00535-005-1570-7; Ochiai M, 2013, BIOSCI BIOTECH BIOCH, V77, P243, DOI 10.1271/bbb.120638; Oh WS, 2020, FOOD SCI NUTR, V8, P1718, DOI 10.1002/fsn3.1460; Oxford John S., 2005, Antiviral Chemistry & Chemotherapy, V16, P129; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; Boas LCPV, 2019, CELL MOL LIFE SCI, V76, P3525, DOI 10.1007/s00018-019-03138-w; Poland GA, 2009, CLIN INFECT DIS, V48, P1254, DOI 10.1086/598989; Popkin Daniel L, 2017, Pathog Immun, V2, P252, DOI 10.20411/pai.v2i2.200; Shigeta S, 1997, ANTIMICROB AGENTS CH, V41, P1423, DOI 10.1128/AAC.41.7.1423; Shin HY, 2019, FOOD CHEM, V272, P235, DOI 10.1016/j.foodchem.2018.07.174; Shirako S, 2019, NPJ SCI FOOD, V3, DOI 10.1038/s41538-019-0050-z; Shoji M, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1612-8; Shoji M, 2015, J BIOL CHEM, V290, P28001, DOI 10.1074/jbc.M115.669465; Shoji M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066337; Skalickova S, 2015, VIRUSES-BASEL, V7, P5428, DOI 10.3390/v7102883; Takahashi E, 2012, J VIROL, V86, P10924, DOI 10.1128/JVI.01207-12; Takahashi H, 2016, J AGR FOOD CHEM, V64, P8848, DOI 10.1021/acs.jafc.6b03516; Takashita E, 2019, EMERG INFECT DIS, V25, P2108, DOI 10.3201/eid2511.190757; Takeda Y, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12070699; Tatsukami Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190040; Tseng WT, 2016, FOOD FUNCT, V7, P752, DOI [10.1039/c5fo00976f, 10.1039/C5FO00976F]; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Watanabe T, 2014, CELL HOST MICROBE, V16, P795, DOI 10.1016/j.chom.2014.11.002; Webber DM, 2014, J FOOD SCI, V79, pH2383, DOI 10.1111/1750-3841.12658; WHO, INFL SEAS FACT SHEET; Xu X, 2019, MOLECULES, V24, DOI 10.3390/molecules24040671; Zhang L, 2010, MOLECULES, V15, P8507, DOI 10.3390/molecules15118507	58	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0244885	10.1371/journal.pone.0244885	http://dx.doi.org/10.1371/journal.pone.0244885			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449947	Green Published, gold			2022-12-26	WOS:000609991600013
J	Araujo, MPD; Nunes, VMD; Costa, LD; de Souza, TA; Torres, GD; Nobre, TTX				Araujo, Mayara Priscilla Dantas; Nunes, Vilani Medeiros de Araujo; Costa, Larissa de Albuquerque; de Souza, Talita Araujo; Torres, Gilson de Vasconcelos; Nobre, Thaiza Teixeira Xavier			Health conditions of potential risk for severe Covid-19 in institutionalized elderly people	PLOS ONE			English	Article								The objective of this study was to identify the health conditions considered potential risk factors for severe Covid-19 and analyze its association with the BMI of elderly people living in Long-Term Care Facilities (LTCF). This is a descriptive and cross-sectional study, with a quantitative approach, carried out in eight LTCF in the Metropolitan Region of Natal, Rio Grande do Norte, with a population of 267 elderly people, between the months of February and December 2018. The Elderly Health Handbook was used to collect data on sociodemographic, health and risk factors. The Pearson's Chi-square test and odds ratio were used for the analysis. A higher frequency of low weight was observed in elderly people with cognitive impairment (24.6%), and overweight in those hypertensive (23.3%) and diabetics (12.9%). BMI was associated with the age group of 80 years or over, hypertension and diabetes (p = 0.013; p < 0.001; p = 0.001). Hypertensive elderly people were more likely to have low weight when compared to non-hypertensive individuals (RC = 3.6; 95% CI 1.5-8.6). The institutionalized elderly individuals present health conditions that may contribute to the occurrence of adverse outcomes in case of infection by Covid-19. The importance of protective measures for this population must be reinforced, in view of the devastating action of this disease in these institutions.	[Araujo, Mayara Priscilla Dantas; Nunes, Vilani Medeiros de Araujo] Univ Fed Rio Grande do Norte, Dept Collect Hlth, Natal, RN, Brazil; [Costa, Larissa de Albuquerque] Municipal Secretary Hlth, Natal, RN, Brazil; [de Souza, Talita Araujo; Nobre, Thaiza Teixeira Xavier] Univ Fed Rio Grande do Norte, Fac Hlth Sci Trairi, Santa Cruz, RS, Brazil; [Torres, Gilson de Vasconcelos] Univ Fed Rio Grande do Norte, Dept Nursing, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Araujo, MPD (corresponding author), Univ Fed Rio Grande do Norte, Dept Collect Hlth, Natal, RN, Brazil.	mayaraaraujonutri@gmail.com	Nobre, Thaiza Teixeira Xavier/ABC-5353-2021; Torres, Gilson/AAZ-7788-2021	Nobre, Thaiza Teixeira Xavier/0000-0002-8673-0009; Torres, Gilson/0000-0003-2265-5078; Araujo, Mayara/0000-0002-0611-2949	International Network for Research on Vulnerability, Health, Safety and Quality of Life of the Elderly; Pro-Rectory of Research of Federal University of Rio Grande do Norte (PROPESQ UFRN) [01/2020]; National Council for Scientific and Technological Development (CNPq) [309213/2017-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazil (CAPES) [001]	International Network for Research on Vulnerability, Health, Safety and Quality of Life of the Elderly; Pro-Rectory of Research of Federal University of Rio Grande do Norte (PROPESQ UFRN); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The project was funded by the International Network for Research on Vulnerability, Health, Safety and Quality of Life of the Elderly: Brazil, Portugal and Spain, by the Edital 01/2020 of Pro-Rectory of Research of Federal University of Rio Grande do Norte (PROPESQ UFRN). GVT is a productivity fellow by the National Council for Scientific and Technological Development (CNPq) [process 309213/2017-7] and MPDA is a fellow by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazil (CAPES) - Finance Code 001.	Andrade Fabienne Louise Juvêncio Paes de, 2017, Rev. bras. geriatr. gerontol., V20, P186, DOI 10.1590/1981-22562017020.160151; Barazzoni R, 2020, CLIN NUTR, V39, P1631, DOI 10.1016/j.clnu.2020.03.022; Caccialanza R, 2020, NUTRITION, V74, DOI 10.1016/j.nut.2020.110835; Centers for Disease Control and Prevention, 2020, PEOPL WHO AR HIGH RI; Cordasco Fabrizio, 2020, Med Leg J, V88, P66, DOI 10.1177/0025817220930552; Damião Renata, 2017, Rev. bras. epidemiol., V20, P598, DOI 10.1590/1980-5497201700040004; Damo Cássia Cassol, 2018, Rev. bras. geriatr. gerontol., V21, P711, DOI 10.1590/1981-22562018021.180152; Morais AHD, 2021, BRIT J NUTR, V125, P851, DOI 10.1017/S0007114520003311; Fluetti Marina Tadini, 2018, Rev. bras. geriatr. gerontol., V21, P60, DOI 10.1590/1981-22562018021.170098; Pinheiro NCG, 2016, CIENC SAUDE COLETIVA, V21, P3399, DOI 10.1590/1413-812320152111.19472015; Li T, 2020, EUR J CLIN NUTR, V74, P871, DOI 10.1038/s41430-020-0642-3; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Li X, 2020, INT J INFECT DIS, V94, P128, DOI 10.1016/j.ijid.2020.03.053; McMichael TM, 2020, NEW ENGL J MED, V382, P2005, DOI 10.1056/NEJMoa2005412; Ministerio da Saude, 2017, CAD SAUD PESS ID; Muscogiuri G, 2020, METABOLISM, V108, DOI 10.1016/j.metabol.2020.154251; Nunes BP, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311X00129620, 10.1590/0102-311x00129620]; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Puig-Domingo M, 2020, ENDOCRINE, V68, P2, DOI 10.1007/s12020-020-02294-5; Reis Karine Marques Costa dos, 2017, Texto contexto - enferm., V26, pe03040015, DOI 10.1590/0104-07072017003040015; Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831; Sinclair AJ, 2020, ECLINICALMEDICINE, V22, DOI 10.1016/j.eclinm.2020.100343; Sun HY, 2020, J AM GERIATR SOC, V68, pE19, DOI 10.1111/jgs.16533; Sun JM, 2020, TRENDS MOL MED, V26, P483, DOI 10.1016/j.molmed.2020.02.008; Wang L, 2020, J INFECTION, V80, P639, DOI 10.1016/j.jinf.2020.03.019; World Health Organization, 2020, 64 WHO; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	29	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245432	10.1371/journal.pone.0245432	http://dx.doi.org/10.1371/journal.pone.0245432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444352	gold, Green Published			2022-12-26	WOS:000609988100049
J	Gu, YY; Zhang, M; Cen, H; Wu, YF; Lu, ZY; Lu, FH; Liu, XS; Lan, HY				Gu, Yue-Yu; Zhang, Min; Cen, Huan; Wu, Yi-Fan; Lu, Zhaoyu; Lu, Fuhua; Liu, Xu-Sheng; Lan, Hui-Yao			Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study	PLOS ONE			English	Article							INTEGRATING INFORMATION; SARS-COV-2; GENES	Kidneys are one of the targets for SARS-CoV-2, it is reported that up to 36% of patients with SARS-CoV-2 infection would develop into acute kidney injury (AKI). AKI is associated with high mortality in the clinical setting and contributes to the transition of AKI to chronic kidney disease (CKD). Up to date, the underlying mechanisms are obscure and there is no effective and specific treatment for COVID-19-induced AKI. In the present study, we investigated the mechanisms and interactions between Quercetin and SARS-CoV-2 targets proteins by using network pharmacology and molecular docking. The renal protective effects of Quercetin on COVID-19-induced AKI may be associated with the blockade of the activation of inflammatory, cell apoptosis-related signaling pathways. Quercetin may also serve as SARS-CoV-2 inhibitor by binding with the active sites of SARS-CoV-2 main protease 3CL and ACE2, therefore suppressing the functions of the proteins to cut the viral life cycle. In conclusion, Quercetin may be a novel therapeutic agent for COVID-19-induced AKI. Inhibition of inflammatory, cell apoptosis-related signaling pathways may be the critical mechanisms by which Quercetin protects kidney from SARS-CoV-2 injury.	[Gu, Yue-Yu; Zhang, Min; Wu, Yi-Fan; Lu, Zhaoyu; Lu, Fuhua; Liu, Xu-Sheng] Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Dept Nephrol, Guangzhou, Peoples R China; [Cen, Huan] Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Dept Ultrasound, Guangzhou, Peoples R China; [Lan, Hui-Yao] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut, Hong Kong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Chinese University of Hong Kong	Liu, XS (corresponding author), Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Dept Nephrol, Guangzhou, Peoples R China.; Lan, HY (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut, Hong Kong, Peoples R China.	hylan@cuhk.edu.hk; liuxusheng@gzucm.edu.cn	Lan, Hui Yao/C-9734-2015; Gu, Yue-Yu/AAJ-1947-2021	Lan, Hui Yao/0000-0003-4283-9755; Gu, Yue-Yu/0000-0003-4390-0108; Cen, Huan/0000-0002-9410-7006	Research Grants Council of Hong Kong [GRF 14163317, 14117418, 14104019, R4012-18, C7018-16G]; Lui Che Woo Institute of Innovative Medicine (CARE); Health and Medical Research Fund of Hong Kong [HMRF 05161326, 06173986, 14152321]; National Natural Science Foundation of China [81903956]; Project of Guangdong Province Administration of Traditional Chinese Medicine [20201133]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Lui Che Woo Institute of Innovative Medicine (CARE); Health and Medical Research Fund of Hong Kong; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Guangdong Province Administration of Traditional Chinese Medicine	This work was supported by the Research Grants Council of Hong Kong (Grants GRF 14163317, 14117418, 14104019, R4012-18, and C7018-16G); Lui Che Woo Institute of Innovative Medicine (CARE); the Health and Medical Research Fund of Hong Kong (Grants HMRF 05161326, 06173986, and 14152321); the National Natural Science Foundation of China (No. 81903956), the Project of Guangdong Province Administration of Traditional Chinese Medicine (No. 20201133).	Abian O, 2020, INT J BIOL MACROMOL, V164, P1693, DOI 10.1016/j.ijbiomac.2020.07.235; Ahmed SSSJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040654; Amberger Joanna S, 2017, Curr Protoc Bioinformatics, V58, DOI 10.1002/cpbi.27; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Aucoin M, 2020, ADV INTEGR MED, V7, P247, DOI 10.1016/j.aimed.2020.07.007; Braun F, 2020, LANCET, V396, P597, DOI 10.1016/S0140-6736(20)31759-1; Chaibi K, 2020, AM J RESP CRIT CARE, V202, P1299, DOI 10.1164/rccm.202005-1524LE; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Biancatelli RMLC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01451; Ding T, 2018, PHYTOMEDICINE, V41, P45, DOI 10.1016/j.phymed.2018.01.026; Duret PM, 2020, ANN RHEUM DIS, V79, P1250, DOI 10.1136/annrheumdis-2020-217362; Farkash EA, 2020, J AM SOC NEPHROL, V31, P1683, DOI 10.1681/ASN.2020040432; Fatoki TH, 2021, J BIOMOL STRUCT DYN, V39, P6195, DOI 10.1080/07391102.2020.1794971; Gabarre P, 2020, INTENS CARE MED, V46, P1339, DOI 10.1007/s00134-020-06153-9; Gfeller D, 2014, NUCLEIC ACIDS RES, V42, pW32, DOI 10.1093/nar/gku293; Glinsky GV, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8050129; Gu YY, 2018, PHYTOMEDICINE, V51, P214, DOI 10.1016/j.phymed.2018.10.004; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069; Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006; Hopkins AL, 2014, NAT REV DRUG DISCOV, V13, P105, DOI 10.1038/nrd4163; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YF, 2020, PHARMACOL RES, V158, DOI 10.1016/j.phrs.2020.104939; Kim S, 2016, EXPERT OPIN DRUG DIS, V11, P843, DOI 10.1080/17460441.2016.1216967; Kunutsor SK, 2020, ANN MED, V52, P345, DOI 10.1080/07853890.2020.1790643; Leija-Martinez JJ, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.109935; Li J, 2019, INTERDISCIP SCI, V11, P320, DOI 10.1007/s12539-019-00327-w; Lim JH, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061718; Liu XH, 2019, FOOD FUNCT, V10, P3782, DOI 10.1039/c9fo00373h; Lu H, 2018, BIOCHEM PHARMACOL, V154, P203, DOI 10.1016/j.bcp.2018.05.007; Luo L, 2020, ACTA PHARMACOL SIN B, V10, P1192, DOI 10.1016/j.apsb.2020.05.007; Ma QH, 2020, PHARMACOL RES, V158, DOI 10.1016/j.phrs.2020.104850; Nain Z, 2020, PATHOGENETIC PROFILI, DOI [10.1093/bib/bbaa173, DOI 10.1093/BIB/BBAA173]; Noris M, 2020, KIDNEY INT, V98, P314, DOI 10.1016/j.kint.2020.05.013; Pinero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Pinzi L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184331; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Renu K, 2020, LIFE SCI, V255, DOI 10.1016/j.lfs.2020.117839; Ronco C, 2020, NAT REV NEPHROL, V16, P308, DOI 10.1038/s41581-020-0284-7; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Ruan XF, 2020, CHIN MED-UK, V15, DOI 10.1186/s13020-020-00346-6; Russo M, 2020, CHEM-BIOL INTERACT, V328, DOI 10.1016/j.cbi.2020.109211; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003; Tan RZ, 2020, PHYTOTHER RES, V34, P139, DOI 10.1002/ptr.6507; Tao QY, 2020, DRUG DEV IND PHARM, V46, P1345, DOI 10.1080/03639045.2020.1788070; Ursu O, 2011, WIRES COMPUT MOL SCI, V1, P760, DOI 10.1002/wcms.52; Vijayakumar BG, 2020, EUR J PHARMACOL, V886, DOI 10.1016/j.ejphar.2020.173448; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Vuong W, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18096-2; Wang MZ, 2021, COMB CHEM HIGH T SCR, V24, P294, DOI 10.2174/1386207323666200806164635; Williams VR, 2018, CURR OPIN NEPHROL HY, V27, P35, DOI 10.1097/MNH.0000000000000378; Williamson G, 2020, BIOCHEM PHARMACOL, V178, DOI 10.1016/j.bcp.2020.114123; Yang H, 2018, MED SCI MONITOR, V24, P4760, DOI 10.12659/MSM.909259; Yang Y, 2020, INT J BIOL SCI, V16, P1708, DOI 10.7150/ijbs.45538	58	20	20	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245209	10.1371/journal.pone.0245209	http://dx.doi.org/10.1371/journal.pone.0245209			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444408	Green Published, gold			2022-12-26	WOS:000609988100006
J	Murali, M; Suppes, SL; Feldman, K; Goldman, JL				Murali, Madhavi; Suppes, Sarah L.; Feldman, Keith; Goldman, Jennifer L.			Utilization of the Naranjo scale to evaluate adverse drug reactions at a free-standing children's hospital	PLOS ONE			English	Article							CAUSALITY ASSESSMENT; EXPERT JUDGMENT; PROBABILITY	The relationship between the Naranjo scaling system and pediatric adverse drug reactions (ADR) is poorly understood. We performed a retrospective review of 1,676 pediatric ADRs documented at our hospital from 2014-2018. We evaluated patient demographics, implicated medication, ADR severity, calculated Naranjo score, associated symptoms, and location within the hospital in which the ADR was documented. ADR severity was poorly correlated with Naranjo interpretation. Out of the 10 Naranjo scale questions, 4 had a response of "unknown" greater than 85% of the time. Cardiovascular and oncological/immunologic agents were more likely to have a probable or definite Naranjo interpretation compared to antimicrobials. Further strategies are needed to enhance the causality assessment of pediatric ADRs in clinical care.	[Murali, Madhavi] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Suppes, Sarah L.] Childrens Mercy Kansas City, Div Clin Pharmacol, Kansas City, MO USA; [Feldman, Keith; Goldman, Jennifer L.] Childrens Mercy Kansas City, Dept Pediat, Kansas City, MO 64108 USA; [Feldman, Keith; Goldman, Jennifer L.] Univ Missouri, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City; Children's Mercy Hospital; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City	Goldman, JL (corresponding author), Childrens Mercy Kansas City, Dept Pediat, Kansas City, MO 64108 USA.; Goldman, JL (corresponding author), Univ Missouri, Kansas City, MO 64110 USA.	jlgoldman@cmh.edu	Feldman, Keith/AAH-5861-2020	Feldman, Keith/0000-0001-6935-5844; Murali, Madhavi/0000-0003-0077-9256; Goldman, Jennifer/0000-0001-6628-8949				[Anonymous], 1972, World Health Organ Tech Rep Ser, V498, P1; [Anonymous], **DATA OBJECT**, DOI DOI 10.5281/ZENODO.2587757; Arimone Y, 2005, EUR J CLIN PHARMACOL, V61, P169, DOI 10.1007/s00228-004-0869-2; Avner Marina, 2007, Paediatr Drugs, V9, P267, DOI 10.2165/00148581-200709040-00007; Blumenthal KG, 2019, LANCET, V393, P183, DOI 10.1016/S0140-6736(18)32218-9; Cammack B, 2019, PEDIATR QUAL SAF, V4, DOI 10.1097/pq9.0000000000000203; Gallagher RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028096; Goldman JL, 2019, EUR J CLIN PHARMACOL, V75, P1135, DOI 10.1007/s00228-019-02670-9; Goldman JL, 2013, THER INNOV REGUL SCI, V47, P566, DOI 10.1177/2168479013499153; HARTWIG SC, 1992, AM J HOSP PHARM, V49, P2229, DOI 10.1093/ajhp/49.9.2229; Misirlioglu ED, 2017, J ALLER CL IMM-PRACT, V5, P757, DOI 10.1016/j.jaip.2017.02.013; Murayama H, 2018, PHARMACOL RES PERSPE, V6, DOI 10.1002/prp2.373; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Norton AE, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2497; Opioids, 2012, LIVERTOX CLIN RES IN; Rieder Michael, 2019, J Pediatr Pharmacol Ther, V24, P4, DOI 10.5863/1551-6776-24.1.4; Sassolas B, 2010, CLIN PHARMACOL THER, V88, P60, DOI 10.1038/clpt.2009.252; Shehab N, 2016, JAMA-J AM MED ASSOC, V316, P2115, DOI 10.1001/jama.2016.16201; Shenoy ES, 2019, JAMA-J AM MED ASSOC, V321, P188, DOI 10.1001/jama.2018.19283; Smyth RMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024061; Theophile H, 2010, DRUG SAFETY, V33, P1045, DOI 10.2165/11537780-000000000-00000; Tillman EM, 2021, J CLIN PHARMACOL, V61, P181, DOI 10.1002/jcph.1717; Uppsala Monitoring Centre, US WHO UMC SYST STAN; Varallo FR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171470; Vazquez-Alvarez AO, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0186-x; Vyles D, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0471; World Health Organization, MED SAF MED ADV DRUG; Yu D, 2019, J CLIN PHARMACOL, V59, P1569, DOI 10.1002/jcph.1494	28	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0245368	10.1371/journal.pone.0245368	http://dx.doi.org/10.1371/journal.pone.0245368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439905	Green Published, gold			2022-12-26	WOS:000609985300002
J	Guo, JZ; Shi, WJ; Li, JK; Zhai, ZM				Guo, Jianzhong; Shi, Wenjuan; Li, Jiake; Zhai, Zhongmin			Effects of poly-gamma-glutamic acid and poly-gamma-glutamic acid super absorbent polymer on the sandy loam soil hydro-physical properties	PLOS ONE			English	Article							NITROGEN USE EFFICIENCY; WATER INFILTRATION; BACILLUS-SUBTILIS; YIELD; PRODUCTIVITY; POROSITY; QUALITY	The main forms of poly-gamma-glutamic acid (gamma-PGA) applied in agriculture include agricultural gamma-PGA and gamma-PGA super absorbent polymer (SAP). Laboratory experiments were conducted with a check treatment CK (no gamma-PGA added) and two different forms of gamma-PGA added to sandy loam soil (T and TM stand for gamma-PGA and gamma-PGA SAP) at four different soil mass ratios (0.05% (1), 0.10% (2), 0.15% (3) and 0.20% (4)) to determine their effects on sandy loam soil hydro-physical properties. Both of them could reduce the cumulative infiltration of soil water. The total available water (TAW) which the soil water content (SWC) from field water capacity (FC) to permanent wilting point (PWP) after gamma-PGA added into sandy loam soil had no significant different compared with CK, and the TAW was highest at the treatment of gamma-PGA with 0.10% addition amount into sandy loam soil. However, the TAW of sandy loam soil increased dramatically with the gamma-PGA SAP addition amount increasing. TM3 had the highest soil water absorption among the treatments with gamma-PGA SAP. The T1 to T4 treatments with gamma-PGA addition slightly prolonged retention time (RT) when SWC varied from FC to PWP compared with CK. For gamma-PGA SAP addition treatments, the time for SWC varied from FC to PWP was 1.48 times (TM1), 1.88 times (TM2), 2.01 times (TM3) and 2.87 times (TM4) longer than that of CK, respectively. The results of this study will provide further information for the use of these materials in agricultural application.	[Guo, Jianzhong; Shi, Wenjuan; Li, Jiake; Zhai, Zhongmin] Xian Univ Technol, State Key Lab Ecohydraul Northwest Arid Reg China, Xian, Peoples R China	Xi'an University of Technology	Shi, WJ (corresponding author), Xian Univ Technol, State Key Lab Ecohydraul Northwest Arid Reg China, Xian, Peoples R China.	shiwj@xaut.edu.cn		Guo, Jianzhong/0000-0003-2144-1764	National Natural Science Foundation of China [42077011]; Shaanxi Provincial Natural Science Basic Research Program [2018JM5051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Natural Science Basic Research Program	This work was financially supported by the National Natural Science Foundation of China (42077011), the Shaanxi Provincial Natural Science Basic Research Program (Program No. 2018JM5051).	Agriculture USDo, 2010, KEYS SOIL TAXONOMY, VEleventh; Alam MN, 2019, ACS OMEGA, V4, P9419, DOI 10.1021/acsomega.9b00651; [Anonymous], 2018, CHEM ENG RES DES, V129, pA1; Bai W, 2010, SOIL USE MANAGE, V26, P253, DOI 10.1111/j.1475-2743.2010.00271.x; Buwalda SJ, 2014, J CONTROL RELEASE, V190, P254, DOI 10.1016/j.jconrel.2014.03.052; Cagri-Mehmetoglu A, 2015, POLYM-KOREA, V39, P801, DOI 10.7317/pk.2015.39.5.801; Chen L, 2018, PLANT SOIL ENVIRON, V64, P517, DOI 10.17221/371/2018-PSE; Chen XN, 2005, BIORESOURCE TECHNOL, V96, P1872, DOI 10.1016/j.biortech.2005.01.033; CROMWICK AM, 1995, CAN J MICROBIOL, V41, P902, DOI 10.1139/m95-124; Fei YH, 2019, SOIL TILL RES, V193, P59, DOI 10.1016/j.still.2019.05.024; Ferreira TR, 2018, GEODERMA, V324, P119, DOI 10.1016/j.geoderma.2018.03.015; Flory PJ, 1954, SCI MONTHLY, V79; Gar WX, 2019, MICROB BIOTECHNOL, V12, P932, DOI 10.1111/1751-7915.13446; Guo JZ, 2020, ARCH AGRON SOIL SCI, V66, P1627, DOI 10.1080/03650340.2019.1686137; Han YG, 2010, ENVIRON EARTH SCI, V61, P1197, DOI 10.1007/s12665-009-0443-4; Hillel D., 2013, INTRO SOIL PHYS; Hoisaeter A, 2019, J CONTAM HYDROL, V222, P112, DOI 10.1016/j.jconhyd.2019.02.010; Hou XQ, 2018, J SOIL SEDIMENT, V18, P816, DOI 10.1007/s11368-017-1818-x; Inbaraj BS, 2006, J HAZARD MATER, V137, P226, DOI 10.1016/j.jhazmat.2006.01.057; Jassogne L, 2007, EUR J SOIL SCI, V58, P589, DOI 10.1111/j.1365-2389.2006.00849.x; Kunioka M, 1998, POLYM DEGRAD STABIL, V59, P33, DOI 10.1016/S0141-3910(97)00181-X; Li Z, 2017, RSC ADV, V7, P11085, DOI 10.1039/c6ra26419k; Liang JP, 2019, AGR WATER MANAGE, V218, P48, DOI 10.1016/j.agwat.2019.03.009; Liao RK, 2019, J ENVIRON MANAGE, V248, DOI 10.1016/j.jenvman.2019.109303; Luo ZT, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0537-7; Ma XF, 2020, J POLYM RES, V27, DOI 10.1007/s10965-020-02097-2; Mamberti S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130810; Mostafa KM, 2018, J POLYM ENVIRON, V26, P3250, DOI 10.1007/s10924-018-1209-4; Murakami S, 2006, BIOMACROMOLECULES, V7, P2122, DOI 10.1021/bm0600264; Philip JR, 1957, SOIL SCI, V83; Qiao DL, 2019, INT J BIOL MACROMOL, V129, P679, DOI 10.1016/j.ijbiomac.2019.02.019; Rehm BHA, 2010, NAT REV MICROBIOL, V8, P578, DOI 10.1038/nrmicro2354; Sepaskhah AR, 2010, BIOSYST ENG, V106, P513, DOI 10.1016/j.biosystemseng.2010.05.019; Shen J, 2018, MOLECULES, V23, DOI 10.3390/molecules23102483; Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8; Sun JN, 2019, CAN J SOIL SCI, V99, P357, DOI 10.1139/cjss-2019-0004; Valiantzas JD, 2009, J IRRIG DRAIN ENG, V135, P450, DOI 10.1061/(ASCE)IR.1943-4774.0000011; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Xu Z, 2013, J SOIL SCI PLANT NUT, V13, P744, DOI [10.4067/S0718-95162013005000071, 10.4067/S0718-95162013005000059]; Yang W, 2019, J SCI FOOD AGR, V99, P350, DOI 10.1002/jsfa.9195; Yu J, 2017, SOIL SCI SOC AM J, V81, P889, DOI 10.2136/sssaj2016.07.0231; Zhang BN, 2011, POLYM COMPOSITE, V32, P683, DOI 10.1002/pc.21077; Zhang J, 2017, CATENA, V157, P344, DOI 10.1016/j.catena.2017.05.013; Zohuriaan-Mehr MJ, 2010, J MATER SCI, V45, P5711, DOI 10.1007/s10853-010-4780-1	44	1	2	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245365	10.1371/journal.pone.0245365	http://dx.doi.org/10.1371/journal.pone.0245365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434231	gold, Green Published			2022-12-26	WOS:000609979700009
J	Zhang, ZP; Liu, YC; Dai, HB; Miao, MM				Zhang, Zhi-ping; Liu, Yan-cheng; Dai, Hai-bo; Miao, Min-min			Characteristics and expression patterns of six alpha-galactosidases in cucumber (Cucumis sativus L.)	PLOS ONE			English	Article							MELON FRUIT; RAFFINOSE; METABOLISM; FAMILY; GENE; CARBOHYDRATE; LEAVES; OLIGOSACCHARIDES; PURIFICATION; CLONING	Six putative alpha-galactosidase genes (alpha-Gals), three acid forms (CsGAL1, CsGAL2, CsGAL3) and three alkaline forms (CsAGA1, CsAGA2, CsAGAL3), were found in the cucumber genome. It is interesting to know the expression pattern and possible function of these alpha-Gals in the cucumber plant since it is a stachyose-translocating species. In this study, full-length cDNAs of six alpha-Gals were cloned and heterologously expressed. The result showed that all recombinant proteins revealed acid or alkaline alpha-Gal activities with different substrate specificities and pH or temperature responding curves, indicating their distinct roles in cucumber plants. Phylogenetic analysis of collected alpha-Gal amino acid sequences from different plants indicated that the ancestor of both acid and alkaline alpha-Gals existed before monocots and dicots separated. Generally, six alpha-Gal genes are universally expressed in different cucumber organs. CsGAL2 highly expressed in fasting-growing leaves, fruits and germinating seeds; CsGAL3 mainly distributes in vacuoles and significantly expressed in cucumber fruits, senescent leaves and seeds during late stage germination; The expression of CsAGA1 increased from leaf 1 to leaf 3 (sink leaves) and then declined from leaf 4 to leaf 7 (source leaves), and this isoform also highly expressed in male flowers and germinating seeds at early stage; CsAGA2 significantly expressed in cucumber leaves and female flowers; CsAGA3 is localized in plastids and also actively expressed in senescent leaves and germinating seeds; The role of CsGAL1 in cucumber plants is now unclear since its expression was relatively low in all organs. According to their expression patterns, subcellular localizations and previously reported functions of these isoforms in other plants, combining the data of soluble sugars contents in different tissues, the possible functions of these alpha-Gals were discussed.	[Zhang, Zhi-ping; Liu, Yan-cheng; Dai, Hai-bo; Miao, Min-min] Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China	Yangzhou University	Miao, MM (corresponding author), Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China.	mmmiao@yzu.edu.cn			National Key Research and Development Program of China [2018YFD1000800]; National Natural Science Foundation of China [31872107, 31672160]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This paper was supported by National Key Research and Development Program of China (2018YFD1000800) and National Natural Science Foundation of China (No. 31872107, 31672160).	Aerts JMFG, 2019, CURR OPIN CHEM BIOL, V53, P204, DOI 10.1016/j.cbpa.2019.10.006; Blochl A, 2008, PLANTA, V228, P99, DOI 10.1007/s00425-008-0722-4; Carmi N, 2003, PLANT J, V33, P97, DOI 10.1046/j.1365-313X.2003.01609.x; Chrost B, 1997, J PLANT PHYSIOL, V151, P41, DOI 10.1016/S0176-1617(97)80034-X; Chrost B, 2000, J PLANT PHYSIOL, V156, P483; Chrost B, 2007, PLANTA, V225, P311, DOI 10.1007/s00425-006-0350-9; DELORME E, 1992, BIOCHEMISTRY-US, V31, P9871, DOI 10.1021/bi00156a003; Fedorova EE, 2007, RUSS J PLANT PHYSL+, V54, P25, DOI 10.1134/S1021443707010049; Fujiki Y, 2001, PHYSIOL PLANTARUM, V111, P345, DOI 10.1034/j.1399-3054.2001.1110312.x; Fujimoto Z, 2003, J BIOL CHEM, V278, P20313, DOI 10.1074/jbc.M302292200; Gao ZF, 1999, PLANT PHYSIOL, V119, P979, DOI 10.1104/pp.119.3.979; GAUDREAULT PR, 1986, PLANT SCI, V45, P71, DOI 10.1016/0168-9452(86)90039-7; GAUDREAULT PR, 1983, PLANT PHYSIOL, V71, P662, DOI 10.1104/pp.71.3.662; GAUDREAULT PR, 1982, PLANT SCI LETT, V24, P281, DOI 10.1016/0304-4211(82)90023-2; Geilfus CM, 2017, MOL PLANT, V10, P1371, DOI 10.1016/j.molp.2017.09.018; Grandis A, 2019, ANN BOT-LONDON, V124, P1067, DOI 10.1093/aob/mcz099; GROSS KC, 1982, PLANT PHYSIOL, V69, P117, DOI 10.1104/pp.69.1.117; Gu H, 2018, J PLANT PHYSIOL, V224, P112, DOI 10.1016/j.jplph.2018.03.012; HANDLEY LW, 1983, PLANT PHYSIOL, V72, P498, DOI 10.1104/pp.72.2.498; Hara M, 2008, PLANT BIOTECHNOL, V25, P497, DOI 10.5511/plantbiotechnology.25.497; Hughes D, 2016, MOL GENET METAB, V117, pS59, DOI 10.1016/j.ymgme.2015.12.296; Irving DE, 1997, J AM SOC HORTIC SCI, V122, P310, DOI 10.21273/JASHS.122.3.310; Katrolia P, 2014, CRIT REV BIOTECHNOL, V34, P307, DOI 10.3109/07388551.2013.794124; Keller F., 1996, PHOTOASSIMILATE DIST, P157; Li SH, 2007, BIOSCI BIOTECH BIOCH, V71, P520, DOI 10.1271/bbb.60554; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marraccini P, 2005, PLANT PHYSIOL BIOCH, V43, P909, DOI 10.1016/j.plaphy.2005.08.010; Miao MM, 2007, J PLANT PHYSIOL, V164, P621, DOI 10.1016/j.jplph.2006.02.005; Peters S, 2010, PLANT CELL PHYSIOL, V51, P1815, DOI 10.1093/pcp/pcq127; Pharr D., 1994, ENCY AGR SCI, VVolume 3, P25; PHARR DM, 1984, PLANT SCI LETT, V35, P187, DOI 10.1016/0304-4211(84)90227-X; Phoeurk C, 2018, PHYTOCHEMISTRY, V156, P33, DOI 10.1016/j.phytochem.2018.08.015; Rahfeld P, 2020, J BIOL CHEM, V295, P325, DOI 10.1074/jbc.REV119.008164; Rattanaprasert M, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01788-19; Schaffer AA, 1996, PHOTOASSIMILATE DIST, DOI [10.1104/pp.112.3.931, DOI 10.1104/PP.112.3.931]; Soh CP, 2006, PHYTOCHEMISTRY, V67, P242, DOI 10.1016/j.phytochem.2005.09.032; Sui XL, 2012, J PLANT PHYSIOL, V169, P1883, DOI 10.1016/j.jplph.2012.07.019; Tapernoux-Luthi EM, 2007, FEBS LETT, V581, P1811, DOI 10.1016/j.febslet.2007.03.068; Wang CL, 2016, J PLANT GROWTH REGUL, V35, P851, DOI 10.1007/s00344-016-9589-y; Zhang JJ, 2020, J PLANT PHYSIOL, V245, DOI 10.1016/j.jplph.2019.153111; Zhao TY, 2006, SEED SCI RES, V16, P107, DOI 10.1079/SSR2006243	41	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0244714	10.1371/journal.pone.0244714	http://dx.doi.org/10.1371/journal.pone.0244714			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434225	Green Published, gold			2022-12-26	WOS:000609979700004
J	Guisnet, A; Maitra, M; Pradhan, S; Hendricks, M				Guisnet, Aurelie; Maitra, Malosree; Pradhan, Sreeparna; Hendricks, Michael			A three-dimensional habitat for C. elegans environmental enrichment	PLOS ONE			English	Article								As we learn more about the importance of gene-environment interactions and the effects of environmental enrichment, it becomes evident that minimalistic laboratory conditions can affect gene expression patterns and behaviors of model organisms. In the laboratory, Caenorhabditis elegans is generally cultured on two-dimensional, homogeneous agar plates abundantly covered with axenic bacteria culture as a food source. However, in the wild, this nematode thrives in rotting fruits and plant stems feeding on bacteria and small eukaryotes. This contrast in habitat complexity suggests that studying C. elegans in enriched laboratory conditions can deepen our understanding of its fundamental traits and behaviors. Here, we developed a protocol to create three-dimensional habitable scaffolds for trans-generational culture of C. elegans in the laboratory. Using decellularization and sterilization of fruit tissue, we created an axenic environment that can be navigated throughout and where the microbial environment can be strictly controlled. C. elegans were maintained over generations on this habitat, and showed a clear behavioral bias for the enriched environment. As an initial assessment of behavioral variations, we found that dauer populations in scaffolds exhibit high-frequency, complex nictation behavior including group towering and jumping behavior.	[Guisnet, Aurelie; Hendricks, Michael] McGill Univ, Dept Biol, Montreal, PQ, Canada; [Maitra, Malosree; Pradhan, Sreeparna] McGill Univ, Integrated Program Neurosci, Montreal, PQ, Canada	McGill University; McGill University	Guisnet, A (corresponding author), McGill Univ, Dept Biol, Montreal, PQ, Canada.	aurelie.guisnet@mail.mcgill.ca		Hendricks, Michael/0000-0002-3408-3858; Guisnet, Aurelie/0000-0002-1102-6017; Pradhan, Sreeparna/0000-0002-6827-218X	National Science and Engineering Research Council (NSERC) [RGPIN/05117-2014]; Canadian Foundation for Innovation (CFI) [32581]; Canada Research Chairs Program [950-231541]	National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canada Research Chairs Program(Canada Research Chairs)	This work was supported by funding from the National Science and Engineering Research Council (NSERC) (RGPIN/05117-2014), the Canadian Foundation for Innovation (CFI) (32581), and the Canada Research Chairs Program (950-231541). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada EAE, 2009, MOL CELLS, V28, P209, DOI 10.1007/s10059-009-0124-x; Alfred J, 2015, ELIFE, V4, DOI 10.7554/eLife.06956; Baird SE, 1999, NEMATOLOGY, V1, P471, DOI 10.1163/156854199508478; Barriere Antoine, 2005, P1; BRENNER S, 1974, GENETICS, V77, P71; Busch Karl Emanuel, 2012, Worm, V1, P182, DOI 10.4161/worm.20464; Calhoun AJ, 2014, ELIFE, V3, DOI 10.7554/eLife.04220; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Frezal L, 2015, ELIFE, V4, DOI 10.7554/eLife.05849; GARDNER EB, 1975, PHYSIOL BEHAV, V14, P321, DOI 10.1016/0031-9384(75)90040-2; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Kiontke Karin, 2005, P1; Kwon N, 2015, SCI REP-UK, V5, DOI 10.1038/srep09564; Laviola G, 2008, NEUROBIOL DIS, V31, P159, DOI 10.1016/j.nbd.2008.05.001; Lee D., 2015, BIO-PROTOCOL, V5, P1433, DOI [10.21769/BioProtoc.1433, DOI 10.21769/BIOPROTOC.1433]; Lee D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00386-x; Lee H, 2012, NAT NEUROSCI, V15, P107, DOI 10.1038/nn.2975; Mallory HS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152245; Modulevsky DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097835; Parichy DM, 2015, ELIFE, V4, DOI 10.7554/eLife.05635; Park S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002550; Petersen C, 2015, TRENDS GENET, V31, P120, DOI 10.1016/j.tig.2014.12.001; Petersen C, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-4; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; R Core Team, 2020, R LANG ENV STAT COMP; Rabets Y, 2014, BIOPHYS J, V107, P1980, DOI 10.1016/j.bpj.2014.09.006; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Sterken MG, 2015, TRENDS GENET, V31, P224, DOI 10.1016/j.tig.2015.02.009; Stiernagle Theresa, 2006, WormBook, P1; Vidal-Gadea Andres G, 2012, Worm, V1, P5; Voelkl B, 2020, NAT REV NEUROSCI, V21, P384, DOI 10.1038/s41583-020-0313-3; Volgin AD, 2018, ZEBRAFISH, V15, P425, DOI 10.1089/zeb.2018.1592; Volkers RJM, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-93; Weidner DE, 1996, J COLLOID INTERF SCI, V179, P66, DOI 10.1006/jcis.1996.0189; Yang H, 2020, J NEUROGENET, V34, P510, DOI 10.1080/01677063.2020.1788552; Yu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134401	38	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0245139	10.1371/journal.pone.0245139	http://dx.doi.org/10.1371/journal.pone.0245139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428657	Green Published, gold			2022-12-26	WOS:000630036100036
J	Howlett, L; Camp, EF; Edmondson, J; Henderson, N; Suggett, DJ; Ferse, SCA				Howlett, Lorna; Camp, Emma F.; Edmondson, John; Henderson, Nicola; Suggett, David J.; Ferse, Sebastian C. A.			Coral growth, survivorship and return-on-effort within nurseries at high-value sites on the Great Barrier Reef	PLOS ONE			English	Article								Coral reefs are deteriorating worldwide prompting reef managers and stakeholders to increasingly explore new management tools. Following back-to-back bleaching in 2016/ 2017, multi-taxa coral nurseries were established in 2018 for the first time on the Great Barrier Reef (GBR) to aid reef maintenance and restoration at a "high-value" location-Opal Reef-frequented by the tourism industry. Various coral species (n = 11) were propagated within shallow water (ca. 4-7m) platforms installed across two sites characterised by differing environmental exposure-one adjacent to a deep-water channel (Blue Lagoon) and one that was relatively sheltered (RayBan). Growth rates of coral fragments placed onto nurseries were highly variable across taxa but generally higher at Blue Lagoon (2.1-10.8 cm(2) month(-1) over 12 months) compared to RayBan (0.6-6.6 cm(2) month(-1) over 9 months). Growth at Blue Lagoon was largely independent of season, except for Acropora tenuis and Acropora hyacinthus, where growth rates were 15-20% higher for December 2018-July 2019 ("warm season") compared to August-December 2018 ("cool season"). Survivorship across all 2,536 nursery fragments was ca. 80-100%, with some species exhibiting higher survivorship at Blue Lagoon (Acropora loripes, Porites cylindrica) and others at RayBan (A. hyacinthus, Montipora hispida). Parallel measurements of growth and survivorship were used to determine relative return-on-effort (RRE) scores as an integrated metric of "success" accounting for life history trade-offs, complementing the mutually exclusive assessment of growth or survivorship. RRE scores within sites (across species) were largely driven by growth, whereas RRE scores between sites were largely driven by survivorship. The initial nursery phase of coral propagation therefore appears useful to supplement coral material naturally available for stewardship of frequently visited Great Barrier Reef tourism (high-value) sites, but further assessment is needed to evaluate how well the growth rates and survival for nursery grown corals translate once material is outplanted.	[Howlett, Lorna; Camp, Emma F.; Henderson, Nicola; Suggett, David J.; Ferse, Sebastian C. A.] Univ Technol Sydney, Fac Sci, Climate Change Cluster, Ultimo, NSW, Australia; [Howlett, Lorna; Edmondson, John] Wavelength Reef Cruises, Port Douglas, Qld, Australia	University of Technology Sydney	Camp, EF (corresponding author), Univ Technol Sydney, Fac Sci, Climate Change Cluster, Ultimo, NSW, Australia.	Emma.Camp@uts.edu.au	Camp, Emma/AGK-2519-2022	Camp, Emma/0000-0003-1962-1336	AMP Foundation (Tomorrow Maker Award); Australian Government; Queensland Government; University of Technology Sydney Chancellor's Postdoctoral Research Fellowship; ARC Discovery Early Career Research Award [DE190100142]	AMP Foundation (Tomorrow Maker Award); Australian Government(Australian GovernmentCGIAR); Queensland Government; University of Technology Sydney Chancellor's Postdoctoral Research Fellowship; ARC Discovery Early Career Research Award(Australian Research Council)	Essential funding for the work was provided from the AMP Foundation (Tomorrow Maker Award to DJS), "Future-proofing the Great Barrier Reef through climate change-resilient super corals", and the Australian & Queensland Governments ("Solving the bottleneck of reef rehabilitation through boosting coral abundance: Miniaturising and mechanising coral out-planting" to DJS, EFC, JE). Additional contribution of EFC to manuscript writing and final preparation was through the University of Technology Sydney Chancellor's Postdoctoral Research Fellowship and ARC Discovery Early Career Research Award (DE190100142). Wavelength Reef Cruises provided support in the form of salaries for authors JE and LH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Alvarez-Noriega M, 2016, ECOLOGY, V97, P3485, DOI 10.1002/ecy.1588; Anderson KD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03085-1; Anthony K, 2017, NAT ECOL EVOL, V1, P1420, DOI 10.1038/s41559-017-0313-5; Australian Institute of Marine Science, 2020, LONG TERM MON PROGR; Boch CA, 2012, ECOL ENG, V40, P11, DOI 10.1016/j.ecoleng.2011.12.026; BOHNSACK JA, 1985, B MAR SCI, V37, P11; Bongiorni L, 2011, AQUACULTURE, V322, P191, DOI 10.1016/j.aquaculture.2011.09.024; Burn D, 2018, DIVERSITY-BASEL, V10, DOI 10.3390/d10040122; dela Cruz DW, 2015, ECOL ENG, V84, P408, DOI 10.1016/j.ecoleng.2015.09.042; Drury C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174000; Edwards A.J., 2007, REEF RESTORATION CON; Frias-Torres S, 2015, PEERJ, V3, DOI 10.7717/peerj.1287; Hernandez-Delgado Edwin A., 2014, Open Journal of Ecology, V4, P918, DOI 10.4236/oje.2014.414077; Hudson J.H., 1988, P231; Hughes TP, 2019, NATURE, V568, P387, DOI 10.1038/s41586-019-1081-y; Hughes TP, 2017, NATURE, V546, P82, DOI 10.1038/nature22901; Knoester EG, 2019, MAR ECOL PROG SER, V611, P143, DOI 10.3354/meps12869; Lenihan HS, 2015, ECOLOGY, V96, P1540, DOI 10.1890/14-1115.1; Levy G, 2010, ECOL ENG, V36, P560, DOI 10.1016/j.ecoleng.2009.12.003; Lohr KE, 2017, J EXP MAR BIOL ECOL, V486, P87, DOI 10.1016/j.jembe.2016.10.005; Mbije NEJ, 2010, ECOL ENG, V36, P713, DOI 10.1016/j.ecoleng.2009.12.018; Morikawa MK, 2019, P NATL ACAD SCI USA, V116, P10586, DOI 10.1073/pnas.1721415116; OGDEN JC, 1981, MAR ECOL PROG SER, V4, P97, DOI 10.3354/meps004097; Precoda K, 2017, AM NAT, V190, P420, DOI 10.1086/692758; R Studio Team, 2016, RSTUDIO INT DEV ENV; Rachmilovitz EN, 2017, ECOL ENG, V105, P150, DOI 10.1016/j.ecoleng.2017.04.038; Rinkevich B, 2000, MAR BIOL, V136, P807, DOI 10.1007/s002270000293; Rinkevich B, 2008, MAR POLLUT BULL, V56, P1821, DOI 10.1016/j.marpolbul.2008.08.014; Rinkevich B, 2014, CURR OPIN ENV SUST, V7, P28, DOI 10.1016/j.cosust.2013.11.018; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schopmeyer SA, 2017, CORAL REEFS, V36, P1047, DOI 10.1007/s00338-017-1596-3; Shafir S, 2006, MAR BIOL, V149, P679, DOI 10.1007/s00227-005-0236-6; Shaish L, 2008, J EXP MAR BIOL ECOL, V358, P86, DOI 10.1016/j.jembe.2008.01.024; Spalding M, 2017, MAR POLICY, V82, P104, DOI 10.1016/j.marpol.2017.05.014; Suggett DJ, 2020, RESTOR ECOL, V28, P289, DOI 10.1111/rec.13070; Suggett DJ, 2019, RESTOR ECOL, V27, P683, DOI 10.1111/rec.12916; Van Oppen MJH, 2017, GLOBAL CHANGE BIOL, V23, P3437, DOI 10.1111/gcb.13647; Williams SL, 2019, RESTOR ECOL, V27, P447, DOI 10.1111/rec.12866; Xin Loke H., 2016, AACL Bioflux, V9, P1090; Young CN, 2012, B MAR SCI, V88, P1075, DOI 10.5343/bms.2011.1143	41	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e024496	10.1371/journal.pone.0244961	http://dx.doi.org/10.1371/journal.pone.0244961			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428639	Green Published, gold			2022-12-26	WOS:000630036100028
J	Lawrence, D; Palmisano, A; de Gruchy, MW				Lawrence, Dan; Palmisano, Alessio; de Gruchy, Michelle W.			Collapse and continuity: A multi-proxy reconstruction of settlement organization and population trajectories in the Northern Fertile Crescent during the 4.2kya Rapid Climate Change event	PLOS ONE			English	Article							KA BP EVENT; RADIOCARBON-DATES; BRONZE-AGE; DROUGHT; PATTERNS; TRENDS; DISTRIBUTIONS; ARCHAEOLOGY; RESILIENCE; DEMOGRAPHY	The rise and fall of ancient societies have been attributed to rapid climate change events. One of the most discussed of these is the 4.2kya event, a period of increased aridity and cooling posited as the cause of societal changes across the globe, including the collapse of the Akkadian Empire in Mesopotamia. Studies seeking to correlate social and climatic changes around the 4.2kya event have tended to focus either on highly localized analyses of specific sites or surveys or more synthetic overviews at pan-continental scales, and temporally on the event and its aftermath. Here we take an empirical approach at a large spatial scale to investigate trends in population and settlement organization across the entirety of Northern Fertile Crescent (Northern Mesopotamia and the Northern Levant) from 6,000 to 3,000 cal BP. We use Summed Probability Distributions of radiocarbon dates and data from eighteen archaeological surveys as proxies for population, and a dataset of all settlements over ten hectares in size as a proxy for the degree of urbanization. The goal is to examine the spatial and temporal impact of the 4.2kya event and to contextualize it within longer term patterns of settlement. We find that negative trends are visible during the event horizon in all three proxies. However, these occur against a long-term trend of increased population and urbanization supported through unsustainable overshoot and the exploitation of a drier zone with increased risk of crop failure. We argue that the 4.2kya event occurred during a period of unprecedented urban and rural growth which may have been unsustainable even without an exogenous climate forcing.	[Lawrence, Dan; de Gruchy, Michelle W.] Univ Durham, Dept Archaeol, Durham, England; [Palmisano, Alessio] Ludwig Maximilian Univ Munich, Dept Ancient Hist, Munich, Germany	Durham University; University of Munich	Lawrence, D (corresponding author), Univ Durham, Dept Archaeol, Durham, England.	dan.lawrence@durham.ac.uk		Lawrence, Dan/0000-0001-5613-1243; de Gruchy, Michelle/0000-0002-7856-8013; Palmisano, Alessio/0000-0003-0758-5032	European Research Council under the European Union's Horizon 2020 research and innovation program [802424]	European Research Council under the European Union's Horizon 2020 research and innovation program	This research was supported by the European Research Council under the European Union's Horizon 2020 research and innovation program (https://ec.europa.eu/programmes/horizon2020/en/h2020-section/european-researchcouncil) for the project 'CLaSS - Climate, Landscape, Settlement and Society: Exploring Human Environment Interaction in the Ancient Near East' (grant number 802424, award holder: DL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algaze G, 2004, ROM VILLAGES CITIES, P103, DOI [10.1097/00000542-200410000-00022, DOI 10.1097/00000542-200410000-00022]; [Anonymous], 2016, CDRC BANADORA BANQUE; Arroyo-Kalin M, 2021, PHILOS T R SOC B, V376, DOI 10.1098/rstb.2019.0715; Beardah C, 1996, INTERNET ARCH, P1; Becerra-Valdivia L, 2020, J ARCHAEOL SCI, V113, DOI 10.1016/j.jas.2019.105043; Benz M, 2014, PPND THE PLATFORM NE; Berger JF, 2019, HOLOCENE, V29, P776, DOI 10.1177/0959683619826698; Bevan A, 2020, RCARBON V141 CALIBRA; Bevan A, 2017, P NATL ACAD SCI USA, V114, pE10524, DOI 10.1073/pnas.1709190114; Biga M. G., 2010, TEXTILE TERMINOLOGIE, V8, P146; Bini M, 2019, CLIM PAST, V15, P555, DOI 10.5194/cp-15-555-2019; Bohner U, 2006, RADIOCARBON CONTEXT; Borrell F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134810; Chiotis E., 2019, CLIMATE CHANGES HOLO; Contreras DA, 2014, J ARCHAEOL SCI, V52, P591, DOI 10.1016/j.jas.2014.05.030; Cookson E, 2019, J ARCHAEOL SCI, V106, P1, DOI 10.1016/j.jas.2019.03.009; Crema ER, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154809; Crema ER, 2012, J ARCHAEOL METHOD TH, V19, P440, DOI 10.1007/s10816-011-9122-3; Crema ER, 2010, J ARCHAEOL SCI, V37, P1118, DOI 10.1016/j.jas.2009.12.012; de Gruchy M, 2016, J ARCHAEOL SCI-REP, V8, P250, DOI 10.1016/j.jasrep.2016.05.047; Demarest AA, 2001, LAT AM ANTIQ, V12, P105, DOI 10.2307/971763; deMenocal PB, 2001, SCIENCE, V292, P667, DOI 10.1126/science.1059827; Ebert CE, 2017, QUATERNARY SCI REV, V173, P211, DOI 10.1016/j.quascirev.2017.08.020; Flohr P, 2016, QUATERNARY SCI REV, V136, P23, DOI 10.1016/j.quascirev.2015.06.022; French JC, 2015, J ANTHROPOL ARCHAEOL, V39, P193, DOI 10.1016/j.jaa.2015.04.005; Gaastra JS, 2020, QUATERN INT, V545, P45, DOI 10.1016/j.quaint.2019.03.013; Gaydarska B, 2016, NOR ARCHAEOL REV, V49, P40, DOI 10.1080/00293652.2016.1164749; Guedes JAD, 2016, P NATL ACAD SCI USA, V113, P14483, DOI 10.1073/pnas.1616188113; Henry DO, 2017, HOLOCENE, V27, P625, DOI 10.1177/0959683616670470; Hinz M, 2012, J NEOLITHIC ARCHAEOL, DOI 10.12766/jna.2012.65; Hoflmayer F, 2017, LATE 3 MILLENNIUM AN, P87; Jaffe YY, 2020, QUAT RES, V63, P347; Kalayci T, 2016, SCI TECHNOL ARCHAEOL, V2, P217, DOI 10.1080/20548923.2016.1247512; Kaniewski D, 2018, CLIM PAST, V14, P1529, DOI 10.5194/cp-14-1529-2018; Kintigh KW, 2018, J ARCHAEOL SCI, V89, P25, DOI 10.1016/j.jas.2017.09.006; Kochy M, 2008, REG ENVIRON CHANGE, V8, P73, DOI 10.1007/s10113-008-0048-6; Kuzucuoglu C, 2007, SOCIE TE S HUMAINES, DOI [10.1016/j.jhevol.2007.07.004, DOI 10.1016/J.JHEVOL.2007.07.004]; Laneri N., 2012, LOOKING N SOCIOECONO, P37; Lawrence, 2012, EARLY URBANISM NO FE; Lawrence D, 2015, QUAT INT, DOI [10.1016/j.quaint.2014.10.013, DOI 10.1016/J.QUAINT.2014.10.013]; Lawrence D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157863; Lawrence D, 2015, ANTIQUITY, V89, P328, DOI 10.15184/aqy.2014.44; Manning SW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240799; McCorriston J, 1997, CURR ANTHROPOL, V38, P517, DOI 10.1086/204643; McMahon A, 2020, J ARCHAEOL RES, V28, P289, DOI 10.1007/s10814-019-09136-7; Meller H, 2200 BC A CLIMATIC B; Michczynska DJ, 2004, RADIOCARBON, V46, P733, DOI 10.1017/S0033822200035773; Middleton GD, 2017, UNDERSTANDING COLLAPSE: ANCIENT HISTORY AND MODERN MYTHS, P1, DOI 10.1017/9781316584941; Middleton G.D., 2019, CLIMATE CHANGES HOLO, P271; Milano L, 1995, CIVILIZATIONS ANCIEN, VII, P1219; Morris Ian, 2013, MEAS CIV HOW SOC; ORAU, 2016, OXFORD RADIOCARBON A; Orton David, 2017, Open Quaternary, V3, DOI 10.5334/oq.29; Palmisano A, 2019, HOLOCENE, V29, P708, DOI 10.1177/0959683619826642; Palmisano A, 2017, J ARCHAEOL SCI, V87, P59, DOI 10.1016/j.jas.2017.10.001; Peterson C. E., 2015, REGIONAL SETTLEMENT; Reimer PJ, 2020, RADIOCARBON, V62, P725, DOI 10.1017/RDC.2020.41; Riehl S, 2014, P NATL ACAD SCI USA, V111, P12348, DOI 10.1073/pnas.1409516111; Roberts CN, 2019, HOLOCENE, V29, P923, DOI 10.1177/0959683619826697; Roberts N, 2018, QUATERNARY SCI REV, V184, P47, DOI 10.1016/j.quascirev.2017.09.011; Sallaberger W., 2004, SUBARTU, V12, P51; Shennan S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3486; Smith M.E, 2020, J URBAN ARCHAEOLOGY, V1, P15, DOI 10.1484/J.JUA.5.120907; Smith S, 2014, SETTLEMENT DYNAMICS, P151; Staubwasser M, 2006, QUATERNARY RES, V66, P372, DOI 10.1016/j.yqres.2006.09.001; Surovell TA, 2009, J ARCHAEOL SCI, V36, P1715, DOI 10.1016/j.jas.2009.03.029; Tainter JA, 2006, ANNU REV ANTHROPOL, V35, P59, DOI 10.1146/annurev.anthro.35.081705.123136; TAY project, 2019, 14C DATABASE 22 UPDA; Timpson A, 2014, J ARCHAEOL SCI, V52, P549, DOI 10.1016/j.jas.2014.08.011; Torfing T, 2015, J ARCHAEOL SCI, V63, P203, DOI 10.1016/j.jas.2015.08.017; Ur J.A., 2010, URBANISM CULTURAL LA; Van Strydonck M, 2011, RADIOCARBON, V53, P367, DOI 10.1017/S0033822200056629; Walker M, 2019, J QUATERNARY SCI, V34, P173, DOI 10.1002/jqs.3097; Weiberg E, 2018, WORLD ARCHAEOL, V50, P584, DOI 10.1080/00438243.2018.1515035; Weiberg E, 2019, HOLOCENE, V29, P742, DOI 10.1177/0959683619826641; Weiss, 2012, 7 GENERATIONS FALL A, P25; WEISS H, 1993, SCIENCE, V261, P995, DOI 10.1126/science.261.5124.995; Weiss H, 2017, MEGADROUGHT COLLAPSE; Weiss H., 2012, 7 GENERATIONS FALL A, P1; Weiss Harvey, 2016, J SALT LAKE RES, V24, P62; Weninger B., 2018, CALPAL ARCHAEOLOGICA; Weninger B, 2015, WORLD ARCHAEOL, V47, P543, DOI 10.1080/00438243.2015.1064022; Wilkinson TJ, 2014, J WORLD PREHIST, V27, P43, DOI 10.1007/s10963-014-9072-2; WILKINSON TJ, 1994, CURR ANTHROPOL, V35, P483, DOI 10.1086/204314; Williams AN, 2012, J ARCHAEOL SCI, V39, P578, DOI 10.1016/j.jas.2011.07.014; Woodbridge J, 2019, HOLOCENE, V29, P728, DOI 10.1177/0959683619826635; Wossink A., 2009, CHALLENGING CLIMATE; Yan M, 2019, CLIM PAST, V15, P265, DOI 10.5194/cp-15-265-2019; Zerboni A, 2019, GEOMORPHOLOGY, V331, P22, DOI 10.1016/j.geomorph.2018.10.011	89	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0244871	10.1371/journal.pone.0244871	http://dx.doi.org/10.1371/journal.pone.0244871			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY4UJ	33428648	Green Accepted, Green Published, gold			2022-12-26	WOS:000630036100025
J	Chen, X; Lungova, V; Zhang, HY; Mohanty, C; Kendziorski, C; Thibeault, SL				Chen, Xia; Lungova, Vlasta; Zhang, Haiyan; Mohanty, Chitrasen; Kendziorski, Christina; Thibeault, Susan L.			Novel immortalized human vocal fold epithelial cell line: In vitro tool for mucosal biology	FASEB JOURNAL			English	Article						human vocal fold epithelial cells; immortalization; telomerase; three&#8208; dimensional VF mucosal model	MODEL; MIGRATION; FIBROBLASTS; TELOMERASE; MECHANISMS; SUFFICIENT; SENESCENCE; RESPONSES; GENE	Study of vocal fold (VF) mucosal biology requires essential human vocal fold epithelial cell (hVFE) lines for use in appropriate model systems. We steadily transfected a retroviral construct containing human telomerase reverse transcriptase (hTERT) into primary normal hVFE to establish a continuously replicating hVFE cell line. Immortalized hVFE across passages have cobblestone morphology, express epithelial markers cytokeratin 4, 13 and 14, induced hTERT gene and protein expression, have similar RNAseq profiling, and can continuously grow for more than 8 months. DNA fingerprinting and karyotype analysis demonstrated that immortalized hVFE were consistent with the presence of a single cell line. Validation of the hVFE, in a three-dimensional in vitro VF mucosal construct revealed a multilayered epithelial structure with VF epithelial cell markers. Wound scratch assay revealed higher migration capability of the immortalized hVFE on the surface of collagen-fibronectin and collagen gel containing human vocal fold fibroblasts (hVFF). Collectively, our report demonstrates the first immortalized hVFE from true VFs providing a novel and invaluable tool for the study of epithelial cell-fibroblast interactions that dictate disease and health of this specialized tissue.	[Chen, Xia; Lungova, Vlasta; Thibeault, Susan L.] Univ Wisconsin, Dept Surg, Div Otolaryngol Head & Neck Surg, 5103 WIMR,1111 Highland Ave, Madison, WI 53705 USA; [Zhang, Haiyan] Shandong Univ, Shandong Prov ENT Hosp, Cheeloo Coll Med, Dept Otolaryngol Head & Neck Surg, Jinan, Peoples R China; [Mohanty, Chitrasen; Kendziorski, Christina] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; Shandong University; University of Wisconsin System; University of Wisconsin Madison	Thibeault, SL (corresponding author), Univ Wisconsin, Dept Surg, Div Otolaryngol Head & Neck Surg, 5103 WIMR,1111 Highland Ave, Madison, WI 53705 USA.	thibeault@surgery.wisc.edu		Lungova, Vlasta/0000-0002-5723-3441	NIDCD NIH HHS [R01 DC004336, R01 DC012773] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alvarez J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41102-7; Andrews S., 2010, FASTQC QUALITY CONTR; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen X, 2008, LARYNGOSCOPE, V118, P1700, DOI 10.1097/MLG.0b013e31817aec6c; Chen X, 2009, TISSUE ENG PART C-ME, V15, P201, DOI 10.1089/ten.tec.2008.0390; Erickson-DiRenzo E, 2019, LARYNGOSCOPE, V129, pE355, DOI 10.1002/lary.27909; Garbe JC, 2014, CELL CYCLE, V13, P3423, DOI 10.4161/15384101.2014.954456; Gregoire L, 2001, CLIN CANCER RES, V7, P4280; Gu YP, 2006, EXP CELL RES, V312, P831, DOI 10.1016/j.yexcr.2005.11.029; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; Hartman CD, 2016, P NATL ACAD SCI USA, V113, P11190, DOI 10.1073/pnas.1611324113; HIRANO M, 1974, FOLIA PHONIATR, V26, P89, DOI 10.1159/000263771; Hu PR, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.25; HURLIN PJ, 1991, P NATL ACAD SCI USA, V88, P570, DOI 10.1073/pnas.88.2.570; INOKUCHI S, 1995, BRIT J CANCER, V71, P819, DOI 10.1038/bjc.1995.158; Iversen Nina, 2005, Genet Vaccines Ther, V3, P2, DOI 10.1186/1479-0556-3-2; Karamichos D, 2009, CELL MOTIL CYTOSKEL, V66, P1, DOI 10.1002/cm.20326; Kim CW, 2016, J PHARMACOL TOX MET, V80, P82, DOI 10.1016/j.vascn.2016.05.013; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Leydon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115389; Leydon C, 2013, TISSUE ENG PT A, V19, P2233, DOI [10.1089/ten.tea.2012.0744, 10.1089/ten.TEA.2012.0744]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li NF, 2007, CELL PROLIFERAT, V40, P780, DOI 10.1111/j.1365-2184.2007.00462.x; Ling C., 2015, SCI TRANSL MED, V18, P314; Ling CY, 2010, WOUND REPAIR REGEN, V18, P89, DOI 10.1111/j.1524-475X.2009.00550.x; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Lungova V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12069-w; Lungova V, 2016, METHODS MOL BIOL, V1307, P237, DOI 10.1007/7651_2014_132; Lungova V, 2015, DEV BIOL, V399, P263, DOI 10.1016/j.ydbio.2014.12.037; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Miyazaki K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36646-z; Palencia L, 2015, J SURG RES, V197, P32, DOI 10.1016/j.jss.2015.02.066; Powell J, 2019, LARYNGOSCOPE, V129, P2640, DOI 10.1002/lary.27761; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Roy N, 2005, LARYNGOSCOPE, V115, P1988, DOI 10.1097/01.mlg.0000179174.32345.41; SCHOR SL, 1980, J CELL SCI, V41, P159; SHAY JW, 1991, BIOCHIM BIOPHYS ACTA, V1072, P1, DOI 10.1016/0304-419X(91)90003-4; Shin HY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205297; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Smith JL, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0122-6; Troester MA, 2004, CANCER RES, V64, P4218, DOI 10.1158/0008-5472.CAN-04-0107; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Xie Y, 2010, TISSUE ENG PART C-ME, V16, P1111, DOI [10.1089/ten.tec.2009.0725, 10.1089/ten.TEC.2009.0725]; Yang G, 2007, CARCINOGENESIS, V28, P174, DOI 10.1093/carcin/bgl115; Yip YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078395	48	2	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21243	10.1096/fj.202001423R	http://dx.doi.org/10.1096/fj.202001423R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33428261	Green Published			2022-12-26	WOS:000647789600108
J	Alves, JC; Santos, A; Jorge, P; Lavrador, C; Carreira, LM				Alves, Joao C.; Santos, Ana; Jorge, Patricia; Lavrador, Catarina; Miguel Carreira, L.			The intra-articular administration of triamcinolone hexacetonide in the treatment of osteoarthritis. Its effects in a naturally occurring canine osteoarthritis model	PLOS ONE			English	Article							CAUDOLATERAL CURVILINEAR OSTEOPHYTE; RANDOMIZED CONTROLLED-TRIAL; KNEE OSTEOARTHRITIS; ANIMAL-MODELS; CORTICOSTEROID INJECTION; CARTILAGE LESIONS; PHYSICAL-ACTIVITY; HIP-DYSPLASIA; JOINT DISEASE; DOUBLE-BLIND	Objective To evaluate the effect of an intra-articular (IA) administration of triamcinolone hexacetonide, compared with saline. Patients and methods Forty (N = 40) hip joints were randomly assigned to a treatment group (THG, n = 20, receiving IA triamcinolone hexacetonide) and a control group (CG, n = 20, receiving IA saline). On treatment day (T0), and at 8, 15, 30, 90 and 180 days post-treatment, weight distribution, joint range of motion, thigh girth, digital thermography, radiographic signs, synovial fluid interleukin-1 and C-reactive protein levels were evaluated. Data from four Clinical Metrology Instruments was also gathered. Results were compared Repeated Measures ANOVA, with a Huynh-Feldt correction, Paired Samples T-Test or Wilcoxon Signed Ranks Test. A Kaplan-Meier test was performed to compare both groups, with p<0.05. Results Joints were graded as mild (65%), moderate (20%) and severe (15%). Patients of both sexes, with a mean age of 6.52.4 years and bodyweight of 26.7<plus/minus>5.2kg, were included. No differences were found between groups at T0. Comparing THG to CG, weight distribution showed significant improvements in THG from 8 (p = 0.05) up to 90 days (p = 0.01). THG showed lower values during thermographic evaluation in the Lt view (p<0.01). Pain and function scores also improved from 30 to 180 days. Increasing body weight, age, and presence of caudolateral curvilinear osteophyte corresponded to worse response to treatment. Results of the Kaplan Meier test showed significant differences between groups, with THG performing better considering several evaluations and scores. Conclusion THG recorded significant improvements in weight-bearing and in with the considered CMIs, particularly pain scores. Lower thermographic values were registered in THG up to the last evaluation day. Age, sex, and radiographic findings did significantly influenced response to treatment.	[Alves, Joao C.; Santos, Ana; Jorge, Patricia] Guarda Nacl Republicana GNR, Div Med Vet, Lisbon, Portugal; [Alves, Joao C.; Lavrador, Catarina] Univ Evora, MED Mediterranean Inst Agr Environm & Dev, Inst Invest & Formacao Avancada, Polo Mitra, Evora, Portugal; [Miguel Carreira, L.] Univ Lisbon FMV ULisboa, Fac Vet Med, Lisbon, Portugal; [Miguel Carreira, L.] Univ Lisbon, FMV ULisboa, Interdisciplinary Ctr Res Anim Hlth CIISA, Lisbon, Portugal; [Miguel Carreira, L.] Anjos Assis Vet Med Ctr CMVAA, Barreiro, Portugal	University of Evora; Universidade de Lisboa; Universidade de Lisboa	Alves, JC (corresponding author), Guarda Nacl Republicana GNR, Div Med Vet, Lisbon, Portugal.; Alves, JC (corresponding author), Univ Evora, MED Mediterranean Inst Agr Environm & Dev, Inst Invest & Formacao Avancada, Polo Mitra, Evora, Portugal.	alves.jca@gnr.pt		Lavrador, Catarina/0000-0002-2927-9071; Alves, Joao Carlos/0000-0002-1329-3709				Alves JCA, 2018, VET ANAESTH ANALG, V45, P123, DOI 10.1016/j.vaa.2017.07.006; Anderson KL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23940-z; Augustine AJ, 1997, INFLAMM RES, V46, P60, DOI 10.1007/s000110050073; Bauer DC, 2006, OSTEOARTHR CARTILAGE, V14, P723, DOI 10.1016/j.joca.2006.04.001; Bellamy N, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005328; Bennett D, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-42; Borojevic N, 2011, PERIOD BIOL, V113, P445; Brown DC, 2014, VET SURG, V43, P241, DOI 10.1111/j.1532-950X.2014.12141.x; Caron JP, 2005, VET CLIN N AM-EQUINE, V21, P559, DOI 10.1016/j.cveq.2005.07.003; Celeste C, 2005, J ORTHOP RES, V23, P602, DOI 10.1016/j.orthres.2004.10.003; CHAKRAVARTY K, 1994, BRIT J RHEUMATOL, V33, P464; Chan CB, 2005, JAVMA-J AM VET MED A, V226, P2010, DOI 10.2460/javma.2005.226.2010; Cheng OT, 2012, PAIN MED, V13, P740, DOI 10.1111/j.1526-4637.2012.01394.x; Clough W., 2018, VET COMP ORTHOP TRAU, V31, pA1, DOI [10.1055/s-0038-1668246, DOI 10.1055/S-0038-1668246]; Clough WT, 2018, VET COMP ORTHOPAED, V31, P391, DOI 10.1055/s-0038-1667063; Cuervo B, 2019, OSTEOARTHR CARTILAGE, V27, pS482, DOI 10.1016/j.joca.2019.02.532; Cushman DM, 2019, PM&R, V11, P758, DOI 10.1016/j.pmrj.2018.09.040; Davidson J.R., 2014, CANINE REHABILITATIO, V2nd, P543; ECKERSALL PD, 1988, VET RES COMMUN, V12, P169, DOI 10.1007/BF00362798; Edwards SHR, 2011, VET J, V190, P15, DOI 10.1016/j.tvjl.2010.09.019; Fokam Danielle, 2019, Journal of Basic and Clinical Physiology and Pharmacology, V30, P20170218, DOI 10.1515/jbcpp-2017-0218; Fortrie RR, 2015, VET SURG, V44, P467, DOI 10.1111/j.1532-950X.2014.12309.x; Frisbie DD, 1997, EQUINE VET J, V29, P349, DOI 10.1111/j.2042-3306.1997.tb03138.x; Fujita Y, 2006, VET SURG, V35, P369, DOI 10.1111/j.1532-950X.2006.00159.x; Garg N, 2014, CLIN RHEUMATOL, V33, P1695, DOI 10.1007/s10067-014-2572-8; Gordon WJ, 2003, VET SURG, V32, P451, DOI 10.1053/jvet.2003.50051; Gregory MH, 2012, ARTHRITIS, DOI 10.1155/2012/764621; Gruen ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131839; Henderson AL, 2015, J SMALL ANIM PRACT, V56, P618, DOI 10.1111/jsap.12385; Hercock CA, 2009, J SMALL ANIM PRACT, V50, P266, DOI 10.1111/j.1748-5827.2009.00765.x; Hudson JT, 2004, AM J VET RES, V65, P1634, DOI 10.2460/ajvr.2004.65.1634; Hyytiainen HK, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-29; Jin C, 2013, J MED BIOL ENG, V33, P471, DOI 10.5405/jmbe.1054; Kol A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9116; Kumar A, 2015, OSTEOARTHR CARTILAGE, V23, P151, DOI 10.1016/j.joca.2014.09.019; Lafeber FPJG, 2013, OSTEOARTHR CARTILAGE, V21, P1452, DOI 10.1016/j.joca.2013.08.012; Larsen C, 2008, J PHARM SCI-US, V97, P4622, DOI 10.1002/jps.21346; Lascelles BDX, 2018, OSTEOARTHR CARTILAGE, V26, P175, DOI 10.1016/j.joca.2017.11.011; Lavelle William, 2007, Anesthesiol Clin, V25, P853, DOI 10.1016/j.anclin.2007.07.002; Liu WH, 2003, J ORTHOP RES, V21, P730, DOI 10.1016/S0736-0266(03)00002-0; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lotsikas P, 2016, CANINE SPORTS MED RE, V2nd, P353; Mateescu RG, 2008, AM J VET RES, V69, P1294, DOI 10.2460/ajvr.69.10.1294; Mayhew PD, 2002, J AM VET MED ASSOC, V220, P472, DOI 10.2460/javma.2002.220.472; McCarthy DA, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00203; McCoy AM, 2015, VET PATHOL, V52, P803, DOI 10.1177/0300985815588611; McIlwraith CW., 2016, JOINT DIS HORSE, V2nd ed., P33, DOI DOI 10.1016/B978-1-4557-5969-9.00003-6; Meenagh GK, 2004, ANN RHEUM DIS, V63, P1260, DOI 10.1136/ard.2003.015438; Meeson RL, 2019, NAT REV RHEUMATOL, V15, P273, DOI 10.1038/s41584-019-0202-1; Mendes JG, 2019, CLIN REHABIL, V33, P1015, DOI 10.1177/0269215519827996; Minnema L, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00077; Park KD, 2015, SKELETAL RADIOL, V44, P1333, DOI 10.1007/s00256-015-2174-9; Pascual-Garrido C, 2018, J ORTHOP RES, V36, P1807, DOI 10.1002/jor.23828; PELLETIER JP, 1989, ARTHRITIS RHEUM, V32, P181, DOI 10.1002/anr.1780320211; PELLETIER JP, 1995, LAB INVEST, V72, P578; PELLETIER JP, 1991, J RHEUMATOL, V18, P127; Piel MJ, 2014, GENE, V537, P184, DOI 10.1016/j.gene.2013.11.091; Popma JW, 2015, J RHEUMATOL, V42, P1865, DOI 10.3899/jrheum.141630; Powers MY, 2004, JAVMA-J AM VET MED A, V225, P233, DOI 10.2460/javma.2004.225.233; Previtali D, 2021, CARTILAGE, V13, p185S, DOI 10.1177/1947603520906597; Puckler K., 2016, BSAVA MANUAL CANINE, P212, DOI [10.22233/9781910443293.14, DOI 10.22233/9781910443293.14]; Raynauld JP, 2003, ARTHRITIS RHEUM, V48, P370, DOI 10.1002/art.10777; Reid J, 2018, VET J, V236, P72, DOI 10.1016/j.tvjl.2018.04.013; Ring EFJ, 2004, RHEUMATOLOGY, V43, P800, DOI 10.1093/rheumatology/keg009; Robertson-Plouch C, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw9993; Rocha RH, 2019, AM J PHYS MED REHAB, V98, P872, DOI 10.1097/PHM.0000000000001217; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Sieker JT, 2016, ARTHRITIS RHEUMATOL, V68, P1637, DOI 10.1002/art.39631; Smith G, 2011, VET SURG SMALL ANI M, V1st, P824; Sowers M, 2002, OSTEOARTHR CARTILAGE, V10, P595, DOI 10.1053/joca.2002.0800; Paschoal NDS, 2015, J RHEUMATOL, V42, P1869, DOI 10.3899/jrheum.140736; Stadig S, 2019, VET REC, V185, DOI [10.1136/vetrec-2018-105115, 10.1136/vr.105115]; Tammachote N, 2016, J BONE JOINT SURG AM, V98, P885, DOI 10.2106/JBJS.15.00544; Torres RCS, 1999, ARQ BRAS MED VET ZOO, V51, P157, DOI 10.1590/S0102-09351999000200006; Tudor-Locke C, 2002, SPORTS MED, V32, P795, DOI 10.2165/00007256-200232120-00004; Turmezei TD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27486-y; UEMATSU S, 1988, J NEUROSURG, V69, P552, DOI 10.3171/jns.1988.69.4.0552; Vaishya Raju, 2017, J Clin Orthop Trauma, V8, P85, DOI 10.1016/j.jcot.2016.09.008; Van Vynckt D, 2012, VLAAMS DIERGEN TIJDS, V81, P290; Vandeweerd JM, 2015, FUND CLIN PHARMACOL, V29, P427, DOI 10.1111/fcp.12137; Vanionpaa M, 2012, J VET MED SCI, V74, P1539, DOI 10.1292/jvms.12-0180; Vina ER, 2018, CURR OPIN RHEUMATOL, V30, P160, DOI 10.1097/BOR.0000000000000479; Vincent Tonia L, 2019, F1000Res, V8, DOI 10.12688/f1000research.18831.1; Volstad NJ, 2017, VET COMP ORTHOPAED, V30, P54, DOI 10.3415/VCOT-16-04-0054; Waddell DD, 2007, DRUG AGING, V24, P629, DOI 10.2165/00002512-200724080-00002; Walton B, 2018, IN PRACTICE, V40, DOI 10.1136/inp.k647; Walton MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058125; Weitoft T, 2019, SCAND J RHEUMATOL, V48, P279, DOI 10.1080/03009742.2019.1571222; Wiegant K, 2015, ARTHRITIS RHEUMATOL, V67, P465, DOI 10.1002/art.38906; Wilson L, 2016, ANIMAL PHYSIOTHERAPY, V2nd, P112; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013	91	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245553	10.1371/journal.pone.0245553	http://dx.doi.org/10.1371/journal.pone.0245553			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471857	gold, Green Published			2022-12-26	WOS:000639428800072
J	Oladimeji, O; Adepoju, V; Anyiam, FE; San, JE; Odugbemi, BA; Hyera, FLM; Sibiya, MN; Yaya, S; Zoakah, AI; Lawson, L				Oladimeji, Olanrewaju; Adepoju, Victor; Anyiam, Felix Emeka; San, James Emmanuel; Odugbemi, Babatunde A.; Hyera, Francis Leonard Mpotte; Sibiya, Maureen Nokuthula; Yaya, Sanni; Zoakah, Ayuba Ibrahim; Lawson, Lovett			Treatment outcomes of drug susceptible Tuberculosis in private health facilities in Lagos, South-West Nigeria	PLOS ONE			English	Article							CO-INFECTED PATIENTS; TREATMENT DEFAULT; THERAPY; CARE; ADHERENCE; DEATH; TB	Background The Lagos State Tuberculosis, Buruli Ulcer, and Leprosy Control Program (LSTBLCP) started engaging private hospitals under the Public-Private Mix (PPM) Program in 2008. The study aimed to evaluate the trend and predictors of successful Tuberculosis (TB) treatment outcomes of patients managed across these private health facilities between 2010-2016 in Lagos, Nigeria. Methods Retrospective review of TB treatment register and treatment cards of patients commenced on TB treatment between January 2010 and December 2016 in 36 private health facilities engaged by the LSTBLCP. Between December 2016 and February 2017, data were collected and entered into Microsoft Excel by trained data entry clerks. The analysis was done using SPSS software. Independent predictors of successful treatment outcomes were determined using multivariate analysis at the statistical significance of p<0.05 and 95% confidence interval. Results A total of 1660 records of TB patients were reviewed. 1535 (92.47%) commenced treatment, while 1337 (87.10%) of all records had documented treatment outcomes. Of the 1337 patients with outcomes, 1044 (78.09%) had a successful treatment outcome, and 293 (21.91%) had an unsuccessful outcome. Majority were male, 980 (59.04%), Human Immunodeficiency Virus (HIV) negative status, 1295 (80.24%), diagnosed with smear, 1141 (73.14%), treated in private not-for-profit (PNFP) hospital, 1097 (66.08%), treated for TB between 2014-2016 (18.96%-19.52%). In multivariate analysis, age>20years (aOR = 0.26, p = 0.001), receiving TB treatment in 2013 (aOR = 0.39, p = 0.001), having genexpert for TB diagnosis (aOR = 0.26, p = 0.031) and being HIV positive (aOR = 0.37, p = 0.001) significantly reduced likelihood of successful treatment outcome. The site of TB, being on ART or CPT, were confounding determinants of successful treatment outcomes as they became non-significant at the multivariate analysis level. Conclusion Treatment outcome among Lagos private hospitals was low compared with NTBLCP and World Health Organization (WHO) target. We urge the government and TB stakeholders to strengthen the PPM interventions to improve adherence, particularly among People Living with HIV (PLHIV) and older TB patients. Hence, promotion of early care-seeking, improving diagnostic and case holding efficiencies of health facilities, and TB/HIV collaborative interventions can reduce the risk of an unsuccessful outcome.	[Oladimeji, Olanrewaju; Hyera, Francis Leonard Mpotte] Walter Sisulu Univ, Dept Publ Hlth, Eastern Cape, South Africa; [Oladimeji, Olanrewaju; Sibiya, Maureen Nokuthula] Durban Univ Technol, Fac Hlth Sci, Eastern Cape, South Africa; [Oladimeji, Olanrewaju] Univ Botswana, Dept Family Med & Publ Hlth, Fac Med, Gaborone, Botswana; [Adepoju, Victor] Adolescent Friendly Res Initiat & Care ADOLFRIC, Ado Ekiti, Ekiti State, Nigeria; [Anyiam, Felix Emeka] Univ Port Harcourt, Ctr Hlth & Dev, Port Harcourt, Nigeria; [San, James Emmanuel] Univ KwaZulu Natal, Coll Hlth Sci, Kwazulu Natal Res & Innovat Sequencing Platform K, Durban, South Africa; [Odugbemi, Babatunde A.] Lagos State Univ, Coll Med, Dept Community Hlth & Primary Hlth Care, Lagos, Nigeria; [Yaya, Sanni] Univ Ottawa, Sch Int Dev & Global Studies, Ottawa, ON, Canada; [Yaya, Sanni] Univ Oxford, George Inst Global Hlth, Oxford, England; [Zoakah, Ayuba Ibrahim] Univ Jos, Jos Univ Teaching Hosp, Dept Community Med, Jos, Plateau State, Nigeria; [Lawson, Lovett] Zankli Med Serv Ltd, Abuja, Nigeria	Walter Sisulu University; Durban University of Technology; University of Botswana; University of Port Harcourt; University of Kwazulu Natal; Lagos State University; University of Ottawa; University of Oxford; University of Jos	Oladimeji, O (corresponding author), Walter Sisulu Univ, Dept Publ Hlth, Eastern Cape, South Africa.; Oladimeji, O (corresponding author), Durban Univ Technol, Fac Hlth Sci, Eastern Cape, South Africa.; Oladimeji, O (corresponding author), Univ Botswana, Dept Family Med & Publ Hlth, Fac Med, Gaborone, Botswana.	ooladimeji@wsu.ac.za	Abiola, Adepoju/GZM-7264-2022; Yaya, Sanni/C-1079-2019; Odugbemi, Babatunde/B-9521-2018	Yaya, Sanni/0000-0002-4876-6043; Odugbemi, Babatunde/0000-0001-7551-4450; Anyiam, Felix Emeka/0000-0003-2774-7406; Oladimeji, olanrewaju/0000-0002-5356-901X; Zoakah, Ayuba/0000-0003-1856-7753; ADEPOJU, VICTOR ABIOLA/0000-0001-8379-1001	Fogarty International Center; National Institute of Mental Health, of the National Institutes of Health [D43 TW010543]	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Mental Health, of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research reported in this publication was partially supported by the Fogarty International Center and National Institute of Mental Health, of the National Institutes of Health under Award Number D43 TW010543. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abuaku B, 2010, SCAND J INFECT DIS, V42, P281, DOI 10.3109/00365540903493723; Addis Z., 2013, INT J BIOMEDICAL ADV, V4, P167, DOI [10.7439/ijbar.v4i3.300, DOI 10.7439/IJBAR.V4I3.300]; Adejumo A.O., 2015, J TROP DIS HLTH, V10, P1; Adejumo Olusola Adedeji, 2017, Niger Med J, V58, P44, DOI 10.4103/0300-1652.218417; Akanbi K., 2019, PAN AFR MED J, V32, P1; Alobu I, 2014, ASIAN PAC J TROP MED, V7, P977, DOI 10.1016/S1995-7645(14)60172-3; BAYER R, 1995, LANCET, V345, P1545, DOI 10.1016/S0140-6736(95)91090-5; Berhe G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-537; Beza MG., 2013, J INFECT DIS THER, V1, P6; Bobbio F, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027179; Bukhary ZA, 2007, ANN SAUDI MED, V27, P171, DOI 10.4103/0256-4947.51509; Cattamanchi A, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0668-0; Cayla JA, 2004, INT J TUBERC LUNG D, V8, P458; Torres NMC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226507; Chengsorn N, 2009, INT J TUBERC LUNG D, V13, P888; Dewan PK, 2006, BMJ-BRIT MED J, V332, P574, DOI 10.1136/bmj.38738.473252.7C; Di Gennaro F, 2017, TUBERCULOSIS, V103, P44, DOI 10.1016/j.tube.2017.01.002; Di Tanna GL, 2019, LANCET GLOB HEALTH, V7, pE191, DOI [10.1016/S2214-109X(18)30458-3, 10.1016/s2214-109x(18)30458-3]; Duru C.B., 2016, OPEN ACCESS LIB J, V3, pE2754, DOI [10.4236/oalib.1102754, DOI 10.4236/OALIB.1102754]; Faustini A, 2005, EUR RESPIR J, V26, P503, DOI 10.1183/09031936.05.00103504; Federal Ministry of Health, 2007, PUBL PRIV TUB CONTR; Federal Ministry of Health, 2012, NATL TUB LEPR CONTR, V4th edition, P8; Federal Ministry of Health [FMOH] Department of Public Health, 2019, NATL TB LEPR CONTR P; Federal Ministry of Health-Nigeria, 2015, NATL STRAT PLAN TUB; Gebremariam MK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-651; Gidado M, 2009, ANN AFR MED, V8, P25, DOI 10.4103/1596-3519.55760; Hamusse SD, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25382; Ibrahim L.M., 2014, PAN AFR MED J, V18; Ifebunandu Ngozi A, 2012, J Infect Public Health, V5, P340, DOI 10.1016/j.jiph.2012.06.002; Kuntardina Ari, 2017, ADV INTELLIGENT SYST, V131; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Mabunda TE, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.12; Mesfin MM, 2009, HEALTH POLICY PLANN, V24, P457, DOI 10.1093/heapol/czp030; Munoz-Sellart M, 2010, INT J TUBERC LUNG D, V14, P973; Mupfumi L, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu038; Obermeyer Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001721; Oyefabi A., TUBERCULOSIS DETERMI; Oyeka C.I.A, 2014, PUBLIC HLTH RES, V4, P45; Quelapio I.D., 2000, PHIL J MICROBIOL INF, V29, P80; Sanchez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033129; Tola A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7980-x; Ukwaja K N, 2013, Niger Postgrad Med J, V20, P125; Umanah T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1214-3; Vasankari T, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-291; World Health Organization, 2017, FACT SHEET TOP 10 CA; World Health Organization, 2014, 67 WORLD HLTH ASS 20; World Health Organization (WHO), 2016, STANDARDS IMPROVING	47	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0244581	10.1371/journal.pone.0244581	http://dx.doi.org/10.1371/journal.pone.0244581			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471851	gold, Green Published			2022-12-26	WOS:000639428800064
J	Shishir, TA; Bin Naser, I; Faruque, SM				Shishir, Tushar Ahmed; Bin Naser, Iftekhar; Faruque, Shah M.			In silico comparative genomics of SARS-CoV-2 to determine the source and diversity of the pathogen in Bangladesh	PLOS ONE			English	Article							SARS	The COVID19 pandemic caused by SARS-CoV-2 virus has severely affected most countries of the world including Bangladesh. We conducted comparative analysis of publicly available whole-genome sequences of 64 SARS-CoV-2 isolates in Bangladesh and 371 isolates from another 27 countries to predict possible transmission routes of COVID19 to Bangladesh and genomic variations among the viruses. Phylogenetic analysis indicated that the pathogen was imported in Bangladesh from multiple countries. The viruses found in the southern district of Chattogram were closely related to strains from Saudi Arabia whereas those in Dhaka were similar to that of United Kingdom and France. The 64 SARS-CoV-2 sequences from Bangladesh belonged to three clusters. Compared to the ancestral SARS-CoV-2 sequence reported from China, the isolates in Bangladesh had a total of 180 mutations in the coding region of the genome, and 110 of these were missense. Among these, 99 missense mutations (90%) were predicted to destabilize protein structures. Remarkably, a mutation that leads to an I300F change in the nsp2 protein and a mutation leading to D614G change in the spike protein were prevalent in SARS-CoV-2 genomic sequences, and might have influenced the epidemiological properties of the virus in Bangladesh.	[Shishir, Tushar Ahmed; Bin Naser, Iftekhar] BRAC Univ, Dept Math & Nat Sci, Dhaka, Bangladesh; [Shishir, Tushar Ahmed; Faruque, Shah M.] Independent Univ, Bangladesh IUB, Sch Environm & Life Sci, Dhaka, Bangladesh	Bangladesh Rural Advancement Committee BRAC; BRAC University; Independent University Bangladesh (IUB)	Bin Naser, I (corresponding author), BRAC Univ, Dept Math & Nat Sci, Dhaka, Bangladesh.	iftekhar.naser@bracu.ac.bd	Shishir, Tushar Ahmed/HHS-2252-2022	Shishir, Tushar Ahmed/0000-0002-1347-1739				Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Angeletti S, 2020, J MED VIROL, V92, P584, DOI 10.1002/jmv.25719; Balaban M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221068; Cao HL, 2019, J CHEM INF MODEL, V59, P1508, DOI 10.1021/acs.jcim.8b00697; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Denison MR, 2011, RNA BIOL, V8, P270, DOI 10.4161/rna.8.2.15013; GISAID, 2020, CLAD LIN NOM AIDS GE; Gunalan Vithiagaran, 2011, BMC Res Notes, V4, P446, DOI 10.1186/1756-0500-4-446; Hanel K, 2007, BIOL CHEM, V388, P1325, DOI 10.1515/BC.2007.157; Hossain A, 2020, COVID 19 OUTBREAK SI; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lefkowitz EJ, 2018, NUCLEIC ACIDS RES, V46, pD708, DOI 10.1093/nar/gkx932; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Page AJ, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000056; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042; Schaecher SR, 2007, J VIROL, V81, P11054, DOI 10.1128/JVI.01266-07; Shean RC, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2606-y; Shi XJ, 2020, PROTEIN SCI, V29, P1924, DOI 10.1002/pro.3913; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Taylor JK, 2015, J VIROL, V89, P11820, DOI 10.1128/JVI.02274-15; Webmeter, 2020, CIR AG SEX DEM COVID; WHO, 2020, 169 WHO; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yang Y, 2015, J VIROL, V89, P9119, DOI 10.1128/JVI.01279-15; Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196; Yoshimoto FK, 2020, PROTEIN J, V39, P198, DOI 10.1007/s10930-020-09901-4; Zhang Lizhou, 2020, bioRxiv, DOI 10.1101/2020.06.12.148726; Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2	37	18	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245584	10.1371/journal.pone.0245584	http://dx.doi.org/10.1371/journal.pone.0245584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471859	Green Published, Green Submitted, gold			2022-12-26	WOS:000639428800047
J	Chen, XF; Zhang, RD; Xing, YF; Jiang, B; Li, B; Xu, XX; Zhou, YF				Chen, Xiaofei; Zhang, Ruidong; Xing, Yifan; Jiang, Bing; Li, Bang; Xu, Xiaoxue; Zhou, Yufei			The efficacy of different seed priming agents for promoting sorghum germination under salt stress	PLOS ONE			English	Article							ABIOTIC STRESS; SALINITY TOLERANCE; ANTIOXIDANT ENZYME; GIBBERELLIC-ACID; SALICYLIC-ACID; SUAEDA-SALSA; GROWTH; WHEAT; L.; SEEDLINGS	Sorghum [Sorghum bicolor (L.) Moench] seed germination is sensitive to salinity, and seed priming is an effective method for alleviating the negative effects of salt stress on seed germination. However, few studies have compared the effects of different priming agents on sorghum germination under salt stress. In this study, we quantified the effects of priming with distilled water (HP), sodium chloride (NaCl), potassium chloride (KCl), calcium chloride (CaCl2), and polyethylene glycol (PEG) on sorghum seed germination under 150 mM NaCl stress. The germination potential, germination rate, germination index, vigor index, root length, shoot length, root fresh weight, shoot fresh weight, root dry weight, and shoot dry weight were significantly reduced by salt stress. Different priming treatments alleviated the germination inhibition caused by salt stress to varying degrees, and 50 mM CaCl2 was the most effective treatment. In addition, the mitigation effect of priming was stronger on root traits than on shoot traits. Mitigation efficacy was closely related to both the type of agent and the concentration of the solution. Principal component analysis showed that all concentrations of CaCl2 had higher scores and were clearly distinguished from other treatments based on their positive effects on all germination traits. The effects of the other agents varied with concentration. The priming treatments were divided into three categories based on their priming efficacy, and the 50, 100, and 150 mM CaCl2 treatments were placed in the first category. The 150 mM KCl, 10% PEG, HP, 150 mM NaCl, 30% PEG, and 50 mM KCl treatments were placed in the second category, and the 100 mM NaCl, 100 mM KCl, 20% PEG, and 50 mM NaCl treatments were least effective and were placed in the third category. Choosing appropriate priming agents and methods for future research and applications can ensure that crop seeds germinate healthily under saline conditions.	[Chen, Xiaofei; Zhang, Ruidong; Xing, Yifan; Jiang, Bing; Li, Bang; Xu, Xiaoxue; Zhou, Yufei] Shenyang Agr Univ, Coll Agron, Shenyang, Liaoning, Peoples R China; [Zhang, Ruidong] Shanxi Acad Agr Sci, Inst Econ Crop, Fenyang, Shanxi, Peoples R China; [Xu, Xiaoxue] Tongliao Agr Technol Extens Stn, Tongliao, Inner Mongolia, Peoples R China	Shenyang Agricultural University; Shanxi Agricultural University	Zhou, YF (corresponding author), Shenyang Agr Univ, Coll Agron, Shenyang, Liaoning, Peoples R China.	zhouyufei2002@aliyun.com			China Agriculture Research System [CARS-06]	China Agriculture Research System	This research was funded by the China Agriculture Research System (CARS-06).	Abid M, 2017, ENV EXPT BOT, V145, P12; Afreen F, 2006, J PINEAL RES, V41, P108, DOI 10.1111/j.1600-079X.2006.00337.x; Afzal I, 2008, PLANT SOIL ENVIRON, V54, P382, DOI 10.17221/408-PSE; Anil VS, 2008, J BIOL CHEM, V283, P3497, DOI 10.1074/jbc.M700766200; Ashraf M, 2005, ADV AGRON, V88, P223, DOI 10.1016/S0065-2113(05)88006-X; Aydinoglu B, 2019, CELL MOL BIOL, V65, P18, DOI 10.14715/cmb/2019.65.3.3; Azooz MM, 2009, INT J AGRIC BIOL, V11, P343; Berhanu Abraha, 2013, Agricultural Sciences, V4, P666, DOI 10.4236/as.2013.412089; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Bewley JD, 2013, SEED SCI RES, V23, P289, DOI DOI 10.1017/S0960258513000287; Bybordi A, 2010, NOT BOT HORTI AGROBO, V38, P128; Cesur A, 2011, ACTA PHYSIOL PLANT, V33, P705, DOI 10.1007/s11738-010-0594-7; Chen K, 2013, ENVIRON EXP BOT, V94, P33, DOI 10.1016/j.envexpbot.2012.03.005; Chen KT, 2011, PLANT SCI, V180, P212, DOI 10.1016/j.plantsci.2010.08.007; Cuartero J, 2006, J EXP BOT, V57, P1045, DOI 10.1093/jxb/erj102; Curtidor CM, 2017, J AGRON CROP SCI, V204, P1; Daszkowska-Golec A, 2011, OMICS, V15, P763, DOI 10.1089/omi.2011.0082; Demir I, 2004, SCI HORTIC-AMSTERDAM, V102, P467, DOI 10.1016/j.scienta.2004.04.012; Duan DY, 2007, ANN BOT FENN, V44, P161; Farhoudi R, 2011, AFR J AGR RES, V6, P1363; Farooq M., 2007, Pakistan Journal of Agricultural Sciences, V44, P529; Farooq Muhammad, 2007, Archives of Agronomy and Soil Science, V53, P315, DOI 10.1080/03650340701226166; Farooq S, 2017, ENVIRON SCI POLLUT R, V24, P13638, DOI 10.1007/s11356-017-8957-x; Fercha A, 2013, J PROTEOMICS, V91, P486, DOI 10.1016/j.jprot.2013.08.010; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Ghobadi M., 2012, Journal of Agricultural Science (Toronto), V4, P244; Gholami M., 2015, Journal of Crop Science and Biotechnology, V18, P21, DOI 10.1007/s12892-014-0078-1; Hussain S, 2018, ACTA PHYSIOL PLANT, V40, DOI 10.1007/s11738-018-2644-5; Hussain S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08101; Ibrahim EA, 2016, J PLANT PHYSIOL, V192, P38, DOI 10.1016/j.jplph.2015.12.011; Iqbal M, 2006, J INTEGR PLANT BIOL, V48, P181, DOI 10.1111/j.1744-7909.2006.00181.x; Issam N, 2012, PLANT GROWTH REGUL, V68, P37, DOI 10.1007/s10725-012-9691-5; Jafar MZ, 2012, J AGRON CROP SCI, V198, P38, DOI 10.1111/j.1439-037X.2011.00485.x; Jiang XW, 2020, HORTSCIENCE, V55, P647, DOI 10.21273/HORTSCI14854-20; Jisha KC, 2013, ACTA PHYSIOL PLANT, V35, P1381, DOI 10.1007/s11738-012-1186-5; Bismillah Khan M, 2015, TURK J AGRIC FOR, V39, P193, DOI 10.3906/tar-1405-39; Kibinza S, 2011, PLANT SCI, V181, P309, DOI 10.1016/j.plantsci.2011.06.003; Koster P, 2019, PLANT BIOLOGY, V21, P39, DOI 10.1111/plb.12704; Li J, 2011, IND CROP PROD, V34, P1543, DOI 10.1016/j.indcrop.2011.05.012; Li JP, 2019, PLANT SIGNAL BEHAV, V14, DOI 10.1080/15592324.2019.1659705; Liu W, 2014, ACTA PHYSIOL PLANT, V36, P2183, DOI 10.1007/s11738-014-1595-8; Manishankar P, 2018, J EXP BOT, V69, P4215, DOI 10.1093/jxb/ery201; Maswada HF, 2018, J AGRON CROP SCI, V204, P577, DOI 10.1111/jac.12280; Memoriam In, 2018, ALI REP, V40, P1, DOI DOI 10.1109/LED.2018.2880303; Migahid MM, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01886; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Naglreiter C, 2005, PLANT PHYSIOL BIOCH, V43, P117, DOI 10.1016/j.plaphy.2005.01.005; Nimir NEA, 2015, CROP PASTURE SCI, V66, P145, DOI 10.1071/CP14141; Paparella S, 2015, PLANT CELL REP, V34, P1281, DOI 10.1007/s00299-015-1784-y; Rajjou L, 2008, CR BIOL, V331, P796, DOI 10.1016/j.crvi.2008.07.021; Rajjou L, 2012, ANNU REV PLANT BIOL, V63, P507, DOI 10.1146/annurev-arplant-042811-105550; Shao Q, 2014, FUNCT PLANT BIOL, V41, P790, DOI 10.1071/FP13265; Sun Lu, 2012, Scientia Agricultura Sinica, V45, P1714; Wang JiaChuan, 2016, Journal of Jilin Agricultural University, V38, P656; Yan M, 2016, J HORTIC SCI, V91, P1; Zhang S, 2007, AUST J AGR RES, V58, P811, DOI 10.1071/AR06253; Zhang Xianxiu, 2009, Zhongguo Zhong Yao Za Zhi, V34, P944; Zheng CF, 2009, ENVIRON EXP BOT, V67, P222, DOI 10.1016/j.envexpbot.2009.05.002; Zhu GL, 2019, CHIL J AGR RES, V79, P415, DOI 10.4067/S0718-58392019000300415; Zhu GuangLong, 2018, Acta Agronomica Sinica, V44, P1713	60	15	16	11	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245505	10.1371/journal.pone.0245505	http://dx.doi.org/10.1371/journal.pone.0245505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465130	Green Published, gold			2022-12-26	WOS:000611969200049
J	Wang, Y; Qiao, JL; Zhang, DD; Zhong, CY; Wang, SY; Li, XM; Feng, LY; Shi, S; Wang, BX; Liu, QZ				Wang, Yu; Qiao, Jialu; Zhang, Dandan; Zhong, Chunyan; Wang, Shengya; Li, Xiaomei; Feng, Lingyan; Shi, Shen; Wang, Bingxue; Liu, Qingzhen			Systematic identification of autophagy-related proteins in Aedes albopictus	PLOS ONE			English	Article							VIRUS; INHIBITION; INFECTION; VECTOR; DEGRADATION; COMPLEX; GENES	Autophagy is a conserved cellular process playing a role in maintenance of cellular homeostasis and response to changing nutrient conditions via degradation and recirculation of cellular redundant components. Autophagy-related proteins (Atg) play important function in autophagy pathway. Aedes albopictus mosquito is an effective vector transmitting multiple viruses which cause serious human diseases. Moreover, Aedes albopictus mosquito is becoming a serious threat to human health due to its widening distribution in recent years and thus worth of more research attention. It was reported that autophagy might play a role in viral infection in Aedes mosquito. To better understand the interaction between autophagy and arbovirus infection in mosquito system, it is necessary to identify autophagy pathway in the system. However, autophagy in Aedes albopictus mosquito is still poorly understood so far. We recently identified AaAtg8, the first Atg protein reported in Aedes albopictus mosquito. This work further identified twelve atg genes in Aedes albopictus mosquito. Sequence and phylogenetic analysis of the twelve atg genes were performed. Expression profiles of all the twelve Aaatg genes in different developmental stages and genders of Aedes albopictus mosquito were conducted. Effects of chemicals inhibiting or inducing autophagy on the levels of eight identified AaAtg proteins were examined. The function of two identified AaAtg proteins AaAtg6 and AaAtg16 and their response to arbovirus SINV infection were studied preliminarily. Taken together, this work systematically identified Aedes albopictus atg genes and provided basic information which might help to elucidate the autophagy pathway and the role of autophagy in arbovirus infection in Aedes mosquito system.	[Wang, Yu; Qiao, Jialu; Zhang, Dandan; Zhong, Chunyan; Wang, Shengya; Li, Xiaomei; Feng, Lingyan; Shi, Shen; Wang, Bingxue; Liu, Qingzhen] Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, State Key Lab Virol, Wuhan, Hubei, Peoples R China	Wuhan University	Liu, QZ (corresponding author), Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	qzliu@whu.edu.cn	Feng, Lingyan/GVT-0979-2022		National Natural Science Foundation of China [31370186]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the grant (Grant Number: 31370186) from National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/).Recipient of the grant: Qingzhen Liu (QL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada A, 2014, EMBO REP, V15, P839, DOI 10.15252/embr.201439076; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Brackney DE, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0007754; Brackney DE, 2017, CURR OPIN INSECT SCI, V22, P1, DOI 10.1016/j.cois.2017.05.001; Bryant B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025502; Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006; Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633; Denton D, 2009, CURR BIOL, V19, P1741, DOI 10.1016/j.cub.2009.08.042; Echavarria-Consuegra L, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190009; Eng MW, 2016, INSECT BIOCHEM MOLEC, V76, P70, DOI 10.1016/j.ibmb.2016.07.004; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Guo XX, 2013, ACTA TROP, V128, P566, DOI 10.1016/j.actatropica.2013.08.006; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Hugo LE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1838-1; Jefferson M, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010039; Joubert PE, 2012, J EXP MED, V209, P1029, DOI 10.1084/jem.20110996; Kaminskyy V, 2012, BBA-PROTEINS PROTEOM, V1824, P44, DOI 10.1016/j.bbapap.2011.05.013; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li WW, 2012, CELL MOL LIFE SCI, V69, P1125, DOI 10.1007/s00018-011-0865-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12; Mei Y, 2016, BIOCHEMISTRY-US, V55, P4239, DOI 10.1021/acs.biochem.6b00246; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Panyasrivanit M, 2011, VIROLOGY, V418, P74, DOI 10.1016/j.virol.2011.07.010; Peng HP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050259; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Qiao JL, 2018, PEERJ, V6, DOI 10.7717/peerj.5988; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tasset I, 2016, FEBS J, V283, P2403, DOI 10.1111/febs.13677; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yao ZY, 2015, AUTOPHAGY, V11, P2288, DOI 10.1080/15548627.2015.1107692	41	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245694	10.1371/journal.pone.0245694	http://dx.doi.org/10.1371/journal.pone.0245694			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465164	Green Published, gold			2022-12-26	WOS:000611969200016
J	Yang, LJ; Hsu, SM; Wu, PH; Lin, MY; Huang, TH; Lin, YT; Kuo, HT; Chiu, YW; Hwang, SJ; Tsai, JC; Chen, HC				Yang, Lii-Jia; Hsu, Shan-Min; Wu, Ping-Hsun; Lin, Ming-Yen; Huang, Teng-Hui; Lin, Yi-Ting; Kuo, Hung-Tien; Chiu, Yi-Wen; Hwang, Shang-Jyh; Tsai, Jer-Chia; Chen, Hung-Chun			Association of digoxin with mortality in patients with advanced chronic kidney disease: A population-based cohort study	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; 2016 ESC GUIDELINES; ATRIAL-FIBRILLATION; ISCHEMIC-STROKE; HEART-FAILURE; RISK; OUTCOMES; METAANALYSIS; VALIDATION; PREDICTION	Digoxin is commonly prescribed for heart failure and atrial fibrillation, but there is limited data on its safety in patients with chronic kidney disease (CKD). We conducted a population-based cohort study using the pre-end stage renal disease (ESRD) care program registry and the National Health Insurance Research Database in Taiwan. Of advanced CKD patient cohort (N = 31,933), we identified the digoxin user group (N = 400) matched with age and sex non-user group (N = 2,220). Multivariable Cox proportional hazards and sub-distribution hazards models were used to evaluate the association between digoxin use and the risk of death, cardiovascular events (acute coronary syndrome, ischemic stroke, or hemorrhagic stroke) and renal outcomes (ESRD, rapid decline in estimated glomerular filtration rate-eGFR, or acute kidney injury). Results showed that all-cause mortality was higher in the digoxin user group than in the non-user group, after adjusting for covariates (adjusted hazard ratio, aHR 1.63; 95% CI 1.23-2.17). The risk for acute coronary syndrome (sub-distribution hazard ratio, sHR 1.18; 95% CI 0.75-1.86), ischemic stroke (sHR 1.42; 95% CI 0.85-2.37), and rapid eGFR decline (sHR 1.00 95% CI 0.78-1.27) was not significantly different between two groups. In conclusion, our study demonstrated that digoxin use was associated with increased mortality, but not cardiovascular events or renal function decline in advanced CKD patients. This finding warns the safety of prescribing digoxin in this population. Future prospective studies are needed to overcome the limitations of cohort study design.	[Yang, Lii-Jia] Kaohsiung Municipal CiJin Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Yang, Lii-Jia; Hsu, Shan-Min; Wu, Ping-Hsun; Lin, Ming-Yen; Huang, Teng-Hui; Kuo, Hung-Tien; Chiu, Yi-Wen; Hwang, Shang-Jyh; Tsai, Jer-Chia; Chen, Hung-Chun] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Wu, Ping-Hsun; Lin, Yi-Ting] Kaohsiung Med Univ, Coll Med, Inst Clin Med, Kaohsiung, Taiwan; [Lin, Ming-Yen; Kuo, Hung-Tien; Chiu, Yi-Wen; Hwang, Shang-Jyh; Tsai, Jer-Chia; Chen, Hung-Chun] Kaohsiung Med Univ, Coll Med, Dept Renal Care, Kaohsiung, Taiwan; [Lin, Ming-Yen] Natl Taiwan Univ, Coll Publ Hlth, Publ Hlth Degree Program, Taipei, Taiwan; [Lin, Yi-Ting] Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Lin, Yi-Ting] Kaohsiung Municipal Hsiaokang Hosp, Dept Family Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; National Taiwan University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Tsai, JC (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan.; Tsai, JC (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Renal Care, Kaohsiung, Taiwan.	jerchia.tsai@gmail.com	Lin, Ming Yen/A-8637-2010	Lin, Ming Yen/0000-0002-8194-4833; Yang, Lii-Jia/0000-0002-0543-4313	Kaohsiung Municipal CiJin Hospital [Kmch-108-001]; Kaohsiung Medical University Hospital [KMUH104-4M07, KMUH104-4M08, KMUH104-4R10, KMUH105-5R18, KMUH106-6R18, KMUH107-7R17]; Ministry of Science and Technology, Taiwan, R.O.C. [MOST104-2511-S-037-004-MY2, MOST106-2511-S-037-002, MOST107-2511-H-037-006-MY2]	Kaohsiung Municipal CiJin Hospital; Kaohsiung Medical University Hospital; Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This study was supported by the Kaohsiung Municipal CiJin Hospital under Grant Kmch-108-001 to LJY, and partially supported by grants from the Kaohsiung Medical University Hospital (KMUH104-4M07, KMUH104-4M08, KMUH104-4R10, KMUH105-5R18, KMUH106-6R18, and KMUH107-7R17) and Ministry of Science and Technology, Taiwan, R.O.C. (MOST104-2511-S-037-004-MY2, MOST106-2511-S-037-002, and MOST107-2511-H-037-006-MY2) to JCT. The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	Alonso A, 2011, CIRCULATION, V123, P2946, DOI 10.1161/CIRCULATIONAHA.111.020982; Bansal N, 2017, JAMA CARDIOL, V2, P314, DOI 10.1001/jamacardio.2016.4652; Chan KE, 2010, J AM SOC NEPHROL, V21, P1550, DOI 10.1681/ASN.2009101047; Chang SS, 2013, INT J CARDIOL, V169, pE26, DOI 10.1016/j.ijcard.2013.08.103; Chao TF, 2014, CAN J CARDIOL, V30, P1190, DOI 10.1016/j.cjca.2014.05.009; Chen JY, 2014, CLIN J AM SOC NEPHRO, V9, P513, DOI 10.2215/CJN.03100313; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chirinos JA, 2005, HEART RHYTHM, V2, P525, DOI 10.1016/j.hrthm.2005.01.016; Danaei G, 2013, STAT METHODS MED RES, V22, P70, DOI 10.1177/0962280211403603; Ehle Michael, 2011, Crit Pathw Cardiol, V10, P93, DOI 10.1097/HPC.0b013e318221e7dd; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; FROME EL, 1985, AM J EPIDEMIOL, V121, P309, DOI 10.1093/oxfordjournals.aje.a114001; Gheorghiade M, 2013, EUR J HEART FAIL, V15, P551, DOI 10.1093/eurjhf/hft010; Gjesdal K, 2008, HEART, V94, P191, DOI 10.1136/hrt.2006.108399; Goldberger ZD, 2012, AM J CARDIOL, V109, P1818, DOI 10.1016/j.amjcard.2012.02.028; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Lee M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4249; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LISALO E, 1977, CLIN PHARMACOKINET, V2, P1; Lopes RD, 2018, J AM COLL CARDIOL, V71, P1063, DOI 10.1016/j.jacc.2017.12.060; Macedo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036388; MARCUS FI, 1985, J AM COLL CARDIOL, V5, pA82, DOI 10.1016/S0735-1097(85)80466-6; O'Sullivan ED, 2017, J AM SOC NEPHROL, V28, P407, DOI 10.1681/ASN.2015121308; Ouyang AJ, 2015, AM J CARDIOL, V115, P901, DOI 10.1016/j.amjcard.2015.01.013; Pannu N, 2011, AM J KIDNEY DIS, V58, P206, DOI 10.1053/j.ajkd.2011.01.028; Perry G, 1997, NEW ENGL J MED, V336, P525; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Qureshi W, 2016, CARDIOL J, V23, P333, DOI 10.5603/CJ.a2016.0016; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P871, DOI 10.1001/jama.289.7.871; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Sessa M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160337; Sethi NJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193924; Testani JM, 2013, J CARD FAIL, V19, P295, DOI 10.1016/j.cardfail.2013.03.002; Turakhia MP, 2014, J AM COLL CARDIOL, V64, P660, DOI 10.1016/j.jacc.2014.03.060; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073	37	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245620	10.1371/journal.pone.0245620	http://dx.doi.org/10.1371/journal.pone.0245620			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449946	Green Published, gold			2022-12-26	WOS:000609991600040
J	Nishi, K; Nishitsuka, K; Yamamoto, T; Yamashita, H				Nishi, Katsuhiro; Nishitsuka, Koichi; Yamamoto, Teiko; Yamashita, Hidetoshi			Factors correlated with visual outcomes at two and four years after vitreous surgery for proliferative diabetic retinopathy	PLOS ONE			English	Article							VITRECTOMY; COMPLICATIONS; MANAGEMENT	Proliferative diabetic retinopathy (PDR) is the most severe case of diabetic retinopathy that can cause visual impairment. This study aimed to reveal the factors correlated with better postoperative visual acuity after a long follow-up in patients who underwent vitrectomy for PDR. We retrospectively analyzed the data set including systemic findings, ocular findings, and surgical factors from registered patients who could be completely followed up for 2 or 4 years after vitrectomy. We ultimately enrolled 128 eyes from 100 patients who underwent vitrectomy for PDR between January 2008 and September 2012 and were followed up for >2 years. Among them, 91 eyes from 70 patients could be followed up for 4 years. Factors related to the postoperative visual acuity of >= 20/40 and >= 20/30 after 2 and 4 years were investigated by logistic regression analysis. Better postoperative visual acuity correlated with the following factors: no rubeosis iridis ([>= 20/40 at 2 years; odds ratio {OR}, 0.068; 95% confidence interval {CI}, 0.012-0.39; P = 0.003], [>= 20/30 at 2 years; OR, 0.07; 95% CI, 0.01-0.40; P = 0.03], [>= 20/30 at 4 years; OR, 0.078; 95% CI, 0.006-0.96; P = 0.04]), no fibrovascular membrane [(>= 20/40 at 2 years; OR, 0.22; 95% CI, 0.061-0.81; P = 0.02), (>= 20/40 at 4 years; OR, 0.26; 95% CI, 0.07-0.94; P = 0.04), (>= 20/30 at 4 years; OR, 0.14; 95% CI, 0.04-0.52; P = 0.004)], existing vitreous hemorrhage (>= 20/30 at 2 years; OR, 9.55; 95% CI, 1.03-95.27; P = 0.04), and no reoperation ([>= 20/40 at 4 years; OR, 0.15; 95% CI, 0.03-0.78; P = 0.02], [>= 20/30 at 4 years; OR, 0.06; 95% CI, 0.07-0.54; P = 0.01]). Treatment provision before disease severity and treatment without complications were associated with good postoperative visual acuity.	[Nishi, Katsuhiro; Nishitsuka, Koichi; Yamamoto, Teiko; Yamashita, Hidetoshi] Yamagata Univ, Fac Med, Dept Ophthalmol & Visual Sci, Yamagata, Japan; [Yamamoto, Teiko] Kanamecho Yamamoto Eye Clin, Toshima Ku, Tokyo, Japan	Yamagata University	Nishitsuka, K (corresponding author), Yamagata Univ, Fac Med, Dept Ophthalmol & Visual Sci, Yamagata, Japan.	mlc12186@nifty.com	Nishi, Katsuhiro/HHC-9480-2022	Nishi, Katsuhiro/0000-0002-5596-8962; Nishitsuka, Koichi/0000-0003-2394-9561	JSPS KAKENHI [JP25462704, JP20K18373]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers JP25462704, JP20K18373.	AABERG TM, 1987, OPHTHALMOLOGY, V94, P775; Gupta B, 2012, EYE, V26, P576, DOI 10.1038/eye.2011.348; La Heij EC, 2004, GRAEF ARCH CLIN EXP, V242, P210, DOI 10.1007/s00417-003-0815-5; Machemer R, 1971, Trans Am Acad Ophthalmol Otolaryngol, V75, P813; MADSEN PH, 1971, BRIT J OPHTHALMOL, V55, P368, DOI 10.1136/bjo.55.6.368; Mason JO, 2005, AM J OPHTHALMOL, V140, P231, DOI 10.1016/j.ajo.2005.02.052; Morizane Y, 2019, JPN J OPHTHALMOL, V63, P26, DOI 10.1007/s10384-018-0623-4; Moss SE, 1998, OPHTHALMOLOGY, V105, P998, DOI 10.1016/S0161-6420(98)96025-0; Nakamura J, 2017, J DIABETES INVEST, V8, P397, DOI 10.1111/jdi.12645; Newman DK, 2010, EYE, V24, P441, DOI 10.1038/eye.2009.325; Ratnarajan G, 2011, EYE, V25, P704, DOI 10.1038/eye.2011.65; Sharma T, 2016, CLIN EXP OPHTHALMOL, V44, P340, DOI 10.1111/ceo.12752; Tadera Masaki, 2014, Nippon Ganka Gakkai Zasshi, V118, P502; The Diabetic Retinopathy Vitrectomy Study Research Group, 1985, ARCH OPHTHALMOL-CHIC, V103, P1644; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wong TY, 2018, OPHTHALMOLOGY, V125, P1608, DOI 10.1016/j.ophtha.2018.04.007; Yorston D, 2008, BRIT J OPHTHALMOL, V92, P365, DOI 10.1136/bjo.2007.124495	17	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0244281	10.1371/journal.pone.0244281	http://dx.doi.org/10.1371/journal.pone.0244281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444332	Green Published, gold			2022-12-26	WOS:000609988100074
J	Griffin, K; Pedersen, H; Stauss, K; Lungova, V; Thibeault, SL				Griffin, Kate; Pedersen, Hailey; Stauss, Kari; Lungova, Vlasta; Thibeault, Susan L.			Characterization of intrauterine growth, proliferation and biomechanical properties of the murine larynx	PLOS ONE			English	Article							INNER-EAR; DIFFERENTIATION; FOREGUT	Current research approaches employ traditional tissue engineering strategies to promote vocal fold (VF) tissue regeneration, whereas recent novel advances seek to use principles of developmental biology to guide tissue generation by mimicking native developmental cues, causing tissue or allogenic/autologous progenitor cells to undergo the regeneration process. To address the paucity of data to direct VF differentiation and subsequent new tissue formation, we characterize structure-proliferation relationships and tissue elastic moduli over embryonic development using a murine model. Growth, cell proliferation, and tissue biomechanics were taken at E13.5, E15.5, E16.5, E18.5, P0, and adult time points. Quadratic growth patterns were found in larynx length, maximum transverse diameter, outer dorsoventral diameter, and VF thickness; internal VF length was found to mature linearly. Cell proliferation measured with EdU in the coronal and transverse planes of the VFs was found to decrease with increasing age. Exploiting atomic force microscopy, we measured significant differences in tissue stiffness across all time points except between E13.5 and E15.5. Taken together, our results indicate that as the VF mature and develop quadratically, there is a concomitant tissue stiffness increase. Greater gains in biomechanical stiffness at later prenatal stages, correlated with reduced cell proliferation, suggest that extracellular matrix deposition may be responsible for VF thickening and increased biomechanical function, and that the onset of biomechanical loading (breathing) may also contribute to increased stiffness. These data provide a profile of VF biomechanical and growth properties that can guide the development of biomechanically-relevant scaffolds and progenitor cell differentiation for VF tissue regeneration.	[Griffin, Kate; Pedersen, Hailey; Stauss, Kari; Lungova, Vlasta; Thibeault, Susan L.] Univ Wisconsin Madison, Dept Surg, Div Otolaryngol, Madison, WI 53706 USA; [Griffin, Kate; Stauss, Kari; Thibeault, Susan L.] Univ Wisconsin Madison, Dept Biomed Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Thibeault, SL (corresponding author), Univ Wisconsin Madison, Dept Surg, Div Otolaryngol, Madison, WI 53706 USA.; Thibeault, SL (corresponding author), Univ Wisconsin Madison, Dept Biomed Engn, Madison, WI 53706 USA.	thibeault@surgery.wisc.edu			NIH NIDCD [R01 04336, R01 12773]; NSF through the University of Wisconsin Materials Research Science and Engineering Center [DMR-1720415]	NIH NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NSF through the University of Wisconsin Materials Research Science and Engineering Center	This work was funded by grant NIH NIDCD R01 04336 and R01 12773 to ST. We gratefully acknowledge the use of facilities and instrumentation at the UW-Madison Wisconsin Centers for Nanoscale Technology (wcnt.wisc. edu), partially supported by the NSF through the University of Wisconsin Materials Research Science and Engineering Center (DMR-1720415). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett RS, 2015, TISSUE ENG PT A, V21, P2437, DOI [10.1089/ten.tea.2015.0168, 10.1089/ten.TEA.2015.0168]; Bechtold TE, 2016, J DENT RES, V95, P292, DOI 10.1177/0022034515613508; Brown JP, 2014, J BIOMECH, V47, P214, DOI 10.1016/j.jbiomech.2013.09.018; Chan RW, 2002, OTOLARYNG HEAD NECK, V126, P528, DOI 10.1067/mhn.2002.124936; Chen X, 2010, LARYNGOSCOPE, V120, P1819, DOI 10.1002/lary.21037; Cohen SM, 2012, LARYNGOSCOPE, V122, P1589, DOI 10.1002/lary.23197; DEVRIES JIP, 1986, EUR J OBSTET GYN R B, V21, P271, DOI 10.1016/0028-2243(86)90003-1; Garcia RID, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2011.08.007; Hansen JK, 2006, J VOICE, V20, P110, DOI 10.1016/j.jvoice.2004.12.005; Harding R, 1996, J APPL PHYSIOL, V81, P209, DOI 10.1152/jappl.1996.81.1.209; Heris HK, 2013, J MECH BEHAV BIOMED, V28, P383, DOI 10.1016/j.jmbbm.2013.05.026; Huang AH, 2010, EUR CELLS MATER, V19, P72, DOI 10.22203/eCM.v019a08; Jacobs IJ, 2012, DEV BIOL, V369, P54, DOI 10.1016/j.ydbio.2012.06.016; JANSEN AH, 1991, J APPL PHYSIOL, V70, P1431, DOI 10.1152/jappl.1991.70.4.1431; Johanes I, 2011, J VOICE, V25, P254, DOI 10.1016/j.jvoice.2009.09.006; Johnson PC, 2007, TISSUE ENG, V13, P2827, DOI 10.1089/ten.2007.0335; Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415; Lang HN, 2000, J COMP NEUROL, V417, P205, DOI 10.1002/(SICI)1096-9861(20000207)417:2<205::AID-CNE6>3.0.CO;2-Y; Loebel DAF, 2011, DEVELOPMENT, V138, P4511, DOI 10.1242/dev.063867; Lungova V, 2015, DEV BIOL, V399, P263, DOI 10.1016/j.ydbio.2014.12.037; Marturano JE, 2013, P NATL ACAD SCI USA, V110, P6370, DOI 10.1073/pnas.1300135110; Nowlan NC, 2010, BIRTH DEFECTS RES C, V90, P203, DOI 10.1002/bdrc.20184; Nowlan NC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000250; Ohno S, 2012, LARYNGOSCOPE, V122, P583, DOI 10.1002/lary.22389; Oka K, 2008, DEV BIOL, V321, P303, DOI 10.1016/j.ydbio.2008.03.046; Schiele NR, 2013, CURR OPIN BIOTECH, P24, DOI [10.1016/j.copbio.2013.08.007, DOI 10.1016/J.COPBIO.2013.08.007]; Tabler JM, 2017, ELIFE, V6, DOI 10.7554/eLife.19153; Thibeault Susan L, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P148, DOI 10.1097/01.moo.0000163450.90455.fb; Watts CR, 2011, J VOICE, V25, pE1, DOI 10.1016/j.jvoice.2009.07.010; WILSON DB, 1975, J COMP NEUROL, V164, P23, DOI 10.1002/cne.901640103; Zhang YSS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12588-6	31	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0245073	10.1371/journal.pone.0245073	http://dx.doi.org/10.1371/journal.pone.0245073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439907	gold, Green Published			2022-12-26	WOS:000609985300056
J	da Costa, WG; Barbosa, ID; de Souza, JE; Cruz, CD; Nascimento, M; de Oliveira, ACB				da Costa, Weverton Gomes; Barbosa, Ivan de Paiva; de Souza, Jacqueline Enequio; Cruz, Cosme Damiao; Nascimento, Moyses; de Oliveira, Antonio Carlos Baiao			Machine learning and statistics to qualify environments through multi-traits in Coffea arabica	PLOS ONE			English	Article							ARTIFICIAL-NEURAL-NETWORKS; DISCRIMINANT-ANALYSIS; LAND-COVER; L.; CLASSIFICATION; SHADE; ALTITUDE; GROWTH; YIELD; GENES	Several factors such as genotype, environment, and post-harvest processing can affect the responses of important traits in the coffee production chain. Determining the influence of these factors is of great relevance, as they can be indicators of the characteristics of the coffee produced. The most efficient models choice to be applied should take into account the variety of information and the particularities of each biological material. This study was developed to evaluate statistical and machine learning models that would better discriminate environments through multi-traits of coffee genotypes and identify the main agronomic and beverage quality traits responsible for the variation of the environments. For that, 31 morpho-agronomic and post-harvest traits were evaluated, from field experiments installed in three municipalities in the Matas de Minas region, in the State of Minas Gerais, Brazil. Two types of post-harvest processing were evaluated: natural and pulped. The apparent error rate was estimated for each method. The Multilayer Perceptron and Radial Basis Function networks were able to discriminate the coffee samples in multi-environment more efficiently than the other methods, identifying differences in multi-traits responses according to the production sites and type of post-harvest processing. The local factors did not present specific traits that favored the severity of diseases and differentiated vegetative vigor. Sensory traits acidity and fragrance/aroma score also made little contribution to the discrimination process, indicating that acidity and fragrance/aroma are characteristic of coffee produced and all coffee samples evaluated are of the special type in the Mata of Minas region. The main traits responsible for the differentiation of production sites are plant height, fruit size, and bean production. The sensory trait "Body" is the main one to discriminate the form of post-harvest processing.	[da Costa, Weverton Gomes; Barbosa, Ivan de Paiva; de Souza, Jacqueline Enequio; Cruz, Cosme Damiao] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil; [Nascimento, Moyses] Univ Fed Vicosa, Dept Stat, Vicosa, MG, Brazil; [de Oliveira, Antonio Carlos Baiao] Brazilian Agr Res Corp EMBRAPA, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	da Costa, WG (corresponding author), Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil.	wevertonufv@gmail.com	Nascimento, Moyses/Y-8767-2019	Nascimento, Moyses/0000-0001-5886-9540; de Paiva Barbosa, Ivan/0000-0001-8266-4414; Costa, Weverton Gomes da/0000-0003-0742-5936	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) [001]; CNPq (National Counsel of Technological and Scientific Development); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); Consorcio Pesquisa Cafe	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Consorcio Pesquisa Cafe	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) - Finance Code 001. We also thank the CNPq (National Counsel of Technological and Scientific Development), FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais), and the Consorcio Pesquisa Cafe for the research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A lvarez Venegas V.H., 1999, RECOMENDACAO USO COR, P25, DOI DOI 10.1590/S0100-06832004000600008; Adnan A, 2020, FOODS, V9, DOI 10.3390/foods9060788; Anderson TW, 1984, INTRO MULTIVARIATE S; [Anonymous], 2013, REV BRAS BIOL; Ashrafi E, 2011, BIOINFORM BIOL INSIG, V5, P59, DOI 10.4137/BBI.S6206; Avelino J, 2005, J SCI FOOD AGR, V85, P1869, DOI 10.1002/jsfa.2188; Barbosa, 2011, INFORM AGROPECUARIO, V32, P1; Barbosa CD, 2011, CROP BREED APPL BIOT, V11, P224, DOI 10.1590/S1984-70332011000300004; Barbosa I, 2019, CROP BREED APPL BIOT, V19, P428, DOI 10.1590/1984-70332019v19n4a60; Barbosa ID, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-019-2499-x; Barbosa J. N., 2019, African Journal of Agricultural Research, V14, P354; Beiki AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044164; Bishop Christopher M., 2006, PATTERN RECOGNITION; BOREM FM, 2019, COFFEE SCI, V14, P38, DOI DOI 10.25186/CS.V14I1.1522; Bote AD, 2017, NJAS-WAGEN J LIFE SC, V83, P39, DOI 10.1016/j.njas.2017.09.002; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2018, BREIMAN CUTLERS RAND, DOI DOI 10.1023/A:1010933404324; Cardoso MJ, 2007, REV CIENC AGRON, V38, P78; Carvalho A., 1979, Bragantia, V38, P203, DOI 10.1590/S0006-87051979000100022; Chemura A, 2017, PRECIS AGRIC, V18, P859, DOI 10.1007/s11119-016-9495-0; Cheng B, 2016, TRENDS FOOD SCI TECH, V57, P20, DOI 10.1016/j.tifs.2016.09.003; Cruz C. D., 2018, INTELIGENCIA COMPUTA; Cruz CD, 2012, MODELOS BIOMETRICOS; Cruz CD, 2016, ACTA SCI-AGRON, V38, P547, DOI [10.4025/actasciagron.v38i4.32629, 10.4025/actasciagron.v38i3.32629]; Cunningham J, 2019, CRAN REPOS, V45, P39; Oliveira MD, 2020, EUPHYTICA, V216, DOI 10.1007/s10681-020-2569-0; DaMatta Fábio M., 2007, Braz. J. Plant Physiol., V19, P485, DOI 10.1590/S1677-04202007000400014; de Carvalho AM, 2010, PESQUI AGROPECU BRAS, V45, P269, DOI 10.1590/S0100-204X2010000300006; de Carvalho Vitor Prado, 2018, Cientifica (Jaboticabal), V46, P344, DOI 10.15361/1984-5529.2018v46n4p344-352; de Oliveira ACL, 2013, BIOSCI J, V29, P616; de Sousa IC, 2021, SCI AGR, V78, DOI [10.1590/1678-992x-2020-0021, 10.1590/1678-992X-2020-0021]; Demsar J, 2006, J MACH LEARN RES, V7, P1; Dessalegn Y, 2008, J SCI FOOD AGR, V88, P1726, DOI 10.1002/jsfa.3271; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; dos Santos IG, 2019, ACTA SCI-AGRON, V41, DOI 10.4025/actasciagron.v41i1.39803; Ebrahimi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023146; Gamonal LE, 2017, CIENC RURAL, V47, DOI 10.1590/0103-8478cr20160882; Fazuoli, 1991, METODOLOGIAS CRITERI; Fischer A, 2015, ECOL MODEL, V309, P60, DOI 10.1016/j.ecolmodel.2015.04.015; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Foresee FD, 1997, 1997 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-4, P1930, DOI 10.1109/ICNN.1997.614194; Friedl MA, 1997, REMOTE SENS ENVIRON, V61, P399, DOI 10.1016/S0034-4257(97)00049-7; Geromel C, 2008, PLANT PHYSIOL BIOCH, V46, P569, DOI 10.1016/j.plaphy.2008.02.006; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Haykin S, 2008, CONF REC ASILOMAR C, P3, DOI 10.1109/ACSSC.2008.5074349; Hosseinzadeh F, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040017, 10.1371/annotation/2b218d50-a9d5-45b2-80d0-0e806e530749]; da Silveira LCI, 2012, CIENC RURAL, V42, P587, DOI 10.1590/S0103-84782012000400002; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; Joet T, 2010, PLANT CELL ENVIRON, V33, P1220, DOI 10.1111/j.1365-3040.2010.02141.x; Katsuhama N, 2018, REMOTE SENS LETT, V9, P1186, DOI 10.1080/2150704X.2018.1519269; Kavzoglu T, 2003, INT J REMOTE SENS, V24, P4907, DOI 10.1080/0143116031000114851; KNOKE JD, 1982, BIOMETRICS, V38, P191, DOI 10.2307/2530302; Krasteva V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140123; Laviola BG, 2007, REV BRAS CIENC SOLO, V31, P1451, DOI 10.1590/S0100-06832007000600022; Lingle, 1986, COFFEE CUPPERS HDB S; Martins R, 2009, IEEE GEOSCI REMOTE S, V6, P127, DOI 10.1109/LGRS.2008.2006004; McCoy AM, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008146; Muschler RG, 2001, AGROFOREST SYST, V51, P131, DOI 10.1023/A:1010603320653; Nascimento, 2018, INTELIGENCIA COMPUTA, P151; Nascimento, 2018, INTELIGENCIA COMPUTA, P414; Nascimento M., 2018, INTELIG NCIA COMPUTA, P292; Nguyen D., 1990, IJCNN International Joint Conference on Neural Networks (Cat. No.90CH2879-5), P21, DOI 10.1109/IJCNN.1990.137819; Pavelka, 2004, K MATLAB, V2, P453; Peternelli, 2015, REV BRASILEIRA BIOME, V33, P484, DOI DOI 10.1590/S1984-70332013000200008; Peternelli LA, 2017, CROP BREED APPL BIOT, V17, P299, DOI 10.1590/1984-70332017v17n4a46; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Prieto Martinez Herminia Emilia, 2007, Acta Scientiarum Agronomy, V29, P481, DOI 10.4025/actasciagron.v29i4.404; R Core Team, 2021, R LANGUAGE ENV STAT; Ripley B, 2019, TREE CLASSIFICATION; Saath R., 2012, Energia na Agricultura, V27, P96; Sakiyama N.S., 2015, CAFE ARABICA PLANTIO; Sant'Anna IC, 2015, GENET MOL RES, V14, P9898, DOI 10.4238/2015.August.19.24; SCAA P, 2015, SPEC COFF ASS AM SCA, P10; Schapire RE, 1999, IJCAI-99: PROCEEDINGS OF THE SIXTEENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 & 2, P1401; SENAR, 2017, CAFE CLASS DEG; Souza S. M. C., 1997, INFORM AGROPECUARIO, V18, P5; The MathWorks Inc., 2010, MATLAB; Tibshirani, 2017, DATA INTRO STAT LEAR; Tolessa K, 2017, J SCI FOOD AGR, V97, P2849, DOI 10.1002/jsfa.8114; Torres LG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199492; Vaast P, 2006, J SCI FOOD AGR, V86, P197, DOI 10.1002/jsfa.2338; Wheeler NE, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007333	83	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245298	10.1371/journal.pone.0245298	http://dx.doi.org/10.1371/journal.pone.0245298			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434204	Green Published, gold			2022-12-26	WOS:000609979700021
J	Jung, H; Lee, KS; Choi, JK				Jung, Hyunchul; Lee, Kang Seon; Choi, Jung Kyoon			Comprehensive characterisation of intronic mis-splicing mutations in human cancers	ONCOGENE			English	Article							MESSENGER-RNA DECAY; ANTISENSE OLIGONUCLEOTIDES; SPLICING FACTORS; GENOME; IDENTIFICATION; NONSENSE; ANNOTATION; SUPPRESSOR; MECHANISM; VARIANTS	Previous studies studying mis-splicing mutations were based on exome data and thus our current knowledge is largely limited to exons and the canonical splice sites. To comprehensively characterise intronic mis-splicing mutations, we analysed 1134 pan-cancer whole genomes and transcriptomes together with 3022 normal control samples. The ratio-based splicing analysis resulted in 678 somatic intronic mutations, with 46% residing in deep introns. Among the 309 deep intronic single nucleotide variants, 245 altered core splicing codes, with 38% activating cryptic splice sites, 12% activating cryptic polypyrimidine tracts, and 36% and 12% disrupting authentic polypyrimidine tracts and branchpoints, respectively. All the intronic cryptic splice sites were created at pre-existing GT/AG dinucleotides or by GC-to-GT conversion. Notably, 85 deep intronic mutations indicated gain of splicing enhancers or loss of splicing silencers. We found that 64 tumour suppressors were affected by intronic mutations and blood cancers showed higher proportion of deep intronic mutations. In particular, a telomere maintenance gene, POT1, was recurrently mis-spliced by deep intronic mutations in blood cancers. We validated a pseudoexon activation involving a splicing silencer in POT1 by CRISPR/Cas9. Our results shed light on previously unappreciated mechanisms by which noncoding mutations acting on splicing codes in deep introns contribute to tumourigenesis.	[Jung, Hyunchul; Lee, Kang Seon; Choi, Jung Kyoon] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon 34141, South Korea; [Jung, Hyunchul] Wellcome Sanger Inst, Canc Ageing & Somat Mutat Programme, Cambridge, England; [Choi, Jung Kyoon] Penta Medix Co Ltd, Seongnam Si 13449, Gyeongi Do, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Wellcome Trust Sanger Institute	Jung, H; Choi, JK (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon 34141, South Korea.; Jung, H (corresponding author), Wellcome Sanger Inst, Canc Ageing & Somat Mutat Programme, Cambridge, England.; Choi, JK (corresponding author), Penta Medix Co Ltd, Seongnam Si 13449, Gyeongi Do, South Korea.	hj6@sanger.ac.uk; jungkyoon@kaist.ac.kr			Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIT) [2017M3A9A7050612]; National Research Foundation of Korea - Korean Government [NRF-2020R1A6A3A03039805]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIT)(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. 2017M3A9A7050612). HJ was supported by a grant from the National Research Foundation of Korea funded by the Korean Government (NRF-2020R1A6A3A03039805).	Alexander RP, 2010, NAT REV GENET, V11, P559, DOI 10.1038/nrg2814; Alsamman K, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171672; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cornish AJ, 2019, BLOOD ADV, V3, P21, DOI 10.1182/bloodadvances.2018026419; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cummings BB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5209; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; de Miranda NFCC, 2014, BLOOD, V124, P2544, DOI 10.1182/blood-2013-12-546309; De Paoli L, 2013, LEUKEMIA LYMPHOMA, V54, P1087, DOI 10.3109/10428194.2012.723706; Diederichs S, 2016, EMBO MOL MED, V8, P442, DOI 10.15252/emmm.201506055; Dong XS, 2020, ONCOGENE, V39, P2231, DOI 10.1038/s41388-019-1138-2; Dvinge H, 2016, NAT REV CANCER, V16, P413, DOI 10.1038/nrc.2016.51; El Marabti E, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00080; Erkelenz S, 2013, RNA, V19, P96, DOI 10.1261/rna.037044.112; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Havens MA, 2016, NUCLEIC ACIDS RES, V44, P6549, DOI 10.1093/nar/gkw533; Jaganathan K, 2019, CELL, V176, P535, DOI 10.1016/j.cell.2018.12.015; Jayasinghe RG, 2018, CELL REP, V23, P270, DOI 10.1016/j.celrep.2018.03.052; Jung- H, 2015, NAT GENET, V47, P1242, DOI 10.1038/ng.3414; Kahles A, 2018, CANCER CELL, V34, P211, DOI 10.1016/j.ccell.2018.07.001; Ke SD, 2011, GENOME RES, V21, P1360, DOI 10.1101/gr.119628.110; Khurana E, 2016, NAT REV GENET, V17, P93, DOI 10.1038/nrg.2015.17; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Kremer LS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15824; Lewandowska MA, 2013, INT J CLIN EXP PATHO, V6, P2675; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lindeboom RGH, 2016, NAT GENET, V48, P1112, DOI 10.1038/ng.3664; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Mercer TR, 2015, GENOME RES, V25, P290, DOI 10.1101/gr.182899.114; Morin RD, 2016, CLIN CANCER RES, V22, P2290, DOI 10.1158/1078-0432.CCR-15-2123; Oltean S, 2014, ONCOGENE, V33, P5311, DOI 10.1038/onc.2013.533; Parker JDK, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a000679; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pinzaru AM, 2016, CELL REP, V15, P2170, DOI 10.1016/j.celrep.2016.05.008; Ramsay AJ, 2013, NAT GENET, V45, P526, DOI 10.1038/ng.2584; Rinaldi C, 2018, NAT REV NEUROL, V14, P9, DOI 10.1038/nrneurol.2017.148; Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shiraishi Y, 2018, GENOME RES, V28, P1111, DOI 10.1101/gr.231951.117; Sibley CR, 2016, NAT REV GENET, V17, P407, DOI 10.1038/nrg.2016.46; Sickmier EA, 2006, MOL CELL, V23, P49, DOI 10.1016/j.molcel.2006.05.025; Signal B, 2018, BIOINFORMATICS, V34, P920, DOI 10.1093/bioinformatics/btx688; Soemedi R, 2017, NAT GENET, V49, P848, DOI 10.1038/ng.3837; Sterne-Weiler T, 2011, GENOME RES, V21, P1563, DOI 10.1101/gr.118638.110; Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051; Taggart AJ, 2017, GENOME RES, V27, P639, DOI 10.1101/gr.202820.115; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vaz-Drago R, 2017, HUM GENET, V136, P1093, DOI 10.1007/s00439-017-1809-4; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Vorechovsky I, 2006, NUCLEIC ACIDS RES, V34, P4630, DOI 10.1093/nar/gkl535; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang Y, 2012, NAT STRUCT MOL BIOL, V19, P1044, DOI 10.1038/nsmb.2377; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	64	6	6	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2021	40	7					1347	1361		10.1038/s41388-020-01614-3	http://dx.doi.org/10.1038/s41388-020-01614-3		JAN 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QK0LS	33420369	hybrid, Green Published			2022-12-26	WOS:000607346000005
J	Amato, F; Castaldo, A; Castaldo, G; Cernera, G; Corso, G; Ferrari, E; Gelzo, M; Monzani, R; Villella, VR; Raia, V				Amato, Felice; Castaldo, Alice; Castaldo, Giuseppe; Cernera, Gustavo; Corso, Gaetano; Ferrari, Eleonora; Gelzo, Monica; Monzani, Romina; Villella, Valeria Rachela; Raia, Valeria			Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study	PLOS ONE			English	Article							PLASMA; ABSORPTION; STEROLS; ENZYME; ACAT2	This study aims to investigate cholesterol metabolism in a mouse model with cystic fibrosis (CF) by the comparison of affected homozygous versus wild type (WT) mice. In particular, we evaluated the effects of a diet enriched with cholesterol in both mice groups in comparison with the normal diet. To this purpose, beyond serum and liver cholesterol, we analyzed serum phytosterols as indirect markers of intestinal absorption of cholesterol, liver lathosterol as indirect marker of de novo cholesterol synthesis, liver cholestanol (a catabolite of bile salts synthesis) and the liver mRNA levels of LDL receptor (LDLR), 3-hydroxy-3-methylglutaryl-CoA reductase (HMG-CoAR), acyl CoA:cholesterol acyl transferase 2 (ACAT2), cytochrome P450 7A1 (CYP7A1) and tumor necrosis factor alpha (TNF alpha). CF mice showed lower intestinal absorption and higher liver synthesis of cholesterol than WT mice. In WT mice, the cholesterol supplementation inhibits the synthesis of liver cholesterol and enhances its catabolism, while in CF mice we did not observe a reduction of LDLR and HMG-CoAR expression (probably due to an altered feed-back), causing an increase of intracellular cholesterol. In addition, we observed a further increase (5-fold) in TNF alpha mRNA levels. This preliminary study suggests that in CF mice there is a vicious circle in which the altered synthesis/secretion of bile salts may reduce the digestion/absorption of cholesterol. As a result, the liver increases the biosynthesis of cholesterol that accumulates in the cells, triggering inflammation and further compromising the metabolism of bile salts.	[Amato, Felice; Castaldo, Giuseppe; Cernera, Gustavo; Gelzo, Monica] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Amato, Felice; Castaldo, Giuseppe; Cernera, Gustavo; Gelzo, Monica] Scarl, CEINGE Biotecnol Avanzate, Naples, Italy; [Castaldo, Alice; Raia, Valeria] Univ Naples Federico II, Dipartimento Sci Med Traslaz, Naples, Italy; [Corso, Gaetano] Univ Foggia, Dipartimento Med Clin & Sperimentale, Foggia, Italy; [Ferrari, Eleonora; Monzani, Romina; Villella, Valeria Rachela] Ist Sci San Raffaele, European Inst Res Cyst Fibrosis, Milan, Italy; [Ferrari, Eleonora; Monzani, Romina] Univ Piemonte Orientale, Dipartimento Sci Salute, Novara, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Foggia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Eastern Piedmont Amedeo Avogadro	Corso, G (corresponding author), Univ Foggia, Dipartimento Med Clin & Sperimentale, Foggia, Italy.	gaetano.corso@unifg.it	Raia, Valeria/AAC-3029-2022; Castaldo, Giuseppe/AAC-6782-2022; Amato, Felice/AAC-6805-2022; Corso, Gaetano/H-9450-2013	Castaldo, Giuseppe/0000-0002-4036-0874; Corso, Gaetano/0000-0003-4720-1320; MONZANI, ROMINA/0000-0001-9750-8342	Regione Campania	Regione Campania(Regione Campania)	GCa: Quota vincolata per la prevenzione e cura della Fibrosi Cistica L. 548/94, Ricerca. FSN 2015, 2016, 2017 and 2018. Regione Campania. http://www.regione.campania.it/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cantin AM, 2015, J CYST FIBROS, V14, P419, DOI 10.1016/j.jcf.2015.03.003; Corso G, 2017, WORLD J GASTROENTERO, V23, P5257, DOI 10.3748/wjg.v23.i29.5257; Corso G, 2011, CLIN CHEM LAB MED, V49, P2039, DOI 10.1515/CCLM.2011.689; Crescenzo R, 2017, BENEF MICROBES, V8, P823, DOI 10.3920/BM2017.0025; Fang DJ, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-61; Gelzo M, 2020, CLIN CHEM LAB MED, V58, P1725, DOI 10.1515/cclm-2019-1112; Gelzo M, 2016, CLIN CHEM LAB MED, V54, P1461, DOI 10.1515/cclm-2015-1151; Gelzo M, 2012, J CHROMATOGR B, V907, P154, DOI 10.1016/j.jchromb.2012.08.025; Gentzsch M, 2007, J CELL SCI, V120, P447, DOI 10.1242/jcs.03350; Gibson-Corley KN, 2016, J PATHOL, V238, P311, DOI 10.1002/path.4634; Go Gwang-woong, 2012, Yale Journal of Biology and Medicine, V85, P19; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gylling H, 2015, NUTRIENTS, V7, P7965, DOI 10.3390/nu7095374; Hu YW, 2010, CLIN CHIM ACTA, V411, P617, DOI 10.1016/j.cca.2009.12.027; Miettinen TA, 2011, NUTR METAB CARDIOVAS, V21, P765, DOI 10.1016/j.numecd.2011.05.005; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Peretti N, 2005, Nutr Metab (Lond), V2, P11, DOI 10.1186/1743-7075-2-11; Repa JJ, 2004, HEPATOLOGY, V40, P1088, DOI 10.1002/hep.20439; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Schwarz M, 2001, J LIPID RES, V42, P1812; Scorza M, 2014, INT J HEPATOL, V2014, DOI 10.1155/2014/713754; Semaniakou A, 2019, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01475; Turck D, 2016, CLIN NUTR, V35, P557, DOI 10.1016/j.clnu.2016.03.004; van de Peppel IP, 2019, J CYST FIBROS, V18, P313, DOI 10.1016/j.jcf.2018.08.009; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; Walters MP, 2001, J CLIN PHARM THER, V26, P425, DOI 10.1046/j.1365-2710.2001.00379.x; White NM, 2007, AM J PHYSIOL-LUNG C, V292, pL476, DOI 10.1152/ajplung.00262.2006; White NM, 2004, AM J RESP CELL MOL, V31, P538, DOI 10.1165/rcmb.2004-0117OC; Yang Yoon Mee, 2015, Curr Pathobiol Rep, V3, P253; Zarrilli F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/697940	30	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2021	16	1							e0245302	10.1371/journal.pone.0245302	http://dx.doi.org/10.1371/journal.pone.0245302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PS6NW	33412572	gold, Green Published			2022-12-26	WOS:000608044300036
J	Inaba, H; Miao, QQ; Nakata, T				Inaba, Hironori; Miao, Qianqian; Nakata, Takao			Optogenetic control of small GTPases reveals RhoA mediates intracellular calcium signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C-EPSILON; PROTEIN-COUPLED-RECEPTOR; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; PLASMA-MEMBRANE; RAS SUPERFAMILY; PLC-EPSILON; ACTIVATION; LIGHT; KINASE; PATHWAYS	Rho/Ras family small GTPases are known to regulate numerous cellular processes, including cytoskeletal reorganization, cell proliferation, and cell differentiation. These processes are also controlled by Ca2+, and consequently, cross talk between these signals is considered likely. However, systematic quantitative evaluation has not yet been reported. To fill this gap, we constructed optogenetic tools to control the activity of small GTPases (RhoA, Rac1, Cdc42, Ras, Rap, and Ral) using an improved light-inducible dimer system (iLID). We characterized these optogenetic tools with genetically encoded red fluorescence intensity-based small GTPase biosensors and confirmed these optogenetic tools' specificities. Using these optogenetic tools, we investigated calcium mobilization immediately after small GTPase activation. Unexpectedly, we found that a transient intracellular calcium elevation was specifically induced by RhoA activation in RPE1 and HeLa cells. RhoA activation also induced transient intracellular calcium elevation in MDCK and HEK293T cells, suggesting that generally RhoA induces calcium signaling. Interestingly, the molecular mechanisms linking RhoA activation to calcium increases were shown to be different among the different cell types: In RPE1 and HeLa cells, RhoA activated phospholipase C epsilon (PLCe) at the plasma membrane, which in turn induced Ca2+ release from the endoplasmic reticulum (ER). The RhoA-PLCe axis induced calcium-dependent nuclear factor of activated T cells nuclear translocation, suggesting that it does activate intracellular calcium signaling. Conversely, in MDCK and HEK293T cells, RhoA-ROCK-myosin II axis induced the calcium transients. These data suggest universal coordination of RhoA and calcium signaling in cellular processes, such as cellular contraction and gene expression.	[Inaba, Hironori; Miao, Qianqian; Nakata, Takao] Tokyo Med & Dent Univ TMDU, Grad Sch Med & Dent Sci, Dept Cell Biol, Tokyo, Japan; [Inaba, Hironori; Miao, Qianqian; Nakata, Takao] Tokyo Med & Dent Univ TMDU, Ctr Brain Integrat Res CBIR, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Nakata, T (corresponding author), Tokyo Med & Dent Univ TMDU, Grad Sch Med & Dent Sci, Dept Cell Biol, Tokyo, Japan.; Nakata, T (corresponding author), Tokyo Med & Dent Univ TMDU, Ctr Brain Integrat Res CBIR, Tokyo, Japan.	info.cbio@tmd.ac.jp	Inaba, Hironori/C-7794-2016	Inaba, Hironori/0000-0002-9622-6017	JSPS KAKENHI [18K15002, 20K16105, 18K19328]; Takeda Science Foundation; Kanehara Ichiro Memorial Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kanehara Ichiro Memorial Foundation	This work was supported in part by JSPS KAKENHI (18K15002 and 20K16105 to H. I., and 18K19328 to T. N.), by Research Grants from the Takeda Science Foundation (to H. I. and T. N.), and the Kanehara Ichiro Memorial Foundation (to H. I.).	Ada-Nguema AS, 2006, J CELL SCI, V119, P1307, DOI 10.1242/jcs.02835; Alford SC, 2012, CHEM BIOL, V19, P353, DOI 10.1016/j.chembiol.2012.01.006; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Aspenstrom P, 2004, BBA-MOL CELL RES, V1742, P51, DOI 10.1016/j.bbamcr.2004.09.029; Atilla-Gokcumen GE, 2010, ACS CHEM BIOL, V5, P79, DOI 10.1021/cb900256m; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bong AHL, 2018, BBA-MOL CELL RES, V1865, P1786, DOI 10.1016/j.bbamcr.2018.05.015; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; CHAO TSO, 1992, J BIOL CHEM, V267, P19876; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cox CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10366; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; de Beco S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07286-8; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; Guglielmi G, 2016, TRENDS CELL BIOL, V26, P864, DOI 10.1016/j.tcb.2016.09.006; Guntas G, 2015, P NATL ACAD SCI USA, V112, P112, DOI 10.1073/pnas.1417910112; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; Harden TK, 2009, J LIPID RES, V50, pS243, DOI 10.1194/jlr.R800045-JLR200; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; IKEBE M, 1985, J BIOL CHEM, V260, P27; Irannejad R, 2010, J BIOL CHEM, V285, P32393, DOI 10.1074/jbc.M110.154963; Ishii T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9021; Jin P, 2020, ANNU REV NEUROSCI, V43, P207, DOI 10.1146/annurev-neuro-070918-050509; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Kakumoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070861; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kim J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08217-3; Knoepp L, 1999, Int J Surg Investig, V1, P285; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Li Y, 2017, J CEREBR BLOOD F MET, V37, P140, DOI 10.1177/0271678X15621069; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Madukwe JC, 2018, J BIOL CHEM, V293, P6387, DOI 10.1074/jbc.RA118.002354; Malik S, 2015, MOL BIOL CELL, V26, P1188, DOI 10.1091/mbc.E14-10-1476; Martins M, 2012, J CELL SCI, V125, P5758, DOI 10.1242/jcs.110007; Martz MK, 2013, MOL BIOL CELL, V24, P2785, DOI 10.1091/mbc.E12-07-0533; Mehta D, 2003, J BIOL CHEM, V278, P33492, DOI 10.1074/jbc.M302401200; Miller AL, 2011, CURR BIOL, V21, pR976, DOI 10.1016/j.cub.2011.10.044; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Nash CA, 2019, ELIFE, V8, DOI 10.7554/eLife.48167; O'Neill PR, 2018, DEV CELL, V46, P9, DOI 10.1016/j.devcel.2018.05.029; O'Neill PR, 2016, MOL BIOL CELL, V27, P1442, DOI 10.1091/mbc.E15-12-0832; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Poddar A, 2021, MOL BIOL CELL, V32, P15, DOI 10.1091/mbc.E20-09-0609; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seifert JP, 2008, J BIOL CHEM, V283, P29690, DOI 10.1074/jbc.M805038200; Shiwarski DJ, 2017, MOL BIOL CELL, V28, P2202, DOI 10.1091/mbc.E17-01-0030; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Tischer D, 2014, NAT REV MOL CELL BIO, V15, P551, DOI 10.1038/nrm3837; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Toettcher JE, 2011, NAT METHODS, V8, P35, DOI [10.1038/nmeth.f.326, 10.1038/NMETH.F.326]; Valon L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14396; Wagner E, 2016, J CELL BIOL, V213, P641, DOI 10.1083/jcb.201603025; Weng YQ, 2018, AIP ADV, V8, DOI 10.1063/1.5025036; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wilsher N, 2007, DRUG METAB DISPOS, V35, P1017, DOI 10.1124/dmd.106.014498; Wing MR, 2003, J BIOL CHEM, V278, P41253, DOI 10.1074/jbc.M306904200; Wing MR, 2001, J BIOL CHEM, V276, P48257, DOI 10.1074/jbc.C100574200; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yu OM, 2015, MOL PHARMACOL, V88, P171, DOI 10.1124/mol.115.097857; Zago G, 2018, ELIFE, V7, DOI 10.7554/eLife.40474; Zhang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092917; Zhang LH, 2013, CELL, V153, P216, DOI 10.1016/j.cell.2013.02.047; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	80	4	4	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100290	10.1016/j.jbc.2021.100290	http://dx.doi.org/10.1016/j.jbc.2021.100290			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33453281	Green Published, gold, Green Submitted			2022-12-26	WOS:000672866400264
J	Solovyev, N; El-Khatib, AH; Costas-Rodriguez, M; Schwab, K; Griffin, E; Raab, A; Platt, B; Theuring, F; Vogl, J; Vanhaecke, F				Solovyev, Nikolay; El-Khatib, Ahmed H.; Costas-Rodriguez, Marta; Schwab, Karima; Griffin, Elizabeth; Raab, Andrea; Platt, Bettina; Theuring, Franz; Vogl, Jochen; Vanhaecke, Frank			Cu, Fe, and Zn isotope ratios in murine Alzheimer's disease models suggest specific signatures of amyloidogenesis and tauopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; AMYLOID-BETA; NEUROFIBRILLARY TANGLES; TRANSGENIC MICE; MOUSE MODEL; METAL-IONS; TAU; COPPER; ZINC; MUTATIONS	Alzheimer's disease (AD) is characterized by accumulation of tau and amyloid-beta in the brain, and recent evidence suggests a correlation between associated protein aggregates and trace elements, such as copper, iron, and zinc. In AD, a distorted brain redox homeostasis and complexation by amyloid-beta and hyperphosphorylated tau may alter the isotopic composition of essential mineral elements. Therefore, high-precision isotopic analysis may reveal changes in the homeostasis of these elements. We used inductively coupled plasma-mass spectrometry (ICP-MS)-based techniques to determine the total Cu, Fe, and Zn contents in the brain, as well as their isotopic compositions in both mouse brain and serum. Results for male transgenic tau (Line 66, L66) and amyloid/presenilin (5xFAD) mice were compared with those for the corresponding age- and sex-matched wild-type control mice (WT). Our data show that L66 brains showed significantly higher Fe levels than did those from the corresponding WT. Significantly less Cu, but more Zn was found in 5xFAD brains. We observed significantly lighter isotopic compositions of Fe (enrichment in the lighter isotopes) in the brain and serum of L66 mice compared with WT. For 5xFAD mice, Zn exhibited a trend toward a lighter isotopic composition in the brain and a heavier isotopic composition in serum compared with WT. Neither mouse model yielded differences in the isotopic composition of Cu. Our findings indicate significant pathology-specific alterations of Fe and Zn brain homeostasis in mouse models of AD. The associated changes in isotopic composition may serve as a marker for proteinopathies underlying AD and other types of dementia.	[Solovyev, Nikolay; Costas-Rodriguez, Marta; Vanhaecke, Frank] Univ Ghent, Dept Chem, Atom & Mass Spectrometry A&MS Res Unit, Ghent, Belgium; [El-Khatib, Ahmed H.; Vogl, Jochen] BAM Bundesanstalt Mat Forsch & Prufung, Div Inorgan Trace Anal 1 1, Berlin, Germany; [El-Khatib, Ahmed H.] Ain Shams Univ, Fac Pharm, Dept Pharmaceut Analyt Chem, African Union Author St, Cairo, Egypt; [Schwab, Karima; Platt, Bettina] Univ Aberdeen, Sch Med Med Sci & Nutr, Inst Med Sci, Foresterhill, Aberdeen, Scotland; [Griffin, Elizabeth; Raab, Andrea] Univ Aberdeen, Dept Chem, Trace Element Speciat Lab TESLA, Aberdeen, Scotland; [Raab, Andrea] Karl Franzens Univ Graz, Inst Chem, Environm Analyt Chem, Graz, Austria; [Theuring, Franz] Charite Univ Med Berlin, Inst Pharmacol, Berlin, Germany; [Solovyev, Nikolay] Inst Technol Sligo, Ash Lane, Sligo F91 YW50, Ireland	Ghent University; Federal Institute for Materials Research & Testing; Egyptian Knowledge Bank (EKB); Ain Shams University; University of Aberdeen; University of Aberdeen; University of Graz; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institute of Technology Sligo	Vanhaecke, F (corresponding author), Univ Ghent, Dept Chem, Atom & Mass Spectrometry A&MS Res Unit, Ghent, Belgium.	frank.vanhaecke@ugent.be	Elkhatib, Ahmed/GXF-8385-2022; Vogl, Jochen/A-5960-2009; Solovyev, Nikolay/B-8100-2013; Vanhaecke, Frank/F-5341-2014	Vogl, Jochen/0000-0002-0104-748X; Solovyev, Nikolay/0000-0002-6217-6963; Platt, Bettina/0000-0002-7852-0749; Vanhaecke, Frank/0000-0002-1884-3853; Schwab, Karima/0000-0001-7063-7136	EMPIR research project [15HLT02]; EMPIR programme; European Union	EMPIR research project; EMPIR programme; European Union(European Commission)	This work was carried out in the context of the EMPIR research project 15HLT02 (ReMiND). This project has received funding from the EMPIR programme cofinanced by the Participating States and from the European Union's Horizon 2020 research and innovation program.	Adlard PA, 2018, J ALZHEIMERS DIS, V62, P1369, DOI 10.3233/JAD-170662; Ahmadi S, 2019, J INORG BIOCHEM, V194, P44, DOI 10.1016/j.jinorgbio.2019.02.007; Albarede F, 2016, METALLOMICS, V8, P1056, DOI 10.1039/c5mt00316d; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Anoshkina Y, 2017, METALLOMICS, V9, P517, DOI 10.1039/c7mt00021a; Attems J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0206-2; Bal W, 2013, BBA-GEN SUBJECTS, V1830, P5444, DOI 10.1016/j.bbagen.2013.06.018; Balter V, 2015, P NATL ACAD SCI USA, V112, P982, DOI 10.1073/pnas.1415151112; Balter V, 2013, METALLOMICS, V5, P1470, DOI 10.1039/c3mt00151b; Balusu S, 2016, NEURAL REGEN RES, V11, P534, DOI 10.4103/1673-5374.180372; Baum L, 2010, BIOMETALS, V23, P173, DOI 10.1007/s10534-009-9277-5; Baxter DC, 2006, J ANAL ATOM SPECTROM, V21, P427, DOI 10.1039/b517457k; Bonda DJ, 2011, METALLOMICS, V3, P267, DOI 10.1039/c0mt00074d; Boopathi S, 2016, PROTEINS, V84, P1257, DOI 10.1002/prot.25075; Born HA, 2014, J NEUROSCI, V34, P3826, DOI 10.1523/JNEUROSCI.5171-13.2014; Bundy JL, 2019, J COMP NEUROL, V527, P462, DOI 10.1002/cne.24551; Bush AI, 2013, J ALZHEIMERS DIS, V33, pS277, DOI 10.3233/JAD-2012-129011; Buskila Y, 2013, NEUROSCIENCE, V254, P152, DOI 10.1016/j.neuroscience.2013.09.016; Campos-Bedolla P, 2014, ARCH MED RES, V45, P610, DOI 10.1016/j.arcmed.2014.11.018; Choi TS, 2017, J AM CHEM SOC, V139, P15437, DOI 10.1021/jacs.7b08584; Cicero CE, 2017, ENVIRON RES, V159, P82, DOI 10.1016/j.envres.2017.07.048; Coplen TB, 2011, RAPID COMMUN MASS SP, V25, P2538, DOI 10.1002/rcm.5129; Costas-Rodriguez M, 2019, METALLOMICS, V11, P1093, DOI 10.1039/c8mt00362a; Costas-Rodriguez M, 2016, TRAC-TREND ANAL CHEM, V76, P182, DOI 10.1016/j.trac.2015.10.008; Costas-Rodriguez M, 2015, METALLOMICS, V7, P491, DOI 10.1039/c4mt00319e; Cranston AL, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa033; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Crowe SE, 2014, BRAIN STRUCT FUNCT, V219, P571, DOI 10.1007/s00429-013-0518-6; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; Esquerda-Canals G, 2017, J ALZHEIMERS DIS, V57, P1171, DOI 10.3233/JAD-170045; Ferretti MT, 2018, NAT REV NEUROL, V14, P457, DOI 10.1038/s41582-018-0032-9; Fukuchi K, 1996, AM J PATHOL, V149, P219; Gaugler J, 2019, ALZHEIMERS DEMENT, V15, P321, DOI 10.1016/j.jalz.2019.01.010; Geilert S, 2019, RAPID COMMUN MASS SP, V33, P1137, DOI 10.1002/rcm.8455; Gerber H, 2017, J BIOL CHEM, V292, P3751, DOI 10.1074/jbc.M116.754101; Gernot R., 2020, CURR ALZHEIMER RES, V17, P1; Giannoni P, 2016, NEUROBIOL DIS, V88, P107, DOI 10.1016/j.nbd.2016.01.001; Goedert M, 1998, NEURON, V21, P955, DOI 10.1016/S0896-6273(00)80615-7; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gray P. J., 2015, INDUCTIVELY COUPLED; Grochowski C, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00115; Guo C, 2013, NEUROCHEM INT, V62, P165, DOI 10.1016/j.neuint.2012.12.005; Guo QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080706; Guo QX, 2012, NEUROBIOL AGING, V33, P2678, DOI 10.1016/j.neurobiolaging.2012.01.002; Guzman EA, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-13; Halliday MR, 2016, J CEREBR BLOOD F MET, V36, P216, DOI 10.1038/jcbfm.2015.44; Hastuti AAMB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71764-7; Hotz K, 2011, J ANAL ATOM SPECTROM, V26, P1347, DOI 10.1039/c0ja00195c; Huo ZG, 2020, NEUROBIOL AGING, V86, P123, DOI 10.1016/j.neurobiolaging.2019.10.014; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Kametani F, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00025; Killin LOJ, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0342-y; Kim AC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010128; Kitazawa M, 2009, J NEUROCHEM, V108, P1550, DOI 10.1111/j.1471-4159.2009.05901.x; Koss DJ, 2016, ACTA NEUROPATHOL, V132, P875, DOI 10.1007/s00401-016-1632-3; Kozlowski H, 2012, COORDIN CHEM REV, V256, P2129, DOI 10.1016/j.ccr.2012.03.013; Larner F, 2015, METALLOMICS, V7, P107, DOI 10.1039/c4mt00260a; Lauwens S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30683; Lee JC, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0250-2; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Linert W., 2012, METAL IONS NEUROLOGI; Loef M, 2011, J ALZHEIMERS DIS, V26, P81, DOI 10.3233/JAD-2011-110414; Mahan B, 2018, METALLOMICS, V10, P1264, DOI [10.1039/c8mt00179k, 10.1039/C8MT00179K]; Maynard CJ, 2006, J INORG BIOCHEM, V100, P952, DOI 10.1016/j.jinorgbio.2006.02.010; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; Melis V, 2015, CELL MOL LIFE SCI, V72, P2199, DOI 10.1007/s00018-014-1804-z; Michalke B, 2018, TRAC-TREND ANAL CHEM, V104, P160, DOI 10.1016/j.trac.2017.08.008; Michalke B, 2010, ANAL CHIM ACTA, V682, P23, DOI 10.1016/j.aca.2010.09.054; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Moynier F, 2017, GEOCHEM PERSPECT LET, V3, P142, DOI 10.7185/geochemlet.1717; Moynier F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47790-5; Muoio V, 2014, ACTA PHYSIOL, V210, P790, DOI 10.1111/apha.12250; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Plucinska K, 2016, DIABETOLOGIA, V59, P1513, DOI 10.1007/s00125-016-3960-1; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; Rao SS, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00276; Roberts BR, 2012, J NEUROCHEM, V120, P149, DOI 10.1111/j.1471-4159.2011.07500.x; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Savelieff MG, 2013, ACS CHEM BIOL, V8, P856, DOI 10.1021/cb400080f; Schilling K, 2020, METALLOMICS, V12, P752, DOI 10.1039/d0mt00061b; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; Skillback T, 2017, NEUROBIOL AGING, V59, P1, DOI 10.1016/j.neurobiolaging.2017.06.028; Solovyev N, 2019, J TRACE ELEM MED BIO, V56, P69, DOI 10.1016/j.jtemb.2019.07.005; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Sullivan K, 2020, METALLOMICS, V12, P1380, DOI [10.1039/d0mt00122h, 10.1039/D0MT00122H]; Van Heghe L, 2012, J ANAL ATOM SPECTROM, V27, P1327, DOI 10.1039/c2ja30070b; Vanhaecke F, 2012, ISOTOPIC ANAL FUNDAM, DOI DOI 10.1002/9783527650484.CH2; Vanhaecke F, 2009, J ANAL ATOM SPECTROM, V24, P863, DOI 10.1039/b903887f; Vogl J, 2010, J ANAL ATOM SPECTROM, V25, P923, DOI 10.1039/c000509f; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; Xiong Y, 2015, NEUROSCI BULL, V31, P331, DOI 10.1007/s12264-014-1519-z; Yanamandra K, 2015, ANN CLIN TRANSL NEUR, V2, P278, DOI 10.1002/acn3.176; Zenaro E, 2017, NEUROBIOL DIS, V107, P41, DOI 10.1016/j.nbd.2016.07.007	96	8	8	2	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100292	10.1016/j.jbc.2021.100292	http://dx.doi.org/10.1016/j.jbc.2021.100292			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33453282	Green Published, gold			2022-12-26	WOS:000672866400266
J	El Fersioui, Y; Pinton, G; Allaman-Pillet, N; Schorderet, DF				El Fersioui, Younes; Pinton, Gaeetan; Allaman-Pillet, Nathalie; Schorderet, Daniel F.			Hmx1 regulates urfh1 expression in the craniofacial region in zebrafish	PLOS ONE			English	Article							DNA METHYLATION; GENES; EYE; NEURONS; SYSTEM; FAMILY; GROWTH	H6 family homeobox 1 (HMX1) regulates multiple aspects of craniofacial development as it is widely expressed in the eye, peripheral ganglia and branchial arches. Mutations in HMX1 are linked to an ocular defect termed Oculo-auricular syndrome of Schorderet-Munier-Franceschetti (MIM #612109). We identified UHRF1 as a target of HMX1 during development. UHRF1 and its partner proteins actively regulate chromatin modifications and cellular proliferation. Luciferase assays and in situ hybridization analyses showed that HMX1 exerts a transcriptional inhibitory effect on UHRF1 and a modification of its expression pattern. Overexpression of hmx1 in hsp70-hmx1 zebrafish increased uhrf1 expression in the cranial region, while mutations in the hmx1 dimerization domains reduced uhrf1 expression. Moreover, the expression level of uhrf1 and its partner dnmt1 was increased in the eye field in response to hmx1 overexpression. These results indicate that hmx1 regulates uhrf1 expression and, potentially through regulating the expression of factors involved in DNA methylation, contribute to the development of the craniofacial region of zebrafish.	[El Fersioui, Younes; Pinton, Gaeetan; Allaman-Pillet, Nathalie; Schorderet, Daniel F.] IRO Inst Res Ophthalmol, Sion, Switzerland; [Schorderet, Daniel F.] Swiss Fed Inst Technol EPFL, Fac Life Sci, Lausanne, Switzerland; [Schorderet, Daniel F.] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne	El Fersioui, Y; Schorderet, DF (corresponding author), IRO Inst Res Ophthalmol, Sion, Switzerland.; Schorderet, DF (corresponding author), Swiss Fed Inst Technol EPFL, Fac Life Sci, Lausanne, Switzerland.; Schorderet, DF (corresponding author), Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland.	elfersioui@gmail.com; daniel.schorderet@unil.ch		El Fersioui, Younes/0000-0002-6064-927X	Fondation pour la recherche sur les maladies hereditaires	Fondation pour la recherche sur les maladies hereditaires	Funding was received from Fondation pour la recherche sur les maladies hereditaires to DFS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Salam GMH, 2018, OPHTHALMIC GENET, V39, P215, DOI 10.1080/13816810.2017.1401089; Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Adamska M, 2001, DEV GENES EVOL, V211, P338, DOI 10.1007/s004270100162; Alestrom P, 2020, LAB ANIM-UK, V54, P213, DOI 10.1177/0023677219869037; Amendt BA, 1999, J BIOL CHEM, V274, P11635, DOI 10.1074/jbc.274.17.11635; Balasubramanian S, 2019, GENE, V718, DOI 10.1016/j.gene.2019.144049; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Boisset G, 2012, EXP EYE RES, V105, P34, DOI 10.1016/j.exer.2012.10.002; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Boulling A, 2013, MOL VIS, V19, P1779; Cao YM, 2019, FASEB J, V33, P8294, DOI 10.1096/fj.201801696RRRR; Edwards JR, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0130-8; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Favet N, 2001, CELL DEATH DIFFER, V8, P603, DOI 10.1038/sj.cdd.4400847; Furlan A, 2013, EMBO J, V32, P1613, DOI 10.1038/emboj.2013.85; Gillespie RL, 2015, INVEST OPHTH VIS SCI, V56, P883, DOI 10.1167/iovs.14-15861; Gongal PA, 2011, DEV BIOL, V355, P55, DOI 10.1016/j.ydbio.2011.04.018; Jacob V, 2015, DEVELOPMENT, V142, P510, DOI 10.1242/dev.115980; Kainuma S, 2017, INT J MOL MED, V40, P1057, DOI 10.3892/ijmm.2017.3119; Kent B, 2016, DEV BIOL, V412, P99, DOI 10.1016/j.ydbio.2016.01.036; Kim M, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.10; Maenohara S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007042; Marcelli F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100096; Mayor R, 2013, DEVELOPMENT, V140, P2247, DOI 10.1242/dev.091751; Meinecke L, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006569; Munroe RJ, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-27; Prise Ian, 2019, Wellcome Open Res, V4, P41, DOI 10.12688/wellcomeopenres.15091.1; Quina LA, 2012, DEV BIOL, V365, P152, DOI 10.1016/j.ydbio.2012.02.022; Richardson R, 2017, EYE, V31, P68, DOI 10.1038/eye.2016.198; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; Schorderet DF, 2008, AM J HUM GENET, V82, P1178, DOI 10.1016/j.ajhg.2008.03.007; Tittle RK, 2011, DEV BIOL, V350, P50, DOI 10.1016/j.ydbio.2010.11.009; Trainor PA, 2001, CURR OPIN CELL BIOL, V13, P698, DOI 10.1016/S0955-0674(00)00273-8; Vaclavik V, 2011, OPHTHALMIC GENET, V32, P114, DOI 10.3109/13816810.2011.562955; Wang WD, 2000, MECH DEVELOP, V99, P123, DOI 10.1016/S0925-4773(00)00488-3; Williams AL, 2015, BIRTH DEFECTS RES C, V105, P87, DOI 10.1002/bdrc.21095; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Yamashita M, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.157412; Yoshiura K, 1998, GENOMICS, V50, P61, DOI 10.1006/geno.1998.5284	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245239	10.1371/journal.pone.0245239	http://dx.doi.org/10.1371/journal.pone.0245239			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465110	Green Published, gold			2022-12-26	WOS:000611969200053
J	Liu, YC; Wang, MR; Chen, MY; Zhu, M; Liao, MQ				Liu, Yucheng; Wang, Maoren; Chen, Mingyan; Zhu, Meng; Liao, Maoqi			Facilitating the natural semi-drying of oily sludge by changing the form of water	PLOS ONE			English	Article							SEWAGE-SLUDGE; MASS TRANSFERS; PERFORMANCE; HEAT; SIMULATION; HYDRATION; DRYER; ASH; CAO	Reducing the water content of oily sludge is essential for the disposal of it. Despite conditioning and solid-liquid separation, the water content of oily sludge generally exceeds 65%. A large amount of this water exists in the form of emulsified and bound water, reducing the efficiency of water removal during the natural semi-drying process of oily sludge. To shorten the time required for natural semi-drying, this study applied an orthogonal test to screen an oily sludge modified material (OSM). The effect and mechanism of OSM on the natural semi-drying of oily sludge were studied using a thermal gravimetric analyzer (TGA), scanning electron microscope (SEM), surface tension measurement, and microscopic observations. The results show that when the ambient temperature exceeded 10 degrees C, the OSM increased in mass by 8-10%, and the time required for the natural semi-drying of oily sludge was shortened from 15 days to less than 5 days. OSM can rupture the emulsion, reduce the surface tension, convert the emulsion and bound water in the oily sludge into free water, and accelerate the rate of water migration, diffusion, and natural evaporation from the inside of the oily sludge to the surface and air. The research results show that changing the form of water can speed up the drying of oily sludge, creating positive economic benefits in the process of oily sludge reduction and recycling.	[Liu, Yucheng; Wang, Maoren; Chen, Mingyan; Zhu, Meng; Liao, Maoqi] Southwest Petr Univ, Coll Chem & Chem Engn, Chengdu, Sichuan, Peoples R China; [Liu, Yucheng; Chen, Mingyan] Southwest Petr Univ, Res Inst Ind Hazardous Waste Disposal & Resource, Chengdu, Sichuan, Peoples R China	Southwest Petroleum University; Southwest Petroleum University	Liu, YC (corresponding author), Southwest Petr Univ, Coll Chem & Chem Engn, Chengdu, Sichuan, Peoples R China.; Liu, YC (corresponding author), Southwest Petr Univ, Res Inst Ind Hazardous Waste Disposal & Resource, Chengdu, Sichuan, Peoples R China.	rehuo2013@sina.cn		patil, mayur/0000-0002-2042-0390	Sichuan Science and Technology Plan Key Research and Development Project Funding [2018GZ0421]	Sichuan Science and Technology Plan Key Research and Development Project Funding	This work was financially supported by Sichuan Science and Technology Plan Key Research and Development Project Funding (2018GZ0421).	Al Kanej Y, 2016, DESALIN WATER TREAT, V57, P25985, DOI 10.1080/19443994.2016.1157988; Ameri B, 2018, SOL ENERGY, V159, P722, DOI 10.1016/j.solener.2017.11.032; Ben Hassine N, 2017, J APPL FLUID MECH, V10, P651, DOI 10.18869/acadpub.jafm.73.238.26854; Ben Hassine N, 2017, ENRGY PROCED, V139, P804, DOI 10.1016/j.egypro.2017.11.292; Buyukkamaci N, 2007, J HAZARD MATER, V144, P323, DOI 10.1016/j.jhazmat.2006.10.034; Chen Z, 2017, CONSTR BUILD MATER, V154, P791, DOI 10.1016/j.conbuildmat.2017.08.003; Cheng S, 2017, APPL ENERG, V185, P146, DOI 10.1016/j.apenergy.2016.10.055; da Costa EB, 2016, CONSTR BUILD MATER, V122, P373, DOI 10.1016/j.conbuildmat.2016.06.022; Danish M, 2016, APPL THERM ENG, V106, P141, DOI 10.1016/j.applthermaleng.2016.05.191; Deng SH, 2021, BIOMASS CONVERS BIOR, V11, P393, DOI 10.1007/s13399-020-00697-y; Doganci MD, 2011, J COLLOID INTERF SCI, V362, P524, DOI 10.1016/j.jcis.2011.06.060; Font R, 2011, SEP PURIF TECHNOL, V77, P146, DOI 10.1016/j.seppur.2010.12.001; Gong ZQ, 2018, J ENERGY INST, V91, P877, DOI 10.1016/j.joei.2017.10.001; Koolivand A, 2020, J MATER CYCLES WASTE, V22, P1475, DOI 10.1007/s10163-020-01036-z; Koolivand A, 2020, ECOTOX ENVIRON SAFE, V198, DOI 10.1016/j.ecoenv.2020.110645; Krawczyk P, 2016, PROCEDIA ENGINEER, V157, P230, DOI 10.1016/j.proeng.2016.08.361; Liu H, 2014, CHEMOSPHERE, V117, P559, DOI 10.1016/j.chemosphere.2014.09.038; Mi LL, 2012, ADV MATER RES-SWITZ, V443-444, P54, DOI 10.4028/www.scientific.net/AMR.443-444.54; Milhe M, 2015, DRY TECHNOL, V33, P1276, DOI 10.1080/07373937.2015.1026976; Mohit MA, 2020, ENVIRON MONIT ASSESS, V192, DOI 10.1007/s10661-020-08373-4; Ohm TI, 2010, J HAZARD MATER, V178, P483, DOI 10.1016/j.jhazmat.2010.01.107; Petri I, 2019, J PETROL SCI ENG, V176, P362, DOI 10.1016/j.petrol.2019.01.075; Poblete R, 2019, ENVIRON PROG SUSTAIN, V38, P345, DOI 10.1002/ep.12951; Puasa SW, 2019, MATER TODAY-PROC, V19, P1159, DOI 10.1016/j.matpr.2019.11.009; Roux N, 2010, COMPUT-AIDED CHEM EN, V28, P715; Singh S, 2020, ENERG SOURCE PART A, DOI 10.1080/15567036.2020.1716891; Taleghani ST, 2019, CHEMOSPHERE, V233, P157, DOI 10.1016/j.chemosphere.2019.05.161; Vorhauer N, 2019, DRY TECHNOL, V37, P664, DOI 10.1080/07373937.2018.1547740; Wang CQ, 2019, J CLEAN PROD, V206, P282, DOI 10.1016/j.jclepro.2018.09.128; Wang PL, 2019, RENEW ENERG, V136, P1071, DOI 10.1016/j.renene.2018.09.081; Wang T, 2019, J ENVIRON MANAGE, V239, P316, DOI 10.1016/j.jenvman.2019.03.074; Yang PH, 2018, PETROL SCI TECHNOL, V36, P520, DOI 10.1080/10916466.2018.1431661; Zain AM, 2014, KEY ENG MATER, V594-595, P385, DOI 10.4028/www.scientific.net/KEM.594-595.385; Zhang XC, 2019, J ENVIRON MANAGE, V230, P14, DOI 10.1016/j.jenvman.2018.09.049; Zhao M, 2020, J HAZARD MATER, V389, DOI 10.1016/j.jhazmat.2019.121826; Zhu FF, 2012, PROCEDIA ENVIRON SCI, V16, P363, DOI 10.1016/j.proenv.2012.10.052	36	0	0	8	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245430	10.1371/journal.pone.0245430	http://dx.doi.org/10.1371/journal.pone.0245430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444389	Green Published, gold			2022-12-26	WOS:000609988100048
J	Nantha, YS; Chelliah, AAP; Haque, S; Yen, GK; Zain, AZM				Swarna Nantha, Yogarabindranath; Chelliah, Azriel Abisheg Paul; Haque, Shamsul; Yen, Gan Kim; Md. Zain, Anuar Zaini			The external realities of people with type 2 diabetes-Understanding disease perspective and self-management behaviour via Grounded Theory Approach	PLOS ONE			English	Article							HEALTH; CARE	Background Qualitative strategies can uncover the relationship between the external realities of people living with type 2 diabetes (T2D) and the barriers that are associated with disease self-management. Information from in-depth interviews (IDI) and focus group discussions (FGD) can be used to devise psychological models that could potentially facilitate behaviour changes in people with T2D. We aim to identify salient factors that govern the external realities of people with T2D in relation to disease management. Methods A qualitative study was conducted at a regional primary care clinic in Malaysia using a Grounded Theory Approach. People with T2D were recruited through purposeful sampling to determine their living experiences with the disease. A total of 34 IDIs with 24 people with T2D and 10 health care professionals, followed by two FGDs with people with T2D, were conducted. Results Three major processes that arbitrate self-management practices include- 1) external reality, 2) internal reality, 3) mediators of behaviour. Within the context of external reality, three important sub-themes were identified-intrinsic background status, personal experience, and worldview. Lifestyle habits of persons with T2D play a central role in their disease management. Another common recurring concern is the issue of a low-quality food environment in the country. More importantly, individuals with T2D have a high degree of expectations for a more person-centered approach to their illness. Conclusions We identified modifiable and non-modifiable behavioural factors that influence the daily living environment of people with T2D. This information can be used to customize the management of T2D through targeted behavioural interventions.	[Swarna Nantha, Yogarabindranath; Md. Zain, Anuar Zaini] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Clin Sch Johor Bahru, Subang Jaya, Malaysia; [Swarna Nantha, Yogarabindranath; Chelliah, Azriel Abisheg Paul; Yen, Gan Kim] Seremban Primary Hlth Care Clin, Noncommunicable Dis Dept, Seremban, Malaysia; [Swarna Nantha, Yogarabindranath; Chelliah, Azriel Abisheg Paul] Sibu Hosp, Sibu, Malaysia; [Haque, Shamsul] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Dept Psychol, Subang Jaya, Malaysia	Monash University; Monash University Sunway; Monash University; Monash University Sunway	Nantha, YS (corresponding author), Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Clin Sch Johor Bahru, Subang Jaya, Malaysia.; Nantha, YS (corresponding author), Seremban Primary Hlth Care Clin, Noncommunicable Dis Dept, Seremban, Malaysia.; Nantha, YS (corresponding author), Sibu Hosp, Sibu, Malaysia.	yoga.rabindranath@monash.edu			MOH-NIH grant [:91000440]; Ministry of Health Malaysia	MOH-NIH grant; Ministry of Health Malaysia	YSN received funding from the MOH-NIH grant (Grant No.:91000440) from the Ministry of Health Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaa Ahmed M, 2019, PLoS One, V14, pe0213653, DOI 10.1371/journal.pone.0213653; Bootle S, 2015, DIABETES RES CLIN PR, V109, P6, DOI 10.1016/j.diabres.2015.04.004; Bridges HA, 2016, J HEALTH PSYCHOL, V21, P1956, DOI 10.1177/1359105315569094; Burt RS, 2005, BROKERAGE CLOSURE IN; Charmaz K, 2007, SAGE HDB GROUNDED TH, DOI DOI 10.4135/9781848607941; Claramita M, 2011, ADV HEALTH SCI EDUC, V16, P69, DOI 10.1007/s10459-010-9242-7; D Damayanti D., 2018, BULLWHIP EFFECT SUPP, V1, P1, DOI DOI 10.1080/09593330.2018.1526217; Gearhardt AN, 2011, ADDICTION, V106, P1208, DOI 10.1111/j.1360-0443.2010.03301.x; Glanz K., 2015, HLTH BEHAV THEORY RE; Hussein Z, 2015, ANN GLOB HEALTH, V81, P851, DOI 10.1016/j.aogh.2015.12.016; Institute for Public Health, 2015, NATIONAL HEALTH AND; letchuman G. R., 2010, Medical Journal of Malaysia, V65, P173; Nafradi L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186458; Nantha YS, 2020, J PRIM CARE COMMUNIT, V11, DOI 10.1177/2150132719900710; Nantha YS, 2020, PUBLIC HEALTH NUTR, V23, P402, DOI 10.1017/S1368980019002684; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; National Institutes of Health, 2019, NAT HLTH MORB SURV 2; Non-Communicable Control Division, 2012, NATL DIABETES REGIST; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Odgers-Jewell K, 2017, DIABETIC MED, V34, P1027, DOI 10.1111/dme.13340; Olesen K, 2020, DIABETIC MED, V37, P909, DOI 10.1111/dme.14284; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Peimani M, 2020, CHRONIC ILLN, V16, P3, DOI 10.1177/1742395318782378; Phillips AS, 2020, J HEALTH PSYCHOL, V25, P44, DOI 10.1177/1359105317737606; Shojania KG, 2019, JAMA-J AM MED ASSOC, V296, P427; Shrivastava SR, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-14; Strauss, 2015, BASICS QUALITATIVE R; Timonen V, 2018, INT J QUAL METH, V17, DOI 10.1177/1609406918758086; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2	29	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245041	10.1371/journal.pone.0245041	http://dx.doi.org/10.1371/journal.pone.0245041			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444368	Green Published, gold			2022-12-26	WOS:000609988100007
J	Kumar, N; Chander, Y; Kumar, R; Khandelwal, N; Riyesh, T; Chaudhary, K; Shanmugasundaram, K; Kumar, S; Kumar, A; Gupta, MK; Pal, Y; Barua, S; Tripathi, BN				Kumar, Naveen; Chander, Yogesh; Kumar, Ram; Khandelwal, Nitin; Riyesh, Thachamvally; Chaudhary, Khushboo; Shanmugasundaram, Karuppusamy; Kumar, Sanjit; Kumar, Anand; Gupta, Madhurendu K.; Pal, Yash; Barua, Sanjay; Tripathi, Bhupendra N.			Isolation and characterization of lumpy skin disease virus from cattle in India	PLOS ONE			English	Article								Lumpy skin disease (LSD) has devastating economic impact. During the last decade, LSD had spread to climatically new and previously disease-free countries, which also includes its recent emergence in the Indian subcontinent (2019). This study deals with the LSD outbreak(s) from cattle in Ranchi (India). Virus was isolated from the scabs (skin lesions) in the primary goat kidney cells. Phylogenetic analysis based on nucleotide sequencing of LSD virus (LSDV) ORF011, ORF012 and ORF036 suggested that the isolated virus (LSDV/Bos taurus-tc/India/2019/Ranchi) is closely related to Kenyan LSDV strains. Further, we adapted the isolated virus in Vero cells. Infection of the isolated LSDV to Vero cells did not produce cytopathic effect (CPE) until the 4th blind passage, but upon adaptation, it produced high viral titres in the cultured cells. The kinetics of viral DNA synthesis and one-step growth curve analysis suggested that Vero cell-adapted LSDV initiates synthesizing its genome at similar to 24 hours post-infection (hpi) with a peak level at similar to 96 hpi whereas evidence of progeny virus particles was observed at 36-48 hours (h) with a peak titre at similar to 120 h. To the best of our knowledge, this study describes the first successful isolation of LSDV in India, besides providing insights into the life cycle Vero cell-adapted LSDV.	[Kumar, Naveen; Chander, Yogesh; Kumar, Ram; Khandelwal, Nitin; Riyesh, Thachamvally; Chaudhary, Khushboo; Shanmugasundaram, Karuppusamy; Pal, Yash; Barua, Sanjay; Tripathi, Bhupendra N.] ICAR Natl Res Ctr Equines, Natl Ctr Vet Type Cultures, Hisar, Haryana, India; [Kumar, Sanjit; Gupta, Madhurendu K.] Birsa Agr Univ, Coll Vet Sci, Dept Vet Pathol, Ranchi, Bihar, India; [Kumar, Anand] Birsa Agr Univ, Coll Vet Sci, Dept Vet Gynaecol & Obstet, Ranchi, Bihar, India	Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Equines; Birsa Agricultural University; Birsa Agricultural University	Kumar, N; Barua, S; Tripathi, BN (corresponding author), ICAR Natl Res Ctr Equines, Natl Ctr Vet Type Cultures, Hisar, Haryana, India.	naveenkumar.icar@gmail.com; sbarua06@gmail.com; bntripath1@yahoo.co.in	Kumar, Naveen/AAR-9084-2021	, Shanmugasundaram Karuppusamy/0000-0001-5965-2087	Science and Engineering Research Board, Department of Science and Technology, Government of India [CRG/2018/004747, CVD/2020/000103]; Indian Council of Agricultural Research [IXX11882]	Science and Engineering Research Board, Department of Science and Technology, Government of India; Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR))	This work was supported by the Science and Engineering Research Board, Department of Science and Technology, Government of India, Grant number CRG/2018/004747 and CVD/2020/000103 to NKu and Indian Council of Agricultural Research, Grant Number IXX11882 to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutarbush SM, 2018, TRANSBOUND EMERG DIS, V65, P1657, DOI 10.1111/tbed.12923; Babiuk S, 2007, J VET DIAGN INVEST, V19, P486, DOI 10.1177/104063870701900505; Binepal YS, 2001, ONDERSTEPOORT J VET, V68, P151; CABI, 2019, LUMPY SKIN DIS; Casal J, 2018, TRANSBOUND EMERG DIS, V65, P1680, DOI 10.1111/tbed.12926; Coves-Datson EM, 2020, P NATL ACAD SCI USA, V117, P2122, DOI 10.1073/pnas.1915152117; Edelsten M, 2014, VET REC, V175, DOI 10.1136/vr.g5969; Fay PC, 2020, J VIROL METHODS, V285, DOI 10.1016/j.jviromet.2020.113943; House J A, 1990, J Vet Diagn Invest, V2, P111; Khandelwal N, 2017, ANTIVIR RES, V144, P196, DOI 10.1016/j.antiviral.2017.06.006; Kitching R. P., 2003, VVolume 114, P161; Kumar N, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00209; Kumar N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156110; Kumar N, 2014, VIRUS GENES, V48, P312, DOI 10.1007/s11262-013-1025-9; Kumar R, 2018, ANTIVIR RES, V160, P126, DOI 10.1016/j.antiviral.2018.10.022; Lojkic I, 2018, GENOME ANNOUNCEMENTS, V6, DOI 10.1128/genomeA.00482-18; Moeller J, 2019, ARCH VIROL, V164, P2931, DOI 10.1007/s00705-019-04411-w; Molla W, 2017, PREV VET MED, V147, P100, DOI 10.1016/j.prevetmed.2017.09.003; Munyanduki H, 2020, J GEN VIROL, V101, P645, DOI 10.1099/jgv.0.001423; OIE, 2017, LUMPY SKIN DIS OIE T; Ras M., 1931, PSEUDO URTICARIA CAT, P20; Saegerman C, 2019, TRANSBOUND EMERG DIS, V66, P957, DOI 10.1111/tbed.13111; Salnikov N, 2018, TRANSBOUND EMERG DIS, V65, P916, DOI 10.1111/tbed.12818; Sprygin A, 2019, VIRUS RES, V269, DOI 10.1016/j.virusres.2019.05.015; Sudhakar SB, 2020, TRANSBOUND EMERG DIS, V67, P2408, DOI 10.1111/tbed.13579; Tasioudi KE, 2016, TRANSBOUND EMERG DIS, V63, P260, DOI 10.1111/tbed.12497; Tuppurainen ESM, 2015, TICKS TICK-BORNE DIS, V6, P134, DOI 10.1016/j.ttbdis.2014.11.002; Tuppurainen ESM, 2012, TRANSBOUND EMERG DIS, V59, P40, DOI 10.1111/j.1865-1682.2011.01242.x; Tuppurainen ESM, 2014, ANTIVIR RES, V109, P1, DOI 10.1016/j.antiviral.2014.06.009; Wallace DB, 2002, ARCH VIROL, V147, P659, DOI 10.1007/s007050200016; WOODS JA, 1988, TROP ANIM HEALTH PRO, V20, P11, DOI 10.1007/BF02239636; YERUHAM I, 1995, VET REC, V137, P91, DOI 10.1136/vr.137.4.91	32	23	24	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0241022	10.1371/journal.pone.0241022	http://dx.doi.org/10.1371/journal.pone.0241022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428633	Green Submitted, Green Published, gold			2022-12-26	WOS:000630036100006
J	Abd Elaziz, M; Al-qaness, MAA; Zaid, EOA; Lu, SF; Ibrahim, RA; Ewees, AA				Abd Elaziz, Mohamed; Al-qaness, Mohammed A. A.; Zaid, Esraa Osama Abo; Lu, Songfeng; Ibrahim, Rehab Ali; Ewees, Ahmed A.			Automatic clustering method to segment COVID-19 CT images	PLOS ONE			English	Article							LUNG-CANCER; FAST SEARCH; ENTROPY; TUMOR; FIND	Coronavirus pandemic (COVID-19) has infected more than ten million persons worldwide. Therefore, researchers are trying to address various aspects that may help in diagnosis this pneumonia. Image segmentation is a necessary pr-processing step that implemented in image analysis and classification applications. Therefore, in this study, our goal is to present an efficient image segmentation method for COVID-19 Computed Tomography (CT) images. The proposed image segmentation method depends on improving the density peaks clustering (DPC) using generalized extreme value (GEV) distribution. The DPC is faster than other clustering methods, and it provides more stable results. However, it is difficult to determine the optimal number of clustering centers automatically without visualization. So, GEV is used to determine the suitable threshold value to find the optimal number of clustering centers that lead to improving the segmentation process. The proposed model is applied for a set of twelve COVID-19 CT images. Also, it was compared with traditional k-means and DPC algorithms, and it has better performance using several measures, such as PSNR, SSIM, and Entropy.	[Abd Elaziz, Mohamed; Lu, Songfeng] Huazhong Univ Sci & Technol, Hubei Engn Res Ctr Big Data Secur, Sch Cyber Sci & Engn, Wuhan, Peoples R China; [Abd Elaziz, Mohamed; Ibrahim, Rehab Ali] Zagazig Univ, Fac Sci, Dept Math, Zagazig, Egypt; [Al-qaness, Mohammed A. A.] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan, Peoples R China; [Zaid, Esraa Osama Abo] Seuz Univ, Fac Sci, Dept Math, Suez, Egypt; [Ewees, Ahmed A.] Damietta Univ, Dept Comp, Dumyat, Egypt	Huazhong University of Science & Technology; Egyptian Knowledge Bank (EKB); Zagazig University; Wuhan University; Egyptian Knowledge Bank (EKB); Damietta University	Abd Elaziz, M; Lu, SF (corresponding author), Huazhong Univ Sci & Technol, Hubei Engn Res Ctr Big Data Secur, Sch Cyber Sci & Engn, Wuhan, Peoples R China.; Abd Elaziz, M (corresponding author), Zagazig Univ, Fac Sci, Dept Math, Zagazig, Egypt.	abd_el_aziz_m@yahoo.com; lusongfeng@hust.edu.cn	, mohamed/AAH-8886-2019; A., Ahmed/O-8211-2016; Al-qaness, Mohammed/ABE-7552-2020	, mohamed/0000-0002-7682-6269; Al-qaness, Mohammed/0000-0002-6956-7641	China Postdoctoral Science Foundation [2019M652647]; Hubei Provincinal Science and Technology Major Project of China [2020AEA011]; Key Research & Developement Plan of Hubei Province of China [2020BAB100]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Hubei Provincinal Science and Technology Major Project of China; Key Research & Developement Plan of Hubei Province of China	The paper has fund from China Postdoctoral Science Foundation Grant No. 2019M652647, also, the Hubei Provincinal Science and Technology Major Project of China under Grant No. 2020AEA011 and the Key Research & Developement Plan of Hubei Province of China under Grant No. 2020BAB100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Elaziz M, 2020, IEEE ACCESS, V8, P125306, DOI 10.1109/ACCESS.2020.3007928; Abd Elaziz M, 2020, EXPERT SYST APPL, V146, DOI 10.1016/j.eswa.2020.113201; Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; Al-qaness MAA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103520; Al-qaness MAA, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030674; [Anonymous], 2019, P IEEE C COMP VIS PA; Chen G, 2019, IEEE T MED IMAGING, V38, P1736, DOI 10.1109/TMI.2018.2890510; Cohen J. P., 2020, ARXIV PREPRINT ARXIV; Dai SF, 2015, NEUROCOMPUTING, V168, P799, DOI 10.1016/j.neucom.2015.05.044; Demner-Fushman D, 2016, J AM MED INFORM ASSN, V23, P304, DOI 10.1093/jamia/ocv080; Dev Chethan, 2019, Ambient Communications and Computer Systems. RACCCS-2018. Advances in Intelligent Systems and Computing (AISC 904), P161, DOI 10.1007/978-981-13-5934-7_15; Han C, 2019, INT CONF 3D VISION, P729, DOI 10.1109/3DV.2019.00085; Havaei M, 2017, MED IMAGE ANAL, V35, P18, DOI 10.1016/j.media.2016.05.004; Huang PK, 2020, RADIOLOGY, V295, P22, DOI 10.1148/radiol.2020200330; Irvin J, 2019, AAAI CONF ARTIF INTE, P590; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Katzmann M., 2019, ARXIV PREPRINT ARXIV; Kotz S., 2000, EXTREME VALUE DISTRI; Majkowska A, 2020, RADIOLOGY, V294, P421, DOI 10.1148/radiol.2019191293; Medeiros AG, 2019, MEASUREMENT, V148, DOI 10.1016/j.measurement.2019.05.078; Mehmood R, 2016, NEUROCOMPUTING, V208, P210, DOI 10.1016/j.neucom.2016.01.102; Pauraj T, 2019, INT J IMAG SYST TECH, V29, P374, DOI 10.1002/ima.22340; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Shakeel PM, 2019, MEASUREMENT, V145, P702, DOI 10.1016/j.measurement.2019.05.027; Shariaty F, 2019, J PHYS CONF SER, V1236, DOI 10.1088/1742-6596/1236/1/012028; Sousa AM, 2019, MED PHYS, V46, P4970, DOI [10.1002/mp.13773], 10.1002/mp.13773]; Sun Y, 2019, MED PHYS, V46, P2214, DOI 10.1002/mp.13463; Swierczynski P, 2018, COMPUT MED IMAG GRAP, V65, P58, DOI 10.1016/j.compmedimag.2017.06.003; Valente IRS, 2016, COMPUT METH PROG BIO, V124, P91, DOI 10.1016/j.cmpb.2015.10.006; Vishnuvarthanan A, 2017, APPL SOFT COMPUT, V57, P399, DOI 10.1016/j.asoc.2017.04.023; Wang EK, 2020, FUTURE GENER COMP SY, V108, P135, DOI 10.1016/j.future.2020.02.054; Wang YB, 2017, PROC CVPR IEEE, P2097, DOI 10.1109/CVPR.2017.226; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wu J, 2016, INT J RADIAT ONCOL, V95, P1504, DOI 10.1016/j.ijrobp.2016.03.018; Xia W, 2020, PEDIATR PULM, V55, P1169, DOI 10.1002/ppul.24718; Ye CQ, 2019, IEEE ACCESS, V7, P23421, DOI 10.1109/ACCESS.2019.2899635; Yin PY, 2007, APPL MATH COMPUT, V184, P503, DOI 10.1016/j.amc.2006.06.057; Zhang W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184290; Zhu H, 2018, COMPUT MATH METHOD M, V2018, DOI 10.1155/2018/3052852	40	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0244416	10.1371/journal.pone.0244416	http://dx.doi.org/10.1371/journal.pone.0244416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4OF	33417610	Green Published, gold			2022-12-26	WOS:000630020100006
J	Goetz, TG; Becker, JB; Mazure, CM				Goetz, Teddy G.; Becker, Jill B.; Mazure, Carolyn M.			Women, opioid use and addiction	FASEB JOURNAL			English	Article						addiction medicine; opioid&#8208; related disorders; sex characteristics	NEONATAL ABSTINENCE SYNDROME; SEX-DIFFERENCES; UNITED-STATES; SUBSTANCE USE; GENDER-DIFFERENCES; DRUG-USE; CHRONIC PAIN; BUPRENORPHINE TREATMENT; NATIONAL-SURVEY; PREGNANT-WOMEN	In the midst of the current coronavirus pandemic, the United States continues to struggle with an ongoing opioid epidemic, initially fueled by widespread prescribing of opioid medications during the 1990s. The primary reason for prescribing opioids is to treat pain. Women have more acute and chronic pain and have been prescribed these drugs in significantly greater numbers than men. Comparison of women and men with chronic pain also shows that women receive the majority of prescription opioids, and the use of these prescribed medications became the major pathway to misuse and addiction for women. Yet, recognition of the extent of women's exposure to opioids and the attendant consequences has been limited. Attempts to stem the overall tide of the epidemic focused on reducing the availability of prescription opioids. However, as these medications became more difficult to obtain and treatment opportunities were limited, many turned to other synthetic opioids, such as heroin and fentanyl. Thus, the public health crisis of opioid addiction has endured. This paper highlights the importance of understanding differences among women and men in opioid use and its biological and psychosocial effects to advance the gender-based treatment approaches and effective public health policy.	[Goetz, Teddy G.] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY USA; [Becker, Jill B.] Univ Michigan, Biopsychol Area Chair, Ann Arbor, MI 48109 USA; [Mazure, Carolyn M.] Yale Univ, Sch Med, Dept Psychiat, Womens Hlth Res Yale, 135 Coll St,Suite 220, New Haven, CT 06510 USA	Columbia University; University of Michigan System; University of Michigan; Yale University	Mazure, CM (corresponding author), Yale Univ, Sch Med, Dept Psychiat, Womens Hlth Res Yale, 135 Coll St,Suite 220, New Haven, CT 06510 USA.	Carolyn.Mazure@yale.edu		Goetz, Teddy/0000-0002-1138-6602				Ailes Elizabeth C, 2015, MMWR Morb Mortal Wkly Rep, V64, P37; Alderks C.E., 2017, CBHSQ REPORT, P2013; Alexander MJ, 2018, EPIDEMIOLOGY, V29, P707, DOI [10.1097/EDE.0000000000000858, 10.1097/ede.0000000000000858]; Algren DA, 2013, J MED TOXICOL, V9, P106, DOI 10.1007/s13181-012-0285-4; Ashrafioun L, 2017, J PSYCHIATR RES, V92, P1, DOI 10.1016/j.jpsychires.2017.03.011; Averitt DL, 2019, NEUROPSYCHOPHARMACOL, V44, P155, DOI 10.1038/s41386-018-0127-4; Back SE, 2011, AM J DRUG ALCOHOL AB, V37, P313, DOI 10.3109/00952990.2011.596982; Back SE, 2010, ADDICT BEHAV, V35, P1001, DOI 10.1016/j.addbeh.2010.06.018; Barger BT, 2021, SUBST ABUS, V42, P104, DOI 10.1080/08897077.2019.1702610; Bartley EJ, 2013, BRIT J ANAESTH, V111, P52, DOI 10.1093/bja/aet127; Bawor M, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0038-6; Becker JB, 2019, BIOL SEX DIFFER, V10, DOI 10.1186/s13293-018-0215-5; Becker JB, 2019, NEUROPSYCHOPHARMACOL, V44, P166, DOI 10.1038/s41386-018-0125-6; Becker JB, 2016, ADDICT BIOL, V21, P1052, DOI 10.1111/adb.12383; Becker JB, 2016, PHARMACOL REV, V68, P242, DOI 10.1124/pr.115.011163; Becker WC, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3115; Buchting FO, 2017, AM J PREV MED, V53, pE1, DOI 10.1016/j.amepre.2016.11.022; Carroll ME, 2002, PSYCHOPHARMACOLOGY, V161, P304, DOI 10.1007/s00213-002-1030-5; Center for Behavioral Health Statistics and Quality, 2018, NATL SURVEY DRUG USE, P948; Centers for Disease Control and Prevention, HEALTHC COST UT PROJ; Choo RE, 2004, DRUG ALCOHOL DEPEN, V75, P253, DOI 10.1016/j.drugalcdep.2004.03.012; Ciccarone D, 2017, INT J DRUG POLICY, V46, P107, DOI 10.1016/j.drugpo.2017.06.010; Cicero TJ, 2017, ADDICT BEHAV, V74, P63, DOI 10.1016/j.addbeh.2017.05.030; Cicero TJ, 2014, JAMA PSYCHIAT, V71, P821, DOI 10.1001/jamapsychiatry.2014.366; Cicero TJ, 2009, PAIN, V144, P20, DOI 10.1016/j.pain.2009.01.026; Cochran SD, 2004, ADDICTION, V99, P989, DOI 10.1111/j.1360-0443.2004.00759.x; Dahlhamer J, 2018, MMWR-MORBID MORTAL W, V67, P1001, DOI 10.15585/mmwr.mm6736a2; Dale R, 2016, MED CLIN N AM, V100, P55, DOI 10.1016/j.mcna.2015.08.012; Debelak K, 2013, AM J ADDICTION, V22, P252, DOI 10.1111/j.1521-0391.2012.12005.x; Doyle HH, 2017, J NEUROSCI, V37, P3202, DOI 10.1523/JNEUROSCI.2906-16.2017; Falletta L, 2018, CHILD ABUSE NEGLECT, V79, P125, DOI 10.1016/j.chiabu.2018.01.026; Fausto-Sterling A., 2012, SEXGENDER BIOL SOCIA, DOI 10.4324/9780203127971; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Fitzsimons HE, 2007, J SUBST ABUSE TREAT, V32, P19, DOI 10.1016/j.jsat.2006.06.015; Floyd CN, 2018, BRIT J CLIN PHARMACO, V84, P813, DOI 10.1111/bcp.13346; Fuentes M, 2007, J NATL MED ASSOC, V99, P1160; Giovino GA, 2002, ONCOGENE, V21, P7326, DOI 10.1038/sj.onc.1205808; Gonzalez CA, 2017, J PRIM PREV, V38, P419, DOI 10.1007/s10935-017-0469-4; Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584; Green CR, 2003, J PAIN, V4, P176, DOI 10.1016/S1526-5900(02)65013-8; Greenfield SF, 2007, DRUG ALCOHOL DEPEN, V86, P1, DOI 10.1016/j.drugalcdep.2006.05.012; Guttmacher Institute, SUBSTANCE USE PREGNA; Guy GP, 2017, MMWR-MORBID MORTAL W, V66, P697, DOI 10.15585/mmwr.mm6626a4; Hales CM., 2020, NCHS DATE BRIEF NUMB; Harrison JM, 2018, AM J PUBLIC HEALTH, V108, P788, DOI 10.2105/AJPH.2018.304349; Hedegaard Holly, 2017, NCHS Data Brief, P1; Hendricks ML, 2012, PROF PSYCHOL-RES PR, V43, P460, DOI 10.1037/a0029597; Herbeck DM, 2016, J ADDICT DIS, V35, P305, DOI 10.1080/10550887.2016.1189659; Hirschtritt Matthew E, 2018, Prev Med Rep, V9, P49, DOI 10.1016/j.pmedr.2017.12.010; Humphreys K, 2017, LANCET, V390, P437, DOI 10.1016/S0140-6736(17)31918-9; Hutcheson DM, 2001, PSYCHOPHARMACOLOGY, V153, P464, DOI 10.1007/s002130000635; Hwang CS, 2016, AM J PREV MED, V51, P151, DOI 10.1016/j.amepre.2016.02.014; Johnson RE, 2003, DRUG ALCOHOL DEPEN, V70, pS87, DOI 10.1016/S0376-8716(03)00062-0; Johnson RE, 2001, DRUG ALCOHOL DEPEN, V63, P97, DOI 10.1016/S0376-8716(00)00194-0; Jones Emlyn S, 2007, Subst Abus, V28, P3, DOI 10.1300/J465v28n02_02; Jones HE, 2005, DRUG ALCOHOL DEPEN, V79, P1, DOI 10.1016/j.drugalcdep.2004.11.013; Jones HE, 2008, AM J ADDICTION, V17, P372, DOI 10.1080/10550490802266276; Jones HE, 2012, ADDICTION, V107, P5, DOI 10.1111/j.1360-0443.2012.04035.x; Jones HE, 2010, NEW ENGL J MED, V363, P2320, DOI 10.1056/NEJMoa1005359; Kandall SR., 1998, NIH PUBLICATION, P53; Kandall SR., 1998, NIH PUBLICATION, P33; Kandall SR, 2010, J ADDICT DIS, V29, P117, DOI 10.1080/10550881003684491; Kecojevic A, 2012, ADDICT BEHAV, V37, P1289, DOI 10.1016/j.addbeh.2012.06.006; Kennedy PJ, PRESIDENTS COMMISSIO; Kidd Jeremy D, 2018, Curr Addict Rep, V5, P158, DOI 10.1007/s40429-018-0196-9; Kolodny A, 2017, JAMA-J AM MED ASSOC, V318, P1537, DOI 10.1001/jama.2017.14567; Kuhn C, 2015, PHARMACOL THERAPEUT, V153, P55, DOI 10.1016/j.pharmthera.2015.06.003; Lagisetty PA, 2019, JAMA PSYCHIAT, V76, P979, DOI 10.1001/jamapsychiatry.2019.0876; Levy B, 2015, AM J PREV MED, V49, P409, DOI 10.1016/j.amepre.2015.02.020; Ling S, 2019, DRUG ALCOHOL DEPEN, V197, P168, DOI 10.1016/j.drugalcdep.2019.02.007; Lynch WJ, 1999, PSYCHOPHARMACOLOGY, V144, P77, DOI 10.1007/s002130050979; MacLean RR, 2019, ADDICT BEHAV, V98, DOI 10.1016/j.addbeh.2019.05.034; Manhapra A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1947; Marsh JC, 2018, J SUBST ABUSE TREAT, V87, P79, DOI 10.1016/j.jsat.2018.01.001; Martin CE, 2015, J SUBST ABUSE TREAT, V48, P37, DOI 10.1016/j.jsat.2014.07.007; Mazure CM, 2018, LANCET, V392, P9, DOI 10.1016/S0140-6736(18)31203-0; Mazure CM, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0068-8; McGinty EE, 2020, JAMA-J AM MED ASSOC, V324, P93, DOI 10.1001/jama.2020.9740; McHugh RK, 2020, J BEHAV MED, V43, P623, DOI 10.1007/s10865-019-00086-5; McHugh RK, 2018, CLIN PSYCHOL REV, V66, P12, DOI 10.1016/j.cpr.2017.10.012; McHugh RK, 2013, J SUBST ABUSE TREAT, V45, P38, DOI 10.1016/j.jsat.2012.12.007; Mckee SA, 2016, NICOTINE TOB RES, V18, P1002, DOI 10.1093/ntr/ntv207; Meints SM, 2018, J PAIN, V19, P1461, DOI 10.1016/j.jpain.2018.07.001; Meyer JP, 2019, DRUG ALCOHOL DEPEN, V197, P158, DOI 10.1016/j.drugalcdep.2019.01.017; Miller TR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.0607; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; Moore BA, 2016, J SUBST ABUSE TREAT, V71, P54, DOI 10.1016/j.jsat.2016.08.016; Moran LM, 2018, AM J DRUG ALCOHOL AB, V44, P512, DOI 10.1080/00952990.2018.1454934; National Academies of Sciences: Engineering and Medicine, 2019, MED OP US DIS SAV LI, DOI [10.17226/25310, DOI 10.17226/25310, DOI 10.1016/j.drugpo.2020.102704]; National Academy of Medicine, PRIORITIES STRATEGIE; National Academy of Medicine, RESOURCES ADDICTION; Ndao-Brumblay S Khady, 2005, J Natl Med Assoc, V97, P1369; Nelson LS, 2012, JAMA-J AM MED ASSOC, V308, P457, DOI 10.1001/jama.2012.8165; Nicholson HL, 2019, SUBST USE MISUSE, V54, P639, DOI 10.1080/10826084.2018.1531427; Nicholson HL, 2018, DRUG ALCOHOL DEPEN, V186, P264, DOI 10.1016/j.drugalcdep.2017.12.006; Niv N, 2007, DRUG ALCOHOL DEPEN, V87, P194, DOI 10.1016/j.drugalcdep.2006.08.017; Pallatino C, 2021, SUBST ABUS, V42, P197, DOI 10.1080/08897077.2019.1671296; Panchal N., IMPLICATIONS COVID 1; Pardue M.L, 2001, EXPLORING BIOLOGICAL; Peterson AB, 2016, MMWR-MORBID MORTAL W, V65, P844, DOI 10.15585/mmwr.mm6533a3; Roos CR, 2020, PSYCHOL ADDICT BEHAV, V34, P660, DOI 10.1037/adb0000581; Rose ME, 2018, PAIN MED, V19, P793, DOI 10.1093/pm/pnx048; Roth ME, 2002, PHARMACOL BIOCHEM BE, V72, P313, DOI 10.1016/S0091-3057(01)00777-8; Scambler G, 2009, SOCIOL HEALTH ILL, V31, P441, DOI 10.1111/j.1467-9566.2009.01161.x; Schieber LZ, 2020, MMWR-MORBID MORTAL W, V69, P298, DOI 10.15585/mmwr.mm6911a5; Schuler MS, 2018, DRUG ALCOHOL DEPEN, V189, P139, DOI 10.1016/j.drugalcdep.2018.05.008; SKINNER WF, 1994, AM J PUBLIC HEALTH, V84, P1307, DOI 10.2105/AJPH.84.8.1307; Soelberg CD, 2017, ANESTH ANALG, V125, P1675, DOI 10.1213/ANE.0000000000002403; Sorge RE, 2017, J NEUROSCI RES, V95, P1271, DOI 10.1002/jnr.23841; Sorge RE, 2015, NAT NEUROSCI, V18, P1081, DOI 10.1038/nn.4053; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/nmeth.2935, 10.1038/NMETH.2935]; Sumner SA, 2016, PREHOSP EMERG CARE, V20, P220, DOI 10.3109/10903127.2015.1076096; Tetrault JM, 2018, ANN INTERN MED, V168, P73, DOI 10.7326/M17-2854; Townsend EA, 2019, NEUROPSYCHOPHARMACOL, V44, P2022, DOI 10.1038/s41386-019-0356-1; Volkow ND, 2014, NEW ENGL J MED, V370, P2063, DOI 10.1056/NEJMp1402780; Wager TD, 2007, P NATL ACAD SCI USA, V104, P11056, DOI 10.1073/pnas.0702413104; Wetherington CL, 2007, EXP CLIN PSYCHOPHARM, V15, P411, DOI 10.1037/1064-1297.15.5.411; Yoest KE, 2019, BRIT J PHARMACOL, V176, P4136, DOI 10.1111/bph.14531; Yoest KE, 2018, HORM BEHAV, V104, P119, DOI 10.1016/j.yhbeh.2018.04.002; Yu XB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13839-2; Zedler BK, 2016, ADDICTION, V111, P2115, DOI 10.1111/add.13462; Zelaya CE., 2020, CHRONIC PAIN HIGH IM, V390, P1	122	7	7	6	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21303	10.1096/fj.202002125R	http://dx.doi.org/10.1096/fj.202002125R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33433026	Green Published			2022-12-26	WOS:000647789600091
J	Weng, YC; Huang, YT; Chiang, IC; Tsai, PJ; Su, YW; Chou, WH				Weng, Yi-Chinn; Huang, Yu-Ting; Chiang, I-Chen; Tsai, Pei-Ju; Su, Yu-Wen; Chou, Wen-Hai			Lipocalin-2 mediates the rejection of neural transplants	FASEB JOURNAL			English	Article						graft; Lipocalin&#8208; 2; neuroinflammation; neutrophil gelatinase&#8208; associated lipocalin; rejection; transplantation	GELATINASE-ASSOCIATED LIPOCALIN; INTRACEREBRAL TRANSPLANTATION; CELL TRANSPLANTATION; IRON HOMEOSTASIS; UP-REGULATION; ASTROCYTES; SURVIVAL; MODEL; RECOGNITION; GENERATION	Lipocalin-2 (LCN2) has been implicated in promoting apoptosis and neuroinflammation in neurological disorders; however, its role in neural transplantation remains unknown. In this study, we cultured and differentiated Lund human mesencephalic (LUHMES) cells into human dopaminergic-like neurons and found that LCN2 mRNA was progressively induced in mouse brain after the intrastriatal transplantation of human dopaminergic-like neurons. The induction of LCN2 protein was detected in a subset of astrocytes and neutrophils infiltrating the core of the engrafted sites, but not in neurons and microglia. LCN2-immunoreactive astrocytes within the engrafted sites expressed lower levels of A1 and A2 astrocytic markers. Recruitment of microglia, neutrophils, and monocytes after transplantation was attenuated in LCN2 deficiency mice. The expression of M2 microglial markers was significantly elevated and survival of engrafted neurons was markedly improved after transplantation in LCN2 deficiency mice. Brain type organic cation transporter (BOCT), the cell surface receptor for LCN2, was induced in dopaminergic-like neurons after differentiation, and treatment with recombinant LCN2 protein directly induced apoptosis in dopaminergic-like neurons in a dose-dependent manner. Our results, therefore, suggested that LCN2 is a neurotoxic factor for the engrafted neurons and a modulator of neuroinflammation. LCN2 inhibition may be useful in reducing rejection after neural transplantation.	[Weng, Yi-Chinn; Huang, Yu-Ting; Chiang, I-Chen; Chou, Wen-Hai] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Miaoli, Taiwan; [Tsai, Pei-Ju; Su, Yu-Wen] Natl Hlth Res Inst, Immunol Res Ctr, Miaoli, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Chou, WH (corresponding author), Natl Hlth Res Inst, Ctr Neuropsychiat Res, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	wenhaichou@nhri.edu.tw	Chou, Wen-Hai/H-1970-2016	Chou, Wen-Hai/0000-0002-7899-1129				Bonnamain V, 2012, FRONT CELL NEUROSCI, V6; Caines AE, 2005, J HEART LUNG TRANSPL, V24, P486, DOI 10.1016/j.healun.2004.02.009; Carlson AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10862; Chou WH, 2010, J NEUROSCI, V30, P13955, DOI 10.1523/JNEUROSCI.0270-10.2010; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; De Vocht N, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt312; De Vocht N, 2013, IMMUNOBIOLOGY, V218, P696, DOI 10.1016/j.imbio.2012.08.266; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Dunnett SB, 1998, EXP NEUROL, V154, P31, DOI 10.1006/exnr.1998.6926; Enderby C, 2015, AM J MANAG CARE, V21, pS12; Grade S, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0033-0; Hare DJ, 2015, NAT REV NEUROL, V11, P536, DOI 10.1038/nrneurol.2015.100; Hoornaert CJ, 2017, STEM CELL TRANSL MED, V6, P1434, DOI 10.1002/sctm.16-0434; Jang E, 2013, FASEB J, V27, P1176, DOI 10.1096/fj.12-222257; Kim BW, 2016, J NEUROSCI, V36, P5608, DOI 10.1523/JNEUROSCI.4261-15.2016; Kjeldsen L, 2000, BBA-PROTEIN STRUCT M, V1482, P272, DOI 10.1016/S0167-4838(00)00152-7; Kowdley KV, 2005, GASTROENTEROLOGY, V129, P494, DOI 10.1053/j.gastro.2005.05.004; Kumar V, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0479-z; Le Blon D, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0756-7; Lee S, 2011, J BIOL CHEM, V286, P43855, DOI 10.1074/jbc.M111.299248; Liddelow S, 2015, CELL, V162, P1170, DOI 10.1016/j.cell.2015.08.029; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Matejuk A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01416; Mudge DW, 2004, TRANSPLANTATION, V77, P206, DOI 10.1097/01.TP.0000100446.44001.00; Ndayisaba A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00180; Parmar T, 2018, J IMMUNOL, V200, P3128, DOI 10.4049/jimmunol.1701573; Piquet AL, 2012, BRAIN RES BULL, V88, P320, DOI 10.1016/j.brainresbull.2012.03.001; Posel C, 2016, JOVE-J VIS EXP, DOI 10.3791/53658; Praet J, 2015, CELL TRANSPLANT, V24, P1481, DOI 10.3727/096368914X682800; Praet J, 2012, CELL TRANSPLANT, V21, P1867, DOI 10.3727/096368912X636920; Resch T, 2017, J HEART LUNG TRANSPL, V36, P732, DOI 10.1016/j.healun.2017.03.004; Rodriguez-Arellano JJ, 2016, NEUROSCIENCE, V323, P170, DOI 10.1016/j.neuroscience.2015.01.007; Sandmeier P, 2005, CHEST, V128, P1379, DOI 10.1378/chest.128.3.1379; Scholz D, 2011, J NEUROCHEM, V119, P957, DOI 10.1111/j.1471-4159.2011.07255.x; Smirnova L, 2016, ARCH TOXICOL, V90, P2725, DOI 10.1007/s00204-015-1637-z; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Suk K, 2016, PROG NEUROBIOL, V144, P158, DOI 10.1016/j.pneurobio.2016.08.001; Takano T, 2009, STROKE, V40, pS8, DOI 10.1161/STROKEAHA.108.533166; Tomov N, 2020, NEURAL REGEN RES, V15, P1173, DOI 10.4103/1673-5374.270296; Wang GN, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176253; Wang G, 2015, J CELL MOL MED, V19, P1637, DOI 10.1111/jcmm.12538; Xiao X, 2017, ANNU REV NUTR, V37, P103, DOI 10.1146/annurev-nutr-071816-064559; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	47	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21317	10.1096/fj.202001018R	http://dx.doi.org/10.1096/fj.202001018R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33421207	hybrid			2022-12-26	WOS:000647789600062
J	Zhang, XW; Sakamoto, W; Canals, D; Ishibashi, M; Matsuda, M; Nishida, K; Toyoshima, M; Shigeta, S; Taniguchi, M; Senkal, CE; Okazaki, T; Yaegashi, N; Hannun, YA; Nabe, T; Kitatani, K				Zhang, Xuewei; Sakamoto, Wataru; Canals, Daniel; Ishibashi, Masumi; Matsuda, Masaya; Nishida, Kentaro; Toyoshima, Masafumi; Shigeta, Shogo; Taniguchi, Makoto; Senkal, Can E.; Okazaki, Toshiro; Yaegashi, Nobuo; Hannun, Yusuf A.; Nabe, Takeshi; Kitatani, Kazuyuki			Ceramide synthase 2-C-24:1-ceramide axis limits the metastatic potential of ovarian cancer cells	FASEB JOURNAL			English	Article						cell motility; ceramide; metastasis; sphingolipids; sphingolipid metabolism	SPHINGOLIPID METABOLISM; V-ATPASE; EXPRESSION; PATHWAY; BIOSYNTHESIS; LOCALIZATION; PROGNOSIS; MECHANISM; MOTILITY; INVASION	Regulation of sphingolipid metabolism plays a role in cellular homeostasis, and dysregulation of these pathways is involved in cancer progression. Previously, our reports identified ceramide as an anti-metastatic lipid. In the present study, we investigated the biochemical alterations in ceramide-centered metabolism of sphingolipids that were associated with metastatic potential. We established metastasis-prone sublines of SKOV3 ovarian cancer cells using an in vivo selection method. These cells showed decreases in ceramide levels and ceramide synthase (CerS) 2 expression. Moreover, CerS2 downregulation in ovarian cancer cells promoted metastasis in vivo and potentiated cell motility and invasiveness. Moreover, CerS2 knock-in suppressed the formation of lamellipodia required for cell motility in this cell line. In order to define specific roles of ceramide species in cell motility controlled by CerS2, the effect of exogenous long- and very long-chain ceramide species on the formation of lamellipodia was evaluated. Treatment with distinct ceramides increased cellular ceramides and had inhibitory effects on the formation of lamellipodia. Interestingly, blocking the recycling pathway of ceramides by a CerS inhibitor was ineffective in the suppression of exogenous C-24:1-ceramide for the formation of lamellipodia. These results suggested that C-24:1-ceramide, a CerS2 metabolite, predominantly suppresses the formation of lamellipodia without the requirement for deacylation/reacylation. Moreover, knockdown of neutral ceramidase suppressed the formation of lamellipodia concomitant with upregulation of C-24:1-ceramide. Collectively, the CerS2-C-24:1-ceramide axis, which may be countered by neutral ceramidase, is suggested to limit cell motility and metastatic potential. These findings may provide insights that lead to further development of ceramide-based therapy and biomarkers for metastatic ovarian cancer.	[Zhang, Xuewei; Ishibashi, Masumi; Toyoshima, Masafumi; Shigeta, Shogo; Yaegashi, Nobuo] Tohoku Univ, Dept Obstet & Gynecol, Grad Sch Med, Sendai, Miyagi, Japan; [Sakamoto, Wataru; Canals, Daniel; Hannun, Yusuf A.] Stony Brook Canc Ctr, Dept Med, Stony Brook, NY USA; [Matsuda, Masaya; Nabe, Takeshi; Kitatani, Kazuyuki] Setsunan Univ, Lab Immunopharmacol, Osaka, Japan; [Nishida, Kentaro] Setsunan Univ, Fac Pharmaceut Sci, Dept Integrat Pharmaceut Sci, Osaka, Japan; [Taniguchi, Makoto; Okazaki, Toshiro] Kanazawa Med Univ, Med Res Inst, Kanazawa, Ishikawa, Japan; [Okazaki, Toshiro] Kanazawa Med Univ, Dept Hematol & Immunol, Kanazawa, Ishikawa, Japan; [Senkal, Can E.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA; [Hannun, Yusuf A.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Biochem, Stony Brook, NY 11794 USA	Tohoku University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Setsunan University; Setsunan University; Kanazawa Medical University; Kanazawa Medical University; Virginia Commonwealth University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kitatani, K (corresponding author), Setsunan Univ, Fac Pharmaceut Sci, Lab Immunopharmacol, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan.	kazuyuki.kitatani@pharm.setsunan.ac.jp	Kitatani, Kazuyuki/H-7100-2019; Taniguchi, Makoto/L-5757-2019; Canals, Daniel/AAW-1998-2021	Kitatani, Kazuyuki/0000-0002-8516-6135; Taniguchi, Makoto/0000-0001-5920-8285; Canals, Daniel/0000-0002-9293-5123; Nishida, Kentaro/0000-0001-8597-4848; Ishibashi, Masumi/0000-0003-4112-8716; Matsuda, Masaya/0000-0001-6498-8335	Japan Society for the Promotion of Science (JSPS) [16K11125] Funding Source: Medline; NCI NIH HHS [P01 CA097132, R01 CA218678] Funding Source: Medline	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anelli V, 2010, FASEB J, V24, P2727, DOI 10.1096/fj.09-150540; Barth BM, 2011, ANTI-CANCER AGENT ME, V11, P911; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Canals D, 2020, FASEB J, V34, P7610, DOI 10.1096/fj.202000205R; Coant Nicolas, 2019, Advances in Biological Regulation, V71, P141, DOI 10.1016/j.jbior.2018.10.005; Coant Nicolas, 2017, Advances in Biological Regulation, V63, P122, DOI 10.1016/j.jbior.2016.10.002; Dimchev G, 2020, J CELL SCI, V133, DOI 10.1242/jcs.239020; Edmond V, 2015, ONCOGENE, V34, P996, DOI 10.1038/onc.2014.55; Fan S, 2013, ONCOGENE, V32, P1682, DOI 10.1038/onc.2012.183; Fan SH, 2015, J CELL BIOCHEM, V116, P502, DOI 10.1002/jcb.24978; Gulluni F, 2019, TRENDS CELL BIOL, V29, P339, DOI 10.1016/j.tcb.2019.01.001; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hwang YH, 2005, BIOCHEM BIOPH RES CO, V331, P37, DOI 10.1016/j.bbrc.2005.03.134; Ito M, 2014, BBA-MOL CELL BIOL L, V1841, P682, DOI 10.1016/j.bbalip.2013.09.008; Kester M, 2003, PHARMACOL RES, V47, P365, DOI 10.1016/S1043-6618(03)00048-3; Kester M, 2015, BIOL CHEM, V396, P737, DOI 10.1515/hsz-2015-0129; Kim MH, 2018, ONCOL REP, V40, P2977, DOI 10.3892/or.2018.6689; Kitatani K, 2016, ONCOGENE, V35, P2801, DOI 10.1038/onc.2015.330; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Koshkaryev A, 2012, CANCER BIOL THER, V13, P50, DOI 10.4161/cbt.13.1.18871; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lu P, 2019, CANCER BIOL THER, V20, P922, DOI 10.1080/15384047.2019.1579962; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; Mizutani Y, 2009, BIOCHIMIE, V91, P784, DOI 10.1016/j.biochi.2009.04.001; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Ogiso H, 2014, METABOLITES, V4, P98, DOI 10.3390/metabo4010098; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Pan H, 2001, GENOMICS, V77, P58, DOI 10.1006/geno.2001.6614; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Sheng N, 2019, J CELL PHYSIOL, V234, P13001, DOI 10.1002/jcp.27970; Shi YN, 2020, AM J TRANSL RES, V12, P5924; Sivan G, 2015, MBIO, V6, DOI 10.1128/mBio.01122-15; Stepanovska B, 2020, PHARMACOL RES, V154, DOI 10.1016/j.phrs.2019.02.009; Stiban J, 2015, BBA-BIOMEMBRANES, V1848, P561, DOI 10.1016/j.bbamem.2014.11.018; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Tagaram HRS, 2011, GUT, V60, P695, DOI 10.1136/gut.2010.216671; Takabe K, 2014, J LIPID RES, V55, P1839, DOI 10.1194/jlr.R046656; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van Vlerken LE, 2007, CANCER RES, V67, P4843, DOI 10.1158/0008-5472.CAN-06-1648; Waters RJ, 2012, METHOD ENZYMOL, V508, P89, DOI 10.1016/B978-0-12-391860-4.00005-7; Wells A, 2013, TRENDS PHARMACOL SCI, V34, P283, DOI 10.1016/j.tips.2013.03.001; Wu BX, 2009, BBA-MOL CELL BIOL L, V1791, P730, DOI 10.1016/j.bbalip.2009.03.012; YAGINUMA Y, 1992, CANCER RES, V52, P4196; Yamaji T, 2015, TRAFFIC, V16, P101, DOI 10.1111/tra.12239; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Zhang XW, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030627; Zhang XW, 2018, MOL CANCER THER, V17, P50, DOI 10.1158/1535-7163.MCT-17-0173; Zhang Y., 2020, Hepatology.	56	4	4	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21287	10.1096/fj.202001504RR	http://dx.doi.org/10.1096/fj.202001504RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33423335	Green Accepted			2022-12-26	WOS:000647789600070
J	Zhang, F; Wang, SH; Zhao, MS; Qin, F; Liu, XY				Zhang, Feng; Wang, Shihang; Zhao, Mingsong; Qin, Falv; Liu, Xiaoyu			Regional simulation of soil organic carbon dynamics for dry farmland in Northeast China using the CENTURY model	PLOS ONE			English	Article							SEQUESTRATION; STOCKS	Soil organic carbon content has a significant impact on soil fertility and grain yield, making it an important factor affecting agricultural production and food security. Dry farmland, the main type of cropland in China, has a lower soil organic carbon content than that of paddy soil, and it may have a significant carbon sequestration potential. Therefore, in this study we applied the CENTURY model to explore the temporal and spatial changes of soil organic carbon (SOC) in Jilin Province from 1985 to 2015. Dry farmland soil polygons were extracted from soil and land use layers (at the 1:1,000,000 scale). Spatial overlay analysis was also used to extract 1282 soil polygons from dry farmland. Modelled results for SOC dynamics in the dry farmland, in conjunction with those from the Yushu field-validation site, indicated a good level of performance. From 1985 to 2015, soil organic carbon density (SOCD) of dry farmland decreased from 34.36 Mg C ha(-1) to 33.50 Mg C ha(-1) in general, having a rate of deterioration of 0.03 Mg C ha(-1) per year. Also, SOC loss was 4.89 Tg from dry farmland soils in the province, with a deterioration rate of 0.16 Tg C per year. 35.96% of the dry farmland its SOCD increased but 64.04% of the area released carbon. Moreover, SOC dynamics recorded significant differences between different soil groups. The method of coupling the CENTURY model with a detailed soil database can simulate temporal and spatial variations of SOC at a regional scale, and it can be used as a precise simulation method for dry farmland SOC dynamics.	[Zhang, Feng; Wang, Shihang; Zhao, Mingsong] Anhui Univ Sci & Technol, Sch Surveying & Mapping, Huainan, Peoples R China; [Qin, Falv] Yuxi Normal Univ, Sch Geog & Land Engn, Yuxi, Peoples R China; [Liu, Xiaoyu] Jiangsu Vocat Coll Agr & Forestry, Sch Informat Engn, Jurong, Peoples R China	Anhui University of Science & Technology; Yuxi Normal University; Jiangsu Vocational College of Agriculture & Forestry	Wang, SH (corresponding author), Anhui Univ Sci & Technol, Sch Surveying & Mapping, Huainan, Peoples R China.	wangshihang122@sina.vip.com			National Natural Science Foundation of China [31700369, 31800358, 41807081]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by [National Natural Science Foundation of China], grant number [31700369, 31800358 and 41807081].	[Anonymous], 2016, LANCET ONCOL, V17, P1, DOI 10.1016/S1470-2045(15)00568-9; Ardo J, 2003, J ARID ENVIRON, V54, P633, DOI 10.1006/jare.2002.1105; [陈辰 Chen Chen], 2012, [草地学报, Acta Agrestia Sinica], V20, P1011; Falloon P, 2002, SOIL USE MANAGE, V18, P164, DOI [10.1079/SUM2002118, 10.1111/j.1475-2743.2002.tb00236.x]; Foereid B, 2004, NUTR CYCL AGROECOSYS, V68, P13, DOI 10.1023/B:FRES.0000012231.89516.80; Galdos MV, 2009, SOIL SCI SOC AM J, V73, P802, DOI 10.2136/sssaj2007.0285; Gao Lupeng, 2004, Ying Yong Sheng Tai Xue Bao, V15, P772; Lufafa A, 2008, AGR ECOSYST ENVIRON, V128, P1, DOI 10.1016/j.agee.2008.04.013; Lugato E, 2008, AGR ECOSYST ENVIRON, V128, P97, DOI 10.1016/j.agee.2008.05.005; Ogle SM, 2010, GLOBAL CHANGE BIOL, V16, P810, DOI 10.1111/j.1365-2486.2009.01951.x; PARTON WJ, 1988, BIOGEOCHEMISTRY, V5, P109, DOI 10.1007/BF02180320; PAUSTIAN K, 1992, SOIL SCI SOC AM J, V56, P476, DOI 10.2136/sssaj1992.03615995005600020023x; Shi X. Z., 2004, Soil Survey Horizons, V45, P129; Smith WN, 2000, GLOBAL CHANGE BIOL, V6, P557, DOI 10.1046/j.1365-2486.2000.00340.x; SOMBROEK WG, 1993, AMBIO, V22, P417; Sommer R, 2014, J ENVIRON MANAGE, V144, P83, DOI 10.1016/j.jenvman.2014.05.017; Sun T, 2015, J ANHUI AGR SCI, V43, P202; Tang J, 2010, QUATERNARY SCI, P584; Tornquist CG, 2009, GEODERMA, V150, P404, DOI 10.1016/j.geoderma.2009.03.001; Tornquist CG, 2009, SOIL TILL RES, V105, P33, DOI 10.1016/j.still.2009.05.005; *UN FAO, 1988, 60 UN FAO; Wang DY, 2014, SIMULATION PREDICTIO; Wang SH, 2011, PEDOSPHERE, V21, P277, DOI 10.1016/S1002-0160(11)60128-8; Wang XB, 2005, PEDOSPHERE, V15, P473; Wang XuYang, 2019, Acta Prataculturae Sinica, V28, P179; Xie ZB, 2007, GLOBAL CHANGE BIOL, V13, P1989, DOI 10.1111/j.1365-2486.2007.01409.x; Xu JiaHui, 2018, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V26, P222; [许文强 Xu Wenqiang], 2010, [生态学报, Acta Ecologica Sinica], V30, P3707; Yang Yan-hua, 2019, Yingyong Shengtai Xuebao, V30, P668, DOI 10.13287/j.1001-9332.201902.026; Yu FY, 2018, SIMULATION SOIL ORGA; [于沙沙 Yu Shasha], 2014, [农业环境科学学报, Journal of Agro-Environment Science], V33, P1973; Zhang W, 2011, PROCEEDINGS OF THE 4TH CONFERENCE ON SYSTEMS SCIENCE, MANAGEMENT SCIENCE AND SYSTEMS DYNAMICS, SSMSSD10, VOL 5, P183; Zhao YC, 2006, SOIL SCI SOC AM J, V70, P1377, DOI 10.2136/sssaj2004.0165	33	2	2	13	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245040	10.1371/journal.pone.0245040	http://dx.doi.org/10.1371/journal.pone.0245040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465085	Green Published, gold			2022-12-26	WOS:000611969200008
J	Habiba, U; Anwar, M; Khatoon, R; Hussain, M; Khan, KA; Khalil, S; Bano, SA; Hussain, A				Habiba, Ume; Anwar, Maqsood; Khatoon, Rukhsana; Hussain, Majid; Khan, Kamal Ahmed; Khalil, Sangam; Bano, Syeda Asma; Hussain, Ahmed			Feeding habits and habitat use of barking deer (Muntiacus vaginalis) in Himalayan foothills, Pakistan	PLOS ONE			English	Article							SITE SELECTION; STRATEGIES; BEHAVIOR; ECOLOGY; DIETS	Northern red muntjac (Muntiacus vaginalis; "barking deer") is a shy and small-sized cervid mammal, limited to the outer Himalayan foothill forests in Pakistan. Habitat characteristics were measured by locating direct and indirect signs. To quantify habitat utilization of barking deer, 80 field surveys were conducted in the study area along transects. 1200 Quadrats at 50 m intervals were deployed along these transect lines to determine microhabitat factors associated with seasonal distribution. The food composition of the barking deer was determined through fecal droppings analysis by micro-histological technique. Forty-five fecal samples of barking deer were collected from the study area (Murree-Kotli Sattian-Kahuta National Pak); summer (28) and winter (17). The micro-histological analysis revealed that more plant species are available in its habitat during the summer season (27) as compared to winter (19). Due to browsing nature barking deer mostly feed on trees in both seasons. While shrubs are slightly higher in winters. In summer barking deer consumed 10 Trees, 6 Shrubs, 5 Herbs, and 6 kinds of grass species. Dominant tree species were Phyllanthus emblica and Acacia modesta. Dominant shrub species were Ziziphus nummularia and Justicia adhatoda. In winter barking deer consumed 8 Trees, 7 Shrubs, 3 Herbs, and 1 Grass. Dominant tree species were Bauhinia variegata and Acacia modesta while shrubs included Ziziphus nummularia and Carissa opaca.	[Habiba, Ume; Anwar, Maqsood; Khatoon, Rukhsana] Arid Agr Univ Rawalpindi, PMAS, Dept Wildlife Management, Rawalpindi, Pakistan; [Habiba, Ume; Hussain, Majid; Hussain, Ahmed] Univ Haripur, Dept Forestry & Wildlife Management, Haripur, Pakistan; [Khan, Kamal Ahmed] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China; [Khalil, Sangam] Islamia Univ Bahawalpur, Dept Forestry Range & Wildlife Management, Bahawalpur, Pakistan; [Bano, Syeda Asma] Univ Haripur, Dept Microbiol, Haripur, Pakistan	Arid Agriculture University; Shandong Normal University; Islamia University of Bahawalpur	Habiba, U (corresponding author), Arid Agr Univ Rawalpindi, PMAS, Dept Wildlife Management, Rawalpindi, Pakistan.; Habiba, U (corresponding author), Univ Haripur, Dept Forestry & Wildlife Management, Haripur, Pakistan.	ume.habiba8@uoh.edu.pk	Khan, Kamal Ahmed/ABD-3159-2021; Khalil, Sangam/GOK-0079-2022	Khan, Kamal Ahmed/0000-0001-8403-2322; 	Pakistan Agricultural Research Council (PARC) Islamabad Pakistan [AS 156]	Pakistan Agricultural Research Council (PARC) Islamabad Pakistan	The project was funded by Pakistan Agricultural Research Council (PARC) Islamabad Pakistan, under Agricultural Linkages Programme (ALP) with project number AS 156. The award received by Ms. Ume Habiba. In particular, special thanks are due to Anwar Gill and staff of the Punjab Wildlife Department for their assistance in the fieldwork. URL of funder website: http://www.parc.gov.pk/.No, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIPAYO D, 1992, J RANGE MANAGE, V45, P148, DOI 10.2307/4002773; awahar A, 2005, NEUROSURG FOCUS, V18, pE8; BARRETTE C, 1977, MAMMALIA, V41, P1, DOI 10.1515/mamm.1977.41.1.1; BELOVSKY GE, 1986, AM ZOOL, V26, P51; Bowyer RT, 1999, J MAMMAL, V80, P1070, DOI 10.2307/1383161; Bronson FH, 1989, MAMMALIAN REPROD BIO; CHAPLIN RE, 1977, DEER; DINERSTEIN E, 1980, BIOL CONSERV, V18, P5, DOI 10.1016/0006-3207(80)90063-4; GEIST V, 1974, AM ZOOL, V14, P205, DOI 10.1093/icb/14.1.205; GERLACH TP, 1991, SOUTHWEST NAT, V36, P255, DOI 10.2307/3671933; Grubb P., 2005, MAMMAL SPECIES WORLD, V3rd, P683; Hameed W., 2009, PAKISTAN J ZOOLOGY, V41; HOLECHEK JL, 1982, J RANGE MANAGE, V35, P309, DOI 10.2307/3898308; Hoogerwerf A, 1970, UDJUNG KULON LAND LA; Hussain F, 1983, MANUAL PLANT ECOLOGY; Ilyas O, 2003, MAMMALIA, V67, P521; KESSLER WB, 1981, J WILDLIFE MANAGE, V45, P612, DOI 10.2307/3808694; Kie JG, 1999, J MAMMAL, V80, P1114, DOI 10.2307/1383163; Lekagul B., 1977, MAMMALS THAILAND; Leslie DM, 1999, J MAMMAL, V80, P1067; Liu JG, 2002, CAM STU LAN, P3; Main MB, 1996, J MAMMAL, V77, P449, DOI 10.2307/1382821; McShea W. J., 1997, DEER ECOLOGY POPULAT; Nagarkoti erwerf A, 1970, U KULON LAND LAND LA; Prior R, 2007, DEER IDENTIFICATION; Roberts TJ, 1997, BERNHARD PRINCIPE OL; SCHEMNITZ SD, 1980, WILDLIFE MANAGEMENT; SPARKS DR, 1968, J RANGE MANAGE, V21, P264, DOI 10.2307/3895829; Tilman D., 1982, Monographs in Population Biology, pi; Yonzon PB, 1978, J NATURAL HIST MUSEU	30	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0245279	10.1371/journal.pone.0245279	http://dx.doi.org/10.1371/journal.pone.0245279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33450743	Green Published, gold			2022-12-26	WOS:000609991600056
J	Lin, SH; Zhang, XC; Huang, GH; Cheng, L; Lv, J; Zheng, DW; Lin, SM; Wang, SN; Wu, QT; Long, YG; Li, BH; Wei, W; Liu, PT; Pei, DQ; Li, YQ; Wen, ZS; Cui, SZ; Li, P; Sun, XF; Wu, YL; Yao, Y				Lin, Shouheng; Zhang, Xuchao; Huang, Guohua; Cheng, Lin; Lv, Jiang; Zheng, Diwei; Lin, Simiao; Wang, Suna; Wu, Qiting; Long, Youguo; Li, Baiheng; Wei, Wei; Liu, Pentao; Pei, Duanqing; Li, Yangqiu; Wen, Zhesheng; Cui, Shuzhong; Li, Peng; Sun, Xiaofang; Wu, Yilong; Yao, Yao			Myeloid-derived suppressor cells promote lung cancer metastasis by CCL11 to activate ERK and AKT signaling and induce epithelial-mesenchymal transition in tumor cells	ONCOGENE			English	Article							CORRELATE; EOTAXIN-1; MICROENVIRONMENT; EXPRESSION; PATHWAYS; MARKER; STAGE	Myeloid-derived suppressor cells (MDSCs) suppress antitumor immune activities and facilitate cancer progression. Although the concept of immunosuppressive MDSCs is well established, the mechanism that MDSCs regulate non-small cell lung cancer (NSCLC) progression through the paracrine signals is still lacking. Here, we reported that the infiltration of MDSCs within NSCLC tissues was associated with the progression of cancer status, and was positively correlated with the Patient-derived xenograft model establishment, and poor patient prognosis. Intratumoral MDSCs directly promoted NSCLC metastasis and highly expressed chemokines that promote NSCLC cells invasion, including CCL11. CCL11 was capable of activating the AKT and ERK signaling pathways to promote NSCLC metastasis through the epithelial-mesenchymal transition (EMT) process. Moreover, high expression of CCL11 was associated with a poor prognosis in lung cancer as well as other types of cancer. Our findings underscore that MDSCs produce CCL11 to promote NSCLC metastasis via activation of ERK and AKT signaling and induction of EMT, suggesting that the MDSCs-CCL11-ERK/AKT-EMT axis contains potential targets for NSCLC metastasis treatment.	[Lin, Shouheng; Sun, Xiaofang] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstetr Dis Guangdong Prov, Key Lab Reprod & Genet Guangdong Higher Educ Inst, Guangzhou, Guangdong, Peoples R China; [Lin, Shouheng; Cheng, Lin; Lv, Jiang; Zheng, Diwei; Lin, Simiao; Wang, Suna; Wu, Qiting; Long, Youguo; Pei, Duanqing; Li, Peng; Yao, Yao] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Peoples R China; [Lin, Shouheng; Cheng, Lin; Pei, Duanqing; Li, Peng; Sun, Xiaofang] Bioland Lab, Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou, Peoples R China; [Zhang, Xuchao; Wu, Yilong] Guangdong Acad Med Sci, Guangdong Prov Key Lab Translat Med Lung Canc, Guangdong Lung Canc Inst, Med Res Ctr, Guangzhou, Peoples R China; [Huang, Guohua] Southern Med Univ, Nanfang Hosp, Dept Resp Med, Guangzhou, Peoples R China; [Li, Baiheng] Hunan Zhaotai Biopharmaceut Co Ltd, Changsha, Peoples R China; [Wei, Wei] Guangdong Cord Blood Bank, Guangzhou, Guangdong, Peoples R China; [Liu, Pentao] Univ Hong Kong, Li Ka Shing Fac Med, Stem Cell & Regenerat Med Ctr, Sch Biomed Sci, Hong Kong, Peoples R China; [Li, Yangqiu] Jinan Univ, Med Coll, Inst Hematol, Guangzhou, Peoples R China; [Wen, Zhesheng] Sun Yat Sen Univ, Dept Thorac Oncol, Canc Ctr, Guangzhou, Peoples R China; [Cui, Shuzhong] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Guangzhou, Peoples R China	Guangzhou Medical University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China; University of Hong Kong; Jinan University; Sun Yat Sen University; Guangzhou Medical University	Sun, XF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstetr Dis Guangdong Prov, Key Lab Reprod & Genet Guangdong Higher Educ Inst, Guangzhou, Guangdong, Peoples R China.; Yao, Y (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Peoples R China.; Sun, XF (corresponding author), Bioland Lab, Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou, Peoples R China.; Wu, YL (corresponding author), Guangdong Acad Med Sci, Guangdong Prov Key Lab Translat Med Lung Canc, Guangdong Lung Canc Inst, Med Res Ctr, Guangzhou, Peoples R China.	xiaofangsun@gzhmu.edu.cn; syylwu@live.cn; yao_yao@gibh.ac.cn	zhang, xian/GYA-0290-2022; Wu, Yi-Long/AAB-9137-2022; Li, Peng/AER-7520-2022; zhang, xu/GRX-9733-2022; yao, yao/HHZ-7438-2022; Wu, Yi-Long/GRJ-9238-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GYE-3558-2022	Wu, Yi-Long/0000-0002-3611-0258; lin, shouheng/0000-0002-6248-5926	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19030205]; National Key Research and Development Plan [2017YFE0131600, 2019YFA0111500]; National Natural Science Foundation of China [81961128003, 81972672, 31872800, 81773301, 82003054]; China Postdoctoral Science Foundation [2018M640771]; Guangdong Provincial Significant New Drugs Development [2019B020202003]; Guangdong Basic and Applied Basic Research Foundation [2019A1515110084, 2019A1515010062, 2020A1515011516]; Guangdong Special Support Program [2017TX04R102]; Science and Technology Planning Project of Guangdong Province [2017B030314056]; Natural Science Foundation of Guangdong Province [2020A0505100062]; Guangdong Provincial Key Lab of Translational Medicine in Lung Cancer [2017B030314120]; Guangzhou City Science and Technology Key Topics Project [201904020025]; Guangzhou Science and Technology Plan Project [201907010042, 201904010473]; Foundation of Guangzhou Science and Information Technology of Guangzhou Key Project [201803040009]; Guangzhou Regenerative Medicine and Health Guangdong Laboratory Frontier Research Program [2018GZR110105003]; Clinical Innovation Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR0201002]; Research Program of the Hefei Institute of Stem Cell and Regenerative Medicine [2019YF001]; Science and Technology Program of Guangzhou [202002020083]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Research and Development Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangdong Provincial Significant New Drugs Development; Guangdong Basic and Applied Basic Research Foundation; Guangdong Special Support Program; Science and Technology Planning Project of Guangdong Province; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Provincial Key Lab of Translational Medicine in Lung Cancer; Guangzhou City Science and Technology Key Topics Project; Guangzhou Science and Technology Plan Project; Foundation of Guangzhou Science and Information Technology of Guangzhou Key Project; Guangzhou Regenerative Medicine and Health Guangdong Laboratory Frontier Research Program; Clinical Innovation Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory; Research Program of the Hefei Institute of Stem Cell and Regenerative Medicine; Science and Technology Program of Guangzhou	We thank the cancer patients who donated their tissues. This work was supported by Strategic Priority Research Program of the Chinese Academy of Sciences (XDB19030205); and National Key Research and Development Plan (2017YFE0131600, 2019YFA0111500); and National Natural Science Foundation of China (81961128003; 81972672; 31872800; 81773301; 82003054); and China Postdoctoral Science Foundation (2018M640771); and Guangdong Provincial Significant New Drugs Development (2019B020202003); and Guangdong Basic and Applied Basic Research Foundation (2019A1515110084, 2019A1515010062, 2020A1515011516); and Guangdong Special Support Program (2017TX04R102); and Science and Technology Planning Project of Guangdong Province (2017B030314056); and Natural Science Foundation of Guangdong Province (2020A0505100062); and Guangdong Provincial Key Lab of Translational Medicine in Lung Cancer (2017B030314120); and Guangzhou City Science and Technology Key Topics Project (201904020025); and Guangzhou Science and Technology Plan Project (201907010042, 201904010473) and Foundation of Guangzhou Science and Information Technology of Guangzhou Key Project (201803040009); and Guangzhou Regenerative Medicine and Health Guangdong Laboratory Frontier Research Program (2018GZR110105003); and Clinical Innovation Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory (2018GZR0201002); and Research Program of the Hefei Institute of Stem Cell and Regenerative Medicine (2019YF001); and Science and Technology Program of Guangzhou (202002020083).	Agarwal M, 2013, PROSTATE, V73, P573, DOI 10.1002/pros.22597; Alzahrani AS, 2019, SEMIN CANCER BIOL, V59, P125, DOI 10.1016/j.semcancer.2019.07.009; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Blank S, 2017, ONCOTARGET, V8, P47518, DOI 10.18632/oncotarget.17671; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Huang A, 2013, CANCER IMMUNOL IMMUN, V62, P1439, DOI 10.1007/s00262-013-1450-6; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; John T, 2011, CLIN CANCER RES, V17, P134, DOI 10.1158/1078-0432.CCR-10-2224; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Lai YX, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0470-7; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Levina V, 2009, CLIN CANCER RES, V15, P2647, DOI 10.1158/1078-0432.CCR-08-2024; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin SH, 2018, MABS-AUSTIN, V10, P1301, DOI 10.1080/19420862.2018.1518948; Lin SH, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01713; Lindau D, 2012, IMMUNOLOGY, V137, P589, DOI 10.1111/imm.12036; Liu H, 2019, NEOPLASMA, V66, P487, DOI 10.4149/neo_2018_181029N805; Mao YM, 2013, CANCER RES, V73, P3877, DOI 10.1158/0008-5472.CAN-12-4115; Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Meyer C, 2014, CANCER IMMUNOL IMMUN, V63, P247, DOI 10.1007/s00262-013-1508-5; Miller KD, 2019, CA-CANCER J CLIN, V69, P363, DOI 10.3322/caac.21565; Miyagaki T, 2011, CANCER RES, V71, P2056, DOI 10.1158/0008-5472.CAN-10-3764; Miyagaki T, 2010, J INVEST DERMATOL, V130, P2304, DOI 10.1038/jid.2010.128; NAGY A, 2018, SCI REP UK, V8; Oh K, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3473; Ouzounova M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14979; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sun HL, 2012, WORLD J GASTROENTERO, V18, P3303, DOI 10.3748/wjg.v18.i25.3303; Tian M, 2016, ONCOTARGET, V7, P32617, DOI 10.18632/oncotarget.8958; Tian W, 2016, ONCOL REP, V35, P2171, DOI 10.3892/or.2016.4561; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Wang DZ, 2017, CANCER RES, V77, P3655, DOI 10.1158/0008-5472.CAN-16-3199; Wang L, 2013, J IMMUNOL, V190, P794, DOI 10.4049/jimmunol.1202088; Watanabe-Takano H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127888; Xu WF, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1118-y; Xu WT, 2015, CELL ADHES MIGR, V9, P317, DOI 10.1080/19336918.2015.1016686; Yang ZZ, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-0843-1; Ye W, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0156-y; Zajkowska M, 2020, CANCERS, V12, DOI 10.3390/cancers12061383; Zhang GB, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.977164; Zhao F, 2012, IMMUNOLOGY, V136, P176, DOI 10.1111/j.1365-2567.2012.03566.x; Zhu F, 2014, ONCOL REP, V31, P2049, DOI 10.3892/or.2014.3060; Zohny SF, 2010, MED ONCOL, V27, P1246, DOI 10.1007/s12032-009-9366-x	49	12	13	3	20	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2021	40	8					1476	1489		10.1038/s41388-020-01605-4	http://dx.doi.org/10.1038/s41388-020-01605-4		JAN 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QM6NM	33452453				2022-12-26	WOS:000607998600011
J	Cid-Garcia, NM; Rios-Solis, YA				Cid-Garcia, Nestor M.; Rios-Solis, Yasmin A.			Exact solutions for the 2d-strip packing problem using the positions-and-covering methodology	PLOS ONE			English	Article							CUTTING STOCK PROBLEMS; HEURISTIC ALGORITHMS; GENETIC ALGORITHM; STRIP	We use the Positions and Covering methodology to obtain exact solutions for the two-dimensional, non-guillotine restricted, strip packing problem. In this classical NP-hard problem, a given set of rectangular items has to be packed into a strip of fixed weight and infinite height. The objective consists in determining the minimum height of the strip. The Positions and Covering methodology is based on a two-stage procedure. First, it is generated, in a pseudo-polynomial way, a set of valid positions in which an item can be packed into the strip. Then, by using a set-covering formulation, the best configuration of items into the strip is selected. Based on the literature benchmark, experimental results validate the quality of the solutions and method's effectiveness for small and medium-size instances. To the best of our knowledge, this is the first approach that generates optimal solutions for some literature instances for which the optimal solution was unknown before this study.	[Cid-Garcia, Nestor M.] CONACYT Ctr Invest Ciencias Informac Geoespacial, Lab Nacl Geointeligencia, Aguascalientes, Aguascalientes, Mexico; [Rios-Solis, Yasmin A.] Tecnol Monterrey, Escuela Ingn & Ciencias, Monterrey, Nuevo Leon, Mexico	Tecnologico de Monterrey	Cid-Garcia, NM (corresponding author), CONACYT Ctr Invest Ciencias Informac Geoespacial, Lab Nacl Geointeligencia, Aguascalientes, Aguascalientes, Mexico.	ncid@centrogeo.edu.mx	Rios solis, yasmin/GLU-5226-2022	Rios solis, yasmin/0000-0003-3785-4440	CONACYT; project 843 from the Chairs Program of the Mexican National Council for Science and Technology;  [2016-01-1948];  [710289]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); project 843 from the Chairs Program of the Mexican National Council for Science and Technology; ; 	This work has been supported by grants 2016-01-1948, 710289, and FC-2016 from CONACYT, (Y.A.R.S.), and the project 843 from the Chairs Program of the Mexican National Council for Science and Technology (N.M.C.G.). There was no additional external funding received for this study.	Abedini A, 2016, PROCEDIA MANUF, V5, P15, DOI 10.1016/j.promfg.2016.08.005; Alvarez-Valdes R, 2008, COMPUT OPER RES, V35, P1065, DOI 10.1016/j.cor.2006.07.004; Alvarez-Valdes R, 2009, OR SPECTRUM, V31, P431, DOI 10.1007/s00291-008-0128-5; Arahori Y, 2012, COMPUT OPER RES, V39, P2991, DOI 10.1016/j.cor.2012.03.003; Augustine J., 2006, P 18 ANN ACM S PAR A, P180; Aydin N, 2020, COMPUT OPER RES, V121, DOI 10.1016/j.cor.2020.104959; BAKER BS, 1980, SIAM J COMPUT, V9, P846, DOI 10.1137/0209064; Bayliss C, 2021, EUR J OPER RES, V289, P727, DOI 10.1016/j.ejor.2020.07.027; BEASLEY JE, 1985, OPER RES, V33, P49, DOI 10.1287/opre.33.1.49; Bekrar A, 2007, J IND SYSTEMS ENG, V1, P151; BENGTSSON BE, 1982, COMPUT J, V25, P353, DOI 10.1093/comjnl/25.3.353; BERKEY JO, 1987, J OPER RES SOC, V38, P423, DOI 10.2307/2582731; Bezerra VMR, 2020, J OPER RES SOC, V71, P606, DOI 10.1080/01605682.2019.1578914; Bortfeldt A, 2006, EUR J OPER RES, V172, P814, DOI 10.1016/j.ejor.2004.11.016; Boschetti MA, 2010, OPER RES, V58, P1774, DOI 10.1287/opre.1100.0833; Buchwald T, 2016, INT T OPER RES, V23, P93, DOI 10.1111/itor.12100; Burke EK, 2004, OPER RES, V52, P655, DOI 10.1287/opre.1040.0109; Burke EK, 1999, P WORLD MAN C DURH U, P27; Burke EK, 2006, NOTTCSTR20063 U NOTT; CHAZELLE B, 1983, IEEE T COMPUT, V32, P697, DOI 10.1109/TC.1983.1676307; Chen MF, 2019, IEEE ACCESS, V7, P179086, DOI 10.1109/ACCESS.2019.2953531; CHRISTOFIDES N, 1977, OPER RES, V25, P30, DOI 10.1287/opre.25.1.30; Cid-Garcia  NM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229358; Cid-Garcia NM, 2019, COMPUT ELECTRON AGR, V164, DOI 10.1016/j.compag.2019.104925; Cid-Garcia NM, 2013, COMPUT ELECTRON AGR, V93, P1, DOI 10.1016/j.compag.2013.01.009; Dagli CH, 1997, J INTELL MANUF, V8, P177, DOI 10.1023/A:1018517106992; DOWSLAND KA, 1992, EUR J OPER RES, V56, P2, DOI 10.1016/0377-2217(92)90288-K; Fekete SP, 2007, OPER RES, V55, P569, DOI 10.1287/opre.1060.0369; Feng DQ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211729; Firat H, 2020, COMPUT IND ENG, V148, DOI 10.1016/j.cie.2020.106687; GILMORE PC, 1965, OPER RES, V13, P94, DOI 10.1287/opre.13.1.94; Goncalves JF, 2013, INT J PROD ECON, V145, P500, DOI 10.1016/j.ijpe.2013.04.019; HAESSLER RW, 1991, EUR J OPER RES, V54, P141, DOI 10.1016/0377-2217(91)90293-5; Hifi M, 1998, COMPUT OPER RES, V25, P925, DOI 10.1016/S0305-0548(98)00008-2; HOCHBAUM DS, 1985, J ACM, V32, P130, DOI 10.1145/2455.214106; Hopper E, 2001, EUR J OPER RES, V128, P34, DOI 10.1016/S0377-2217(99)00357-4; Hopper E, 2001, ARTIF INTELL REV, V16, P257, DOI 10.1023/A:1012590107280; Iori M, 2003, APPL OPTIMIZAT, V78, P159; Jakobs S, 1996, EUR J OPER RES, V88, P165, DOI 10.1016/0377-2217(94)00166-9; Kenmochi M, 2009, EUR J OPER RES, V198, P73, DOI 10.1016/j.ejor.2008.08.020; Lesh N, 2004, INFORM PROCESS LETT, V90, P7, DOI 10.1016/j.ipl.2004.01.006; LESH N, 2005, ACM J EXPT ALGORITHM, V10, P1; Li F, 2016, HEALTH CARE MANAG SC, V19, P261, DOI 10.1007/s10729-015-9318-2; Liu DQ, 1999, EUR J OPER RES, V112, P413, DOI 10.1016/S0377-2217(97)00437-2; Lodi A, 2004, ANN OPER RES, V131, P203, DOI 10.1023/B:ANOR.0000039519.03572.08; Lodi A, 2002, DISCRETE APPL MATH, V123, P379, DOI 10.1016/S0166-218X(01)00347-X; Martello S, 1998, MANAGE SCI, V44, P388, DOI 10.1287/mnsc.44.3.388; Martello S, 2003, INFORMS J COMPUT, V15, P310, DOI 10.1287/ijoc.15.3.310.16082; Maschler J, 2017, OPERAT RES PROCEED, P393, DOI 10.1007/978-3-319-42902-1_53; Mumford-Valenzuela CL, 2004, APPL OPTIMIZAT, V86, P501; Neuenfeldt A, 2019, EXPERT SYST APPL, V118, P365, DOI 10.1016/j.eswa.2018.10.006; Ntene N, 2009, DISCRETE OPTIM, V6, P174, DOI 10.1016/j.disopt.2008.11.002; Oliveira José Fernando, 2016, Pesqui. Oper., V36, P197, DOI 10.1590/0101-7438.2016.036.02.0197; Pisinger D., 2005, DISCRETE OPTIM, V2, P154, DOI [DOI 10.1016/J.DISOPT.2005.01.002, 10.1016/j.disopt.2005.01.002]; PluSS-Aragonus, 2015, HDB OPERATIONS RES A, P129; Poshyanonda P, 2004, J INTELL MANUF, V15, P201, DOI 10.1023/B:JIMS.0000018033.05556.65; Rakotonirainy RG, 2020, APPL SOFT COMPUT, V92, DOI 10.1016/j.asoc.2020.106268; Ratanapan K, 1998, IEEE C EVOL COMPUTAT, P581, DOI 10.1109/ICEC.1998.700093; Ratanapan K, 1997, P ART NEUR NETW ENG, P383; Rhiat A, 2020, PROCEDIA MANUF, V44, P536, DOI 10.1016/j.promfg.2020.02.258; Riff MC, 2009, ENG APPL ARTIF INTEL, V22, P823, DOI 10.1016/j.engappai.2008.10.025; Sugi M, 2020, INT J AUTO TECH-JPN, V14, P447, DOI 10.20965/ijat.2020.p0447; Tapia JFD, 2016, PROCESS SAF ENVIRON, V104, P358, DOI 10.1016/j.psep.2016.09.013; Vijayakumar B, 2013, EUR J OPER RES, V224, P583, DOI 10.1016/j.ejor.2012.09.010; Wascher G, 2007, EUR J OPER RES, V183, P1109, DOI 10.1016/j.ejor.2005.12.047; Wei LJ, 2017, COMPUT OPER RES, V80, P113, DOI 10.1016/j.cor.2016.11.024; Ye DS, 2022, J COMB OPTIM, V44, P2224, DOI 10.1007/s10878-020-00601-4	68	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245267	10.1371/journal.pone.0245267	http://dx.doi.org/10.1371/journal.pone.0245267			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444394	Green Published, gold			2022-12-26	WOS:000609988100036
J	Gaudet, A; Devos, M; Keignart, S; Pouly, O; Lecailtel, S; Wallet, F; Nseir, S				Gaudet, Alexandre; Devos, Matthieu; Keignart, Sylvain; Pouly, Olivier; Lecailtel, Sylvain; Wallet, Frederic; Nseir, Saad			Usefulness of Sepsis-3 in diagnosing and predicting mortality of ventilator-associated lower respiratory tract infections	PLOS ONE			English	Article							INTRAHOSPITAL TRANSPORT; PNEUMONIA; TRACHEOBRONCHITIS; SURVEILLANCE	Background Early distinguishing ventilator-associated tracheobronchitis (VAT) and ventilator-associated pneumonia (VAP) remains difficult in the daily practice. However, this question appears clinically relevant, as treatments of VAT and VAP currently differ. In this study, we assessed the accuracy of sepsis criteria according to the Sepsis-3 definition in the early distinction between VAT and VAP. Methods Retrospective single-center cohort, including all consecutive patients with a diagnosis of VAT (n = 70) or VAP (n = 136), during a 2-year period. Accuracy of sepsis criteria according to Sepsis-3, total SOFA and respiratory SOFA, calculated at time of microbiological sampling were assessed in differentiating VAT from VAP, and in predicting mortality on ICU discharge. Results Sensitivity and specificity of sepsis criteria were found respectively at 0.4 and 0.91 to distinguish VAT from VAP, and at 0.38 and 0.75 for the prediction of mortality in VA-LRTI. A total SOFA >= 6 and a respiratory SOFA >= 3 were identified as the best cut-offs for these criteria in differentiating VAT from VAP, with sensitivity and specificity respectively found at 0.63 and 0.69 for total SOFA, and at 0.49 and 0.7 for respiratory SOFA. Additionally, for prediction of mortality, a total SOFA >= 7 and a respiratory SOFA = 4 were identified as the best-cut-offs, respectively yielding sensitivity and specificity at 0.56 and 0.61 for total SOFA, and at 0.22 and 0.95 for respiratory SOFA. Conclusions Sepsis criteria according to the Sepsis-3 definition show a high specificity but a low sensitivity for the diagnosis of VAP. Our results do not support the use of these criteria for the early diagnosis of VAP in patients with VA-LRTI.	[Gaudet, Alexandre; Devos, Matthieu; Keignart, Sylvain; Pouly, Olivier; Lecailtel, Sylvain; Nseir, Saad] CHU Lille, Dept Intens Care Med, Crit Care Ctr, Lille, France; [Gaudet, Alexandre] Univ Lille, Inst Pasteur Lille, Ctr Infect & Immunite Lille, CNRS,Inserm,CHU Lille,U1019,UMR9017, Lille, France; [Wallet, Frederic] CHU Lille, Microbiol Lab, Lille, France; [Nseir, Saad] Univ Lille, Lille Inflammat Res Int Ctr, Team Fungal Associated Invas & Inflammatory Dis, INSERM,U995, Lille, France	Universite de Lille - ISITE; CHU Lille; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Nseir, S (corresponding author), CHU Lille, Dept Intens Care Med, Crit Care Ctr, Lille, France.; Nseir, S (corresponding author), Univ Lille, Lille Inflammat Res Int Ctr, Team Fungal Associated Invas & Inflammatory Dis, INSERM,U995, Lille, France.	s-nseir@chru-lille.fr						Bercault N, 2005, CRIT CARE MED, V33, P2471, DOI 10.1097/01.CCM.0000185644.54646.65; Bouhemad B, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.10.46; Butler KL, 1999, AM SURGEON, V65, P805; Coelho L, 2018, J CRIT CARE, V48, P385, DOI 10.1016/j.jcrc.2018.09.036; da Silveira F, 2019, J CRIT CARE, V49, P124, DOI 10.1016/j.jcrc.2018.10.034; Fan YZ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1506-z; Graat ME, 2006, CRIT CARE, V10, DOI 10.1186/cc3955; Kalil AC, 2016, CLIN INFECT DIS, V63, pE61, DOI 10.1093/cid/ciw353; Keane S, 2018, CLIN CHEST MED, V39, P785, DOI 10.1016/j.ccm.2018.08.003; Magill SS, 2013, CRIT CARE MED, V41, P2467, DOI 10.1097/CCM.0b013e3182a262db; Martin-Loeches I, 2010, CLIN PULM MED, V17, P117; Martin-Loeches I, 2015, LANCET RESP MED, V3, P859, DOI 10.1016/S2213-2600(15)00326-4; Parmentier-Decrucq E, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-10; Poole GV, 1999, AM SURGEON, V65, P809; Pouly O, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-0624-6; Pradhan S, 2020, J CRIT CARE, V58, P65, DOI 10.1016/j.jcrc.2020.03.012; Ramirez P, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1342-1; Ramirez-Estrada S, 2018, INTENS CARE MED, V44, P1212, DOI 10.1007/s00134-018-5269-7; Self WH, 2013, AM J EMERG MED, V31, P401, DOI 10.1016/j.ajem.2012.08.041; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Torres A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00582-2017	21	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245552	10.1371/journal.pone.0245552	http://dx.doi.org/10.1371/journal.pone.0245552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444395	Green Published, gold			2022-12-26	WOS:000609988100046
J	Domokos, D; Szabo, A; Banhegyi, G; Major, L; Kiss, RG; Becker, D; Edes, IF; Ruzsa, Z; Merkely, B; Hizoh, I				Domokos, Dominika; Szabo, Andras; Banhegyi, Gyongyver; Major, Laszlo; Kiss, Robert Gabor; Becker, David; Edes, Istvan Ferenc; Ruzsa, Zoltan; Merkely, Bela; Hizoh, Istvan			Impact of periprocedural morphine use on mortality in STEMI patients treated with primary PCI	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; DOUBLE-BLIND; TASK-FORCE; ASSOCIATION; REPERFUSION; MANAGEMENT; OUTCOMES	Background Intravenous morphine (MO) decreases the effect of all oral platelet P2Y(12) receptor inhibitors in vitro and observational reports suggest that its use may be associated with larger infarct size. Yet, there are limited data available about the impact of this interaction on clinical outcomes. We studied the effect of MO on mortality in ST-segment elevation myocardial infarction (STEMI) patients treated with primary PCI using a prospective registry. Methods Of the 1255 patients who underwent primary PCI, 397 received MO based on physician's judgment. Clopidogrel was used as P2Y(12) receptor antagonist in all cases. Median follow-up time was 7.5 years with 457 deaths. To adjust for confounding, two propensity score-based procedures were performed: 1 to 1 matching (PSM, 728 cases), and inverse probability of treatment weighting (IPTW) retaining data from all patients. Primary outcome measure was time to all-cause death, whereas predischarge left ventricular ejection fraction (LVEF) was used as secondary end point. Results An adequate balance on baseline covariates was achieved by both methods. We found no difference in survival as the HR (MO/no MO) was 0.98 (95% confidence interval [CI]: 0.76-1.26), p = 0.86 using PSM and 1.01 (95% CI: 0.84-1.23), p = 0.88 with IPTW. Likewise, distributions of LVEFs were similar using either methods: with PSM, median LVEFs were 50.0% (interquartile range [IQR]: 43.0%-55.3%) vs 50.0% (IQR: 42.0%-55.0%) in the no MO and MO groups, respectively (p = 0.76), whereas using IPTW, they were 50.0% (IQR: 42.5%-55.0%) vs 50.0% (IQR: 41.0%-55.0%), respectively (p = 0.86). Conclusions Our data suggest that morphine use may have no impact on long-term mortality and on predischarge ejection fraction in STEMI patients treated with primary PCI.	[Domokos, Dominika; Becker, David; Edes, Istvan Ferenc; Ruzsa, Zoltan; Merkely, Bela; Hizoh, Istvan] Semmelweis Univ, Heart & Vasc Ctr, Budapest, Hungary; [Szabo, Andras] Semmelweis Univ, Dept Anesthesiol & Intens Care, Budapest, Hungary; [Major, Laszlo; Kiss, Robert Gabor] Hungarian Def Forces, Dept Cardiol, Med Ctr, Budapest, Hungary; [Ruzsa, Zoltan] Bacs Kiskun Cty Univ Teaching Hosp, Dept Invas Cardiol, Kecskemet, Hungary	Semmelweis University; Semmelweis University	Hizoh, I (corresponding author), Semmelweis Univ, Heart & Vasc Ctr, Budapest, Hungary.	istvan.hizoh@alumni.uni-heidelberg.de	Hizoh, Istvan/D-6990-2011	Hizoh, Istvan/0000-0001-5141-2070; Szabo, Dominika/0000-0002-1458-2772	Hungarian Artificial Intelligence National Laboratory [NKFIH-870-1/2020]; National Research, Development and Innovation Office of Hungary	Hungarian Artificial Intelligence National Laboratory; National Research, Development and Innovation Office of Hungary(National Research, Development & Innovation Office (NRDIO) - Hungary)	The present work was supported by the Hungarian Artificial Intelligence National Laboratory (NKFIH-870-1/2020, a grant from the National Research, Development and Innovation Office of Hungary to BM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2016, STAT MED, V35, P5642, DOI 10.1002/sim.7084; Austin PC, 2013, STAT MED, V32, P2837, DOI 10.1002/sim.5705; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Batchelor R, 2020, CATHETER CARDIO INTE, V96, P76, DOI 10.1002/ccd.28561; Bellandi B, 2016, INT J CARDIOL, V221, P567, DOI 10.1016/j.ijcard.2016.06.204; Bin Gwag H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170115; Bonin M, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.006833; Cung TT, 2015, NEW ENGL J MED, V373, P1021, DOI 10.1056/NEJMoa1505489; de Waha S, 2015, CLIN RES CARDIOL, V104, P727, DOI 10.1007/s00392-015-0835-2; Farag M, 2018, THROMB HAEMOSTASIS, V118, P601, DOI 10.1055/s-0038-1629896; Hobl EL, 2016, CLIN RES CARDIOL, V105, P349, DOI 10.1007/s00392-015-0927-z; Hobl EL, 2014, J AM COLL CARDIOL, V63, P630, DOI 10.1016/j.jacc.2013.10.068; Iakobishvili Z, 2010, AM J CARDIOL, V105, P912, DOI 10.1016/j.amjcard.2009.11.027; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Khan N, 2016, THROMB RES, V143, P141, DOI 10.1016/j.thromres.2016.05.019; Kubica J, 2016, INT J CARDIOL, V215, P201, DOI 10.1016/j.ijcard.2016.04.077; Kubica J, 2016, EUR HEART J, V37, P245, DOI 10.1093/eurheartj/ehv547; Lapostolle F, 2019, AM J CARDIOVASC DRUG, V19, P173, DOI 10.1007/s40256-018-0305-0; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; McCarthy CP, 2018, J INTERV CARDIOL, V31, P150, DOI 10.1111/joic.12464; Montalescot G, 2014, NEW ENGL J MED, V371, P1016, DOI 10.1056/NEJMoa1407024; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Parodi G, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001593; Puymirat E, 2016, EUR HEART J, V37, P1063, DOI 10.1093/eurheartj/ehv567; Silvain J, 2016, THROMB HAEMOSTASIS, V116, P369, DOI 10.1160/TH15-12-0944	26	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0245433	10.1371/journal.pone.0245433	http://dx.doi.org/10.1371/journal.pone.0245433			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439911	Green Published, gold			2022-12-26	WOS:000609985300052
J	Laraba, I; McCormick, SP; Vaughan, MM; Geiser, DM; O'Donnell, K				Laraba, Imane; McCormick, Susan P.; Vaughan, Martha M.; Geiser, David M.; O'Donnell, Kerry			Phylogenetic diversity, trichothecene potential, and pathogenicity within Fusarium sambucinum species complex	PLOS ONE			English	Article							HEAD BLIGHT PATHOGEN; POPULATION GENETIC-STRUCTURE; SMALL-GRAIN CEREALS; F-PSEUDOGRAMINEARUM; SEQUENCE ALIGNMENT; TOXIC PRINCIPLE; CAUSAL AGENT; NEW-ZEALAND; SP NOV.; GRAMINEARUM	The Fusarium sambucinum species complex (FSAMSC) is one of the most taxonomically challenging groups of fusaria, comprising prominent mycotoxigenic plant pathogens and other species with various lifestyles. Among toxins produced by members of the FSAMSC, trichothecenes pose the most significant threat to public health. Herein a global collection of 171 strains, originating from diverse hosts or substrates, were selected to represent FSAMSC diversity. This strain collection was used to assess their species diversity, evaluate their potential to produce trichothecenes, and cause disease on wheat. Maximum likelihood and Bayesian analyses of a combined 3-gene dataset used to infer evolutionary relationships revealed that the 171 strains originally received as 48 species represent 74 genealogically exclusive phylogenetically distinct species distributed among six strongly supported clades: Brachygibbosum, Graminearum, Longipes, Novel, Sambucinum, and Sporotrichioides. Most of the strains produced trichothecenes in vitro but varied in type, indicating that the six clades correspond to type A, type B, or both types of trichothecene-producing lineages. Furthermore, five strains representing two putative novel species within the Sambucinum Clade produced two newly discovered type A trichothecenes, 15-keto NX-2 and 15-keto NX-3. Strains of the two putatively novel species together with members of the Graminearum Clade were aggressive toward wheat when tested for pathogenicity on heads of the susceptible cultivar Apogee. In planta, the Graminearum Clade strains produced nivalenol or deoxynivalenol and the aggressive Sambucinum Clade strains synthesized NX-3 and 15-keto NX-3. Other strains within the Brachygibbosum, Longipes, Novel, Sambucinum, and Sporotrichioides Clades were nonpathogenic or could infect the inoculated floret without spreading within the head. Moreover, most of these strains did not produce any toxin in the inoculated spikelets. These data highlight aggressiveness toward wheat appears to be influenced by the type of toxin produced and that it is not limited to members of the Graminearum Clade.	[Laraba, Imane; McCormick, Susan P.; Vaughan, Martha M.; O'Donnell, Kerry] ARS, USDA, Natl Ctr Agr Utilizat Res, Mycotoxin Prevent & Appl Microbiol Res Unit, 1815 N Univ, Peoria, IL 61604 USA; [Geiser, David M.] Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA	United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Laraba, I (corresponding author), ARS, USDA, Natl Ctr Agr Utilizat Res, Mycotoxin Prevent & Appl Microbiol Res Unit, 1815 N Univ, Peoria, IL 61604 USA.	Imane.Laraba@usda.gov			NSF [DEB-1655980]; US Department of Energy (DOE); US Department of Agriculture (USDA) [DE-SC0014664]; DOE [DE-SC0014664]	NSF(National Science Foundation (NSF)); US Department of Energy (DOE)(United States Department of Energy (DOE)); US Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); DOE(United States Department of Energy (DOE))	The USDA-ARS National Program for Food Safety and NSF DEB-1655980 provided funding for this study. This research was supported in part by an appointment to the ARS Research Participation Program administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the US Department of Energy (DOE) and the US Department of Agriculture (USDA). ORISE is managed by ORAU under DOE contract number DE-SC0014664. All opinions expressed in this paper are the author's and do not necessarily reflect the policies and views of USDA, DOE, or ORAU/ORISE.	Alexander NJ, 2011, FUNGAL GENET BIOL, V48, P485, DOI 10.1016/j.fgb.2011.01.003; ALTOMARE C, 1995, MYCOPATHOLOGIA, V130, P179, DOI 10.1007/BF01103102; ALTOMARE C, 1995, MYCOPATHOLOGIA, V129, P177, DOI 10.1007/BF01103344; Amarasinghe C, 2019, TOXINS, V11, DOI 10.3390/toxins11050263; Aoki T., 2012, Mycotoxins, V62, P91, DOI 10.2520/myco.62.91; Aoki Takayuki, 1998, Mycoscience, V39, P1, DOI 10.1007/BF02461571; Aoki T, 2015, MYCOLOGIA, V107, P409, DOI 10.3852/14-213; Aoki T, 2014, J GEN PLANT PATHOL, V80, P189, DOI 10.1007/s10327-014-0509-3; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bahadoor A, 2016, J NAT PROD, V79, P81, DOI 10.1021/acs.jnatprod.5b00676; Bai GH, 2002, MYCOPATHOLOGIA, V153, P91, DOI 10.1023/A:1014419323550; Bottalico A, 2002, EUR J PLANT PATHOL, V108, P611, DOI 10.1023/A:1020635214971; Boutigny AL, 2011, FUNGAL GENET BIOL, V48, P914, DOI 10.1016/j.fgb.2011.05.005; Bugbee B, 1997, CROP SCI, V37, P626, DOI 10.2135/cropsci1997.0011183X003700020053x; Chernomor O, 2016, SYST BIOL, V65, P997, DOI 10.1093/sysbio/syw037; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Foroud NA, 2012, PLANT DIS, V96, P1271, DOI 10.1094/PDIS-10-11-0863-RE; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gardiner DM, 2009, FUNGAL GENET BIOL, V46, P604, DOI 10.1016/j.fgb.2009.04.004; Geiser DM, 2013, PHYTOPATHOLOGY, V103, P400, DOI 10.1094/PHYTO-07-12-0150-LE; GERLACH W, 1977, PHYTOPATHOL Z, V88, P29; Goswami RS, 2005, PHYTOPATHOLOGY, V95, P1397, DOI 10.1094/PHYTO-95-1397; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grafenhan T, 2016, MYCOLOGIA, V108, P1229, DOI 10.3852/16-110; Hartman GL, 2019, PLANT DIS, V103, P2070, DOI 10.1094/PDIS-12-18-2286-RE; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; KASITU GC, 1992, CAN J CHEM, V70, P1308, DOI 10.1139/v92-168; Kelly A, 2016, FUNGAL GENET BIOL, V95, P39, DOI 10.1016/j.fgb.2016.08.003; Kelly AC, 2015, FUNGAL GENET BIOL, V82, P22, DOI 10.1016/j.fgb.2015.05.016; Khaneghah AM, 2019, FOOD CHEM, V294, P587, DOI 10.1016/j.foodchem.2019.05.034; King R, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4612-2; Kristensen R, 2005, MYCOL RES, V109, P173, DOI 10.1017/S0953756204002114; Langseth W, 1998, MYCOPATHOLOGIA, V144, P103, DOI [10.1023/A:1007153416269, 10.1023/A:1007016820879]; Laraba I, 2020, MYCOLOGIA, V112, P39, DOI 10.1080/00275514.2019.1668991; Laraba I, 2017, FUNGAL GENET BIOL, V103, P34, DOI 10.1016/j.fgb.2017.04.001; Lee T, 2016, PLANT PATHOLOGY J, V32, P407, DOI 10.5423/PPJ.OA.05.2016.0123; Liang JM, 2014, FUNGAL GENET BIOL, V73, P83, DOI 10.1016/j.fgb.2014.10.002; Lofgren LA, 2018, NEW PHYTOL, V217, P1203, DOI 10.1111/nph.14894; LOGRIECO A, 1990, MYCOL RES, V94, P587, DOI 10.1016/S0953-7562(09)80656-4; Logrieco A, 1998, APPL ENVIRON MICROB, V64, P3084; Lombard L., 2019, Fungal Systematics and Evolution, V4, P183, DOI 10.3114/fuse.2019.04.10; Mackintosh CA, 2006, PLANT CELL REP, V25, P313, DOI 10.1007/s00299-005-0059-4; Marasas WFO, 1998, MYCOLOGIA, V90, P505, DOI 10.2307/3761409; Marasas WFO, 1984, TOXIGENIC FUSARIUM S, DOI [10.1002/ijc.2910340315, DOI 10.1002/IJC.2910340315]; McCormick SP, 2010, APPL ENVIRON MICROB, V76, P136, DOI 10.1128/AEM.02017-09; McCormick SP, 2011, TOXINS, V3, P802, DOI 10.3390/toxins3070802; MILLER JD, 1991, MYCOLOGIA, V83, P121, DOI 10.2307/3759927; Miller JD, 2000, MYCOLOGIA, V92, P764, DOI 10.2307/3761433; Monds RD, 2005, MYCOL RES, V109, P410, DOI 10.1017/S0953756204002217; Morin L, 2000, MYCOL RES, V104, P993, DOI 10.1017/S0953756200002616; Mule G, 1997, APPL ENVIRON MICROB, V63, P1843; Munkvold GP, 2017, METHODS MOL BIOL, V1542, P51, DOI 10.1007/978-1-4939-6707-0_4; Nganje W.E., 2004, AGRIBUSINESS APPL EC, DOI [10.22004/ag.econ.23627, DOI 10.22004/AG.ECON.23627]; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Nichea MJ, 2015, WORLD MYCOTOXIN J, V8, P451, DOI 10.3920/WMJ2014.1770; NIRENBERG HI, 1995, MYCOPATHOLOGIA, V129, P131, DOI 10.1007/BF01103337; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; O'Donnell K, 1998, FUNGAL GENET BIOL, V23, P57, DOI 10.1006/fgbi.1997.1018; O'Donnell K, 2008, FUNGAL GENET BIOL, V45, P1514, DOI 10.1016/j.fgb.2008.09.002; O'Donnell K, 2018, MYCOLOGIA, V110, P1058, DOI 10.1080/00275514.2018.1519773; O'Donnell K, 2015, PHYTOPARASITICA, V43, P583, DOI 10.1007/s12600-015-0484-z; O'Donnell K, 2013, FUNGAL GENET BIOL, V52, P20, DOI 10.1016/j.fgb.2012.12.004; O'Donnell K, 2010, J CLIN MICROBIOL, V48, P3708, DOI 10.1128/JCM.00989-10; Padwick GW, 1945, HI MYCO PAPERS, V12, P1; Pereira CB, 2018, MYCOLOGIA, V110, P860, DOI 10.1080/00275514.2018.1512296; Pestka JJ, 2010, WORLD MYCOTOXIN J, V3, P323, DOI 10.3920/WMJ2010.1247; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Proctor RH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006946; Proctor RH, 2009, MOL MICROBIOL, V74, P1128, DOI 10.1111/j.1365-2958.2009.06927.x; Ramdass AC, 2019, TOXINS, V11, DOI 10.3390/toxins11120689; Rocha LO, 2015, TOXINS, V7, P4577, DOI 10.3390/toxins7114577; Sandoval-Denis M, 2018, MYCOKEYS, P63, DOI 10.3897/mycokeys.34.25974; Sarver BAJ, 2011, FUNGAL GENET BIOL, V48, P1096, DOI 10.1016/j.fgb.2011.09.002; Scherm B, 2013, MOL PLANT PATHOL, V14, P323, DOI 10.1111/mpp.12011; Sherbakoff CD, 1928, PHYTOPATHOLOGY, V18, P219; Starkey DE, 2007, FUNGAL GENET BIOL, V44, P1191, DOI 10.1016/j.fgb.2007.03.001; Stevens R.R., 1974, MYCOLOGY GUIDEBOOK; Summerell BA, 2010, FUNGAL DIVERSITY, V46, P1; Summerell BA, 2019, ANNU REV PHYTOPATHOL, V57, P323, DOI 10.1146/annurev-phyto-082718-100204; Tan Diana C, 2011, Mycotoxin Res, V27, P123, DOI 10.1007/s12550-010-0085-0; TATSUNO T, 1968, CHEM PHARM BULL, V16, P2519; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; THRANE U, 1995, MYCOPATHOLOGIA, V129, P183, DOI 10.1007/BF01103345; Thrane U, 2004, INT J FOOD MICROBIOL, V95, P257, DOI 10.1016/j.ijfoodmicro.2003.12.005; Torp M, 1999, MYCOPATHOLOGIA, V147, P89, DOI 10.1023/A:1007060108935; TRINCI APJ, 1992, MYCOL RES, V96, P1, DOI 10.1016/S0953-7562(09)80989-1; UENO Y, 1969, EXPERIENTIA, V25, P1062, DOI 10.1007/BF01901430; UENO Y, 1973, APPL MICROBIOL, V25, P699, DOI 10.1128/AEM.25.4.699-704.1973; Ueno Y, 1997, MYCOTOXINS, V45, P25; Varga E, 2015, ENVIRON MICROBIOL, V17, P2588, DOI 10.1111/1462-2920.12718; Vaughan M, 2016, WORLD MYCOTOXIN J, V9, P685, DOI 10.3920/WMJ2016.2053; Villani A, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5567-7; Waalwijk C, 2018, IMA FUNGUS, V9, P13, DOI 10.5598/imafungus.2018.09.01.02; Ward TJ, 2002, P NATL ACAD SCI USA, V99, P9278, DOI 10.1073/pnas.142307199; Ward TJ, 2008, FUNGAL GENET BIOL, V45, P473, DOI 10.1016/j.fgb.2007.10.003; Watanabe M, 2013, FOOD ADDIT CONTAM A, V30, P1370, DOI 10.1080/19440049.2013.794305; Whittaker JA., 2020, GRAND CHALLENGES FUN, P59, DOI [DOI 10.1007/978-3-030-29541-7_3, 10.1007/978-3-030-29541-7_3]; Wipfler R, 2019, TOXINS, V11, DOI 10.3390/toxins11100555; Woelflingseder L, 2019, ARCH TOXICOL, V93, P1729, DOI 10.1007/s00204-019-02459-w; Wu F, 2014, ANNU REV FOOD SCI T, V5, P351, DOI 10.1146/annurev-food-030713-092431; Yli-Mattila T, 2011, INT J FOOD MICROBIOL, V147, P58, DOI 10.1016/j.ijfoodmicro.2011.03.007; Yli-Mattila T, 2009, MYCOLOGIA, V101, P841, DOI 10.3852/08-217	104	27	27	8	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245037	10.1371/journal.pone.0245037	http://dx.doi.org/10.1371/journal.pone.0245037			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434214	gold, Green Published			2022-12-26	WOS:000609979700044
J	Gillis, AB; Guy, EL; Kouba, AJ; Allen, PJ; Marcec-Greaves, RM; Kouba, CK				Gillis, Amanda B.; Guy, Emmet L.; Kouba, Andrew J.; Allen, Peter J.; Marcec-Greaves, Ruth M.; Kouba, Carrie K.			Short-term storage of tiger salamander (Ambystoma tigrinum) spermatozoa: The effect of collection type, temperature and time	PLOS ONE			English	Article								The aims of this project were to characterize tiger salamander (Ambystoma tigrinum) spermatozoa motility over time, when excreted as either milt or spermic urine prior to packaging into a spermatophore, and to determine the effect of temperature on sperm motility. A split-plot design was utilized to assess the motility of the two pre-spermatophore sample types at two temperatures, 0 degrees C and 20 degrees C (n = 10 for each treatment). Spermiation was induced through exogenous hormone treatment of luteinizing hormone releasing hormone analog in order to collect both milt and spermic urine, which were evaluated for motility, divided into two separate aliquots, and subsequently stored in either an ice-bath (0 degrees C) or on the benchtop (20 degrees C). The decay rate of sperm motility was assessed by reevaluating subsamples at 0.5, 1, 2, 3, 5, 7, and 24 hours following the initial assessment. Results showed that sperm stored at 0 degrees C had significantly higher progressive, non-progressive, and total motility for both sperm collection types over time. An interaction was found between collection type and time, with milt exhibiting lower initial motility that was more sustainable over time, compared to spermic urine. For both milt and spermic urine, motility decreased rapidly with storage duration, indicating samples should be used as soon as possible to maximize motility for in-vitro fertilization and cryopreservation. This is the first study to describe the differences in sperm motility between milt and spermic urine from an internally fertilizing caudate and demonstrates the benefits of near freezing temperatures on sperm longevity.	[Gillis, Amanda B.; Guy, Emmet L.; Kouba, Carrie K.] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Kouba, Andrew J.; Allen, Peter J.] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA; [Marcec-Greaves, Ruth M.] Detroit Zool Soc, Natl Amphibian Conservat Ctr, Royal Oak, MI USA	Mississippi State University; Mississippi State University	Kouba, CK (corresponding author), Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA.	ckv7@msstate.edu		Vance, Carrie/0000-0001-8466-6077	Institute of Museum and Library Services (IMLS) National Leadership Grant [MG-30-17-0052-17]; National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch project [W3173]; USDA-ARS Biophotonics Initiative grant [G00003581]	Institute of Museum and Library Services (IMLS) National Leadership Grant; National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch project; USDA-ARS Biophotonics Initiative grant	This work was sponsored by the Institute of Museum and Library Services (IMLS) National Leadership Grant (#MG-30-17-0052-17; imls.gov; CKV, AJK, RMMG) and is a contribution of the Mississippi Agricultural and Forestry Experiment Station (mafes.msstate.edu) and the material is based upon work supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch project under the accession number W3173 (nifa.usda.gov). In addition, the study was partially supported by the USDA-ARS Biophotonics Initiative grant #G00003581.(ars. usda.gov; CKV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; [Anonymous], 2016, DEV ASSISTED REPROD; Bencic DC, 1999, FISH PHYSIOL BIOCHEM, V20, P389, DOI 10.1023/A:1007749703803; Billard R, 2004, AQUACULTURE, V236, P1, DOI 10.1016/j.aquaculture.2003.10.029; Browne RK, 2015, THERIOGENOLOGY, V83, P1, DOI 10.1016/j.theriogenology.2014.09.018; Browne RK, 2002, REPROD FERT DEVELOP, V14, P267, DOI 10.1071/RD01045; Browne RK, 2001, REPRODUCTION, V121, P167, DOI 10.1530/rep.0.1210167; Della Togna G, 2018, THERIOGENOLOGY, V108, P153, DOI 10.1016/j.theriogenology.2017.11.032; Germano JM, 2013, AQUACULTURE, V396, P20, DOI 10.1016/j.aquaculture.2013.02.018; Gordon BK, 1981, THESIS EMORY U; Guy EL, 2020, CRYOBIOLOGY, V94, P80, DOI 10.1016/j.cryobiol.2020.04.005; Harding G, 2016, CONSERV BIOL, V30, P340, DOI 10.1111/cobi.12612; IUCN, 2020, AMBYSTOMA TIGRINUM T; Jenkins JA, 1997, J WORLD AQUACULT SOC, V28, P282, DOI 10.1111/j.1749-7345.1997.tb00644.x; Keogh LM, 2017, GEN COMP ENDOCR, V243, P51, DOI 10.1016/j.ygcen.2016.11.005; Kouba A, 2012, REPROD FERT DEVELOP, V24, P170, DOI 10.1071/RDv24n1Ab116; Kouba AJ, 2009, REPROD FERT DEVELOP, V21, P719, DOI 10.1071/RD09038; Lahnsteiner F, 2012, J FISH BIOL, V81, P197, DOI 10.1111/j.1095-8649.2012.03323.x; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; Mansour N, 2011, THERIOGENOLOGY, V75, P354, DOI 10.1016/j.theriogenology.2010.09.006; Peng LY, 2011, ACTA HYDROBIOL SIN, V35, P331; Pramuk JB, 2012, AMPHIBIAN HUSBANDRY, P4; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; SAAD A, 1988, AQUACULTURE, V71, P133, DOI 10.1016/0044-8486(88)90280-3; Silla AJ, 2019, ANNU REV ANIM BIOSCI, V7, P499, DOI 10.1146/annurev-animal-020518-115056; Silla AJ, 2015, REPROD FERT DEVELOP, V27, P1147, DOI 10.1071/RD14062; Ukita M, 1999, ZOOL SCI, V16, P793, DOI 10.2108/zsj.16.793; Unger S, 2013, AM MIDL NAT, V170, P382, DOI 10.1674/0003-0031-170.2.382; Uteshev VK, 2015, RUSS J HERPETOL, V22, P35; Watanabe T, 2003, ZOOL SCI, V20, P345, DOI 10.2108/zsj.20.345; Zhao H., 2012, J HYDROECOLOGY, V33, P149	31	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0245047	10.1371/journal.pone.0245047	http://dx.doi.org/10.1371/journal.pone.0245047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428658	Green Published, gold			2022-12-26	WOS:000630036100031
J	Wu, LX; Huang, ZY; Pan, ZH				Wu, Lianxia; Huang, Zuyu; Pan, Zehan			The spatiality and driving forces of population ageing in China	PLOS ONE			English	Article								Studying the spatial characteristics of China's ageing and its influencing factors is of great practical significance because China has the largest elderly population in the world. Using 2000 and 2010 census data, this study explores the degree, pace, and pattern of population ageing and its driving mechanism using exploratory spatial data analysis and the geographically weighed regression model. Between 2000 and 2010, population ageing increased rapidly countrywide; yet, spatial differences between eastern and western China narrowed. The degree of provincial population ageing and its spatiality were determined by natural population growth, migration, and local economic development. Life expectancy and mortality were the primary long-term factors, and GDP per capita was the prime contributor in the early days of economic development; the migration rate was the dominant influence after 2010. China's overall spatial differentiation of population ageing shifted from a north-south to an east-west division.	[Wu, Lianxia] East China Normal Univ, Sch Social Dev, Shanghai, Peoples R China; [Huang, Zuyu] Hunan Univ, Sch Publ Adm, Changsha, Hunan, Peoples R China; [Pan, Zehan] Fudan Univ, Sch Social Dev & Publ Policy, Shanghai, Peoples R China	East China Normal University; Hunan University; Fudan University	Pan, ZH (corresponding author), Fudan Univ, Sch Social Dev & Publ Policy, Shanghai, Peoples R China.	panzehan@fudan.edu.cn		Wu, Lianxia/0000-0002-7060-215X	National social science found youth project in China [19CRK010]; Humanities and Social Sciences projects of the Ministry of Education of China [18YJC840043, 19YJC840032]; Social Science planning youth Project of Shanghai [2017ESH001]; fundamental research funds for the central universities (Hunan University)	National social science found youth project in China; Humanities and Social Sciences projects of the Ministry of Education of China(Ministry of Education, China); Social Science planning youth Project of Shanghai; fundamental research funds for the central universities (Hunan University)(Fundamental Research Funds for the Central Universities)	This study was funded by National social science found youth project in China (Grant Number: 19CRK010), Humanities and Social Sciences projects of the Ministry of Education of China (18YJC840043 & 19YJC840032), Social Science planning youth Project of Shanghai (2017ESH001), the fundamental research funds for the central universities (Hunan University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L., GEOGRAPHICAL INFORM, P253; Cai F, 2006, CHINA WORLD ECON, V14, P20, DOI 10.1111/j.1749-124X.2006.00035.x; COWGILL DO, 1978, J GERONTOL, V33, P446, DOI 10.1093/geronj/33.3.446; Dong XQ, 2010, GERIATR GERONTOL INT, V10, P85, DOI 10.1111/j.1447-0594.2009.00563.x; Feng Q, 2015, EUR J AGEING, V12, P83, DOI 10.1007/s10433-014-0329-5; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; GOODMAN AC, 1987, URBAN STUD, V24, P77, DOI 10.1080/00420988720080071; GRAFF TO, 1978, GEOGR REV, V68, P379, DOI 10.2307/214213; HAHN WA, 1992, ANN AM ACAD POLIT SS, V522, P116, DOI 10.1177/0002716292522001011; HILTNER J, 1974, J GEOGR, V73, P23, DOI 10.1080/00221347408980276; Holzmann B, 2013, CURR PROTEIN PEPT SC, V14, P268, DOI 10.2174/13892037113149990046; Kacerova M, 2012, MORAV GEOGR REP, V20, P26; Kurek S, 2011, GEOGR ANN B, V93B, P163, DOI 10.1111/j.1468-0467.2011.00367.x; Lee R, 2011, SCIENCE, V333, P569, DOI 10.1126/science.1208859; Li R B, 1999, GEOGRAPHICAL RES, V18, P113; MacInnes J, 2007, POPUL SPACE PLACE, V13, P3, DOI 10.1002/psp.447; ROGERS A, 1990, RES AGING, V12, P251, DOI 10.1177/0164027590123001; Sagaza H., 2004, GERIATR GERONTOL INT, V4, pS34; Visaria Pravin, 2001, ECON POLIT WEEKLY, V36, P1967; Walford NS, 2008, POPUL SPACE PLACE, V14, P365, DOI 10.1002/psp.488; [王志宝 Wang Zhibao], 2015, [地理科学, Scientia Geographica Sinica], V35, P822; Yao J, 2000, HUMAN GEOGRAPHY, V15, P24; Yu S., 2000, J CHINA NORMAL U PHI, V32, P94; Zhai Z., 2017, POPUL RES, V41, P60; Zhang NJ, 2012, GERONTOLOGIST, V52, P589, DOI 10.1093/geront/gns105; Zhengzheng Y.J.W.D.W, 2007, CHINESE J POPULATION, V3	28	16	16	22	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0243559	10.1371/journal.pone.0243559	http://dx.doi.org/10.1371/journal.pone.0243559			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY4UJ	33428682	gold, Green Published			2022-12-26	WOS:000630036100012
J	Ahmad, N; Baharom, M; Aizuddin, AN; Ramli, R				Ahmad, Norfazilah; Baharom, Mazni; Aizuddin, Azimatun Noor; Ramli, Rohaya			Sex-related differences in smear-positive pulmonary tuberculosis patients in Kuala Lumpur, Malaysia: Prevalence and associated factors	PLOS ONE			English	Article							RISK; GENDER	Smear-positive pulmonary tuberculosis (PTB) is more infectious compared to smear-negative PTB and have great significance for epidemiology and infection control. The prevalence of smear-positive PTB rarely affects males and females equally. Hence, we aimed to identify the sex-related differences in the prevalence of smear-positive PTB and its associated factors in Kuala Lumpur, Malaysia. A cross-sectional study was conducted using data from the National Tuberculosis Information System (TBIS) from 1 January, 2015, to 31 December, 2019. The study population was selected using simple random sampling from the list of registered PTB patients in TBIS. The criteria for inclusion were all Malaysian adults aged >= 18 years residing in Kuala Lumpur and registered as PTB in TBIS. Factors associated with smear-positive PTB in male and female patients were determined using multiple logistic regression analysis. Overall prevalence of smear-positive PTB was 68.6%, and male patients predominated (71%). The male:female prevalence ratio of smear-positive PTB was 2.4:1. Male patients who worked as machine operators and elementary workers (adjusted odds ratio (aOR) 2.23, 95% confidence interval (CI) 1.24-4.02, p = 0.007), were self-employed (aOR 2.58, 95% CI 1.46-4.56, p = 0.001), lived in a residence categorized as `other' (aOR 2.49, 95% CI 1.28-4.86, p = 0.007) and were smokers (aOR 1.37, 95% CI 1.01-1.87, p = 0.045) had higher odds for smear-positive PTB. Meanwhile, female patients with diabetes mellitus had higher odds for smear-positive PTB (aOR 1.92, 95% CI 1.05-3.54, p = 0.035), while female patients who were healthcare workers had lower odds (aOR 0.33, 95% CI 0.12, 0.94, p = 0.039). The prevalence of smear-positive PTB is higher in males compared to females. The factors associated with smear-positive PTB differed based on sex. The current TB control program, especially on smear-positive PTB, should likely be strategized and stratified by sex.	[Ahmad, Norfazilah; Baharom, Mazni; Aizuddin, Azimatun Noor] Univ Kebangsaan Malaysia, Fac Med, Dept Community Hlth, Kuala Lumpur, Malaysia; [Ramli, Rohaya] Minist Hlth Malaysia, TB & Leprosy Unit, Hlth Dept Fed Terr Kuala Lumpur & Putrajaya, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Kementerian Kesihatan Malaysia	Baharom, M (corresponding author), Univ Kebangsaan Malaysia, Fac Med, Dept Community Hlth, Kuala Lumpur, Malaysia.	mazni_baharom@yahoo.com		Baharom, Mazni/0000-0003-3850-7555; Ahmad, Dr. Norfazilah/0000-0003-4964-8652				Abd Wahab F, 2016, MALAYS J MED SCI, V23, P25, DOI 10.21315/mjms2016.23.6.3; Abedi Siavosh, 2019, Indian J Tuberc, V66, P353, DOI 10.1016/j.ijtb.2017.01.004; Ahmad T, 2016, EGYPT J CHEST DIS TU, V65, P461, DOI 10.1016/j.ejcdt.2015.12.004; Aizuddin AN, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6871-5; Al-Darraji HAA, 2016, TROP MED INT HEALTH, V21, P1049, DOI 10.1111/tmi.12726; Atif M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-399; Azit NA, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7814-x; Babalik A, 2012, TUBERK TORAK, V60, P32, DOI 10.5578/tt.3030; Baloch S, 2013, ELIXIR HUMAN PHYSIO, V60, P16447; Boyce C, 2015, CHECKLIST INTEGRATIN; Cakar B, 2013, TUBERK TORAK, V61, P327, DOI 10.5578/tt.6094; Centers for Disease Control and Prevention, 2013, TRANSMISSION PATHOGE; Chan MW, 2019, SE ASIAN J TROPICAL, V50; CHANG FY, 1995, DIABETES RES CLIN PR, V28, P137, DOI 10.1016/0168-8227(95)00168-8; Choe SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196719; Dara M, 2015, INT J INFECT DIS, V32, P111, DOI 10.1016/j.ijid.2014.12.029; Department of Statistics Malaysia, 2018, DEP STAT MAL OFF POR; Dhanaraj B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124260; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; El-Hamid NA, 2007, EGYPTIAN J MED MICRO, V16, P251; Hassan M R, 2005, Bangladesh Med Res Counc Bull, V31, P7; Hermosilla S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172942; Institute for Public Health. National Health Morbidity Survey, 2015, NONC DIS RISK FACT O; Ismail I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073250; Jimenez-Corona ME, 2006, THORAX, V61, P348, DOI 10.1136/thx.2005.049452; Liew SM, 2019, ASIA-PAC J PUBLIC HE, V31, P61, DOI 10.1177/1010539518817980; Malaysian Prison Department, 2018, JUMLAH BANDUAN SABIT; Marcoa R, 2018, PULMONOLOGY, V24, P199, DOI 10.1016/j.pulmoe.2018.03.004; Martin-Sanchez M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215322; Matsumoto Kenji, 2012, Kekkaku, V87, P541; McLean D, 2017, NEW ZEAL MED J, V130, P78; Ministry of Health Malaysia, 2018, B SEKTOR TIBI KUSTA; Ministry of Human Resources, 2013, MAL STAND CLASS OCC; Ministry of Women Family and Community Development, 2016, STAT WOM FAM COMM 20; Nhamoyebonde S, 2014, J INFECT DIS, V209, pS100, DOI 10.1093/infdis/jiu147; Rahmanian K, 2013, BIOCH MOL BIOL, V1; Selangor Town And Country Planning Department, 2010, MAN GUID SEL STAT PL; Shafee M, 2014, PAK J MED SCI, V30, P36, DOI 10.12669/pjms.301.4129; Uplekar M, 1999, GENDER TUBERCULOSIS; WHO, 2020, GLOB TUB REP; World Health Organization, 2013, DEFINITIONS REPORTIN; Yarahmadi Aliakbar, 2013, Tanaffos, V12, P34	43	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0245304	10.1371/journal.pone.0245304	http://dx.doi.org/10.1371/journal.pone.0245304			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4OF	33417609	Green Published, gold			2022-12-26	WOS:000630020100026
J	Al-Akhrass, H; Conway, JRW; Poulsen, ASA; Paatero, I; Kaivola, J; Padzik, A; Andersen, OM; Ivaska, J				Al-Akhrass, Hussein; Conway, James R. W.; Poulsen, Annemarie Svane Aavild; Paatero, Ilkka; Kaivola, Jasmin; Padzik, Artur; Andersen, Olav M.; Ivaska, Johanna			A feed-forward loop between SorLA and HER3 determines heregulin response and neratinib resistance	ONCOGENE			English	Article							AMYLOID PRECURSOR PROTEIN; BREAST-CANCER; NERVOUS-SYSTEM; INHIBITION; TRASTUZUMAB; CONTRIBUTES; TRAFFICKING; FULVESTRANT; EXPRESSION; METASTASES	Current evidence indicates that resistance to the tyrosine kinase-type cell surface receptor (HER2)-targeted therapies is frequently associated with HER3 and active signaling via HER2-HER3 dimers, particularly in the context of breast cancer. Thus, understanding the response to HER2-HER3 signaling and the regulation of the dimer is essential to decipher therapy relapse mechanisms. Here, we investigate a bidirectional relationship between HER2-HER3 signaling and a type-1 transmembrane sorting receptor, sortilin-related receptor (SorLA; SORL1). We demonstrate that heregulin-mediated signaling supports SorLA transcription downstream of the mitogen-activated protein kinase pathway. In addition, we demonstrate that SorLA interacts directly with HER3, forming a trimeric complex with HER2 and HER3 to attenuate lysosomal degradation of the dimer in a Ras-related protein Rab4-dependent manner. In line with a role for SorLA in supporting the stability of the HER2 and HER3 receptors, loss of SorLA compromised heregulin-induced cell proliferation and sensitized metastatic anti-HER2 therapy-resistant breast cancer cells to neratinib in cancer spheroids in vitro and in vivo in a zebrafish brain xenograft model.	[Al-Akhrass, Hussein; Conway, James R. W.; Paatero, Ilkka; Kaivola, Jasmin; Padzik, Artur; Ivaska, Johanna] Univ Turku, Turku Biosci Ctr, FI-20520 Turku, Finland; [Al-Akhrass, Hussein; Conway, James R. W.; Paatero, Ilkka; Kaivola, Jasmin; Padzik, Artur; Ivaska, Johanna] Abo Akad Univ, FI-20520 Turku, Finland; [Poulsen, Annemarie Svane Aavild; Andersen, Olav M.] Aarhus Univ, Dept Biomed, Danish Res Inst Translat Neurosci DANDRITE Nord E, Aarhus, Denmark	University of Turku; Abo Akademi University; Aarhus University	Al-Akhrass, H; Ivaska, J (corresponding author), Univ Turku, Turku Biosci Ctr, FI-20520 Turku, Finland.; Al-Akhrass, H; Ivaska, J (corresponding author), Abo Akad Univ, FI-20520 Turku, Finland.	hussein.al-akhrass@utu.fi; joivaska@utu.fi		Kaivola, Jasmin/0000-0002-1437-1828; Ivaska, Johanna/0000-0002-6295-6556; Al-Akhrass, Hussein/0000-0002-9630-3000	Academy of Finland [312517]; Academy of Finland CoE for Translational Cancer Biology; European Research Council CoG grant [615258]; Sigrid Juselius Foundation; Finnish Cancer Organization; Finnish Cultural Foundation Central Fund [190150]; European Union's Horizon 2020 research and innovation program under Marie Sklodowska-Curie grant [841973]; Independent Research Fund Denmark [DFF-4004-00371]; TuDMM Doctoral Program, University of Turku	Academy of Finland(Academy of Finland); Academy of Finland CoE for Translational Cancer Biology; European Research Council CoG grant; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Organization; Finnish Cultural Foundation Central Fund; European Union's Horizon 2020 research and innovation program under Marie Sklodowska-Curie grant; Independent Research Fund Denmark; TuDMM Doctoral Program, University of Turku	We thank J. Siivonen and P. Laasola for technical assistance. H. Hamidi is acknowledged for illustrations and editing of the manuscript. The Ivaska laboratory is acknowledged for lively discussions and critical feedback on the manuscript. Guillaume Jacquemet, Jukka Westermarck, Majid Momeny, and Patrick Brest are acknowledged for critical reading of the manuscript. The Cell Imaging and Cytometry and Genome Editing core facilities (Turku Bioscience Centre, University of Turku and Abo Akademi University and Biocenter, Finland); the EuroBioimaging node in Turku and the Zebrafish core facility (Turku Bioscience Centre, University of Turku and Abo Akademi University) are acknowledged for services, instrumentation, and expertise. This study was supported by the Academy of Finland (J. Ivaska grant 312517), the Academy of Finland CoE for Translational Cancer Biology (J. Ivaska), the European Research Council CoG grant 615258 (J. Ivaska), the Sigrid Juselius Foundation (J. Ivaska) and the Finnish Cancer Organization (J. Ivaska). H. AlAkhrass has been supported by the Finnish Cultural Foundation Central Fund 190150. J.R.W. Conway has been supported by the European Union's Horizon 2020 research and innovation program under Marie Sklodowska-Curie grant agreement 841973. O.M. Andersen has been supported by The Independent Research Fund Denmark grant DFF-4004-00371. J. Kaivola has been supported by TuDMM Doctoral Program, University of Turku.	Al-Akhrass H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01172-5; Amin DN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000389; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Baselga J, 2017, LANCET ONCOL, V18, P904, DOI 10.1016/S1470-2045(17)30376-5; Bertelsen V, 2014, MEMBRANES, V4, P424, DOI 10.3390/membranes4030424; Boulbes DR, 2015, BREAST CANCER RES TR, V151, P501, DOI 10.1007/s10549-015-3414-3; Caldieri G, 2018, PROG MOL SUBCELL BIO, V57, P235, DOI 10.1007/978-3-319-96704-2_9; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Croucher DR, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf0793; Ding Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06651-x; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fazio M, 2020, NAT REV CANCER, V20, P263, DOI 10.1038/s41568-020-0252-3; Fjorback AW, 2012, J NEUROSCI, V32, P1467, DOI 10.1523/JNEUROSCI.2272-11.2012; Freal A, 2019, NEURON, V104, P305, DOI 10.1016/j.neuron.2019.07.029; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Gijsen M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000563; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Hutcheson IR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2848; Jacobsen L, 2002, FEBS LETT, V511, P155, DOI 10.1016/S0014-5793(01)03299-9; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kang JC, 2014, MABS-AUSTIN, V6, P340, DOI 10.4161/mabs.27658; Kodack DP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4682; Kodack DP, 2015, CANCER CELL, V27, P163, DOI 10.1016/j.ccell.2015.01.001; Kodack DP, 2012, P NATL ACAD SCI USA, V109, pE3119, DOI 10.1073/pnas.1216078109; Liu JY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07258-y; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mehmedbasic A, 2015, J BIOL CHEM, V290, P3359, DOI 10.1074/jbc.M114.619940; Mei L, 2014, NEURON, V83, P27, DOI 10.1016/j.neuron.2014.06.007; Mishra R, 2020, P A I C C AUT ROBOT, P124, DOI 10.1109/ICCAR49639.2020.9108074; Navaroli DM, 2012, P NATL ACAD SCI USA, V109, pE471, DOI 10.1073/pnas.1115495109; Nusinow DP, 2020, CELL, V180, P387, DOI 10.1016/j.cell.2019.12.023; Olson EM, 2013, ANN ONCOL, V24, P1526, DOI 10.1093/annonc/mdt036; Paatero I, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.3027; Parachoniak CA, 2011, DEV CELL, V20, P751, DOI 10.1016/j.devcel.2011.05.007; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Peuhu E, 2017, DEVELOPMENT, V144, P4103, DOI 10.1242/dev.154229; Pietila M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10275-0; Research C for DE and, 2020, FDA APPR NER MET HER; Rhost S, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-1060-5; Roselli S, 2015, ONCOTARGET, V6, P10473, DOI 10.18632/oncotarget.3401; Sato T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127360; Schmidt V, 2016, J CLIN INVEST, V126, P2706, DOI 10.1172/JCI84708; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Small SA, 2015, NAT REV NEUROSCI, V16, P126, DOI 10.1038/nrn3896; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Tubbesing K, 2020, MOL CANCER RES, P19; Vaught DB, 2012, CANCER RES, V72, P2672, DOI 10.1158/0008-5472.CAN-11-3594; Wang CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8597; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Willnow TE, 2010, REV NEUROSCIENCE, V21, P315; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Xia WL, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3480; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Zhang SY, 2013, CANCER RES, V73, P5764, DOI 10.1158/0008-5472.CAN-12-1803; Zhang YQ, 2016, CANCER LETT, V382, P176, DOI 10.1016/j.canlet.2016.08.026	65	10	10	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2021	40	7					1300	1317		10.1038/s41388-020-01604-5	http://dx.doi.org/10.1038/s41388-020-01604-5		JAN 2021	18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QK0LS	33420373	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000607346000002
J	Kosuge, H; Nakakido, M; Nagatoishi, S; Fukuda, T; Bando, Y; Ohnuma, S; Tsumoto, K				Kosuge, Hirofumi; Nakakido, Makoto; Nagatoishi, Satoru; Fukuda, Tetsuya; Bando, Yasuhiko; Ohnuma, Shin-ichi; Tsumoto, Kouhei			Proteomic identification and validation of novel interactions of the putative tumor suppressor PRELP with membrane proteins including IGFI-R and p75NTR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH REPEAT; NERVE GROWTH-FACTOR; STATISTICAL-MODEL; DECORIN; PROTEOGLYCANS; RECEPTOR; INSULIN; BINDS; PROLIFERATION; ANTAGONIST	Proline and arginine-rich end leucine-rich repeat protein (PRELP) is a member of the small leucine-rich repeat proteoglycans (SLRPs) family. Levels of PRELP mRNA are downregulated in many types of cancer, and PRELP has been reported to have suppressive effects on tumor cell growth, although the molecular mechanism has yet to be fully elucidated. Given that other SLRPs regulate signaling pathways through interactions with various membrane proteins, we reasoned that PRELP likely interacts with membrane proteins to maintain cellular homeostasis. To identify membrane proteins that interact with PRELP, we carried out coimmunoprecipitation coupled with mass spectrometry (CoIP-MS). We prepared membrane fractions from Expi293 cells transfected to overexpress FLAG-tagged PRELP or control cells and analyzed samples precipitated with anti-FLAG antibody by mass spectrometry. Comparison of membrane proteins in each sample identified several that seem to interact with PRELP; among them, we noted two growth factor receptors, insulin-like growth factor I receptor (IGFI-R) and low-affinity nerve growth factor receptor (p75NTR), interactions with which might help to explain PRELP's links to cancer. We demonstrated that PRELP directly binds to extracellular domains of these two growth factor receptors with low micromolar affinities by surface plasmon resonance analysis using recombinant proteins. Furthermore, cell-based analysis using recombinant PRELP protein showed that PRELP suppressed cell growth and affected cell morphology of A549 lung carcinoma cells, also at micromolar concentration. These results suggest that PRELP regulates cellular functions through interactions with IGFI-R and p75NTR and provide a broader set of candidate partners for further exploration.	[Kosuge, Hirofumi; Nakakido, Makoto; Tsumoto, Kouhei] Univ Tokyo, Sch Engn, Tokyo, Japan; [Nagatoishi, Satoru; Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Fukuda, Tetsuya; Bando, Yasuhiko] Biosys Technol, Tokyo, Japan; [Ohnuma, Shin-ichi] UCL, Inst Ophthalmol, London, England	University of Tokyo; University of Tokyo; University of London; University College London	Tsumoto, K (corresponding author), Univ Tokyo, Sch Engn, Tokyo, Japan.; Tsumoto, K (corresponding author), Univ Tokyo, Inst Med Sci, Tokyo, Japan.	tsumoto@bioeng.t.u-tokyo.ac.jp	Satoru, NAGATOISHI/AAY-8198-2021	Satoru, NAGATOISHI/0000-0002-0794-3963	Japan Society for the Promotion of Science [16H02420, 19H05766, 18H02082]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research of Japan Society for the Promotion of Science (grant no. 16H02420 and 19H05766 to K. T. and 18H02082 to S. N.).	Adriaenssens E, 2008, CANCER RES, V68, P346, DOI 10.1158/0008-5472.CAN-07-1183; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becker K, 2018, VET PATHOL, V55, P786, DOI 10.1177/0300985818781930; Bengtsson E, 2002, J BIOL CHEM, V277, P15061, DOI 10.1074/jbc.M108285200; Bengtsson E, 2000, J BIOL CHEM, V275, P40695, DOI 10.1074/jbc.M007917200; Bengtsson E, 2016, BIOCHEM J, V473, P1153, DOI 10.1042/BCJ20160095; Borch J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O110.006775; Bothwell M., 2019, F1000RES, V8; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Brandan E, 2006, J BIOL CHEM, V281, P31562, DOI 10.1074/jbc.M602919200; Cabello-Verrugio C, 2012, J BIOL CHEM, V287, P6773, DOI 10.1074/jbc.M111.312488; Chen HX, 2013, CHIN J CANCER, V32, P242, DOI 10.5732/cjc.012.10263; Dellett M, 2012, DEV GROWTH DIFFER, V54, P327, DOI 10.1111/j.1440-169X.2012.01339.x; Descamps S, 2001, J BIOL CHEM, V276, P17864, DOI 10.1074/jbc.M010499200; Edwards IJ, 2012, NAT REV UROL, V9, P196, DOI 10.1038/nrurol.2012.19; Furstenberger G, 2002, LANCET ONCOL, V3, P298, DOI 10.1016/S1470-2045(02)00731-3; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Hakuno F, 2018, J MOL ENDOCRINOL, V61, pT69, DOI 10.1530/JME-17-0311; Happonen KE, 2012, J BIOL CHEM, V287, P8092, DOI 10.1074/jbc.M111.291476; Hayashi S, 2015, J CELL SCI, V128, P1455, DOI 10.1242/jcs.166306; Hong RQ, 2020, J CANCER, V11, P6376, DOI 10.7150/jca.46309; Hopper JTS, 2012, ANAL BIOCHEM, V421, P788, DOI 10.1016/j.ab.2011.10.034; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Iozzo RV, 2011, J BIOL CHEM, V286, P34712, DOI 10.1074/jbc.M111.262766; Kamal AM, 2019, MOL CELL PROTEOMICS, V18, P1732, DOI 10.1074/mcp.RA119.001377; Kavran JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03772; Kawamura T, 2010, J PROTEOMICS, V73, P1089, DOI 10.1016/j.jprot.2009.11.011; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khan GA, 2011, MOL ENDOCRINOL, V25, P1431, DOI 10.1210/me.2010-0426; Kim SY, 2011, CELL ADHES MIGR, V5, P97, DOI 10.4161/cam.5.2.14374; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Lewis M, 2003, AGEING RES REV, V2, P95, DOI 10.1016/S1568-1637(02)00044-2; Luehders K, 2015, DEVELOPMENT, V142, P3351, DOI 10.1242/dev.124438; Molloy Niamh H, 2011, Cancers (Basel), V3, P510, DOI 10.3390/cancers3010510; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ohta K, 2011, P NATL ACAD SCI USA, V108, P14962, DOI 10.1073/pnas.1100513108; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Papadaki V, 2020, CANCERS, V12, DOI 10.3390/cancers12113362; Pietraszek-Gremplewicz K, 2019, MATRIX BIOL, V75-76, P271, DOI 10.1016/j.matbio.2017.12.006; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rucci N, 2013, J BONE MINER RES, V28, P1912, DOI 10.1002/jbmr.1951; Rucci N, 2009, J CELL BIOL, V187, P669, DOI 10.1083/jcb.200906014; Scalf M, 2000, ANAL CHEM, V72, P52, DOI 10.1021/ac990878c; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Urner LH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14424-8; Werner H, 2019, EXPERT OPIN INV DRUG, V28, P1101, DOI 10.1080/13543784.2019.1694660; Wu CC, 2003, NAT BIOTECHNOL, V21, P532, DOI 10.1038/nbt819; Xie HW, 2006, J PROTEOME RES, V5, P1003, DOI 10.1021/pr050472i; Yin H, 2016, ANNU REV BIOMED ENG, V18, P51, DOI 10.1146/annurev-bioeng-092115-025322; Zilberberg A, 2004, J BIOL CHEM, V279, P17535, DOI 10.1074/jbc.M311292200; Zougman A, 2014, PROTEOMICS, V14, P1006, DOI 10.1002/pmic.201300553	55	3	4	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100278	10.1016/j.jbc.2021.100278	http://dx.doi.org/10.1016/j.jbc.2021.100278			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33428936	gold, Green Published			2022-12-26	WOS:000672866400254
J	Ojala, KS; Ginebaugh, SP; Wu, M; Miller, EW; Ortiz, G; Covarrubias, M; Meriney, SD				Ojala, Kristine S.; Ginebaugh, Scott P.; Wu, Man; Miller, Evan W.; Ortiz, Gloria; Covarrubias, Manuel; Meriney, Stephen D.			A high-affinity, partial antagonist effect of 3,4-diaminopyridine mediates action potential broadening and enhancement of transmitter release at NMJs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EATON-MYASTHENIC-SYNDROME; GATED K+ CHANNELS; CALCIUM-CHANNELS; NEUROTRANSMITTER RELEASE; POTASSIUM CHANNELS; DIHYDROPYRIDINE SENSITIVITY; SYNAPTIC-TRANSMISSION; PASSIVE TRANSFER; KV3 CHANNELS; 4-AMINOPYRIDINE	3,4-Diaminopyridine (3,4-DAP) increases transmitter release from neuromuscular junctions (NMJs), and low doses of 3,4-DAP (estimated to reach similar to 1 mu M in serum) are the Food and Drug Administration (FDA)-approved treatment for neuromuscular weakness caused by Lambert-Eaton myasthenic syndrome. Canonically, 3,4-DAP is thought to block voltage-gated potassium (Kv) channels, resulting in prolongation of the pre-synaptic action potential (AP). However, recent reports have shown that low millimolar concentrations of 3,4-DAP have an off-target agonist effect on the Cav1 subtype ("L-type") of voltage-gated calcium (Cav) channels and have speculated that this agonist effect might contribute to 3,4-DAP effects on transmitter release at the NMJ. To address 3,4-DAP's mechanism(s) of action, we first used the patch-clamp electrophysiology to characterize the concentration-dependent block of 3,4-DAP on the predominant presynaptic Kv channel subtypes found at the mammalian NMJ (Kv3.3 and Kv3.4). We identified a previously unreported high-affinity (1-10 mu M) partial antagonist effect of 3,4-DAP in addition to the well-known low-affinity (0.1-1 mM) antagonist activity. We also showed that 1.5-mu M DAP had no effects on Cav1.2 or Cav2.1 current. Next, we used voltage imaging to show that 1.5- or 100-mu M 3,4-DAP broadened the AP waveform in a dose-dependent manner, independent of Cav1 calcium channels. Finally, we demonstrated that 1.5- or 100-mu M 3,4-DAP augmented transmitter release in a dose-dependent manner and this effect was also independent of Cav1 channels. From these results, we conclude that low micromolar concentrations of 3,4-DAP act solely on Kv channels to mediate AP broadening and enhance transmitter release at the NMJ.	[Ojala, Kristine S.; Ginebaugh, Scott P.; Wu, Man; Meriney, Stephen D.] Univ Pittsburgh, Dept Neurosci, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Miller, Evan W.; Ortiz, Gloria] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Miller, Evan W.; Ortiz, Gloria] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Covarrubias, Manuel] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Jefferson University	Meriney, SD (corresponding author), Univ Pittsburgh, Dept Neurosci, Ctr Neurosci, Pittsburgh, PA 15260 USA.	meriney@pitt.edu		Covarrubias, Manuel/0000-0002-0881-4143; Ginebaugh, Scott/0000-0001-8820-606X; Meriney, Stephen/0000-0002-2005-9726	NIH [NS090644, F31 NS106753, NS098088]; MDA grant [603852]; Cure SMA grant [MER2021]; Gilliam Fellowship from the Howard Hughes Medical Institute; Farber Discovery Fund; Jefferson Synaptic Biology Center	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MDA grant; Cure SMA grant; Gilliam Fellowship from the Howard Hughes Medical Institute; Farber Discovery Fund; Jefferson Synaptic Biology Center	This work was supported by the NIH grant NS090644, MDA grant 603852, and Cure SMA grant MER2021 to S. D. M., NIH F31 NS106753 to K. S. O., a Gilliam Fellowship from the Howard Hughes Medical Institute to G. O., NIH grant NS098088 to E. W. M, and grants from the Farber Discovery Fund and Jefferson Synaptic Biology Center to M. C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alle H, 2011, J NEUROSCI, V31, P8001, DOI 10.1523/JNEUROSCI.0972-11.2011; ATCHISON WD, 1989, J PHARMACOL EXP THER, V251, P672; ATCHISON WD, 1987, BRAIN RES, V419, P315, DOI 10.1016/0006-8993(87)90599-3; Banwell BL, 2004, NEUROMUSCULAR DISORD, V14, P202, DOI 10.1016/j.nmd.2003.11.004; Bonanno S, 2018, SAGE OPEN MED, V6, DOI 10.1177/2050312118819013; Brooke RE, 2004, EUR J NEUROSCI, V20, P3313, DOI 10.1111/j.1460-9568.2004.03730.x; CASTLE NA, 1994, MOL PHARMACOL, V45, P1242; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Cruz PMR, 2019, BRAIN, V142, P1547, DOI 10.1093/brain/awz107; Cruz PMR, 2016, J NEUROL NEUROSUR PS, V87, P802, DOI 10.1136/jnnp-2016-313163; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; FDA, 2019, FDA APPR 1 TREATM CH; FDA, 2018, FDA APPR 1 TREATM LA; Flet L, 2010, J NEUROL, V257, P937, DOI 10.1007/s00415-009-5442-6; Flink MT, 2002, J PHYSIOL-LONDON, V543, P567, DOI 10.1113/jphysiol.2002.021048; Ginebaugh SP, 2020, J NEUROSCI, V40, P3504, DOI 10.1523/JNEUROSCI.2415-19.2020; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Haroldsen PE, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.99; Haroldsen PE, 2015, CLIN THER, V37, P1555, DOI 10.1016/j.clinthera.2015.05.498; Heredia DJ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00276; Huang YL, 2015, J AM CHEM SOC, V137, P10767, DOI 10.1021/jacs.5b06644; Ishida N, 2015, INT J CLIN PHARM TH, V53, P674, DOI 10.5414/CP202133; Kaczmarek LK, 2017, PHYSIOL REV, V97, P1431, DOI 10.1152/physrev.00002.2017; KIRSCH GE, 1993, J GEN PHYSIOL, V102, P797, DOI 10.1085/jgp.102.5.797; KIRSCH GE, 1978, BIOPHYS J, V22, P507, DOI 10.1016/S0006-3495(78)85503-9; LAMBERT EH, 1956, AM J PHYSIOL, V187, P612; LANG B, 1983, J PHYSIOL-LONDON, V344, P335, DOI 10.1113/jphysiol.1983.sp014943; LEMEIGNAN M, 1984, BRAIN RES, V304, P166, DOI 10.1016/0006-8993(84)90875-8; Li L, 2014, MOL PHARMACOL, V86, P760, DOI 10.1124/mol.114.095505; Lindquist S, 2014, EXPERT OPIN ORPHAN D, V2, P293, DOI 10.1517/21678707.2014.887464; Lindquist S, 2011, NEUROPSYCH DIS TREAT, V7, P341, DOI 10.2147/NDT.S10464; LUNEAU CJ, 1991, P NATL ACAD SCI USA, V88, P3932, DOI 10.1073/pnas.88.9.3932; Luo FJ, 2015, J NEUROPHYSIOL, V113, P2480, DOI 10.1152/jn.00879.2014; Luo FJ, 2011, J NEUROSCI, V31, P11268, DOI 10.1523/JNEUROSCI.1394-11.2011; Mainero C, 2004, NEUROLOGY, V62, P2044, DOI 10.1212/01.WNL.0000129263.14219.A8; MCLACHLAN EM, 1981, J PHYSIOL-LONDON, V311, P307, DOI 10.1113/jphysiol.1981.sp013586; Meriney SD, 1996, ANN NEUROL, V40, P739, DOI 10.1002/ana.410400510; Meriney SD, 2018, J BIOL CHEM, V293, P16100, DOI 10.1074/jbc.L118.005425; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; MOLGO J, 1980, EUR J PHARMACOL, V61, P25, DOI 10.1016/0014-2999(80)90378-7; Muqeem T, 2018, J NEUROSCI, V38, P3729, DOI 10.1523/JNEUROSCI.3212-17.2018; NAGEL A, 1988, ANN NEUROL, V24, P552, DOI 10.1002/ana.410240412; Natera-de Benito D, 2016, NEUROMUSCULAR DISORD, V26, P789, DOI 10.1016/j.nmd.2016.08.005; Natera-de Benito D, 2016, NEUROMUSCULAR DISORD, V26, P153, DOI 10.1016/j.nmd.2015.10.013; Ng F, 2017, MUSCLE NERVE, V55, P223, DOI 10.1002/mus.25208; Oh SJ, 2016, MUSCLE NERVE, V53, P20, DOI 10.1002/mus.24921; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PANCRAZIO JJ, 1989, NEUROSCIENCE, V30, P215, DOI 10.1016/0306-4522(89)90366-7; POLMAN CH, 1994, ARCH NEUROL-CHICAGO, V51, P292, DOI 10.1001/archneur.1994.00540150090022; RETTIG J, 1992, EMBO J, V11, P2473, DOI 10.1002/j.1460-2075.1992.tb05312.x; Rosenthal JC, 1996, J GEN PHYSIOL, V108, P207, DOI 10.1085/jgp.108.3.207; Rowan MJM, 2017, CELL REP, V18, P2018, DOI 10.1016/j.celrep.2017.01.068; Rowan MJM, 2016, NEURON, V91, P370, DOI 10.1016/j.neuron.2016.05.035; Rowan MJM, 2014, J NEUROSCI, V34, P6611, DOI 10.1523/JNEUROSCI.4208-13.2014; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Sanders DB, 1998, ANN NY ACAD SCI, V841, P811, DOI 10.1111/j.1749-6632.1998.tb11022.x; Sanders DB, 2018, MUSCLE NERVE, V57, P561, DOI 10.1002/mus.26052; Schaarschmidt G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006168; Sheean GL, 1998, BRAIN, V121, P967, DOI 10.1093/brain/121.5.967; Sheng ZH, 1998, J BIOENERG BIOMEMBR, V30, P335, DOI 10.1023/A:1021985521748; Shieh Perry, 2019, J Clin Neuromuscul Dis, V20, P111, DOI 10.1097/CND.0000000000000239; SOSA MA, 1993, NEUROSCI LETT, V157, P235, DOI 10.1016/0304-3940(93)90745-7; STEPHENS GJ, 1994, J PHYSIOL-LONDON, V477, P187, DOI 10.1113/jphysiol.1994.sp020183; Strupp M, 2017, NEUROL-CLIN PRACT, V7, P65, DOI 10.1212/CPJ.0000000000000321; Tarr TB, 2014, J PHYSIOL-LONDON, V592, P3687, DOI 10.1113/jphysiol.2014.276493; Tarr TB, 2013, J NEUROSCI, V33, P10559, DOI 10.1523/JNEUROSCI.4629-12.2013; Tarr TB, 2013, TRENDS NEUROSCI, V36, P14, DOI 10.1016/j.tins.2012.09.009; Thakkar N, 2017, CPT-PHARMACOMET SYST, V6, P625, DOI 10.1002/psp4.12218; Thurtell MJ, 2012, CURR TREAT OPTION NE, V14, P60, DOI 10.1007/s11940-011-0154-5; Tseng QZ, 2012, P NATL ACAD SCI USA, V109, P1506, DOI 10.1073/pnas.1106377109; Tseng QZ, 2011, LAB CHIP, V11, P2231, DOI 10.1039/c0lc00641f; Urbano FJ, 2002, MOL MEMBR BIOL, V19, P293, DOI 10.1080/0968768021000035087; VEGA-SAENZ DE MIERA E, 1992, P ROY SOC B-BIOL SCI, V248, P9, DOI 10.1098/rspb.1992.0036; VINCENT A, 1989, TRENDS NEUROSCI, V12, P496, DOI 10.1016/0166-2236(89)90109-4; Voelker R, 2019, JAMA-J AM MED ASSOC, V321, P239, DOI 10.1001/jama.2018.21321; Wirtz PW, 2009, CLIN PHARMACOL THER, V86, P44, DOI 10.1038/clpt.2009.35; Wirtz PW, 2010, EXPERT REV CLIN IMMU, V6, P867, DOI 10.1586/ECI.10.57; Witting N, 2015, CLIN NEUROL NEUROSUR, V130, P168, DOI 10.1016/j.clineuro.2015.01.010; Wu M, 2018, NEUROPHARMACOLOGY, V131, P176, DOI 10.1016/j.neuropharm.2017.12.022; Wu ZZ, 2018, J BIOL CHEM, V293, P16101, DOI 10.1074/jbc.RL118.005655; Wu ZZ, 2009, J BIOL CHEM, V284, P36453, DOI 10.1074/jbc.M109.075523; Xu YF, 1998, J NEUROPHYSIOL, V80, P1056, DOI 10.1152/jn.1998.80.3.1056; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7; Yoon CH, 2020, ANN PHARMACOTHER, V54, P56, DOI 10.1177/1060028019864574; Zemel BM, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00253	85	7	7	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100302	10.1016/j.jbc.2021.100302	http://dx.doi.org/10.1016/j.jbc.2021.100302			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33465376	Green Published, gold			2022-12-26	WOS:000672866400276
J	Kunz, HE; Dorschner, JM; Berent, TE; Meyer, T; Wang, XW; Jatoi, A; Kumar, R; Lanza, IR				Kunz, Hawley E.; Dorschner, Jessica M.; Berent, Taylor E.; Meyer, Thomas; Wang, Xuewei; Jatoi, Aminah; Kumar, Rajiv; Lanza, Ian R.			Methylarginine metabolites are associated with attenuated muscle protein synthesis in cancer-associated muscle wasting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; protein synthesis; protein turnover; metabolomics; mitochondria; cachexia; ADMA; l-NMMA; skeletal muscle; methylarginines	SKELETAL-MUSCLE; ASYMMETRIC DIMETHYLARGININE; MITOCHONDRIAL FISSION; INSULIN-RESISTANCE; DIAPHRAGM MUSCLE; ENDOGENOUS METHYLARGININES; PLASMA-CONCENTRATIONS; QUALITY-CONTROL; CACHEXIA; DYNAMICS	Cancer cachexia is characterized by reductions in peripheral lean muscle mass. Prior studies have primarily focused on increased protein breakdown as the driver of cancer-associated muscle wasting. Therapeutic interventions targeting catabolic pathways have, however, largely failed to preserve muscle mass in cachexia, suggesting that other mechanisms might be involved. In pursuit of novel pathways, we used untargeted metabolomics to search for metabolite signatures that may be linked with muscle atrophy. We injected 7-week-old C57/BL6 mice with LLC1 tumor cells or vehicle. After 21 days, tumor-bearing mice exhibited reduced body and muscle mass and impaired grip strength compared with controls, which was accompanied by lower synthesis rates of mixed muscle protein and the myofibrillar and sarcoplasmic muscle fractions. Reductions in protein synthesis were accompanied by mitochondrial enlargement and reduced coupling efficiency in tumor-bearing mice. To generate mechanistic insights into impaired protein synthesis, we performed untargeted metabolomic analyses of plasma and muscle and found increased concentrations of two methylarginines, asymmetric dimethylarginine (ADMA) and N-G-monomethyl-l-arginine, in tumor-bearing mice compared with control mice. Compared with healthy controls, human cancer patients were also found to have higher levels of ADMA in the skeletal muscle. Treatment of C2C12 myotubes with ADMA impaired protein synthesis and reduced mitochondrial protein quality. These results suggest that increased levels of ADMA and mitochondrial changes may contribute to impaired muscle protein synthesis in cancer cachexia and could point to novel therapeutic targets by which to mitigate cancer cachexia.	[Kunz, Hawley E.; Lanza, Ian R.] Mayo Clin, Endocrine Res Unit, Div Endocrinol, Dept Internal Med, Rochester, MN 55905 USA; [Dorschner, Jessica M.; Berent, Taylor E.; Meyer, Thomas; Kumar, Rajiv] Mayo Clin, Nephrol & Hypertens Res Unit, Div Nephrol & Hypertens, Dept Internal Med, Rochester, MN 55905 USA; [Wang, Xuewei] Mayo Clin, Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Jatoi, Aminah] Mayo Clin, Dept Med Oncol, Rochester, MN USA; [Kumar, Rajiv] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Dorschner, Jessica M.] Oakland Univa, Auburn Hills, MI USA; [Meyer, Thomas] Amherst Coll, Amherst, MA 01002 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Amherst College	Lanza, IR (corresponding author), Mayo Clin, Endocrine Res Unit, Div Endocrinol, Dept Internal Med, Rochester, MN 55905 USA.; Kumar, R (corresponding author), Mayo Clin, Nephrol & Hypertens Res Unit, Div Nephrol & Hypertens, Dept Internal Med, Rochester, MN 55905 USA.; Kumar, R (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	rkumar@mayo.edu; Lanza.lan@mayo.edu		Wang, Xuewei/0000-0003-3679-7421; Kunz, Hawley/0000-0002-4291-4455; Berent, Taylor/0000-0002-9421-7176; Kumar, Rajiv/0000-0003-3497-3057	Fred C. and Katherine B. Andersen Foundation [T32AR056950]	Fred C. and Katherine B. Andersen Foundation	This work was supported by a grant from the Fred C. and Katherine B. Andersen Foundation (to I. R. L. and R. K.). Dr. Hawley Kunz is supported by T32AR056950.	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Aoyagi T, 2015, WORLD J GASTRO ONCOL, V7, P17, DOI 10.4251/wjgo.v7.i4.17; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Argiles JM, 2015, CURR OPIN CLIN NUTR, V18, P221, DOI 10.1097/MCO.0000000000000164; Argiles JM, 2014, J CACHEXIA SARCOPENI, V5, P279, DOI 10.1007/s13539-014-0154-x; Asp ML, 2010, INT J CANCER, V126, P756, DOI 10.1002/ijc.24784; Aversa Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep30340; Baltgalvis KA, 2010, J APPL PHYSIOL, V109, P1155, DOI 10.1152/japplphysiol.00442.2010; Baracos VE, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2017.105; Berent TE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226440; Biesemann N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27614-8; Blackwell TA, 2018, PHYSIOL GENOMICS, V50, P1071, DOI 10.1152/physiolgenomics.00061.2018; Brown JL, 2018, J CACHEXIA SARCOPENI, V9, P987, DOI 10.1002/jcsm.12354; Brown JL, 2017, J CACHEXIA SARCOPENI, V8, P926, DOI 10.1002/jcsm.12232; Busquets S, 2007, CLIN NUTR, V26, P614, DOI 10.1016/j.clnu.2007.06.005; Cardounel AJ, 2007, J BIOL CHEM, V282, P879, DOI 10.1074/jbc.M603606200; Carson JA, 2016, SEMIN CELL DEV BIOL, V54, P53, DOI 10.1016/j.semcdb.2015.11.005; Castro B, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2237; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Coen PM, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01883; Cold Spring Harbor Press, 2017, COLD SPRING HARB PRO, DOI 10.1101/pdb.rec101428; Craig TA, 2012, MOL ENDOCRINOL, V26, P1630, DOI 10.1210/me.2012-1113; Fontes-Oliveira CC, 2013, BBA-GEN SUBJECTS, V1830, P2770, DOI 10.1016/j.bbagen.2012.11.009; de Castro GS, 2019, CANCERS, V11, DOI 10.3390/cancers11091264; Dev R, 2018, ANN ONCOL, V29, P18, DOI 10.1093/annonc/mdx815; Dodson S, 2011, ANNU REV MED, V62, P265, DOI 10.1146/annurev-med-061509-131248; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; EVANS WK, 1985, CANCER RES, V45, P3347; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Garcia RG, 2007, INT J CARDIOL, V122, P176, DOI 10.1016/j.ijcard.2006.11.058; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Greising SM, 2015, MUSCLE NERVE, V52, P76, DOI 10.1002/mus.24641; Greising SM, 2013, EXP GERONTOL, V48, P881, DOI 10.1016/j.exger.2013.06.001; Guido C, 2012, ONCOTARGET, V3, P798, DOI 10.18632/oncotarget.574; Halle JL, 2019, AM J PHYSIOL-REG I, V317, pR68, DOI 10.1152/ajpregu.00028.2019; Holley AK, 2009, FUTURE ONCOL, V5, P117, DOI 10.2217/14796694.5.1.117; Hou C, 2008, SCIENCE, V322, P736, DOI 10.1126/science.1162302; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jaleel A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1255, DOI 10.1152/ajpendo.90586.2008; Johnson ML, 2015, AGING CELL, V14, P734, DOI 10.1111/acel.12352; Judge SM, 2018, JNCI CANCER SPECT, V2, DOI 10.1093/jncics/pky043; Judge SM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-997; Julienne CM, 2012, J CACHEXIA SARCOPENI, V3, P265, DOI 10.1007/s13539-012-0071-9; Kielstein JT, 2003, CIRCULATION, V107, P1891, DOI 10.1161/01.CIR.0000060496.23144.A7; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, pC881, DOI 10.1152/ajpcell.00104.2005; Krumschnabel Gerhard, 2015, Methods Mol Biol, V1264, P245, DOI 10.1007/978-1-4939-2257-4_22; Lalia AZ, 2017, AGING-US, V9, P1096, DOI 10.18632/aging.101210; Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235; Lee DE, 2017, PHYSIOL GENOMICS, V49, P253, DOI 10.1152/physiolgenomics.00006.2017; Lee W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20549-0; Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Maas R, 2007, CRIT CARE MED, V35, P1876, DOI 10.1097/01.CCM.0000277038.11630.71; Marchenko ND, 2014, MOL CELL ONCOL, V1, DOI 10.1080/23723548.2014.955995; Marliss EB, 2006, DIABETOLOGIA, V49, P351, DOI 10.1007/s00125-005-0066-6; Marzetti E, 2017, EXP GERONTOL, V87, P92, DOI 10.1016/j.exger.2016.10.003; Miyamoto Y, 2016, CLIN CANCER RES, V22, P3999, DOI 10.1158/1078-0432.CCR-16-0495; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Padrao AI, 2013, INT J BIOCHEM CELL B, V45, P1399, DOI 10.1016/j.biocel.2013.04.014; Penna F, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7153610; Perry CGR, 2011, BIOCHEM J, V437, P215, DOI 10.1042/BJ20110366; Picard M, 2013, AM J PHYSIOL-REG I, V304, pR393, DOI 10.1152/ajpregu.00584.2012; Pope AJ, 2009, PHARMACOL RES, V60, P461, DOI 10.1016/j.phrs.2009.07.016; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Ryan ZC, 2016, J BIOL CHEM, V291, P1514, DOI 10.1074/jbc.M115.684399; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shum AMY, 2012, AGING-US, V4, P133, DOI 10.18632/aging.100436; Shutt TE, 2013, BBA-MOL CELL RES, V1833, P417, DOI 10.1016/j.bbamcr.2012.05.024; Sieck DC, 2012, RESP PHYSIOL NEUROBI, V180, P88, DOI 10.1016/j.resp.2011.10.015; Smuder AJ, 2010, FREE RADICAL BIO MED, V49, P1152, DOI 10.1016/j.freeradbiomed.2010.06.025; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sydow K, 2005, VASC MED, V10, pS35, DOI 10.1191/1358863x05vm604oa; Tardif N, 2013, AM J CLIN NUTR, V98, P1485, DOI 10.3945/ajcn.113.063859; TAYEK JA, 1992, J AM COLL NUTR, V11, P445; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Tsoli M, 2013, TRENDS ENDOCRIN MET, V24, P174, DOI 10.1016/j.tem.2012.10.006; Tzika AA, 2013, INT J ONCOL, V43, P886, DOI 10.3892/ijo.2013.1998; van der Ende M, 2018, BBA-REV CANCER, V1870, P137, DOI 10.1016/j.bbcan.2018.07.008; VanderVeen BN, 2017, OXID MED CELL LONGEV, V2017, P1, DOI 10.1155/2017/3292087; Vitorino R, 2015, CURR OPIN CLIN NUTR, V18, P226, DOI 10.1097/MCO.0000000000000161; Wang RX, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7569127; Wang WL, 2010, BIOCHEM BIOPH RES CO, V400, P587, DOI 10.1016/j.bbrc.2010.08.108; White JP, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-14; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang LQ, 2009, FREE RADICAL BIO MED, V46, P1500, DOI 10.1016/j.freeradbiomed.2009.03.001; Zhou JY, 2012, AUTOPHAGY, V8, P1712, DOI 10.4161/auto.21830	100	7	7	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17441	17459		10.1074/jbc.RA120.014884	http://dx.doi.org/10.1074/jbc.RA120.014884			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453990	hybrid, Green Published			2022-12-26	WOS:000603272300006
J	Ermagun, A; Tajik, N				Ermagun, Alireza; Tajik, Nazanin			Recovery patterns and physics of the network	PLOS ONE			English	Article							COMPLEX; RESILIENCE; DYNAMICS	In a progressively interconnected world, the loss of system resilience has consequences for human health, the economy, and the environment. Research has exploited the science of networks to explain the resilience of complex systems against random attacks, malicious attacks, and the localized attacks induced by natural disasters or mass attacks. Little is known about the elucidation of system recovery by the network topology. This study adds to the knowledge of network resilience by examining the nexus of recoverability and network topology. We establish a new paradigm for identifying the recovery behavior of networks and introduce the recoverability measure. Results indicate that the recovery response behavior and the recoverability measure are the function of both size and topology of networks. In small sized networks, the return to recovery exhibits homogeneous recovery behavior over topology, while the return shape is dispersed with an increase in the size of network. A network becomes more recoverable as connectivity measures of the network increase, and less recoverable as accessibility measures of network increase. Overall, the results not only offer guidance on designing recoverable networks, but also depict the recovery nature of networks deliberately following a disruption. Our recovery behavior and recoverability measure has been tested on 16 distinct network topologies. The relevant recovery behavior can be generalized based on our definition for any network topology recovering deliberately.	[Ermagun, Alireza] Mississippi State Univ, Dept Civil & Environm Engn, Mississippi State, MS 39762 USA; [Tajik, Nazanin] Mississippi State Univ, Dept Ind & Syst Engn, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University	Ermagun, A (corresponding author), Mississippi State Univ, Dept Civil & Environm Engn, Mississippi State, MS 39762 USA.	aermagun@cee.msstate.edu						Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; [Anonymous], 2019, FRONTIERS PLANT SCI; Averbakh I, 2017, NETWORKS, V70, P60, DOI 10.1002/net.21750; Bai YN, 2016, SCI REP-UK, V6, DOI 10.1038/srep37749; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bashan A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1705; Berezin Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08934; Boers N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6199; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Chen LC, 2012, TRANSPORT SCI, V46, P109, DOI 10.1287/trsc.1110.0376; Chen PY, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.022805; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; De Corte A, 2016, NETWORKS, V67, P187, DOI 10.1002/net.21673; De Domenico M, 2016, NAT PHYS, V12, P901, DOI 10.1038/nphys3865; De Domenico M, 2014, P NATL ACAD SCI USA, V111, P8351, DOI 10.1073/pnas.1318469111; Duan DL, 2019, P NATL ACAD SCI USA, V116, P22452, DOI 10.1073/pnas.1904421116; Farr RS, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.138701; Fisher L, 2015, NATURE, V518, P35, DOI 10.1038/518035a; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Hu FY, 2016, SCI REP-UK, V6, DOI 10.1038/srep24522; Kim IJ, 2014, NETWORKS, V63, P160, DOI 10.1002/net.21532; Latora V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.015103; Li W, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228702; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Majdandzic A, 2014, NAT PHYS, V10, P34, DOI [10.1038/nphys2819, 10.1038/NPHYS2819]; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; Newman MEJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11863; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Perrings C, 1998, ENVIRON RESOUR ECON, V11, P503, DOI 10.1023/A:1008255614276; Pyrzynska K, 2019, SEP PURIF REV, V48, P65, DOI 10.1080/15422119.2018.1430589; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; Sundar K, 2018, NETWORKS, V71, P302, DOI 10.1002/net.21806; Vass B, 2020, NETWORKS, V75, P340, DOI 10.1002/net.21936; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Vespignani A, 2012, NAT PHYS, V8, P32, DOI 10.1038/nphys2160; Zitnik M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04948-5	41	0	0	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245396	10.1371/journal.pone.0245396	http://dx.doi.org/10.1371/journal.pone.0245396			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465154	gold, Green Published			2022-12-26	WOS:000611969200031
J	Arbelaez, JAV; Giraldo, AS; Villa, GJC; Espinosa, LFV; Gutierrez, MRS; Vargas, G				Valencia Arbelaez, Julian Andres; Soto Giraldo, Alberto; Villa, Gabriel Jaime Castano; Espinosa, Luis Fernando Vallejo; Salazar Gutierrez, Melba Ruth; Vargas, German			Population dynamics of sugarcane borers, Diatraea spp., under different climatic scenarios in Colombia	PLOS ONE			English	Article							TEMPERATURE-DEPENDENT DEVELOPMENT; SPECIES DISTRIBUTIONS; HEAT ACCUMULATION; RATE MODEL; FUTURE; LEPIDOPTERA; PATTERNS; MAXIMUM	Seasonal temperature and precipitation patterns on a global scale are main factors to which insects and plants adapt through natural selection, although periodic outbreaks in insect populations may occur in areas where they had not been previously reported, a phenomenon considered as a consequence of global warming. In this study, we estimate the distribution of sugarcane borers, Diatraea spp., under different climate scenarios (rcp26, rcp45, rcp60 and rcp85.) Insects were collected weekly in four sugarcane fields from four different towns in the department of Caldas (Colombia) during 2017, and also in several sugarcane fields in the Cauca River Valley (CRV) between 2010 and 2017. The influence of climatic variables on different agro-ecological zones of the CRV sugarcane fields was defined by climatic data between 2010 and 2017 (maximum and minimum daily temperatures, and accumulated precipitation). The estimate of an optimal niche for Diatraea spp. includes temperatures between 20 degrees C and 23 degrees C, accumulated annual rainfall between 1200 and 1500 mm, dry months with precipitations below 50 mm, slopes of less than 0.05 degrees, crop heterogeneity with an index of 0.2 and primary production values of 1.0. Data suggests Diatraea population is considerably influenced by adverse climate change effects, under the premise of an increase in local and global temperatures, reducing its population niches as well as the number of individuals.	[Valencia Arbelaez, Julian Andres] Corp Univ Santa Rosa de Cabal, Fac Ciencias Agr, Santa Rosa De Cabal, Risaralda, Colombia; [Soto Giraldo, Alberto; Espinosa, Luis Fernando Vallejo] Univ Caldas, Fac Ciencias Agr, Manizales, Caldas, Colombia; [Villa, Gabriel Jaime Castano] Univ Caldas, Dept Ciencias Nat, Manizales, Caldas, Colombia; [Salazar Gutierrez, Melba Ruth] Washington State Univ, Biol Syst Engn Dept, Prosser, WA USA; [Vargas, German] Ctr Invest Cana Azucar Colombia, Florida, Colombia	Universidad de Caldas; Universidad de Caldas; Washington State University	Arbelaez, JAV (corresponding author), Corp Univ Santa Rosa de Cabal, Fac Ciencias Agr, Santa Rosa De Cabal, Risaralda, Colombia.	julian.valencia@unisarc.edu.co		Valencia Arbelaez, Julian Andres/0000-0002-1873-784X; Vargas, German/0000-0002-8273-0140; Castano-Villa, Gabriel Jaime/0000-0001-5327-8063	Colombian Institute for the Development of Science and Technology (COLCIENCIAS) [647]; Colombian Sugarcane Research Center (Centro de Investigacion de la Cana de Azucar de Colombia, Cenicana)	Colombian Institute for the Development of Science and Technology (COLCIENCIAS)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Colombian Sugarcane Research Center (Centro de Investigacion de la Cana de Azucar de Colombia, Cenicana)	The Colombian Institute for the Development of Science and Technology (COLCIENCIAS) provided funding for this study through grant program number 647. The Colombian Sugarcane Research Center (Centro de Investigacion de la Cana de Azucar de Colombia, Cenicana) provided support for this study in the form of use of infrastructure and laboratories.	ABRAMI G, 1972, ECOLOGY, V53, P893, DOI 10.2307/1934305; ALLEN PM, 1976, P NATL ACAD SCI USA, V73, P665, DOI 10.1073/pnas.73.3.665; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2016, EVIDENCE, V8, pe1000; BARBOSA J C, 1982, Cientifica (Jaboticabal), V10, P181; BASKERVILLE GL, 1969, ECOLOGY, V50, P514, DOI 10.2307/1933912; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Belehradek J, 1935, PROTOPLASMA MONOGR, V8; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; Candolle AP, 1855, GEOGRAPHIE BOT RAISO; Carvalho H, 2011, 2011 INTERNATIONAL CONFERENCE ON INSTRUMENTATION, MEASUREMENT, CIRCUITS AND SYSTEMS (ICIMCS 2011), VOL 3: COMPUTER-AIDED DESIGN, MANUFACTURING AND MANAGEMENT, P61; Chen C, 2014, B ENTOMOL RES, V104, P12, DOI 10.1017/S0007485313000266; Davidson J, 1944, J ANIM ECOL, V13, P26, DOI 10.2307/1326; Edelstein JD, 2010, ARTROPOB SISTEMA SIM; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Estay P, 2009, USO GRADOS DIA EFICA, P14; Estrada-Pena A, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-43; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Foody GM, 2008, PROG PHYS GEOG, V32, P223, DOI 10.1177/0309133308094656; Franklin J, 1995, PROG PHYS GEOG, V19, P474, DOI 10.1177/030913339501900403; Gibert P, 2016, BIOL INVASIONS, V18, P1089, DOI 10.1007/s10530-016-1087-4; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HILBERT DW, 1983, ENVIRON ENTOMOL, V12, P1, DOI 10.1093/ee/12.1.1; Hill MP, 2012, AGR FOREST ENTOMOL, V14, P127, DOI 10.1111/j.1461-9563.2011.00544.x; Hoffmann AA, 2008, AUST J EXP AGR, V48, P1481, DOI 10.1071/EA08185; Hulle M, 2010, CR BIOL, V333, P497, DOI 10.1016/j.crvi.2010.03.005; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Janisch E, 1925, PFLUG ARCH GES PHYS, V209, P414, DOI 10.1007/BF01730929; Jaramillo A, 2011, AVANCE TECNICO CENIC, V411; Jaramillo A, 2009, AVANCES TECNICOS 390, P8; Klapwijk Maartje J., 2012, P429; Kocmankova E, 2011, J AGR SCI, V149, P185, DOI 10.1017/S0021859610001140; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; Lange CL, 2004, B ENTOMOL RES, V94, P457, DOI 10.1079/BER2004320; Larkin Daniel, 2006, P142; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Marco V. S., 2001, B SOC ENTOMOLOGICA A, V28, P147; Mateo RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055648; Mateo RG, 2011, REV CHIL HIST NAT, V84, P217, DOI 10.4067/S0716-078X2011000200008; Munoz LG, 2012, 76 C NAC CAF INF GER, P148; Nelson WA, 2013, SCIENCE, V341, P796, DOI 10.1126/science.1238477; ARNOLD C. Y., 1960, Proceedings. American Society for Horticultural Science, V76, P682; Pelayo-Villamil P, 2015, DIVERS DISTRIB, V21, P345, DOI 10.1111/ddi.12271; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Perecin D., 1992, REV MATEMATICA ESTAT, V10, P207; Perez-Garcia B, 2013, REV MEX BIODIVERS, V84, P600, DOI 10.7550/rmb.32234; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Reibisch J., 1902, Wissenschaftliche Meeresuntersuchungen, Vvi, P213; Rodriguez A, 2012, IDEAMMETEO1472012; Rojas-Soto OR, 2012, BIODIVERS CONSERV, V21, P2671, DOI 10.1007/s10531-012-0327-x; Romo H, 2013, SHILAP-REV LEPIDOPT, V41, P267; Roy HE, 2012, NONNATIVE SPECIES GR; Rushton SP, 2004, J APPL ECOL, V41, P193, DOI 10.1111/j.0021-8901.2004.00903.x; Sanderson ED, 1913, NH COLL AGR EXP STN, P7; SEVACHERIAN V, 1977, J ECON ENTOMOL, V70, P399, DOI 10.1093/jee/70.4.399; SHARPE PJH, 1977, J THEOR BIOL, V64, P649, DOI 10.1016/0022-5193(77)90265-X; Solis MA, 2016, ZOOKEYS, P73, DOI 10.3897/zookeys.565.6797; Stoeckli S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035723; Swenson NG, 2008, J EVOLUTION BIOL, V21, P421, DOI 10.1111/j.1420-9101.2007.01487.x; Vargas G, 2015, FLA ENTOMOL, V98, P728, DOI 10.1653/024.098.0249; Vazquez FX, 2011, ABSTR PAP AM CHEM S, V242; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; Wu T, 2012, J CLIMATE UNPUB; You L., 2011, CLIMATE CHANGE IMPAC; Zhang CL, 2017, CURR ZOOL, V63, P131, DOI 10.1093/cz/zow024	68	1	1	8	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0244694	10.1371/journal.pone.0244694	http://dx.doi.org/10.1371/journal.pone.0244694			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449921	Green Published, gold			2022-12-26	WOS:000609991600039
J	Bongiorno, C; Challet, D				Bongiorno, Christian; Challet, Damien			Covariance matrix filtering with bootstrapped hierarchies	PLOS ONE			English	Article							NONLINEAR SHRINKAGE; ESTIMATOR	Cleaning covariance matrices is a highly non-trivial problem, yet of central importance in the statistical inference of dependence between objects. We propose here a probabilistic hierarchical clustering method, named Bootstrapped Average Hierarchical Clustering (BAHC), that is particularly effective in the high-dimensional case, i.e., when there are more objects than features. When applied to DNA microarray, our method yields distinct hierarchical structures that cannot be accounted for by usual hierarchical clustering. We then use global minimum-variance risk management to test our method and find that BAHC leads to significantly smaller realized risk compared to state-of-the-art linear and nonlinear filtering methods in the high-dimensional case. Spectral decomposition shows that BAHC better captures the persistence of the dependence structure between asset price returns in the calibration and the test periods.	[Bongiorno, Christian; Challet, Damien] Univ Paris Saclay, Cent Supelec, Math & Informat Complexite & Syst, Gif Sur Yvette, France	UDICE-French Research Universities; Universite Paris Saclay	Bongiorno, C (corresponding author), Univ Paris Saclay, Cent Supelec, Math & Informat Complexite & Syst, Gif Sur Yvette, France.	christian.bongiorno@centralesupelec.fr		Bongiorno, Christian/0000-0002-1730-2895	CNRS; Region Ilede-France	CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Ilede-France(Region Ile-de-France)	This publication stems from a partnership between CentraleSupelec and BNP Paribas. This work was performed using HPC resources from the "Mesocentre" computing center of CentraleSupelec and Ecole Normale Superieure Paris-Saclay supported by CNRS and Region Ilede-France.	Arnesano M, 2012, ENERGY, V39, P112, DOI 10.1016/j.energy.2011.06.053; Bartz D, 2016, CROSS VALIDATION BAS; Begusic S, 2019, INT SYMP IMAGE SIG, P301, DOI 10.1109/ISPA.2019.8868482; Bongiorno C, 2019, NESTED PARTITIONS HI; Bongiorno C, 2019, NONPARAMETRIC SIGN P; Bun J, 2017, PHYS REP, V666, P1, DOI 10.1016/j.physrep.2016.10.005; Bun J, 2016, IEEE T INFORM THEORY, V62, P7475, DOI 10.1109/TIT.2016.2616132; DUNLOP J, 2004, J PRIV EQUITY, V7, P83; Friedman J, 2001, SPRINGER SERIES STAT, V10; Hira Zena M., 2015, Advances in Bioinformatics, V2015, P198363, DOI 10.1155/2015/198363; Hubbard DW, 2014, MEASURE ANYTHING FIN; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Ledoit O, 2017, REV FINANC STUD, V30, P4349, DOI 10.1093/rfs/hhx052; Ledoit O, 2012, ANN STAT, V40, P1024, DOI 10.1214/12-AOS989; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; Markowitz HM, 2000, MEAN VARIANCE ANAL P, V66; Pantaleo E, 2011, QUANT FINANC, V11, P1067, DOI 10.1080/14697688.2010.534813; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Roques FA, 2008, ENERG ECON, V30, P1831, DOI 10.1016/j.eneco.2007.11.008; Tumminello M, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/30006; Tumminello M, 2007, INT J BIFURCAT CHAOS, V17, P2319, DOI 10.1142/S0218127407018415; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245092	10.1371/journal.pone.0245092	http://dx.doi.org/10.1371/journal.pone.0245092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444350	Green Submitted, Green Published, gold			2022-12-26	WOS:000609988100073
J	Elser, H; Kiang, MV; John, EM; Simard, JF; Bondy, M; Nelson, LM; Chen, WT; Linos, E				Elser, Holly; Kiang, Mathew V.; John, Esther M.; Simard, Julia F.; Bondy, Melissa; Nelson, Lorene M.; Chen, Wei-ting; Linos, Eleni			The Impact of the first COVID-19 shelter-in-place announcement on social distancing, difficulty in daily activities, and levels of concern in the San Francisco Bay Area: A cross-sectional social media survey	PLOS ONE			English	Article								Background The U.S. has experienced an unprecedented number of orders to shelter in place throughout the ongoing COVID-19 pandemic. We aimed to ascertain whether social distancing; difficulty with daily activities; and levels of concern regarding COVID-19 changed after the March 16, 2020 announcement of the nation's first shelter-in-place orders (SIPO) among individuals living in the seven affected counties in the San Francisco Bay Area. Methods We conducted an online, cross-sectional social media survey from March 14 -April 1, 2020. We measured changes in social distancing behavior; experienced difficulties with daily activities (i.e., access to healthcare, childcare, obtaining essential food and medications); and level of concern regarding COVID-19 after the March 16 shelter-in-place announcement in the San Francisco Bay Area versus elsewhere in the U.S. Results In this non-representative sample, the percentage of respondents social distancing all of the time increased following the shelter-in-place announcement in the Bay Area (9.2%, 95% CI: 6.6, 11.9) and elsewhere in the U.S. (3.4%, 95% CI: 2.0, 5.0). Respondents also reported increased difficulty obtaining hand sanitizer, medications, and in particular respondents reported increased difficulty obtaining food in the Bay Area (13.3%, 95% CI: 10.4, 16.3) and elsewhere (8.2%, 95% CI: 6.6, 9.7). We found limited evidence that level of concern regarding the COVID-19 crisis changed following the announcement. Conclusion This study characterizes early changes in attitudes, behaviors, and difficulties. As states and localities implement, rollback, and reinstate shelter-in-place orders, ongoing efforts to more fully examine the social, economic, and health impacts of COVID-19, especially among vulnerable populations, are urgently needed.	[Elser, Holly] Stanford Univ, Stanford Med Sch, Stanford, CA 94305 USA; [Elser, Holly; Kiang, Mathew V.] Stanford Univ, Ctr Populat Hlth Sci, Stanford, CA 94305 USA; [Kiang, Mathew V.; John, Esther M.; Simard, Julia F.; Bondy, Melissa; Nelson, Lorene M.; Linos, Eleni] Stanford Univ, Dept Epidemiol & Populat Hlth, Stanford, CA 94305 USA; [Chen, Wei-ting] Stanford Univ, Off Community Engagement, Stanford, CA 94305 USA; [Linos, Eleni] Stanford Univ, Dept Dermatol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Linos, E (corresponding author), Stanford Univ, Dept Epidemiol & Populat Hlth, Stanford, CA 94305 USA.; Linos, E (corresponding author), Stanford Univ, Dept Dermatol, Stanford, CA 94305 USA.	linos@stanford.edu	Kiang, Mathew/J-5390-2019	Kiang, Mathew/0000-0001-9198-150X	NIH [DP2CA225433, K24AR075060]; National Institute on Drug Abuse [T32DA035165]; Clinical and Translational Science Award Program of the National Institutes of Health's National Center for Advancing Translational Science [UL1 TR001085]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Clinical and Translational Science Award Program of the National Institutes of Health's National Center for Advancing Translational Science	EL is supported by the NIH (grants DP2CA225433 and K24AR075060). MVK is supported by the National Institute on Drug Abuse (T32DA035165). LMN is supported by the Clinical and Translational Science Award Program of the National Institutes of Health's National Center for Advancing Translational Science (UL1 TR001085). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Abouk R, 2021, PUBLIC HEALTH REP, V136, P245, DOI 10.1177/0033354920976575; Allday, 2020, LOCAL POLITICS WEB S; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 2002, Bull World Health Organ, V80, P983; Badr HS, 2020, LANCET INFECT DIS, V20, P1247, DOI 10.1016/S1473-3099(20)30553-3; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Baker, 2020, ASS STATE LEVEL PHYS; Bogoch II, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa008; Bui Q, 2020, THERE IS PLENTY FOOD; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; CHANG HH, 2020, AM J AGR ECON, DOI DOI 10.1111/AJAE.12158; Dave, 2020, 27522 NBER; Dave D, 2020, W26992 NBER; Dave D.M., 2020, 27408 NAT BUR EC RES, DOI [DOI 10.3386/W27408, 10.3386/w27408]; Dave D, 2021, SOUTH ECON J, V87, P769, DOI 10.1002/soej.12475; Dave D, 2021, ECON INQ, V59, P29, DOI 10.1111/ecin.12944; Domonoske, 2020, EMPTY GROCERY SHELVE; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Fairlie R.W., 2020, IMPACTS COVID 19 MIN, DOI [10.3386/W27246, DOI 10.3386/W27246]; Faria-e-Castro M, 2020, BACK OF THE ENVELOPE; Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Gostin LO, 2020, JAMA-J AM MED ASSOC, V323, P2137, DOI 10.1001/jama.2020.5460; Gratz KL, 2020, SUICIDE LIFE-THREAT, V50, P1140, DOI 10.1111/sltb.12654; Gupta S, 2020, TRACKING PUBLIC PRIV, DOI [10.3386/w27027, DOI 10.3386/W27027]; Imperial College London, 2020, 13 IMP COLL LOND; Kamerow D, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1367; Kauffman BY, 2022, J AM COLL HEALTH, V70, P478, DOI 10.1080/07448481.2020.1754223; Kishore N, 2020, LANCET DIGIT HEALTH, V2, pE622, DOI 10.1016/S2589-7500(20)30193-X; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Lyu W, 2020, HEALTH AFFAIR, V39, P1615, DOI 10.1377/hlthaff.2020.00719; Marroquin B, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113419; Puhani PA, 2012, ECON LETT, V115, P85, DOI 10.1016/j.econlet.2011.11.025; Richardson S, 2020, JAMA, DOI [DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.6775]; Swales V, SEE WHICH STATES CIT, V1, P2020; Tan CC, 2006, ANN ACAD MED SINGAP, V35, P345; The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WEEKLY, V2, P1, DOI DOI 10.5194/GCHRON-2-1-2020; U.S. Department of Housing and Urban Development, 2020, HUD USPS ZIP COD CRO; United States Census Bureau, 2020, CART BOUND FIL SHAP; van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X; Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X; Weill JA, 2020, P NATL ACAD SCI USA, V117, P19658, DOI 10.1073/pnas.2009412117; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2020, TECH REP; World Health Organization, 2020, PNEUM UNKN CAUS CHIN; World Health Organization (WHO), 2020, Q COR COVID 19; Wright T, 2020, IZA DISCUSSION PAPER; Yaffe-Bellany, 2020, US FOOD SUPPLY CHAIN; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Yang, 2020, COVID 19 PREVENTION, P898; Zhang, 2020, RAPID ASSESSMENT PSY; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	55	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0244819	10.1371/journal.pone.0244819	http://dx.doi.org/10.1371/journal.pone.0244819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4VV	33444363	Green Published, gold			2022-12-26	WOS:000609988100095
J	Katewa, A; Suto, E; Hui, J; Heredia, J; Liang, J; Hackney, J; Anderson, K; Alcantar, TM; Bacarro, N; Dunlap, D; Eastham, J; Paler-Martinez, A; Rairdan, XY; Modrusan, Z; Lee, WP; Austin, CD; Lafkas, D; Ghilardi, N				Katewa, Arna; Suto, Eric; Hui, Jessica; Heredia, Jose; Liang, Jie; Hackney, Jason; Anderson, Keith; Alcantar, Tuija M.; Bacarro, Natasha; Dunlap, Debra; Eastham, Jeffrey; Paler-Martinez, Andres; Rairdan, Xin Y.; Modrusan, Zora; Lee, Wyne P.; Austin, Cary D.; Lafkas, Daniel; Ghilardi, Nico			The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine models	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY RESPONSES; TRANSPORTER SLC15A4; FAMILY SLC15; INTERFERON; AUTOIMMUNITY; ANIFROLUMAB; SPECIFICITY; EXPRESSION; SIGNATURE	Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease representing a serious unmet medical need. The disease is associated with the loss of self-tolerance and exaggerated B cell activation, resulting in autoantibody production and the formation of immune complexes that accumulate in the kidney, causing glomerulonephritis. TLR7, an important mediator of the innate immune response, drives the expression of type-1 interferon (IFN), which leads to expression of type-1 IFN induced genes and aggravates lupus pathology. Because the lysosomal peptide symporter slc15a4 is critically required for type-1 interferon production by pDC, and for certain B cell functions in response to TLR7 and TLR9 signals, we considered it as a potential target for pharmacological intervention in SLE. We deleted the slc15a4 gene in C57BL/6, NZB, and NZW mice and found that pristane-challenged slc15a4(-/-) mice in the C57BL/6 background and lupus prone slc15a4(-/-) NZB/W F1 mice were both completely protected from lupus like disease. In the NZB/W F1 model, protection persisted even when disease development was accelerated with an adenovirus encoding IFN alpha, emphasizing a broad role of slc15a4 in disease initiation. Our results establish a non-redundant function of slc15a4 in regulating both innate and adaptive components of the immune response in SLE pathobiology and suggest that it may be an attractive drug target.	[Katewa, Arna] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Suto, Eric; Paler-Martinez, Andres; Lee, Wyne P.] Genentech Inc, Dept Translat Immunol, San Francisco, CA USA; [Hui, Jessica] Evercore ISI, New York, NY USA; [Heredia, Jose; Lafkas, Daniel] Genentech Inc, Dept Immunol, San Francisco, CA USA; [Liang, Jie] Genentech Inc, Dept Mol Oncol, San Francisco, CA USA; [Hackney, Jason] Genentech Inc, Dept Bioinformat, San Francisco, CA USA; [Anderson, Keith; Alcantar, Tuija M.; Bacarro, Natasha] Genentech Inc, Dept Mol Biol, San Francisco, CA USA; [Dunlap, Debra; Eastham, Jeffrey; Austin, Cary D.] Genentech Inc, Dept Pathol, San Francisco, CA USA; [Rairdan, Xin Y.] gRED Anim Resources, San Francisco, CA USA; [Modrusan, Zora] Genentech Inc, Dept Microchem Prote & Lipid, San Francisco, CA USA; [Ghilardi, Nico] DiCE Mol, San Francisco, CA 94103 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Katewa, A (corresponding author), Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA.; Ghilardi, N (corresponding author), DiCE Mol, San Francisco, CA 94103 USA.	katewaa@gene.com; nico.ghilardi@gmail.com	Lafkas, Daniel/AAI-8718-2021	Lafkas, Daniel/0000-0001-7395-476X; Katewa, Arna/0000-0001-6293-6814; Hackney, Jason/0000-0002-5922-563X	Genentech	Genentech(Roche HoldingGenentech)	The funder (Genentech) provided support in the form of salaries for authors [AK, ES, JH, JH, JL, JH, KA, TMA, NB, DD, JE-A, APM, XYR, ZM, WPL, CDA, DL and NG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. At the time of this study NG was employed by Genentech. NG is currently employed by DiCE Molecules.	Agrawal H, 2009, J IMMUNOL, V183, P6021, DOI 10.4049/jimmunol.0803872; Anderson KR, 2018, NAT METHODS, V15, P512, DOI 10.1038/s41592-018-0011-5; [Anonymous], 2011, NAT REV DRUG DISCOV, V10, P243, DOI 10.1038/nrd3413; Baccala R, 2013, P NATL ACAD SCI USA, V110, P2940, DOI 10.1073/pnas.1222798110; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Berthier CC, 2012, J IMMUNOL, V189, P988, DOI 10.4049/jimmunol.1103031; Blasius AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002915; Blasius AL, 2010, P NATL ACAD SCI USA, V107, P19973, DOI 10.1073/pnas.1014051107; Condon MB, 2013, ANN RHEUM DIS, V72, P1280, DOI 10.1136/annrheumdis-2012-202844; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CONLON KC, 1990, CANCER, V65, P2237, DOI 10.1002/1097-0142(19900515)65:10<2237::AID-CNCR2820651013>3.0.CO;2-5; Corzo CA, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aaz1053; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Deng Y, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0695-z; Drappa J, 2003, J EXP MED, V198, P809, DOI 10.1084/jem.20021358; Furie RA, 2019, LANCET RHEUMATOL, V1, pE208, DOI 10.1016/S2665-9913(19)30076-1; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; He CF, 2010, LUPUS, V19, P1181, DOI 10.1177/0961203310367918; Heinz LX, 2020, NATURE, V581, P316, DOI 10.1038/s41586-020-2282-0; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Katewa A, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90111; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Knutter I, 2009, DRUG METAB DISPOS, V37, P143, DOI 10.1124/dmd.108.022418; Kobayashi T, 2017, INT IMMUNOL, V29, P551, DOI 10.1093/intimm/dxx063; Kobayashi T, 2014, IMMUNITY, V41, P375, DOI 10.1016/j.immuni.2014.08.011; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee HS, 2014, ANN RHEUM DIS, V73, P1240, DOI 10.1136/annrheumdis-2012-202675; Lee PY, 2008, J IMMUNOL, V180, P5101, DOI 10.4049/jimmunol.180.7.5101; Lisnevskaia L, 2014, LANCET, V384, P1878, DOI 10.1016/S0140-6736(14)60128-8; Lu Q, 2007, GENES IMMUN, V8, P590, DOI 10.1038/sj.gene.6364421; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Morand EF, 2020, NEW ENGL J MED, V382, P211, DOI 10.1056/NEJMoa1912196; Nacionales DC, 2007, ARTHRITIS RHEUM, V56, P3770, DOI 10.1002/art.23023; Nakamura N, 2014, NATURE, V509, P240, DOI 10.1038/nature13133; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Phipson B, 2016, ANN APPL STAT, V10, P946, DOI 10.1214/16-AOAS920; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; RONNBLOM LE, 1991, ANN INTERN MED, V115, P178, DOI 10.7326/0003-4819-115-3-178; Rovin BH, 2012, ARTHRITIS RHEUM-US, V64, P1215, DOI 10.1002/art.34359; Ryden-Aulin M, 2016, LUPUS SCI MED, V3, DOI 10.1136/lupus-2016-000163; Sasawatari S, 2011, GASTROENTEROLOGY, V140, P1513, DOI 10.1053/j.gastro.2011.01.041; Smith DE, 2013, MOL ASPECTS MED, V34, P323, DOI 10.1016/j.mam.2012.11.003; Song FF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0809-1; Thorlacius GE, 2018, CURR OPIN RHEUMATOL, V30, P471, DOI 10.1097/BOR.0000000000000524; Wahren-Herlenius M, 2013, LANCET, V382, P819, DOI 10.1016/S0140-6736(13)60954-X; Wang C, 2013, EUR J HUM GENET, V21, P994, DOI 10.1038/ejhg.2012.277; Wang YQ, 2014, MOL PHARMACEUT, V11, P1880, DOI 10.1021/mp500014r; Waters ST, 2001, CLIN IMMUNOL, V100, P372, DOI 10.1006/clim.2001.5079; Weckerle CE, 2011, ARTHRITIS RHEUM-US, V63, P1044, DOI 10.1002/art.30187; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zhang MW, 2016, GENET TEST MOL BIOMA, V20, P451, DOI 10.1089/gtmb.2015.0289; Zhuang HY, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00291; Zuo XB, 2014, RHEUMATOL INT, V34, P459, DOI 10.1007/s00296-013-2864-3	58	3	4	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0244439	10.1371/journal.pone.0244439	http://dx.doi.org/10.1371/journal.pone.0244439			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444326	gold, Green Published			2022-12-26	WOS:000609988100051
J	Zhang, YM; Schepartz, LA				Zhang, Yameng; Schepartz, Lynne A.			Three-dimensional geometric morphometric studies of modern human occipital variation	PLOS ONE			English	Article							DISCRIMINANT FUNCTION-ANALYSIS; CRANIOFACIAL SHAPE VARIATION; PLATE SPLINE ANALYSIS; BRAIN SIZE PREDICTS; SEXUAL-DIMORPHISM; FORAMEN MAGNUM; CRANIAL BASE; POPULATION VARIATION; BASICRANIAL FLEXION; MUSCLE-SPINDLES	Objectives To investigate three-dimensional morphological variation of the occipital bone between sexes and among populations, to determine how ancestry, sex and size account for occipital shape variation and to describe the exact forms by which the differences are expressed. Methods CT data for 214 modern crania of Asian, African and European ancestry were compared using 3D geometric morphometrics and multivariate statistics, including principal component analysis, Hotelling's T-2 test, multivariate regression, ANOVA, and MANCOVA. Results Sex differences in average occipital morphology are only observed in Europeans, with males exhibiting a pronounced inion. Significant ancestral differences are observed among all samples and are shared by males and females. Asian and African crania have smaller biasterionic breadths and flatter clivus angles compared to Europeans. Asian and European crania are similar in their nuchal and occipital plane proportions, nuchal and occipital angles, and lower inion positions compared to Africans. Centroid size significantly differs between sexes and among populations. The overall allometry, while significant, explains little of the shape variation. Larger occipital bones were associated with a more curved occipital plane, a pronounced inion, a narrower biasterionic breadth, a more flexed clivus, and a lower and relatively smaller foramen magnum. Conclusions Although significant shape differences were observed among populations, it is not recommended to use occipital morphology in sex or population estimation as both factors explained little of the observed variance. Other factors, relating to function and the environment, are suggested to be greater contributors to occipital variation. For the same reason, it is also not recommended to use the occiput in phylogenetic studies.	[Zhang, Yameng] Shandong Univ, Joint Int Res Lab Environm & Social Archaeol, Qingdao, Peoples R China; [Zhang, Yameng] Shandong Univ, Inst Cultural Heritage, Qingdao, Peoples R China; [Schepartz, Lynne A.] Univ Witwatersrand, Sch Anat Sci, Human Variat & Identificat Res Unit HVIRU, Fac Hlth Sci, Johannesburg, South Africa; [Schepartz, Lynne A.] Univ Penn, Museum Archaeol & Anthropol, Philadelphia, PA 19104 USA	Shandong University; Shandong University; University of Witwatersrand; University of Pennsylvania	Zhang, YM (corresponding author), Shandong Univ, Joint Int Res Lab Environm & Social Archaeol, Qingdao, Peoples R China.; Zhang, YM (corresponding author), Shandong Univ, Inst Cultural Heritage, Qingdao, Peoples R China.	ymzh@sdu.edu.cn		Zhang, Yameng/0000-0002-7055-4709	Strategic Priority Research Program of Chinese Academy of Sciences [XDB26000000]; Key Laboratory of Vertebrate Evolution and Human Origins, IVPP, CAS [LVEHO20005]; Fundamental Research Funds of Shandong University; National Natural Science Foundation of China [41630102, 41672020]	Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Key Laboratory of Vertebrate Evolution and Human Origins, IVPP, CAS; Fundamental Research Funds of Shandong University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Y. Zhang received funding from the Strategic Priority Research Program of Chinese Academy of Sciences (XDB26000000) (http://www.cas.cn/), the Key Laboratory of Vertebrate Evolution and Human Origins, IVPP, CAS (NO. LVEHO20005) (http://lveho.ivpp.cas.cn/), the Fundamental Research Funds of Shandong University and the National Natural Science Foundation of China (41630102, 41672020) (http://www.nsfc.gov.cn/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS VC, 1988, PROG BRAIN RES, V76, P125; Adams D.C., 2021, GEOMORPH SOFTWARE GE; ADAMS LM, 1975, ACTA ANAT, V92, P580; Ahlstrom T, 1996, NATO ADV SCI INST SE, V284, P415; Akgun, 1998, T J MED SCI, V28, P505; AUGUST DA, 1985, CANCER-AM CANCER SOC, V55, P1490, DOI 10.1002/1097-0142(19850401)55:7<1490::AID-CNCR2820550712>3.0.CO;2-N; Baab KL, 2010, VERTEBR PALEOBIOL PA, P57, DOI 10.1007/978-90-481-9094-2_6; Babu YPR, 2012, J FORENSIC LEG MED, V19, P162, DOI 10.1016/j.jflm.2011.12.019; Bastir M, 2006, ARCH ORAL BIOL, V51, P814, DOI 10.1016/j.archoralbio.2006.03.009; Bastir M, 2010, J HUM EVOL, V58, P424, DOI 10.1016/j.jhevol.2010.03.001; Bastir M, 2009, EVOL BIOL, V36, P57, DOI 10.1007/s11692-008-9037-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson-Amram S, 2016, P NATL ACAD SCI USA, V113, P2532, DOI 10.1073/pnas.1505913113; Bigoni L, 2010, HOMO, V61, P16, DOI 10.1016/j.jchb.2009.09.004; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; Bookstein FL, 2014, MEASURING AND REASONING: NUMERICAL INFERENCE IN THE SCIENCES, P291; Broca P., 1875, INSTRUCTIONS CRANIOL; Buikstra Jane., 1994, STANDARDS DATA COLLE, V44, P209, DOI DOI 10.1002/AJHB.1310070519; Burger JR, 2019, J MAMMAL, V100, P276, DOI 10.1093/jmammal/gyz043; Caspari, 1991, EVOLUTION POSTERIOR; Dabelow A, 1929, MORPH JB, V63, P1; Dayal MR, 2009, AM J PHYS ANTHROPOL, V140, P324, DOI 10.1002/ajpa.21072; DE VILLIERS H., 1968, S AFR J SCI, V64, P118; Demes, 1985, BIOMECHANICS PRIMATE; DESTEFANO GF, 1984, J HUM EVOL, V13, P349, DOI 10.1016/S0047-2484(84)80041-X; deVilliers H., 1968, SKULL S AFRICAN NEGR; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; DRYDEN I. L, 2019, SHAPES STAT SHAPE AN; Dryden I. L., 2016, R WILEY SERIES PROBA, V2nd; DUBRUL EL, 1961, AM J ANAT, V109, P117, DOI 10.1002/aja.1001090203; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; ENLOW DH, 1971, ANGLE ORTHOD, V41, P161; FOX JH, 1986, BRAIN BEHAV EVOLUT, V28, P157, DOI 10.1159/000118700; Franklin D, 2007, AM J HUM BIOL, V19, P20, DOI 10.1002/ajhb.20569; Franklin D, 2006, S AFR J SCI, V102, P229; Franklin D, 2005, HOMO, V55, P213, DOI 10.1016/j.jchb.2004.08.001; Franklin D, 2012, INT J LEGAL MED, V126, P549, DOI 10.1007/s00414-012-0684-8; Franklin D, 2010, AM J HUM BIOL, V22, P23, DOI 10.1002/ajhb.20908; Friess M, 2010, CR PALEVOL, V9, P435, DOI 10.1016/j.crpv.2010.07.016; Gapert R, 2009, AM J PHYS ANTHROPOL, V138, P384, DOI 10.1002/ajpa.20946; Gapert R, 2009, INT J LEGAL MED, V123, P25, DOI 10.1007/s00414-008-0256-0; Garvin HM, 2014, AM J PHYS ANTHROPOL, V154, P259, DOI 10.1002/ajpa.22502; Gonzalez-Jose R, 2008, AM J PHYS ANTHROPOL, V137, P175, DOI 10.1002/ajpa.20854; Gonzalez-Voyer A, 2016, EVOLUTION, V70, P1364, DOI 10.1111/evo.12943; Gruber P, 2009, ANAT REC, V292, P1713, DOI 10.1002/ar.21005; Gulekon IN, 2003, J FORENSIC SCI, V48, P513; Gunay Y, 2000, J Clin Forensic Med, V7, P147, DOI 10.1054/jcfm.2000.0430; HOFER HO, 1969, ANN NY ACAD SCI, V162, P15, DOI 10.1111/j.1749-6632.1969.tb56343.x; HOLLAND TD, 1986, AM J PHYS ANTHROPOL, V70, P203, DOI 10.1002/ajpa.1330700207; Howells W. W., 1989, SKULL SHAPES MAP CRA; Howells W. W., 1973, PAPERS PEABODY MUSEU; Isler K, 2006, BIOL LETTERS, V2, P557, DOI 10.1098/rsbl.2006.0538; Jeffery N, 2004, J ANAT, V204, P71, DOI 10.1111/j.1469-7580.2004.00250.x; Jeffery N, 2002, AM J PHYS ANTHROPOL, V118, P324, DOI 10.1002/ajpa.10040; Johnson LK, 2002, FOREIGN POLICY, P6; KENDALL DG, 1977, ADV APPL PROBAB, V9, P428, DOI 10.2307/1426091; Kimmerle EH, 2008, J FORENSIC SCI, V53, P54, DOI 10.1111/j.1556-4029.2007.00627.x; Klingenberg CP, 2013, HYSTRIX, V24, P15, DOI 10.4404/hystrix-24.1-7691; KLINGENBERG CP, 1992, AM NAT, V140, P601, DOI 10.1086/285430; Kouchi M, 1999, J Hum Ergol (Tokyo), V28, P15; Kulkarni V, 2001, NEUROL INDIA, V49, P355; Langley NR, 2018, J FORENSIC SCI, V63, P31, DOI 10.1111/1556-4029.13534; Lieberman DE, 2008, J ANAT, V212, P720, DOI 10.1111/j.1469-7580.2008.00900.x; Lieberman DE, 2000, J HUM EVOL, V38, P291, DOI 10.1006/jhev.1999.0335; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; Liu JX, 2003, J HISTOCHEM CYTOCHEM, V51, P175, DOI 10.1177/002215540305100206; Macaluso J. Jr., 2011, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V23, P19, DOI 10.1007/s13219-010-0023-x; MacLarnon A, 1996, J HUM EVOL, V30, P121, DOI 10.1006/jhev.1996.0009; Martin R., 1957, LEHRBUCH ANTHR, V3rd; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Mitteroecker P, 2013, HYSTRIX, V24, P59, DOI 10.4404/hystrix-24.1-6369; Morimoto N, 2008, J ANAT, V212, P627, DOI 10.1111/j.1469-7580.2008.00884.x; OLIVIER G, 1975, J ANAT, V120, P507; Patil KR, 2005, FORENSIC SCI INT, V147, P175, DOI 10.1016/j.forsciint.2004.09.071; Pelabon C, 2013, AM NAT, V181, P195, DOI 10.1086/668820; R Core Team, 2021, R LANGUAGE ENV STAT; Rosas A, 2002, AM J PHYS ANTHROPOL, V117, P236, DOI 10.1002/ajpa.10023; Rosas A, 2008, ARCH ORAL BIOL, V53, P826, DOI 10.1016/j.archoralbio.2008.02.005; ROSS CF, 1993, AM J PHYS ANTHROPOL, V91, P305, DOI 10.1002/ajpa.1330910306; Schlager S., 2017, STAT SHAPE DEFORMATI, P217; SCOTT JH, 1958, AM J PHYS ANTHROPOL, V16, P319, DOI 10.1002/ajpa.1330160305; Shahar D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21625-1; Shahar D, 2016, J ANAT, V229, P286, DOI 10.1111/joa.12466; Small C, 2018, FORENSIC SCI INT, V287, P127, DOI 10.1016/j.forsciint.2018.02.012; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Sperber G.H., 2001, CRANIOFACIAL DEV; SRIVASTAVA HC, 1992, J ANAT, V180, P219; Strait DS, 1999, J HUM EVOL, V37, P701, DOI 10.1006/jhev.1999.0314; Galdames ICS, 2009, INT J MORPHOL, V27, P21, DOI 10.4067/S0717-95022009000100003; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Tobias, 1959, S AFR J MED SCI, V23, P135; Walker PL, 2008, AM J PHYS ANTHROPOL, V136, P39, DOI 10.1002/ajpa.20776; WEIDENREICH FRANZ, 1941, TRANS AMER PHIL SOC, V31, P321; Weidenreich F, 1924, Z MORPHOL ANTHROPOL, V24, P157; Wescott DJ, 2001, J FORENSIC SCI, V46, P1159; Woo TL, 1941, ANTHROP J I HIST PHI, V2, P1; Wood CG, 1996, NATO ADV SCI INST SE, V284, P407; Yan Y, 1941, ANTHROP J I HIST PHI, V2, P21; YOUNG RW, 1959, AM J ANAT, V105, P383, DOI 10.1002/aja.1001050304; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1; [张亚盟 Zhang Yameng], 2016, [人类学学报, Acta Anthropologica Sinica], V35, P172	101	5	5	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245445	10.1371/journal.pone.0245445	http://dx.doi.org/10.1371/journal.pone.0245445			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4VV	33444349	Green Published, gold			2022-12-26	WOS:000609988100003
J	Petratou, K; Spencer, SA; Kelsh, RN; Lister, JA				Petratou, Kleio; Spencer, Samantha A.; Kelsh, Robert N.; Lister, James A.			The MITF paralog tfec is required in neural crest development for fate specification of the iridophore lineage from a multipotent pigment cell progenitor	PLOS ONE			English	Article							MITOCHONDRIAL PROTEIN MPV17; ZEBRAFISH TFAP2A; FOXD3 ACTIVITY; EXPRESSION; ENCODES; SOX10; GENES; KIT; MICROPHTHALMIA; ESTABLISHMENT	Understanding how fate specification of distinct cell-types from multipotent progenitors occurs is a fundamental question in embryology. Neural crest stem cells (NCSCs) generate extraordinarily diverse derivatives, including multiple neural, skeletogenic and pigment cell fates. Key transcription factors and extracellular signals specifying NCSC lineages remain to be identified, and we have only a little idea of how and when they function together to control fate. Zebrafish have three neural crest-derived pigment cell types, black melanocytes, light-reflecting iridophores and yellow xanthophores, which offer a powerful model for studying the molecular and cellular mechanisms of fate segregation. Mitfa has been identified as the master regulator of melanocyte fate. Here, we show that an Mitf-related transcription factor, Tfec, functions as master regulator of the iridophore fate. Surprisingly, our phenotypic analysis of tfec mutants demonstrates that Tfec also functions in the initial specification of all three pigment cell-types, although the melanocyte and xanthophore lineages recover later. We show that Mitfa represses tfec expression, revealing a likely mechanism contributing to the decision between melanocyte and iridophore fate. Our data are consistent with the long-standing proposal of a tripotent progenitor restricted to pigment cell fates. Moreover, we investigate activation, maintenance and function of tfec in multipotent NCSCs, demonstrating for the first time its role in the gene regulatory network forming and maintaining early neural crest cells. In summary, we build on our previous work to characterise the gene regulatory network governing iridophore development, establishing Tfec as the master regulator driving iridophore specification from multipotent progenitors, while shedding light on possible cellular mechanisms of progressive fate restriction.	[Petratou, Kleio; Kelsh, Robert N.] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Petratou, Kleio; Kelsh, Robert N.] Univ Bath, Ctr Regenerat Med, Bath, Avon, England; [Spencer, Samantha A.; Lister, James A.] Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, Richmond, VA USA; [Spencer, Samantha A.; Lister, James A.] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA USA; [Petratou, Kleio] Westfalische Wilhelms Univ Munster, Inst Cardiovasc Organogenesis & Regenerat, Fac Med, Munster, Germany	University of Bath; University of Bath; Virginia Commonwealth University; Virginia Commonwealth University; University of Munster	Kelsh, RN (corresponding author), Univ Bath, Dept Biol & Biochem, Bath, Avon, England.; Kelsh, RN (corresponding author), Univ Bath, Ctr Regenerat Med, Bath, Avon, England.	r.n.kelsh@bath.ac.uk	; Kelsh, Robert/B-6445-2008	Lister, James/0000-0002-8505-6710; Spencer, Samantha/0000-0001-5048-1736; Kelsh, Robert/0000-0002-9381-0066	University of Bath within the Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/L00769X/1]; National Institutes of Health Clinical and Translational Science Award from the National Center for Advancing Translational Sciences [UL1TR000058]; AD Williams' Fund of Virginia Commonwealth University	University of Bath within the Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health Clinical and Translational Science Award from the National Center for Advancing Translational Sciences; AD Williams' Fund of Virginia Commonwealth University	This work was supported by the University of Bath (KP, RNK) within the Biotechnology and Biological Sciences Research Council (BBSRC; https://bbsrc.ukri.org/)-funded South West Biosciences Doctoral Training Partnership, by BBSRC grant BB/L00769X/1 (RNK), and by a National Institutes of Health Clinical and Translational Science Award UL1TR000058 from the National Center for Advancing Translational Sciences) to Virginia Commonwealth University and the AD Williams' Fund of Virginia Commonwealth University (SS, JAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; [Anonymous], 2014, PREV CHRONIC DIS, V11, pE62; Arduini BL, 2009, DEVELOPMENT, V136, P1987, DOI 10.1242/dev.033209; BAGNARA JT, 1979, SCIENCE, V203, P410, DOI 10.1126/science.760198; Betancur P, 2010, P NATL ACAD SCI USA, V107, P3570, DOI 10.1073/pnas.0906596107; Bharti K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002757; Budi EH, 2008, DEVELOPMENT, V135, P2603, DOI 10.1242/dev.019299; Calloni GW, 2009, P NATL ACAD SCI USA, V106, P8947, DOI 10.1073/pnas.0903780106; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Clancey LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065096; Cooper CD, 2009, DEV DYNAM, V238, P875, DOI 10.1002/dvdy.21910; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; Curran K, 2009, DEV BIOL, V332, P408, DOI 10.1016/j.ydbio.2009.06.010; D'Agati G, 2017, DEV BIOL, V430, P11, DOI 10.1016/j.ydbio.2017.07.017; Delfino-Machin M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172947; Delous M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002754; Dooley CM, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008213; Dorsky RI, 2000, GENE DEV, V14, P158; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Elworthy S, 2003, DEVELOPMENT, V130, P2809, DOI 10.1242/dev.00461; Fadeev A, 2016, PIGM CELL MELANOMA R, V29, P284, DOI 10.1111/pcmr.12454; Greenhill ER, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002265; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Higdon CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067801; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hultman KA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000544; Ignatius MS, 2008, DEV BIOL, V313, P568, DOI 10.1016/j.ydbio.2007.10.045; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kelsh RN, 2000, DEVELOPMENT, V127, P515; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knight RD, 2004, DEV DYNAM, V229, P87, DOI 10.1002/dvdy.10494; Knight RD, 2003, DEVELOPMENT, V130, P5755, DOI 10.1242/dev.00575; Krauss J, 2013, BIOL OPEN, V2, P703, DOI 10.1242/bio.20135132; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; LaFave MC, 2014, GENETICS, V198, P167, DOI 10.1534/genetics.114.166769; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; LEDOUARIN N, 1991, GLIA, V4, P175; Li W, 2007, DEV BIOL, V304, P338, DOI 10.1016/j.ydbio.2006.12.042; Lister JA, 2006, DEV BIOL, V290, P92, DOI 10.1016/j.ydbio.2005.11.014; Lister JA, 1999, DEVELOPMENT, V126, P3757; Lister JA, 2011, DEV DYNAM, V240, P2529, DOI 10.1002/dvdy.22743; Lopes SS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000026; Lukoseviciute M, 2018, DEV CELL, V47, P608, DOI 10.1016/j.devcel.2018.11.009; Mahony CB, 2016, BLOOD, V128, P1336, DOI 10.1182/blood-2016-04-710137; Manfroid I, 2012, DEV BIOL, V366, P268, DOI 10.1016/j.ydbio.2012.04.002; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Miesfeld JB, 2015, DEVELOPMENT, V142, P3021, DOI 10.1242/dev.119008; Minchin JEN, 2008, DEV BIOL, V317, P508, DOI 10.1016/j.ydbio.2008.02.058; Mo ES, 2017, P NATL ACAD SCI USA, V114, P12027, DOI 10.1073/pnas.1710254114; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Montero-Balaguer M, 2006, DEV DYNAM, V235, P3199, DOI 10.1002/dvdy.20959; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Ng A, 2009, DEVELOPMENT, V136, P2601, DOI 10.1242/dev.038315; Nord H, 2016, MOL BIOL CELL, V27, P1853, DOI 10.1091/mbc.E15-12-0821; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Parichy DM, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12332; Parichy DM, 2000, DEVELOPMENT, V127, P3031; Petratou K., 2017, NEURAL CREST METHODO, DOI [10.1111/pcmr.12580, DOI 10.1111/PCMR.12580]; Petratou K, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007402; Pogenberg V, 2012, GENE DEV, V26, P2647, DOI 10.1101/gad.198192.112; RAIBLE DW, 1994, DEVELOPMENT, V120, P495; Rodrigues FSLM, 2012, ACS CHEM BIOL, V7, P1968, DOI 10.1021/cb300361a; Saunders LM, 2019, ELIFE, V8, DOI 10.7554/eLife.45181; Schartl M, 2016, PIGM CELL MELANOMA R, V29, P8, DOI 10.1111/pcmr.12409; Schilling TF, 1996, DEVELOPMENT, V123, P329; Seberg HE, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006636; SERBEDZIJA GN, 1994, DEVELOPMENT, V120, P1709; SIEBERBLUM M, 1980, DEV BIOL, V80, P96, DOI 10.1016/0012-1606(80)90501-1; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Sinagoga KL, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.187047; Singh AP, 2016, DEV CELL, V38, P316, DOI 10.1016/j.devcel.2016.06.020; Soldatov R, 2019, SCIENCE, V364, P971, DOI 10.1126/science.aas9536; Stewart RA, 2006, DEV BIOL, V292, P174, DOI 10.1016/j.ydbio.2005.12.035; Van Otterloo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001122; Vibert L, 2017, PIGM CELL MELANOMA R, V30, P219, DOI 10.1111/pcmr.12568; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Wang WD, 2011, DEV BIOL, V360, P173, DOI 10.1016/j.ydbio.2011.09.019; WESTON JA, 1991, CURR TOP DEV BIOL, V25, P133	81	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0244794	10.1371/journal.pone.0244794	http://dx.doi.org/10.1371/journal.pone.0244794			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439865	Green Published, Green Submitted, gold			2022-12-26	WOS:000609985300009
J	Kainga, HW; Ssendagire, S; Ssanyu, JN; Nabukeera, S; Namuhani, N; Mangen, FW				Kainga, Hamilton Wales; Ssendagire, Steven; Ssanyu, Jacquellyn Nambi; Nabukeera, Sarah; Namuhani, Noel; Mangen, Fred Wabwire			Proportion of children aged 9-59 months reached by the 2017 measles supplementary immunization activity among the children with or without history of measles vaccination in Lilongwe district, Malawi	PLOS ONE			English	Article							COVERAGE; IMPACT	Background The measles Supplementary Immunization Activity (SIA) was implemented in June, 2017 to close immunity gaps by providing an additional opportunity to vaccinate children aged between 9 months and up to 14 years in Lilongwe District, Malawi. This study was conducted to determine the proportion of eligible children that were reached by the 2017 measles SIA among those children with or without history of measles vaccination, and possible reasons for non-vaccination. Methods A cross-sectional survey using mixed methods was conducted. Caretakers of children who were eligible for the 2017 measles SIA were sampled from 19 households from each of the 25 clusters (villages) that were randomly selected in Lilongwe District. A child was taken to have been vaccinated if the caretaker was able to explain when and where the child was vaccinated. Eight Key Informant Interviews (KIIs) were conducted with planners and health care workers who were involved in the implementation of the 2017 measles SIA. Modified Poisson regression was used to examine the association between non-vaccination and child, caretaker and household related factors. A thematic analysis of transcripts from KIIs was also conducted to explore health system factors associated with non-vaccination of eligible children in this study. Results A total of 476 children and their caretakers were surveyed. The median age of the children was 52.0 months. Overall, 41.2% [95% CI 36.8-45.7] of the children included in the study were not vaccinated during the SIA. Only 59.6% of children with previous measles doses received SIA dose; while 77% of those without previous measles vaccination were reached by the SIA. Low birth order, vaccination history under routine services, low level of education among caretakers, unemployment of the household head, younger household head, provision of insufficient information by health authorities about the SIA were significantly associated with non-vaccination among eligible children during the 2017 measles SIA. Qualitative findings revealed strong beliefs against vaccinations, wrong perceptions about the SIA (from caretakers' perspectives), poor delivery of health education, logistical and human resource challenges as possible reasons for non-vaccination. Conclusion Many children (41%) were left unvaccinated during the SIA and several factors were found to be associated with this finding. The Lilongwe District Health Team should endeavor to optimize routine immunization program; and community mobilization should be intensified as part of SIA activities.	[Kainga, Hamilton Wales; Ssendagire, Steven; Ssanyu, Jacquellyn Nambi; Nabukeera, Sarah; Namuhani, Noel; Mangen, Fred Wabwire] Makerere Univ, Sch Publ Hlth Uganda, Kampala, Uganda	Makerere University	Kainga, HW (corresponding author), Makerere Univ, Sch Publ Hlth Uganda, Kampala, Uganda.	kaingahamilton@gmail.com		Ssanyu, Jacquellyn/0000-0003-0417-6030				Abadura SA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2315-z; [Anonymous], 2020, WORLD HLTH ORG, DOI DOI 10.1080/09639284.2021.1971095; Babirye JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035432; Bbaale E, 2013, J HEALTH POPUL NUTR, V31, P118; Doumtsop JGT, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.4.2475; Goldstein H., 2011, MULTILEVEL STAT MODE, V922; Grilli R, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000389, DOI 10.1002/14651858.CD000389]; Hogg GG, 2006, J PAEDIATR CHILD H, V42, P165, DOI 10.1111/j.1440-1754.2006.00823.x; Israel G.D., 1992, DETERMINING SAMPLE S; Kinara J., 2016, INFLUENCE HLTH INFOR; Kundrick A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5628-x; Kyere P., 2014, COMP REGIONAL LEVEL; Lilongwe M.o., 2015, 2015 MALAWI DEMOGRAP; Luman ET, 2009, AM J PREV MED, V36, P105, DOI 10.1016/j.amepre.2008.09.035; Lungu EA, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1678-x; MANEPI, 2018, 2017 MEASLES RUBELLA; MOH, 2007, NAT HLTH POL CREAT W; MoH Government of Malawi, 2008, NATL STRATEGIC PLAN; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Office L.D.H., 2018, CHILD IMMUNIZATION L; Portnoy A, 2018, VACCINE, V36, P170, DOI 10.1016/j.vaccine.2017.10.080; Rossi PG, 2004, EUR J EPIDEMIOL, V19, P979, DOI 10.1007/s10654-004-5758-6; Sridhar S, 2014, VACCINE, V32, P6870, DOI 10.1016/j.vaccine.2014.10.063; UNICEF, 2013, FEM GEN MUT CUTT STA; UNICEF WHO and the World Bank Group, 2020, LEVELS TRENDS CHILD; Uthman OA, 2018, HUM VACC IMMUNOTHER, V14, P2397, DOI 10.1080/21645515.2018.1504524; Verma S.K., 2017, INT J CONT PEDIAT, V4, P1748; Wang SA, 2013, VACCINE, V31, pB122, DOI 10.1016/j.vaccine.2012.10.116; Winter SC, 2016, INT J ENVIRON HEAL R, V26, P291, DOI 10.1080/09603123.2015.1111309; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0243137	10.1371/journal.pone.0243137	http://dx.doi.org/10.1371/journal.pone.0243137			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428640	Green Published, gold			2022-12-26	WOS:000630036100008
J	Dekeyser, JM; Thompson, CH; George, AL				Dekeyser, Jean-Marc; Thompson, Christopher H.; George, Alfred L., Jr.			Cryptic prokaryotic promoters explain instability of recombinant neuronal sodium channels in bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL-TRANSFER-RNA; EPILEPSY; EXPRESSION	Mutations in genes encoding the human-brain-expressed voltage-gated sodium (Na-V) channels Na(V)1.1, Na(V)1.2, and Na(V)1.6 are associated with a variety of human diseases including epilepsy, autism spectrum disorder, familial migraine, and other neurodevelopmental disorders. A major obstacle hindering investigations of the functional consequences of brain NaV channel mutations is an unexplained instability of the corresponding recombinant complementary DNA (cDNA) when propagated in commonly used bacterial strains manifested by high spontaneous rates of mutation. Here, using a combination of in silico analysis, random and site-directed mutagenesis, we investigated the cause for instability of human Na(V)1.1 cDNA. We identified nucleotide sequences within the Na(V)1.1 coding region that resemble prokaryotic promoter-like elements, which are presumed to drive transcription of translationally toxic mRNAs in bacteria as the cause of the instability. We further demonstrated that mutations disrupting these elements mitigate the instability. Extending these observations, we generated full-length human Na(V)1.1, Na(V)1.2, and Na(V)1.6 plasmids using one or two introns that interrupt the latent reading frames along with a minimum number of silent nucleotide changes that achieved stable propagation in bacteria. Expression of the stabilized sequences in cultured mammalian cells resulted in functional Na-V channels with properties that matched their parental constructs. Our findings explain a widely observed instability of recombinant neuronal human Na-V channels, and we describe re-engineered plasmids that attenuate this problem.	[Dekeyser, Jean-Marc; Thompson, Christopher H.; George, Alfred L., Jr.] Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	George, AL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA.	al.george@northwestern.edu			National Institutes of Health [NS108874]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant NS108874 (A. L. G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bertalovitz AC, 2018, J BIOL CHEM, V293, P12120, DOI 10.1074/jbc.RA118.001805; Bertelli S, 2019, CEPHALALGIA, V39, P477, DOI 10.1177/0333102418788336; Bhattacharjee, 2019, OXFORD HDB NEURONAL, P1; Bieth E, 1997, GENE, V194, P97, DOI 10.1016/S0378-1119(97)00173-X; Catterall WA, 2014, ANNU REV PHARMACOL, V54, P317, DOI 10.1146/annurev-pharmtox-011112-140232; Cruz-Vera LR, 2003, J BIOL CHEM, V278, P26065, DOI 10.1074/jbc.M301129200; Feldman DH, 2014, METHODSX, V1, P6, DOI 10.1016/j.mex.2014.01.002; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Hernandez-Sanchez J, 1998, EMBO J, V17, P3758, DOI 10.1093/emboj/17.13.3758; Johansen IE, 1996, P NATL ACAD SCI USA, V93, P12400, DOI 10.1073/pnas.93.22.12400; Kahlig KM, 2010, P NATL ACAD SCI USA, V107, P1343, DOI 10.1073/pnas.0910383107; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Mason E. R., 2019, ENEURO 6 ENEURO; Mauro VP, 2014, TRENDS MOL MED, V20, P604, DOI 10.1016/j.molmed.2014.09.003; Patel RR, 2016, BRAIN, V139, P2164, DOI 10.1093/brain/aww129; Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10; Shabalina SA, 2013, NUCLEIC ACIDS RES, V41, P2073, DOI 10.1093/nar/gks1205; Solovjev V, 2011, METAGENOMICITAPP, P61; Thompson CH, 2012, J BIOL CHEM, V287, P42001, DOI 10.1074/jbc.M112.421883; Thompson CH, 2011, EPILEPSIA, V52, P1000, DOI 10.1111/j.1528-1167.2011.03040.x	21	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100298	10.1016/j.jbc.2021.100298	http://dx.doi.org/10.1016/j.jbc.2021.100298			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33460646	Green Submitted, Green Published, gold			2022-12-26	WOS:000672866400272
J	Weston, LJ; Stackhouse, TL; Spinelli, KJ; Boutros, SW; Rose, EP; Osterberg, VR; Luk, KC; Raber, J; Weissman, TA; Unni, VK				Weston, Leah J.; Stackhouse, Teresa L.; Spinelli, Kateri J.; Boutros, Sydney W.; Rose, Elizabeth P.; Osterberg, Valerie R.; Luk, Kelvin C.; Raber, Jacob; Weissman, Tamily A.; Unni, Vivek K.			Genetic deletion of Polo-like kinase 2 reduces alpha-synuclein serine-129 phosphorylation in presynaptic terminals but not Lewy bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; RAT MODEL; SER129 PHOSPHORYLATION; MOUSE MODEL; PROTEIN; AGGREGATION; INHIBITOR; TOXICITY; PLK2; S129	Phosphorylation of alpha-synuclein at serine-129 is an important marker of pathologically relevant, aggregated forms of the protein in several important human diseases, including Parkinson's disease, Dementia with Lewy bodies, and Multiple system atrophy. Although several kinases have been shown to be capable of phosphorylating alpha-synuclein in various model systems, the identity of the kinase that phosphorylates alpha-synuclein in the Lewy body remains unknown. One member of the Polo-like kinase family, PLK2, is a strong candidate for being the Lewy body kinase. To examine this possibility, we have used a combination of approaches, including biochemical, immunohistochemical, and in vivo multiphoton imaging techniques to study the consequences of PLK2 genetic deletion on alpha-synuclein phosphorylation in both the presynaptic terminal and preformed fibril-induced Lewy body pathology in mouse cortex. We find that PLK2 deletion reduces presynaptic terminal alpha-synuclein serine-129 phosphorylation, but has no effect on Lewy body phosphorylation levels. Serine-129 mutation to the phosphomimetic alanine or the unphosphorylatable analog aspartate does not change the rate of cell death of Lewy inclusion-bearing neurons in our in vivo multiphoton imaging paradigm, but PLK2 deletion does slow the rate of neuronal death. Our data indicate that inhibition of PLK2 represents a promising avenue for developing new therapeutics, but that the mechanism of neuroprotection by PLK2 inhibition is not likely due to reducing alpha-synuclein serine-129 phosphorylation and that the true Lewy body kinase still awaits discovery.	[Weston, Leah J.; Stackhouse, Teresa L.; Spinelli, Kateri J.; Rose, Elizabeth P.; Osterberg, Valerie R.; Unni, Vivek K.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Weston, Leah J.; Stackhouse, Teresa L.; Spinelli, Kateri J.; Rose, Elizabeth P.; Osterberg, Valerie R.; Unni, Vivek K.] Oregon Hlth & Sci Univ, Jungers Ctr Neurosci Res, Portland, OR 97201 USA; [Boutros, Sydney W.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Rose, Elizabeth P.] Oregon Hlth & Sci Univ, Vollum Inst, Neurosci Grad Program, L474, Portland, OR 97201 USA; [Luk, Kelvin C.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Luk, Kelvin C.] Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Philadelphia, PA 19104 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Dept Behav Neurosci, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Dept Neurol, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Dept Radiat Med, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Div Neurosci, Portland, OR 97201 USA; [Weissman, Tamily A.] Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA; [Unni, Vivek K.] Oregon Hlth & Sci Univ, OHSU Parkinson Ctr, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University	Unni, VK (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA.; Unni, VK (corresponding author), Oregon Hlth & Sci Univ, Jungers Ctr Neurosci Res, Portland, OR 97201 USA.; Unni, VK (corresponding author), Oregon Hlth & Sci Univ, OHSU Parkinson Ctr, Portland, OR 97201 USA.	unni@ohsu.edu	Luk, Kelvin/AAZ-4202-2020	Luk, Kelvin/0000-0002-6591-6269; Unni, Vivek/0000-0001-8833-6542; Boutros, Sydney/0000-0001-5832-150X; Weissman, Tamily/0000-0001-9361-6071	NIH [NS102227, NS096190, NS061800]; Storm Family Foundation; Parkinson's Disease Foundation; American Parkinson Disease Association	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Storm Family Foundation; Parkinson's Disease Foundation; American Parkinson Disease Association	This work was supported in part by the NIH (grants NS102227 (VKU), NS096190 (VKU), NS061800 (VKU), the Storm Family Foundation (VKU), the Parkinson's Disease Foundation (KJS), and the American Parkinson Disease Association (VKU).	Adler CH, 2016, MOVEMENT DISORD, V31, P1114, DOI 10.1002/mds.26605; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Aubele DL, 2013, CHEMMEDCHEM, V8, P1295, DOI 10.1002/cmdc.201300166; Ball N, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00218; Basso E, 2013, MOL NEUROBIOL, V48, P854, DOI 10.1007/s12035-013-8473-z; Beach TG, 2008, ACTA NEUROPATHOL, V116, P277, DOI 10.1007/s00401-008-0409-8; Bergeron M, 2014, NEUROSCIENCE, V256, P72, DOI 10.1016/j.neuroscience.2013.09.061; Buck K, 2015, NEUROBIOL DIS, V78, P100, DOI 10.1016/j.nbd.2015.03.008; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chen L, 2009, J CLIN INVEST, V119, P3257, DOI 10.1172/JCI39088; Chen M, 2016, ONCOTARGET, V7, P8466, DOI 10.18632/oncotarget.6445; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Del Tredici K, 2016, NEUROPATH APPL NEURO, V42, P33, DOI 10.1111/nan.12298; Eckerdt F, 2005, J BIOL CHEM, V280, P36575, DOI 10.1074/jbc.M504548200; Escobar VD, 2014, NEUROSCI LETT, V563, P96, DOI 10.1016/j.neulet.2014.01.033; Febbraro F, 2013, NEUROBIOL DIS, V56, P47, DOI 10.1016/j.nbd.2013.03.014; Goncalves S, 2013, MOL NEUROBIOL, V47, P1081, DOI 10.1007/s12035-013-8406-x; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Johnson EF, 2007, BIOCHEMISTRY-US, V46, P9551, DOI 10.1021/bi7008745; Karampetsou M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15813-8; Kim JY, 2014, JOVE-J VIS EXP, DOI 10.3791/51863; Kofoed RH, 2017, NEUROBIOL DIS, V106, P49, DOI 10.1016/j.nbd.2017.06.014; Kothe M, 2007, CHEM BIOL DRUG DES, V70, P540, DOI 10.1111/j.1747-0285.2007.00594.x; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Lee KW, 2011, J NEUROSCI, V31, P6963, DOI 10.1523/JNEUROSCI.6513-10.2011; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; McFarland NR, 2009, J NEUROPATH EXP NEUR, V68, P515, DOI 10.1097/NEN.0b013e3181a24b53; NAKAJO S, 1993, EUR J BIOCHEM, V217, P1057, DOI 10.1111/j.1432-1033.1993.tb18337.x; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Osterberg VR, 2015, CELL REP, V10, P1252, DOI 10.1016/j.celrep.2015.01.060; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Pinho R, 2019, HUM MOL GENET, V28, P31, DOI 10.1093/hmg/ddy326; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Rockenstein E, 2005, J NEUROSCI RES, V80, P247, DOI 10.1002/jnr.20446; Sakamoto M, 2009, BIOCHEM BIOPH RES CO, V384, P378, DOI 10.1016/j.bbrc.2009.04.130; Sancenon V, 2012, HUM MOL GENET, V21, P2432, DOI 10.1093/hmg/dds058; Sato H, 2011, J NEUROSCI, V31, P16884, DOI 10.1523/JNEUROSCI.3967-11.2011; Schaser AJ, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-01026-0; Schaser AJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47227-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schoffski P, 2012, EUR J CANCER, V48, P179, DOI 10.1016/j.ejca.2011.11.001; Scott DA, 2010, J NEUROSCI, V30, P8083, DOI 10.1523/JNEUROSCI.1091-10.2010; Seeburg DP, 2005, ONCOGENE, V24, P292, DOI 10.1038/sj.onc.1208277; Spinelli KJ, 2014, J NEUROSCI, V34, P2037, DOI 10.1523/JNEUROSCI.2581-13.2014; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Sugeno N, 2008, J BIOL CHEM, V283, P23179, DOI 10.1074/jbc.M802223200; Surguchov A, 2015, INT REV CEL MOL BIO, V320, P103, DOI 10.1016/bs.ircmb.2015.07.007; Unni VK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010589; Vancraenenbroeck R, 2011, CNS NEUROL DISORD-DR, V10, P724, DOI 10.2174/187152711797247858; Villasana LE, 2016, J NEUROCHEM, V138, P896, DOI 10.1111/jnc.13737; Wang Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002566; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Waxman EA, 2011, J NEUROSCI RES, V89, P231, DOI 10.1002/jnr.22537	55	12	12	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100273	10.1016/j.jbc.2021.100273	http://dx.doi.org/10.1016/j.jbc.2021.100273			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33428941	gold, Green Published			2022-12-26	WOS:000672866400249
J	Karmakar, B; Saha, B; Jana, K; Bhattacharya, SG				Karmakar, Bijoya; Saha, Bodhisattwa; Jana, Kuladip; Bhattacharya, Swati Gupta			Identification and biochemical characterization of Asp t 36, a new fungal allergen from Aspergillus terreus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aspergillus terreus; allergen; triose-phosphate isomerase; proteomics; chromatography; circular dichroism; epitope mapping; airway inflammation; immunoglobulin E (IgE); immunoglobulin G (IgG); circular dichroism (CD)	MAJOR ALLERGEN; TRIOSEPHOSPHATE ISOMERASE; IGE; EPITOPES; REACTIVITY; ORYZAE	Aspergillus terreus is an allergenic fungus, in addition to causing infections in both humans and plants. However, the allergens in this fungus are still unknown, limiting the development of diagnostic and therapeutic strategies. We used a proteomic approach to search for allergens, identifying 16 allergens based on two-dimensional immunoblotting with A. terreus susceptible patient sera. We further characterized triose-phosphate isomerase (Asp t 36), one of the dominant IgE (IgE)-reactive proteins. The gene was cloned and expressed in Escherichia coli. Phylogenetic analysis showed Asp t 36 to be highly conserved with close similarity to the triose-phosphate isomerase protein sequence from Dermatophagoides farinae, an allergenic dust mite. We identified four immunodominant epitopes using synthetic peptides, and mapped them on a homology-based model of the tertiary structure of Asp t 36. Among these, two were found to create a continuous surface patch on the 3D structure, rendering it an IgE-binding hotspot. Biophysical analysis indicated that Asp t 36 shows similar secondary structure content and temperature sensitivity with other reported triose-phosphate isomerase allergens. In vivo studies using a murine model displayed that the recombinant Asp t 36 was able to stimulate airway inflammation, as demonstrated by an influx of eosinophils, goblet cell hyperplasia, elevated serum Igs, and induction of Th2 cytokines. Collectively, our results reveal the immunogenic property of Asp t 36, a major allergen from A. terreus, and define a new fungal allergen more broadly. This allergen could serve as a potent candidate for investigating component resolved diagnosis and immunotherapy.	[Karmakar, Bijoya; Bhattacharya, Swati Gupta] Bose Inst, Div Plant Biol, Main Campus, Kolkata, India; [Saha, Bodhisattwa] CSIR Inst Genom & Integrat Biol, New Delhi, India; [Jana, Kuladip] Bose Inst, Div Mol Med, Centenary Bldg, Kolkata, India	Department of Science & Technology (India); Bose Institute; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Department of Science & Technology (India); Bose Institute	Bhattacharya, SG (corresponding author), Bose Inst, Div Plant Biol, Main Campus, Kolkata, India.; Saha, B (corresponding author), CSIR Inst Genom & Integrat Biol, New Delhi, India.	bodhisattwasaha@gmail.com; swati@jcbose.ac.in	Jana, Kuladip/GXG-3481-2022	Jana, Kuladip/0000-0003-4748-253X	Department of Science and Technology (DST), India; DST	Department of Science and Technology (DST), India(Department of Science & Technology (India)); DST(Department of Science & Technology (India))	This work was supported by the Department of Science and Technology (DST), India and DST, Inspire-Faculty Grant (to B. K. and B. S.).	Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434; Adhikari A, 2004, SCI TOTAL ENVIRON, V326, P123, DOI 10.1016/j.scitotenv.2003.12.007; Banerjee B, 1998, INFECT IMMUN, V66, P5175, DOI 10.1128/IAI.66.11.5175-5182.1998; Bhattacharya K, 2018, INT ARCH ALLERGY IMM, V177, P219, DOI 10.1159/000490805; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Chuang JG, 2010, PROTEOMICS, V10, P3854, DOI 10.1002/pmic.201000348; Devos FC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180690; Ganguly HK, 2013, BIOCHEMISTRY-US, V52, P6348, DOI 10.1021/bi4007918; Ghosh D, 2014, J BIOL CHEM, V289, P21374, DOI 10.1074/jbc.M114.559971; Groeme R, 2016, J BIOL CHEM, V291, P13076, DOI 10.1074/jbc.M115.702001; Haahtela T, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-3; Hasan MK, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01492; Jayanthi Savio, 2019, Indian Journal of Allergy, Asthma & Immunology, V33, P19; Kamath SD, 2014, MOL NUTR FOOD RES, V58, P1144, DOI 10.1002/mnfr.201300584; Karmakar B, 2020, SN APPL SCI, V2, DOI 10.1007/s42452-020-2323-1; Li XH, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/483905; Louis Bengyella, 2014, BMC Res Notes, V7, P350, DOI 10.1186/1756-0500-7-350; MALDONADO H, 2015, CHEST S, V148, DOI DOI 10.1378/chest.2278744; Marth K, 2013, J IMMUNOL, V190, P3068, DOI 10.4049/jimmunol.1202441; Mattes J, 2001, J IMMUNOL, V167, P1683, DOI 10.4049/jimmunol.167.3.1683; Nayak AP, 2013, ANN ALLERG ASTHMA IM, V111, P32, DOI 10.1016/j.anai.2013.04.018; Negi SS, 2017, BIOINFORMATICS, V33, P1014, DOI 10.1093/bioinformatics/btw767; Nugraha R, 2018, J ALLERGY CLIN IMMUN, V141, P1501, DOI 10.1016/j.jaci.2017.11.028; Pekar J, 2018, MOL IMMUNOL, V100, P14, DOI 10.1016/j.molimm.2018.03.017; Ramachandran H, 2002, CLIN IMMUNOL, V103, P324, DOI 10.1006/clim.2002.5219; Saha B, 2017, J PROTEOMICS, V165, P1, DOI 10.1016/j.jprot.2017.05.021; Saha B, 2015, J PROTEOME RES, V14, P4823, DOI 10.1021/acs.jproteome.5b00657; Sander I, 2011, ALLERGY, V66, P1208, DOI 10.1111/j.1398-9995.2011.02636.x; Shankar J, 2006, MOL IMMUNOL, V43, P1927, DOI 10.1016/j.molimm.2005.12.006; Shen HD, 1998, INT ARCH ALLERGY IMM, V116, P29, DOI 10.1159/000023921; Sircar G, 2020, J BIOL CHEM, V295, P2736, DOI 10.1074/jbc.RA119.011659; Sircar G, 2016, J BIOL CHEM, V291, P18016, DOI 10.1074/jbc.M116.732032; Sircar G, 2012, J PROTEOMICS, V77, P455, DOI 10.1016/j.jprot.2012.09.023; Templeton SP, 2010, MED MYCOL, V48, P217, DOI 10.3109/13693780903420658; Xia F, 2019, J AGR FOOD CHEM, V67, P12918, DOI 10.1021/acs.jafc.9b05279; Yang Y, 2017, MOL IMMUNOL, V85, P35, DOI 10.1016/j.molimm.2017.02.004; Yang Y, 2017, J AGR FOOD CHEM, V65, P950, DOI 10.1021/acs.jafc.6b04587; Yu CJ, 1999, BIOCHEM BIOPH RES CO, V261, P669, DOI 10.1006/bbrc.1999.1093; Zahirovic A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01449; Zinsser VL, 2013, BIOCHIMIE, V95, P2182, DOI 10.1016/j.biochi.2013.08.014	40	3	3	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17852	17864		10.1074/jbc.RA120.015801	http://dx.doi.org/10.1074/jbc.RA120.015801			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454019	hybrid, Green Published			2022-12-26	WOS:000603272300035
J	D'Amico, D; Gammazza, AM; Macaluso, F; Paladino, L; Scalia, F; Spinoso, G; Dimauro, I; Caporossi, D; Cappello, F; Di Felice, V; Barone, R				D'Amico, Daniela; Gammazza, Antonella Marino; Macaluso, Filippo; Paladino, Letizia; Scalia, Federica; Spinoso, Giulio; Dimauro, Ivan; Caporossi, Daniela; Cappello, Francesco; Di Felice, Valentina; Barone, Rosario			Sex-based differences after a single bout of exercise on PGC1 alpha isoforms in skeletal muscle: A pilot study	FASEB JOURNAL			English	Article						heat shock protein 60; interleukin 6; Myosin Heavy Chain; physical exercise; skeletal muscle	RECEPTOR-GAMMA COACTIVATOR-1; MESSENGER-RNA; EXPRESSION; STRENGTH; PROTEIN; ALPHA; RESISTANCE; RESPONSES; FIBERS; CELLS	To date, there are limited and incomplete data on possible sex-based differences in fiber-types of skeletal muscle and their response to physical exercise. Adult healthy male and female mice completed a single bout of endurance exercise to examine the sex-based differences of the peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC1 alpha), heat shock protein 60 (Hsp60), interleukin 6 (IL-6) expression, as well as the Myosin Heavy Chain (MHC) fiber-type distribution in soleus and extensor digitorum longus (EDL) muscles. Our results showed for the first time that in male soleus, a muscle rich of type IIa fibers, endurance exercise activates specifically genes involved in mitochondrial biogenesis such as PGC1 alpha 1 isoform, Hsp60 and IL-6, whereas the expression of PGC1 alpha 2 and alpha 3 was significantly upregulated in EDL muscle, a fast-twitch skeletal muscle, independently from the gender. Moreover, we found that the acute response of different PGC1 alpha isoforms was muscle and gender dependent. These findings add a new piece to the huge puzzle of muscle response to physical exercise. Given the importance of these genes in the physiological response of the muscle to exercise, we strongly believe that our data could support future research studies to personalize a specific and sex-based exercise training protocol.	[D'Amico, Daniela; Gammazza, Antonella Marino; Paladino, Letizia; Scalia, Federica; Spinoso, Giulio; Cappello, Francesco; Di Felice, Valentina; Barone, Rosario] Univ Palermo, Dept Biomed Neurosci & Adv Diagnost BiND, Palermo, Italy; [D'Amico, Daniela; Scalia, Federica; Cappello, Francesco] Univ Texas Med Branch, Dept Neurosci Cell Biol & Anat, Galveston, TX 77555 USA; [Macaluso, Filippo; Scalia, Federica; Cappello, Francesco] eCampus Univ, SMART Engn Solut & Technol Res Ctr, Novedrate, Italy; [Macaluso, Filippo; Scalia, Federica; Cappello, Francesco] Euromediterranean Inst Sci & Technol IEMEST, Palermo, Italy; [Dimauro, Ivan; Caporossi, Daniela] Univ Rome Foro Ital, Dept Movement Human & Hlth Sci, Rome, Italy	University of Palermo; University of Texas System; University of Texas Medical Branch Galveston; Universita Ecampus; Foro Italico University of Rome	Barone, R (corresponding author), Dept Biomed Neurosci & Adv Diagnost BiND, Human Anat Sect, Via Vespro 129, I-90127 Palermo, Italy.	rusbarone@hotmail.it	Di Felice, Valentina/AAG-3740-2021; barone, rosario/ABA-6758-2021; Dimauro, Ivan/AAG-1178-2019; Caporossi, Daniela/D-7434-2011; Cappello, Francesco/F-9153-2012	Di Felice, Valentina/0000-0002-4132-1260; Dimauro, Ivan/0000-0003-0577-3144; Caporossi, Daniela/0000-0001-9628-0665; barone, rosario/0000-0002-8240-1240; Scalia, Federica/0000-0001-9948-9712; D'Amico, Daniela/0000-0002-8630-304X; Marino Gammazza, Antonella/0000-0002-1683-3803; Macaluso, Filippo/0000-0001-5109-2070; Cappello, Francesco/0000-0001-9288-1148				Antonioni A, 2020, FREE RADICAL BIO MED, V152, P301, DOI 10.1016/j.freeradbiomed.2020.03.013; Barone R, 2009, SCAND J MED SCI SPOR, V19, P782, DOI 10.1111/j.1600-0838.2008.00863.x; Barone R, 2017, J CELL MOL MED, V21, P1636, DOI 10.1111/jcmm.13092; Barone R, 2017, J CELL PHYSIOL, V232, P1086, DOI 10.1002/jcp.25511; Barone R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19781; Barone R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079686; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Bottinelli R, 1996, J PHYSIOL-LONDON, V495, P573, DOI 10.1113/jphysiol.1996.sp021617; Cappello F, 2008, CANCER BIOL THER, V7, P801, DOI 10.4161/cbt.7.6.6281; Di Felice V, 2015, J TISSUE ENG REGEN M, V9, pE51, DOI 10.1002/term.1739; Dimauro I, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101183; Dimauro I, 2016, FREE RADICAL BIO MED, V98, P46, DOI 10.1016/j.freeradbiomed.2016.03.028; Enns DL, 2010, SPORTS MED, V40, P41, DOI 10.2165/11319760-000000000-00000; Gammazza AM, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120224; Gidlund EK, 2015, J APPL PHYSIOL, V119, P374, DOI 10.1152/japplphysiol.01000.2014; Gouspillou G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103044; Haizlip KM, 2015, PHYSIOLOGY, V30, P30, DOI 10.1152/physiol.00024.2014; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hiscock N, 2004, FASEB J, V18, P992, DOI 10.1096/fj.03-1259fje; HOPPELER H, 1986, INT J SPORTS MED, V7, P187, DOI 10.1055/s-2008-1025758; Hunter SK, 2014, ACTA PHYSIOL, V210, P768, DOI 10.1111/apha.12234; Hyzewicz Janek, 2015, J Neuromuscul Dis, V2, P325; Jeon Y, 2019, J EXERC REHABIL, V15, P537, DOI 10.12965/jer.1938336.168; Jia WH, 2019, BIOCHEM BIOPH RES CO, V514, P407, DOI 10.1016/j.bbrc.2019.04.155; Khassaf M, 2001, J APPL PHYSIOL, V90, P1031, DOI 10.1152/jappl.2001.90.3.1031; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Larsson L, 1997, ACTA PHYSIOL SCAND, V159, P81, DOI 10.1046/j.1365-201X.1997.559328000.x; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Little JP, 2010, AM J PHYSIOL-REG I, V298, pR912, DOI 10.1152/ajpregu.00409.2009; MAUGHAN RJ, 1983, J PHYSIOL-LONDON, V338, P37, DOI 10.1113/jphysiol.1983.sp014658; MAUGHAN RJ, 1986, EUR J APPL PHYSIOL, V55, P395, DOI 10.1007/BF00422739; Mendham AE, 2016, J APPL PHYSIOL, V121, P1326, DOI 10.1152/japplphysiol.00289.2016; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; MILLER AEJ, 1993, EUR J APPL PHYSIOL O, V66, P254, DOI 10.1007/BF00235103; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Ryu S, 2006, CELL CYCLE, V5, P1140, DOI 10.4161/cc.5.11.2779; SALE DG, 1987, J APPL PHYSIOL, V62, P1786, DOI 10.1152/jappl.1987.62.5.1786; Samelman TR, 2000, EXP PHYSIOL, V85, P97, DOI 10.1111/j.1469-445X.2000.01894.x; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Schiaffino S, 2018, FEBS J, V285, P3688, DOI 10.1111/febs.14502; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shu JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183118; Silvennoinen M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12563; Staron RS, 2000, J HISTOCHEM CYTOCHEM, V48, P623, DOI 10.1177/002215540004800506; Tadaishi M, 2011, AM J PHYSIOL-ENDOC M, V300, pE341, DOI 10.1152/ajpendo.00400.2010; Trollet C, 2010, HUM MOL GENET, V19, P2191, DOI 10.1093/hmg/ddq098; Waters RE, 2004, AM J PHYSIOL-CELL PH, V287, pC1342, DOI 10.1152/ajpcell.00247.2004; Weiss A, 1999, P NATL ACAD SCI USA, V96, P2958, DOI 10.1073/pnas.96.6.2958; Weiss A, 1999, J MOL BIOL, V290, P61, DOI 10.1006/jmbi.1999.2865; Wen XY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/402175; Ydfors M, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.140	58	8	8	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21328	10.1096/fj.202002173R	http://dx.doi.org/10.1096/fj.202002173R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33433932				2022-12-26	WOS:000647789600003
J	Goetzl, EJ; Srihari, VH; Guloksuz, S; Ferrara, M; Tek, C; Heninger, GR				Goetzl, Edward J.; Srihari, Vinod H.; Guloksuz, Sinan; Ferrara, Maria; Tek, Cenk; Heninger, George R.			Neural cell-derived plasma exosome protein abnormalities implicate mitochondrial impairment in first episodes of psychosis	FASEB JOURNAL			English	Article						ATP synthase; cyclophilin D; humanin; mitofusin 2; MOTS&#8208; c; schizophrenia	PEPTIDE HUMANIN; EMERGING ROLE; DYSFUNCTION; APOPTOSIS; TRANSPORT; SURVIVAL; AGE	Neuroprotective and other functional proteins of mitochondria were quantified in extracts of plasma neural-derived exosomes from ten first-episode psychosis (FP) patients and ten matched psychiatrically normal controls (ctls). Astrocyte-derived extracellular vesicles (ADEVs) and neuron-derived extracellular vesicles (NDEVs) were immunoabsorbed separately from physically precipitated plasma total EVs. Extracted mitochondrial ATP synthase was specifically immunofixed to plastic wells for quantification of catalytic activity based on conversion of NADH to NAD(+). Other extracted mitochondrial functional proteins were quantified by ELISAs. All protein levels were normalized with EV content of the CD81 exosome marker. FP patient ADEV level but not NDEV level of mitochondrial ATP synthase activity was significantly lower than that of ctls. FP patient ADEV and NDEV levels of the functionally critical mitochondrial proteins mitofusin 2 and cyclophilin D, but not of transcription factor A of mitochondria, and of the mitochondrial short open-reading frame neuroprotective and metabolic regulatory peptides humanin and MOTS-c were significantly lower than those of ctls. In contrast, FP patient NDEV, but not ADEV, level of the mitochondrial-tethering protein syntaphilin, but not of myosin VI, was significantly higher than that of ctls. The distinctively different neural levels of some mitochondrial proteins in FP patients than ctls now should be correlated with diverse clinical characteristics. Drugs that increase depressed levels of proteins and mimetics of deficient short open-reading frame peptides may be of therapeutic value in early phases of schizophrenia.	[Goetzl, Edward J.] Univ Calif San Francisco, Dept Med, Med Ctr, San Francisco, CA 94143 USA; [Goetzl, Edward J.] Campus Jewish Living, San Francisco, CA USA; [Srihari, Vinod H.; Guloksuz, Sinan; Ferrara, Maria; Tek, Cenk; Heninger, George R.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Guloksuz, Sinan] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Med Ctr, Maastricht, Netherlands	University of California System; University of California San Francisco; Yale University; Maastricht University	Goetzl, EJ (corresponding author), UCSF, Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94143 USA.	edward.goetzl@ucsf.edu	Ferrara, Maria/AHE-21602-2022; Srihari, Vinod/B-9040-2018	Ferrara, Maria/0000-0003-2143-1101; Srihari, Vinod/0000-0003-1556-2332; Guloksuz, Sinan/0000-0002-6626-1874	NIMH NIH HHS [R01 MH103831] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adav SS, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0430-y; Amanakis G, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00595; Cannon TD, 2015, BIOL PSYCHIAT, V77, P147, DOI 10.1016/j.biopsych.2014.05.023; Cobb LJ, 2016, AGING-US, V8, P796, DOI 10.18632/aging.100943; Zarate SC, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00123; Filadi R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0023-6; Flippo KH, 2017, SCHIZOPHR RES, V187, P26, DOI 10.1016/j.schres.2017.05.003; Goetzl EJ, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-01046-3; Goetzl EJ, 2018, ANN NEUROL, V83, P544, DOI 10.1002/ana.25172; Goetzl EJ, 2016, FASEB J, V30, P3853, DOI 10.1096/fj.201600756R; Goldsmith David R, 2018, Focus (Am Psychiatr Publ), V16, P153, DOI 10.1176/appi.focus.20170046; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Ho NF, 2017, MOL PSYCHIATR, V22, P142, DOI 10.1038/mp.2016.4; Hornung S, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00038; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Kang I, 2018, FEBS LETT, V592, P793, DOI 10.1002/1873-3468.12989; Kneussel M, 2013, NAT REV NEUROSCI, V14, P233, DOI 10.1038/nrn3445; Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009; Li SN, 2020, NAT METAB, V2, P1077, DOI 10.1038/s42255-020-00289-0; Lin MY, 2017, NEURON, V94, P595, DOI 10.1016/j.neuron.2017.04.004; Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703, DOI 10.1093/oxfordjournals.schbul.a007040; Mustapic M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00278; Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334; Ni P., 2019, MOL PSYCHIATR; Ohno N, 2014, P NATL ACAD SCI USA, V111, P9953, DOI 10.1073/pnas.1401155111; Park YU, 2010, P NATL ACAD SCI USA, V107, P17785, DOI 10.1073/pnas.1004361107; Perkovic MN, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040733; Rollins Brandi L, 2018, Mol Neuropsychiatry, V3, P157, DOI 10.1159/000484348; Garcia-Gutierrez MS, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00432; Schobel SA, 2013, NEURON, V78, P81, DOI 10.1016/j.neuron.2013.02.011; Srihari VH, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0335-3; Yen K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32616-7; Yen K, 2013, J MOL ENDOCRINOL, V50, pR11, DOI 10.1530/JME-12-0203	34	10	12	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21339	10.1096/fj.202002519R	http://dx.doi.org/10.1096/fj.202002519R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33454965				2022-12-26	WOS:000647789600028
J	Wagner, PM; Prucca, CG; Velazquez, FN; Alderete, LGS; Caputto, BL; Guido, ME				Wagner, Paula M.; Prucca, Cesar G.; Velazquez, Fabiola N.; Sosa Alderete, Lucas G.; Caputto, Beatriz L.; Guido, Mario E.			Temporal regulation of tumor growth in nocturnal mammals: In vivo studies and chemotherapeutical potential	FASEB JOURNAL			English	Article						Bortezomib; cancer chronotherapy; circadian clock; light; dark differences; tumor growth	CLOCK GENE BMAL1; CELL-CYCLE PROGRESSION; CIRCADIAN CLOCK; DNA-DAMAGE; DEREGULATED EXPRESSION; PANCREATIC-CANCER; PROSTATE-CANCER; DAILY RHYTHMS; PER1; GLIOBLASTOMA	Tumors of the nervous system including glioblastoma multiforme (GBM) are the most frequent and aggressive form of brain tumors; however, little is known about the impact of the circadian timing system on the formation, growth, and treatment of these tumors. We investigated day/night differences in tumor growth after injection of A530 glioma cells isolated from malignant peripheral nerve sheath tumor (MPNSTs) of NPcis (Trp53(+/-); Nf1(+/-)) mice. Synchronized A530 cell cultures expressing typical glial markers were injected at the beginning of the day or night into the sciatic nerve zone of C57BL/6 mice subject to a 12:12 hours light/dark (LD) cycle or after being released to constant darkness (DD). Tumors generated in animals injected early at night in the LD cycle or in DD showed higher growth rates than in animals injected diurnally. No differences were found when animals were injected at the same time with cultures synchronized 12 hours apart. Similar experiments performed with B16 melanoma cells showed higher tumor growth rates in animals injected at the beginning of the night compared to those injected in the daytime. A higher tumor growth rate than that in controls was observed when mice were injected with knocked-down clock gene Bmal1 cells. Finally, when we compared day/night administration of different doses of the proteasome inhibitor Bortezomib (0.5-1.5 mg/kg) in tumor-bearing animals, we found that low-dose chemotherapy displayed higher efficacy when administered at night. Results suggest the existence of a precise temporal control of tumor growth and of drug efficacy in which the host state and susceptibility are critical.	[Wagner, Paula M.; Prucca, Cesar G.; Caputto, Beatriz L.; Guido, Mario E.] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba CIQUIBIC CONICET, Cordoba, Argentina; [Wagner, Paula M.; Prucca, Cesar G.; Caputto, Beatriz L.; Guido, Mario E.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol Ranwel Caputto, Cordoba, Argentina; [Velazquez, Fabiola N.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Velazquez, Fabiola N.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Sosa Alderete, Lucas G.] Univ Nacl Rio Cuarto, UNRC CONICET, Inst Biotecnol Ambiental & Salud INBIAS, Fac Ciencias Exactas Fisicoquim & Nat, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional Rio Cuarto	Guido, ME (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, CIQUIBIC CONICET Dept Quim Biol Ranwel Caputto, Haya Torre S-N,Ciudad Univ, RA-5000 Cordoba, Argentina.	mguido@fcci.unc.edu.ar	Prucca, César Germán/AAC-4630-2021	Prucca, César Germán/0000-0003-4165-4660				Acosta-Rodriguez VA, 2013, J LIPID RES, V54, P1798, DOI 10.1194/jlr.M034264; Antoch MP, 2013, CELL CYCLE, V12, P3673, DOI 10.4161/cc.26614; Arjona A, 2006, BRAIN BEHAV IMMUN, V20, P469, DOI 10.1016/j.bbi.2005.10.002; Benzekry S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003800; Bjarnason G A, 2000, Prog Cell Cycle Res, V4, P193; Boccadoro M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-18; Bollinger T, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13984; Cao Q, 2009, CANCER RES, V69, P7619, DOI 10.1158/0008-5472.CAN-08-4199; Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075; Chu LW, 2008, PROSTATE CANCER P D, V11, P342, DOI 10.1038/sj.pcan.4501024; COLLINS VP, 1956, AMER J ROENTGENOL RA, V76, P988; Comba A, 2019, MOL NEUROBIOL, V56, P1653, DOI 10.1007/s12035-018-1182-x; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Dai HJ, 2011, BREAST CANCER RES TR, V127, P531, DOI 10.1007/s10549-010-1231-2; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fu LN, 2013, PROG MOL BIOL TRANSL, V119, P221, DOI 10.1016/B978-0-12-396971-2.00009-9; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gallego-Ortega D, 2011, ADV ENZYME REGUL, V51, P183, DOI 10.1016/j.advenzreg.2010.09.010; Garbarino-Pico E, 2004, J BIOL CHEM, V279, P51172, DOI 10.1074/jbc.M309248200; Gerlee P, 2013, CANCER RES, V73, P2407, DOI 10.1158/0008-5472.CAN-12-4355; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Geyfman M, 2012, P NATL ACAD SCI USA, V109, P11758, DOI 10.1073/pnas.1209592109; Gooley JJ, 2014, J GENET GENOMICS, V41, P231, DOI 10.1016/j.jgg.2014.04.001; Gorbacheva VY, 2005, P NATL ACAD SCI USA, V102, P3407, DOI 10.1073/pnas.0409897102; Gorne LD, 2015, CHRONOBIOL INT, V32, P11, DOI 10.3109/07420528.2014.949734; Grechez-Cassiau A, 2015, CHRONOBIOL INT, V32, P774, DOI 10.3109/07420528.2015.1046601; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Gu X, 2012, CELL DEATH DIFFER, V19, P397, DOI 10.1038/cdd.2011.103; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Hsu CM, 2012, TUMOR BIOL, V33, P149, DOI 10.1007/s13277-011-0258-2; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Huang XL, 2011, J INT MED RES, V39, P2061, DOI 10.1177/147323001103900601; Jiang WL, 2016, CANCER LETT, V371, P314, DOI 10.1016/j.canlet.2015.12.002; Joseph NM, 2008, CANCER CELL, V13, P129, DOI 10.1016/j.ccr.2008.01.003; Jung-Hynes B, 2010, J PINEAL RES, V49, P60, DOI 10.1111/j.1600-079X.2010.00767.x; Khapre RV, 2011, CELL CYCLE, V10, P4162, DOI 10.4161/cc.10.23.18381; Kubo T, 2006, AM J EPIDEMIOL, V164, P549, DOI 10.1093/aje/kwj232; Lahti T, 2012, ANN MED, V44, P847, DOI 10.3109/07853890.2012.727018; Lahti TA, 2008, INT J CANCER, V123, P2148, DOI 10.1002/ijc.23566; Laposky AD, 2008, FEBS LETT, V582, P142, DOI 10.1016/j.febslet.2007.06.079; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010995; Lenting K, 2017, ACTA NEUROPATHOL, V133, P263, DOI 10.1007/s00401-017-1671-4; Lin YM, 2008, MOL CARCINOGEN, V47, P925, DOI 10.1002/mc.20446; Liu YM, 2002, ONCOGENE, V21, P7680, DOI 10.1038/sj.onc.1205883; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madden MH, 2014, CANCER CAUSE CONTROL, V25, P25, DOI 10.1007/s10552-013-0305-y; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Masri S, 2018, NAT MED, V24, P1795, DOI 10.1038/s41591-018-0271-8; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Mehrara E, 2009, ACTA ONCOL, V48, P591, DOI 10.1080/02841860802616736; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Niu ZF, 2015, ONCOTARGET, V6, P9951, DOI 10.18632/oncotarget.3179; Oda A, 2009, ANTICANCER RES, V29, P1201; Papagiannakopoulos T, 2016, CELL METAB, V24, P324, DOI 10.1016/j.cmet.2016.07.001; Plikus MV, 2013, P NATL ACAD SCI USA, V110, pE2106, DOI 10.1073/pnas.1215935110; Pogue-Geile KL, 2006, CANCER LETT, V243, P55, DOI 10.1016/j.canlet.2005.11.049; Puram RV, 2016, CORE CIRCADIAN CLOCK; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Razorenova OV, 2012, CELL CYCLE, V11, P213, DOI 10.4161/cc.11.2.18786; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Rijo-Ferreira F, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0704-0; Rios-Doria J, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000416; Sarma HD, 2011, CURR RADIOPHARM, V4, P150, DOI 10.2174/1874471011104020150; Scheiermann C, 2018, NAT REV IMMUNOL, V18, P423, DOI 10.1038/s41577-018-0008-4; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Slat EA, 2017, J BIOL RHYTHM, V32, P121, DOI 10.1177/0748730417696788; Spyra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021099; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Stylli SS, 2015, J CLIN NEUROSCI, V22, P619, DOI 10.1016/j.jocn.2014.10.013; Sulli G, 2019, TRENDS CANCER, V5, P475, DOI 10.1016/j.trecan.2019.07.002; Sun CM, 2010, PATHOL ONCOL RES, V16, P403, DOI 10.1007/s12253-009-9227-0; Takahashi JS, 2015, DIABETES OBES METAB, V17, P6, DOI 10.1111/dom.12514; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tang QM, 2017, CANCER RES, V77, P532, DOI 10.1158/0008-5472.CAN-16-1322; Taniguchi H, 2009, CANCER RES, V69, P8447, DOI 10.1158/0008-5472.CAN-09-0551; Vlachostergios PJ, 2013, CELL MOL NEUROBIOL, V33, P313, DOI 10.1007/s10571-013-9910-2; Wagner PM, 2019, ASN NEURO, V11, DOI 10.1177/1759091419892713; Wagner PM, 2019, MOL NEUROBIOL, V56, P1276, DOI 10.1007/s12035-018-1152-3; Winter SL, 2007, NEOPLASIA, V9, P797, DOI 10.1593/neo.07595; Wood PA, 2008, MOL CANCER RES, V6, P1786, DOI 10.1158/1541-7786.MCR-08-0196; Wu G, 2016, BIOINFORMATICS, V32, P3351, DOI 10.1093/bioinformatics/btw405; Xia HC, 2010, CAN J NEUROL SCI, V37, P365, DOI 10.1017/S031716710001026X; Yang YY, 2018, P NATL ACAD SCI USA, V115, pE4777, DOI 10.1073/pnas.1804493115; Zhou F, 2012, CANCER-AM CANCER SOC, V118, P937, DOI 10.1002/cncr.26348; Zhu Y, 2009, CANCER RES, V69, P9315, DOI 10.1158/0008-5472.CAN-09-0648	90	9	9	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21231	10.1096/fj.202001753R	http://dx.doi.org/10.1096/fj.202001753R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33428275				2022-12-26	WOS:000647789600097
J	Chuang, FC; Wang, CC; Chen, JH; Hwang, TZ; Yeh, SA; Su, YC				Chuang, Fu-Cheng; Wang, Chih-Chun; Chen, Jian-Han; Hwang, Tzer-Zen; Yeh, Shyh-An; Su, Yu-Chieh			PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy	PLOS ONE			English	Article							IN-VITRO; RECURRENT; CANCER; COMBINATION; STRATEGY; IMPROVES; PATHWAY	Approximately 500,000 new cases of head and neck squamous cell carcinoma (HNSCC) are reported annually. Radiation therapy is an important treatment for oral squamous cell carcinoma (OSCC). The survival rate of patients with HNSCC remained low (50%) in decades because of radiation therapy failure caused by the radioresistance of HNSCC cells. This study aimed to identify PI3K inhibitors that can enhance radiosensitivity. Results showed that pan-Phosphoinositide 3-kinases (PI3K) inhibitor BKM120 and class I alpha -specific PI3K inhibitor BYL719 dose-dependently reduced the growth of OSCC cells but not that of radioresistant OML1-R cells. The combination treatment of BKM120 or BYL719 with radiation showed an enhanced inhibitory effect on OSCC cells and radioresistant OML1-R cells. Furthermore, the enhanced inhibitory effect of the combination treatment was confirmed in patient-derived OSCC cells. The triple combination treatment of mTOR inhibitor AZD2014 and BKM120 or AZD2014 and BYL719 with radiation showed a significantly enhanced inhibitory effect on radioresistant OML1-R cells. These results suggest that the PI3K inhibitors are potential therapeutic agents with radiosensitivity for patients with OSCC.	[Chuang, Fu-Cheng; Yeh, Shyh-An] E Da Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Chuang, Fu-Cheng; Wang, Chih-Chun; Chen, Jian-Han; Hwang, Tzer-Zen; Su, Yu-Chieh] I Shou Univ, Sch Med, Dept Med, Kaohsiung, Taiwan; [Wang, Chih-Chun; Hwang, Tzer-Zen] E Da Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Chen, Jian-Han] E Da Hosp, Dept Gen Surg, Kaohsiung, Taiwan; [Yeh, Shyh-An] I Shou Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan; [Su, Yu-Chieh] E Da Hosp, Dept Internal Med, Div Hematol Oncol, Kaohsiung, Taiwan	E-Da Hospital; I Shou University; E-Da Hospital; E-Da Hospital; I Shou University; E-Da Hospital	Su, YC (corresponding author), I Shou Univ, Sch Med, Dept Med, Kaohsiung, Taiwan.; Su, YC (corresponding author), E Da Hosp, Dept Internal Med, Div Hematol Oncol, Kaohsiung, Taiwan.	hepatoma@gmail.com		Su, Yu-Chieh/0000-0002-1771-9017				Burris HA, 2013, CANCER CHEMOTH PHARM, V71, P829, DOI 10.1007/s00280-012-2043-3; Chang L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.415; Creak AL, 2005, CLIN ONCOL-UK, V17, P138, DOI 10.1016/j.clon.2004.10.008; Freudlsperger C, 2011, EXPERT OPIN THER TAR, V15, P63, DOI 10.1517/14728222.2011.541440; Fritsch C, 2014, MOL CANCER THER, V13, P1117, DOI 10.1158/1535-7163.MCT-13-0865; GAPANY M, 1995, MOL MED, V1, P659, DOI 10.1007/BF03401606; Geiger JL, 2016, HEAD NECK-J SCI SPEC, V38, P1759, DOI 10.1002/hed.24501; Heavey S, 2014, CANCER TREAT REV, V40, P445, DOI 10.1016/j.ctrv.2013.08.006; Horn D, 2015, EXPERT OPIN THER TAR, V19, P795, DOI 10.1517/14728222.2015.1012157; Keam B, 2015, ANTICANCER RES, V35, P175; Khan KH, 2013, CHIN J CANCER, V32, P253, DOI 10.5732/cjc.013.10057; Lavaf A, 2008, CANCER-AM CANCER SOC, V112, P535, DOI 10.1002/cncr.23206; Lawrence TS, 2003, SEMIN RADIAT ONCOL, V13, P13, DOI 10.1053/srao.2003.50002; Liu WL, 2014, ONCOTARGET, V5, P3662, DOI 10.18632/oncotarget.1978; Martini M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00108; Mery B, 2017, ORAL ONCOL, V65, P51, DOI 10.1016/j.oraloncology.2016.12.010; Michmerhuizen NL, 2019, MOL PHARMACOL, V95, P528, DOI 10.1124/mol.118.115162; Skvortsov S, 2014, BRIT J CANCER, V110, P2677, DOI 10.1038/bjc.2014.221; Tai TS, 2019, ANTICANCER RES, V39, P713, DOI 10.21873/anticanres.13167; Wheler J, 2017, ONCOLOGIST, V22, P377, DOI 10.1634/theoncologist.2016-0257; Yang WC, 2014, ANTICANCER RES, V34, P3765; Yu CC, 2017, ONCOTARGET, V8, P68641, DOI 10.18632/oncotarget.19817; Yu CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151942; Yu CC, 2014, ANTICANCER RES, V34, P2927	24	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245715	10.1371/journal.pone.0245715	http://dx.doi.org/10.1371/journal.pone.0245715			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471836	gold, Green Published			2022-12-26	WOS:000639428800063
J	Millan, MF; Carranza, J; Perez-Gonzalez, J; Valencia, J; Torres-Porras, J; Seoane, JM; de la Pena, E; Alarcos, S; Sanchez-Prieto, CB; Castillo, L; Flores, A; Membrillo, A				F. Millan, Marina; Carranza, Juan; Perez-Gonzalez, Javier; Valencia, Juliana; Torres-Porras, Jeronimo; Seoane, Jose M.; de la Pena, Eva; Alarcos, Susana; Sanchez-Prieto, Cristina B.; Castillo, Leticia; Flores, Antonio; Membrillo, Alberto			Rainfall decrease and red deer rutting behaviour: Weaker and delayed rutting activity though higher opportunity for sexual selection	PLOS ONE			English	Article							CLIMATE-CHANGE IMPACTS; VEGETATION CHANGES; TEMPORARY PONDS; CERVUS-ELAPHUS; FEMALE AGGREGATION; BREEDING PHENOLOGY; PLANT PHENOLOGY; SW SPAIN; DONANA; TRAITS	In the last decades, climate change has caused an increase in mean temperatures and a reduction in average rainfall in southern Europe, which is expected to reduce resource availability for herbivores. Resource availability can influence animals' physical condition and population growth. However, much less is known on its effects on reproductive performance and sexual selection. In this study, we assessed the impact of three environmental factors related to climate change (rainfall, temperature and vegetation index) on Iberian red deer Cervus elaphus hispanicus reproductive timing and sexual behaviour, and their effects on the opportunity for sexual selection in the population. We measured rutting phenology as rut peak date, the intensity of male rutting activity as roaring rate, and the opportunity for sexual selection from the distribution of females among harem holding males in Donana Biological Reserve (Southwest Spain), from data of daily observations collected during the rut over a period of 25 years. For this study period, we found a trend for less raining and hence poorer environmental conditions, which associated with delayed rutting season and decreased rutting intensity, but that appeared to favour a higher degree of polygyny and opportunity for sexual selection, all these relationships being modulated by population density and sex ratio. This study highlights how climate change (mainly rainfall reduction in this area) can alter the conditions for mating and the opportunity for sexual selection in a large terrestrial mammal.	[F. Millan, Marina; Carranza, Juan; Seoane, Jose M.; de la Pena, Eva; Membrillo, Alberto] Univ Cordoba, Wildlife Res Unit UIRCP, Cordoba, Spain; [Perez-Gonzalez, Javier; Alarcos, Susana; Sanchez-Prieto, Cristina B.; Castillo, Leticia; Flores, Antonio] Univ Extremadura, Biol & Ethol Unit, Caceres, Spain; [Valencia, Juliana] Univ Malaga, Fac Ciencias Educ, Didact Ciencias Expt, Malaga, Spain; [Torres-Porras, Jeronimo] Univ Cordoba, Fac Educ Sci, Dept Social & Expt Sci Teaching, Cordoba, Spain	Universidad de Cordoba; Universidad de Extremadura; Universidad de Malaga; Universidad de Cordoba	Millan, MF; Carranza, J (corresponding author), Univ Cordoba, Wildlife Res Unit UIRCP, Cordoba, Spain.	b22femim@uco.es; jcarranza@uco.es	Pérez-González, Javier/AAF-6106-2020; De la Peña, Eva/ABI-7470-2020; Membrillo, Alberto/ABF-5308-2021; Torres-Porras, Jeronimo/L-3005-2015	De la Peña, Eva/0000-0001-9567-1111; Membrillo, Alberto/0000-0001-9770-0537; Torres-Porras, Jeronimo/0000-0003-1900-7870; Perez-Gonzalez, Javier/0000-0003-0624-835X; , Marina/0000-0002-0116-8134; Carranza, Juan/0000-0002-0368-7173	Spanish Ministry of Science [CGL201677052-P]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study did not received specific funding. Financial support came from consecutive projects funded by the Spanish Ministry of Science to JC, the most recent of them being CGL201677052-P, which made possible the maintenance of the long-term red deer research project in Donana for more than 25 years. b) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. d)The authors received no specific funding for this work.	ALES RF, 1992, LANDSCAPE ECOL, V7, P3, DOI 10.1007/BF02573953; Alin A, 2010, WIRES COMPUT STAT, V2, P370, DOI 10.1002/wics.84; Andersson Malte, 1994; Archibold OW., ECOLOGY WORLD VEGETA; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; AYRES MP, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P75; Azorit C, 2002, Z JAGDWISS, V48, P137, DOI 10.1007/BF02189987; Babak N., 2015, R PACKAGE VERSION 1, P1; Bailey LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167980; BEEBEE TJC, 1995, NATURE, V374, P219, DOI 10.1038/374219a0; Borowik T, 2013, EUR J WILDLIFE RES, V59, P675, DOI 10.1007/s10344-013-0720-0; Bowler DE, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0067; BRAZA F, 1987, Miscellania Zoologica (Barcelona), V11, P363; Bronson FH, 2009, PHILOS T R SOC B, V364, P3331, DOI 10.1098/rstb.2009.0140; BRONSON FH, 1985, BIOL REPROD, V32, P1, DOI 10.1095/biolreprod32.1.1; Bugalho MN, 2003, FOREST ECOL MANAG, V181, P23, DOI 10.1016/S0378-1127(03)00125-7; Munoz-Reinoso JC, 2020, J COASTAL RES, P113, DOI 10.2112/SI95-022.1; CARRANZA J, 1990, ANIM BEHAV, V40, P79, DOI 10.1016/S0003-3472(05)80667-0; Carranza J, 1999, BEHAV ECOL, V10, P525, DOI 10.1093/beheco/10.5.525; CARRANZA J, 1995, ANIM BEHAV, V50, P445, DOI 10.1006/anbe.1995.0258; Carranza J., 2000, VERTEBRATE MATING SY, P106, DOI [10.1142/9789812793584_0006, DOI 10.1142/9789812793584_0006]; Carrion D, 2008, J EXP ZOOL PART A, V309A, P1, DOI 10.1002/jez.425; Chavez PS, 1996, PHOTOGRAMM ENG REM S, V62, P1025; Cleland EE, 2012, ECOLOGY, V93, P1765, DOI 10.1890/11-1912.1; Clutton-Brock T.H., 1988, P325; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; CLUTTONBROCK TH, 1983, J ANIM ECOL, V52, P367, DOI 10.2307/4560; Congedo L., 2015, SEMIAUTOMATIC CLASSI; CORONA MG, 1988, VEGETATIO, V75, P73, DOI 10.1007/BF00044628; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Dimitriou E, 2017, J ARID ENVIRON, V147, P90, DOI 10.1016/j.jaridenv.2017.09.004; EMLEN DJ, 1994, P ROY SOC B-BIOL SCI, V256, P131, DOI 10.1098/rspb.1994.0060; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; ESPIGARES T, 1993, J VEG SCI, V4, P189, DOI 10.2307/3236104; Fei SL, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603055; Fernandez-Ayuso A, 2018, HYDROLOG SCI J, V63, P2048, DOI 10.1080/02626667.2018.1560449; FESTABIANCHET M, 1988, J ZOOL, V214, P653, DOI 10.1111/j.1469-7998.1988.tb03764.x; Forchhammer MC, 1998, NATURE, V391, P29, DOI 10.1038/34070; Guardiola-Albert C, 2011, WETLANDS, V31, P907, DOI 10.1007/s13157-011-0205-4; Huin N, 2000, BIRD STUDY, V47, P22, DOI 10.1080/00063650009461157; IPCC, 2014, CLIMATE CHANGE 2014, DOI DOI 10.1017/CBO9781107415379; IPCC, 2013, CLIM CHANG 2013; Janicke T, 2018, ECOL LETT, V21, P384, DOI 10.1111/ele.12907; Klein D.R., 1985, Royal Society of New Zealand Bulletin, P13; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; Landete-Castillejos T, 2002, BIOL REPROD, V67, P1613, DOI 10.1095/biolreprod.102.004507; Langvatn R, 2004, AM NAT, V163, P763, DOI 10.1086/383594; Lazaro R, 2001, J ARID ENVIRON, V48, P373, DOI 10.1006/jare.2000.0755; LEHNER PN, 1992, POULTRY SCI, V71, P643, DOI 10.3382/ps.0710643; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Loe LE, 2005, J ANIM ECOL, V74, P579, DOI 10.1111/j.1365-2656.2005.00987.x; MCCOMB KE, 1991, ANIM BEHAV, V41, P79, DOI 10.1016/S0003-3472(05)80504-4; Moller AP, 2004, GLOBAL CHANGE BIOL, V10, P2028, DOI 10.1111/j.1365-2486.2004.00874.x; MOller AP, 2010, EFFECTS CLIMATE CHAN; Moyes K, 2011, GLOBAL CHANGE BIOL, V17, P2455, DOI 10.1111/j.1365-2486.2010.02382.x; Munoz-Reinoso JC, 2001, J HYDROL, V242, P197, DOI 10.1016/S0022-1694(00)00397-8; Murtaugh PA, 2014, ECOLOGY, V95, P611, DOI 10.1890/13-0590.1; Mysterud A, 2005, OIKOS, V111, P245, DOI 10.1111/j.0030-1299.2005.14197.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Naranjo-Fernandez N., STOCH ENV RES RISK A, V2020, P1; Nogueira C, 2017, ENVIRON EXP BOT, V138, P99, DOI 10.1016/j.envexpbot.2017.03.005; Pacifici M, 2017, NAT CLIM CHANGE, V7, P205, DOI 10.1038/NCLIMATE3223; Palomo I, 2014, REG ENVIRON CHANGE, V14, P237, DOI 10.1007/s10113-013-0488-5; Paoli A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195603; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Passilongo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063841; Pearce-Higgins JW, 2015, J ANIM ECOL, V84, P943, DOI 10.1111/1365-2656.12364; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Pecl GT, 2017, SCIENCE, V355, DOI 10.1126/science.aai9214; Pelaez M, 2017, INTEGR ZOOL, V12, P396, DOI 10.1111/1749-4877.12252; PEMBERTON JM, 1992, BEHAV ECOL, V3, P66, DOI 10.1093/beheco/3.1.66; Perez-Barberia FJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233809; Perez-Barberia FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134788; Perez-Barberia FJ, 2015, CAN J ZOOL, V93, P249, DOI 10.1139/cjz-2015-0042; Perez-Gonzalez J, 2009, MOL ECOL, V18, P1591, DOI 10.1111/j.1365-294X.2009.04150.x; Perez-Gonzalez J, 2011, ANIM BEHAV, V82, P957, DOI 10.1016/j.anbehav.2011.07.023; Perez-Gonzalez J, 2010, WILDLIFE RES, V37, P301, DOI 10.1071/WR09033; Pettorelli N, 2005, P ROY SOC B-BIOL SCI, V272, P2357, DOI 10.1098/rspb.2005.3218; Pettorelli N, 2006, OIKOS, V112, P565, DOI 10.1111/j.0030-1299.2006.14447.x; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Plard F, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001828; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Post E, 1997, P ROY SOC B-BIOL SCI, V264, P1317, DOI 10.1098/rspb.1997.0182; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; QGIS Development Team, 2009, QGIS GEOGR INF SYST; RCore Team, 2020, R LANG ENV STAT COMP; Sanchez-Prieto CB, 2004, J MAMMAL, V85, P761, DOI 10.1644/BJK-122; Sanchez-Prieto CB, 2010, J NAT CONSERV, V18, P196, DOI 10.1016/j.jnc.2009.09.002; Serrano L, 1996, J ENVIRON MANAGE, V46, P229, DOI 10.1006/jema.1996.0018; Serrano L, 2008, AQUAT CONSERV, V18, P261, DOI 10.1002/aqc.830; SHUSTER SM, 2003, MG BEH ECOL, pR7; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Stopher KV, 2014, ECOLOGY, V95, P3124; SUSO J, 1993, J HYDROL, V141, P239, DOI 10.1016/0022-1694(93)90052-B; Sykes MT, 2009, CLIMATE CHANGE IMPAC; Tomkins JL, 2005, P ROY SOC B-BIOL SCI, V272, P543, DOI 10.1098/rspb.2004.2950; Toni P, 2020, OECOLOGIA, V193, P97, DOI 10.1007/s00442-020-04653-5; Torres-Porras J, 2009, WILDLIFE BIOL, V15, P213, DOI 10.2981/08-059; Twiss SD, 2007, BIOL LETTERS, V3, P12, DOI 10.1098/rsbl.2006.0559; van de Pol M, 2016, METHODS ECOL EVOL, V7, P1246, DOI 10.1111/2041-210X.12590; VINCENT PJ, 1983, J BIOGEOGR, V10, P153, DOI 10.2307/2844625; Wade MJ, 2004, AM NAT, V164, pE83, DOI 10.1086/424531; WADE MJ, 1995, EVOL ECOL, V9, P118, DOI 10.1007/BF01237701; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Walther GR., 2001, FINGERPRINTS CLIMATE; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Woodward F.I., 1987, CLIMATE PLANT DISTRI	110	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0244802	10.1371/journal.pone.0244802	http://dx.doi.org/10.1371/journal.pone.0244802			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471796	Green Published, gold			2022-12-26	WOS:000639428800023
J	Khoo, SP; Shafii, MKA; Bhoo-Pathy, N; Yap, SH; Subramaniam, S; Nasir, NH; Lin, Z; Belinson, J; Goh, PP; Qu, XF; Gravitt, P; Woo, YL				Khoo, Su Pei; Shafii, Mohd Khairul Anwar; Bhoo-Pathy, Nirmala; Yap, Siew Hwei; Subramaniam, Shridevi; Nasir, Nazrila Hairizan; Lin, Zhang; Belinson, Jerome; Goh, Pik Pin; Qu, Xinfeng; Gravitt, Patti; Woo, Yin Ling			Prevalence and sociodemographic correlates of anogenital Human Papillomavirus (HPV) carriage in a cross-sectional, multi-ethnic, community-based Asian male population	PLOS ONE			English	Article							RISK-FACTORS; CERVICAL-CANCER; PENILE CANCER; INFECTION; MEN; SEX; WOMEN; PREVENTION; ATTENDEES; COVERAGE	Background Addressing the burden of HPV-associated diseases among men is increasingly becoming a public health issue. The main objective of this study was to determine HPV prevalence among a healthy community-based Malaysian men. Method This was a cross-sectional study that recruited 503 healthy males from 3 community-based clinics in Selangor, Malaysia. Genital and anal samples were collected from each participant for 14 high risk and 2 low risk HPV DNA detection and genotyping. All participants responded to a set of detailed sociodemographic and sexual behaviour questionnaire. Results The median age at enrolment was 40 years old (IQR: 31-50). The anogenital HPV6/11 prevalence was 3.2% whereas high risk HPV prevalence was 27.1%. The genital HPV prevalence for HPV6/11 was 2.9% while high risk HPV was 18.8%. HPV6/11 prevalence in the anal canal was 1.6% and high risk HPV was 12.7%. HPV 18 was the most prevalent genotype detected in the anogenital area. There was a significant independent association between genital and anal HPV infections. Conclusion Anogenital HPV infection is common among Malaysian men. These findings emphasize the ubiquity of HPV infection and thus the value of population-wide access to HPV prevention.	[Khoo, Su Pei; Shafii, Mohd Khairul Anwar; Bhoo-Pathy, Nirmala; Yap, Siew Hwei; Woo, Yin Ling] Univ Malaya, Fac Med, Kuala Lumpur, Malaysia; [Subramaniam, Shridevi; Goh, Pik Pin] Minist Hlth, Natl Clin Res Ctr, Putrajaya, Malaysia; [Nasir, Nazrila Hairizan] Minist Hlth, Div Family Hlth Dev, Putrajaya, Malaysia; [Lin, Zhang] Beijing Genome Inst, Shenzhen, Peoples R China; [Belinson, Jerome; Qu, Xinfeng] Prevent Oncol Int Inc, Cleveland, OH USA; [Belinson, Jerome; Qu, Xinfeng] Cleveland Clin, Cleveland, OH 44106 USA; [Gravitt, Patti] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA	Universiti Malaya; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Beijing Genomics Institute (BGI); Cleveland Clinic Foundation; University System of Maryland; University of Maryland Baltimore	Woo, YL (corresponding author), Univ Malaya, Fac Med, Kuala Lumpur, Malaysia.	ylwoo@ummc.edu.my	Woo, Yin Ling/B-5198-2010; Woo, Yin Ling/GPX-0086-2022; Pathy, Nirmala Bhoo/C-1228-2010	Woo, Yin Ling/0000-0003-1742-1066; Woo, Yin Ling/0000-0003-1742-1066; Pathy, Nirmala Bhoo/0000-0003-0568-8863	Merck Sharp Dohme	Merck Sharp Dohme(Merck & Company)	This study is supported by Merck Sharp & Dohme funding to YLW (https://www.msdmalaysia.com/home/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicken CRH, 2011, J PUBLIC HEALTH-UK, V33, P262, DOI 10.1093/pubmed/fdq056; [Anonymous], 2018, COUNTR PROGR REP HIV, P4; [Anonymous], 2017, STD FACTS HPV MEN; Arya M, 2013, CANCER CAUSE CONTROL, V24, P2169, DOI 10.1007/s10552-013-0293-y; Beachler DC, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv302; Buang SN, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4602; Chan PKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107573; Cheng YP, 2012, DERMATOL SIN, V30, P85, DOI 10.1016/j.dsi.2012.04.002; Darwich L, 2013, DIS COLON RECTUM, V56, P1043, DOI 10.1097/DCR.0b013e31829c654f; Dayyani F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15; de Araujo LA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199557; Deshmukh AA, 2017, CLIN INFECT DIS, V64, P1360, DOI 10.1093/cid/cix159; Dunne EF, 2006, J INFECT DIS, V194, P1044, DOI 10.1086/507432; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Giuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151; Goldstone S, 2011, J INFECT DIS, V203, P66, DOI 10.1093/infdis/jiq016; Han JJ, 2017, JAMA ONCOL, V3, P810, DOI 10.1001/jamaoncol.2016.6192; Hebnes JB, 2015, SEX TRANSM DIS, V42, P463, DOI 10.1097/OLQ.0000000000000315; Hernandez BY, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00009; Rodriguez-Alvarez MI, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102210; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Johnson AM, 2012, SEX TRANSM INFECT, V88, P212, DOI 10.1136/sextrans-2011-050306; Johnson KL, 2017, J COMMUN HEALTH, V42, P522, DOI 10.1007/s10900-016-0284-5; Kalra R, 2000, J PHARMACOL EXP THER, V293, P166; Khoo SP, 2018, SEX TRANSM INFECT, V94, P276, DOI 10.1136/sextrans-2017-053320; Kidd LC, 2017, TRANSL ANDROL UROL, V6, P791, DOI 10.21037/tau.2017.06.27; Lee HY, 2018, J COMMUN HEALTH, V43, P459, DOI 10.1007/s10900-018-0482-4; Leung WY, 2011, HONG KONG J DERMATOL, V19, P6; Malagon T, 2019, LANCET INFECT DIS, V19, P317, DOI 10.1016/S1473-3099(18)30655-8; Nyitray AG, 2010, J INFECT DIS, V201, P1498, DOI 10.1086/652187; Pamnani SJ, 2016, J INFECT DIS, V214, P1180, DOI 10.1093/infdis/jiw334; Quek SC, 2013, INT J GYNECOL CANCER, V23, P148, DOI 10.1097/IGC.0b013e31827670fd; Scarinci IC, 2010, CANCER-AM CANCER SOC, V116, P2531, DOI 10.1002/cncr.25065; Schabath MB, 2014, INT J CANCER, V134, P2448, DOI 10.1002/ijc.28567; Schabath MB, 2015, SEX TRANSM INFECT, V91, P61, DOI 10.1136/sextrans-2013-051422; Smith JS, 2011, J ADOLESCENT HEALTH, V48, P540, DOI 10.1016/j.jadohealth.2011.03.010; Szabo G, 1997, ALCOHOL HEALTH RES W, V21, P30; Wei FX, 2019, INT J CANCER, V145, P807, DOI 10.1002/ijc.32255; Xin HN, 2017, EPIDEMIOL INFECT, V145, P2838, DOI [10.1017/S0950268817001698, 10.1017/s0950268817001698]; Yi X, 2014, AM J CLIN PATHOL, V141, P796, DOI 10.1309/AJCP9P2KJSXEKCJB	40	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245731	10.1371/journal.pone.0245731	http://dx.doi.org/10.1371/journal.pone.0245731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM1OE	33471825	Green Published, gold			2022-12-26	WOS:000639428800022
J	Klepinina, L; Klepinin, A; Truu, L; Chekulayev, V; Vija, H; Kuus, K; Teino, I; Pook, M; Maimets, T; Kaambre, T				Klepinina, Ljudmila; Klepinin, Aleksandr; Truu, Laura; Chekulayev, Vladimir; Vija, Heiki; Kuus, Kaisa; Teino, Indrek; Pook, Martin; Maimets, Toivo; Kaambre, Tuuli			Colon cancer cell differentiation by sodium butyrate modulates metabolic plasticity of Caco-2 cells via alteration of phosphotransfer network	PLOS ONE			English	Article							HUMAN EMBRYONIC STEM; ACTIVATED PROTEIN-KINASE; OCT4 SPLICED VARIANTS; ALKALINE-PHOSPHATASE; COLORECTAL-CANCER; PROSTATE-CANCER; SELF-RENEWAL; NANOG; SOX2; EXPRESSION	The ability of butyrate to promote differentiation of cancer cells has important implication for colorectal cancer (CRC) prevention and therapy. In this study, we examined the effect of sodium butyrate (NaBT) on the energy metabolism of colon adenocarcinoma Caco-2 cells coupled with their differentiation. NaBT increased the activity of alkaline phosphatase indicating differentiation of Caco-2 cells. Changes in the expression of pluripotency-associated markers OCT4, NANOG and SOX2 were characterized during the induced differentiation at mRNA level along with the measures that allowed distinguishing the expression of different transcript variants. The functional activity of mitochondria was studied by high-resolution respirometry. Glycolytic pathway and phosphotransfer network were analyzed using enzymatical assays. The treatment of Caco-2 cells with NaBT increased production of ATP by oxidative phosphorylation, enhanced mitochondrial spare respiratory capacity and caused rearrangement of the cellular phosphotransfer networks. The flexibility of phosphotransfer networks depended on the availability of glutamine, but not glucose in the cell growth medium. These changes were accompanied by suppressed cell proliferation and altered gene expression of the main pluripotency-associated transcription factors. This study supports the view that modulating cell metabolism through NaBT can be an effective strategy for treating CRC. Our data indicate a close relationship between the phosphotransfer performance and metabolic plasticity of CRC, which is associated with the cell differentiation state.	[Klepinina, Ljudmila; Klepinin, Aleksandr; Truu, Laura; Chekulayev, Vladimir; Kaambre, Tuuli] NICPB, Lab Chem Biol, Tallinn, Estonia; [Vija, Heiki] NICPB, Lab Environm Toxicol, Tallinn, Estonia; [Kuus, Kaisa; Teino, Indrek; Pook, Martin; Maimets, Toivo] Univ Tartu, Inst Mol & Cell Biol, Dept Cell Biol, Tartu, Estonia	National Institute of Chemical Physics & Biophysics (NICPB); National Institute of Chemical Physics & Biophysics (NICPB); University of Tartu	Klepinina, L (corresponding author), NICPB, Lab Chem Biol, Tallinn, Estonia.	ljudmila.ounpuu@gmail.com	Kaambre, Tuuli/A-9536-2008; KLEPININ, Aleksandr/AAD-2705-2022	Kaambre, Tuuli/0000-0001-5755-4694; Teino, Indrek/0000-0002-2381-4715	Estonian Ministry of Education and Research [IUT23-1]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This work was supported by the institutional research funding IUT23-1 of the Estonian Ministry of Education and Research.	AINSWORTH S, 1973, BIOCHEM J, V131, P223, DOI 10.1042/bj1310223; Alcarraz-Vizan G, 2010, METABOLOMICS, V6, P229, DOI 10.1007/s11306-009-0192-0; Amini S, 2014, ANAT CELL BIOL, V47, P1, DOI 10.5115/acb.2014.47.1.1; Amoedo ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022264; Asadi MH, 2011, INT J CANCER, V128, P2645, DOI 10.1002/ijc.25643; Asadi MH, 2016, J NEURO-ONCOL, V130, P455, DOI 10.1007/s11060-016-2255-1; Asadzadeh J, 2012, UROL J, V9, P574; Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Blouin JM, 2011, INT J CANCER, V128, P2591, DOI 10.1002/ijc.25599; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Chekulayev Vladimir, 2015, Biochem Biophys Rep, V4, P111, DOI 10.1016/j.bbrep.2015.08.020; Chung YS., 1985, CANCER RES, V45; Cormio A, 2009, BIOCHEM BIOPH RES CO, V390, P1182, DOI 10.1016/j.bbrc.2009.10.114; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Dzeja PP, 1999, CIRC RES, V84, P1137, DOI 10.1161/01.RES.84.10.1137; Dzeja PP, 2004, MOL CELL BIOCHEM, V256, P13, DOI 10.1023/B:MCBI.0000009856.23646.38; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Dzeja PP, 2002, P NATL ACAD SCI USA, V99, P10156, DOI 10.1073/pnas.152259999; Eberle I, 2010, NUCLEIC ACIDS RES, V38, P5384, DOI 10.1093/nar/gkq307; Eckschlager T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071414; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Fan J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.65; Friedmann-Morvinski D, 2014, EMBO REP, V15, P244, DOI 10.1002/embr.201338254; Fujisawa K, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0322-2; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Gazouli M, 2012, MOL CARCINOGEN, V51, P165, DOI 10.1002/mc.20773; Goncalves P, 2013, CURR DRUG METAB, V14, P994; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; HENTHORN PS, 1988, J BIOL CHEM, V263, P12011; HERZ F, 1981, ARCH BIOCHEM BIOPHYS, V210, P581, DOI 10.1016/0003-9861(81)90224-1; Izumi D, 2015, J CANC METASTASIS TR, V1, P156, DOI DOI 10.4103/2394-4722.165532; Jan YH, 2012, CANCER RES, V72, P5119, DOI 10.1158/0008-5472.CAN-12-1842; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Ji YP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15308; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Kaiko GE., 2016, CELL, P165, DOI [10.1016/j.cell.2016.01.020, DOI 10.1016/J.CELL.2016.01.020]; Kim JS, 2005, EXP MOL MED, V37, P601, DOI 10.1038/emm.2005.73; Klepinin A, 2016, J BIOENERG BIOMEMBR, V48, P531, DOI 10.1007/s10863-016-9687-3; Phi LTH, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/5416923; Li QR, 2018, MOL CELL PROTEOMICS, V17, P1531, DOI 10.1074/mcp.RA118.000752; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; MATSUMOTO H, 1990, GASTROENTEROLOGY, V98, P1199, DOI 10.1016/0016-5085(90)90334-W; Meng HM, 2010, CANCER BIOL THER, V9, P295, DOI 10.4161/cbt.9.4.10666; Monge C, 2009, CAN J PHYSIOL PHARM, V87, P318, DOI 10.1139/Y09-018; Moore SR, 2015, AM J PHYSIOL-GASTR L, V308, pG831, DOI 10.1152/ajpgi.00422.2014; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ordonez-Moran P, 2015, CANCER CELL, V28, P815, DOI 10.1016/j.ccell.2015.11.001; Oshima N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101735; Ounpuu L, 2017, BBA-GEN SUBJECTS, V1861, P2146, DOI 10.1016/j.bbagen.2017.05.020; Panagopoulos I, 2008, GENE CHROMOSOME CANC, V47, P521, DOI 10.1002/gcc.20555; Pant K, 2017, CHEM-BIOL INTERACT, V273, P99, DOI 10.1016/j.cbi.2017.06.001; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; PESCE A, 1964, J BIOL CHEM, V239, P1753; Poursani EM, 2017, GENE, V627, P369, DOI 10.1016/j.gene.2017.06.032; Rambhatla L, 2003, CELL TRANSPLANT, V12, P1, DOI 10.3727/000000003783985179; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Robey RB, 2000, KIDNEY INT, V57, P2308, DOI 10.1046/j.1523-1755.2000.00091.x; Rodrigues MF, 2015, J CELL BIOCHEM, V116, P797, DOI 10.1002/jcb.25036; SABOKBAR A, 1994, BONE MINER, V27, P57, DOI 10.1016/S0169-6009(08)80187-0; Shin J, 2014, J BIOL CHEM, V289, P25306, DOI 10.1074/jbc.M114.557546; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Suo GL, 2005, BIOCHEM BIOPH RES CO, V337, P1047, DOI 10.1016/j.bbrc.2005.09.157; Takeda K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36251-0; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Voutsadakis IA, 2018, BIOMARK MED, V12, P653, DOI 10.2217/bmm-2017-0369; Wang FL, 2018, CELL METAB, V28, P463, DOI 10.1016/j.cmet.2018.08.012; Wang WQ, 2020, ONCOTARGETS THER, V13, P4691, DOI 10.2147/OTT.S235575; Wang X, 2010, STEM CELLS, V28, P885, DOI 10.1002/stem.419; YAMAMOTO N, 1973, Acta Histochemica et Cytochemica, V6, P107; Yang F, 2018, ONCOTARGETS THER, V11, P7873, DOI 10.2147/OTT.S173522; Zhu FY, 2017, STEM CELL REP, V9, P429, DOI 10.1016/j.stemcr.2017.07.004	77	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245348	10.1371/journal.pone.0245348	http://dx.doi.org/10.1371/journal.pone.0245348			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471801	Green Published, gold			2022-12-26	WOS:000639428800039
J	Kimani, M; van der Elst, EM; Chirro, O; Wahome, E; Ibrahim, F; Mukuria, N; de Wit, TFR; Graham, SM; Operario, D; Sanders, EJ				Kimani, Makobu; van der Elst, Elise M.; Chirro, Oscar; Wahome, Elizabeth; Ibrahim, Fauz; Mukuria, Nana; de Wit, Tobias F. Rinke; Graham, Susan M.; Operario, Don; Sanders, Eduard J.			"I wish to remain HIV negative": Pre-exposure prophylaxis adherence and persistence in transgender women and men who have sex with men in coastal Kenya	PLOS ONE			English	Article							DRIED BLOOD SPOTS; EMTRICITABINE-TRIPHOSPHATE; TENOFOVIR-DIPHOSPHATE; PREP; FACILITATORS; PREVENTION; BARRIERS	Background Transgender women (TGW) and men who have sex with men (MSM) in sub-Saharan Africa have high HIV acquisition risks and can benefit from daily pre-exposure prophylaxis (PrEP). We assessed PrEP adherence by measuring tenofovir-diphosphate (TFV-DP) levels and explore motives for PrEP persistence in TGW and MSM. Methods Participants were enrolled in a one-year PrEP programme and made quarterly visits irrespective of whether they were still using PrEP. At their month 6 visit, participants provided a dried blood spot to test for TFV-DP levels; protective levels were defined as those compatible with >= 4 pills per week (700-1249 fmol/punch). Before TFV-DP levels were available, a sub-set of these participants were invited for an in-depth interview (IDI). Semi-structured IDI topic guides were used to explore motives to uptake, adhere to, and discontinue PrEP. IDI data were analyzed thematically. Results Fifty-three participants (42 MSM and 11 TGW) were enrolled. At month 6, 11 (20.7%) participants (8 MSM and 3 TGW) were lost to follow up or stopped taking PrEP. Any TFV-DP was detected in 62.5% (5/8) of TGW vs. 14.7% of MSM (5/34, p = 0.01). Protective levels were detected in 37.5% of TGW (3/8), but not in any MSM. Nineteen IDI were conducted with 7 TGW and 9 MSM on PrEP, and 1 TGW and 2 MSM off PrEP. Unplanned or frequent risky sexual risk behaviour were the main motives for PrEP uptake. Among participants on PrEP, TGW had a more complete understanding of the benefits of PrEP. Inconsistent PrEP use was attributed to situational factors. Motives to discontinue PrEP included negative reactions from partners and stigmatizing healthcare services. Conclusion While MSM evinced greater adherence challenges in this PrEP programme, almost 40% of TGW were protected by PrEP. Given high HIV incidences in TGW these findings hold promise for TGW PrEP programming in the region.	[Kimani, Makobu; van der Elst, Elise M.; Chirro, Oscar; Wahome, Elizabeth; Mukuria, Nana; Sanders, Eduard J.] KEMRI Wellcome Trust Res Program, Kilifi, Kenya; [Ibrahim, Fauz] Dept Hlth, Kilifi, Kilifi County, Kenya; [de Wit, Tobias F. Rinke] Univ Amsterdam, Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, Amsterdam, Netherlands; [Graham, Susan M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Operario, Don] Brown Univ, Dept Publ Hlth, Providence, RI 02912 USA; [Sanders, Eduard J.] Univ Oxford, Nufield Dept Med, Oxford, England	University of Amsterdam; University of Washington; University of Washington Seattle; Brown University; University of Oxford	Sanders, EJ (corresponding author), KEMRI Wellcome Trust Res Program, Kilifi, Kenya.; Sanders, EJ (corresponding author), Univ Oxford, Nufield Dept Med, Oxford, England.	ESanders@kemri-wellcome.org	Kimani, Makobu/V-6369-2019	Kimani, Makobu/0000-0001-9275-4018	Sub-Saharan African Network for TB/HIV-1 Research Excellence (SANTHE), a DELTAS Africa Initiative [DEL-15-006]; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107752/Z/15/Z]; UK government; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA)	Sub-Saharan African Network for TB/HIV-1 Research Excellence (SANTHE), a DELTAS Africa Initiative; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK government; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA)	This work was supported through the Sub-Saharan African Network for TB/HIV-1 Research Excellence (SANTHE), a DELTAS Africa Initiative [grant #DEL-15-006]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [grant #107752/Z/15/Z] and the UK government. The views expressed in this publication are those of the author(s) and not necessarily those of AAS, NEPAD Agency, Wellcome Trust or the UK government.	Adams LM, 2016, AIDS CARE, V28, P1154, DOI 10.1080/09540121.2016.1153595; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Broussard J, 2020, IAS C SAN FRANSC; Castillo-Mancilla J, 2016, ANTIMICROB AGENTS CH, V60, P6692, DOI 10.1128/AAC.01017-16; Castillo-Mancilla JR, 2013, AIDS RES HUM RETROV, V29, P384, DOI [10.1089/aid.2012.0089, 10.1089/AID.2012.0089]; Corneli A, 2016, JAIDS-J ACQ IMM DEF, V71, P452, DOI 10.1097/QAI.0000000000000880; Gomez-Gil E, 2012, PSYCHONEUROENDOCRINO, V37, P662, DOI 10.1016/j.psyneuen.2011.08.010; Grace D, 2018, AIDS PATIENT CARE ST, V32, P24, DOI 10.1089/apc.2017.0153; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Haberer JE, 2020, C RETR OPP INF BOST; Hoornenborg E, 2019, LANCET HIV, V6, pE447, DOI 10.1016/S2352-3018(19)30136-5; Jobson GA, 2012, SAHARA J-J SOC ASP H, V9, P160, DOI 10.1080/17290376.2012.743829; Kimani M, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25323; Landovitz RJ, 2020, IAS C SAN FRANSC; Liu AY, 2016, JAMA INTERN MED, V176, P75, DOI 10.1001/jamainternmed.2015.4683; Mehta SD, 2021, AIDS BEHAV, V25, P2219, DOI 10.1007/s10461-020-03150-3; Molina JM, 2017, LANCET HIV, V4, pE402, DOI 10.1016/S2352-3018(17)30089-9; Mugwanya KK, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002885; NASCOP, 2016, GUID US ANT DRUGS TR; National AIDS and STI Control Programme (NASCOP), 2020, PREL KENPHIA 2018 RE; Odoyo JB, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25303; Poundstone KE, 2004, EPIDEMIOL REV, V26, P22, DOI 10.1093/epirev/mxh005; Ramadhani HO, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25599; Sevelius JM, 2016, GLOB PUBLIC HEALTH, V11, P1060, DOI 10.1080/17441692.2016.1154085; Sevelius JM, 2014, ANN BEHAV MED, V47, P5, DOI 10.1007/s12160-013-9565-8; Sullivan PS, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25591; Van der Elst EM, 2012, AIDS BEHAV; Wahome EW, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100541; Wahome EW, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25593; Were D, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25537; Zheng JH, 2016, J PHARMACEUT BIOMED, V122, P16, DOI 10.1016/j.jpba.2016.01.038	33	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0244226	10.1371/journal.pone.0244226	http://dx.doi.org/10.1371/journal.pone.0244226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PY3TH	33465090	Green Published, gold			2022-12-26	WOS:000611969200029
J	Bai, J; Yokomizo-Nakano, T; Kubota, S; Sun, YQ; Kanai, A; Iimori, M; Harada, H; Iwama, A; Sashida, G				Bai, Jie; Yokomizo-Nakano, Takako; Kubota, Sho; Sun, Yuqi; Kanai, Akinori; Iimori, Mihoko; Harada, Hironori; Iwama, Atsushi; Sashida, Goro			Overexpression of Hmga2 activates Igf2bp2 and remodels transcriptional program of Tet2-deficient stem cells in myeloid transformation	ONCOGENE			English	Article							SELF-RENEWAL; MYELOFIBROSIS; GENE; EZH2; MOUSE; PATHOGENESIS; MUTATIONS; PROTEINS; PROMOTES; BINDING	High Mobility Group AT-hook 2 (HMGA2) is a chromatin modifier and its overexpression has been found in patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Level of Hmga2 expression is fine-tuned by Lin28b-Let-7 axis and Polycomb Repressive Complex 2, in which deletion of Ezh2 leads to activation of Hmga2 expression in hematopoietic stem cells. To elucidate the mechanisms by which the overexpression of HMGA2 helps transformation of stem cells harboring a driver mutation of TET2, we generated an Hmga2-expressing Tet2-deficient mouse model showing the progressive phenotypes of MDS and AML. The overexpression of Hmga2 remodeled the transcriptional program of Tet2-deficient stem and progenitor cells, leading to the impaired differentiation of myeloid cells. Furthermore, Hmga2 was bound to a proximal region of Igf2bp2 oncogene, and activated its transcription, leading to enhancing self-renewal of Tet2-deficient stem cells that was suppressed by inhibition of the DNA binding of Hmga2. These combinatory effects on the transcriptional program and cellular function were not redundant to those in Tet2-deficient cells. The present results elucidate that Hmga2 targets key oncogenic pathways during the transformation and highlight the Hmga2-Igf2bp2 axis as a potential target for therapeutic intervention.	[Bai, Jie; Yokomizo-Nakano, Takako; Kubota, Sho; Sun, Yuqi; Iimori, Mihoko; Sashida, Goro] Kumamoto Univ, Int Res Ctr Med Sci IRCMS, Lab Transcript Regulat Leukemogenesis, Kumamoto, Japan; [Kanai, Akinori] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Oncol, Hiroshima, Japan; [Harada, Hironori] Tokyo Univ Pharm & Life Sci, Lab Oncol, Tokyo, Japan; [Iwama, Atsushi] Univ Tokyo, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci, Div Stem Cell & Mol Med, Tokyo, Japan	Kumamoto University; Hiroshima University; Tokyo University of Pharmacy & Life Sciences; University of Tokyo	Sashida, G (corresponding author), Kumamoto Univ, Int Res Ctr Med Sci IRCMS, Lab Transcript Regulat Leukemogenesis, Kumamoto, Japan.	sashidag@kumamoto-u.ac.jp	Sashida, Goro/N-5259-2014	Sashida, Goro/0000-0003-2318-5987; Kubota, Sho/0000-0001-6119-1259	Daiichi Sankyo Foundation of Life Science; Uehara Memorial Foundation; Princess Takamatsu Cancer Research Fund; Japanese Society of Hematology; International Joint Usage/Research Center, the Institute of Medical Science, the University of Tokyo; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [16KT0113, 18H02842, 19K22640, 19K08842]	Daiichi Sankyo Foundation of Life Science; Uehara Memorial Foundation(Uehara Memorial Foundation); Princess Takamatsu Cancer Research Fund; Japanese Society of Hematology; International Joint Usage/Research Center, the Institute of Medical Science, the University of Tokyo; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank the members of the Sashida Laboratory for their discussions during the preparation of this manuscript and Mr. Shinji Kudoh and Dr. Takaaki Ito for their technical help. This work was supported in part by a grant from the Daiichi Sankyo Foundation of Life Science (to GS), the Uehara Memorial Foundation (to GS), the Princess Takamatsu Cancer Research Fund (to GS), the Japanese Society of Hematology (to GS), International Joint Usage/Research Center, the Institute of Medical Science, the University of Tokyo (to GS), and Grants-in-Aid for Scientific Research (16KT0113, 18H02842, 19K22640 and 19K08842) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Abdel-Wahab O, 2013, J EXP MED, V210, P2641, DOI 10.1084/jem.20131141; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Chin MT, 1998, J BIOL CHEM, V273, P9755, DOI 10.1074/jbc.273.16.9755; Cleynen I, 2007, MOL CANCER RES, V5, P363, DOI 10.1158/1541-7786.MCR-06-0331; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Dai N, 2017, ELIFE, V6, DOI [10.7554/eLife.27155.001, 10.7554/eLife.27155]; Degrauwe N, 2016, CELL REP, V15, P1634, DOI 10.1016/j.celrep.2016.04.086; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dutta A, 2017, BLOOD, V130, P920, DOI 10.1182/blood-2016-12-757344; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Guglielmelli P, 2007, STEM CELLS, V25, P165, DOI 10.1634/stemcells.2006-0351; Hasegawa N, 2017, LEUKEMIA, V31, P861, DOI 10.1038/leu.2016.268; He X, 2018, CELL PHYSIOL BIOCHEM, V51, P1945, DOI 10.1159/000495719; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Kishi Y, 2012, NAT NEUROSCI, V15, P1127, DOI 10.1038/nn.3165; Marquis M, 2018, BLOOD CANCER J, V8, DOI 10.1038/s41408-018-0103-6; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Muto T, 2013, J EXP MED, V210, P2627, DOI 10.1084/jem.20131144; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Oguro H, 2012, J EXP MED, V209, P445, DOI 10.1084/jem.20111709; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Oshima M, 2016, EXP HEMATOL, V44, P282, DOI 10.1016/j.exphem.2015.12.009; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Pellagatti A, 2018, BLOOD, V132, P1225, DOI 10.1182/blood-2018-04-843771; Platzbecker U, 2017, LANCET ONCOL, V18, P1338, DOI 10.1016/S1470-2045(17)30615-0; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rowe RG, 2016, J EXP MED, V213, P1497, DOI 10.1084/jem.20151912; Sashida G, 2016, J EXP MED, V213, P1459, DOI 10.1084/jem.20151121; Shastri A, 2017, BLOOD, V129, P1586, DOI 10.1182/blood-2016-10-696062; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Shimizu T, 2016, J EXP MED, V213, P1479, DOI 10.1084/jem.20151136; Sperling AS, 2017, NAT REV CANCER, V17, P5, DOI 10.1038/nrc.2016.112; Sternberg A, 2005, BLOOD, V106, P2982, DOI 10.1182/blood-2005-04-1543; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; Watanabe-Okochi N, 2008, BLOOD, V111, P4297, DOI 10.1182/blood-2007-01-068346; Yokomizo-Nakano T, 2020, CANCER RES, V80, P2523, DOI 10.1158/0008-5472.CAN-19-3167; Zhang XT, 2016, NAT GENET, V48, P1014, DOI 10.1038/ng.3610; Zhou T, 2015, BLOOD, V126, P1057, DOI 10.1182/blood-2015-01-624239	39	4	4	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2021	40	8					1531	1541		10.1038/s41388-020-01629-w	http://dx.doi.org/10.1038/s41388-020-01629-w		JAN 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QM6NM	33452460				2022-12-26	WOS:000607998600010
J	Xie, L; Yang, HL; Zheng, XD; Wu, YY; Lin, XY; Shen, Z				Xie, Lin; Yang, Hualei; Zheng, Xiaodong; Wu, Yuanyang; Lin, Xueyu; Shen, Zheng			Medical resources and coronavirus disease (COVID-19) mortality rate: Evidence and implications from Hubei province in China	PLOS ONE			English	Article								In light of the ongoing coronavirus disease (COVID-19) pandemic, this study aims to examine the relationship between the availability of public health resources and the mortality rate of this disease. We conducted empirical analyses using linear regression, a time-varying effect model, and a regression discontinuity design to investigate the association of medical resources with the mortality rate of the COVID-19 patients in Hubei, China. The results showed that the numbers of hospital beds, healthcare system beds, and medical staff per confirmed cases all had significant negative effects on the coronavirus disease mortality rate. Furthermore, in the context of the severe pandemic currently being experienced worldwide, the present study summarized the experience and implications in pandemic prevention and control in Hubei province from the perspective of medical resource integration as follows: First, hospitals' internal medical resources were integrated, breaking interdepartmental barriers. Second, joint pandemic control was realized by integrating regional healthcare system resources. Finally, an external medical resource allocation system was developed.	[Xie, Lin] Chinese Acad Social Sci, Inst Populat & Labor Econ, Beijing, Peoples R China; [Yang, Hualei; Wu, Yuanyang; Lin, Xueyu] Zhongnan Univ Econ & Law, Sch Publ Adm, Wuhan, Peoples R China; [Zheng, Xiaodong] Zhejiang Gongshang Univ, Sch Econ, Hangzhou, Peoples R China; [Shen, Zheng] Zhejiang A&F Univ, Sch Econ & Management, Hangzhou, Peoples R China	Chinese Academy of Social Sciences; Zhongnan University of Economics & Law; Zhejiang Gongshang University; Zhejiang A&F University	Zheng, XD (corresponding author), Zhejiang Gongshang Univ, Sch Econ, Hangzhou, Peoples R China.	zhengxd@zjgsu.edu.cn			National Natural Science Foundation of China [72003173]; Humanities and Social Science Fund of the Ministry of Education of China [20YJC790187, 19YJC790167]; Natural Science Foundation of Zhejiang Province, China [LY21G030008]; Project Funding of Innovation and Entrepreneurship Training Program for College Students of Zhongnan University of Economics and Law [202010520030]; Scientific Research Foundation of Zhejiang AF University [2018FR023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Humanities and Social Science Fund of the Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Project Funding of Innovation and Entrepreneurship Training Program for College Students of Zhongnan University of Economics and Law; Scientific Research Foundation of Zhejiang AF University	This study was supported by the National Natural Science Foundation of China to XZ (Grant numbers:72003173), the Humanities and Social Science Fund of the Ministry of Education of China to XZ and HY (Grant numbers: 20YJC790187 and 19YJC790167), Natural Science Foundation of Zhejiang Province, China to XZ (Grant number: LY21G030008), Project Funding of Innovation and Entrepreneurship Training Program for College Students of Zhongnan University of Economics and Law to XL (Grant number: 202010520030) and the Scientific Research Foundation of Zhejiang A&F University to ZS (Grant number: 2018FR023). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Chen SM, 2020, LANCET, V395, P764, DOI 10.1016/S0140-6736(20)30421-9; Deng SQ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020575; Gong FH, 2020, FRONT MED-PRC, V14, P220, DOI 10.1007/s11684-020-0755-z; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Ji YP, 2020, LANCET GLOB HEALTH, V8, pE480, DOI 10.1016/S2214-109X(20)30068-1; Kaplan EH, 2020, HEALTH CARE MANAG SC, V23, P311, DOI 10.1007/s10729-020-09504-6; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang FS, 2020, LANCET, V395, P391, DOI 10.1016/S0140-6736(20)30300-7; Xu JY, 2020, FRONT MED-PRC, V14, P225, DOI 10.1007/s11684-020-0753-1; Zhang H, 2020, LANCET, V395, P687, DOI 10.1016/S0140-6736(20)30356-1	12	13	13	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2021	16	1							e0244867	10.1371/journal.pone.0244867	http://dx.doi.org/10.1371/journal.pone.0244867			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4XD	33449940	Green Published, gold			2022-12-26	WOS:000609991600052
J	Al-Hashemi, HMB; Al-Amoudi, OSB; Yamani, ZH; Mustafa, YM; Ahmed, HUR				Al-Hashemi, Hamzah M. Beakawi; Al-Amoudi, Omar S. Baghabra; Yamani, Zain H.; Mustafa, Yassir M.; Ahmed, Habib-ur-Rehman			The validity of laser diffraction system to reproduce hydrometer results for grain size analysis in geotechnical applications	PLOS ONE			English	Article							COMPLEX REFRACTIVE-INDEX; SCATTERING; PARTICLES; SOILS	The grain size analysis plays a significant role in any geotechnical study. The grain size analysis, by means of sieving, is usually used for coarse material of particle size > 75 mu m. For the fine material; the sedimentation methods are frequently adopted (e.g., hydrometers). Other methods also exist such as electron microscopy, digital image analysis and laser diffraction. The fine geomaterials commonly undergo agglomeration which makes the recognition of individual grain size using digital image analysis or electron microscopy challenging. To facilitate and enhance the grain-size analysis, this study was conducted using the Laser Diffraction System (LDS). Seven samples with different nature (composition and texture) and sources were analyzed by hydrometer and LDS. For LDS, various factors were studied such as air pressure, sonication, dilution, refractive index, and distribution method (volume or number). The results were compared qualitatively and quantitatively based on soil classification systems, fractal dimensions, and other parameters. Furthermore, this study provided a novel criterion to determine which LDS distribution method (volume or number) is to be used depending on the Liquid Limit. A combined sieve-LDS system is recommended to obtain the entire grain size distribution. It is concluded that the LDS is a viable technique that can replace the time-consuming hydrometer method to assess the grain-size distribution.	[Al-Hashemi, Hamzah M. Beakawi] Univ Bahrain, Dept Civil Engn, Isa Town, Bahrain; [Al-Amoudi, Omar S. Baghabra; Mustafa, Yassir M.; Ahmed, Habib-ur-Rehman] King Fahd Univ Petr & Minerals, Dept Civil & Environm Engn, Dhahran, Saudi Arabia; [Yamani, Zain H.] King Fahd Univ Petr & Minerals, Dept Phys, Dhahran, Saudi Arabia; [Yamani, Zain H.] King Fahd Univ Petr & Minerals, Ctr Excellence Nanotechnol, Dhahran, Saudi Arabia	University of Bahrain; King Fahd University of Petroleum & Minerals; King Fahd University of Petroleum & Minerals; King Fahd University of Petroleum & Minerals	Al-Hashemi, HMB (corresponding author), Univ Bahrain, Dept Civil Engn, Isa Town, Bahrain.	halhashemi@uob.edu.bh	Mustafa, Yassir/AAY-7459-2021; Yamani, Zain/J-3482-2015; Ahmed, Habib-ur-Rehman/G-4980-2016	Mustafa, Yassir/0000-0001-8169-809X; Amoudi, Omar/0000-0001-5078-9204; Yamani, Zain/0000-0002-6031-9385; Ahmed, Habib-ur-Rehman/0000-0003-2452-5111; Al-Hashemi, Hamzah M. B./0000-0002-3991-1712				Adi H, 2007, POWDER TECHNOL, V179, P90, DOI 10.1016/j.powtec.2007.01.018; [Anonymous], 2007, ASTMD422632007E2, P1; [Anonymous], 2014, ASTMD854; [Anonymous], 2018, STANDARD TEST METHOD, DOI [DOI 10.1520/C0305-13.2, 10.1520/C0039_C0039M-18, DOI 10.1520/D2584-11]; [Anonymous], 2009, 74043 ISO; [Anonymous], 2013, CAN J DIABETES S3, V37, pS357; [Anonymous], 2014, ASTMC107001, P1; [Anonymous], 2017, ASTMD4318, P1; [Anonymous], 2020, STM C618 17A, DOI [10.1520/D3385-09.responsibility, DOI 10.1520/C0150, 10.1520/C0150_C0150M-20]; Blott SJ, 2006, SEDIMENTOLOGY, V53, P671, DOI 10.1111/j.1365-3091.2006.00786.x; Di Stefano C, 2010, BIOSYST ENG, V106, P205, DOI 10.1016/j.biosystemseng.2010.03.013; Eshel G, 2004, SOIL SCI SOC AM J, V68, P736, DOI 10.2136/sssaj2004.0736; Fisher P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176510; FITZGERALD A, 1926, COMMUNICATION; ISHIDA T, 1991, REMOTE SENS ENVIRON, V38, P173, DOI 10.1016/0034-4257(91)90087-M; JABRO JD, 1992, T ASAE, V35, P557, DOI 10.13031/2013.28633; Kaiser M, 2014, J PLANT NUTR SOIL SC, V177, P479, DOI 10.1002/jpln.201300339; KAUFFMAN A. M., 1967, THIN SOLID FILMS, V1, P131; Kinoshita T, 2001, ADV POWDER TECHNOL, V12, P589, DOI 10.1163/15685520152756697; Kwak BM, 2009, J FOOD ENG, V92, P324, DOI 10.1016/j.jfoodeng.2008.12.005; Lee KL., 1967, CAN GEOTECH J, V4, P68, DOI [10.1139/t67-012, DOI 10.1139/T67-012]; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; Mie G, 1908, ANN PHYS-BERLIN, V25, P377, DOI 10.1002/andp.19083300302; PECORA R, 1964, J CHEM PHYS, V40, P1604, DOI 10.1063/1.1725368; Pye K, 2004, FORENSIC SCI INT, V144, P19, DOI 10.1016/j.forsciint.2004.02.028; RAYLEIGH LORD, 1881, MAG J SCI, V12, P81; Skiles SM, 2017, J GLACIOL, V63, P133, DOI 10.1017/jog.2016.126; Su YZ, 2004, GEODERMA, V122, P43, DOI 10.1016/j.geoderma.2003.12.003; Wang JP, 2017, WATER RESOUR RES, V53, P6069, DOI 10.1002/2017WR020411	29	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245452	10.1371/journal.pone.0245452	http://dx.doi.org/10.1371/journal.pone.0245452			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444412	Green Published, gold			2022-12-26	WOS:000609988100018
J	Grover, M; Kolla, BP; Pamarthy, R; Mansukhani, MP; Breen-Lyles, M; He, JP; Merikangas, KR				Grover, Madhusudan; Kolla, Bhanu Prakash; Pamarthy, Rahul; Mansukhani, Meghna P.; Breen-Lyles, Margaret; He, Jian-Ping; Merikangas, Kathleen R.			Psychological, physical, and sleep comorbidities and functional impairment in irritable bowel syndrome: Results from a national survey of US adults	PLOS ONE			English	Article							GASTROINTESTINAL DISORDERS; PREVALENCE; SYMPTOMS; IMPACT; DISTURBANCES; SOMATIZATION; DEPRESSION; SEVERITY; RISK; IBS	Background/Aims Patients with irritable bowel syndrome (IBS) in referral practice commonly report mental disorders and functional impairment. Our aim was to determine the prevalence of mental, physical and sleep-related comorbidities in a nationally representative sample of IBS patients and their impact on functional impairment. Methods IBS was defined by modified Rome Criteria based on responses to the chronic conditions section of the National Comorbidity Survey-Replication. Associations between IBS and mental, physical and sleep disorders and 30-day functional impairment were examined using logistic regression models. Results Of 5,650 eligible responders, 186 met criteria for IBS {weighted prevalence 2.5% (SE = 0.3)}. Age >60 years was associated with decreased odds (OR = 0.3; 95% CI:.1-.6); low family income (OR = 2.4; 95% CI:1.2-4.9) and unemployed status (OR = 2.3; 95% CI:1.2-4.2) were associated with increased odds of IBS. IBS was significantly associated with anxiety, behavior, mood disorders (ORs 1.8-2.4), but not eating or substance use disorders. Among physical conditions, IBS was associated with increased odds of headache, chronic pain, diabetes mellitus and both insomnia and hypersomnolence related symptoms (ORs 1.9-4.0). While the association between IBS and patients' role impairment persisted after adjusting for mental disorders (OR = 2.4, 95% CI 1.5-3.7), associations with impairment in self-care, cognition, and social interaction in unadjusted models (ORs 2.5-4.2) were no longer significant after adjustment for mental disorders. Conclusion IBS is associated with socioeconomic disadvantage, comorbidity with mood, anxiety and sleep disorders, and role impairment. Other aspects of functional impairment appear to be moderated by presence of comorbid mental disorders.	[Grover, Madhusudan; Pamarthy, Rahul; Breen-Lyles, Margaret] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55902 USA; [Kolla, Bhanu Prakash] Mayo Clin, Dept Psychiat, Rochester, MN USA; [Kolla, Bhanu Prakash; Mansukhani, Meghna P.] Mayo Clin, Ctr Sleep Med, Rochester, MN USA; [Mansukhani, Meghna P.] Mayo Clin, Dept Family Med, Rochester, MN USA; [He, Jian-Ping; Merikangas, Kathleen R.] NIMH, Genet Epidemiol Res Branch, Bethesda, MD 20892 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Grover, M (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55902 USA.	grover.madhusudan@mayo.edu			intramural research program of the National Institute of Mental Health (NIMH) [ZIAMH002806]; NIDDK [K23 103911]	intramural research program of the National Institute of Mental Health (NIMH); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the intramural research program of the National Institute of Mental Health (NIMH, ZIAMH002806). Additionally, M. Grover is supported by NIDDK K23 103911. The other authors have no conflicts to disclose. There was no additional external funding received for this study.	Andrews EB, 2005, ALIMENT PHARM THER, V22, P935, DOI 10.1111/j.1365-2036.2005.02671.x; Association A.P., 2013, DIAGNOSTIC STAT MANU; Bellini M, 2011, WORLD J GASTROENTERO, V17, P5089, DOI 10.3748/wjg.v17.i46.5089; Bommelaer G, 2004, GASTROEN CLIN BIOL, V28, P554, DOI 10.1016/S0399-8320(04)95011-7; Canavan C, 2014, CLIN EPIDEMIOL, V6, P71, DOI 10.2147/CLEP.S40245; Chang FY, 2013, J NEUROGASTROENTEROL, V19, P301, DOI 10.5056/jnm.2013.19.3.301; Clauwaert N, 2012, NEUROGASTROENT MOTIL, V24, P1088, DOI 10.1111/j.1365-2982.2012.01985.x; Cole JA, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-26; CORNEY RH, 1990, J PSYCHOSOM RES, V34, P483, DOI 10.1016/0022-3999(90)90022-V; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; Drossman DA, 2016, GASTROENTEROLOGY, V150, P1262, DOI 10.1053/j.gastro.2016.02.032; Fass R, 2000, AM J GASTROENTEROL, V95, P1195; Grinsvall C, 2018, UNITED EUR GASTROENT, V6, P300, DOI 10.1177/2050640617715851; Grover M, 2009, DIGEST DIS SCI, V54, P1284, DOI 10.1007/s10620-009-0723-6; Heitkemper MM, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2012.01915.x; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2004, INT J METH PSYCH RES, V13, P60, DOI 10.1002/mpr.166; Kessler RC, 2004, INT J METH PSYCH RES, V13, P69, DOI 10.1002/mpr.167; Klem F, 2017, GASTROENTEROLOGY, V152, P1042, DOI 10.1053/j.gastro.2016.12.039; Koloski NA, 2000, AM J GASTROENTEROL, V95, P67; KUMAR D, 1992, GASTROENTEROLOGY, V103, P12, DOI 10.1016/0016-5085(92)91089-M; Lackner JM, 2014, AM J GASTROENTEROL, V109, P224, DOI 10.1038/ajg.2013.410; Lackner JM, 2013, CLIN GASTROENTEROL H, V11, P1147, DOI 10.1016/j.cgh.2013.03.011; Lacy BE, 2016, GASTROENTEROLOGY, V150, P1393, DOI 10.1053/j.gastro.2016.02.031; Li FX, 2003, CAN J GASTROENTEROL, V17, P259, DOI 10.1155/2003/706891; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Orr WC, 1997, GUT, V41, P390, DOI 10.1136/gut.41.3.390; Pae CU, 2013, EXPERT OPIN INV DRUG, V22, P565, DOI 10.1517/13543784.2013.782392; Park JW, 2013, GUT LIVER, V7, P668, DOI 10.5009/gnl.2013.7.6.668; Ranjbaran Z, 2007, J GASTROEN HEPATOL, V22, P1748, DOI 10.1111/j.1440-1746.2006.04820.x; Rotem AY, 2003, SLEEP, V26, P747, DOI 10.1093/sleep/26.6.747; Sperber AD, 2020, GASTROENTEROLOGY, DOI [10.1053/j.gastro.2020.04.014, DOI 10.1053/J.GASTR0.2020.04.014]; Van Oudenhove L, 2016, GASTROENTEROLOGY, V150, P1355, DOI 10.1053/j.gastro.2016.02.027; Vandvik PO, 2004, ALIMENT PHARM THER, V20, P1195, DOI 10.1111/j.1365-2036.2004.02250.x; Whitehead WE, 2002, GASTROENTEROLOGY, V122, P1140, DOI 10.1053/gast.2002.32392; Whitehead WE, 2007, AM J GASTROENTEROL, V102, P2767, DOI 10.1111/j.1572-0241.2007.01540.x; Wu MF, 2017, J CLIN NEUROSCI, V44, P342, DOI 10.1016/j.jocn.2017.06.009; Yang TY, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006657	38	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245323	10.1371/journal.pone.0245323	http://dx.doi.org/10.1371/journal.pone.0245323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4VV	33444383	Green Published, gold			2022-12-26	WOS:000609988100009
J	Oliveira, TM; Penna-Franca, PA; Dias-Silva, CH; Bittencourt, VZ; Cahue, FFLC; Fonseca, SJ; Pierucci, APTR				Oliveira, Taillan M.; Penna-Franca, Paula A.; Dias-Silva, Christian H.; Bittencourt, Victor Z.; Cahue, Fabio F. L. C.; Fonseca-Junior, Sidnei J.; Pierucci, Anna Paola T. R.			Predictive equations for resting metabolic rate are not appropriate to use in Brazilian male adolescent football athletes	PLOS ONE			English	Article							BODY-COMPOSITION; SOCCER PLAYERS; ENERGY-EXPENDITURE; PERFORMANCE; AGREEMENT; ACCURACY; COLLEGE; GAMES; AGE	High accuracy in estimating energy expenditure is essential for enhancing sports performance. The resting metabolic rate (RMR), as a primary component of total energy expenditure (TEE), is commonly estimated using predictive equations. However, these references may not be applicable to adolescent athletes. The purpose of this cross-sectional study was to analyse the differences between predicted RMR in relation to energy expenditure measured by indirect calorimetry (IC) among 45 Brazilian male adolescent football athletes. Indirect calorimetry (IC) and anthropometric (bioimpedance) measurements were recorded at a single visit to the laboratory after fasting overnight. The mean age was 15.6 +/- 1.14 years, body mass was 63.05 +/- 7.8 kg, and height was 172 +/- 7.5 cm. The RMR values predicted by equations proposed by the Food and Agriculture Organization (FAO) (United Nations), Henry and Rees (HR), Harris Benedict (HB), and Cunningham (CUN) were compared with IC RMR values, by correlation analysis. The FAO and HR predictive equations yielded different values from IC (IC: 1716.26 +/- 202.58, HR: 1864.87 +/- 147.78, FAO: 1854.28 +/- 130.19, p = 0.001). A moderate correlation of 0.504 was found between the results of HB and IC. In the survival-agreement model, the CUN equation showed low disagreement with the IC RMR, with error values between 200 and 300 kcal/day. The results showed that HB and CUN yielded similar values as IC, with the CUN equation showing low disagreement with IC; hence, adolescent athletes should undergo evaluation with precise laboratory methods to ensure that accurate information about RMR is recorded.	[Oliveira, Taillan M.; Penna-Franca, Paula A.; Dias-Silva, Christian H.; Bittencourt, Victor Z.; Cahue, Fabio F. L. C.; Fonseca-Junior, Sidnei J.; Pierucci, Anna Paola T. R.] Fed Univ Rio de Janeiro UFRJ, Nutr Inst Josue de Castro INJC, Lab Food Dev Special Hlth Purpose & Educ DAFEE, Grad Program Nutr, Rio De Janeiro, Brazil; [Fonseca-Junior, Sidnei J.] Univ Estado Rio de Janeiro, Colegio Aplicacao, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Pierucci, APTR (corresponding author), Fed Univ Rio de Janeiro UFRJ, Nutr Inst Josue de Castro INJC, Lab Food Dev Special Hlth Purpose & Educ DAFEE, Grad Program Nutr, Rio De Janeiro, Brazil.	appierucci@gmail.com	Fonseca-Junior, Sidnei Jorge SJ/O-3560-2018; Pierucci, Anna Paola T R/L-7979-2013	Fonseca Junior, Sidnei Jorge/0000-0001-8708-1613; Bittencourt, Victor Zaban/0000-0001-5647-0800; Martins de Oliveira, Taillan/0000-0003-0540-3194; Cahue, Fabio/0000-0003-2273-8893	Rio de Janeiro State Research Support Foundation [E-26/203.319/2017, E26/190.227/2013]; Coordination for the Improvement of Higher Education Personnel [23038.004469/2019-12/PROEX PPGN/UFRJ]	Rio de Janeiro State Research Support Foundation; Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study received financial support from Rio de Janeiro State Research Support Foundation (BR), E-26/203.319/2017 and E26/190.227/2013 and Coordination for the Improvement of Higher Education Personnel, Finance Code 001 PROCESS No.: 23038.004469/2019-12/PROEX PPGN/UFRJ.	[Anonymous], 1985, WHO TECH REP SER, P1; Aragon AA, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0174-y; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Cherian KS, 2018, AM J HUM BIOL, V30, DOI 10.1002/ajhb.23066; Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009; CUNNINGHAM JJ, 1980, AM J CLIN NUTR, V33, P2372, DOI 10.1093/ajcn/33.11.2372; Dunford Marie, 2006, SPORTS NUTR PRACTICE; Fonseca SJ, 2017, PEDIATR EXERC SCI, V29, P285, DOI 10.1123/pes.2016-0101; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Haugen HA, 2007, NUTR CLIN PRACT, V22, P377, DOI 10.1177/0115426507022004377; HENRY CJK, 1991, EUR J CLIN NUTR, V45, P177; Hoff J, 2004, SPORTS MED, V34, P165, DOI 10.2165/00007256-200434030-00003; Jagim AR, 2018, J STRENGTH COND RES, V32, P1875, DOI 10.1519/JSC.0000000000002111; Kendall KL, 2017, J SPORT SCI, V35, P624, DOI 10.1080/02640414.2016.1183802; Kim JH, 2015, NUTR RES PRACT, V9, P370, DOI 10.4162/nrp.2015.9.4.370; Koshimizu T, 2012, J MED INVESTIG, V59, P253, DOI 10.2152/jmi.59.253; Logue DM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030835; Loureiro LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142859; Luiz RR, 2003, J CLIN EPIDEMIOL, V56, P963, DOI 10.1016/S0895-4356(03)00164-1; Madzima TA, 2014, BRIT J NUTR, V111, P71, DOI 10.1017/S000711451300192X; Mohr M, 2016, EUR J APPL PHYSIOL, V116, P179, DOI 10.1007/s00421-015-3245-2; Muller L, 2017, J SPORT SCI MED, V16, P195; Rankin Janet Walberg, 2002, Curr Sports Med Rep, V1, P208, DOI 10.1249/00149619-200208000-00004; RAVUSSIN E, 1989, AM J CLIN NUTR, V49, P968, DOI 10.1093/ajcn/49.5.968; Re AHN, 2014, INT J PERF ANAL SPOR, V14, P482; Sagayama H, 2014, APPL PHYSIOL NUTR ME, V39, P21, DOI 10.1139/apnm-2013-0096; Goncalves VSS, 2013, J PEDIAT-BRAZIL, V89, P567, DOI 10.1016/j.jped.2013.03.023; Schofield KL, 2019, EXP PHYSIOL, V104, P469, DOI 10.1113/EP087512; Speakman JR, 2003, P NUTR SOC, V62, P621, DOI 10.1079/PNS2003282; Stewart E, 2011, PROG THEOR PHYS SUPP, P50, DOI 10.1143/PTPS.190.50; Stolen T, 2005, SPORTS MED, V35, P501; Stroyer J, 2004, MED SCI SPORT EXER, V36, P168, DOI 10.1249/01.MSS.0000106187.05259.96; ten Haaf T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108460; Thomas DT, 2016, J ACAD NUTR DIET, V116, P501, DOI 10.1016/j.jand.2015.12.006; Tinsley GM, 2019, APPL PHYSIOL NUTR ME, V44, P397, DOI 10.1139/apnm-2018-0412; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Westerterp KR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00090	37	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0244970	10.1371/journal.pone.0244970	http://dx.doi.org/10.1371/journal.pone.0244970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444373	Green Published, gold			2022-12-26	WOS:000609988100032
J	Seow, H; McMillan, K; Civak, M; Bainbridge, D; van der Wal, A; Haanstra, C; Goldhar, J; Winemaker, S				Seow, Hsien; McMillan, Kayla; Civak, Margaret; Bainbridge, Daryl; van der Wal, Alison; Haanstra, Christa; Goldhar, Jodeme; Winemaker, Samantha			#Caremongering: A community-led social movement to address health and social needs during COVID-19	PLOS ONE			English	Article								Background To combat social distancing and stay-at-home restrictions due to COVID-19, Canadian communities began a Facebook social media movement, #Caremongering, to support vulnerable individuals in their communities. Little research has examined the spread and use of #Caremongering to address community health and social needs. Objectives We examined the rate at which #Caremongering grew across Canada, the main ways the groups were used, and differences in use by membership size and activity. Methods We searched Facebook Groups using the term "Caremongering" combined with the names of the largest population centres in every province and territory in Canada. We extracted available Facebook analytics on all the groups found, restricted to public groups that operated in English. We further conducted a content analysis of themes from postings in 30 groups using purposive sampling. Posted content was qualitatively analyzed to determine consistent themes across the groups and between those with smaller and larger member numbers. Results The search of Facebook groups across 185 cities yielded 130 unique groups, including groups from all 13 provinces and territories in Canada. Total membership across all groups as of May 4, 2020 was 194,879. The vast majority were formed within days of the global pandemic announcement, two months prior. There were four major themes identified: personal protective equipment, offer, need, and information. Few differences were found between how large and small groups were being used. Conclusions The #Caremongering Facebook groups spread across the entire nation in a matter of days, engaging hundreds of thousands of Canadians. Social media appears to be a useful tool for spreading community-led solutions to address health and social needs.	[Seow, Hsien; McMillan, Kayla; Civak, Margaret; Bainbridge, Daryl] McMaster Univ, Dept Oncol, Hamilton, ON, Canada; [van der Wal, Alison] McMaster Univ, Dept Hlth Res Methods, Hamilton, ON, Canada; [Haanstra, Christa] Change Fdn, Toronto, ON, Canada; [Goldhar, Jodeme] Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Winemaker, Samantha] McMaster Univ, Dept Family Med, Hamilton, ON, Canada	McMaster University; McMaster University; University of Toronto; McMaster University	Seow, H (corresponding author), McMaster Univ, Dept Oncol, Hamilton, ON, Canada.	seowh@mcmaster.ca	Seow, Hsien/AAQ-1438-2021	Seow, Hsien/0000-0001-6701-1714	Labarge Centre for Mobility in Aging [COVID-19]	Labarge Centre for Mobility in Aging	This work was funded by the Labarge Centre for Mobility in Aging COVID-19 Grant. HS received this funding. https://mira.mcmaster.ca/research/research-centre/centre-for-mobility The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agdal R, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193778; Apperson A, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16203789; Bender JL, 2011, J MED INTERNET RES, V13, P165, DOI 10.2196/jmir.1560; Brown G, 2014, HEALTH PROMOT J AUST, V25, P35, DOI 10.1071/HE13078; Campbell C, 2020, SOC SCI MED, V257, DOI 10.1016/j.socscimed.2019.02.004; Cao BL, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7997; Capurro D, 2014, J MED INTERNET RES, V16, P213, DOI 10.2196/jmir.2679; Creswell J. W., 2017, QUAL INQ; Devi S, 2020, LANCET, V395, P1331, DOI 10.1016/S0140-6736(20)30967-3; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365, DOI DOI 10.1016/J.JACR.2018.09.023; Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562; Gerken T., 2020, BBC NEWS; Grant MP, 2019, INTERN MED J, V49, P1177, DOI 10.1111/imj.14426; Harfield SG, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0332-2; Kellehear A., 1999, MORTALITY, V4, P75, DOI DOI 10.1080/713685967; Khosravi P, 2016, COMPUT HUM BEHAV, V63, P594, DOI 10.1016/j.chb.2016.05.092; Krippendorff K., 2018, CONTENT ANAL INTRO I; Laverack G, 2011, HEALTH PROMOT INT, V26, pII258, DOI 10.1093/heapro/dar068; Matias T, 2020, J HEALTH PSYCHOL, V25, P871, DOI 10.1177/1359105320925149; Moscrop D., 2020, WASHINGTON POST; Naslund JA, 2017, ADDICT BEHAV, V73, P81, DOI 10.1016/j.addbeh.2017.05.002; Plummer D, 2006, INT J STD AIDS, V17, P787, DOI 10.1258/095646206779307612; Saan H, 2011, HEALTH PROMOT INT, V26, pII187, DOI 10.1093/heapro/dar069; Schillinger D, 2020, AM J PUBLIC HEALTH, V110, P1393, DOI 10.2105/AJPH.2020.305746; Statistics Canada, POP CTR 2020; Subica AM, 2016, AM J PREV MED, V51, P916, DOI 10.1016/j.amepre.2016.06.020; Tanne JH, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1090; Wilson V, 2016, EVID BASED LIB INF P, V11, P41, DOI 10.18438/B8CG9D; World Health Organization, WHO CHAR COVID 19 PA; World Health Organization,, OTT CHART HLTH PROM; Zhang JW, 2019, ANNU REV SOCIOL, V45, P91, DOI 10.1146/annurev-soc-073117-041421; 2018, CURR OPIN TOXICOL, V10	33	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245483	10.1371/journal.pone.0245483	http://dx.doi.org/10.1371/journal.pone.0245483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4VV	33444420	Green Published, gold			2022-12-26	WOS:000609988100056
J	Sim, MS; Skennerton, CT; Orphan, VJ				Sim, Min Sub; Skennerton, Connor T.; Orphan, Victoria J.			Physiological, genomic, and sulfur isotopic characterization of methanol metabolism by Desulfovibrio carbinolicus	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIUM; SP-NOV.; GEN. NOV.; THERMOPHILIC SULFATE; EMENDED DESCRIPTION; WASTE-WATER; ALCOHOL-DEHYDROGENASE; FRACTIONATION; REDUCTION; PURIFICATION	Methanol is often considered as a non-competitive substrate for methanogenic archaea, but an increasing number of sulfate-reducing microorganisms (SRMs) have been reported to be capable of respiring with methanol as an electron donor. A better understanding of the fate of methanol in natural or artificial anaerobic systems thus requires knowledge of the methanol dissimilation by SRMs. In this study, we describe the growth kinetics and sulfur isotope effects of Desulfovibrio carbinolicus, a methanol-oxidizing sulfate-reducing deltaproteobacterium, together with its genome sequence and annotation. D. carbinolicus can grow with a series of alcohols from methanol to butanol. Compared to longer-chain alcohols, however, specific growth and respiration rates decrease by several fold with methanol as an electron donor. Larger sulfur isotope fractionation accompanies slowed growth kinetics, indicating low chemical potential at terminal reductive steps of respiration. In a medium containing both ethanol and methanol, D. carbinolicus does not consume methanol even after the cessation of growth on ethanol. Among the two known methanol dissimilatory systems, the genome of D. carbinolicus contains the genes coding for alcohol dehydrogenase but lacks enzymes analogous to methanol methyltransferase. We analyzed the genomes of 52 additional species of sulfate-reducing bacteria that have been tested for methanol oxidation. There is no apparent relationship between phylogeny and methanol metabolizing capacity, but most gram-negative methanol oxidizers grow poorly, and none carry homologs for methyltransferase (mtaB). Although the amount of available data is limited, it is notable that more than half of the known gram-positive methanol oxidizers have both enzymatic systems, showing enhanced growth relative to the SRMs containing only alcohol dehydrogenase genes. Thus, physiological, genomic, and sulfur isotopic results suggest that D. carbinolicus and close relatives have the ability to metabolize methanol but likely play a limited role in methanol degradation in most natural environments.	[Sim, Min Sub] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea; [Skennerton, Connor T.; Orphan, Victoria J.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	Seoul National University (SNU); California Institute of Technology	Sim, MS (corresponding author), Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea.	mssim@snu.ac.kr		Skennerton, Connor/0000-0003-1320-4873; Sim, Min Sub/0000-0002-3491-9002	National Research Foundation of Korea (NRF) - Korea government (MSIT) [2019R1A2C1087039]; Gordon and Betty Moore Foundation [GBMF 3306]; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research program [DE-SC0020373]	National Research Foundation of Korea (NRF) - Korea government (MSIT); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research program(United States Department of Energy (DOE))	This work was supported by the Mid-Career Researcher Program (2019R1A2C1087039) through the National Research Foundation of Korea (NRF) funded by the Korea government (MSIT) to MSS, and Gordon and Betty Moore Foundation Grant GBMF 3306 and the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research program DE-SC0020373 to VJO. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildgaard L, 2006, INT J SYST EVOL MICR, V56, P1019, DOI 10.1099/ijs.0.63909-0; Alain K, 2010, INT J SYST EVOL MICR, V60, P33, DOI 10.1099/ijs.0.009449-0; Alazard D, 2010, EXTREMOPHILES, V14, P305, DOI 10.1007/s00792-010-0309-4; An TT, 2014, INT J SYST EVOL MICR, V64, P2907, DOI 10.1099/ijs.0.064873-0; [Anonymous], 2013, J CARDIOLOGY CASES, V8, pe13; Antler G, 2017, GEOCHIM COSMOCHIM AC, V203, P364, DOI 10.1016/j.gca.2017.01.015; Arfman N, 1997, EUR J BIOCHEM, V244, P426, DOI 10.1111/j.1432-1033.1997.00426.x; Balk M, 2002, INT J SYST EVOL MICR, V52, P1361, DOI [10.1099/ijs.0.02165-0, 10.1099/00207713-52-4-1361]; Balk M, 2007, APPL MICROBIOL BIOT, V73, P1203, DOI 10.1007/s00253-006-0590-4; Bevington P. R., 2003, DATA REDUCTION ERROR, DOI 10.2307/2284752; Bradley AS, 2016, GEOBIOLOGY, V14, P91, DOI 10.1111/gbi.12149; BRAUN M, 1985, ARCH MICROBIOL, V142, P77, DOI 10.1007/BF00409241; CAMPBELL LL, 1966, J BACTERIOL, V92, P1122, DOI 10.1128/JB.92.4.1122-1127.1966; CHAMBERS LA, 1975, CAN J MICROBIOL, V21, P1602, DOI 10.1139/m75-234; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Cravo-Laureau C, 2004, INT J SYST EVOL MICR, V54, P1639, DOI 10.1099/ijs.0.63104-0; Detmers J, 2001, APPL ENVIRON MICROB, V67, P888, DOI 10.1128/AEM.67.2.888-894.2001; EGLI T, 1980, ARCH MICROBIOL, V124, P115, DOI 10.1007/BF00427715; Finster K, 1997, SYST APPL MICROBIOL, V20, P201, DOI 10.1016/S0723-2020(97)80066-5; Goorissen HP, 2004, FEMS MICROBIOL ECOL, V49, P489, DOI 10.1016/j.femsec.2004.05.004; Goorissen HP, 2003, INT J SYST EVOL MICR, V53, P1223, DOI 10.1099/ijs.0.02476-0; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Haouari O, 2008, INT J SYST EVOL MICR, V58, P2529, DOI 10.1099/ijs.0.65339-0; Hard BC, 1995, J BASIC MICROB, V35, P385, DOI 10.1002/jobm.3620350605; HARRISON AG, 1958, T FARADAY SOC, V54, P84, DOI 10.1039/tf9585400084; Havig JR, 2017, EARTH-SCI REV, V174, P1, DOI 10.1016/j.earscirev.2017.06.014; HENSGENS CMH, 1993, J BACTERIOL, V175, P2859, DOI 10.1128/JB.175.10.2859-2863.1993; HENSGENS CMH, 1995, ARCH MICROBIOL, V164, P265, DOI 10.1007/BF02529960; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jakobsen TF, 2006, INT J SYST EVOL MICR, V56, P2063, DOI 10.1099/ijs.0.64323-0; Jeanthon C, 2002, INT J SYST EVOL MICR, V52, P765, DOI [10.1099/ijs.0.02025-0, 10.1099/00207713-52-3-765]; Jing ZQ, 2013, BIORESOURCE TECHNOL, V137, P349, DOI 10.1016/j.biortech.2013.03.137; Junier P, 2010, ENVIRON MICROBIOL, V12, P2738, DOI 10.1111/j.1462-2920.2010.02242.x; KAPLAN IR, 1964, J GEN MICROBIOL, V34, P195, DOI 10.1099/00221287-34-2-195; KING GM, 1984, APPL ENVIRON MICROB, V48, P719, DOI 10.1128/AEM.48.4.719-725.1984; Kleikemper J, 2004, GEOCHIM COSMOCHIM AC, V68, P4891, DOI 10.1016/j.gca.2004.05.034; KLEMPS R, 1985, ARCH MICROBIOL, V143, P203, DOI 10.1007/BF00411048; Klouche N, 2009, INT J SYST EVOL MICR, V59, P3100, DOI 10.1099/ijs.0.010363-0; Knoblauch C, 1999, INT J SYST BACTERIOL, V49, P1631, DOI 10.1099/00207713-49-4-1631; KODAKI T, 1983, BIOCHIM BIOPHYS ACTA, V761, P223, DOI 10.1016/0304-4165(83)90069-7; Konneke M, 2013, INT J SYST EVOL MICR, V63, P959, DOI 10.1099/ijs.0.043703-0; KREMER DR, 1988, ARCH MICROBIOL, V150, P552, DOI 10.1007/BF00408248; Krog A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059188; Kuever J, 1999, INT J SYST BACTERIOL, V49, P1801, DOI 10.1099/00207713-49-4-1801; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Leavitt WD, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2075.01392, 10.3389/fmicb.2015.01392]; Leavitt WD, 2013, P NATL ACAD SCI USA, V110, P11244, DOI 10.1073/pnas.1218874110; Lens PNL, 2008, MICROBIAL SULFUR METABOLISM, P285, DOI 10.1007/978-3-540-72682-1_22; Mangalo M, 2007, GEOCHIM COSMOCHIM AC, V71, P4161, DOI 10.1016/j.gca.2007.06.058; MARIOTTI A, 1981, PLANT SOIL, V62, P413, DOI 10.1007/BF02374138; Mayeux B, 2013, INT J SYST EVOL MICR, V63, P593, DOI 10.1099/ijs.0.035238-0; Mori K, 2003, EXTREMOPHILES, V7, P283, DOI 10.1007/s00792-003-0320-0; Myhr S, 2000, INT J SYST EVOL MICR, V50, P1611, DOI 10.1099/00207713-50-4-1611; NANNINGA HJ, 1986, FEMS MICROBIOL ECOL, V38, P125; NANNINGA HJ, 1987, APPL ENVIRON MICROB, V53, P802, DOI 10.1128/AEM.53.4.802-809.1987; Nielsen JT, 1999, INT J SYST BACTERIOL, V49, P859, DOI 10.1099/00207713-49-2-859; OLLIVIER B, 1988, ARCH MICROBIOL, V149, P447, DOI 10.1007/BF00425586; OREMLAND RS, 1982, APPL ENVIRON MICROB, V44, P1270, DOI 10.1128/AEM.44.6.1270-1276.1982; Paris G, 2014, SCIENCE, V346, P739, DOI 10.1126/science.1258211; Paris G, 2013, CHEM GEOL, V345, P50, DOI 10.1016/j.chemgeo.2013.02.022; QATIBI AI, 1991, ARCH MICROBIOL, V155, P143, DOI 10.1007/BF00248608; Rabus R., 2013, DISSIMILATORY SULFAT, P309; Ramamoorthy S, 2006, INT J SYST EVOL MICR, V56, P2729, DOI 10.1099/ijs.0.63610-0; Robertson WJ, 2001, INT J SYST EVOL MICR, V51, P133, DOI 10.1099/00207713-51-1-133; SAKAGUCHI T, 1993, NATURE, V365, P47, DOI 10.1038/365047a0; Sanchez-Andrea I, 2015, EXTREMOPHILES, V19, P39, DOI 10.1007/s00792-014-0701-6; SCHNELL S, 1989, ARCH MICROBIOL, V152, P556, DOI 10.1007/BF00425486; Sekiguchi Y, 2008, INT J SYST EVOL MICR, V58, P2541, DOI 10.1099/ijs.0.2008/000893-0; Sim MS, 2017, GEOCHIM COSMOCHIM AC, V206, P57, DOI 10.1016/j.gca.2017.02.024; Sim MS, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00171; Sim MS, 2011, GEOCHIM COSMOCHIM AC, V75, P4244, DOI 10.1016/j.gca.2011.05.021; Sim MS, 2019, NAT COMMUN, P10, DOI [10.1038/s41467-018-07709-6, DOI 10.1038/S41467-018-07709-6]; Sousa DZ, 2018, NAT COMMUN, P9, DOI [10.1038/s41467-017-01881-x, DOI 10.1038/S41467-017-01881-X]; Suzuki D, 2007, INT J SYST EVOL MICR, V57, P520, DOI 10.1099/ijs.0.64600-0; Tebo BM, 1998, FEMS MICROBIOL LETT, V162, P193, DOI 10.1111/j.1574-6968.1998.tb12998.x; Thabet OB, 2011, CURR MICROBIOL, V62, P486, DOI 10.1007/s00284-010-9733-z; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; Thevenieau F, 2007, EXTREMOPHILES, V11, P295, DOI 10.1007/s00792-006-0039-9; Vandieken V, 2017, INT J SYST EVOL MICR, V67, P1887, DOI 10.1099/ijsem.0.001883; Wankel SD, 2014, GEOCHIM COSMOCHIM AC, V125, P694, DOI 10.1016/j.gca.2013.08.039; Weijma J, 2000, BIODEGRADATION, V11, P429, DOI 10.1023/A:1011616900294; Weijma J, 2001, WATER SCI TECHNOL, V44, P7, DOI 10.2166/wst.2001.0452; Wenk CB, 2018, ISME J, V12, P495, DOI 10.1038/ismej.2017.185; WIDDEL F, 1983, ARCH MICROBIOL, V134, P286, DOI 10.1007/BF00407804; Wing BA, 2014, P NATL ACAD SCI USA, V111, P18116, DOI 10.1073/pnas.1407502111; Yanagawa K, 2016, MICROBES ENVIRON, V31, P190, DOI 10.1264/jsme2.ME15204; Zavarzina DG, 2000, INT J SYST EVOL MICR, V50, P1287, DOI 10.1099/00207713-50-3-1287; ZELLNER G, 1989, ARCH MICROBIOL, V152, P329, DOI 10.1007/BF00425169	88	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245069	10.1371/journal.pone.0245069	http://dx.doi.org/10.1371/journal.pone.0245069			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444327	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000609988100083
J	Ishtiaq, M; Maqbool, M; Ajaib, M; Ahmed, M; Hussain, I; Khanam, H; Mushtaq, W; Hussain, T; Azam, S; Bhatti, KH; Ghani, A				Ishtiaq, Muhammad; Maqbool, Mehwish; Ajaib, Muhammad; Ahmed, Maqsood; Hussain, Iqbal; Khanam, Humaira; Mushtaq, Waheeda; Hussain, Tanveer; Azam, Shehzad; Hayat Bhatti, Khizar; Ghani, Abdul			Ethnomedicinal and folklore inventory of wild plants used by rural communities of valley Samahni, District Bhimber Azad Jammu and Kashmir, Pakistan	PLOS ONE			English	Article							XANTHOCARPUM FRUIT EXTRACT; MEDICINAL-PLANTS; INDIGENOUS KNOWLEDGE; SOLANUM-XANTHOCARPUM; ETHNOBOTANICAL SURVEY; NATIONAL-PARK; ETHNOPHARMACOLOGICAL SURVEY; TRADITIONAL KNOWLEDGE; HERBAL DRUGS; FOOD PLANTS	The current study describes ethnobotanical (EB) and traditional ethnomedicinal (TEMs) uses of medicinal plants (MPs) of Tehsil Samahni area of Azad Jammu and Kashmir, Pakistan. Indigenous inhabitants of the area mostly reside in remote mountainous areas and depend on wild plants for life necessities and treatment of different diseases. This paper presents first quantitative ethnobotanical study describing the popularity level of MPs in indigenous communities by using relative popularity level (RPL) and rank order of priority (ROP) indices. The data of TEMs and EB uses were collected from 200 interviewees consisting of traditional herbal practioners (110) and farmers (90) from study area using structured and semi-structured interview methodology during year 2019. It was found that illiterate peasants have more knowledge and practice of TEMs than other people. A total of 150 plant species belonging to 58 families with botanical and local names, parts used, mode of recipes preparation, administration mechanism and TEMs uses were documented in systematic manner. It was explored that highest number (7.69%) of plants of Moraceae were used in TEMs and followed by species of Asteraceae (6.29%). The ethnobotanical data was analyzed by using quantitative ethnobotanical tools viz: informant consensus factor (ICF), fidelity level (FL), relative frequency of citation (RFC), use value index (UVI), relative importance of plants (RIP), relative populatiry level (RPL) and rank order of popularity (ROP). The leaf ranked first (36.49%) and fruit 2(nd) (12.07%) being used in TEMs while prevalent use-form was decoction (29.28%), followed by tea (23.05%) and preferably taken as oral (46.66%). ICF analysis proved that diabetes, hypertension, rabies, snake sting and joint pains were the most prevalent occurring infirmities. The highest RFC (0.95) was found for Acacia modesta, followed by Boerhavia procumbens (RFC:0.87) and Berberis lycium (RFC:0.85). The relative importance of MPs was calculated by using UVI and Moringa oleifera showed highest (1.38), followed by Zanthoxylum armatum (1.25) and Withania somnifera (1.24) use-values. High UVI of plants depicts that these species are predominantly used in local health care system. The plants Phyllanthus emblica, Morus macruora, Justicia adhatoda and Melia azedarach depicted high values (1.00) of FL and RPL proving that these taxa are commonly used in indigenous medicines by local inhabitants and have better potential for drug discovery by ethnopharmacological analysis. Out of total, 26 species had more than 50% ROP index and Phyllanthus emblica and Flacourtia indica (ROP = 100) followed by Morus macruora (ROP: 97) were used to cure 'hypertension and hyperlipidemia' and 'cough, chest infection', respectively. It was found that 30% of total species were previously reported as medicinal while 70% plants were first time reported to be used in TEMs and authenticated by using of quantitative ethnobotanical tools. Ethnopharmacological potential of indigenous plants was confirmed by RIP and RPL indices which had been used to cure one or more body systems and were promulgated in the local herbal medicine system. The research provides clues to screen these plant species by using latest phytochemical and pharmacological analysis for novel drug discovery. This study will also be useful for conservation of bioculture traditional knowledge of indigenous communities and the most important is to conserve medicinal plants of the study area for future generations.	[Ishtiaq, Muhammad; Maqbool, Mehwish; Ajaib, Muhammad; Ahmed, Maqsood; Khanam, Humaira; Mushtaq, Waheeda; Hussain, Tanveer; Azam, Shehzad] Mirpur Univ Sci & Technol MUST, Dept Bot, Mirpur, Azad Jammu & Ka, Pakistan; [Hussain, Iqbal] Univ Faisalabad, Dept Bot, Govt Coll, Faisalabad, Pakistan; [Hayat Bhatti, Khizar] Univ Gujrat, Dept Bot, Ahmedabad, Gujarat, Pakistan; [Ghani, Abdul] Univ Sargodha, Dept Bot, Sargodha, Pakistan	Government College University Faisalabad; University of Sargodha	Ishtiaq, M (corresponding author), Mirpur Univ Sci & Technol MUST, Dept Bot, Mirpur, Azad Jammu & Ka, Pakistan.	drishtiaq.bot@must.edu.pk	Ishtiaq, Muhammad/AAG-3124-2021; Hussain, Tanveer/GWQ-5172-2022; Ishtiaq, Muhammad/GSN-4278-2022; Hussain, Iqbal/B-2295-2013; Ishtiaq, Muhammad/F-5152-2010	Hussain, Iqbal/0000-0002-8449-0494; Ishtiaq, Muhammad/0000-0003-2468-1413				Abbasi AM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-66; Abbasi MA, 2011, ASIAN J CHEM, V23, P3353; Abbasi MA, 2009, J CHEM SOC PAKISTAN, V31, P955; Ahmed E, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-13; Ajaib M., 2016, FUUAST J BIOL, V6, P247; Alam N, 2011, PAK J BOT, V43, P773; Ali H, 2009, PAK J BOT, V41, P2009; Ali SI, 2008, PAK J BOT, V40, P967; Ali SI, 1990, FLORA PAKISTAN 191 1; Ali SI., 2001, NATURAL HIST RES PAK; Ali-Shtayeh MS, 2000, J ETHNOPHARMACOL, V73, P221, DOI 10.1016/S0378-8741(00)00316-0; Amjad MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171896; Amjad Muhammad Shoaib, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P234, DOI 10.1016/S2221-1691(15)30011-3; Amjad Muhammad Shoaib, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P952; Arshad M, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-13; Awang DVC, 1997, FOOD DRUG LAW J, V52, P341; Ayyanar M, 2011, J ETHNOPHARMACOL, V134, P851, DOI 10.1016/j.jep.2011.01.029; Azam S, 2017, PAK J BOT, V49, P211; Belayneh A, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-18; Bernhoft A.J.A.B., 2010, BRIEF REV BIOACTIVE, P11; Bibi T, 2014, J ETHNOPHARMACOL, V157, P79, DOI 10.1016/j.jep.2014.08.042; Bolson M, 2015, J ETHNOPHARMACOL, V161, P1, DOI 10.1016/j.jep.2014.11.045; Boudjelal A, 2013, J ETHNOPHARMACOL, V148, P395, DOI 10.1016/j.jep.2013.03.082; Bradacs G, 2011, J ETHNOPHARMACOL, V137, P434, DOI 10.1016/j.jep.2011.05.050; BUDHIRAJA RD, 1987, J SCI IND RES INDIA, V46, P488; Cakilcioglu U, 2011, J ETHNOPHARMACOL, V137, P469, DOI 10.1016/j.jep.2011.05.046; Cechinel-Filho, 2012, PLANT BIOACTIVES DRU; Colvard MD, 2006, J ETHNOPHARMACOL, V107, P134, DOI 10.1016/j.jep.2006.04.005; Cook F. E. M., 1995, Economic botany data collection standard.; Cox PA, 2000, SCIENCE, V287, P44, DOI 10.1126/science.287.5450.44; De Wet H, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-51; Devi P. Uma, 1993, Indian Journal of Experimental Biology, V31, P607; FAIZ AUH, 2014, BIOLOGIA-LAHORE, V60, P43; Farnsworth NR, 1988, BIODIVERSITY, P83; Farooq S., 2012, PAKISTAN J WEED SCI, V18, P277; Frei B, 1998, J ETHNOPHARMACOL, V62, P149, DOI 10.1016/S0378-8741(98)00051-8; FRIEDMAN J, 1986, J ETHNOPHARMACOL, V16, P275, DOI 10.1016/0378-8741(86)90094-2; Gilani AH, 2005, J ETHNOPHARMACOL, V100, P43, DOI 10.1016/j.jep.2005.06.001; Govaerts R, 2001, TAXON, V50, P1085, DOI 10.2307/1224723; Govindan S, 1999, J ETHNOPHARMACOL, V66, P205, DOI 10.1016/S0378-8741(98)00160-3; Hamayun M., 2005, ETHNOBOTANICAL LEAFL, V2005, P1; Hayta S, 2014, J ETHNOPHARMACOL, V154, P613, DOI 10.1016/j.jep.2014.04.026; HEINRICH M, 1992, J ETHNOPHARMACOL, V36, P63, DOI 10.1016/0378-8741(92)90062-V; Heinrich M, 1998, SOC SCI MED, V47, P1859, DOI 10.1016/S0277-9536(98)00181-6; Husain SZ, 2008, PAK J BOT, V40, P1897; Hussain F, 1996, P 1 TRAIN WORKSH ETH, P207; Hussain T., 2009, ETHNOBOTANICAL LEAFL, V2009, P6; Hussain Talib, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P454, DOI 10.1016/S2221-1691(12)60075-6; Ibrar M, 2007, PAKISTAN J BOT, V39, P329; Ignacimuthu S, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-25; Inta A, 2013, J ETHNOPHARMACOL, V149, P344, DOI 10.1016/j.jep.2013.06.047; Ishtiaq Ch. Muhammad, 2006, Asian Journal of Plant Sciences, V5, P390; Ishtiaq M, 2010, PLANT BIOSYST, V144, P288, DOI 10.1080/11263501003750185; Ishtiaq M., 2017, INT J BIOSCI, V10, P265, DOI DOI 10.12692/ijb/10.3.265-274; Ishtiaq M., 2016, J MED PLANTS, V3, P97; Ishtiaq M, 2015, J ETHNOPHARMACOL, V168, P201, DOI 10.1016/j.jep.2015.01.054; Ishtiaq M, 2013, PAK J BOT, V45, P157; Ishtiaq M, 2012, PAK J BOT, V44, P245; Ishtiaq Muhammad, 2007, Pak J Biol Sci, V10, P2241, DOI 10.3923/pjbs.2007.2241.2256; Ju Y, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-28; Kadir MF, 2012, J ETHNOPHARMACOL, V144, P627, DOI 10.1016/j.jep.2012.10.003; Kamal M., 2009, PAKISTAN J PLANT SCI, V15, P87; Kaval I, 2014, J ETHNOPHARMACOL, V155, P171, DOI 10.1016/j.jep.2014.05.014; Kayani S, 2015, J ETHNOPHARMACOL, V164, P186, DOI 10.1016/j.jep.2015.02.004; Kayani S, 2014, J ETHNOPHARMACOL, V156, P47, DOI 10.1016/j.jep.2014.08.005; Khaling Mikawlrawng, 2014, International Journal of Herbal Medicine, V2, P1; Khan M. A., 2012, Pakistan Journal of Weed Science Research, V18, P495; Khan M. A., 2010, Ethnobotany Research and Applications, V8, P107; Khan M. B., 2008, THESIS; Khatoon S., 2004, INT J BIOTECHNOLOGY, V1, P584; Lai YJ, 2016, MOLECULES, V21, DOI 10.3390/molecules21050553; Leto C, 2013, J ETHNOPHARMACOL, V146, P90, DOI 10.1016/j.jep.2012.11.042; Luitel DR, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-5; Mahmood A, 2013, J ETHNOPHARMACOL, V148, P714, DOI 10.1016/j.jep.2013.05.035; Mahmood A, 2011, J MED PLANTS RES, V5, P4493; Mahmood A, 2011, PAK J BOT, V43, P105; Mahmood A, 2011, J MED PLANTS RES, V5, P2348; Mahmood AS, 2011, J APPL PHARM, V3, P212, DOI DOI 10.21065/19204159.3.212; MANANDHAR NP, 1995, ECON BOT, V49, P371, DOI 10.1007/BF02863087; MAQBOOL M, 2019, APPL ECOL ENV RES, V17, P12023; Maqbool M., 2019, P PAKISTAN ACAD SCI, V56, P55; Mehwish M, P PAKISTAN ACAD SCI, V56, P5574; Mesfin F, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-28; Moerman DE, 1996, J ETHNOPHARMACOL, V52, P1, DOI 10.1016/0378-8741(96)01393-1; Mugisha MK, 2014, J ETHNOPHARMACOL, V155, P194, DOI 10.1016/j.jep.2014.05.012; Muhammad Ishtiaq, 2012, African Journal of Biotechnology, V11, P3087; Neeraj Kumar, 2010, Indian Journal of Natural Products and Resources, V1, P470; Njoroge N. G., 2004, Lyonia, V7, P71; Padmavathi B, 2005, EVID-BASED COMPL ALT, V2, P99, DOI 10.1093/ecam/neh064; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Patel PK, 2012, J YOUNG PHARM, V4, P164, DOI 10.4103/0975-1483.100022; Priya P., 2010, Pharmacognosy Journal, V2, P400; Qaisar, 2009, FLORA W PAKISTAN KAS; Qaisar M, 2009, FLORA PAKISTAN 194 2; Qureshi R, 2001, PAKISTAN J BOT, V33, P109; Qureshi R., 2002, HAMDARD MED, V45, P86; Qureshi R, 2008, FITOTERAPIA, V79, P468, DOI 10.1016/j.fitote.2008.03.010; Rehman MN, 2017, REV BRAS FARMACOGN, V27, P751, DOI 10.1016/j.bjp.2017.09.004; Revathi P., 2013, Journal of Medicinal Plants Research, V7, P2083; Rokaya MB, 2010, J ETHNOPHARMACOL, V130, P485, DOI 10.1016/j.jep.2010.05.036; Saric-Kundalic B, 2010, J ETHNOPHARMACOL, V131, P33, DOI 10.1016/j.jep.2010.05.061; Seshagirirao K., 2016, ROXBURGHIA, V6, P111; Shinwari MI, 2000, J ETHNOPHARMACOL, V69, P45, DOI 10.1016/S0378-8741(99)00135-X; Shinwari ZK, 2010, J MED PLANTS RES, V4, P161; Singh H, 2014, J ETHNOPHARMACOL, V154, P98, DOI 10.1016/j.jep.2014.03.026; Singh OM, 2010, J SCI IND RES INDIA, V69, P732; Song MJ, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-48; Srithi K, 2009, J ETHNOPHARMACOL, V123, P335, DOI 10.1016/j.jep.2009.02.035; Ssegawa P, 2007, J ETHNOPHARMACOL, V113, P521, DOI 10.1016/j.jep.2007.07.014; STEVENS PF, 2001, ANGIOSPERM PHYLOGENY; Stewart RR, 1982, HIST EXPLORATION PLA, P86; Tabuti JRS, 2003, J ETHNOPHARMACOL, V88, P19, DOI 10.1016/S0378-8741(03)00161-2; Trotter R.T., 1986, PLANTS INDIGENOUS ME, P91, DOI DOI 10.4324/9781315060385-6; Ugulu I, 2009, J MED PLANTS RES, V3, P345; Umair M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177912; Vijayakumar S, 2015, J ETHNOPHARMACOL, V161, P238, DOI 10.1016/j.jep.2014.12.006; Vitalini S, 2013, J ETHNOPHARMACOL, V145, P517, DOI 10.1016/j.jep.2012.11.024; Vyas S, 2004, AGROBIOS; WHO, 2002, TRAD MED ALT MED; Yuan HD, 2017, MOLECULES, V22, DOI 10.3390/molecules22071135; Zandial, 1994, THESIS; Zheng XL, 2013, J ETHNOPHARMACOL, V148, P964, DOI 10.1016/j.jep.2013.05.051	122	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0243151	10.1371/journal.pone.0243151	http://dx.doi.org/10.1371/journal.pone.0243151			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439877	gold, Green Published			2022-12-26	WOS:000609985300017
J	Yabe, SG; Fukuda, S; Nishida, J; Takeda, F; Nashiro, K; Okochi, H				Yabe, Shigeharu G.; Fukuda, Satsuki; Nishida, Junko; Takeda, Fujie; Nashiro, Kiyoko; Okochi, Hitoshi			Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling	PLOS ONE			English	Article								Diabetes mellitus is caused by breakdown of blood glucose homeostasis, which is maintained by an exquisite balance between insulin and glucagon produced respectively by pancreatic beta cells and alpha cells. However, little is known about the mechanism of inducing glucagon secretion from human alpha cells. Many methods for generating pancreatic beta cells from human pluripotent stem cells (hPSCs) have been reported, but only two papers have reported generation of pancreatic alpha cells from hPSCs. Because NKX6.1 has been suggested as a very important gene for determining cell fate between pancreatic beta and alpha cells, we searched for the factors affecting expression of NKX6.1 in our beta cell differentiation protocols. We found that BMP antagonism and activation of retinoic acid signaling at stage 2 (from definitive endoderm to primitive gut tube) effectively suppressed NKX6.1 expression at later stages. Using two different hPSCs lines, treatment with BMP signaling inhibitor (LDN193189) and retinoic acid agonist (EC23) at Stage 2 reduced NKX6.1 expression and allowed differentiation of almost all cells into pancreatic alpha cells in vivo after transplantation under a kidney capsule. Our study demonstrated that the cell fate of pancreatic cells can be controlled by adjusting the expression level of NKX6.1 with proper timing of BMP antagonism and activation of retinoic acid signaling during the pancreatic differentiation process. Our method is useful for efficient induction of pancreatic alpha cells from hPSCs.	[Yabe, Shigeharu G.; Fukuda, Satsuki; Nishida, Junko; Takeda, Fujie; Nashiro, Kiyoko; Okochi, Hitoshi] Natl Ctr Global Hlth & Med, Res Inst, Dept Regenerat Med, Tokyo, Japan	National Center for Global Health & Medicine - Japan	Yabe, SG; Okochi, H (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Regenerat Med, Tokyo, Japan.	syabe@ri.ncgm.go.jp; hokochi@ri.ncgm.go.jp			National Center for Global Health and Medicine [27A1201, 29A1016, 20K08321]; Japan Society for the Promotion of Science (JSPS)	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the National Center for Global Health and Medicine (27A1201) to HO and (29A1016) to SGY and Grant-in-Aid for Scientific Research (C) 20K08321 from Japan Society for the Promotion of Science (JSPS) to SGY.	Aigha II, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0834-0; Basford CL, 2012, DIABETOLOGIA, V55, P358, DOI 10.1007/s00125-011-2335-x; BOLLI G, 1983, DIABETES, V32, P134, DOI 10.2337/diabetes.32.2.134; Bruin JE, 2015, MED, V7, DOI [10.1126/scitranslmed.aaa9359, DOI 10.1126/SCITRANSLMED.AAA9359]; Bruin JE, 2016, DIABETES, V65, P1297, DOI 10.2337/db15-1439; Cho CHH, 2012, DIABETOLOGIA, V55, P3284, DOI 10.1007/s00125-012-2687-x; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057; Demant M, 2018, METAB SYNDR RELAT D, V16, P530, DOI 10.1089/met.2018.0066; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; Fukuda S, 2019, REGEN THER, V11, P65, DOI 10.1016/j.reth.2019.05.003; GERICH JE, 1973, SCIENCE, V182, P171, DOI 10.1126/science.182.4108.171; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Konstantinova I, 2004, BIOESSAYS, V26, P1069, DOI 10.1002/bies.20105; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kunisada Y, 2012, STEM CELL RES, V8, P274, DOI 10.1016/j.scr.2011.10.002; Le Marchand SJ, 2010, J BIOL CHEM, V285, P14389, DOI 10.1074/jbc.M109.069195; Lemos NE, 2017, ISLETS, V9, P73, DOI 10.1080/19382014.2017.1335842; Liu HK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179353; Mahmoud AI, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204595; Mfopou JK, 2010, GASTROENTEROLOGY, V139, P2224; Nostro MC, 2015, STEM CELL REP, V4, P591, DOI 10.1016/j.stemcr.2015.02.017; Olsen HL, 2005, ENDOCRINOLOGY, V146, P4861, DOI 10.1210/en.2005-0800; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pepper AR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/352315; Peterson QP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16049-3; Rezania A, 2013, STEM CELLS, V31, P2432, DOI 10.1002/stem.1489; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Rodriguez-Diaz R, 2018, CELL METAB, V27, P549, DOI 10.1016/j.cmet.2018.01.015; Russ HA, 2015, EMBO J, V34, P1759, DOI 10.15252/embj.201591058; Saber N, 2018, ENDOCRINOLOGY, V159, P1827, DOI 10.1210/en.2018-00048; Salehi A, 2006, DIABETES, V55, P2318, DOI 10.2337/db06-0080; Sherr J, 2014, DIABETES CARE, V37, P1741, DOI 10.2337/dc13-2612; Siafarikas A, 2012, DIABETES CARE, V35, P1757, DOI 10.2337/dc11-2010; Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195; Sui LN, 2013, STEM CELL REV REP, V9, P569, DOI 10.1007/s12015-013-9435-6; UNGER RH, 1981, NEW ENGL J MED, V304, P1518, DOI 10.1056/NEJM198106183042504; Vieira E, 2007, DIABETOLOGIA, V50, P370, DOI 10.1007/s00125-006-0511-1; Yabe SG, 2019, INT J DEV BIOL, V63, P271, DOI 10.1387/ijdb.180251sy; Yabe SG, 2019, REGEN THER, V10, P69, DOI 10.1016/j.reth.2018.11.003; Yabe SG, 2017, J DIABETES, V9, P168, DOI 10.1111/1753-0407.12400	44	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0245204	10.1371/journal.pone.0245204	http://dx.doi.org/10.1371/journal.pone.0245204			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	33428669	Green Published, gold			2022-12-26	WOS:000630036100041
J	Kludt, E; Nogueira, W; Lenarz, T; Buechner, A				Kludt, Eugen; Nogueira, Waldo; Lenarz, Thomas; Buechner, Andreas			A sound coding strategy based on a temporal masking model for cochlear implants	PLOS ONE			English	Article								Auditory masking occurs when one sound is perceptually altered by the presence of another sound. Auditory masking in the frequency domain is known as simultaneous masking and in the time domain is known as temporal masking or non-simultaneous masking. This works presents a sound coding strategy that incorporates a temporal masking model to select the most relevant channels for stimulation in a cochlear implant (CI). A previous version of the strategy, termed psychoacoustic advanced combination encoder (PACE), only used a simultaneous masking model for the same purpose, for this reason the new strategy has been termed temporal-PACE (TPACE). We hypothesized that a sound coding strategy that focuses on stimulating the auditory nerve with pulses that are as masked as possible can improve speech intelligibility for CI users. The temporal masking model used within TPACE attenuates the simultaneous masking thresholds estimated by PACE over time. The attenuation is designed to fall exponentially with a strength determined by a single parameter, the temporal masking half-life T-1/2. This parameter gives the time interval at which the simultaneous masking threshold is halved. The study group consisted of 24 postlingually deaf subjects with a minimum of six months experience after CI activation. A crossover design was used to compare four variants of the new temporal masking strategy TPACE (T-1/2 ranging between 0.4 and 1.1 ms) with respect to the clinical MP3000 strategy, a commercial implementation of the PACE strategy, in two prospective, within-subject, repeated-measure experiments. The outcome measure was speech intelligibility in noise at 15 to 5 dB SNR. In two consecutive experiments, the TPACE with T-1/2 of 0.5 ms obtained a speech performance increase of 11% and 10% with respect to the MP3000 (T-1/2 = 0 ms), respectively. The improved speech test scores correlated with the clinical performance of the subjects: CI users with above-average outcome in their routine speech tests showed higher benefit with TPACE. It seems that the consideration of short-acting temporal masking can improve speech intelligibility in CI users. The half-live with the highest average speech perception benefit (0.5 ms) corresponds to time scales that are typical for neuronal refractory behavior.	[Kludt, Eugen; Nogueira, Waldo; Lenarz, Thomas; Buechner, Andreas] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany; [Nogueira, Waldo; Lenarz, Thomas; Buechner, Andreas] Hearing4all, Oldenburg, Germany	Hannover Medical School	Kludt, E (corresponding author), Hannover Med Sch, Dept Otolaryngol, Hannover, Germany.	kludt.eugen@mh-hannover.de		Buechner, Andreas/0000-0001-6788-3985; Kludt, Eugen/0000-0001-7030-7604	DFG Cluster of Excellence [EXC 1077/1]; Cochlear Ltd.	DFG Cluster of Excellence(German Research Foundation (DFG)); Cochlear Ltd.	This work was supported by the DFG Cluster of Excellence EXC 1077/1 "Hearing4all" (http://www.hearing4all.eu) and Cochlear Ltd. EK received travel support by Cochlear Ltd. to meetings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierer JA, 2010, TRENDS AMPLIF, V14, P84, DOI 10.1177/1084713810375249; Botros A, 2010, EAR HEARING, V31, P367, DOI 10.1097/AUD.0b013e3181c9fd86; Boulet J, 2016, JARO-J ASSOC RES OTO, V17, P1, DOI 10.1007/s10162-015-0545-5; Buchner A, 2008, OTOL NEUROTOL, V29, P189, DOI 10.1097/mao.0b013e318162512c; Buechner Andreas, 2011, Cochlear Implants Int, V12, P194, DOI 10.1179/1754762811Y0000000009; Fastl H., 2007, PSYCHOACOUSTICS, Vthird; Goldberg RE, 2003, INTRO DIGITAL AUDIO; Harczos T, 2013, IEEE T BIOMED CIRC S, V7, P414, DOI 10.1109/TBCAS.2012.2219530; Hay-McCutcheon MJ, 2005, J ACOUST SOC AM, V118, P2444, DOI 10.1121/1.2035593; HochmairDesoyer I, 1997, AM J OTOL, V18, pS83; Hughes ML, 2012, HEARING RES, V285, P46, DOI 10.1016/j.heares.2012.01.010; Lamping W, 2020, HEARING RES, V391, DOI 10.1016/j.heares.2020.107969; Langner F, 2017, HEARING RES, V345, P96, DOI 10.1016/j.heares.2017.01.010; Lazard DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048739; Loizou PC, 1999, IEEE ENG MED BIOL, V18, P34, DOI 10.1109/51.765187; Macherey O, 2014, CURR BIOL, V24, pR878, DOI 10.1016/j.cub.2014.06.053; Miller CA, 2000, EAR HEARING, V21, P280, DOI 10.1097/00003446-200008000-00003; Moore B. C. J., 2013, INTRO PSYCHOL HEARIN, V6th; Moore BCJ, 1999, J ACOUST SOC AM, V106, P2761, DOI 10.1121/1.428133; Moore BCJ, 2012, PHILOS T R SOC B, V367, P919, DOI 10.1098/rstb.2011.0355; Morsnowski A, 2006, AUDIOL NEURO-OTOL, V11, P389, DOI 10.1159/000095966; Nogueira W, 2005, EURASIP J APPL SIG P, V2005, P3044, DOI 10.1155/ASP.2005.3044; Nogueira W, 2007, P ANN INT IEEE EMBS, P4127, DOI 10.1109/IEMBS.2007.4353244; Nogueira W, 2016, J ACOUST SOC AM, V139, P728, DOI 10.1121/1.4939896; QUADE D, 1979, J AM STAT ASSOC, V74, P680, DOI 10.2307/2286991; Richter CP, 2013, PROC SPIE, V8565, DOI 10.1117/12.2010337; Seligman P., 1995, Annals of Otology Rhinology and Laryngology, V104, P139; Tabibi S, 2020, HEARING RES, V388, DOI 10.1016/j.heares.2020.107885; Wilson BS, 2008, HEARING RES, V242, P3, DOI 10.1016/j.heares.2008.06.005; Wilson BS, 1997, AM J OTOL, V18, pS30; Wouters J, 2015, IEEE SIGNAL PROC MAG, V32, P67, DOI 10.1109/MSP.2014.2371671	31	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0244433	10.1371/journal.pone.0244433	http://dx.doi.org/10.1371/journal.pone.0244433			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4OF	33417608	Green Published, gold			2022-12-26	WOS:000630020100008
J	Gerak, CAN; Cho, SY; Kolesnikov, M; Okon, M; Murphy, MEP; Sessions, RB; Roberge, M; McIntosh, LP				Gerak, Chloe A. N.; Cho, Sophia Y.; Kolesnikov, Maxim; Okon, Mark; Murphy, Michael E. P.; Sessions, Richard B.; Roberge, Michel; McIntosh, Lawrence P.			Biophysical characterization of the ETV6 PNT domain polymerization interfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; HYDROGEN-EXCHANGE; TYROSINE KINASE; SAM DOMAIN; BINDING; TEL; IDENTIFICATION; DIVERSITY; INSIGHTS; SYSTEM	ETV6 is an E26 transformation specific family transcriptional repressor that self-associates by its PNT domain to facilitate cooperative DNA binding. Chromosomal translocations frequently generate constitutively active oncoproteins with the ETV6 PNT domain fused to the kinase domain of one of many protein tyrosine kinases. Although an attractive target for therapeutic intervention, the propensity of the ETV6 PNT domain to polymerize via the tight head-to-tail association of two relatively flat interfaces makes it challenging to identify suitable small molecule inhibitors of this protein-protein interaction. Herein, we provide a comprehensive biophysical characterization of the ETV6 PNT domain interaction interfaces to aid future drug discovery efforts and help define the mechanisms by which its self-association mediates transcriptional repression. Using NMR spectroscopy, X-ray crystallography, and molecular dynamics simulations, along with amide hydrogen exchange measurements, we demonstrate that monomeric PNT domain variants adopt very stable helical bundle folds that do not change in conformation upon self-association into heterodimer models of the ETV6 polymer. Surface plasmon resonance-monitored alanine scanning mutagenesis studies identified hot spot regions within the self-association interfaces. These regions include both central hydrophobic residues and flanking salt-bridging residues. Collectively, these studies indicate that small molecules targeted to these hydrophobic or charged regions within the relatively rigid interfaces could potentially serve as orthosteric inhibitors of ETV6 PNT domain polymerization.	[Gerak, Chloe A. N.; Cho, Sophia Y.; Okon, Mark; Roberge, Michel; McIntosh, Lawrence P.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Kolesnikov, Maxim; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Sessions, Richard B.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [McIntosh, Lawrence P.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of Bristol; University of British Columbia	McIntosh, LP (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada.; McIntosh, LP (corresponding author), Univ British Columbia, Dept Chem, Vancouver, BC, Canada.	mcintosh@chem.ubc.ca		Gerak, Chloe/0000-0002-5329-9443; Sessions, Richard/0000-0003-0320-0895	Canadian Cancer Society Research Institute [703349]; Canadian Institutes of Health Research [CIHR MOP-136834]; University of British Columbia; CIHR	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of British Columbia; CIHR(Canadian Institutes of Health Research (CIHR))	This study was supported by funds from the Canadian Cancer Society Research Institute (703349) to L.P.M and M.R., and from the Canadian Institutes of Health Research (CIHR MOP-136834) to L.P.M. C.A.N.G. held graduate scholarships from CIHR and the University of British Columbia.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPHICS S; Arkin MR, 2003, P NATL ACAD SCI USA, V100, P1603, DOI 10.1073/pnas.252756299; Ashraf SS, 2004, PROTEIN EXPRES PURIF, V33, P238, DOI 10.1016/j.pep.2003.10.016; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Bohlander SK, 2005, SEMIN CANCER BIOL, V15, P162, DOI 10.1016/j.semcancer.2005.01.008; Cetinbas N, 2013, J BIOL CHEM, V288, P27940, DOI 10.1074/jbc.M113.475301; CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111; De Braekeleer E, 2012, LEUKEMIA RES, V36, P945, DOI 10.1016/j.leukres.2012.04.010; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 2008, FEBS LETT, V582, P1495, DOI 10.1016/j.febslet.2008.03.043; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fodje M, 2014, J SYNCHROTRON RADIAT, V21, P633, DOI 10.1107/S1600577514005578; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gerak CAN, 2021, SLAS DISCOV, V26, P698, DOI 10.1177/2472555220979599; Goddard T. D., 1999, SPARKY 3; Green SM, 2010, J BIOL CHEM, V285, P18496, DOI 10.1074/jbc.M109.096958; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang-Hobbs H., 2013, THESIS U BRIT COLUMB; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Knight MJ, 2011, PROTEIN SCI, V20, P1697, DOI 10.1002/pro.703; Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lopez R, 1999, J BIOL CHEM, V274, P30132, DOI 10.1074/jbc.274.42.30132; Mackereth CD, 2004, J MOL BIOL, V342, P1249, DOI 10.1016/j.jmb.2004.07.094; Mandell JG, 1998, P NATL ACAD SCI USA, V95, P14705, DOI 10.1073/pnas.95.25.14705; McIntosh-Smith S, 2015, INT J HIGH PERFORM C, V29, P119, DOI 10.1177/1094342014528252; Mercurio FA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17684-5; Nauli S, 2007, PROTEIN SCI, V16, P2542, DOI 10.1110/ps.073074207; PATERSON Y, 1990, SCIENCE, V249, P755, DOI 10.1126/science.1697101; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Potter MD, 2000, BLOOD, V95, P3341, DOI 10.1182/blood.V95.11.3341.011k44_3341_3348; Poulos S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174485; Qiao F, 2004, CELL, V118, P163, DOI 10.1016/j.cell.2004.07.010; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Sessions RB, 1998, BIOPHYS J, V74, P138, DOI 10.1016/S0006-3495(98)77775-6; Shen Y, 2012, J BIOMOL NMR, V52, P211, DOI 10.1007/s10858-012-9602-0; Skinner JJ, 2012, PROTEIN SCI, V21, P987, DOI 10.1002/pro.2082; Tognon CE, 2004, MOL CELL BIOL, V24, P4636, DOI 10.1128/MCB.24.11.4636-4650.2004; Tran Hoang H, 2002, BMC Struct Biol, V2, P5, DOI 10.1186/1472-6807-2-5; Vivekanand P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037151; Wai DH, 2000, ONCOGENE, V19, P906, DOI 10.1038/sj.onc.1203396; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wilson AJ, 2009, CHEM SOC REV, V38, P3289, DOI 10.1039/b807197g; Zhang Y. Z., 1995, THESIS U PENNSYLVANN	58	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100284	10.1016/j.jbc.2021.100284	http://dx.doi.org/10.1016/j.jbc.2021.100284			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33450226	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400260
J	Ramalingam, N; Dettmer, U				Ramalingam, Nagendran; Dettmer, Ulf			Temperature is a key determinant of alpha- and beta-synuclein membrane interactions in neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAROYL-COA DESATURASE; PARKINSONS-DISEASE; GAMMA-SYNUCLEIN; PATHOGENIC MUTATIONS; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; LEWY BODIES; DEMENTIA; LOCALIZATION; ACCUMULATION	Aggregation of alpha-synuclein (alpha S) leads to the hallmark neuropathology of Parkinson's disease (PD) and related synucleinopathies. alpha S has been described to exist in both cytosolic and membrane-associated forms, the relative abundance of which has remained unsettled. To study alpha S under the most relevant conditions by a quantitative method, we cultured and matured rodent primary cortical neurons for >17 days and determined alpha S cytosol:membrane distribution via centrifugation-free sequential extractions based on the weak ionic detergent digitonin. We noticed that at lower temperatures (4 degrees C or room temperature), alpha S was largely membrane-associated. At 37 degrees C, however, alpha S solubility was markedly increased. In contrast, the extraction of control proteins (GAPDH, cytosolic; calnexin, membrane) was not affected by temperature. When we compared the relative distribution of the synuclein homologs alpha S and beta-synuclein (beta S) under various conditions that differed in temperature and digitonin concentration (200-1200 mu g/ml), we consistently found alpha S to be more membrane-associated than beta S. Both proteins, however, exhibited temperature-dependent membrane binding. Under the most relevant conditions (37 degrees C and 800 mu g/ml digitonin, i.e., the lowest digitonin concentration that extracted cytosolic GAPDH to near completion), cytosolic distribution was 49.8% +/- 9.0% for alpha S and 63.6% +/- 6.6% for beta S. PD-linked alpha S A30P was found to be largely cytosolic, confirming previous studies that had used different methods. Our work highlights the dynamic nature of cellular synuclein behavior and has important implications for protein-biochemical and cell-biological studies of alpha S proteostasis, such as testing the effects of genetic and pharmacological manipulations.	[Ramalingam, Nagendran; Dettmer, Ulf] Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ramalingam, N; Dettmer, U (corresponding author), Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA.	nramalingam@bwh.harvard.edu; udettmer@bwh.harvard.edu		Dettmer, Ulf/0000-0001-6676-0107	NIH [NS099328]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant NS099328 (to U. D). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baba M, 1998, AM J PATHOL, V152, P879; Brucale M, 2009, CHEMBIOCHEM, V10, P176, DOI 10.1002/cbic.200800581; Buchman VL, 1998, J NEUROSCI, V18, P9335; Burre J, 2015, J NEUROSCI, V35, P5221, DOI 10.1523/JNEUROSCI.4650-14.2015; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dettmer U, 2017, HUM MOL GENET, V26, P3466, DOI 10.1093/hmg/ddx227; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fanning S, 2019, MOL CELL, V73, P1001, DOI 10.1016/j.molcel.2018.11.028; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Fortin DL, 2010, MOVEMENT DISORD, V25, pS21, DOI 10.1002/mds.22722; Galvagnion C, 2015, NAT CHEM BIOL, V11, P229, DOI [10.1038/NCHEMBIO.1750, 10.1038/nchembio.1750]; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Galvin JE, 2000, AM J PATHOL, V157, P361, DOI 10.1016/S0002-9440(10)64548-8; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Imberdis T, 2019, P NATL ACAD SCI USA, V116, P20760, DOI 10.1073/pnas.1903216116; Inigo-Marco I, 2017, P NATL ACAD SCI USA, V114, pE8274, DOI 10.1073/pnas.1703420114; Irizarry MC, 1996, J NEUROPATH EXP NEUR, V55, P889, DOI 10.1097/00005072-199608000-00004; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Kim YS, 2006, J MOL BIOL, V360, P386, DOI 10.1016/j.jmb.2006.05.004; Lavedan C, 1998, HUM GENET, V103, P106, DOI 10.1007/s004390050792; Lavedan C, 1998, DNA Res, V5, P401, DOI 10.1093/dnares/5.6.401; Lazaro DF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004741; Lincoln S, 1999, NEUROSCI LETT, V269, P107, DOI 10.1016/S0304-3940(99)00420-6; Liu XY, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002373; MAROTEAUX L, 1991, MOL BRAIN RES, V11, P335, DOI 10.1016/0169-328X(91)90043-W; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nishioka K, 2010, ARCH NEUROL-CHICAGO, V67, P970, DOI 10.1001/archneurol.2010.177; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; SCHULZ I, 1990, METHOD ENZYMOL, V192, P280; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Unni VK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010589; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; Viennet T, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0049-z; Vincent BM, 2018, CELL REP, V25, P2742, DOI 10.1016/j.celrep.2018.11.028; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Yeboah F, 2019, NEUROBIOL DIS, V132, DOI 10.1016/j.nbd.2019.104543	43	5	5	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100271	10.1016/j.jbc.2021.100271	http://dx.doi.org/10.1016/j.jbc.2021.100271			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33428933	gold, Green Published			2022-12-26	WOS:000672866400247
J	Donepudi, AC; Lee, Y; Lee, JY; Schuetz, JD; Manautou, JE				Donepudi, Ajay C.; Lee, Yoojin; Lee, Ji-Young; Schuetz, John D.; Manautou, Jose E.			Multidrug resistance-associated protein 4 (Mrp4) is a novel genetic factor in the pathogenesis of obesity and diabetes	FASEB JOURNAL			English	Article						Adipogenesis; Drug transporters; Mrp4	TRANSPORTER EXPRESSION; BILE-ACID; TRANSCRIPTIONAL REGULATION; ADIPOCYTE DIFFERENTIATION; EFFLUX TRANSPORTER; LIPID-ACCUMULATION; INSULIN-RESISTANCE; HEPATIC STEATOSIS; ADIPOSE-TISSUE; CAMP	Multidrug resistance protein 4 (Mrp4) is an efflux transporter known to transport several xenobiotics and endogenous molecules. We recently identified that the lack of Mrp4 increases adipose tissue and body weights in mice. However, the role of Mrp4 in adipose tissue physiology are unknown. The current study aimed at characterizing these specific roles of Mrp4 using wild-type (WT) and knockout (Mrp4(-/-)) mice. Our studies determined that Mrp4 is expressed in mouse adipose tissue and that the lack of Mrp4 expression is associated with adipocyte hypertrophy. Furthermore, the lack of Mrp4 increased blood glucose and leptin levels, and impaired glucose tolerance. Additionally, in 3T3-L1 cells and human pre-adipocytes, pharmacological inhibition of Mrp4 increased adipogenesis and altered expression of adipogenic genes. Lack of Mrp4 activity in both of our in vivo and in vitro models leads to increased activation of adipose tissue cAMP response element-binding protein (Creb) and decreased plasma prostaglandin E (PGE) metabolite levels. These changes in Creb activation, coupled with decreased PGE levels, together promoted the observed metabolic phenotype in Mrp4(-/-) mice. In conclusion, our results indicate that Mrp4 as a novel genetic factor involved in the pathogenesis of metabolic diseases, such as obesity and diabetes.	[Donepudi, Ajay C.; Manautou, Jose E.] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, 69 North Eagleville Rd,Unit 3092, Storrs, CT 06269 USA; [Lee, Yoojin; Lee, Ji-Young] Univ Connecticut, Dept Nutr Sci, Storrs, CT 06269 USA; [Schuetz, John D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN USA	University of Connecticut; University of Connecticut; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Manautou, JE (corresponding author), Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, 69 North Eagleville Rd,Unit 3092, Storrs, CT 06269 USA.	jose.manautou@uconn.edu			NCI NIH HHS [P30 CA021765, R01 CA194206] Funding Source: Medline; NIDDK NIH HHS [R01 DK069557] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bhupathiraju SN, 2016, CIRC RES, V118, P1723, DOI 10.1161/CIRCRESAHA.115.306825; Casanueva FF, 2010, CLIN ENDOCRINOL, V73, P35, DOI 10.1111/j.1365-2265.2009.03727.x; Cheepala SB, 2015, BLOOD, V126, P2307, DOI 10.1182/blood-2014-08-595942; Cheng QQ, 2008, MOL PHARMACEUT, V5, P77, DOI 10.1021/mp700114j; Cheung L, 2014, BIOCHEM PHARMACOL, V91, P97, DOI 10.1016/j.bcp.2014.05.023; Cyranka M, 2019, OBESITY, V27, P1292, DOI 10.1002/oby.22521; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Donepudi AC, 2020, TOXICOL SCI, V175, P301, DOI 10.1093/toxsci/kfaa032; Donepudi AC, 2019, TOXICOL REP, V6, P841, DOI 10.1016/j.toxrep.2019.08.005; Donepudi AC, 2018, HEPATOL COMMUN, V2, P99, DOI 10.1002/hep4.1129; Donepudi AC, 2017, HEPATOLOGY, V65, P813, DOI 10.1002/hep.28707; Donepudi AC, 2016, DRUG METAB DISPOS, V44, P518, DOI 10.1124/dmd.115.066779; Donepudi AC, 2012, LIVER INT, V32, P560, DOI 10.1111/j.1478-3231.2011.02724.x; Fujimori K, 2012, PPAR RES, V2012, DOI 10.1155/2012/527607; Fujimori K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044698; Ghaben AL, 2019, NAT REV MOL CELL BIO, V20, P242, DOI 10.1038/s41580-018-0093-z; Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957; Hara Y, 2011, J CLIN INVEST, V121, P2888, DOI 10.1172/JCI45023; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Lee MJ, 2014, METHOD ENZYMOL, V538, P49, DOI 10.1016/B978-0-12-800280-3.00004-9; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Lin ZP, 2008, MOL PHARMACOL, V73, P243, DOI 10.1124/mol.107.039594; Maher JM, 2005, DRUG METAB DISPOS, V33, P947, DOI 10.1124/dmd.105.003780; Mennone A, 2006, HEPATOLOGY, V43, P1013, DOI 10.1002/hep.21158; More VR, 2011, DRUG METAB DISPOS, V39, P992, DOI 10.1124/dmd.110.037507; Morton GJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE392, DOI 10.1152/ajpendo.00546.2010; Ortega FB, 2016, CIRC RES, V118, P1752, DOI 10.1161/CIRCRESAHA.115.306883; Park HK, 2015, METABOLISM, V64, P24, DOI 10.1016/j.metabol.2014.08.004; Petersen RK, 2008, MOL CELL BIOL, V28, P3804, DOI 10.1128/MCB.00709-07; Pezzolesi MG, 2010, SEMIN NEPHROL, V30, P126, DOI 10.1016/j.semnephrol.2010.01.004; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Reusch JEB, 2002, J BIOL CHEM, V277, P1426, DOI 10.1074/jbc.M107923200; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Sato H, 2014, CELL METAB, V20, P119, DOI 10.1016/j.cmet.2014.05.002; Tanaka Y, 2015, PHARMACOGENOMICS J, V15, P380, DOI 10.1038/tpj.2014.74; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Xu H, 2016, J MOL CELL BIOL, V8, P518, DOI 10.1093/jmcb/mjw035; Xu JL, 2016, TOXICOL APPL PHARM, V290, P21, DOI 10.1016/j.taap.2015.11.002; Xu JL, 2015, OBESITY, V23, P335, DOI 10.1002/oby.20929; Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716; Yacovino LL, 2012, TOXICOL LETT, V211, P304, DOI 10.1016/j.toxlet.2012.04.008; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200	45	2	2	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21304	10.1096/fj.202001299RR	http://dx.doi.org/10.1096/fj.202001299RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33417247	Green Accepted			2022-12-26	WOS:000647789600090
J	Bertrand-Charette, M; Nielsen, JB; Bouyer, LJ				Bertrand-Charette, Michael; Nielsen, Jens Bo; Bouyer, Laurent J.			A simple, clinically applicable motor learning protocol to increase push-off during gait: A proof-of-concept	PLOS ONE			English	Article							IMPROVES LOCOMOTOR FUNCTION; MUSCLE STRENGTH; WALKING; STROKE; ADAPTATION; SPEED; REHABILITATION; PERFORMANCE; POSTSTROKE; RESISTANCE	Objective Task-specific training is often used in functional rehabilitation for its potential to improve performance at locomotor tasks in neurological populations. As push-off impairment are often seen with these patients, this functional approach shows potential to retrain gait overground to normalize the gait pattern and retrain the ability to improve gait speed. The main objective of this project was to validate, in healthy participants, a simple, low-cost push-off retraining protocol based on task-specific training that could be implemented during overground walking in the clinic. Methods 30 healthy participants walked in an 80-meter long corridor before, during, and after the application of an elastic resistance to the right ankle. Elastic tubing attached to the front of a modified ankle-foot orthosis delivered the resistance during push-off. Relative ankle joint angular displacements were recorded bilaterally and continuously during each walking condition. Results On the resisted side, participants presented aftereffects (increased peak plantarflexion angle from 13.4 +/- 4.2 degrees to 20.0 +/- 6.4 degrees, p<0.0001 and increased peak plantarflexion angular velocity from 145.8 +/- 22.7 degrees/s to 174.4 +/- 37.4 degrees/s, p<0.0001). On the non-resisted side, aftereffects were much smaller than on the resisted side suggesting that the motor learning process was mainly specific to the trained leg. Conclusion This study shows the feasibility of modifying push-off kinematics using an elastic resistance applied at the ankle while walking overground. This approach represents an interesting venue for future gait rehabilitation.	[Bertrand-Charette, Michael; Bouyer, Laurent J.] Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada; [Nielsen, Jens Bo] Univ Copenhagen, Dept Neurosci, Copenhagen, Denmark; [Bouyer, Laurent J.] Laval Univ, Fac Med, Dept Rehabil, Quebec City, PQ, Canada	Laval University; University of Copenhagen; Laval University	Bouyer, LJ (corresponding author), Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada.; Bouyer, LJ (corresponding author), Laval Univ, Fac Med, Dept Rehabil, Quebec City, PQ, Canada.	laurent.bouyer@rea.ulaval.ca	Bertrand-Charette, Michael/GRO-4286-2022; Bouyer, Laurent/A-9255-2010; Nielsen, Jens Bo/C-7632-2015	Bertrand-Charette, Michael/0000-0002-5479-4278; Bouyer, Laurent/0000-0003-2034-4516; Nielsen, Jens Bo/0000-0001-5568-2916	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2018-06184]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by an operating grant to LJB from the Natural Sciences and Engineering Research Council of Canada (NSERC; grant #RGPIN-2018-06184) (https://www.nserc-crsng.gc.ca) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthelemy D, 2012, EXP BRAIN RES, V217, P99, DOI 10.1007/s00221-011-2977-4; Barthelemy D, 2011, PROG BRAIN RES, V192, P181, DOI 10.1016/B978-0-444-53355-5.00012-9; Betschart M, 2020, PHYSIOTHER THEOR PR, V36, P989, DOI 10.1080/09593985.2018.1530708; Blanchette A, 2012, J NEUROPHYSIOL, V108, P275, DOI 10.1152/jn.01098.2011; Blanchette A, 2011, GAIT POSTURE, V34, P358, DOI 10.1016/j.gaitpost.2011.06.001; Blanchette A, 2009, J NEUROPHYSIOL, V102, P568, DOI 10.1152/jn.91096.2008; Blanchette AK, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-98; Bohannon RW, 1996, J ORTHOP SPORT PHYS, V24, P86, DOI 10.2519/jospt.1996.24.2.86; Bohannon RW., 1986, PHYSIOTHER CAN, V38, P204, DOI 10.3138/ptc.38.4.204; Bouyer LJ, 2011, PROG BRAIN RES, V188, P119, DOI 10.1016/B978-0-444-53825-3.00013-9; Buchner DM, 1996, AGE AGEING, V25, P386, DOI 10.1093/ageing/25.5.386; Chen B, 2016, J ORTHOP TRANSL, V5, P26, DOI 10.1016/j.jot.2015.09.007; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Dean CM, 2000, ARCH PHYS MED REHAB, V81, P409, DOI 10.1053/mr.2000.3839; Diaz I, 2011, J ROBOT, V2011, DOI 10.1155/2011/759764; Dickstein R, 2008, NEUROREHAB NEURAL RE, V22, P649, DOI 10.1177/1545968308315997; Eek MN, 2008, GAIT POSTURE, V28, P366, DOI 10.1016/j.gaitpost.2008.05.004; Ferris Daniel P, 2005, Top Spinal Cord Inj Rehabil, V11, P34; Fortin K, 2009, EXP BRAIN RES, V199, P145, DOI 10.1007/s00221-009-1989-9; Goldie PA, 1996, ARCH PHYS MED REHAB, V77, P1074, DOI 10.1016/S0003-9993(96)90072-6; Gordon KE, 2013, J NEUROPHYSIOL, V109, P1804, DOI 10.1152/jn.01128.2011; Grey MJ, 2013, NEURAL CONTROL WALKI, P197; Hendricks HT, 2002, ARCH PHYS MED REHAB, V83, P1629, DOI 10.1053/apmr.2002.35473; Kim CY, 2015, GAIT POSTURE, V41, P425, DOI 10.1016/j.gaitpost.2014.11.004; Kim CM, 2003, PHYS THER, V83, P49, DOI 10.1093/ptj/83.1.49; Lam T, 2006, J NEUROPHYSIOL, V95, P766, DOI 10.1152/jn.00473.2005; Lamontagne A, 2002, GAIT POSTURE, V15, P244, DOI 10.1016/S0966-6362(01)00190-4; Lorentzen J, 2020, HUM MOVEMENT SCI, V69, DOI 10.1016/j.humov.2019.102565; Nadeau S, 1999, CLIN BIOMECH, V14, P125, DOI 10.1016/S0268-0033(98)00062-X; Noel M, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-16; Patton JL, 2004, IEEE T BIO-MED ENG, V51, P636, DOI 10.1109/TBME.2003.821035; Reisman DS, 2013, NEUROREHAB NEURAL RE, V27, P460, DOI 10.1177/1545968312474118; Reisman DS, 2009, NEUROREHAB NEURAL RE, V23, P735, DOI 10.1177/1545968309332880; ROBINETT CS, 1988, PHYS THER, V68, P1371, DOI 10.1093/ptj/68.9.1371; Salem Y, 2009, NEUROREHABILITATION, V24, P307, DOI 10.3233/NRE-2009-0483; Sawicki GS, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-3; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Stewart John D, 2008, Pract Neurol, V8, P158, DOI 10.1136/jnnp.2008.149393; Tillin NA, 2012, P ROY SOC B-BIOL SCI, V279, P2106, DOI 10.1098/rspb.2011.2109; Wevers L, 2009, STROKE, V40, P2450, DOI 10.1161/STROKEAHA.108.541946; Wu M, 2014, ARCH PHYS MED REHAB, V95, P799, DOI 10.1016/j.apmr.2013.12.021; Wu M, 2012, ARCH PHYS MED REHAB, V93, P782, DOI 10.1016/j.apmr.2011.12.018; Yen SC, 2015, HUM MOVEMENT SCI, V42, P212, DOI 10.1016/j.humov.2015.05.010; Yen SC, 2013, J REHABIL RES DEV, V50, P1187, DOI 10.1682/JRRD.2012.09.0175; Yen SC, 2012, EXP BRAIN RES, V216, P473, DOI 10.1007/s00221-011-2950-2; Yokoyama H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194875	46	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245523	10.1371/journal.pone.0245523	http://dx.doi.org/10.1371/journal.pone.0245523			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PY3TH	33465113	Green Published, gold			2022-12-26	WOS:000611969200036
J	Jobira, B; Frank, DN; Silveira, LJ; Pyle, L; Kelsey, MM; Garcia-Reyes, Y; Robertson, CE; Ir, D; Nadeau, KJ; Cree-Green, M				Jobira, Beza; Frank, Daniel N.; Silveira, Lori J.; Pyle, Laura; Kelsey, Megan M.; Garcia-Reyes, Yesenia; Robertson, Charles E.; Ir, Diana; Nadeau, Kristen J.; Cree-Green, Melanie			Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; GUT MICROBIOTA; ADOLESCENT; SENSITIVITY; MANAGEMENT; DYSBIOSIS; DIAGNOSIS; GLUCOSE	Objective Hepatic steatosis (HS) is common in adolescents with obesity and polycystic ovary syndrome (PCOS). Gut microbiota are altered in adults with obesity, HS, and PCOS, which may worsen metabolic outcomes, but similar data is lacking in youth. Methods Thirty-four adolescents with PCOS and obesity underwent stool and fasting blood collection, oral glucose tolerance testing, and MRI for hepatic fat fraction (HFF). Fecal bacteria were profiled by high-throughput 16S rRNA gene sequencing. Results 50% had HS (N = 17, age 16.2 +/- 1.5 years, BMI 38 +/- 7 kg/m(2), HFF 9.8[6.5, 20.7]%) and 50% did not (N = 17, age 15.8 +/- 2.2 years, BMI 35 +/- 4 kg/m(2), HFF 3.8[2.6, 4.4]%). The groups showed no difference in bacterial alpha-diversity (richness p = 0.202; evenness p = 0.087; and diversity p = 0.069) or global difference in microbiota (beta-diversity). Those with HS had lower % relative abundance (%RA) of Bacteroidetes (p = 0.013), Bacteroidaceae (p = 0.009), Porphyromonadaceae (p = 0.011), and Ruminococcaceae (p = 0.008), and higher Firmicutes:Bacteroidetes (F:B) ratio (47.8% vs. 4.3%, p = 0.018) and Streptococcaceae (p = 0.034). Bacterial taxa including phyla F:B ratio, Bacteroidetes, and family Bacteroidaceae, Ruminococcaceae and Porphyromonadaceae correlated with metabolic markers. Conclusions Obese adolescents with PCOS and HS have differences in composition of gut microbiota, which correlate with metabolic markers, suggesting a modifying role of gut microbiota in HS and PCOS.	[Jobira, Beza; Silveira, Lori J.; Pyle, Laura; Kelsey, Megan M.; Garcia-Reyes, Yesenia; Nadeau, Kristen J.; Cree-Green, Melanie] Univ Colorado, Div Pediat Endocrinol, Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA; [Jobira, Beza; Frank, Daniel N.; Robertson, Charles E.; Ir, Diana] Univ Colorado, Div Infect Dis, Dept Med, Anschutz Med Campus, Aurora, CO USA; [Silveira, Lori J.; Pyle, Laura] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Kelsey, Megan M.; Nadeau, Kristen J.; Cree-Green, Melanie] Univ Colorado, Ctr Womens Hlth Res, Anschutz Med Campus, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Cree-Green, M (corresponding author), Univ Colorado, Div Pediat Endocrinol, Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA.; Cree-Green, M (corresponding author), Univ Colorado, Ctr Womens Hlth Res, Anschutz Med Campus, Aurora, CO 80045 USA.	Melanie.green@childrenscolorado.org	Cree-Green, Melanie/HGF-0832-2022; Cree-Green, Melanie/S-9494-2019	Cree-Green, Melanie/0000-0003-1593-1695; ROBERTSON, CHARLES/0000-0002-4136-4121; Kelsey, Megan/0000-0002-0755-1951	NIDDK [K23DK107871]; Doris Duke Foundation [2015212]; Boettcher Webb-Waring Foundation; University of Colorado GI & Liver Innate Immune Program; Center for Women's health research; NIH/NCATS Colorado CTSA [UL1 TR002535]	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Boettcher Webb-Waring Foundation; University of Colorado GI & Liver Innate Immune Program; Center for Women's health research; NIH/NCATS Colorado CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	MCG: NIDDK K23DK107871, Doris Duke Foundation 2015212, Boettcher Webb-Waring Foundation; MCG, DNF, CER, DI: University of Colorado GI & Liver Innate Immune Program; MMK: Center for Women's health research. This research was also supported by NIH/NCATS Colorado CTSA Grant Number UL1 TR002535. The funders had no role in any part of the research project.1Z	Abdou RM, 2016, DIGEST DIS SCI, V61, P1268, DOI 10.1007/s10620-016-4045-1; Anderson AD, 2014, SEMIN REPROD MED, V32, P202, DOI 10.1055/s-0034-1371092; Baranova A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-133; Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Carreau AM, 2019, CLIN ENDOCRINOL, V91, P544, DOI 10.1111/cen.14062; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Costea PI, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0072-8; Cree-Green M, 2016, OBESITY, V24, P2399, DOI 10.1002/oby.21651; Del Chierico F, 2017, HEPATOLOGY, V65, P451, DOI 10.1002/hep.28572; DiBaise JK, 2012, AM J GASTROENTEROL S, V1, P22, DOI [10.1038/ajgsup.2012.5, DOI 10.1038/AJGSUP.2012.5]; Duranti S, 2017, GENES NUTR, V12, DOI 10.1186/s12263-017-0566-2; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Franks S, 2008, INT J OBESITY, V32, P1035, DOI 10.1038/ijo.2008.61; Fukuda S, 2014, SEMIN IMMUNOPATHOL, V36, P103, DOI 10.1007/s00281-013-0399-z; Gastaldelli A, 2017, CLIN SCI, V131, P2701, DOI 10.1042/CS20170987; Greene MW, 2010, J BIOL CHEM, V285, P42115, DOI 10.1074/jbc.M110.168575; Guo YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153196; Holterman AXL, 2013, OBESITY, V21, P591, DOI 10.1002/oby.20174; Jobira B, 2020, J CLIN ENDOCR METAB, V105, pE2134, DOI 10.1210/clinem/dgz263; Jones H, 2012, J CLIN ENDOCR METAB, V97, P3709, DOI 10.1210/jc.2012-1382; Kelley ST, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146509; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Legro RS, 2013, J CLIN ENDOCR METAB, V98, P4565, DOI 10.1210/jc.2013-2350; Lindheim L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168390; Liu R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00324; Macut D, 2016, HUM REPROD, V31, P1347, DOI 10.1093/humrep/dew076; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mayer-Davis EJ, 2006, J AM DIET ASSOC, V106, P689, DOI 10.1016/j.jada.2006.02.002; Moschen AR, 2010, GUT, V59, P1259, DOI 10.1136/gut.2010.214577; Motl RW, 2004, RES Q EXERCISE SPORT, V75, P259, DOI 10.1080/02701367.2004.10609159; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Tang MH, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01848; Thackray VG, 2019, TRENDS ENDOCRIN MET, V30, P54, DOI 10.1016/j.tem.2018.11.001; Tremellen K, 2012, MED HYPOTHESES, V79, P104, DOI 10.1016/j.mehy.2012.04.016; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wieland A, 2015, ALIMENT PHARM THER, V42, P1051, DOI 10.1111/apt.13376; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093	44	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2021	16	1							e0245219	10.1371/journal.pone.0245219	http://dx.doi.org/10.1371/journal.pone.0245219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PY3TH	33465100	gold, Green Published			2022-12-26	WOS:000611969200011
J	Lahiri, A; Jha, SS; Acharya, R; Dey, A; Chakraborty, A				Lahiri, Arista; Jha, Sweety Suman; Acharya, Rudraprasad; Dey, Abhijit; Chakraborty, Arup			Has loneliness and poor resilient coping influenced the magnitude of psychological distress among apparently healthy Indian adults during the lockdown? Evidence from a rapid online nation-wide cross-sectional survey	PLOS ONE			English	Article							CARE	Background The burden of psychological distress is increasing with the spread of the pandemic and also with the enforcement of its containment measures. The aim of this research was to determine the proportion of self-reported psychological distress, loneliness and degrees of resilient coping, and to also investigate the relationship of loneliness, coping and other variables with psychological distress among apparently healthy Indians during nation-wide lockdown period. Methods A cross-sectional, region-stratified survey using pre-designed pre-tested Google form disseminated via different social media platforms was conducted. A total of 1249 responses were analysed all over India. The form enquired about Socio-demographic profile, awareness on COVID pandemic and cases in the surroundings. UCLA Loneliness scale, Brief resilience and coping scale (BRCS) and Psychological distress scale (K6) assessed self-reported loneliness, coping and psychological distress, respectively. Special regressor technique adjusting for endogeneity and heteroskedasticity was used to extract the average marginal effects. Results Majority of the respondents were 18-35 years old, male, single and urban residents. News media, social media mostly acted as sources of information regarding COVID related news. Overall, 54.47% (95% CI: 51.39-57.53%) and 38.39% (95% CI: 35.57-41.29%) were reported to be lonely and had low resilient coping ability respectively. Around 44.68% had high risk of developing psychological distress. Being a student (average marginal effect coefficient (AME(Coef))(.): -0.07, 95% CI: [-0.12, -0.01]) and perceiving lockdown as an effective measure (AME(Coef): -0.11, 95% CI: [-0.19, -0.03]) were protective against psychological distress. Psychological distress was associated with male respondents (AME(Coef) 0.07, 95% CI: [0.02, 0.11]), low or medium resilient copers (AME(Coef) 0.89, 95% CI: [0.17, 1.61]), and perceiving a serious impact of social distancing measures (AME(Coef) 0.17, 95% CI: [0.09, 0.26]). Conclusions Psychological distress among Indian population during lockdown was prevalent. Poor coping ability and perceiving social distancing to have a serious impact was found to be significantly contributing to psychological distress. Appropriate measures to address these issues would be beneficial for the community mental health.	[Lahiri, Arista] Coll Med, Dept Community Med, Kolkata, W Bengal, India; [Lahiri, Arista] Sagore Dutta Hosp, Kolkata, W Bengal, India; [Jha, Sweety Suman] All India Inst Hyg & Publ Hlth, Dept Prevent & Social Med, Kolkata, W Bengal, India; [Acharya, Rudraprasad] Med Coll & Hosp, Dept Psychiat, Kolkata, W Bengal, India; [Dey, Abhijit] WHO RNTCP Tech Support Network, Kolkata, W Bengal, India; [Chakraborty, Arup] Med Coll & Hosp, Dept Community Med, Kolkata, W Bengal, India		Chakraborty, A (corresponding author), Med Coll & Hosp, Dept Community Med, Kolkata, W Bengal, India.	dr.arupchakraborty@gmail.com	Jha, Sweety Suman/AAZ-1851-2020; Lahiri, Arista/AAG-4154-2020	Jha, Sweety Suman/0000-0003-2204-746X; Chakraborty, Arup/0000-0002-5349-9920; Dey, Abhijit/0000-0003-0136-5995; Lahiri, Arista/0000-0001-9486-2565				Ahmed MZ, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102092; Anand Nitin, 2018, Ind Psychiatry J, V27, P131, DOI 10.4103/ipj.ipj_28_18; Anand N, 2018, INDIAN J PSYCHOL MED, V40, P458, DOI 10.4103/IJPSYM.IJPSYM_135_18; Balhara YPS, 2020, INDIAN J PUBLIC HLTH, V64, P172, DOI 10.4103/ijph.IJPH_465_20; Baum C.F., 2012, STAT SOFTWARE COMPON; Chehal D, 2021, INT J SOC PSYCHIATR, V67, P64, DOI 10.1177/0020764020940741; Dong Y, SIMPLE ESTIMATORS BI, P1; Fradelos Evangelos C, 2019, Mater Sociomed, V31, P262, DOI 10.5455/msm.2019.31.262-267; Gomez-Salgado J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113947; Hinz A, 2019, EUR J CANCER CARE, V28, DOI 10.1111/ecc.12952; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; Jaisoorya TS, 2017, ASIAN J PSYCHIATR, V28, P28, DOI 10.1016/j.ajp.2017.03.026; Jann B, 2008, STAT SOFTWARE COMPON; Kaushik Samander, 2020, VirusDisease, V31, DOI 10.1007/s13337-020-00587-x; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kocalevent RD, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0822-6; Lee M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17092977; Losada-Baltar A, 2021, J GERONTOL B-PSYCHOL, V76, pE10, DOI 10.1093/geronb/gbaa048; Mackolil J, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102156; Petzold MB, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1745; Rehman U, 2021, COMMUNITY MENT HLT J, V57, P42, DOI 10.1007/s10597-020-00664-x; Shechter A, 2020, GEN HOSP PSYCHIAT, V66, P1, DOI 10.1016/j.genhosppsych.2020.06.007; Shi L, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.14053; Taylor MR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-347; Verma S, 2020, INT J SOC PSYCHIATR, V66, P756, DOI 10.1177/0020764020934508; Wang HY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233410; WHO Regional Office for Europe, MENT HLTH PSYCH RES; Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8; Yasien S, 2016, SAUDI MED J, V37, P777, DOI 10.15537/smj.2016.7.15004	30	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0245509	10.1371/journal.pone.0245509	http://dx.doi.org/10.1371/journal.pone.0245509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4VV	33444423	Green Published, gold			2022-12-26	WOS:000609988100094
J	Ptacek, J; Hawtin, RE; Sun, DM; Louie, B; Evensen, E; Mittleman, BB; Cesano, A; Cavet, G; Bingham, CO; Cofield, SS; Curtis, JR; Danila, MI; Raman, C; Furie, RA; Genovese, MC; Robinson, WH; Levesque, MC; Moreland, LW; Nigrovic, PA; Shadick, NA; O'Dell, JR; Thiele, GM; St Clair, EW; Striebich, CC; Hale, MB; Khalili, H; Batliwalla, F; Aranow, C; Mackay, M; Diamond, B; Nolan, GP; Gregersen, PK; Bridges, SL				Ptacek, Jason; Hawtin, Rachael E.; Sun, Dongmei; Louie, Brent; Evensen, Erik; Mittleman, Barbara B.; Cesano, Alessandra; Cavet, Guy; Bingham, Clifton O., III; Cofield, Stacey S.; Curtis, Jeffrey R.; Danila, Maria I.; Raman, Chander; Furie, Richard A.; Genovese, Mark C.; Robinson, William H.; Levesque, Marc C.; Moreland, Larry W.; Nigrovic, Peter A.; Shadick, Nancy A.; O'Dell, James R.; Thiele, Geoffrey M.; St Clair, E. William; Striebich, Christopher C.; Hale, Matthew B.; Khalili, Houman; Batliwalla, Franak; Aranow, Cynthia; Mackay, Meggan; Diamond, Betty; Nolan, Garry P.; Gregersen, Peter K.; Bridges, S. Louis, Jr.			Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; ACUTE MYELOID-LEUKEMIA; PERIPHERAL-BLOOD; THERAPY; METHOTREXATE; VALIDATION; EXPRESSION; PATHWAY; GAMMA; RESPONSIVENESS	Rheumatoid arthritis (RA) is a systemic and incurable autoimmune disease characterized by chronic inflammation in synovial lining of joints. To identify the signaling pathways involved in RA, its disease activity, and treatment response, we adapted a systems immunology approach to simultaneously quantify 42 signaling nodes in 21 immune cell subsets (e.g., IFN alpha -> p-STAT5 in B cells) in peripheral blood mononuclear cells (PBMC) from 194 patients with longstanding RA (including 98 patients before and after treatment), and 41 healthy controls (HC). We found multiple differences between patients with RA compared to HC, predominantly in cytokine-induced Jak/STAT signaling in many immune cell subsets, suggesting pathways that may be associated with susceptibility to RA. We also found that high RA disease activity, compared to low disease activity, was associated with decreased (e.g., IFN alpha -> p-STAT5, IL-10 -> p-STAT1) or increased (e.g., IL-6 -> STAT3) response to stimuli in multiple cell subsets. Finally, we compared signaling in patients with established, refractory RA before and six months after initiation of methotrexate (MTX) or TNF inhibitors (TNFi). We noted significant changes from pre-treatment to post-treatment in IFN alpha -> p-STAT5 signaling and IL-10 -> p-STAT1 signaling in multiple cell subsets; these changes brought the aberrant RA signaling profiles toward those of HC. This large, comprehensive functional signaling pathway study provides novel insights into the pathogenesis of RA and shows the potential of quantification of cytokine-induced signaling as a biomarker of disease activity or treatment response.	[Ptacek, Jason; Hawtin, Rachael E.; Louie, Brent; Evensen, Erik; Mittleman, Barbara B.; Cesano, Alessandra; Cavet, Guy; Nolan, Garry P.] Nodality Inc, San Francisco, CA USA; [Sun, Dongmei; Cofield, Stacey S.; Curtis, Jeffrey R.; Danila, Maria I.; Raman, Chander] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Bingham, Clifton O., III] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Furie, Richard A.; Khalili, Houman; Batliwalla, Franak; Aranow, Cynthia; Mackay, Meggan; Diamond, Betty; Gregersen, Peter K.] Feinstein Inst Med Res, Manhasset, NY USA; [Furie, Richard A.; Khalili, Houman; Batliwalla, Franak; Aranow, Cynthia; Mackay, Meggan; Diamond, Betty; Gregersen, Peter K.] Northwell Hlth, Manhasset, NY USA; [Genovese, Mark C.; Robinson, William H.; Hale, Matthew B.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Levesque, Marc C.] Abbvie Inc, N Chicago, IL USA; [Moreland, Larry W.; Striebich, Christopher C.] Univ Colorado, Anschutz Med Campus, Boulder, CO 80309 USA; [Nigrovic, Peter A.; Shadick, Nancy A.] Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA; [O'Dell, James R.; Thiele, Geoffrey M.] Univ Nebraska, Med Ctr, Lincoln, NE USA; [St Clair, E. William] Duke Univ, Med Ctr, Durham, NC USA; [Bridges, S. Louis, Jr.] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA; [Bridges, S. Louis, Jr.] Weill Cornell Med Coll, New York, NY 10065 USA	University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; Northwell Health; Northwell Health; Stanford University; AbbVie; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder; Harvard University; Brigham & Women's Hospital; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; Duke University; Cornell University	Bridges, SL (corresponding author), Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA.; Bridges, SL (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.	LBridges@uab.edu		Robinson, William/0000-0003-4385-704X; Nolan, Garry/0000-0002-8862-9043	NIH [RC2 AR058964]; Department of Defense Congressionally Directed Medical Research Program [PR151462]; Fundacion Bechara	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Congressionally Directed Medical Research Program(United States Department of Defense); Fundacion Bechara	This work was supported by grants NIH RC2 AR058964 (SLB), Department of Defense Congressionally Directed Medical Research Program Grant PR151462 (SLB and CR) and the Fundacion Bechara (PAN). Nodality, Inc., a now inactive company, provided in-kind support for this work, but no financial contributions, and Investigators at Nodality played important roles in the study design, hands-on analysis of samples, and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Anderson AE, 2016, ANN RHEUM DIS, V75, P466, DOI 10.1136/annrheumdis-2014-205850; Boyle DL, 2015, ANN RHEUM DIS, V74, P1311, DOI 10.1136/annrheumdis-2014-206028; Cantaert T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3150; Cesano A, 2013, HAEMATOLOGICA, V98, P626, DOI 10.3324/haematol.2012.071910; Cesano A, 2012, CYTOM PART B-CLIN CY, V82B, P158, DOI 10.1002/cyto.b.21007; Chinnaiya K, 2017, HAEMATOLOGICA, V102, pE336, DOI 10.3324/haematol.2017.165738; Covey TM, 2010, BEST PRACT RES CL HA, V23, P319, DOI 10.1016/j.beha.2010.07.002; Cronstein BN, 2020, NAT REV RHEUMATOL, V16, P145, DOI 10.1038/s41584-020-0373-9; Crow Mary K, 2010, Arthritis Res Ther, V12 Suppl 1, pS5, DOI 10.1186/ar2886; Farrugia Mark, 2016, J Clin Transl Res, V2, P84; Firestein GS, 2017, IMMUNITY, V46, P183, DOI 10.1016/j.immuni.2017.02.006; Golubovskaya V, 2016, CANCERS, V8, DOI 10.3390/cancers8030036; Greenhill CJ, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0419-y; Hawtin RE, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0075-z; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Kim K, 2013, LUPUS, V22, P1336, DOI 10.1177/0961203313504479; Kornblau SM, 2010, CLIN CANCER RES, V16, P3721, DOI 10.1158/1078-0432.CCR-10-0093; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lacayo NJ, 2013, BRIT J HAEMATOL, V162, P250, DOI 10.1111/bjh.12370; Longo DM, 2012, J IMMUNOL, V188, P1717, DOI 10.4049/jimmunol.1102514; Lubbers J, 2013, ANN RHEUM DIS, V72, P776, DOI 10.1136/annrheumdis-2012-202753; Mavragani CP, 2010, ARTHRITIS RHEUM-US, V62, P392, DOI 10.1002/art.27226; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Moreland LW, 2012, ARTHRITIS RHEUM-US, V64, P2824, DOI 10.1002/art.34498; MORGAN SL, 1994, ANN INTERN MED, V121, P833, DOI 10.7326/0003-4819-121-11-199412010-00002; Muskardin TW, 2016, ANN RHEUM DIS, V75, P1757, DOI 10.1136/annrheumdis-2015-208001; Navarro-Millan I, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1126-7; Ormseth MJ, 2016, ARTHRITIS RHEUMATOL, V68, P2099, DOI 10.1002/art.39675; Palucka AK, 2005, P NATL ACAD SCI USA, V102, P3372, DOI 10.1073/pnas.0408506102; Povoleri GAM, 2020, EUR J IMMUNOL, V50, P445, DOI 10.1002/eji.201948190; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ptacek J, 2013, ARTHRITIS RHEUM-US, V65, pS974; Ptacek J, 2013, ARTHRITIS RHEUM-US, V65, pS375; Smolen JS, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.1; Stone SL, 2019, IMMUNITY, V50, P1172, DOI 10.1016/j.immuni.2019.04.004; Tang Q, 2015, ARTHRITIS RHEUMATOL, V67, P1165, DOI 10.1002/art.39056; Thomas S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130078; van Baarsen LGM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2912; Van Roon JAG, 2003, J RHEUMATOL, V30, P648; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Vashish P, 2014, ARTHRITIS RHEUMATOL, V66, pS1279; Wang JS, 2006, J CLIN INVEST, V116, P414, DOI 10.1172/JCI26631; Wright HL, 2015, RHEUMATOLOGY, V54, P188, DOI 10.1093/rheumatology/keu299; Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1; Zumaquero E, 2019, ELIFE, V8, DOI 10.7554/eLife.41641	45	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2021	16	1							e0244187	10.1371/journal.pone.0244187	http://dx.doi.org/10.1371/journal.pone.0244187			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4VV	33444321	Green Published, gold			2022-12-26	WOS:000609988100047
J	Rosen, DL; Travers, D				Rosen, David L.; Travers, Debbie			Emergency department visits among patients transported by law enforcement officers	PLOS ONE			English	Article								Law enforcement officers frequently encounter people with health conditions. We sought to estimate the rates, diagnoses, and characteristics of emergency department (ED) visits among patients transported directly by law enforcement. We analyzed statewide North Carolina Emergency Department data for adults, aged 18+ years, from 2009 to 2016. We estimated transport rates using census data; categorized primary ED diagnoses into 13 major and 8 substituent categories; compared county transport rates by rurality; and examined patient characteristics. There were 136,240 patients transported by law enforcement; annual rates increased from 186.9 (per 100,000 adult residents) in 2009 to 279.2 in 2016. Among visits, 67.7% were among men, the median age was 37 years, and 20.4% resulted in a hospital admission. Most common primary diagnoses were Mental Health Diagnoses (43.1%)-including Schizophrenia and other Psychotic Disorders (7.6%), Mood Disorders (9.7%), and Alcohol and Substance Use (10.7%)-followed by Injury and Poisoning (12.4%) and Circulatory conditions (4.1%). Involuntary commitments constituted 22% of all visits. The median transport rate in rural counties, 291.1, was 2 times that of large metro counties, 145.1. The visit rate increased by nearly 50% during the study period, with the highest rates in rural counties. Many transports were for Mental Illness and involuntary commitments. The relatively common occurrence of law enforcement transports suggests the need for greater research to understand factors influencing law enforcement transport decisions, the impact of these transports on patient health and safety, and the repercussions on patient care of a growing officer presence in EDs.	[Rosen, David L.] Univ North Carolina Chapel Hill, Sch Med, Div Infect Dis, Carrboro, NC USA; [Travers, Debbie] Univ N Carolina, Sch Nursing, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Rosen, DL (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Div Infect Dis, Carrboro, NC USA.	drosen@med.unc.edu			National Institute on Minority Health and Health Disparities of the National Institutes of Health [1R01MD012469-01]; North Carolina Division of Public Health (NC DPH); Public Health Emergency Preparedness Grant (PHEP)	National Institute on Minority Health and Health Disparities of the National Institutes of Health; North Carolina Division of Public Health (NC DPH); Public Health Emergency Preparedness Grant (PHEP)	DR, DT, 1R01MD012469-01, National Institute on Minority Health and Health Disparities of the National Institutes of Health, https://www.nimhd.nih.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The North Carolina Disease Event Tracking and Epidemiologic Collection Tool (NC DETECT) is an advanced, statewide public health surveillance system. NC DETECT is funded with federal funds by North Carolina Division of Public Health (NC DPH), Public Health Emergency Preparedness Grant (PHEP), and managed through a collaboration between NC DPH and the University of North Carolina at Chapel Hill Department of Emergency Medicine's Carolina Center for Health Informatics (UNC CCHI). The NC Office of Emergency Medical Services (NC OEMS) and NC DETECT Data Oversight Committees do not take responsibility for the scientific validity or accuracy of methodology, results, statistical analyses, or conclusions presented.	Allen L, 2014, BILL HLTH; Baker EF, 2016, ANN EMERG MED, V68, P599, DOI 10.1016/j.annemergmed.2016.02.013; Band RA, 2014, ANN EMERG MED, V63, P608, DOI 10.1016/j.annemergmed.2013.11.008; Caldwell EW, 2018, E COMMUNICATION; Craver R, 2018, WINSTON SALEM J 1103; Davis E, 2018, 251145 NCJ US DEP JU; Department rather than EMS, 2019, COMMUNICATION; Gainor D, 2019, COMMUNICATION; Harmon KJ, 2017, REPORT VIOLENT INJUR; Hawkins SC, 2007, RESUSCITATION, V72, P386, DOI 10.1016/j.resuscitation.2006.07.021; Huybrechts I, 2019, EUR J NUTR, P1; Ingram Deborah D, 2014, Vital Health Stat 2, P1; Kansagra Susan M, 2018, N C Med J, V79, P157, DOI 10.18043/ncm.79.3.157; Klassen AB, 2018, PREHOSP DISASTER MED, V33, P165, DOI 10.1017/S1049023X18000213; Kurtz R, 2015, RESULTS 2014 END YEA; Morrison J, 2018, 915 WUNC N CAR PUBL; North Carolina College of Emergency Physicians Standards for Medical Oversight and Data Collection, 2019, EMS PAT CAR TREATM P; Reaves B. A., 2011, 233982 NCJ US DEP JU; The UNC Department of Emergency Medicine Carolina Center for Health Informatics Report, 2011, OV AN NC DETECT EM D; United States Department of Health and Human Services (US DHHS) Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS), BRIDG RAC POP EST US; University of Memphis CIT CENTER, WELC U MEMPH CIT CTR; Wandling MW, 2016, J TRAUMA ACUTE CARE, V81, P931, DOI 10.1097/TA.0000000000001228; Watson AC, 2014, INT J LAW PSYCHIAT, V37, P351, DOI 10.1016/j.ijlp.2014.02.005; Watson AC, 2011, INT J LAW PSYCHIAT, V34, P287, DOI 10.1016/j.ijlp.2011.07.008	24	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0244679	10.1371/journal.pone.0244679	http://dx.doi.org/10.1371/journal.pone.0244679			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4UT	33439860	Green Published, gold			2022-12-26	WOS:000609985300005
J	Soulier, MC				Soulier, Marie-Cecile			Exploring meat processing in the past: Insights from the Nunamiut people	PLOS ONE			English	Article							CUT-MARKS; EXPERIMENTAL BUTCHERY; OLDUVAI GORGE; BODY-SIZE; BONES; STONE; BRAIN; CUTMARKS; PATTERNS; HOMINID	Improving our knowledge of subsistence strategies and food processing techniques of past societies is of prime interest for better understanding human cultures as well as multiple aspects of human evolution. Beyond the simple matter of food itself, a substantial portion of socio-economic behavior is expressed in what, how, when, and with whom we eat. Over the last few decades, diverse methodologies for the analysis and interpretation of cut marks have progressively provided new insights for past butchery practices. For example, a recent study of the production of antelope biltong in South Africa concluded that the drying of meat generates high frequencies of longitudinal cut marks. This paper presents a cut mark analysis of faunal remains recovered by Lewis Binford from 8 campsites occupied by Nunamiut groups from the end of 19(th) to middle of the 20(th) century in the area around Anaktuvuk Pass, Alaska. The preparation of meat-primarily from caribou (Rangifer tarandus)-varied at these sites according to the season of occupation and was, depending on the site, either immediately consumed, processed after being stored in ice-cellars, or dried and stored. These faunal assemblages therefore provide a unique opportunity to explore the material traces of different meat preparation and preservation techniques in order to identify whether specific patterns can be identified and subsequently used to explore subsistence practices in the past. Binford's Nunamiut faunal assemblages, which were produced by individuals using traditional techniques and methods, were analyzed in order to 1) further test the hypothesis that meat drying produces high frequencies of longitudinal cut marks, 2) explore the common assumption that skilled butchers leave smaller numbers of cut marks on bones compared to less experienced individuals, and 3) test whether cut mark patterns vary as a function of the processing techniques employed. The introduction of a %cutL index represents a quicker alternative to geo-referencing cut marks on bones when exploring meat processing techniques and methods and can easily be integrated in zooarchaeological analyses. While the results obtained support processing techniques linked to meat drying to leave high numbers of longitudinal cut marks, they are inconsistent with cut mark frequencies varying as a function of the butcher's skill and experience. Analyzing cut mark patterns is therefore a reliable means for exploring food processing by past human societies and, by extension, their methods for safeguarding against unfavorable seasonal variations in both the abundance and condition of prey species. Identifying food storage in the archaeological record equally provides a unique window on to the social dynamics and potential inequalities of past societies.	[Soulier, Marie-Cecile] Univ Toulouse Jean Jaures, CNRS UMR 5608 TRACES, Maison Rech, Toulouse, France	Universite de Toulouse; Universite de Toulouse - Jean Jaures	Soulier, MC (corresponding author), Univ Toulouse Jean Jaures, CNRS UMR 5608 TRACES, Maison Rech, Toulouse, France.	mariecsoulier@gmail.com		Soulier, Marie-Cecile/0000-0003-2439-7308	Academie francaise (via a J. W. Zellidja grant); CNRS (Centre national de la recherche Scientifique)	Academie francaise (via a J. W. Zellidja grant); CNRS (Centre national de la recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS))	MCS received the financial support from the Academie francaise (via a J. W. Zellidja grant) and from the CNRS (Centre national de la recherche Scientifique) with a Momentum project named 'L'alimentation au coeur de la vie quotidienne des chasseurs-cueilleurs: nouveaux outils, nouvelles donnees, nouvelle vision des societes pre historiques'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2005, HUNTING BUTCHERING P; AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; ANDREWS P, 1995, J ARCHAEOL SCI, V22, P147, DOI 10.1006/jasc.1995.0016; ANDREWS P, 1985, MAN, V20, P675, DOI 10.2307/2802756; [Anonymous], 2004, HUNGRY COUNTRY ESSAY; [Anonymous], 2008, HUNTER LABS APPL NOT, V9, P1, DOI DOI 10.2202/1565-3404.1167; Bartram LE, 1993, BONES BEHAV ETHNOARC, P115; BEHRENSMEYER AK, 1986, NATURE, V319, P768, DOI 10.1038/319768a0; Binford L.R., 1981, BONES ANCIENT MEN MO; Binford L. R., 1978, NUNAMIUT ETHNOARCHAE; Blackman MB, 2004, UPSIDE SEASONS NUNAM; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; Boschin F, 2012, INT J OSTEOARCHAEOL, V22, P549, DOI 10.1002/oa.1272; Braun DR, 2008, J ARCHAEOL SCI, V35, P1216, DOI 10.1016/j.jas.2007.08.015; Brown W.E., 2007, HIST CENTRAL BROOKS; CAMERON RD, 1979, J WILDLIFE MANAGE, V43, P626, DOI 10.2307/3808740; Campbell JM, 1998, N ALASKA CHRONICLE N; Carmody RN, 2009, J HUM EVOL, V57, P379, DOI 10.1016/j.jhevol.2009.02.011; Cochard D., 2004, THESIS; Costamagno S., 2012, THESIS; Costamagno S, 2009, ARCHAEOFAUNA, V18, P9; Courtenay LA, 2019, ARCHAEOL ANTHROP SCI, V11, P651, DOI 10.1007/s12520-017-0554-x; Courtenay LA, 2018, PEERJ, V6, DOI 10.7717/peerj.5133; Courtin J., 1982, B SOC PREHISTORIQUE, V79, P117, DOI DOI 10.3406/bspf.1982.5372; Cunningham P, 2011, J ANTHROPOL ARCHAEOL, V30, P135, DOI 10.1016/j.jaa.2010.12.005; Curtis E, 1930, N AM INDIAN, V20, P409; de Juana S, 2010, J ARCHAEOL SCI, V37, P1841, DOI 10.1016/j.jas.2010.02.002; Dewbury AG, 2007, J ARCHAEOL SCI, V34, P354, DOI 10.1016/j.jas.2006.05.009; Discamps E., 2021, PEER COMMUN, V1, pe67, DOI [10.24072/pcjournal.61, DOI 10.31219/OSF.IO/AEW5C]; Discamps E, 2015, J ARCHAEOL SCI, V58, P62, DOI 10.1016/j.jas.2015.03.021; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P2643, DOI 10.1016/j.jas.2009.07.017; Dominguez-Rodrigo Manuel, 2005, Journal of Taphonomy, V3, P121; Dominguez-Rodrigo M, 2017, J ARCHAEOL SCI, V86, P14, DOI 10.1016/j.jas.2017.08.001; Egeland CP, 2014, J ARCHAEOL SCI, V49, P126, DOI 10.1016/j.jas.2014.05.007; Egeland CP, 2003, PLAINS ANTHROPOL, V48, P39, DOI 10.1080/2052546.2003.11949279; Fonseca-Azevedo K, 2012, P NATL ACAD SCI USA, V109, P18571, DOI 10.1073/pnas.1206390109; Greenfield HJ, 2006, J FIELD ARCHAEOL, V31, P147, DOI 10.1179/009346906791071972; Greenfield HJ, 1999, J ARCHAEOL SCI, V26, P797, DOI 10.1006/jasc.1998.0348; Gubser N. J., 1965, NUNAMIUT ESKIMOS HUN; Haynes G., 1986, CURRENT RES PLEISTOC, V3, P45; Henri-Martin L, 1909, B SOC PREHISTORIQUE, V6, P303; Henrikson LS, 2003, PLAINS ANTHROPOL, V48, P263, DOI 10.1080/2052546.2003.11949267; Ingold T, 1987, EVOLUTION SOCIAL LIF; Ingold Tim, 1982, CURR ANTHROPOL, V23, P531; Ingstad H, 1987, NUNAMIUT STORIES; Ingstad H, 1954, NUNAMIUT ALASKAS INL; Jones R, 2011, STONE METAL DIAGNOSI; Lam YM, 1999, AM ANTIQUITY, V64, P343, DOI 10.2307/2694283; Laroulandie V., 2001, PREHISTOIRE APPROCHE, P97; Lartet M, 1860, ARCH DES SCI PHYS NA, VVIII, P193; Leonard WR, 2003, COMP BIOCHEM PHYS A, V136, P5, DOI 10.1016/S1095-6433(03)00132-6; LEONARD WR, 1994, AM J HUM BIOL, V6, P77, DOI 10.1002/ajhb.1310060111; Lyman R.L., 1987, J ARCHAEOL METHOD TH, V10, P249; Mallye JB, 2011, ARCHAEOFAUNA, V20, P7; Moclan A, 2018, QUATERN INT, V493, P1, DOI 10.1016/j.quaint.2018.09.033; Moretti E, 2015, ETHNOBIOL LETT, V6, P267, DOI 10.14237/ebl.6.2.2015.349; Morgan C, 2012, AM ANTIQUITY, V77, P714, DOI 10.7183/0002-7316.77.4.714; Nilssen P., 2000, THESIS; OLSEN SL, 1988, J ARCHAEOL SCI, V15, P535, DOI 10.1016/0305-4403(88)90081-7; Otarola-Castillo E, 2010, J ARCHAEOL SCI, V37, P1, DOI 10.1016/j.jas.2009.08.005; Pasda K, 2013, ANTHROPOZOOLOGICA, V48, P111, DOI 10.5252/az2013n1a6; Pobiner B. L, 2005, J TAPHONOMY, V3, P107; Pobiner BL, 2018, INT J OSTEOARCHAEOL, V28, P377, DOI 10.1002/oa.2661; POTTS R, 1981, NATURE, V291, P577, DOI 10.1038/291577a0; Roberts SJ, 2002, ARCHAEOMETRY, V44, P485, DOI 10.1111/1475-4754.t01-1-00080; SCHRECK RR, 1974, EXP CELL RES, V88, P31, DOI 10.1016/0014-4827(74)90614-4; SHIPMAN P, 1984, CURR ANTHROPOL, V25, P116, DOI 10.1086/203091; Shipman P., 1981, LIFE HIST FOSSIL INT; Soulier MC, 2017, J ARCHAEOL SCI-REP, V11, P782, DOI 10.1016/j.jasrep.2016.12.033; Soulier MC, 2016, J HUM EVOL, V97, P37, DOI 10.1016/j.jhevol.2016.05.006; Soulier MC., 2018, TECH CULT, V69, P88, DOI [10.4000/tc.8810, DOI 10.4000/TC.8810]; Steele TE, 2002, J ARCHAEOL SCI, V29, P317, DOI 10.1006/jasc.2001.0733; STINER MC, 1995, J ARCHAEOL SCI, V22, P223, DOI 10.1006/jasc.1995.0024; Stopp MP, 2002, J ANTHROPOL ARCHAEOL, V21, P301, DOI 10.1016/S0278-4165(02)00004-1; Taylor J.G., 1969, ETHNOHISTORY, V16, P141; TESTART A, 1982, CURR ANTHROPOL, V23, P523, DOI 10.1086/202894; Testart Alain, 1982, CHASSEURS CUEILLEURS; Thery-Parisot I., 2005, ZOOARCHAEOLOGY FATS, P50; Thiebaut C, 2010, MISE COMMUN APPROACH, P109; WALKER PL, 1977, AM ANTIQUITY, V42, P605, DOI 10.2307/278934; Whitten KR, 1993, MOVEMENTS PATTERNS P; Willis LA, 2008, J ARCHAEOL SCI, V35, P1438, DOI 10.1016/j.jas.2007.10.010; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083	83	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2021	16	1							e0245213	10.1371/journal.pone.0245213	http://dx.doi.org/10.1371/journal.pone.0245213			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PV4UT	33439906	Green Published, gold			2022-12-26	WOS:000609985300018
J	Anzan, M; Alwhaibi, M; Almetwazi, M; Alhawassi, TM				Anzan, Mona; Alwhaibi, Monira; Almetwazi, Mansour; Alhawassi, Tariq M.			Prescribing errors and associated factors in discharge prescriptions in the emergency department: A prospective cross-sectional study	PLOS ONE			English	Article							MEDICATION ERRORS; PHARMACISTS	Objectives Evidence regarding the prevalence of medication prescribing errors (PEs) and potential factors that increase PEs among patients treated in the emergency department (ED) are limited. This study aimed to explore the prevalence and nature of PEs in discharge prescriptions in the ED and identify potential risk factors associated with PEs. Methods This was a prospective observational cross-sectional study in an ambulatory ED in a tertiary teaching hospital. Data were collected for six months using a customized reporting tool. All patients discharged from ED with a discharged prescription within the study period were enrolled in this study. Results About 13.5% (n = 68) of the 504 prescriptions reviewed (for 504 patients) had at least one error. Main PEs encountered were wrong dose (23.2%), wrong frequency (20.7%), and wrong strength errors (14.6%). About 36.8% of identified PEs were related to pediatric prescriptions, followed by the acute care emergency unit (26.5%) and the triage emergency unit (20.6%). The main leading human-related causes associated with PEs were lack of knowledge (40.9%) followed by an improper selection from a computer operator list (31.8%). The leading contributing systems related factors were pre-printed medication orders (50%), lack of training (31.5%), noise level (13.0%), and frequent interruption of prescriber and distraction (11.1%). Prescribers' involved with the identified errors were resident physicians (39.4%), specialists (30.3%), and (24.4%) were made by general practitioners. Physicians rejected around 12% of the pharmacist-raised recommendations related to the identified PEs as per their clinical judgment. Conclusion PEs in ED setting are common, and multiple human and systems-related factors may contribute to the development of PEs. Further training to residents and proper communication between the healthcare professionals may reduce the risk of PEs in ED.	[Anzan, Mona; Alhawassi, Tariq M.] King Saud Univ Med City, Pharm Serv, Riyadh, Saudi Arabia; [Anzan, Mona; Alwhaibi, Monira; Almetwazi, Mansour; Alhawassi, Tariq M.] King Saud Univ, Dept Clin Pharm, Coll Pharm, Riyadh, Saudi Arabia; [Alwhaibi, Monira; Alhawassi, Tariq M.] King Saud Univ, Coll Pharm, Medicat Safety Res Chair, Riyadh, Saudi Arabia	King Saud University; King Saud University; King Saud University	Alhawassi, TM (corresponding author), King Saud Univ Med City, Pharm Serv, Riyadh, Saudi Arabia.; Alhawassi, TM (corresponding author), King Saud Univ, Dept Clin Pharm, Coll Pharm, Riyadh, Saudi Arabia.; Alhawassi, TM (corresponding author), King Saud Univ, Coll Pharm, Medicat Safety Res Chair, Riyadh, Saudi Arabia.	Tarriq@ksu.edu.sa		Alwhaibi, Monira/0000-0003-3707-0582	Vice Deanship of Research Chairs, King Saud University Riyadh, Saudi Arabia	Vice Deanship of Research Chairs, King Saud University Riyadh, Saudi Arabia	The project was fully supported financially by the Vice Deanship of Research Chairs, King Saud University Riyadh, Saudi Arabia.	Alanazi MQ, 2015, DRUG HEALTHC PATIENT, V7, P103, DOI 10.2147/DHPS.S83770; Alshaikh M, 2013, J PATIENT SAF, V9, P145, DOI 10.1097/PTS.0b013e3182845044; Alsulami Z, 2013, EUR J CLIN PHARMACOL, V69, P995, DOI 10.1007/s00228-012-1435-y; [Anonymous], 2015, NATL COORDINATING CO; Perez-Moreno MA, 2017, EMERG MED J, V34, P495, DOI 10.1136/emermed-2015-204726; Aronson JK, 2009, QJM-INT J MED, V102, P513, DOI 10.1093/qjmed/hcp052; Aronson JK, 2009, BRIT J CLIN PHARMACO, V67, P599, DOI 10.1111/j.1365-2125.2009.03415.x; Benjamin L, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-4066; Brown JN, 2008, AM J HEALTH-SYST PH, V65, P330, DOI 10.2146/ajhp070391; Choi I, 2016, RES SOC ADMIN PHARM, V12, P428, DOI 10.1016/j.sapharm.2015.08.006; Dabaghzadeh F, 2013, IRAN J PHARM RES, V12, P937; Farmer BM, 2018, J MED TOXICOL, V14, P114, DOI 10.1007/s13181-017-0634-4; Flynn EA, 2010, AM J HEALTH-SYST PH, V67, P347, DOI 10.2146/ajhp090623; Honey BL, 2015, J PATIENT SAF, V11, P100, DOI 10.1097/PTS.0000000000000048; Izadpanah Fatemeh, 2018, J Med Life, V11, P299, DOI 10.25122/jml-2018-0046; Khattab E, 2019, INT J EMERG MED, V12, DOI 10.1186/s12245-019-0232-0; Larose G, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-3200; Murray KA, 2017, BAYL U MED CTR P; Murray Kelly A, 2017, Proc (Bayl Univ Med Cent), V30, P143; National Coordinating Council for Medication Error Reporting and Prevention, TAX MED ERR; Patanwala AE, 2010, ANN EMERG MED, V55, P522, DOI 10.1016/j.annemergmed.2009.12.017; Poornima P, 2015, J YOUNG PHARM, V7, P241, DOI 10.5530/jyp.2015.3.15; Sanguansak T, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000539; Shaw KN, 2013, EMERG MED J, V30, P815, DOI 10.1136/emermed-2012-201642; Shitu Z, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-4921-4; Stang AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074214; Surgeons AAO, 2013, EMERGENCY CARE TRANS, DOI [10.1007/s00068-018-0992-x, DOI 10.1007/S00068-018-0992-X]; Thomas B, 2019, EUR J CLIN PHARMACOL, V75, P1269, DOI 10.1007/s00228-019-02689-y; Weant KA, 2014, OPEN ACCESS EMERG M, V6, P45, DOI 10.2147/OAEM.S64174; Wittich CM, 2014, MAYO CLIN PROC, V89, P1116, DOI 10.1016/j.mayocp.2014.05.007; World Health Organization, 2016, MED ERRORS	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245321	10.1371/journal.pone.0245321	http://dx.doi.org/10.1371/journal.pone.0245321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434202	Green Published, gold			2022-12-26	WOS:000609979700008
J	Sivanantham, P; Sahoo, J; Lakshminarayanan, S; Bobby, Z; Kar, SS				Sivanantham, Parthibane; Sahoo, Jayaprakash; Lakshminarayanan, Subitha; Bobby, Zachariah; Kar, Sitanshu Sekhar			Profile of risk factors for Non-Communicable Diseases (NCDs) in a highly urbanized district of India: Findings from Puducherry district-wide STEPS Survey, 2019-20	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PREVALENCE; KERALA	Introduction Rapid urbanization and industrialization drives the rising burden of Non-Communicable Diseases (NCDs) worldwide that are characterized by uptake of unhealthy lifestyle such as tobacco and alcohol use, physical inactivity and unhealthy diet. In India, the prevalence of various NCDs and its risk factors shows wide variations across geographic regions necessitating region-specific evidence for population-based prevention and control of NCDs. Objective To estimate the prevalence of behavioral and biological risk factors of NCDs among adult population (18-69 years) in the Puducherry district located in Southern part of India. Methodology We surveyed adults using the World Health Organization (WHO) prescribed STEPwise approach to NCD surveillance (STEPS) during February 2019 to February 2020. A total of 2560 individuals were selected from urban and rural areas (50 clusters in each) through multi-stage cluster random sampling method. STEPS instrument was used to assess behavioral and physical measurements. Fasting blood sample was collected to estimate biochemical risk factors (Diabetes, Hypercholesterolemia) of NCDs. Results Among men, alcohol use 40.4% (95% CI: 37.4-43.4) was almost twice higher compared to tobacco use 24.4% (95% CI: 21.7-26.9). Nearly half of the population was physically inactive 45.8% (95% CI: 43.8-47.8) and obese 46.1% (95% CI: 44-48.1). Hypertension and diabetes mellitus were present among one-third 33.6% (95% CI: 31.6-35.5) and one-fourth 26.7% (95% CI: 24.1-29.1) of the population which were significantly higher among men (37.1% vs 30.8% and 31.6% vs 23.2% respectively). Physical inactivity and overweight/obesity increased with increasing education levels. Tobacco and alcohol use was more common among men, whereas physical inactivity with obesity and hypercholesterolemia was higher among women. Conclusion We found high prevalence of various NCDs and its risk factors among the adult population of Puducherry district.	[Sivanantham, Parthibane; Lakshminarayanan, Subitha; Kar, Sitanshu Sekhar] Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Dept Prevent & Social Med, Pondicherry, India; [Sahoo, Jayaprakash] Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Dept Endocrinol, Pondicherry, India; [Bobby, Zachariah] Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Dept Biochem, Pondicherry, India	Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research	Kar, SS (corresponding author), Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Dept Prevent & Social Med, Pondicherry, India.	drsitanshukar@gmail.com	Kar, Sitanshu Sekhar/E-6031-2011	Kar, Sitanshu Sekhar/0000-0001-7122-523X; Lakshminarayanan, Subitha/0000-0002-1205-5741	Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) [(R)/Intramural/Phs 1/2019-20]	Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)	Dr Sitanshu Sekhar Kar received the grant for the study. This work was funded by the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) Grant No. JIP/Dean (R)/Intramural/Phs 1/2019-20 The url of Funder website: jipmer.edu.in/The funder did not have any role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Agarwal D, 2018, INT J MED DENT SCI, V7, P1667; American Diabetes Association, 2016, Clin Diabetes, V34, P3, DOI 10.2337/diaclin.34.1.3; Anchala R, 2014, J HYPERTENS, V32, P1170, DOI 10.1097/HJH.0000000000000146; Anjana RM, 2017, LANCET DIABETES ENDO, V5, P585, DOI 10.1016/S2213-8587(17)30174-2; [Anonymous], 2017, LANCET GLOBAL HLTH, V5, pe428; Armstrong T, 2006, J PUBLIC HEALTH-HEID, V14, P66, DOI 10.1007/s10389-006-0024-x; Aryal KK., 2014, NONCOMMUNICABLE DIS; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Basu G, 2013, IOSR J DENT MED SCI, V4, P19; Census of India, 2011, DELH POP SEX RAT DEL; Dandona L, 2017, LANCET, V390, P2437, DOI 10.1016/S0140-6736(17)32804-0; Devarajan R, 2020, OBES REV, V21, DOI 10.1111/obr.12938; Directorate General of Health Services Ministry of Health & Family Welfare, 2013, NAT PROGR PREV CONTR, P78; Ei Sandar Oo K M M T, 2014, REPORT NATL SURVEY D; Goverment of India, 2020, LEV URB; Gupta M, 2006, CIRCULATION, V113, pE924, DOI 10.1161/CIRCULATIONAHA.105.583815; Harikrishnan S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192372; Indian Council of Medical Research Public Health Foundation of India and Institute for Health Metrics and Evaluation, 2017, IND HLTH NAT STAT IN; Indian Institute of Population Sciences (IIPS) Ministry of Health and Family Welfare, 2017, NATL FAMILY HLTH SUR, P6; Indian Institute of Population Sciences (IIPS) Ministry of Health and Family Welfare, 2017, NAT FAM HLTH SURV 4, P637; Indian Institute of Population Sciences (IIPS) Ministry of Health and Family Welfare, 2009, NAT FAM HLTH SURV 3; International Institute for Population Sciences Ministry of Health and Family Welfare World Health Organization, 2011, GLOBAL ADULT TOBACCO, P289; Islami F, 2015, TRANSL LUNG CANCER R, V4, P327, DOI 10.3978/j.issn.2218-6751.2015.08.04; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Joshi SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096808; Kashyap VH, 2019, INDIAN J HLTH SCI BI, V12, P21; Khorrami Z, 2017, E MEDITERR HEALTH J, V23, P469, DOI 10.26719/2017.23.7.469; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Kokane AM, 2020, PEERJ, V8, DOI 10.7717/peerj.9568; Luhar S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229438; Ministry of Commerce and Industry, 2015, AGR PROC FOOD PROD E; Ministry of Health, 2014, NONC DIS RISK FACT B; Ministry of Health and Family Welfare, 2017, NAT MULT ACT PLAN PR, P52; Ministry of Health (Division of Non Communicable Diseases) Kenya National Bureau of Statistics World Health Organization, KEN STEPW SURV NONC; Ministry of Health Nutrition and Indigenous Medicine World Health Organization, 2015, NONC DIS RISK FACT S; Ministry of Health (Republic of Botswana) World Health Organization, 2014, BOTSW STEPS SURV REP; Nanditha A, 2019, DIABETES CARE, V42, P476, DOI 10.2337/dc18-1559; National Institute of Medical Statistics Council of Medical Research, 2009, INT DIS SURV PROJ ID; Nethan Suzanne, 2017, Asian Pac J Cancer Prev, V18, P2005, DOI 10.22034/APJCP.2017.18.7.2005; Newtonraj A, 2017, J CLIN DIAGN RES, V11, DOI 10.7860/JCDR/2017/24028.9853; Oommen AM, 2016, INDIAN J MED RES, V144, P460, DOI 10.4103/0971-5916.198668; Oommen Anu Mary, 2016, Indian Heart J, V68, P263, DOI 10.1016/j.ihj.2015.09.014; Pitchai P, 2018, INT J COMMUNITY MED, V5, P5259; Ritchie H., 2018, MENTAL HLTH; Saju C, 2019, INT J MED SCI CURREN, V2, P241; Sathish T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178949; Selvaraj K, 2019, INDIAN J PUBLIC HLTH, V63, P186, DOI 10.4103/ijph.IJPH_158_18; Srivastav Shalini, 2017, J Family Med Prim Care, V6, P491, DOI 10.4103/2249-4863.222027; Sugathan TN, 2008, INDIAN J MED RES, V127, P555; Thakur J S, 2020, Med J Armed Forces India, V76, P261, DOI 10.1016/j.mjafi.2020.03.002; Thakur JS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208872; Thakur JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157705; Thakur Jarnail Singh, 2017, Indian J Community Med, V42, P30, DOI 10.4103/0970-0218.199795; Thankappan KR, 2010, INDIAN J MED RES, V131, P53; Tondare MB, 2017, INT J COMMUNITY MED, V4, P2681; Tripathy JP, 2016, BMC PUBLIC HLTH, P16; Vijayakarthikeyan M., 2017, INT J COMMUNITY MED, V4, P4600; WHO country office for India Government of India, NAT ACT PLAN MON FRA; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; World Health Organization, 2017, WHO STEPS SURV MAN S; World Health Organization, 2015, IND 1 AD GLOB MON FR; World Health Organization Ministry of Health and Family Welfare Tata Institute of Social Sciences (TISS), 2018, IND DEM PROF 2018, P4; Yadav K, 2008, OBES REV, V9, P400, DOI 10.1111/j.1467-789X.2008.00505.x; Zaman Mohammad Mostafa, 2016, Indian J Public Health, V60, P17, DOI 10.4103/0019-557X.177290	70	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2021	16	1							e0245254	10.1371/journal.pone.0245254	http://dx.doi.org/10.1371/journal.pone.0245254			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PV4SP	33434194	Green Published, gold			2022-12-26	WOS:000609979700020
J	Andrianou, XD; Riccardo, F; Caporali, MG; Fazio, C; Neri, A; Vacca, P; Ambrosio, L; Pezzotti, P; Stefanelli, P				Andrianou, Xanthi D.; Riccardo, Flavia; Caporali, Maria Grazia; Fazio, Cecilia; Neri, Arianna; Vacca, Paola; Ambrosio, Luigina; Pezzotti, Patrizio; Stefanelli, Paola			Evaluation of the national surveillance system for invasive meningococcal disease, Italy, 2015-2018	PLOS ONE			English	Article								Enhanced laboratory-based surveillance of invasive meningococcal disease (IMD) in Italy was only assessed indirectly by numerically comparing surveillance data cases with hospital discharge records (HDR). In this study, we evaluated the completeness, timeliness and sensitivity of the IMD surveillance in Italy from 2015 to 2018. Completeness and timeliness were described at the national and subnational level. A capture-recapture analysis was conducted to evaluate the sensitivity and positive predictive value (PPV) using HDR as the external source with a combination of deterministic and probabilistic approaches. The characteristics of the unmatched vs. matched cases were compared using multivariable Poisson modeling. Overall, the completeness of data improved, except for specific variables. Timeliness of notifications also improved to a median of 4 days from onset to reporting. For the years 2015-2017, the sensitivity of the surveillance was estimated at 71.4% and the PPV at 77.5%, changing to 80.6% and 66.9% respectively after removing cases with a secondary meningitis diagnosis. We noted substantial sub-national differences. In 2018 sensitivity was 66.5% (135/203) and the PPV was 79.4% (135/170). The adjusted relative risk of being unmatched in 2015-2017 was higher in cases that were >= 60 years, had missing information or symptom onset in December. The IMD surveillance system overall performs well with completeness and timeliness improving in time. Specific challenges identified for individual variables should guide further improvement. Notwithstanding limitations posed by the comparison database, sensitivity and PPV are promising. The study highlights that promoting etiological ascertainment in people >= 60 years and addressing sub-national challenges are the main current challenges to address.	[Andrianou, Xanthi D.; Riccardo, Flavia; Caporali, Maria Grazia; Fazio, Cecilia; Neri, Arianna; Vacca, Paola; Ambrosio, Luigina; Pezzotti, Patrizio; Stefanelli, Paola] Ist Super Sanita, Dept Infect Dis, Italian Natl Inst Hlth, Rome, Italy	Istituto Superiore di Sanita (ISS)	Stefanelli, P (corresponding author), Ist Super Sanita, Dept Infect Dis, Italian Natl Inst Hlth, Rome, Italy.	paola.stefanelli@iss.it	STEFANELLI, PAOLA/B-8729-2016; FAZIO, CECILIA/ABA-8534-2021; NERI, ARIANNA/B-8726-2016; Ambrosio, Luigina/O-8154-2018; Riccardo, Flavia/GRJ-5156-2022; Vacca, Paola/I-4796-2018; PEZZOTTI, PATRIZIO/C-6480-2016	STEFANELLI, PAOLA/0000-0003-1620-4385; Ambrosio, Luigina/0000-0002-9063-3973; Riccardo, Flavia/0000-0002-1582-6329; Vacca, Paola/0000-0003-3076-1604; PEZZOTTI, PATRIZIO/0000-0002-0805-2927; Andrianou, Xanthi D./0000-0002-2906-5743; Neri, Arianna/0000-0001-5748-880X				[Anonymous], 2017, R LANG ENV STAT COMP, V55, P275; [Anonymous], 2018, ASTM C33C33M 18, DOI DOI 10.1520/C0033_C0033M-18; Baldovin T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012478; Benson FG, 2017, INT J INFECT DIS, V59, P141, DOI 10.1016/j.ijid.2017.03.007; Enamorado T, 2020, **DATA OBJECT**; International Diabetes Federation, 2019, IDF DIABETES ATLAS, VNinth; Ministero della Salute, COV 19 CAS IT 18 DIC; O'Lorcain P, 2018, PUBLIC HEALTH, V156, P44, DOI 10.1016/j.puhe.2017.11.027; Pezzotti P, 2019, VACCINE, V37, P41, DOI 10.1016/j.vaccine.2018.11.047; Salute M della, NUOVO CORONAVIRUS; Schrauder A, 2007, EPIDEMIOL INFECT, V135, P657, DOI 10.1017/S0950268806007151; Signorelli C, 2017, VACCINE, V35, P4057, DOI 10.1016/j.vaccine.2017.06.011; Stefanelli P, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.12.30176	13	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0244889	10.1371/journal.pone.0244889	http://dx.doi.org/10.1371/journal.pone.0244889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4OF	33417620	gold, Green Published			2022-12-26	WOS:000630020100014
J	Bizimana, T; Hagen, N; Gnegel, G; Kayumba, PC; Heide, L				Bizimana, Thomas; Hagen, Nhomsai; Gnegel, Gesa; Kayumba, Pierre Claver; Heide, Lutz			Quality of oxytocin and misoprostol in health facilities of Rwanda	PLOS ONE			English	Article								Sustainable Development Goal 3.1 calls for a reduction of the maternal mortality ratio to less than 70 per 100,000 live births by 2030. The most important cause of maternal mortality is post-partum haemorrhage (PPH). Oxytocin injections and misoprostol tablets are medicines of first choice for the management of PPH in low- and middle-income countries (LMICs). Unfortunately, both substances are chemically unstable, and previous studies have revealed serious quality problems of these medicines in LMICs. The present study is the first report on their quality in Rwanda. From 40 randomly selected health facilities (hospitals, health centers, retail pharmacies and private clinics) in different parts of Rwanda, as well as from six wholesalers and government stores, oxytocin injections and misoprostol tablets were collected. Oxytocin storage temperatures in the health facilities were monitored for six months using temperature data loggers, and found to correctly follow the storage requirements stated by the manufacturers (2-8 degrees C, or room temperature) with few minor deviations. Oxytocin injections (57 samples, representing seven batches of four brands) were tested for their oxytocin content and pH value according to the United States Pharmacopeia. Twenty-four samples from three European manufacturers passed all tests. However, all nine samples of one batch of a Chinese manufacturer showed an excessive content of oxytocin (range 117.2-121.5% of the declared amount). Another batch of the same manufacturer showed extreme variations of the concentration of the preservative benzyl alcohol. Misoprostol tablets (25 samples, representing ten batches of six brands) were tested for content and dissolution according to the International Pharmacopoeia. Fifteen samples passed, but all 10 samples of two brands from India failed with extreme deviations, containing only 42.5-48.7% of the stated amount of misoprostol. In conclusion, oxytocin quality in Rwanda was better than reported from other African countries. However, two extremely substandard brands of misoprostol tablets were found. The Rwandan authorities reacted quickly and efficiently, and recalled these substandard medicines from the market. For oxytocin and misoprostol, with their well-known problems of quality and stability, procurement should possibly be restricted to medicines which are WHO-prequalified or which have been manufactured in countries with stringent regulatory authorities.	[Bizimana, Thomas] Univ Rwanda, Coll Med & Hlth Sci CMHS, Sch Med & Pharm, Dept Pharm, Kigali, Rwanda; [Hagen, Nhomsai; Gnegel, Gesa; Heide, Lutz] Eberhard Karls Univ Tubingen, Pharmaceut Inst, Tubingen, Germany; [Kayumba, Pierre Claver] Univ Rwanda, East African Community Reg Ctr Excellence Vaccine, Kigali, Rwanda	University of Rwanda; Eberhard Karls University of Tubingen; University of Rwanda	Heide, L (corresponding author), Eberhard Karls Univ Tubingen, Pharmaceut Inst, Tubingen, Germany.	heide@uni-tuebingen.de	Bizimana, Thomas/GLV-3526-2022	Bizimana, Thomas/0000-0003-3110-1018	Baden-WurttembergSTIPENDIUM for University Students - BWS plus, a programme of the Baden-Wurttemberg Stiftung; Deutsche Forschungsgemeinschaft; University of Tubingen	Baden-WurttembergSTIPENDIUM for University Students - BWS plus, a programme of the Baden-Wurttemberg Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Tubingen	The authors gratefully acknowledge financial support from the Baden-WurttembergSTIPENDIUM for University Students - BWS plus, a programme of the Baden-Wurttemberg Stiftung. This publication was produced in the BWS plus project "Joint teaching and research on essential medicines in Rwanda". We furthermore acknowledge support for open access publication by the Deutsche Forschungsgemeinschaft and the Open Access Publishing Fund of the University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, INT PHARM; Anyakora C, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1671-y; Avanti C, 2012, MOL PHARMACEUT, V9, P554, DOI 10.1021/mp200622z; Berard V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112401; Bizimana T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236411; European Medicines Agency (EMA), 2017, EMACHMP2; Hagen N, 2020, AM J TROP MED HYG; Hagen N, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2810-9; Hall PE, 2016, QUALITY MED QUALITY, V30; Hawe A, 2009, PHARM RES-DORDR, V26, P1679, DOI 10.1007/s11095-009-9878-2; Hogerzeil HV, 1993, STABILITY INJECTABLE; ICH guidelines, 2005, VAL AN PROC TEXT MET; Irish Medicines Board, 2011, GUID LAB LEAFL HUM M; KARARLI TT, 1990, PHARMACEUT RES, V7, P1186, DOI 10.1023/A:1015996712794; Karikari-Boateng E, 2013, POSTMARKET QUALITY S; Kartoglu U, 2017, BIOLOGICALS, V50, P117, DOI 10.1016/j.biologicals.2017.05.004; Lambert P, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.020415; Ministry of Health-Rwanda, 2015, NAT LIST ESS MED AD; National Institute of Statistics of Rwanda (NISR) [Rwanda] Ministry of Health (MOH) [Rwanda] ICF International, 2016, RWAND DEM HLTH SURV; Newton PN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000052; PATH USAID RHS Coalition, 2018, BUY QUAL OX KEEP IT; Pete L, 2019, J GLOB HLTH REPORTS, V3; REGO A, 1982, J PHARM SCI, V71, P1219, DOI 10.1002/jps.2600711109; Schocken C., 2014, BUSINESS CASE INVEST; SDGs, SUST DEV KNOWL PLATF; Stanton C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000431; Storey RA, 2009, HDB PHARM EXCIPIENTS, V6th, P64; Suryanarayanan R, 2018, REVISITING STABILITY; 't Hoen EFM, 2014, J PUBLIC HEALTH POL, V35, P137, DOI 10.1057/jphp.2013.53; Torloni MR, 2016, BJOG-INT J OBSTET GY, V123, P2076, DOI 10.1111/1471-0528.13998; Torloni MR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236060; Nguyen TH, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029083; UN Commission on Life-Saving Commodities for Women and Children, 2012, COMM REP; Victora CG, 2016, LANCET, V387, P2049, DOI 10.1016/S0140-6736(15)00519-X; WHO, 2016, WHO TECH REP SER, V996, P1; WHO, 2011, WHO TECH REP SER, V961, P1; WHO, 2011, SURV QUAL SEL ANT ME; WHO recommendations, 2018, WHO REC UT PREV POST; WHO UNICEF UNFPA, 2019, APPR STOR MAN OX KEY; WHO UNICEF UNFPA World Bank Group United Nations Population Division, 2019, TRENDS MAT MORT 2000, P93; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World Health Organization, PREQ LISTS MED FIN P; World Health Organization, 2015, SURV QUAL MED ID UN, V2; World Health Organization, 2017, WHO GLOB SURV MON SY; World Health Organization (WHO), 2019, WHO MOD LIST ESS MED, DOI DOI 10.1002/14651858.CD002207.PUB4; World Health Organization WHO, 2012, RECOMMENDATIONS PREV; World Health Organization (WHO), 2017, 1 10 MED PROD DEV CO	47	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0245054	10.1371/journal.pone.0245054	http://dx.doi.org/10.1371/journal.pone.0245054			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4OF	33417602	Green Published, gold			2022-12-26	WOS:000630020100016
J	Sy, M; Brandt, AU; Lee, SU; Newton, BL; Pawling, J; Golzar, A; Rahman, AMA; Yu, ZX; Cooper, G; Scheel, M; Paul, F; Dennis, JW; Demetriou, M				Sy, Michael; Brandt, Alexander U.; Lee, Sung-Uk; Newton, Barbara L.; Pawling, Judy; Golzar, Autreen; Rahman, Anas M. A.; Yu, Zhaoxia; Cooper, Graham; Scheel, Michael; Paul, Friedemann; Dennis, James W.; Demetriou, Michael			N-acetylglucosamine drives myelination by triggering oligodendrocyte precursor cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N-glycan branching; N-acetylglucosamine; oligodendrocytes; myelination; myelin repair; multiple sclerosis; N-linked glycosylation; oligodendrocyte; myelin; metabolism; oligodendrocyte precursor cell	MULTIPLE-SCLEROSIS; WHITE-MATTER; AXONAL INJURY; REMYELINATION; DEMYELINATION; ACTIVATION; AUTOIMMUNITY; GLUCOSAMINE; DIETARY; DISEASE	Myelination plays an important role in cognitive development and in demyelinating diseases like multiple sclerosis (MS), where failure of remyelination promotes permanent neuro-axonal damage. Modification of cell surface receptors with branched N-glycans coordinates cell growth and differentiation by controlling glycoprotein clustering, signaling, and endocytosis. GlcNAc is a rate-limiting metabolite for N-glycan branching. Here we report that GlcNAc and N-glycan branching trigger oligodendrogenesis from precursor cells by inhibiting platelet-derived growth factor receptor-alpha cell endocytosis. Supplying oral GlcNAc to lactating mice drives primary myelination in newborn pups via secretion in breast milk, whereas genetically blocking N-glycan branching markedly inhibits primary myelination. In adult mice with toxin (cuprizone)-induced demyelination, oral GlcNAc prevents neuro-axonal damage by driving myelin repair. In MS patients, endogenous serum GlcNAc levels inversely correlated with imaging measures of demyelination and microstructural damage. Our data identify N-glycan branching and GlcNAc as critical regulators of primary myelination and myelin repair and suggest that oral GlcNAc may be neuroprotective in demyelinating diseases like MS.	[Sy, Michael; Brandt, Alexander U.; Lee, Sung-Uk; Newton, Barbara L.; Golzar, Autreen; Demetriou, Michael] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Brandt, Alexander U.; Cooper, Graham; Paul, Friedemann] Charite Univ Med Berlin, Expt & Clin Res Ctr, Berlin, Germany; [Brandt, Alexander U.; Cooper, Graham; Paul, Friedemann] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Brandt, Alexander U.; Cooper, Graham; Scheel, Michael; Paul, Friedemann] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Irvine, CA USA; [Brandt, Alexander U.; Cooper, Graham; Scheel, Michael; Paul, Friedemann] Free Univ Berlin, Berlin, Germany; [Brandt, Alexander U.; Cooper, Graham; Scheel, Michael; Paul, Friedemann] Humboldt Univ, Berlin, Germany; [Brandt, Alexander U.; Cooper, Graham; Scheel, Michael; Paul, Friedemann] Berlin Inst Hlth, Berlin, Germany; [Pawling, Judy; Dennis, James W.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON, Canada; [Demetriou, Michael] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Rahman, Anas M. A.; Dennis, James W.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Yu, Zhaoxia] Univ Calif Irvine, Donald Bren Sch Informat & Comp Sci, Dept Stat, Irvine, CA USA; [Cooper, Graham] Einstein Ctr Neurosci, Berlin, Germany; [Cooper, Graham; Paul, Friedemann] Charite Univ Med Berlin, Dept Expt Neurol, Berlin, Germany; [Cooper, Graham; Paul, Friedemann] Charite Univ Med Berlin, Ctr Stroke Res Berlin, Berlin, Germany	University of California System; University of California Irvine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of California System; University of California Irvine; University of Toronto; University of California System; University of California Irvine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Demetriou, M (corresponding author), Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA.; Demetriou, M (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.	mdemetriou@uci.edu	Cooper, Graham/AAF-5762-2021; Abdel Rahman, Anas/AEC-1515-2022	Cooper, Graham/0000-0001-8383-6476; Abdel Rahman, Anas/0000-0002-9527-9424; LEE, SUNG-UK/0000-0002-2324-0918; paul, friedemann/0000-0002-6378-0070; Golzar, Autreen/0000-0003-1827-7166; Scheel, Michael/0000-0002-3505-2914	Marilyn Hilton innovator award; NIAID National Institutes of Health [R01AT007452]; NCCIH National Institutes of Health [R01AI144403]; Deutsche Forschungsgemeinschaft [Exc. 257]	Marilyn Hilton innovator award; NIAID National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCCIH National Institutes of Health; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Research was supported by a Marilyn Hilton innovator award to M. Sy, NIAID National Institutes of Health Grant R01AT007452 (to M. D.), and NCCIH National Institutes of Health Grant R01AI144403 (to M. D.). The multiple sclerosis cohort and MRI study were supported by Deutsche Forschungsgemeinschaft Grant Exc. 257 to F. P. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Araujo L, 2017, ELIFE, V6, DOI 10.7554/eLife.21330; Backer-Koduah P, 2020, ANN CLIN TRANSL NEUR, V7, P1628, DOI 10.1002/acn3.51148; Bahaie NS, 2011, J BIOL CHEM, V286, P38231, DOI 10.1074/jbc.M111.279554; Bar-Or A, 2010, ANN NEUROL, V67, P452, DOI 10.1002/ana.21939; Beer A, 2016, J NEUROL, V263, P1495, DOI 10.1007/s00415-016-8156-6; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Brynedal B, 2010, J NEUROIMMUNOL, V220, P120, DOI 10.1016/j.jneuroim.2010.01.003; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Cross AH, 2006, J NEUROIMMUNOL, V180, P63, DOI 10.1016/j.jneuroim.2006.06.029; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Deoni SCL, 2013, NEUROIMAGE, V82, P77, DOI 10.1016/j.neuroimage.2013.05.090; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Galloway DA, 2020, GLIA, V68, P859, DOI 10.1002/glia.23711; GAULDEN EC, 1964, METABOLISM, V13, P466, DOI 10.1016/0026-0495(64)90120-9; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Goldschmidt T, 2009, NEUROLOGY, V72, P1914, DOI 10.1212/WNL.0b013e3181a8260a; Gonzalez GA, 2016, SCI REP-UK, V6, DOI 10.1038/srep31599; Granovsky M, 2000, NAT MED, V6, P306; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Grigorian Ani, 2011, ISRN Neurol, V2011, P374314, DOI 10.5402/2011/374314; Grigorian A, 2011, J BIOL CHEM, V286, P40133, DOI 10.1074/jbc.M111.277814; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Hu JG, 2008, NEUROSCIENCE, V151, P138, DOI 10.1016/j.neuroscience.2007.10.050; Hughes EG, 2018, NAT NEUROSCI, V21, P696, DOI 10.1038/s41593-018-0121-5; Isaacs EB, 2010, PEDIATR RES, V67, P357, DOI 10.1203/PDR.0b013e3181d026da; Jakel S, 2019, NATURE, V566, P543, DOI 10.1038/s41586-019-0903-2; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lawson MAE, 2020, ISME J, V14, P635, DOI 10.1038/s41396-019-0553-2; Lee KY, 2004, FOOD CHEM TOXICOL, V42, P687, DOI 10.1016/j.fct.2003.12.005; Lee SU, 2007, J BIOL CHEM, V282, P33725, DOI 10.1074/jbc.M704839200; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; LEVIN RM, 1961, J LAB CLIN MED, V58, P927; Li CF, 2013, J NEUROIMMUNOL, V256, P71, DOI 10.1016/j.jneuroim.2012.12.008; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Mei F, 2016, ELIFE, V5, DOI 10.7554/eLife.18246; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Mi S, 2009, ANN NEUROL, V65, P304, DOI 10.1002/ana.21581; Michalski JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019772; MILLER JB, 1994, J PEDIATR GASTR NUTR, V19, P371, DOI 10.1097/00005176-199411000-00001; Mkhikian H, 2016, ELIFE, V5, DOI 10.7554/eLife.14814; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Mortales CL, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101380; Mortales CL, 2020, J IMMUNOL, V205, P630, DOI 10.4049/jimmunol.2000101; Nakamura K, 2017, ANN NEUROL, V82, P635, DOI 10.1002/ana.25019; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pasquini LA, 2011, CELL DEATH DIFFER, V18, P1746, DOI 10.1038/cdd.2011.40; Patani R, 2007, NEUROPATH APPL NEURO, V33, P277, DOI 10.1111/j.1365-2990.2007.00805.x; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Paul F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001928; Prineas J. W., 1997, GREENFIELDS NEUROPAT, P813; Rahman AMA, 2013, ACS CHEM BIOL, V8, P2053, DOI 10.1021/cb4004173; Reich DS, 2018, NEW ENGL J MED, V378, P169, DOI 10.1056/NEJMra1401483; Righart R, 2017, ANN NEUROL, V82, P519, DOI 10.1002/ana.25020; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Saab AS, 2016, NEURON, V91, P119, DOI 10.1016/j.neuron.2016.05.016; Sachs HH, 2014, ASN NEURO, V6, DOI 10.1177/1759091414551955; Salvatore S, 2000, ALIMENT PHARM THER, V14, P1567, DOI 10.1046/j.1365-2036.2000.00883.x; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Stoffels JMJ, 2013, BRAIN, V136, P116, DOI 10.1093/brain/aws313; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Takahashi M, 2009, FOOD CHEM TOXICOL, V47, P462, DOI 10.1016/j.fct.2008.12.002; Ye ZY, 2004, GLYCOBIOLOGY, V14, P547, DOI 10.1093/glycob/cwh069; Yeung MSY, 2019, NATURE, V566, P538, DOI 10.1038/s41586-018-0842-3; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhang Y, 2014, J ALLERGY CLIN IMMUN, V133, P1400, DOI 10.1016/j.jaci.2014.02.013; Zhou RW, 2014, NAT IMMUNOL, V15, P1038, DOI 10.1038/ni.3007	76	16	16	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17413	17424		10.1074/jbc.RA120.015595	http://dx.doi.org/10.1074/jbc.RA120.015595			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	32978254	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000603272300004
J	Di Muzio, M; Wildner, S; Huber, S; Hauser, M; Vejvar, E; Auzinger, W; Regl, C; Laimer, J; Zennaro, D; Wopfner, N; Huber, CG; van Ree, R; Mari, A; Lackner, P; Ferreira, F; Schubert, M; Gadermaier, G				Di Muzio, Martina; Wildner, Sabrina; Huber, Sara; Hauser, Michael; Vejvar, Eva; Auzinger, Werner; Regl, Christof; Laimer, Josef; Zennaro, Danila; Wopfner, Nicole; Huber, Christian G.; van Ree, Ronald; Mari, Adriano; Lackner, Peter; Ferreira, Fatima; Schubert, Mario; Gadermaier, Gabriele			Hydrogen/deuterium exchange memory NMR reveals structural epitopes involved in IgE cross-reactivity of allergenic lipid transfer proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allergen; monoclonal antibody; epitope mapping; NMR spectroscopy; lipid transfer protein; hydrogen; deuterium exchange; Art v 3; mugwort pollen; allergen; epitope mapping; nuclear magnetic resonance (NMR); immunoglobulin E (IgE); immunoglobulin G (IgG)	B-CELL EPITOPES; ART V 3; HYDROGEN-EXCHANGE; CONFORMATIONAL EPITOPE; ANTIBODY EPITOPES; MAJOR ALLERGEN; POLLEN; ANTIGEN; IDENTIFICATION; RECOGNITION	Identification of antibody-binding epitopes is crucial to understand immunological mechanisms. It is of particular interest for allergenic proteins with high cross-reactivity as observed in the lipid transfer protein (LTP) syndrome, which is characterized by severe allergic reactions. Art v 3, a pollen LTP from mugwort, is frequently involved in this cross-reactivity, but no antibody-binding epitopes have been determined so far. To reveal human IgE-binding regions of Art v 3, we produced three murine high-affinity mAbs, which showed 70-90% coverage of the allergenic epitopes from mugwort pollen-allergic patients. As reliable methods to determine structural epitopes with tightly interacting intact antibodies under native conditions are lacking, we developed a straightforward NMR approach termed hydrogen/deuterium exchange memory (HDXMEM). It relies on the slow exchange between the invisible antigen-mAb complex and the free N-15-labeled antigen whose H-1-N-15 correlations are detected. Due to a memory effect, changes of NH protection during antibody binding are measured. Differences in H/D exchange rates and analyses of mAb reactivity to homologous LTPs revealed three structural epitopes: two partially cross-reactive regions around alpha-helices 2 and 4 as well as a novel Art v 3-specific epitope at the C terminus. Protein variants with exchanged epitope residues confirmed the antibody-binding sites and revealed strongly reduced IgE reactivity. Using the novel HDXMEM for NMR epitope mapping allowed identification of the first structural epitopes of an allergenic pollen LTP. This knowledge enables improved cross-reactivity prediction for patients suffering from LTP allergy and facilitates design of therapeutics.	[Di Muzio, Martina; Wildner, Sabrina; Huber, Sara; Hauser, Michael; Vejvar, Eva; Auzinger, Werner; Regl, Christof; Laimer, Josef; Wopfner, Nicole; Huber, Christian G.; Lackner, Peter; Ferreira, Fatima; Schubert, Mario; Gadermaier, Gabriele] Univ Salzburg, Dept Biosci, Salzburg, Austria; [Di Muzio, Martina; Wildner, Sabrina; Regl, Christof; Huber, Christian G.; Schubert, Mario; Gadermaier, Gabriele] Univ Salzburg, Christian Doppler Lab Innovat Took Biosimilar Cha, Salzburg, Austria; [Zennaro, Danila; Mari, Adriano] Centri Associati Allergolog Mol CAAM, Latina, Italy; [van Ree, Ronald] Univ Amsterdam, Dept Expt Immunol & Otorhinolaryngol, Med Ctr, Amsterdam, Netherlands; [Di Muzio, Martina] Inst Bioengn Catalunya IBEC, Barcelona, Spain	Salzburg University; Salzburg University; University of Amsterdam; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya	Schubert, M; Gadermaier, G (corresponding author), Univ Salzburg, Dept Biosci, Salzburg, Austria.; Schubert, M; Gadermaier, G (corresponding author), Univ Salzburg, Christian Doppler Lab Innovat Took Biosimilar Cha, Salzburg, Austria.	Mario.Schubert@sbg.ac.at; Gabriele.Gadermaier@sbg.ac.at	Huber, Sara/AAG-6474-2019; Schubert, Mario/B-3972-2008; Ferreira, Fatima/AAB-4321-2019; Laimer, Josef/H-3226-2016; Huber, Christian G./E-5445-2011; Gadermaier, Gabriele/L-5997-2015	Huber, Sara/0000-0003-3589-4924; Schubert, Mario/0000-0003-0278-4091; Ferreira, Fatima/0000-0003-0989-2335; Laimer, Josef/0000-0001-6413-4268; Huber, Christian G./0000-0001-8358-1880; Gadermaier, Gabriele/0000-0002-4886-417X; Hauser, Michael/0000-0001-6558-755X; Di Muzio, Martina/0000-0001-6525-7972	Austrian Federal Ministry for Digital and Economic Affairs; National Foundation for Research, Technology, and Development; Start-up Grant of the Province of Salzburg; Austrian Science Fund (FWF) [P26125]	Austrian Federal Ministry for Digital and Economic Affairs; National Foundation for Research, Technology, and Development; Start-up Grant of the Province of Salzburg; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Federal Ministry for Digital and Economic Affairs; the National Foundation for Research, Technology, and Development; a Start-up Grant of the Province of Salzburg; and Austrian Science Fund (FWF) Grant P26125.	Abbott WM, 2014, IMMUNOLOGY, V142, P526, DOI 10.1111/imm.12284; Asam C, 2014, CLIN EXP ALLERGY, V44, P1083, DOI 10.1111/cea.12361; Asero R, 2018, EUR ANN ALLERGY CLIN, V50, P156, DOI 10.23822/EurAnnACI.1764-1489.57; Asero R, 2018, CLIN EXP ALLERGY, V48, P6, DOI 10.1111/cea.13053; Asturias JA, 2003, CLIN EXP ALLERGY, V33, P518, DOI 10.1046/j.1365-2222.2003.01631.x; Azofra J, 2016, INT ARCH ALLERGY IMM, V169, P181, DOI 10.1159/000445893; BENJAMIN DC, 1992, BIOCHEMISTRY-US, V31, P9539, DOI 10.1021/bi00155a005; Boschert V, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160120; Egger M, 2010, CURR ALLERGY ASTHM R, V10, P326, DOI 10.1007/s11882-010-0128-9; Eichhorn S, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900336; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Gadermaier G, 2008, ALLERGY, V63, P1543, DOI 10.1111/j.1398-9995.2008.01780.x; Gadermaier G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024150; Gadermaier G, 2011, MOL NUTR FOOD RES, V55, P568, DOI 10.1002/mnfr.201000443; Gadermaier G, 2009, MOL IMMUNOL, V46, P1919, DOI 10.1016/j.molimm.2009.03.021; Gao ZS, 2013, J ALLERGY CLIN IMMUN, V131, P224, DOI 10.1016/j.jaci.2012.07.015; Garcia-Casado G, 2003, J ALLERGY CLIN IMMUN, V112, P599, DOI 10.1037/mai.2003.1638; Gessner C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03922-3; Gomez-Casado C, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/385615; Gouda H, 1998, BIOCHEMISTRY-US, V37, P129, DOI 10.1021/bi970923f; Ichikawa S, 2005, J BIOCHEM, V137, P255, DOI 10.1093/jb/mvi039; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kringelum JV, 2013, MOL IMMUNOL, V53, P24, DOI 10.1016/j.molimm.2012.06.001; Laimer J, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0548-6; Liu CQ, 2018, J AGR FOOD CHEM, V66, P7238, DOI 10.1021/acs.jafc.8b01967; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Mueller GA, 2001, J BIOL CHEM, V276, P9359, DOI 10.1074/jbc.M010812200; Mueller GA, 2019, CURR ALLERGY ASTHM R, V19, DOI 10.1007/s11882-019-0848-4; Naik MT, 2008, STRUCTURE, V16, P125, DOI 10.1016/j.str.2007.10.022; Oezguen N, 2008, MOL IMMUNOL, V45, P3740, DOI 10.1016/j.molimm.2008.05.026; Pacios LF, 2008, MOL IMMUNOL, V45, P2269, DOI 10.1016/j.molimm.2007.11.022; Padavattan S, 2009, J IMMUNOL, V182, P2141, DOI 10.4049/jimmunol.0803018; Palacin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050799; PATERSON Y, 1990, SCIENCE, V249, P755, DOI 10.1126/science.1697101; Percy AJ, 2012, ANAL CHIM ACTA, V721, P7, DOI 10.1016/j.aca.2012.01.037; Peri S, 2001, TRENDS BIOCHEM SCI, V26, P687, DOI 10.1016/S0968-0004(01)01954-5; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pomes A, 2015, J ALLERGY CLIN IMMUN, V136, P29, DOI 10.1016/j.jaci.2015.05.016; Pomes Anna, 2015, Curr Allergy Asthma Rep, V15, P506, DOI 10.1007/s11882-014-0506-9; Pomes A, 2010, INT ARCH ALLERGY IMM, V152, P1, DOI 10.1159/000260078; Razzera G, 2010, STRUCTURE, V18, P1011, DOI 10.1016/j.str.2010.05.012; Salcedo G, 2004, CLIN EXP ALLERGY, V34, P1336, DOI 10.1111/j.1365-2222.2004.02018.x; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Trincado JL, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/2680160; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scala E, 2015, ALLERGY, V70, P933, DOI 10.1111/all.12635; Scarselli M, 2009, J MOL BIOL, V386, P97, DOI 10.1016/j.jmb.2008.12.005; Schmutzler G., 2005, THESIS; Schocker F, 2004, J ALLERGY CLIN IMMUN, V113, P141, DOI 10.1016/j.jaci.2003.09.013; Schwarz R., 2004, THESIS; Simonelli L, 2018, METHODS MOL BIOL, V1785, P29, DOI 10.1007/978-1-4939-7841-0_3; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Tordesillas L, 2011, INT ARCH ALLERGY IMM, V156, P291, DOI 10.1159/000323503; Tordesillas L, 2009, MOL IMMUNOL, V47, P534, DOI 10.1016/j.molimm.2009.07.028; Tscheppe A, 2017, INT ARCH ALLERGY IMM, V172, P187, DOI 10.1159/000464104; Vallurupalli P, 2012, J AM CHEM SOC, V134, P8148, DOI 10.1021/ja3001419; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Wildner S, 2019, MOL IMMUNOL, V116, P140, DOI 10.1016/j.molimm.2019.10.012; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Williams DC, 1996, J MOL BIOL, V257, P866, DOI 10.1006/jmbi.1996.0207; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Willison LN, 2013, MOL IMMUNOL, V55, P253, DOI 10.1016/j.molimm.2013.02.004; Zhang Q, 2018, ANAL CHEM, V90, P11315, DOI 10.1021/acs.analchem.8b01864; Zuidmeer L, 2005, INT ARCH ALLERGY IMM, V137, P273, DOI 10.1159/000086420	64	4	4	2	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17398	17410		10.1074/jbc.RA120.014243	http://dx.doi.org/10.1074/jbc.RA120.014243			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453986	Green Published, hybrid			2022-12-26	WOS:000603272300002
J	Klickstein, JA; Mukkavalli, S; Raman, M				Klickstein, Jacob Aaron; Mukkavalli, Sirisha; Raman, Malavika			AggreCount: an unbiased image analysis tool for identifying and quantifying cellular aggregates in a spatially defined manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein quality control; proteostasis; misfolded protein; aggregate; inclusion body; stress granule; polyQ inclusion body; ubiquitin; image-based analysis; ImageJ; p97; valosin-containing protein; microscopic imaging; polyubiquitin chain; aggregation; aggresome; protein aggregation; Huntington disease; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); protein misfolding; p97; valosin-containing protein	AGGRESOME FORMATION; PROTEIN; HUNTINGTIN; DEGRADATION; DISRUPTION; PROTEASOME; CANCER	Protein quality control is maintained by a number of integrated cellular pathways that monitor the folding and functionality of the cellular proteome. Defects in these pathways lead to the accumulation of misfolded or faulty proteins that may become insoluble and aggregate over time. Protein aggregates significantly contribute to the development of a number of human diseases such as amyotrophic lateral sclerosis, Huntington's disease, and Alzheimer's disease. In vitro, imaging-based, cellular studies have defined key biomolecular components that recognize and clear aggregates; however, no unifying method is available to quantify cellular aggregates, limiting our ability to reproducibly and accurately quantify these structures. Here we describe an ImageJ macro called AggreCount to identify and measure protein aggregates in cells. AggreCount is designed to be intuitive, easy to use, and customizable for different types of aggregates observed in cells. Minimal experience in coding is required to utilize the script. Based on a user-defined image, AggreCount will report a number of metrics: (i) total number of cellular aggregates, (ii) percentage of cells with aggregates, (iii) aggregates per cell, (iv) area of aggregates, and (v) localization of aggregates (cytosol, perinuclear, or nuclear). A data table of aggregate information on a per cell basis, as well as a summary table, is provided for further data analysis. We demonstrate the versatility of AggreCount by analyzing a number of different cellular aggregates including aggresomes, stress granules, and inclusion bodies caused by huntingtin polyglutamine expansion.	[Klickstein, Jacob Aaron; Mukkavalli, Sirisha; Raman, Malavika] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA	Tufts University	Raman, M (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.	malavika.raman@tufts.edu	mukkavalli, sirisha/GNH-6227-2022	Klickstein, Jacob/0000-0002-0759-4724; Mukkavalli, Sirisha V./0000-0002-8875-7985; raman, malavika/0000-0002-4773-8673	National Institutes of Health [R01GM127557]; American Cancer Society [RSG-19-022-01-CSM]; Russo Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Russo Award	This work is supported by National Institutes of Health Grant R01GM127557, American Cancer Society Research Scholar Grant RSG-19-022-01-CSM, and a Russo Award (to M. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Aviner R, 2020, COMPUT STRUCT BIOTEC, V18, P1074, DOI 10.1016/j.csbj.2020.04.014; Bauerlein FJB, 2017, CELL, V171, P179, DOI 10.1016/j.cell.2017.08.009; Bersuker K, 2016, J CELL BIOL, V213, P229, DOI 10.1083/jcb.201511024; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; den Engelsman J, 2011, PHARM RES-DORDR, V28, P920, DOI 10.1007/s11095-010-0297-1; Ganji R, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00154-18; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Guo Q, 2018, CELL, V172, P696, DOI 10.1016/j.cell.2017.12.030; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hoffner G, 2002, J CELL SCI, V115, P941; Iwabuchi S, 2014, J NEUROSCI METH, V223, P92, DOI 10.1016/j.jneumeth.2013.12.003; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Joazeiro CAP, 2019, NAT REV MOL CELL BIO, V20, P368, DOI 10.1038/s41580-019-0118-2; Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Leeman DS, 2018, SCIENCE, V359, P1277, DOI 10.1126/science.aag3048; Matus Soledad, 2013, Int J Cell Biol, V2013, P674751, DOI 10.1155/2013/674751; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Moen E, 2019, NAT METHODS, V16, P1233, DOI 10.1038/s41592-019-0403-1; Nawrocki ST, 2006, CANCER RES, V66, P3773, DOI 10.1158/0008-5472.CAN-05-2961; Park J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15730; Peters LZ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005178; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Raman M, 2015, NAT CELL BIOL, V17, P1356, DOI 10.1038/ncb3238; Roodveldt C, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00565; Salemi LM, 2014, BIOL OPEN, V3, P418, DOI 10.1242/bio.20147021; Saudou F, 2016, NEURON, V89, P910, DOI 10.1016/j.neuron.2016.02.003; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sontag EM, 2017, ANNU REV BIOCHEM, V86, P97, DOI 10.1146/annurev-biochem-060815-014616; Stroo E, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00064; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Turakhiya A, 2018, MOL CELL, V70, P906, DOI 10.1016/j.molcel.2018.04.021; Wang B, 2019, MOL CELL, V74, P742, DOI 10.1016/j.molcel.2019.03.027; Wheeler JR, 2016, ELIFE, V5, DOI 10.7554/eLife.18413; Wiesmann V, 2015, J MICROSC-OXFORD, V257, P39, DOI 10.1111/jmi.12184; Wolozin B, 2019, NAT REV NEUROSCI, V20, P649, DOI 10.1038/s41583-019-0222-5; Xu Z, 2013, J CELL SCI, V126, P4173, DOI 10.1242/jcs.126102; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P8923, DOI 10.1073/pnas.0903621106	45	6	6	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17672	17683		10.1074/jbc.RA120.015398	http://dx.doi.org/10.1074/jbc.RA120.015398			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454006	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000603272300022
J	Xu, F; Qi, H; Li, JQ; Sun, L; Gong, JJ; Chen, YY; Shen, AD; Li, W				Xu, Fang; Qi, Hui; Li, Jieqiong; Sun, Lin; Gong, Juanjuan; Chen, Yuanying; Shen, Adong; Li, Wei			Mycobacterium tuberculosis infection up-regulates MFN2 expression to promote NLRP3 inflammasome formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; microarray; mitochondria; mitofusin 2; Mycobacterium tuberculosis; NLRP3 inflammasome; cytokine; inflammasome; microarray; mitochondria	ENDOPLASMIC-RETICULUM; INTERLEUKIN-1-BETA RELEASE; PULMONARY TUBERCULOSIS; GENE-EXPRESSION; MITOFUSIN 2; ACTIVATION; MITOCHONDRIA; MORPHOLOGY; SIGNATURE; ESAT-6	Tuberculosis (TB), caused by the infection of Mycobacterium tuberculosis (MTB), is one of the leading causes of death worldwide, especially in children. However, the mechanisms by which MTB infects its cellular host, activates an immune response, and triggers inflammation remain unknown. Mitochondria play important roles in the initiation and activation of the nucleotide-binding oligomerization domain-like receptor with a pyrin domain 3 (NLRP3) inflammasome, where mitochondria-associated endoplasmic reticulum membranes (MAMs) may serve as the platform for inflammasome assembly and activation. Additionally, mitofusin 2 (MFN2) is implicated in the formation of MAMs, but, the roles of mitochondria and MFN2 in MTB infection have not been elucidated. Using mircroarry profiling of TB patients and in vitro MTB stimulation of macrophages, we observed an up-regulation of MFN2 in the peripheral blood mononuclear cells of active TB patients. Furthermore, we found that MTB stimulation by MTB-specific antigen ESAT-6 or lysate of MTB promoted MFN2 interaction with NLRP3 inflammasomes, resulting in the assembly and activation of the inflammasome and, subsequently, IL-1 beta secretion. These findings suggest that MFN2 and mitochondria play important role in the pathogen-host interaction during MTB infection.	[Xu, Fang; Qi, Hui; Li, Jieqiong; Sun, Lin; Shen, Adong] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Beijing Pediat Res Inst,Beijing Key Lab Resp & In, Beijing, Peoples R China; [Gong, Juanjuan; Chen, Yuanying; Li, Wei] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Beijing Pediat Res Inst,Beijing Key Lab Genet Bir, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Shen, AD (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Beijing Pediat Res Inst,Beijing Key Lab Resp & In, Beijing, Peoples R China.; Li, W (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Beijing Pediat Res Inst,Beijing Key Lab Genet Bir, Beijing, Peoples R China.	shenad16@hotmail.com; liwei@bch.com.cn	孙, 琳/HGE-6966-2022	Li, Wei/0000-0002-0248-5510	Ministry of Science and Technology of China [2019YFA0802104]; National Natural Science Foundation of China [31830054, 91954000, 81871617, 81701971]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grant 2019YFA0802104 and National Natural Science Foundation of China Grants 31830054, 91954000, 81871617, and 81701971.	Basu S, 2018, MICROB PATHOGENESIS, V114, P219, DOI 10.1016/j.micpath.2017.11.044; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Briken V, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00062; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dubey RK, 2016, INT J MYCOBACT, V5, P379, DOI 10.1016/j.ijmyco.2016.06.001; Fine-Coulson K, 2015, MICROBES INFECT, V17, P689, DOI 10.1016/j.micinf.2015.06.003; Francisco NM, 2017, J INFECTION, V75, P499, DOI 10.1016/j.jinf.2017.09.012; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110; Kim BR, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008294; Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003722; Lebeau J, 2018, CELL REP, V22, P2827, DOI 10.1016/j.celrep.2018.02.055; Maertzdorf J, 2016, EMBO MOL MED, V8, P86, DOI 10.15252/emmm.201505790; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Misawa T, 2017, ADV EXP MED BIOL, V997, P187, DOI 10.1007/978-981-10-4567-7_14; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Qi H, 2017, HUM MOL GENET, V26, P4752, DOI 10.1093/hmg/ddx365; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; Sarup P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015644; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sohn H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002435; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Sugawara I, 2001, MICROBIOL IMMUNOL, V45, P743, DOI 10.1111/j.1348-0421.2001.tb01310.x; Sweeney TE, 2016, LANCET RESP MED, V4, P213, DOI 10.1016/S2213-2600(16)00048-5; Wang JP, 2003, FEMS IMMUNOL MED MIC, V39, P163, DOI 10.1016/S0928-8244(03)00223-2; Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x; World Health Organization, 2021, 10 THREATS GLOB HLTH; Yu CY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005350; Zhang ZR, 2017, J EXP MED, V214, P2671, DOI 10.1084/jem.20162040; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	38	10	11	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17684	17697		10.1074/jbc.RA120.014077	http://dx.doi.org/10.1074/jbc.RA120.014077			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454007	hybrid, Green Published			2022-12-26	WOS:000603272300023
J	Gunther, LK; Rohde, JA; Tang, WJ; Cirilo, JA; Marang, CP; Scott, BD; Thomas, DD; Debold, EP; Yengo, CM				Gunther, Laura K.; Rohde, John A.; Tang, Wanjian; Cirilo, Joseph A., Jr.; Marang, Christopher P.; Scott, Brent D.; Thomas, David D.; Debold, Edward P.; Yengo, Christopher M.			FRET and optical trapping reveal mechanisms of actin activation of the power stroke and phosphate release in myosin V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myosin; actin; ATPase; fluorescence resonance energy transfer (FRET); optical tweezers; single-molecule biophysics	RABBIT SKELETAL ACTOMYOSIN; REAL-TIME DETECTION; FORCE-GENERATION; TROPONIN-TROPOMYOSIN; STRUCTURAL KINETICS; MOTOR-ACTIVITY; BINDING-SITE; WEAK BINDING; MUSCLE; NUCLEOTIDE	Myosins generate force and motion by precisely coordinating their mechanical and chemical cycles, but the nature and timing of this coordination remains controversial. We utilized a FRET approach to examine the kinetics of structural changes in the force-generating lever arm in myosin V. We directly compared the FRET results with single-molecule mechanical events examined by optical trapping. We introduced a mutation (S217A) in the conserved switch I region of the active site to examine how myosin couples structural changes in the actin- and nucleotide-binding regions with force generation. Specifically, S217A enhanced the maximum rate of lever arm priming (recovery stroke) while slowing ATP hydrolysis, demonstrating that it uncouples these two steps. We determined that the mutation dramatically slows both actin-induced rotation of the lever arm (power stroke) and phosphate release (>= 10-fold), whereas our simulations suggest that the maximum rate of both steps is unchanged by the mutation. Time-resolved FRET revealed that the structure of the pre- and post-power stroke conformations and mole fractions of these conformations were not altered by the mutation. Optical trapping results demonstrated that S217A does not dramatically alter unitary displacements or slow the working stroke rate constant, consistent with the mutation disrupting an actin-induced conformational change prior to the power stroke. We propose that communication between the actin- and nucleotide-binding regions of myosin assures a proper actin-binding interface and active site have formed before producing a power stroke. Variability in this coupling is likely crucial for mediating motor-based functions such as muscle contraction and intracellular transport.	[Gunther, Laura K.; Tang, Wanjian; Cirilo, Joseph A., Jr.; Yengo, Christopher M.] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Rohde, John A.; Thomas, David D.] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Marang, Christopher P.; Scott, Brent D.; Debold, Edward P.] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Minnesota System; University of Minnesota Twin Cities; University of Massachusetts System; University of Massachusetts Amherst	Yengo, CM (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.	cmy11@psu.edu		Yengo, Christopher/0000-0003-3987-9019; Tang, Wanjian/0000-0001-7374-6442; Cirilo, Joseph/0000-0003-2135-5831	National Institutes of Health [HL127699, R01AR32961, R01AG26160]; National Research Service Award Postdoctoral Fellowship [F32DC016788]; American Heart Association [19PRE34380569, 14GRNT20450002, 18IPA34170048]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by an National Institutes of Health Grants HL127699 (to C. M. Y.) and R01AR32961 and R01AG26160 (to D.D.T.). L. K. G. is supported by National Research Service Award Postdoctoral Fellowship F32DC016788, and W. T. is supported by American Heart Association Predoctoral Fellowship 19PRE34380569. This work was also supported by American Heart Association Grants 14GRNT20450002 and 18IPA34170048 (to E. P. D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Batters C, 2016, TRAFFIC, V17, P860, DOI 10.1111/tra.12400; Beausang JF, 2011, METHOD ENZYMOL, P431, DOI [10.1016/S0076-6879(11)87015-1, 10.1016/B978-0-12-381270-4.00015-9]; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Capitanio M, 2012, NAT METHODS, V9, P1013, DOI [10.1038/nmeth.2152, 10.1038/NMETH.2152]; Caremani M, 2015, J PHYSIOL-LONDON, V593, P3313, DOI 10.1113/JP270265; Caremani M, 2013, J PHYSIOL-LONDON, V591, P5187, DOI 10.1113/jphysiol.2013.257410; CHALOVICH JM, 1982, J BIOL CHEM, V257, P2432; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; DANTZIG JA, 1992, J PHYSIOL-LONDON, V451, P247, DOI 10.1113/jphysiol.1992.sp019163; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Debold EP, 2013, BIOPHYS J, V105, P2374, DOI 10.1016/j.bpj.2013.09.046; Debold EP, 2011, AM J PHYSIOL-REG I, V300, pR1401, DOI 10.1152/ajpregu.00772.2010; Fischer S, 2005, P NATL ACAD SCI USA, V102, P6873, DOI 10.1073/pnas.0408784102; Forgacs E, 2009, J BIOL CHEM, V284, P2138, DOI 10.1074/jbc.M805530200; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; Geeves MA, 2016, BIOPOLYMERS, V105, P483, DOI 10.1002/bip.22853; Gunther LK, 2019, J BIOL CHEM, V294, P1554, DOI 10.1074/jbc.RA118.006128; Hartman MA, 2012, J CELL SCI, V125, P1627, DOI 10.1242/jcs.094300; Heissler SM, 2016, J MOL BIOL, V428, P1927, DOI 10.1016/j.jmb.2016.01.022; Holmes KC, 1997, CURR BIOL, V7, pR112, DOI 10.1016/S0960-9822(06)00051-0; Houdusse A, 2016, TRENDS BIOCHEM SCI, V41, P989, DOI 10.1016/j.tibs.2016.09.006; Huxley AF, 2000, PHILOS T ROY SOC B, V355, P433, DOI 10.1098/rstb.2000.0584; Ishii Y, 2001, TRENDS BIOTECHNOL, V19, P211, DOI 10.1016/S0167-7799(01)01635-3; Joel PB, 2003, BIOCHEMISTRY-US, V42, P9160, DOI 10.1021/bi034415j; Joel PB, 2001, J BIOL CHEM, V276, P2998, DOI 10.1074/jbc.M006930200; Kiani FA, 2016, CYTOSKELETON, V73, P643, DOI 10.1002/cm.21333; Kintses B, 2007, EMBO J, V26, P265, DOI 10.1038/sj.emboj.7601482; Kull FJ, 1998, J MUSCLE RES CELL M, V19, P877, DOI 10.1023/A:1005489907021; Li XD, 1998, J BIOL CHEM, V273, P27404, DOI 10.1074/jbc.273.42.27404; Llinas P, 2015, DEV CELL, V33, P401, DOI 10.1016/j.devcel.2015.03.025; Lombardi V, 2004, PHILOS T R SOC B, V359, P1883, DOI 10.1098/rstb.2004.1557; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; Malnasi-Csizmadia A, 2001, BIOCHEMISTRY-US, V40, P12727, DOI 10.1021/bi010963q; MCKILLOP DFA, 1991, BIOCHEM J, V279, P711, DOI 10.1042/bj2790711; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Muretta JM, 2015, P NATL ACAD SCI USA, V112, P14272, DOI 10.1073/pnas.1514859112; Muretta JM, 2013, P NATL ACAD SCI USA, V110, P7211, DOI 10.1073/pnas.1222257110; Murphy CT, 2000, J MUSCLE RES CELL M, V21, P139, DOI 10.1023/A:1005610007209; Nesmelov YE, 2011, P NATL ACAD SCI USA, V108, P1891, DOI 10.1073/pnas.1012320108; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Preller M, 2013, STRUCTURE, V21, P1911, DOI 10.1016/j.str.2013.09.015; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Robert-Paganin J, 2020, CHEM REV, V120, P5, DOI 10.1021/acs.chemrev.9b00264; Rohde JA, 2017, P NATL ACAD SCI USA, V114, pE1796, DOI 10.1073/pnas.1611698114; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; Smith DA, 2001, BIOPHYS J, V81, P2795, DOI 10.1016/S0006-3495(01)75922-X; Stehle R, 2017, J MUSCLE RES CELL M, V38, P275, DOI 10.1007/s10974-017-9482-8; Sun MX, 2008, P NATL ACAD SCI USA, V105, P8631, DOI 10.1073/pnas.0710793105; Sun YJ, 2011, BIOPHYS J, V101, P1, DOI 10.1016/j.bpj.2011.05.026; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Swenson AM, 2014, J BIOL CHEM, V289, P23977, DOI 10.1074/jbc.M114.562231; Trivedi DV, 2020, ANNU REV BIOCHEM, V89, P667, DOI [10.1146/annurev-biochem-011520-105234, 10.1146/annurev-biochem-011520105234]; Trivedi DV, 2015, P NATL ACAD SCI USA, V112, P14593, DOI 10.1073/pnas.1517566112; Trivedi DV, 2013, BIOCHEMISTRY-US, V52, P4710, DOI 10.1021/bi4004364; Trivedi DV, 2012, BIOPHYS J, V102, P2545, DOI 10.1016/j.bpj.2012.04.025; TRYBUS KM, 1980, P NATL ACAD SCI-BIOL, V77, P7209, DOI 10.1073/pnas.77.12.7209; Tyska MJ, 2002, CELL MOTIL CYTOSKEL, V51, P1, DOI 10.1002/cm.10014; Unger M, 2019, AM J PHYSIOL-CELL PH, V317, pC714, DOI 10.1152/ajpcell.00196.2019; Varkuti BH, 2012, NAT STRUCT MOL BIOL, V19, P299, DOI 10.1038/nsmb.2216; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; Visser I, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i07; WALKER JW, 1992, J BIOL CHEM, V267, P2459; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Woody MS, 2019, ELIFE, V8, DOI 10.7554/eLife.49266; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v; Yengo CM, 2002, BIOCHEMISTRY-US, V41, P8508, DOI 10.1021/bi015969u	70	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17383	17397		10.1074/jbc.RA120.015632	http://dx.doi.org/10.1074/jbc.RA120.015632			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33055236	hybrid, Green Published			2022-12-26	WOS:000603272300001
J	Shukla, MK; Watanabe, A; Wilson, S; Giovagnetti, V; Moustafa, EI; Minagawa, J; Ruban, AV				Shukla, Mahendra K.; Watanabe, Akimasa; Wilson, Sam; Giovagnetti, Vasco; Moustafa, Ece Imam; Minagawa, Jun; Ruban, Alexander, V			A novel method produces native light-harvesting complex II aggregates from the photosynthetic membrane revealing their role in nonphotochemical quenching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NoM; lincomycin; LHCII trimer; LHCII aggregate; amphipol A8-35; nonphotochemical quenching; photosystem II; plant biochemistry; light-harvesting complex (antenna complex); chlorophyll; fluorescence; NPQ	PHOTOPROTECTIVE ENERGY-DISSIPATION; ABSORBED EXCITATION-ENERGY; PH-DEPENDENT DISSIPATION; EXCITED-STATE LIFETIME; PHOTOSYSTEM-II; CHLOROPHYLL FLUORESCENCE; PSBS PROTEIN; CHLOROPLAST MEMBRANES; THYLAKOID MEMBRANES; MOLECULAR-BASIS	Nonphotochemical quenching (NPQ) is a mechanism of regulating light harvesting that protects the photosynthetic apparatus from photodamage by dissipating excess absorbed excitation energy as heat. In higher plants, the major light-harvesting antenna complex (LHCII) of photosystem (PS) II is directly involved in NPQ. The aggregation of LHCII is proposed to be involved in quenching. However, the lack of success in isolating native LHCII aggregates has limited the direct interrogation of this process. The isolation of LHCII in its native state from thylakoid membranes has been problematic because of the use of detergent, which tends to dissociate loosely bound proteins, and the abundance of pigment-protein complexes (e.g. PSI and PSII) embedded in the photosynthetic membrane, which hinders the preparation of aggregated LHCII. Here, we used a novel purification method employing detergent and amphipols to entrap LHCII in its natural states. To enrich the photosynthetic membrane with the major LHCII, we used Arabidopsis thaliana plants lacking the PSII minor antenna complexes (NoM), treated with lincomycin to inhibit the synthesis of PSI and PSII core proteins. Using sucrose density gradients, we succeeded in isolating the trimeric and aggregated forms of LHCII antenna. Violaxanthin- and zeaxanthin-enriched complexes were investigated in dark-adapted, NPQ, and dark recovery states. Zeaxanthin-enriched antenna complexes showed the greatest amount of aggregated LHCII. Notably, the amount of aggregated LHCII decreased upon relaxation of NPQ. Employing this novel preparative method, we obtained a direct evidence for the role of in vivo LHCII aggregation in NPQ.	[Shukla, Mahendra K.; Wilson, Sam; Giovagnetti, Vasco; Moustafa, Ece Imam; Ruban, Alexander, V] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Watanabe, Akimasa; Minagawa, Jun] Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi, Japan; [Watanabe, Akimasa; Minagawa, Jun] Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, SOKENDAI, Okazaki, Aichi, Japan	University of London; Queen Mary University London; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Ruban, AV (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.; Minagawa, J (corresponding author), Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi, Japan.; Minagawa, J (corresponding author), Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, SOKENDAI, Okazaki, Aichi, Japan.	minagawa@nibb.ac.jp; a.ruban@qmul.ac.uk	Shukla, Mahendra Kumar/J-5994-2014	Shukla, Mahendra Kumar/0000-0002-6858-1441; Watanabe, Akimasa/0000-0001-6068-1328; Wilson, Sam/0000-0002-1273-3071; Minagawa, Jun/0000-0002-3028-3203; Giovagnetti, Vasco/0000-0002-3298-4310	Biotechnology and Biological Sciences Research Council [BB/R015694/1]; Leverhulme Trust [RPG-2018-199]; Royal Society International Exchanges Standard Scheme [IES\R2\170087]; Royal Society [IES\R2\170087]; BBSRC [BB/R015694/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); Royal Society International Exchanges Standard Scheme; Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/R015694/1, Leverhulme Trust Grant RPG-2018-199, and Royal Society International Exchanges Standard Scheme Grant IES\R2\170087 (to A. V. R.). The collaboration between the Ruban and Minagawa laboratories was supported by Royal Society Grant IES\R2\170087.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; BARBER J, 1995, AUST J PLANT PHYSIOL, V22, P201, DOI 10.1071/PP9950201; Belgio E, 2012, BIOPHYS J, V102, P2761, DOI 10.1016/j.bpj.2012.05.004; Bergantino E, 2003, P NATL ACAD SCI USA, V100, P15265, DOI 10.1073/pnas.2533072100; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Blankenship R. E., 2014, MOL MECH PHOTOSYNTHE; Boekema EJ, 1999, BIOCHEMISTRY-US, V38, P2233, DOI 10.1021/bi9827161; Burton-Smith RN, 2019, J BIOL CHEM, V294, P15003, DOI 10.1074/jbc.RA119.009341; Champeil P, 2000, J BIOL CHEM, V275, P18623, DOI 10.1074/jbc.M000470200; Chmeliov J, 2019, J PHYS CHEM LETT, V10, P7340, DOI 10.1021/acs.jpclett.9b03100; Chmeliov J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.45, 10.1038/nplants.2016.45]; Correa-Galvis V, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.225, 10.1038/nplants.2015.225]; Dall'Osto L, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.33; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Dominici P, 2002, J BIOL CHEM, V277, P22750, DOI 10.1074/jbc.M200604200; Eijckelhoff C, 1997, BBA-BIOENERGETICS, V1321, P10, DOI 10.1016/S0005-2728(97)00040-6; Enriquez MM, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4919239; Goral TK, 2012, PLANT J, V69, P289, DOI 10.1111/j.1365-313X.2011.04790.x; Horton P, 2000, PHILOS T R SOC B, V355, P1361, DOI 10.1098/rstb.2000.0698; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; HORTON P, 1992, PHOTOSYNTH RES, V34, P375, DOI 10.1007/BF00029812; Ilioaia C, 2013, J PHYS CHEM B, V117, P5841, DOI 10.1021/jp402469d; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Johnson MP, 2011, J BIOL CHEM, V286, P19973, DOI 10.1074/jbc.M111.237255; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; Johnson MP, 2010, CHEM PHYS, V373, P23, DOI 10.1016/j.chemphys.2009.12.012; Johnson MP, 2009, J BIOL CHEM, V284, P23592, DOI 10.1074/jbc.M109.013557; Johnson MP, 2009, PLANT PHYSIOL, V149, P1061, DOI 10.1104/pp.108.129957; Kim E, 2020, J BIOL CHEM, V295, P14537, DOI 10.1074/jbc.RA120.014198; KRIEGER A, 1992, BIOCHIM BIOPHYS ACTA, V1102, P167, DOI 10.1016/0167-4838(92)90507-A; Kromdijk J, 2016, SCIENCE, V354, P857, DOI 10.1126/science.aai8878; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Magdaong NM, 2013, PHOTOSYNTH RES, V118, P259, DOI 10.1007/s11120-013-9924-0; Martinez KL, 2002, FEBS LETT, V528, P251, DOI 10.1016/S0014-5793(02)03306-9; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; NISHIMURA M, 1975, PLANT PHYSIOL, V55, P712, DOI 10.1104/pp.55.4.712; NOCTOR G, 1993, BIOCHIM BIOPHYS ACTA, V1183, P339, DOI 10.1016/0005-2728(93)90237-A; NOCTOR G, 1991, BIOCHIM BIOPHYS ACTA, V1057, P320, DOI 10.1016/S0005-2728(05)80143-4; Ostroumov EE, 2020, PHOTOSYNTH RES, V144, P171, DOI 10.1007/s11120-020-00745-8; Pandit A, 2011, BIOPHYS J, V101, P2507, DOI 10.1016/j.bpj.2011.09.055; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Petrou K, 2014, BBA-BIOENERGETICS, V1837, P1533, DOI 10.1016/j.bbabio.2013.11.018; Phillip D, 1996, P NATL ACAD SCI USA, V93, P1492, DOI 10.1073/pnas.93.4.1492; Picard M, 2004, PROTEIN SCI, V13, P3056, DOI 10.1110/ps.04962104; Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219; Popot JL, 2003, CELL MOL LIFE SCI, V60, P1559, DOI 10.1007/s00018-003-3169-6; POWLES SB, 1984, ANNU REV PLANT PHYS, V35, P15, DOI 10.1146/annurev.pp.35.060184.000311; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2018, FEBS LETT, V592, P3030, DOI 10.1002/1873-3468.13111; Ruban AV, 2016, PLANT PHYSIOL, V170, P1903, DOI 10.1104/pp.15.01935; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Ruban AV, 2009, PHOTOSYNTH RES, V99, P173, DOI 10.1007/s11120-008-9387-x; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; RUBAN AV, 1994, BBA-BIOENERGETICS, V1186, P123, DOI 10.1016/0005-2728(94)90143-0; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P39, DOI 10.1016/0167-4838(92)90496-Z; RUBAN AV, 1991, BIOCHIM BIOPHYS ACTA, V1059, P355, DOI 10.1016/S0005-2728(05)80221-X; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0005-2728(92)90061-6; Ruban AV, 1997, BIOCHEMISTRY-US, V36, P7855, DOI 10.1021/bi9630725; Saccon F, 2020, J EXP BOT, V71, P3626, DOI 10.1093/jxb/eraa126; Sacharz J, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2016.225; Sheng X, 2019, NAT PLANTS, V5, P1320, DOI 10.1038/s41477-019-0543-4; Townsend AJ, 2018, BBA-BIOENERGETICS, V1859, P666, DOI 10.1016/j.bbabio.2018.03.005; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Tribet C, 2009, LANGMUIR, V25, P12623, DOI 10.1021/la9018772; Ware MA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00841; Ware MA, 2015, J PHOTOCH PHOTOBIO B, V152, P301, DOI 10.1016/j.jphotobiol.2015.07.016; Ware MA, 2015, J EXP BOT, V66, P1259, DOI 10.1093/jxb/eru477; Watanabe A, 2019, FEBS LETT, V593, P1072, DOI 10.1002/1873-3468.13394; Zoonens M, 2005, P NATL ACAD SCI USA, V102, P8893, DOI 10.1073/pnas.0503750102; Zoonens M, 2007, BIOCHEMISTRY-US, V46, P10392, DOI 10.1021/bi7007596	74	8	8	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17816	17826		10.1074/jbc.RA120.016181	http://dx.doi.org/10.1074/jbc.RA120.016181			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454016	Green Published, hybrid			2022-12-26	WOS:000603272300032
J	Watanabe, Y; Seya, D; Ihara, D; Ishii, S; Uemoto, T; Kubo, A; Arai, Y; Isomoto, Y; Nakano, A; Abe, T; Shigeta, M; Kawamura, T; Saito, Y; Ogura, T; Nakagawa, O				Watanabe, Yusuke; Seya, Daiki; Ihara, Dai; Ishii, Shuhei; Uemoto, Taiki; Kubo, Atsushi; Arai, Yuji; Isomoto, Yoshie; Nakano, Atsushi; Abe, Takaya; Shigeta, Mayo; Kawamura, Teruhisa; Saito, Yoshihiko; Ogura, Toshihiko; Nakagawa, Osamu			Importance of endothelial Hey1 expression for thoracic great vessel development and its distal enhancer for Notch-dependent endothelial transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hey1; pharyngeal arch artery; great vessel morphogenesis; development; cardiovascular disease; transcription regulation; gene knockout; embryo; endothelial cell; great vessel morphogenesis; Hey1; Notch signaling	CONGENITAL HEART-DEFECTS; ARCH ARTERY DEFECTS; AORTIC-ARCH; PHARYNGEAL ARCH; DIGEORGE-SYNDROME; MICE DEFICIENT; NEURAL CREST; PHENOTYPIC ROBUSTNESS; HEY1-NCOA2 FUSION; ESSENTIAL ROLES	Thoracic great vessels such as the aorta and subclavian arteries are formed through dynamic remodeling of embryonic pharyngeal arch arteries (PAAs). Previous work has shown that loss of a basic helix-loop-helix transcription factor Hey1 in mice causes abnormal fourth PAA development and lethal great vessel anomalies resembling congenital malformations in humans. However, how Hey1 mediates vascular formation remains unclear. In this study, we revealed that Hey1 in vascular endothelial cells, but not in smooth muscle cells, played essential roles for PAA development and great vessel morphogenesis in mouse embryos. Tek-Cre-mediated Hey1 deletion in endothelial cells affected endothelial tube formation and smooth muscle differentiation in embryonic fourth PAAs and resulted in interruption of the aortic arch and other great vessel malformations. Cell specificity and signal responsiveness of Hey1 expression were controlled through multiple cis-regulatory regions. We found two distal genomic regions that had enhancer activity in endothelial cells and in the pharyngeal epithelium and somites, respectively. The novel endothelial enhancer was conserved across species and was specific to large-caliber arteries. Its transcriptional activity was regulated by Notch signaling in vitro and in vivo, but not by ALK1 signaling and other transcription factors implicated in endothelial cell specificity. The distal endothelial enhancer was not essential for basal Hey1 expression in mouse embryos but may likely serve for Notch-dependent transcriptional control in endothelial cells together with the proximal regulatory region. These findings help in understanding the significance and regulation of endothelial Hey1 as a mediator of multiple signaling pathways in embryonic vascular formation.	[Watanabe, Yusuke; Seya, Daiki; Ihara, Dai; Ishii, Shuhei; Uemoto, Taiki; Arai, Yuji; Nakagawa, Osamu] Natl Cerebral & Cardiovasc Ctr, Dept Mol Physiol Natl, Res Inst, Suita, Osaka, Japan; [Watanabe, Yusuke; Ishii, Shuhei; Uemoto, Taiki; Saito, Yoshihiko; Nakagawa, Osamu] Nara Med Univ, Grad Sch Med Sci, Kashihara, Nara, Japan; [Ihara, Dai; Kawamura, Teruhisa] Ritsumeikan Univ, Coll Life Sci, Dept Biomed Sci, Lab Stem Cell & Regenerat Med, Kusatsu, Shiga, Japan; [Kubo, Atsushi; Ogura, Toshihiko] Tohoku Univ, Inst Dev Aging & Canc, Dept Dev Neurobiol, Sendai, Miyagi, Japan; [Arai, Yuji; Isomoto, Yoshie; Nakano, Atsushi] Natl Cerebral & Cardiovasc Ctr, Lab Anim Expt & Med Management, Res Inst, Suita, Osaka, Japan; [Abe, Takaya; Shigeta, Mayo] RIKEN Ctr Biosyst Dynam Res, Lab Anim Resources & Genet Engn, Kobe, Hyogo, Japan; [Saito, Yoshihiko] Nara Med Univ, Dept Cardiovasc Med, Kashihara, Nara, Japan	National Cerebral & Cardiovascular Center - Japan; Nara Medical University; Ritsumeikan University; Tohoku University; National Cerebral & Cardiovascular Center - Japan; RIKEN; Nara Medical University	Watanabe, Y; Nakagawa, O (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Mol Physiol Natl, Res Inst, Suita, Osaka, Japan.; Watanabe, Y; Nakagawa, O (corresponding author), Nara Med Univ, Grad Sch Med Sci, Kashihara, Nara, Japan.	ywatanabe@ncvc.go.jp; osamu.nakagawa@ncvc.go.jp		Watanabe, Yusuke/0000-0001-9486-4085; Seya, Daiki/0000-0002-1319-177X	Japan Society for the Promotion of Science [15H04883, 15K15407, 16K08605, 18H02787, 19H03398]; Takeda Science Foundation; NOVARTIS Foundation for the Promotion of Science; Miyata Cardiac Research Promotion Foundation; Smoking Research Foundation; Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging, and Cancer, Tohoku University; Japan Agency for Medical Research and Development (AMED-CREST) [JP19gm0810001]; Intramural Research Fund for Cardiovascular Diseases of National Cerebral and Cardiovascular Center	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); NOVARTIS Foundation for the Promotion of Science; Miyata Cardiac Research Promotion Foundation; Smoking Research Foundation; Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging, and Cancer, Tohoku University; Japan Agency for Medical Research and Development (AMED-CREST)(Japan Agency for Medical Research and Development (AMED)); Intramural Research Fund for Cardiovascular Diseases of National Cerebral and Cardiovascular Center	This work was supported in part by the grants from the Japan Society for the Promotion of Science (Grants-in Aid for Scientific Research 15H04883, 15K15407, 16K08605, 18H02787, and 19H03398) (to Y. W. and O. N.), the Takeda Science Foundation (to Y. W. and O. N.), the NOVARTIS Foundation for the Promotion of Science (to Y. W. and O. N.), the Miyata Cardiac Research Promotion Foundation (to Y. W.), the Smoking Research Foundation (to O. N.), the Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging, and Cancer, Tohoku University (to Y. W.), Japan Agency for Medical Research and Development (AMED-CREST) Grant JP19gm0810001) (to T. O.), and the Intramural Research Fund for Cardiovascular Diseases of National Cerebral and Cardiovascular Center (to Y. W. and O. N.).	Barhoumi T, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00534; BARRY A, 1951, ANAT RECORD, V111, P221, DOI 10.1002/ar.1091110207; Becker PW, 2016, ARTERIOSCL THROM VAS, V36, P1209, DOI 10.1161/ATVBAHA.116.307517; Belyea BC, 2011, CLIN CANCER RES, V17, P7324, DOI 10.1158/1078-0432.CCR-11-1004; Bergwerff M, 1999, CARDIOVASC RES, V44, P185, DOI 10.1016/S0008-6363(99)00186-8; Bezzina CR, 2013, NAT GENET, V45, P1044, DOI 10.1038/ng.2712; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Byrd NA, 2005, DEV BIOL, V284, P233, DOI 10.1016/j.ydbio.2005.05.023; Calmont A, 2009, DEVELOPMENT, V136, P3173, DOI 10.1242/dev.028902; Candy PA, 2013, BRIT J CANCER, V109, P1023, DOI 10.1038/bjc.2013.431; Chiang IKN, 2017, DEVELOPMENT, V144, P2629, DOI 10.1242/dev.146241; Chin MT, 2000, J BIOL CHEM, V275, P6381, DOI 10.1074/jbc.275.9.6381; Churko JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07333-4; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Copeland JN, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-12; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Fang JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01742-7; Feiner L, 2001, DEVELOPMENT, V128, P3061; Fischer A, 2004, MAMM GENOME, V15, P711, DOI 10.1007/s00335-004-2389-x; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Frank DU, 2002, DEVELOPMENT, V129, P4591; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Fujita M, 2016, MECH DEVELOP, V139, P65, DOI 10.1016/j.mod.2015.11.002; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12658; Heisig J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002728; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; High FA, 2007, J CLIN INVEST, V117, P353, DOI 10.1172/JCI30070; High FA, 2009, J CLIN INVEST, V119, P1986, DOI 10.1172/JCI38922; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Ihara D, 2020, DEV BIOL, V461, P124, DOI 10.1016/j.ydbio.2020.02.001; Iida K, 1997, DEVELOPMENT, V124, P4627; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Kokubo H, 2005, DEV BIOL, V278, P301, DOI 10.1016/j.ydbio.2004.10.025; Kokubo H, 1999, BIOCHEM BIOPH RES CO, V260, P459, DOI 10.1006/bbrc.1999.0880; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; KURIHARA Y, 1995, J CLIN INVEST, V96, P293, DOI 10.1172/JCI118033; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Lau EYT, 2016, CELL REP, V15, P1175, DOI 10.1016/j.celrep.2016.04.019; Leimeister C, 2000, DEV BIOL, V227, P91, DOI 10.1006/dbio.2000.9884; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Li G, 2018, J MOL CELL CARDIOL, V123, P92, DOI 10.1016/j.yjmcc.2018.09.002; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Molin DGM, 2004, CIRC RES, V95, P1109, DOI 10.1161/01.RES.0000150047.16909.ab; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Morioka T, 2014, GENESIS, V52, P897, DOI 10.1002/dvg.22825; Moya IM, 2012, DEV CELL, V22, P501, DOI 10.1016/j.devcel.2012.01.007; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Nakayama R, 2012, PATHOL INT, V62, P823, DOI 10.1111/pin.12022; Osterwalder M, 2018, NATURE, V554, P239, DOI 10.1038/nature25461; Payne S, 2015, DEV BIOL, V405, P82, DOI 10.1016/j.ydbio.2015.06.017; Robinson AS, 2014, DEV BIOL, V395, P379, DOI 10.1016/j.ydbio.2014.08.027; Sacilotto N, 2013, P NATL ACAD SCI USA, V110, P11893, DOI 10.1073/pnas.1300805110; Simrick S, 2012, DEV DYNAM, V241, P1310, DOI 10.1002/dvdy.23812; Southgate L, 2015, CIRC-CARDIOVASC GENE, V8, P572, DOI 10.1161/CIRCGENETICS.115.001086; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stalmans I, 2003, NAT MED, V9, P173, DOI 10.1038/nm819; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Tsuru A, 2015, BRIT J CANCER, V112, P1232, DOI 10.1038/bjc.2015.84; van Bueren KL, 2010, DEV BIOL, V340, P369, DOI 10.1016/j.ydbio.2010.01.020; Vitelli F, 2002, DEVELOPMENT, V129, P4605; Wang L, 2012, GENE CHROMOSOME CANC, V51, P127, DOI 10.1002/gcc.20937; Watanabe Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep46135; Watanabe Y, 2012, P NATL ACAD SCI USA, V109, P18273, DOI 10.1073/pnas.1215360109; Weber D, 2015, J MOL CELL CARDIOL, V79, P79, DOI 10.1016/j.yjmcc.2014.11.004; Wurdak H, 2006, BIOESSAYS, V28, P1078, DOI 10.1002/bies.20484; Wythe JD, 2013, DEV CELL, V26, P45, DOI 10.1016/j.devcel.2013.06.007; Xin M, 2007, P NATL ACAD SCI USA, V104, P7975, DOI 10.1073/pnas.0702447104; Yanagisawa H, 1998, J CLIN INVEST, V102, P22, DOI 10.1172/JCI2698; Yashiro K, 2007, NATURE, V450, P285, DOI 10.1038/nature06254; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhang Z, 2005, DEVELOPMENT, V132, P5307, DOI 10.1242/dev.02086; Zhang Z, 2006, DEVELOPMENT, V133, P3587, DOI 10.1242/dev.02539; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820; Zhou JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032429; Zhou PZ, 2017, ELIFE, V6, DOI 10.7554/eLife.22039	86	5	6	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17632	17645		10.1074/jbc.RA120.015003	http://dx.doi.org/10.1074/jbc.RA120.015003			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454003	hybrid, Green Published			2022-12-26	WOS:000603272300019
J	Jiang, XG; Zhang, LJ; Teng, MK; Li, X				Jiang, Xuguang; Zhang, Linjuan; Teng, Maikun; Li, Xu			Antibiotic binding releases autoinhibition of the TipA multidrug-resistance transcriptional regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						multidrug resistance (MDR); transcriptional regulator; TipA; autoinhibition; drug resistance; antibiotic resistance; transcription regulation; transcription promoter; DNA-binding protein; crystal structure; activation mechanism; structure biology	THIOSTREPTON-INDUCED GENE; STRUCTURAL BASIS; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; RECOGNITION; PROTEIN; ACTIVATION; MECHANISM; EXPRESSION; SEQUENCE	Investigations of bacterial resistance strategies can aid in the development of new antimicrobial drugs as a countermeasure to the increasing worldwide prevalence of bacterial antibiotic resistance. One such strategy involves the TipA class of transcription factors, which constitute minimal autoregulated multidrug resistance (MDR) systems against diverse antibiotics. However, we have insufficient information regarding how antibiotic binding induces transcriptional activation to design molecules that could interfere with this process. To learn more, we determined the crystal structure of SkgA from Caulobacter crescentus as a representative TipA protein. We identified an unexpected spatial orientation and location of the antibiotic-binding TipAS effector domain in the apo state. We observed that the alpha 6-alpha 7 region of the TipAS domain, which is canonically responsible for forming the lid of antibiotic-binding cleft to tightly enclose the bound antibiotic, is involved in the dimeric interface and stabilized via interaction with the DNA-binding domain in the apo state. Further structural and biochemical analyses demonstrated that the unliganded TipAS domain sterically hinders promoter DNA binding but undergoes a remarkable conformational shift upon antibiotic binding to release this autoinhibition via a switch of its alpha 6-alpha 7 region. Hence, the promoters for MDR genes including tipA and RNA polymerases become available for transcription, enabling efficient antibiotic resistance. These insights into the molecular mechanism of activation of TipA proteins advance our understanding of TipA proteins, as well as bacterial MDR systems, and may provide important clues to block bacterial resistance.	[Jiang, Xuguang; Zhang, Linjuan; Teng, Maikun; Li, Xu] Univ Sci & Technol China, Natl Synchrotron Radiat Lab, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China; [Jiang, Xuguang] Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo, Japan	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Tokyo	Jiang, XG; Li, X (corresponding author), Univ Sci & Technol China, Natl Synchrotron Radiat Lab, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China.; Jiang, XG (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo, Japan.	xgjiang@m.u-tokyo.ac.jp; sachem@ustc.edu.cn	Jiang, Xuguang/J-8345-2019	Jiang, Xuguang/0000-0001-7997-872X	Chinese National Natural Science Foundation [31971124, U1732114, 31770788, 31770895]; National Key Research and Development Program of China [2017YFA0503600]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by Chinese National Natural Science Foundation Grants 31971124, U1732114, 31770788, and 31770895 and National Key Research and Development Program of China Grant 2017YFA0503600.	Bachas S, 2011, P NATL ACAD SCI USA, V108, P11046, DOI 10.1073/pnas.1104850108; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baranova NN, 1999, MOL MICROBIOL, V31, P1549, DOI 10.1046/j.1365-2958.1999.01301.x; BARRINEAU P, 1984, Journal of Molecular and Applied Genetics, V2, P601; Chiu ML, 1996, BIOCHEMISTRY-US, V35, P2332, DOI 10.1021/bi952073e; Chiu ML, 2001, BIOCHEMISTRY-US, V40, P12950, DOI 10.1021/bi010328k; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Deng WY, 2013, CELL SIGNAL, V25, P1608, DOI 10.1016/j.cellsig.2013.04.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Godsey MH, 2001, J BIOL CHEM, V276, P47178, DOI 10.1074/jbc.M105819200; Habazettl J, 2014, P NATL ACAD SCI USA, V111, pE5498, DOI 10.1073/pnas.1412070111; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; HOLMES DJ, 1993, EMBO J, V12, P3183, DOI 10.1002/j.1460-2075.1993.tb05987.x; Jiang XG, 2020, FEBS J, V287, P2292, DOI 10.1111/febs.15138; Kahmann JD, 2003, EMBO J, V22, P1824, DOI 10.1093/emboj/cdg181; KELLEY SL, 1988, SCIENCE, V241, P1813, DOI 10.1126/science.3175622; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; MURAKAMI T, 1989, J BACTERIOL, V171, P1459, DOI 10.1128/jb.171.3.1459-1466.1989; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Myers CL, 2014, CHEMBIOCHEM, V15, P681, DOI 10.1002/cbic.201300724; Newberry KJ, 2004, J BIOL CHEM, V279, P20356, DOI 10.1074/jbc.M400960200; NEYFAKH AA, 1991, P NATL ACAD SCI USA, V88, P4781, DOI 10.1073/pnas.88.11.4781; Neyfakh AA, 2002, MOL MICROBIOL, V44, P1123, DOI 10.1046/j.1365-2958.2002.02965.x; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Paulsen IT, 2003, CURR OPIN MICROBIOL, V6, P446, DOI 10.1016/j.mib.2003.08.005; Rava PS, 1999, J BACTERIOL, V181, P6152, DOI 10.1128/JB.181.19.6152-6159.1999; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rostock L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05551-4; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Schumacher MA, 2002, MOL MICROBIOL, V45, P885, DOI 10.1046/j.1365-2958.2002.03039.x; Sikandar A, 2018, J AM CHEM SOC, V140, P16641, DOI 10.1021/jacs.8b08895; SUMMERS AO, 1992, J BACTERIOL, V174, P3097, DOI 10.1128/jb.174.10.3097-3101.1992; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wade H, 2010, CURR OPIN STRUC BIOL, V20, P489, DOI 10.1016/j.sbi.2010.06.003; Wang QS, 2018, NUCL SCI TECH, V29, DOI 10.1007/s41365-018-0398-9; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6; Zhu YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep23147	41	1	1	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17865	17876		10.1074/jbc.RA120.016295	http://dx.doi.org/10.1074/jbc.RA120.016295			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33093172	Green Published, hybrid			2022-12-26	WOS:000603272300036
J	Acquistapace, IM; Zietek, MA; Li, AWH; Salmon, M; Kuhn, I; Bedford, MR; Brearley, CA; Hemmings, AM				Acquistapace, Isabella M.; Zietek, Monika A.; Li, Arthur W. H.; Salmon, Melissa; Kuhn, Imke; Bedford, Mike R.; Brearley, Charles A.; Hemmings, Andrew M.			Snapshots during the catalytic cycle of a histidine acid phytase reveal an induced-fit structural mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phytase; cell surface protein; induced fit; enzyme mechanism; enzyme structure; crystallography; thermostabilization; stereospecificity; inositol phosphate; cell surface enzyme; enzyme mechanism; substrate specificity; enzyme mutation; structural biology; structure-function; induced fit; phytase; phytic acid; thermostabilization	INOSITOL-POLYPHOSPHATE PHOSPHATASE; MYOINOSITOL HEXAKISPHOSPHATE DEPHOSPHORYLATION; MULTIPLE SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURE; ENDOPLASMIC-RETICULUM; ASPERGILLUS-FUMIGATUS; DEGRADING ENZYME; COLI PHYTASE; ACTIVE-SITE; 1 MINPP1	Highly engineered phytases, which sequentially hydrolyze the hexakisphosphate ester of inositol known as phytic acid, are routinely added to the feeds of monogastric animals to improve phosphate bioavailability. New phytases are sought as starting points to further optimize the rate and extent of dephosphorylation of phytate in the animal digestive tract. Multiple inositol polyphosphate phosphatases (MINPPs) are clade 2 histidine phosphatases (HP2P) able to carry out the stepwise hydrolysis of phytate. MINPPs are not restricted by a strong positional specificity making them attractive targets for development as feed enzymes. Here, we describe the characterization of a MINPP from the Gram-positive bacterium Bifidobacterium longum (BlMINPP). BlMINPP has a typical HP2P-fold but, unusually, possesses a large alpha-domain polypeptide insertion relative to other MINPPs. This insertion, termed the U-loop, spans the active site and contributes to substrate specificity pockets underpopulated in other HP2Ps. Mutagenesis of U-loop residues reveals its contribution to enzyme kinetics and thermostability. Moreover, four crystal structures of the protein along the catalytic cycle capture, for the first time in an HP2P, a large ligand-driven alpha-domain motion essential to allow substrate access to the active site. This motion recruits residues both downstream of a molecular hinge and on the U-loop to participate in specificity subsites, and mutagenesis identified a mobile lysine residue as a key determinant of positional specificity of the enzyme. Taken together, these data provide important new insights to the factors determining stability, substrate recognition, and the structural mechanism of hydrolysis in this industrially important group of enzymes.	[Acquistapace, Isabella M.; Zietek, Monika A.; Li, Arthur W. H.; Salmon, Melissa; Brearley, Charles A.; Hemmings, Andrew M.] Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England; [Hemmings, Andrew M.] Univ East Anglia, Sch Chem, Norwich, Norfolk, England; [Kuhn, Imke] AB Vista, Darmstadt, Germany; [Bedford, Mike R.] AB Vista, Marlborough, Wilts, England	University of East Anglia; University of East Anglia	Hemmings, AM (corresponding author), Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England.; Hemmings, AM (corresponding author), Univ East Anglia, Sch Chem, Norwich, Norfolk, England.	a.hemmings@uea.ac.uk	Bedford, Michael/AAV-8204-2020; HEMMINGS, ANDREW MICHAEL/E-5517-2011	Bedford, Michael/0000-0002-5308-4290; HEMMINGS, ANDREW MICHAEL/0000-0003-3053-3134; Li, Arthur Wing Hang/0000-0003-4291-3900; Brearley, Charles/0000-0001-6179-9109; Acquistapace, Isabella Maria/0000-0002-5820-7683	Biotechnology and Biological Sciences Research Council; AB Vista Ltd. through IPA Award [BB/M022978/1]; joint UEA-AB Vista Ltd. Ph.D. studentships; BBSRC [BB/M022978/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AB Vista Ltd. through IPA Award; joint UEA-AB Vista Ltd. Ph.D. studentships; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council and AB Vista Ltd. through IPA Award BB/M022978/1 and joint UEA-AB Vista Ltd. Ph.D. studentships (to I. M. A. and M. Z.).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Tamayo-Ramos JA, 2012, APPL ENVIRON MICROB, V78, P5013, DOI 10.1128/AEM.00782-12; Arboleya S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01204; Ariza A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065062; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; BARRIENTOS L, 1994, PLANT PHYSIOL, V106, P1489, DOI 10.1104/pp.106.4.1489; Bohm K, 2010, FEBS J, V277, P1284, DOI 10.1111/j.1742-4658.2010.07559.x; Cheng YL, 2015, CELL REP, V13, P2174, DOI 10.1016/j.celrep.2015.10.071; Chi HB, 1999, GENOMICS, V56, P324, DOI 10.1006/geno.1998.5736; Cho J, 2008, P NATL ACAD SCI USA, V105, P5998, DOI 10.1073/pnas.0710980105; Cho J, 2006, J BIOTECHNOL, V126, P248, DOI 10.1016/j.jbiotec.2006.04.028; Craxton A, 1997, BIOCHEM J, V328, P75, DOI 10.1042/bj3280075; Dersjant-Li Y, 2015, J SCI FOOD AGR, V95, P878, DOI 10.1002/jsfa.6998; Dhatwalia R, 2015, ARCH BIOCHEM BIOPHYS, V585, P32, DOI 10.1016/j.abb.2015.09.010; Dror DK, 2018, ADV NUTR, V9, p278S, DOI 10.1093/advances/nmy022; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferranti P, 2004, J DAIRY RES, V71, P74, DOI 10.1017/S0022029903006599; Forsberg CW, 2013, TRANSGENIC RES, V22, P379, DOI 10.1007/s11248-012-9646-7; Goris J, 2001, INT J SYST EVOL MICR, V51, P1773, DOI 10.1099/00207713-51-5-1773; Greiner R, 2001, J AGR FOOD CHEM, V49, P2228, DOI 10.1021/jf0100090; Greiner R, 2000, J BIOTECHNOL, V84, P53, DOI 10.1016/S0168-1656(00)00331-X; Humer E, 2015, J ANIM PHYSIOL AN N, V99, P605, DOI 10.1111/jpn.12258; Indyk HE, 2016, INT DAIRY J, V56, P33, DOI 10.1016/j.idairyj.2016.01.002; Irving G. C. J., 1980, INOSITOL PHOSPHATES, P99; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kilaparty SP, 2016, CELL STRESS CHAPERON, V21, P593, DOI 10.1007/s12192-016-0684-6; Kilaparty SP, 2014, EVOL BIOINFORM, V10, P239, DOI 10.4137/EBO.S18948; Kostrewa D, 1999, J MOL BIOL, V288, P965, DOI 10.1006/jmbi.1999.2736; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lei XG, 2013, ANNU REV ANIM BIOSCI, V1, P283, DOI 10.1146/annurev-animal-031412-103717; LENSTRUP EINAR, 1926, JOUR BIOL CHEM, V70, P193; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Lim D, 2000, NAT STRUCT BIOL, V7, P108; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Liu O, 2004, STRUCTURE, V12, P1575, DOI 10.1016/j.str.2004.06.015; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Ma XF, 2012, MOL BREEDING, V30, P377, DOI 10.1007/s11032-011-9628-0; Mallin MA, 2020, BIOSCIENCE, V70, P315, DOI 10.1093/biosci/biaa001; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Menezes-Blackburn D, 2015, J AGR FOOD CHEM, V63, P6142, DOI 10.1021/acs.jafc.5b01996; Nagul EA, 2015, ANAL CHIM ACTA, V890, P60, DOI 10.1016/j.aca.2015.07.030; NOGIMORI K, 1991, J BIOL CHEM, V266, P16499; Oakley AJ, 2010, BIOCHEM BIOPH RES CO, V397, P745, DOI 10.1016/j.bbrc.2010.06.024; Oh BC, 2004, APPL MICROBIOL BIOT, V63, P362, DOI 10.1007/s00253-003-1345-0; Ortlund E, 2003, BIOCHEMISTRY-US, V42, P383, DOI 10.1021/bi0265067; OSTANIN K, 1993, J BIOL CHEM, V268, P20778; OSTANIN K, 1992, J BIOL CHEM, V267, P22830; Prenafeta-Boldu FX, 2012, FEMS MICROBIOL ECOL, V80, P722, DOI 10.1111/j.1574-6941.2012.01344.x; Qi GY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-13; Ragon M, 2009, ACTA CRYSTALLOGR F, V65, P321, DOI 10.1107/S1744309109008653; Ragon M, 2008, APPL MICROBIOL BIOT, V78, P47, DOI 10.1007/s00253-007-1275-3; Riedel K., 2011, ENCY GEOBIOLOGY, P355, DOI [10.1007/978-1-4020-9212-1_85, DOI 10.1007/978-1-4020-9212-1_85]; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Romano N., 2018, Enzymes in human and animal nutrition, P73; Romano PR, 1998, J CELL SCI, V111, P803; Sanchez-Romero I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070013; Satola B, 2013, APPL MICROBIOL BIOT, V97, P541, DOI 10.1007/s00253-012-4585-z; Schippers A, 2005, INT J SYST EVOL MICR, V55, P655, DOI 10.1099/ijs.0.63305-0; Shivange A.V., 2017, DIRECTED ENZYME EVOL, P145, DOI [10.1007/978-3-319-50413-16, DOI 10.1007/978-3-319-50413-16, DOI 10.1007/978-3-319-50413-1_6]; Stentz R, 2014, CELL REP, V6, P646, DOI 10.1016/j.celrep.2014.01.021; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Underwood MA, 2015, PEDIATR RES, V77, P229, DOI 10.1038/pr.2014.156; VANETTEN RL, 1991, J BIOL CHEM, V266, P2313; VANETTEN RL, 1982, ANN NY ACAD SCI, V390, P27; Wang YL, 2006, J BIOL CHEM, V281, P39642, DOI 10.1074/jbc.M606421200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Windhorst S, 2013, BIOCHEM J, V450, P115, DOI 10.1042/BJ20121524; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wyss M, 1999, APPL ENVIRON MICROB, V65, P367; Xiang T, 2004, J MOL BIOL, V339, P437, DOI 10.1016/j.jmb.2004.03.057; Yao MZ, 2012, J APPL MICROBIOL, V112, P1, DOI 10.1111/j.1365-2672.2011.05181.x; Yu J, 2003, J BIOL CHEM, V278, P46210, DOI 10.1074/jbc.M303743200; Zhao YF, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9010132	74	4	4	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17724	17737		10.1074/jbc.RA120.015925	http://dx.doi.org/10.1074/jbc.RA120.015925			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33055237	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000603272300026
J	Karlsson, E; Paissoni, C; Erkelens, AM; Tehranizadeh, ZA; Sorgenfrei, FA; Andersson, E; Ye, WH; Camilloni, C; Jemth, P				Karlsson, Elin; Paissoni, Cristina; Erkelens, Amanda M.; Tehranizadeh, Zeinab A.; Sorgenfrei, Frieda A.; Andersson, Eva; Ye, Weihua; Camilloni, Carlo; Jemth, Per			Mapping the transition state for a binding reaction between ancient intrinsically disordered proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intrinsically disordered proteins; phi value analysis; transition state; protein evolution; coupled binding and folding; protein folding; pre-steady-state kinetics; protein complex; IDP; protein binding	DOMAIN; COACTIVATOR; DYNAMICS; COMPLEX; MODEL; KIX; CBP; ASSOCIATION; INTERFACE; MECHANISM	Intrinsically disordered protein domains often have multiple binding partners. It is plausible that the strength of pairing with specific partners evolves from an initial low affinity to a higher affinity. However, little is known about the molecular changes in the binding mechanism that would facilitate such a transition. We previously showed that the interaction between two intrinsically disordered domains, NCBD and CID, likely emerged in an ancestral deuterostome organism as a low-affinity interaction that subsequently evolved into a higher-affinity interaction before the radiation of modern vertebrate groups. Here we map native contacts in the transition states of the low-affinity ancestral and high-affinity human NCBD/CID interactions. We show that the coupled binding and folding mechanism is overall similar but with a higher degree of native hydrophobic contact formation in the transition state of the ancestral complex and more heterogeneous transient interactions, including electrostatic pairings, and an increased disorder for the human complex. Adaptation to new binding partners may be facilitated by this ability to exploit multiple alternative transient interactions while retaining the overall binding and folding pathway.	[Karlsson, Elin; Erkelens, Amanda M.; Tehranizadeh, Zeinab A.; Sorgenfrei, Frieda A.; Andersson, Eva; Ye, Weihua; Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Paissoni, Cristina; Camilloni, Carlo] Univ Milan, Dipartimento Biosci, Milan, Italy; [Tehranizadeh, Zeinab A.] Mashhad Univ Med Sci, Sch Pharm, Dept Med Chem, Mashhad, Razavi Khorasan, Iran; [Erkelens, Amanda M.] Leiden Univ, Dept Chem, Leiden, Netherlands; [Sorgenfrei, Frieda A.] Karl Franzens Univ Graz, Inst Organ & Bioorgan Chem, Dept Chem, Heinrichstr, Graz, Austria	Uppsala University; University of Milan; Mashhad University Medical Science; Leiden University; Leiden University - Excl LUMC; University of Graz	Jemth, P (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.; Camilloni, C (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	carlo.camilloni@unimi.it; PerJemth@imbim.uu.se	Camilloni, Carlo/A-4395-2009; Paissoni, Cristina/AAH-3181-2020	Camilloni, Carlo/0000-0002-9923-8590; Paissoni, Cristina/0000-0002-3101-6705; Sorgenfrei, Frieda A./0000-0002-0690-7848; Karlsson, Elin/0000-0001-5526-4968; Erkelens, Amanda M/0000-0001-9369-5814; Jemth, Per/0000-0003-1516-7228	Swedish Research Council [2016-04134]; Knut and Alice Wallenberg Foundation (evolution of new genes and proteins); Department of Chemistry - BMC; Disciplinary Domain of Medicine and Pharmacy; CINECA under the ISCRA initiative	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation (evolution of new genes and proteins); Department of Chemistry - BMC; Disciplinary Domain of Medicine and Pharmacy; CINECA under the ISCRA initiative(CINECA, Italy)	This work was funded by the Swedish Research Council Grant 2016-04134 (to P. J.) and the Knut and Alice Wallenberg Foundation (evolution of new genes and proteins) (to P. J.). We used the NMR Uppsala infrastructure, which is funded by the Department of Chemistry - BMC and the Disciplinary Domain of Medicine and Pharmacy. C. C. acknowledges CINECA for an award under the ISCRA initiative, for the availability of high-performance computing resources and support.	Abascal JLF, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121687; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; [Anonymous], PYMOL MOL GRAPH SYST; Anthis NJ, 2013, PROTEIN SCI, V22, P851, DOI 10.1002/pro.2253; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Best RB, 2010, J PHYS CHEM B, V114, P14916, DOI 10.1021/jp108618d; Bokhovchuk F, 2020, BIOCHEMISTRY-US, V59, P1804, DOI 10.1021/acs.biochem.0c00217; Bonetti D, 2018, BIOPHYS J, V114, P1889, DOI 10.1016/j.bpj.2018.03.017; Bonomi M, 2019, NAT METHODS, V16, P670, DOI 10.1038/s41592-019-0506-8; Brown CJ, 2010, MOL BIOL EVOL, V27, P609, DOI 10.1093/molbev/msp277; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Camilloni C, 2016, SCI REP-UK, V6, DOI 10.1038/srep28285; Campbell E, 2016, NAT CHEM BIOL, V12, P944, DOI [10.1038/NCHEMBIO.2175, 10.1038/nchembio.2175]; Crabtree MD, 2018, J BIOL CHEM, V293, P9718, DOI 10.1074/jbc.RA118.002791; Dahal L, 2017, BIOPHYS J, V113, P2713, DOI 10.1016/j.bpj.2017.10.016; Demarest SJ, 2004, PROTEIN SCI, V13, P203, DOI 10.1110/ps.03366504; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Dogan J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02076; Dogan J, 2012, J BIOL CHEM, V287, P34316, DOI 10.1074/jbc.M112.399436; Dyson HJ, 2016, J BIOL CHEM, V291, P6714, DOI 10.1074/jbc.R115.692020; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ebert MO, 2008, BIOCHEMISTRY-US, V47, P1299, DOI 10.1021/bi701767j; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; FERSHT AR, 1994, P NATL ACAD SCI USA, V91, P10426, DOI 10.1073/pnas.91.22.10426; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Gianni S, 2014, BIOPHYS CHEM, V189, P33, DOI 10.1016/j.bpc.2014.03.003; Giri R, 2013, P NATL ACAD SCI USA, V110, P14942, DOI 10.1073/pnas.1307337110; Haq SR, 2012, J AM CHEM SOC, V134, P599, DOI 10.1021/ja209341w; Harman JL, 2020, ELIFE, V9, DOI 10.7554/eLife.54100; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hiscott J, 2005, STRUCTURE, V13, P1235, DOI 10.1016/j.str.2005.08.001; Hultqvist G, 2017, ELIFE, V6, DOI 10.7554/eLife.16059; Iesmantavicius V, 2014, ANGEW CHEM INT EDIT, V53, P1548, DOI 10.1002/anie.201307712; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Jemth P, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau4130; Jemth P, 2014, J BIOL CHEM, V289, P5528, DOI 10.1074/jbc.M113.537068; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karlsson E, 2019, BIOPHYS J, V117, P729, DOI 10.1016/j.bpj.2019.07.014; Karlsson E, 2020, PROTEIN SCI, V29, P1687, DOI 10.1002/pro.3868; Karlsson E, 2019, J BIOL CHEM, V294, P1230, DOI 10.1074/jbc.RA118.005854; Karlsson OA, 2012, J MOL BIOL, V417, P253, DOI 10.1016/j.jmb.2012.01.042; KARPLUS M, 1994, PROTEIN SCI, V3, P650; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lindstrom I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26213-x; Lindstrom I, 2017, BIOCHEMISTRY-US, V56, P4145, DOI 10.1021/acs.biochem.7b00428; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; Paci E, 2002, J MOL BIOL, V324, P151, DOI 10.1016/S0022-2836(02)00944-0; Pancsa R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113315; Pillai AS, 2020, NATURE, V581, P480, DOI 10.1038/s41586-020-2292-y; Qin BY, 2005, STRUCTURE, V13, P1269, DOI 10.1016/j.str.2005.06.011; Rogers JM, 2014, P NATL ACAD SCI USA, V111, P15420, DOI 10.1073/pnas.1409122111; Rouet R, 2017, P NATL ACAD SCI USA, V114, P3897, DOI 10.1073/pnas.1613477114; Sato S, 2006, J MOL BIOL, V360, P850, DOI 10.1016/j.jmb.2006.05.051; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; Stiffler MA, 2015, CELL, V160, P882, DOI 10.1016/j.cell.2015.01.035; Sturzenegger F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07043-x; Tantos A, 2012, MOL CELL ENDOCRINOL, V348, P457, DOI 10.1016/j.mce.2011.07.015; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Toto A, 2020, J BIOL CHEM, V295, P6586, DOI 10.1074/jbc.REV120.012413; Toto A, 2019, ARCH BIOCHEM BIOPHYS, V671, P255, DOI 10.1016/j.abb.2019.07.011; Toto A, 2016, BIOCHEMISTRY-US, V55, P3957, DOI 10.1021/acs.biochem.6b00505; Toto A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21994; Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Nguyen V, 2017, SCIENCE, V355, P289, DOI 10.1126/science.aah3717; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wu D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42717-6; Xia Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000413; Yang J, 2019, PROTEIN SCI, V28, P1952, DOI 10.1002/pro.3718; Zosel F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05725-0	78	6	6	3	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17698	17712		10.1074/jbc.RA120.015645	http://dx.doi.org/10.1074/jbc.RA120.015645			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33067355	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000603272300024
